Citrus Sinensis ID: 036739
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 323 | 2.2.26 [Sep-21-2011] | |||||||
| P93101 | 294 | Cell division control pro | N/A | no | 0.910 | 1.0 | 0.835 | 1e-156 | |
| Q38772 | 294 | Cell division control pro | N/A | no | 0.910 | 1.0 | 0.823 | 1e-155 | |
| Q41639 | 294 | Cell division control pro | N/A | no | 0.910 | 1.0 | 0.801 | 1e-150 | |
| P24923 | 291 | Cell division control pro | N/A | no | 0.897 | 0.996 | 0.799 | 1e-148 | |
| Q05006 | 294 | Cell division control pro | N/A | no | 0.910 | 1.0 | 0.795 | 1e-147 | |
| P29618 | 294 | Cyclin-dependent kinase A | yes | no | 0.907 | 0.996 | 0.773 | 1e-146 | |
| P24100 | 294 | Cyclin-dependent kinase A | yes | no | 0.910 | 1.0 | 0.773 | 1e-145 | |
| P23111 | 294 | Cell division control pro | N/A | no | 0.907 | 0.996 | 0.773 | 1e-145 | |
| P52389 | 294 | Cell division control pro | N/A | no | 0.910 | 1.0 | 0.789 | 1e-143 | |
| P29619 | 292 | Cyclin-dependent kinase A | no | no | 0.897 | 0.993 | 0.768 | 1e-141 |
| >sp|P93101|CDC2_CHERU Cell division control protein 2 homolog OS=Chenopodium rubrum GN=CDC2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 552 bits (1423), Expect = e-156, Method: Compositional matrix adjust.
Identities = 270/323 (83%), Positives = 285/323 (88%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MDQYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDSCPDFA DPR+IK FLYQILRGIAYCHS
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPDFAKDPRMIKRFLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDR+TNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRQTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ+PLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQKPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFR LGTPNE+TWPGVTSLPDFKS+FPKW SK+L VV NL+PAGIDLL+KMLC+D
Sbjct: 212 ELFKIFRTLGTPNEETWPGVTSLPDFKSSFPKWISKDLSAVVPNLDPAGIDLLNKMLCLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
PS+RITAR+ALEHEYF+D+ FVP
Sbjct: 272 PSKRITARNALEHEYFKDIGFVP 294
|
Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II. Chenopodium rubrum (taxid: 3560) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3 |
| >sp|Q38772|CDC2A_ANTMA Cell division control protein 2 homolog A OS=Antirrhinum majus GN=CDC2A PE=2 SV=2 | Back alignment and function description |
|---|
Score = 546 bits (1408), Expect = e-155, Method: Compositional matrix adjust.
Identities = 266/323 (82%), Positives = 284/323 (87%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+QYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MEQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDSCP+F+ DPRL+K FLYQILRGIAYCHS
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPEFSQDPRLVKMFLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFRV+GTPNE+TWPGVTSLPDFKSAFPKWP+KEL VV NL+ +G+DLL KML +D
Sbjct: 212 ELFKIFRVMGTPNEETWPGVTSLPDFKSAFPKWPAKELAAVVPNLDASGLDLLDKMLRLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
PS+RITAR+AL+HEYF+D+ FVP
Sbjct: 272 PSKRITARNALQHEYFKDIGFVP 294
|
Plays a key role in the control of the eukaryotic cell cycle. Antirrhinum majus (taxid: 4151) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q41639|CDC2_VIGAC Cell division control protein 2 homolog OS=Vigna aconitifolia GN=CDC2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 530 bits (1366), Expect = e-150, Method: Compositional matrix adjust.
Identities = 259/323 (80%), Positives = 279/323 (86%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+QYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MEQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDS P+F DPR +K FLYQIL GIAYCHS
Sbjct: 61 RNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPEFVKDPRQVKMFLYQILCGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTN+LKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN+RPLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNRRPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFR+LGTPNE+TWPGVT+LPDFKS FPKWP K+L TVV NL+ AG++LLS MLC+D
Sbjct: 212 ELFKIFRILGTPNEETWPGVTALPDFKSTFPKWPPKDLATVVPNLDAAGLNLLSSMLCLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
PS+RITAR A+EHEYF+D++FVP
Sbjct: 272 PSKRITARIAVEHEYFKDIKFVP 294
|
Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II. Vigna aconitifolia (taxid: 3918) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|P24923|CDC21_MEDSA Cell division control protein 2 homolog 1 (Fragment) OS=Medicago sativa GN=CDC2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 523 bits (1348), Expect = e-148, Method: Compositional matrix adjust.
Identities = 255/319 (79%), Positives = 275/319 (86%), Gaps = 29/319 (9%)
Query: 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
E VEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH NIV
Sbjct: 2 ENVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHRNIV 61
Query: 65 RLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVL 124
RLQDVVHS+K+LYLVFEYLDLDLKKHMDS P+F DPR +K FLYQ+L GIAYCHSHRVL
Sbjct: 62 RLQDVVHSDKRLYLVFEYLDLDLKKHMDSSPEFIKDPRQVKMFLYQMLCGIAYCHSHRVL 121
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAG 184
HRDLKPQNLLIDRRTN+LKLADFGLARAFGIPVRTFTHE
Sbjct: 122 HRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHE--------------------- 160
Query: 185 SLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM N+RPL PGDSEIDELFK
Sbjct: 161 --------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMANRRPLSPGDSEIDELFK 212
Query: 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRR 304
IFR+LGTPNEDTWPGVTSLPDFKS FP+WPSK+L TVV NLEPAG+DLL+ MLC+DP++R
Sbjct: 213 IFRILGTPNEDTWPGVTSLPDFKSTFPRWPSKDLATVVPNLEPAGLDLLNSMLCLDPTKR 272
Query: 305 ITARSALEHEYFRDVEFVP 323
ITARSA+EHEYF+D++FVP
Sbjct: 273 ITARSAVEHEYFKDIKFVP 291
|
Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II. Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q05006|CDC22_MEDSA Cell division control protein 2 homolog 2 OS=Medicago sativa GN=CDC2B PE=2 SV=1 | Back alignment and function description |
|---|
Score = 521 bits (1343), Expect = e-147, Method: Compositional matrix adjust.
Identities = 257/323 (79%), Positives = 274/323 (84%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+QYEKVEKIGEGTYGVVYKAR+ TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MEQYEKVEKIGEGTYGVVYKARDRATNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIVRLQDVVHSEK+LYLVFEYLDLDLKK MDS P+FA D R IK FLYQIL GIAYCHS
Sbjct: 61 RNIVRLQDVVHSEKRLYLVFEYLDLDLKKFMDSSPEFAKDQRQIKMFLYQILCGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDR +NA+KLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRSSNAVKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM+NQRPLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMINQRPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFR+ GTPNE+TWPGVTSLPDFKSAFPKWP+K+L T V NLEPAG+DLLS +D
Sbjct: 212 ELFKIFRITGTPNEETWPGVTSLPDFKSAFPKWPAKDLATQVPNLEPAGLDLLSSTCRLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
P+RRITAR ALEHEYF+D++FVP
Sbjct: 272 PTRRITARGALEHEYFKDIKFVP 294
|
Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II. Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P29618|CDKA1_ORYSJ Cyclin-dependent kinase A-1 OS=Oryza sativa subsp. japonica GN=CDKA-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 516 bits (1329), Expect = e-146, Method: Compositional matrix adjust.
Identities = 249/322 (77%), Positives = 276/322 (85%), Gaps = 29/322 (9%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+QYEK EKIGEGTYGVVY+AR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEM H
Sbjct: 1 MEQYEKEEKIGEGTYGVVYRARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMHH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRL DV+HSEK++YLVFEYLDLDLKK MDSCP+FA +P LIK++LYQILRG+AYCHS
Sbjct: 61 GNIVRLHDVIHSEKRIYLVFEYLDLDLKKFMDSCPEFAKNPTLIKSYLYQILRGVAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSR YSTPVD+WSVGCIFAEMVNQ+PLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRQYSTPVDMWSVGCIFAEMVNQKPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFRVLGTPNE +WPGV+SLPD+KSAFPKW +++L T+V L+PAG+DLLSKML +
Sbjct: 212 ELFKIFRVLGTPNEQSWPGVSSLPDYKSAFPKWQAQDLATIVPTLDPAGLDLLSKMLRYE 271
Query: 301 PSRRITARSALEHEYFRDVEFV 322
P++RITAR ALEHEYF+D+E V
Sbjct: 272 PNKRITARQALEHEYFKDLEMV 293
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|P24100|CDKA1_ARATH Cyclin-dependent kinase A-1 OS=Arabidopsis thaliana GN=CDKA-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 513 bits (1321), Expect = e-145, Method: Compositional matrix adjust.
Identities = 250/323 (77%), Positives = 274/323 (84%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MDQYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV+LQDVVHSEK+LYLVFEYLDLDLKKHMDS PDF+ D +IKT+LYQILRGIAYCHS
Sbjct: 61 SNIVKLQDVVHSEKRLYLVFEYLDLDLKKHMDSTPDFSKDLHMIKTYLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTN+LKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGS HYSTPVD+WSVGCIFAEM++Q+PLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSHHYSTPVDIWSVGCIFAEMISQKPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
+LFKIFR++GTP EDTW GVTSLPD+KSAFPKW +L T V NL+P G+DLLSKML MD
Sbjct: 212 QLFKIFRIMGTPYEDTWRGVTSLPDYKSAFPKWKPTDLETFVPNLDPDGVDLLSKMLLMD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
P++RI AR+ALEHEYF+D+ +P
Sbjct: 272 PTKRINARAALEHEYFKDLGGMP 294
|
Involved in the control of the cell cycle. Essential for both G1/S and G2/M (mitosis) phase transitions. Functions in cell morphogenesis as well as cell proliferation. Required for cell division (entry into mitosis) of the generative cell in male gametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|P23111|CDC2_MAIZE Cell division control protein 2 homolog OS=Zea mays GN=CDC2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 513 bits (1321), Expect = e-145, Method: Compositional matrix adjust.
Identities = 249/322 (77%), Positives = 274/322 (85%), Gaps = 29/322 (9%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+QYEKVEKIGEGTYGVVYKA + TNETIALKKIRLEQEDEGVPSTAIREISLLKEM H
Sbjct: 1 MEQYEKVEKIGEGTYGVVYKALDKATNETIALKKIRLEQEDEGVPSTAIREISLLKEMNH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRL DVVHSEK++YLVFEYLDLDLKK MDSCP+FA +P LIK++LYQIL G+AYCHS
Sbjct: 61 GNIVRLHDVVHSEKRIYLVFEYLDLDLKKFMDSCPEFAKNPTLIKSYLYQILHGVAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLG+R YSTPVDVWSVGCIFAEMVNQ+PLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGARQYSTPVDVWSVGCIFAEMVNQKPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFR+LGTPNE +WPGV+ LPDFK+AFP+W +++L TVV NL+PAG+DLLSKML +
Sbjct: 212 ELFKIFRILGTPNEQSWPGVSCLPDFKTAFPRWQAQDLATVVPNLDPAGLDLLSKMLRYE 271
Query: 301 PSRRITARSALEHEYFRDVEFV 322
PS+RITAR ALEHEYF+D+E V
Sbjct: 272 PSKRITARQALEHEYFKDLEVV 293
|
Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|P52389|CDC2_VIGUN Cell division control protein 2 homolog OS=Vigna unguiculata GN=CDC2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 508 bits (1308), Expect = e-143, Method: Compositional matrix adjust.
Identities = 255/323 (78%), Positives = 278/323 (86%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+QYEKVEKIGEGTYGVVYKAR+ VT+ETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MEQYEKVEKIGEGTYGVVYKARDRVTDETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDS P+F DPR +K FLYQIL GIAYCHS
Sbjct: 61 RNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPEFVKDPRQVKMFLYQILCGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTN+LKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGC+FAEMVN+RPLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCLFAEMVNRRPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFR+LGTPNE+TWPGVT+LPDFKS FPKWP K+L T+V NL+ AG++LLS ML +D
Sbjct: 212 ELFKIFRILGTPNEETWPGVTALPDFKSTFPKWPPKDLATMVPNLDAAGLNLLSSMLSLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
PS+RITAR A+EHEYF+D++FVP
Sbjct: 272 PSKRITARIAVEHEYFKDIKFVP 294
|
Plays a key role in the control of the eukaryotic cell cycle. Component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II. Vigna unguiculata (taxid: 3917) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|P29619|CDKA2_ORYSJ Cyclin-dependent kinase A-2 OS=Oryza sativa subsp. japonica GN=CDKA-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 501 bits (1290), Expect = e-141, Method: Compositional matrix adjust.
Identities = 246/320 (76%), Positives = 270/320 (84%), Gaps = 30/320 (9%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+QYEKVEKIGEGTYGVVYK ++ TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MEQYEKVEKIGEGTYGVVYKGKHRHTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIVRLQDVVH EK +YLVFEYLDLDLKKHMDS PDF N R++K+FLYQILRGIAYCHS
Sbjct: 61 RNIVRLQDVVHKEKCIYLVFEYLDLDLKKHMDSSPDFKNH-RIVKSFLYQILRGIAYCHS 119
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTN+LKLADFGLARAFGIPVRTFTHE
Sbjct: 120 HRVLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHE----------------- 162
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLG+RHYSTPVD+WSVGCIFAEMVNQ+PLFPGDSEID
Sbjct: 163 ------------VVTLWYRAPEILLGARHYSTPVDMWSVGCIFAEMVNQKPLFPGDSEID 210
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIF ++GTPNE+TWPGV SLPD+ S FPKWPS +L TVV L+ +G+DLLSKML +D
Sbjct: 211 ELFKIFSIMGTPNEETWPGVASLPDYISTFPKWPSVDLATVVPTLDSSGLDLLSKMLRLD 270
Query: 301 PSRRITARSALEHEYFRDVE 320
PS+RI AR+ALEHEYF+D+E
Sbjct: 271 PSKRINARAALEHEYFKDLE 290
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 323 | ||||||
| 8671339 | 294 | cdc2Pnc [Pinus contorta] | 0.910 | 1.0 | 0.845 | 1e-156 | |
| 224080065 | 294 | hypothetical protein POPTRDRAFT_648419 [ | 0.910 | 1.0 | 0.845 | 1e-156 | |
| 89111297 | 294 | cyclin dependent kinase A [Camellia sine | 0.910 | 1.0 | 0.845 | 1e-156 | |
| 359489125 | 294 | PREDICTED: cell division control protein | 0.910 | 1.0 | 0.857 | 1e-156 | |
| 454980 | 294 | cdc2Pa [Picea abies] gi|116778762|gb|ABK | 0.910 | 1.0 | 0.845 | 1e-156 | |
| 13249052 | 294 | CDC2 homolog [Populus tremula x Populus | 0.910 | 1.0 | 0.842 | 1e-155 | |
| 319439585 | 294 | cyclin dependent kinase A [Cucurbita max | 0.910 | 1.0 | 0.842 | 1e-155 | |
| 118483833 | 294 | unknown [Populus trichocarpa] | 0.910 | 1.0 | 0.842 | 1e-155 | |
| 1196796 | 294 | protein kinase p34cdc2 [Petroselinum cri | 0.910 | 1.0 | 0.845 | 1e-155 | |
| 350539219 | 294 | cyclin-dependent protein kinase p34cdc2 | 0.910 | 1.0 | 0.839 | 1e-155 |
| >gi|8671339|emb|CAA56815.2| cdc2Pnc [Pinus contorta] | Back alignment and taxonomy information |
|---|
Score = 558 bits (1438), Expect = e-156, Method: Compositional matrix adjust.
Identities = 273/323 (84%), Positives = 287/323 (88%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+QYEKVEKIGEGTYGVVYKAR+ +TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MEQYEKVEKIGEGTYGVVYKARDRLTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDSCP+ A DPRLIKTFLYQILRGIAYCHS
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPELAKDPRLIKTFLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDR+TNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRKTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFRVLGTPNE+TWPGVTSLPDFKSAFPKWP+K+L TVV LEPAGID+LSKMLC++
Sbjct: 212 ELFKIFRVLGTPNEETWPGVTSLPDFKSAFPKWPAKDLATVVSGLEPAGIDILSKMLCLE 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
PSRRITARSALEHEYF+D+ FVP
Sbjct: 272 PSRRITARSALEHEYFKDLGFVP 294
|
Source: Pinus contorta Species: Pinus contorta Genus: Pinus Family: Pinaceae Order: Coniferales Class: Coniferopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224080065|ref|XP_002306004.1| hypothetical protein POPTRDRAFT_648419 [Populus trichocarpa] gi|222848968|gb|EEE86515.1| hypothetical protein POPTRDRAFT_648419 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 557 bits (1436), Expect = e-156, Method: Compositional matrix adjust.
Identities = 273/323 (84%), Positives = 286/323 (88%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MDQYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDS P+FANDPRL+KTFLYQILRGIAYCHS
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPEFANDPRLVKTFLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ+PLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQKPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFR+LGTPNEDTWPGVTSLPDFKSAFPKWPSK+L TVV LE AG+DLLSKML +D
Sbjct: 212 ELFKIFRILGTPNEDTWPGVTSLPDFKSAFPKWPSKDLATVVPTLEKAGVDLLSKMLFLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
P++RITARSALEHEYF+D+ FVP
Sbjct: 272 PTKRITARSALEHEYFKDIGFVP 294
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|89111297|dbj|BAE80323.1| cyclin dependent kinase A [Camellia sinensis] | Back alignment and taxonomy information |
|---|
Score = 557 bits (1435), Expect = e-156, Method: Compositional matrix adjust.
Identities = 273/323 (84%), Positives = 286/323 (88%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+QYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEM+H
Sbjct: 1 MEQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMKH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GN+VRLQDVVHSEK+LYLVFEYLDLDLKKHMDSCP+F+ DPRLIK FLYQILRGIAYCHS
Sbjct: 61 GNVVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPEFSKDPRLIKMFLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFR+LGTPNEDTWPGVTSL DFKSAFPKWPSK+L TVV NL+ AGIDLLSKMLC+D
Sbjct: 212 ELFKIFRILGTPNEDTWPGVTSLADFKSAFPKWPSKDLATVVPNLDSAGIDLLSKMLCLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
PSRRITARSALEHEYF+D+ FVP
Sbjct: 272 PSRRITARSALEHEYFKDIGFVP 294
|
Source: Camellia sinensis Species: Camellia sinensis Genus: Camellia Family: Theaceae Order: Ericales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489125|ref|XP_002266125.2| PREDICTED: cell division control protein 2 homolog [Vitis vinifera] gi|297744790|emb|CBI38058.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 557 bits (1435), Expect = e-156, Method: Compositional matrix adjust.
Identities = 277/323 (85%), Positives = 284/323 (87%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MDQYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDS PDFA D RLIK FL+QILRGIAYCHS
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKDLRLIKMFLHQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWP K+L TVV NLE AGIDLLSKMLC+D
Sbjct: 212 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPPKDLATVVPNLESAGIDLLSKMLCLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
PSRRITARSALEHEYF+D+ FVP
Sbjct: 272 PSRRITARSALEHEYFKDIGFVP 294
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|454980|emb|CAA54746.1| cdc2Pa [Picea abies] gi|116778762|gb|ABK20983.1| unknown [Picea sitchensis] | Back alignment and taxonomy information |
|---|
Score = 557 bits (1435), Expect = e-156, Method: Compositional matrix adjust.
Identities = 273/323 (84%), Positives = 287/323 (88%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+QYEKVEKIGEGTYGVVYKAR+ +TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MEQYEKVEKIGEGTYGVVYKARDRLTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDSCP+ A DPRLIKTFLYQILRGIAYCHS
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPELAKDPRLIKTFLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDR+TNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRKTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFRVLGTPNE+TWPGVTSLPDFKSAFPKWP+K+L TVV LEPAGIDLLSKMLC++
Sbjct: 212 ELFKIFRVLGTPNEETWPGVTSLPDFKSAFPKWPAKDLATVVPGLEPAGIDLLSKMLCLE 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
PS+RITARSALEHEYF+D+ FVP
Sbjct: 272 PSKRITARSALEHEYFKDLGFVP 294
|
Source: Picea abies Species: Picea abies Genus: Picea Family: Pinaceae Order: Coniferales Class: Coniferopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|13249052|gb|AAK16652.1| CDC2 homolog [Populus tremula x Populus tremuloides] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1429), Expect = e-155, Method: Compositional matrix adjust.
Identities = 272/323 (84%), Positives = 285/323 (88%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MDQYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDS P+FA DPRL+KTFLYQILRGIAYCHS
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPEFAKDPRLVKTFLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ+PLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQKPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFR+LGTPNEDTWPGVTSLPDFKSAFPKWPSK+L TVV LE AG+DLLSKML +D
Sbjct: 212 ELFKIFRILGTPNEDTWPGVTSLPDFKSAFPKWPSKDLATVVPTLEKAGVDLLSKMLFLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
P++RITARSALEHEYF+D+ FVP
Sbjct: 272 PTKRITARSALEHEYFKDIGFVP 294
|
Source: Populus tremula x Populus tremuloides Species: Populus tremula x Populus tremuloides Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|319439585|emb|CBJ18166.1| cyclin dependent kinase A [Cucurbita maxima] | Back alignment and taxonomy information |
|---|
Score = 554 bits (1428), Expect = e-155, Method: Compositional matrix adjust.
Identities = 272/323 (84%), Positives = 285/323 (88%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+QYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MEQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDS P+FA DPR +K FLYQILRGIAYCHS
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPEFAKDPRQVKRFLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFRVLGTPNED+WPGVTSLPDFKSAFPKWPSK+L +VV NLE AGIDLLSKMLC+D
Sbjct: 212 ELFKIFRVLGTPNEDSWPGVTSLPDFKSAFPKWPSKDLASVVPNLESAGIDLLSKMLCLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
P++R+TARSALEHEYF+DV FVP
Sbjct: 272 PTKRVTARSALEHEYFKDVGFVP 294
|
Source: Cucurbita maxima Species: Cucurbita maxima Genus: Cucurbita Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|118483833|gb|ABK93808.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 554 bits (1428), Expect = e-155, Method: Compositional matrix adjust.
Identities = 272/323 (84%), Positives = 285/323 (88%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M QYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MGQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDS P+FANDPRL+KTFLYQILRGIAYCHS
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPEFANDPRLVKTFLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ+PLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQKPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFR+LGTPNEDTWPGVTSLPDFKSAFPKWPSK+L TVV LE AG+DLLSKML +D
Sbjct: 212 ELFKIFRILGTPNEDTWPGVTSLPDFKSAFPKWPSKDLATVVPTLEKAGVDLLSKMLFLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
P++RITARSALEHEYF+D+ FVP
Sbjct: 272 PTKRITARSALEHEYFKDIGFVP 294
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1196796|gb|AAC41680.1| protein kinase p34cdc2 [Petroselinum crispum] | Back alignment and taxonomy information |
|---|
Score = 554 bits (1427), Expect = e-155, Method: Compositional matrix adjust.
Identities = 273/323 (84%), Positives = 283/323 (87%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MDQYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDSCP+FA DPRLIK FLYQILRGIAYCHS
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPEFAKDPRLIKMFLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFR+ GTPNEDTWPGVTSLPDFKSAFPKWPSKEL TVV NL+ AG++LL KMLC+D
Sbjct: 212 ELFKIFRITGTPNEDTWPGVTSLPDFKSAFPKWPSKELETVVPNLDSAGLNLLKKMLCLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
PSRRITAR ALEHEYF+D+ VP
Sbjct: 272 PSRRITARIALEHEYFKDIGIVP 294
|
Source: Petroselinum crispum Species: Petroselinum crispum Genus: Petroselinum Family: Apiaceae Order: Apiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350539219|ref|NP_001234381.1| cyclin-dependent protein kinase p34cdc2 [Solanum lycopersicum] gi|3123616|emb|CAA76701.1| cyclin-dependent protein kinase p34cdc2 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1424), Expect = e-155, Method: Compositional matrix adjust.
Identities = 271/323 (83%), Positives = 284/323 (87%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MDQYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDSCP+F+ DPRL+K FLYQILRGIAYCHS
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSCPEFSKDPRLVKMFLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTN LKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNVLKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFRV+GTPNEDTWPGVTSLPDFKSAFPKWPSK+LGTVV NL AG+DL+ KML +D
Sbjct: 212 ELFKIFRVVGTPNEDTWPGVTSLPDFKSAFPKWPSKDLGTVVPNLGAAGLDLIGKMLTLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
PS+RITARSALEHEYF+D+ FVP
Sbjct: 272 PSKRITARSALEHEYFKDIGFVP 294
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 323 | ||||||
| UNIPROTKB|P29618 | 294 | CDKA-1 "Cyclin-dependent kinas | 0.504 | 0.554 | 0.889 | 9.5e-135 | |
| TAIR|locus:2099478 | 294 | CDC2 "cell division control 2" | 0.504 | 0.554 | 0.920 | 2.5e-134 | |
| UNIPROTKB|Q00526 | 305 | CDK3 "Cyclin-dependent kinase | 0.501 | 0.531 | 0.699 | 1e-107 | |
| UNIPROTKB|A5PJJ9 | 305 | CDK3 "Uncharacterized protein" | 0.501 | 0.531 | 0.699 | 1.9e-106 | |
| UNIPROTKB|F1RW06 | 305 | CDK3 "Uncharacterized protein" | 0.501 | 0.531 | 0.699 | 4e-106 | |
| UNIPROTKB|E2RPT8 | 304 | CDK3 "Uncharacterized protein" | 0.498 | 0.529 | 0.699 | 1.1e-105 | |
| ZFIN|ZDB-GENE-040426-2741 | 298 | cdk2 "cyclin-dependent kinase | 0.501 | 0.543 | 0.693 | 3.5e-105 | |
| UNIPROTKB|P51958 | 302 | cdk1 "Cyclin-dependent kinase | 0.501 | 0.536 | 0.689 | 7.3e-105 | |
| UNIPROTKB|P43450 | 298 | cdk2 "Cyclin-dependent kinase | 0.501 | 0.543 | 0.693 | 9.4e-105 | |
| ZFIN|ZDB-GENE-010320-1 | 302 | cdk1 "cyclin-dependent kinase | 0.498 | 0.533 | 0.690 | 1.9e-104 |
| UNIPROTKB|P29618 CDKA-1 "Cyclin-dependent kinase A-1" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 763 (273.6 bits), Expect = 9.5e-135, Sum P(2) = 9.5e-135
Identities = 145/163 (88%), Positives = 156/163 (95%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+QYEK EKIGEGTYGVVY+AR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEM H
Sbjct: 1 MEQYEKEEKIGEGTYGVVYRARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMHH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRL DV+HSEK++YLVFEYLDLDLKK MDSCP+FA +P LIK++LYQILRG+AYCHS
Sbjct: 61 GNIVRLHDVIHSEKRIYLVFEYLDLDLKKFMDSCPEFAKNPTLIKSYLYQILRGVAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
|
|
| TAIR|locus:2099478 CDC2 "cell division control 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 776 (278.2 bits), Expect = 2.5e-134, Sum P(2) = 2.5e-134
Identities = 150/163 (92%), Positives = 157/163 (96%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MDQYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDKVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV+LQDVVHSEK+LYLVFEYLDLDLKKHMDS PDF+ D +IKT+LYQILRGIAYCHS
Sbjct: 61 SNIVKLQDVVHSEKRLYLVFEYLDLDLKKHMDSTPDFSKDLHMIKTYLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
HRVLHRDLKPQNLLIDRRTN+LKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNSLKLADFGLARAFGIPVRTFTHE 163
|
|
| UNIPROTKB|Q00526 CDK3 "Cyclin-dependent kinase 3" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 596 (214.9 bits), Expect = 1.0e-107, Sum P(2) = 1.0e-107
Identities = 114/163 (69%), Positives = 140/163 (85%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MD ++KVEKIGEGTYGVVYKA+N T + +ALKKIRL+ E EGVPSTAIREISLLKE++H
Sbjct: 1 MDMFQKVEKIGEGTYGVVYKAKNRETGQLVALKKIRLDLEMEGVPSTAIREISLLKELKH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIVRL DVVH+E+KLYLVFE+L DLKK+MDS P LIK++L+Q+L+G+++CHS
Sbjct: 61 PNIVRLLDVVHNERKLYLVFEFLSQDLKKYMDSTPGSELPLHLIKSYLFQLLQGVSFCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
HRV+HRDLKPQNLLI+ A+KLADFGLARAFG+P+RT+THE
Sbjct: 121 HRVIHRDLKPQNLLINE-LGAIKLADFGLARAFGVPLRTYTHE 162
|
|
| UNIPROTKB|A5PJJ9 CDK3 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 592 (213.5 bits), Expect = 1.9e-106, Sum P(2) = 1.9e-106
Identities = 114/163 (69%), Positives = 136/163 (83%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MD ++KVEKIGEGTYGVVYKARN T + +ALKKIRL+ E EGVPSTAIREISLLKE++H
Sbjct: 1 MDMFQKVEKIGEGTYGVVYKARNKETGQLVALKKIRLDLETEGVPSTAIREISLLKELKH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIVRL DVVHSEKKLYLVFE+L DLKK+MDS P L+K +L+Q+L+G+ +CH+
Sbjct: 61 PNIVRLLDVVHSEKKLYLVFEFLSQDLKKYMDSTPASELPLHLVKRYLFQLLQGVNFCHT 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
HRV+HRDLKPQNLLI +KLADFGLARAFG+P+RT+THE
Sbjct: 121 HRVIHRDLKPQNLLISE-LGTIKLADFGLARAFGVPLRTYTHE 162
|
|
| UNIPROTKB|F1RW06 CDK3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 593 (213.8 bits), Expect = 4.0e-106, Sum P(2) = 4.0e-106
Identities = 114/163 (69%), Positives = 138/163 (84%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MD ++KVEKIGEGTYGVVYKA+N T + +ALKKIRL+ E EGVPSTAIREISLLKE++H
Sbjct: 1 MDVFQKVEKIGEGTYGVVYKAKNKETGQLVALKKIRLDLETEGVPSTAIREISLLKELKH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIVRL DVVHSEKKLYLVFE+L DLKK+MD+ P L+K++L+Q+L+G+ +CHS
Sbjct: 61 PNIVRLLDVVHSEKKLYLVFEFLSQDLKKYMDATPASELPLHLVKSYLFQLLQGVNFCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
HRV+HRDLKPQNLLI A+KLADFGLARAFG+P+RT+THE
Sbjct: 121 HRVIHRDLKPQNLLISE-LGAIKLADFGLARAFGVPLRTYTHE 162
|
|
| UNIPROTKB|E2RPT8 CDK3 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 1.1e-105, Sum P(2) = 1.1e-105
Identities = 114/163 (69%), Positives = 139/163 (85%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MD ++KVEKIGEGTYGVVYKA+N T + +ALKKIRL+ E EGVPSTAIREISL KE++H
Sbjct: 1 MDVFQKVEKIGEGTYGVVYKAKNKETGQLVALKKIRLDLETEGVPSTAIREISL-KELKH 59
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIVRL DVVHSEKKLYLVFE+L DLKK+MDS P L+K++L+Q+L+G+++CHS
Sbjct: 60 PNIVRLLDVVHSEKKLYLVFEFLSQDLKKYMDSAPASELPLHLVKSYLFQLLQGVSFCHS 119
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
HRV+HRDLKPQNLLI+ A+KLADFGLARAFG+P+RT+THE
Sbjct: 120 HRVIHRDLKPQNLLINE-LGAIKLADFGLARAFGVPLRTYTHE 161
|
|
| ZFIN|ZDB-GENE-040426-2741 cdk2 "cyclin-dependent kinase 2" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 591 (213.1 bits), Expect = 3.5e-105, Sum P(2) = 3.5e-105
Identities = 113/163 (69%), Positives = 139/163 (85%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+ ++KVEKIGEGTYGVVYKA+N VT ET+ALKKIRL+ E EGVPSTAIREISLLKE+ H
Sbjct: 1 MESFQKVEKIGEGTYGVVYKAKNKVTGETVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV+L+DV+H+E KLYLVFE+L DLK+ MDS L+K++L+Q+L+G+A+CHS
Sbjct: 61 PNIVKLRDVIHTENKLYLVFEFLHQDLKRFMDSTSVSGISLPLVKSYLFQLLQGLAFCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
HRVLHRDLKPQNLLI+ + +KLADFGLARAFG+PVRT+THE
Sbjct: 121 HRVLHRDLKPQNLLINAQ-GEIKLADFGLARAFGVPVRTYTHE 162
|
|
| UNIPROTKB|P51958 cdk1 "Cyclin-dependent kinase 1" [Carassius auratus (taxid:7957)] | Back alignment and assigned GO terms |
|---|
Score = 593 (213.8 bits), Expect = 7.3e-105, Sum P(2) = 7.3e-105
Identities = 113/164 (68%), Positives = 134/164 (81%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MD Y K+EKIGEGTYGVVYK RN T + +A+KKIRLE E+EGVPSTA+REISLLKE+QH
Sbjct: 1 MDDYLKIEKIGEGTYGVVYKGRNKTTGQVVAMKKIRLESEEEGVPSTAVREISLLKELQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFA-NDPRLIKTFLYQILRGIAYCH 119
N+VRL DV+ E KLYLVFE+L +DLKK++DS P DP L+K++LYQIL GI +CH
Sbjct: 61 PNVVRLLDVLMQESKLYLVFEFLSMDLKKYLDSIPSGQFMDPMLVKSYLYQILEGILFCH 120
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
RVLHRDLKPQNLLID + +KLADFGLARAFG+PVR +THE
Sbjct: 121 CRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGVPVRVYTHE 163
|
|
| UNIPROTKB|P43450 cdk2 "Cyclin-dependent kinase 2" [Carassius auratus (taxid:7957)] | Back alignment and assigned GO terms |
|---|
Score = 590 (212.7 bits), Expect = 9.4e-105, Sum P(2) = 9.4e-105
Identities = 113/163 (69%), Positives = 138/163 (84%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+ ++KVEKIGEGTYGVVYKA+N VT ET+ALKKIRL+ E EGVPSTAIREISLLKE+ H
Sbjct: 1 MESFQKVEKIGEGTYGVVYKAKNKVTGETVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV+L DV+H+E KLYLVFE+L DLK+ MDS L+K++L+Q+L+G+A+CHS
Sbjct: 61 PNIVKLHDVIHTENKLYLVFEFLHQDLKRFMDSSTVTGISLPLVKSYLFQLLQGLAFCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
HRVLHRDLKPQNLLI+ + +KLADFGLARAFG+PVRT+THE
Sbjct: 121 HRVLHRDLKPQNLLINAQ-GEIKLADFGLARAFGVPVRTYTHE 162
|
|
| ZFIN|ZDB-GENE-010320-1 cdk1 "cyclin-dependent kinase 1" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 595 (214.5 bits), Expect = 1.9e-104, Sum P(2) = 1.9e-104
Identities = 114/165 (69%), Positives = 136/165 (82%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MD Y K+EKIGEGTYGVVYK RN T + +A+KKIRLE E+EGVPSTA+REISLLKE+QH
Sbjct: 1 MDDYLKIEKIGEGTYGVVYKGRNKTTGQVVAMKKIRLESEEEGVPSTAVREISLLKELQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCP--DFANDPRLIKTFLYQILRGIAYC 118
N+VRL DV+ E KLYLVFE+L +DLKK++DS P +F DP L+K++LYQIL GI +C
Sbjct: 61 PNVVRLLDVLMQESKLYLVFEFLSMDLKKYLDSIPSGEFM-DPMLVKSYLYQILEGILFC 119
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
H RVLHRDLKPQNLLID + +KLADFGLARAFG+PVR +THE
Sbjct: 120 HCRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGVPVRVYTHE 163
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q63699 | CDK2_RAT | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6081 | 0.8947 | 0.9697 | yes | no |
| P43063 | CDK1_CANAL | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6206 | 0.8854 | 0.9022 | N/A | no |
| Q41639 | CDC2_VIGAC | 2, ., 7, ., 1, 1, ., 2, 3 | 0.8018 | 0.9102 | 1.0 | N/A | no |
| Q7RM49 | CDC2H_PLAYO | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5781 | 0.8885 | 0.9930 | N/A | no |
| Q9DG98 | CDK1_ORYLU | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5825 | 0.8978 | 0.9570 | N/A | no |
| Q26671 | CDC2H_THEAN | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5893 | 0.8885 | 0.9630 | yes | no |
| Q00646 | CDK1_EMENI | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5786 | 0.8885 | 0.8885 | yes | no |
| P54119 | CDK1_AJECA | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5857 | 0.8885 | 0.8858 | N/A | no |
| P35567 | CDK1A_XENLA | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5950 | 0.8978 | 0.9602 | N/A | no |
| P23572 | CDK1_DROME | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5741 | 0.8854 | 0.9629 | yes | no |
| Q00526 | CDK3_HUMAN | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6284 | 0.9071 | 0.9606 | yes | no |
| P24100 | CDKA1_ARATH | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7739 | 0.9102 | 1.0 | yes | no |
| Q9DGA2 | CDK1_ORYJA | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5825 | 0.8978 | 0.9570 | N/A | no |
| P51958 | CDK1_CARAU | 2, ., 7, ., 1, 1, ., 2, 3 | 0.6074 | 0.8978 | 0.9602 | N/A | no |
| Q05006 | CDC22_MEDSA | 2, ., 7, ., 1, 1, ., 2, 2 | 0.7956 | 0.9102 | 1.0 | N/A | no |
| P24033 | CDK1B_XENLA | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5950 | 0.8978 | 0.9602 | N/A | no |
| P23111 | CDC2_MAIZE | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7732 | 0.9071 | 0.9965 | N/A | no |
| P24923 | CDC21_MEDSA | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7993 | 0.8978 | 0.9965 | N/A | no |
| Q38772 | CDC2A_ANTMA | 2, ., 7, ., 1, 1, ., 2, 3 | 0.8235 | 0.9102 | 1.0 | N/A | no |
| Q38773 | CDC2B_ANTMA | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7483 | 0.8575 | 0.9892 | N/A | no |
| P29618 | CDKA1_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7732 | 0.9071 | 0.9965 | yes | no |
| P29619 | CDKA2_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7687 | 0.8978 | 0.9931 | no | no |
| P34117 | CDK5_DICDI | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5875 | 0.8947 | 0.9897 | yes | no |
| Q9XZD6 | CDC2H_PLAVI | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5974 | 0.8854 | 0.9930 | N/A | no |
| Q9W739 | CDK1_RANDY | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5763 | 0.8978 | 0.9602 | N/A | no |
| Q4Y4B1 | CDC2H_PLACH | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5799 | 0.8885 | 0.9965 | N/A | no |
| P04551 | CDK1_SCHPO | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5907 | 0.8916 | 0.9696 | yes | no |
| P00546 | CDK1_YEAST | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5820 | 0.8916 | 0.9664 | yes | no |
| P52389 | CDC2_VIGUN | 2, ., 7, ., 1, 1, ., 2, 3 | 0.7894 | 0.9102 | 1.0 | N/A | no |
| P23437 | CDK2_XENLA | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6112 | 0.8947 | 0.9730 | N/A | no |
| Q9DGD3 | CDK1_ORYLA | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5825 | 0.8978 | 0.9570 | N/A | no |
| Q27032 | CDC2H_THEPA | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5820 | 0.9009 | 0.9765 | yes | no |
| Q9DGA5 | CDK1_ORYCU | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5825 | 0.8978 | 0.9570 | N/A | no |
| Q4Z6R1 | CDC2H_PLABA | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5830 | 0.8885 | 0.9965 | N/A | no |
| P93101 | CDC2_CHERU | 2, ., 7, ., 1, 1, ., 2, 3 | 0.8359 | 0.9102 | 1.0 | N/A | no |
| O96821 | CDC2H_PLAKH | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5943 | 0.8854 | 0.9930 | yes | no |
| P43450 | CDK2_CARAU | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6112 | 0.8947 | 0.9697 | N/A | no |
| P48963 | CDK2_MESAU | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6081 | 0.8947 | 0.9697 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.22 | 0.994 |
| 3rd Layer | 2.7.11.23 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 323 | |||
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 0.0 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.0 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 0.0 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-174 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-171 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-143 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-142 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-139 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-136 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-131 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-126 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-126 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-124 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-122 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-112 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-111 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-110 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-110 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-103 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-101 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-98 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-97 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-96 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-96 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-95 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-94 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-93 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-91 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-89 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-86 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-86 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-86 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-86 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-81 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-78 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-78 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-76 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-75 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-74 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-73 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-68 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-66 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-66 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-63 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-62 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-60 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-60 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-57 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-57 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-56 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-56 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-56 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-56 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-55 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-53 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-52 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-48 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-47 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-43 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-42 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-41 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-39 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-36 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-36 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-34 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-28 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-28 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-26 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-25 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-24 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-23 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-19 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-19 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-18 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-16 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 9e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.001 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 612 bits (1580), Expect = 0.0
Identities = 267/323 (82%), Positives = 283/323 (87%), Gaps = 29/323 (8%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
MDQYEKVEKIGEGTYGVVYKAR+ VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
GNIVRLQDVVHSEK+LYLVFEYLDLDLKKHMDS PDFA +PRLIKT+LYQILRGIAYCHS
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLGSRHYSTPVD+WSVGCIFAEMVNQ+PLFPGDSEID
Sbjct: 164 ------------VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELFKIFR+LGTPNE+TWPGVTSLPD+KSAFPKWP K+L TVV LEPAG+DLLSKML +D
Sbjct: 212 ELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLD 271
Query: 301 PSRRITARSALEHEYFRDVEFVP 323
PS+RITAR+ALEHEYF+D+ P
Sbjct: 272 PSKRITARAALEHEYFKDLGDAP 294
|
Length = 294 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 586 bits (1514), Expect = 0.0
Identities = 222/313 (70%), Positives = 252/313 (80%), Gaps = 30/313 (9%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Y+KVEKIGEGTYGVVYKAR+ +T E +ALKKIRLE EDEGVPSTAIREISLLKE+ H NI
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 64 VRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
VRL DVVHSE KLYLVFE+LDLDLKK+MDS P DP LIK++LYQ+L+GIAYCHSHRV
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
LHRDLKPQNLLID R ALKLADFGLARAFG+PVRT+THE
Sbjct: 121 LHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHE-------------------- 159
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243
VVTLWYRAPEILLGSR YSTPVD+WS+GCIFAEMVN+RPLFPGDSEID+LF
Sbjct: 160 ---------VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210
Query: 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303
+IFR LGTP+ED WPGVTSLPD+K FPKW ++L VV NL+ G+DLLSKML DP++
Sbjct: 211 RIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAK 270
Query: 304 RITARSALEHEYF 316
RI+A++AL+H YF
Sbjct: 271 RISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 520 bits (1341), Expect = 0.0
Identities = 200/313 (63%), Positives = 246/313 (78%), Gaps = 31/313 (9%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
YEK+EK+GEGTYGVVYKAR+ T E +ALKKIRL+ E+EG+PSTA+REISLLKE++H NI
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 64 VRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
V+L DV+H+E+KLYLVFEY D+DLKK++D P P LIK+ +YQ+LRG+AYCHSHR+
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRI 119
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
LHRDLKPQN+LI+ R LKLADFGLARAFGIP+RT+THE
Sbjct: 120 LHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHE-------------------- 158
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243
VVTLWYRAPEILLGS+HYST VD+WSVGCIFAEM+ +PLFPGDSEID+LF
Sbjct: 159 ---------VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF 209
Query: 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303
KIF++LGTP E++WPGVT LPD+K FPK+P K+L V+ L+P GIDLLSKML +P++
Sbjct: 210 KIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK 269
Query: 304 RITARSALEHEYF 316
RI+A+ AL+H YF
Sbjct: 270 RISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 482 bits (1242), Expect = e-174
Identities = 196/313 (62%), Positives = 238/313 (76%), Gaps = 30/313 (9%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
++KVEKIGEGTYGVVYKARN +T E +ALKKIRL+ E EGVPSTAIREISLLKE+ H NI
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 64 VRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
V+L DV+H+E KLYLVFE+L DLKK MD+ P LIK++L+Q+L+G+A+CHSHRV
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
LHRDLKPQNLLI+ A+KLADFGLARAFG+PVRT+THE
Sbjct: 122 LHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHE-------------------- 160
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243
VVTLWYRAPEILLG ++YST VD+WS+GCIFAEMV +R LFPGDSEID+LF
Sbjct: 161 ---------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211
Query: 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303
+IFR LGTP+E WPGVTSLPD+K +FPKW ++ VV L+ G DLLS+ML DP++
Sbjct: 212 RIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNK 271
Query: 304 RITARSALEHEYF 316
RI+A++AL H +F
Sbjct: 272 RISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 476 bits (1227), Expect = e-171
Identities = 195/314 (62%), Positives = 234/314 (74%), Gaps = 31/314 (9%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Y K+EKIGEGTYGVVYK RN T + +A+KKIRLE E+EGVPSTAIREISLLKE+QH NI
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 64 VRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCP-DFANDPRLIKTFLYQILRGIAYCHSHR 122
V LQDV+ E +LYL+FE+L +DLKK++DS P D L+K++LYQIL+GI +CHS R
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
VLHRDLKPQNLLID + +KLADFGLARAFGIPVR +THE
Sbjct: 122 VLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVYTHE------------------- 161
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242
VVTLWYRAPE+LLGS YSTPVD+WS+G IFAEM ++PLF GDSEID+L
Sbjct: 162 ----------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
F+IFR+LGTP ED WPGVTSLPD+K+ FPKW L + V+NL+ G+DLL KML DP+
Sbjct: 212 FRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPA 271
Query: 303 RRITARSALEHEYF 316
+RI+A+ AL H YF
Sbjct: 272 KRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 406 bits (1045), Expect = e-143
Identities = 173/316 (54%), Positives = 226/316 (71%), Gaps = 34/316 (10%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+YEK+EKIGEGTYG V+KA+N T+E +ALK++RL+ +DEGVPS+A+REI LLKE++H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 63 IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
IVRL DV+HS+KKL LVFEY D DLKK+ DSC DP ++K+F++Q+L+G+A+CHSH
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-DPEIVKSFMFQLLKGLAFCHSHN 119
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
VLHRDLKPQNLLI++ LKLADFGLARAFGIPVR ++ E
Sbjct: 120 VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAE------------------- 159
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ-RPLFPGDSEIDE 241
VVTLWYR P++L G++ YST +D+WS GCIFAE+ N RPLFPG+ D+
Sbjct: 160 ----------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 209
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPS-KELGTVVRNLEPAGIDLLSKMLCMD 300
L +IFR+LGTP E++WPGV+ LPD+K +P +P+ L VV L G DLL +L +
Sbjct: 210 LKRIFRLLGTPTEESWPGVSKLPDYK-PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCN 268
Query: 301 PSRRITARSALEHEYF 316
P +RI+A AL+H YF
Sbjct: 269 PVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 403 bits (1037), Expect = e-142
Identities = 177/324 (54%), Positives = 224/324 (69%), Gaps = 39/324 (12%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D YEK+EKIGEGTYG VYKAR+ T + +ALKK RLE ++EG+P TA+REISLL+ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 62 N-IVRLQDVVHSEKK-----LYLVFEYLDLDLKKHMDSC---PDFANDPRLIKTFLYQIL 112
IVRL DV H E+K LYLVFEYLD DLKK MDS P + IK+F+YQ+L
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
+G+A+CH H V+HRDLKPQNLL+D++ LK+AD GL RAF IPV+++THE
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE--------- 171
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
+VTLWYRAPE+LLGS HYSTPVD+WSVGCIFAEM ++PL
Sbjct: 172 --------------------IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
FPGDSE+ +L IF++LGTP E WPGV+ L D+ FP+W ++L V +L P G+DL
Sbjct: 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHE-FPQWKPQDLSRAVPDLSPEGLDL 270
Query: 293 LSKMLCMDPSRRITARSALEHEYF 316
L KML DP++RI+A++AL H YF
Sbjct: 271 LQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 396 bits (1019), Expect = e-139
Identities = 174/315 (55%), Positives = 227/315 (72%), Gaps = 32/315 (10%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
++++EK+GEGTY VYK RN T E +ALK+I L+ E EG PSTAIREISL+KE++H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHEN 59
Query: 63 IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDF-ANDPRLIKTFLYQILRGIAYCHSH 121
IVRL DV+H+E KL LVFEY+D DLKK+MD+ A DP +K+F YQ+L+GIA+CH +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
RVLHRDLKPQNLLI++R LKLADFGLARAFGIPV TF++E
Sbjct: 120 RVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVNTFSNE------------------ 160
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
VVTLWYRAP++LLGSR YST +D+WSVGCI AEM+ RPLFPG + D+
Sbjct: 161 -----------VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ 209
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301
L KIFR++GTP E TWPG++ LP++K FP++P ++L + + +P GIDLL ++L ++P
Sbjct: 210 LLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNP 269
Query: 302 SRRITARSALEHEYF 316
RI+A AL+H +F
Sbjct: 270 ELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 387 bits (997), Expect = e-136
Identities = 162/320 (50%), Positives = 215/320 (67%), Gaps = 36/320 (11%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
++ Y+K++K+GEG+Y VYK R+ +T + +ALK+IRLE E EG P TAIRE SLLK+++H
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKH 62
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV L D++H++K L LVFEYLD DLK++MD C + ++ FL+Q+LRG+AYCH
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLS-MHNVRLFLFQLLRGLAYCHQ 121
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
RVLHRDLKPQNLLI R LKLADFGLARA +P +T+++E
Sbjct: 122 RRVLHRDLKPQNLLISER-GELKLADFGLARAKSVPSKTYSNE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI- 239
VVTLWYR P++LLGS YST +D+W VGCIF EM RPLFPG +++
Sbjct: 164 ------------VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRNLE--PAGIDLLSKM 296
D+L KIFRVLGTP E+TWPGV+S P+FK +FP +P + L L+ P G +L K
Sbjct: 212 DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKF 271
Query: 297 LCMDPSRRITARSALEHEYF 316
L +P +RI+A A++H YF
Sbjct: 272 LQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 375 bits (964), Expect = e-131
Identities = 169/314 (53%), Positives = 211/314 (67%), Gaps = 32/314 (10%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Y+K+ KIGEGTYGVVYKAR+ +T E +A+KKI+L E EG+P TA+REI LLKE+ H NI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 64 VRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
++L DV + LYLVFE++D DL K + LIK++LYQ+L+G+A+CHSH +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
LHRDLKP+NLLI+ LKLADFGLAR+FG PVR +TH
Sbjct: 120 LHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHY-------------------- 158
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243
VVT WYRAPE+LLG + YSTPVD+WSVGCIFAE++++RPLFPG SEID+LF
Sbjct: 159 ---------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
Query: 244 KIFRVLGTPNEDTWPGVTSLPDF-KSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
KIFR LGTP+ + WP TSL K +FPK L + N P +DLLS+ML DP
Sbjct: 210 KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH 269
Query: 303 RRITARSALEHEYF 316
+RITA AL H YF
Sbjct: 270 KRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 363 bits (934), Expect = e-126
Identities = 147/317 (46%), Positives = 204/317 (64%), Gaps = 34/317 (10%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
YEK+ +IGEGTYG VYKARN T E +ALKKIR+E E EG P TAIREI LL++++H NI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 64 VRLQDVVHSEKK--LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
VRL+++V S+ K +Y+VFEY+D DL +DS P+ IK ++ Q+L G+ Y HS+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+LHRD+K N+LI+ LKLADFGLA R +T + Y +
Sbjct: 120 GILHRDIKGSNILINNDGV-LKLADFGLA-------RPYTKRNSA-----DYTN------ 160
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
+V+TLWYR PE+LLG+ Y VD+WSVGCI AE+ +P+F G +E+++
Sbjct: 161 ----------RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ 210
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKE-LGTVVRNLE-PAGIDLLSKMLCM 299
L KIF + G+P ++ WPGV+ LP F++ PK P K L ++L P+ +DLL K+L +
Sbjct: 211 LEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL 270
Query: 300 DPSRRITARSALEHEYF 316
DP +RI+A AL+HEYF
Sbjct: 271 DPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 363 bits (935), Expect = e-126
Identities = 149/319 (46%), Positives = 198/319 (62%), Gaps = 37/319 (11%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE---DEGVPSTAIREISLLKEMQ 59
+YEK +K+GEGTY VVYKAR+ T +A+KKI+L + +G+ TA+REI LL+E++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHM-DSCPDFANDPRLIKTFLYQILRGIAYC 118
H NI+ L DV + + LVFE+++ DL+K + D P IK+++ LRG+ Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLT--PADIKSYMLMTLRGLEYL 118
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
HS+ +LHRDLKP NLLI LKLADFGLAR+FG P R TH
Sbjct: 119 HSNWILHRDLKPNNLLIAS-DGVLKLADFGLARSFGSPNRKMTH---------------- 161
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
+VVT WYRAPE+L G+RHY VD+WSVGCIFAE++ + P PGDS+
Sbjct: 162 -------------QVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
ID+L KIF LGTP E+ WPGVTSLPD+ F +P L + +DLL ++L
Sbjct: 209 IDQLGKIFEALGTPTEENWPGVTSLPDY-VEFKPFPPTPLKQIFPAASDDALDLLQRLLT 267
Query: 299 MDPSRRITARSALEHEYFR 317
++P++RITAR ALEH YF
Sbjct: 268 LNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 357 bits (918), Expect = e-124
Identities = 145/321 (45%), Positives = 206/321 (64%), Gaps = 38/321 (11%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D+YEK+ +I EGTYGVVY+AR+ T E +ALKK+++E+E EG P T++REI++L ++QH
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 62 NIVRLQDVVHSEK--KLYLVFEYLDLDLKKHMDSCPD-FANDPRLIKTFLYQILRGIAYC 118
NIV +++VV K+Y+V EY++ DLK M++ F +K + Q+L G+A+
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFL--QSEVKCLMLQLLSGVAHL 122
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
H + +LHRDLK NLL++ R LK+ DFGLAR +G P++ +T
Sbjct: 123 HDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPLKPYTQ---------------- 165
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
VVTLWYRAPE+LLG++ YST +D+WSVGCIFAE++ ++PLFPG SE
Sbjct: 166 -------------LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRN--LEPAGIDLLSK 295
ID+L KIF++LGTP E WPG + LP K F K+P +L L G DLL++
Sbjct: 213 IDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNR 272
Query: 296 MLCMDPSRRITARSALEHEYF 316
+L DP++RI+A AL+H YF
Sbjct: 273 LLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 351 bits (904), Expect = e-122
Identities = 147/321 (45%), Positives = 199/321 (61%), Gaps = 42/321 (13%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ---H 60
YE++ +IGEG YG VYKAR+ T +ALKK+R+ +EG+P + +REI+LLK+++ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 61 GNIVRLQDVVH-----SEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
NIVRL DV H E KL LVFE++D DL ++ CP P IK + Q+LRG+
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
+ HSHR++HRDLKPQN+L+ +K+ADFGLAR + + T S+
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIYSFEMA-LT---------SV--- 166
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
VVTLWYRAPE+LL S Y+TPVD+WSVGCIFAE+ +RPLF G
Sbjct: 167 -----------------VVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRG 208
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSK 295
SE D+L KIF V+G P+E+ WP SLP +S+FP + + + V + G+DLL K
Sbjct: 209 TSEADQLDKIFDVIGLPSEEEWPRNVSLP--RSSFPSYTPRSFKSFVPEICEEGLDLLKK 266
Query: 296 MLCMDPSRRITARSALEHEYF 316
ML +P +RI+A AL+H YF
Sbjct: 267 MLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 327 bits (840), Expect = e-112
Identities = 165/320 (51%), Positives = 216/320 (67%), Gaps = 33/320 (10%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+ Y K+EK+GEGTY V+K R+ +T +ALK+IRLE E EG P TAIRE+SLLK+++H
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKH 63
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV L D+VH++K L LVFEYLD DLK++MD C + + +K FLYQILRG+AYCH
Sbjct: 64 ANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN-VKIFLYQILRGLAYCHR 122
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
+VLHRDLKPQNLLI+ R LKLADFGLARA +P +T+++E
Sbjct: 123 RKVLHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTYSNE----------------- 164
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYR P++LLGS YST +D+W VGCIF EM + RPLFPG + D
Sbjct: 165 ------------VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
EL IFR+LGTP E+TWPG++S +FK+ FPK+ + L L+ GI+LL+K L
Sbjct: 213 ELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQY 272
Query: 300 DPSRRITARSALEHEYFRDV 319
+ +RI+A A++H YFR +
Sbjct: 273 ESKKRISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 323 bits (828), Expect = e-111
Identities = 154/317 (48%), Positives = 213/317 (67%), Gaps = 33/317 (10%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
++ Y K++K+GEGTY V+K R+ +T +ALK+IRLE E EG P TAIRE+SLLK ++H
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKH 62
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV L D++H+E+ L LVFEYLD DLK+++D+C + + +K F++Q+LRG++YCH
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN-VKIFMFQLLRGLSYCHK 121
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
++LHRDLKPQNLLI+ + LKLADFGLARA +P +T+++E
Sbjct: 122 RKILHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYSNE----------------- 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYR P++LLGS YSTP+D+W VGCI EM RP+FPG + +
Sbjct: 164 ------------VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
EL IFR+LGTP E+TWPG+TS +F+S FP++ ++ L L+ GIDLLS +L
Sbjct: 212 ELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLY 271
Query: 300 DPSRRITARSALEHEYF 316
+ RI+A +AL H YF
Sbjct: 272 ETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 322 bits (828), Expect = e-110
Identities = 130/316 (41%), Positives = 190/316 (60%), Gaps = 33/316 (10%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+Y+ + +IGEG +G+V+KA++ T ET+ALKK+ L + + G+P+ A+REI L+ QH
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 63 IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
+V+L DV LV EY+ DL + + +K+++ +L+G+AY H++
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEHWGSTGISIYFSFLRYRV 181
++HRDLKP NLLI LK+ADFGLAR F R ++H+
Sbjct: 120 IMHRDLKPANLLISA-DGVLKIADFGLARLFSEEEPRLYSHQ------------------ 160
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
V T WYRAPE+L G+R Y VD+W+VGCIFAE++N PLFPG+++I++
Sbjct: 161 -----------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ 209
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDF-KSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
L +FR LGTPNE+TWPG+TSLPD+ K FP+ L + + P +DLL +L D
Sbjct: 210 LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYD 269
Query: 301 PSRRITARSALEHEYF 316
PS+R++A AL H YF
Sbjct: 270 PSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 321 bits (824), Expect = e-110
Identities = 160/320 (50%), Positives = 213/320 (66%), Gaps = 33/320 (10%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
++ Y K++K+GEGTY VYK R+ +T+ +ALK+IRLE E EG P TAIRE+SLLK+++H
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKH 63
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV L D++H+EK L LVFEYLD DLK+++D C + N +K FL+Q+LRG+ YCH
Sbjct: 64 ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN-VKLFLFQLLRGLNYCHR 122
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
+VLHRDLKPQNLLI+ R LKLADFGLARA IP +T+++E
Sbjct: 123 RKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYSNE----------------- 164
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYR P+ILLGS YST +D+W VGCIF EM RPLFPG + +
Sbjct: 165 ------------VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
+L IFR+LGTP E+TWPG+ S +FKS +PK+ + L L+ G +LLSK+L
Sbjct: 213 QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQF 272
Query: 300 DPSRRITARSALEHEYFRDV 319
+ +RI+A A++H YF +
Sbjct: 273 EGRKRISAEEAMKHPYFHCL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 303 bits (779), Expect = e-103
Identities = 140/326 (42%), Positives = 190/326 (58%), Gaps = 31/326 (9%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ YE + K+GEGT+G VYKAR T +ALKKI + E +G P TA+REI +LK+++H
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKH 66
Query: 61 GNIVRLQD--VVHSEKKL------YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQIL 112
N+V L D V +K Y+V Y+D DL +++ P IK ++ Q+L
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-PSVKLTESQIKCYMLQLL 125
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
GI Y H + +LHRD+K N+LID + LK+ADFGLAR + P G T
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGI-LKIADFGLARPYDGPPPNPKGGGGGGTR--- 181
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
+Y L VVT WYR PE+LLG R Y+T VD+W +GC+FAEM +RP+
Sbjct: 182 -----KYTNL----------VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKS--AFPKWPSKELGTVVRNLEPAGI 290
G S+ID+L IF++ GTP E+TWPG SLP + +F +P L L P G+
Sbjct: 227 LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT-LEERFGKLGPEGL 285
Query: 291 DLLSKMLCMDPSRRITARSALEHEYF 316
DLLSK+L +DP +R+TA ALEH YF
Sbjct: 286 DLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 300 bits (769), Expect = e-101
Identities = 133/319 (41%), Positives = 195/319 (61%), Gaps = 34/319 (10%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
++EK+ +IGEGTYG+VY+AR+ + E +ALKK+R++ E +G+P +++REI+LL ++H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 63 IVRLQDVV--HSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
IV L++VV ++LV EY + DL +D+ P ++ + +K + Q+LRG+ Y H
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ-VKCLMLQLLRGLQYLHE 126
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
+ ++HRDLK NLL+ + LK+ADFGLAR +G+P + T
Sbjct: 127 NFIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLPAKPMTP------------------ 167
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
KVVTLWYRAPE+LLG Y+T +D+W+VGCI AE++ +PL PG SEI+
Sbjct: 168 -----------KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
+L I ++LGTPNE WPG + LP PK P L L AG+ LL+ +L
Sbjct: 217 QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMY 276
Query: 300 DPSRRITARSALEHEYFRD 318
DP +R TA ALE YF++
Sbjct: 277 DPKKRATAEEALESSYFKE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 293 bits (751), Expect = 1e-98
Identities = 128/342 (37%), Positives = 186/342 (54%), Gaps = 54/342 (15%)
Query: 3 QYEKVEKIGEGTYGVVYKAR--NCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQ 59
+YE IG GTYG VYKA+ N + A+KK + ++E G+ +A REI+LL+E++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 60 HGNIVRLQDVV--HSEKKLYLVFEYLDLDLK---KHMDSCPDFANDPRLIKTFLYQILRG 114
H N+V L +V H++K +YL+F+Y + DL K + P ++K+ L+QIL G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
+ Y HS+ VLHRDLKP N+L+ +K+ D GLAR F P++
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD------- 173
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231
V VVT+WYRAPE+LLG+RHY+ +D+W++GCIFAE++ P
Sbjct: 174 --------PV-----------VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214
Query: 232 LFPGDSE---------IDELFKIFRVLGTPNEDTWPGVTSLPDFK-----SAFPKWPSKE 277
+F G D+L +IF VLGTP E WP + +P++ +PS
Sbjct: 215 IFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNS 274
Query: 278 LGTVV---RNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316
L + + + G DLL K+L DP++RITA ALEH YF
Sbjct: 275 LAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 290 bits (744), Expect = 3e-97
Identities = 127/323 (39%), Positives = 174/323 (53%), Gaps = 36/323 (11%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
YE ++ IG G YGVV A + T +A+KKI +D +REI LL+ ++H NI
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 64 VRLQDVV-----HSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
+ L D++ +Y+V E ++ DL K + S +D I+ FLYQILRG+ Y
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDH--IQYFLYQILRGLKYL 119
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
HS V+HRDLKP N+L++ LK+ DFGLAR + ++ Y
Sbjct: 120 HSANVIHRDLKPSNILVNS-NCDLKICDFGLARGVD-------PDEDEKGFLTEY----- 166
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
VVT WYRAPE+LL S Y+ +D+WSVGCIFAE++ ++PLFPG
Sbjct: 167 --------------VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSL--PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKM 296
ID+L I VLGTP+E+ +TS ++ + PK P K L + P IDLL KM
Sbjct: 213 IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKM 272
Query: 297 LCMDPSRRITARSALEHEYFRDV 319
L DP +RITA AL H Y +
Sbjct: 273 LVFDPKKRITADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 286 bits (733), Expect = 4e-96
Identities = 158/322 (49%), Positives = 202/322 (62%), Gaps = 36/322 (11%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D YEK+EK+GEG+Y VYK ++ V + +ALK IRL QE+EG P TAIRE SLLK ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL-QEEEGTPFTAIREASLLKGLKHA 63
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
NIV L D++H+++ L LVFEY+ DL ++MD P + P +K FL+Q+LRG++Y H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLH-PENVKLFLFQLLRGLSYIHQR 122
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+LHRDLKPQNLLI T LKLADFGLARA +P T+++E
Sbjct: 123 YILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNE------------------ 163
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI-D 240
VVTLWYR P++LLGS YST +D+W VGCIF EM+ FPG +I D
Sbjct: 164 -----------VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFK-SAFPKWPSKELGTVVRNLEPA--GIDLLSKML 297
+L +IF VLGTPNEDTWPGV SLP FK F + K L L DL SK+L
Sbjct: 213 QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLL 272
Query: 298 CMDPSRRITARSALEHEYFRDV 319
P R++A++AL HEYF D+
Sbjct: 273 QCFPKNRLSAQAALSHEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 284 bits (729), Expect = 4e-96
Identities = 107/314 (34%), Positives = 156/314 (49%), Gaps = 61/314 (19%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
YE +EK+GEG++G VY AR+ T + +A+K I+ ++ + +REI +LK+++H NI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK-DRERILREIKILKKLKHPNI 59
Query: 64 VRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
VRL DV E KLYLV EY + DL + + +L QIL + Y HS
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRL--SEDEARFYLRQILSALEYLHSKG 117
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
++HRDLKP+N+L+D + +KLADFGLAR + T
Sbjct: 118 IVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTT--------------------- 155
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242
V T Y APE+LLG + Y VD+WS+G I E++ +P FPGD D+L
Sbjct: 156 ---------FVGTPEYMAPEVLLG-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQL 202
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
++F+ +G P P + P DL+ K+L DP
Sbjct: 203 LELFKKIGKPKPPFPPPEWDIS----------------------PEAKDLIRKLLVKDPE 240
Query: 303 RRITARSALEHEYF 316
+R+TA AL+H +F
Sbjct: 241 KRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 282 bits (725), Expect = 2e-95
Identities = 106/314 (33%), Positives = 150/314 (47%), Gaps = 55/314 (17%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
YE + K+G G++G VYKA++ T + +A+K ++ E TA REI +L+ + H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 64 VRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
VRL D + LYLV EY + DL ++ K QILRG+ Y HS+
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
++HRDLKP+N+L+D +K+ADFGLA+ + T
Sbjct: 119 IIHRDLKPENILLDENGV-VKIADFGLAKKLLKSSSSLTTF------------------- 158
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242
V T WY APE+LLG Y VDVWS+G I E++ +P F G++ +D+L
Sbjct: 159 ----------VGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL 208
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
I R+LG P E P +S DL+ K L DPS
Sbjct: 209 QLIRRILGPPLEFDEPKWSSGS----------------------EEAKDLIKKCLNKDPS 246
Query: 303 RRITARSALEHEYF 316
+R TA L+H +F
Sbjct: 247 KRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 281 bits (720), Expect = 3e-94
Identities = 141/317 (44%), Positives = 192/317 (60%), Gaps = 36/317 (11%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Y +EK+GEG+Y VYK + + + +ALK I ++ E EGVP TAIRE SLLK ++H NI
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANI 65
Query: 64 VRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
V L D++H+++ L VFEY+ DL ++M P + P ++ F++Q+LRG+AY H +
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH-PYNVRLFMFQLLRGLAYIHGQHI 124
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
LHRDLKPQNLLI LKLADFGLARA IP +T++ E
Sbjct: 125 LHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSE-------------------- 163
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI-DEL 242
VVTLWYR P++LLG+ YS+ +D+W GCIF EM+ +P FPG S++ ++L
Sbjct: 164 ---------VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL 214
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRN---LEPAGIDLLSKMLCM 299
KI+ VLG P EDTWPGV+ LP++K + + VV P DL S+ML M
Sbjct: 215 EKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMM 274
Query: 300 DPSRRITARSALEHEYF 316
P RI+A+ AL H YF
Sbjct: 275 FPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 279 bits (716), Expect = 2e-93
Identities = 122/328 (37%), Positives = 184/328 (56%), Gaps = 42/328 (12%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+YEK+ KIG+GT+G V+KAR+ T + +ALKK+ +E E EG P TA+REI +L+ ++H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 62 NIVRLQDVVHSEKK--------LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILR 113
N+V L ++ ++ YLVFE+ + DL + S + IK + +L
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLL-SNKNVKFTLSEIKKVMKMLLN 130
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
G+ Y H +++LHRD+K N+LI + LKLADFGLARAF + + +
Sbjct: 131 GLYYIHRNKILHRDMKAANILIT-KDGILKLADFGLARAFSLSKNSKPN----------- 178
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
RY +VVTLWYR PE+LLG R Y P+D+W GCI AEM + P+
Sbjct: 179 ----RYTN----------RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDF-KSAFPK----WPSKELGTVVRNLEPA 288
G++E +L I ++ G+ + WPGV L F K P+ + L V++ P
Sbjct: 225 QGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKD--PH 282
Query: 289 GIDLLSKMLCMDPSRRITARSALEHEYF 316
+DL+ K+L +DP++RI A +AL H++F
Sbjct: 283 ALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 272 bits (697), Expect = 9e-91
Identities = 129/322 (40%), Positives = 181/322 (56%), Gaps = 48/322 (14%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKI--RLEQEDEGVPSTAIREI-SLLKEMQH 60
Y+ ++++G+GT+G VY ARN T E +A+KK+ + +E +RE+ SL K +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE---CMNLREVKSLRKLNEH 57
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV+L++V +LY VFEY++ +L + M +I++ +YQIL+G+A+ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR---TFTHEHWGSTGISIYFSFL 177
H HRDLKP+NLL+ +K+ADFGLAR +R +T Y S
Sbjct: 118 HGFFHRDLKPENLLVSGPEV-VKIADFGLAR----EIRSRPPYTD----------YVS-- 160
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
T WYRAPEILL S YS+PVD+W++GCI AE+ RPLFPG S
Sbjct: 161 -----------------TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLP---DFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294
EID+L+KI VLGTP + WP L F+ FP++ L ++ N P IDL+
Sbjct: 204 EIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR--FPQFAPTSLHQLIPNASPEAIDLIK 261
Query: 295 KMLCMDPSRRITARSALEHEYF 316
ML DP +R TA AL+H YF
Sbjct: 262 DMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 267 bits (685), Expect = 5e-89
Identities = 121/319 (37%), Positives = 182/319 (57%), Gaps = 35/319 (10%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++YE + +GEG YGVV K RN T E +A+KK + ++DE V TA+RE+ +L++++H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
NIV L++ + +LYLVFEY++ L + +++ P P ++++++Q+L+ IAYCHSH
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
++HRD+KP+N+L+ + LKL DFG ARA S +
Sbjct: 120 NIIHRDIKPENILVS-ESGVLKLCDFGFARALRAR------------PASPLTDY----- 161
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
V T WYRAPE+L+G +Y PVDVW++GCI AE+++ PLFPGDS+ID+
Sbjct: 162 -----------VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ 210
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVR---NLEPAGIDLLSKML 297
L+ I + LG +S P F AFP+ PS+ R + +D L L
Sbjct: 211 LYLIQKCLGPLPPSHQELFSSNPRFAGVAFPE-PSQPESLERRYPGKVSSPALDFLKACL 269
Query: 298 CMDPSRRITARSALEHEYF 316
MDP R+T L+H YF
Sbjct: 270 RMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 262 bits (670), Expect = 2e-86
Identities = 130/328 (39%), Positives = 183/328 (55%), Gaps = 45/328 (13%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+D+++ + +IGEGTYG VYKAR+ T E +ALKK+RL+ E EG P TAIREI +L+++ H
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 61 GNIVRLQDVVH------SEKK----LYLVFEYLDLDLKKHMDS-CPDFANDPRLIKTFLY 109
NIV L+++V KK YLVFEY+D DL ++S F+ D IK+F+
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH--IKSFMK 123
Query: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEHWGST 168
Q+L G+ YCH LHRD+K N+L++ + +KLADFGLAR + R +T+
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPYTN------ 176
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228
KV+TLWYR PE+LLG Y +DVWS GCI E+
Sbjct: 177 -----------------------KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
Query: 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWP-SKELGTVVRNLEP 287
++P+F + E+ +L I R+ G+P WP V LP F + PK + L +
Sbjct: 214 KKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPT 273
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEY 315
+DLL ML +DPS+R TA AL +
Sbjct: 274 PALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 261 bits (667), Expect = 2e-86
Identities = 138/323 (42%), Positives = 198/323 (61%), Gaps = 43/323 (13%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-- 59
QYE V +IGEG YG V+KAR+ +ALK++R++ +EG+P + IRE+++L+ ++
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 60 -HGNIVRLQDV-----VHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILR 113
H N+VRL DV E KL LVFE++D DL ++D P+ IK ++Q+LR
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
G+ + HSHRV+HRDLKPQN+L+ + +KLADFGLAR +
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYS------------------- 161
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
+++ S+ VVTLWYRAPE+LL S Y+TPVD+WSVGCIFAEM ++PLF
Sbjct: 162 -----FQMALTSV------VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLF 209
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
G S++D+L KI V+G P E+ WP +LP + AF ++ + V +++ G DLL
Sbjct: 210 RGSSDVDQLGKILDVIGLPGEEDWPRDVALP--RQAFHSKSAQPIEKFVTDIDELGKDLL 267
Query: 294 SKMLCMDPSRRITARSALEHEYF 316
K L +P++RI+A SAL H YF
Sbjct: 268 LKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 262 bits (670), Expect = 3e-86
Identities = 124/319 (38%), Positives = 177/319 (55%), Gaps = 31/319 (9%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPS------------TAIREISLLKE 57
+GEGTYG V KA + +T + +A+KK+++ + V T +RE+ ++ E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
++H NI+ L DV + LV + + DLKK +D + + +K L QIL G+
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLT-ESQ-VKCILLQILNGLNV 134
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
H +HRDL P N+ I+ + K+ADFGLAR +G P Y L
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGIC-KIADFGLARRYGYPP---------------YSDTL 178
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
KVVTLWYRAPE+L+G+ Y VD+WSVGCIFAE++ +PLFPG++
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
EID+L +IF +LGTPNED WP LP + + F K+L T+ N IDLL +L
Sbjct: 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLL 297
Query: 298 CMDPSRRITARSALEHEYF 316
++P RI+A+ AL+HEYF
Sbjct: 298 KLNPLERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 260 bits (665), Expect = 4e-86
Identities = 134/322 (41%), Positives = 192/322 (59%), Gaps = 42/322 (13%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ--- 59
QYE V +IG G YG VYKAR+ + +ALK +R++ ++G+P + +RE++LLK ++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 60 HGNIVRLQDVVHS-----EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
H NIVRL DV + E K+ LVFE++D DL+ ++D P IK + Q LRG
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+ + H++ ++HRDLKP+N+L+ +KLADFGLAR + T +
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIYSC--------QMALTPV---- 167
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
VVTLWYRAPE+LL S Y+TPVD+WSVGCIFAEM ++PLF
Sbjct: 168 ------------------VVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFC 208
Query: 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294
G+SE D+L KIF ++G P ED WP +LP + AF + + +VV +E +G LL
Sbjct: 209 GNSEADQLGKIFDLIGLPPEDDWPRDVTLP--RGAFSPRGPRPVQSVVPEIEESGAQLLL 266
Query: 295 KMLCMDPSRRITARSALEHEYF 316
+ML +P +RI+A AL+H +F
Sbjct: 267 EMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 249 bits (639), Expect = 2e-81
Identities = 125/323 (38%), Positives = 176/323 (54%), Gaps = 42/323 (13%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+Y+ + IGEG YG+V A + T +A+KKI E + +REI +L+ +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHE 63
Query: 62 NIVRLQDVVHSE-----KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
NI+ + D++ +Y+V E ++ DL K + + +ND I+ FLYQILRG+
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDH--IQYFLYQILRGLK 120
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNA-LKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y HS VLHRDLKP NLL++ TN LK+ DFGLAR + H+H G
Sbjct: 121 YIHSANVLHRDLKPSNLLLN--TNCDLKICDFGLAR-----IADPEHDHTG--------- 164
Query: 176 FL-RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
FL Y V T WYRAPEI+L S+ Y+ +D+WSVGCI AEM++ RPLFP
Sbjct: 165 FLTEY-------------VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211
Query: 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLP--DFKSAFPKWPSKELGTVVRNLEPAGIDL 292
G + +L I VLGTP+++ + SL ++ + P P + N +P +DL
Sbjct: 212 GKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDL 271
Query: 293 LSKMLCMDPSRRITARSALEHEY 315
L KML +P +RIT AL H Y
Sbjct: 272 LDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 1e-78
Identities = 127/343 (37%), Positives = 176/343 (51%), Gaps = 79/343 (23%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPST----AIREISLLKEM- 58
YE ++K+G+G YG+V+KA + T E +ALKKI D +T REI L+E+
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF----DAFRNATDAQRTFREIMFLQELG 64
Query: 59 QHGNIVRLQDVVHSE--KKLYLVFEYLDLDL----KK------HMDSCPDFANDPRLIKT 106
H NIV+L +V+ +E K +YLVFEY++ DL + H R I
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK----------RYI-- 112
Query: 107 FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-------GIPVRT 159
+YQ+L+ + Y HS V+HRDLKP N+L++ +KLADFGLAR+ PV T
Sbjct: 113 -MYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLT 170
Query: 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSV 219
Y V T WYRAPEILLGS Y+ VD+WSV
Sbjct: 171 ------------------DY-------------VATRWYRAPEILLGSTRYTKGVDMWSV 199
Query: 220 GCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFK----SAFPKWPS 275
GCI EM+ +PLFPG S +++L KI V+G P+ + + S F + P P
Sbjct: 200 GCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS--PFAATMLDSLPSRPR 257
Query: 276 KELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
K L ++ +DLL K+L +P++R+TA ALEH Y
Sbjct: 258 KPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 239 bits (613), Expect = 4e-78
Identities = 116/328 (35%), Positives = 179/328 (54%), Gaps = 55/328 (16%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++YEK+ KIGEG+YGVV+K RN T + +A+KK ++D + A+REI +LK+++H
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDL----DLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
N+V L +V ++KL+LVFEY D +L+K+ P+ LIK ++Q L+ + +
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPE-----HLIKKIIWQTLQAVNF 115
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
CH H +HRD+KP+N+LI + +KL DFG AR P +T Y
Sbjct: 116 CHKHNCIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTD----------Y---- 160
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
V T WYRAPE+L+G Y PVDVW++GC+FAE++ +PL+PG S
Sbjct: 161 ---------------VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205
Query: 238 EIDELFKIFRVLGT---------PNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPA 288
++D+L+ I + LG + G+ S+P+ ++ P L + N+
Sbjct: 206 DVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL-SIPEPETREP------LESKFPNISSP 258
Query: 289 GIDLLSKMLCMDPSRRITARSALEHEYF 316
+ L L MDP+ R++ LEH YF
Sbjct: 259 ALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 236 bits (603), Expect = 5e-76
Identities = 111/327 (33%), Positives = 170/327 (51%), Gaps = 46/327 (14%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA---IREISLLKEM 58
+Y+ +E IG G YGVV A + + + +A+KKI + VP+ A +RE+ +L+
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD---VPTLAKRTLRELKILRHF 61
Query: 59 QHGNIVRLQDVVHSE----KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
+H NI+ ++D++ K +Y+V + ++ DL + S + I+ FLYQ+LRG
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEE--HIRYFLYQLLRG 119
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA---FGIPVRTFTHEHWGSTGIS 171
+ Y HS V+HRDLKP NLL++ L++ DFG+AR + F E+
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEY------- 171
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231
V T WYRAPE+LL Y+T +D+WSVGCIFAEM+ +R
Sbjct: 172 ---------------------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210
Query: 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAG 289
LFPG + + +L I VLG+P+E+ + S + + P+ + P
Sbjct: 211 LFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEA 270
Query: 290 IDLLSKMLCMDPSRRITARSALEHEYF 316
+DLLS+ML DP RIT AL+H +
Sbjct: 271 LDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 6e-75
Identities = 114/332 (34%), Positives = 176/332 (53%), Gaps = 63/332 (18%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++YE + +GEG+YG+V K ++ T + +A+KK ++D+ V A+REI +LK+++H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFAN--DPRLIKTFLYQILRGIAYCH 119
N+V L +V +K+LYLVFE++D + +D + N D ++ +L+QILRGI +CH
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTV---LDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
SH ++HRD+KP+N+L+ ++ +KL DFG AR P +T
Sbjct: 118 SHNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTD----------------- 159
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
V T WYRAPE+L+G Y VD+W+VGC+ EM+ PLFPGDS+I
Sbjct: 160 ------------YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI 207
Query: 240 DELFKIFRVLGT--PNEDT-------WPGVTSLPDFKSA------FPKWPSKELGTVVRN 284
D+L+ I + LG P + G+ LP+ K FPK
Sbjct: 208 DQLYHIIKCLGNLIPRHQEIFQKNPLFAGM-RLPEVKEIEPLEKRFPKL----------- 255
Query: 285 LEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316
+DL + L +DP R ++ L HE+F
Sbjct: 256 -SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 9e-74
Identities = 120/327 (36%), Positives = 174/327 (53%), Gaps = 51/327 (15%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+Y ++ IG G YG+V A+N TNE +A+KKI ++ +REI LL+ + H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 63 IVRLQDVVHSEKK-----LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
++ ++D++ + +Y+V+E +D DL + + S ++D + FLYQ+LRG+ Y
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDH--CQYFLYQLLRGLKY 123
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNA---LKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
HS VLHRDLKP NLL+ NA LK+ DFGLAR
Sbjct: 124 IHSANVLHRDLKPSNLLL----NANCDLKICDFGLAR----------------------- 156
Query: 175 SFLRYRVLAGSLILQFLK--VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
S F+ VVT WYRAPE+LL Y+T +DVWSVGCIFAE++ ++PL
Sbjct: 157 --------TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL 208
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKS---AFPKWPSKELGTVVRNLEPAG 289
FPG + +L I +LG+P+E+ + + + + P P + + + P
Sbjct: 209 FPGKDYVHQLKLITELLGSPSEEDLGFIRN-EKARRYIRSLPYTPRQSFARLFPHANPLA 267
Query: 290 IDLLSKMLCMDPSRRITARSALEHEYF 316
IDLL KML DPS+RIT AL H Y
Sbjct: 268 IDLLEKMLVFDPSKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 229 bits (587), Expect = 2e-73
Identities = 112/324 (34%), Positives = 159/324 (49%), Gaps = 44/324 (13%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D+Y+ + +G G YG V A + T +A+KK+ + RE+ LLK M H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 62 NIVRLQDVVHSEKKL------YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
N++ L DV L YLV + DL + +D I+ +YQILRG+
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDH-IQFLVYQILRGL 131
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y HS ++HRDLKP N+ ++ LK+ DFGLAR
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLAR------------------------ 166
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
+ + V T WYRAPEI+L HY+ VD+WSVGCI AE++ + LFPG
Sbjct: 167 ------HTDDEMTGY--VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
ID+L +I ++GTP+E+ ++S ++ + P+ P K+ V P IDLL
Sbjct: 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLL 278
Query: 294 SKMLCMDPSRRITARSALEHEYFR 317
KML +DP +RITA AL H Y
Sbjct: 279 EKMLVLDPDKRITAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 216 bits (553), Expect = 2e-68
Identities = 124/330 (37%), Positives = 179/330 (54%), Gaps = 55/330 (16%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTN--ETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-H 60
YE ++++G+G YG+V ARN T+ ET+A+KKI + + A+RE+ LL+ + H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 61 GNIVRL--QDVVHSEK--KLYLVFEYLDLDLKKHMDSCPDFANDPRL----IKTFLYQIL 112
NI L D+V +LYL E ++ DL + + S L ++F+YQIL
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS------GQPLTDAHFQSFIYQIL 115
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNA---LKLADFGLARAFGIPVRTFTHEHWGSTG 169
G+ Y HS VLHRDLKP NLL+ NA LK+ DFGLAR F E+ G
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLV----NADCELKICDFGLARGF--------SENPGENA 163
Query: 170 ISIYFSFLRYRVLAGSLILQFLK--VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
F+ V T WYRAPEI+L + Y+ +DVWSVGCI AE++
Sbjct: 164 -------------------GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204
Query: 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLP--DFKSAFPKWPSKELGTVVRNL 285
++P+F G +D+L +I +VLGTP+E+T + S ++ + P P K ++ N
Sbjct: 205 GRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNA 264
Query: 286 EPAGIDLLSKMLCMDPSRRITARSALEHEY 315
P +DLL K+L DP++RI+ ALEH Y
Sbjct: 265 NPLALDLLEKLLAFDPTKRISVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 1e-66
Identities = 115/328 (35%), Positives = 173/328 (52%), Gaps = 61/328 (18%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIR-----LEQEDEGVPSTAIREISLLKEM 58
Y+ + KIGEGT+ V KA++ T + A+K ++ LEQ +REI L+ +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ------VNNLREIQALRRL 54
Query: 59 Q-HGNIVRLQDVVHSEK--KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
H NI+RL +V+ K +L LVFE +D++L + + + R +K+++YQ+L+ +
Sbjct: 55 SPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKR-VKSYMYQLLKSL 113
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT-FTHEHWGSTGISIYF 174
+ H + + HRD+KP+N+LI + LKLADFG R GI + +T Y
Sbjct: 114 DHMHRNGIFHRDIKPENILIKD--DILKLADFGSCR--GIYSKPPYT----------EYI 159
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
S T WYRAPE LL +Y +D+W+VGC+F E+++ PLFP
Sbjct: 160 S-------------------TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200
Query: 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFK------SAFPKWPSKELGTVVRNLEPA 288
G +E+D++ KI VLGTP+ + L F+ FP L ++ N
Sbjct: 201 GTNELDQIAKIHDVLGTPDAEV------LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAE 254
Query: 289 GIDLLSKMLCMDPSRRITARSALEHEYF 316
G+DLL K+L DP RITA+ AL H YF
Sbjct: 255 GLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 3e-66
Identities = 117/317 (36%), Positives = 167/317 (52%), Gaps = 39/317 (12%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++Y ++ +G G +G+V AR+ +T + +A+KKI + RE+ LLK ++H
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 62 NIVRLQDVVHSEKK-LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NI+ L D+ S + +Y V E L DL + + S P + + I+ FLYQILRG+ Y HS
Sbjct: 70 NIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP---LEKQFIQYFLYQILRGLKYVHS 126
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
V+HRDLKP N+LI+ + LK+ DFGLAR + TG
Sbjct: 127 AGVVHRDLKPSNILINENCD-LKICDFGLAR---------IQDP-QMTGY---------- 165
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
V T +YRAPEI+L + Y VD+WS GCIFAEM+ +PLFPG ++
Sbjct: 166 ------------VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213
Query: 241 ELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
+ I +LGTP +D + S F + PK +N +P+ IDLL KML
Sbjct: 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLV 273
Query: 299 MDPSRRITARSALEHEY 315
DP +RI+A AL H Y
Sbjct: 274 FDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 2e-63
Identities = 121/332 (36%), Positives = 170/332 (51%), Gaps = 54/332 (16%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+Y ++++G G YG V A + T E +A+KK+ + E A RE++LLK MQH N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 63 IVRLQDVVHSE------KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
++ L DV S + YLV Y+ DL+K M + D ++ +YQ+L G+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH--PLSEDK--VQYLVYQMLCGLK 131
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
Y HS ++HRDLKP NL ++ LK+ DFGLAR H TG
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR----------HADAEMTGY------ 174
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
VVT WYRAPE++L HY+ VD+WSVGCI AEM+ + LF G
Sbjct: 175 ----------------VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPD-----FKSAFPKWPSKELGTVVRNLEPAGID 291
+D+L +I +V G P + V L D + + PK+P K+ T+ P +D
Sbjct: 219 DYLDQLTQILKVTGVPGPEF---VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVD 275
Query: 292 LLSKMLCMDPSRRITARSALEHEYF---RDVE 320
LL KML +D +R+TA ALEH YF RD +
Sbjct: 276 LLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 9e-62
Identities = 114/330 (34%), Positives = 171/330 (51%), Gaps = 47/330 (14%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D+Y ++++G G YG V A + T +A+KK+ + E A RE+ LLK M+H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 62 NIVRLQDVVHSEKKL------YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
N++ L DV + L YLV ++ DL K M + ++ R I+ +YQ+L+G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDR-IQFLVYQMLKGL 131
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y H+ ++HRDLKP NL ++ LK+ DFGLAR TG
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR----------QTDSEMTGY----- 175
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
VVT WYRAPE++L HY+ VD+WSVGCI AEM+ +PLF G
Sbjct: 176 -----------------VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
+D+L +I +V GTP+++ + S ++ P++ K+ +++ N P +++L
Sbjct: 219 HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVL 278
Query: 294 SKMLCMDPSRRITARSALEHEYF---RDVE 320
KML +D RITA AL H YF D E
Sbjct: 279 EKMLVLDAESRITAAEALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 194 bits (493), Expect = 3e-60
Identities = 111/320 (34%), Positives = 176/320 (55%), Gaps = 38/320 (11%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+++E + +GEG YGVV K R+ T E +A+KK + +E+E V T +RE+ +L+ ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
NIV L++ KLYLVFEY++ ++ + ++ P+ P +++++YQ+++ I +CH +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV-PPEKVRSYIYQLIKAIHWCHKN 119
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
++HRD+KP+NLLI + LKL DFG AR S G + ++ Y
Sbjct: 120 DIVHRDIKPENLLIS-HNDVLKLCDFGFARNL-------------SEGSNA--NYTEY-- 161
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
V T WYR+PE+LLG+ Y VD+WSVGCI E+ + +PLFPG+SEID+
Sbjct: 162 -----------VATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRN----LEPAGIDLLSKM 296
LF I +VLG + S P F FP + ++ R L +DL+ +
Sbjct: 210 LFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQ--SLERRYLGILSGVLLDLMKNL 267
Query: 297 LCMDPSRRITARSALEHEYF 316
L ++P+ R L H F
Sbjct: 268 LKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 9e-60
Identities = 104/334 (31%), Positives = 165/334 (49%), Gaps = 46/334 (13%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+Y + +G G+ G+V+ A + ++ +A+KKI L D A+REI +++ + H N
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDN 63
Query: 63 IVRLQDVVHSE--------------KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFL 108
IV++ +V+ +Y+V EY++ DL ++ P RL F+
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL---FM 120
Query: 109 YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGST 168
YQ+LRG+ Y HS VLHRDLKP N+ I+ LK+ DFGLAR I ++H+ + S
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR---IVDPHYSHKGYLSE 177
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228
G +VT WYR+P +LL +Y+ +D+W+ GCIFAEM+
Sbjct: 178 G-----------------------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214
Query: 229 QRPLFPGDSEIDELFKIFR-VLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEP 287
+PLF G E++++ I V ED + +P F P + L ++ + P
Sbjct: 215 GKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNP 274
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEYFRDVEF 321
+D L ++L +P R+TA AL H Y
Sbjct: 275 EALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC 308
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 6e-57
Identities = 114/327 (34%), Positives = 162/327 (49%), Gaps = 59/327 (18%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
IG G +GVV+ + + +ALKK+ ++ RE+ +L +H N++ D+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 70 VHSE-----KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVL 124
+ +++Y+V E + DL K + S ++D +K FLYQILRG+ Y HS +L
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDH--VKVFLYQILRGLKYLHSAGIL 125
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEHWGSTGISIYFSFLRYRVLA 183
HRD+KP NLL++ LK+ DFGLAR + T E
Sbjct: 126 HRDIKPGNLLVNSNC-VLKICDFGLARVEEPDESKHMTQE-------------------- 164
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243
VVT +YRAPEIL+GSRHY++ VD+WSVGCIFAE++ +R LF S I +L
Sbjct: 165 ---------VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215
Query: 244 KIFRVLGTPNEDTWPGVTSLPDFKSAF-----------PKWPSKE-LGTVVRNLEPAGID 291
I +LGTP SL +SA K PS L T+ +
Sbjct: 216 LITDLLGTP---------SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVH 266
Query: 292 LLSKMLCMDPSRRITARSALEHEYFRD 318
LL +ML DP +RI+A AL H Y +
Sbjct: 267 LLCRMLVFDPDKRISAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 6e-57
Identities = 75/218 (34%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
+GEG +G VY AR+ T + +A+K I+ E + +REI +LK++ H NIV+L V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGV 59
Query: 70 VHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDL 128
E LYLV EY + LK + I L QIL G+ Y HS+ ++HRDL
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 129 KPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLIL 188
KP+N+L+D +KLADFGL++
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-------------------------- 152
Query: 189 QFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
V T Y APE+LLG +YS D+WS+G I E+
Sbjct: 153 ---IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 186 bits (472), Expect = 9e-57
Identities = 119/340 (35%), Positives = 182/340 (53%), Gaps = 62/340 (18%)
Query: 9 KIGEGTYGVVYKAR--NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
K+G GTYG VYKA+ + + ALK+I E G+ +A REI+LL+E++H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIAL 63
Query: 67 QDVV--HSEKKLYLVFEYLDLDL----KKHMDSCPDFA--NDPR-LIKTFLYQILRGIAY 117
Q V HS++K++L+F+Y + DL K H S + PR ++K+ LYQIL GI Y
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 118 CHSHRVLHRDLKPQNLLI---DRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
H++ VLHRDLKP N+L+ +K+AD G AR F P++
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD---------- 173
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
VVT WYRAPE+LLG+RHY+ +D+W++GCIFAE++ P+F
Sbjct: 174 ----------------PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
Query: 235 GDSEI---------DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELG--TVVR 283
E D+L +IF V+G P + W + +P++ + + ++++
Sbjct: 218 CRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIK 277
Query: 284 NLEPAGID-------LLSKMLCMDPSRRITARSALEHEYF 316
+E + LL K+L MDP++RIT+ AL+ YF
Sbjct: 278 YMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 186 bits (472), Expect = 2e-56
Identities = 113/323 (34%), Positives = 159/323 (49%), Gaps = 44/323 (13%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++Y+ + +G G YG V A + T +A+KK+ + RE+ LLK M+H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 62 NIVRLQDVVHSEKKL------YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
N++ L DV + L YLV + DL ++ C +D ++ +YQILRG+
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN-NIVKCQKLTDDH--VQFLIYQILRGL 133
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y HS ++HRDLKP NL ++ LK+ DFGLAR H TG
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR----------HTDDEMTGY----- 177
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
V T WYRAPEI+L HY+ VD+WSVGCI AE++ R LFPG
Sbjct: 178 -----------------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
ID+L I R++GTP + ++S ++ + + P V P +DLL
Sbjct: 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 280
Query: 294 SKMLCMDPSRRITARSALEHEYF 316
KML +D +RITA AL H YF
Sbjct: 281 EKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 2e-56
Identities = 105/323 (32%), Positives = 166/323 (51%), Gaps = 44/323 (13%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++Y+ + +G G YG V A + + +A+KK+ + RE+ LLK M+H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 62 NIVRLQDV------VHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
N++ L DV + + ++YLV + DL ++ C +++ ++ +YQ+LRG+
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLN-NIVKCQKLSDEH--VQFLIYQLLRGL 131
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y HS ++HRDLKP N+ ++ L++ DFGLAR + +
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQADDEMTGY--------------- 175
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
V T WYRAPEI+L HY+ VD+WSVGCI AE++ + LFPG
Sbjct: 176 -----------------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
+ ID+L +I V+GTP+ + ++S + + P P ++L + R P IDLL
Sbjct: 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLL 278
Query: 294 SKMLCMDPSRRITARSALEHEYF 316
KML +D +RI+A AL H YF
Sbjct: 279 EKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 2e-56
Identities = 113/339 (33%), Positives = 159/339 (46%), Gaps = 64/339 (18%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+Y+ ++ IG G G+V A + VT + +A+KK+ ++ A RE+ L+K + H N
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKN 76
Query: 63 IVRLQDVVHSEKKL------YLVFEYLDLDLKK--HMDSCPDFANDPRLIKTFLYQILRG 114
I+ L +V +K L YLV E +D +L + MD D + LYQ+L G
Sbjct: 77 IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDL------DHERMSYLLYQMLCG 130
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
I + HS ++HRDLKP N+++ LK+ DFGLAR G S ++ Y
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAG-----------TSFMMTPY- 177
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
VVT +YRAPE++LG Y VD+WSVGCI EM+ LFP
Sbjct: 178 ------------------VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFP 218
Query: 235 GDSEIDELFKIFRVLGTPNED--------------TWPGVTSLPDFKSAFPKW--PSKEL 278
G ID+ KI LGTP+++ P F+ FP P
Sbjct: 219 GTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYS-FEELFPDVLFPPDSE 277
Query: 279 GTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317
A DLLSKML +DP +RI+ AL+H Y
Sbjct: 278 SHNKLKASQAR-DLLSKMLVIDPEKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 8e-56
Identities = 117/340 (34%), Positives = 180/340 (52%), Gaps = 62/340 (18%)
Query: 9 KIGEGTYGVVYKAR--NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
K+G GTYG VYKA+ + + ALK+I E G+ +A REI+LL+E++H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISL 63
Query: 67 QDVV--HSEKKLYLVFEYLDLDL----KKHMDSCPDF--ANDPR-LIKTFLYQILRGIAY 117
Q V H+++K++L+F+Y + DL K H S + PR ++K+ LYQIL GI Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 118 CHSHRVLHRDLKPQNLLI---DRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
H++ VLHRDLKP N+L+ +K+AD G AR F P++
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD---------- 173
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
VVT WYRAPE+LLG+RHY+ +D+W++GCIFAE++ P+F
Sbjct: 174 ----------------PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
Query: 235 GDSEI---------DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELG--TVVR 283
E D+L +IF V+G P + W + +P+ + + ++++
Sbjct: 218 CRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIK 277
Query: 284 NLEPAGID-------LLSKMLCMDPSRRITARSALEHEYF 316
+E + LL K+L MDP +RIT+ A++ YF
Sbjct: 278 YMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 1e-55
Identities = 116/330 (35%), Positives = 172/330 (52%), Gaps = 51/330 (15%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+Y+ E IG+G+YGVV A + T E +A+KKI E + +REI LL+ ++H +
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 63 IVRLQDVV-----HSEKKLYLVFEYLDLDLKKHMDSCPDFAND---PRLIKTFLYQILRG 114
IV ++ ++ K +Y+VFE ++ DL + + AND P + FLYQ+LR
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK-----ANDDLTPEHHQFFLYQLLRA 115
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNA---LKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
+ Y H+ V HRDLKP+N+L NA LK+ DFGLAR + T +
Sbjct: 116 LKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARV-----------AFNDTPTA 160
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS--RHYSTPVDVWSVGCIFAEMVNQ 229
I+++ Y V T WYRAPE L GS Y+ +D+WS+GCIFAE++
Sbjct: 161 IFWT--DY-------------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
Query: 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLP--DFKSAFPKWPSKELGTVVRNLEP 287
+PLFPG + + +L I +LGTP+ +T V + + S+ K N +P
Sbjct: 205 KPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADP 264
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEYFR 317
+ LL ++L DP R TA AL YF+
Sbjct: 265 LALRLLERLLAFDPKDRPTAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 181 bits (459), Expect = 4e-54
Identities = 96/324 (29%), Positives = 140/324 (43%), Gaps = 54/324 (16%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE-QEDEGVPSTAIREISLLKEMQH-G 61
Y + K+GEG++G VY AR+ + +ALK + + + +REI +L + H
Sbjct: 2 YRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFAN-DPRLIKTFLYQILRGIAYCH 119
NIV+L D E LYLV EY+D L+ + L QIL + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
S ++HRD+KP+N+L+DR +KL DFGLA+ P T + ST
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST----------- 167
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGS--RHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
V T Y APE+LLG + S+ D+WS+G E++ P F G+
Sbjct: 168 ------------SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
Query: 238 E---IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294
+ KI L TP+ + P+ SK DLL
Sbjct: 216 NSSATSQTLKIILELPTPS--------LASPLSPSNPELISKAA-----------SDLLK 256
Query: 295 KMLCMDPSRRITARSALEHEYFRD 318
K+L DP R+++ S L H+
Sbjct: 257 KLLAKDPKNRLSSSSDLSHDLLAH 280
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 5e-53
Identities = 87/318 (27%), Positives = 130/318 (40%), Gaps = 62/318 (19%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
++ + E +G G++G VY A + T E +A+K + L + E REI +L +QH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 63 IVR-LQDVVHSEKKLYLVF-EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
IVR EK +F EY+ L + +I+ + QIL G+AY H
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL--PEPVIRKYTRQILEGLAYLH 118
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
S+ ++HRD+K N+L+D KLADFG A+ TG
Sbjct: 119 SNGIVHRDIKGANILVDSDGVV-KLADFGCAK----------RLGDIETGEGT------- 160
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSE 238
+ G T ++ APE++ G Y D+WS+GC EM + P +
Sbjct: 161 GSVRG----------TPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNP 209
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
+ L+KI P P+ S+E D L K L
Sbjct: 210 MAALYKIGSSGEPPE----------------IPEHLSEEA-----------KDFLRKCLR 242
Query: 299 MDPSRRITARSALEHEYF 316
DP +R TA L+H +
Sbjct: 243 RDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-52
Identities = 111/327 (33%), Positives = 173/327 (52%), Gaps = 60/327 (18%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
IG G++GVVY+A T+E +A+KK+ + P RE+ ++K + H NI+ L+D
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDY 127
Query: 70 VHSE------KKLYL--VFEYLDLDLKKHM-------DSCPDFANDPRLIKTFLYQILRG 114
++E K ++L V E++ + K+M + P F L+K + YQ+ R
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF-----LVKLYSYQLCRA 182
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+AY HS + HRDLKPQNLLID T+ LKL DFG A+
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK----------------------- 219
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
+LAG + + + + +YRAPE++LG+ +Y+T +D+WS+GCI AEM+ P+F
Sbjct: 220 -----NLLAGQRSVSY--ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272
Query: 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSA-FPKWPSKELGTVVRNLEP-AGIDL 292
G S +D+L +I +VLGTP ED + P++ FP K+L V P I+
Sbjct: 273 GQSSVDQLVRIIQVLGTPTEDQLKEMN--PNYADIKFPDVKPKDLKKVFPKGTPDDAINF 330
Query: 293 LSKMLCMDPSRRITARSALEHEYFRDV 319
+S+ L +P +R+ AL +F D+
Sbjct: 331 ISQFLKYEPLKRLNPIEALADPFFDDL 357
|
Length = 440 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 9e-48
Identities = 112/342 (32%), Positives = 164/342 (47%), Gaps = 71/342 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ +Y++++ IG G G+V A + V +A+KK+ +++ A RE+ LLK + H
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 61 GNIVRLQDVVHSEKKL------YLVFEYLDLDLKK--HMDSCPDFANDPRLIKTFLYQIL 112
NI+ L +V +K L YLV E +D +L + HM+ D + LYQ+L
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMEL------DHERMSYLLYQML 133
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
GI + HS ++HRDLKP N+++ + LK+ DFGLAR
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLART-----------------ACT 175
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
F Y VVT +YRAPE++LG Y VD+WSVGCI E+V +
Sbjct: 176 NFMMTPY-------------VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVI 221
Query: 233 FPGDSEIDELFKIFRVLGTP-----------------NEDTWPGVTSLPDFKSAFPKW-- 273
F G ID+ K+ LGTP N +PG++ F+ FP W
Sbjct: 222 FQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGIS----FEELFPDWIF 277
Query: 274 PSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315
PS+ ++ + DLLSKML +DP +RI+ AL H Y
Sbjct: 278 PSESERDKLKTSQAR--DLLSKMLVIDPDKRISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 159 bits (406), Expect = 2e-47
Identities = 79/315 (25%), Positives = 138/315 (43%), Gaps = 66/315 (20%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+YE +++IG+G++G VY R + LK+I L E A+ E+ +LK++ H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 63 IVRLQDVVHSEKKLYLVFEY-----LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
I++ + + KL +V EY L +KK F + +++ F+ Q+ + Y
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-QILDWFV-QLCLALKY 118
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
HS ++LHRD+KPQN+ + +KL DFG+++
Sbjct: 119 LHSRKILHRDIKPQNIFLTS-NGLVKLGDFGISK-------------------------- 151
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
VL+ ++ L V T +Y +PE+ + Y+ D+WS+GC+ E+ + F G++
Sbjct: 152 ---VLSSTVDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
++ KI + G P S EL +L+S +L
Sbjct: 208 LLELALKILK--GQY---------------PPIPSQYSSEL-----------RNLVSSLL 239
Query: 298 CMDPSRRITARSALE 312
DP R + L+
Sbjct: 240 QKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-44
Identities = 110/340 (32%), Positives = 165/340 (48%), Gaps = 67/340 (19%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ +Y+ ++ IG G G+V A + V + +A+KK+ +++ A RE+ L+K + H
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 61 GNIVRLQDVVHSEKKL------YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
NI+ L +V +K L YLV E +D +L + + D + LYQ+L G
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCG 131
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
I + HS ++HRDLKP N+++ + LK+ DFGLAR
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLART---------------------- 168
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
AG+ + VVT +YRAPE++LG Y VD+WSVGCI EMV + LFP
Sbjct: 169 --------AGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFP 219
Query: 235 GDSEIDELFKIFRVLGTP-----------------NEDTWPGVTSLPDFKSAFPK--WPS 275
G ID+ K+ LGTP N + G+T F FP +P+
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT----FPKLFPDSLFPA 275
Query: 276 KELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315
++ + DLLSKML +DP++RI+ AL+H Y
Sbjct: 276 DSEHNKLKASQAR--DLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-43
Identities = 85/318 (26%), Positives = 140/318 (44%), Gaps = 72/318 (22%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
+E +EKIG+G +G VYKAR+ T + +A+K I+LE +++ I EI +LK+ +H NI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK--KEKIINEIQILKKCKHPNI 59
Query: 64 VRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
V+ + +L++V E+ DL K + + I ++L+G+ Y H
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ----IAYVCKELLKGLEYLH 115
Query: 120 SHRVLHRDLKPQNLLIDRRTNA-LKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
S+ ++HRD+K N+L+ ++ +KL DFGL S S +
Sbjct: 116 SNGIIHRDIKAANILLT--SDGEVKLIDFGL---------------------SAQLSDTK 152
Query: 179 YR-VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
R + G T ++ APE++ G Y D+WS+G E+ +P +
Sbjct: 153 ARNTMVG----------TPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELP 201
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
+ LFKI P ++ P+ S E D L K L
Sbjct: 202 PMKALFKIATN-------------GPPGLRN--PEKWSDEF-----------KDFLKKCL 235
Query: 298 CMDPSRRITARSALEHEY 315
+P +R TA L+H +
Sbjct: 236 QKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 107/336 (31%), Positives = 163/336 (48%), Gaps = 59/336 (17%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ +Y+ ++ IG G G+V A + + +A+KK+ +++ A RE+ L+K + H
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 61 GNIVRLQDVVHSEKKL------YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
NI+ L +V +K L Y+V E +D +L + + D + LYQ+L G
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCG 138
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
I + HS ++HRDLKP N+++ + LK+ DFGLAR
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLART---------------------- 175
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
AG+ + VVT +YRAPE++LG Y VD+WSVGCI EM+ LFP
Sbjct: 176 --------AGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFP 226
Query: 235 GDSEIDELFKIFRVLGTP----NEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPA-- 288
G ID+ K+ LGTP + P V + + + + + ++L V L PA
Sbjct: 227 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDV--LFPADS 284
Query: 289 ---------GIDLLSKMLCMDPSRRITARSALEHEY 315
DLLSKML +D S+RI+ AL+H Y
Sbjct: 285 EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-42
Identities = 86/318 (27%), Positives = 139/318 (43%), Gaps = 68/318 (21%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Y+ + IG G +GVVYK N T + +A+K+I LE+ E + ++EI LLK ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 63 IVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
IV+ + + LY++ EY + + K P+ L+ ++YQ+L+G+AY
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE-----SLVAVYVYQVLQGLAYL 115
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
H V+HRD+K N+L + KLADFG+A +
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVV-KLADFGVA-------TKLNDVSKDDASV-------- 159
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
V T ++ APE++ S ST D+WS+GC E++ P + +
Sbjct: 160 --------------VGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNP 204
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
+ LF+I +D P LP+ + P D L +
Sbjct: 205 MAALFRIV------QDDHPP----LPE------------------GISPELKDFLMQCFQ 236
Query: 299 MDPSRRITARSALEHEYF 316
DP+ R TA+ L+H +
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 3e-41
Identities = 91/317 (28%), Positives = 142/317 (44%), Gaps = 68/317 (21%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Y+ +EKIGEG G VYKA + T + +A+KK+RL ++++ I EI ++K+ +H NI
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNI 77
Query: 64 VRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
V D +L++V EY+D D+ + N+P+ I ++L+G+ Y H
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDI---ITQNFVRMNEPQ-IAYVCREVLQGLEYLH 133
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
S V+HRD+K N+L+ + + +KLADFG A T E +
Sbjct: 134 SQNVIHRDIKSDNILLSKDGS-VKLADFGFA-------AQLTKEKSKRNSV--------- 176
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
V T ++ APE++ Y VD+WS+G + EM P + + +
Sbjct: 177 -------------VGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPL 222
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
LF I G P K+ KW S E D L+K L
Sbjct: 223 RALFLI-TTKGI------------PPLKNP-EKW-SPEF-----------KDFLNKCLVK 256
Query: 300 DPSRRITARSALEHEYF 316
DP +R +A L+H +
Sbjct: 257 DPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-39
Identities = 91/323 (28%), Positives = 142/323 (43%), Gaps = 70/323 (21%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
++++ KIG GT+G VY A N T E +A+K+IR++ D E+ +L+ ++H N
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 63 IVRLQDV-VHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
+V+ V VH EK +Y+ EY L+ + +D +I+ + Q+L G
Sbjct: 61 LVKYYGVEVHREK-VYIFMEYCSGGTLEELLEHGRILDE--------HVIRVYTLQLLEG 111
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+AY HSH ++HRD+KP N+ +D +KL DFG A T E G
Sbjct: 112 LAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMGEEVQSLAG----- 165
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR--HYSTPVDVWSVGCIFAEMVNQRPL 232
T Y APE++ G + + D+WS+GC+ EM +
Sbjct: 166 --------------------TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
+ SE+D F+I +G ++ P P L P G D
Sbjct: 206 W---SELDNEFQIMFHVGAGHK----------------PPIPDSL------QLSPEGKDF 240
Query: 293 LSKMLCMDPSRRITARSALEHEY 315
L + L DP +R TA L+H +
Sbjct: 241 LDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 6e-39
Identities = 85/317 (26%), Positives = 131/317 (41%), Gaps = 70/317 (22%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQH 60
+ K E +G G++G VY+ N + A+K++ L + + +EI+LL ++QH
Sbjct: 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
NIV+ E LY+ E + L K S P+ +I+ + QIL G+
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE-----PVIRLYTRQILLGLE 116
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
Y H +HRD+K N+L+D +KLADFG+A+
Sbjct: 117 YLHDRNTVHRDIKGANILVD-TNGVVKLADFGMAK------------------------- 150
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
+V+ S F + ++ APE++ Y D+WS+GC EM +P +
Sbjct: 151 ---QVVEFSFAKSF--KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKM 296
+ +FKI R SKEL + +L D + K
Sbjct: 206 EGVAAVFKIGR---------------------------SKELPPIPDHLSDEAKDFILKC 238
Query: 297 LCMDPSRRITARSALEH 313
L DPS R TA LEH
Sbjct: 239 LQRDPSLRPTAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 6e-38
Identities = 86/319 (26%), Positives = 140/319 (43%), Gaps = 69/319 (21%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ ++ +EK+GEG+YG VYKA + T + +A+K + +E++ + + I+EIS+LK+
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEI----IKEISILKQCDSP 58
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
IV+ L++V EY D+ M + I LYQ L+G+ Y
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDI---MKITNKTLTE-EEIAAILYQTLKGLEY 114
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
HS++ +HRD+K N+L++ A KLADFG++ G T
Sbjct: 115 LHSNKKIHRDIKAGNILLNEEGQA-KLADFGVS---GQLTDTMA---------------- 154
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
++I T ++ APE++ Y+ D+WS+G EM +P + S
Sbjct: 155 ----KRNTVI------GTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPY---S 200
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
+I + IF + PN P P P+ S E D + K L
Sbjct: 201 DIHPMRAIFMI---PN---KPP----PTLSD--PEKWSPEF-----------NDFVKKCL 237
Query: 298 CMDPSRRITARSALEHEYF 316
DP R +A L+H +
Sbjct: 238 VKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-36
Identities = 85/326 (26%), Positives = 134/326 (41%), Gaps = 79/326 (24%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
YE +E IG+G++G V K R + + K+I E + E+++L+E++H N
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 63 IVRLQD--VVHSEKKLYLVFEYLDL-DLKKHMDSCP---DFANDPRLIKTFLYQILRGIA 116
IVR D + S + LY+V EY + DL + + C + + + + Q+L +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QLLLALY 119
Query: 117 YCH-----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
CH + VLHRDLKP N+ +D N KL DFGLA+ G +F + G
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNV-KLGDFGLAKILGHD-SSFAKTYVG----- 172
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231
T +Y +PE L Y D+WS+GC+ E+ P
Sbjct: 173 -----------------------TPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSP 208
Query: 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSA-FPKWP---SKELGTVVRNLEP 287
F +++ KI K F + P S EL V+++
Sbjct: 209 PFTARNQLQLASKI---------------------KEGKFRRIPYRYSSELNEVIKS--- 244
Query: 288 AGIDLLSKMLCMDPSRRITARSALEH 313
ML +DP +R + L+
Sbjct: 245 --------MLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-36
Identities = 84/324 (25%), Positives = 142/324 (43%), Gaps = 53/324 (16%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEM 58
D ++ + IGEG++ V A+ TN+ A+K K +L +E + V I + L +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK-VKYVKIEKEVLTRLN 59
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYL-DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
H I++L E+ LY V EY + +L +++ D + + + +IL + Y
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSL--DEKCTRFYAAEILLALEY 117
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
HS ++HRDLKP+N+L+D+ +K+ DFG A+ E +I
Sbjct: 118 LHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSS---PESNKGDATNIDSQIE 173
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
+ R S V T Y +PE LL + D+W++GCI +M+ +P F G +
Sbjct: 174 KNRRRFASF------VGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226
Query: 238 EIDELFKIF-RVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKM 296
E + F ++L E ++P P +P P DL+ K+
Sbjct: 227 E----YLTFQKIL--KLEYSFP------------PNFP------------PDAKDLIEKL 256
Query: 297 LCMDPSRRITARSALE----HEYF 316
L +DP R+ + H +F
Sbjct: 257 LVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 95/323 (29%), Positives = 148/323 (45%), Gaps = 69/323 (21%)
Query: 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRL-----EQEDEGVPST--AIR-EISLLKE 57
K E IG+GTYG VY A N T E +A+K++ L + D A+R EI LK+
Sbjct: 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSC----PDFANDPRLIKTFLYQILR 113
+ H NIV+ +E+ L + EY+ + SC F + +L++ F Q+L
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVP---GGSIGSCLRTYGRF--EEQLVRFFTEQVLE 119
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
G+AY HS +LHRDLK NLL+D K++DFG+++ IY
Sbjct: 120 GLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISK----------------KSDDIY 162
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEIL-LGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
+ ++ +Q ++++ APE++ S+ YS VD+WS+GC+ EM R
Sbjct: 163 DND-------QNMSMQG----SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
+ + I +FK+ K + P P V NL P +D
Sbjct: 212 WSDEEAIAAMFKLGN-------------------KRSAPPIPPD----VSMNLSPVALDF 248
Query: 293 LSKMLCMDPSRRITARSALEHEY 315
L+ ++P R TAR L+H +
Sbjct: 249 LNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-35
Identities = 85/314 (27%), Positives = 137/314 (43%), Gaps = 71/314 (22%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIR--LEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
+G+G++G V R T + A+K ++ + + V T + E ++L + H IV+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHT-LTERNILSRINHPFIVKLH 59
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHR 126
+E+KLYLV EY +L H+ F + + +I+ + Y HS +++R
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRF--SEERARFYAAEIVLALEYLHSLGIIYR 117
Query: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSL 186
DLKP+N+L+D + +KL DFGLA+ S G +F
Sbjct: 118 DLKPENILLDADGH-IKLTDFGLAKEL------------SSEGSRTN-TF---------- 153
Query: 187 ILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF-KI 245
T Y APE+LLG Y VD WS+G + EM+ +P F + E++ KI
Sbjct: 154 ------CGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKI 205
Query: 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI 305
+ FP++ S E DL+S +L DP++R+
Sbjct: 206 LKD------------------PLRFPEFLSPEA-----------RDLISGLLQKDPTKRL 236
Query: 306 TARSALE---HEYF 316
+ A E H +F
Sbjct: 237 GSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 84/321 (26%), Positives = 136/321 (42%), Gaps = 78/321 (24%)
Query: 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
E+V+ +G+G+ GVVYK R+ T + ALKKI ++ DE +RE+ L+ + +V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVD-GDEEFRKQLLRELKTLRSCESPYVV 62
Query: 65 RLQDVVHSEKKLYLVFEYLDL----DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
+ + E ++ +V EY+D DL K + P ++ QIL+G+ Y H+
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP-----EPVLAYIARQILKGLDYLHT 117
Query: 121 -HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
++HRD+KP NLLI+ + +K+ADFG+++ + +F
Sbjct: 118 KRHIIHRDIKPSNLLINSK-GEVKIADFGISKVL-------------ENTLDQCNTF--- 160
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM-VNQRPLFPGDSE 238
V T+ Y +PE + G YS D+WS+G E + + P P
Sbjct: 161 -------------VGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLP---- 202
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAF-----PKWPSKELGTVVRNLEPAGIDLL 293
PG S + A P P++E P D +
Sbjct: 203 -------------------PGQPSFFELMQAICDGPPPSLPAEE-------FSPEFRDFI 236
Query: 294 SKMLCMDPSRRITARSALEHE 314
S L DP +R +A L+H
Sbjct: 237 SACLQKDPKKRPSAAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-34
Identities = 88/317 (27%), Positives = 140/317 (44%), Gaps = 61/317 (19%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
I +G YG V+ A+ T + A+K I + + + + E +L + Q +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 69 VVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRD 127
+K LYLV EYL DL +++ D + + ++ +I+ + Y HS+ ++HRD
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSL--DEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 128 LKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLI 187
LKP N+LID LKL DFGL+ +R ++
Sbjct: 119 LKPDNILIDS-NGHLKLTDFGLS----------------------KVGLVRRQINLNDDE 155
Query: 188 LQFLKVV-TLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF-KI 245
+ ++V T Y APE++LG H S VD WS+GCI E + P F G++ +E+F I
Sbjct: 156 KEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETP-EEIFQNI 213
Query: 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI 305
WP + IDL+SK+L DP +R+
Sbjct: 214 --------------------LNGKIE-WPEDV------EVSDEAIDLISKLLVPDPEKRL 246
Query: 306 TARSALE---HEYFRDV 319
A+S E H +F+ +
Sbjct: 247 GAKSIEEIKNHPFFKGI 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-34
Identities = 80/311 (25%), Positives = 133/311 (42%), Gaps = 66/311 (21%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQ 59
+ ++ +KIG+G + VVYKA + +ALKK+++ E D ++EI LLK++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIK-----TFLYQILR 113
H N+++ +L +V E D DL + + F RLI + Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKH---FKKQKRLIPERTIWKYFVQLCS 117
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
+ + HS R++HRD+KP N+ I T +KL D GL R F S+ +
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITA-TGVVKLGDLGLGRFF-------------SSKTTAA 163
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
S V T +Y +PE + + Y+ D+WS+GC+ EM + F
Sbjct: 164 HS----------------LVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPF 206
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
GD L+ + + + K +P P+ +R DL+
Sbjct: 207 YGDKM--NLYSLCKKIE----------------KCDYPPLPADHYSEELR-------DLV 241
Query: 294 SKMLCMDPSRR 304
S+ + DP +R
Sbjct: 242 SRCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 37/227 (16%)
Query: 5 EKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+K+GEG +G VYK + +A+K ++ + ++ + +RE +++++ H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI-EEFLREARIMRKLDH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
N+V+L V E+ LY+V EY++ DL ++ + L+ F QI RG+ Y
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLS-FALQIARGMEYLE 119
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
S +HRDL +N L+ +K++DFGL+R Y
Sbjct: 120 SKNFIHRDLAARNCLVGEN-LVVKISDFGLSRD------------LYDDDY--------Y 158
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
R G L ++ W APE L +++ DVWS G + E+
Sbjct: 159 RKRGGKLPIR-------WM-APESLK-EGKFTSKSDVWSFGVLLWEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 36/227 (15%)
Query: 5 EKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+K+GEG +G VYK +A+K ++ + ++ + +RE +++++ H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI-EEFLREARIMRKLDH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
NIV+L V E+ L +V EY+ DL ++ + +F QI RG+ Y
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
S +HRDL +N L+ +K++DFGL+R Y
Sbjct: 121 SKNFIHRDLAARNCLVGEN-LVVKISDFGLSRD------------LYDDDY--------Y 159
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
+V G L ++ W APE L +++ DVWS G + E+
Sbjct: 160 KVKGGKLPIR-------WM-APESLK-EGKFTSKSDVWSFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-30
Identities = 86/323 (26%), Positives = 138/323 (42%), Gaps = 63/323 (19%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ----EDEGVPSTAIREISLLKEM 58
++ K +++G G + Y+AR+ T +A+K++ + E E V +EI L+ +
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDF-ANDPRLIKTFLYQILRGIAY 117
H +I+R+ + L E++ H+ S + A +I + Q+LRG++Y
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSY 118
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
H ++++HRD+K NLLID L++ADFG A TG
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG----------TG-------- 160
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
AG Q L T+ + APE+L G Y DVWSVGC+ EM +P + +
Sbjct: 161 -----AGEFQGQLLG--TIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212
Query: 238 EIDEL---FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294
+ L FKI P S+P+ +L P D+
Sbjct: 213 HSNHLALIFKIASATTAP---------SIPE------------------HLSPGLRDVTL 245
Query: 295 KMLCMDPSRRITARSALEHEYFR 317
+ L + P R +R L+H FR
Sbjct: 246 RCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 82/324 (25%), Positives = 130/324 (40%), Gaps = 66/324 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D YE +E IG G VVY A NE +A+K+I LE+ V +E+ + + H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE-LRKEVQAMSQCNHP 59
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
N+V+ +L+LV YL LD+ K S P D +I T L ++L+G+ Y
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKS--SYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RTFTHEHWGSTGISIYFSF 176
HS+ +HRD+K N+L+ ++K+ADFG++ + RT
Sbjct: 118 LHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRT---------------RK 161
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP----L 232
+R V T + APE++ Y D+WS G E+
Sbjct: 162 VRKTF-----------VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
P K+ + + + + +F K +
Sbjct: 211 PP--------MKVLMLTLQNDPPSLETGADYKKYSKSFRK-------------------M 243
Query: 293 LSKMLCMDPSRRITARSALEHEYF 316
+S L DPS+R TA L+H++F
Sbjct: 244 ISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 76/324 (23%), Positives = 130/324 (40%), Gaps = 77/324 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ + +E IG+G++G VYKA + TN+ +A+K I LE+ ++ + +EI L + +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-EDIQQEIQFLSQCRSP 59
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
I + KL+++ EY LDL + D I L ++L G+ Y
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDL---LKPGKL---DETYIAFILREVLLGLEY 113
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
H +HRD+K N+L+ + KLADFG
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDV-KLADFG----------------------------- 143
Query: 178 RYRVLAGSLILQFLK----VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
++G L K V T ++ APE++ S Y D+WS+G E+ P
Sbjct: 144 ----VSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPL 198
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
S++ + ++ ++ N + G FK D +
Sbjct: 199 ---SDLHPM-RVLFLIPKNNPPSLEGNKFSKPFK-----------------------DFV 231
Query: 294 SKMLCMDPSRRITARSALEHEYFR 317
S L DP R +A+ L+H++ +
Sbjct: 232 SLCLNKDPKERPSAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-29
Identities = 87/322 (27%), Positives = 134/322 (41%), Gaps = 61/322 (18%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D E + ++G G GVV K + T + +A+K IRLE +E + +RE+ +L +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSP 59
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
IV ++ + + EY+D L K + + L K +L+G+ Y H
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIA-VAVLKGLTYLHE 118
Query: 121 -HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
H+++HRD+KP N+L++ R +KL DFG++
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQ-IKLCDFGVSG---------------------------- 149
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
L SL F V T Y APE + G+ YS D+WS+G E+ R FP E
Sbjct: 150 -QLVNSLAKTF--VGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGR--FPYPPEN 203
Query: 240 DELFKIFRVLG-TPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
D IF +L NE P+ PS + P D ++ L
Sbjct: 204 DPPDGIFELLQYIVNEPP--------------PRLPSGK-------FSPDFQDFVNLCLI 242
Query: 299 MDPSRRITARSALEHEYFRDVE 320
DP R + + LEH + + E
Sbjct: 243 KDPRERPSYKELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 65/245 (26%), Positives = 110/245 (44%), Gaps = 32/245 (13%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
+E + KIG+G++GVV+K A+K+I L + + AI E +L ++ I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 64 VRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
+R + + KL +V EY + DL K + + F QIL G+A+ HS +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
+LHRD+K NL +D N +K+ D G+A+ +L
Sbjct: 122 ILHRDIKSLNLFLDAYDN-VKIGDLGVAK-----------------------------LL 151
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242
+ + V T +Y +PE L + Y+ DVW++G + E + F +++ +
Sbjct: 152 SDNTNFANTIVGTPYYLSPE-LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI 210
Query: 243 FKIFR 247
KI R
Sbjct: 211 LKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 70/246 (28%), Positives = 117/246 (47%), Gaps = 31/246 (12%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+YE ++KIGEG++G +Y A+ +E +K+I L + + +E+ LL +M+H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 63 IVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
IV +L++V EY D DL K ++ I ++ QI G+ + H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
++LHRD+K QN+ + + KL DFG+AR
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIAR-----------------------------Q 151
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
L S+ L + V T +Y +PEI +R Y+ D+WS+GC+ E+ + F G++
Sbjct: 152 LNDSMELAYTCVGTPYYLSPEIC-QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL 210
Query: 242 LFKIFR 247
+ KI +
Sbjct: 211 VLKICQ 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 91/324 (28%), Positives = 140/324 (43%), Gaps = 74/324 (22%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ YE +++IG GTYG VYKAR+ T E +A+K I+LE D+ +EIS+LKE +H
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD--FEIIQQEISMLKECRHP 60
Query: 62 NIVRLQDVVHSEKKLYLVFEY-----LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
NIV KL++V EY L + + I + L+G+A
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSE-----LQIAYVCRETLKGLA 115
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
Y H +HRD+K N+L+ + +KLADFG++ + I+ SF
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGD-VKLADFGVSAQL-------------TATIAKRKSF 161
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH--YSTPVDVWSVG--CI-FAEMVNQRP 231
+ T ++ APE+ R Y D+W++G I AE+ Q P
Sbjct: 162 ----------------IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAEL--QPP 203
Query: 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291
+F ++ + +F + S +F PK KE + P D
Sbjct: 204 MF----DLHPMRALFLI-------------SKSNFPP--PKLKDKEKWS------PVFHD 238
Query: 292 LLSKMLCMDPSRRITARSALEHEY 315
+ K L DP +R TA L+H +
Sbjct: 239 FIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 44/225 (19%)
Query: 5 EKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTA----IREISLLK 56
E +K+GEG +G VYK T +A+K ++ EG + E S++K
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK-----EGASEEEREEFLEEASIMK 56
Query: 57 EMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
++ H NIVRL V + LY+V EY+ DL + + L++ QI +G+
Sbjct: 57 KLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQ-MALQIAKGM 115
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y S +HRDL +N L+ +K++DFGL+R IY
Sbjct: 116 EYLESKNFVHRDLAARNCLVT-ENLVVKISDFGLSRD-------------------IY-E 154
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
YR G + W APE L + +++ DVWS G
Sbjct: 155 DDYYRKRGGGKLPIK------WM-APESLKDGK-FTSKSDVWSFG 191
|
Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 78/321 (24%), Positives = 131/321 (40%), Gaps = 74/321 (23%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHG-NIVRLQ 67
I +G +G VY A+ T + A+K ++ T ++ E +++ + +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 68 DVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
S+ LYLV EYL+ L K + P+ K ++ +++ G+ H +
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE-----DWAKQYIAEVVLGVEDLHQRGI 118
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
+HRD+KP+NLLID +T LKL DFGL+R +
Sbjct: 119 IHRDIKPENLLID-QTGHLKLTDFGLSRNGLENKKFVG---------------------- 155
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243
T Y APE +LG D WS+GC+ E + P F ++ D +F
Sbjct: 156 -----------TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVF 202
Query: 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303
+L + P+ F P +DL++++LCMDP++
Sbjct: 203 D--NILS--------RRINWPEEVKEF--------------CSPEAVDLINRLLCMDPAK 238
Query: 304 RITARSALE---HEYFRDVEF 321
R+ A E H +F+ + +
Sbjct: 239 RLGANGYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 15/156 (9%)
Query: 8 EKIGEGTYGVVYKAR---NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
+K+GEG +G VYK + +A+K ++ E E ++E ++K++ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 65 RLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDP--------RLIKTFLYQILRGI 115
RL V E+ LYLV EY++ DL ++ P L+ F QI +G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS-FAIQIAKGM 118
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
Y S + +HRDL +N L+ +K++DFGL+R
Sbjct: 119 EYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 77/318 (24%), Positives = 126/318 (39%), Gaps = 68/318 (21%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQD 68
+G G +G V + N T ALK ++ + G E +L+E H IV+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 69 VVHSEKKLYLVFEY-LDLDLKKHMDSCPDFAN-DPRLIKTFLYQILRGIAYCHSHRVLHR 126
+K +Y++ EY L +L D D + ++ ++ Y H+ +++R
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL---WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSL 186
DLKP+NLL+D +KL DFG A+ +T+T G
Sbjct: 118 DLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWT--------------------FCG-- 154
Query: 187 ILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIF 246
T Y APEI+L + Y VD WS+G + E++ RP F D E +I+
Sbjct: 155 --------TPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIY 203
Query: 247 RVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI- 305
+ N K FP ++ A DL+ ++L +P R+
Sbjct: 204 NDILKGNG------------KLEFPN-----------YIDKAAKDLIKQLLRRNPEERLG 240
Query: 306 ----TARSALEHEYFRDV 319
+ +H++F
Sbjct: 241 NLKGGIKDIKKHKWFNGF 258
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 32/254 (12%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+YEK+ +G G +G+V+ R + + +K+I +EQ + A E +LK + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 63 IVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
I+ + +K L +V EY L +++ + D I F QIL + + H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+LHRDLK QN+L+D+ +K+ DFG+++ + +T
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-------------------- 160
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
V T Y +PE+ G + Y+ D+W++GC+ E+ + + F +
Sbjct: 161 ----------VVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPAL 209
Query: 242 LFKIFRVLGTPNED 255
+ KI P D
Sbjct: 210 VLKIMSGTFAPISD 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 82/315 (26%), Positives = 144/315 (45%), Gaps = 65/315 (20%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDE-------GVPSTAIREISLLKEMQHGN 62
IG G++G VY N + E +A+K++ L + REI+LLKE+QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 63 IVRLQDVVHSEKKLYLVFEYL-DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
IV+ L + EY+ + +++ F + L++ F+ QIL+G+ Y H+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAF--EETLVRNFVRQILKGLNYLHNR 125
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEHWGSTGISIYFSFLRYR 180
++HRD+K N+L+D + +K++DFG+++ + T T+ S
Sbjct: 126 GIIHRDIKGANILVDNK-GGIKISDFGISKKLEANSLSTKTNGARPS------------- 171
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
L GS +++ APE++ + Y+ D+WS+GC+ EM+ + FP +++
Sbjct: 172 -LQGS----------VFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
+FKI G + P+ S N+ ID L K +D
Sbjct: 220 AIFKI-------------GENASPEIPS---------------NISSEAIDFLEKTFEID 251
Query: 301 PSRRITARSALEHEY 315
++R TA L+H +
Sbjct: 252 HNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 70/251 (27%), Positives = 113/251 (45%), Gaps = 42/251 (16%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
++ ++K+G+G+YG VYK + N+ ALK++ L + A+ EI +L + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 63 IVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKT-----FLYQILRGIA 116
I+ ++ KL +V EY DL K + +LI Q+LRG+
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKR---KKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
H ++LHRDLK N+L+ + +K+ D G++
Sbjct: 118 ALHEQKILHRDLKSANILL-VANDLVKIGDLGIS-------------------------- 150
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
+VL ++ ++ T Y APE+ G R YS D+WS+GC+ EM P F
Sbjct: 151 ---KVLKKNMA--KTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEAR 204
Query: 237 SEIDELFKIFR 247
S D +K+ R
Sbjct: 205 SMQDLRYKVQR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 75/323 (23%), Positives = 130/323 (40%), Gaps = 74/323 (22%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHG 61
+E + IG+G +G V + T + A+K + ++ E G + E +L+E+ H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDL----DLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
+V L E+ +YLV +DL DL+ H+ F+ + +K ++ +I+ + Y
Sbjct: 61 FLVNLWYSFQDEENMYLV---VDLLLGGDLRYHLSQKVKFSEE--QVKFWICEIVLALEY 115
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
HS ++HRD+KP N+L+D + + + DF +A T T G+ G
Sbjct: 116 LHSKGIIHRDIKPDNILLDEQGHV-HITDFNIATKV--TPDTLTTSTSGTPG-------- 164
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
Y APE+L + YS VD WS+G E + + + G S
Sbjct: 165 --------------------YMAPEVLC-RQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
Query: 238 --EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSK 295
D++ T+ + + W ID ++K
Sbjct: 204 RTIRDQIRAKQ-------------ETADVLYPAT---WS------------TEAIDAINK 235
Query: 296 MLCMDPSRRI--TARSALEHEYF 316
+L DP +R+ + H YF
Sbjct: 236 LLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-26
Identities = 91/334 (27%), Positives = 155/334 (46%), Gaps = 86/334 (25%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKK------IRLEQEDEGVPSTAIREISLL 55
D E+++ +G GT+G V+ R+ ++ ALK IRL+QE + V + E +L
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE-QHVHN----EKRVL 55
Query: 56 KEMQHGNIVRLQDVVHSEKKLYLVFEYL-DLDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
KE+ H I+RL H ++ LY++ EY+ +L ++ + F+N L + +I+
Sbjct: 56 KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF--YASEIVCA 113
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+ Y HS +++RDLKP+N+L+D+ + +KL DFG A+ + RT+T
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGH-IKLTDFGFAKK--LRDRTWT------------- 157
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
L G T Y APE+ + S+ ++ VD W++G + EM+ P F
Sbjct: 158 -------LCG----------TPEYLAPEV-IQSKGHNKAVDWWALGILIYEMLVGYPPFF 199
Query: 235 GDSEIDELFKIFR--VLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
D+ F I+ + G K FP R+L+ DL
Sbjct: 200 DDN----PFGIYEKILAG----------------KLEFP-----------RHLDLYAKDL 228
Query: 293 LSKMLCMDPSRRI-----TARSALEHEYFRDVEF 321
+ K+L +D +RR+ A H +F+ V++
Sbjct: 229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 74/316 (23%), Positives = 131/316 (41%), Gaps = 71/316 (22%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIR------EISLLKEMQHGNI 63
+G+G +G VY + T +A+K++ + + P T EI LLK +QH I
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS---PETKKEVNALECEIQLLKNLQHERI 66
Query: 64 VRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
V+ + ++ L + EY+ +K + + + + + QIL G+ Y HS+
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTET--VTRKYTRQILEGVEYLHSNM 124
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
++HRD+K N+L D N +KL DFG ++ R+
Sbjct: 125 IVHRDIKGANILRDSAGN-VKLGDFGASK----------------------------RLQ 155
Query: 183 AGSLILQFLKVV--TLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
+K V T ++ +PE++ G Y DVWSVGC EM+ ++P + +E +
Sbjct: 156 TICSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPW---AEFE 211
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
+ IF++ P P+ PS ++ P + L + +
Sbjct: 212 AMAAIFKIATQPTN----------------PQLPS--------HVSPDARNFLRRTFVEN 247
Query: 301 PSRRITARSALEHEYF 316
+R +A L H +
Sbjct: 248 AKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-25
Identities = 70/241 (29%), Positives = 106/241 (43%), Gaps = 62/241 (25%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
+G+GTYG+VY AR+ T IA+K+I P EI+L ++H NIV+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP--LHEEIALHSYLKHRNIVQYLGS 73
Query: 70 VHSEKKLYLVFEYLDLDLKKHMDSCPD-------------FANDPRLIKTFLYQILRGIA 116
SE + +F M+ P ++ + I + QIL G+
Sbjct: 74 D-SENGFFKIF----------MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA-RAFGI-PV-RTFTHEHWGSTGISIY 173
Y H ++++HRD+K N+L++ + +K++DFG + R GI P TFT
Sbjct: 123 YLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTG----------- 171
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEIL-LGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
TL Y APE++ G R Y P D+WS+GC EM +P
Sbjct: 172 ---------------------TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
Query: 233 F 233
F
Sbjct: 211 F 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 84/340 (24%), Positives = 135/340 (39%), Gaps = 67/340 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIR--EISLLKE-- 57
D +E ++ IG G +G V+ R+ T + A+K +R S I+ +I+ ++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLR--------KSDMIKRNQIAHVRAER 52
Query: 58 --MQHGN---IVRLQDVVHSEKKLYLVFEYL-DLDLKKHMDSCPDFANDPRLIKTFLYQI 111
+ + IV+L E+ LYLV EY+ DL + F + ++ ++
Sbjct: 53 DILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF--PEETARFYIAEL 110
Query: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-----GIPVRTFTHEHWG 166
+ + H +HRD+KP N+LID +KLADFGL + +H
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 167 STGISIYFSFL-RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAE 225
+ + + RV A S V T Y APE+L G Y D WS+G I E
Sbjct: 170 RDNVLVRRRDHKQRRVRANST------VGTPDYIAPEVLRG-TPYGLECDWWSLGVILYE 222
Query: 226 MVNQRPLFPGDSEIDELFKIFRV---LGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVV 282
M+ P F D+ + KI L P +
Sbjct: 223 MLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVS------------------------ 258
Query: 283 RNLEPAGIDLLSKMLCMDPSRRIT-ARSALEHEYFRDVEF 321
P IDL+ ++LC DP R+ H +F+ +++
Sbjct: 259 ----PEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 82/332 (24%), Positives = 140/332 (42%), Gaps = 82/332 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKK------IRLEQEDEGVPSTAIREISLL 55
D +E ++ +G G++G V R+ + + ALK ++L+Q + + E +L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-----VLNEKRIL 55
Query: 56 KEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRG 114
+ ++H +V L + LYLV EY+ +L H+ F + + + Q++
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP--VARFYAAQVVLA 113
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+ Y HS +++RDLKP+NLL+D +K+ DFG A+ + RT+T
Sbjct: 114 LEYLHSLDIVYRDLKPENLLLD-SDGYIKITDFGFAKR--VKGRTYT------------- 157
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
L G T Y APEI+L S+ Y VD W++G + EM+ P F
Sbjct: 158 -------LCG----------TPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFF 199
Query: 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294
D+ I KI + G K FP + P DL+
Sbjct: 200 DDNPIQIYEKI--LEG----------------KVRFPSF-----------FSPDAKDLIR 230
Query: 295 KMLCMDPSRRITARSA-----LEHEYFRDVEF 321
+L +D ++R+ H +F +++
Sbjct: 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 86/325 (26%), Positives = 130/325 (40%), Gaps = 68/325 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D +E + ++G+G +G VYKA++ T A K I++E E+E + EI +L E +H
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE--LEDFMVEIDILSECKHP 62
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD---LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
NIV L + E KL+++ E+ D LD M +P+ I+ Q+L + +
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALD--SIMLELERGLTEPQ-IRYVCRQMLEALNFL 119
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
HSH+V+HRDLK N+L+ +KLADFG++ A G
Sbjct: 120 HSHKVIHRDLKAGNILLT-LDGDVKLADFGVS-AKNKSTLQKRDTFIG------------ 165
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILL----GSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
T ++ APE++ Y D+WS+G E+ P
Sbjct: 166 ----------------TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209
Query: 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294
+ + L KI + S P KW S D L
Sbjct: 210 ELNPMRVLLKILK--------------SEPPTLDQPSKW-SSSFN-----------DFLK 243
Query: 295 KMLCMDPSRRITARSALEHEYFRDV 319
L DP R TA L+H + D
Sbjct: 244 SCLVKDPDDRPTAAELLKHPFVSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 4e-24
Identities = 68/310 (21%), Positives = 130/310 (41%), Gaps = 60/310 (19%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Y + +G+G +G R + + K++ L + E A+ EI +L +QH NI
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 64 VRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
+ + + L + EY + L + + ++ +L+QI+ ++Y H
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
+LHRD+K N+ + + +KL DFG+++ G + S +
Sbjct: 122 ILHRDIKTLNIFLTKA-GLIKLGDFGISKILG-------------SEYS----------M 157
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242
A ++ V T +Y +PE+ G + Y+ D+W++GC+ E++ + F + ++ +
Sbjct: 158 AETV------VGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLV 210
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
KI + TP + S EL ++V +L L DP
Sbjct: 211 VKIVQGNYTPVVSVY-----------------SSELISLVHSL-----------LQQDPE 242
Query: 303 RRITARSALE 312
+R TA L+
Sbjct: 243 KRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-24
Identities = 74/328 (22%), Positives = 135/328 (41%), Gaps = 71/328 (21%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG- 61
Y+++E IG G YG VY+ ++ T +ALK I L+ D+ V S RE++LL +++
Sbjct: 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQ 60
Query: 62 --NIVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
NI + +L+++ EY + ++ M + P + I + ++L + Y
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPI---AEKYISVIIREVLVALKYI 117
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
H V+HRD+K N+L+ T +KL DFG+A + +
Sbjct: 118 HKVGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQ-------------------NSSK 157
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
G T ++ APE++ ++Y T D+WS+G EM
Sbjct: 158 RSTFVG----------TPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT---------- 197
Query: 239 IDELFKIFRVLGTP---NEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSK 295
G P + D + + +P KS P+ ++R + ++
Sbjct: 198 -----------GNPPYSDVDAFRAMMLIP--KSKPPRLEDNGYSKLLR-------EFVAA 237
Query: 296 MLCMDPSRRITARSALEHEYFRDVEFVP 323
L +P R++A L+ ++ + P
Sbjct: 238 CLDEEPKERLSAEELLKSKWIKAHSKTP 265
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-23
Identities = 64/246 (26%), Positives = 115/246 (46%), Gaps = 32/246 (13%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+Y KV+KIGEG++G ++ + +K+I + + + +E+++L M+H N
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 63 IVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
IV+ Q+ LY+V +Y + DL K +++ I + QI + + H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
++LHRD+K QN+ + + +KL DFG+AR V
Sbjct: 121 KILHRDIKSQNIFL-TKDGTIKLGDFGIAR-----------------------------V 150
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
L ++ L + T +Y +PEI +R Y+ D+W++GC+ EM + F + +
Sbjct: 151 LNSTVELARTCIGTPYYLSPEIC-ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL 209
Query: 242 LFKIFR 247
+ KI R
Sbjct: 210 VLKIIR 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 83/324 (25%), Positives = 145/324 (44%), Gaps = 65/324 (20%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIR---LEQEDEGVPSTAIREISLLKEMQ 59
++ + ++G+G YG V+ A+ T E +ALK+++ L + +E + E +L +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE--VRHVLTERDILTTTK 59
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYL-DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
+V+L ++ LYL EY+ D + +++ + D + ++ ++ +
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH--ARFYMAEMFEAVDAL 117
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
H +HRDLKP+N LID + +KL DFGL++ T+ + GS
Sbjct: 118 HELGYIHRDLKPENFLID-ASGHIKLTDFGLSKGI----VTYANSVVGSPD--------- 163
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
Y APE+L G + Y VD WS+GC+ E + P F G
Sbjct: 164 -------------------YMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGS-- 201
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
TPNE TW +L +K + P + NL DL++K++
Sbjct: 202 ------------TPNE-TW---ENLKYWKETL-QRPVYD--DPRFNLSDEAWDLITKLI- 241
Query: 299 MDPSRRITARSALE-HEYFRDVEF 321
DPSRR + ++ H +F++V++
Sbjct: 242 NDPSRRFGSLEDIKNHPFFKEVDW 265
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-23
Identities = 80/321 (24%), Positives = 139/321 (43%), Gaps = 73/321 (22%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+Y + EKIG+G G VY A + T + +A+K++ L+Q+ + I EI +++E +H N
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK--KELIINEILVMRENKHPN 77
Query: 63 IVRLQDVVHSEKKLYLVFEYL------DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
IV D +L++V EYL D+ + MD I + L+ +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------QIAAVCRECLQALE 129
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
+ HS++V+HRD+K N+L+ ++KL DFG T E + +
Sbjct: 130 FLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFC-------AQITPEQSKRSTM------ 175
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
V T ++ APE++ + Y VD+WS+G + EMV P + +
Sbjct: 176 ----------------VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKM 296
+ + L+ I P+ ++ P K L D L++
Sbjct: 219 NPLRALYLI-------------ATNGTPELQN-----PEK--------LSAIFRDFLNRC 252
Query: 297 LCMDPSRRITARSALEHEYFR 317
L MD +R +A+ L+H + +
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 4e-23
Identities = 74/262 (28%), Positives = 121/262 (46%), Gaps = 59/262 (22%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+++YE ++KIG G +G V+ ++ T E K I E S + E+++++E++H
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71
Query: 61 GNIVRLQD--VVHSEKKLYLVFEYLDL-DLKKHMDSCPDFAN--DPRLIKTFLYQILRGI 115
NIVR D + + +KLY++ E+ D DL +++ C + I Q+L +
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 116 AYCHS-------HRVLHRDLKPQNLL----------IDRRTNAL------KLADFGLARA 152
AYCH+ RVLHRDLKPQN+ I + N L K+ DFGL++
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG-SRHYS 211
GI + H G T +Y +PE+LL ++ Y
Sbjct: 192 IGI--ESMAHSCVG----------------------------TPYYWSPELLLHETKSYD 221
Query: 212 TPVDVWSVGCIFAEMVNQRPLF 233
D+W++GCI E+ + + F
Sbjct: 222 DKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-23
Identities = 80/316 (25%), Positives = 133/316 (42%), Gaps = 75/316 (23%)
Query: 9 KIGEGTYGVVYKARNCVTNETIALKK--IRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
KIGEG+ G+V A + T +A+KK +R +Q E E+ ++++ QH NIV +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRE----LLFNEVVIMRDYQHPNIVEM 81
Query: 67 QDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
+L++V E+L+ D+ H N+ + I T +L+ +++ H+
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQ-IATVCLAVLKALSFLHAQG 135
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
V+HRD+K ++L+ KL+DFG V R + L
Sbjct: 136 VIHRDIKSDSILLTSDGRV-KLSDFGFCAQVSKEVP-------------------RRKSL 175
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRH-YSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
G T ++ APE++ SR Y T VD+WS+G + EMV+ P + + +
Sbjct: 176 VG----------TPYWMAPEVI--SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA 223
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301
+ +I D P P K+ + P L +ML DP
Sbjct: 224 MKRI--------RDNLP-----PKLKNL-------------HKVSPRLRSFLDRMLVRDP 257
Query: 302 SRRITARSALEHEYFR 317
++R TA L H +
Sbjct: 258 AQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-22
Identities = 55/150 (36%), Positives = 82/150 (54%), Gaps = 13/150 (8%)
Query: 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
E+V +IG G G VYK + T ALK I ED V REI +L+++ H N+V
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT-VRRQICREIEILRDVNHPNVV 135
Query: 65 RLQDVVHSEKKLYLVFEYLD---LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
+ D+ ++ ++ E++D L+ H+ A+ R QIL GIAY H
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLE-GTHIADEQFLADVAR-------QILSGIAYLHRR 187
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
++HRD+KP NLLI+ N +K+ADFG++R
Sbjct: 188 HIVHRDIKPSNLLINSAKN-VKIADFGVSR 216
|
Length = 353 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 70/236 (29%), Positives = 107/236 (45%), Gaps = 41/236 (17%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQHGNIVRL 66
+KIG G + VY+A + + +ALKK+++ E D ++EI LLK++ H N+++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIK-----TFLYQILRGIAYCHS 120
D + +L +V E D DL + + F RLI + Q+ + + HS
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKY---FKKQKRLIPERTVWKYFVQLCSAVEHMHS 124
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
RV+HRD+KP N+ I T +KL D GL R F
Sbjct: 125 RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTA--------------------- 162
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
A SL V T +Y +PE + Y+ D+WS+GC+ EM + F GD
Sbjct: 163 --AHSL------VGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-22
Identities = 87/317 (27%), Positives = 140/317 (44%), Gaps = 68/317 (21%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLE--QEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
+G+G++G V A TNE A+K ++ + ED+ V T + L +H + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHR 126
+++ L+ V EYL+ DL H+ S F D + + +I+ G+ + H +++R
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRF--DEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSL 186
DLK N+L+D+ + +K+ADFG+ + G S +
Sbjct: 121 DLKLDNVLLDKDGH-IKIADFGMCK----------ENMNGEGKASTFCG----------- 158
Query: 187 ILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM-VNQRPLFPGDSEIDELFKI 245
T Y APEIL G + Y+ VD WS G + EM + Q P F G+ E DELF
Sbjct: 159 --------TPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSP-FHGEDE-DELFDS 207
Query: 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI 305
N+ FP+W SKE D LSK+ DP++R+
Sbjct: 208 IL-----NDRPH------------FPRWISKE-----------AKDCLSKLFERDPTKRL 239
Query: 306 TARSAL-EHEYFRDVEF 321
+ +H +FR +++
Sbjct: 240 GVDGDIRQHPFFRGIDW 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 67/246 (27%), Positives = 112/246 (45%), Gaps = 37/246 (15%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
QY + +GEG++G ++ +++ A+K+IRL + V + +E LL +M+H N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV-EDSRKEAVLLAKMKHPN 59
Query: 63 IVRLQDVVHSEKKLYLVFEYL---DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
IV ++ ++ LY+V EY DL K + F D I + Q+ G+ + H
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPED--TILQWFVQMCLGVQHIH 117
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
RVLHRD+K +N+ + + +KL DFG AR P + + G
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGK-VKLGDFGSARLLTSPG-AYACTYVG------------- 162
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
T +Y PEI + Y+ D+WS+GCI E+ + F +S
Sbjct: 163 ---------------TPYYVPPEI-WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK 206
Query: 240 DELFKI 245
+ + K+
Sbjct: 207 NLILKV 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-21
Identities = 76/315 (24%), Positives = 139/315 (44%), Gaps = 61/315 (19%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+Y + EKIG+G G VY A + T + +A++++ L+Q+ + I EI +++E ++ N
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPN 78
Query: 63 IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
IV D +L++V EYL D + D I + L+ + + HS++
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
V+HRD+K N+L+ ++KL DFG P ++ G
Sbjct: 137 VIHRDIKSDNILLG-MDGSVKLTDFGFCAQI-TPEQSKRSTMVG---------------- 178
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242
T ++ APE++ + Y VD+WS+G + EM+ P + ++ + L
Sbjct: 179 ------------TPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
+ I P+ ++ P K L + R D L++ L MD
Sbjct: 226 YLI-------------ATNGTPELQN-----PEK-LSAIFR-------DFLNRCLDMDVE 259
Query: 303 RRITARSALEHEYFR 317
+R +A+ L+H++ +
Sbjct: 260 KRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 82/330 (24%), Positives = 141/330 (42%), Gaps = 82/330 (24%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALK------KIRLEQEDEGVPSTAIREISLLKE 57
+E E +G G++G V A++ T E A+K ++++Q +E S+L E
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-----VAQEKSILME 74
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEY-LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
+ H IV + E ++Y + E+ + +L H+ F ND + K + +++
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPND--VAKFYHAELVLAFE 132
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
Y HS +++RDLKP+NLL+D + + +K+ DFG A+ +P RTFT
Sbjct: 133 YLHSKDIIYRDLKPENLLLDNKGH-VKVTDFGFAKK--VPDRTFT--------------- 174
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
L G T Y APE+ + S+ + VD W++G + E + P F D
Sbjct: 175 -----LCG----------TPEYLAPEV-IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKM 296
+ F+I+ E G + FP W + DL+ +
Sbjct: 219 TP----FRIY-------EKILAG-------RLKFPNW-----------FDGRARDLVKGL 249
Query: 297 LCMDPSRRI-TARSALE----HEYFRDVEF 321
L D ++R+ T + + H YF +
Sbjct: 250 LQTDHTKRLGTLKGGVADVKNHPYFHGANW 279
|
Length = 329 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (224), Expect = 6e-21
Identities = 79/315 (25%), Positives = 138/315 (43%), Gaps = 61/315 (19%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+Y + EKIG+G G VY A + T + +A+K++ L+Q+ + I EI +++E ++ N
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPN 77
Query: 63 IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
IV D +L++V EYL D + D I + L+ + + HS++
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
V+HRD+K N+L+ ++KL DFG T E + +
Sbjct: 136 VIHRDIKSDNILLG-MDGSVKLTDFGFC-------AQITPEQSKRSTM------------ 175
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242
V T ++ APE++ + Y VD+WS+G + EMV P + ++ + L
Sbjct: 176 ----------VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
+ I P+ ++ + L V R D L++ L MD
Sbjct: 225 YLI-------------ATNGTPELQN------PERLSAVFR-------DFLNRCLEMDVD 258
Query: 303 RRITARSALEHEYFR 317
RR +A+ L+H + +
Sbjct: 259 RRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 8e-21
Identities = 68/232 (29%), Positives = 103/232 (44%), Gaps = 37/232 (15%)
Query: 2 DQYEKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKE 57
+ ++++GEG +G V R T E +A+K + E E S REI +L+
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-EQHRSDFEREIEILRT 62
Query: 58 MQHGNIVRLQDVVHS--EKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRG 114
+ H NIV+ + V + L L+ EYL L+ ++ D N RL+ F QI +G
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL-FSSQICKG 121
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+ Y S R +HRDL +N+L++ +K++DFGLA+ ++
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDL-VKISDFGLAKVL-----PEDKDY---------- 165
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
Y V F WY APE L S+ S DVWS G E+
Sbjct: 166 ----YYVKEPGESPIF------WY-APECLRTSKFSSAS-DVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 1e-20
Identities = 78/315 (24%), Positives = 139/315 (44%), Gaps = 61/315 (19%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+Y + EKIG+G G V+ A + T + +A+K+I L+++ + I EI ++KE+++ N
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK--KELIINEILVMKELKNPN 77
Query: 63 IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
IV D +L++V EYL D + D I + L+ + + H+++
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGG--SLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
V+HRD+K N+L+ ++KL DFG T E + +
Sbjct: 136 VIHRDIKSDNVLLGMD-GSVKLTDFGFC-------AQITPEQSKRSTM------------ 175
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242
V T ++ APE++ + Y VD+WS+G + EMV P + ++ + L
Sbjct: 176 ----------VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
+ I P+ ++ P K L P D L++ L MD
Sbjct: 225 YLI-------------ATNGTPELQN-----PEK--------LSPIFRDFLNRCLEMDVE 258
Query: 303 RRITARSALEHEYFR 317
+R +A+ L+H + +
Sbjct: 259 KRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 75/263 (28%), Positives = 120/263 (45%), Gaps = 53/263 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEM-Q 59
+E VE IGEGTYG VYKAR+ T + +A+K + + +++E I+ E ++L++
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYSN 61
Query: 60 HGNIVR------LQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLY 109
H NI ++ ++ +L+LV E DL K + + I L
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEE-WIAYILR 120
Query: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA-LKLADFGLARAFGIPVRTFTHEHWGST 168
+ LRG+AY H ++V+HRD+K QN+L+ + NA +KL DFG++ + G
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTK--NAEVKLVDFGVSAQLDSTL--------GRR 170
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS----RHYSTPVDVWSVGCIFA 224
I G T ++ APE++ Y DVWS+G
Sbjct: 171 NTFI-----------G----------TPYWMAPEVIACDEQPDASYDARSDVWSLGITAI 209
Query: 225 EMVNQRPLFPGDSEIDELFKIFR 247
E+ + +P + LFKI R
Sbjct: 210 ELADGKPPLCDMHPMRALFKIPR 232
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 69/246 (28%), Positives = 108/246 (43%), Gaps = 63/246 (25%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA-----IREISLLKEM 58
+ + +IG G++G VY AR+ TNE +A+KK+ G S I+E+ L+++
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSY----SGKQSNEKWQDIIKEVRFLQQL 72
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEY--------LDLDLKKHMDSCPDFANDPRLIKTFLYQ 110
+H N + + E +LV EY L++ KK + I +
Sbjct: 73 RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEV-HKKPLQEVE--------IAAICHG 123
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGI 170
L+G+AY HSH +HRD+K N+L+ +KLADFG A + P +F
Sbjct: 124 ALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSA-SLVSPANSF---------- 171
Query: 171 SIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVN 228
V T ++ APE++L Y VDVWS+G E+
Sbjct: 172 ----------------------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
Query: 229 QR-PLF 233
++ PLF
Sbjct: 210 RKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-20
Identities = 68/236 (28%), Positives = 105/236 (44%), Gaps = 41/236 (17%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQHGNIVRL 66
+KIG G + VY+A + +ALKK+++ + D + I+EI LLK++ H N+++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIK-----TFLYQILRGIAYCHS 120
+ +L +V E D DL + + F RLI + Q+ + + HS
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKH---FKKQKRLIPEKTVWKYFVQLCSALEHMHS 124
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
RV+HRD+KP N+ I T +KL D GL R F T H G
Sbjct: 125 RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKT-TAAHSLVG-------------- 168
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
T +Y +PE + Y+ D+WS+GC+ EM + F GD
Sbjct: 169 --------------TPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-20
Identities = 74/264 (28%), Positives = 121/264 (45%), Gaps = 49/264 (18%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIR------EISLLKEMQHGNI 63
+G+G +G VY + T +A K+++ + E P T+ EI LLK +QH I
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPES---PETSKEVSALECEIQLLKNLQHERI 66
Query: 64 VR----LQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDF-ANDPRLIKTFLYQILRGIAYC 118
V+ L+D +EK L + EY+ K D + A + + + QIL G++Y
Sbjct: 67 VQYYGCLRD--RAEKTLTIFMEYMPGGSVK--DQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
HS+ ++HRD+K N+L D N +KL DFG ++ +I S
Sbjct: 123 HSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRLQ----------------TICMSGTG 165
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
R + G T ++ +PE++ G Y DVWS+GC EM+ ++P + +E
Sbjct: 166 IRSVTG----------TPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPW---AE 211
Query: 239 IDELFKIFRVLGTPNEDTWPGVTS 262
+ + IF++ P P S
Sbjct: 212 YEAMAAIFKIATQPTNPQLPSHIS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-20
Identities = 72/262 (27%), Positives = 123/262 (46%), Gaps = 44/262 (16%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEMQHGNIVR- 65
+G G +G VY + T +A+K++ + QE + EI LLK ++H IV+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 66 ---LQDVVHSEKKLYLVFEYL-DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
L+D EKKL + EY+ +K + + A + + + QIL+G++Y HS+
Sbjct: 70 YGCLRD--PEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN 125
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
++HRD+K N+L D N +KL DFG ++ +I S +
Sbjct: 126 MIVHRDIKGANILRDSAGN-VKLGDFGASKRIQ----------------TICMSGTGIKS 168
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
+ G T ++ +PE++ G Y DVWSV C EM+ ++P + +E +
Sbjct: 169 VTG----------TPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPW---AEYEA 214
Query: 242 LFKIFRVLGTPNEDTWP-GVTS 262
+ IF++ P + P GV+
Sbjct: 215 MAAIFKIATQPTKPMLPDGVSD 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 6e-20
Identities = 79/325 (24%), Positives = 141/325 (43%), Gaps = 78/325 (24%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEMQHGNIVRL 66
+G+G++G V A T+E A+K ++ + Q+D+ V T + L +H + +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD-VECTMTEKRVLALAGKHPFLTQL 61
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
++ +L+ V EY++ DL H+ F ++PR + + +I+ G+ + H +++
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRF-DEPR-ARFYAAEIVLGLQFLHERGIIY 119
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARA---FGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
RDLK N+L+D + +K+ADFG+ + G+ TF
Sbjct: 120 RDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCG-------------------- 158
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242
T Y APEIL Y VD W++G + EM+ + F GD E DEL
Sbjct: 159 ------------TPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDE-DEL 204
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
F+ S+ + + +P+W SKE +L L +P
Sbjct: 205 FQ-----------------SILEDEVRYPRWLSKE-----------AKSILKSFLTKNPE 236
Query: 303 RRITA-----RSALEHEYFRDVEFV 322
+R+ + H +FR++++
Sbjct: 237 KRLGCLPTGEQDIKGHPFFREIDWD 261
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-19
Identities = 83/316 (26%), Positives = 139/316 (43%), Gaps = 70/316 (22%)
Query: 8 EKIGEGTYGVVY--KARNCVTNETI-ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
+++G+G++G VY K + V E + LK+I + + + A +E LL ++ H IV
Sbjct: 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 65 RLQDVVHSEKKLYLVFEYL---DLDLK-KHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
+ ++ EY DLD K + + ++ ++ + F+ Q+L G+ Y H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI-QLLLGVHYMHQ 124
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
R+LHRDLK +N+ + + N LK+ DFG++R
Sbjct: 125 RRILHRDLKAKNIFL--KNNLLKIGDFGVSR----------------------------- 153
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
+L GS L T +Y +PE L + Y + D+WS+GCI EM F G + +
Sbjct: 154 LLMGSCDLATTFTGTPYYMSPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212
Query: 241 ELFKIFRVLG-TPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
+ +I V G TP SLP+ S++L + ++ ML
Sbjct: 213 VVLRI--VEGPTP---------SLPETY-------SRQLNS-----------IMQSMLNK 243
Query: 300 DPSRRITARSALEHEY 315
DPS R +A L + +
Sbjct: 244 DPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-19
Identities = 82/319 (25%), Positives = 139/319 (43%), Gaps = 76/319 (23%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
+ K+E+IG+G++G V+K + T + +A+K I LE+ ++ + +EI++L + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYV 64
Query: 64 VRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
+ KL+++ EYL LDL + + P D I T L +IL+G+ Y H
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDL---LRAGP---FDEFQIATMLKEILKGLDYLH 118
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
S + +HRD+K N+L+ + + +KLADFG+A
Sbjct: 119 SEKKIHRDIKAANVLLSEQGD-VKLADFGVAGQ--------------------------- 150
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
L + I + V T ++ APE++ S Y + D+WS+G E+ P
Sbjct: 151 --LTDTQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP-------- 199
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAF--PKWPSKEL-GTVVRNLEPAGIDLLSKM 296
PN D P + F PK L G + + + +
Sbjct: 200 ------------PNSDMHP-------MRVLFLIPKNNPPTLTGEFSKPFK----EFIDAC 236
Query: 297 LCMDPSRRITARSALEHEY 315
L DPS R TA+ L+H++
Sbjct: 237 LNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-19
Identities = 71/233 (30%), Positives = 113/233 (48%), Gaps = 36/233 (15%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
YE ++++G GTYG VYKARN T E A+K I+LE D+ S +EI ++KE +H NI
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF--SLIQQEIFMVKECKHCNI 68
Query: 64 VRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
V S +KL++ EY + + ++ + I + L+G+AY HS
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ-IAYVCRETLQGLAYLHSKGK 127
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
+HRD+K N+L+ + +KLADFG+A + I+ SF
Sbjct: 128 MHRDIKGANILLTDNGD-VKLADFGVAAKI-------------TATIAKRKSF------- 166
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRH--YSTPVDVWSVGCIFAEMVN-QRPLF 233
+ T ++ APE+ ++ Y+ D+W+VG E+ Q P+F
Sbjct: 167 ---------IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-19
Identities = 81/323 (25%), Positives = 131/323 (40%), Gaps = 68/323 (21%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D+ E ++++G+G YG VYK + T T+A+K+IRLE DE + I E+ +L +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSP 59
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD---LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
IV E +Y+ EY+D LD K + +++ Y +++G+ +
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 119 -HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
H ++HRD+KP N+L++ +KL DFG++ G V + + G
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVS---GNLVASLAKTNIGCQS-------- 166
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEIL-----LGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
Y APE + + Y+ DVWS+G EM R
Sbjct: 167 --------------------YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
+P ++ + IF L + P LP S D
Sbjct: 207 YPPETYAN----IFAQLSAIVDGDPPT---LPSGYS------------------DDAQDF 241
Query: 293 LSKMLCMDPSRRITARSALEHEY 315
++K L P+RR T LEH +
Sbjct: 242 VAKCLNKIPNRRPTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-19
Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 53/272 (19%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETI-ALKKIRL---------EQEDEGVPSTAIREIS 53
Y +E +G G +G VYK R + + ALK+I + + D+ + + E++
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDI-VSEVT 60
Query: 54 LLKE-MQHGNIVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPD----FANDPRLIKTF 107
++KE ++H NIVR +LY+V + ++ L +H +S + F + R+ F
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE-RIWNIF 119
Query: 108 LYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166
+ Q++ + Y H R++HRDL P N+++ + + + DFGLA+ P T
Sbjct: 120 V-QMVLALRYLHKEKRIVHRDLTPNNIMLGED-DKVTITDFGLAKQKQ-PESKLTS---- 172
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
V T+ Y PEI + + Y DVW+ GCI +M
Sbjct: 173 -------------------------VVGTILYSCPEI-VKNEPYGEKADVWAFGCILYQM 206
Query: 227 VNQRPLFPGDSEIDELFKIFRVLGTP-NEDTW 257
+P F + + KI + P E +
Sbjct: 207 CTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 6e-19
Identities = 86/318 (27%), Positives = 146/318 (45%), Gaps = 70/318 (22%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLE--QEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
+G+G++G V+ A TN+ A+K ++ + D+ V T + + L +H + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLY-QILRGIAYCHSHRVLH 125
+++ L+ V EYL+ DL H+ SC F + PR TF +I+ G+ + HS +++
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKF-DLPR--ATFYAAEIICGLQFLHSKGIVY 119
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGS 185
RDLK N+L+D + +K+ADFG+ + + G +
Sbjct: 120 RDLKLDNILLDTDGH-IKIADFGMCKENML----------GDAKTCTFCG---------- 158
Query: 186 LILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM-VNQRPLFPGDSEIDELFK 244
T Y APEILLG + Y+T VD WS G + EM + Q P D E ELF+
Sbjct: 159 ---------TPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQ 206
Query: 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRR 304
R + P +P+W ++E D+L K+ +P RR
Sbjct: 207 SIR-MDNP----------------CYPRWLTRE-----------AKDILVKLFVREPERR 238
Query: 305 ITARSAL-EHEYFRDVEF 321
+ + + +H +FR++++
Sbjct: 239 LGVKGDIRQHPFFREIDW 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-19
Identities = 81/316 (25%), Positives = 138/316 (43%), Gaps = 77/316 (24%)
Query: 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
KIGEG+ G+V AR + +A+K + L ++ E+ ++++ QH N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHQNVVEMYK 85
Query: 69 VVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRL----IKTFLYQILRGIAYCHSHRVL 124
++L+++ E+L + D + RL I T +L+ + Y HS V+
Sbjct: 86 SYLVGEELWVLMEFL------QGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVI 139
Query: 125 HRDLKPQNLL--IDRRTNALKLADFGLARAFG--IPVRTFTHEHWGSTGISIYFSFLRYR 180
HRD+K ++L +D R +KL+DFG +P R +
Sbjct: 140 HRDIKSDSILLTLDGR---VKLSDFGFCAQISKDVPKR---------------------K 175
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
L G T ++ APE++ + Y T VD+WS+G + EMV+ P + DS +
Sbjct: 176 SLVG----------TPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 224
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
+ ++ D+ P P K+A P V+R D L +ML +
Sbjct: 225 AMKRL--------RDSPP-----PKLKNAHKISP------VLR-------DFLERMLTRE 258
Query: 301 PSRRITARSALEHEYF 316
P R TA+ L+H +
Sbjct: 259 PQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 8e-19
Identities = 85/346 (24%), Positives = 145/346 (41%), Gaps = 71/346 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D +EK+ ++G G GVV+K + + +A K I LE + + + IRE+ +L E
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 63
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFAND--PRLIKTFLYQILRGIAYC- 118
IV +S+ ++ + E++D +D A +++ +++G+ Y
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
H+++HRD+KP N+L++ R +KL DFG++ G S+ SF+
Sbjct: 121 EKHKIMHRDVKPSNILVNSR-GEIKLCDFGVS---------------GQLIDSMANSFVG 164
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM-VNQRPLFPGDS 237
R Y +PE L G+ HYS D+WS+G EM + + P+ P D+
Sbjct: 165 TRS----------------YMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207
Query: 238 EIDELFKIFRVLGTPNEDTW---------PGVTSLPDFKSAF--------------PKWP 274
+ EL V G P E P + PD + PK P
Sbjct: 208 KELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP 267
Query: 275 SKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
S G + D ++K L +P+ R + + H + + E
Sbjct: 268 SGVFGAEFQ-------DFVNKCLIKNPAERADLKQLMVHAFIKRSE 306
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 9e-19
Identities = 70/251 (27%), Positives = 113/251 (45%), Gaps = 50/251 (19%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRL--EQEDEGVPSTAIREISLLKEMQHG 61
+ + +IG G++G VY AR+ TNE +A+KK+ +Q +E I+E+ L+ ++H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVKFLQRIKHP 85
Query: 62 NIVRLQDVVHSEKKLYLVFEYL-----DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
N + + E +LV EY DL L+ H + I + L+G+A
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLGSASDL-LEVHKKPLQEVE-----IAAITHGALQGLA 139
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
Y HSH ++HRD+K N+L+ +KLADFG A + P +F
Sbjct: 140 YLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSA-SIASPANSF---------------- 181
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
V T ++ APE++L Y VDVWS+G E+ ++P
Sbjct: 182 ----------------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225
Query: 235 GDSEIDELFKI 245
+ + L+ I
Sbjct: 226 NMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 91/344 (26%), Positives = 139/344 (40%), Gaps = 66/344 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIR----LEQEDEGVPSTAIR-EISLLK 56
D +E ++ IG G +G V + T A+KK+R LE+E +R E +L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVA----HVRAERDILA 56
Query: 57 EMQHGNIVRLQDVVHSEKKLYLVFEYL------DLDLKKHMDSCPDFANDPRLIKTFLY- 109
E + +V+L E LYL+ EYL L +KK F + +T Y
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT-----FTEE----ETRFYI 107
Query: 110 -QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGST 168
+ + I H +HRD+KP NLL+D + + +KL+DFGL RT +
Sbjct: 108 AETILAIDSIHKLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 169 GISIYFSFLRYRVLAGSLI---------LQFLKVVTLWYRAPEILLGSRHYSTPVDVWSV 219
S + F+ + + L + V T Y APE+ L + Y+ D WS+
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSL 225
Query: 220 GCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELG 279
G I EM+ P F D+ + KI W PD E+
Sbjct: 226 GVIMYEMLVGYPPFCSDNPQETYRKII---------NWKETLQFPD-----------EV- 264
Query: 280 TVVRNLEPAGIDLLSKMLCMDPSRRITARSALE---HEYFRDVE 320
L P DL+ ++ C + RR+ E H +F+ V+
Sbjct: 265 ----PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 67/258 (25%), Positives = 119/258 (46%), Gaps = 45/258 (17%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIR------EISLLKEMQHGNI 63
+G+G +G VY + T +A+K+++ + E P T+ EI LLK + H I
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPES---PETSKEVNALECEIQLLKNLLHERI 66
Query: 64 VRLQDVVHS--EKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
V+ + E+ L + E++ +K + S A + + + QIL G++Y HS
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHS 124
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
+ ++HRD+K N+L D N +KL DFG ++ L+
Sbjct: 125 NMIVHRDIKGANILRDSVGN-VKLGDFGASKR------------------------LQTI 159
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
L+G+ + T ++ +PE++ G Y D+WSVGC EM+ ++P + +E +
Sbjct: 160 CLSGTGMKSVTG--TPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPW---AEFE 213
Query: 241 ELFKIFRVLGTPNEDTWP 258
+ IF++ P P
Sbjct: 214 AMAAIFKIATQPTNPVLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 8 EKIGEGTYGVVYKAR-NCVTNETI--ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
+K+G+G++GVV + + + I A+K ++ ++ + + ++E +++ + H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLI 59
Query: 65 RLQDVVHSEKKLYLVFEYLDLD--LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
RL VV + L +V E L L + L + QI G+ Y S R
Sbjct: 60 RLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCD-YAVQIANGMRYLESKR 117
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
+HRDL +N+L+ + +K+ DFGL RA +H+
Sbjct: 118 FIHRDLAARNILLASD-DKVKIGDFGLMRALPQ-----NEDHY----------------- 154
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
+++ V + APE L +R +S DVW G EM
Sbjct: 155 ----VMEEHLKVPFAWCAPES-LRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-18
Identities = 85/316 (26%), Positives = 136/316 (43%), Gaps = 70/316 (22%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
+ K+E+IG+G++G VYK + T E +A+K I LE+ ++ + +EI++L + I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYI 64
Query: 64 VRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
R KL+++ EYL LDL K P + I T L +IL+G+ Y H
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLLK-----PGPLEET-YIATILREILKGLDYLH 118
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
S R +HRD+K N+L+ + + +KLADFG+A
Sbjct: 119 SERKIHRDIKAANVLLSEQGD-VKLADFGVAGQ--------------------------- 150
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
L + I + V T ++ APE++ S Y D+WS+G E+ P +
Sbjct: 151 --LTDTQIKRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPM 207
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
LF I + S P + + K P K + + L
Sbjct: 208 RVLFLIPK-------------NSPPTLEGQYSK-PFK--------------EFVEACLNK 239
Query: 300 DPSRRITARSALEHEY 315
DP R TA+ L+H++
Sbjct: 240 DPRFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 81/331 (24%), Positives = 132/331 (39%), Gaps = 70/331 (21%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++ ++ ++GEG G V K R T ALK I + + + +RE+ + K +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-LQKQILRELEINKSCKSP 59
Query: 62 NIVRLQDVVHSEKK--LYLVFEYLD---LD-LKKHMDSCPDFANDPRLIKTFLYQILRGI 115
IV+ E + + EY + LD + K + + +++ +L+G+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE-KVLGKIAESVLKGL 118
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-RTFTHEHWGSTGISIYF 174
+Y HS +++HRD+KP N+L+ R+ KL DFG++ + TFT
Sbjct: 119 SYLHSRKIIHRDIKPSNILLTRKGQV-KLCDFGVSGELVNSLAGTFTG------------ 165
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
T +Y APE + G + YS DVWS+G E+ R FP
Sbjct: 166 --------------------TSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFP 204
Query: 235 GDSE-----IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAG 289
+ E I+ L I + L D KW S+E
Sbjct: 205 PEGEPPLGPIELLSYIVNM----------PNPELKDEPGNGIKW-SEEFK---------- 243
Query: 290 IDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
D + + L DP+RR T LEH + +
Sbjct: 244 -DFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 70/248 (28%), Positives = 112/248 (45%), Gaps = 50/248 (20%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRL--EQEDEGVPSTAIREISLLKEMQHGNIV 64
+ +IG G++G VY A N TNE +A+KK+ +Q +E I+E+ L++++H N +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDI-IKEVKFLQQLKHPNTI 84
Query: 65 RLQDVVHSEKKLYLVFEYL-----DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
+ E +LV EY DL L+ H + I + L+G+AY H
Sbjct: 85 EYKGCYLKEHTAWLVMEYCLGSASDL-LEVHKKPLQEVE-----IAAITHGALQGLAYLH 138
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
SH ++HRD+K N+L+ +KLADFG A + P +F
Sbjct: 139 SHNMIHRDIKAGNILLT-EPGQVKLADFGSA-SKSSPANSF------------------- 177
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
V T ++ APE++L Y VDVWS+G E+ ++P +
Sbjct: 178 -------------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224
Query: 238 EIDELFKI 245
+ L+ I
Sbjct: 225 AMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-18
Identities = 83/333 (24%), Positives = 133/333 (39%), Gaps = 84/333 (25%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ +E + ++G+G +G VYKA+N T A K I + E+E + EI +L H
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYMVEIEILATCNHP 69
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRL-----------IKTFLYQ 110
IV+L + + KL+++ E+ CP A D + I+ Q
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEF-----------CPGGAVDAIMLELDRGLTEPQIQVICRQ 118
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGI 170
+L + Y HS +++HRDLK N+L+ + +KLADFG++ V+T
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGD-IKLADFGVSAK---NVKTLQRRD------ 168
Query: 171 SIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTP----VDVWSVGCIFAEM 226
SF + T ++ APE+++ TP D+WS+G EM
Sbjct: 169 ----SF----------------IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
Query: 227 VNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLE 286
+ P E++ + RVL + P ++ PSK
Sbjct: 209 AQ---IEPPHHELNPM----RVLLKIAKSEPPTLSQ-----------PSK--------WS 242
Query: 287 PAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319
D L L P R +A LEH + V
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 7e-18
Identities = 84/348 (24%), Positives = 145/348 (41%), Gaps = 81/348 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI---------RLEQEDEGVPSTAIREI 52
+ +E ++ I G YG VY R+ T + A+KKI +++Q E
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQ--------VFVER 52
Query: 53 SLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFL 108
+L ++ +V + +++ L +V EY++ L K++ + P + + +
Sbjct: 53 DILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALP-----VDMARMYF 107
Query: 109 YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGST 168
+ + + Y H++ ++HRDLKP NLLI +KL DFGL++ + + T +E
Sbjct: 108 AETVLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228
FL +V T Y APE++L + Y PVD W++G I E +
Sbjct: 167 DTR---EFLDKQVCG-----------TPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLV 211
Query: 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPA 288
F GD+ +ELF ++D +WP + L
Sbjct: 212 GCVPFFGDTP-EELFG-----QVISDDI---------------EWPEGD-----EALPAD 245
Query: 289 GIDLLSKMLCMDPSRRITARSALE---HEYFRDV----------EFVP 323
DL+S++L +P R+ A E H +F + EF+P
Sbjct: 246 AQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIP 293
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-18
Identities = 83/316 (26%), Positives = 140/316 (44%), Gaps = 70/316 (22%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
+ K+EKIG+G++G V+K + T + +A+K I LE+ ++ + +EI++L + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSPYV 64
Query: 64 VRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
+ + KL+++ EYL LDL ++ P D I T L +IL+G+ Y H
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDL---LEPGP---LDETQIATILREILKGLDYLH 118
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
S + +HRD+K N+L+ +KLADFG+A
Sbjct: 119 SEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQ--------------------------- 150
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
L + I + V T ++ APE++ S Y + D+WS+G E+ P SE+
Sbjct: 151 --LTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGE---PPHSEL 204
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
+ +F + P + P + + K P KE N E
Sbjct: 205 HPMKVLFLI---PKNNP-------PTLEGNYSK-PLKEFVEACLNKE------------- 240
Query: 300 DPSRRITARSALEHEY 315
PS R TA+ L+H++
Sbjct: 241 -PSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-18
Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 50/237 (21%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRL--EQEDEGVPSTAIREISLLKEMQHG 61
+ + +IG G++G VY AR+ +E +A+KK+ +Q +E I+E+ L++++H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-IKEVRFLQKLRHP 75
Query: 62 NIVRLQDVVHSEKKLYLVFEYL-----DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
N ++ + E +LV EY DL L+ H + I + L+G+A
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDL-LEVHKKPLQEVE-----IAAVTHGALQGLA 129
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
Y HSH ++HRD+K N+L+ +KL DFG A P F
Sbjct: 130 YLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA-PANXF---------------- 171
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRP 231
V T ++ APE++L Y VDVWS+G E+ ++P
Sbjct: 172 ----------------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 82/324 (25%), Positives = 131/324 (40%), Gaps = 74/324 (22%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
+G+G +G V + T + A KK+ RL++ A+ E +L+++ IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKR--KGEQMALNEKKILEKVSSRFIVSL 58
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSC--PDFANDPRLIKTFLYQILRGIAYCHSHRV 123
++ L LV ++ DLK H+ + P F + R I + QI+ G+ + H R+
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGF-PEARAI-FYAAQIICGLEHLHQRRI 116
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
++RDLKP+N+L+D N ++++D GLA G+ G
Sbjct: 117 VYRDLKPENVLLDDHGN-VRISDLGLAVEL--KGGKKIKGRAGTPG-------------- 159
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243
Y APE+L G Y VD +++GC EM+ R F E E
Sbjct: 160 --------------YMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204
Query: 244 KI-FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
++ R L E PD S P DL +L DP
Sbjct: 205 ELKRRTLEMAVE--------YPDKFS------------------PEAKDLCEALLQKDPE 238
Query: 303 RRI-----TARSALEHEYFRDVEF 321
+R+ +A EH F+D+ +
Sbjct: 239 KRLGCRGGSADEVREHPLFKDLNW 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-17
Identities = 71/230 (30%), Positives = 108/230 (46%), Gaps = 39/230 (16%)
Query: 5 EKVEKIGEGTYGVV----YKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+K+ +GEG +G V Y N T E +A+K ++ E + S +EI++LK + H
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ-NTSGWKKEINILKTLYH 65
Query: 61 GNIVRLQDVV--HSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
NIV+ + K L L+ EY+ L L+ ++ P + + F QI G+AY
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAY 122
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
HS +HRDL +N+L+D +K+ DFGLA+A +P HE+
Sbjct: 123 LHSQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKA--VPE---GHEY------------- 163
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
YRV F WY A E L ++ +S DVWS G E++
Sbjct: 164 -YRVREDGDSPVF------WY-AVECLKENK-FSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 89/354 (25%), Positives = 135/354 (38%), Gaps = 81/354 (22%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIR---LEQEDEGVPSTAIREISLLKEMQH 60
+ K++ IG G +G V R TN A+K +R + ++ A R+I L E +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI--LAEADN 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYL---DL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
+V+L + LY V +Y+ D+ L + + L + ++ ++ I
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEE-----DLARFYIAELTCAIE 115
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH-------------- 162
H +HRD+KP N+LIDR + +KL DFGL F +TH
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGF-----RWTHDSKYYQKGDHHRQD 169
Query: 163 -----EHWGSTGISIYFSFLR------YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYS 211
E W R R LA SL V T Y APE+LL + Y+
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSL------VGTPNYIAPEVLLRT-GYT 222
Query: 212 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFP 271
D WSVG I EM+ +P F D+ + K+ W +P
Sbjct: 223 QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVI---------NWETTLHIPS------ 267
Query: 272 KWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE---HEYFRDVEFV 322
L DL+ + LC R+ A E H +F+ ++F
Sbjct: 268 ----------QAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFFKGIDFA 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-17
Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 47/251 (18%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D +E++ ++G G GVV K ++ + +A K I LE + + + IRE+ +L E
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 63
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD---LD-LKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
IV +S+ ++ + E++D LD + K P+ ++ +LRG+AY
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-----EILGKVSIAVLRGLAY 118
Query: 118 C-HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
H+++HRD+KP N+L++ R +KL DFG++ G S+ SF
Sbjct: 119 LREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVS---------------GQLIDSMANSF 162
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM-VNQRPLFPG 235
+ R Y +PE L G+ HYS D+WS+G E+ + + P+ P
Sbjct: 163 VGTRS----------------YMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPP 205
Query: 236 DSEIDELFKIF 246
D++ EL IF
Sbjct: 206 DAK--ELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-17
Identities = 80/314 (25%), Positives = 127/314 (40%), Gaps = 61/314 (19%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Y V +G+G+YG V R+ + +KK+ L A +E LL +++H NI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 64 VRLQDVVHSEK-KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
V ++ E LY+V + + DL + + + QI + Y H
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+LHRDLK QN+ + R TN +K+ D G+AR ST I
Sbjct: 122 HILHRDLKTQNVFLTR-TNIIKVGDLGIARVLE------NQCDMASTLIG---------- 164
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
T +Y +PE L ++ Y+ DVW++GC EM + F +++
Sbjct: 165 -------------TPYYMSPE-LFSNKPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNS 209
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301
L ++R++ E P PK S ELG +L++ ML P
Sbjct: 210 L--VYRII----EGKLP----------PMPKDYSPELG-----------ELIATMLSKRP 242
Query: 302 SRRITARSALEHEY 315
+R + +S L Y
Sbjct: 243 EKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 81/337 (24%), Positives = 137/337 (40%), Gaps = 68/337 (20%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Y ++ + G+ G V+ A + + LK G T + E LL+ + H ++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI--------GQKGTTLIEAMLLQNVNHPSV 119
Query: 64 VRLQDVVHSEKKLYLVFEYLDLDLKKH--MDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
+R++D + S +V + DL + S P + +I+ QIL G+ Y H+
Sbjct: 120 IRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK---QILEGLRYLHAQ 176
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
R++HRD+K +N+ I+ + + + D G A+ PV + +FL
Sbjct: 177 RIIHRDVKTENIFIN-DVDQVCIGDLGAAQ---FPV--------------VAPAFLG--- 215
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV-------NQRPLFP 234
LAG T+ APE+L + Y++ D+WS G + EM+ P P
Sbjct: 216 LAG----------TVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTP 264
Query: 235 GDSEID---ELFKIFRVLGTPNEDTWPGVTSLPDFK--SAFPKWPSKELGTVVR------ 283
+ L KI L + + +P P + F ++ S E R
Sbjct: 265 EEYVKSCHSHLLKIISTLKV-HPEEFPRD---PGSRLVRGFIEYASLERQPYTRYPCFQR 320
Query: 284 -NLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319
NL G L+ KML D + R +A L + F +
Sbjct: 321 VNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-17
Identities = 90/324 (27%), Positives = 136/324 (41%), Gaps = 79/324 (24%)
Query: 10 IGEGTYGVVYKARNCV---TNETIALK-----KIRLEQEDEGVPSTAIREISLLKEMQHG 61
+G+G YG V++ R T + A+K I Q+D + A R I L+ ++H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTA-HTKAERNI--LEAVKHP 60
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
IV L + KLYL+ EYL +L H++ F D +L +I + + H
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMED--TACFYLSEISLALEHLHQ 118
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
+++RDLKP+N+L+D + + +KL DFGL + I T TH G
Sbjct: 119 QGIIYRDLKPENILLDAQGH-VKLTDFGLCKE-SIHEGTVTHTFCG-------------- 162
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
T+ Y APEIL+ S H VD WS+G + +M+ P F ++
Sbjct: 163 --------------TIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKK 207
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
+ KI + G +LP + L P DLL K+L +
Sbjct: 208 TIDKILK-----------GKLNLPPY------------------LTPEARDLLKKLLKRN 238
Query: 301 PSRRI-----TARSALEHEYFRDV 319
PS R+ A H +FR V
Sbjct: 239 PSSRLGAGPGDAAEVQSHPFFRHV 262
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 67/240 (27%), Positives = 110/240 (45%), Gaps = 52/240 (21%)
Query: 8 EKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
E++GEG +G VYK ++ ++A+K ++ E + V +E L+ ++QH N
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHPN 69
Query: 63 IVRLQDVVHSEKKLYLVFEYLDL-DLKKHM-----DSCPDFANDPRLIKTFL-------- 108
IV L V E+ ++FEYL DL + + S + +K+ L
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 109 -YQILRGIAYCHSHRVLHRDLKPQNLLI-DRRTNALKLADFGLARAFGIPVRTFTHEHWG 166
QI G+ Y SH +HRDL +N L+ + T +K++DFGL+R
Sbjct: 130 AIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT--VKISDFGLSR--------------- 172
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
IY S YRV + SL+ + + PE +L + ++T D+WS G + E+
Sbjct: 173 ----DIY-SADYYRVQSKSLL-------PVRWMPPEAILYGK-FTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 52/242 (21%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ +E + ++G+G +G VYKA+N T A K I + E+E + EI +L H
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHP 62
Query: 62 NIVRLQDVVHSEKKLYLVFEY--------LDLDLKKHMDSCPDFANDPRLIKTFLYQILR 113
NIV+L D + E L+++ E+ + L+L++ + +P+ I+ Q L
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPL-------TEPQ-IRVVCKQTLE 114
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
+ Y H ++++HRDLK N+L + +KLADFG++ RT
Sbjct: 115 ALNYLHENKIIHRDLKAGNILFTLDGD-IKLADFGVSAK---NTRTIQRRD--------- 161
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILL----GSRHYSTPVDVWSVGCIFAEMVNQ 229
SF + T ++ APE+++ R Y DVWS+G EM
Sbjct: 162 -SF----------------IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQI 204
Query: 230 RP 231
P
Sbjct: 205 EP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 94/353 (26%), Positives = 142/353 (40%), Gaps = 77/353 (21%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ---EDEGVPSTAIREISLLKEMQH 60
+ K++ +G G +G V AR T A+K +R + ++ A R+I L E +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDI--LAEADN 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
+VRL + LY V +Y+ + L M P+ L + ++ ++ +
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE-----DLARFYIAELTCAVE 115
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-----------GIPVRT----FT 161
H +HRD+KP N+LIDR + +KL DFGL F G VR F+
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 162 HEHWGSTGISIYFSFLR----------YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYS 211
+E WG L+ R LA SL V T Y APE+LL + Y+
Sbjct: 175 NE-WGDPANCRCGDRLKPLERRAARQHQRCLAHSL------VGTPNYIAPEVLLRT-GYT 226
Query: 212 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFP 271
D WSVG I EM+ +P F + ++ K+ W +P
Sbjct: 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN---------WQTSLHIP------- 270
Query: 272 KWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE---HEYFRDVEF 321
L P DL+ K LC P R+ A E H +F+ ++F
Sbjct: 271 ---------PQAKLSPEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFKTIDF 313
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-16
Identities = 78/316 (24%), Positives = 138/316 (43%), Gaps = 75/316 (23%)
Query: 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
KIGEG+ G+V A T + +A+KK+ L ++ E+ ++++ H N+V + +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR--RELLFNEVVIMRDYHHENVVDMYN 86
Query: 69 VVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRL----IKTFLYQILRGIAYCHSHRVL 124
+L++V E+L+ + D R+ I T +LR ++Y H+ V+
Sbjct: 87 SYLVGDELWVVMEFLE------GGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVI 140
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFG--IPVRTFTHEHWGSTGISIYFSFLRYRVL 182
HRD+K ++L+ +KL+DFG +P R + L
Sbjct: 141 HRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKR---------------------KSL 178
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSR-HYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
G T ++ APE++ SR Y T VD+WS+G + EM++ P + + +
Sbjct: 179 VG----------TPYWMAPEVI--SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301
+ +I D P P K S ++ +V+R L ML +P
Sbjct: 227 MRRI--------RDNLP-----PRVKD------SHKVSSVLRG-------FLDLMLVREP 260
Query: 302 SRRITARSALEHEYFR 317
S+R TA+ L+H + +
Sbjct: 261 SQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 82/318 (25%), Positives = 140/318 (44%), Gaps = 70/318 (22%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQ 67
+G+G++G V A E A+K ++ + D+ V T + + L ++ + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLY--QILRGIAYCHSHRVL 124
+++ L+ V E+L+ DL H+ F L + Y +I+ G+ + HS ++
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF----DLYRATFYAAEIVCGLQFLHSKGII 118
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAG 184
+RDLK N+++DR + +K+ADFG+ + +G S +
Sbjct: 119 YRDLKLDNVMLDRDGH-IKIADFGMCK----------ENVFGDNRASTFCG--------- 158
Query: 185 SLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244
T Y APEIL G + Y+ VD WS G + EM+ + F GD E DELF+
Sbjct: 159 ----------TPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFE 206
Query: 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRR 304
RV TP+ +P+W +KE D+L K+ DP+RR
Sbjct: 207 SIRV-DTPH----------------YPRWITKE-----------SKDILEKLFERDPTRR 238
Query: 305 ITARSALE-HEYFRDVEF 321
+ + H +F+ + +
Sbjct: 239 LGVVGNIRGHPFFKTINW 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 7e-16
Identities = 84/340 (24%), Positives = 126/340 (37%), Gaps = 89/340 (26%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKE---- 57
++ +G G +G V R T + A+K ++ A +S +E
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV------LLAQETVSFFEEERDI 54
Query: 58 MQHGN---IVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLY 109
+ N I +LQ + LYLV EY DL L ++ D D + + +L
Sbjct: 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF-----DEDMAQFYLA 109
Query: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTG 169
+++ I H +HRD+KP+N+LID RT +KLADFG A
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAA------------------ 150
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILL-----GSRHYSTPVDVWSVGCIFA 224
R+ A ++ L V T Y APE+L G Y D WS+G I
Sbjct: 151 ----------RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY 200
Query: 225 EMVNQRPLFPGDSEIDELFKIF---RVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTV 281
EM+ R F + I R L P + P V+S DF
Sbjct: 201 EMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED---PKVSS--DFL-------------- 241
Query: 282 VRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVEF 321
DL+ +LC R+ H +F +++
Sbjct: 242 ---------DLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-16
Identities = 77/321 (23%), Positives = 125/321 (38%), Gaps = 65/321 (20%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIR----EISLLKEM 58
++ K E +G+G YG VY + IA+K++ L+ + E+ LLK +
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
+H NIV+ + + + E++ + P+ + + QIL G
Sbjct: 60 KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEP-----VFCKYTKQILDG 114
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+AY H++ V+HRD+K N+++ +KL DFG AR TH
Sbjct: 115 VAYLHNNCVVHRDIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTH------------ 161
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
S +L+ + W APE++ S Y D+WS+GC EM +P
Sbjct: 162 ----------SNMLKSMHGTPYWM-APEVINES-GYGRKSDIWSIGCTVFEMATGKPPLA 209
Query: 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294
+ +F I G + LPD SA A ID ++
Sbjct: 210 SMDRLAAMFYIGAHRGL--------MPRLPDSFSA------------------AAIDFVT 243
Query: 295 KMLCMDPSRRITARSALEHEY 315
L D R +A L H++
Sbjct: 244 SCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 37/222 (16%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
K+G G +G V++ +A+K ++ +D +E+ LK ++H +++ L
Sbjct: 12 RKLGSGYFGEVWEGL-WKNRVRVAIKILK--SDDLLKQQDFQKEVQALKRLRHKHLISLF 68
Query: 68 DVVHSEKKLYLVFEYLDLDLKKHMDSCPDFAN--DPRLIKTFLYQILRGIAYCHSHRVLH 125
V + +Y++ E ++ P+ LI Q+ G+AY +H
Sbjct: 69 AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLID-MACQVAEGMAYLEEQNSIH 127
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGS 185
RDL +N+L+ K+ADFGLAR V + +
Sbjct: 128 RDLAARNILVGEDL-VCKVADFGLARLIKEDVYL-SSDK--------------------- 164
Query: 186 LILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
K+ W APE +ST DVWS G + EM
Sbjct: 165 ------KIPYKW-TAPEA-ASHGTFSTKSDVWSFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 87/347 (25%), Positives = 137/347 (39%), Gaps = 81/347 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D +EK+ ++G G GVV K + + +A K I LE + + + IRE+ +L E
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPA-IRNQIIRELKVLHECNSP 59
Query: 62 NIVRLQDVVHSEKKLYLVFEY-----LDLDLKKHMDSCPDFANDPRLIKTFL----YQIL 112
IV +S+ ++ + E+ LD LKK R+ + L +L
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----------GRIPENILGKISIAVL 109
Query: 113 RGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
RG+ Y H+++HRD+KP N+L++ R +KL DFG++ G S
Sbjct: 110 RGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVS---------------GQLIDS 153
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR- 230
+ SF V T Y +PE L G+ HY+ D+WS+G EM R
Sbjct: 154 MANSF----------------VGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRY 196
Query: 231 PLFPGDSEIDELFKIFRV------LGTPNEDTWPGVTSLPDFKSAF-----------PKW 273
P+ P D++ EL +F + P + F PK
Sbjct: 197 PIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKL 254
Query: 274 PSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
PS D + K L +P R + +H + + E
Sbjct: 255 PS-------GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 38/236 (16%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH 60
+ +E +++IG GTYG VYKARN T E A+K I+LE ED V +EI ++K+ +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMKDCKH 65
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV KL++ E+ + + ++ + I + L+G+ Y HS
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQ-IAYVSRETLQGLYYLHS 124
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
+HRD+K N+L+ +KLADFG++ + I+ SF
Sbjct: 125 KGKMHRDIKGANILLT-DNGHVKLADFGVSAQI-------------TATIAKRKSF---- 166
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRH--YSTPVDVWSVGCIFAEMVN-QRPLF 233
+ T ++ APE+ R Y+ D+W+VG E+ Q P+F
Sbjct: 167 ------------IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 72/312 (23%), Positives = 130/312 (41%), Gaps = 69/312 (22%)
Query: 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
KIGEG+ G+V A + + +A+KK+ L ++ E+ ++++ QH N+V + +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYN 84
Query: 69 VVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRL----IKTFLYQILRGIAYCHSHRVL 124
+L++V E+L+ + D R+ I +L+ ++ H+ V+
Sbjct: 85 SYLVGDELWVVMEFLE------GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVI 138
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAG 184
HRD+K ++L+ +KL+DFG V R + L G
Sbjct: 139 HRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVP-------------------RRKSLVG 178
Query: 185 SLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244
T ++ APE L+ Y VD+WS+G + EMV+ P + + + + K
Sbjct: 179 ----------TPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-K 226
Query: 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRR 304
+ R D P P K+ + P+ L ++L DP++R
Sbjct: 227 MIR-------DNLP-----PKLKNL-------------HKVSPSLKGFLDRLLVRDPAQR 261
Query: 305 ITARSALEHEYF 316
TA L+H +
Sbjct: 262 ATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 69/233 (29%), Positives = 104/233 (44%), Gaps = 50/233 (21%)
Query: 7 VEKIGEGTYGVVYKAR------NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
++++G+G +G V R N T E +A+KK L+ REI +LK +QH
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDN--TGEVVAVKK--LQHSTAEHLRDFEREIEILKSLQH 64
Query: 61 GNIVRLQDVVHS--EKKLYLVFEYLDLD-----LKKHMDSCPDFANDPRLIKTFLYQILR 113
NIV+ + V +S + L LV EYL L+KH + D R + + QI +
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL-----DHRKLLLYASQICK 119
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
G+ Y S R +HRDL +N+L++ N +K+ DFGL + + G + I
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESE-NRVKIGDFGLTKVLPQDKEYYKVREPGESPI--- 175
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
WY APE L S+ +S DVWS G + E+
Sbjct: 176 ----------------------FWY-APESLTESK-FSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-15
Identities = 41/144 (28%), Positives = 75/144 (52%), Gaps = 5/144 (3%)
Query: 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
K+G G YG VY+ + T+A+K ++ ED ++E +++KE++H N+V+L
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 69 VVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRD 127
V E Y++ E++ +L ++ C + ++ QI + Y +HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 128 LKPQNLLIDRRTNALKLADFGLAR 151
L +N L+ + +K+ADFGL+R
Sbjct: 130 LAARNCLVGEN-HLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-15
Identities = 52/161 (32%), Positives = 85/161 (52%), Gaps = 24/161 (14%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH--- 60
+E VE +G GTYG VYK R+ T + A+K + + +++E EI++LK+ H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE---EEIKLEINMLKKYSHHRN 74
Query: 61 -----GNIVRLQDVVHSEKKLYLVFEY------LDLDLKKHMDSCPDFANDPRLIKTFLY 109
G ++ H ++ L+LV E+ DL +K + D I
Sbjct: 75 IATYYGAFIKKSPPGHDDQ-LWLVMEFCGAGSVTDL-VKNTKGNA--LKED--WIAYICR 128
Query: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150
+ILRG+A+ H+H+V+HRD+K QN+L+ +KL DFG++
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAE-VKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 57/263 (21%)
Query: 10 IGEGTYGVVYKARNCVTNE-------TIALKKIRLEQEDEGVPSTAIREISLLKEM-QHG 61
+GEG +G V +A ++ T+A+K ++ D+ + + I E+ L+K + +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDL-ADLISEMELMKLIGKHK 78
Query: 62 NIVRLQDVVHSEKKLYLVFEY-----LDLDLKKHMDSCPDFAND-PRLIKTFL------- 108
NI+ L V E LY++ EY L L+ PD+ D ++ + L
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 109 --YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166
YQ+ RG+ Y S R +HRDL +N+L+ N +K+ADFGLAR G
Sbjct: 139 CAYQVARGMEYLESRRCIHRDLAARNVLV-TEDNVMKIADFGLAR--------------G 183
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
I Y + G L ++++ APE L R Y+ DVWS G + E+
Sbjct: 184 VHDIDYY-----KKTSNGRLPVKWM--------APEALF-DRVYTHQSDVWSFGILMWEI 229
Query: 227 --VNQRPLFPGDSEIDELFKIFR 247
+ P +PG ++ELFK+ R
Sbjct: 230 FTLGGSP-YPG-IPVEELFKLLR 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 65/232 (28%), Positives = 97/232 (41%), Gaps = 59/232 (25%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
EKIG+G +G VYK N +A+K R + + ++E +LK+ H NIV+L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPD-LKRKFLQEAEILKQYDHPNIVKLI 58
Query: 68 DVVHSEKKLYLVFEYL--------------DLDLKKHMDSCPDFANDPRLIKTFLYQILR 113
V ++ +Y+V E + L +KK + D A
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAA-------------- 104
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
G+ Y S +HRDL +N L+ N LK++DFG++R E G
Sbjct: 105 GMEYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSR----------EEEGGI------ 147
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAE 225
Y V G LK + + + APE L R Y++ DVWS G + E
Sbjct: 148 -----YTVSDG------LKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 53/239 (22%)
Query: 7 VEKIGEGTYGVVYKAR---NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
+ IG G +G V + R +A+K ++ + + E S++ + H NI
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK-AGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 64 VRLQDVVHSEKKLYLVFEYLD---LD--LKKHMDSCPDFANDPRLIKTFLYQILRGIA-- 116
+RL+ VV + + ++ EY++ LD L+++ D + L +LRGIA
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLREN---------DGKFTVGQLVGMLRGIASG 118
Query: 117 --YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
Y +HRDL +N+L++ K++DFGL+R T+T
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDSEATYT------------- 164
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QRP 231
G K+ W APE + R +++ DVWS G + E+++ +RP
Sbjct: 165 ------TKGG-------KIPIRW-TAPEA-IAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 80/333 (24%), Positives = 137/333 (41%), Gaps = 49/333 (14%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEM 58
++K++ +G+G G V+ R T + ALK K + + ++ +EI L +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATL 58
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEY-----LDLDLKKHMDSCPDFANDPRLIKTFLYQILR 113
H + L +E L LV +Y L L++ C + + + + ++L
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC--LSEEV--ARFYAAEVLL 114
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEHWGSTGISI 172
+ Y H +++RDLKP+N+L+ + + L+DF L++ + P GS S+
Sbjct: 115 ALEYLHLLGIVYRDLKPENILL-HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
S V T Y APE++ G H + VD W++G + EM+
Sbjct: 174 N-SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTP 231
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
F G + DE F +L +P V + DL
Sbjct: 232 FKGSN-RDETF--SNILKKE------------------VTFPGS--PPVSSSAR----DL 264
Query: 293 LSKMLCMDPSRRI-TARSALE---HEYFRDVEF 321
+ K+L DPS+R+ + R A E H +FR V +
Sbjct: 265 IRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 40/223 (17%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
E+IG G +G V+ R N +A+K R E + + ++E +LK+ H NIVRL
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 68 DVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILR----GIAYCHSHR 122
V ++ +Y+V E + D + + PRL L Q++ G+ Y S
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRT-----EGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
+HRDL +N L+ + N LK++DFG++R V + STG
Sbjct: 115 CIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGV-------YASTG------------- 153
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAE 225
+K + + + APE L R YS+ DVWS G + E
Sbjct: 154 -------GMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 82/319 (25%), Positives = 135/319 (42%), Gaps = 71/319 (22%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIR---LEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
IG+G++G V + R T ALK IR + E + A R ++L ++ IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAER--TVLAQVNCPFIVPL 58
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
+ S +KLYLV +++ +L H+ F D + + ++L + H V++
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQREGRF--DLSRARFYTAELLCALENLHKFNVIY 116
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGS 185
RDLKP+N+L+D + + + L DFGL + + T+ G
Sbjct: 117 RDLKPENILLDYQGH-IALCDFGLCK-LNMKDDDKTNTFCG------------------- 155
Query: 186 LILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKI 245
T Y APE+LLG Y+ VD W++G + EM+ P F D ++E+++
Sbjct: 156 ---------TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFY-DENVNEMYR- 203
Query: 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI 305
++L P PD + DLL +L DP+RR+
Sbjct: 204 -KILQEP--------LRFPD------------------GFDRDAKDLLIGLLSRDPTRRL 236
Query: 306 TARSALE---HEYFRDVEF 321
A E H +F + +
Sbjct: 237 GYNGAQEIKNHPFFSQLSW 255
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 20/153 (13%)
Query: 7 VEKIGEGTYGVVYKARNCVTNET--IALKKIRLEQEDEGVPSTA--IREISLLKEMQHGN 62
K+G G +G V+ N T +A+K ++ G S ++E ++K+++H
Sbjct: 11 ERKLGAGQFGEVWMG---TWNGTTKVAVKTLK-----PGTMSPEAFLQEAQIMKKLRHDK 62
Query: 63 IVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
+V+L V E+ +Y+V EY+ LD K + P+L+ QI G+AY
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG--KKLRLPQLVD-MAAQIAEGMAYL 119
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
S +HRDL +N+L+ K+ADFGLAR
Sbjct: 120 ESRNYIHRDLAARNILVG-ENLVCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 81/330 (24%), Positives = 133/330 (40%), Gaps = 78/330 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQ- 59
D +E +E IG+GTYG V+K N A+K + + DE + + E ++LK +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA----EYNILKALSD 73
Query: 60 HGNIVRL------QDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLY 109
H N+V+ +DV + ++ L+LV E + DL K + +P +I L+
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQ-LWLVLELCNGGSVTDLVKGFLKRGERMEEP-IIAYILH 131
Query: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTG 169
+ L G+ + H ++ +HRD+K N+L+ +KL DFG
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFG--------------------- 169
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH----YSTPVDVWSVGCIFAE 225
+S + R R + V T ++ APE++ + Y DVWS+G E
Sbjct: 170 VSAQLTSTRLR--------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIE 221
Query: 226 MVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNL 285
+ + P + LFKI R + P EL + N
Sbjct: 222 LGDGDPPLADLHPMRALFKIPR--------------------NPPPTLHQPELWSNEFN- 260
Query: 286 EPAGIDLLSKMLCMDPSRRITARSALEHEY 315
D + K L D +R T L+H +
Sbjct: 261 -----DFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 37/222 (16%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIR---LEQEDEGVPSTAIREISLLKEMQHGN-IVR 65
IG+GT+G VY+ R T A+K + + + E + R I + + IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 66 LQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVL 124
L+ ++ LYLV +Y+ +L H+ F+ D K ++ +++ + + H + ++
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR--AKFYIAELVLALEHLHKYDIV 118
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAG 184
+RDLKP+N+L+D T + L DFGL++A + T+ G+T
Sbjct: 119 YRDLKPENILLD-ATGHIALCDFGLSKA-NLTDNKTTNTFCGTTE--------------- 161
Query: 185 SLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
Y APE+LL + Y+ VD WS+G + EM
Sbjct: 162 -------------YLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-14
Identities = 69/232 (29%), Positives = 105/232 (45%), Gaps = 42/232 (18%)
Query: 8 EKIGEGTYGVV----YKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
+++G G +G V Y ++ E +A+K ++ E G +RE S++ ++ H I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVE-VAVKTLKQEHIAAG-KKEFLREASVMAQLDHPCI 58
Query: 64 VRLQDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
VRL V E L LV E L L K++ + +K +Q+ G+AY S
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSD--LKELAHQVAMGMAYLESKH 115
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
+HRDL +N+L+ R A K++DFG++RA G GS Y+
Sbjct: 116 FVHRDLAARNVLLVNRHQA-KISDFGMSRALGA----------GSD----YYRATT---- 156
Query: 183 AGSLILQFLKVVTLWYRAPE-ILLGSRHYSTPVDVWSVGCIFAEMVN--QRP 231
AG L+ WY APE I G +S+ DVWS G E + +P
Sbjct: 157 AGRWPLK-------WY-APECINYGK--FSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 50/244 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYK--ARNCVTNETIALKKIRLEQEDEGVPSTAIR-----EIS 53
++ + ++G+G++G+VY+ A+ V E I+ E+ S R E S
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN---ASMRERIEFLNEAS 61
Query: 54 LLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSC-PDFAND-----PRLIKT 106
++KE ++VRL VV + + +V E + DLK ++ S P+ N+ P L K
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 107 FLY--QILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLARAFGIPVRTFTHE 163
+I G+AY + + +HRDL +N ++ T +K+ DFG+ R + +
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDI------YETD 173
Query: 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIF 223
+ YR L L V W APE L ++T DVWS G +
Sbjct: 174 Y--------------YRKGGKGL----LPV--RWM-APESLK-DGVFTTKSDVWSFGVVL 211
Query: 224 AEMV 227
EM
Sbjct: 212 WEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 70/267 (26%), Positives = 110/267 (41%), Gaps = 51/267 (19%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA----IREISLLKEMQHGN 62
++GEG +G V+ + + ++ E + A RE LL QH N
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 63 IVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDS-CPDFA----NDP---RLIKTFLYQILR 113
IV+ V +VFEY++ DL K + S PD A D L + L QI
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 114 GIA----YCHSHRVLHRDLKPQNLLIDRRTNAL-KLADFGLARAFGIPVRTFTHEHWGST 168
IA Y S +HRDL +N L+ + + K+ DFG++R
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVG--YDLVVKIGDFGMSR----------------- 170
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228
+Y + YRV G +L + + PE ++ R ++T DVWS G + E+
Sbjct: 171 --DVY-TTDYYRV-GGHTML------PIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFT 219
Query: 229 --QRPLFP-GDSEIDELFKIFRVLGTP 252
++P + + E+ E R+L P
Sbjct: 220 YGKQPWYGLSNEEVIECITQGRLLQRP 246
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 74/275 (26%), Positives = 115/275 (41%), Gaps = 39/275 (14%)
Query: 51 EISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHM-DSCPDFANDPRLIKT--F 107
EI L + H NI+++++++ SE Y++ + D DL M D D+ + P L +T
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272
Query: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167
+ Q+L + Y H +++HRD+K +N+ ++ + L DFG A F F + W
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV-LGDFGTAMPFEKEREAFDY-GW-- 328
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
V T+ +PEIL G Y D+WS G I +M+
Sbjct: 329 -------------------------VGTVATNSPEILAGD-GYCEITDIWSCGLILLDML 362
Query: 228 NQRPLFPGDSEID---ELFKIFRVLGTPNEDTWPGVTSLPDF-KSAFPKWPSKELGTVVR 283
+ GD +L KI L +E+ L D+ SA + ++R
Sbjct: 363 SHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR 422
Query: 284 NLE-PAGIDL-LSKMLCMDPSRRITARSALEHEYF 316
NL PA + L KML D R A L F
Sbjct: 423 NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457
|
Length = 501 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-14
Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 37/230 (16%)
Query: 5 EKVEKIGEGTYGVV----YKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+++ +GEG +G V Y T E +A+K ++ E + +EI +L+ + H
Sbjct: 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRNLYH 65
Query: 61 GNIVRLQDVVHSE--KKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
NIV+ + + + + L+ E+L LK+++ + N + +K + QI +G+ Y
Sbjct: 66 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICKGMDY 124
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
S + +HRDL +N+L++ + +K+ DFGL +A +T
Sbjct: 125 LGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYT---------------- 167
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
+ L WY APE L+ S+ Y DVWS G E++
Sbjct: 168 ---------VKDDLDSPVFWY-APECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 8e-14
Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 53/268 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKAR----NCVTNE-TIALKKIRLEQEDEGVPSTAIREISLLK 56
D+ + +GEG +G V KA + T+A+K ++ + ++ + S + E+ ++K
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL-SDLVSEMEMMK 70
Query: 57 EM-QHGNIVRLQDVVHSEKKLYLVFEY-----LDLDLKKH----MDSCPDFANDP----- 101
+ +H NI+ L V E LY+V EY L L+ + PD P
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 102 -RLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160
+ + +F YQ+ RG+ + S + +HRDL +N+L+ + +K+ADFGLAR
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLARDI------- 182
Query: 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
H I Y + G L ++++ APE L R Y+ DVWS G
Sbjct: 183 -HH------IDYY-----RKTTNGRLPVKWM--------APEALF-DRVYTHQSDVWSFG 221
Query: 221 CIFAEMVNQRPL-FPGDSEIDELFKIFR 247
+ E+ +PG ++ELFK+ +
Sbjct: 222 VLLWEIFTLGGSPYPG-IPVEELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 9e-14
Identities = 85/330 (25%), Positives = 129/330 (39%), Gaps = 89/330 (26%)
Query: 10 IGEGTYGVVYKARNCVTNETIA---LKKIRLEQEDEGVPSTAI--REISLLKEMQHGNIV 64
+G G +G V A T E A LKK + DE V S R +H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE-VESLMCEKRIFETANSERHPFLV 65
Query: 65 RLQDVVHSEKKLYLVFEYL---DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
L +E + V EY DL + H D + PR + ++ G+ Y H +
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE----PR-AVFYAACVVLGLQYLHEN 120
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTF--THEHWGSTGISIYFSF 176
++++RDLK NLL+D +K+ADFGL + FG TF T E F
Sbjct: 121 KIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPE------------F 167
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
L APE+L + Y+ VD W +G + EM+ FPGD
Sbjct: 168 L----------------------APEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGD 204
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKM 296
E +E+F N++ ++P R L I ++ ++
Sbjct: 205 DE-EEVFD-----SIVNDE---------------VRYP--------RFLSREAISIMRRL 235
Query: 297 LCMDPSRRI-----TARSALEHEYFRDVEF 321
L +P RR+ A + +FRD+ +
Sbjct: 236 LRRNPERRLGSGEKDAEDVKKQPFFRDINW 265
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 44/225 (19%)
Query: 7 VEKIGEGTYGVVY--KARNCVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGN 62
++++G G +GVV+ K R + +A+K IR EG S I E ++ ++ H N
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID---VAIKMIR-----EGAMSEDDFIEEAKVMMKLSHPN 60
Query: 63 IVRLQDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
+V+L V ++ +++V EY+ L ++ L+ + + Y S+
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS-DVCEAMEYLESN 119
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+HRDL +N L+ N +K++DFGLAR ++ S G
Sbjct: 120 GFIHRDLAARNCLVGED-NVVKVSDFGLARY------VLDDQYTSSQGT----------- 161
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
K W PE+ SR +S+ DVWS G + E+
Sbjct: 162 ----------KFPVKW-APPEVFDYSR-FSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 78/323 (24%), Positives = 141/323 (43%), Gaps = 76/323 (23%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVRLQ 67
+G+G++G V A T+E A+K ++ + +D+ V T + + L + + + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHR 126
+ +LY V EY++ DL H+ F +P+ + + +I G+ + H +++R
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKF-KEPQAV-FYAAEISVGLFFLHRRGIIYR 125
Query: 127 DLKPQNLLIDRRTNALKLADFGLARAF---GIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
DLK N+++D + +K+ADFG+ + G+ RTF
Sbjct: 126 DLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCG--------------------- 163
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243
T Y APEI + + Y VD W+ G + EM+ +P F G+ E DELF
Sbjct: 164 -----------TPDYIAPEI-IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELF 210
Query: 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303
+ S+ + ++PK SKE ++ + L + PS+
Sbjct: 211 Q-----------------SIMEHNVSYPKSLSKEAVSICKGL-----------MTKHPSK 242
Query: 304 RITA-----RSALEHEYFRDVEF 321
R+ R EH +FR +++
Sbjct: 243 RLGCGPEGERDIREHAFFRRIDW 265
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 82/325 (25%), Positives = 137/325 (42%), Gaps = 85/325 (26%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEMQHGNIVRL 66
+G+GT+G V R T + A+K ++ E +DE V T + E +L+ +H + L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE-VAHT-LTESRVLQNTRHPFLTAL 60
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLY--QILRGIAYCHSHRV 123
+ + +L V EY + +L H+ F+ D + Y +I+ + Y HS V
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARFYGAEIVSALGYLHSCDV 116
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
++RDLK +NL++D+ + +K+ DFGL + + G ++TF
Sbjct: 117 VYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCG------------------ 157
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR-PLFPGDSEI 239
T Y APE+L + Y VD W +G + EM+ R P + D E
Sbjct: 158 --------------TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
LF++ + E+ FP R L P LL+ +L
Sbjct: 203 --LFELILM-----EEI------------RFP-----------RTLSPEAKSLLAGLLKK 232
Query: 300 DPSRRI-----TARSALEHEYFRDV 319
DP +R+ A+ +EH +F +
Sbjct: 233 DPKQRLGGGPEDAKEIMEHRFFASI 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 69/261 (26%), Positives = 114/261 (43%), Gaps = 50/261 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEM-Q 59
D +E +E IG+GTYG VYK N A+K + + DE + + E ++L+ +
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA----EYNILQSLPN 77
Query: 60 HGNIVRLQDVVHSEKK-----LYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQ 110
H N+V+ + + K L+LV E + +L K + C ++ +I LY
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA-MISYILYG 136
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGI 170
L G+ + H++R++HRD+K N+L+ +KL DFG +
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFG---------------------V 174
Query: 171 SIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTP----VDVWSVGCIFAEM 226
S + R R + V T ++ APE++ + Y DVWS+G E+
Sbjct: 175 SAQLTSTRLR--------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
Query: 227 VNQRPLFPGDSEIDELFKIFR 247
+ P + LFKI R
Sbjct: 227 GDGDPPLFDMHPVKTLFKIPR 247
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-13
Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
+G+G +G V + T + A KK+ RL+++ A+ E +L+++ IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK--SGEKMALLEKEILEKVNSPFIVNL 58
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
S+ L LV ++ DLK H+ + + + + + QI GI + HS +++
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGS 185
RD+KP+N+L+D + N +L+D GLA + G
Sbjct: 119 RDMKPENVLLDDQGNC-RLSDLGLA----------------------------VELKDGK 149
Query: 186 LILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
I Q + T Y APEIL YS PVD +++GC EMV R F
Sbjct: 150 TITQ--RAGTNGYMAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-13
Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 45/230 (19%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
E +G G G VYKA + +T +A+K I L+ E + + E+ +L + I+
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-LQKQIMSELEILYKCDSPYIIGFY 65
Query: 68 DVVHSEKKLYLVFEYLD---LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVL 124
E ++ + E++D LD+ + + P+ ++ +++G+ Y S ++L
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKI---PE-----HVLGRIAVAVVKGLTYLWSLKIL 117
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAG 184
HRD+KP N+L++ R +KL DFG++ L
Sbjct: 118 HRDVKPSNMLVNTR-GQVKLCDFGVSTQ-----------------------------LVN 147
Query: 185 SLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
S+ + V T Y APE + G + Y DVWS+G F E+ R +P
Sbjct: 148 SIAKTY--VGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYP 194
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 78/288 (27%), Positives = 118/288 (40%), Gaps = 57/288 (19%)
Query: 51 EISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDLDL------KKHMDSCPDFANDPRLI 104
E +L+ + H +I++L+ K L+ DL K+++ C I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICD--------I 184
Query: 105 KTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164
+LR I Y H +R++HRD+K +N+ I+ + L DFG A PV +++
Sbjct: 185 LAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVC-LGDFGAA---CFPVDINANKY 240
Query: 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFA 224
+G G T+ APE LL Y VD+WS G +
Sbjct: 241 YGWAG-------------------------TIATNAPE-LLARDPYGPAVDIWSAGIVLF 274
Query: 225 EMVN-QRPLFP-----GDSEIDELFK-IFRVLGT-PNEDTWPGVTSLPDFKSAFPKWPSK 276
EM LF GD + D K I R GT PNE +L + K S+
Sbjct: 275 EMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSR 334
Query: 277 ELGT--VVRNLEPAGID---LLSKMLCMDPSRRITARSALEHEYFRDV 319
+ G+ + NL ID L+ KML D R +A + L+ F+D+
Sbjct: 335 KPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382
|
Length = 391 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-13
Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 27/156 (17%)
Query: 7 VEKIGEGTYGVV----YKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
V+K+G G +G V Y + +A+K ++ + P + E +L+K++QH
Sbjct: 11 VKKLGAGQFGEVWMGYYN-----GHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPR 62
Query: 63 IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLY-------QILRGI 115
+VRL VV E +Y++ EY++ S DF P IK + QI G+
Sbjct: 63 LVRLYAVVTQE-PIYIITEYME------NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM 115
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
A+ +HRDL+ N+L+ T K+ADFGLAR
Sbjct: 116 AFIERKNYIHRDLRAANILVS-ETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 10 IGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
IG+G++G V A++ + A+K K + ++ E A R + LLK ++H +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
+ KLY V +Y++ +L H+ F +PR + + +I + Y HS +++
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFP-EPR-ARFYAAEIASALGYLHSLNIIY 119
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGS 185
RDLKP+N+L+D + + + L DFGL + GI T G
Sbjct: 120 RDLKPENILLDSQGH-VVLTDFGLCKE-GIEHSKTTSTFCG------------------- 158
Query: 186 LILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
T Y APE+L + Y VD W +G + EM+ P F
Sbjct: 159 ---------TPEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 78/323 (24%), Positives = 140/323 (43%), Gaps = 72/323 (22%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVRLQ 67
+G+G++G V A T+E A+K ++ + +D+ V T + L +H + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHR 126
++ +L+ V EY++ DL + F ++PR + + ++ + + H H V++R
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKF-DEPR-SRFYAAEVTLALMFLHRHGVIYR 120
Query: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSL 186
DLK N+L+D + KLADFG+ + GI L G
Sbjct: 121 DLKLDNILLDAEGHC-KLADFGMCKE-GI--------------------------LNGVT 152
Query: 187 ILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIF 246
F T Y APEI L Y VD W++G + EM+ +P F D+E D+LF+
Sbjct: 153 TTTFCG--TPDYIAPEI-LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFE-- 206
Query: 247 RVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI- 305
++D +P W SKE + +L + +P++R+
Sbjct: 207 ---SILHDDV------------LYPVWLSKE-----------AVSILKAFMTKNPNKRLG 240
Query: 306 ------TARSALEHEYFRDVEFV 322
+ +H +F+++++V
Sbjct: 241 CVASQGGEDAIKQHPFFKEIDWV 263
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-13
Identities = 48/162 (29%), Positives = 83/162 (51%), Gaps = 26/162 (16%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH--- 60
+E VE +G GTYG VYK R+ T + A+K + + ++E +EI++LK+ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 64
Query: 61 -----GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPR-------LIKTFL 108
G ++ ++ + +L+LV E+ S D + + I
Sbjct: 65 IATYYGAFIK-KNPPGMDDQLWLVMEFCG------AGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 109 YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150
+ILRG+++ H H+V+HRD+K QN+L+ +KL DFG++
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-13
Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 59/260 (22%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGV--PSTAI----REISLL 55
+ ++ ++ IG G +G V R+ + + A+K + + E + +A R+I
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL---SKFEMIKRSDSAFFWEERDI--- 96
Query: 56 KEMQHGN---IVRLQDVVHSEKKLYLVFEYL---DL-DLKKHMDSCPDFANDPRLIKTFL 108
M H N IV+L +K LY+V EY+ DL +L + D +A + +
Sbjct: 97 --MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWA------RFYT 148
Query: 109 YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGST 168
+++ + HS +HRD+KP N+L+D ++ LKLADFG T +
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFG------------TCMKMDAN 195
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH---YSTPVDVWSVGCIFAE 225
G ++ V T Y +PE+L Y D WSVG E
Sbjct: 196 G----------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
Query: 226 MVNQRPLFPGDSEIDELFKI 245
M+ F DS + KI
Sbjct: 240 MLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA-IREISLLKEMQHGNI 63
+ IG+G +G V + +A+K ++ D+ + A + E S++ ++H N+
Sbjct: 9 KLGATIGKGEFGDVMLGD--YRGQKVAVKCLK----DDSTAAQAFLAEASVMTTLRHPNL 62
Query: 64 VRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
V+L VV LY+V EY+ L ++ S F + G+ Y
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARA 152
+HRDL +N+L+ A K++DFGLA+
Sbjct: 123 FVHRDLAARNVLVSEDLVA-KVSDFGLAKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 81/324 (25%), Positives = 137/324 (42%), Gaps = 78/324 (24%)
Query: 10 IGEGTYGVVYKARNCVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
+G+G++G V A T+E A LKK + Q+D+ V T + + L + + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDD-VECTMVEKRVLALPGKPPFLTQL 66
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
+ +LY V EY++ DL H+ F +P + + +I G+ + HS +++
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKF-KEPHAV-FYAAEIAIGLFFLHSKGIIY 124
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARAF---GIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
RDLK N+++D + +K+ADFG+ + G RTF
Sbjct: 125 RDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCG-------------------- 163
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242
T Y APEI+ + Y VD W+ G + EM+ +P F G+ E DEL
Sbjct: 164 ------------TPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DEL 209
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
F S+ + ++PK SKE + + +L P+
Sbjct: 210 F-----------------QSIMEHNVSYPKSLSKE-----------AVSICKGLLTKHPA 241
Query: 303 RRITA-----RSALEHEYFRDVEF 321
+R+ R EH +FR +++
Sbjct: 242 KRLGCGPTGERDIREHAFFRRIDW 265
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 75/269 (27%), Positives = 114/269 (42%), Gaps = 56/269 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNET-IALKKIRLEQEDEGVPSTA-----IREISLL 55
+ + V+K+G G +G V+ N T +A+K ++ P T + E +L+
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGY--YNNSTKVAVKTLK--------PGTMSVQAFLEEANLM 55
Query: 56 KEMQHGNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQI 111
K +QH +VRL VV E+ +Y++ EY+ LD K + P+LI F QI
Sbjct: 56 KTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLID-FSAQI 112
Query: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
G+AY +HRDL+ N+L+ K+ADFGLAR I +T I
Sbjct: 113 AEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARV--IEDNEYTAREGAKFPIK 169
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPE-ILLGSRHYSTPVDVWSVGCIFAEMVNQR 230
+ APE I GS ++ DVWS G + E+V
Sbjct: 170 --------------------------WTAPEAINFGS--FTIKSDVWSFGILLYEIVTYG 201
Query: 231 PL-FPGDSEIDELFKIFRVLGTPNEDTWP 258
+ +PG S D + + R P + P
Sbjct: 202 KIPYPGMSNSDVMSALQRGYRMPRMENCP 230
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 76/323 (23%), Positives = 136/323 (42%), Gaps = 76/323 (23%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVRLQ 67
+G+G++G V A T+E A+K ++ + +D+ V T + + L + + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHR 126
+ +LY V EY++ DL + F +P + + +I G+ + HS +++R
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRF-KEPHAV-FYAAEIAIGLFFLHSKGIIYR 125
Query: 127 DLKPQNLLIDRRTNALKLADFGLARAF---GIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
DLK N+++D + +K+ADFG+ + G+ +TF
Sbjct: 126 DLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCG--------------------- 163
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243
T Y APEI + + Y VD W+ G + EM+ + F G+ E DELF
Sbjct: 164 -----------TPDYIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELF 210
Query: 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303
+ S+ + A+PK SKE + + L + P +
Sbjct: 211 Q-----------------SIMEHNVAYPKSMSKEAVAICKGL-----------MTKHPGK 242
Query: 304 RITA-----RSALEHEYFRDVEF 321
R+ R EH +FR +++
Sbjct: 243 RLGCGPEGERDIKEHAFFRYIDW 265
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 51/230 (22%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
+ K+G G +G V++ T +A+K ++ D P + E ++K+++H +++L
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQL 66
Query: 67 QDVVHSEKKLYLV---------FEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
V E+ +Y+V EYL + + P+LI Q+ G+AY
Sbjct: 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL-------KLPQLIDM-AAQVASGMAY 118
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
+ +HRDL +N+L+ N K+ADFGLAR +
Sbjct: 119 LEAQNYIHRDLAARNVLVG-ENNICKVADFGLARVIKEDIYEAREG-------------- 163
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
K W APE L +R +S DVWS G + E+V
Sbjct: 164 -------------AKFPIKW-TAPEAALYNR-FSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 40/231 (17%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQ 59
+ V++IG G +G+V+ + +A+K IR EG S I E ++ ++
Sbjct: 4 SELTLVQEIGSGQFGLVWLG-YWLEKRKVAIKTIR-----EGAMSEEDFIEEAQVMMKLS 57
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
H +V+L V + LVFE+++ L ++ + + L+ L + G+AY
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL-DVCEGMAYL 116
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
S V+HRDL +N L+ +K++DFG+ R ++ STG
Sbjct: 117 ESSNVIHRDLAARNCLVGE-NQVVKVSDFGMTRF------VLDDQYTSSTGT-------- 161
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ 229
K W +PE+ S+ YS+ DVWS G + E+ ++
Sbjct: 162 -------------KFPVKW-SSPEVFSFSK-YSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 83/323 (25%), Positives = 129/323 (39%), Gaps = 56/323 (17%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
QY + + G+ G V+ C + KK+ ++ G T REI +LK + H
Sbjct: 93 QYNILSSLTPGSEGEVFV---CTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRA 147
Query: 63 IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLY---QILRGIAYCH 119
I+ L + + +V DL ++D + P ++ + ++L +AY H
Sbjct: 148 IINLIHAYRWKSTVCMVMPKYKCDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLH 202
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
++HRD+K +N+ +D NA+ L DFG A T + +G +G
Sbjct: 203 GRGIIHRDVKTENIFLDEPENAV-LGDFGAACKLD--AHPDTPQCYGWSG---------- 249
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM-VNQRPLF----P 234
TL +PE LL Y D+WS G + EM V LF
Sbjct: 250 ---------------TLETNSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293
Query: 235 GDSEIDELFKIFRVLGT-PNEDTWPGVTSL-PDFKS-AFPKWPSKELGTVVRNLEPAGID 291
S +L I R + P E G T+L FK A P + V+R +D
Sbjct: 294 SSSS--QLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMH-MD 350
Query: 292 ---LLSKMLCMDPSRRITARSAL 311
L++KML D R +A+ L
Sbjct: 351 VEYLIAKMLTFDQEFRPSAQDIL 373
|
Length = 392 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 47/278 (16%)
Query: 10 IGEGTYGVVYKARNCVTNET------IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
+G+G++G V+ R + LKK L+ D V + R+I L E+ H I
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDR-VRTKMERDI--LAEVNHPFI 60
Query: 64 VRLQDVVHSEKKLYLVFEYL-DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
V+L +E KLYL+ ++L DL + F + +K +L ++ + + HS
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYLAELALALDHLHSLG 118
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
+++RDLKP+N+L+D + +KL DFGL++ + HE +SF
Sbjct: 119 IIYRDLKPENILLDEEGH-IKLTDFGLSK------ESIDHE-------KKAYSFCG---- 160
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242
T+ Y APE+ + R ++ D WS G + EM+ F G + +
Sbjct: 161 ------------TVEYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM 207
Query: 243 FKIFRV-LGTPNEDTWPGVTSLPDFKSAFPKWPSKELG 279
I + LG P + P SL ++ F + P+ LG
Sbjct: 208 TMILKAKLGMPQFLS-PEAQSL--LRALFKRNPANRLG 242
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 88/351 (25%), Positives = 138/351 (39%), Gaps = 73/351 (20%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEMQH 60
+ K++ +G G +G V A T+ A+K +R + ++ A R+I L E +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDI--LAEADN 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
+V+L + LY V +Y+ + L M+ P+ L + ++ ++ I
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPE-----VLARFYIAELTLAIE 115
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-----------GIPVRTFTHE-- 163
H +HRD+KP N+LID + +KL DFGL F G +R + E
Sbjct: 116 SVHKMGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 164 -HWGSTGISIYFSFLR----------YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYST 212
W L+ R LA SL V T Y APE+LL + Y+
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSL------VGTPNYIAPEVLL-RKGYTQ 227
Query: 213 PVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPK 272
D WSVG I EM+ +P F + + K+ W +P
Sbjct: 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI---------NWENTLHIPP------- 271
Query: 273 WPSKELGTVVRNLEPAGIDLLSKMLCMDPSR--RITARSALEHEYFRDVEF 321
L P +DL++K+ C R R A H +F +V+F
Sbjct: 272 ---------QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 65/250 (26%), Positives = 104/250 (41%), Gaps = 54/250 (21%)
Query: 2 DQYEKVEKIGEGTYGVVYKAR--NCVTNETIALKKIRLEQEDEGVPSTA--IREISLLKE 57
+ E V IG+G +G V++AR + E + +++ +E+ A RE +L+ E
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFA----------------ND 100
H NIV+L V K + L+FEY+ DL + + A N
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 101 PRLIKTFLYQILR----GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156
L T I + G+AY + +HRDL +N L+ +K+ADFGL+R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSR----- 178
Query: 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDV 216
+IY S Y+ I + + PE + +R Y+T DV
Sbjct: 179 --------------NIY-SADYYKASENDAI-------PIRWMPPESIFYNR-YTTESDV 215
Query: 217 WSVGCIFAEM 226
W+ G + E+
Sbjct: 216 WAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 72/262 (27%), Positives = 119/262 (45%), Gaps = 55/262 (20%)
Query: 10 IGEGTYGVVYKARNCVTNE-------TIALKKIRLEQEDEGVPSTAIREISLLKEM-QHG 61
+GEG +G V A ++ T+A+K ++ + D+ + S + E+ ++K + +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDL-SDLVSEMEMMKMIGKHK 78
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDL-DLKKH--------MDSCPDFANDPRLIKTF----- 107
NI+ L + LY++ EY +L+++ MD D P TF
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 108 -LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166
YQ+ RG+ Y S + +HRDL +N+L+ N +K+ADFGLAR H
Sbjct: 139 CAYQVARGMEYLASQKCIHRDLAARNVLVT-EDNVMKIADFGLARD--------VHN--- 186
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
I Y + G L ++++ APE L R Y+ DVWS G + E+
Sbjct: 187 ---IDYY-----KKTTNGRLPVKWM--------APEALF-DRVYTHQSDVWSFGVLLWEI 229
Query: 227 VNQRPL-FPGDSEIDELFKIFR 247
+PG ++ELFK+ +
Sbjct: 230 FTLGGSPYPG-IPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 58/251 (23%), Positives = 96/251 (38%), Gaps = 56/251 (22%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG-NIVRL 66
+IG G +G V K + + +A+K+IR DE + ++ ++ IV+
Sbjct: 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV-DEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 67 QDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC-------- 118
+ E ++ E +D+ L D + + L +IL IA
Sbjct: 69 YGALFREGDCWICMELMDISL----DKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYL 123
Query: 119 -HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
+++HRD+KP N+L+DR N +KL DFG
Sbjct: 124 KEELKIIHRDVKPSNILLDRNGN-IKLCDFG----------------------------- 153
Query: 178 RYRVLAGSLILQFLKVVTLW---YRAPEILLGSRH--YSTPVDVWSVGCIFAEMVNQRPL 232
++G L+ K Y APE + S Y DVWS+G E+ +
Sbjct: 154 ----ISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
Query: 233 FPG-DSEIDEL 242
+P +S D+L
Sbjct: 210 YPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 66/246 (26%), Positives = 105/246 (42%), Gaps = 28/246 (11%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE-QEDEGVPSTAIREISLLKEMQ 59
M +Y+ + IG+G G VY A + V + +ALKKIR + E+ + +RE + ++
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHM-------DSCPDFANDPRLIKTFL---Y 109
H IV + + +Y Y++ K + +S + + FL +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTG 169
+I I Y HS VLHRDLKP N+L+ + L D+G A + E
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL-DWGAAIF-----KKLEEEDLLDID 174
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVV-TLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228
+ + G K+V T Y APE LLG S D++++G I +M+
Sbjct: 175 VDERNICYSSMTIPG-------KIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLT 226
Query: 229 QRPLFP 234
FP
Sbjct: 227 LS--FP 230
|
Length = 932 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 71/263 (26%), Positives = 121/263 (46%), Gaps = 57/263 (21%)
Query: 10 IGEGTYGVVYKARNCVTNE-------TIALKKIRLEQEDEGVPSTAIREISLLKEM-QHG 61
+GEG +G V A ++ T+A+K ++ + ++ + S + E+ ++K + +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 81
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDL-DLKKH--------MDSCPDFANDPRLIKTF----- 107
NI+ L + LY++ EY +L+++ M+ D A P TF
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 108 -LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166
YQ+ RG+ Y S + +HRDL +N+L+ N +K+ADFGLAR
Sbjct: 142 CTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDV------------- 187
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
I Y + G L ++++ APE L R Y+ DVWS G + E+
Sbjct: 188 -NNIDYY-----KKTTNGRLPVKWM--------APEALF-DRVYTHQSDVWSFGVLMWEI 232
Query: 227 --VNQRPLFPGDSEIDELFKIFR 247
+ P +PG ++ELFK+ +
Sbjct: 233 FTLGGSP-YPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 68/330 (20%), Positives = 130/330 (39%), Gaps = 67/330 (20%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNET------IALKKIRLEQEDEGVPSTAIREISLLKE 57
+E + +G G YG V+ R ++ LKK + Q+ + T L
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
+ +V L ++ KL+L+ +Y++ +L H+ F ++ ++ +I+ +
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE--VRVYIAEIVLALD 119
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
+ H +++RD+K +N+L+D + + L DFGL++ F + G
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCG---------- 168
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILL-GSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
T+ Y APE++ GS + VD WS+G + E++ F
Sbjct: 169 ------------------TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSK 295
D E + +I R + P +P + D + K
Sbjct: 211 DGEQNSQSEISRRILKSK-----------------PPFPKT--------MSAEARDFIQK 245
Query: 296 MLCMDPSRRITARSALE---HEYFRDVEFV 322
+L DP +R+ A A E H +F+ +++
Sbjct: 246 LLEKDPKKRLGANGADEIKNHPFFQGIDWD 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 3e-12
Identities = 81/324 (25%), Positives = 139/324 (42%), Gaps = 79/324 (24%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEMQHGNIVRL 66
+G+GT+G V R + + A+K ++ E +DE + + E +LK +H + L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE--VAHTLTESRVLKNTRHPFLTSL 60
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLY--QILRGIAYCHSHRV 123
+ ++ +L V EY++ +L H+ F+ D +T Y +I+ + Y HS ++
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED----RTRFYGAEIVSALDYLHSGKI 116
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
++RDLK +NL++D+ + +K+ DFGL + G T + +F
Sbjct: 117 VYRDLKLENLMLDKDGH-IKITDFGLCKE-------------GITDAATMKTFCG----- 157
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR-PLFPGDSEIDEL 242
T Y APE+ L Y VD W +G + EM+ R P + D E
Sbjct: 158 -----------TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---- 201
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
K+F ++ + D K FP R L LLS +L DP+
Sbjct: 202 -KLFELI------------LMEDIK--FP-----------RTLSADAKSLLSGLLIKDPN 235
Query: 303 RRI-----TARSALEHEYFRDVEF 321
+R+ A+ + H +F V +
Sbjct: 236 KRLGGGPDDAKEIMRHSFFTGVNW 259
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 42/232 (18%)
Query: 10 IGEGTYGVVYKAR---NCVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
+G G +G V+ A+ ET+ L K + +DE + S RE+ + +++ H N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 66 LQDVVHSEKKLYLVFEYLDL-DLKKHM--DSCPDFANDPRLIKT-----FLYQILRGIAY 117
L + + Y++ EY DL DLK+ + D P + T QI G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
+ R +HRDL +N L+ +K++ L++ + E Y+
Sbjct: 133 LSNARFVHRDLAARNCLVS-SQREVKVSLLSLSKD------VYNSE---------YYKLR 176
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ 229
++ L + APE + +ST DVWS G + E+ Q
Sbjct: 177 N-------------ALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQ 214
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 38/228 (16%)
Query: 10 IGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
IG+G++G V A+ A+K K + ++ E A R + LLK ++H +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGL 61
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
+ +KLY V +Y++ +L H+ F +PR + + ++ I Y HS +++
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL-EPR-ARFYAAEVASAIGYLHSLNIIY 119
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGS 185
RDLKP+N+L+D + + + L DFGL + G+ T G
Sbjct: 120 RDLKPENILLDSQGHVV-LTDFGLCKE-GVEPEETTSTFCG------------------- 158
Query: 186 LILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
T Y APE+ L Y VD W +G + EM+ P F
Sbjct: 159 ---------TPEYLAPEV-LRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 70/321 (21%), Positives = 127/321 (39%), Gaps = 68/321 (21%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQD 68
+G+G +G V + T + A KK+ ++ + + A+ E +L+++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 69 VVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRD 127
++ L LV ++ DLK H+ + + D + +I G+ H R+++RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127
Query: 128 LKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGS 185
LKP+N+L+D + ++++D GLA G +R
Sbjct: 128 LKPENILLDDYGH-IRISDLGLAVEIPEGETIRG-------------------------- 160
Query: 186 LILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKI 245
+V T+ Y APE++ R Y+ D W +GC+ EM+ + F E K+
Sbjct: 161 ------RVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKE-----KV 208
Query: 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI 305
R E+ V + ++ K A + ++L DP R+
Sbjct: 209 KR------EEVERRVKEDQE------EYSEK--------FSEAARSICRQLLTKDPGFRL 248
Query: 306 -----TARSALEHEYFRDVEF 321
A H +FR F
Sbjct: 249 GCRGEGAEEVKAHPFFRTANF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 28/171 (16%)
Query: 7 VEKIGEGTYGVVYKARNCVTNET----------------IALKKIRLEQEDEGVPSTAIR 50
VEK+GEG +G V+ + +A+K +R + ++
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLR-PDASDNAREDFLK 68
Query: 51 EISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDLD-----LKKHMDSCPDFANDPRLI- 104
E+ +L + NI RL V + L ++ EY++ L+KH+ A + + +
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 105 -KTFLY---QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
T LY QI G+ Y S +HRDL +N L+ + +K+ADFG++R
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT-IKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-12
Identities = 75/319 (23%), Positives = 131/319 (41%), Gaps = 64/319 (20%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQD 68
+G+G +G V + T + A KK+ ++ + S A+ E +L+++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 69 VVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRD 127
++ L LV ++ DLK H+ + + + +I G+ H R+++RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127
Query: 128 LKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLI 187
LKP+N+L+D + ++++D GLA H G T + G
Sbjct: 128 LKPENILLDDHGH-IRISDLGLA----------VHVPEGQT-------------IKG--- 160
Query: 188 LQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFR 247
+V T+ Y APE++ R+ +P D W++GC+ EM+ + F + KI R
Sbjct: 161 ----RVGTVGYMAPEVVKNERYTFSP-DWWALGCLLYEMIAGQSPFQQRKK-----KIKR 210
Query: 248 VLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-- 305
E+ V + + S P L +LC DP R+
Sbjct: 211 ------EEVERLVKEVQEEYSE--------------KFSPDARSLCKMLLCKDPKERLGC 250
Query: 306 ---TARSALEHEYFRDVEF 321
AR EH F+ + F
Sbjct: 251 QGGGAREVKEHPLFKQINF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-12
Identities = 63/235 (26%), Positives = 100/235 (42%), Gaps = 45/235 (19%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
E +G+G +G V+K + ++T K E + + + E +LK+ H NIV+L
Sbjct: 1 ELLGKGNFGEVFKG--TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 68 DVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHR 126
V + +Y+V E + D + D +L+K F G+AY S +HR
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVK-FALDAAAGMAYLESKNCIHR 117
Query: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSL 186
DL +N L+ N LK++DFG++R + + S+G
Sbjct: 118 DLAARNCLVG-ENNVLKISDFGMSRQEDDGI-------YSSSG----------------- 152
Query: 187 ILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG-----------CIFAEMVNQR 230
LK + + + APE L R YS+ DVWS G C + M NQ+
Sbjct: 153 ----LKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-12
Identities = 38/159 (23%), Positives = 76/159 (47%), Gaps = 15/159 (9%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAIREISLLKE 57
+ EK++ +G G +G VYK E + + K+ E+ + E ++
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS 65
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDLD-----LKKHMDSCPDFANDPRLIKTFLYQIL 112
+ H ++VRL + S + + L+ + + L ++ H D+ + + + QI
Sbjct: 66 VDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNI-----GSQYLLNWCVQIA 119
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
+G++Y R++HRDL +N+L+ +K+ DFGLA+
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTP-QHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 38/222 (17%)
Query: 22 RNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81
R E + K + L DE + A E+ L H IV+ D S+ KL L+ E
Sbjct: 88 RGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145
Query: 82 Y-----LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLID 136
Y L+ +K+ + F + YQI+ + HS +++HRDLK N+ +
Sbjct: 146 YGSGGDLNKQIKQRLKEHLPFQEYE--VGLLFYQIVLALDEVHSRKMMHRDLKSANIFL- 202
Query: 137 RRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTL 196
T +KL DFG F+ ++ S + + SF T
Sbjct: 203 MPTGIIKLGDFG-----------FSKQYSDSVSLDVASSFCG----------------TP 235
Query: 197 WYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
+Y APE L + YS D+WS+G I E++ F G S+
Sbjct: 236 YYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276
|
Length = 478 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 70/266 (26%), Positives = 112/266 (42%), Gaps = 52/266 (19%)
Query: 9 KIGEGTYGVVYKARNCV----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
++GEG +G V+ A C T + + + L+ RE LL +QH +IV
Sbjct: 12 ELGEGAFGKVFLAE-CYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 65 RLQDVVHSEKKLYLVFEYL---DLD--LKKH-------MDSCPDFANDPRLIKTFLY--- 109
+ V L +VFEY+ DL+ L+ H +D P A + L+
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTG 169
QI G+ Y S +HRDL +N L+ +K+ DFG++R
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSRDV---------------- 173
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN- 228
+S YRV +++ + + PE ++ R ++T DVWS G I E+
Sbjct: 174 ----YSTDYYRVGGHTML-------PIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTY 221
Query: 229 -QRPLFP-GDSEIDELFKIFRVLGTP 252
++P F ++E+ E RVL P
Sbjct: 222 GKQPWFQLSNTEVIECITQGRVLERP 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 74/331 (22%), Positives = 137/331 (41%), Gaps = 68/331 (20%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNET------IALKKIRLEQEDEGVPSTAIREISLLKE 57
+E ++ +G G YG V+ R ++T L+K L Q+ + V T L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
Q +V L +E KL+L+ +Y+ ++ H+ +F+ D ++ + +I+ +
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDE--VRFYSGEIILALE 119
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
+ H +++RD+K +N+L+D + + L DFGL++ F + T+ G
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCG---------- 168
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
T+ Y APEI+ G + VD WS+G + E++ F +
Sbjct: 169 ------------------TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKM 296
E + ++ R + P +PS + P DLL K+
Sbjct: 211 GERNTQSEVSRRI-----------------LKCDPPFPSF--------IGPEAQDLLHKL 245
Query: 297 LCMDPSRRI-----TARSALEHEYFRDVEFV 322
L DP +R+ A EH +F+ +++
Sbjct: 246 LRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 43/232 (18%)
Query: 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
K+G+G +G V+ T +A+K ++ P ++E ++K+++H +V+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 69 VVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVL 124
VV SE+ +Y+V EY+ LD K + P+L+ QI G+AY +
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVD-MAAQIASGMAYVERMNYV 124
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAG 184
HRDL+ N+L+ K+ADFGLAR I +T I
Sbjct: 125 HRDLRAANILVGENL-VCKVADFGLARL--IEDNEYTARQGAKFPIK------------- 168
Query: 185 SLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ-RPLFPG 235
+ APE L R ++ DVWS G + E+ + R +PG
Sbjct: 169 -------------WTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 61/265 (23%)
Query: 10 IGEGTYGVVYKAR---------NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-Q 59
+GEG +G V A N VT +A+K ++ + ++ + S I E+ ++K + +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTK--VAVKMLKSDATEKDL-SDLISEMEMMKMIGK 82
Query: 60 HGNIVRLQDVVHSEKKLYLVFE---------YLDLDLKKHMDSC--PDFANDPRL----I 104
H NI+ L + LY++ E YL M+ C P + +L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 105 KTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164
+ YQ+ RG+ Y S + +HRDL +N+L+ N +K+ADFGLAR
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLAR------------- 188
Query: 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFA 224
I+ + G L ++++ APE L R Y+ DVWS G +
Sbjct: 189 ------DIHHIDYYKKTTNGRLPVKWM--------APEALF-DRIYTHQSDVWSFGVLLW 233
Query: 225 EM--VNQRPLFPGDSEIDELFKIFR 247
E+ + P +PG ++ELFK+ +
Sbjct: 234 EIFTLGGSP-YPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 46/222 (20%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA-IREISLLKEMQHGNIVRL 66
E IGEG +G V + T + +A+K I+ + V + A + E +++ ++ H N+VRL
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-----VTAQAFLEETAVMTKLHHKNLVRL 64
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFA-NDPRLIKTFLYQILRGIAYCHSHRVL 124
V+ LY+V E + +L + + + +L++ F + G+ Y S +++
Sbjct: 65 LGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ-FSLDVAEGMEYLESKKLV 122
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAG 184
HRDL +N+L+ K++DFGLAR G
Sbjct: 123 HRDLAARNILVS-EDGVAKVSDFGLAR-------------------------------VG 150
Query: 185 SLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
S+ + K+ W APE L + +S+ DVWS G + E+
Sbjct: 151 SMGVDNSKLPVKW-TAPEALKHKK-FSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 73/323 (22%), Positives = 136/323 (42%), Gaps = 75/323 (23%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIR----LEQEDEGVPSTAIREISLLKEMQHGNIVR 65
+G+G++G V AR + A+K ++ L+ +D T R +SL + H + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFLTQ 60
Query: 66 LQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVL 124
L + +L+ V E+++ DL H+ F ++ R + + +I + + H ++
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-DEAR-ARFYAAEITSALMFLHDKGII 118
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAG 184
+RDLK N+L+D + KLADFG+ + GI T G+
Sbjct: 119 YRDLKLDNVLLDHEGHC-KLADFGMCKE-GIFNGKTTSTFCGTPD--------------- 161
Query: 185 SLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244
Y APEI L Y VD W++G + EM+ F ++E D+LF+
Sbjct: 162 -------------YIAPEI-LQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFE 206
Query: 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRR 304
L D + +P W S++ +D+L + +P+ R
Sbjct: 207 AI----------------LND-EVVYPTWLSQD-----------AVDILKAFMTKNPTMR 238
Query: 305 ITA------RSALEHEYFRDVEF 321
+ + + L H +F+++++
Sbjct: 239 LGSLTLGGEEAILRHPFFKELDW 261
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 79/325 (24%), Positives = 134/325 (41%), Gaps = 81/325 (24%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEMQHGNIVRL 66
+G+GT+G V R T A+K +R E +DE V T + E +L+ +H + L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHT-VTESRVLQNTRHPFLTAL 60
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
+ + +L V EY + +L H+ F + + + +I+ + Y HS V++
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER--ARFYGAEIVSALEYLHSRDVVY 118
Query: 126 RDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
RD+K +NL++D+ + +K+ DFGL + + G ++TF
Sbjct: 119 RDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCG-------------------- 157
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR-PLFPGDSEIDE 241
T Y APE+ L Y VD W +G + EM+ R P + D E
Sbjct: 158 ------------TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--R 202
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301
LF++ + E +P R L P LL+ +L DP
Sbjct: 203 LFELILM----EEIRFP------------------------RTLSPEAKSLLAGLLKKDP 234
Query: 302 SRRI-----TARSALEHEYFRDVEF 321
+R+ A+ +EH +F + +
Sbjct: 235 KQRLGGGPSDAKEVMEHRFFLSINW 259
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 8/149 (5%)
Query: 8 EKIGEGTYGVVYKA-RNCVTNETI--ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
IGEG +G VY+ NE I A+K + V ++E ++++ H +IV
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS-VREKFLQEAYIMRQFDHPHIV 70
Query: 65 RLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
+L V+ +E +++V E L +L+ ++ + LI + YQ+ +AY S R
Sbjct: 71 KLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLI-LYSYQLSTALAYLESKRF 128
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARA 152
+HRD+ +N+L+ +KL DFGL+R
Sbjct: 129 VHRDIAARNVLVSSPDC-VKLGDFGLSRY 156
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 75/326 (23%), Positives = 136/326 (41%), Gaps = 78/326 (23%)
Query: 10 IGEGTYGVVYKARNCVTNETIALK-----KIRLEQEDEGVPSTAIREISLLKEMQHGN-- 62
IG G +G VY R T + A+K +I+++Q + + A+ E +L + G+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE----TLALNERIMLSLVSTGDCP 57
Query: 63 -IVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
IV + H+ KL + + ++ DL H+ F+ + ++ + +I+ G+ + H+
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE--KEMRFYATEIILGLEHMHN 115
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
V++RDLKP N+L+D + +++D GLA F + H G+ G
Sbjct: 116 RFVVYRDLKPANILLDEHGHV-RISDLGLACDFS---KKKPHASVGTHG----------- 160
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
Y APE+L Y + D +S+GC+ +++ F D
Sbjct: 161 -----------------YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
+ +I R+ T N LPD + P LL +L D
Sbjct: 204 K-HEIDRMTLTVN-------VELPD------------------SFSPELKSLLEGLLQRD 237
Query: 301 PSRRI-----TARSALEHEYFRDVEF 321
S+R+ A+ EH +F+ +++
Sbjct: 238 VSKRLGCLGRGAQEVKEHVFFKGIDW 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 58/244 (23%), Positives = 102/244 (41%), Gaps = 43/244 (17%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ E + +G G G V K ++ T +A K + + V +RE+ ++ E +
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSP 63
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFAN--DPRLIKTFLYQILRGIAYCH 119
IV +E + + E++D +D ++ ++ G+ Y +
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMD---CGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 120 S-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
+ HR++HRD+KP N+L++ R +KL DFG++ G SI +F
Sbjct: 121 NVHRIMHRDIKPSNILVNSR-GQIKLCDFGVS---------------GELINSIADTF-- 162
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP-GDS 237
V T Y +PE + G + Y+ DVWS+G E+ + FP S
Sbjct: 163 --------------VGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELALGK--FPFAFS 205
Query: 238 EIDE 241
ID+
Sbjct: 206 NIDD 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 70/256 (27%), Positives = 102/256 (39%), Gaps = 67/256 (26%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEM 58
D E +E++G G YGVV K R+ T +A+K+IR QE + LL ++
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK----------RLLMDL 50
Query: 59 QHG-------NIVRLQDVVHSEKKLYLVFEYLD--LD-LKKHMDSCPDFANDPRLIKTFL 108
V + E +++ E +D LD K + + L K +
Sbjct: 51 DISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV 110
Query: 109 YQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167
I++ + Y HS V+HRD+KP N+LI+R +KL DF
Sbjct: 111 -SIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-VKLCDF-------------------- 148
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLW---YRAPEIL---LGSRHYSTPVDVWSVGC 221
GIS G L+ K + Y APE + L + Y DVWS+G
Sbjct: 149 -GIS------------GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGI 195
Query: 222 IFAEMVNQRPLFPGDS 237
E+ R FP DS
Sbjct: 196 TMIELATGR--FPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-11
Identities = 67/258 (25%), Positives = 108/258 (41%), Gaps = 47/258 (18%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIVR 65
+K+G G +G V+ A + +A+K ++ G S + E +++K +QH +V+
Sbjct: 12 KKLGAGQFGEVWMA-TYNKHTKVAVKTMK-----PGSMSVEAFLAEANVMKTLQHDKLVK 65
Query: 66 LQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
L VV E +Y++ E++ LD K + P+LI F QI G+A+
Sbjct: 66 LHAVVTKEP-IYIITEFMAKGSLLDFLKSDEG--SKQPLPKLID-FSAQIAEGMAFIEQR 121
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+HRDL+ N+L+ K+ADFGLAR +E+ G
Sbjct: 122 NYIHRDLRAANILVSASL-VCKIADFGLARVIE------DNEYTAREGA----------- 163
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ-RPLFPGDSEID 240
K W I GS ++ DVWS G + E+V R +PG S +
Sbjct: 164 ----------KFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
Query: 241 ELFKIFRVLGTPNEDTWP 258
+ + R P + P
Sbjct: 212 VIRALERGYRMPRPENCP 229
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-11
Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 40/229 (17%)
Query: 10 IGEGTYGVVYKARNCVTNETIALK----KIRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
IG+G++G V A+ + + A+K KI L ++++ A R + LLK ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQK-HIMAERNV-LLKNVKHPFLVG 60
Query: 66 LQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVL 124
L + +KLY V ++++ +L H+ F +PR + + +I + Y HS ++
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP-EPR-ARFYAAEIASALGYLHSINIV 118
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAG 184
+RDLKP+N+L+D + + + L DFGL + GI T G
Sbjct: 119 YRDLKPENILLDSQGHVV-LTDFGLCKE-GIAQSDTTTTFCG------------------ 158
Query: 185 SLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
T Y APE++ + Y VD W +G + EM+ P F
Sbjct: 159 ----------TPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 84/313 (26%), Positives = 128/313 (40%), Gaps = 82/313 (26%)
Query: 26 TNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV-VHSEKKLYLVFEYL 83
T +A+K +R E+E + RE +L + H NIV L D L+ VFEY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 84 D-LDLKKHMDSCPDFANDPRL--IKT--FLYQILRGIAYCHSHRVLHRDLKPQNLLI--- 135
L++ + A D L +T + Q+L +A H+ ++HRDLKPQN+++
Sbjct: 62 PGRTLREVL------AADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115
Query: 136 DRRTNALKLADFGL------ARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQ 189
R +A K+ DFG+ R + T T E G+
Sbjct: 116 GVRPHA-KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPT-------------------- 154
Query: 190 FLKVVTLWYRAPEILLGSRHYSTP-VDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRV 248
Y APE L G TP D+++ G IF E + + + G S + +++
Sbjct: 155 --------YCAPEQLRGEP--VTPNSDLYAWGLIFLECLTGQRVVQGASVAE---ILYQQ 201
Query: 249 LGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308
L P SLP + + P LG V+R L+K DP +R +
Sbjct: 202 LS-------PVDVSLPPWIAGHP------LGQVLR-------KALNK----DPRQRAASA 237
Query: 309 SALEHEYFRDVEF 321
AL E FR +E
Sbjct: 238 PALA-ERFRALEL 249
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 67/245 (27%), Positives = 107/245 (43%), Gaps = 55/245 (22%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ + ++K+G G +G V+ N +A+K ++ P + + E ++K+++H
Sbjct: 6 ESLQLIKKLGNGQFGEVWMG-TWNGNTKVAVKTLK---PGTMSPESFLEEAQIMKKLRHD 61
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFAND--------PRLIKTFLYQILR 113
+V+L VV SE+ +Y+V EY+ S DF D P L+ Q+
Sbjct: 62 KLVQLYAVV-SEEPIYIVTEYMS------KGSLLDFLKDGEGRALKLPNLVD-MAAQVAA 113
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNAL--KLADFGLARAFGIPVRTFTHEHWGSTGIS 171
G+AY +HRDL+ N+L+ + L K+ADFGLAR I +T
Sbjct: 114 GMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARL--IEDNEYTAR-------- 160
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ-R 230
Q K W APE L R ++ DVWS G + E+V + R
Sbjct: 161 -----------------QGAKFPIKW-TAPEAALYGR-FTIKSDVWSFGILLTELVTKGR 201
Query: 231 PLFPG 235
+PG
Sbjct: 202 VPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 42/230 (18%)
Query: 10 IGEGTYGVVYKARNCVTNETIALK-----KIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
IG+G++G V AR+ + A+K I ++E++ + S R + LLK ++H +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSE--RNV-LLKNVKHPFLV 59
Query: 65 RLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
L + KLY V +Y++ +L H+ F +PR + + +I + Y HS +
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL-EPR-ARFYAAEIASALGYLHSLNI 117
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
++RDLKP+N+L+D + + + L DFGL + EH G+T
Sbjct: 118 VYRDLKPENILLDSQGHIV-LTDFGLCKE--------NIEHNGTTS-----------TFC 157
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
G T Y APE+ L + Y VD W +G + EM+ P F
Sbjct: 158 G----------TPEYLAPEV-LHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 42/176 (23%)
Query: 10 IGEGTYGVVYKA-------RNCVTNETIALKKIRLEQEDEGVPSTAIR----EISLLKEM 58
+GEG +G V KA R T T+A+K ++ E S+ +R E +LLK++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYT--TVAVKMLK-----ENASSSELRDLLSEFNLLKQV 60
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEY---------LDLDLK---------KHMDSCPDFAND 100
H ++++L + L L+ EY L K + +S D
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 101 PRLIK-----TFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
R + +F +QI RG+ Y +++HRDL +N+L+ +K++DFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 38/233 (16%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQD 68
+G+G +G V + T + A K++ ++ + S A+ E +L+++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 69 VVHSEKKLYLVFEYLDL-DLKKHMDSC--PDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
++ L LV ++ DLK H+ + P F + L + +IL G+ H ++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF--YAAEILCGLEDLHRENTVY 125
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGS 185
RDLKP+N+L+D + ++++D GLA ++ G
Sbjct: 126 RDLKPENILLDDYGH-IRISDLGLA----------------------------VKIPEGE 156
Query: 186 LILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
I +V T+ Y APE+L R+ +P D W +GC+ EM+ + F G E
Sbjct: 157 SIRG--RVGTVGYMAPEVLNNQRYTLSP-DYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 43/232 (18%)
Query: 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
K+G+G +G V+ T + +A+K ++ +P ++E ++K+++H +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 69 VVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVL 124
VV SE+ +Y+V E++ LD K D + P+L+ QI G+AY +
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDG--KYLKLPQLVD-MAAQIADGMAYIERMNYI 124
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAG 184
HRDL+ N+L+ K+ADFGLAR I +T I
Sbjct: 125 HRDLRAANILVGDNL-VCKIADFGLARL--IEDNEYTARQGAKFPIK------------- 168
Query: 185 SLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ-RPLFPG 235
+ APE L R ++ DVWS G + E+V + R +PG
Sbjct: 169 -------------WTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 47/262 (17%)
Query: 9 KIGEGTYGVVYKARN---CVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
++GEG +G V+ A C + I + L+ + RE LL +QH +IV+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 66 LQDVVHSEKKLYLVFEYLDL-DLKKHMDS-CPDF-----ANDP-RLIKTFLY----QILR 113
V L +VFEY+ DL K + + PD N P L ++ + QI
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
G+ Y S +HRDL +N L+ +K+ DFG++R
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGENL-LVKIGDFGMSRDV-------------------- 170
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QRP 231
+S YRV +++ + + PE ++ R ++T DVWS+G + E+ ++P
Sbjct: 171 YSTDYYRVGGHTML-------PIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQP 222
Query: 232 LFP-GDSEIDELFKIFRVLGTP 252
+ ++E+ E RVL P
Sbjct: 223 WYQLSNNEVIECITQGRVLQRP 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 78/329 (23%), Positives = 135/329 (41%), Gaps = 84/329 (25%)
Query: 10 IGEGTYGVVYKARNCVTNETIALK-----KIRLEQEDEGVPSTAIREISLLKEMQHGN-- 62
IG G +G VY R T + A+K +I+++Q + + A+ E +L + G+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE----TLALNERIMLSLVSTGDCP 57
Query: 63 -IVRLQDVVHSEKKLYLVFEYLDL----DLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
IV + H+ KL + LDL DL H+ F+ ++ + +I+ G+ +
Sbjct: 58 FIVCMSYAFHTPDKLSFI---LDLMNGGDLHYHLSQHGVFSEAE--MRFYAAEIILGLEH 112
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
H+ V++RDLKP N+L+D + +++D GLA F + H G+ G
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHV-RISDLGLACDFS---KKKPHASVGTHG-------- 160
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
Y APE+L Y + D +S+GC+ +++ F
Sbjct: 161 --------------------YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
D+ +I R+ T P S P+ +S LL +L
Sbjct: 201 TKDKH-EIDRMTLTMAV-ELPDSFS-PELRS-----------------------LLEGLL 234
Query: 298 CMDPSRRI-----TARSALEHEYFRDVEF 321
D +RR+ A+ EH +FR +++
Sbjct: 235 QRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 66/235 (28%), Positives = 103/235 (43%), Gaps = 46/235 (19%)
Query: 9 KIGEGTYGVVYKAR--NCVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQHGNIVR 65
++GEG +G V+ A N + + L ++ L++ E RE LL +QH +IVR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 66 LQDVVHSEKKLYLVFEYL---DLD--LKKH------MDSCPDFANDPRLIKTFLY---QI 111
V + L +VFEY+ DL+ L+ H + D A + L QI
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
G+ Y S +HRDL +N L+ + +K+ DFG++R
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSR-------------------D 171
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
IY S YRV G +L + + PE +L R ++T D+WS G + E+
Sbjct: 172 IY-STDYYRV-GGRTML------PIRWMPPESIL-YRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 67/243 (27%), Positives = 107/243 (44%), Gaps = 18/243 (7%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQH 60
D +E ++ IG G +G V + T A+K +R E IR E +L E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
+V++ ++ LYL+ E+L + L D+ + A + +T L I
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-----AID 115
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY-FS 175
H +HRD+KP NLL+D + + +KL+DFGL RT + + S + F
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 176 FLRYRVLAGSLI-----LQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230
+ + A + L + V T Y APE+ + + Y+ D WS+G I EM+
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGY 233
Query: 231 PLF 233
P F
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 46/226 (20%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIR--LEQEDEGVPSTAIREISLLKEMQHGNIV 64
++++G G +GVV K +A+K I+ EDE I E ++ ++ H +V
Sbjct: 9 LKELGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSEDE-----FIEEAKVMMKLSHEKLV 62
Query: 65 RLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
+L V ++ +Y+V EY+ L+ + P + + G+AY S
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQ----PSQLLEMCKDVCEGMAYLES 118
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
+ +HRDL +N L+D + +K++DFGL+R E+ S G
Sbjct: 119 KQFIHRDLAARNCLVDDQ-GCVKVSDFGLSR------YVLDDEYTSSVGS---------- 161
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
K W PE+LL S+ +S+ DVW+ G + E+
Sbjct: 162 -----------KFPVRW-SPPEVLLYSK-FSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-10
Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 55/242 (22%)
Query: 6 KVEK-IGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
K+EK IG G +G V R + + +A+K ++ ++ + E S++ + H
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHP 65
Query: 62 NIVRLQDVVHSEKKLYLVFEY-----LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
NI+ L+ VV K + +V EY LD L+KH D + L +LRGIA
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH---------DGQFTVIQLVGMLRGIA 116
Query: 117 ----YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEHWGSTGIS 171
Y +HRDL +N+L++ K++DFGL+R P +T + G
Sbjct: 117 SGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYT-----TRGGK 170
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--Q 229
I + + APE + R +++ DVWS G + E+++ +
Sbjct: 171 I----------------------PIRWTAPEA-IAYRKFTSASDVWSYGIVMWEVMSYGE 207
Query: 230 RP 231
RP
Sbjct: 208 RP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 69/247 (27%), Positives = 110/247 (44%), Gaps = 26/247 (10%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIR----LEQEDEGVPSTAIR-EISLLK 56
+ +E ++ IG G +G V + T A+K +R LE+E G IR E +L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG----HIRAERDILV 56
Query: 57 EMQHGNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQIL 112
E +V++ + LYL+ E+L + L D+ + + +T L
Sbjct: 57 EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL---- 112
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
I H +HRD+KP NLL+D + + +KL+DFGL RT + + + S
Sbjct: 113 -AIDSIHQLGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170
Query: 173 Y-FSFLRYRVLAGSLI-----LQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
+ F + + A + L F V T Y APE+ + + Y+ D WS+G I EM
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229
Query: 227 VNQRPLF 233
+ P F
Sbjct: 230 LIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 77/326 (23%), Positives = 137/326 (42%), Gaps = 82/326 (25%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEMQHGNIVRL 66
+G+GT+G V + T A+K ++ E +DE + + E +L+ +H + L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLTENRVLQNSRHPFLTAL 60
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR-VL 124
+ + +L V EY + +L H+ F+ D + + +I+ + Y HS + V+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR--ARFYGAEIVSALDYLHSEKNVV 118
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAF---GIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+RDLK +NL++D+ + +K+ DFGL + G ++TF
Sbjct: 119 YRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCG------------------- 158
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR-PLFPGDSEID 240
T Y APE+ L Y VD W +G + EM+ R P + D E
Sbjct: 159 -------------TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-- 202
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
K+F ++ + + + FP R L P LLS +L D
Sbjct: 203 ---KLFELI------------LMEEIR--FP-----------RTLSPEAKSLLSGLLKKD 234
Query: 301 PSRRI-----TARSALEHEYFRDVEF 321
P +R+ A+ ++H++F + +
Sbjct: 235 PKQRLGGGPDDAKEIMQHKFFAGIVW 260
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 81/345 (23%), Positives = 136/345 (39%), Gaps = 57/345 (16%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEM 58
+ + V+ IG+G +G V + T + A+K K + ++D+ A R++ L E
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV--LAES 58
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYL-DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
+V L + LYL+ E+L DL + F+ D + + ++ + + I
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED--VTRFYMAECVLAIEA 116
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--------------GIPVRTFTHE 163
H +HRD+KP N+LIDR + +KL+DFGL+ F G +
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 164 HWGSTGISIYFSFLRYRVLA----GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSV 219
SI + +A ++ + V T Y APEI L + Y D WS+
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSL 234
Query: 220 GCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELG 279
G I E + P F ++ + KI W PD
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKII---------NWRETLYFPD-------------- 271
Query: 280 TVVRNLEPAGIDLLSKMLCMDPSRRITARSALE---HEYFRDVEF 321
+L DL+ +++ + R+ A E H +FR V++
Sbjct: 272 --DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 72/282 (25%), Positives = 133/282 (47%), Gaps = 58/282 (20%)
Query: 7 VEKIGEGTYGVVYKARNCVTN----ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
+E++GE +G +YK + + +A+K ++ + + +E SL+ E+ H N
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPN 68
Query: 63 IVRLQDVVHSEKKLYLVFEYLDL-DLKK-------HMD-SCPDFANDPRLIKT------F 107
IV L VV E+ + ++FEYL+ DL + H D C +++ +K+ F
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCS--SDEDGTVKSSLDHGDF 126
Query: 108 LY---QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164
L+ QI G+ Y SH +H+DL +N+LI + + +K++D GL+R
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-VKISDLGLSREI----------- 174
Query: 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFA 224
+S YRV SL+ + + PE ++ + +S+ D+WS G +
Sbjct: 175 ---------YSADYYRVQPKSLL-------PIRWMPPEAIMYGK-FSSDSDIWSFGVVLW 217
Query: 225 EMVN--QRPLFP-GDSEIDELFKIFRVLGTPNEDTWPGVTSL 263
E+ + +P + + E+ E+ + ++L ED P + SL
Sbjct: 218 EIFSFGLQPYYGFSNQEVIEMVRKRQLLPCS-EDCPPRMYSL 258
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 68/248 (27%), Positives = 108/248 (43%), Gaps = 63/248 (25%)
Query: 8 EKIGEGTYGVVYKARNCVTNE--------------TIALKKIRLEQEDEGVPSTA----I 49
EK+GEG +G V+ E +A+K +R + V TA +
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-----VTKTARNDFL 65
Query: 50 REISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL---DLDL---KKHMDSCPDFAND-PR 102
+EI ++ +++ NI+RL V S+ L ++ EY+ DL+ ++ ++S AN+ P
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 103 L-IKTFLY---QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158
+ I LY QI G+ Y S +HRDL +N L+ +K+ADFG++R
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY-TIKIADFGMSRNL----- 179
Query: 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218
+S YR+ G +L W ILLG ++T DVW+
Sbjct: 180 ---------------YSGDYYRI-QGRAVLPI-----RWMAWESILLGK--FTTASDVWA 216
Query: 219 VGCIFAEM 226
G EM
Sbjct: 217 FGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 56/247 (22%)
Query: 8 EKIGEGTYGVV----------YKARNCVTNET------IALKKIRLEQEDEGVPSTAIRE 51
EK+GEG +G V + ++ + + +A+K +R E ++ + ++E
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR-EDANKNARNDFLKE 69
Query: 52 ISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLI-- 104
I ++ ++ NI+RL V + L ++ EY+ DL+ L +H D I
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 105 ---KTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161
QI G+ Y S +HRDL +N L+ + +K+ADFG++R
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN-YTIKIADFGMSRNL-------- 180
Query: 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGC 221
+S YR+ G +L W ILLG ++T DVW+ G
Sbjct: 181 ------------YSGDYYRI-QGRAVLPI-----RWMSWESILLGK--FTTASDVWAFGV 220
Query: 222 IFAEMVN 228
E++
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 66/256 (25%), Positives = 106/256 (41%), Gaps = 65/256 (25%)
Query: 10 IGEGTYGVVYKARNCVTNETIALK------KI----RLEQEDEGVPSTAIREISLLKEMQ 59
+GEG +G V + + + + LK KI R E ED + E +KE
Sbjct: 7 LGEGEFGSVMEGQ--LNQDDSILKVAVKTMKIAICTRSEMED------FLSEAVCMKEFD 58
Query: 60 HGNIVRLQDVV--HSEKKLY----LVFEYL---DLD---LKKHMDSCPDFANDPRLIKTF 107
H N++RL V E + Y ++ ++ DL L + CP + L+K F
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-F 117
Query: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167
+ I G+ Y S +HRDL +N +++ N + +ADFGL++ + + +++
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMN-VCVADFGLSK------KIYNGDYYRQ 170
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
I+ K+ W L R Y+T DVWS G E+
Sbjct: 171 GRIA--------------------KMPVKWIAIES--LADRVYTTKSDVWSFGVTMWEIA 208
Query: 228 N--QRPLFPG--DSEI 239
Q P +PG +SEI
Sbjct: 209 TRGQTP-YPGVENSEI 223
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 9/149 (6%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQHGNIVR 65
V+ I G +G VY R ++ A+K ++ + ++ + E L + IV
Sbjct: 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVH 68
Query: 66 LQDVVHSEKKLYLVFEYL---DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
L + S +YLV EYL D+ H+ + ++ +K ++ ++ + Y H H
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVK-YISEVALALDYLHRHG 124
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLAR 151
++HRDLKP N+LI + +KL DFGL++
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 67/276 (24%), Positives = 109/276 (39%), Gaps = 46/276 (16%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLE--QEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
IG G+Y V R T A+K ++ E +DE + + + H +V L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHR 126
+E +L+ V EY++ DL HM + + + +I + Y H +++R
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH--ARFYSAEISLALNYLHERGIIYR 120
Query: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSL 186
DLK N+L+D + +KL D+G+ + P T T G+
Sbjct: 121 DLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDT-TSTFCGTPN----------------- 161
Query: 187 ILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF--------PGDSE 238
Y APEIL G Y VD W++G + EM+ R F P +
Sbjct: 162 -----------YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 209
Query: 239 IDELFKIF--RVLGTPNEDTWPGVTSLPDFKSAFPK 272
D LF++ + + P + + L F + PK
Sbjct: 210 EDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPK 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 43/252 (17%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60
+ Y+ V+ IG G +G V R+ + + A+K + + E + E ++
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 61 GNIVRLQDVVHSEKKLYLVFEYL---DL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
+V+L +K LY+V EY+ DL +L + D +A K + +++ +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA------KFYTAEVVLALD 156
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
HS ++HRD+KP N+L+D+ + LKLADFG T TG+
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGH-LKLADFG------------TCMKMDETGM------ 197
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILL---GSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
+R G T Y +PE+L G +Y D WSVG EM+ F
Sbjct: 198 VRCDTAVG----------TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
Query: 234 PGDSEIDELFKI 245
DS + KI
Sbjct: 248 YADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 70/331 (21%), Positives = 136/331 (41%), Gaps = 69/331 (20%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNET------IALKKIRLEQEDEGVPSTAIREISLLKE 57
+E ++ +G G YG V+ R +++ LKK + Q+ + T L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
Q +V L ++ KL+L+ +Y++ +L H+ F ++ + +I+ +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQE--VQIYSGEIVLALE 119
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
+ H +++RD+K +N+L+D + + L DFGL++ F HE S
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEF--------HEDEVERAYSF---- 166
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH-YSTPVDVWSVGCIFAEMVNQRPLFPG 235
T+ Y AP+I+ G + VD WS+G + E++ F
Sbjct: 167 ----------------CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSK 295
D E + +I R + KS P +P +E+ + + D++ +
Sbjct: 211 DGEKNSQAEISRRI----------------LKSE-PPYP-QEMSALAK-------DIIQR 245
Query: 296 MLCMDPSRRI-----TARSALEHEYFRDVEF 321
+L DP +R+ A +H +F+ + +
Sbjct: 246 LLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 67/255 (26%), Positives = 102/255 (40%), Gaps = 46/255 (18%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60
D +E ++ IG G +G V + T + A+K + + E + E +L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEY------LDLDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
I L E LYLV +Y L L L K D P + + +L +++
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTL-LSKFEDRLP-----EDMARFYLAEMVLA 114
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
I H +HRD+KP N+L+D+ + ++LADFG
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGH-IRLADFG-------------------------- 147
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILL----GSRHYSTPVDVWSVGCIFAEMVNQR 230
S L R+LA + + V T Y +PEIL G Y D WS+G EM+
Sbjct: 148 SCL--RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
Query: 231 PLFPGDSEIDELFKI 245
F +S ++ KI
Sbjct: 206 TPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 70/319 (21%), Positives = 136/319 (42%), Gaps = 64/319 (20%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQD 68
+G+G +G V + T + A KK+ ++ + + A+ E +L+++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 69 VVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRD 127
++ L LV ++ DLK H+ + + D + + ++ G+ R+++RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127
Query: 128 LKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLI 187
LKP+N+L+D R + ++++D GLA IP G T +R R
Sbjct: 128 LKPENILLDDRGH-IRISDLGLAVQ--IPE--------GET--------VRGR------- 161
Query: 188 LQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFR 247
V T+ Y APE++ ++ +P D W +GC+ EM+ + F E + ++ R
Sbjct: 162 -----VGTVGYMAPEVINNEKYTFSP-DWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR 215
Query: 248 VLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307
+ E ++ F S++ ++ R L L +P R+
Sbjct: 216 RVKEDQE----------EYSEKF----SEDAKSICRML-----------LTKNPKERLGC 250
Query: 308 RS-----ALEHEYFRDVEF 321
R +H F+++ F
Sbjct: 251 RGNGAAGVKQHPIFKNINF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 63/242 (26%), Positives = 104/242 (42%), Gaps = 56/242 (23%)
Query: 5 EKVEKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+KV IG G +G V++ + +A+K ++ E + E S++ + H
Sbjct: 10 QKV--IGAGEFGEVFRGILKMPGRKEVAVAIKTLK-PGYTEKQRQDFLSEASIMGQFSHH 66
Query: 62 NIVRLQDVVHSEKKLYLVFEY-----LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
NI+RL+ VV K ++ EY LD L+ H D L +LRGIA
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH---------DGEFSSYQLVGMLRGIA 117
Query: 117 ----YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEHWGSTGIS 171
Y +HRDL +N+L++ K++DFGL+R P T+T ++G
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYT-----TSGGK 171
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--Q 229
I + + APE + R +++ DVWS G + E+++ +
Sbjct: 172 I----------------------PIRWTAPEA-IAYRKFTSASDVWSFGIVMWEVMSFGE 208
Query: 230 RP 231
RP
Sbjct: 209 RP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 47/234 (20%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKI---RLEQED--EGVPSTAIREISLLKEMQHGNIV 64
+G+G +G V + T + A KK+ RL++ EG A+ E +L ++ IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEG----AMVEKRILAKVHSRFIV 56
Query: 65 RLQDVVHSEKKLYLVFEYLDL-DLKKHM----DSCPDFANDPRLIKTFLYQILRGIAYCH 119
L ++ L LV ++ DL+ H+ + P F +PR + QI+ G+ + H
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGF-PEPRAC-FYTAQIISGLEHLH 114
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
R+++RDLKP+N+L+D N ++++D GLA ++ T + G+ G
Sbjct: 115 QRRIIYRDLKPENVLLDNDGN-VRISDLGLAVEL-KDGQSKTKGYAGTPG---------- 162
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
+ APE+L G Y VD +++G EM+ R F
Sbjct: 163 ------------------FMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 42/231 (18%)
Query: 9 KIGEGTYGVVYKA--RNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
++G G +G V K + + +T+A+K ++ + D + +RE ++++++ + IVR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 67 QDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
+ +E LV E +L L K + + I ++Q+ G+ Y +H
Sbjct: 62 IGICEAES-WMLVMELAELGPLNKFLQKNKHVTE--KNITELVHQVSMGMKYLEETNFVH 118
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF---THEHWGSTGISIYFSFLRYRVL 182
RDL +N+L+ + A K++DFGL++A G + TH W
Sbjct: 119 RDLAARNVLLVTQHYA-KISDFGLSKALGADENYYKAKTHGKWP---------------- 161
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QRP 231
+K WY APE + +S+ DVWS G + E + Q+P
Sbjct: 162 --------VK----WY-APEC-MNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 59/241 (24%), Positives = 110/241 (45%), Gaps = 52/241 (21%)
Query: 7 VEKIGEGTYGVVYKARNCVT-----NETIALKKIRLEQEDEGVPSTAIREISLLK-EMQH 60
+E++GE +G VYK T + +A+K L+ + EG + ++++ +QH
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKT--LKDKAEGPLREEFKHEAMMRSRLQH 67
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHM-----DSCPDFANDPRLIKTFL------ 108
NIV L VV E+ L ++F Y DL + + S +D + +K+ L
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 109 ---YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHW 165
QI G+ + SH V+H+DL +N+L+ + N +K++D GL R
Sbjct: 128 HIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN-VKISDLGLFREV------------ 174
Query: 166 GSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAE 225
++ Y+++ SL+ + + +PE ++ + +S D+WS G + E
Sbjct: 175 --------YAADYYKLMGNSLL-------PIRWMSPEAIMYGK-FSIDSDIWSYGVVLWE 218
Query: 226 M 226
+
Sbjct: 219 V 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 66/265 (24%), Positives = 109/265 (41%), Gaps = 46/265 (17%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60
+ YE V+ IG G +G V R+ T + A+K + + E + E ++
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 61 GNIVRLQDVVHSEKKLYLVFEYL---DL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
+V+L ++ LY+V EY+ DL +L + D +A + + +++ +
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA------RFYTAEVVLALD 156
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
HS +HRD+KP N+L+D ++ LKLADFG
Sbjct: 157 AIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC-------------------------- 189
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILL---GSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
++ ++ V T Y +PE+L G +Y D WSVG EM+ F
Sbjct: 190 --MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWP 258
DS + KI + N T+P
Sbjct: 248 YADSLVGTYSKI---MNHKNSLTFP 269
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-09
Identities = 62/235 (26%), Positives = 107/235 (45%), Gaps = 44/235 (18%)
Query: 8 EKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
E IG G +G V + R + + +A+K ++ ++ + E S++ + H NI+
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNII 68
Query: 65 RLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDF--ANDPRLIKTFLYQILRGIA----YC 118
L+ VV + + ++ E+++ +DS F ND + L +LRGIA Y
Sbjct: 69 HLEGVVTKSRPVMIITEFME---NGALDS---FLRQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
+HRDL +N+L++ K++DFGL+R F + T Y S
Sbjct: 123 SEMNYVHRDLAARNILVNSNL-VCKVSDFGLSR--------FLED---DTSDPTYTS--- 167
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QRP 231
L G K+ W APE + R +++ DVWS G + E+++ +RP
Sbjct: 168 --SLGG-------KIPIRW-TAPEA-IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 41/156 (26%), Positives = 81/156 (51%), Gaps = 14/156 (8%)
Query: 9 KIGEGTYGVVYK--ARNCVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIV 64
++G+G++G+VY+ A+ V +E I+ E + + E S++KE ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 65 RLQDVVHSEKKLYLVFEYLDL-DLKKHMDSC-PDFANDPRLIKTFLYQILR-------GI 115
RL VV + ++ E + DLK ++ S P+ N+P L ++++ G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
AY ++++ +HRDL +N ++ +K+ DFG+ R
Sbjct: 133 AYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 81/344 (23%), Positives = 119/344 (34%), Gaps = 103/344 (29%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ E + +IG GT G VYK R T +A+K++R E E +
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--------------ENKR- 59
Query: 62 NIVRLQDVV-HSEKKLYLV--FEYL--DLDLK---KHMDSCPDFANDPRLIKT----FLY 109
I+ DVV S Y+V + Y D D+ + M +C D +L+K
Sbjct: 60 -ILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLD-----KLLKRIQGPIPE 113
Query: 110 QILRGIAYC---------HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160
IL + H V+HRD+KP N+L+D N +KL DFG++ G V +
Sbjct: 114 DILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN-VKLCDFGIS---GRLVDSK 169
Query: 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH---YSTPVDVW 217
S G + Y APE + Y DVW
Sbjct: 170 AKTR--SAGCAAYM-------------------------APERIDPPDPNPKYDIRADVW 202
Query: 218 SVGCIFAEMVNQRPLFPG-DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSK 276
S+G E+ + + +E + L KI E+ P P
Sbjct: 203 SLGISLVELATGQFPYKNCKTEFEVLTKIL------QEEP--------------PSLPPN 242
Query: 277 ELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
E P + L D +R R L+H + R E
Sbjct: 243 E------GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALK-KIRLEQEDEGVPSTA--IREISLLKEMQ 59
+ ++V+ +G G +G VYK ET+ + I++ E G + + E ++ M
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDLD-----LKKHMDSCPDFANDPRLIKTFLYQILRG 114
H ++VRL V S + LV + + + +H D+ +L+ + QI +G
Sbjct: 68 HPHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNI-----GSQLLLNWCVQIAKG 121
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
+ Y R++HRDL +N+L+ + N +K+ DFGLAR
Sbjct: 122 MMYLEERRLVHRDLAARNVLV-KSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 78/334 (23%), Positives = 128/334 (38%), Gaps = 83/334 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTN-ETIALKK------IRLEQEDEGVPSTAIREISL 54
+ + + +G G++G V A + +A+K+ I+ +Q D E +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDH-----VFSERKI 84
Query: 55 LKEMQHGNIVRLQDVVHSEKKLYLVFEY-LDLDLKKHMDSCPDFANDPRLIKTFLYQILR 113
L + H V L E LYLV E+ + + + F ND + QI+
Sbjct: 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF--YAAQIVL 142
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
Y S +++RDLKP+NLL+D + +K+ DFG A+ + RT+T
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLD-KDGFIKMTDFGFAKV--VDTRTYT------------ 187
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
L G T Y APEILL H D W++G E++ P F
Sbjct: 188 --------LCG----------TPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPF 228
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
+ + KI G+ P F L+ L+
Sbjct: 229 YANEPLLIYQKILE-----------GIIYFPKF------------------LDNNCKHLM 259
Query: 294 SKMLCMDPSRRI-----TARSALEHEYFRDVEFV 322
K+L D ++R A++ EH +F ++++V
Sbjct: 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293
|
Length = 340 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 53/238 (22%)
Query: 10 IGEGTYGVVYKARNCVTNETI----ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
IGEG +G V KAR + + + A+K+++ + A L K H NI+
Sbjct: 15 IGEGNFGQVLKAR--IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 66 LQDVVHSEKKLYLVFEY------LDLDLKKH-MDSCPDFANDPRLIKT--------FLYQ 110
L LYL EY LD K +++ P FA T F
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGI 170
+ RG+ Y + +HRDL +N+L+ A K+ADFGL+R G
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSR-----------------GQ 174
Query: 171 SIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228
+Y + G L ++++ + +L Y Y+T DVWS G + E+V+
Sbjct: 175 EVYV-----KKTMGRLPVRWMAIESLNYSV---------YTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 49/236 (20%)
Query: 10 IGEGTYGVVYKAR-NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQ 67
IGEG +G V +A + A K+ E E E+ +L ++ H NI+ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 68 DVVHSEKKLYLVFEY------LDLDLKKH-MDSCPDFAND--------PRLIKTFLYQIL 112
+ LY+ EY LD K +++ P FA + + + F +
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
G+ Y + +HRDL +N+L+ + K+ADFGL+R G +
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGENLAS-KIADFGLSR-----------------GEEV 171
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228
Y + G L ++++ + +L Y Y+T DVWS G + E+V+
Sbjct: 172 YV-----KKTMGRLPVRWMAIESLNYSV---------YTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 70/320 (21%), Positives = 123/320 (38%), Gaps = 82/320 (25%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL-QD 68
+G G G V A+ E A+K + +E E + A E+ L +IV+ +D
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 69 VVHSEKK-------LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTF--------LYQIL 112
+ + + LV +Y + DL++ + + + +TF Q+L
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQ------EIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNAL-KLADFGLARAFGIPVRTFTHEHWGSTGIS 171
+ + HS ++HRD+K N+L+ +N L KL DFG ++ + V G
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILL--CSNGLVKLGDFGFSKMYAATVS-------DDVG-- 202
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231
R G T +Y APEI + YS D++S+G + E++ +
Sbjct: 203 --------RTFCG----------TPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKR 243
Query: 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291
F G++ + + K +L P S E+ +V
Sbjct: 244 PFDGENMEEVMHK-----------------TLAGRYDPLPPSISPEMQEIV--------- 277
Query: 292 LLSKMLCMDPSRRITARSAL 311
+ +L DP RR ++ L
Sbjct: 278 --TALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 89/359 (24%), Positives = 135/359 (37%), Gaps = 93/359 (25%)
Query: 9 KIGEGTYGVVYKA----RNCVTNETIALKKIRLEQEDEGVPSTAIR-------------- 50
K+GEG +GVVYKA + LKK E + +R
Sbjct: 139 KLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGF 198
Query: 51 --EISLLKEMQHGNIVR------LQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPR 102
+S KE ++ + R L D++ S++ Y V YL L K D + +
Sbjct: 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYL---LGKVQDLPKGLERENK 255
Query: 103 LIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162
+I+T + QIL + HS ++HRD+KPQN++ + + K+ D G A + +
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK 315
Query: 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHY----STPV---- 214
E L R Y APE + S S PV
Sbjct: 316 EF-----------LLDPR-----------------YAAPEQYIMSTQTPSAPSAPVATAL 347
Query: 215 -------------DVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVT 261
D++S G IF +M FP L + R L + D
Sbjct: 348 SPVLWQLNLPDRFDIYSAGLIFLQMA-----FPNLRSDSNLIQFNRQLKRNDYD------ 396
Query: 262 SLPDFKSAFPKWPSKEL--GTVVRNLEP-AGIDLLSKMLCMDPSRRITARSALEHEYFR 317
L ++ S +L G V +L+ AG +LL M+ +RI+A++AL H YF
Sbjct: 397 -LVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454
|
Length = 566 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 60/247 (24%), Positives = 96/247 (38%), Gaps = 44/247 (17%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLE--QEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
IG G+Y V T A+K I+ E +DE + + H +V L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHR 126
+E +L+ V E++ DL HM + + + +I + + H +++R
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEH--ARFYSAEISLALNFLHERGIIYR 120
Query: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSL 186
DLK N+L+D + +KL D+G+ + GI T G+
Sbjct: 121 DLKLDNVLLDAEGH-IKLTDYGMCKE-GIRPGDTTSTFCGTPN----------------- 161
Query: 187 ILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF--------PGDSE 238
Y APEIL G Y VD W++G + EM+ R F P +
Sbjct: 162 -----------YIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT 209
Query: 239 IDELFKI 245
D LF++
Sbjct: 210 EDYLFQV 216
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 42/228 (18%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M + + ++ IG+G +G V +A+K I+ ++ + E S++ +++H
Sbjct: 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIK----NDATAQAFLAEASVMTQLRH 58
Query: 61 GNIVRLQDVVHSEK-KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
N+V+L V+ EK LY+V EY+ L ++ S + F + + Y
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
++ +HRDL +N+L+ N K++DFGL +
Sbjct: 119 EANNFVHRDLAARNVLVS-EDNVAKVSDFGLTK--------------------------- 150
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
S K+ W APE L + +ST DVWS G + E+
Sbjct: 151 ----EASSTQDTGKLPVKW-TAPEALREKK-FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 40/165 (24%), Positives = 66/165 (40%), Gaps = 43/165 (26%)
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYL---DL-DLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
+ N ++L V + K L+ +Y+ DL DL K +K + Q++ +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKL-----SEAEVKKIIRQLVEAL 122
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
H H ++H D+K +N+L DR + + L D+GL + G P ++ G YFS
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CYD-----GTLDYFS 174
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
PE + G +Y D W+VG
Sbjct: 175 -------------------------PEKIKG-HNYDVSFDWWAVG 193
|
Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 54/227 (23%), Positives = 93/227 (40%), Gaps = 36/227 (15%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLE--QEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
IG G+Y V R ++ A+K ++ E +DE + + + + +V L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHR 126
+ +L+LV EY++ DL HM + + + +I + + H +++R
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEH--ARFYAAEICIALNFLHERGIIYR 120
Query: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSL 186
DLK N+L+D + +KL D+G+ + G+ T G+
Sbjct: 121 DLKLDNVLLDADGH-IKLTDYGMCKE-GLGPGDTTSTFCGTPN----------------- 161
Query: 187 ILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
Y APEIL G Y VD W++G + EM+ R F
Sbjct: 162 -----------YIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 67/324 (20%), Positives = 117/324 (36%), Gaps = 56/324 (17%)
Query: 16 GVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKK 75
+V+ A++ TN +A+KKI L+ + +EI +++QH NI+ + +
Sbjct: 14 MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE 73
Query: 76 LYLVFEYL------DLDLKKH-MDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDL 128
LY+V + DL LK H + P+ A I L +L + Y HS +HR +
Sbjct: 74 LYVVSPLMAYGSCEDL-LKTHFPEGLPELA-----IAFILKDVLNALDYIHSKGFIHRSV 127
Query: 129 KPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLIL 188
K ++L+ L+ + + H F +
Sbjct: 128 KASHILLSGDGKV-VLSGLRYSVSM------IKHGKRQRV----VHDFPKS--------- 167
Query: 189 QFLKVVTLWYRAPEILLGSRH-YSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKIF 246
V L + +PE+L + Y+ D++SVG E+ N P D +
Sbjct: 168 ---SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK--DMP-ATQMLLE 221
Query: 247 RVLGTPNE--DTWPGVTSLPDFKSAFPKWPSKELGTV---------VRNLEPAGIDLLSK 295
+V GT D ++ P ++ + + S R +
Sbjct: 222 KVRGTVPCLLDK----STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL 277
Query: 296 MLCMDPSRRITARSALEHEYFRDV 319
L DP R +A L H +F+
Sbjct: 278 CLQRDPESRPSASQLLNHSFFKQC 301
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 51/237 (21%)
Query: 10 IGEGTYGVVYKA--RNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRL 66
IGEG +G V KA + A+K+++ E + E+ +L ++ H NI+ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 67 QDVVHSEKKLYLVFEY------LDLDLKKH-MDSCPDFAND--------PRLIKTFLYQI 111
LYL EY LD K +++ P FA + + F +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
RG+ Y + +HRDL +N+L+ K+ADFGL+R G
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSR-----------------GQE 163
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228
+Y + G L ++++ + +L Y Y+T DVWS G + E+V+
Sbjct: 164 VYV-----KKTMGRLPVRWMAIESLNYSV---------YTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 37/151 (24%), Positives = 70/151 (46%), Gaps = 12/151 (7%)
Query: 12 EGTYGVVYKA---RNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
EGT+G ++ E K + E + ++E LL + H NI+ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 69 VVHSE-KKLYLVFEYLDL-DLKKHMDSCPDF-ANDPRLIKT-----FLYQILRGIAYCHS 120
V + + ++++ Y++ +LK + C AN+P+ + T QI G++Y H
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
V+H+D+ +N +ID +K+ D L+R
Sbjct: 136 RGVIHKDIAARNCVIDEELQ-VKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 42/224 (18%)
Query: 7 VEKIGEGTYGVVY--KARNCVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGN 62
++++G G +GVV+ K R +A+K I EG S I E ++ ++ H
Sbjct: 9 MKELGSGQFGVVHLGKWR---AQIKVAIKAIN-----EGAMSEEDFIEEAKVMMKLSHPK 60
Query: 63 IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
+V+L V +K LY+V E+++ + ++ + + G+ Y +
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
+HRDL +N L+ T +K++DFG+ R E+ S+G
Sbjct: 121 FIHRDLAARNCLVS-STGVVKVSDFGMTRY------VLDDEYTSSSGA------------ 161
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
K W PE+ S+ YS+ DVWS G + E+
Sbjct: 162 ---------KFPVKW-SPPEVFNFSK-YSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-07
Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 40/230 (17%)
Query: 9 KIGEGTYGVV----YKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
++G G +G V YK R + I K+ + ++ V +RE ++ ++ + IV
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAI---KVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 65 RLQDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
R+ V +E L LV E L K + D +++ ++Q+ G+ Y
Sbjct: 59 RMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVE-LMHQVSMGMKYLEGKNF 116
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
+HRDL +N+L+ + A K++DFGL++A G + G
Sbjct: 117 VHRDLAARNVLLVNQHYA-KISDFGLSKALGADDSYYKARSAG----------------- 158
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QRP 231
K WY APE + R +S+ DVWS G E + Q+P
Sbjct: 159 --------KWPLKWY-APECIN-FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 40/158 (25%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 7 VEKIGEGTYGVVYK--ARNCVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGN 62
+ ++G+G++G+VY+ AR+ + E ++ E + + E S++K +
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 70
Query: 63 IVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSC-PDFANDPRLIKTFLYQILR------- 113
+VRL VV + +V E + DLK ++ S P+ N+P L ++++
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
G+AY ++ + +HRDL +N ++ +K+ DFG+ R
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 31/189 (16%)
Query: 46 STAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIK 105
++++ E LL+ + H ++ L DV LV DL ++ + + +
Sbjct: 205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQ-VT 263
Query: 106 TFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHW 165
Q+L I Y H ++HRD+K +N+L++ + + L DFG A F W
Sbjct: 264 AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED-ICLGDFGAA--------CFARGSW 314
Query: 166 GSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG-CIFA 224
+ ++ +AG T+ APE+L G Y+ VD+WS G IF
Sbjct: 315 ST---PFHYG------IAG----------TVDTNAPEVLAGDP-YTPSVDIWSAGLVIFE 354
Query: 225 EMVNQRPLF 233
V+ LF
Sbjct: 355 AAVHTASLF 363
|
Length = 461 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 46/206 (22%)
Query: 52 ISLLKEM----QHGNIVRLQDVVHSEKKLYLVFEYL---DL--DLKKHMDSCPDFANDPR 102
+S LK M H NIV L + ++ EY DL L++ +S +
Sbjct: 86 MSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED--- 142
Query: 103 LIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162
+ +F YQ+ +G+A+ S +HRDL +N+L+ +K+ DFGLA R +
Sbjct: 143 -LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLA-------RDIMN 193
Query: 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGC- 221
+ S Y V+ G+ L V + APE + Y+ DVWS G
Sbjct: 194 D-------SNY-------VVKGN---ARLPVK---WMAPESIFNCV-YTFESDVWSYGIL 232
Query: 222 ---IFAEMVNQRPLFPGDSEIDELFK 244
IF+ N P P DS+ +L K
Sbjct: 233 LWEIFSLGSNPYPGMPVDSKFYKLIK 258
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 15/156 (9%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALK-KIRLEQEDEGVPS-TAIREISL-LKEMQ 59
+ K++ +G G +G V+K ++I + I+ Q+ G + I + L + +
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDLD-----LKKHMDSCPDFANDPRLIKTFLYQILRG 114
H IVRL + L LV + L +++H DS DP+ + + QI +G
Sbjct: 68 HAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSL-----DPQRLLNWCVQIAKG 121
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150
+ Y HR++HR+L +N+L+ + + +++ADFG+A
Sbjct: 122 MYYLEEHRMVHRNLAARNILL-KSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 60/254 (23%), Positives = 98/254 (38%), Gaps = 44/254 (17%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIRE-ISLLKEMQH 60
D +E ++ IG G +G V + T A+K + + + + RE ++L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEY-----LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
I L E LYLV +Y L L K D P+ + + ++ +++ I
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPE-----DMARFYIAEMVLAI 115
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
H +HRD+KP N+L+D + ++LADFG
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGH-IRLADFGSC------------------------- 149
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILL----GSRHYSTPVDVWSVGCIFAEMVNQRP 231
++ + + V T Y +PEIL G Y D WS+G EM+
Sbjct: 150 ---LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206
Query: 232 LFPGDSEIDELFKI 245
F +S ++ KI
Sbjct: 207 PFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 18/154 (11%)
Query: 8 EKIGEGTYGVVYKARNCVTNETI----ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
IG+G +G VY + ++ A+K + + E V ++E ++K+ H N+
Sbjct: 1 RVIGKGHFGCVYHG-TLIDSDGQKIHCAVKSLNRITDLEEV-EQFLKEGIIMKDFSHPNV 58
Query: 64 VRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKT------FLYQILRGIAY 117
+ L + + LV L KH D +F T F Q+ +G+ Y
Sbjct: 59 LSLLGICLPSEGSPLVV----LPYMKHGD-LRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
S + +HRDL +N ++D + +K+ADFGLAR
Sbjct: 114 LASKKFVHRDLAARNCMLD-ESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 43/154 (27%), Positives = 66/154 (42%), Gaps = 34/154 (22%)
Query: 92 DSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
D LI + +Q+ +G+ + S + +HRDL +N+L+ N +K+ DFGLAR
Sbjct: 170 DLYKKVLTLEDLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR 227
Query: 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYS 211
IY R L L+++ APE + R Y+
Sbjct: 228 -------------------DIYKDPDYVRKGDARLPLKWM--------APETIF-DRVYT 259
Query: 212 TPVDVWSVGCIFAEM--VNQRPLFPGDSEIDELF 243
DVWS G + E+ + P +PG +IDE F
Sbjct: 260 IQSDVWSFGVLLWEIFSLGASP-YPG-VKIDEEF 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 64/228 (28%)
Query: 92 DSCPDFANDPRLIKTFL---YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148
+ + +P ++ + +Q+ RG+ + S + +HRDL +N+L+ N +K+ DFG
Sbjct: 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFG 218
Query: 149 LARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR 208
LAR IY R L L+++ APE + +
Sbjct: 219 LAR-------------------DIYKDPDYVRKGDARLPLKWM--------APESIF-DK 250
Query: 209 HYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKS 268
Y+T DVWS G + L++IF + +P +PGV +F
Sbjct: 251 VYTTQSDVWSFGVL-------------------LWEIFSLGASP----YPGVQIDEEFCR 287
Query: 269 AFPKWPSKELGTVVRNLEPAGIDLLSKML-CM--DPSRRITARSALEH 313
+ GT +R E A ++ S ML C +P R T +E
Sbjct: 288 RLKE------GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 4e-06
Identities = 59/255 (23%), Positives = 100/255 (39%), Gaps = 44/255 (17%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIRE-ISLLKEMQH 60
+ +E ++ IG G +G V + ++ A+K + + + + RE +L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEY-----LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
I L E LYLV +Y L L K D P+ + + +L +++ I
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE-----DMARFYLAEMVIAI 115
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
H +HRD+KP N+L+D + ++LADFG
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSC------------------------- 149
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILL----GSRHYSTPVDVWSVGCIFAEMVNQRP 231
+++ + + V T Y +PEIL G Y D WS+G EM+
Sbjct: 150 ---LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET 206
Query: 232 LFPGDSEIDELFKIF 246
F +S ++ KI
Sbjct: 207 PFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 8e-06
Identities = 38/156 (24%), Positives = 72/156 (46%), Gaps = 15/156 (9%)
Query: 10 IGEGTYGVVYKARNCVTNET---IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
+G+G +G V +A+ + + +A+K ++ + +RE + +KE H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 67 QDV-VHSEKKLYLVFEYLDLDLKKHMDS-----CPDFANDP-----RLIKTFLYQILRGI 115
V + S K L + L KH D +P + + F+ I G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
Y S +HRDL +N +++ + +ADFGL++
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMT-VCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-06
Identities = 32/152 (21%), Positives = 67/152 (44%), Gaps = 14/152 (9%)
Query: 8 EKIGEGTYGVVY--KARNCVTNETIALKKIRLEQEDEGVPS---TAIREISLLKEMQHGN 62
++IG G +G V +A ++ + +K++R P ++E+ +E+ H N
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELR----ASATPDEQLLFLQEVQPYRELNHPN 56
Query: 63 IVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDF---ANDPRLIKTFLYQILRGIAYC 118
+++ LV E+ L DLK ++ S +++ ++ G+ +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150
H +H DL +N + + +K+ D+GLA
Sbjct: 117 HQADFIHSDLALRNCQLTADLS-VKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 40/139 (28%), Positives = 65/139 (46%), Gaps = 33/139 (23%)
Query: 107 FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166
+ +Q+ RG+ + S + +HRDL +N+L+ N +K+ DFGLAR
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLAR--------------- 222
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
IY R + L L+++ APE + + Y+T DVWS G + E+
Sbjct: 223 ----DIYKDPDYVRKGSARLPLKWM--------APESIF-DKVYTTQSDVWSFGVLLWEI 269
Query: 227 --VNQRPLFPGDSEIDELF 243
+ P +PG +I+E F
Sbjct: 270 FSLGASP-YPG-VQINEEF 286
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 24/63 (38%), Positives = 36/63 (57%), Gaps = 1/63 (1%)
Query: 88 KKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147
KK D+ P D +IK + Q+L G+ H ++HRD+KP+NLL+ +K+ DF
Sbjct: 295 KKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT-VDGQVKIIDF 353
Query: 148 GLA 150
G A
Sbjct: 354 GAA 356
|
Length = 507 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 64/265 (24%), Positives = 104/265 (39%), Gaps = 76/265 (28%)
Query: 10 IGEGTYGVVYK--ARNCVTNET----IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
+G G +G VY+ A + + + +A+K +R D+ ++E L+ H NI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHPNI 61
Query: 64 VRLQDVVHSEKKLYLVFEYLD--------------------LDLKKHMDSCPDFANDPRL 103
V+L V + Y++ E ++ L LK+ +D C D A
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK---- 117
Query: 104 IKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA----LKLADFGLARAFGIPVRT 159
G Y +HRDL +N L+ + +K+ DFGLAR
Sbjct: 118 ----------GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-------- 159
Query: 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSV 219
IY S YR L+ + + APE LL + ++T DVWS
Sbjct: 160 -----------DIYKSDY-YRKEGEGLL-------PVRWMAPESLLDGK-FTTQSDVWSF 199
Query: 220 GCIFAEMVN--QRPLFPGDSEIDEL 242
G + E++ Q+P +P + + L
Sbjct: 200 GVLMWEILTLGQQP-YPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 44/234 (18%)
Query: 102 RLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160
R + ++Q + Y H+ ++H DLKP+N+L++ V
Sbjct: 231 RHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTV---------------VDPV 275
Query: 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLK---VVTLWYRAPEILLG-SRHYSTPVDV 216
T+ + R L G + + V T YR+PE++LG YST D+
Sbjct: 276 TNRALPPDPCRV-----RICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DM 328
Query: 217 WSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGT-PNEDTWPGVTSLPDFKSAF----- 270
WS+GCI E+ + L+ ++ L + + LG P+E W G + + +
Sbjct: 329 WSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSE--WAGRCGTEEARLLYNSAGQ 386
Query: 271 --PKWPSKELGTVVRN-------LEPAGIDLLSKMLCMDPSRRITARSALEHEY 315
P K L + R + DL+ +L D +R+ AR H Y
Sbjct: 387 LRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 41/165 (24%), Positives = 68/165 (41%), Gaps = 18/165 (10%)
Query: 2 DQYEKVEKIGEGTYGVVYKA-----RNCVTNETIALKKIR--LEQEDEGVPSTAIREISL 54
D + +G G +G VY+ +A+K + ++DE S + E +
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE---SDFLMEALI 62
Query: 55 LKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDP-RLIKTFLYQIL 112
+ + H NIVRL V +++ E + DLK + P L L
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 113 RGIA----YCHSHRVLHRDLKPQNLLIDRR--TNALKLADFGLAR 151
R +A Y + +HRD+ +N L+ + K+ADFG+AR
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 53/234 (22%), Positives = 100/234 (42%), Gaps = 45/234 (19%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETI----ALKKIRLEQEDEGVPSTAIREISLLKEM 58
+++K++ +G G +G VYK E + A+K++R E + E ++ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASV 66
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYLD----LD-LKKHMDSCPDFANDPRLIKTFLYQILR 113
+ ++ RL + + + L+ + + LD +++H D+ + + + QI +
Sbjct: 67 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGS-----QYLLNWCVQIAK 120
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
G+ Y R++HRDL +N+L+ + +K+ DFGLA+ G + + H G
Sbjct: 121 GMNYLEERRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLGADEKEY-HAEGG------- 171
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
KV W IL R Y+ DVWS G E++
Sbjct: 172 ------------------KVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 25/161 (15%)
Query: 10 IGEGTYGVVYKAR---NCVTNETIALKKIRLE----QEDEGVPSTAIREISLLKEMQHGN 62
+GEG +G V + + + + +A+K ++L+ E E S A +K+ H N
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAAC----MKDFDHPN 62
Query: 63 IVRLQDV-VHSEKKLYLVFEYLDLDLKKHMD-----------SCPDFANDPRLIKTFLYQ 110
+++L V + + + L KH D P+ L+K F+
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK-FMVD 121
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
I G+ Y + +HRDL +N ++ +ADFGL++
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVC-VADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 66/255 (25%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALK---------------KIRLEQEDEGVPSTAIREI 52
EK+GEG +G V+ + L+ KI ++ + ++E+
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 53 SLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL---DLD--------LKKHMDSCPDFAND- 100
+L ++ NI+RL V E L ++ EY+ DL+ K +
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 101 -------PRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153
L+ L QI G+ Y S +HRDL +N L+ +K+ADFG++R
Sbjct: 131 CLPAISYSSLLHVAL-QIASGMKYLSSLNFVHRDLATRNCLVGENLT-IKIADFGMSRNL 188
Query: 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPE-ILLGSRHYST 212
++ YR+ Q V+ + + A E IL+G ++T
Sbjct: 189 --------------------YAGDYYRI-------QGRAVLPIRWMAWECILMGK--FTT 219
Query: 213 PVDVWSVGCIFAEMV 227
DVW+ G E++
Sbjct: 220 ASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 27/106 (25%), Positives = 49/106 (46%), Gaps = 5/106 (4%)
Query: 49 IREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSC---PDFANDPRLI 104
+ E + +QH N+++ LV E+ L DLK ++ SC DP +
Sbjct: 43 LEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL 102
Query: 105 KTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150
+ +I G+ + H + +H DL +N L+ +K+ D+GL+
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 73/328 (22%), Positives = 125/328 (38%), Gaps = 53/328 (16%)
Query: 18 VYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77
VY AR+ T + ++ LE E E+ L +H NI+ V + L+
Sbjct: 16 VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLW 75
Query: 78 LVFEYLDLDLKKHM--DSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLI 135
++ ++ + P+ ++ LI L+ LRG+ Y H + +HR++K ++LI
Sbjct: 76 VISPFMAYGSANSLLKTYFPEGMSEA-LIGNILFGALRGLNYLHQNGYIHRNIKASHILI 134
Query: 136 DRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY--RVLAGSLILQFLKV 193
+ GL +G+S +S +R + QF
Sbjct: 135 ---------SGDGLVSL---------------SGLSHLYSLVRNGQKAKVVYDFPQFSTS 170
Query: 194 VTLWYRAPEILLGSRH-YSTPVDVWSVGCIFAEMVNQRPLF---------------PGDS 237
V W +PE+L + Y+ D++SVG E+ R F P S
Sbjct: 171 VLPWL-SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS 229
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTS----LPDFKSAFPKWPSKELGT-VVRNLEPAGIDL 292
+D F + +++ GV S S+ L T + PA +L
Sbjct: 230 PLD--ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNL 287
Query: 293 LSKMLCMDPSRRITARSALEHEYFRDVE 320
+ L DP +R +A S L H +F+ V+
Sbjct: 288 VELCLQQDPEKRPSASSLLSHAFFKQVK 315
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 34/118 (28%), Positives = 50/118 (42%), Gaps = 29/118 (24%)
Query: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTG 169
QI +G++Y R++HRDL +N+L+ + N +K+ DFGLAR I + H G
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLV-KSPNHVKITDFGLARLLDIDETEY-HADGG--- 171
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
KV W IL R ++ DVWS G E++
Sbjct: 172 ----------------------KVPIKWMALESIL--HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 23/70 (32%), Positives = 39/70 (55%), Gaps = 1/70 (1%)
Query: 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA 141
Y+D D+ + + A D + +F YQ+ +G+++ S +HRDL +N+L+
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253
Query: 142 LKLADFGLAR 151
K+ DFGLAR
Sbjct: 254 -KICDFGLAR 262
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 40/172 (23%), Positives = 74/172 (43%), Gaps = 34/172 (19%)
Query: 6 KVEK-IGEGTYGVVY----KARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
K++K IG G +G VY + +C+ N+ +A K LE E T + E + +
Sbjct: 15 KIDKLIGCGGFGCVYETQCASDHCINNQAVA-KIENLENE------TIVMETLVYNNIYD 67
Query: 61 GNIVRLQDVVHSEKKL-------------------YLVFEYLDLDLKKHMDSCPDFANDP 101
+ + L +H+ L +++ E L + K+ +
Sbjct: 68 IDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCK--NK 125
Query: 102 RLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153
+LIK + +L + Y H H + H D+KP+N+++D + D+G+A F
Sbjct: 126 KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 37/134 (27%), Positives = 64/134 (47%), Gaps = 21/134 (15%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
I G G YK ++ +K+I + +PS+ EI+ + ++QH NIV+L +
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEIN---DVNSIPSS---EIADMGKLQHPNIVKLIGL 751
Query: 70 VHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA------YCH-SHR 122
SEK YL+ EY ++ K + + + + R +I GIA +C S
Sbjct: 752 CRSEKGAYLIHEY--IEGKNLSEVLRNLSWERR------RKIAIGIAKALRFLHCRCSPA 803
Query: 123 VLHRDLKPQNLLID 136
V+ +L P+ ++ID
Sbjct: 804 VVVGNLSPEKIIID 817
|
Length = 968 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 39/121 (32%), Positives = 57/121 (47%), Gaps = 29/121 (23%)
Query: 106 TFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHW 165
+F YQ+ RG+ + S +HRDL +N+L+ + +K+ DFGLAR H+
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQ-GKIVKICDFGLAR-------DIMHD-- 290
Query: 166 GSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAE 225
S Y S GS FL V + APE + + Y+T DVWS G + E
Sbjct: 291 -----SNYVS-------KGS---TFLPVK---WMAPESIFDNL-YTTLSDVWSYGILLWE 331
Query: 226 M 226
+
Sbjct: 332 I 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 37/120 (30%), Positives = 53/120 (44%), Gaps = 29/120 (24%)
Query: 107 FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166
F YQ+ G+ + S +HRDL +N+LI +K+ DFGLAR +R + G
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI-CEGKLVKICDFGLARDI---MRDSNYISKG 299
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
ST FL L + APE + + Y+T DVWS G + E+
Sbjct: 300 ST---------------------FLP---LKWMAPESIFNNL-YTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 42/179 (23%), Positives = 71/179 (39%), Gaps = 39/179 (21%)
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPR--LIKTFLYQILRG 114
+QH NI++ LVFEY +L DLK ++ + + L++ +I G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+ + H H LH DL +N + +K+ D+G+
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLT-VKVGDYGIG------------------------ 146
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH-------YSTPVDVWSVGCIFAEM 226
RY+ + + K V L + APE L+G H + P +VW++G E+
Sbjct: 147 -PSRYK--EDYIETEDDKCVPLRWLAPE-LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 43/192 (22%), Positives = 74/192 (38%), Gaps = 50/192 (26%)
Query: 51 EISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY-----LDLDLKKHMDSCPDFANDPRLIK 105
E L + H NIVRL+ V+ + +V EY LD L+KH + +L+
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH---------EGQLVA 106
Query: 106 TFLYQILRGIA----YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161
L +L G+A Y +H+ L +L++ K++ F +
Sbjct: 107 GQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQ---------- 155
Query: 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGC 221
++ + + LW APE + H+S+ DVWS G
Sbjct: 156 -----EDKSEAIYTTMSGKSPV------------LW-AAPEA-IQYHHFSSASDVWSFGI 196
Query: 222 IFAEMVN--QRP 231
+ E+++ +RP
Sbjct: 197 VMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 323 | |||
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.47 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.13 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.93 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.9 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.81 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.73 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.72 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.46 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.38 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.37 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.26 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.21 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.14 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.13 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.12 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.03 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.02 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.01 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.95 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.89 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.87 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.75 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.75 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.73 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.65 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.6 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.58 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.57 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.5 | |
| PLN02236 | 344 | choline kinase | 97.42 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.32 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.16 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.15 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.12 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.06 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.03 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.96 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.62 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.6 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.55 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.45 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.37 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.25 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.17 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.83 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.13 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.0 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.68 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.35 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.34 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.97 |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=346.22 Aligned_cols=289 Identities=53% Similarity=0.923 Sum_probs=262.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|..++++|+|.||+||+|++..+|+.||||+++.............+|+..++.++|+||+.++++|...+.+.+|+
T Consensus 1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 47899999999999999999999999999999999888777777788889999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||++.+|...+..... .+++..++.++.+++.||+|+|.+.|+||||||.|+|++.+|. +||+|||+++.++++....
T Consensus 81 Efm~tdLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~-lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ-LKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred EeccccHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc-EEeecccchhccCCCCccc
Confidence 9999999988876544 5789999999999999999999999999999999999999998 9999999999998776654
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
... +.|..|.|||.+.+.+.|+...|+||.|||+.||+.|.+.|.+.++.+
T Consensus 159 ~~~-----------------------------V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid 209 (318)
T KOG0659|consen 159 THQ-----------------------------VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID 209 (318)
T ss_pred ccc-----------------------------eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH
Confidence 431 448999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
.+..+++.++.+.++.|++...+++...-. ..........+...++++.+|+.+|+..||.+|+++.++|+|+||++.+
T Consensus 210 QL~~If~~LGTP~~~~WP~~~~lpdY~~~~-~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 210 QLSKIFRALGTPTPDQWPEMTSLPDYVKIQ-QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HHHHHHHHcCCCCcccCccccccccHHHHh-cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 999999999999999999999999876544 3444444557778899999999999999999999999999999999765
Q ss_pred c
Q 036739 321 F 321 (323)
Q Consensus 321 ~ 321 (323)
.
T Consensus 289 ~ 289 (318)
T KOG0659|consen 289 L 289 (318)
T ss_pred C
Confidence 3
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=370.71 Aligned_cols=262 Identities=29% Similarity=0.465 Sum_probs=218.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC-----CCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE-----GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
+-|.+.+.||+|+||.|-+|.++.+++.||||++.+..... .......+|+++|++++||||++++++|......
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 45888999999999999999999999999999997764222 1223456999999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEeccccceec
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAF 153 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~~~ 153 (323)
|+|+||++| +|++.+..... +.+..-+.+++|++.||.|||+.||+||||||+|||+..+.. .+||+|||++...
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999965 99999987654 456666789999999999999999999999999999976622 4999999999887
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC--CCCCCchhhHHHHHHHHHHHhCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS--RHYSTPVDVWSVGCIFAEMVNQRP 231 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~ll~~l~tg~~ 231 (323)
+.... +.+-+||+.|.|||++.+. ..+..+.|+||+||++|-+++|.+
T Consensus 330 g~~sf------------------------------m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~p 379 (475)
T KOG0615|consen 330 GEGSF------------------------------MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYP 379 (475)
T ss_pred cccee------------------------------hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCC
Confidence 53222 2334889999999999763 224458899999999999999999
Q ss_pred CCCCCChHH-HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh
Q 036739 232 LFPGDSEID-ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310 (323)
Q Consensus 232 p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i 310 (323)
||+...... ...++.++-....+ ..+..+|+.+++||.+||..||++||++.++
T Consensus 380 PFS~~~~~~sl~eQI~~G~y~f~p-------------------------~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea 434 (475)
T KOG0615|consen 380 PFSEEYTDPSLKEQILKGRYAFGP-------------------------LQWDRISEEALDLINWMLVVDPENRPSADEA 434 (475)
T ss_pred CcccccCCccHHHHHhcCcccccC-------------------------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHH
Confidence 999877665 45556554333322 3346789999999999999999999999999
Q ss_pred hcCCCCcccc
Q 036739 311 LEHEYFRDVE 320 (323)
Q Consensus 311 l~h~~~~~~~ 320 (323)
|+||||++++
T Consensus 435 L~hpW~~~~~ 444 (475)
T KOG0615|consen 435 LNHPWFKDAP 444 (475)
T ss_pred hcChhhhccc
Confidence 9999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-53 Score=379.90 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=222.2
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+|...+.||+|||++||++++..+|+.||+|++.+.. ......+.+.+|+++.++|+|||||+++++|++.+++|+|.|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 5999999999999999999999999999999997764 355567899999999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
.|..+.+..+.++ ...+.|.+++.+++||+.||.|||+.+|+|||||..|++++++.+ +||+|||++..+..+....
T Consensus 99 LC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~-VKIgDFGLAt~le~~~Erk- 175 (592)
T KOG0575|consen 99 LCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN-VKIGDFGLATQLEYDGERK- 175 (592)
T ss_pred ecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc-EEecccceeeeecCccccc-
Confidence 9976444444443 336788899999999999999999999999999999999999888 9999999999886553322
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
.+.+|||.|.|||++.. .-.+..+||||+||++|.|+.|++||....-.++
T Consensus 176 ----------------------------~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket 226 (592)
T KOG0575|consen 176 ----------------------------KTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET 226 (592)
T ss_pred ----------------------------ceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH
Confidence 12488999999999987 5579999999999999999999999999999899
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
+.++...-.. .+..+|..+++||++||+.||.+|||+++||.|+||+
T Consensus 227 y~~Ik~~~Y~-----------------------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 227 YNKIKLNEYS-----------------------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred HHHHHhcCcc-----------------------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 8887653211 1235899999999999999999999999999999994
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-54 Score=353.70 Aligned_cols=287 Identities=40% Similarity=0.730 Sum_probs=239.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
|+.|+.+.++|+|++|+||+++++.+|+.||||++.-...+........+|++++++++|+|+|.++..|.....+++||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 78999999999999999999999999999999999655555556677789999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|||+.++++.+...+.. .++..+..+++|++.|+.|+|+++++||||||+||+++.++. +||+|||+++.+..+....
T Consensus 81 E~~dhTvL~eLe~~p~G-~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv-vKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNG-VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV-VKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred eecchHHHHHHHhccCC-CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc-EEeccchhhHhhcCCcchh
Confidence 99999999999887764 688889999999999999999999999999999999999887 9999999998876443332
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
.. -+-|..|.|||.+.+...|+...|||++||++.||++|.+.|.+.++.+
T Consensus 159 TD-----------------------------YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD 209 (396)
T KOG0593|consen 159 TD-----------------------------YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID 209 (396)
T ss_pred hh-----------------------------hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence 21 1338999999999998899999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcc---cccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKEL---GTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
.+..|...++...+....--...+.|. -..-...... +.-.+.++.-+.+|+.+||..||.+|++.++++.||||.
T Consensus 210 QLy~I~ktLG~L~prhq~iF~~N~~F~-Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 210 QLYLIRKTLGNLIPRHQSIFSSNPFFH-GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred HHHHHHHHHcccCHHHHHHhccCCcee-eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 999999988886654322111111111 1111111111 122345677889999999999999999999999999996
Q ss_pred cc
Q 036739 318 DV 319 (323)
Q Consensus 318 ~~ 319 (323)
+.
T Consensus 289 ~~ 290 (396)
T KOG0593|consen 289 GF 290 (396)
T ss_pred HH
Confidence 53
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-54 Score=374.26 Aligned_cols=286 Identities=41% Similarity=0.748 Sum_probs=251.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCc-eEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEK-KLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~-~~~l 78 (323)
|++|.++++||.|.||.||+|+.+.+++.||||.++.....-+ ...-.+|+..++++. ||||+++.+.+.+.. .+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 5899999999999999999999999999999999876543321 122336999999998 999999999998876 9999
Q ss_pred EEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 79 VFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
||||++.+|.+.|..+ ...+++..++.|+.||++||+|+|++|++|||+||+|||+..+.. +||+|||+++.......
T Consensus 88 VfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~-iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 88 VFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV-IKIADFGLAREVRSKPP 165 (538)
T ss_pred eHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce-eEecccccccccccCCC
Confidence 9999999999999988 667999999999999999999999999999999999999997665 99999999987653322
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
++-| +.|..|.|||++.....|+.+.|+|++|||++|+.+-++.|.+.+.
T Consensus 166 -----------YTeY-------------------VSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 166 -----------YTEY-------------------VSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred -----------cchh-------------------hhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 1112 3399999999999989999999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccC-CcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSL-PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
.+.+.++...++.+....|++.-.+ ......+.............+.++++.++|.+||++||.+||+|.+.|+||||+
T Consensus 216 ~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq 295 (538)
T KOG0661|consen 216 IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ 295 (538)
T ss_pred HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence 9999999999999999999885443 335556777777778888888999999999999999999999999999999998
Q ss_pred cc
Q 036739 318 DV 319 (323)
Q Consensus 318 ~~ 319 (323)
.-
T Consensus 296 ~~ 297 (538)
T KOG0661|consen 296 VG 297 (538)
T ss_pred cc
Confidence 54
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-52 Score=351.22 Aligned_cols=288 Identities=68% Similarity=1.162 Sum_probs=263.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC-eeeeeEEEecCc------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN-IVRLQDVVHSEK------ 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~------ 74 (323)
..|..+++||+|.+|+||+|+.+.+|+.||+|++......+.......+|+.+++.++|+| |+.+++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4588889999999999999999999999999999888766677888899999999999999 999999998776
Q ss_pred eEEEEEecchhhHHHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 75 KLYLVFEYLDLDLKKHMDSCPD--FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 75 ~~~lv~e~~~g~l~~~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
.+++||||++-++.+++..... ...+...++.++.||+.||+|||+++|+||||||+||+++.+|. +||+|||++..
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~-lKlaDFGlAra 169 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV-LKLADFGLARA 169 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc-EeeeccchHHH
Confidence 8999999999999999988764 35677889999999999999999999999999999999999888 99999999987
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
...+...... .++|+.|.|||++.+...|+...|+||+|||+.||+++++.
T Consensus 170 ~~ip~~~yt~-----------------------------evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 170 FSIPMRTYTP-----------------------------EVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred hcCCcccccc-----------------------------cEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 7655554332 37799999999999988999999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCC-CCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhh
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWP-SKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSAL 311 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il 311 (323)
|.+....+.+.++.+.++.+.+..|++....+++...+..|. ........+..+++..+++.+||+.+|.+|.|++.+|
T Consensus 221 FpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al 300 (323)
T KOG0594|consen 221 FPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGAL 300 (323)
T ss_pred CCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHh
Confidence 999999999999999999999999999999999999999888 6666677777888999999999999999999999999
Q ss_pred cCCCCccc
Q 036739 312 EHEYFRDV 319 (323)
Q Consensus 312 ~h~~~~~~ 319 (323)
.||||..+
T Consensus 301 ~h~yf~~~ 308 (323)
T KOG0594|consen 301 THPYFSEL 308 (323)
T ss_pred cChhhccc
Confidence 99999987
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-52 Score=347.22 Aligned_cols=289 Identities=50% Similarity=0.915 Sum_probs=258.4
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--CceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (323)
|++|+.+.+|++|.||.||+|+++.+++.||+|.++.........-.-.+|+.++.+.+|||||.+-.+... -+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 468999999999999999999999999999999998887666666777789999999999999999888754 457999
Q ss_pred EEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 79 VFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||||+.+|...+.+.. ..+...+++.+..|++.||.|||++.|+||||||+|+|+...|. +||+|||+++.++.+..
T Consensus 155 VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~-lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI-LKIADFGLAREYGSPLK 232 (419)
T ss_pred eHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc-EEecccchhhhhcCCcc
Confidence 99999999999988765 46888899999999999999999999999999999999999888 99999999999887744
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
... ..+.|+.|.|||.+.+...|+.+.|+||+|||+.|++++.+.|.+...
T Consensus 233 ~~T-----------------------------~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE 283 (419)
T KOG0663|consen 233 PYT-----------------------------PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE 283 (419)
T ss_pred cCc-----------------------------ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence 332 246699999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCccc-ccCCCCCCCcccccccC--CChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFK-SAFPKWPSKELGTVVRN--LEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~--~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
.+.+.++++.++.+.+..|++...++.+. ..+.+.........+.- +++...+|++.+|..||.+|.||.+.|+|+|
T Consensus 284 ~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 284 IDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred HHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 99999999999999999999999999884 56666665554444433 5699999999999999999999999999999
Q ss_pred Ccccc
Q 036739 316 FRDVE 320 (323)
Q Consensus 316 ~~~~~ 320 (323)
|.+.+
T Consensus 364 F~e~P 368 (419)
T KOG0663|consen 364 FRETP 368 (419)
T ss_pred cccCC
Confidence 99864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-52 Score=368.10 Aligned_cols=272 Identities=28% Similarity=0.423 Sum_probs=233.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 79 (323)
++|.+.+.||.|+|++|++|+++.+++.||||++.+.. ....-...+..|-.+|.+| .||+|++++..|+++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 68999999999999999999999999999999987663 2334456677888999999 799999999999999999999
Q ss_pred Eecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
+||+. |+|++.|.+.. .+++..++.++.+|+.||+|||++||+||||||+|||++.++. +||+|||.+..++....
T Consensus 153 Le~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh-ikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH-IKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc-EEEeeccccccCChhhc
Confidence 99995 69999998864 5788899999999999999999999999999999999999999 99999999999876655
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
...........-+ ....-+||-.|.+||++.. ...++.+|+|+||||+|.|+.|.+||.+.++
T Consensus 230 ~~~~~~~~~~a~s----------------~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 230 SQENPVDPNQASS----------------RRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred cccCccCcccccC----------------cccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 4332211111000 0122377999999999988 7789999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.-..++++...... .+.+++.+.+||.++|..||++|+++.+|.+||||.+
T Consensus 293 yliFqkI~~l~y~f-----------------------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 293 YLIFQKIQALDYEF-----------------------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred HHHHHHHHHhcccC-----------------------------CCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 88888887753322 2457899999999999999999999999999999999
Q ss_pred cccc
Q 036739 319 VEFV 322 (323)
Q Consensus 319 ~~~~ 322 (323)
|+|.
T Consensus 344 Vdw~ 347 (604)
T KOG0592|consen 344 VDWE 347 (604)
T ss_pred CChh
Confidence 9984
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-52 Score=352.00 Aligned_cols=260 Identities=31% Similarity=0.489 Sum_probs=226.1
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
.++|++++.||+|+||.||.++.+.+++.||+|++.+... .....+....|..++..++||.|++++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 3689999999999999999999999999999999977753 334567888999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
+||+.| .|..++.+.. .+++..++.++..|+.||.|||++||+||||||+|||++.+|. ++|+|||+|..--....
T Consensus 104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH-i~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH-IKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc-EEEeccccchhcccCCC
Confidence 999976 8998888765 4689999999999999999999999999999999999999999 99999999975422211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
. ..+.+||+.|+|||++.. ..++.++|.||||+++|+|++|.+||.+.+.
T Consensus 181 ~-----------------------------t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 181 A-----------------------------TRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred c-----------------------------cccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 1 112488999999999998 5799999999999999999999999999998
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC----CHhhhhcCC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI----TARSALEHE 314 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~----s~~~il~h~ 314 (323)
...+.++.+.- .......++..++++++++|..||++|. ++.+|-+||
T Consensus 231 ~~~~~~I~~~k----------------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hp 282 (357)
T KOG0598|consen 231 KKMYDKILKGK----------------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHP 282 (357)
T ss_pred HHHHHHHhcCc----------------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCc
Confidence 88888876531 0111233789999999999999999996 678888999
Q ss_pred CCccccc
Q 036739 315 YFRDVEF 321 (323)
Q Consensus 315 ~~~~~~~ 321 (323)
||.+++|
T Consensus 283 fF~~inW 289 (357)
T KOG0598|consen 283 FFKGINW 289 (357)
T ss_pred ccccCCH
Confidence 9999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=354.19 Aligned_cols=254 Identities=27% Similarity=0.432 Sum_probs=211.7
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc-eEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-KLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e 81 (323)
+.+.++.||+|+.|+||++.++.++..+|+|++.. ..+.....++.+|+++++..+||+||.+||+|...+ ...|+||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 56788999999999999999999999999999943 344555678889999999999999999999999988 4999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++|+.++.+.... ..+++.....++.++++||.|||. .+|+||||||+|||++..|. +||+|||.+..+...
T Consensus 159 YMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe-VKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE-VKICDFGVSGILVNS---- 232 (364)
T ss_pred hcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC-EEeccccccHHhhhh----
Confidence 99874444444332 357999999999999999999995 89999999999999999998 999999999776322
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC----
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD---- 236 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~---- 236 (323)
..++-+||..|||||.+.+ ..|+.++||||||+.++|+.+|+.||...
T Consensus 233 ---------------------------~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~ 284 (364)
T KOG0581|consen 233 ---------------------------IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY 284 (364)
T ss_pred ---------------------------hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCC
Confidence 1122367999999999999 68999999999999999999999999875
Q ss_pred -ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCccccccc-CCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 237 -SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVR-NLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
...+.+..+.. ..++. .+. .+|+++++||.+||++||.+||++.++++||
T Consensus 285 ~~~~~Ll~~Iv~----~ppP~------------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 285 LDIFELLCAIVD----EPPPR------------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CCHHHHHHHHhc----CCCCC------------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 33344444432 11111 112 3899999999999999999999999999999
Q ss_pred CCccc
Q 036739 315 YFRDV 319 (323)
Q Consensus 315 ~~~~~ 319 (323)
|++..
T Consensus 337 fi~~~ 341 (364)
T KOG0581|consen 337 FIKKF 341 (364)
T ss_pred HHhhc
Confidence 99864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=360.10 Aligned_cols=288 Identities=48% Similarity=0.861 Sum_probs=251.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC--ceEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 79 (323)
+.|+.+++||+|-||.||+|++..+|+.||+|++.....+........+|+.+|+++.||||+++.+...+. +.+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 568899999999999999999999999999999999988888888999999999999999999999998875 799999
Q ss_pred EecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 80 FEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|||++.+|.-.+.+ +...+++..++.+++||+.||+|+|++|++|||||.+|||++.+|. +||+|||++..+......
T Consensus 197 FeYMdhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~-LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 197 FEYMDHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV-LKIADFGLARFYTPSGSA 274 (560)
T ss_pred EecccchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC-EEeccccceeeccCCCCc
Confidence 99999988877654 4456889999999999999999999999999999999999999888 999999999987654433
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.. +..+.|+.|.|||.+.+...|+.+.|+||.|||+.||++|++.|.+....
T Consensus 275 ~~----------------------------T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv 326 (560)
T KOG0600|consen 275 PY----------------------------TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV 326 (560)
T ss_pred cc----------------------------ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH
Confidence 21 22466999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCC-CCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWP-SKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
+.+.+|++..+.+.+..|. ..+++.+........ ..........+++.+.+|+..||+.||.+|.||.++|.|+||..
T Consensus 327 eQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 327 EQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred HHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 9999999999999999998 555553333222222 23334457789999999999999999999999999999999955
Q ss_pred cc
Q 036739 319 VE 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 406 ~p 407 (560)
T KOG0600|consen 406 EP 407 (560)
T ss_pred CC
Confidence 43
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-51 Score=358.19 Aligned_cols=291 Identities=27% Similarity=0.410 Sum_probs=234.4
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++++.||+|+||.||+|+.+.+|+.+|+|++++..+ ..+..+.+..|-++|....+|.||+++.+|++..++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 5799999999999999999999999999999999987764 445667888999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| ++...+.... .+++..++.++.+++.||+.+|+.|++|+||||+|+|++..|. +||+|||+|..+.....
T Consensus 220 MEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH-iKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH-IKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC-Eeeccccccchhhhhhh
Confidence 999966 7777766644 5788899999999999999999999999999999999999999 99999999977655333
Q ss_pred ccccc-------cc-----CCcC----ccee--ehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHH
Q 036739 159 TFTHE-------HW-----GSTG----ISIY--FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220 (323)
Q Consensus 159 ~~~~~-------~~-----~~~~----~~~~--~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG 220 (323)
..... .. ...+ .... .......+...-....+..+|||.|+|||++.+ ..|+...|.||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHH
Confidence 22100 00 0000 0000 011112223333334566799999999999999 4599999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccC
Q 036739 221 CIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300 (323)
Q Consensus 221 ~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~d 300 (323)
||+|||+.|.+||.+.++.++..++..--..... +....+++.+.+||.+||. |
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f-------------------------P~~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF-------------------------PEEVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC-------------------------CCcCcccHHHHHHHHHHhc-C
Confidence 9999999999999999999999888763211111 1112367899999999999 9
Q ss_pred CCCCC---CHhhhhcCCCCccccc
Q 036739 301 PSRRI---TARSALEHEYFRDVEF 321 (323)
Q Consensus 301 p~~R~---s~~~il~h~~~~~~~~ 321 (323)
|++|. ++.||.+||||++|+|
T Consensus 430 ~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHhcCcccHHHHhcCCccccCCc
Confidence 99999 4889999999999976
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=335.90 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=226.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++++.||.|+||+|.+++.+.+|..||+|++.+.. -+....+...+|..+++.+.||.++++++.|.+.+.+|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 478999999999999999999999999999999997663 2233456777899999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||++| .+.+++.+.. .+++..++.++.||+.||+|||+++|++|||||+|||++.+|. +||+|||++......
T Consensus 123 meyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~-iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH-IKITDFGFAKRVSGR-- 197 (355)
T ss_pred EeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc-EEEEeccceEEecCc--
Confidence 999975 8888888765 4688899999999999999999999999999999999999999 999999999876422
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
..+.+|||.|+|||.+.. ..++.++|.|+||+++|||+.|.+||.+..+
T Consensus 198 ------------------------------T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 198 ------------------------------TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ------------------------------EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 223488999999999988 6789999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h 313 (323)
...+.+|....- ..+..+++.+++||.++|+.|-++|. ...+|..|
T Consensus 247 ~~iY~KI~~~~v-----------------------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H 297 (355)
T KOG0616|consen 247 IQIYEKILEGKV-----------------------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNH 297 (355)
T ss_pred HHHHHHHHhCcc-----------------------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccC
Confidence 999998876421 12345899999999999999999994 56789999
Q ss_pred CCCcccccc
Q 036739 314 EYFRDVEFV 322 (323)
Q Consensus 314 ~~~~~~~~~ 322 (323)
|||+++.|-
T Consensus 298 ~wF~~v~W~ 306 (355)
T KOG0616|consen 298 PWFKGVDWE 306 (355)
T ss_pred cccccccHH
Confidence 999999873
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=346.03 Aligned_cols=284 Identities=54% Similarity=0.985 Sum_probs=233.2
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++.+.||.|++|.||++++..++..||+|.+..... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 5789999999999999999999999999999999865432 223456778999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||+.|++.+.+..... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+..........
T Consensus 83 e~~~~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~-~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 83 EYLDSDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE-LKLADFGLARAKSVPTKTY 160 (288)
T ss_pred eCCCcCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-EEECcCcceeeccCCCccc
Confidence 9999998888765433 4678888999999999999999999999999999999998887 9999999987643221111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+....+
T Consensus 161 -----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~ 211 (288)
T cd07871 161 -----------------------------SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE 211 (288)
T ss_pred -----------------------------cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 012458889999998876678999999999999999999999999988888
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccC-CCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAF-PKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
....+.+..+.+....|+.......+.... ..+...........+++.+++||.+||+.||.+|||+.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 212 ELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 888888888887777776655544433222 1221122222334678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=340.45 Aligned_cols=287 Identities=54% Similarity=0.905 Sum_probs=223.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.++...++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 689999999999999999999988999999999865432 2234567789999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|+.+++.+.+..... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+..........
T Consensus 84 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~- 160 (303)
T cd07869 84 YVHTDLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE-LKLADFGLARAKSVPSHTY- 160 (303)
T ss_pred CCCcCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEECCCCcceeccCCCccC-
Confidence 999999988876533 4688889999999999999999999999999999999998887 9999999986543221110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH-H
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI-D 240 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~-~ 240 (323)
....+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+..+. +
T Consensus 161 ----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 212 (303)
T cd07869 161 ----------------------------SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212 (303)
T ss_pred ----------------------------CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 01245888999999877667899999999999999999999999876543 4
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCccccc-CCCCCCCccccc--ccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSA-FPKWPSKELGTV--VRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
.+..+....+.+....++.....+.+... +....+...... ....++.+.+|+.+||+.||++|||+.++++||||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~ 292 (303)
T cd07869 213 QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292 (303)
T ss_pred HHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence 44555555555544444433322222111 111111111111 113567899999999999999999999999999999
Q ss_pred ccc
Q 036739 318 DVE 320 (323)
Q Consensus 318 ~~~ 320 (323)
+++
T Consensus 293 ~~~ 295 (303)
T cd07869 293 DLP 295 (303)
T ss_pred cCC
Confidence 885
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=346.09 Aligned_cols=257 Identities=33% Similarity=0.503 Sum_probs=218.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC---CCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 76 (323)
++.|++.+.||+|+||.|+++.+..++..||+|++...... ....+.+.+|+.+++.+. ||||+++++++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 36899999999999999999999999999999977665221 234567778999999999 99999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC-CCceEEeccccceecC
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFG 154 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~-~~~~kl~df~~~~~~~ 154 (323)
++||||+.| +|++.+.+ ...+.+..+++++.||++|++|+|++||+||||||+||+++.+ ++ +||+|||++....
T Consensus 96 ~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~-~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN-LKLSDFGLSAISP 172 (370)
T ss_pred EEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC-EEEeccccccccC
Confidence 999999975 99999998 3357889999999999999999999999999999999999999 77 9999999998763
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCC-CCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR-HYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
..... ....+||+.|+|||++.+.. .-+.++||||+|++||.|++|+.||
T Consensus 173 -~~~~~----------------------------l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF 223 (370)
T KOG0583|consen 173 -GEDGL----------------------------LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPF 223 (370)
T ss_pred -CCCCc----------------------------ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCC
Confidence 11111 11237899999999999966 5568999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCC-ChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNL-EPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+......++.+.- -.+...+ |+.+++|+.+||..||.+|+++.+|+.
T Consensus 224 ~d~~~~~l~~ki~~~~-----------------------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 224 DDSNVPNLYRKIRKGE-----------------------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCccHHHHHHHHhcCC-----------------------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 9977777776654321 1112235 899999999999999999999999999
Q ss_pred CCCCcc
Q 036739 313 HEYFRD 318 (323)
Q Consensus 313 h~~~~~ 318 (323)
||||+.
T Consensus 275 h~w~~~ 280 (370)
T KOG0583|consen 275 HPWFQK 280 (370)
T ss_pred Chhhcc
Confidence 999995
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=335.87 Aligned_cols=292 Identities=24% Similarity=0.320 Sum_probs=234.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++++.||.|..|+||+|+...++..+|+|++.+.... .+-......|.++|..+.||.++.+|..|+.+.+.|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 5688999999999999999999999999999999877643 444567778999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|||.| +|-....++++..+++..++.++..++.||+|||..||++|||||+|||+.++|. +.|+||+++......++.
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH-IMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH-IMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc-EEeeeccccccCCCCCee
Confidence 99965 8888888888999999999999999999999999999999999999999999999 999999998877432222
Q ss_pred ccccccCC----cCcce-eehhh---------------------hhhhccCcc-ceeeccccccccccchhhhCCCCCCC
Q 036739 160 FTHEHWGS----TGISI-YFSFL---------------------RYRVLAGSL-ILQFLKVVTLWYRAPEILLGSRHYST 212 (323)
Q Consensus 160 ~~~~~~~~----~~~~~-~~~~~---------------------~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~ 212 (323)
........ +.+.. ..+-. .+.....+. ...+.-+||-+|.|||++.+.. -+.
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-Hgs 314 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGS 314 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-CCc
Confidence 11110000 00000 00000 000111111 2345568999999999999955 488
Q ss_pred chhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHH
Q 036739 213 PVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292 (323)
Q Consensus 213 ~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 292 (323)
+.|.|.||+++|||+.|..||++....+++..+...--. +++ ...++..+++|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~-----Fp~----------------------~~~vs~~akDL 367 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK-----FPE----------------------EPEVSSAAKDL 367 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc-----CCC----------------------CCcchhHHHHH
Confidence 999999999999999999999999999998877642111 100 11477899999
Q ss_pred HHhhcccCCCCCCC----HhhhhcCCCCcccccc
Q 036739 293 LSKMLCMDPSRRIT----ARSALEHEYFRDVEFV 322 (323)
Q Consensus 293 i~~~l~~dp~~R~s----~~~il~h~~~~~~~~~ 322 (323)
|+++|.+||++|.. |.||-+||||++|+|.
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred HHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 99999999999998 9999999999999984
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=337.11 Aligned_cols=294 Identities=90% Similarity=1.415 Sum_probs=247.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++.+.||+|++|+||++.++.+++.|++|.+............+.+|+.++++++|+|++++++++.+....++|+
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 58999999999999999999999889999999988655444444567888999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||+++++.+.+........++..+..++.||+.||.+||+++++|+||+|+||+++.++..+||+|||.+..........
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 99999999988776666678888889999999999999999999999999999998766569999999987654322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...+++.|+|||.+.+...++.++|+||+|+++|+|++|..||......+
T Consensus 161 ~-----------------------------~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~ 211 (294)
T PLN00009 161 T-----------------------------HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID 211 (294)
T ss_pred c-----------------------------cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0 01347789999998775668899999999999999999999999888888
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
...++......+....|+.....+.+......+...........+++.+.++|.+||+.+|++||++.++++||||.+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 212 ELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred HHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 88777777777777777766666665555555444444445567889999999999999999999999999999999998
Q ss_pred ccC
Q 036739 321 FVP 323 (323)
Q Consensus 321 ~~~ 323 (323)
-||
T Consensus 292 ~~~ 294 (294)
T PLN00009 292 DAP 294 (294)
T ss_pred cCC
Confidence 887
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=324.27 Aligned_cols=260 Identities=32% Similarity=0.473 Sum_probs=230.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|.|+.|+++.+..+|..+++|++..........+++.+|+++-+.++||||+++++.+...+..|+|||
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 57999999999999999999999999999999998887766788999999999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec--CCCceEEeccccceecCCCcc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~--~~~~~kl~df~~~~~~~~~~~ 158 (323)
++.| ++...+..+ .-.++..+...+.||+++|.|+|.+||+|+|+||.|+++-. .+--+||+|||++..+... .
T Consensus 91 ~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g-~ 167 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG-E 167 (355)
T ss_pred cccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc-c
Confidence 9976 887777765 35688999999999999999999999999999999999943 2335999999999887621 1
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.. ...+|||.|+|||++.. .+++..+|||+.|+++|-|+.|.+||.+.+.
T Consensus 168 ~~-----------------------------~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~ 217 (355)
T KOG0033|consen 168 AW-----------------------------HGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQ 217 (355)
T ss_pred cc-----------------------------ccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccH
Confidence 11 12377999999999988 6699999999999999999999999999988
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
...+.++.++.....++.| +++++++++||++||..||.+|.|+.|.|+|||+.+
T Consensus 218 ~rlye~I~~g~yd~~~~~w-------------------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 218 HRLYEQIKAGAYDYPSPEW-------------------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHHHhccccCCCCccc-------------------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 8899999887766665554 568899999999999999999999999999999986
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
-
T Consensus 273 r 273 (355)
T KOG0033|consen 273 R 273 (355)
T ss_pred h
Confidence 4
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=333.68 Aligned_cols=288 Identities=41% Similarity=0.711 Sum_probs=247.4
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec-----CceEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKKLY 77 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 77 (323)
.|..++.||+|++|.|+.+.++.+|+.||||++.....+.-......+|+.+++.++|+||+.+.+.+.. -+.+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 4556799999999999999999999999999997555555566788899999999999999999999865 36799
Q ss_pred EEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 78 LVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 78 lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
+|+|+++.+|-+.+.++. .+++..+..+++||+.||.|+|+.+++||||||+|++++.+-. +||+|||+++......
T Consensus 103 iV~elMetDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~-lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD-LKICDFGLARYLDKFF 179 (359)
T ss_pred EehhHHhhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC-EEeccccceeeccccC
Confidence 999999989999888765 3688999999999999999999999999999999999999888 9999999998875430
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. . . ++..+.|..|.|||.+.....|+.+.||||+|||+.||++|++.|.+.+
T Consensus 180 ~~-~----~----------------------mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 180 ED-G----F----------------------MTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred cc-c----c----------------------hhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 00 0 0 0112449999999999988999999999999999999999999999999
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCccc--CCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
..+.+..+...++.+.++.+..... ......++............++.++.+.+|+.+||..||.+|+|++++|+|||
T Consensus 233 ~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 233 YVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred hHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence 9999999999999987765544441 22255667777777777888899999999999999999999999999999999
Q ss_pred Ccccc
Q 036739 316 FRDVE 320 (323)
Q Consensus 316 ~~~~~ 320 (323)
|...+
T Consensus 313 l~~~h 317 (359)
T KOG0660|consen 313 LAPYH 317 (359)
T ss_pred hhhhc
Confidence 98763
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=334.16 Aligned_cols=259 Identities=29% Similarity=0.496 Sum_probs=220.0
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|.+.++||+|+|++||+|+.+.++..||||.+.+........+.+..|+.+++.++||||+.++++.+..+.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 47899999999999999999999999999999999877666666788889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC-C----CceEEeccccceecC
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR-T----NALKLADFGLARAFG 154 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~-~----~~~kl~df~~~~~~~ 154 (323)
|||+| +|-.++.+.. .+++..++.++.||+.||++||+++|+||||||+|||++.. . -.+||+|||+++.+.
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99975 7877777655 57999999999999999999999999999999999999774 2 258999999998876
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
...-. .+.+|++.|||||++.. ..|+-|.|+||+|+++|+|++|.+||.
T Consensus 167 ~~~~a------------------------------~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 167 PGSMA------------------------------ETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred chhHH------------------------------HHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 32221 12478999999999987 789999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
.....+....+.+..... +.....+++.+.+++...++.+|.+|.+..+-..|+
T Consensus 216 a~t~~eL~~~~~k~~~~~--------------------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~ 269 (429)
T KOG0595|consen 216 AETPKELLLYIKKGNEIV--------------------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHP 269 (429)
T ss_pred ccCHHHHHHHHhcccccc--------------------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence 998888877555432111 111223566677899999999999999999888888
Q ss_pred CCcc
Q 036739 315 YFRD 318 (323)
Q Consensus 315 ~~~~ 318 (323)
++..
T Consensus 270 ~l~~ 273 (429)
T KOG0595|consen 270 FLAA 273 (429)
T ss_pred hccc
Confidence 8764
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=338.55 Aligned_cols=288 Identities=57% Similarity=1.006 Sum_probs=231.9
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++.+.||+|++|.||+++++.+++.+|+|.+..... ......+.+|+.+++.++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 5789999999999999999999999999999999865432 233456778999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||+++++.+.+..... .++...+..++.||+.||.|||++|++||||||+||+++.++. +||+|||.+..........
T Consensus 84 e~~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 84 EYLDKDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE-LKLADFGLARAKSVPTKTY 161 (309)
T ss_pred eCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEECccccceecCCCcccc
Confidence 9999999888766543 4688888999999999999999999999999999999998887 9999999987543322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...+++.|+|||.+.+...++.++|+||||+++|+|++|..||......+
T Consensus 162 ~-----------------------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 212 (309)
T cd07872 162 S-----------------------------NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212 (309)
T ss_pred c-----------------------------cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 0 11347889999998876678999999999999999999999999988888
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCccc-ccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFK-SAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
....+.+..+.+....|+.......+. .++..............+++.+.++|.+||+.||.+||++.++++||||+.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 213 ELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred HHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 888887777766665554433222211 1112221111222334688999999999999999999999999999999986
Q ss_pred c
Q 036739 320 E 320 (323)
Q Consensus 320 ~ 320 (323)
.
T Consensus 293 ~ 293 (309)
T cd07872 293 G 293 (309)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=351.03 Aligned_cols=259 Identities=33% Similarity=0.488 Sum_probs=229.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEec-ccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE-QEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+=|++.+.||.|+.|.|-+|++..+|+..|||++.+. .........+..|+.+|+.+.|||++++++.|++...+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4588999999999999999999999999999999777 445556788899999999999999999999999999999999
Q ss_pred ecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+. |.|++++.... .+.+.++.+++.||+.|+.|+|..+|||+||||+|+|++..++ +||+|||.+...-.+.-.
T Consensus 92 Eyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n-IKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN-IKIADFGMASLEVPGKLL 168 (786)
T ss_pred EecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC-EeeeccceeecccCCccc
Confidence 9995 59999998865 4677888899999999999999999999999999999999998 999999999875432221
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
. +-+|+|.|++||.+.+..+-+.++||||.|+|||.|+||+.||.+.+.+
T Consensus 169 e------------------------------TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir 218 (786)
T KOG0588|consen 169 E------------------------------TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR 218 (786)
T ss_pred c------------------------------ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH
Confidence 1 2378999999999999888899999999999999999999999988888
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
..+.++.++..... ..+|+++++||.+||..||++|.+..+|++|||+.+.
T Consensus 219 ~LLlKV~~G~f~MP-----------------------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 219 VLLLKVQRGVFEMP-----------------------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred HHHHHHHcCcccCC-----------------------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 88888877543332 4589999999999999999999999999999999886
Q ss_pred ccc
Q 036739 320 EFV 322 (323)
Q Consensus 320 ~~~ 322 (323)
+-.
T Consensus 270 ~~~ 272 (786)
T KOG0588|consen 270 TSL 272 (786)
T ss_pred CCC
Confidence 543
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=333.70 Aligned_cols=284 Identities=68% Similarity=1.159 Sum_probs=236.9
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||+|++|.||++++..++..|++|.+............+.+|+.+++++.|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999988999999999866544444456788899999999999999999999999999999999
Q ss_pred chhhHHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDLDLKKHMDSCPD-FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g~l~~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+.+++.+.+..... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||.+...+.+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV-IKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc-EEECcccceeecCCCccccc
Confidence 99988888865443 46788999999999999999999999999999999999998887 99999999876543321111
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
...+++.|+|||.+.+...++.++|+||||+++|+|++|++||......+.
T Consensus 160 -----------------------------~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~ 210 (285)
T cd07861 160 -----------------------------HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ 210 (285)
T ss_pred -----------------------------CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 113477899999987766678999999999999999999999998887777
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
.....+..+.+....|+.......+......+...........+++.+.++|++||+.||++||++.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 211 LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 777777666666666655555555555555555544445556789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=332.65 Aligned_cols=281 Identities=48% Similarity=0.860 Sum_probs=222.6
Q ss_pred CCcceeeeeccccceeEEEEEEcc-CCceEEEEEEEecccCCCCchhHHHHHHHHHhc---CCCCeeeeeEEEe-----c
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-TNETIALKKIRLEQEDEGVPSTAIREISLLKEM---QHGNIVRLQDVVH-----S 72 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~ 72 (323)
++|++.+.||+|++|.||+|++.. ++..||+|.+............+.+|+.+++.+ .||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 589999999999999999999854 467899999876554444445566777777766 6999999999885 3
Q ss_pred CceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 73 EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 73 ~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
...+++|+|++.+++.+.+.......+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~-~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC-EEEccccceEe
Confidence 45689999999999999987766556788999999999999999999999999999999999998887 99999999876
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
....... ....|++.|+|||.+.+ ..++.++|+|||||++|+|++|.+|
T Consensus 160 ~~~~~~~------------------------------~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~ 208 (290)
T cd07862 160 YSFQMAL------------------------------TSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPL 208 (290)
T ss_pred ccCCccc------------------------------ccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCC
Confidence 5322110 01245888999999977 5688999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
|.+....+.+..+....+.+....++........ .+..............+++.+.++|.+||+.||++||++.++++
T Consensus 209 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 209 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ--AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cCCCCHHHHHHHHHHHhCCCChhhchhhhcccch--hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 9998888888888777665554444333221111 11111222222344568889999999999999999999999999
Q ss_pred CCCC
Q 036739 313 HEYF 316 (323)
Q Consensus 313 h~~~ 316 (323)
||||
T Consensus 287 hp~f 290 (290)
T cd07862 287 HPYF 290 (290)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=334.45 Aligned_cols=284 Identities=38% Similarity=0.722 Sum_probs=219.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++++..++..||+|++............+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 68999999999999999999999999999999987654444456778899999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|+.+++++.+.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+...........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV-LKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc-EEEeeccCcccccccccccc
Confidence 99988877776543 35788889999999999999999999999999999999998887 99999999876532211110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
....|++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||......+.
T Consensus 159 ----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~ 209 (287)
T cd07848 159 ----------------------------TEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209 (287)
T ss_pred ----------------------------cccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 01245888999999987 5589999999999999999999999998776666
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccc-cCC--CCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKS-AFP--KWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
...+....+......+......+.+.. ... .............+++.+.+||++||+.||++||+++++++||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 210 LFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 555444333322111100000000000 000 000000112223578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=347.34 Aligned_cols=257 Identities=31% Similarity=0.502 Sum_probs=226.8
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
|++|.+.+.||+|+||+||+++.+.+.+.||+|.+.+..........+.+|+++++.++||||+.++++|++...+|+|+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 78999999999999999999999999999999999887776667778999999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||+.|+|...+.... .++++.++.++.|++.||+|||+.+|.|+|+||.||++..++. +|++|||+++.+......
T Consensus 81 e~a~g~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~-~KlcdFg~Ar~m~~~t~v- 156 (808)
T KOG0597|consen 81 EYAVGDLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT-LKLCDFGLARAMSTNTSV- 156 (808)
T ss_pred hhhhhhHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc-eeechhhhhhhcccCcee-
Confidence 999999998887644 5789999999999999999999999999999999999999887 999999999887653332
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
.....|||.|||||.+.+ +.|+..+|+||||||+||+++|++||....-.+
T Consensus 157 ----------------------------ltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~ 207 (808)
T KOG0597|consen 157 ----------------------------LTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQ 207 (808)
T ss_pred ----------------------------eeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHH
Confidence 233577999999999997 889999999999999999999999998877666
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.+..|...- .. -+...|..+.+|++.+|.+||.+|.+=.+++.|||+++.
T Consensus 208 Lv~~I~~d~-----v~------------------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 208 LVKSILKDP-----VK------------------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHhcCC-----CC------------------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 666554310 00 012478899999999999999999999999999998764
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=330.83 Aligned_cols=287 Identities=55% Similarity=0.988 Sum_probs=229.4
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++.+.||+|++|.||++.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 5789999999999999999999988999999999865432 223456778999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||+.+++.+.+..... .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 84 e~~~~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 84 EYLDKDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTY 161 (301)
T ss_pred eccccCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc-EEECcCcchhccCCCCCcc
Confidence 9999998888765433 4688889999999999999999999999999999999998887 9999999986543222111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...+++.|+|||.+.+...++.++|+||||+++|+|++|++||...+..+
T Consensus 162 ~-----------------------------~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~ 212 (301)
T cd07873 162 S-----------------------------NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212 (301)
T ss_pred c-----------------------------ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0 11347789999998876678899999999999999999999999888777
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccc-cCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
....+.+....+....|+.......+.. ................+++.+.+||.+||+.||.+|||+.++++||||+.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 213 QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred HHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 7777776666665555544322222211 111111111222334678899999999999999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=325.79 Aligned_cols=280 Identities=39% Similarity=0.704 Sum_probs=230.0
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC-----ceEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KKLY 77 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 77 (323)
.|+-.+.+|+|+||.||.+....+++.||||....... .-..|+.+|+.+.||||+++..+|... -+..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 36778999999999999999989999999998854432 223689999999999999999988632 2567
Q ss_pred EEEecchhhHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 78 LVFEYLDLDLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 78 lv~e~~~g~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
+||||+.-+|.+.+.. ..+..++...++-+..||+.||.|||+.|||||||||+|+|++.+...+||+|||++..+..
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999999888874 22345666678889999999999999999999999999999999988899999999999865
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
...... |. -|..|.|||.+.+...|+.+.||||.||++.||+-|++.|.+
T Consensus 179 ~epniS-----------Yi-------------------cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 179 GEPNIS-----------YI-------------------CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred CCCcee-----------EE-------------------EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 554432 22 277899999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCccc-ccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELG-TVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
.+..+.+..+.+.++.+..+........-. ..++.+....... ......++++.+|+.++|..+|.+|.++.+++.||
T Consensus 229 ~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~ 307 (364)
T KOG0658|consen 229 DSSVDQLVEIIKVLGTPTREDIKSMNPNYT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP 307 (364)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcCcccc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence 999999999999999987765544333211 1222222222222 24567899999999999999999999999999999
Q ss_pred CCccc
Q 036739 315 YFRDV 319 (323)
Q Consensus 315 ~~~~~ 319 (323)
||..+
T Consensus 308 fFdel 312 (364)
T KOG0658|consen 308 FFDEL 312 (364)
T ss_pred hhHHh
Confidence 99876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=327.83 Aligned_cols=272 Identities=26% Similarity=0.352 Sum_probs=226.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++...||.|..++||+|+....++.||||++..+..+.+ .+.+.+|+..++.++||||++.+.+|..+..+|+||+
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 589999999999999999999999999999999988766555 6889999999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
++.+ ++++.+...-...+++..+..|+++++.||.|||++|.+|||||+.|||++.+|. |||+|||.+..+.......
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~-VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT-VKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc-EEEcCceeeeeecccCcee
Confidence 9964 8888887766667899999999999999999999999999999999999999999 9999999988775432111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhh-hCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEIL-LGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.... .+-+||+.|+|||++ ..-.-|+.|+||||||++..||.+|..||....+.
T Consensus 184 ~~rf-------------------------~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 184 VTRF-------------------------NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred eEee-------------------------ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 1110 223779999999994 44455899999999999999999999999999988
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
..+....+.... .... . .....-...++..++.+|..||+.||++||+++++++|+||+..
T Consensus 239 kvLl~tLqn~pp--~~~t------~-----------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 239 KVLLLTLQNDPP--TLLT------S-----------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred HHHHHHhcCCCC--Cccc------c-----------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 877655443111 0000 0 00011123467789999999999999999999999999999876
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=338.46 Aligned_cols=290 Identities=37% Similarity=0.621 Sum_probs=217.8
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC-----ceEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KKLY 77 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 77 (323)
+|++.+.||+|++|.||++++..++..||+|.+............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999998864433333345678899999999999999999988543 3589
Q ss_pred EEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 78 LVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 78 lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
+||||+++++.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||.+.......
T Consensus 81 lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~-~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc-EEEccCcccccccccc
Confidence 999999999988887644 4688889999999999999999999999999999999999887 9999999986542211
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.... ......|++.|+|||.+.+. ..++.++|||||||++|+|++|+.||...
T Consensus 158 ~~~~--------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 158 PTAI--------------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred Cccc--------------------------cccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 1100 00112458899999998652 46788999999999999999999999887
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccC--CcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSL--PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
........+....+.+....+...... ..+..................+++.+.++|.+||+.||++||++.++++||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 212 NVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 765555544444333322211111000 000011111111111122345778899999999999999999999999999
Q ss_pred CCccccc
Q 036739 315 YFRDVEF 321 (323)
Q Consensus 315 ~~~~~~~ 321 (323)
||+++..
T Consensus 292 ~f~~~~~ 298 (338)
T cd07859 292 YFKGLAK 298 (338)
T ss_pred hhhhcCc
Confidence 9998754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=329.38 Aligned_cols=284 Identities=68% Similarity=1.155 Sum_probs=237.8
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++++.||.|++|.||+|+++.++..|++|.+............+.+|++++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 58999999999999999999988999999998865544444556788999999999999999999999999999999999
Q ss_pred chhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 83 LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 83 ~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
+.+++.+.+.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~-~~l~dfg~~~~~~~~~~~~~- 158 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYT- 158 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEEeeccchhhcccCccccc-
Confidence 9888888887766667889999999999999999999999999999999999999887 99999999876543221110
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~ 242 (323)
...+++.|+|||.+.+...++.++|+||||+++|+|+||..||......+..
T Consensus 159 ----------------------------~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~ 210 (284)
T cd07860 159 ----------------------------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 210 (284)
T ss_pred ----------------------------cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 1133677999999877566788999999999999999999999988887777
Q ss_pred HHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
.+..+..+.+....++.....+.....+..+...........+++.+.++|.+||+.||++||++.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 211 FRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 77777776666555554444445555555555555555556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=325.39 Aligned_cols=280 Identities=47% Similarity=0.837 Sum_probs=221.5
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc---CCCCeeeeeEEEec-----Cc
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM---QHGNIVRLQDVVHS-----EK 74 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~~ 74 (323)
+|++++.||+|++|+||+|++..+++.||+|.+............+.+|+.+++.+ .||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999876544333344566677777665 69999999998864 34
Q ss_pred eEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 75 KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 75 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
..++++|++.+++.+.+.......+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~-~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ-VKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEECccCcccccc
Confidence 689999999999988887765556789999999999999999999999999999999999998887 9999999987653
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
..... ....+++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.
T Consensus 160 ~~~~~------------------------------~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 160 CQMAL------------------------------TPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred CcccC------------------------------CCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 21110 01244888999999987 568999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
.....+...++....+.+....++.....+. ..+..............+++.+.++|.+||+.||++||++.+++.||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp 286 (288)
T cd07863 209 GNSEADQLGKIFDLIGLPPEDDWPRDVTLPR--GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP 286 (288)
T ss_pred CCCHHHHHHHHHHHhCCCChhhCcccccccc--cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 8888777777777665555444433222111 11111222222333456788999999999999999999999999999
Q ss_pred CC
Q 036739 315 YF 316 (323)
Q Consensus 315 ~~ 316 (323)
||
T Consensus 287 ~f 288 (288)
T cd07863 287 FF 288 (288)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=343.21 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=222.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 78 (323)
+++|++++.||+|+||.|+++..+.+++.||||++++.. ...+..+....|.++++... ||.++.++.+|++..++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 578999999999999999999999999999999998775 45566788888999988885 9999999999999999999
Q ss_pred EEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 79 VFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
||||+.|+..-.+. ....+++..++.++..|+.||.|||++||+|||||.+|||++.+|. +||+|||+++..-....
T Consensus 447 vmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh-~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH-VKIADFGLCKEGMGQGD 523 (694)
T ss_pred EEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc-EEecccccccccCCCCC
Confidence 99999875533333 3346899999999999999999999999999999999999999999 99999999976321111
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
...+-+|||.|+|||++.+ ..|+.+.|.|+||++||||+.|..||.+.+.
T Consensus 524 -----------------------------~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE 573 (694)
T KOG0694|consen 524 -----------------------------RTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDE 573 (694)
T ss_pred -----------------------------ccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 1123488999999999998 7899999999999999999999999999998
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----HhhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~h 313 (323)
.+....|... ....+..+|.++.++++++|.++|++|+. +.+|.+|
T Consensus 574 ee~FdsI~~d-----------------------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 574 EEVFDSIVND-----------------------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred HHHHHHHhcC-----------------------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 8888777641 11223457899999999999999999995 5688889
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||+.++|
T Consensus 625 pFFr~i~w 632 (694)
T KOG0694|consen 625 PFFRSIDW 632 (694)
T ss_pred CccccCCH
Confidence 99999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=327.62 Aligned_cols=259 Identities=31% Similarity=0.495 Sum_probs=210.1
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc--eEEEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK--KLYLVF 80 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~ 80 (323)
+|...+.||+|.||+||++.++.+|...|+|......... .+.+.+|+.+++.++|||||+++|...... .+++.|
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 5788899999999999999999899999999886652222 567889999999999999999999855444 799999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec-CCCceEEeccccceecCCCcc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~-~~~~~kl~df~~~~~~~~~~~ 158 (323)
||+.| ++.+.+....+ .+++..++.+..||++||.|||++|++|+||||+|||++. ++. +||+|||++........
T Consensus 96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~-~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD-VKLADFGLAKKLESKGT 173 (313)
T ss_pred eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe-EEeccCccccccccccc
Confidence 99975 77777776655 7899999999999999999999999999999999999999 566 99999999887653111
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC-C
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD-S 237 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~-~ 237 (323)
.... .....||+.|+|||++........++|||||||++.||+||..||... .
T Consensus 174 ~~~~--------------------------~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~ 227 (313)
T KOG0198|consen 174 KSDS--------------------------ELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE 227 (313)
T ss_pred cccc--------------------------cccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc
Confidence 1000 112366999999999986233446999999999999999999999883 4
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
..+.+..+... ...+.++..+|+.+++||.+|+..||++||||.++|+|||.+
T Consensus 228 ~~~~~~~ig~~---------------------------~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 228 EAEALLLIGRE---------------------------DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred hHHHHHHHhcc---------------------------CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 33433333221 012244466899999999999999999999999999999997
Q ss_pred c
Q 036739 318 D 318 (323)
Q Consensus 318 ~ 318 (323)
+
T Consensus 281 ~ 281 (313)
T KOG0198|consen 281 Q 281 (313)
T ss_pred c
Confidence 5
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=339.45 Aligned_cols=256 Identities=29% Similarity=0.526 Sum_probs=221.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
..|....+||+|+.|.||.|....+++.||||.+.+..... .+.+.+|+.+|+..+|+||+.+++.|..++.+|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 46888899999999999999999999999999998765433 4788899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| +|.+.+... .+++..+..|++.++.||+|||.+||+|+|||.+|||++.++. +||+|||+|..+.....+.
T Consensus 351 ym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~-vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS-VKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred ecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc-EEEeeeeeeeccccccCcc
Confidence 9987 555554443 4789999999999999999999999999999999999999998 9999999999886655533
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. +++||+.|||||++.. ..|+.+.||||||+++.||+.|.+||-..++..
T Consensus 427 ~-----------------------------TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr 476 (550)
T KOG0578|consen 427 S-----------------------------TMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 476 (550)
T ss_pred c-----------------------------cccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHH
Confidence 2 3588999999999987 679999999999999999999999999877776
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.++.+... +.+. ......+|+.+++|+.+||..|+++|+++.++|+||||+-.
T Consensus 477 AlyLIa~n-g~P~-------------------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 477 ALYLIATN-GTPK-------------------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHHhhc-CCCC-------------------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 66665432 1111 11234689999999999999999999999999999999754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=335.62 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=213.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|++|.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 4789999999999999999999999999999999875432 223446788899999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++........
T Consensus 97 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVPDRTF 173 (329)
T ss_pred EcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC-EEEeeccCceEcCCCcc
Confidence 999965 7777776543 4678888899999999999999999999999999999999887 99999999876532111
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
...|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+...
T Consensus 174 --------------------------------~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 220 (329)
T PTZ00263 174 --------------------------------TLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220 (329)
T ss_pred --------------------------------eecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCH
Confidence 1245889999999987 5578999999999999999999999988776
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----HhhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~h 313 (323)
......+.... ......+++.+.+||.+||+.||++|++ +.++++|
T Consensus 221 ~~~~~~i~~~~-----------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 221 FRIYEKILAGR-----------------------------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHHHhcCC-----------------------------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 55554443210 0011236788999999999999999996 7999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||+++.|
T Consensus 272 p~f~~~~~ 279 (329)
T PTZ00263 272 PYFHGANW 279 (329)
T ss_pred CccCCCCH
Confidence 99998654
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=326.99 Aligned_cols=282 Identities=60% Similarity=1.086 Sum_probs=221.7
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||+|++|.||++++..+|+.+++|.+............+.+|+.+++.++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 68999999999999999999999999999999876544444556778899999999999999999999999999999999
Q ss_pred chhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 83 LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 83 ~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
+++++.+.+.+... .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||.+...+.......
T Consensus 81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~- 157 (284)
T cd07839 81 CDQDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE-LKLADFGLARAFGIPVRCYS- 157 (284)
T ss_pred CCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc-EEECccchhhccCCCCCCcC-
Confidence 99999888775433 4789999999999999999999999999999999999998887 99999999876543222111
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC-CCCChHHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF-PGDSEIDE 241 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~-~~~~~~~~ 241 (323)
...+++.|+|||.+.+...++.++|+||||+++|+|++|..|+ ...+..+.
T Consensus 158 ----------------------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~ 209 (284)
T cd07839 158 ----------------------------AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 209 (284)
T ss_pred ----------------------------CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH
Confidence 1134778999999887666799999999999999999988775 44444455
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCC-CcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPS-KELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
...+.+.........++.......... ...... .......+.+++.+.++|++||+.||.+|||+.++++||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 210 LKRIFRLLGTPTEESWPGVSKLPDYKP-YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHHHHHHhCCCChHHhHHhhhcccccc-cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 555555555444433332222222110 111111 11123345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=346.84 Aligned_cols=280 Identities=38% Similarity=0.652 Sum_probs=216.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC--------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-------- 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-------- 73 (323)
++|++.+.||+|+||.||+|.+..+++.||+|.+... .....+|+.+++.++||||++++++|...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4799999999999999999999889999999987432 13445799999999999999998887432
Q ss_pred ceEEEEEecchhhHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccce
Q 036739 74 KKLYLVFEYLDLDLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (323)
Q Consensus 74 ~~~~lv~e~~~g~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~ 151 (323)
..+++||||+++++.+.+.. .....+++..++.++.||+.||.|||+.||+||||||+||+++.++..+||+|||++.
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 25789999999988777653 2334678888999999999999999999999999999999999776569999999997
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCC
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~ 231 (323)
......... ...||+.|+|||.+.+...++.++|||||||++|+|++|.+
T Consensus 220 ~~~~~~~~~------------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~ 269 (440)
T PTZ00036 220 NLLAGQRSV------------------------------SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269 (440)
T ss_pred hccCCCCcc------------------------------cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 653221110 01458889999998876678999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCccc-ccCCCCCCCcc-cccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFK-SAFPKWPSKEL-GTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
||.+....+.+.++.+..+.+....+..... .+. ..+........ .......++.+.+||.+||+.||++||++.+
T Consensus 270 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e 347 (440)
T PTZ00036 270 IFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP--NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE 347 (440)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhch--hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 9999888888887777666544322211000 000 00111111111 1122357889999999999999999999999
Q ss_pred hhcCCCCccc
Q 036739 310 ALEHEYFRDV 319 (323)
Q Consensus 310 il~h~~~~~~ 319 (323)
+++||||.++
T Consensus 348 ~l~hp~f~~~ 357 (440)
T PTZ00036 348 ALADPFFDDL 357 (440)
T ss_pred HhCChhHHhh
Confidence 9999999876
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=326.80 Aligned_cols=262 Identities=23% Similarity=0.367 Sum_probs=211.6
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.|++.+.||+|+||.||++.+..++..||+|.+...... ......+.+|+.+++.+.|+|++++++++.+.+..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 488999999999999999999999999999998655322 2233567789999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| ++...+.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~- 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETV- 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC-EEEeeCCCcEEcCCCCee-
Confidence 9976 6666665444446788889999999999999999999999999999999998887 999999998764321110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.......
T Consensus 159 -----------------------------~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~ 208 (285)
T cd05631 159 -----------------------------RGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV 208 (285)
T ss_pred -----------------------------cCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcch
Confidence 01245889999999987 568999999999999999999999998765433
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----HhhhhcCCC
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALEHEY 315 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~h~~ 315 (323)
....+....... .......+++.+.+||++||+.||++||+ ++++++|||
T Consensus 209 ~~~~~~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 209 KREEVDRRVKED-------------------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred hHHHHHHHhhcc-------------------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 322222211110 01122357889999999999999999997 899999999
Q ss_pred Cccccc
Q 036739 316 FRDVEF 321 (323)
Q Consensus 316 ~~~~~~ 321 (323)
|.+++|
T Consensus 264 ~~~~~~ 269 (285)
T cd05631 264 FKNINF 269 (285)
T ss_pred hcCCCH
Confidence 999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=307.37 Aligned_cols=256 Identities=30% Similarity=0.476 Sum_probs=227.3
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||.|.||.||+|+.+.++..||+|++.+.. .......++.+|+++...++||||++++++|.++...|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 578999999999999999999999999999999987664 3555677889999999999999999999999999999999
Q ss_pred Eecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
+||.. |.+.+.+..+....+++..+..++.|++.||.|+|.++++||||||+|+|++.++. +||+|||.+...+....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~-lkiAdfGwsV~~p~~kR 179 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSNKR 179 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC-eeccCCCceeecCCCCc
Confidence 99995 69999999888878899999999999999999999999999999999999999998 99999999876542222
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.+.+||..|.+||+..+ ...+...|+|++|++.||++.|.+||.+...
T Consensus 180 -------------------------------~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~ 227 (281)
T KOG0580|consen 180 -------------------------------KTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSH 227 (281)
T ss_pred -------------------------------eeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhh
Confidence 12478999999999998 6689999999999999999999999999997
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+.+.++.+.-. ..+..++..+.++|.+|+..+|.+|....+++.|||...
T Consensus 228 ~etYkrI~k~~~-----------------------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 228 SETYKRIRKVDL-----------------------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHHHccc-----------------------------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 777777765311 112458999999999999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=322.87 Aligned_cols=247 Identities=30% Similarity=0.494 Sum_probs=207.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeE-EEecCce-EEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD-VVHSEKK-LYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~-~~lv 79 (323)
.+|+++++||+|+||.||++++..+|..+|.|.+.....+....+.+..|+.+|++++||||+++++ .|-+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3699999999999999999999999999999999876677777788999999999999999999998 5544444 8999
Q ss_pred Eecchh-hHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccCCCCCCcEEEecCCCceEEecccccee
Q 036739 80 FEYLDL-DLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHS--HR--VLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~--i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
||+|++ +|.+.+.. ..+..+++..+++++.|++.||..+|+ .. +.||||||.||+++.+|. +||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv-vKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV-VKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc-eeeccchhHhH
Confidence 999975 66655542 334578999999999999999999998 44 889999999999999887 99999999988
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
+.....- .+ .-+|||.|||||.+.. ..|+.+|||||+||++|||+.-++|
T Consensus 178 l~s~~tf-A~----------------------------S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~P 227 (375)
T KOG0591|consen 178 LSSKTTF-AH----------------------------SLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSP 227 (375)
T ss_pred hcchhHH-HH----------------------------hhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCC
Confidence 7644331 11 1377999999999998 6799999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccc-cCCChHHHHHHHhhcccCCCCCCCH
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVV-RNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
|.+.+-.+...++.+.... +.+ ..+|..+..+|.-|+..||+.||+.
T Consensus 228 F~g~n~~~L~~KI~qgd~~----------------------------~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 228 FYGDNLLSLCKKIEQGDYP----------------------------PLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred cccccHHHHHHHHHcCCCC----------------------------CCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 9999665655666553211 112 4588999999999999999999985
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=330.40 Aligned_cols=256 Identities=28% Similarity=0.438 Sum_probs=213.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 589999999999999999999998999999999865432 2233466788999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~-~kl~Dfg~~~~~~~~~~- 156 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTW- 156 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC-EEEEecCcchhccCCcc-
Confidence 99975 7777776543 4688888999999999999999999999999999999998887 99999999865432110
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
...|++.|+|||.+.+ ..++.++|||||||++|+|++|..||......
T Consensus 157 -------------------------------~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~ 204 (291)
T cd05612 157 -------------------------------TLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPF 204 (291)
T ss_pred -------------------------------cccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1245888999999877 55789999999999999999999999887766
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----HhhhhcCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALEHE 314 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~h~ 314 (323)
+....+.... ......+++.++++|.+||+.||.+|++ +.++++||
T Consensus 205 ~~~~~i~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 205 GIYEKILAGK-----------------------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred HHHHHHHhCC-----------------------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 6555544310 0112346788999999999999999995 99999999
Q ss_pred CCcccccc
Q 036739 315 YFRDVEFV 322 (323)
Q Consensus 315 ~~~~~~~~ 322 (323)
||+.++|.
T Consensus 256 ~~~~~~~~ 263 (291)
T cd05612 256 WFKSVDWD 263 (291)
T ss_pred cccCCCHH
Confidence 99988764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=289.09 Aligned_cols=288 Identities=59% Similarity=1.038 Sum_probs=262.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
|..|.-.++||+|.+|+||++++..+++.||+|.......++.......+|+-+++.++|.||+++++....++.+-+||
T Consensus 1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 46788889999999999999999999999999999988888888899999999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+|..++.+++.+..+ .++.+.++.++.|++.+|.+.|+.++.|+|+||+|.+++.+|. +|+.|||+++.++.+..-.
T Consensus 81 e~cdqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge-lkladfglarafgipvrcy 158 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE-LKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHhhHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc-EEecccchhhhcCCceEee
Confidence 9999999999999877 4788999999999999999999999999999999999999998 9999999999998777655
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
..+ +.|+.|.+|.++.+..-|+...|+||-|||+.|+.. |++.|.+.+..
T Consensus 159 sae-----------------------------vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd 209 (292)
T KOG0662|consen 159 SAE-----------------------------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_pred ece-----------------------------eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence 432 569999999999998889999999999999999997 88999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+.+.+++..++.+.++.|+....+++....---.......++.+.++..-+++++++|.-+|.+|.+++..++||||.+.
T Consensus 210 dqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 210 DQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred HHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 99999999999999999999999888765443344445566777788888999999999999999999999999999874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=339.41 Aligned_cols=282 Identities=34% Similarity=0.549 Sum_probs=230.0
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-C-----CCeeeeeEEEecCceE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-H-----GNIVRLQDVVHSEKKL 76 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~~~~~~~ 76 (323)
+|++++.||+|.||+|-+|.+..+++.||||+++... ....+...|+.+|..++ | -|+|+++++|...+.+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 6899999999999999999999999999999986443 33456667899999986 3 4799999999999999
Q ss_pred EEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC-CceEEeccccceecCC
Q 036739 77 YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~-~~~kl~df~~~~~~~~ 155 (323)
|||+|.++-+|.+.+..+.-..++...++.++.||+.||.+||+.||+|+||||+|||+...+ ..+||+|||+++....
T Consensus 264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 999999999999999988877899999999999999999999999999999999999995433 3699999999988654
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
..-.. +.+.-|.|||++.+ .+|+.+.||||||||+.||++|.+.|.+
T Consensus 344 ~vytY--------------------------------iQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 344 RVYTY--------------------------------IQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cceee--------------------------------eeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCC
Confidence 43322 22777999999999 7799999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccC-C-------------------------------CC-CCCcccccc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAF-P-------------------------------KW-PSKELGTVV 282 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-------------------------------~~-~~~~~~~~~ 282 (323)
.+..+.+..++..++.+....++...+...+.... . .. .........
T Consensus 391 ~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~ 470 (586)
T KOG0667|consen 391 DNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGL 470 (586)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhc
Confidence 99999999999999987665444444332222220 0 00 000011111
Q ss_pred c-CCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 283 R-NLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 283 ~-~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
. .-...+.++|.+||..||.+|+++.++|+||||.+..
T Consensus 471 ~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 471 PKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred ccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence 1 1223579999999999999999999999999999653
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=333.62 Aligned_cols=282 Identities=36% Similarity=0.604 Sum_probs=215.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------c
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------K 74 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 74 (323)
+++|++.+.||+|+||.||++.+..++..||+|.+............+.+|+.+++.++||||+++++++... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 4789999999999999999999999999999999866544444456778899999999999999999998644 3
Q ss_pred eEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 75 KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 75 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
..|+||||+++++.+.+.. .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++....
T Consensus 100 ~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~-~kl~Dfg~a~~~~ 174 (359)
T cd07876 100 DVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAC 174 (359)
T ss_pred eeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-EEEecCCCccccc
Confidence 5799999999988877643 3677888899999999999999999999999999999999887 9999999986432
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
..... ....||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.
T Consensus 175 ~~~~~------------------------------~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 175 TNFMM------------------------------TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred cCccC------------------------------CCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 11110 01245888999999987 568899999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcc-----------cC--CcccccCCCCCCCcccccccCCChHHHHHHHhhcccCC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVT-----------SL--PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp 301 (323)
..+..+.........+.+....+.... .. ..+...+..|............++.+++||.+||+.||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 303 (359)
T cd07876 224 GTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDP 303 (359)
T ss_pred CCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCc
Confidence 887666555554443332211100000 00 00011111121111222233457889999999999999
Q ss_pred CCCCCHhhhhcCCCCcc
Q 036739 302 SRRITARSALEHEYFRD 318 (323)
Q Consensus 302 ~~R~s~~~il~h~~~~~ 318 (323)
++||++.++++||||..
T Consensus 304 ~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 304 DKRISVDEALRHPYITV 320 (359)
T ss_pred ccCCCHHHHhcCchhhh
Confidence 99999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=333.27 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=213.2
Q ss_pred CCCcceeeeeccccceeEEEEEEccCC-ceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTN-ETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
+++|++.+.||+|++|.||+|.+..++ ..||+|.+..... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 368999999999999999999876554 6899999865432 23345677889999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| +|.+.+.... .+++..++.++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.......
T Consensus 109 v~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~-ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVVDTRT 185 (340)
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC-EEEecCCCCeecCCCc
Confidence 9999965 7777776543 4688889999999999999999999999999999999998887 9999999987653211
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
. ...||+.|+|||++.+ ..++.++|+||+||++|+|++|..||....
T Consensus 186 ~--------------------------------~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 186 Y--------------------------------TLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred c--------------------------------eecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 0 1245889999999987 567899999999999999999999998877
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALE 312 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~ 312 (323)
.......+..... .....+++.+.++|.+||+.||++|+ ++.++++
T Consensus 233 ~~~~~~~i~~~~~-----------------------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 233 PLLIYQKILEGII-----------------------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HHHHHHHHhcCCC-----------------------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 6655555432110 11134678899999999999999996 8999999
Q ss_pred CCCCcccccc
Q 036739 313 HEYFRDVEFV 322 (323)
Q Consensus 313 h~~~~~~~~~ 322 (323)
||||++++|.
T Consensus 284 hp~f~~~~~~ 293 (340)
T PTZ00426 284 HPWFGNIDWV 293 (340)
T ss_pred CCCcCCCCHH
Confidence 9999998764
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=335.31 Aligned_cols=290 Identities=27% Similarity=0.384 Sum_probs=220.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|+||+|++..+++.||+|++..... .......+..|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 589999999999999999999998999999999876532 2244567888999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~-~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC-EEeecCCCCccCcccCcc
Confidence 99965 777777665 35788889999999999999999999999999999999999888 999999998776543311
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
..................................||+.|+|||.+.+ ..++.++|||||||++|+|++|..||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11000000000000000000000001111223467999999999988 57899999999999999999999999988766
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-HhhhhcCCCCcc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-ARSALEHEYFRD 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-~~~il~h~~~~~ 318 (323)
.....+........ .+....+++.+.++|.+||. ||.+|++ +.++++||||++
T Consensus 237 ~~~~~i~~~~~~~~-------------------------~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 237 ETYNKIINWKESLR-------------------------FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHhccCCccc-------------------------CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 55555443110000 00112268999999999997 9999999 999999999998
Q ss_pred ccc
Q 036739 319 VEF 321 (323)
Q Consensus 319 ~~~ 321 (323)
++|
T Consensus 291 ~~~ 293 (350)
T cd05573 291 IDW 293 (350)
T ss_pred CCH
Confidence 765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=321.43 Aligned_cols=283 Identities=77% Similarity=1.278 Sum_probs=238.8
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
|++.+.||.|++|.||++.+..+|..|++|++............+.+|+.+++.++|+|++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 78899999999999999999889999999998766544445567888999999999999999999999999999999999
Q ss_pred hhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccc
Q 036739 84 DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163 (323)
Q Consensus 84 ~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~ 163 (323)
++++.+.+.......+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~-~~l~df~~~~~~~~~~~~~~-- 157 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA-LKLADFGLARAFGVPVRTYT-- 157 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc-EEEeecccccccCCCccccC--
Confidence 889888887766556789999999999999999999999999999999999999777 99999999876543221110
Q ss_pred ccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 036739 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243 (323)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~ 243 (323)
...+++.|+|||.+.+...++.++|+||||+++|+|++|..||..........
T Consensus 158 ---------------------------~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 210 (283)
T cd07835 158 ---------------------------HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210 (283)
T ss_pred ---------------------------ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 01336779999988775567899999999999999999999999888877777
Q ss_pred HHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
++.+....+....++.....+.+...+..+...........+++.+.++|.+||+.||++||++.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 211 RIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 7777777776666666666666666666665555555667788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=324.16 Aligned_cols=264 Identities=28% Similarity=0.439 Sum_probs=214.9
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC------------CCCchhHHHHHHHHHhcCCCCeeeeeE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED------------EGVPSTAIREISLLKEMQHGNIVRLQD 68 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 68 (323)
+|+|++.+.||+|.+|.|-+|++..+++.||||++.+.... ....+...+|+.++++++|||||+++.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 58999999999999999999999999999999999765321 112358889999999999999999999
Q ss_pred EEec--CceEEEEEecchhhHHHhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEe
Q 036739 69 VVHS--EKKLYLVFEYLDLDLKKHMDSCPDFA-NDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLA 145 (323)
Q Consensus 69 ~~~~--~~~~~lv~e~~~g~l~~~~~~~~~~~-~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~ 145 (323)
+..+ ...+|+|+|||+.+-..+.-. ... +++.+++.++.+++.||+|||.+||+||||||+|+|++.++. +||+
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~-VKIs 252 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT-VKIS 252 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc-EEee
Confidence 9865 568999999998544333222 223 788999999999999999999999999999999999999987 9999
Q ss_pred ccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC---CCCCCCchhhHHHHHH
Q 036739 146 DFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG---SRHYSTPVDVWSVGCI 222 (323)
Q Consensus 146 df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~l 222 (323)
|||.+.............. .. .-+|||.|+|||.+.. ....+.+.||||+|++
T Consensus 253 DFGVs~~~~~~~~~~~d~~-----------------------L~-~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVT 308 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQ-----------------------LS-RTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVT 308 (576)
T ss_pred ccceeeecccCCccccHHH-----------------------Hh-hcCCCccccchHhhcCCCCccccchhhhhhhhhhh
Confidence 9999987644311111000 00 1377999999999987 3456778999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCC
Q 036739 223 FAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 223 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~ 302 (323)
||-|+.|+.||.+....+...+|...- -.++ ..+.+.+.+++||.+||.+||+
T Consensus 309 LYCllfG~~PF~~~~~~~l~~KIvn~p-----L~fP----------------------~~pe~~e~~kDli~~lL~KdP~ 361 (576)
T KOG0585|consen 309 LYCLLFGQLPFFDDFELELFDKIVNDP-----LEFP----------------------ENPEINEDLKDLIKRLLEKDPE 361 (576)
T ss_pred HHHhhhccCCcccchHHHHHHHHhcCc-----ccCC----------------------CcccccHHHHHHHHHHhhcChh
Confidence 999999999999999888888876521 1110 1123678899999999999999
Q ss_pred CCCCHhhhhcCCCCcc
Q 036739 303 RRITARSALEHEYFRD 318 (323)
Q Consensus 303 ~R~s~~~il~h~~~~~ 318 (323)
+|.++.+|..|||...
T Consensus 362 ~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 362 QRITLPDIKLHPWVTR 377 (576)
T ss_pred heeehhhheecceecc
Confidence 9999999999999864
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=321.89 Aligned_cols=289 Identities=46% Similarity=0.876 Sum_probs=228.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC--ceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 78 (323)
+++|++.+.||+|++|.||++.+..+++.||+|.+............+.+|+.++++++|+|++++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4789999999999999999999999999999999876544444444566899999999999999999998754 57899
Q ss_pred EEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 79 VFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|+||+++++.+.+.... ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 86 v~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 86 VMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC-LKIADFGLARTYGLPAK 163 (309)
T ss_pred EEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEECccceeeecCCccC
Confidence 99999998888776543 35788889999999999999999999999999999999998887 99999999887653321
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.... ..+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||...+.
T Consensus 164 ~~~~-----------------------------~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 164 PMTP-----------------------------KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred CCCc-----------------------------ccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1100 12367799999988766789999999999999999999999999888
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccc-cCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
.+....+.+..+.+....++.....+.... ................+++.+.++|.+||+.||++||++.+++.||||+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 215 IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred HHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 888888777766665554443322221100 0111111111122234688999999999999999999999999999998
Q ss_pred ccc
Q 036739 318 DVE 320 (323)
Q Consensus 318 ~~~ 320 (323)
+..
T Consensus 295 ~~~ 297 (309)
T cd07845 295 EKP 297 (309)
T ss_pred cCC
Confidence 653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=311.48 Aligned_cols=260 Identities=30% Similarity=0.482 Sum_probs=223.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC--C----CchhHHHHHHHHHhcC-CCCeeeeeEEEecCc
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE--G----VPSTAIREISLLKEMQ-HGNIVRLQDVVHSEK 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 74 (323)
+.|.-.+.||.|..++|-++..+.++..+|+|++....... + ..+.-.+|+.+++++. ||+|+++.+.|+...
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 45777889999999999999999999999999987654221 1 1233446999999994 999999999999999
Q ss_pred eEEEEEecc-hhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 75 KLYLVFEYL-DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 75 ~~~lv~e~~-~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
.+++|||.+ .|.|++++.+.- +++++..++|++|++.+++|||.++|||+||||+|||++++.+ ++|+|||+++.+
T Consensus 97 F~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~-i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN-IKISDFGFACQL 173 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc-eEEeccceeecc
Confidence 999999999 489999998854 6799999999999999999999999999999999999999888 999999999988
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-----CCCCCchhhHHHHHHHHHHHh
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-----RHYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~Di~slG~ll~~l~t 228 (323)
.+...... .+|||+|.|||.+..+ +-|+...|+|++|+|+|.|+.
T Consensus 174 ~~GekLre------------------------------lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLa 223 (411)
T KOG0599|consen 174 EPGEKLRE------------------------------LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLA 223 (411)
T ss_pred CCchhHHH------------------------------hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHc
Confidence 76554433 4789999999998643 458889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|.+||-..+..-.+..+.++......+.| ..+|..+++||.+||+.||++|.|++
T Consensus 224 GcpPFwHRkQmlMLR~ImeGkyqF~speW-------------------------adis~~~KdLIsrlLqVdp~~Ritak 278 (411)
T KOG0599|consen 224 GCPPFWHRKQMLMLRMIMEGKYQFRSPEW-------------------------ADISATVKDLISRLLQVDPTKRITAK 278 (411)
T ss_pred CCCchhHHHHHHHHHHHHhcccccCCcch-------------------------hhccccHHHHHHHHHeeCchhcccHH
Confidence 99999888877777777776555554444 45788999999999999999999999
Q ss_pred hhhcCCCCccc
Q 036739 309 SALEHEYFRDV 319 (323)
Q Consensus 309 ~il~h~~~~~~ 319 (323)
++|+||||+.+
T Consensus 279 e~LaHpff~q~ 289 (411)
T KOG0599|consen 279 EALAHPFFIQI 289 (411)
T ss_pred HHhcChHHHHH
Confidence 99999999654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=329.30 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=206.0
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL- 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g- 85 (323)
+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999875432 222345677899999999999999999999999999999999976
Q ss_pred hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccccc
Q 036739 86 DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHW 165 (323)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 165 (323)
+|.+.+.... .+++..+..++.||+.||+|||+.||+|+||||+||+++.++. +||+|||++.........
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~-~kl~DfG~a~~~~~~~~~------ 151 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGAT------ 151 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC-EEEeeCCCCcccccCCCc------
Confidence 6766666543 5688889999999999999999999999999999999998887 999999987643211100
Q ss_pred CCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 036739 166 GSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKI 245 (323)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~ 245 (323)
.....||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+
T Consensus 152 -----------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~ 207 (323)
T cd05571 152 -----------------------MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207 (323)
T ss_pred -----------------------ccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence 011256899999999987 56899999999999999999999999877665544433
Q ss_pred HHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcCCCCcccc
Q 036739 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEHEYFRDVE 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h~~~~~~~ 320 (323)
... . ......+++.+.++|.+||+.||++|| ++.++++||||.+++
T Consensus 208 ~~~--~---------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 208 LME--E---------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred HcC--C---------------------------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 221 0 011234788999999999999999999 899999999999875
Q ss_pred c
Q 036739 321 F 321 (323)
Q Consensus 321 ~ 321 (323)
|
T Consensus 259 ~ 259 (323)
T cd05571 259 W 259 (323)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=335.87 Aligned_cols=287 Identities=37% Similarity=0.593 Sum_probs=221.2
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc-----eEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-----KLY 77 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 77 (323)
+|++.+.||+|++|.||++.+..+++.||+|.+............+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 588999999999999999999889999999988544333333457788999999999999999999998765 789
Q ss_pred EEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 78 LVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 78 lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
+|+||+.+++.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~-~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccccCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC-EEeccccceeecccCc
Confidence 999999999888876543 5788889999999999999999999999999999999998887 9999999987653322
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
..... ...+++.|+|||.+.+...++.++|+||+||++|+|++|+.||.+..
T Consensus 158 ~~~~~----------------------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 158 SKHMT----------------------------QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred cccCC----------------------------CCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 11110 12447889999999886678999999999999999999999999888
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCC-cccccCCCCCC--CcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLP-DFKSAFPKWPS--KELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
..+....+.+..+.+....+....... ........... ..........++.+.+||.+||+.||++||++.++++||
T Consensus 210 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 210 PIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 877777776665544332211100000 00000000000 000112234688899999999999999999999999999
Q ss_pred CCcccc
Q 036739 315 YFRDVE 320 (323)
Q Consensus 315 ~~~~~~ 320 (323)
||.+..
T Consensus 290 ~~~~~~ 295 (372)
T cd07853 290 YLDEGR 295 (372)
T ss_pred hhCCCc
Confidence 999853
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=331.77 Aligned_cols=290 Identities=27% Similarity=0.381 Sum_probs=217.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||+||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.++..+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 589999999999999999999999999999999975432 2333456778999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.... .+++..++.++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||++..+......
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC-EEEeecccceeccccccc
Confidence 99965 7777766543 4788899999999999999999999999999999999999887 999999998765432211
Q ss_pred ccccccCCcCcc-----eeehh----hhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 160 FTHEHWGSTGIS-----IYFSF----LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 160 ~~~~~~~~~~~~-----~~~~~----~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
............ ...+. ....+...........+||+.|+|||++.. ..++.++|+|||||++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCC
Confidence 100000000000 00000 000000000011223578999999999877 56899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC---H
Q 036739 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT---A 307 (323)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s---~ 307 (323)
.||......+....+....... ..+....+++.+.++|.+|+. +|.+|++ +
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETL-------------------------QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCcc-------------------------CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 9999887665554443210000 000012478899999999996 9999998 9
Q ss_pred hhhhcCCCCccccc
Q 036739 308 RSALEHEYFRDVEF 321 (323)
Q Consensus 308 ~~il~h~~~~~~~~ 321 (323)
.++++||||++++|
T Consensus 291 ~~ll~h~~~~~~~~ 304 (364)
T cd05599 291 NEIKSHPFFKGVDW 304 (364)
T ss_pred HHHhcCCCcCCCCH
Confidence 99999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=327.02 Aligned_cols=263 Identities=25% Similarity=0.425 Sum_probs=214.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 589999999999999999999998999999999875532 2233456778999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.... .+++..++.++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kL~Dfg~a~~~~~~~-- 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIVTYA-- 155 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC-EEEEeCcCCccccccc--
Confidence 99976 7777665433 4688889999999999999999999999999999999998887 9999999987543200
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
....|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||......
T Consensus 156 ------------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 204 (333)
T cd05600 156 ------------------------------NSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN 204 (333)
T ss_pred ------------------------------CCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHH
Confidence 11255889999999987 47899999999999999999999999887766
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+....+.........+. .......+++.+.++|.+||..+|.+||++.++++||||.++
T Consensus 205 ~~~~~i~~~~~~~~~~~---------------------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 205 ETWENLKYWKETLQRPV---------------------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHhccccccCCC---------------------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 65554433211110000 000013478899999999999999999999999999999987
Q ss_pred cc
Q 036739 320 EF 321 (323)
Q Consensus 320 ~~ 321 (323)
++
T Consensus 264 ~~ 265 (333)
T cd05600 264 DW 265 (333)
T ss_pred CH
Confidence 54
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=317.91 Aligned_cols=286 Identities=61% Similarity=1.076 Sum_probs=226.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCce-----
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKK----- 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~----- 75 (323)
++|++.+.||+|++|.||++++..+++.||+|.+............+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5899999999999999999999999999999988665444445567888999999995 6999999999876555
Q ss_pred EEEEEecchhhHHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 76 LYLVFEYLDLDLKKHMDSCP---DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
.|++|||+++++.+.+.... ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++..++|+|||.+..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 89999999999888876543 235788999999999999999999999999999999999998444599999999876
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
......... ...+++.|+|||.+.+...++.++|+||||+++|+|++|..|
T Consensus 161 ~~~~~~~~~-----------------------------~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 161 FSIPVKSYT-----------------------------HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred cCCCccccC-----------------------------CcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 533221110 113377799999987756689999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
|.+....+...++.+....+....++......... ....+...........+++.+.++|.+||+.||.+||++.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWH-EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchh-hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 99888877777777766655554443333322211 12222222233334568899999999999999999999999999
Q ss_pred CCCCc
Q 036739 313 HEYFR 317 (323)
Q Consensus 313 h~~~~ 317 (323)
||||+
T Consensus 291 ~~~~~ 295 (295)
T cd07837 291 HPYFD 295 (295)
T ss_pred CCCcC
Confidence 99995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=317.51 Aligned_cols=285 Identities=45% Similarity=0.821 Sum_probs=228.4
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||+|++|.||+|.+..++..|++|.+............+.+|+.++++++|||++++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 69999999999999999999988999999999876654444557888999999999999999999999999999999999
Q ss_pred chhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 83 LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 83 ~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
+++++.+.+.... ..+++..++.++.||+.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus 81 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~-~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 81 MPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc-EEEeeeeecccccCCCCCccc
Confidence 9668888776543 45788999999999999999999999999999999999998877 999999998776433211000
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~ 242 (323)
...++..|+|||.+.+...++.++|+||+|+++|+|++|.++|.+.......
T Consensus 159 ----------------------------~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~ 210 (286)
T cd07832 159 ----------------------------HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL 210 (286)
T ss_pred ----------------------------cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH
Confidence 1144788999999877666799999999999999999999999888877777
Q ss_pred HHHHHHhCCCCCCCCCCcccCCcccc-cCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 243 FKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
..+....+.+....++.......+.. .+...............++.+.++|++||+.+|++||+++++++||||.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 211 AIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 77777666665554444333322211 0111111111223345678999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=330.47 Aligned_cols=282 Identities=35% Similarity=0.604 Sum_probs=217.2
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------c
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------K 74 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 74 (323)
+++|++.+.||+|++|.||++.+..+++.||+|++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4789999999999999999999999999999999865544444456778899999999999999999988543 3
Q ss_pred eEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 75 KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 75 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
..|+||||+++++.+.+.. .++...+..++.|++.||.|||++|++|+||||+||+++.++. +||+|||++...+
T Consensus 103 ~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~DfG~a~~~~ 177 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAG 177 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc-EEEEeCCCccccC
Confidence 5799999999988887754 3677888899999999999999999999999999999998887 9999999987543
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
...... ...||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.
T Consensus 178 ~~~~~~------------------------------~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 178 TSFMMT------------------------------PYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred CCCccc------------------------------CCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 221110 1245888999999987 568999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccC-----------Cc--ccccCCCCCCCcccccccCCChHHHHHHHhhcccCC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSL-----------PD--FKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~--~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp 301 (323)
+.+..+....+....+.+....+...... .. +...+...............++.+++||.+||+.||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 306 (364)
T cd07875 227 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306 (364)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCc
Confidence 88877777666655444332211111000 00 000001111111111223356788999999999999
Q ss_pred CCCCCHhhhhcCCCCcc
Q 036739 302 SRRITARSALEHEYFRD 318 (323)
Q Consensus 302 ~~R~s~~~il~h~~~~~ 318 (323)
++|||+.++|+||||+.
T Consensus 307 ~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 307 SKRISVDEALQHPYINV 323 (364)
T ss_pred ccCCCHHHHhcCccccc
Confidence 99999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=329.67 Aligned_cols=290 Identities=22% Similarity=0.327 Sum_probs=214.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|+||+|.+..+++.||+|++..... .......+..|..+++.++|+||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 689999999999999999999999999999999865432 2333456778999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++.........
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~-vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC-EEEeeccCcccccccccc
Confidence 99976 7777776543 5788899999999999999999999999999999999998887 999999998765432111
Q ss_pred ccccccCCc-Ccceeehhhhh-----hhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 160 FTHEHWGST-GISIYFSFLRY-----RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 160 ~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
......... ........... .+...........+||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 000000000 00000000000 000000011223578999999999987 56889999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCC---CCCCHhhh
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS---RRITARSA 310 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~---~R~s~~~i 310 (323)
.+....+...++........ + +....+++.+.++|.+|+. +|. .||++.++
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~---~----------------------p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei 290 (363)
T cd05628 237 CSETPQETYKKVMNWKETLI---F----------------------PPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEI 290 (363)
T ss_pred CCCCHHHHHHHHHcCcCccc---C----------------------CCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence 88777666655543110000 0 0012378899999999875 444 46899999
Q ss_pred hcCCCCccccc
Q 036739 311 LEHEYFRDVEF 321 (323)
Q Consensus 311 l~h~~~~~~~~ 321 (323)
++||||++++|
T Consensus 291 ~~hp~f~~~~~ 301 (363)
T cd05628 291 KTNPFFEGVDW 301 (363)
T ss_pred hCCCCCCCCCH
Confidence 99999999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=324.18 Aligned_cols=259 Identities=33% Similarity=0.521 Sum_probs=224.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC-CCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 79 (323)
+.|++.+.||.|.||.||+++.+.+|+.+|+|++.+..... .....+.+|+.+|+++. ||||+.+++.|++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 46999999999999999999999999999999997775432 34578999999999998 99999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC---ceEEeccccceecCC
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGLARAFGI 155 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~---~~kl~df~~~~~~~~ 155 (323)
||++.| .|++.+... .+++..+..++.|++.++.|||+.|++|+||||+|+++..... .+|++|||++.....
T Consensus 115 mEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999975 999999887 2799999999999999999999999999999999999965432 599999999988764
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
... ....+||+.|+|||++.. ..++...|+||+|+++|.|+.|.+||.+
T Consensus 192 ~~~------------------------------~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~ 240 (382)
T KOG0032|consen 192 GER------------------------------LHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWG 240 (382)
T ss_pred Cce------------------------------EeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcC
Confidence 211 122478999999999987 6799999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
.........+......... ..+..++..+.++|..||..||.+|+++.++|+|||
T Consensus 241 ~~~~~~~~~i~~~~~~f~~-------------------------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 241 ETEFEIFLAILRGDFDFTS-------------------------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CChhHHHHHHHcCCCCCCC-------------------------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 9888777766654332222 334568999999999999999999999999999999
Q ss_pred Cccc
Q 036739 316 FRDV 319 (323)
Q Consensus 316 ~~~~ 319 (323)
+++.
T Consensus 296 i~~~ 299 (382)
T KOG0032|consen 296 IKSI 299 (382)
T ss_pred ccCC
Confidence 9975
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=329.44 Aligned_cols=282 Identities=37% Similarity=0.622 Sum_probs=214.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------c
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------K 74 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 74 (323)
+++|++.+.||+|+||.||++.+...++.+|+|.+............+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 4789999999999999999999988999999999865544444456777899999999999999999998643 3
Q ss_pred eEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 75 KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 75 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
..++||||+++++.+.+.. .+++..+..++.|++.||.|||+.|++|+||||+||+++.++. +||+|||.+....
T Consensus 96 ~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~-~kl~Dfg~~~~~~ 170 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAG 170 (355)
T ss_pred eeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC-EEEeeCcccccCC
Confidence 5799999999988887754 3678888899999999999999999999999999999998887 9999999987543
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
..... ....||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.
T Consensus 171 ~~~~~------------------------------~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 171 TSFMM------------------------------TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred Ccccc------------------------------CCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 22110 01245888999999987 568999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCccc--------CCc-----ccccCCCCCCCcccccccCCChHHHHHHHhhcccCC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTS--------LPD-----FKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~-----~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp 301 (323)
+....+.........+.+..+.+..... .+. +...+...............+..+++||.+||+.||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 299 (355)
T cd07874 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299 (355)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCc
Confidence 8876666655555443322211100000 000 000000000000111223356788999999999999
Q ss_pred CCCCCHhhhhcCCCCcc
Q 036739 302 SRRITARSALEHEYFRD 318 (323)
Q Consensus 302 ~~R~s~~~il~h~~~~~ 318 (323)
++|||+.++++||||+.
T Consensus 300 ~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 300 AKRISVDEALQHPYINV 316 (355)
T ss_pred hhcCCHHHHhcCcchhc
Confidence 99999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=318.98 Aligned_cols=285 Identities=51% Similarity=0.933 Sum_probs=226.1
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC--ceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 78 (323)
+++|++.+.||.|++|.||+|.+..++..+++|.+............+.+|+.++++++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4689999999999999999999988999999999976654444445667899999999999999999998876 89999
Q ss_pred EEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 79 VFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|+||+.+++.+.+..... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 84 v~e~~~~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~-~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLK 161 (293)
T ss_pred EehhcCcCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc-EEEeecCceeeccCCcc
Confidence 999999888887765443 5788999999999999999999999999999999999999887 99999999877654321
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
... ...+++.|+|||.+.+....+.++|+||+|+++|+|++|..||.....
T Consensus 162 ~~~-----------------------------~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~ 212 (293)
T cd07843 162 PYT-----------------------------QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212 (293)
T ss_pred ccc-----------------------------cccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 110 013477899999988766678999999999999999999999998888
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccc-cCCCCCCCcccccccC--CChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRN--LEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
.+...++....+.+....|+.....+.... ..............+. +++.+.++|++||+.+|++||++.+++.|||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~ 292 (293)
T cd07843 213 IDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292 (293)
T ss_pred HHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence 777777777666655544443332222111 1111111111111222 5888999999999999999999999999999
Q ss_pred C
Q 036739 316 F 316 (323)
Q Consensus 316 ~ 316 (323)
|
T Consensus 293 f 293 (293)
T cd07843 293 F 293 (293)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=329.09 Aligned_cols=264 Identities=26% Similarity=0.381 Sum_probs=214.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|.||++.+..+++.||+|++..... .......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 589999999999999999999999999999999976543 2334466788999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+... ...+++..+..++.||+.||+|||+.|++|+||||+||+++.++. +||+|||++..+......
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~-~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC-EEeccCCCCeECCCCCce
Confidence 99965 777666554 235788899999999999999999999999999999999998887 999999998765432221
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC-----CCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG-----SRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
.. ....||+.|+|||++.. ...++.++|||||||++|+|++|..||.
T Consensus 159 ~~----------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 159 NS----------------------------KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred ee----------------------------ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 10 11245889999999863 3557889999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
..........+....... .+ +....+++.+.+||++||+ +|++||++.++++||
T Consensus 211 ~~~~~~~~~~i~~~~~~~---~~----------------------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 211 EGTSAKTYNNIMNFQRFL---KF----------------------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred CCCHHHHHHHHHcCCCcc---CC----------------------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 877666555544321000 00 0112478899999999998 999999999999999
Q ss_pred CCccccc
Q 036739 315 YFRDVEF 321 (323)
Q Consensus 315 ~~~~~~~ 321 (323)
||..+++
T Consensus 265 ~~~~~~~ 271 (330)
T cd05601 265 FFSKIDW 271 (330)
T ss_pred CcCCCCH
Confidence 9998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=315.53 Aligned_cols=283 Identities=61% Similarity=1.105 Sum_probs=230.0
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||.|++|.||++++..++..|++|.+..... ......+.+|+.+++.++|+|++++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 68999999999999999999988999999999865533 22346677899999999999999999999999999999999
Q ss_pred chhhHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDLDLKKHMDSCP-DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g~l~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+.+++.+.+.... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~-~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc-EEEeecchhhhhcCCccccc
Confidence 9999888876543 245788999999999999999999999999999999999998887 99999999875543221110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
...+++.|++||.+.+...++.++|+||||+++|+|++|..||......+.
T Consensus 159 -----------------------------~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~ 209 (284)
T cd07836 159 -----------------------------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ 209 (284)
T ss_pred -----------------------------cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 113477899999987766678999999999999999999999998888777
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
..++.+....+....+......+.+..................+++.+.++|.+||+.||++||++.++++||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 210 LLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 777777666666555544444444333333332222333445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=329.37 Aligned_cols=282 Identities=37% Similarity=0.691 Sum_probs=218.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 75 (323)
++|++++.||+|+||+||++.+..++..||+|.+............+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 689999999999999999999999999999999865433333345677899999999999999999988543 45
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
.+++++++++++.+.+... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.....
T Consensus 95 ~~~~~~~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~-~kl~Dfg~~~~~~~ 170 (343)
T cd07878 95 VYLVTNLMGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQADD 170 (343)
T ss_pred EEEEeecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC-EEEcCCccceecCC
Confidence 7999999988887766532 4788899999999999999999999999999999999998887 99999999876532
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.... ..|++.|+|||.+.+...++.++|||||||++|+|++|..||..
T Consensus 171 ~~~~--------------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 171 EMTG--------------------------------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CcCC--------------------------------ccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 1110 14588899999998766789999999999999999999999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCccc--CCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
....+.+..+....+.+.......... ...+...................++.+.+||.+||+.||.+|||+.++++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 877766666655544433221111100 000111111222222223344567889999999999999999999999999
Q ss_pred CCCccc
Q 036739 314 EYFRDV 319 (323)
Q Consensus 314 ~~~~~~ 319 (323)
|||...
T Consensus 299 p~~~~~ 304 (343)
T cd07878 299 PYFSQY 304 (343)
T ss_pred cchhcc
Confidence 999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=328.81 Aligned_cols=263 Identities=25% Similarity=0.360 Sum_probs=212.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|.||++.+..++..||+|.+..... .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 579999999999999999999999999999999865432 2233456778999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+... .+++..+..++.||+.||+|||+.||+|+||||+||+++.++. +||+|||.+.........
T Consensus 123 Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~-~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 123 EYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMDANGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC-EEEEeccceeeccCCCcc
Confidence 99975 666665443 4678888899999999999999999999999999999999887 999999998765322111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC---CCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS---RHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
. .....||+.|+|||++... ..++.++|+|||||++|+|++|..||...
T Consensus 199 ~----------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 199 R----------------------------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred c----------------------------CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 0 0112568999999998753 24788999999999999999999999988
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC--CCCHhhhhcCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR--RITARSALEHE 314 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~--R~s~~~il~h~ 314 (323)
........+....... .+ +....+|+.+.++|.+||+.+|.+ |+++.++++||
T Consensus 251 ~~~~~~~~i~~~~~~~---~~----------------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 251 SLVGTYSKIMDHKNSL---TF----------------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CHHHHHHHHHcCCCcC---CC----------------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 7665555544311100 00 011247899999999999999988 99999999999
Q ss_pred CCccccc
Q 036739 315 YFRDVEF 321 (323)
Q Consensus 315 ~~~~~~~ 321 (323)
||++..|
T Consensus 306 ~~~~~~~ 312 (370)
T cd05596 306 FFKNDQW 312 (370)
T ss_pred ccCCCCh
Confidence 9998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=314.18 Aligned_cols=284 Identities=56% Similarity=1.002 Sum_probs=219.8
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++.+.||+|++|.||++.++.+++.|++|.+...... .....+.+|+.+++.++|+||+++++++.++...++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 57899999999999999999999889999999998654322 22345678999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||+.+++.+.+..... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 83 e~~~~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 83 EYLDTDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE-LKLADFGLARAKSVPSKTY 160 (291)
T ss_pred ecCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC-EEECccccccccCCCCccc
Confidence 9999988888765543 5788889999999999999999999999999999999998887 9999999986543221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-hH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS-EI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~-~~ 239 (323)
. ...++..|+|||.+.+...++.++|+||+|+++|+|++|..||.... ..
T Consensus 161 ~-----------------------------~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~ 211 (291)
T cd07844 161 S-----------------------------NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211 (291)
T ss_pred c-----------------------------ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence 0 01236779999998775668899999999999999999999997765 44
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccC-CCCCCCcccccccCCC--hHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAF-PKWPSKELGTVVRNLE--PAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s--~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
+....+.+..+.+....++............ ..............++ ..+.+++.+||+.+|++||++.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 212 DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred HHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 4455555555555444443333222211111 1111111122223344 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=326.99 Aligned_cols=258 Identities=32% Similarity=0.494 Sum_probs=231.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCce-EEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKK-LYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv 79 (323)
+++|.+++.+|.|+||.+++++.+..+..+++|.+..............+|+.++.+++||||+.+.++|..++. ++|+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 689999999999999999999999999999999998887777777788999999999999999999999998877 9999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|+||+| ++.+.+....+..++++.+..|+.|++.|+.|||++.|+|||||++||++++++. |+|+|||+++.++++..
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~-VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK-VKLGDFGLAKILNPEDS 161 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc-eeecchhhhhhcCCchh
Confidence 999976 7777777777788999999999999999999999999999999999999999998 79999999998875541
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
....+.||+.|++||.+.+ .+|+.|+|||||||++|||++-+++|...+.
T Consensus 162 -----------------------------~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 162 -----------------------------LASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred -----------------------------hhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccch
Confidence 1123578999999999999 7899999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
...+.++.+....+.+ ...+.+++.+|..||+.+|+.||++.++|.+|.+.
T Consensus 212 ~~Li~ki~~~~~~Plp----------------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 212 SELILKINRGLYSPLP----------------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHHhhccCCCCC----------------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 8888888876544333 34788999999999999999999999999998765
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=328.50 Aligned_cols=278 Identities=24% Similarity=0.302 Sum_probs=209.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++++.||+|++|.||++.+..+++.||+|... ...+.+|+.++++++||||++++++|......++|+|
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 57999999999999999999999999999999642 2346789999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
++.+++...+.... .+++..+..++.||+.||.|||+.||+|+||||+||+++.++. +||+|||++..........
T Consensus 164 ~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~-vkL~DFG~a~~~~~~~~~~- 239 (391)
T PHA03212 164 RYKTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD-VCLGDFGAACFPVDINANK- 239 (391)
T ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC-EEEEeCCcccccccccccc-
Confidence 99999988887654 4678889999999999999999999999999999999998887 9999999986432111000
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC----
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS---- 237 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~---- 237 (323)
.....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||....
T Consensus 240 ---------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~ 291 (391)
T PHA03212 240 ---------------------------YYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDG 291 (391)
T ss_pred ---------------------------cccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccc
Confidence 011256999999999977 568999999999999999999998765432
Q ss_pred ---hHHHHHHHHHHhCCCCCCCCCCcc--cCCccc-cc----CCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH
Q 036739 238 ---EIDELFKIFRVLGTPNEDTWPGVT--SLPDFK-SA----FPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 238 ---~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~----~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
....+..+....+..... ++... ...... .. ...............++..+.+||.+||+.||++|||+
T Consensus 292 ~~~~~~~l~~i~~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta 370 (391)
T PHA03212 292 DCDSDRQIKLIIRRSGTHPNE-FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA 370 (391)
T ss_pred cCchhHHHHHHHHHhcCChhh-cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH
Confidence 223344444444332211 11000 000000 00 00000000001112356789999999999999999999
Q ss_pred hhhhcCCCCcccc
Q 036739 308 RSALEHEYFRDVE 320 (323)
Q Consensus 308 ~~il~h~~~~~~~ 320 (323)
.++|+||||++++
T Consensus 371 ~elL~hp~f~~~~ 383 (391)
T PHA03212 371 EALLDFAAFQDIP 383 (391)
T ss_pred HHHhcChhhccCC
Confidence 9999999999874
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=315.53 Aligned_cols=286 Identities=51% Similarity=0.908 Sum_probs=226.7
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC---CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+|++.+.||+|++|.||++.+..++..|++|.+...... ......+.+|+.+++.++|+||+++++++.++...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999889999999998765433 22345567899999999999999999999999999999
Q ss_pred EecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 80 FEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|||+.|++.+.+.... ..+++..+..++.||++||.+||++|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~-~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 81 FEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV-LKLADFGLARSFGSPNRK 158 (298)
T ss_pred EcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC-EEEccceeeeeccCCCcc
Confidence 9999778888876544 35788889999999999999999999999999999999998887 999999998776433211
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.. ...+++.|.|||.+.+...++.++|+|||||++|+|++|.++|......
T Consensus 159 ~~-----------------------------~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~ 209 (298)
T cd07841 159 MT-----------------------------HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI 209 (298)
T ss_pred cc-----------------------------ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH
Confidence 10 0123677999999876667889999999999999999999889888777
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+...++......+....++.......... ................+..+.++|.+||+.||++||++.++++||||.+.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 210 DQLGKIFEALGTPTEENWPGVTSLPDYVE-FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred HHHHHHHHHcCCCchhhhhhccccccccc-ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 77766666655554444433333222111 11111122223445678899999999999999999999999999999986
Q ss_pred c
Q 036739 320 E 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 289 ~ 289 (298)
T cd07841 289 P 289 (298)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=322.81 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=205.6
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL- 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g- 85 (323)
+.||+|+||.||++.+..++..||+|++..... .......+.+|+.+++.++||||+++++++...+..|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999999999999999875532 223345667899999999999999999999999999999999976
Q ss_pred hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccccc
Q 036739 86 DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHW 165 (323)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 165 (323)
+|...+.... .+++..++.++.||+.||.|||++|++|+||||+||+++.++. +||+|||++..........
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~Dfg~~~~~~~~~~~~----- 152 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATM----- 152 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC-EEecccHHhccccCCCCcc-----
Confidence 6666655433 5688889999999999999999999999999999999998887 9999999876432111100
Q ss_pred CCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 036739 166 GSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKI 245 (323)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~ 245 (323)
....|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+
T Consensus 153 ------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~ 207 (323)
T cd05595 153 ------------------------KTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207 (323)
T ss_pred ------------------------ccccCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 01246889999999977 56899999999999999999999999887665554443
Q ss_pred HHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcCCCCcccc
Q 036739 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEHEYFRDVE 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h~~~~~~~ 320 (323)
.... ......+++.+.++|.+||+.||++|+ ++.++++||||.+++
T Consensus 208 ~~~~-----------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 208 LMEE-----------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred hcCC-----------------------------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 3210 011234789999999999999999998 899999999999876
Q ss_pred c
Q 036739 321 F 321 (323)
Q Consensus 321 ~ 321 (323)
|
T Consensus 259 ~ 259 (323)
T cd05595 259 W 259 (323)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=323.20 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=207.1
Q ss_pred CcceeeeeccccceeEEEEEEc---cCCceEEEEEEEeccc--CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNC---VTNETIALKKIRLEQE--DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 76 (323)
+|++.+.||+|++|+||++.+. .++..||+|++..... .......+..|+.+++.+ +|+||+++++++.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 4678999999865432 223345677899999999 489999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
++||||+.| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~-~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC-EEEeeCcCCccccc
Confidence 999999976 7777776543 4688889999999999999999999999999999999999887 99999999865432
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
...... ....||+.|+|||.+.+...++.++|||||||++|+|++|..||..
T Consensus 158 ~~~~~~----------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 158 EEKERT----------------------------YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cCCCcc----------------------------ccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 211110 1125689999999998755678999999999999999999999975
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhh
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSA 310 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~i 310 (323)
.........+....... .......+++.+.++|.+||+.||++|| ++.++
T Consensus 210 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 264 (332)
T cd05614 210 EGERNTQSEVSRRILKC-------------------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEI 264 (332)
T ss_pred CCCCCCHHHHHHHHhcC-------------------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHH
Confidence 43222111111111000 0112234788999999999999999999 88899
Q ss_pred hcCCCCccccc
Q 036739 311 LEHEYFRDVEF 321 (323)
Q Consensus 311 l~h~~~~~~~~ 321 (323)
++||||+++.|
T Consensus 265 l~h~~~~~~~~ 275 (332)
T cd05614 265 KEHPFFKGLDW 275 (332)
T ss_pred HcCCCcCCCCH
Confidence 99999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=320.34 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=209.0
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCC-CCeeeeeEEEecCceEEEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQH-GNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 80 (323)
+|++++.||+|++|.||+|.+..+++.||+|++..... .......+..|..+++.+.| ++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999876532 23334567788889988876 46888999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||++| +|.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~-~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC-EEEeecCcceecCCCCCc
Confidence 99975 7777765543 4678889999999999999999999999999999999998887 999999987643211110
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.....||+.|+|||++.+ ..++.++|+||+||++|+|++|+.||......
T Consensus 158 -----------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (324)
T cd05587 158 -----------------------------TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 207 (324)
T ss_pred -----------------------------eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 011256899999999987 56889999999999999999999999887766
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH-----hhhhcCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA-----RSALEHE 314 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~-----~~il~h~ 314 (323)
+....+.... ......+++.+.+++.+||..||.+|+++ .++++||
T Consensus 208 ~~~~~i~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp 258 (324)
T cd05587 208 ELFQSIMEHN-----------------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHA 258 (324)
T ss_pred HHHHHHHcCC-----------------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 5555443210 01123478899999999999999999976 7999999
Q ss_pred CCccccc
Q 036739 315 YFRDVEF 321 (323)
Q Consensus 315 ~~~~~~~ 321 (323)
||..++|
T Consensus 259 ~~~~~~~ 265 (324)
T cd05587 259 FFRRIDW 265 (324)
T ss_pred CcCCCCH
Confidence 9998765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=313.99 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=211.3
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+|++.+.||+|++|.||++.+..++..||+|.+..... .......+.+|+.+++.++|+||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 58999999999999999999988999999999865432 22223556789999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| ++...+.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIR 159 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC-EEEeeCCCceecCCCCccc
Confidence 9975 6666665544446788999999999999999999999999999999999998877 9999999987643211100
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
...|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.....
T Consensus 160 ------------------------------~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~ 208 (285)
T cd05605 160 ------------------------------GRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208 (285)
T ss_pred ------------------------------cccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence 1245888999999977 568899999999999999999999998765543
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcCCC
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEHEY 315 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h~~ 315 (323)
....+....... .......+++.+.++|.+||+.||++|| ++.++++|||
T Consensus 209 ~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 209 KREEVERRVKED-------------------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred HHHHHHHHhhhc-------------------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence 333332221110 0111234788999999999999999999 8999999999
Q ss_pred Cccccc
Q 036739 316 FRDVEF 321 (323)
Q Consensus 316 ~~~~~~ 321 (323)
|...+|
T Consensus 264 ~~~~~~ 269 (285)
T cd05605 264 FRTANF 269 (285)
T ss_pred ccCCCH
Confidence 998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=320.50 Aligned_cols=250 Identities=29% Similarity=0.442 Sum_probs=204.3
Q ss_pred eccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-hH
Q 036739 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DL 87 (323)
Q Consensus 10 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g-~l 87 (323)
||+|+||.||++++..+++.||+|++.... ........+..|+.++++++||||+++++++.+.+..++||||+.| +|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999999999999999986543 2233345677899999999999999999999999999999999976 77
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCC
Q 036739 88 KKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167 (323)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 167 (323)
.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. ++|+|||++.........
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~-------- 149 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDK-------- 149 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc-EEEEECcccccCccCCCc--------
Confidence 77776543 4688889999999999999999999999999999999998887 999999988643211110
Q ss_pred cCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 036739 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFR 247 (323)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~ 247 (323)
.....||+.|+|||.+.+ ..++.++|+||+||++|+|++|..||......+....+..
T Consensus 150 ---------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~ 207 (312)
T cd05585 150 ---------------------TNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207 (312)
T ss_pred ---------------------cccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence 011256899999999987 5689999999999999999999999988766555444332
Q ss_pred HhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC---CHhhhhcCCCCccccc
Q 036739 248 VLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI---TARSALEHEYFRDVEF 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~---s~~~il~h~~~~~~~~ 321 (323)
. .......+++.+.++|.+||+.||++|| ++.++++||||++..+
T Consensus 208 ~-----------------------------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 208 E-----------------------------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred C-----------------------------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence 1 0011234788999999999999999997 5789999999998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=328.99 Aligned_cols=290 Identities=26% Similarity=0.373 Sum_probs=214.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
.+|++++.||+|++|.||+|++..+++.||+|++..... .......+.+|+.+++.+.|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999865432 2233467788999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++..+......
T Consensus 81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~-ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC-EEEEeCCCCccccccccc
Confidence 99975 7777766543 4688888999999999999999999999999999999998887 999999997644211110
Q ss_pred cccccc-----CCc-Ccceee-------hh-hhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHH
Q 036739 160 FTHEHW-----GST-GISIYF-------SF-LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAE 225 (323)
Q Consensus 160 ~~~~~~-----~~~-~~~~~~-------~~-~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~ 225 (323)
...... ... ...... .. .................||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeee
Confidence 000000 000 000000 00 000000000011123478999999999987 568999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC
Q 036739 226 MVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI 305 (323)
Q Consensus 226 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~ 305 (323)
|++|..||......+....+....... ..+....+++.+.++|.+|+ .+|++|+
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTL-------------------------HIPSQAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccc-------------------------cCCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence 999999998887665544432210000 00111347889999999976 5999999
Q ss_pred ---CHhhhhcCCCCccccc
Q 036739 306 ---TARSALEHEYFRDVEF 321 (323)
Q Consensus 306 ---s~~~il~h~~~~~~~~ 321 (323)
++.++++||||+++++
T Consensus 291 ~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 291 GKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred CCCCHHHHhCCCCcCCCCH
Confidence 9999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=320.35 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=205.6
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHH---HhcCCCCeeeeeEEEecCceEEEE
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLL---KEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
|++++.||+|++|.||++.+..++..||+|++..... .......+..|.+++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 7899999999999999999999999999999875432 222334566666655 456799999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| +|...+.. ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++........
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~-~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc-EEeCcccCCccCCCCCC
Confidence 999977 55555433 25788889999999999999999999999999999999999887 99999998764321111
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
. .....|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+...
T Consensus 157 ~-----------------------------~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~ 206 (324)
T cd05589 157 R-----------------------------TSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206 (324)
T ss_pred c-----------------------------ccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCH
Confidence 0 011256889999999987 5689999999999999999999999988876
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h 313 (323)
.+....+.... ......+++.+.++|.+||+.||++|| ++.++++|
T Consensus 207 ~~~~~~i~~~~-----------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 207 EEVFDSIVNDE-----------------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHHHHhCC-----------------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 66555443310 011234788999999999999999999 79999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||+++.+
T Consensus 258 ~~f~~~~~ 265 (324)
T cd05589 258 PFFRDINW 265 (324)
T ss_pred CCcCCCCH
Confidence 99998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=321.87 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=205.1
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL- 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g- 85 (323)
+.||+|+||.||++.+..++..||+|++..... .......+.+|+.+++.++||||+++++.+.+.+..++||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999999999999999875432 233345677899999999999999999999999999999999976
Q ss_pred hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccccc
Q 036739 86 DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHW 165 (323)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 165 (323)
++...+.... .+++..+..++.||+.||+|||++|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~-~kL~DfG~~~~~~~~~~~------ 151 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAAT------ 151 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc-EEEecCcCCccCCCcccc------
Confidence 6666665433 5688889999999999999999999999999999999998887 999999987643211110
Q ss_pred CCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 036739 166 GSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKI 245 (323)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~ 245 (323)
.....||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||......+....+
T Consensus 152 -----------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~ 207 (328)
T cd05593 152 -----------------------MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207 (328)
T ss_pred -----------------------cccccCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh
Confidence 011246889999999987 56799999999999999999999999877655444332
Q ss_pred HHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcCCCCcccc
Q 036739 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEHEYFRDVE 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h~~~~~~~ 320 (323)
... .......+++.+.++|.+||+.||++|+ ++.++++||||.+++
T Consensus 208 ~~~-----------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 208 LME-----------------------------DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred ccC-----------------------------CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 210 0011235788999999999999999997 899999999999875
Q ss_pred c
Q 036739 321 F 321 (323)
Q Consensus 321 ~ 321 (323)
|
T Consensus 259 ~ 259 (328)
T cd05593 259 W 259 (328)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=318.54 Aligned_cols=282 Identities=24% Similarity=0.380 Sum_probs=209.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++++..++..+|+|.+.... .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 78999999999999999999999999999999886542 22234578899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|+.| +|.+.+.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++. ++|+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~- 159 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMA- 159 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc-EEEccCccccccccccc-
Confidence 9976 6766665543 468888999999999999999986 6999999999999998887 99999998865422111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
....|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||......
T Consensus 160 ------------------------------~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 160 ------------------------------NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred ------------------------------ccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 01245888999999987 56899999999999999999999999876654
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCc-----cc-c-----------cCCCCC-CCccc-ccccCCChHHHHHHHhhcccC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPD-----FK-S-----------AFPKWP-SKELG-TVVRNLEPAGIDLLSKMLCMD 300 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~-~-----------~~~~~~-~~~~~-~~~~~~s~~~~~li~~~l~~d 300 (323)
+......................... .. . ....+. ....+ .....+++.+++||.+||+.|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~ 288 (331)
T cd06649 209 ELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKN 288 (331)
T ss_pred HHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCC
Confidence 43222111110000000000000000 00 0 000000 00000 011247889999999999999
Q ss_pred CCCCCCHhhhhcCCCCccc
Q 036739 301 PSRRITARSALEHEYFRDV 319 (323)
Q Consensus 301 p~~R~s~~~il~h~~~~~~ 319 (323)
|++||++.++++||||+..
T Consensus 289 P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 289 PAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccCCCHHHHhcChHHhhc
Confidence 9999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=328.88 Aligned_cols=290 Identities=24% Similarity=0.360 Sum_probs=212.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++++.||+|+||.||++.++.+++.||+|++..... .......+.+|+.+++.+.||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 589999999999999999999999999999999865432 2233466788999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.... .+++..++.++.|++.||+|||+.||+|+||||+||+++.++. +||+|||++.........
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~-~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC-EEEeeccccccccccccc
Confidence 99965 7777776543 5688889999999999999999999999999999999998887 999999998643221110
Q ss_pred ccccc--cCCc------C--------cceee--hhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHH
Q 036739 160 FTHEH--WGST------G--------ISIYF--SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGC 221 (323)
Q Consensus 160 ~~~~~--~~~~------~--------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 221 (323)
..... .... . ..... ...................||+.|+|||++.+ ..++.++|+|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGv 236 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecch
Confidence 00000 0000 0 00000 00000000000001112468999999999977 56899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCC
Q 036739 222 IFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301 (323)
Q Consensus 222 ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp 301 (323)
++|+|++|..||......+....+....... .+ +....+++.+.+||.+||. +|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~----------------------p~~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETL---YF----------------------PDDIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCcc---CC----------------------CCCCCCCHHHHHHHHHHhc-CH
Confidence 9999999999998877655554443210000 00 0012468899999999997 66
Q ss_pred CCC---CCHhhhhcCCCCccccc
Q 036739 302 SRR---ITARSALEHEYFRDVEF 321 (323)
Q Consensus 302 ~~R---~s~~~il~h~~~~~~~~ 321 (323)
.+| +++.++++||||++++|
T Consensus 291 ~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 291 ENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hhcCCCCCHHHHhcCCCcCCCCH
Confidence 665 59999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=324.58 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=209.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||.||++++..+++.+|+|++..... .......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 579999999999999999999999999999999865432 2233456778999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+... .+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~-~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 123 EYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC-EEEEecccceecccCCce
Confidence 99975 777766443 4688889999999999999999999999999999999998887 999999998765322111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC---CCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS---RHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
. .....||+.|+|||.+... ..++.++|+||+||++|+|++|..||...
T Consensus 199 ~----------------------------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 199 R----------------------------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred e----------------------------cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 0 0123569999999998753 23788999999999999999999999888
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC--CCCHhhhhcCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR--RITARSALEHE 314 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~--R~s~~~il~h~ 314 (323)
........+........ + +....+++.++++|.+||..++.+ |+++.++++||
T Consensus 251 ~~~~~~~~i~~~~~~~~---~----------------------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 251 SLVGTYSKIMDHKNSLN---F----------------------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred CHHHHHHHHHhCCcccC---C----------------------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 76666555543211110 0 001236889999999999866544 88999999999
Q ss_pred CCccc
Q 036739 315 YFRDV 319 (323)
Q Consensus 315 ~~~~~ 319 (323)
||++.
T Consensus 306 ~~~~~ 310 (370)
T cd05621 306 FFKND 310 (370)
T ss_pred ccCCC
Confidence 99875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=308.07 Aligned_cols=283 Identities=39% Similarity=0.739 Sum_probs=218.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||+++++.+++.|++|++............+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 68999999999999999999998899999999986554333444667889999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|++++++..+..... .+++..+..++.||+.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ-IKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc-EEECccccceecCCCccccc
Confidence 999877776654433 4788899999999999999999999999999999999998887 99999999877643221100
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
...++..|+|||.+.+...++.++|+||+|+++|+|++|..||.+....+.
T Consensus 159 -----------------------------~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~ 209 (286)
T cd07847 159 -----------------------------DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ 209 (286)
T ss_pred -----------------------------CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 012367799999987756678999999999999999999999998877666
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCC---CcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPS---KELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
...+.+.............. ...+......... .........++..+.+||.+||+.+|++||++.+++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 210 LYLIRKTLGDLIPRHQQIFS-TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHHHHHHhCCCChHHhhhcc-cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 66555443332211000000 0000000000000 00112234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=325.36 Aligned_cols=290 Identities=26% Similarity=0.385 Sum_probs=212.7
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.|++++.||+|+||+||+|++..++..||+|++.... ........+.+|+.+++.++|+||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6999999999999999999999999999999986543 223344678889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+.... .+++..++.++.||+.||.|||+.||+|+||||+||+++.++. +||+|||++..+.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~-~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC-EEEeeCcCCcccccccccc
Confidence 9965 7777766543 4688888999999999999999999999999999999998887 9999999876543221110
Q ss_pred cccccC------CcC------cce-----eehhhh-hhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHH
Q 036739 161 THEHWG------STG------ISI-----YFSFLR-YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCI 222 (323)
Q Consensus 161 ~~~~~~------~~~------~~~-----~~~~~~-~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~l 222 (323)
...... ... .+. ...... ...............||+.|+|||.+.+ ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhH
Confidence 000000 000 000 000000 0000000111223578999999999987 568999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhccc--C
Q 036739 223 FAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM--D 300 (323)
Q Consensus 223 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~--d 300 (323)
+|+|++|..||......+....+........ .+....+++.+.+||.+|+.. +
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLH-------------------------IPPQVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccC-------------------------CCCCCCCCHHHHHHHHHHccCccc
Confidence 9999999999988776555444432100000 001124789999999996654 4
Q ss_pred CCCCCCHhhhhcCCCCccccc
Q 036739 301 PSRRITARSALEHEYFRDVEF 321 (323)
Q Consensus 301 p~~R~s~~~il~h~~~~~~~~ 321 (323)
|..|+++.++++||||++++|
T Consensus 293 ~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 293 RLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred ccCCCCHHHHhcCcccCCCCh
Confidence 555999999999999998765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=319.28 Aligned_cols=266 Identities=24% Similarity=0.369 Sum_probs=211.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|.||++.+..+++.||+|++.+.. ........+.+|..+++.++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 68999999999999999999999999999999986532 22233456788999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+... ...+++..++.++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC-EEEEECCceeecCCCCCc
Confidence 99965 777776543 335788889999999999999999999999999999999998887 999999998665322111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.. ....||+.|+|||++.. ...++.++|+||+||++|+|++|..||..
T Consensus 159 ~~----------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 159 QS----------------------------NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred cc----------------------------cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 00 01246899999999873 24578899999999999999999999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC--CCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR--RITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~--R~s~~~il~h 313 (323)
....+....+....... ..+.....+++.++++|++||..++++ |+++.++++|
T Consensus 211 ~~~~~~~~~i~~~~~~~------------------------~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 211 ESLVETYGKIMNHKEHF------------------------QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCHHHHHHHHHcCCCcc------------------------cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 77666555443211000 011112347889999999998765444 7899999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 267 p~~~~~~~ 274 (331)
T cd05597 267 PFFEGIDW 274 (331)
T ss_pred CCCCCCCH
Confidence 99998765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=319.13 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=204.7
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|++|+||+|.++.+++.||+|++..... .......+..|..++..+ +||||+++++++.+.+.+++||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999999999999999875432 233345666788888776 699999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|...+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~-~kL~DfG~~~~~~~~~~~----- 152 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKT----- 152 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc-EEEeeCCCCeecCcCCCc-----
Confidence 7766665543 4688889999999999999999999999999999999999887 999999987653211110
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
.....||+.|+|||.+.+ ..++.++|+|||||++|+|++|+.||......+....
T Consensus 153 ------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 207 (320)
T cd05590 153 ------------------------TSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 207 (320)
T ss_pred ------------------------ccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 011256889999999977 5689999999999999999999999988876665555
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH------hhhhcCCCCcc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA------RSALEHEYFRD 318 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~------~~il~h~~~~~ 318 (323)
+.+.. ......+++.+.++|.+||+.||++|+++ +++++||||++
T Consensus 208 i~~~~-----------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 208 ILNDE-----------------------------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred HhcCC-----------------------------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 43210 01112367889999999999999999998 89999999998
Q ss_pred ccc
Q 036739 319 VEF 321 (323)
Q Consensus 319 ~~~ 321 (323)
+.|
T Consensus 259 ~~~ 261 (320)
T cd05590 259 LDW 261 (320)
T ss_pred CCH
Confidence 764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=324.06 Aligned_cols=290 Identities=23% Similarity=0.344 Sum_probs=216.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|+||++.+..+++.||+|++.... ........+..|..++..++|++|+++++.+.+++.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999986543 23334567788999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.+.. .+++..++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++.........
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~-vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC-EEEeeccCCccccccccc
Confidence 99976 7777766543 4688889999999999999999999999999999999998887 999999998765332211
Q ss_pred ccccccCCcCcc--eeehhhh----hhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 160 FTHEHWGSTGIS--IYFSFLR----YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 160 ~~~~~~~~~~~~--~~~~~~~----~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
............ ....... ..............+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCC
Confidence 100000000000 0000000 0000000111223578999999999987 56889999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC---CHhhh
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI---TARSA 310 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~---s~~~i 310 (323)
...........+........ + +....+++.++++|.+|+ .||.+|+ ++.++
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~---~----------------------p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 290 (360)
T cd05627 237 CSETPQETYRKVMNWKETLV---F----------------------PPEVPISEKAKDLILRFC-TDSENRIGSNGVEEI 290 (360)
T ss_pred CCCCHHHHHHHHHcCCCcee---c----------------------CCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHH
Confidence 88777665554432100000 0 001237889999999987 4999998 47899
Q ss_pred hcCCCCccccc
Q 036739 311 LEHEYFRDVEF 321 (323)
Q Consensus 311 l~h~~~~~~~~ 321 (323)
++||||++++|
T Consensus 291 ~~hp~f~~~~~ 301 (360)
T cd05627 291 KSHPFFEGVDW 301 (360)
T ss_pred hcCCCCCCCCH
Confidence 99999999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=325.89 Aligned_cols=290 Identities=26% Similarity=0.381 Sum_probs=214.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
.+|++++.||+|+||+||+|++..++..||+|++..... .......+.+|+.++++++|+||+++++.+.++..+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 379999999999999999999999999999999865432 2233457788999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.+.. .+++..++.++.||+.||+|||+.||+|+||||+|||++.++. +||+|||++..+......
T Consensus 81 E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~-~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEEeECCCCccccccccc
Confidence 99975 7777776543 4688889999999999999999999999999999999999887 999999997644221111
Q ss_pred cccccc-----CCcC----------cc--eeehhhhh-hhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHH
Q 036739 160 FTHEHW-----GSTG----------IS--IYFSFLRY-RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGC 221 (323)
Q Consensus 160 ~~~~~~-----~~~~----------~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 221 (323)
...... .... +. ........ ..............||+.|+|||++.+ ..++.++|+|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGv 236 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechH
Confidence 000000 0000 00 00000000 000000011233578999999999987 56899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCC
Q 036739 222 IFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301 (323)
Q Consensus 222 ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp 301 (323)
++|+|++|..||......+....+....... ..+....+++.+.++|.+|+ .+|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~p~~~~~s~~~~~li~~l~-~~p 290 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSL-------------------------HIPPQAKLSPEASDLIIKLC-RGP 290 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCCc-------------------------CCCCcccCCHHHHHHHHHHc-cCH
Confidence 9999999999998877665554443211000 00111347899999999986 599
Q ss_pred CCCCC---HhhhhcCCCCccccc
Q 036739 302 SRRIT---ARSALEHEYFRDVEF 321 (323)
Q Consensus 302 ~~R~s---~~~il~h~~~~~~~~ 321 (323)
++|++ +.++++||||++++|
T Consensus 291 ~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 291 EDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred hHcCCCCCHHHHhcCCCcCCcCh
Confidence 99997 999999999998765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=316.86 Aligned_cols=257 Identities=23% Similarity=0.381 Sum_probs=208.5
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+|++.+.||+|+||.||++.+..++..||+|++..... .......+..|..++..+ +|++|+++++++.+.+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 68999999999999999999999999999999875532 222234456677777777 5899999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|...+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~-~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc-EEEccCCCceecCCCCCc
Confidence 99975 7777765543 4688889999999999999999999999999999999999887 999999988653211110
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.....||+.|+|||.+.. ..++.++|+|||||++|+|++|..||......
T Consensus 158 -----------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~ 207 (323)
T cd05616 158 -----------------------------TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207 (323)
T ss_pred -----------------------------cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHH
Confidence 011256889999999987 66899999999999999999999999888776
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH-----hhhhcCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA-----RSALEHE 314 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~-----~~il~h~ 314 (323)
+....+.... ......+++.+.+++.+||+.||++|++. .++++||
T Consensus 208 ~~~~~i~~~~-----------------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~ 258 (323)
T cd05616 208 ELFQSIMEHN-----------------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 258 (323)
T ss_pred HHHHHHHhCC-----------------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCC
Confidence 6555544310 01113478899999999999999999984 7999999
Q ss_pred CCccccc
Q 036739 315 YFRDVEF 321 (323)
Q Consensus 315 ~~~~~~~ 321 (323)
||+.++|
T Consensus 259 ~~~~~~~ 265 (323)
T cd05616 259 FFRYIDW 265 (323)
T ss_pred CcCCCCH
Confidence 9998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.08 Aligned_cols=279 Identities=41% Similarity=0.754 Sum_probs=201.9
Q ss_pred eeeeccccceeEEEEEEc--cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--CceEEEEEec
Q 036739 7 VEKIGEGTYGVVYKARNC--VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKKLYLVFEY 82 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~ 82 (323)
.++||+|+||+||+|+++ .++..||+|.+... .....+.+|+.+++.++||||+++++.+.. +...++++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC----CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999965 36678999987432 223567789999999999999999999854 5678999999
Q ss_pred chhhHHHhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEe----cCCCceEEeccccce
Q 036739 83 LDLDLKKHMDSCP-------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLID----RRTNALKLADFGLAR 151 (323)
Q Consensus 83 ~~g~l~~~~~~~~-------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~----~~~~~~kl~df~~~~ 151 (323)
+++++...+.... ...+++..++.++.||+.||.|||+.|++|+||||+||++. .++ .+||+|||++.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~-~~kl~DfG~a~ 160 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR 160 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcC-cEEEeecCcee
Confidence 9998887765321 23478888999999999999999999999999999999994 334 49999999997
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCC
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~ 231 (323)
........... .....||+.|+|||++.+...++.++|+||+||++|+|++|.+
T Consensus 161 ~~~~~~~~~~~--------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 214 (317)
T cd07868 161 LFNSPLKPLAD--------------------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred ccCCCCccccc--------------------------cCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 65432211100 0112558899999999876678999999999999999999999
Q ss_pred CCCCCCh---------HHHHHHHHHHhCCCCCCCCCCcccCCcccc---cCCC----CCC--CcccccccCCChHHHHHH
Q 036739 232 LFPGDSE---------IDELFKIFRVLGTPNEDTWPGVTSLPDFKS---AFPK----WPS--KELGTVVRNLEPAGIDLL 293 (323)
Q Consensus 232 p~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~----~~~--~~~~~~~~~~s~~~~~li 293 (323)
||..... ......+.+..+.+....|......+.... .+.. ... ..........++.+.+||
T Consensus 215 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 294 (317)
T cd07868 215 IFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 294 (317)
T ss_pred CccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHH
Confidence 9975432 233444555444443333322221111100 0000 000 000011123456789999
Q ss_pred HhhcccCCCCCCCHhhhhcCCCC
Q 036739 294 SKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 294 ~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
.+||+.||.+|||++++|+||||
T Consensus 295 ~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 295 QKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHhccCcccCCCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=317.77 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=204.7
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|+||.||+|++..+++.||+|++..... .......+..|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999988999999999875432 233345566788888766 799999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|...+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+.........
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~-~kL~Dfg~~~~~~~~~~~----- 152 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVT----- 152 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC-EEEeecccceecccCCcc-----
Confidence 6766665543 4688888999999999999999999999999999999999887 999999988653211110
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
.....|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||......+....
T Consensus 153 ------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~ 207 (321)
T cd05591 153 ------------------------TTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES 207 (321)
T ss_pred ------------------------ccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 011246889999999877 5689999999999999999999999998877666655
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-------CHhhhhcCCCCc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-------TARSALEHEYFR 317 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-------s~~~il~h~~~~ 317 (323)
+.... ......+++.+.++|.+||+.||++|+ ++.++++||||.
T Consensus 208 i~~~~-----------------------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~ 258 (321)
T cd05591 208 ILHDD-----------------------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFK 258 (321)
T ss_pred HHcCC-----------------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccC
Confidence 44310 001123678899999999999999999 899999999999
Q ss_pred cccc
Q 036739 318 DVEF 321 (323)
Q Consensus 318 ~~~~ 321 (323)
+++|
T Consensus 259 ~~~~ 262 (321)
T cd05591 259 EIDW 262 (321)
T ss_pred CCCH
Confidence 8755
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=310.06 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=202.1
Q ss_pred eccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-hH
Q 036739 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DL 87 (323)
Q Consensus 10 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g-~l 87 (323)
||+|+||+||++.+..+++.||+|.+...... ......+..|+.+++.++|+||+++.+++..+...++||||+.| +|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998654322 22235667899999999999999999999999999999999976 66
Q ss_pred HHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccccc
Q 036739 88 KKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHW 165 (323)
Q Consensus 88 ~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 165 (323)
...+.. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~~l~dfg~~~~~~~~~~~~----- 154 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKT----- 154 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEeeCccceecCCCCccc-----
Confidence 555532 22345788999999999999999999999999999999999998887 9999999987654322110
Q ss_pred CCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 036739 166 GSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKI 245 (323)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~ 245 (323)
....|++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||............
T Consensus 155 ------------------------~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 209 (280)
T cd05608 155 ------------------------KGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 209 (280)
T ss_pred ------------------------cccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH
Confidence 01245888999999987 56889999999999999999999999765433222222
Q ss_pred HHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcCCCCcccc
Q 036739 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEHEYFRDVE 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h~~~~~~~ 320 (323)
....... .......+++.+.+++.+||+.||++|| +++++++||||+++.
T Consensus 210 ~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 210 KQRILND-------------------------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred HHhhccc-------------------------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 2111000 0011234788999999999999999999 889999999999875
Q ss_pred c
Q 036739 321 F 321 (323)
Q Consensus 321 ~ 321 (323)
|
T Consensus 265 ~ 265 (280)
T cd05608 265 W 265 (280)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=310.21 Aligned_cols=289 Identities=40% Similarity=0.756 Sum_probs=217.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC-------
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------- 73 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------- 73 (323)
+++|++.+.||+|++|.||+|.+..++..||+|.+............+.+|+.++++++||||+++++.+...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 4789999999999999999999999999999999865544444445567899999999999999999998654
Q ss_pred -ceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 74 -KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 74 -~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
...++|+||+++++.+.+.... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~ 168 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI-LKLADFGLARA 168 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc-EEECcCCCccc
Confidence 3569999999998888776543 35788899999999999999999999999999999999998887 99999999876
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
........... .....++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus 169 ~~~~~~~~~~~-------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~ 223 (310)
T cd07865 169 FSLSKNSKPNR-------------------------YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI 223 (310)
T ss_pred ccCCcccCCCC-------------------------ccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC
Confidence 64332211000 00123477899999987766678999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccc-cCCCCCCCcccc--cccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGT--VVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
|...........+.+..+....+.++.......+.. ............ .....++.+.++|.+||+.||++||++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e 303 (310)
T cd07865 224 MQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303 (310)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 988776666555555544444333332221111100 000000000000 00124567889999999999999999999
Q ss_pred hhcCCCC
Q 036739 310 ALEHEYF 316 (323)
Q Consensus 310 il~h~~~ 316 (323)
+++||||
T Consensus 304 ~l~h~~f 310 (310)
T cd07865 304 ALNHDFF 310 (310)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=314.28 Aligned_cols=251 Identities=28% Similarity=0.389 Sum_probs=205.9
Q ss_pred cceeeeeccccceeEEEEEEccCCce-EEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc-eEEEEEe
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNET-IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-KLYLVFE 81 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~-~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e 81 (323)
..+...+|+|+||+||++.+ .|.. ||+|.+............|.+|+.++.+++||||++++|++.+.. .+++|||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 44566799999999999986 5555 999999766544444679999999999999999999999998877 7999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR-VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|+.+ +|.+.+.......++...+..++.||+.||.|||+++ |+|+||||+|||++.++..+||+|||++.........
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 9976 6666655545667899999999999999999999999 9999999999999998745999999999876533210
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC-CCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG-SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.....||+.|||||++.+ ...++.++||||||+++|||+||..||.....
T Consensus 201 -----------------------------~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 201 -----------------------------MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred -----------------------------ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 111366999999999995 26799999999999999999999999999988
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
......+......+ .+....++.+..++..||+.||++||+..+++.
T Consensus 252 ~~~~~~v~~~~~Rp---------------------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 252 VQVASAVVVGGLRP---------------------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 66555554322221 222337788999999999999999999998875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=318.87 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=204.0
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL- 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g- 85 (323)
+.||+|+||.||++.+..++..||+|++..... .......+.+|+.+++.++||||+++++.+.+....++||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999999999999999875532 222345667899999999999999999999999999999999976
Q ss_pred hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|...+.... .+++..+..++.||+.||.|||+ .|++|+||||+||+++.++. +||+|||++..........
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~-~kL~Dfg~~~~~~~~~~~~---- 153 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATM---- 153 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC-EEEecCCCCeecCCCCccc----
Confidence 6666555433 46888899999999999999997 79999999999999998887 9999999876432111100
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
....||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||...........
T Consensus 154 -------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~ 207 (325)
T cd05594 154 -------------------------KTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207 (325)
T ss_pred -------------------------ccccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH
Confidence 01246889999999977 5689999999999999999999999987766544443
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcCCCCccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEHEYFRDV 319 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h~~~~~~ 319 (323)
+.... ......+++.+.++|.+||+.||++|+ ++.++++||||.++
T Consensus 208 i~~~~-----------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 208 ILMEE-----------------------------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HhcCC-----------------------------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 32110 011234788999999999999999997 99999999999987
Q ss_pred cc
Q 036739 320 EF 321 (323)
Q Consensus 320 ~~ 321 (323)
.+
T Consensus 259 ~~ 260 (325)
T cd05594 259 VW 260 (325)
T ss_pred CH
Confidence 54
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=316.50 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=200.5
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|++|.||++.+..++..||+|++..... .......+..|..+++.+ +||||+++++++.+.+.+++||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999999999999999976532 222345677899999888 699999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|...+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~-~kL~Dfg~~~~~~~~~~~----- 152 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDT----- 152 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC-EEECcCccccccccCCCc-----
Confidence 7766665432 5788999999999999999999999999999999999998887 999999988642111100
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh------
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE------ 238 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~------ 238 (323)
.....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.....
T Consensus 153 ------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~ 207 (329)
T cd05588 153 ------------------------TSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207 (329)
T ss_pred ------------------------cccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccc
Confidence 011256889999999987 6688999999999999999999999963211
Q ss_pred --HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC------Hhhh
Q 036739 239 --IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT------ARSA 310 (323)
Q Consensus 239 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s------~~~i 310 (323)
.+...+.... ........+++.+.++|.+||+.||++|++ +.++
T Consensus 208 ~~~~~~~~~~~~----------------------------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i 259 (329)
T cd05588 208 NTEDYLFQVILE----------------------------KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDI 259 (329)
T ss_pred cchHHHHHHHHc----------------------------CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHH
Confidence 1111111110 001122457889999999999999999997 7899
Q ss_pred hcCCCCccccc
Q 036739 311 LEHEYFRDVEF 321 (323)
Q Consensus 311 l~h~~~~~~~~ 321 (323)
++||||.+++|
T Consensus 260 ~~hp~~~~~~~ 270 (329)
T cd05588 260 KSHPFFRNIDW 270 (329)
T ss_pred hcCCCCCCCCH
Confidence 99999998765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=321.03 Aligned_cols=262 Identities=25% Similarity=0.346 Sum_probs=209.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||.||++.++.++..+|+|++.... ........+.+|..+++.++||||+++++.+.+++.+++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999986533 22223456778999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+... .+++..++.++.||+.||.|||++||+|+||||+||+++.++. +||+|||++.........
T Consensus 123 Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~-ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 123 EYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMV 198 (371)
T ss_pred cCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC-EEEEeCCceeEcCcCCcc
Confidence 99975 666665443 4688888999999999999999999999999999999999887 999999998765322111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC---CCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS---RHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
. .....||+.|+|||++... ..++.++|+|||||++|+|++|..||...
T Consensus 199 ~----------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 199 R----------------------------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred c----------------------------ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 0 1123569999999998753 23788999999999999999999999987
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC--CCCHhhhhcCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR--RITARSALEHE 314 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~--R~s~~~il~h~ 314 (323)
........+........ + +....+++.+.++|.+||..++.+ |+++.++++||
T Consensus 251 ~~~~~~~~i~~~~~~~~---~----------------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 251 SLVGTYSKIMNHKNSLT---F----------------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CHHHHHHHHHcCCCccc---C----------------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 76655555543211100 0 111347899999999999844433 78999999999
Q ss_pred CCcccc
Q 036739 315 YFRDVE 320 (323)
Q Consensus 315 ~~~~~~ 320 (323)
||++..
T Consensus 306 ~~~~~~ 311 (371)
T cd05622 306 FFKNDQ 311 (371)
T ss_pred ccCCCC
Confidence 998854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=320.85 Aligned_cols=257 Identities=27% Similarity=0.401 Sum_probs=200.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|+.++.||+|++|.||++++..+++.||+|++.... .......+.+|+.+++.++|+||+++++++.+++.+++|+|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 56889999999999999999998899999999985432 22234678899999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|+.|+.+.. ....++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++..........
T Consensus 153 ~~~~~~L~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~-~kL~DfG~~~~~~~~~~~~- 225 (353)
T PLN00034 153 FMDGGSLEG-----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN-VKIADFGVSRILAQTMDPC- 225 (353)
T ss_pred cCCCCcccc-----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-EEEcccccceecccccccc-
Confidence 998744322 113456778889999999999999999999999999999998887 9999999987653221110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC----CCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS----RHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
....||..|+|||.+... ...+.++|||||||++|+|++|+.||....
T Consensus 226 ----------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 277 (353)
T PLN00034 226 ----------------------------NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277 (353)
T ss_pred ----------------------------cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 112568899999987431 334568999999999999999999997443
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
..+........... ........+++.+.+||.+||+.||++||++.++++||||.
T Consensus 278 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~ 332 (353)
T PLN00034 278 QGDWASLMCAICMS-------------------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL 332 (353)
T ss_pred CccHHHHHHHHhcc-------------------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 32221111111000 00111234788999999999999999999999999999998
Q ss_pred cc
Q 036739 318 DV 319 (323)
Q Consensus 318 ~~ 319 (323)
+-
T Consensus 333 ~~ 334 (353)
T PLN00034 333 RA 334 (353)
T ss_pred cC
Confidence 64
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=315.57 Aligned_cols=253 Identities=29% Similarity=0.449 Sum_probs=204.2
Q ss_pred eeeeccccceeEEEEEEc---cCCceEEEEEEEeccc--CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 7 VEKIGEGTYGVVYKARNC---VTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++.||+|+||.||++.+. .++..||+|++..... .......+.+|+.+++.++||||+++++.+.+++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 468999999999999863 4678999999865432 22234566789999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+.... .+.+..++.++.||+.||.|||++|++|+||||+||+++.++. +||+|||++..........
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC-EEEeeCcCCeecccCCCcc
Confidence 9976 7777665543 4677888899999999999999999999999999999998887 9999999886432111100
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.......
T Consensus 158 -----------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~ 207 (323)
T cd05584 158 -----------------------------HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK 207 (323)
T ss_pred -----------------------------cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHH
Confidence 01245889999999987 557899999999999999999999998877665
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcCCC
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEHEY 315 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h~~ 315 (323)
....+.... ......+++.+.++|.+||+.||++|| ++.++++|||
T Consensus 208 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 208 TIDKILKGK-----------------------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred HHHHHHcCC-----------------------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 555443210 011234678999999999999999999 8999999999
Q ss_pred Cccccc
Q 036739 316 FRDVEF 321 (323)
Q Consensus 316 ~~~~~~ 321 (323)
|....+
T Consensus 259 ~~~~~~ 264 (323)
T cd05584 259 FRHVNW 264 (323)
T ss_pred cCCCCH
Confidence 987643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=307.25 Aligned_cols=279 Identities=37% Similarity=0.651 Sum_probs=212.5
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecC--ceEEEEE
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSE--KKLYLVF 80 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~ 80 (323)
|++.+.||+|++|.||++.+..++..||+|.+........ .....+|+..++++. |+|++++++++.+. +..++|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 7899999999999999999988999999998865432222 233456888888885 99999999999887 8999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||++|++++.+..... .+++..+..++.|++.||.+||+.|++|+||+|+||+++. +. ++|+|||.+..........
T Consensus 80 e~~~~~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~-~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKR-PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI-LKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred ecCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC-eEEEecccccccccCCCcC
Confidence 9999999988876443 5788899999999999999999999999999999999998 66 9999999987653221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ..++..|+|||.+......+.++|+||+||++|+|++|..||.+.+..+
T Consensus 157 ~------------------------------~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~ 206 (282)
T cd07831 157 E------------------------------YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD 206 (282)
T ss_pred C------------------------------CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH
Confidence 0 1237789999987665667899999999999999999999998887776
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
....+....+..................................++..+.++|.+||+.+|++||++.++++||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 207 QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 6665555443332211000000000000111111111222334678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=330.64 Aligned_cols=279 Identities=22% Similarity=0.365 Sum_probs=206.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCC------CCeeeeeEEEecC-c
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH------GNIVRLQDVVHSE-K 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~-~ 74 (323)
++|++++.||+|+||+||+|.+..++..||+|++.... ........|+.+++.+.| .++++++++|..+ .
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 57999999999999999999998899999999985322 122345567777777754 4588899988764 5
Q ss_pred eEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCC-------------
Q 036739 75 KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTN------------- 140 (323)
Q Consensus 75 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~------------- 140 (323)
.+|+|+|++++++.+.+.... .+++..+..++.||+.||.|||+ .||+|+||||+|||++.++.
T Consensus 206 ~~~iv~~~~g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 206 HMCIVMPKYGPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred eEEEEEeccCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 789999999999998887653 57888899999999999999997 59999999999999987653
Q ss_pred --ceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 141 --ALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 141 --~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
.+||+|||.+....... ....||+.|+|||++.+ ..++.++||||
T Consensus 284 ~~~vkl~DfG~~~~~~~~~--------------------------------~~~~gt~~Y~APE~~~~-~~~~~~~DiwS 330 (467)
T PTZ00284 284 PCRVRICDLGGCCDERHSR--------------------------------TAIVSTRHYRSPEVVLG-LGWMYSTDMWS 330 (467)
T ss_pred CceEEECCCCccccCcccc--------------------------------ccccCCccccCcHHhhc-CCCCcHHHHHH
Confidence 38999999764321110 01256899999999988 66899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCC---cccccCCC---CCC--------CcccccccC
Q 036739 219 VGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLP---DFKSAFPK---WPS--------KELGTVVRN 284 (323)
Q Consensus 219 lG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---~~~--------~~~~~~~~~ 284 (323)
|||++|+|++|+.||......+.+..+....+..... |....... .+...... ... .........
T Consensus 331 lGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (467)
T PTZ00284 331 MGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSE-WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVI 409 (467)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH-HHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhh
Confidence 9999999999999999888777777666655543221 11000000 00000000 000 000000001
Q ss_pred CChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 285 LEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 285 ~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.++.+.+||.+||+.||++||++.++|+||||+..
T Consensus 410 ~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 410 RDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred chHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 24668899999999999999999999999999874
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=311.52 Aligned_cols=290 Identities=23% Similarity=0.356 Sum_probs=219.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC-CCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|+||++.+..++..|++|.+....... .....+..|+.+++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 58999999999999999999998889999999987653321 24457888999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+....+..+++..+..++.|++.+|.|||+.|++|+||||+||+++.++. ++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC-EEEeecchhhcccccccc
Confidence 99976 7777776655567888999999999999999999999999999999999998887 999999998765433221
Q ss_pred ccccccCCcCcceeehhhhhhhc-cCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVL-AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
................. ..... .......+...|+..|+|||++.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 160 VSKALRKGSRRSSVNSI-PSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccc-chhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 11000000000000000 00000 000111223467889999999987 5578899999999999999999999988776
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC----HhhhhcCC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT----ARSALEHE 314 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s----~~~il~h~ 314 (323)
......+..... .+ +....+++.+.++|.+||..||++||+ +.++++||
T Consensus 238 ~~~~~~~~~~~~-----~~----------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 238 DETFSNILKKEV-----TF----------------------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred HHHHHHHhcCCc-----cC----------------------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 555544332100 00 001126889999999999999999999 99999999
Q ss_pred CCccccc
Q 036739 315 YFRDVEF 321 (323)
Q Consensus 315 ~~~~~~~ 321 (323)
||++++|
T Consensus 291 ~~~~~~~ 297 (316)
T cd05574 291 FFRGVNW 297 (316)
T ss_pred hhhcCCh
Confidence 9999865
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=313.52 Aligned_cols=252 Identities=27% Similarity=0.391 Sum_probs=201.2
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|+||.||+++++.+++.||+|++..... .......+..|..++... .||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999876532 122334556677777654 899999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|...+.... .+++..+..++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||++.........
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~----- 152 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNR----- 152 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC-EEeCccCCCeecccCCCc-----
Confidence 7777766543 4678888999999999999999999999999999999998887 999999987542111000
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
.....||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||......+....
T Consensus 153 ------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~ 207 (316)
T cd05620 153 ------------------------ASTFCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES 207 (316)
T ss_pred ------------------------eeccCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011356899999999987 5689999999999999999999999987766544443
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH-hhhhcCCCCccccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA-RSALEHEYFRDVEF 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~-~~il~h~~~~~~~~ 321 (323)
+... . ......+++.+.++|.+||+.||++|+++ .++++||||+++++
T Consensus 208 ~~~~--~---------------------------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 208 IRVD--T---------------------------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred HHhC--C---------------------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 3211 0 01112367889999999999999999998 47888999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=309.48 Aligned_cols=296 Identities=45% Similarity=0.774 Sum_probs=225.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC-------
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------- 73 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------- 73 (323)
+++|++.+.||+|++|.||++++..+++.+++|.+............+.+|+.+++.++|+||+++++.+.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4799999999999999999999999999999999876554444445677899999999999999999887543
Q ss_pred -ceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 74 -KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 74 -~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
..+++|+||+.+++...+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~ 164 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI-LKIADFGLARP 164 (311)
T ss_pred CceEEEEEecCCcCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEECcCccchh
Confidence 357999999998888877654 335789999999999999999999999999999999999999887 99999999876
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
............. ..........+++.|+|||.+.+...++.++|+||+|+++|+|++|.+|
T Consensus 165 ~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~ 226 (311)
T cd07866 165 YDGPPPNPKGGGG------------------GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226 (311)
T ss_pred ccCCCcccccCCc------------------ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCC
Confidence 5433221111000 0000011235578899999987756689999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccc-cCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhh
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSAL 311 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il 311 (323)
|.+.........+....+.+....++.....+.... ................+++.+.++|.+||+.||++||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 227 LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 998888777777776666555444433322222211 0001111111122345668899999999999999999999999
Q ss_pred cCCCC
Q 036739 312 EHEYF 316 (323)
Q Consensus 312 ~h~~~ 316 (323)
.||||
T Consensus 307 ~~~~f 311 (311)
T cd07866 307 EHPYF 311 (311)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=306.58 Aligned_cols=256 Identities=28% Similarity=0.380 Sum_probs=201.2
Q ss_pred eccccceeEEEEEEccCCceEEEEEEEecccCC-CCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-hH
Q 036739 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DL 87 (323)
Q Consensus 10 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g-~l 87 (323)
||+|+||.||++.++.+|+.||+|.+....... .....+..|+.+++.++||||+++++.+.++...++||||+.| ++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999999999999999986543222 1233455699999999999999999999999999999999976 67
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCC
Q 036739 88 KKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167 (323)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 167 (323)
...+.......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~-~~l~Dfg~~~~~~~~~~~~------- 152 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN-CRLSDLGLAVELKDGKTIT------- 152 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC-EEEeeceeeeecCCCceee-------
Confidence 66665555556788888899999999999999999999999999999998887 9999999987653221110
Q ss_pred cCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 036739 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFR 247 (323)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~ 247 (323)
...|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...........+..
T Consensus 153 -----------------------~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05607 153 -----------------------QRAGTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208 (277)
T ss_pred -----------------------ccCCCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH
Confidence 1245888999999987 4589999999999999999999999976543222222211
Q ss_pred HhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH----hhhhcCCCCccccc
Q 036739 248 VLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA----RSALEHEYFRDVEF 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~----~~il~h~~~~~~~~ 321 (323)
..... ........+++.+.++|.+||+.||++||++ .++++||||++++|
T Consensus 209 ~~~~~------------------------~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 209 RTLED------------------------EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred Hhhcc------------------------ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 10000 0000113478899999999999999999999 67779999998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=315.62 Aligned_cols=266 Identities=23% Similarity=0.352 Sum_probs=211.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||.||++..+.++..+|+|++.... ........+.+|..++..++|++|+++++.+.+...+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 68999999999999999999999999999999986432 22223355778999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++. +||+|||++.........
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~-~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC-EEEeecchheecccCCcc
Confidence 99965 7777776533 25788889999999999999999999999999999999998887 999999998654321111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
. .....||+.|+|||++.. ...++.++|+|||||++|+|++|..||..
T Consensus 159 ~----------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 159 Q----------------------------SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred e----------------------------ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 0 011256899999999863 34578899999999999999999999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC--CCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR--RITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~--R~s~~~il~h 313 (323)
....+....+....... ..+.....+++.+.+||.+||..++.+ |+++.++++|
T Consensus 211 ~~~~~~~~~i~~~~~~~------------------------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 211 ESLVETYGKIMNHKERF------------------------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCHHHHHHHHhCCCccc------------------------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 87766665544211000 011112347899999999999765544 6899999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||.+++|
T Consensus 267 ~~f~~~~~ 274 (332)
T cd05623 267 PFFTGIDW 274 (332)
T ss_pred CCcCCCCH
Confidence 99998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=300.91 Aligned_cols=291 Identities=43% Similarity=0.780 Sum_probs=243.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc----eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec-CceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE----TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (323)
..|++++.||+|-+|.||+|..+.++. .+|||.+.-...........-+|+.++|.++|||++.+...|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 469999999999999999996555443 78999987665556667788899999999999999999999987 8899
Q ss_pred EEEEecchhhHHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC----CCceEEecccc
Q 036739 77 YLVFEYLDLDLKKHMDSCP---DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR----TNALKLADFGL 149 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~----~~~~kl~df~~ 149 (323)
++++||.+.+|++.+...+ ...++...++.|+.||+.+++|||++=++||||||.||++..+ |. +||+|+|+
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~-VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGR-VKIADLGL 182 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCe-eEeecccH
Confidence 9999999999999986433 2467888999999999999999999999999999999999887 55 99999999
Q ss_pred ceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhC
Q 036739 150 ARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ 229 (323)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg 229 (323)
++.+..+..... ..+.++.|..|.|||.+.+...|+.+.|+|++|||+.||+|-
T Consensus 183 aR~~~~plkpl~--------------------------s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl 236 (438)
T KOG0666|consen 183 ARLFNNPLKPLA--------------------------SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTL 236 (438)
T ss_pred HHHhhccccccc--------------------------cCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHcc
Confidence 998865543221 123367799999999999999999999999999999999999
Q ss_pred CCCCCCC---------ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcc-----c---ccccCCChHHHHH
Q 036739 230 RPLFPGD---------SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKEL-----G---TVVRNLEPAGIDL 292 (323)
Q Consensus 230 ~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~---~~~~~~s~~~~~l 292 (323)
.+.|.+. ...+.+.+++..++.+....|+...+++++...+..+..... . ...+.-++...+|
T Consensus 237 ~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~L 316 (438)
T KOG0666|consen 237 EPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDL 316 (438)
T ss_pred CccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHH
Confidence 9999653 345678899999999999999999999887544433322111 1 1223356668999
Q ss_pred HHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 293 LSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 293 i~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+.+||..||.+|.+++++|+|+||..-
T Consensus 317 L~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 317 LQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred HHHHhccCchhhccHHHHhcccccccC
Confidence 999999999999999999999999865
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=308.07 Aligned_cols=282 Identities=71% Similarity=1.232 Sum_probs=236.1
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
|++.+.||+|++|.||++.+..+++.|++|.+............+.+|+.+++.++|+|++++++++.+....++|+|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67889999999999999999889999999998766544445577888999999999999999999999999999999999
Q ss_pred hhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccc
Q 036739 84 DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163 (323)
Q Consensus 84 ~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~ 163 (323)
++++.+.+.+.. ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+............
T Consensus 81 ~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~-~~l~d~g~~~~~~~~~~~~~~- 157 (282)
T cd07829 81 DMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV-LKLADFGLARAFGIPLRTYTH- 157 (282)
T ss_pred CcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC-EEEecCCcccccCCCccccCc-
Confidence 999888887653 35788999999999999999999999999999999999999887 999999998766433221110
Q ss_pred ccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 036739 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243 (323)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~ 243 (323)
..++..|+|||.+.....++.++|+||||++++++++|..||......+...
T Consensus 158 ----------------------------~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 209 (282)
T cd07829 158 ----------------------------EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF 209 (282)
T ss_pred ----------------------------cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 1226679999998875578999999999999999999999999988888888
Q ss_pred HHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
.+.+..+.+....|........+...+..+.........+.++..+.++|.+||+.||++||++.+++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 210 KIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 8887777777666665555544444555555544445555678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=318.05 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=205.7
Q ss_pred eeeeccccceeEEEEEEc---cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc
Q 036739 7 VEKIGEGTYGVVYKARNC---VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
++.||+|++|.||++.+. .++..||+|++............+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999999763 56889999999765433333456678999999999999999999999999999999999
Q ss_pred hh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 84 DL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 84 ~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
.| +|.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+.........
T Consensus 81 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kL~Dfg~~~~~~~~~~~--- 154 (318)
T cd05582 81 RGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKK--- 154 (318)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc-EEEeeccCCcccCCCCCc---
Confidence 65 7777775433 4688899999999999999999999999999999999998887 999999988654322110
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~ 242 (323)
.....|++.|+|||.+.. ..++.++|+|||||++|+|++|..||......+..
T Consensus 155 --------------------------~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 207 (318)
T cd05582 155 --------------------------AYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM 207 (318)
T ss_pred --------------------------eecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHH
Confidence 011245888999999987 55789999999999999999999999887766555
Q ss_pred HHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----HhhhhcCCCCc
Q 036739 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALEHEYFR 317 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~h~~~~ 317 (323)
..+.+.. ......+++.+.++|++||+.||++||+ +.++++||||.
T Consensus 208 ~~i~~~~-----------------------------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~ 258 (318)
T cd05582 208 TMILKAK-----------------------------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFS 258 (318)
T ss_pred HHHHcCC-----------------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcC
Confidence 5443210 0112347889999999999999999999 67799999999
Q ss_pred cccc
Q 036739 318 DVEF 321 (323)
Q Consensus 318 ~~~~ 321 (323)
.+.|
T Consensus 259 ~~~~ 262 (318)
T cd05582 259 TIDW 262 (318)
T ss_pred CCCH
Confidence 8754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=309.42 Aligned_cols=259 Identities=34% Similarity=0.540 Sum_probs=205.6
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
|++.+.||+|++|+||++.+..+++.||+|.+...............|+.++++++||||+++++++.+....+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999766543333334455999999999999999999999999999999999
Q ss_pred hh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 84 DL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 84 ~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
.+ ++.+.+... ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~-~~l~Dfg~~~~~~~~~~~~-- 155 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE-VKLIDFGSSVKLSENNENF-- 155 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE-EEESSGTTTEESTSTTSEB--
T ss_pred cccccccccccc--cccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccc--
Confidence 88 777777732 25688899999999999999999999999999999999998777 9999999987641111110
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~ 242 (323)
....++..|.|||.+......+.++|+||||+++|+|++|..||......+..
T Consensus 156 ---------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~ 208 (260)
T PF00069_consen 156 ---------------------------NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL 208 (260)
T ss_dssp ---------------------------SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH
T ss_pred ---------------------------ccccccccccccccccccccccccccccccccccccccccccccccccchhhh
Confidence 01244888999999983477899999999999999999999999987433333
Q ss_pred HHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
....+.......... ......++.+.++|.+||+.||++||++.++++||||
T Consensus 209 ~~~~~~~~~~~~~~~----------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 209 EIIEKILKRPLPSSS----------------------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHTHHHHHT----------------------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred hhhhhcccccccccc----------------------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 332222111000000 0001123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=310.94 Aligned_cols=252 Identities=30% Similarity=0.473 Sum_probs=222.0
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+|++.+.||+|-+|.|-+|++...|+.||||.+.+.. .+....-.+++|+++|..++||||++++..|++.....||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 6999999999999999999999999999999997775 345566788899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|.+| .|.+++.++. .+++.+++.+++||++|++|+|+++++|+|||.+|||++.+++ +||.|||++..+.......
T Consensus 134 YaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N-iKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 134 YASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN-IKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred ecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC-eeeeccchhhhhccccHHH
Confidence 9964 8888888776 4699999999999999999999999999999999999999999 9999999998875433322
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. -+|++.|++||.+.+.++-++..|.||||+++|.|+.|..||.+.+...
T Consensus 211 T------------------------------FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~ 260 (668)
T KOG0611|consen 211 T------------------------------FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR 260 (668)
T ss_pred H------------------------------hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH
Confidence 1 2678999999999998888999999999999999999999999999888
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
.+.++.++.... +..+..+.-||+.||..||++|.++.+|..|=|.+
T Consensus 261 lvrQIs~GaYrE------------------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 261 LVRQISRGAYRE------------------------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHhhcccccC------------------------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 887776643221 12345678999999999999999999999998875
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=312.69 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=201.0
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHh-cCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKE-MQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|+||.||+|++..+++.||+|++..... .......+..|..++.. .+||||+++++++.++..+++||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999876532 22233444556666654 4799999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|...+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~-~kL~Dfg~a~~~~~~~~~----- 152 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGK----- 152 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC-EEEccCcCCeECCCCCCc-----
Confidence 6666665543 4688888999999999999999999999999999999998887 999999998654221110
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
.....||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+....+....
T Consensus 153 ------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~ 207 (316)
T cd05592 153 ------------------------ASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS 207 (316)
T ss_pred ------------------------cccccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011256899999999987 5689999999999999999999999988776555544
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh-hhhcCCCCccccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR-SALEHEYFRDVEF 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~-~il~h~~~~~~~~ 321 (323)
+... .......+++.+.++|.+||+.||++||++. ++++||||..+.|
T Consensus 208 i~~~-----------------------------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 208 ILND-----------------------------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred HHcC-----------------------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 3221 0111234778899999999999999999875 7889999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=300.26 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=212.3
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||+|++|.||+++++.++..|++|.+............+.+|+.+++.++|||++++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 58999999999999999999999999999999876544455567788899999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+.| ++.+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~-~~l~df~~~~~~~~~~~~~- 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN-VKIGDLGVAKLLSDNTNFA- 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC-EEEcccccceeccCccchh-
Confidence 965 8777777655556788889999999999999999999999999999999998887 9999999987654321111
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
....|++.|+|||++.+ ..++.++|+||||+++++|++|..||......+.
T Consensus 159 ----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 209 (256)
T cd08529 159 ----------------------------NTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209 (256)
T ss_pred ----------------------------hccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 01244778999999987 5578999999999999999999999988775544
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
...+.... .......+++.+.++|.+|++.+|++||++.++++|||+
T Consensus 210 ~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 210 ILKIIRGV----------------------------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHcCC----------------------------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 44332210 011112467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=304.33 Aligned_cols=283 Identities=49% Similarity=0.874 Sum_probs=215.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+..++..|++|.+..... ......+.+|+.+++.++|+||+++++++.++...++|+|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 579999999999999999999989999999999865432 2334467789999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|+.+++++.+..... .+.+..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||.+...........
T Consensus 84 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 84 YMHTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE-LKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred cccCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc-EEEeccccccccCCCCCCCC
Confidence 999998888765433 4677778899999999999999999999999999999998887 99999998865432211100
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH-H
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI-D 240 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~-~ 240 (323)
...+++.|+|||.+.+...++.++|+||||+++|+|++|..||...... +
T Consensus 162 -----------------------------~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~ 212 (291)
T cd07870 162 -----------------------------SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE 212 (291)
T ss_pred -----------------------------CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH
Confidence 1134788999999876556788999999999999999999999765543 4
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCC-CCccccccc--CCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWP-SKELGTVVR--NLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
.+.+.....+.+....+......+.......... ......... ..++.+.+++.+|+..||++|||+.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 213 QLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 4444544444444333333322222211111111 111111111 236788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=314.99 Aligned_cols=266 Identities=23% Similarity=0.350 Sum_probs=211.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||.||+++++.+++.||+|++.... ........+.+|..+++.++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999986532 22233455778899999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC-EEEEeccceeeccCCCce
Confidence 99965 7777766533 25788889999999999999999999999999999999998887 999999998765432211
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC----CCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS----RHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.. ....|++.|+|||++... ..++.++|+||+|+++|+|++|+.||..
T Consensus 159 ~~----------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 159 QS----------------------------SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ee----------------------------ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 10 012468999999998652 3468899999999999999999999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC--CCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR--RITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~--R~s~~~il~h 313 (323)
....+....+....... ..+.....+++.+.++|.+||..++.+ |+++.++++|
T Consensus 211 ~~~~~~~~~i~~~~~~~------------------------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 211 ESLVETYGKIMNHEERF------------------------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCHHHHHHHHHcCCCcc------------------------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 77665555443211000 011112347889999999999876544 5689999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 267 ~~f~~~~~ 274 (331)
T cd05624 267 AFFEGIDW 274 (331)
T ss_pred CCcCCCCH
Confidence 99998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=313.08 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=204.0
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|+||+||++.+..++..||+|++..... .......+..|..+++.+ +||||+++++++.+.+.+++||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999988999999999975532 233345666788888877 699999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|...+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||++..........
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~---- 153 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTT---- 153 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc-EEecccCCCeecCcCCCcc----
Confidence 6666665543 5788889999999999999999999999999999999999887 9999999886421111100
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
....|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...........
T Consensus 154 -------------------------~~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~ 207 (318)
T cd05570 154 -------------------------STFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS 207 (318)
T ss_pred -------------------------cceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 01245888999999987 5689999999999999999999999987765554443
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH-----hhhhcCCCCccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA-----RSALEHEYFRDV 319 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~-----~~il~h~~~~~~ 319 (323)
+.... ......+++.+.++|++||+.||++||++ .++++||||+.+
T Consensus 208 i~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 208 ILEDE-----------------------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HHcCC-----------------------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 32210 01123478899999999999999999999 999999999987
Q ss_pred cc
Q 036739 320 EF 321 (323)
Q Consensus 320 ~~ 321 (323)
.|
T Consensus 259 ~~ 260 (318)
T cd05570 259 DW 260 (318)
T ss_pred CH
Confidence 65
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=309.13 Aligned_cols=278 Identities=41% Similarity=0.754 Sum_probs=202.9
Q ss_pred eeeccccceeEEEEEEcc--CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEe--cCceEEEEEecc
Q 036739 8 EKIGEGTYGVVYKARNCV--TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKKLYLVFEYL 83 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~ 83 (323)
.+||+|+||.||+|+... ++..||+|.+... .....+.+|+.+++.++||||+++++++. .+...++++||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT----GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 589999999999999643 5578999987432 22356778999999999999999999985 356789999999
Q ss_pred hhhHHHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEe----cCCCceEEecccccee
Q 036739 84 DLDLKKHMDSC-------PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLID----RRTNALKLADFGLARA 152 (323)
Q Consensus 84 ~g~l~~~~~~~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~----~~~~~~kl~df~~~~~ 152 (323)
++++.+.+... ....+++..+..++.||+.||.|||+.|++|+||||+||++. .++ .+||+|||++..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~~ 161 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIADMGFARL 161 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCC-cEEEeeccceec
Confidence 99888877532 123467888999999999999999999999999999999994 334 499999999976
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
.......... .....||+.|+|||.+.+...++.++|+||+||++|+|+||.+|
T Consensus 162 ~~~~~~~~~~--------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~ 215 (317)
T cd07867 162 FNSPLKPLAD--------------------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred cCCCcccccc--------------------------cCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCC
Confidence 6433221110 01124588899999998766789999999999999999999999
Q ss_pred CCCCCh---------HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCC---C------CCcccccccCCChHHHHHHH
Q 036739 233 FPGDSE---------IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKW---P------SKELGTVVRNLEPAGIDLLS 294 (323)
Q Consensus 233 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~~~~~s~~~~~li~ 294 (323)
|..... ......+....+.+....|......+.+....... . ...........+..+.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 295 (317)
T cd07867 216 FHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQ 295 (317)
T ss_pred cccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHH
Confidence 975432 23344455555544444443333222211100000 0 00001111234667899999
Q ss_pred hhcccCCCCCCCHhhhhcCCCC
Q 036739 295 KMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 295 ~~l~~dp~~R~s~~~il~h~~~ 316 (323)
+||+.||.+|||+.++|+||||
T Consensus 296 ~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 296 KLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhccCcccccCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=299.24 Aligned_cols=255 Identities=25% Similarity=0.447 Sum_probs=208.9
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec-CceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 81 (323)
.|++.+.||.|++|.||++.++.+++.|++|.+............+.+|+.++++++|+|++++++.+.. +..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999998899999999986654444445678889999999999999999998864 456899999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
++.+ ++.+.+.......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~-~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI-IKVGDLGIARVLENQCDMA 159 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc-EEEecccceEEecccCCcc
Confidence 9975 7777777655556789999999999999999999999999999999999998887 9999999987653321110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...+++.|+|||.+.+ ..++.++|+||+|++++++++|..||...+...
T Consensus 160 ~-----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~ 209 (257)
T cd08223 160 S-----------------------------TLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209 (257)
T ss_pred c-----------------------------cccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 0 1134788999999877 568899999999999999999999998766544
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
....+..... ......+++.+.+++.+|++.||++||++.++++||||
T Consensus 210 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 210 LVYRIIEGKL----------------------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHhcCC----------------------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 4443332110 01113477899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=312.45 Aligned_cols=292 Identities=20% Similarity=0.230 Sum_probs=208.2
Q ss_pred eeeeeccc--cceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc
Q 036739 6 KVEKIGEG--TYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 6 ~~~~lg~g--~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
+++.||+| ++++||++.++.+|+.||+|.+............+.+|+.+++.++||||+++++++.+++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7789999999999999999998665444444567778999999999999999999999999999999999
Q ss_pred hh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 84 DL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 84 ~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
++ ++.+.+.......+++..+..++.|++.||.|||+++++|+||||+||+++.++. ++++||+..............
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~-~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK-VYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc-EEEcccchhhccccccccccc
Confidence 75 6777765544445788889999999999999999999999999999999998887 999999865443211000000
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
. ... .....++..|+|||++... ..++.++|+|||||++|+|++|..||........
T Consensus 161 ~-~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 218 (327)
T cd08227 161 V-HDF---------------------PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 218 (327)
T ss_pred c-ccc---------------------cccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 0 000 0001346779999998763 3578999999999999999999999987654443
Q ss_pred HHHHHHHhCCCCC-------CCCCCcccCCcccc----------cCCCCCCCcccccccCCChHHHHHHHhhcccCCCCC
Q 036739 242 LFKIFRVLGTPNE-------DTWPGVTSLPDFKS----------AFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRR 304 (323)
Q Consensus 242 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R 304 (323)
............. +............. ................+++.+.+||.+||+.||++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 298 (327)
T cd08227 219 LLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDAR 298 (327)
T ss_pred HHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhc
Confidence 3222211000000 00000000000000 000001111122334578899999999999999999
Q ss_pred CCHhhhhcCCCCcccc
Q 036739 305 ITARSALEHEYFRDVE 320 (323)
Q Consensus 305 ~s~~~il~h~~~~~~~ 320 (323)
||+.++++||||+++.
T Consensus 299 pt~~ell~~p~f~~~~ 314 (327)
T cd08227 299 PSASTLLNHSFFKQIK 314 (327)
T ss_pred CCHHHHhcChhhhhcc
Confidence 9999999999998863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.73 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=200.5
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHH-HHHhcCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREIS-LLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|++|+||++.++.+++.||+|++..... .......+..|.. +++.++||||+++++.+.+.+..++||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999865432 1222233444444 56788999999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|...+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~-~kl~Dfg~~~~~~~~~~~----- 152 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKT----- 152 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc-EEEeccCCCcccccCCCc-----
Confidence 6766665533 5688888999999999999999999999999999999999887 999999987542111100
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
.....||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||......+....
T Consensus 153 ------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 207 (323)
T cd05575 153 ------------------------TSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN 207 (323)
T ss_pred ------------------------cccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHH
Confidence 001246889999999987 6689999999999999999999999988776555544
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH----hhhhcCCCCcccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA----RSALEHEYFRDVE 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~----~~il~h~~~~~~~ 320 (323)
+.... ......+++.+.++|.+||+.||.+||++ .++++||||..++
T Consensus 208 i~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 208 ILNKP-----------------------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred HHcCC-----------------------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 43210 01123468899999999999999999988 5999999998865
Q ss_pred c
Q 036739 321 F 321 (323)
Q Consensus 321 ~ 321 (323)
|
T Consensus 259 ~ 259 (323)
T cd05575 259 W 259 (323)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=306.12 Aligned_cols=286 Identities=43% Similarity=0.788 Sum_probs=224.0
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc------
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK------ 74 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 74 (323)
+++|++.+.||+|++|+||++.++.+++.|++|.+............+.+|+.+++.++|||++++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 46899999999999999999999889999999998765444444567778999999999999999999987654
Q ss_pred ----eEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccc
Q 036739 75 ----KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (323)
Q Consensus 75 ----~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~ 150 (323)
.+++++||+++++.+.+.+. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. +||+|||.+
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~-~kl~dfg~~ 163 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ-IKLADFGLA 163 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc-EEeCccccc
Confidence 79999999999888877665 335788899999999999999999999999999999999998887 999999998
Q ss_pred eecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 151 RAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
........... ....++..|+|||.+.+....+.++|+||+|+++++|++|+
T Consensus 164 ~~~~~~~~~~~----------------------------~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 164 RLYNSEESRPY----------------------------TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred ccccCCccccc----------------------------ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 76643221100 00123667999999876556788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCC-CCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFP-KWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
.||......+....+.+..+.+....++.....+.+..... .............+++.+.++|.+||+.||++||++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 295 (302)
T cd07864 216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295 (302)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 99998877777777776665555544443332222111000 00001111223457889999999999999999999999
Q ss_pred hhcCCCC
Q 036739 310 ALEHEYF 316 (323)
Q Consensus 310 il~h~~~ 316 (323)
++.||||
T Consensus 296 il~~~~~ 302 (302)
T cd07864 296 ALNSPWL 302 (302)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=311.22 Aligned_cols=252 Identities=29% Similarity=0.468 Sum_probs=201.6
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHh-cCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKE-MQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|+||.||++++..+++.||+|.+..... ..........|..++.. +.||||+++++++.+.+.+++||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999876532 12233455567777765 4899999999999999999999999965
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|...+.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~----- 152 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAK----- 152 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC-EEEccCCcceECCCCCCc-----
Confidence 7777776543 4677888899999999999999999999999999999999887 999999988643211110
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
.....||+.|+|||++.+ ..++.++|+||+||++|+|++|..||......+....
T Consensus 153 ------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (316)
T cd05619 153 ------------------------TCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207 (316)
T ss_pred ------------------------eeeecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011246889999999987 5689999999999999999999999988776554444
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh-hhhcCCCCccccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR-SALEHEYFRDVEF 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~-~il~h~~~~~~~~ 321 (323)
+... . ......++..+.++|.+||+.||++|+++. ++++||||+++.|
T Consensus 208 i~~~--~---------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 208 IRMD--N---------------------------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred HHhC--C---------------------------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 3211 0 001123678899999999999999999997 8999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=313.97 Aligned_cols=253 Identities=28% Similarity=0.413 Sum_probs=199.2
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|+||.||++++..++..||+|++..... .......+..|..++.++ +||||+++++++.+++..++||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999876532 223345567788888776 799999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|...+.... .+++..++.++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~-~kL~DfG~~~~~~~~~~~----- 152 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDT----- 152 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC-EEEeeCCccccccCCCCc-----
Confidence 6666655433 5788889999999999999999999999999999999999887 999999988643211110
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC-------
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS------- 237 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~------- 237 (323)
.....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||....
T Consensus 153 ------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 207 (329)
T cd05618 153 ------------------------TSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207 (329)
T ss_pred ------------------------cccccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc
Confidence 011256889999999987 568899999999999999999999995311
Q ss_pred -hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC------Hhhh
Q 036739 238 -EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT------ARSA 310 (323)
Q Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s------~~~i 310 (323)
......+.... .....+..++..+.++|.+||+.||++|++ +.++
T Consensus 208 ~~~~~~~~~i~~----------------------------~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i 259 (329)
T cd05618 208 NTEDYLFQVILE----------------------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADI 259 (329)
T ss_pred ccHHHHHHHHhc----------------------------CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHH
Confidence 11111111110 001122457888999999999999999998 4799
Q ss_pred hcCCCCccccc
Q 036739 311 LEHEYFRDVEF 321 (323)
Q Consensus 311 l~h~~~~~~~~ 321 (323)
++||||++++|
T Consensus 260 ~~hp~f~~~~~ 270 (329)
T cd05618 260 QGHPFFRNVDW 270 (329)
T ss_pred hcCCCCCCCCH
Confidence 99999998865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=306.58 Aligned_cols=262 Identities=25% Similarity=0.409 Sum_probs=208.2
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC-CCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.|++.+.||+|+||.||++.+..+++.||+|.+....... .....+.+|+.+++.++|++++++++.+.+++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4889999999999999999999999999999886543222 223456789999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC-EEEeeccceeecCCCcccc
Confidence 9975 6767665544456788889999999999999999999999999999999998887 9999999886543211100
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
...|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.......
T Consensus 160 ------------------------------~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~ 208 (285)
T cd05630 160 ------------------------------GRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 208 (285)
T ss_pred ------------------------------CCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccc
Confidence 1245888999999977 568999999999999999999999998654321
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----HhhhhcCCC
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALEHEY 315 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~h~~ 315 (323)
............ .......+++.+.+|+.+||+.||++||+ +.++++|||
T Consensus 209 ~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 209 KREEVERLVKEV-------------------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred hHHHHHhhhhhh-------------------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 111111100000 00112347788999999999999999999 899999999
Q ss_pred Cccccc
Q 036739 316 FRDVEF 321 (323)
Q Consensus 316 ~~~~~~ 321 (323)
|+.+.|
T Consensus 264 ~~~~~~ 269 (285)
T cd05630 264 FKQINF 269 (285)
T ss_pred hhccCH
Confidence 998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=315.19 Aligned_cols=290 Identities=37% Similarity=0.680 Sum_probs=222.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEe----cCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH----SEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~ 77 (323)
++|++.+.||+|++|.||++.+..++..|++|.+............+.+|+.+++.++||||+++++++. .....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 5799999999999999999999999999999998755433344567778999999999999999999875 345789
Q ss_pred EEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 78 LVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 78 lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
+|+||++|++.+.+.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. +||+|||.+.......
T Consensus 85 lv~e~~~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 85 VVMDLMESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEehhhhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc-EEecccccceeecccC
Confidence 999999998888876543 4788899999999999999999999999999999999999887 9999999987654322
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
...... .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||....
T Consensus 162 ~~~~~~-------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 162 TEHKYF-------------------------MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred cCCCcc-------------------------cccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 211000 0012457889999998765668999999999999999999999998887
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCC--cccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLP--DFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
.......+....+.+....+....... .....+............+..++.+.++|++||+.+|++||++.+++.|||
T Consensus 217 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 217 YVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 766666666655554333221111100 000111111111112233557899999999999999999999999999999
Q ss_pred Cccc
Q 036739 316 FRDV 319 (323)
Q Consensus 316 ~~~~ 319 (323)
|++.
T Consensus 297 ~~~~ 300 (334)
T cd07855 297 LAQY 300 (334)
T ss_pred hhhc
Confidence 9865
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=306.97 Aligned_cols=284 Identities=39% Similarity=0.749 Sum_probs=216.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.++.+++.||+|.+............+.+|+.+++.++||||+++++++.+++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 58999999999999999999998889999999886544333345678889999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|+.+++++.+..... .+++..+..++.||+.+|.|||+.|++|+||+|+||+++.++. ++|+|||++...........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~-~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc-EEEEeeeeeeeccCCccccC
Confidence 999877666654432 4788899999999999999999999999999999999998887 99999999876533221110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
...++..|+|||++.+...++.++|+||||+++|+|++|.+||......+.
T Consensus 159 -----------------------------~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~ 209 (286)
T cd07846 159 -----------------------------DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ 209 (286)
T ss_pred -----------------------------cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence 013477899999987756678899999999999999999999987776665
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCccc-ccCCCCC-CCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFK-SAFPKWP-SKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
...+...................... ....... ........+.++..+.+++++||+.+|++||++.++++||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 210 LYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 55555443332111000000000000 0000000 001112234678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=310.92 Aligned_cols=257 Identities=24% Similarity=0.410 Sum_probs=207.9
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+|+..+.||+|++|+||+|.++.+++.||+|++..... .......+..|..+++.+. |++|+++++++.+.+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 58899999999999999999999999999999875432 2233455667888888875 577888999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. ++|+|||++.........
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~-ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC-EEEeccccccccCCCCcc
Confidence 99975 7776665433 4788889999999999999999999999999999999999887 999999988643211110
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.....||+.|+|||.+.+ ..++.++|+||+|+++|+|++|..||......
T Consensus 158 -----------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (323)
T cd05615 158 -----------------------------TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207 (323)
T ss_pred -----------------------------ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 001245889999999987 56899999999999999999999999888766
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----HhhhhcCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALEHE 314 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~h~ 314 (323)
.....+.... ......+++.+.+++.+||+.+|.+|++ ..++++||
T Consensus 208 ~~~~~i~~~~-----------------------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~ 258 (323)
T cd05615 208 ELFQSIMEHN-----------------------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHA 258 (323)
T ss_pred HHHHHHHhCC-----------------------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCc
Confidence 5555544310 0111346788999999999999999997 46899999
Q ss_pred CCccccc
Q 036739 315 YFRDVEF 321 (323)
Q Consensus 315 ~~~~~~~ 321 (323)
||..++|
T Consensus 259 ~f~~~~~ 265 (323)
T cd05615 259 FFRRIDW 265 (323)
T ss_pred ccCCCCH
Confidence 9998865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=303.79 Aligned_cols=262 Identities=24% Similarity=0.388 Sum_probs=211.7
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.|+..+.||+|+||+||++.+..+++.+|+|.+...... ......+.+|+.+++.++|+|++.+.+.+.+++..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 488999999999999999999999999999998654322 2233556789999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+ ++...+.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIR 159 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC-EEEecCCcceecCCCCccc
Confidence 9976 6666665544446889999999999999999999999999999999999998876 9999999886543211100
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
...|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.......
T Consensus 160 ------------------------------~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~ 208 (285)
T cd05632 160 ------------------------------GRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208 (285)
T ss_pred ------------------------------CCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1245888999999977 568999999999999999999999998776554
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----HhhhhcCCC
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALEHEY 315 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~h~~ 315 (323)
....+........ ......+++.+.+|+.+||+.||++||+ +.+++.|+|
T Consensus 209 ~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05632 209 KREEVDRRVLETE-------------------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPF 263 (285)
T ss_pred HHHHHHHhhhccc-------------------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChh
Confidence 4433332211110 0112346788999999999999999999 889999999
Q ss_pred Cccccc
Q 036739 316 FRDVEF 321 (323)
Q Consensus 316 ~~~~~~ 321 (323)
|+++.+
T Consensus 264 ~~~~~~ 269 (285)
T cd05632 264 FRNMNF 269 (285)
T ss_pred hhcCCH
Confidence 998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=298.65 Aligned_cols=255 Identities=27% Similarity=0.476 Sum_probs=212.2
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||+|++|.+|++.+..++..|++|.+............+.+|+.+++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 69999999999999999999999999999999875543333446788999999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+.| ++.+.+.......+++..+..++.|++.+|.+||+++++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~-~~l~d~~~~~~~~~~~~~~- 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT-IKLGDFGIARVLNSTVELA- 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC-EEEeeccceeecCcchhhh-
Confidence 965 8888777655556788889999999999999999999999999999999998887 9999999987653321110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
....|++.|+|||.+.+ ...+.++|+||||+++++|++|..||......+.
T Consensus 159 ----------------------------~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~ 209 (256)
T cd08218 159 ----------------------------RTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL 209 (256)
T ss_pred ----------------------------hhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH
Confidence 01134778999999877 5678899999999999999999999987776665
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
...+..... ......++..+.++|.+||+.+|++||++.++++||||
T Consensus 210 ~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 210 VLKIIRGSY----------------------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhcCCC----------------------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 554432110 01123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=315.83 Aligned_cols=275 Identities=24% Similarity=0.321 Sum_probs=203.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.+|++++.||+|++|.||++.+..++..||+|+... .....|+.+++.++|+||+++++++......++|+|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 369999999999999999999988999999997421 223468999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
++.+++.+.+..... .+++..+..++.||+.||.|||+.||+|+||||+||+++.++. ++|+|||.+.........
T Consensus 138 ~~~~~l~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~~~~-- 213 (357)
T PHA03209 138 HYSSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ-VCIGDLGAAQFPVVAPAF-- 213 (357)
T ss_pred ccCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEEecCccccccccCccc--
Confidence 999999988865433 5788899999999999999999999999999999999998887 999999988642211110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC-CCCCCh--
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL-FPGDSE-- 238 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p-~~~~~~-- 238 (323)
....||+.|+|||++.+ ..++.++|+|||||++|+|+++..+ |.....
T Consensus 214 ----------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~ 264 (357)
T PHA03209 214 ----------------------------LGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTP 264 (357)
T ss_pred ----------------------------ccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcH
Confidence 01245889999999987 5689999999999999999986544 433211
Q ss_pred -------HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCC-------CCCCcccccccCCChHHHHHHHhhcccCCCCC
Q 036739 239 -------IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPK-------WPSKELGTVVRNLEPAGIDLLSKMLCMDPSRR 304 (323)
Q Consensus 239 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R 304 (323)
...+..+....+... ..++..... .....+.. ............++..+.+||.+||+.||++|
T Consensus 265 ~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 342 (357)
T PHA03209 265 EEYVKSCHSHLLKIISTLKVHP-EEFPRDPGS-RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMR 342 (357)
T ss_pred HHHHHHHHHHHHHHHHHhccCh-hhcCCCCcc-HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccC
Confidence 112222333322211 111111100 00000000 00000001112467788899999999999999
Q ss_pred CCHhhhhcCCCCccc
Q 036739 305 ITARSALEHEYFRDV 319 (323)
Q Consensus 305 ~s~~~il~h~~~~~~ 319 (323)
||+.++|+||||+++
T Consensus 343 pta~e~l~hp~f~~~ 357 (357)
T PHA03209 343 PSAEEILNYPMFAQL 357 (357)
T ss_pred cCHHHHhcCchhccC
Confidence 999999999999874
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=304.72 Aligned_cols=282 Identities=60% Similarity=1.029 Sum_probs=225.8
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
|++.+.||+|++|.||++.+..+++.+++|.+............+.+|+.+++.++|+|++++++.+.++...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 77899999999999999999889999999998665444344567888999999999999999999999999999999999
Q ss_pred hhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccc
Q 036739 84 DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163 (323)
Q Consensus 84 ~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~ 163 (323)
++++.+.+.... ..+++..+..++.||+.+|.+||+.+++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 ~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~-~~l~df~~~~~~~~~~~~~~-- 156 (283)
T cd05118 81 DTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV-LKLADFGLARSFGSPVRPYT-- 156 (283)
T ss_pred CCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc-EEEeeeeeeEecCCCccccc--
Confidence 999888877644 46788899999999999999999999999999999999998877 99999999887754431110
Q ss_pred ccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 036739 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243 (323)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~ 243 (323)
...++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+...
T Consensus 157 ---------------------------~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~ 209 (283)
T cd05118 157 ---------------------------HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209 (283)
T ss_pred ---------------------------CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 01236779999999875578999999999999999999999999888877777
Q ss_pred HHHHHhCCCCCCCCCCcccCCc-ccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 244 KIFRVLGTPNEDTWPGVTSLPD-FKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
++....+.+....+........ ....+..............+++.+.++|++||+.||.+||++.+++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 210 KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 7666655554443333222100 111111111122223345678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=312.07 Aligned_cols=289 Identities=43% Similarity=0.721 Sum_probs=229.0
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc-----eEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-----KLY 77 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 77 (323)
+|++.+.||+|++|.||++++..++..|++|.+............+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 699999999999999999999888999999998655443445578889999999999999999999987764 789
Q ss_pred EEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 78 LVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 78 lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
+++||+++++.+.+.... .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~-~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD-LKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEcccCceEeecccc
Confidence 999999988888876644 6788889999999999999999999999999999999999877 9999999998765432
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
..... .....++..|+|||.+.+...++.++|+||+|+++|+|++|.+||.+..
T Consensus 158 ~~~~~--------------------------~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 158 DEKGF--------------------------LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ccccc--------------------------ccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 11000 0012347789999999885478999999999999999999999999988
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcc--cCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVT--SLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
..+....+....+.+....+.... ....+..................+++.+.++|++||+.+|++||++.+++.|||
T Consensus 212 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 212 YIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred HHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 877777777766555544332111 111111111111222222334557899999999999999999999999999999
Q ss_pred Ccccc
Q 036739 316 FRDVE 320 (323)
Q Consensus 316 ~~~~~ 320 (323)
|+++.
T Consensus 292 ~~~~~ 296 (330)
T cd07834 292 LAQLH 296 (330)
T ss_pred HHhhc
Confidence 98874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=308.38 Aligned_cols=299 Identities=41% Similarity=0.707 Sum_probs=227.3
Q ss_pred CCcce-eeeeccccceeEEEEEEccCCceEEEEEEEecccCCC------------CchhHHHHHHHHHhcCCCCeeeeeE
Q 036739 2 DQYEK-VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG------------VPSTAIREISLLKEMQHGNIVRLQD 68 (323)
Q Consensus 2 ~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~~ 68 (323)
++|.. .+.||+|++|+||++.+..++..||+|++........ ....+.+|+.++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 57765 4679999999999999988999999999865432211 0124678999999999999999999
Q ss_pred EEecCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccc
Q 036739 69 VVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148 (323)
Q Consensus 69 ~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~ 148 (323)
++..+...+++||+++|++.+.+.... .+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~-~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI-CKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccccCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC-EEECCcc
Confidence 999999999999999999988886543 4688889999999999999999999999999999999998887 9999999
Q ss_pred cceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh
Q 036739 149 LARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t 228 (323)
.+................... .........+++.|+|||.+.+...++.++|+||||+++|+|++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t 229 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQ---------------RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229 (335)
T ss_pred ceeeccccccccccccccccc---------------ccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHh
Confidence 987765322111100000000 00000112457889999998875667899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|..||......+....+....+.+....|+.....+... ......+..........++.+.++|.+||+.+|++||++.
T Consensus 230 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 308 (335)
T PTZ00024 230 GKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYT-EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308 (335)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhccccc-ccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence 999999988887777777766666554444333222111 1111222223333456788999999999999999999999
Q ss_pred hhhcCCCCccc
Q 036739 309 SALEHEYFRDV 319 (323)
Q Consensus 309 ~il~h~~~~~~ 319 (323)
+++.||||++-
T Consensus 309 ~~l~~~~~~~~ 319 (335)
T PTZ00024 309 EALKHEYFKSD 319 (335)
T ss_pred HHhcCcccCCC
Confidence 99999999875
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=307.00 Aligned_cols=287 Identities=43% Similarity=0.795 Sum_probs=214.5
Q ss_pred CcceeeeeccccceeEEEEEEcc--CCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC--ceEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCV--TNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KKLY 77 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 77 (323)
+|++.+.||+|++|.||+|.+.. .+..||+|.+.... ........+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 78999999987643 2233346777899999999999999999999987 8899
Q ss_pred EEEecchhhHHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec----CCCceEEeccccc
Q 036739 78 LVFEYLDLDLKKHMDSCP---DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR----RTNALKLADFGLA 150 (323)
Q Consensus 78 lv~e~~~g~l~~~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~----~~~~~kl~df~~~ 150 (323)
+|+|++++++.+.+.... ...+++..+..++.||+.||+|||+.+++|+||+|+||+++. ++. +||+|||.+
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~-~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV-VKIGDLGLA 159 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce-EEECCCccc
Confidence 999999988887765332 236788899999999999999999999999999999999998 666 999999998
Q ss_pred eecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 151 RAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
........... ......+++.|+|||.+.+...++.++|+||||+++++|++|+
T Consensus 160 ~~~~~~~~~~~--------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~ 213 (316)
T cd07842 160 RLFNAPLKPLA--------------------------DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213 (316)
T ss_pred cccCCCccccc--------------------------ccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcC
Confidence 76543322100 0111245788999999887667899999999999999999999
Q ss_pred CCCCCCChH---------HHHHHHHHHhCCCCCCCCCCcccCCcccc---cCCCCCCC--cc---cccccCCChHHHHHH
Q 036739 231 PLFPGDSEI---------DELFKIFRVLGTPNEDTWPGVTSLPDFKS---AFPKWPSK--EL---GTVVRNLEPAGIDLL 293 (323)
Q Consensus 231 ~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~~---~~~~~~~s~~~~~li 293 (323)
.||...... ..+..+...+..+....+......+++.. ........ .. .......+..+.++|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 293 (316)
T cd07842 214 PIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLL 293 (316)
T ss_pred CCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHH
Confidence 999765432 23334444444333322222222211111 00000000 00 001125778899999
Q ss_pred HhhcccCCCCCCCHhhhhcCCCC
Q 036739 294 SKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 294 ~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
.+||+.||++||++.++++||||
T Consensus 294 ~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 294 RKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhcCCcccCcCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=301.65 Aligned_cols=283 Identities=49% Similarity=0.880 Sum_probs=223.0
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC--ceEEEEEe
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KKLYLVFE 81 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 81 (323)
|++.+.||+|++|.||++.+..++..+++|.+............+.+|+.+++.++|+|++++++.+.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 7899999999999999999988899999999976643334446778899999999999999999999887 89999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|+++++.+.+.... ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~-~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 81 YMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADY 158 (287)
T ss_pred cccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC-EEEccccceeeccCCCcccc
Confidence 99998888876653 35788889999999999999999999999999999999999887 99999999877644321100
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
....++..|+|||.+.+...++.++|+||||+++|+|++|..||........
T Consensus 159 ----------------------------~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~ 210 (287)
T cd07840 159 ----------------------------TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ 210 (287)
T ss_pred ----------------------------cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 0113367799999887656678999999999999999999999998887777
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCC-CCCCcccccccC-CChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPK-WPSKELGTVVRN-LEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
...+......+....++.............. ............ +++.+.++|++||+.+|++||++.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 211 LEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 7777776666555544433322111000000 000111112223 48899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.78 Aligned_cols=263 Identities=26% Similarity=0.357 Sum_probs=207.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+.|++++.||.|++|.||++.+..++..+++|.+.... ......+.+|+.+++.++|+|++++++.+..++..++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 46999999999999999999998899999999985432 2234567789999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|+.|+.+..+.......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~kl~dfg~~~~~~~~~~~~- 167 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD-IKLADFGVSAKNVKTLQRR- 167 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC-EEEccCccceecccccccc-
Confidence 99875544433322335788999999999999999999999999999999999998777 9999999876532211110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
....+++.|+|||.+.+ ...++.++|+||||+++|+|++|..||....
T Consensus 168 ----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 168 ----------------------------DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred ----------------------------ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 01134778999999853 2446889999999999999999999997765
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
......+..+. . .. .......++..+.++|.+||..+|++||++.++++||||+
T Consensus 220 ~~~~~~~~~~~---~-~~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 273 (292)
T cd06644 220 PMRVLLKIAKS---E-PP----------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS 273 (292)
T ss_pred HHHHHHHHhcC---C-Cc----------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 54433332211 0 00 0011234678899999999999999999999999999999
Q ss_pred ccccc
Q 036739 318 DVEFV 322 (323)
Q Consensus 318 ~~~~~ 322 (323)
.++..
T Consensus 274 ~~~~~ 278 (292)
T cd06644 274 SVTSN 278 (292)
T ss_pred ccccc
Confidence 88654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=311.84 Aligned_cols=287 Identities=40% Similarity=0.736 Sum_probs=221.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC-----ceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 76 (323)
++|++.+.||+|++|+||++++..++..|++|.+............+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 689999999999999999999999999999999865433333445677899999999999999999988643 358
Q ss_pred EEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 77 YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
++++||+++++.+.+.... .+++..+..++.|++.||.+||+++++|+||+|+||+++.++. +||+|||++......
T Consensus 85 ~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~-~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 85 YIVYELMDTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSEK 161 (337)
T ss_pred EEEEeCCCCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC-EEECcCccccccCCC
Confidence 9999999999988877643 5788889999999999999999999999999999999998887 999999998765322
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.. ... ...++..|+|||.+.....++.++|+||||+++|+|++|..||.+.
T Consensus 162 ~~-~~~----------------------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 162 GD-FMT----------------------------EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cc-ccc----------------------------ccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 10 000 1134778999999876456899999999999999999999999887
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccC--CcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSL--PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
+.......+....+.+..+.+...... ..+................+.+++.+.++|++||+.+|++||++.++++||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~ 292 (337)
T cd07858 213 DYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292 (337)
T ss_pred ChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence 766666555555544433322111110 001111111111112223356889999999999999999999999999999
Q ss_pred CCcccc
Q 036739 315 YFRDVE 320 (323)
Q Consensus 315 ~~~~~~ 320 (323)
||+.++
T Consensus 293 ~~~~~~ 298 (337)
T cd07858 293 YLASLH 298 (337)
T ss_pred chhhhc
Confidence 998763
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.09 Aligned_cols=282 Identities=24% Similarity=0.387 Sum_probs=207.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+..++..+|+|.+.... .......+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 68999999999999999999999899999999876542 22234568899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|+.| +|.+.+.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++. +||+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~-~kL~Dfg~~~~~~~~~~- 159 (333)
T cd06650 84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMA- 159 (333)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC-EEEeeCCcchhhhhhcc-
Confidence 9975 7777765533 468888899999999999999975 7999999999999998887 99999998865422110
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
....|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||......
T Consensus 160 ------------------------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 160 ------------------------------NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred ------------------------------ccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 01145888999999977 56889999999999999999999999876543
Q ss_pred HHHHHHHHHhC-CCCCCCC-CCcccCCc----ccccCCC---------CCCCc-cccc-ccCCChHHHHHHHhhcccCCC
Q 036739 240 DELFKIFRVLG-TPNEDTW-PGVTSLPD----FKSAFPK---------WPSKE-LGTV-VRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 240 ~~~~~~~~~~~-~~~~~~~-~~~~~~~~----~~~~~~~---------~~~~~-~~~~-~~~~s~~~~~li~~~l~~dp~ 302 (323)
+.......... ....... ........ ....... ..... .+.. ...+++.+++||.+||+.||+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 288 (333)
T cd06650 209 ELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPA 288 (333)
T ss_pred HHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcc
Confidence 33221111000 0000000 00000000 0000000 00000 0000 123678899999999999999
Q ss_pred CCCCHhhhhcCCCCccc
Q 036739 303 RRITARSALEHEYFRDV 319 (323)
Q Consensus 303 ~R~s~~~il~h~~~~~~ 319 (323)
+||++.+++.||||+..
T Consensus 289 ~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 289 ERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCcCHHHHhhCHHHhcC
Confidence 99999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=296.33 Aligned_cols=255 Identities=27% Similarity=0.468 Sum_probs=212.7
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||+|++|.||++.+..++..+++|.+............+.+|+.+++.++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 69999999999999999999999999999999876554444557788999999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+.| ++.+.+.......+++..+..++.|++.+|.+||++|++|+||+|+||+++.++..++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~- 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY- 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc-
Confidence 976 787777765555678889999999999999999999999999999999998776668999999988764322111
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
...++..|+|||.+.. ...+.++|+||+|+++|+|++|..||........
T Consensus 160 -----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 209 (256)
T cd08220 160 -----------------------------TVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPAL 209 (256)
T ss_pred -----------------------------ccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHH
Confidence 1134778999999877 5678899999999999999999999987765544
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
...+.... .......+++.+.+++.+||+.+|++||++.++++||||
T Consensus 210 ~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 210 VLKIMSGT----------------------------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHhcC----------------------------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 44333211 011123468889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=325.21 Aligned_cols=260 Identities=23% Similarity=0.358 Sum_probs=211.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc-------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK------- 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------- 74 (323)
++|++.+.||+|+||+||++.+..+++.||+|.+............+.+|+..+..+.|+|+++++..+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 6899999999999999999999999999999998766544444566778999999999999999988875322
Q ss_pred -eEEEEEecchh-hHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccc
Q 036739 75 -KLYLVFEYLDL-DLKKHMDSCP--DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (323)
Q Consensus 75 -~~~lv~e~~~g-~l~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~ 150 (323)
.+++||||+.+ +|.+.+.... ...+++..+..++.|++.||+|||+.+++|+||||+||+++.++. +||+|||++
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~-vkL~DFGls 190 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL-VKLGDFGFS 190 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC-EEEEecccC
Confidence 47899999975 8877775432 345788889999999999999999999999999999999999887 999999998
Q ss_pred eecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 151 RAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
..+........ .....||+.|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 191 ~~~~~~~~~~~---------------------------~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~ 242 (496)
T PTZ00283 191 KMYAATVSDDV---------------------------GRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLK 242 (496)
T ss_pred eeccccccccc---------------------------cccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCC
Confidence 76543211110 012356899999999987 56899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh
Q 036739 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310 (323)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i 310 (323)
.||......+....+..... .+....+++.+.+++.+||+.||.+||++.++
T Consensus 243 ~Pf~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~el 294 (496)
T PTZ00283 243 RPFDGENMEEVMHKTLAGRY----------------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKL 294 (496)
T ss_pred CCCCCCCHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 99988766555544432110 11223578899999999999999999999999
Q ss_pred hcCCCCcc
Q 036739 311 LEHEYFRD 318 (323)
Q Consensus 311 l~h~~~~~ 318 (323)
++|||++.
T Consensus 295 l~~p~~~~ 302 (496)
T PTZ00283 295 LNMPICKL 302 (496)
T ss_pred HhCHHHHH
Confidence 99999864
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=308.95 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=200.7
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|++|.||++.+..++..||+|++..... .......+.+|..+++++ +||+|+++++++.+.+.+++||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976532 223345677889988888 599999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|...+.... .+++..++.++.||+.||+|||++|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~----- 152 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDT----- 152 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC-EEEeccccceeccCCCCc-----
Confidence 6766665433 4788899999999999999999999999999999999999887 999999988643211110
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC------h
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS------E 238 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~------~ 238 (323)
.....||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||.... .
T Consensus 153 ------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~ 207 (327)
T cd05617 153 ------------------------TSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT 207 (327)
T ss_pred ------------------------eecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc
Confidence 011256889999999987 668999999999999999999999996422 1
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH------hhhhc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA------RSALE 312 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~------~~il~ 312 (323)
.+........ . .......+++.+.++|.+||+.||++|+++ .++++
T Consensus 208 ~~~~~~~~~~--~--------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 208 EDYLFQVILE--K--------------------------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred HHHHHHHHHh--C--------------------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 1222222110 0 011223478889999999999999999984 69999
Q ss_pred CCCCccccc
Q 036739 313 HEYFRDVEF 321 (323)
Q Consensus 313 h~~~~~~~~ 321 (323)
||||++++|
T Consensus 260 h~~f~~~~~ 268 (327)
T cd05617 260 HTFFRSIDW 268 (327)
T ss_pred CCCCCCCCH
Confidence 999998864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=303.50 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=213.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|.||++.+..+++.+|+|++..... .......+.+|+.+++++.||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 589999999999999999999988999999999865432 2233467888999999999999999999999999999999
Q ss_pred ecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+. ++|.+.+.... .+++..+..++.||+.||.+||+.|++|+||+|.||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~-~kl~dfg~~~~~~~~~~- 156 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY-IKITDFGFAKRVKGRTY- 156 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC-EEEeeCCCccccCCCCC-
Confidence 9995 58877776653 5688889999999999999999999999999999999998887 99999999876532200
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
...+++.|++||.+.+ ...+.++|+||||+++|+|++|..||......
T Consensus 157 -------------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 204 (290)
T cd05580 157 -------------------------------TLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPI 204 (290)
T ss_pred -------------------------------CCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1134788999999877 46788999999999999999999999877754
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEHE 314 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h~ 314 (323)
.....+... . ......+++.++++|++||..||.+|+ ++.++++||
T Consensus 205 ~~~~~~~~~--~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 205 QIYEKILEG--K---------------------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred HHHHHHhcC--C---------------------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence 444433211 0 011234678899999999999999999 999999999
Q ss_pred CCcccccc
Q 036739 315 YFRDVEFV 322 (323)
Q Consensus 315 ~~~~~~~~ 322 (323)
||+.+.|.
T Consensus 256 ~~~~~~~~ 263 (290)
T cd05580 256 WFAGIDWI 263 (290)
T ss_pred ccccCCHH
Confidence 99998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=311.92 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=200.0
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHH-HHHhcCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREIS-LLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|+||.||++.++.+++.+|+|++..... .......+..|.. +++.++||||+++++.+..++..++||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 468999999999999999999999999865432 2222234444544 56778999999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
++...+.... .+++..+..++.||+.||+|||+.|++|+||||+||+++.++. +||+|||++..........
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~-~kL~DfG~~~~~~~~~~~~---- 153 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTT---- 153 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC-EEEeecCCcccCCCCCCCc----
Confidence 6666665433 5788889999999999999999999999999999999999887 9999999876421111100
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
....|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..+....
T Consensus 154 -------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (325)
T cd05604 154 -------------------------TTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN 207 (325)
T ss_pred -------------------------ccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHH
Confidence 11256889999999987 5678999999999999999999999988776555544
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH----hhhhcCCCCcccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA----RSALEHEYFRDVE 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~----~~il~h~~~~~~~ 320 (323)
+.... ......++..+.++|++||+.+|++||++ .++++||||++++
T Consensus 208 ~~~~~-----------------------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 208 ILHKP-----------------------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred HHcCC-----------------------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 43210 01113467889999999999999999977 4899999999875
Q ss_pred c
Q 036739 321 F 321 (323)
Q Consensus 321 ~ 321 (323)
|
T Consensus 259 ~ 259 (325)
T cd05604 259 W 259 (325)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=297.41 Aligned_cols=265 Identities=28% Similarity=0.406 Sum_probs=212.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||.|++|+||++.+..++..+++|++....... ....+.+|+..++.++|+|++++++.+..++..++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 68999999999999999999988899999999986543333 45778899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCPD-FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
++.| ++.+.+..... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~-~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS-VKIADFGVSASLADGGDR 158 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC-EEEcccchHHHhccCccc
Confidence 9976 66666654332 45788889999999999999999999999999999999999887 999999998776543222
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.... .....|+..|++||.+......+.++|+||||+++++|++|..||......
T Consensus 159 ~~~~-------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~ 213 (267)
T cd06610 159 TRKV-------------------------RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM 213 (267)
T ss_pred cccc-------------------------cccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh
Confidence 1000 011245788999999887547899999999999999999999999877665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
.......+.. ..... .......+++.+.+++.+||..||++||++.++++||||
T Consensus 214 ~~~~~~~~~~----~~~~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 214 KVLMLTLQND----PPSLE-------------------TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred hhHHHHhcCC----CCCcC-------------------CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 4444433210 00000 000123578899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=310.76 Aligned_cols=288 Identities=40% Similarity=0.698 Sum_probs=217.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC-----ceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 76 (323)
++|++.+.||+|++|.||++.+..++..||+|.+... ........+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 6899999999999999999999999999999988532 2223345677899999999999999999887543 358
Q ss_pred EEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 77 YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
++++|++++++.+.+... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 ~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~-~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD-LKICDFGLARIADPE 159 (336)
T ss_pred EEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC-EEECcccceeecccc
Confidence 999999999888777543 5788889999999999999999999999999999999998887 999999998765432
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
...... .....|++.|+|||.+.+...++.++|+||+|+++|+|++|+.||...
T Consensus 160 ~~~~~~--------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 160 HDHTGF--------------------------LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccccCC--------------------------cCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 211100 001245888999999876566899999999999999999999999887
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCC--cccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLP--DFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
+.......+...+..+..+.+....... .+..................+++.+.++|.+||+.+|++||++.++++||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp 293 (336)
T cd07849 214 DYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293 (336)
T ss_pred CHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 6665555555544443332221111000 00000000011111122345688899999999999999999999999999
Q ss_pred CCcccc
Q 036739 315 YFRDVE 320 (323)
Q Consensus 315 ~~~~~~ 320 (323)
||+...
T Consensus 294 ~~~~~~ 299 (336)
T cd07849 294 YLEQYH 299 (336)
T ss_pred cccccC
Confidence 998763
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=300.87 Aligned_cols=285 Identities=41% Similarity=0.781 Sum_probs=219.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+..+++.|++|.+............+.+|+.+++.++|+||+++++++.+++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 58999999999999999999998899999999886654445556788899999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|++++++..+..... .+++..+..++.||+.||.+||+.+++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~-~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV-LKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC-EEEEeeecccccCCCccccc
Confidence 999887776655433 4788889999999999999999999999999999999998887 99999999877643322010
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
. ...++..|+|||++.....++.++|+||+|+++|+|++|..||......+.
T Consensus 159 ~----------------------------~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~ 210 (288)
T cd07833 159 T----------------------------DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ 210 (288)
T ss_pred c----------------------------CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0 113477799999998854789999999999999999999999988776666
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccc-cCCCCCC-Cc-ccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPS-KE-LGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~-~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
........+...............+.. .+..... .. .......+++.+.++|++||..+|++||++.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 211 LYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 555544433322211111100000000 0000000 00 001123358889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=296.46 Aligned_cols=258 Identities=26% Similarity=0.473 Sum_probs=208.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC---CCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE---GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|++|.||++.+..++.++++|.+....... .....+.+|+.++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 68999999999999999999998899999999886543222 123567889999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
++|++.| ++.+.+.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~-~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEeecccceeccccc
Confidence 9999976 7777766543 4678888999999999999999999999999999999998887 9999999987653211
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
..... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||....
T Consensus 159 ~~~~~--------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 159 SSGTG--------------------------MKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred ccccc--------------------------ccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 11000 001234678999999988 558999999999999999999999998776
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
............ ........+++.+.++|.+||..+|.+||++.++++||||
T Consensus 212 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 212 AMAAIFKIATQP---------------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred hHHHHHHHhccC---------------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 654444332110 0111223578889999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=311.94 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=215.0
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
.|+.+.+||+|+||.||+|.+..+++.||||++..... ....+.+++|+.++.+++++||.+.|+.|..+..++++|||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 57888999999999999999999999999999987744 44568889999999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
++| ++.+.+.... .+.+..+..++++++.||.|||..+.+|+|||+.||++..++. +|+.|||.+..+.......
T Consensus 93 ~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~-vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD-VKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred hcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc-EEEEecceeeeeechhhcc-
Confidence 976 6666655543 2366667789999999999999999999999999999999988 9999999998775433322
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
.+-+||+-|||||++.. ..|+.++||||||++.+||.+|.+|+....++..
T Consensus 169 ----------------------------~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv 219 (467)
T KOG0201|consen 169 ----------------------------KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV 219 (467)
T ss_pred ----------------------------ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceE
Confidence 12377999999999996 6799999999999999999999999998877433
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+..+- +...+.....+|+.+++||..||.+||+.||+|.++|+|+|++..
T Consensus 220 lflIp----------------------------k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 220 LFLIP----------------------------KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred EEecc----------------------------CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 32221 111222223689999999999999999999999999999999864
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=310.18 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=200.0
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHH-HHHHhcCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREI-SLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|+||+||++++..++..||+|++...... ......+..|. .+++.+.|+||+++++++.+.+..++||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999998754321 11222333343 456788999999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
++.+.+.... .+++..++.++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.........
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~-~kl~DfG~a~~~~~~~~~----- 152 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGT----- 152 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC-EEEccCCCCcccccCCCC-----
Confidence 6666665433 4677888899999999999999999999999999999998887 999999988643211110
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
.....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||......+....
T Consensus 153 ------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 207 (325)
T cd05602 153 ------------------------TSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 207 (325)
T ss_pred ------------------------cccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 011256899999999987 6689999999999999999999999988776665554
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh----hhhcCCCCcccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR----SALEHEYFRDVE 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~----~il~h~~~~~~~ 320 (323)
+.... ......+++.+.++|.+||+.||.+|+++. ++++|+||..++
T Consensus 208 i~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 208 ILNKP-----------------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred HHhCC-----------------------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 43210 011234788999999999999999999876 889999998775
Q ss_pred c
Q 036739 321 F 321 (323)
Q Consensus 321 ~ 321 (323)
|
T Consensus 259 ~ 259 (325)
T cd05602 259 W 259 (325)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=317.73 Aligned_cols=277 Identities=22% Similarity=0.283 Sum_probs=205.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
..|.+.+.||+|++|.||++.+...+..|++|... ...+.+|++++++++|+||+++++++..++..++|+|
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 36999999999999999999999999999999532 2345689999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
++.+++...+..... .+++..+..++.||+.||.|||++||+|+||||+||+++.++. ++|+|||++...........
T Consensus 241 ~~~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~-vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 241 KYRSDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED-ICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred ccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC-EEEcccCCceeccccccccc
Confidence 999999888876433 5788999999999999999999999999999999999998887 99999999876532111100
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC----
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS---- 237 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~---- 237 (323)
.....||+.|+|||++.+ ..++.++|||||||++|||++|..++....
T Consensus 319 ---------------------------~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~ 370 (461)
T PHA03211 319 ---------------------------HYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370 (461)
T ss_pred ---------------------------ccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence 011356999999999987 568999999999999999999876543221
Q ss_pred ---hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCC-----CCCCccc---ccccCCChHHHHHHHhhcccCCCCCCC
Q 036739 238 ---EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPK-----WPSKELG---TVVRNLEPAGIDLLSKMLCMDPSRRIT 306 (323)
Q Consensus 238 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~---~~~~~~s~~~~~li~~~l~~dp~~R~s 306 (323)
....+.++.+....... .++.... ..+...... ....... .....+++.+.+||.+||+.||.+||+
T Consensus 371 ~~~~~~~l~~~i~~~~~~~~-~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs 448 (461)
T PHA03211 371 RRPYDAQILRIIRQAQVHVD-EFPQHAG-SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS 448 (461)
T ss_pred cCCcHHHHHHHHHhhccccc-cCCCCcc-hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC
Confidence 11233333333222111 1110000 000000000 0000000 011245678999999999999999999
Q ss_pred HhhhhcCCCCcc
Q 036739 307 ARSALEHEYFRD 318 (323)
Q Consensus 307 ~~~il~h~~~~~ 318 (323)
+.|+|+||||++
T Consensus 449 a~elL~hp~f~~ 460 (461)
T PHA03211 449 AAELLRLPLFQS 460 (461)
T ss_pred HHHHhhCcccCC
Confidence 999999999975
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=312.55 Aligned_cols=281 Identities=37% Similarity=0.636 Sum_probs=213.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 75 (323)
++|++.+.||+|++|.||++.+..++..||+|.+............+.+|+.+++.++|+||++++++|... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 579999999999999999999999999999998865433334445677899999999999999999998643 35
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
.|+|+||+.+++.+.+... ++...+..++.|++.||++||+.|++|+||||+||+++.++. ++|+|||.+.....
T Consensus 96 ~~lv~e~~~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~-~kL~Dfg~~~~~~~ 170 (353)
T cd07850 96 VYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGT 170 (353)
T ss_pred EEEEEeccCCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC-EEEccCccceeCCC
Confidence 7999999999888887643 678888999999999999999999999999999999999887 99999999876543
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
..... ...++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 171 ~~~~~------------------------------~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 171 SFMMT------------------------------PYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred CCCCC------------------------------CCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 21100 1134778999999987 6689999999999999999999999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccC--------C-----cccccCCCCC-CCcccccccCCChHHHHHHHhhcccCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSL--------P-----DFKSAFPKWP-SKELGTVVRNLEPAGIDLLSKMLCMDP 301 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~-----~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~dp 301 (323)
.+.......+....+.+........... . .+...+.... ...........++.+.++|.+||+.||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 299 (353)
T cd07850 220 TDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP 299 (353)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCCh
Confidence 7766666555554444322110000000 0 0000000000 000001122456778999999999999
Q ss_pred CCCCCHhhhhcCCCCcc
Q 036739 302 SRRITARSALEHEYFRD 318 (323)
Q Consensus 302 ~~R~s~~~il~h~~~~~ 318 (323)
++||++.++|.||||+.
T Consensus 300 ~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 300 EKRISVDDALQHPYINV 316 (353)
T ss_pred hhCcCHHHHhcChhHhh
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.17 Aligned_cols=279 Identities=23% Similarity=0.310 Sum_probs=208.3
Q ss_pred CCcceeeeeccccceeEEEEEEcc--CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV--TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
.+|++++.||+|++|.||++.... ++..|++|.+... ....+|+.+++.++||||+++++.+......+++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 369999999999999999997543 4578999976432 2456899999999999999999999999999999
Q ss_pred EecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 80 FEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||++.+++.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++. ++|+|||++.........
T Consensus 165 ~e~~~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~-~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 165 MPKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN-AVLGDFGAACKLDAHPDT 241 (392)
T ss_pred ehhcCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC-EEEccCccccccCccccc
Confidence 999999999888443 35788899999999999999999999999999999999998887 999999998765432111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE- 238 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~- 238 (323)
.. .....||+.|+|||++.. ..++.++|+|||||++|+|++|..||.+...
T Consensus 242 ~~---------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 293 (392)
T PHA03207 242 PQ---------------------------CYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293 (392)
T ss_pred cc---------------------------ccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCC
Confidence 00 111356899999999987 5689999999999999999999999976543
Q ss_pred --HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCC-----cccc--cccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 239 --IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSK-----ELGT--VVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 239 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
...+..+.+..+..... ++.... ..+...+...... ..+. ....++..++++|.+||..||++||++.+
T Consensus 294 ~~~~~l~~i~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e 371 (392)
T PHA03207 294 SSSSQLRSIIRCMQVHPLE-FPQNGS-TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQD 371 (392)
T ss_pred CcHHHHHHHHHHhccCccc-cCCccc-hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHH
Confidence 23344444443322211 110000 0000000000000 0000 11245678999999999999999999999
Q ss_pred hhcCCCCcccc
Q 036739 310 ALEHEYFRDVE 320 (323)
Q Consensus 310 il~h~~~~~~~ 320 (323)
++.||||...+
T Consensus 372 ~l~~p~f~~~~ 382 (392)
T PHA03207 372 ILSLPLFTKEP 382 (392)
T ss_pred HhhCchhhccc
Confidence 99999998764
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=298.88 Aligned_cols=279 Identities=51% Similarity=0.922 Sum_probs=218.1
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc---CCCCeeeeeEEEecCce-----
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM---QHGNIVRLQDVVHSEKK----- 75 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~----- 75 (323)
|++.+.||+|++|.||++.++.++..||+|.+............+.+|+.+++++ .|+|++++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999988899999999876544433345566788777766 59999999999987766
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
.++++|++.+++.+.+.......+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~-~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC-EEEeccCcceeccC
Confidence 99999999998888877655546788999999999999999999999999999999999999877 99999999877543
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
..... ...++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||..
T Consensus 160 ~~~~~------------------------------~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 160 EMALT------------------------------SVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred Ccccc------------------------------cccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 21110 0134778999999987 5688999999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
....+...++.+.........++...... ...+..............+++.+.++|++||+.||++||++.+++.|||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~ 286 (287)
T cd07838 209 TSEADQLDKIFDVIGLPSEEEWPRNVSLP--RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286 (287)
T ss_pred CChHHHHHHHHHHcCCCChHhcCCCcccc--hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence 88877777776655443333222111100 0111111111122333456788999999999999999999999999999
Q ss_pred C
Q 036739 316 F 316 (323)
Q Consensus 316 ~ 316 (323)
|
T Consensus 287 ~ 287 (287)
T cd07838 287 F 287 (287)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=299.37 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=210.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||.|++|.||++.+..++..+++|.+.... .......+.+|+.+++.++|+|++++++++.++...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 58999999999999999999998899999999986543 22334567889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
++.+ ++.+.+... .+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 80 ~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~-~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD-VKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-EEEcccccceeeccccccc
Confidence 9976 777776654 5788889999999999999999999999999999999999887 9999999987765432111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.......
T Consensus 156 ~-----------------------------~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~ 205 (274)
T cd06609 156 N-----------------------------TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMR 205 (274)
T ss_pred c-----------------------------cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHH
Confidence 0 1134778999999987 448999999999999999999999998766544
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCccccccc-CCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVR-NLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
....+.... . ..... .+++.+.+++.+||..+|++||++.++++||||++.
T Consensus 206 ~~~~~~~~~----~------------------------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 206 VLFLIPKNN----P------------------------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred HHHHhhhcC----C------------------------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 433322210 0 00111 267889999999999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=309.78 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=199.0
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHH-HHHHhcCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREI-SLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|++|.||+|++..++..||+|++..... .......+..|. .+++.++||||+++++.+.+.+..++||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999865432 222223444444 467889999999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
++...+... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++..........
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~~~~---- 153 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGVEPEETT---- 153 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC-EEEccCCCCccCCCCCCcc----
Confidence 666666543 24678888899999999999999999999999999999999887 9999999876432111100
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
....|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......
T Consensus 154 -------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 207 (321)
T cd05603 154 -------------------------STFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDN 207 (321)
T ss_pred -------------------------ccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHH
Confidence 01245889999999877 5689999999999999999999999988765554444
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH----hhhhcCCCCcccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA----RSALEHEYFRDVE 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~----~~il~h~~~~~~~ 320 (323)
+... . .......+..+.++|.+||+.||.+|+++ .++++|+||..++
T Consensus 208 i~~~---~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 208 ILHK---P--------------------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred HhcC---C--------------------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 3321 0 01123467889999999999999999976 4999999998875
Q ss_pred c
Q 036739 321 F 321 (323)
Q Consensus 321 ~ 321 (323)
|
T Consensus 259 ~ 259 (321)
T cd05603 259 W 259 (321)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=309.10 Aligned_cols=257 Identities=32% Similarity=0.517 Sum_probs=228.0
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
|.+.+.||+|.|+.|-+|++-.+|+.||+|++.+...+......+.+|++-|+.++||||+++|....+...+|+|.|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 77889999999999999999999999999999988888888889999999999999999999999999999999999999
Q ss_pred hh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 84 DL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 84 ~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
+| ++.+++++... .+++..+++++.||+.|+.|+|+..+||+||||+||++.+.-.-+||+|||++..+.+......
T Consensus 100 D~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T- 177 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT- 177 (864)
T ss_pred CCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc-
Confidence 65 99999988765 4799999999999999999999999999999999999866555599999999988755443322
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~ 242 (323)
-+|++.|.|||.+.+..+.-++.||||||+|+|-|+.|++||...++.+.+
T Consensus 178 -----------------------------sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL 228 (864)
T KOG4717|consen 178 -----------------------------SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL 228 (864)
T ss_pred -----------------------------ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh
Confidence 277999999999999777788999999999999999999999998888887
Q ss_pred HHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
-.+..-. =.++..+|.++++||+.||..||.+|.++++|..|+|++.++
T Consensus 229 TmImDCK-----------------------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 229 TMIMDCK-----------------------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred hhhhccc-----------------------------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 7765411 123356899999999999999999999999999999999874
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.44 Aligned_cols=259 Identities=30% Similarity=0.427 Sum_probs=207.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||.|++|.||++.+..++..+++|.+.... ......+..|+.+++.++|+|++++++.+.++...++|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 68999999999999999999998889999999986432 2233567789999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| ++.+.+.. ....+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 83 ~~~~~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~-~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 83 FCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD-VKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred ccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC-EEEccCccchhhccccccc
Confidence 9987 55555443 3335788899999999999999999999999999999999998887 9999999876543211100
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
....+++.|+|||.+.. ...++.++|+||||+++|+|++|..||...
T Consensus 161 -----------------------------~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 161 -----------------------------DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred -----------------------------ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 01245788999999852 244678999999999999999999999877
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
........+..... .. ......++..+.++|.+||+.+|.+||++.++++||||
T Consensus 212 ~~~~~~~~~~~~~~----~~----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 212 NPMRVLLKILKSEP----PT----------------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred CHHHHHHHHhcCCC----CC----------------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 65544433322100 00 00113467889999999999999999999999999999
Q ss_pred ccc
Q 036739 317 RDV 319 (323)
Q Consensus 317 ~~~ 319 (323)
.+.
T Consensus 266 ~~~ 268 (280)
T cd06611 266 SDQ 268 (280)
T ss_pred ccc
Confidence 876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=293.79 Aligned_cols=259 Identities=30% Similarity=0.414 Sum_probs=213.7
Q ss_pred CCcce-eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEec----Cce
Q 036739 2 DQYEK-VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS----EKK 75 (323)
Q Consensus 2 ~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~ 75 (323)
++|++ .+.||-|-.|.|-.+.++.+++.+|+|++. +....++|+++.-.. .|||||.+++.|.+ ...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-------DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHh-------cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 56777 578999999999999999999999999873 235667888875444 69999999999864 467
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEecccccee
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARA 152 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~~ 152 (323)
+.+|||.++| .|++.+..+.+.++.+.++..|++||..|+.|||+.+|.||||||+|+|+..... .+||+|||++..
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 8999999975 9999999999999999999999999999999999999999999999999966444 699999999977
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
-......... +-|+.|.|||++-. ..|+..-|+||+|+++|-|+.|.+|
T Consensus 214 t~~~~~L~TP------------------------------c~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPP 262 (400)
T KOG0604|consen 214 TQEPGDLMTP------------------------------CFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPP 262 (400)
T ss_pred cCCCccccCC------------------------------cccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCc
Confidence 5433332222 34999999999877 5689999999999999999999999
Q ss_pred CCCCChH----HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 233 FPGDSEI----DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 233 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|.+.... ....++..+......+ -+..+|+.++++|+++|..+|++|.++.
T Consensus 263 FYS~hg~aispgMk~rI~~gqy~FP~p-------------------------EWs~VSe~aKdlIR~LLkt~PteRlTI~ 317 (400)
T KOG0604|consen 263 FYSNHGLAISPGMKRRIRTGQYEFPEP-------------------------EWSCVSEAAKDLIRKLLKTEPTERLTIE 317 (400)
T ss_pred ccccCCccCChhHHhHhhccCccCCCh-------------------------hHhHHHHHHHHHHHHHhcCCchhheeHH
Confidence 9876542 2223333332222222 2345889999999999999999999999
Q ss_pred hhhcCCCCccccccC
Q 036739 309 SALEHEYFRDVEFVP 323 (323)
Q Consensus 309 ~il~h~~~~~~~~~~ 323 (323)
+++.|||+++-+-||
T Consensus 318 ~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 318 EVMDHPWINQYEAVP 332 (400)
T ss_pred HhhcCchhcccccCC
Confidence 999999999988776
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=312.96 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=198.3
Q ss_pred eccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhc---CCCCeeeeeEEEecCceEEEEEecchh
Q 036739 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM---QHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 10 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
||+|+||+||++++..++..||+|++..... ..........|..++... .||||+++++.+.+...+++||||+.|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999999999999999999865432 122223344566666555 699999999999999999999999975
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|...+.... .+++..+..++.||+.||+|||++|++|+||||+||+++.++. ++|+|||++.........
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~-~kl~Dfg~a~~~~~~~~~----- 152 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKT----- 152 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC-EEEecCCcCcCCCCCCCC-----
Confidence 7776665533 5688889999999999999999999999999999999999887 999999988643211110
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
.....||+.|+|||.+.+...++.++|+|||||++|+|++|..||......+....
T Consensus 153 ------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~ 208 (330)
T cd05586 153 ------------------------TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN 208 (330)
T ss_pred ------------------------ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH
Confidence 01125689999999998756689999999999999999999999988766555444
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC----CHhhhhcCCCCcccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI----TARSALEHEYFRDVE 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~----s~~~il~h~~~~~~~ 320 (323)
+.... . . .....+++.+.++|.+||+.||.+|| ++.++++||||.+..
T Consensus 209 i~~~~--~---~-----------------------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 209 IAFGK--V---R-----------------------FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred HHcCC--C---C-----------------------CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 32210 0 0 00123688899999999999999998 789999999998764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=308.41 Aligned_cols=287 Identities=33% Similarity=0.624 Sum_probs=213.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC--------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-------- 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-------- 73 (323)
.+|++.+.||.|++|.||++++..++..|++|.+..... .....+.+|+.+++.++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 589999999999999999999999999999998865432 3346778899999999999999999876543
Q ss_pred ------ceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 74 ------KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 74 ------~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
...++|+||+++++.+.+... .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++..++|+||
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccccceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 357999999998887777543 46888899999999999999999999999999999999866666999999
Q ss_pred ccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH
Q 036739 148 GLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~ 227 (323)
|.+............. ....++..|+|||.+.....++.++|+|||||++|+|+
T Consensus 160 g~~~~~~~~~~~~~~~--------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~ 213 (342)
T cd07854 160 GLARIVDPHYSHKGYL--------------------------SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213 (342)
T ss_pred ccceecCCcccccccc--------------------------ccccccccccCHHHHhCccccCchhhHHHHHHHHHHHH
Confidence 9987653221111000 01134778999998876567889999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcc-cCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC
Q 036739 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVT-SLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT 306 (323)
Q Consensus 228 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 306 (323)
+|+.||......+..................... ..+....................++..+.+||++||+.||++||+
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 293 (342)
T cd07854 214 TGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC
Confidence 9999998887766655544432221111100000 000000000000011111223457889999999999999999999
Q ss_pred HhhhhcCCCCccc
Q 036739 307 ARSALEHEYFRDV 319 (323)
Q Consensus 307 ~~~il~h~~~~~~ 319 (323)
+.++++||||+..
T Consensus 294 ~~ell~h~~~~~~ 306 (342)
T cd07854 294 AEEALMHPYMSCY 306 (342)
T ss_pred HHHHhCCCccccc
Confidence 9999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=297.26 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=203.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecC------c
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE------K 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~------~ 74 (323)
++|++.+.||+|++|.||++.++.++..||+|.+.... .....+.+|+.+++.+ +|+|++++++++... .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 46899999999999999999999999999999986432 2335778899999998 699999999998642 4
Q ss_pred eEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
.+++++||+.+ ++.+.+.......+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||++...
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~-~~l~Dfg~~~~~ 161 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQL 161 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC-EEEccCCCceec
Confidence 68999999976 7777776655556788889999999999999999999999999999999999887 999999998765
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHhC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQ 229 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~tg 229 (323)
....... ....|++.|+|||++.. ...++.++|+||+||++|+|++|
T Consensus 162 ~~~~~~~-----------------------------~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g 212 (272)
T cd06637 162 DRTVGRR-----------------------------NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212 (272)
T ss_pred ccccccC-----------------------------CcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhC
Confidence 3221110 11245888999999863 23578899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
..||............... . ........++..+.+|+.+||+.||++||++.+
T Consensus 213 ~~p~~~~~~~~~~~~~~~~---~------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 265 (272)
T cd06637 213 APPLCDMHPMRALFLIPRN---P------------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQ 265 (272)
T ss_pred CCCccccCHHHHHHHHhcC---C------------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence 9999766544333322110 0 000111246788999999999999999999999
Q ss_pred hhcCCCC
Q 036739 310 ALEHEYF 316 (323)
Q Consensus 310 il~h~~~ 316 (323)
+++||||
T Consensus 266 il~~~~~ 272 (272)
T cd06637 266 LMKHPFI 272 (272)
T ss_pred HhhCCCC
Confidence 9999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=292.16 Aligned_cols=255 Identities=25% Similarity=0.443 Sum_probs=213.5
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++++.||.|++|.||.+.+..++..+++|.+............+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 69999999999999999999999999999999876544444556788999999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+.| ++.+.+.......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. +||+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~-~kl~d~~~~~~~~~~~~~~- 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL-IKLGDFGISKILGSEYSMA- 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC-EEECcCcceEEcccccccc-
Confidence 975 8888777655556788899999999999999999999999999999999999887 9999999987654322100
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
....+++.|.|||.+.+ ...+.++|+||+|+++|+|++|..||......+.
T Consensus 159 ----------------------------~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~ 209 (256)
T cd08221 159 ----------------------------ETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL 209 (256)
T ss_pred ----------------------------cccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 11245888999999887 4578899999999999999999999988766655
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
...+..... ......++..+.++|.+||+.+|.+||++.++++|||+
T Consensus 210 ~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 210 VVKIVQGNY----------------------------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHcCCC----------------------------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 555432110 01113467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=301.04 Aligned_cols=256 Identities=22% Similarity=0.395 Sum_probs=202.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+..++..||+|.+.... .......+.+|+.+++++.||||+++++++...+..++|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 57999999999999999999999999999999886442 22233568889999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|++++.+.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~-~~l~dfg~~~~~~~~~~~-- 151 (279)
T cd06619 80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ-VKLCDFGVSTQLVNSIAK-- 151 (279)
T ss_pred cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC-EEEeeCCcceeccccccc--
Confidence 99885554332 3577888899999999999999999999999999999999887 999999998765322111
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
...|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+.
T Consensus 152 -----------------------------~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~ 201 (279)
T cd06619 152 -----------------------------TYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG 201 (279)
T ss_pred -----------------------------CCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhccccc
Confidence 1245788999999987 5689999999999999999999999965322111
Q ss_pred ---HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 242 ---LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 242 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.....+......... ......++.+.++|.+||+.+|++||++.++++||||..
T Consensus 202 ~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 202 SLMPLQLLQCIVDEDPPV-----------------------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred ccchHHHHHHHhccCCCC-----------------------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 011111110000000 011236788999999999999999999999999999986
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 259 ~ 259 (279)
T cd06619 259 Y 259 (279)
T ss_pred c
Confidence 5
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=294.40 Aligned_cols=256 Identities=29% Similarity=0.511 Sum_probs=211.3
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||+|++|.||++.+..++..+++|.+............+.+|+.+++.++|+|++++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 68999999999999999999999999999999876544444456788999999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+.+ ++.+.+.......+++..+..++.|++.||.+||+.+++|+||+|+||+++.++..++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~- 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA- 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc-
Confidence 965 888877766555678889999999999999999999999999999999999887667999999887654221110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
....|++.|+|||.+.. ..++.++|+||+|+++++|++|..||......+.
T Consensus 160 ----------------------------~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 210 (257)
T cd08225 160 ----------------------------YTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL 210 (257)
T ss_pred ----------------------------cccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 01134788999999877 5688999999999999999999999987665544
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
...+.... .......++..+.++|.+|+..+|++||++.++++||||
T Consensus 211 ~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 211 VLKICQGY----------------------------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccc----------------------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 43332110 011123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=306.85 Aligned_cols=247 Identities=28% Similarity=0.431 Sum_probs=207.8
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
+++++.||+|.||.||++.. .....||+|.++..... .+.|.+|+.+|++++|+||+++++++..+..++|||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHhcCCccceEEEEEE-cCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 45688999999999999997 34448999998655333 367889999999999999999999999988999999999
Q ss_pred h-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 84 D-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 84 ~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
. |+|++++....+..++......++.||++|++||++++++||||...|||++.+.. +||+|||+++......=..
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~-vKIsDFGLAr~~~d~~Y~~-- 360 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV-VKISDFGLARLIGDDEYTA-- 360 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce-EEEcccccccccCCCceee--
Confidence 4 79999999866667788888899999999999999999999999999999998876 9999999998432111110
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDE 241 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~ 241 (323)
..|. .-...|.|||.+.. ..++.||||||||++||||+| |+.||......+.
T Consensus 361 -------------------~~~~-------kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev 413 (468)
T KOG0197|consen 361 -------------------SEGG-------KFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV 413 (468)
T ss_pred -------------------cCCC-------CCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHH
Confidence 0011 11456999999988 668999999999999999999 9999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+..+.++...+-+. .+|+.+.++++.||..+|++|||...+..
T Consensus 414 ~~~le~GyRlp~P~----------------------------~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 414 LELLERGYRLPRPE----------------------------GCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHHhccCcCCCCC----------------------------CCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 99988765554333 48899999999999999999999986654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=320.84 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=209.1
Q ss_pred CcceeeeeccccceeEEEEEEccC-CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVT-NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.|.+.+.||+|++|.||+|.+..+ +..|++|.+.... ......+..|+.+++.++||||+++++++..++.+|+|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 389999999999999999998777 7788898764332 2233567789999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 82 YLDL-DLKKHMDSC--PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g-~l~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|+.| +|.+.+... ....+++..+..++.||+.||+|||+.+|+||||||+||+++.++. +||+|||++........
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~-~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-IKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc-EEEEeCcCceecCCccc
Confidence 9965 777666432 2345788889999999999999999999999999999999998887 99999999876542211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.. ......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.....
T Consensus 225 ~~---------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 225 LD---------------------------VASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276 (478)
T ss_pred cc---------------------------cccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 10 0111356999999999887 5689999999999999999999999988776
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+...... +....+++.+.++|.+||+.||++||++.+++.|+|++.
T Consensus 277 ~~~~~~~~~~~~~----------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 277 REIMQQVLYGKYD----------------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHHhCCCC----------------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 6655554432110 111347788999999999999999999999999999875
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
+
T Consensus 329 ~ 329 (478)
T PTZ00267 329 V 329 (478)
T ss_pred H
Confidence 4
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=300.20 Aligned_cols=258 Identities=30% Similarity=0.485 Sum_probs=206.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.+|++++.||+|++|.||++.+..++..|++|.+..... ...+.+.+|+.+++.++|+|++++++++..+...++|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 589999999999999999999988999999998865432 234667889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| ++.+.+.+. .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 97 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~-~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 97 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred ccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEECcCccceEccCCccCc
Confidence 9976 666665432 4678888999999999999999999999999999999998887 9999999887653322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...+++.|+|||.+.+ ..++.++|+||+|+++|++++|..||.......
T Consensus 173 ~-----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~ 222 (297)
T cd06656 173 S-----------------------------TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (297)
T ss_pred C-----------------------------cccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch
Confidence 0 1134778999999987 567899999999999999999999997655432
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
........ +.+ .......+++.+.++|.+||..+|++||++.++++||||+...
T Consensus 223 ~~~~~~~~-~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 223 ALYLIATN-GTP-------------------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred heeeeccC-CCC-------------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 22111100 000 0011234678899999999999999999999999999998765
Q ss_pred c
Q 036739 321 F 321 (323)
Q Consensus 321 ~ 321 (323)
.
T Consensus 277 ~ 277 (297)
T cd06656 277 P 277 (297)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=298.79 Aligned_cols=257 Identities=29% Similarity=0.496 Sum_probs=208.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.+|++.+.||.|++|+||++.+..+++.|++|.+..... .....+.+|+..++.++|+|++++++.+..+...++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 469999999999999999999999999999998865432 234677889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| ++...+... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 97 ~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~-~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 97 YLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS-VKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred ecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEccCccchhcccccccC
Confidence 9976 555554432 4688889999999999999999999999999999999998887 9999999887654322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.......
T Consensus 173 ~-----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~ 222 (296)
T cd06655 173 S-----------------------------TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (296)
T ss_pred C-----------------------------CcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0 1134778999999877 557899999999999999999999998877655
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
....+.... ... ......+++.+.++|.+||..||++||++.+++.||||+...
T Consensus 223 ~~~~~~~~~-~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 223 ALYLIATNG-TPE-------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHHhcC-Ccc-------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 443332210 000 011234778899999999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=297.82 Aligned_cols=257 Identities=28% Similarity=0.487 Sum_probs=207.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.+|++.+.||+|++|.||++.+..++..+++|.+...... ....+.+|+.+++.+.|+|++++++.+..+...++|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 5899999999999999999999889999999988654322 24678889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| ++.+.+... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 98 ~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~-~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 98 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred ccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC-EEECccccchhcccccccc
Confidence 9976 666665432 4678888999999999999999999999999999999998887 9999999887643221111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.......
T Consensus 174 ~-----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~ 223 (296)
T cd06654 174 S-----------------------------TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (296)
T ss_pred C-----------------------------cccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0 1134788999999887 557899999999999999999999998776544
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
........ .. .. ......+++.+.++|.+||..+|++||++.++++||||...+
T Consensus 224 ~~~~~~~~-~~---~~----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 224 ALYLIATN-GT---PE----------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred hHHHHhcC-CC---CC----------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 33322110 00 00 011234678899999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=293.36 Aligned_cols=253 Identities=29% Similarity=0.484 Sum_probs=205.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+..++..+++|.+..... ...+.+|+.+++.++|+|++++++.+.+....++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 689999999999999999999988899999999864422 5788899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
++++ ++.+.+... ...+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 79 ~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~-~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 79 YCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ-AKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred cCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc-EEEcccccchhcccCcccc
Confidence 9987 666555433 345788899999999999999999999999999999999999887 9999999987654322110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.......
T Consensus 157 -----------------------------~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~ 206 (256)
T cd06612 157 -----------------------------NTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206 (256)
T ss_pred -----------------------------ccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh
Confidence 01134778999999877 568899999999999999999999998765433
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
....+.. .... .......++..+.++|.+||+.||++||++.++++||||
T Consensus 207 ~~~~~~~----~~~~----------------------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 207 AIFMIPN----KPPP----------------------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hhhhhcc----CCCC----------------------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 2221110 0000 001123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=307.20 Aligned_cols=282 Identities=40% Similarity=0.708 Sum_probs=214.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 75 (323)
++|.+.+.||+|++|.||+|++..+++.||+|.+............+.+|+.+++.+.|+||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 689999999999999999999988999999998865443333445678899999999999999999998643 35
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
+++|+|++.+++.+... ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 95 ~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~-~kL~dfg~~~~~~~ 169 (342)
T cd07879 95 FYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE-LKILDFGLARHADA 169 (342)
T ss_pred EEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEeeCCCCcCCCC
Confidence 69999999877666542 24688889999999999999999999999999999999999887 99999998865321
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
... ...++..|+|||.+.+...++.++|+||||+++|+|++|+.||..
T Consensus 170 ~~~--------------------------------~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 170 EMT--------------------------------GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred CCC--------------------------------CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 110 013477899999987755688999999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccC--CcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSL--PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
......+..+....+.+........... ..+...................++.+.++|.+||+.||++||++.+++.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 218 KDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 7766666555554332221111111000 00000111111111222234578889999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||++++
T Consensus 298 ~~f~~~~ 304 (342)
T cd07879 298 PYFDSFR 304 (342)
T ss_pred cchhhcc
Confidence 9999875
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.20 Aligned_cols=259 Identities=27% Similarity=0.357 Sum_probs=205.2
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
-|++.+.||+|++|.||++.+..++..+++|.+.... ......+.+|+.+++.+.|+|++++++++..++..++|+||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 4788999999999999999998899999999885332 12245677899999999999999999999999999999999
Q ss_pred chhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 83 LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 83 ~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
+.++.+..+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~-~kl~dfg~~~~~~~~~~~~-- 160 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRR-- 160 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC-EEEcccccccccccccccc--
Confidence 9875544433333345788899999999999999999999999999999999998887 9999999886543211100
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
....+++.|+|||++.. ...++.++|+||+||++|+|++|..||.....
T Consensus 161 ---------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 213 (282)
T cd06643 161 ---------------------------DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213 (282)
T ss_pred ---------------------------ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH
Confidence 01234788999999842 24567899999999999999999999987766
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+.+.... .......++..+.++|.+||+.||++||++.++++||||+.
T Consensus 214 ~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 214 MRVLLKIAKSEPP--------------------------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred HHHHHHHhhcCCC--------------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 5554443321100 00111246788999999999999999999999999999985
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 268 ~ 268 (282)
T cd06643 268 N 268 (282)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.22 Aligned_cols=259 Identities=24% Similarity=0.414 Sum_probs=202.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHH-HHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISL-LKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||.||++++..+|+.||+|.+........ ...+..|+.. ++..+|||++++++++..++..+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 589999999999999999999999999999998865432222 2344445554 66778999999999999999999999
Q ss_pred ecchhhHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 81 EYLDLDLKKHMDSC--PDFANDPRLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 81 e~~~g~l~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||++|++.+.+... ....+++..+..++.||+.||.|||++ +++|+||+|+||+++.++. +||+|||.+.......
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~-~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-VKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC-EEEeeccccccccccc
Confidence 99999887776542 234678999999999999999999997 9999999999999998887 9999999986542111
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC---CCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS---RHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
.. ....++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||.
T Consensus 159 ~~------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (283)
T cd06617 159 AK------------------------------TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208 (283)
T ss_pred cc------------------------------ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence 00 012347789999988652 346789999999999999999999996
Q ss_pred CCC-hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 235 GDS-EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 235 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
... ..+.+.......... .....+++.+.++|.+||..+|.+||++.++++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 209 SWKTPFQQLKQVVEEPSPQ---------------------------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ccccCHHHHHHHHhcCCCC---------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 533 223332222110000 0012368889999999999999999999999999
Q ss_pred CCCccc
Q 036739 314 EYFRDV 319 (323)
Q Consensus 314 ~~~~~~ 319 (323)
|||...
T Consensus 262 ~~~~~~ 267 (283)
T cd06617 262 PFFELH 267 (283)
T ss_pred chhhhc
Confidence 999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=308.71 Aligned_cols=290 Identities=40% Similarity=0.706 Sum_probs=220.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEec--CceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS--EKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~l 78 (323)
++|++.+.||+|++|.||++.+..++..+++|.+............+.+|+.+++++ +|+||+++++++.. ....++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 689999999999999999999988899999998865433333345677899999999 99999999999864 346899
Q ss_pred EEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 79 VFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|+||+.+++.+.+... .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 87 v~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~-~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 87 VFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEE 162 (337)
T ss_pred EecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc-EEEeeccchhccccccc
Confidence 9999999888887654 5677788899999999999999999999999999999999887 99999999876643322
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
...... .....|++.|+|||.+.+...++.++|+||||+++|+|++|+.||.....
T Consensus 163 ~~~~~~------------------------~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 163 NPENPV------------------------LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred cccCcc------------------------hhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 110000 00124588899999987756688999999999999999999999988877
Q ss_pred HHHHHHHHHHhCCCCCCCCCCccc--CCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
.+...++....+.+....+..... ...+................+.++..+.++|.+||+.||++||++.++++||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~ 298 (337)
T cd07852 219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298 (337)
T ss_pred HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhh
Confidence 777666665544332211110000 000001111111111223334578899999999999999999999999999999
Q ss_pred ccc
Q 036739 317 RDV 319 (323)
Q Consensus 317 ~~~ 319 (323)
++.
T Consensus 299 ~~~ 301 (337)
T cd07852 299 AQF 301 (337)
T ss_pred hhh
Confidence 876
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=308.72 Aligned_cols=282 Identities=39% Similarity=0.704 Sum_probs=217.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCce------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKK------ 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------ 75 (323)
++|++.+.||+|++|.||++.+..++..|++|++............+.+|+.+++.+.|+|++++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 57999999999999999999998899999999886543333344567789999999999999999988865543
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
.++|+|++++++.+.+... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 95 ~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~-~kL~dfg~~~~~~~ 170 (343)
T cd07851 95 VYLVTHLMGADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLARHTDD 170 (343)
T ss_pred EEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC-EEEccccccccccc
Confidence 8999999988888877652 5788889999999999999999999999999999999998887 99999999876532
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.... ..++..|+|||.+.+...++.++|+||||+++|++++|+.||..
T Consensus 171 ~~~~--------------------------------~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 171 EMTG--------------------------------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred cccC--------------------------------CcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2110 13377799999987655678999999999999999999999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCccc--CCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
......+..+.+..+.+.+..+..... ...+..................+++.+.++|.+||+.||++||++.+|++|
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 877776666665544333221111110 000000111111111122234568899999999999999999999999999
Q ss_pred CCCccc
Q 036739 314 EYFRDV 319 (323)
Q Consensus 314 ~~~~~~ 319 (323)
|||...
T Consensus 299 ~~~~~~ 304 (343)
T cd07851 299 PYLAEY 304 (343)
T ss_pred CCcccc
Confidence 999865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=306.34 Aligned_cols=282 Identities=38% Similarity=0.710 Sum_probs=215.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc------e
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK------K 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~ 75 (323)
++|++++.||+|++|.||++.+..++..||+|.+............+.+|+.+++.++|+||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 6899999999999999999999899999999988544333333456778999999999999999999987543 4
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
+++|+|++++++...+... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 95 ~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~-~kl~dfg~~~~~~~ 170 (343)
T cd07880 95 FYLVMPFMGTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQTDS 170 (343)
T ss_pred EEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEeeccccccccc
Confidence 6999999977887776542 4788889999999999999999999999999999999998887 99999998875432
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.... ..+++.|++||.+.+...++.++|+||||+++|++++|..||..
T Consensus 171 ~~~~--------------------------------~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 171 EMTG--------------------------------YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred Cccc--------------------------------cccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1110 13377899999987655688999999999999999999999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcc--cCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVT--SLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.........+.+.............. .......................+++.+.++|.+||+.||++||++.+++.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 219 HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 77665555554433222111000000 0000111111111112223345678899999999999999999999999999
Q ss_pred CCCccc
Q 036739 314 EYFRDV 319 (323)
Q Consensus 314 ~~~~~~ 319 (323)
|||+..
T Consensus 299 ~~~~~~ 304 (343)
T cd07880 299 PYFEEF 304 (343)
T ss_pred ccHhhh
Confidence 999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=329.89 Aligned_cols=261 Identities=30% Similarity=0.541 Sum_probs=208.4
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--CceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (323)
+++|++++.||.|+||+||+|.+..++..|++|.+............+..|+.+++.++||||++++++|.+ ...+|+
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 478999999999999999999999999999999987655444445678899999999999999999999854 457999
Q ss_pred EEecchh-hHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccCCCCCCcEEEecCC---------
Q 036739 79 VFEYLDL-DLKKHMDSCP--DFANDPRLIKTFLYQILRGIAYCHSH-------RVLHRDLKPQNLLIDRRT--------- 139 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~-------~i~H~dl~~~Nil~~~~~--------- 139 (323)
||||+.+ +|.+.+.... ...+++..++.|+.||+.||.|||+. +|+|+||||+|||++.+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999975 7877775422 24578999999999999999999984 499999999999996421
Q ss_pred -------CceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-CCCC
Q 036739 140 -------NALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-RHYS 211 (323)
Q Consensus 140 -------~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~ 211 (323)
..+||+|||++......... ....||+.|+|||++... ..++
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~------------------------------~s~vGTp~YmAPEvL~ge~~~~s 221 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIESMA------------------------------HSCVGTPYYWSPELLLHETKSYD 221 (1021)
T ss_pred ccccCCCCceEEccCCccccccccccc------------------------------cccCCCccccCHHHHhccCCCCC
Confidence 13899999998765322111 012568999999998652 4578
Q ss_pred CchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHH
Q 036739 212 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291 (323)
Q Consensus 212 ~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 291 (323)
.++|||||||++|+|++|..||........+....... +. ......++.+.+
T Consensus 222 ~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~--p~--------------------------lpi~~~S~eL~d 273 (1021)
T PTZ00266 222 DKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG--PD--------------------------LPIKGKSKELNI 273 (1021)
T ss_pred chhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC--CC--------------------------CCcCCCCHHHHH
Confidence 99999999999999999999998766554443332210 00 001235788999
Q ss_pred HHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 292 LLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 292 li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
||..||+.+|.+||++.++|.|||+..+
T Consensus 274 LI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 274 LIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 9999999999999999999999999865
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.05 Aligned_cols=281 Identities=43% Similarity=0.767 Sum_probs=221.6
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEEEec
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
|++.+.||+|++|.||+|....+++.|++|.+...... .......+|+..++.+. |+|++++++++.+++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 78899999999999999999888999999988544322 12234456889999999 99999999999999999999999
Q ss_pred chhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 83 LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 83 ~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
++|++.+.+.......+++..+..++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~-~~l~d~~~~~~~~~~~~~~-- 156 (283)
T cd07830 80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV-VKIADFGLAREIRSRPPYT-- 156 (283)
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC-EEEeecccceeccCCCCcC--
Confidence 9889998888766556789999999999999999999999999999999999999887 9999999987653221100
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~ 242 (323)
...++..|+|||.+.....++.++|+||||+++++|++|..||......+..
T Consensus 157 ----------------------------~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~ 208 (283)
T cd07830 157 ----------------------------DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL 208 (283)
T ss_pred ----------------------------CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH
Confidence 0133777999999876566899999999999999999999999988888887
Q ss_pred HHHHHHhCCCCCCCCCCcccCCc-ccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 243 FKIFRVLGTPNEDTWPGVTSLPD-FKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
.++....+.+....+........ ....................++.+.++|++||+.+|++||++.+++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 209 YKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 77777666655544433222111 111111111122222233447889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=292.71 Aligned_cols=263 Identities=28% Similarity=0.501 Sum_probs=207.0
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC----CCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE----GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
+|+..+.||+|++|.||++.+..+++.+++|++....... .....+.+|+.+++.++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5889999999999999999998999999999986443211 124577889999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
|+||+.| +|.+.+.... .+++..+..++.||+.||.+||++|++|+||+|+||+++.++..++|+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 9999987 5666554432 568888999999999999999999999999999999998777669999999987765432
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
...... .....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||....
T Consensus 159 ~~~~~~-------------------------~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 159 TGAGEF-------------------------QGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccCCcc-------------------------ccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 111100 011245788999999877 567899999999999999999999997654
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
.......+.+..... ........+++.+.+++.+||..+|++||++.++++||||+
T Consensus 213 ~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 213 HSNHLALIFKIASAT------------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CcchHHHHHHHhccC------------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 433222222111000 01112234778899999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=300.55 Aligned_cols=282 Identities=40% Similarity=0.713 Sum_probs=214.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec-CceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 80 (323)
++|++.+.||.|++|.||++.+..++..|++|.+............+.+|+.+++.++|||++++.+++.. ....++++
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 68999999999999999999999999999999886544434445678889999999999999999999865 56789999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++++++.+.+... .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 90 e~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~-~~l~dfg~~~~~~~~~~~- 164 (328)
T cd07856 90 ELLGTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD-LKICDFGLARIQDPQMTG- 164 (328)
T ss_pred ehhccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC-EEeCccccccccCCCcCC-
Confidence 99988887766543 4577788899999999999999999999999999999998887 999999988654221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
..+++.|+|||.+.+...++.++|+||||+++|+|++|..||.......
T Consensus 165 -------------------------------~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~ 213 (328)
T cd07856 165 -------------------------------YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213 (328)
T ss_pred -------------------------------CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1336779999987664568999999999999999999999998877655
Q ss_pred HHHHHHHHhCCCCCCCCCCccc--CCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
....+.+.++.+.......... ...+................+.+++.+.++|++||+.+|++||++.+++.||||..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred HHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 5544444433332211110000 00000111111111111223457889999999999999999999999999999975
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 294 ~ 294 (328)
T cd07856 294 Y 294 (328)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=290.70 Aligned_cols=257 Identities=31% Similarity=0.450 Sum_probs=206.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||.|++|.||++.+..++..+++|++...... ....+.+|+.+++.++|||++++++.+.++..++++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 6899999999999999999999888999999998654322 45788899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| ++.+.+... ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~-~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 81 YCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKR 158 (262)
T ss_pred CCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC-EEECccccchhhhhhhhcc
Confidence 9987 555554443 235788899999999999999999999999999999999998887 9999999986643221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS--RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
....++..|+|||.+... ..++.++|+||+|+++|+|++|..||.....
T Consensus 159 -----------------------------~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~ 209 (262)
T cd06613 159 -----------------------------KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP 209 (262)
T ss_pred -----------------------------ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 012347779999998763 2678899999999999999999999988766
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
.............. .. .......+..+.+++++||..+|.+||++.+++.|+|
T Consensus 210 ~~~~~~~~~~~~~~--~~----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 210 MRALFLISKSNFPP--PK----------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHhccCCC--cc----------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 55544332210000 00 0011235678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=291.75 Aligned_cols=259 Identities=29% Similarity=0.535 Sum_probs=205.3
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC-------CchhHHHHHHHHHhcCCCCeeeeeEEEecCce
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG-------VPSTAIREISLLKEMQHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (323)
+|++...||.|++|.||+|.+..++..+++|.+........ ..+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 58899999999999999999988899999998865432211 12457789999999999999999999999999
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
.++++||+.+ ++.+.+.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~-~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG-IKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC-EEecccCCCcccc
Confidence 9999999976 6666665432 4678888899999999999999999999999999999998887 9999999987664
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
.......... ......|+..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.
T Consensus 158 ~~~~~~~~~~-----------------------~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 213 (267)
T cd06628 158 ANSLSTKTNG-----------------------ARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFP 213 (267)
T ss_pred cccccCCccc-----------------------cccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 3211100000 0001234778999999877 557889999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
.......+..+.... .+.....++..+.++|++||+.||.+||++.++++||
T Consensus 214 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 265 (267)
T cd06628 214 DCTQLQAIFKIGENA----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHP 265 (267)
T ss_pred CccHHHHHHHHhccC----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCC
Confidence 776544443322210 0111234678899999999999999999999999999
Q ss_pred CC
Q 036739 315 YF 316 (323)
Q Consensus 315 ~~ 316 (323)
||
T Consensus 266 ~~ 267 (267)
T cd06628 266 FL 267 (267)
T ss_pred CC
Confidence 97
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=294.86 Aligned_cols=255 Identities=28% Similarity=0.421 Sum_probs=202.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEec------Cc
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS------EK 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~~ 74 (323)
+.|++.+.||.|++|.||++.+..++..+++|.+.... .....+..|+.+++.+ .|+|++++++++.. ..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 57899999999999999999998899999999875432 2235677888998888 69999999999853 46
Q ss_pred eEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
..+++|||+.+ ++.+.+.......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~-~~l~dfg~~~~~ 171 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQL 171 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEeeCcchhhh
Confidence 78999999976 7777776655556788888999999999999999999999999999999998887 999999988654
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHhC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQ 229 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~tg 229 (323)
....... ....|++.|+|||.+.. ...++.++|+||||+++|+|++|
T Consensus 172 ~~~~~~~-----------------------------~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g 222 (282)
T cd06636 172 DRTVGRR-----------------------------NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222 (282)
T ss_pred hccccCC-----------------------------CcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhC
Confidence 3211100 01245788999999763 24578899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
..||...........+.... . .......+++.+.++|++||+.||++||++.+
T Consensus 223 ~~p~~~~~~~~~~~~~~~~~----~-----------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~e 275 (282)
T cd06636 223 APPLCDMHPMRALFLIPRNP----P-----------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQ 275 (282)
T ss_pred CCCccccCHHhhhhhHhhCC----C-----------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHH
Confidence 99997765544333221100 0 00111347789999999999999999999999
Q ss_pred hhcCCCC
Q 036739 310 ALEHEYF 316 (323)
Q Consensus 310 il~h~~~ 316 (323)
+++||||
T Consensus 276 ll~~~~~ 282 (282)
T cd06636 276 LLKHPFI 282 (282)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=293.95 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=203.7
Q ss_pred eccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-hH
Q 036739 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DL 87 (323)
Q Consensus 10 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g-~l 87 (323)
||+|++|+||++.+..+++.|++|.+...... ......+.+|+.++++++|||++++++.+...+..|+|+||++| +|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999889999999998654322 22345667899999999999999999999999999999999976 77
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCC
Q 036739 88 KKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167 (323)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 167 (323)
.+.+.+.....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~-~~l~dfg~~~~~~~~~~~~------- 152 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIK------- 152 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-EEEccCcchhhhccCCccc-------
Confidence 77776655456788999999999999999999999999999999999998887 9999999886543211100
Q ss_pred cCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 036739 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFR 247 (323)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~ 247 (323)
...++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...........+..
T Consensus 153 -----------------------~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05577 153 -----------------------GRAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208 (277)
T ss_pred -----------------------cccCCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh
Confidence 0133677999999877 4488999999999999999999999977654222222221
Q ss_pred HhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcCCCCccccc
Q 036739 248 VLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEHEYFRDVEF 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h~~~~~~~~ 321 (323)
.... ........+++.+.++|.+||+.||++|| ++.++++||||++++|
T Consensus 209 ~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 209 RTLE-------------------------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred cccc-------------------------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 1000 01112234688999999999999999999 8888999999998876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=303.52 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=194.1
Q ss_pred CCcceeeeeccccceeEEEEEEc-----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEec-Cc
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS-EK 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~ 74 (323)
++|++.+.||+|+||.||+|.+. .++..||+|.+... ........+.+|+.+++.+ +||||+++++++.. ++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 58999999999999999999742 34568999988533 2222345688899999999 89999999998865 44
Q ss_pred eEEEEEecchh-hHHHhhhcCC----------------------------------------------------------
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCP---------------------------------------------------------- 95 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~---------------------------------------------------------- 95 (323)
.++++|||+.| +|.+.+....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 68999999975 7776665422
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCccee
Q 036739 96 --DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173 (323)
Q Consensus 96 --~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (323)
...++...+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++...........
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~-~kl~DfG~a~~~~~~~~~~~------------ 232 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVR------------ 232 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc-EEEeecccccccccCcchhc------------
Confidence 123566778889999999999999999999999999999998887 99999999875432211100
Q ss_pred ehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 036739 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTP 252 (323)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~ 252 (323)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+...........
T Consensus 233 ---------------~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~- 295 (338)
T cd05102 233 ---------------KGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR- 295 (338)
T ss_pred ---------------ccCCCCCccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-
Confidence 011233677999999977 568999999999999999997 99999876544433322211000
Q ss_pred CCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 253 NEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
......+++.+.++|.+||+.||++||++.++++
T Consensus 296 --------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 296 --------------------------MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0011346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=298.92 Aligned_cols=281 Identities=24% Similarity=0.357 Sum_probs=206.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+..++..+++|.+.... .......+.+|++++++++||||+++++++.+++.+++++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 58999999999999999999998899999999875432 12233567789999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|+.| +|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++. ++|+|||.+........
T Consensus 80 y~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~~- 155 (308)
T cd06615 80 HMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMA- 155 (308)
T ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc-EEEccCCCccccccccc-
Confidence 9976 777776554 346888899999999999999997 59999999999999998887 99999998754321110
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+..
T Consensus 156 ------------------------------~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 204 (308)
T cd06615 156 ------------------------------NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK 204 (308)
T ss_pred ------------------------------ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchh
Confidence 01245788999999876 56889999999999999999999999766533
Q ss_pred HHHHHHHHHhCCCCCCCCC---------CcccCCcccccCCCCCCCccccc-ccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 240 DELFKIFRVLGTPNEDTWP---------GVTSLPDFKSAFPKWPSKELGTV-VRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
.. ................ ....................+.. ...+++.+.++|.+||+.+|++||++.+
T Consensus 205 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 283 (308)
T cd06615 205 EL-EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283 (308)
T ss_pred hH-HHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence 22 2222111000000000 00000000000000000000111 1136888999999999999999999999
Q ss_pred hhcCCCCccc
Q 036739 310 ALEHEYFRDV 319 (323)
Q Consensus 310 il~h~~~~~~ 319 (323)
+++||||.+.
T Consensus 284 ll~~~~~~~~ 293 (308)
T cd06615 284 LTKHPFIKRA 293 (308)
T ss_pred HhcChhhhhc
Confidence 9999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=289.34 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=202.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC---CchhHHHHHHHHHhcCCCCeeeeeEEEec--CceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG---VPSTAIREISLLKEMQHGNIVRLQDVVHS--EKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 76 (323)
.+|++.+.||+|++|.||++.+..++..|++|.+........ ....+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 479999999999999999999988999999998865432221 23467789999999999999999999875 4678
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
++++||+.+ +|.+.+.... .+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~-~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC-EEEccCCCcccccc
Confidence 999999976 7777776543 3678888899999999999999999999999999999998877 99999999876532
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
........ ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||..
T Consensus 159 ~~~~~~~~--------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 159 ICMSGTGI--------------------------RSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred ccccCCcc--------------------------ccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 11110000 01134788999999977 5688999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
........+.... .. .+.....+++.+.+++ +||..+|++||++.++++|||
T Consensus 212 ~~~~~~~~~~~~~---~~------------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~ 263 (266)
T cd06651 212 YEAMAAIFKIATQ---PT------------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPF 263 (266)
T ss_pred cchHHHHHHHhcC---CC------------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence 7655444332210 00 0111234677888998 566789999999999999999
Q ss_pred Cc
Q 036739 316 FR 317 (323)
Q Consensus 316 ~~ 317 (323)
|+
T Consensus 264 ~~ 265 (266)
T cd06651 264 AQ 265 (266)
T ss_pred cc
Confidence 96
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=292.23 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=202.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecC------c
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE------K 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~------~ 74 (323)
++|++.+.||+|++|.||+|.+..++..+++|++..... ....+.+|+.+++++ .|+||+++++++.+. .
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 689999999999999999999988899999998864432 236788999999999 699999999999654 4
Q ss_pred eEEEEEecchh-hHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccce
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCP--DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~ 151 (323)
.+++|+||+++ ++.+.+.... +..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~-~~l~d~~~~~ 161 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSA 161 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe-EEECCCccce
Confidence 58999999986 5555554332 346788889999999999999999999999999999999998887 9999999887
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHH
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~ 227 (323)
......... ....|+..|+|||.+.. ...++.++|+||||+++|+|+
T Consensus 162 ~~~~~~~~~-----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~ 212 (275)
T cd06608 162 QLDSTLGRR-----------------------------NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212 (275)
T ss_pred ecccchhhh-----------------------------cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence 653221110 01245788999999754 234678999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH
Q 036739 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 228 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
+|..||..........++.... . .. .......++.+.++|++||..||++||++
T Consensus 213 ~g~~p~~~~~~~~~~~~~~~~~---~-~~----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~ 266 (275)
T cd06608 213 DGKPPLCDMHPMRALFKIPRNP---P-PT----------------------LKSPENWSKKFNDFISECLIKNYEQRPFM 266 (275)
T ss_pred hCCCCccccchHHHHHHhhccC---C-CC----------------------CCchhhcCHHHHHHHHHHhhcChhhCcCH
Confidence 9999998665544444332210 0 00 00112367889999999999999999999
Q ss_pred hhhhcCCCC
Q 036739 308 RSALEHEYF 316 (323)
Q Consensus 308 ~~il~h~~~ 316 (323)
.++++|||+
T Consensus 267 ~~ll~~~~~ 275 (275)
T cd06608 267 EELLEHPFI 275 (275)
T ss_pred HHHhcCCCC
Confidence 999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=291.98 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=203.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||+|++..++..|++|.+..... .....+.+|+.+++.++||||+++++.+.+.+..++++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 578999999999999999999999999999999865432 223567789999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+++ +|.+.+.... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 87 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~-~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 87 FCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKR 163 (267)
T ss_pred ccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEECcceeeeEccCccccc
Confidence 9986 6666665433 4688899999999999999999999999999999999998887 9999999987653221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
....|++.|+|||.+.. ...++.++|+|||||++|+|++|..||.....
T Consensus 164 -----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 164 -----------------------------KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred -----------------------------ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 01245888999999752 34578899999999999999999999976654
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
.......... ....... .....++..+.++|.+||+.+|++||++.++++|||
T Consensus 215 ~~~~~~~~~~--~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 215 MRALFLMTKS--NFQPPKL----------------------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred hhhHHhhhcc--CCCCCcc----------------------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 4433322111 0000000 001236778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=303.96 Aligned_cols=259 Identities=30% Similarity=0.485 Sum_probs=209.0
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.|++++.||+||.+.||++.. .....||+|.+.....+.....-+.+|+..|.+++ |.+|+++++|-..++.+|+|||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred hhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 699999999999999999986 44566788877666677778889999999999996 8999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+-+.+|-+.+.+.... .+.-.++.+..|++.|+.++|+.||||.||||.|+|+-+ |. +||+|||.+.....+.+...
T Consensus 441 ~Gd~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~-LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 441 CGDIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GR-LKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred cccccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-ee-EEeeeechhcccCcccccee
Confidence 9888999888876553 333468899999999999999999999999999999875 55 99999999998876655432
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC----------CCCCCchhhHHHHHHHHHHHhCCC
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS----------RHYSTPVDVWSVGCIFAEMVNQRP 231 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----------~~~~~~~Di~slG~ll~~l~tg~~ 231 (323)
....+||+.|||||.+... ..++.++||||||||||+|+-|++
T Consensus 518 ---------------------------kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgkt 570 (677)
T KOG0596|consen 518 ---------------------------KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKT 570 (677)
T ss_pred ---------------------------eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCC
Confidence 3345889999999998541 236789999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCCC-CCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh
Q 036739 232 LFPGDSEIDELFKIFRVLGTPNED-TWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310 (323)
Q Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i 310 (323)
||...... ...++.+..+..+ .++..+ -...+++++..||..||.+||++.++
T Consensus 571 Pf~~~~n~---~aKl~aI~~P~~~Iefp~~~-----------------------~~~~li~~mK~CL~rdPkkR~si~eL 624 (677)
T KOG0596|consen 571 PFGQIINQ---IAKLHAITDPNHEIEFPDIP-----------------------ENDELIDVMKCCLARDPKKRWSIPEL 624 (677)
T ss_pred chHHHHHH---HHHHHhhcCCCccccccCCC-----------------------CchHHHHHHHHHHhcCcccCCCcHHH
Confidence 99765432 2223333333221 111111 11238899999999999999999999
Q ss_pred hcCCCCcc
Q 036739 311 LEHEYFRD 318 (323)
Q Consensus 311 l~h~~~~~ 318 (323)
|+|||++-
T Consensus 625 LqhpFl~~ 632 (677)
T KOG0596|consen 625 LQHPFLQI 632 (677)
T ss_pred hcCccccc
Confidence 99999986
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=299.63 Aligned_cols=289 Identities=40% Similarity=0.695 Sum_probs=218.4
Q ss_pred CcceeeeeccccceeEEEEEEccC--CceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEec----Cce
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVT--NETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS----EKK 75 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~ 75 (323)
+|++.+.||+|++|.||++.+... +..||+|.+............+.+|+.+++.+ +||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999877 88999998864433333345677899999999 59999999987532 246
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
.++++++++++|.+.+.... .+++..++.++.||+.||.+||+.|++|+||||+||+++.++. ++|+|||.+.....
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~-~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLARGFSE 157 (332)
T ss_pred EEEEEecccCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC-EEeCcCCCceeccc
Confidence 88999999999988886543 4688889999999999999999999999999999999998887 99999999976643
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
........ .....|++.|+|||.+.+...++.++|+||+|+++|+|++|..||..
T Consensus 158 ~~~~~~~~-------------------------~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 158 NPGENAGF-------------------------MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred cccccccc-------------------------ccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 22211000 00124588899999987756689999999999999999999999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCC--cccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLP--DFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.........+....+.+....+....... .....................+..+.+++.+||+.||++||++.+++.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 213 KDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 87777776666665544332211111000 0011111111111222334568899999999999999999999999999
Q ss_pred CCCccc
Q 036739 314 EYFRDV 319 (323)
Q Consensus 314 ~~~~~~ 319 (323)
|||+..
T Consensus 293 ~~~~~~ 298 (332)
T cd07857 293 PYLAIW 298 (332)
T ss_pred hhhhhh
Confidence 999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=287.87 Aligned_cols=260 Identities=26% Similarity=0.437 Sum_probs=203.8
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC----CCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE----GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
+|++.+.||+|++|.||++.+ .+++.+|+|.+....... .....+.+|+..++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 689999999999999999987 578899999886543221 123467789999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
++||+.| +|.+.+.+.. .+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 80 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 80 FMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI-IKLIDFGCARRLAWVG 156 (265)
T ss_pred EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe-EEeccchhhHhhhhcc
Confidence 9999976 6666665433 4678888899999999999999999999999999999998887 9999999887653211
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
....... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||....
T Consensus 157 ~~~~~~~-----------------------~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 157 LHGTHSN-----------------------MLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred ccccccc-----------------------cccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 1100000 0011245888999999877 567899999999999999999999998765
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
.......+...... .+.....+++.+.++|++||+.+|++||++.++++||||
T Consensus 213 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 213 RLAAMFYIGAHRGL--------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred hHHHHHHhhhccCC--------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 54433322211000 011223478899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=291.10 Aligned_cols=256 Identities=29% Similarity=0.411 Sum_probs=201.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++++..++..|++|++..... .....+.+|+.++++++|||++++++++..+...++|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 579999999999999999999989999999999864422 233567789999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+++ +|.+.+.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 87 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~-~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 87 YCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD-VKLADFGVAAKITATIAKR 163 (267)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC-EEECcCccceeeccccccc
Confidence 9986 6666665432 4688889999999999999999999999999999999998887 9999999987653221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
. ...+++.|+|||.+.. ...++.++|+||+|+++|+|++|..||.....
T Consensus 164 ~-----------------------------~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 164 K-----------------------------SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred C-----------------------------ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 0 1134778999999753 24467899999999999999999999865543
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
......+... . .... .......++..+.++|++||+.+|++||++.++++|+|
T Consensus 215 ~~~~~~~~~~-------~----------------~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 215 MRALFLMSKS-------N----------------FQPP-KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred hhhheeeecC-------C----------------CCCC-CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 3222111100 0 0000 00111346789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.66 Aligned_cols=277 Identities=25% Similarity=0.364 Sum_probs=211.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++++.||+|++|.||++.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 589999999999999999999999999999998865532 1223457778999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||++| ++.+.+.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~-~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC-EEEeeCCCccccCcCccc
Confidence 99976 6666665443 4788888999999999999999999999999999999998877 999999987643211111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
......... ...........++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+....
T Consensus 158 ~~~~~~~~~--------------~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~ 222 (305)
T cd05609 158 NLYEGHIEK--------------DTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222 (305)
T ss_pred ccccccccc--------------chhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 100000000 000000111345788999999877 56899999999999999999999999877665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC---HhhhhcCCCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT---ARSALEHEYF 316 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s---~~~il~h~~~ 316 (323)
+............ +.....+++.+.++|.+||+.||++||+ +.++++||||
T Consensus 223 ~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 223 ELFGQVISDDIEW--------------------------PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred HHHHHHHhcccCC--------------------------CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 5444433211000 0001247888999999999999999997 7899999999
Q ss_pred cccccc
Q 036739 317 RDVEFV 322 (323)
Q Consensus 317 ~~~~~~ 322 (323)
...++.
T Consensus 277 ~~~~~~ 282 (305)
T cd05609 277 LGLDWN 282 (305)
T ss_pred cCCCHH
Confidence 877653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=291.27 Aligned_cols=252 Identities=27% Similarity=0.448 Sum_probs=206.9
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+|++.+.||.|++|.||++.+..++..|++|.+..... .......+.+|+.++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 69999999999999999999988999999999875532 22345788899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+... ..+++..+..++.||+.+|.+||+.+++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTT 157 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC-EEEeecccccccCCCcccc
Confidence 9976 666666554 35788889999999999999999999999999999999999887 9999999987654322110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH-
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI- 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~- 239 (323)
...|+..|+|||.+.. ..++.++|+||+|+++|+|++|..||......
T Consensus 158 ------------------------------~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 206 (258)
T cd05578 158 ------------------------------STSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI 206 (258)
T ss_pred ------------------------------ccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccH
Confidence 1234778999999877 55899999999999999999999999877642
Q ss_pred -HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH--hhhhcCCCC
Q 036739 240 -DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA--RSALEHEYF 316 (323)
Q Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~--~~il~h~~~ 316 (323)
+....... . ........+++.+.++|++||+.||.+||++ .++++||||
T Consensus 207 ~~~~~~~~~---~-------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 207 RDQIRAKQE---T-------------------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHhc---c-------------------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 22211111 0 0111223467899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=287.22 Aligned_cols=251 Identities=28% Similarity=0.452 Sum_probs=206.4
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||+|++|.||++.+..++..+++|.+..... ....+.+.+|+.+++.++|+|++++++.+.+++.+++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 68999999999999999999999999999999865432 23346778899999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+.+ ++.+.+.......+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. ++++|||.+..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~-~~l~dfg~~~~~~~~~~~~- 157 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK-VKLGDFGSARLLTSPGAYA- 157 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc-EEEcccCcceeeccccccc-
Confidence 965 7888776655556788889999999999999999999999999999999998887 9999999987653221110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
....|++.|+|||++.+ ..++.++|+||+|+++|+|++|..||........
T Consensus 158 ----------------------------~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 208 (255)
T cd08219 158 ----------------------------CTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208 (255)
T ss_pred ----------------------------ccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence 01234788999999877 5689999999999999999999999987766555
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
...+.+... ......++..+.++|.+||+.||++||++.++++-
T Consensus 209 ~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 209 ILKVCQGSY----------------------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHhcCCC----------------------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 544432110 01123367789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=299.43 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=223.3
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
++.|+.-+.||+|+||.||-++...+|+-||+|.+.+.- ..........+|..++..++.+.||.+-.+|++...+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 367899999999999999999999999999999886553 2233446777899999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
+..++| +|.-++.......++++.+..++.+|+.+|++||+.+||+||+||+|||+|+.|. +.|+|+|++..+.....
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh-vRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH-VRISDLGLAVEIPEGKP 342 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC-eEeeccceEEecCCCCc
Confidence 999976 7766666665567899999999999999999999999999999999999999999 99999999988764443
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
... .+||.+|||||++.+. .|+...|.|||||++|+|+.|+.||...+.
T Consensus 343 ~~~------------------------------rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 343 IRG------------------------------RVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred ccc------------------------------ccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 322 2679999999999984 499999999999999999999999988776
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h 313 (323)
......+.++.-.. .......+|++++++.+.+|.+||++|+ .+.++-+|
T Consensus 392 Kvk~eEvdrr~~~~-------------------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 392 KVKREEVDRRTLED-------------------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred hhhHHHHHHHHhcc-------------------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 65554444432111 1123356899999999999999999998 67799999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 447 pfFk~lnw 454 (591)
T KOG0986|consen 447 PFFKDLNW 454 (591)
T ss_pred cccccCCH
Confidence 99999987
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=301.71 Aligned_cols=282 Identities=38% Similarity=0.664 Sum_probs=213.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 75 (323)
++|++.+.||+|++|.||++.+..++..||+|++............+.+|+.++++++|+||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 689999999999999999999988999999998865433333345677899999999999999999988543 35
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
.+++++++++++.+.+... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 97 ~~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~-~kl~dfg~~~~~~~ 172 (345)
T cd07877 97 VYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDD 172 (345)
T ss_pred EEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC-EEEecccccccccc
Confidence 7899999888887666543 4688889999999999999999999999999999999999887 99999998865321
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
... ...+++.|+|||.+.+...++.++|+||+|+++|+|++|..||..
T Consensus 173 ~~~--------------------------------~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 173 EMT--------------------------------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred ccc--------------------------------ccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 110 013477899999987756688999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccC--CcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSL--PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.........+.+................ ..+...................++.+.++|.+||+.||.+||++.+++.|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 7766655555554433322211111100 00000111111111111223467889999999999999999999999999
Q ss_pred CCCccc
Q 036739 314 EYFRDV 319 (323)
Q Consensus 314 ~~~~~~ 319 (323)
|||.+.
T Consensus 301 ~~f~~~ 306 (345)
T cd07877 301 AYFAQY 306 (345)
T ss_pred hhhhhc
Confidence 999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=295.33 Aligned_cols=260 Identities=27% Similarity=0.457 Sum_probs=205.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++++.||+|++|.||++.+..++..||+|.+.... .......+.+|+.++++++|+||+++++.+...+..++|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 58999999999999999999998899999999886432 22223577889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 82 YLDL-DLKKHMDSCP-DFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|+.| ++...+.... ...+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++. ++|+|||.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ-VKLCDFGVSGNLVASLA 158 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC-EEEeecCCcccccCCcc
Confidence 9987 5555554421 2357888999999999999999996 59999999999999998777 99999998865432111
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCC-----CCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR-----HYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-----~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
. ...+++.|+|||.+.+.. .++.++|+||+||++|+|++|..||
T Consensus 159 ~-------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 207 (286)
T cd06622 159 K-------------------------------TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207 (286)
T ss_pred c-------------------------------cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCC
Confidence 1 013477899999986522 3578999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
................... .......+++.+.++|.+||+.+|++||++.+++.|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 208 PPETYANIFAQLSAIVDGD-------------------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCcchhhHHHHHHHHhhcC-------------------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 7654433332222111000 011223478899999999999999999999999999
Q ss_pred CCCccc
Q 036739 314 EYFRDV 319 (323)
Q Consensus 314 ~~~~~~ 319 (323)
|||...
T Consensus 263 ~~~~~~ 268 (286)
T cd06622 263 PWLVKY 268 (286)
T ss_pred hhhhhc
Confidence 999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=288.05 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=210.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++++..+++.|++|.+...... .....+.+|+..+..++|+|++++++++...+..++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 5899999999999999999999989999999988654332 345778899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|+.| +|.+.+... ..+++..+..++.|++.+|.+||+ .+++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 80 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~-~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE-VKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC-EEEccCccceecccCCCc
Confidence 9985 777776654 357888999999999999999999 99999999999999999887 999999988765432221
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE- 238 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~- 238 (323)
. ....++..|+|||.+.. ..++.++|+||||+++|+|++|..||.....
T Consensus 157 ~-----------------------------~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~ 206 (264)
T cd06623 157 C-----------------------------NTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQP 206 (264)
T ss_pred c-----------------------------cceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccccc
Confidence 1 01234778999999877 5788999999999999999999999987752
Q ss_pred --HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccC-CChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 239 --IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRN-LEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 239 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
.+....+.. .. ....... ++..+.++|++||..+|++||++.++++|||
T Consensus 207 ~~~~~~~~~~~---~~-------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 207 SFFELMQAICD---GP-------------------------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred CHHHHHHHHhc---CC-------------------------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence 222222211 00 0111123 7789999999999999999999999999999
Q ss_pred Ccccc
Q 036739 316 FRDVE 320 (323)
Q Consensus 316 ~~~~~ 320 (323)
|+.++
T Consensus 259 ~~~~~ 263 (264)
T cd06623 259 IKKAD 263 (264)
T ss_pred HHhcc
Confidence 98764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=291.80 Aligned_cols=257 Identities=27% Similarity=0.393 Sum_probs=201.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecC-----ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE-----KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-----~~ 75 (323)
++|++.+.||+|++|.||++.++.+++.+++|.+... ......+.+|+.+++.+ +|||++++++++... +.
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~ 98 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ 98 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence 6799999999999999999999999999999988533 12235677899999998 799999999998643 46
Q ss_pred EEEEEecchh-hHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 76 LYLVFEYLDL-DLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
.++|+||+.| +|.+.+.. .....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+..
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~-~kl~dfg~~~~ 177 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG-VKLVDFGVSAQ 177 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC-EEEeecccchh
Confidence 8999999976 66665542 22345788889999999999999999999999999999999998887 99999999876
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCC----CCCCchhhHHHHHHHHHHHh
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR----HYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~~Di~slG~ll~~l~t 228 (323)
........ ....|+..|+|||.+.... .++.++|+||||+++|+|++
T Consensus 178 ~~~~~~~~-----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~ 228 (291)
T cd06639 178 LTSTRLRR-----------------------------NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228 (291)
T ss_pred cccccccc-----------------------------cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhh
Confidence 53221110 0123477899999986532 36789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|+.||........+..+.+.. ... .......+..+.++|.+||+.+|++||++.
T Consensus 229 g~~p~~~~~~~~~~~~~~~~~----~~~----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 282 (291)
T cd06639 229 GDPPLFDMHPVKTLFKIPRNP----PPT----------------------LLHPEKWCRSFNHFISQCLIKDFEARPSVT 282 (291)
T ss_pred CCCCCCCCcHHHHHHHHhcCC----CCC----------------------CCcccccCHHHHHHHHHHhhcChhhCcCHH
Confidence 999998776555444332110 000 000123567899999999999999999999
Q ss_pred hhhcCCCCc
Q 036739 309 SALEHEYFR 317 (323)
Q Consensus 309 ~il~h~~~~ 317 (323)
++++||||+
T Consensus 283 ~il~~~~~~ 291 (291)
T cd06639 283 HLLEHPFIK 291 (291)
T ss_pred HHhcCcccC
Confidence 999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=285.47 Aligned_cols=255 Identities=28% Similarity=0.510 Sum_probs=211.6
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||+|++|.||++.+..++..|++|.+............+.+|+++++.++|+|++++.+.+..+...++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 68999999999999999999988899999999876554445567788999999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 83 LDL-DLKKHMDSCP--DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 83 ~~g-~l~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
++| ++.+.+.... ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~-~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL-VKLGDFGISKVLSSTVDL 159 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc-EEECCccceeecccCcce
Confidence 986 7777776543 356788999999999999999999999999999999999998777 999999998765433210
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.....|++.|+|||.... ..++.++|+||+|+++++|++|..||......
T Consensus 160 -----------------------------~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 209 (258)
T cd08215 160 -----------------------------AKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLL 209 (258)
T ss_pred -----------------------------ecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHH
Confidence 011245778999999877 55889999999999999999999999877654
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
+......+.. .......++..+.+++++||..+|++||++.++++||||
T Consensus 210 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 210 ELALKILKGQ----------------------------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 4444332211 001112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=294.85 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=207.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|+||++.+..+++.|++|.+..... .......+.+|+.+++.++|||++++++++.+....++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 468999999999999999999988999999998854422 1222356778999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||+.|++.+.+..... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 95 e~~~g~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~-~kL~dfg~~~~~~~~~~-- 170 (307)
T cd06607 95 EYCLGSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT-VKLADFGSASLVSPANS-- 170 (307)
T ss_pred HhhCCCHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC-EEEeecCcceecCCCCC--
Confidence 9999988877764433 5788899999999999999999999999999999999999887 99999998865432211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
..+++.|+|||.+.+ ...++.++|+||+|+++|+|++|..||.....
T Consensus 171 -------------------------------~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 171 -------------------------------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred -------------------------------ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 133677999998752 35578899999999999999999999987765
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
......+... .... ......+..+.++|.+||+.+|++||++.+++.||||..
T Consensus 220 ~~~~~~~~~~----~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 220 MSALYHIAQN----DSPT-----------------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHHHHHhcC----CCCC-----------------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 5544433211 0000 001125678999999999999999999999999999975
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
-
T Consensus 273 ~ 273 (307)
T cd06607 273 E 273 (307)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.10 Aligned_cols=259 Identities=25% Similarity=0.448 Sum_probs=206.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC---CCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ---HGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 78 (323)
+.|++.+.||+|++|.||++.+..++..+++|.+.... .......+.+|+.+++.++ |||++++++++.++...++
T Consensus 1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 36889999999999999999998899999999886442 2333467788999999996 9999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
++||+.| +|.+.+... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~-~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC-EEEccCCceeecCCCc
Confidence 9999976 666555432 5788889999999999999999999999999999999998777 9999999987764332
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.... ...|+..|+|||.+.+...++.++|+||||+++|+|++|..||....
T Consensus 156 ~~~~-----------------------------~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 156 SKRS-----------------------------TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred cccc-----------------------------cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1110 12347789999998765667899999999999999999999997765
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
.......+.. ..... .....++..+.+++.+||+.||++||++.++++||||+
T Consensus 207 ~~~~~~~~~~----~~~~~-----------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~ 259 (277)
T cd06917 207 AFRAMMLIPK----SKPPR-----------------------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIK 259 (277)
T ss_pred hhhhhhcccc----CCCCC-----------------------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhh
Confidence 4332221100 00000 00112678899999999999999999999999999998
Q ss_pred cccc
Q 036739 318 DVEF 321 (323)
Q Consensus 318 ~~~~ 321 (323)
+..-
T Consensus 260 ~~~~ 263 (277)
T cd06917 260 AHSK 263 (277)
T ss_pred cccc
Confidence 7653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=288.97 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=194.3
Q ss_pred eeccccceeEEEEEEccCCceEEEEEEEecccCCCC-chhHHHHHHHHHh---cCCCCeeeeeEEEecCceEEEEEecch
Q 036739 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGV-PSTAIREISLLKE---MQHGNIVRLQDVVHSEKKLYLVFEYLD 84 (323)
Q Consensus 9 ~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~e~~~l~~---l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (323)
.||+|++|.||++.+..++..+|+|.+......... ...+.++..+++. ..|+|++.+++.+..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999889999999988655332221 2233344444333 468999999999999999999999997
Q ss_pred h-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccc
Q 036739 85 L-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163 (323)
Q Consensus 85 g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~ 163 (323)
| +|.+.+.... .+++..+..++.|++.||.+||+.+++|+||||+||+++.++. ++|+|||++.........
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~-~~l~dfg~~~~~~~~~~~---- 153 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH---- 153 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC-EEEccCCcceeccccCcc----
Confidence 6 6666655432 4788889999999999999999999999999999999998887 999999998654321110
Q ss_pred ccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 036739 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243 (323)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~ 243 (323)
...|++.|+|||.+.....++.++|+||+|+++|+|++|..||..........
T Consensus 154 ---------------------------~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 206 (279)
T cd05633 154 ---------------------------ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206 (279)
T ss_pred ---------------------------CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH
Confidence 11458889999998754668899999999999999999999997653322111
Q ss_pred HHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcCCCCcc
Q 036739 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEHEYFRD 318 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h~~~~~ 318 (323)
....... ........+++.+.++|.+||+.||++|+ ++.++++||||++
T Consensus 207 -~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 207 -IDRMTLT-------------------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred -HHHHhhc-------------------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 1111000 00112234788999999999999999999 6999999999999
Q ss_pred ccc
Q 036739 319 VEF 321 (323)
Q Consensus 319 ~~~ 321 (323)
++|
T Consensus 261 ~~~ 263 (279)
T cd05633 261 IDW 263 (279)
T ss_pred CCH
Confidence 875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.22 Aligned_cols=256 Identities=26% Similarity=0.374 Sum_probs=199.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEe-----cCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVH-----SEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----~~~~ 75 (323)
++|++.+.||+|++|.||++.+..+++.+++|++.... .....+.+|+.+++.+ +|+|++++++++. +++.
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 68999999999999999999999999999999874321 2235677899999999 6999999999873 4567
Q ss_pred EEEEEecchh-hHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 76 LYLVFEYLDL-DLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
.++||||++| +|.+.+.. .....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+..
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~-~kl~dfg~~~~ 173 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG-VKLVDFGVSAQ 173 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC-EEEccCCceee
Confidence 9999999976 66555542 22335688889999999999999999999999999999999999887 99999999876
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHh
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~t 228 (323)
........ ....|++.|+|||.+.. ...++.++|+||+||++|+|++
T Consensus 174 ~~~~~~~~-----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~ 224 (286)
T cd06638 174 LTSTRLRR-----------------------------NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD 224 (286)
T ss_pred cccCCCcc-----------------------------ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc
Confidence 53221110 01245888999999853 2447889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|..||............... ... ........+..+.++|.+||+.||++||++.
T Consensus 225 g~~p~~~~~~~~~~~~~~~~----~~~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 278 (286)
T cd06638 225 GDPPLADLHPMRALFKIPRN----PPP----------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVS 278 (286)
T ss_pred CCCCCCCCchhHHHhhcccc----CCC----------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHH
Confidence 99999776543333221110 000 0001123567899999999999999999999
Q ss_pred hhhcCCCC
Q 036739 309 SALEHEYF 316 (323)
Q Consensus 309 ~il~h~~~ 316 (323)
++++|+||
T Consensus 279 ell~~~~~ 286 (286)
T cd06638 279 DLLQHVFI 286 (286)
T ss_pred HHhhcccC
Confidence 99999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=287.47 Aligned_cols=255 Identities=31% Similarity=0.522 Sum_probs=206.0
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--CceEEEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKKLYLVF 80 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 80 (323)
+|++.+.||.|++|.||++.+..++..+++|.+............+.+|+.+++.++|+|++++++.+.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999986554444445677889999999999999999998753 46789999
Q ss_pred ecchh-hHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 81 EYLDL-DLKKHMDSC--PDFANDPRLIKTFLYQILRGIAYCH-----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 81 e~~~g-~l~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH-----~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
||+.+ ++.+.+... ....+++..+..++.||+.||.+|| +.+++|+||+|+||+++.++. ++|+|||.+..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~-~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN-VKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC-EEEeccccccc
Confidence 99975 777676543 2346788889999999999999999 899999999999999998877 99999999877
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
......... ...+++.|+|||.+.+ ..++.++|+||||+++++|++|..|
T Consensus 160 ~~~~~~~~~-----------------------------~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p 209 (265)
T cd08217 160 LGHDSSFAK-----------------------------TYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPP 209 (265)
T ss_pred ccCCccccc-----------------------------ccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCc
Confidence 643221000 1134788999999877 5588999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
|...........+.... .......+++.+.+++.+||+.+|++||++.+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 210 FTARNQLQLASKIKEGK----------------------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ccCcCHHHHHHHHhcCC----------------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 98876443333322110 01122346788999999999999999999999999
Q ss_pred CCCC
Q 036739 313 HEYF 316 (323)
Q Consensus 313 h~~~ 316 (323)
|||+
T Consensus 262 ~~~~ 265 (265)
T cd08217 262 LPLI 265 (265)
T ss_pred CCCC
Confidence 9996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=285.21 Aligned_cols=261 Identities=31% Similarity=0.512 Sum_probs=206.6
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||+|+++.||++.+..++..|++|.+............+.+|+.+++.++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999988999999999876644434567888999999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+.+ ++.+.+.... ..++..+..++.|++.||.+||+.|++|+||+|+||+++.++. +||+|||.+...........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV-IKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEcccccccccCCCCCccc
Confidence 976 6666655432 3677888899999999999999999999999999999999877 99999999877644332211
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCC--CCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR--HYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
... ....+++.|+|||++.... ..+.++|+||+|++++++++|..||......
T Consensus 158 ~~~-------------------------~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~ 212 (264)
T cd06626 158 EEV-------------------------QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212 (264)
T ss_pred ccc-------------------------cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch
Confidence 100 0113477899999987632 3788999999999999999999999766433
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
......... .. ... .+....+++.+.++|++||+.+|.+||++.+++.|||+
T Consensus 213 ~~~~~~~~~-~~--~~~----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 213 FQIMFHVGA-GH--KPP----------------------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHhc-CC--CCC----------------------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 332221111 00 000 00112357889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=291.76 Aligned_cols=259 Identities=28% Similarity=0.496 Sum_probs=206.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+..+++.+++|.+..... ......+.+|+.+++.+.||||+++++.+...+.+++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 579999999999999999999988999999998865432 2344677889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
++.| +|.+.+.... ..+++..+..++.|++.+|.+||+ .|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~-~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 80 YMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ-IKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred ecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC-EEEeecccchhhHHHHhh
Confidence 9985 6766665543 467888899999999999999999 99999999999999999877 999999988654321111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE- 238 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~- 238 (323)
. ..++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.....
T Consensus 158 ~-------------------------------~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 205 (265)
T cd06605 158 T-------------------------------FVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDP 205 (265)
T ss_pred c-------------------------------ccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccc
Confidence 0 134778999999977 5689999999999999999999999966521
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCccccccc-CCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVR-NLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
........+....... ..... .+++.+.++|.+||..||++||++.+++.||||+
T Consensus 206 ~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~ 261 (265)
T cd06605 206 PDGIFELLQYIVNEPP------------------------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261 (265)
T ss_pred cccHHHHHHHHhcCCC------------------------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence 1111111111100000 00011 1678899999999999999999999999999998
Q ss_pred cc
Q 036739 318 DV 319 (323)
Q Consensus 318 ~~ 319 (323)
..
T Consensus 262 ~~ 263 (265)
T cd06605 262 KY 263 (265)
T ss_pred cc
Confidence 64
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=284.35 Aligned_cols=258 Identities=26% Similarity=0.466 Sum_probs=202.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC---CchhHHHHHHHHHhcCCCCeeeeeEEEec--CceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG---VPSTAIREISLLKEMQHGNIVRLQDVVHS--EKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 76 (323)
++|++.+.||+|++|.||++.+..++..|++|.+........ ....+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 689999999999999999999999999999998865432221 23467789999999999999999999876 3578
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
++++||+.| +|.+.+.+.. .+++..+..++.|++.+|.+||+++++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN-VKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC-EEECcCcccccccc
Confidence 899999976 7777765543 4677888899999999999999999999999999999998887 99999998875432
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
....... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..
T Consensus 159 ~~~~~~~--------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 159 ICLSGTG--------------------------MKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred ccccccc--------------------------cccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 1110000 011245788999999877 5678999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
........+... ... .......++..+.++|.+|+. +|++||+++++++|||
T Consensus 212 ~~~~~~~~~~~~---~~~------------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 212 FEAMAAIFKIAT---QPT------------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263 (265)
T ss_pred cchHHHHHHHhc---CCC------------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence 654444433221 110 011123467889999999995 9999999999999999
Q ss_pred Cc
Q 036739 316 FR 317 (323)
Q Consensus 316 ~~ 317 (323)
++
T Consensus 264 ~~ 265 (265)
T cd06652 264 VH 265 (265)
T ss_pred cC
Confidence 85
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=327.89 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=225.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|.+++.||+|+||-|.+++.+.+++.||+|++.+-.+ .....+.|..|-.+|.--..+=|+.++.+|+++.++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 589999999999999999999999999999999876443 3445678888999988888888999999999999999999
Q ss_pred ecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+. |+++..+.... .+++..++.++..|+.||+.+|+.|+|||||||+|||++..|. +||+|||.|..++.+...
T Consensus 155 dY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH-ikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH-IKLADFGSCLKMDADGTV 231 (1317)
T ss_pred ecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc-EeeccchhHHhcCCCCcE
Confidence 9995 58888777654 6899999999999999999999999999999999999999999 999999999887755554
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.. ...+|||.|.|||++.. ...|+...|.||+|+++|||+.|..||..
T Consensus 232 ~s----------------------------~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 232 RS----------------------------SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred Ee----------------------------ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 33 23488999999999863 25689999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC---Hhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT---ARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s---~~~il~ 312 (323)
..-.+++.+|.+.-....-+ -...+|+.+++||++++ -+|+.|.. +.++-.
T Consensus 284 dslveTY~KIm~hk~~l~FP-------------------------~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 284 DSLVETYGKIMNHKESLSFP-------------------------DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHHHHHHHHHhchhhhcCCC-------------------------cccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 99999999988652211100 01238999999999998 56789998 999999
Q ss_pred CCCCccccc
Q 036739 313 HEYFRDVEF 321 (323)
Q Consensus 313 h~~~~~~~~ 321 (323)
||||.+++|
T Consensus 338 HpFF~g~~W 346 (1317)
T KOG0612|consen 338 HPFFEGIDW 346 (1317)
T ss_pred CccccCCCh
Confidence 999999976
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=286.56 Aligned_cols=251 Identities=27% Similarity=0.458 Sum_probs=203.1
Q ss_pred eccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-hH
Q 036739 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DL 87 (323)
Q Consensus 10 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g-~l 87 (323)
||.|++|.||++++..++..+++|++..... .......+.+|+.+++.++||||+++++.+.++...++++||+.| +|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999988899999999865432 223446788999999999999999999999999999999999975 77
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCC
Q 036739 88 KKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167 (323)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 167 (323)
.+.+.+.. .+++..+..++.||+.||.+||+++++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~-~~l~df~~~~~~~~~~~~-------- 149 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKT-------- 149 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC-EEEeeCCcccccCccccc--------
Confidence 77776543 4688889999999999999999999999999999999998887 999999998765432110
Q ss_pred cCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC--hHHHHHHH
Q 036739 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS--EIDELFKI 245 (323)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~--~~~~~~~~ 245 (323)
....++..|++||.+.. ..++.++|+||+|+++|+|++|..||.... .......+
T Consensus 150 ----------------------~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 206 (262)
T cd05572 150 ----------------------WTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206 (262)
T ss_pred ----------------------ccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence 01234778999999876 567899999999999999999999998776 33333322
Q ss_pred HHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----HhhhhcCCCCcccc
Q 036739 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALEHEYFRDVE 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~h~~~~~~~ 320 (323)
..... ........++.+.++|.+||+.+|++||+ +.++++||||++.+
T Consensus 207 ~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 207 LKGNG---------------------------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred hccCC---------------------------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 21000 01112234788999999999999999999 99999999999876
Q ss_pred c
Q 036739 321 F 321 (323)
Q Consensus 321 ~ 321 (323)
|
T Consensus 260 ~ 260 (262)
T cd05572 260 W 260 (262)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=286.94 Aligned_cols=261 Identities=32% Similarity=0.512 Sum_probs=203.8
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC--------CchhHHHHHHHHHhcCCCCeeeeeEEEecCc
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG--------VPSTAIREISLLKEMQHGNIVRLQDVVHSEK 74 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (323)
+|.+.+.||+|++|.||++.+..++..+++|.+........ ..+.+.+|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 58899999999999999999988999999998864322111 1245678999999999999999999999999
Q ss_pred eEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
..++|+||+.| ++.+.+... ..+++..+..++.||+.||.+||+.+++|+||+|+||+++.++. ++++|||.+...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~-~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI-CKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe-EEEeeccccccc
Confidence 99999999966 676666554 25688888999999999999999999999999999999998887 999999988654
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCC-CCCCchhhHHHHHHHHHHHhCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR-HYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
....... ......++..|+|||.+.... .++.++|+||||+++|++++|..|
T Consensus 159 ~~~~~~~---------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 211 (272)
T cd06629 159 DDIYDND---------------------------QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211 (272)
T ss_pred ccccccc---------------------------ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCC
Confidence 3211100 001124478899999987643 478899999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
|................ .... ........++..+.++|.+||..+|.+||++.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~---~~~~--------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 212 WSDEEAIAAMFKLGNKR---SAPP--------------------IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcCcchHHHHHHhhccc---cCCc--------------------CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 97665544333221100 0000 001122347889999999999999999999999999
Q ss_pred CCCC
Q 036739 313 HEYF 316 (323)
Q Consensus 313 h~~~ 316 (323)
||||
T Consensus 269 ~~~~ 272 (272)
T cd06629 269 HPFI 272 (272)
T ss_pred CCCC
Confidence 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=283.11 Aligned_cols=254 Identities=31% Similarity=0.486 Sum_probs=206.3
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC---CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+|+..+.||+|++|.||+|.+..++..|++|.+...... ......+.+|+.+++.++|+|++++++++.+...++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 588999999999999999999888999999998654322 22346788899999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
+||+.| ++.+.+.+.. .+++..+..++.||+.+|.+||+.|++|+||+|+||+++.++. +||+|||.+........
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~-~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV-VKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEccCccceecccccc
Confidence 999976 6766665432 4678888899999999999999999999999999999998887 99999998876543221
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
. ....++..|++||.+.....++.++|+||+|+++|+|++|..||.....
T Consensus 158 ~------------------------------~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~ 207 (258)
T cd06632 158 A------------------------------KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207 (258)
T ss_pred c------------------------------cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH
Confidence 0 0123477899999987644488999999999999999999999987764
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
.+......... ........+++.+.+++.+||+.+|.+||++.+++.|||+
T Consensus 208 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 208 VAAVFKIGRSK---------------------------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHHhcc---------------------------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 44443322100 0111223477889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=289.68 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=206.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
..|+..+.||.|++|.||++.+..++..+|+|.+..... ......+.+|+.+++.+.|+|++++++++.+....++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 368899999999999999999988999999998864422 2234677889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| +|.+.+... .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 83 ~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~-~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC-EEEcccccceeccCCcccc
Confidence 9976 666666542 4678888899999999999999999999999999999998887 9999999987653221100
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....++..|.|||.+.+ ...+.++|+||||+++|+|++|..||.......
T Consensus 159 -----------------------------~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06640 159 -----------------------------NTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMR 208 (277)
T ss_pred -----------------------------ccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh
Confidence 01134777999999877 557899999999999999999999998766543
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
....+... ..+.....++..+.++|.+||+.+|++||++.++++||||....
T Consensus 209 ~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 209 VLFLIPKN----------------------------NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HhhhhhcC----------------------------CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 33222110 00112234677899999999999999999999999999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=294.74 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=203.8
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
.|.....||+|++|.||++.+..++..|++|.+.... ....+.+.+|+..++.++|+|++++++.+...+..++|+||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 4556778999999999999998899999999875432 22345678899999999999999999999999999999999
Q ss_pred chhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 83 LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 83 ~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
+.|+.+..+.... .+++..+..++.||+.+|.|||+.|++|+||+|+||+++.++. ++|+|||++..........
T Consensus 101 ~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~-~kL~dfg~~~~~~~~~~~~-- 175 (292)
T cd06658 101 LEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKR-- 175 (292)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-EEEccCcchhhcccccccC--
Confidence 9874444443322 4678889999999999999999999999999999999998877 9999999886543221110
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~ 242 (323)
....|+..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.........
T Consensus 176 ---------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~ 227 (292)
T cd06658 176 ---------------------------KSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 227 (292)
T ss_pred ---------------------------ceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 01245788999999876 56789999999999999999999999876655444
Q ss_pred HHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
..+....... ......+++.+.+++.+|+..||++||++.++++||||...
T Consensus 228 ~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 228 RRIRDNLPPR--------------------------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred HHHHhcCCCc--------------------------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 3332211000 00112367889999999999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=287.90 Aligned_cols=251 Identities=17% Similarity=0.217 Sum_probs=196.2
Q ss_pred CCcceeeeeccccceeEEEEEEc---cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC---VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|+||.||++... ..+..||+|.+..... ......+.+|+..++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 47999999999999999999764 3456899998854322 2223567889999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+++ ++.+.+... ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++. ++++|||.+.......
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~-~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 84 VTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV-CKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc-EEECCCcccccccccc
Confidence 9999987 455455443 335788889999999999999999999999999999999998877 9999999765432111
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
... .....++..|+|||.+.. ..++.++|+|||||++|++++ |..||...
T Consensus 162 ~~~----------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 162 IYT----------------------------TMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred hhc----------------------------ccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 000 000123567999999877 668999999999999999775 99999887
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+....+.+.... +....++..+.+++.+||+.+|++||++.+|++
T Consensus 213 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 213 SGQDVIKAVEDGFRL----------------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CHHHHHHHHHCCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 766554444321100 112346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=288.69 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=219.2
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
|++|..++.||+|-||.|-+++.+.+++.||+|++++.. ...+..+.-..|-++++..+||.+..+-..|+....+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 689999999999999999999999999999999987664 2333345556788899999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| .|.-++.+.. .+++..++.+-..|++||.|||+++|+++|||.+|.+++++|. +||+|||+|..--....
T Consensus 247 MeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH-IKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH-IKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc-eEeeecccchhcccccc
Confidence 999976 7777766654 4688888899999999999999999999999999999999999 99999999976432222
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
+. .+-+|||.|.|||++.. ..|+.+.|.|.+|+++|||+.|+.||...+.
T Consensus 324 t~-----------------------------kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 324 TT-----------------------------KTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred ee-----------------------------ccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccch
Confidence 11 12378999999999988 7799999999999999999999999988876
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h 313 (323)
......+.-. ....+..++++++.|+..+|.+||.+|+ ++.+|.+|
T Consensus 374 ~kLFeLIl~e-----------------------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 374 EKLFELILME-----------------------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hHHHHHHHhh-----------------------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 5554443321 1122356899999999999999999998 78999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
+||.+++|
T Consensus 425 ~FF~~v~W 432 (516)
T KOG0690|consen 425 RFFASVDW 432 (516)
T ss_pred hhhccCCH
Confidence 99999987
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=298.28 Aligned_cols=289 Identities=21% Similarity=0.264 Sum_probs=203.7
Q ss_pred eeeccc--cceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEG--TYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g--~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
..||.| ++++||++.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 889999999989999999999865543333446788899999999999999999999999999999999975
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
++.+.+.......+++..+..++.|++.||+|||++|++|+||||+||+++.++. ++++||+.+..............
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL-VSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc-EEEechHHHhhhhccCccccccc
Confidence 7777666554445788889999999999999999999999999999999998877 99999986543321111000000
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~ 243 (323)
.. .....++..|+|||++.+. ..++.++|+||+||++|+|++|..||..........
T Consensus 163 -~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 220 (328)
T cd08226 163 -DF---------------------PQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL 220 (328)
T ss_pred -cc---------------------cccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH
Confidence 00 0001235669999998763 347889999999999999999999998776554443
Q ss_pred HHHHHhCCCCCCCCCCcccCCccccc----------------CCCCC--CCcccccccCCChHHHHHHHhhcccCCCCCC
Q 036739 244 KIFRVLGTPNEDTWPGVTSLPDFKSA----------------FPKWP--SKELGTVVRNLEPAGIDLLSKMLCMDPSRRI 305 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~--~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~ 305 (323)
....................+.+... ..... ..........+++.+.+||++||+.||++||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 300 (328)
T cd08226 221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP 300 (328)
T ss_pred HHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCC
Confidence 33221110000000000000000000 00000 0001112234678899999999999999999
Q ss_pred CHhhhhcCCCCccc
Q 036739 306 TARSALEHEYFRDV 319 (323)
Q Consensus 306 s~~~il~h~~~~~~ 319 (323)
++.++++||||+++
T Consensus 301 ta~e~l~~~~~~~~ 314 (328)
T cd08226 301 SASSLLSHAFFKQV 314 (328)
T ss_pred CHHHHhhCHHHHHH
Confidence 99999999999876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=285.25 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=202.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.+|++.+.||+|++|.||++.+..++..+++|.+... ......+.+|+.+++.+.|+|++++++++..++.+++++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 4688999999999999999999888999999987532 2224578889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+ ++.+.+.......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. +||+|||.+..........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~-~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc-EEeCCCccccccccceeec
Confidence 9965 7877776655556788889999999999999999999999999999999998887 9999999987654321110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus 162 ~~----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 162 HA----------------------------GAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred cC----------------------------CCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 00 0122567999999877 568899999999999999998 99999876554
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+.+... ......+++.+.++|.+||+.||++||++.++++
T Consensus 213 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 213 QVYELLEKGYR----------------------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHCCCC----------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 44333322100 0112347789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=287.71 Aligned_cols=265 Identities=25% Similarity=0.410 Sum_probs=202.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--CceEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 79 (323)
++|+..+.||.|++|.||++.+..++..+++|.+..... ......+.+|+++++.++||||+++++++.+ .+.+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 579999999999999999999988999999998864422 2334678899999999999999999999865 4478999
Q ss_pred Eecchh-hHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 80 FEYLDL-DLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
|||++| +|.+.+.. .....+++..+..++.||+.+|.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~-~~l~dfg~~~~~~~~ 158 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ-VKLCDFGVSGELVNS 158 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe-EEEeecccccccccc
Confidence 999976 66655432 22345688889999999999999999999999999999999998887 999999987654322
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.... ..++..|++||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus 159 ~~~~-------------------------------~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 159 LAGT-------------------------------FTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cccc-------------------------------ccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1110 123677999999877 56889999999999999999999999765
Q ss_pred Ch--HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 237 SE--IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 237 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
.. .... .............. ..........++.+.++|.+||..+|++||++.++++||
T Consensus 207 ~~~~~~~~-~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 207 GEPPLGPI-ELLSYIVNMPNPEL------------------KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred cCCCCChH-HHHHHHhcCCchhh------------------ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 32 0111 11111111000000 000011122467889999999999999999999999999
Q ss_pred CCccc
Q 036739 315 YFRDV 319 (323)
Q Consensus 315 ~~~~~ 319 (323)
||++.
T Consensus 268 ~~~~~ 272 (287)
T cd06621 268 WIKAQ 272 (287)
T ss_pred ccccc
Confidence 99765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=315.13 Aligned_cols=287 Identities=23% Similarity=0.349 Sum_probs=198.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc-eEEEEEE--------------Eec-ccCCCCchhHHHHHHHHHhcCCCCeee
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE-TIALKKI--------------RLE-QEDEGVPSTAIREISLLKEMQHGNIVR 65 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-~~aiK~~--------------~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~ 65 (323)
++|++++.||+|+||+||++..+.... ..+.|.+ .+. .........+.+|+.+++.++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 579999999999999999987543222 2222211 000 011122356778999999999999999
Q ss_pred eeEEEecCceEEEEEecchhhHHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCce
Q 036739 66 LQDVVHSEKKLYLVFEYLDLDLKKHMDSCP---DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNAL 142 (323)
Q Consensus 66 ~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~ 142 (323)
+++++.+....+++++++.+++...+.... ........++.++.||+.||.|||++||+|+||||+|||++.++. +
T Consensus 228 l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~-v 306 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK-I 306 (501)
T ss_pred EeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-E
Confidence 999999999999999999998888775432 112235567789999999999999999999999999999999887 9
Q ss_pred EEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHH
Q 036739 143 KLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCI 222 (323)
Q Consensus 143 kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~l 222 (323)
||+|||++..+........ ....||+.|+|||.+.+ ..++.++|||||||+
T Consensus 307 kL~DFGla~~~~~~~~~~~----------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi 357 (501)
T PHA03210 307 VLGDFGTAMPFEKEREAFD----------------------------YGWVGTVATNSPEILAG-DGYCEITDIWSCGLI 357 (501)
T ss_pred EEEeCCCceecCccccccc----------------------------ccccCCcCCCCchhhcC-CCCCcHHHHHHHHHH
Confidence 9999999976643221111 11256899999999987 568999999999999
Q ss_pred HHHHHhCCC-CCCCC--ChHHHHHHHHHHhCCCCCCCCCCcc-cCCcccccCC-CCCCCcccc--cccCCChHHHHHHHh
Q 036739 223 FAEMVNQRP-LFPGD--SEIDELFKIFRVLGTPNEDTWPGVT-SLPDFKSAFP-KWPSKELGT--VVRNLEPAGIDLLSK 295 (323)
Q Consensus 223 l~~l~tg~~-p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~--~~~~~s~~~~~li~~ 295 (323)
+|+|++|.. |+... .....+.++...+.....+ ++... ....+..... ......... ....++..+.++|.+
T Consensus 358 l~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~k 436 (501)
T PHA03210 358 LLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEE-FPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVK 436 (501)
T ss_pred HHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhh-cCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHH
Confidence 999999874 44332 2333444444433322211 11100 0000000000 000000011 112367788899999
Q ss_pred hcccCCCCCCCHhhhhcCCCCccc
Q 036739 296 MLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 296 ~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
||+.||.+||++.++|+||||.+.
T Consensus 437 mL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 437 MLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HhccCcccCcCHHHHhhChhhhcC
Confidence 999999999999999999999874
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=283.60 Aligned_cols=262 Identities=25% Similarity=0.395 Sum_probs=209.6
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEEEecchh
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
.+.||+|+++.|--+.+..++..||+|++.+... .....+.+|++++.+.+ |+||++++++|+++..+|+|||-+.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 4579999999999999999999999999977643 34578889999999996 99999999999999999999999965
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEeccccceecCCCcccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~~~~~~~~~~~~ 162 (323)
.+++++.++.. +++.++.++..+|+.||.+||++||.|+||||+|||+..-+. -+||+||.+..-..........
T Consensus 161 GplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 161 GPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred chHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 99999998764 588999999999999999999999999999999999966444 3899999987664433222211
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhh----CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILL----GSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~----~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
..+.. -+.+|+..|||||+.. ....|+.+-|.||||+++|-|+.|.+||.+.=.
T Consensus 239 stP~L----------------------~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 239 STPEL----------------------LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred CCccc----------------------cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 11111 1247788999999964 345689999999999999999999999976411
Q ss_pred --------------HHHHH-HHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC
Q 036739 239 --------------IDELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303 (323)
Q Consensus 239 --------------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~ 303 (323)
.+.+. .|..+.... .+..+..+|..++++|..+|-.|+.+
T Consensus 297 ~dCGWdrGe~Cr~CQ~~LFesIQEGkYeF-------------------------PdkdWahIS~eakdlisnLlvrda~~ 351 (463)
T KOG0607|consen 297 ADCGWDRGEVCRVCQNKLFESIQEGKYEF-------------------------PDKDWAHISSEAKDLISNLLVRDAKQ 351 (463)
T ss_pred CcCCccCCCccHHHHHHHHHHHhccCCcC-------------------------ChhhhHHhhHHHHHHHHHHHhccHHh
Confidence 11122 222221111 22334679999999999999999999
Q ss_pred CCCHhhhhcCCCCccc
Q 036739 304 RITARSALEHEYFRDV 319 (323)
Q Consensus 304 R~s~~~il~h~~~~~~ 319 (323)
|.++.++++|||++.+
T Consensus 352 rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 352 RLSAAQVLNHPWVQRC 367 (463)
T ss_pred hhhhhhccCCcccccc
Confidence 9999999999999876
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.51 Aligned_cols=263 Identities=22% Similarity=0.386 Sum_probs=203.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|+..+.||+|++|.||++.+..++..+|+|.+...... .....+.+|+..+.++. |+||+++++++..++..++++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 5788889999999999999999999999999988654322 23456778999999996 999999999999999999999
Q ss_pred ecchhhHHHh---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 81 EYLDLDLKKH---MDSCPDFANDPRLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 81 e~~~g~l~~~---~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
|++.+++.+. +.......+++..+..++.|++.||+|||+. +++|+||+|+||+++.++. ++|+|||++......
T Consensus 83 e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~ 161 (288)
T cd06616 83 ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDS 161 (288)
T ss_pred ecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc-EEEeecchhHHhccC
Confidence 9997655443 2223334678889999999999999999974 9999999999999998887 999999988654322
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC--CCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS--RHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
.... ...|++.|+|||.+.+. ..++.++|+||+|+++|+|++|..||.
T Consensus 162 ~~~~------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 162 IAKT------------------------------RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred Cccc------------------------------cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 1110 11347789999999875 368899999999999999999999997
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
.... ....+.+..... .... .......+++.+.+||.+||+.+|++||++.++++||
T Consensus 212 ~~~~--~~~~~~~~~~~~-~~~~--------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 212 KWNS--VFDQLTQVVKGD-PPIL--------------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred hcch--HHHHHhhhcCCC-CCcC--------------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 6542 112221111100 0000 0011134788999999999999999999999999999
Q ss_pred CCccc
Q 036739 315 YFRDV 319 (323)
Q Consensus 315 ~~~~~ 319 (323)
||++.
T Consensus 269 ~~~~~ 273 (288)
T cd06616 269 FIKDY 273 (288)
T ss_pred hhhch
Confidence 99865
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=292.40 Aligned_cols=283 Identities=20% Similarity=0.237 Sum_probs=200.7
Q ss_pred cceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-hHHHhhh
Q 036739 14 TYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMD 92 (323)
Q Consensus 14 ~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g-~l~~~~~ 92 (323)
+++.||.+++..++..||+|++............+.+|+.+++.++|+||+++++++.+.+..++++||+.+ ++.+.+.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 445677777777999999999976544444567888999999999999999999999999999999999975 6666666
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcce
Q 036739 93 SCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172 (323)
Q Consensus 93 ~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (323)
......+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+||+.+..............
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~-~kl~d~~~~~~~~~~~~~~~~~~-------- 162 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVH-------- 162 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc-eEEecCccceeeccccccccccc--------
Confidence 544456788889999999999999999999999999999999998887 99999998876532211100000
Q ss_pred eehhhhhhhccCccceeeccccccccccchhhhCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 036739 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGT 251 (323)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 251 (323)
.......++..|+|||.+... ..++.++|+||+|+++|+|++|..||..................
T Consensus 163 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (314)
T cd08216 163 --------------DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVP 228 (314)
T ss_pred --------------cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCc
Confidence 000112347789999998763 34788999999999999999999999876554433222211100
Q ss_pred CCC--CCCCCccc-CCcc--cccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 252 PNE--DTWPGVTS-LPDF--KSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 252 ~~~--~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
... ...+.... .... ..................+++.+.+++.+||+.||++||++.++++||||+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 000 00000000 0000 00000000111122233466789999999999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=283.71 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=194.5
Q ss_pred CCcceeeee--ccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKI--GEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~l--g~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.+ |+|++|.||++.++.++..+++|.+....... .|+.....+ +|+|++++++.+...+.+++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 456776776 99999999999999999999999986442211 122222222 69999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| +|.+.+.... .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++..++|+|||.+.......
T Consensus 87 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 164 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164 (267)
T ss_pred EEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc
Confidence 9999965 8887776653 678999999999999999999999999999999999999988349999999887653221
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
. ..++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||....
T Consensus 165 ~---------------------------------~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 165 C---------------------------------YDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred c---------------------------------CCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 1 134788999999977 557899999999999999999999998654
Q ss_pred hHHHH-HHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-HhhhhcCCC
Q 036739 238 EIDEL-FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-ARSALEHEY 315 (323)
Q Consensus 238 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-~~~il~h~~ 315 (323)
..... ....... . ......+.+++.+.++|.+||+.+|.+|++ ++++++|||
T Consensus 211 ~~~~~~~~~~~~~-~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~ 264 (267)
T PHA03390 211 DEELDLESLLKRQ-Q-------------------------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264 (267)
T ss_pred cchhhHHHHHHhh-c-------------------------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence 43221 1111110 0 011122358899999999999999999996 699999999
Q ss_pred Ccc
Q 036739 316 FRD 318 (323)
Q Consensus 316 ~~~ 318 (323)
|++
T Consensus 265 ~~~ 267 (267)
T PHA03390 265 LKI 267 (267)
T ss_pred ccC
Confidence 974
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=292.58 Aligned_cols=255 Identities=29% Similarity=0.432 Sum_probs=203.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+.|+..+.||+|++|.||++.+..++..||+|.+...... .....+.+|+.+++.++||||+++++.+.++...++|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 3578889999999999999999888999999988644322 234578899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| ++.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++++|||.+..........
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~-~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 83 YLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC-EEEccccccccccCcchhh
Confidence 9986 66665543 24688889999999999999999999999999999999998877 9999999886653221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......
T Consensus 159 -----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06642 159 -----------------------------NTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMR 208 (277)
T ss_pred -----------------------------hcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhh
Confidence 01134777999999877 567899999999999999999999997655433
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
....+... ........++..+.++|.+||+.+|++||++.++++||||...
T Consensus 209 ~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 209 VLFLIPKN----------------------------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHhhhhcC----------------------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 32221100 0001112367789999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=286.58 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=205.1
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|...+.||+|++|.||++.+..++..+++|.+..... .....+.+|+.+++.+.|+|++++++++...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 46667899999999999999988999999998754322 2235678899999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+.| +|.+.+.. ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~~l~d~g~~~~~~~~~~~~- 172 (285)
T cd06648 98 LEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCAQVSKEVPRR- 172 (285)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc-EEEcccccchhhccCCccc-
Confidence 976 66666554 24688888999999999999999999999999999999998887 9999999876543211110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
....|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||........
T Consensus 173 ----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~ 223 (285)
T cd06648 173 ----------------------------KSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA 223 (285)
T ss_pred ----------------------------ccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH
Confidence 01235788999999877 5588999999999999999999999987665544
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
...+.... . .. ......+++.+.++|++||+.+|++||++.++++||||+...
T Consensus 224 ~~~~~~~~-~---~~----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 224 MKRIRDNL-P---PK----------------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHhcC-C---CC----------------------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 44333210 0 00 001123678899999999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=288.73 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=201.9
Q ss_pred CCCcceeeeeccccceeEEEEEEccCC-----ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCce
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTN-----ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (323)
+++|++.+.||+|++|.||++.....+ ..+++|.+.... .......+.+|+..++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 368999999999999999999876555 579999875332 22234567889999999999999999999999999
Q ss_pred EEEEEecchh-hHHHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPD--------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN 140 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~ 140 (323)
.+++|||+.+ +|.+++..... ..++...+..++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 9999999975 77777765421 34677888899999999999999999999999999999998877
Q ss_pred ceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHH
Q 036739 141 ALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220 (323)
Q Consensus 141 ~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG 220 (323)
++|+|||.+........... .....+++.|+|||.+.+ ..++.++|+||||
T Consensus 163 -~~L~dfg~~~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG 213 (283)
T cd05048 163 -VKISDFGLSRDIYSADYYRV---------------------------QSKSLLPVRWMPPEAILY-GKFTTESDIWSFG 213 (283)
T ss_pred -EEECCCcceeeccccccccc---------------------------cCCCcccccccCHHHhcc-CcCchhhhHHHHH
Confidence 99999999875432211000 011134678999999877 5689999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhccc
Q 036739 221 CIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299 (323)
Q Consensus 221 ~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 299 (323)
|++|+|++ |..||.+....+....+.... .......+++.+.+++.+||+.
T Consensus 214 ~il~el~~~g~~p~~~~~~~~~~~~i~~~~----------------------------~~~~~~~~~~~~~~l~~~c~~~ 265 (283)
T cd05048 214 VVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ----------------------------LLPCPEDCPARVYALMIECWNE 265 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----------------------------cCCCcccCCHHHHHHHHHHccC
Confidence 99999998 999998877655544433211 0111234789999999999999
Q ss_pred CCCCCCCHhhhhcC
Q 036739 300 DPSRRITARSALEH 313 (323)
Q Consensus 300 dp~~R~s~~~il~h 313 (323)
||.+||++.+|+++
T Consensus 266 ~p~~Rp~~~~i~~~ 279 (283)
T cd05048 266 IPARRPRFKDIHTR 279 (283)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=300.70 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=221.2
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchhh
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDLD 86 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (323)
.+.||+|.||+||-+....+|+.||+|++.+..........+++|+++++.+.||+|+.+...|++.+..++|||-+.|+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 46799999999999999999999999999888777777799999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEeccccceecCCCcccccccc
Q 036739 87 LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 87 l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
.++-+.+.....+++.....++.||+.||.|||.+||+|.||||+|||+..... .+||+|||+++..+....
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF------ 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF------ 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh------
Confidence 999999988889999999999999999999999999999999999999976544 799999999988753322
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
.+.++||+.|.|||++.. .-|...-|+||+|+|+|.-+.|..||....+ .-.+
T Consensus 723 ------------------------RrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQ 775 (888)
T KOG4236|consen 723 ------------------------RRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQ 775 (888)
T ss_pred ------------------------hhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccc--hhHH
Confidence 234688999999999988 5589999999999999999999999965433 2233
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+.+.......+ -+..+++.+.+||+.+|+..=.+|.++..-+.|||+++.
T Consensus 776 IQNAaFMyPp~-------------------------PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 776 IQNAAFMYPPN-------------------------PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred hhccccccCCC-------------------------chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 33322222222 235689999999999999999999999999999999975
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=288.93 Aligned_cols=260 Identities=22% Similarity=0.278 Sum_probs=195.9
Q ss_pred CCcceeeeeccccceeEEEEEEcc----------------CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeee
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV----------------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~----------------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 65 (323)
++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 589999999999999999997532 33479999885432 2223456888999999999999999
Q ss_pred eeEEEecCceEEEEEecchh-hHHHhhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 036739 66 LQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPD-----------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRD 127 (323)
Q Consensus 66 ~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~-----------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~d 127 (323)
+++++.+.+..++||||+.+ +|.+.+..... ..++...+..++.||+.||.|||+.|++|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 99999999999999999965 77776644321 2346677889999999999999999999999
Q ss_pred CCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC
Q 036739 128 LKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS 207 (323)
Q Consensus 128 l~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 207 (323)
|||+||+++.++. +||+|||.+.......... ......++..|+|||++..
T Consensus 164 lkp~Nill~~~~~-~kl~DfG~~~~~~~~~~~~---------------------------~~~~~~~~~~y~aPE~~~~- 214 (304)
T cd05096 164 LATRNCLVGENLT-IKIADFGMSRNLYAGDYYR---------------------------IQGRAVLPIRWMAWECILM- 214 (304)
T ss_pred cchhheEEcCCcc-EEECCCccceecccCceeE---------------------------ecCcCCCCccccCHHHHhc-
Confidence 9999999998887 9999999987653221110 0011233677999999877
Q ss_pred CCCCCchhhHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCC
Q 036739 208 RHYSTPVDVWSVGCIFAEMVN--QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNL 285 (323)
Q Consensus 208 ~~~~~~~Di~slG~ll~~l~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (323)
..++.++|+||||+++|+|++ +..||......+................ .......+
T Consensus 215 ~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~ 273 (304)
T cd05096 215 GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV---------------------YLFRPPPC 273 (304)
T ss_pred CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccc---------------------cccCCCCC
Confidence 568999999999999999987 5678877665554443322211100000 00111246
Q ss_pred ChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 286 EPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 286 s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
++.+.+++.+||+.||++||++.+|.+
T Consensus 274 ~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 274 PQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 788999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=289.44 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=206.9
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.|...+.||+|++|.||++++..++..+++|.+...... ......+.+|+.+++.++|||++++++++.+....++|+|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 366678899999999999999889999999998654322 2223467789999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|+.|++.+.+.... ..+++..+..++.||+.+|.|||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 102 ~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~-~kL~dfg~~~~~~~~~---- 175 (313)
T cd06633 102 YCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-VKLADFGSASKSSPAN---- 175 (313)
T ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC-EEEeecCCCcccCCCC----
Confidence 99998888776543 35788888999999999999999999999999999999998887 9999999875321110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
...|+..|+|||.+.. ...++.++|+||||+++|+|++|..||......
T Consensus 176 -----------------------------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~ 226 (313)
T cd06633 176 -----------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 226 (313)
T ss_pred -----------------------------CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 1244778999999852 255788999999999999999999999887665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.....+.... .+ ......++..+++++.+||+.+|.+||++.+++.||||+..
T Consensus 227 ~~~~~~~~~~-~~--------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 227 SALYHIAQND-SP--------------------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHHHhcC-CC--------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 5554433210 00 00112356789999999999999999999999999999875
Q ss_pred c
Q 036739 320 E 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 280 ~ 280 (313)
T cd06633 280 R 280 (313)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=290.85 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=205.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+..++..|++|.+.... ....+.+.+|+.+++.++|||++++++.+...+..++|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 58999999999999999999998889999999875432 2234677889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| ++.+.+.+. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 97 ~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~-~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 97 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred cCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC-EEEccCcceeccccccccc
Confidence 9976 666665442 3577788899999999999999999999999999999998877 9999999887554322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...+++.|++||.+.. ..++.++|+||||+++|++++|..||.......
T Consensus 173 ~-----------------------------~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~ 222 (293)
T cd06647 173 S-----------------------------TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (293)
T ss_pred c-----------------------------cccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 0 1134778999999877 567899999999999999999999998765433
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
....+... ... .......++..+.++|++||+.+|++||++.+++.||||+..+
T Consensus 223 ~~~~~~~~----~~~----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 223 ALYLIATN----GTP----------------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred heeehhcC----CCC----------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 32211100 000 0011223677899999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=286.77 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=201.8
Q ss_pred CCcceeeeeccccceeEEEEEEcc-----CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|++|.||++..+. .+..||+|.+.... .......+.+|+..++.++|+||+++++++.+....
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 589999999999999999997542 34579999864332 112234567899999999999999999999999999
Q ss_pred EEEEecch-hhHHHhhhcCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 77 YLVFEYLD-LDLKKHMDSCPD--------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 77 ~lv~e~~~-g~l~~~~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
++||||+. |+|.+.+..... ...+...+..++.|++.||.|||+++++|+||||+||+++.++. ++|+||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~-~~L~Df 163 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT-VKIGDF 163 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc-EEECcC
Confidence 99999996 478777754321 22345677889999999999999999999999999999998877 999999
Q ss_pred ccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH
Q 036739 148 GLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~ 227 (323)
|.+............ ....++..|+|||.+.+ ..++.++|+|||||++|+|+
T Consensus 164 g~~~~~~~~~~~~~~---------------------------~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~ 215 (288)
T cd05061 164 GMTRDIYETDYYRKG---------------------------GKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEIT 215 (288)
T ss_pred Ccccccccccccccc---------------------------CCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHH
Confidence 988654321110000 00123567999999877 56899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC
Q 036739 228 N-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT 306 (323)
Q Consensus 228 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 306 (323)
+ |..||......+....+..... .......++.+.+++.+||+.||++||+
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps 267 (288)
T cd05061 216 SLAEQPYQGLSNEQVLKFVMDGGY----------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPT 267 (288)
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 8 7889987665554433321100 0011235788999999999999999999
Q ss_pred Hhhhhc------CCCCccccc
Q 036739 307 ARSALE------HEYFRDVEF 321 (323)
Q Consensus 307 ~~~il~------h~~~~~~~~ 321 (323)
+.++++ ||||.++.|
T Consensus 268 ~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 268 FLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHHHHHHHHhhcCCCCCCCCC
Confidence 999987 999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=282.86 Aligned_cols=249 Identities=26% Similarity=0.351 Sum_probs=201.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.++||+|++|.||++.. .++..|++|.+.... ...+.+.+|+.+++.++|+||+++++.+.+.+..++++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 6899999999999999999986 456679999875322 234678899999999999999999999999999999999
Q ss_pred cch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+. |++.+.+........+...+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~-~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM-CKIADFGLARVIEDNEYTA 160 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc-EEECCCccceecCCCceec
Confidence 996 58888887655556788888899999999999999999999999999999998887 9999999997754221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. ...++..|+|||.+.. ..++.++|+||||+++|+|++ |..||......
T Consensus 161 ~~----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 211 (261)
T cd05072 161 RE----------------------------GAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211 (261)
T ss_pred cC----------------------------CCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence 00 0123567999999877 567889999999999999998 99999877665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+.+... .+....++..+.+++.+|+..+|++||++.++++
T Consensus 212 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 212 DVMSALQRGYR----------------------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 55444432110 0111346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=304.65 Aligned_cols=255 Identities=21% Similarity=0.282 Sum_probs=205.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++..+..+||+|.||+||++.+ . ..||||++....-..+..+.|++|+.++++-+|.||+-+.|++...+. .||+.
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~w--h-GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRW--H-GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHhhccceeccccccceeeccc--c-cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 4567889999999999999986 3 359999998887666678999999999999999999999999977776 99999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+|+|+.+..........+.....+.|+.||++|+.|||.++|+|+|||..||++..++. |||+|||++..-........
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k-VkIgDFGLatvk~~w~g~~q 546 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK-VKIGDFGLATVKTRWSGEQQ 546 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc-EEEecccceeeeeeeccccc
Confidence 99995555554444456788888999999999999999999999999999999998877 99999999876543311111
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
. ....|.+.|+|||++.. ..+++..+||||+|+++|||++|..||+.....
T Consensus 547 ~---------------------------~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d 599 (678)
T KOG0193|consen 547 L---------------------------EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD 599 (678)
T ss_pred c---------------------------CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh
Confidence 0 11245788999999974 366899999999999999999999999966555
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+.+..+-+++..+... .+..+.+.++++|+..|+..++++||...+||.
T Consensus 600 qIifmVGrG~l~pd~s------------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 600 QIIFMVGRGYLMPDLS------------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred heEEEecccccCccch------------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 5555554433222221 223456779999999999999999999998876
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=285.77 Aligned_cols=254 Identities=29% Similarity=0.446 Sum_probs=204.9
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
-|++.+.||+|++|.||++.+..++..+|+|.+..... ......+.+|+..++.+.|||++++++++.++...++|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 47889999999999999999988999999998754322 22346788899999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+++ ++.+.+... .++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 84 ~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~-~~l~dfg~~~~~~~~~~~~- 158 (277)
T cd06641 84 LGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKR- 158 (277)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC-EEEeecccceecccchhhh-
Confidence 976 666555432 4688889999999999999999999999999999999998887 9999999887653221110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
....++..|+|||.+.. ...+.++|+||+|+++|+|++|..||........
T Consensus 159 ----------------------------~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 209 (277)
T cd06641 159 ----------------------------NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKV 209 (277)
T ss_pred ----------------------------ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH
Confidence 01134777999999876 5678899999999999999999999977655443
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
...+... . .+.....++..+.++|.+||+.+|.+||++.++++||||.+.
T Consensus 210 ~~~~~~~----~------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 210 LFLIPKN----N------------------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHhcC----C------------------------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 3332110 0 001123467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=279.21 Aligned_cols=253 Identities=32% Similarity=0.548 Sum_probs=209.0
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||+|++|.||++.+..++..|++|.+............+.+|++++++++|+|++++++++.+++..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 68999999999999999999988999999999876544334556788999999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+++ ++.+.+... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~-~~l~d~~~~~~~~~~~~~~- 156 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDD- 156 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC-EEEeccccceecCCCcccc-
Confidence 977 666666554 35788889999999999999999999999999999999998776 9999999998765332210
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
....++..|++||.... ...+.++|+|++|+++|+|++|..||........
T Consensus 157 ----------------------------~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~ 207 (254)
T cd06627 157 ----------------------------ASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA 207 (254)
T ss_pred ----------------------------cccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 01234778999999877 4488999999999999999999999987665444
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
....... ........+++.+.+++.+||..+|++||++.+++.||||
T Consensus 208 ~~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 208 LFRIVQD----------------------------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHhcc----------------------------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 4332211 0111223578899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=287.25 Aligned_cols=258 Identities=22% Similarity=0.390 Sum_probs=202.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|+||++.+..++..||+|++.... .......+.+|+.+++.++||||+++++++.+.+.+++|+|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 58999999999999999999998889999999886442 23345678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|+.+ ++...+... ..++...+..++.+++.+|.|||+ .+++|+||+|+||+++.++. ++|+|||++.........
T Consensus 84 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~-~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 84 FMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ-IKLCDFGVSGELINSIAD 160 (284)
T ss_pred cCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc-EEEccCCcccchhhhccC
Confidence 9987 555555443 246888899999999999999997 58999999999999998877 999999987543211110
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
...|+..|+|||++.+ ..++.++|+||+||++|++++|..||......
T Consensus 161 -------------------------------~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 208 (284)
T cd06620 161 -------------------------------TFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNID 208 (284)
T ss_pred -------------------------------ccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchh
Confidence 1245888999999877 56889999999999999999999999865542
Q ss_pred HH-------HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DE-------LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.. .....+.......... ....++..+.+||.+|++.||++||++.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~ 265 (284)
T cd06620 209 DDGQDDPMGILDLLQQIVQEPPPRL-----------------------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265 (284)
T ss_pred hhhhhhhhHHHHHHHHHhhccCCCC-----------------------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 10 1111111100000000 00126778999999999999999999999999
Q ss_pred CCCCcc
Q 036739 313 HEYFRD 318 (323)
Q Consensus 313 h~~~~~ 318 (323)
|+||..
T Consensus 266 ~~~~~~ 271 (284)
T cd06620 266 MPPFIQ 271 (284)
T ss_pred Cccccc
Confidence 999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=315.70 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=204.2
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEE-Eec------Cc
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDV-VHS------EK 74 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~~------~~ 74 (323)
+++|.+.|.+|||+.||+|.+...+..||+|.+... +......+.+|+.+|+.|+ |+|||.+++. ... .-
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 578899999999999999999777799999998655 5556788999999999997 9999999993 321 13
Q ss_pred eEEEEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEecCCCceEEeccccce
Q 036739 75 KLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (323)
Q Consensus 75 ~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~~~Nil~~~~~~~~kl~df~~~~ 151 (323)
.+.|+||||. |+|.++|..+-...+++.++++|+.|+++|+.+||..+ |+|||||-+|||+..++. .||||||++.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~-~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN-YKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC-EEeCcccccc
Confidence 5789999998 59999999877777999999999999999999999987 999999999999999998 9999999986
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhh--CCCCCCCchhhHHHHHHHHHHHhC
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILL--GSRHYSTPVDVWSVGCIFAEMVNQ 229 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~~Di~slG~ll~~l~tg 229 (323)
..-...+... +-..+.+ +..+..|+.|.|||++. .....+.|+|||+|||+||.|+..
T Consensus 195 t~~~~~~~~~----------------e~~~ve~----eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~ 254 (738)
T KOG1989|consen 195 TKILSPTSAQ----------------EVNYVEE----EIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYF 254 (738)
T ss_pred cccCCCccHH----------------HHHHHHH----HHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHh
Confidence 5433332100 0011111 11234599999999975 346789999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
..||...-...++. + ++. -+..+.++..+.+||+.||+.||++||++.+
T Consensus 255 t~PFe~sg~laIln----g--------------------~Y~-------~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q 303 (738)
T KOG1989|consen 255 TTPFEESGKLAILN----G--------------------NYS-------FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQ 303 (738)
T ss_pred CCCcCcCcceeEEe----c--------------------ccc-------CCCCccHHHHHHHHHHHHhccCcccCCCHHH
Confidence 99997663221111 1 111 1112458899999999999999999999999
Q ss_pred hhc
Q 036739 310 ALE 312 (323)
Q Consensus 310 il~ 312 (323)
++.
T Consensus 304 v~~ 306 (738)
T KOG1989|consen 304 VLE 306 (738)
T ss_pred HHH
Confidence 885
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=281.12 Aligned_cols=248 Identities=21% Similarity=0.301 Sum_probs=197.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++..+ .+..+++|.+.... .....+.+|+.+++.++||||+++++++.+....+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 57999999999999999999874 45679999874322 224678889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| ++.+.+....+ .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 80 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~-~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 80 FMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV-VKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred cCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe-EEECCCCCccccCCCceec
Confidence 9975 77777665433 4788889999999999999999999999999999999998776 9999999886543211110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. ...++..|+|||.+.. ..++.++|+||+|+++|+|++ |+.||......
T Consensus 158 ~~----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05114 158 SS----------------------------GAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208 (256)
T ss_pred cC----------------------------CCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 00 0122567999999876 568899999999999999999 89999887766
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+.+.... ......+..+.+++.+|++.+|++||++.++++
T Consensus 209 ~~~~~i~~~~~~----------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 209 EVVEMISRGFRL----------------------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHCCCCC----------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 665554431100 001124678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.76 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=200.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+. ++..|++|.+.... .....+.+|+.++++++|+|++++++++...+..++++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 57899999999999999999874 45689999875432 224678899999999999999999999999999999999
Q ss_pred cch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
++. +++.+.+.......++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI-CKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC-EEECCcceEEEccCCcccc
Confidence 995 58888887665556788899999999999999999999999999999999999887 9999999998765221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. + ...+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+....
T Consensus 161 ~~---~-------------------------~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 161 RE---G-------------------------AKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred cC---C-------------------------CcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 00 0 011356999999877 568899999999999999999 99999887665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.....+.+.... ......++.+.+++.+|++.+|.+||++.++++
T Consensus 212 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 212 EVLQQVDQGYRM----------------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHcCCCC----------------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 555443321100 111236788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=297.38 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=196.2
Q ss_pred CCcceeeeeccccceeEEEEEE-----ccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARN-----CVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|+||.||+|++ ..++..||+|++.... .......+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 4799999999999999999974 3356689999885432 222345678899999999 89999999999999999
Q ss_pred EEEEEecchh-hHHHhhhcCC-----------------------------------------------------------
Q 036739 76 LYLVFEYLDL-DLKKHMDSCP----------------------------------------------------------- 95 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~----------------------------------------------------------- 95 (323)
.++||||+.| +|.+.+....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999965 7777765422
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 96 --------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 96 --------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
...+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++...........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~-~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI-TKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc-EEEecCccceeccCcccccc
Confidence 124567788899999999999999999999999999999998776 99999999876532211000
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEID 240 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~ 240 (323)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.......
T Consensus 273 ---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~ 324 (375)
T cd05104 273 ---------------------------KGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324 (375)
T ss_pred ---------------------------cCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH
Confidence 001123567999999977 568999999999999999998 889997765544
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+........ ......+..+.++|.+||+.||++||++.++++
T Consensus 325 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 325 KFYKMIKEGYRM---------------------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred HHHHHHHhCccC---------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 443332211000 001225678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=282.67 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=197.3
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+......||+|++|.||++++..++..+++|.+..... .....+.+|+.+++.++|+||+++++++..++..++++||
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 34455789999999999999988899999998754322 2335788999999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 83 LDL-DLKKHMDSCPD-FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
+.| +|.+.+..... ...++..+..++.||+.||.+||+.|++|+||+|+||+++.+...++|+|||.+..........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence 976 67666654322 2226777888999999999999999999999999999998755459999999886543211100
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
. ...+++.|+|||.+... ..++.++|+||+|+++|+|++|..||......
T Consensus 167 ~-----------------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~ 217 (268)
T cd06624 167 E-----------------------------TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP 217 (268)
T ss_pred c-----------------------------cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 0 01347789999998653 34788999999999999999999999754332
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
.......... ...+.....+++.+.+++++||+.+|.+||++.+++.||||
T Consensus 218 ~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 218 QAAMFKVGMF--------------------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred hhhHhhhhhh--------------------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 2111100000 00111223477889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=278.60 Aligned_cols=256 Identities=32% Similarity=0.501 Sum_probs=208.3
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC--ceEEEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KKLYLVF 80 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 80 (323)
+|++.+.||+|++|.||++.+..++..+++|++............+.+|+..+++++|+|++++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58899999999999999999988999999999876554344567888999999999999999999999888 8999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|++++ ++.+.+.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~-~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC-EEEcccccEEeccccccc
Confidence 99965 7766666544 6788889999999999999999999999999999999999877 999999998876544321
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.. .....++..|.|||.+.. ...+.++|+||||+++++|++|..||......
T Consensus 158 ~~---------------------------~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (260)
T cd06606 158 EG---------------------------TGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNP 209 (260)
T ss_pred cc---------------------------ccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Confidence 00 001234778999999877 45899999999999999999999999877622
Q ss_pred HH-HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 240 DE-LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 240 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
.. ...... ..........+++.+.++|.+|+..+|++||++.++++||||
T Consensus 210 ~~~~~~~~~---------------------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 210 MAALYKIGS---------------------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHhccc---------------------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 11 111110 001112223468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=289.68 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=204.3
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
|.....||+|++|.||++.+..++..|++|.+..... .....+.+|+.+++.+.|||++++++.+..++..++++||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 4556789999999999999988999999999865432 23467888999999999999999999999999999999999
Q ss_pred hhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccc
Q 036739 84 DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163 (323)
Q Consensus 84 ~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~ 163 (323)
.++.+..+... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 101 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~-~kL~dfg~~~~~~~~~~~~--- 174 (297)
T cd06659 101 QGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKR--- 174 (297)
T ss_pred CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc-EEEeechhHhhcccccccc---
Confidence 87444444433 24688889999999999999999999999999999999998887 9999999886543222111
Q ss_pred ccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 036739 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243 (323)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~ 243 (323)
....+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||......+...
T Consensus 175 --------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 227 (297)
T cd06659 175 --------------------------KSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 227 (297)
T ss_pred --------------------------cceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 01245788999999977 557899999999999999999999998766544443
Q ss_pred HHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
.+... ... .......+++.+.++|.+||+.+|++||++.++++||||.+..
T Consensus 228 ~~~~~----~~~----------------------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 228 RLRDS----PPP----------------------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHhcc----CCC----------------------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 32210 000 0011234678899999999999999999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=298.43 Aligned_cols=254 Identities=21% Similarity=0.328 Sum_probs=196.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCC-----ceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTN-----ETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|+||.||++++...+ ..||+|.+.... .......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 46999999999999999999864433 479999885432 222345678899999999 89999999999999999
Q ss_pred EEEEEecchh-hHHHhhhcCC-----------------------------------------------------------
Q 036739 76 LYLVFEYLDL-DLKKHMDSCP----------------------------------------------------------- 95 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~----------------------------------------------------------- 95 (323)
.++||||+.+ +|.+.+....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999965 7777664321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccC
Q 036739 96 ---------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166 (323)
Q Consensus 96 ---------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 166 (323)
...++...+.+++.||+.||.|||++|++|+||||+||+++.++. ++|+|||++...........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~-~kL~DfGla~~~~~~~~~~~----- 270 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV-AKICDFGLARDIMNDSNYVV----- 270 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe-EEEeeceeeeeccCCcceee-----
Confidence 123567788899999999999999999999999999999998776 99999999876532211100
Q ss_pred CcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 036739 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKI 245 (323)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~ 245 (323)
.....+++.|+|||.+.. ..++.++|+||||+++|+|++ |..||............
T Consensus 271 ----------------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~ 327 (374)
T cd05106 271 ----------------------KGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327 (374)
T ss_pred ----------------------ccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH
Confidence 001123567999999876 568999999999999999997 99999876554433333
Q ss_pred HHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
....... .....+++.+.++|.+||+.||.+||++.++++
T Consensus 328 ~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 328 VKRGYQM---------------------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHcccCc---------------------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2211000 011235788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=284.45 Aligned_cols=260 Identities=31% Similarity=0.523 Sum_probs=205.0
Q ss_pred eccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-hH
Q 036739 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DL 87 (323)
Q Consensus 10 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g-~l 87 (323)
||.|++|.||++.+..+++.+++|.+..... .......+.+|+.+++.++|+|++++++.+..+...|+++|++.| ++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999988899999998865432 223456788899999999999999999999999999999999976 77
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCC
Q 036739 88 KKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167 (323)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 167 (323)
.+.+.+.. .+++..+..++.||+.+|.+||+.+++|+||+|+||+++.++. ++|+|||++..............
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~~~~--- 154 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDD--- 154 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC-EEEEecccchhcccCcccccccc---
Confidence 66665543 5788889999999999999999999999999999999999887 99999998775433221100000
Q ss_pred cCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 036739 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFR 247 (323)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~ 247 (323)
........++..|++||.... ...+.++|+||||+++|++++|..||......+....+..
T Consensus 155 ------------------~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (265)
T cd05579 155 ------------------EKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN 215 (265)
T ss_pred ------------------cccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 000111244778999999877 4478899999999999999999999987776555444322
Q ss_pred HhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH---hhhhcCCCCccccc
Q 036739 248 VLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA---RSALEHEYFRDVEF 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~---~~il~h~~~~~~~~ 321 (323)
. ... + +....+++.+.+++.+||+.+|++||++ .++++||||++++|
T Consensus 216 ~--~~~---~----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 216 G--KIE---W----------------------PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred C--CcC---C----------------------CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 0 000 0 0001157889999999999999999999 99999999999876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=282.68 Aligned_cols=252 Identities=28% Similarity=0.448 Sum_probs=196.3
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHH-HHhcCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISL-LKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|++|.||+|.+..+++.||+|.+...... ......+..|..+ .....|+|++++++++..++..++|+||+.|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999889999999988644221 1111233344443 4455899999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|.+.+.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~------- 151 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH-LKLTDFGLSRNGLENK------- 151 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc-EEEeecccceeccccc-------
Confidence 6666655433 4688889999999999999999999999999999999998877 9999999876532200
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
...+++.|++||.+.+ ..++.++|+||+|+++|+|++|..||...........
T Consensus 152 --------------------------~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 204 (260)
T cd05611 152 --------------------------KFVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN 204 (260)
T ss_pred --------------------------cCCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 1134777999999887 4488999999999999999999999988776554444
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC---HhhhhcCCCCccccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT---ARSALEHEYFRDVEF 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s---~~~il~h~~~~~~~~ 321 (323)
+....... .......+++.+.++|.+||+.+|++||+ +.++++||||++++|
T Consensus 205 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 205 ILSRRINW-------------------------PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HHhcccCC-------------------------CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 32210000 00111347889999999999999999995 579999999999876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=277.02 Aligned_cols=252 Identities=31% Similarity=0.487 Sum_probs=205.2
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||+|++|.||++.+..++..+++|.+..... .....+.+|+.+++.+.|+|++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 58999999999999999999988899999999865433 3456888999999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+.| ++.+.+.... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~-~~l~d~~~~~~~~~~~~~-- 154 (253)
T cd05122 79 CSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE-VKLIDFGLSAQLSDTKAR-- 154 (253)
T ss_pred CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe-EEEeeccccccccccccc--
Confidence 986 6666655542 45788889999999999999999999999999999999998877 999999998776433210
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
....++..|+|||.+.. ...+.++|+||||+++|+|++|..||........
T Consensus 155 ----------------------------~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 205 (253)
T cd05122 155 ----------------------------NTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKA 205 (253)
T ss_pred ----------------------------cceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 01234778999999887 4588999999999999999999999987755444
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
........ .... .....++..+.++|.+||+.||++||++.++++|||
T Consensus 206 ~~~~~~~~----~~~~----------------------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 206 LFKIATNG----PPGL----------------------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHhcC----CCCc----------------------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 43322210 0000 001124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=286.08 Aligned_cols=258 Identities=32% Similarity=0.513 Sum_probs=209.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+.|++.+.||+|++|.||++.+..++..+++|++..... ....+.+|+..++.++|+|++++++.+......++++|
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 568899999999999999999988899999999865432 35678889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| +|.+.+.... ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~-~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC-EEECccchhhhhccchhhh
Confidence 9985 7777776644 35788889999999999999999999999999999999998887 9999999876543221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....++..|++||.+.+ ..++.++|+||||+++|+|++|..||.......
T Consensus 174 -----------------------------~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~ 223 (286)
T cd06614 174 -----------------------------NSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223 (286)
T ss_pred -----------------------------ccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 01134678999999877 568999999999999999999999998776654
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
....+....... ......++..+.++|.+||+.+|.+||++.++++||||+..-
T Consensus 224 ~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 224 ALFLITTKGIPP--------------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHHHHHhcCCCC--------------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 444332210000 001123678899999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=278.37 Aligned_cols=290 Identities=39% Similarity=0.747 Sum_probs=240.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--------C
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--------E 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------~ 73 (323)
..|+-+.++|+|.||.||+|+.+.+|+.||+|+...............+|+.++..++|+|++.++..+.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45777889999999999999999999999999877766667777888899999999999999888877642 3
Q ss_pred ceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 74 KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 74 ~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
..+|+||++|+.+|.-.+... ...++...+.+++.++.++|.|+|...|+|||+|+.|++++.++. +||.|||+++.+
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi-lklADFGlar~f 174 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI-LKLADFGLARAF 174 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce-EEeeccccccce
Confidence 469999999999888776544 346788899999999999999999999999999999999999887 999999999776
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
......... .....+.|+.|.+||.+.+.+.++++.|+|+-||++.+|+|+.+.+
T Consensus 175 s~~~n~~kp-------------------------rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim 229 (376)
T KOG0669|consen 175 STSKNVVKP-------------------------RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM 229 (376)
T ss_pred ecccccCCC-------------------------CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc
Confidence 443322211 1233567999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCccccc-CCCCCC---Cccccccc--CCChHHHHHHHhhcccCCCCCCCH
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSA-FPKWPS---KELGTVVR--NLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~--~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
.+......+..+.+..+....+.|++..+++-+.+- .+.... +......+ .-.+.+.+|+.+||..||.+|+++
T Consensus 230 qgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a 309 (376)
T KOG0669|consen 230 QGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA 309 (376)
T ss_pred cCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch
Confidence 999999999999999999999999999887765542 121111 11111111 124578899999999999999999
Q ss_pred hhhhcCCCCcc
Q 036739 308 RSALEHEYFRD 318 (323)
Q Consensus 308 ~~il~h~~~~~ 318 (323)
++++.|.||..
T Consensus 310 d~alnh~~F~k 320 (376)
T KOG0669|consen 310 DQALNHDFFWK 320 (376)
T ss_pred Hhhhchhhhhc
Confidence 99999999964
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=280.31 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=197.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|+||++.+. .+..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+....+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 57999999999999999999864 34569999875322 223678899999999999999999999998889999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+ ++.+.+..... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. +||+|||.+..........
T Consensus 80 ~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~-~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 80 YMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC-VKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred cCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC-EEECCCccceecCCCceee
Confidence 9975 67777655433 5788889999999999999999999999999999999998777 9999999887653221100
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
. . ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus 158 ~---~-------------------------~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 208 (256)
T cd05113 158 S---V-------------------------GSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS 208 (256)
T ss_pred c---C-------------------------CCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 0 0 0123567999999977 558899999999999999998 99999877665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
+....+.+.... ......++.+.+++.+||+.+|++||++.+++++
T Consensus 209 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 209 ETVEKVSQGLRL----------------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 544444332110 0112357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=287.34 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=206.9
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.|...+.||+|++|.||++.+..++..+++|.+..... .......+.+|+++++.++|+|++++++++.++...++|+|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 47888999999999999999988999999998864422 22233567789999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|+.|++.+.+.... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 106 ~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~--- 180 (317)
T cd06635 106 YCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-VKLADFGSASIASPANS--- 180 (317)
T ss_pred CCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC-EEEecCCCccccCCccc---
Confidence 99998877765433 35788889999999999999999999999999999999998887 99999998765432110
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
..+++.|+|||.+.. ...++.++|+||+|+++|+|++|..||......
T Consensus 181 ------------------------------~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 230 (317)
T cd06635 181 ------------------------------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 230 (317)
T ss_pred ------------------------------ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH
Confidence 134778999999752 245788999999999999999999999877665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.....+....... ......++.+.++|.+||+.+|.+||++.++++|+|+...
T Consensus 231 ~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 231 SALYHIAQNESPT---------------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHHHHhccCCC---------------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 5555443311000 0112367789999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=282.41 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=193.9
Q ss_pred eeccccceeEEEEEEccCCceEEEEEEEecccCCCC-chhHHHHHH---HHHhcCCCCeeeeeEEEecCceEEEEEecch
Q 036739 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGV-PSTAIREIS---LLKEMQHGNIVRLQDVVHSEKKLYLVFEYLD 84 (323)
Q Consensus 9 ~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~e~~---~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (323)
.||+|++|.||++.+..+++.||+|.+......... ...+..|.. .++...||+++++++++.+....++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999999889999999998654322211 122333433 3444579999999999999999999999997
Q ss_pred h-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccc
Q 036739 85 L-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163 (323)
Q Consensus 85 g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~ 163 (323)
| +|...+... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~-~kl~dfg~~~~~~~~~~~---- 153 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH---- 153 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC-EEEccCcCccccCccCCc----
Confidence 6 555555432 35788999999999999999999999999999999999998887 999999988654321110
Q ss_pred ccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 036739 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243 (323)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~ 243 (323)
...|+..|+|||.+.+...++.++|+||+|+++|+|++|..||..........
T Consensus 154 ---------------------------~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~ 206 (278)
T cd05606 154 ---------------------------ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206 (278)
T ss_pred ---------------------------CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH
Confidence 11458889999999764568899999999999999999999997763322111
Q ss_pred HHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcCCCCcc
Q 036739 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEHEYFRD 318 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h~~~~~ 318 (323)
. ....... .......+++.+.+++.+||..+|++|| ++.++++||||++
T Consensus 207 ~-~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 207 I-DRMTLTM-------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred H-HHHhhcc-------------------------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 1 0000000 0111233678999999999999999999 9999999999998
Q ss_pred ccc
Q 036739 319 VEF 321 (323)
Q Consensus 319 ~~~ 321 (323)
++|
T Consensus 261 ~~~ 263 (278)
T cd05606 261 LDW 263 (278)
T ss_pred CCc
Confidence 865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=287.78 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=206.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+.|...+.||+|++|.||++++..++..+++|.+..... .......+.+|+.+++.++|+|++++.+++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 357888999999999999999988999999998864322 2222346778999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||+.|++...+.... ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||.+........
T Consensus 95 e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~~~~~~~-- 170 (308)
T cd06634 95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANX-- 170 (308)
T ss_pred EccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc-EEECCcccceeecCccc--
Confidence 999988877765443 34688888999999999999999999999999999999998877 99999998876532111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
..+++.|+|||.+.. ....+.++|+||||+++|+|++|..||.....
T Consensus 171 -------------------------------~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 219 (308)
T cd06634 171 -------------------------------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (308)
T ss_pred -------------------------------ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence 134778999999853 24578899999999999999999999877655
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+..... + ......++..+.++|.+||+.+|++||++.++++|||+..
T Consensus 220 ~~~~~~~~~~~~-~--------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 220 MSALYHIAQNES-P--------------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHHHhhcCC-C--------------------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 444433322100 0 0011246788999999999999999999999999999976
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 273 ~ 273 (308)
T cd06634 273 E 273 (308)
T ss_pred c
Confidence 5
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=282.30 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=204.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||.|++|.||++.+.. +..+++|.+..... .....+..|+.+++.++|+|++++++++.+....++|||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 468999999999999999999866 88999999864432 234678889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+ +|.+.+.+.....++...+..++.||+.||.+||+.|++|+||+|+||+++.++. +||+|||.+..........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~-~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV-CKVADFGLARLIKEDVYLS 161 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce-EEEccccchhhcCCccccc
Confidence 9975 8888887766667788889999999999999999999999999999999998887 9999999987653221111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
. ...++..|++||.+.. ..++.++|+||||+++|+|++ |..||......
T Consensus 162 ~-----------------------------~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~ 211 (261)
T cd05148 162 S-----------------------------DKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH 211 (261)
T ss_pred c-----------------------------CCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 0 0122567999999877 568899999999999999998 89999887765
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+...... +....+++.+.++|.+||+.||++||++.++++
T Consensus 212 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 212 EVYDQITAGYRM----------------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHhCCcC----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 555544321111 111346788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=285.30 Aligned_cols=273 Identities=27% Similarity=0.434 Sum_probs=211.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 79 (323)
++|++.+.||+|++|.||++++..++..|++|++..... .......+..|..+++++. |+||+++++.+.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 589999999999999999999988999999999865322 2223466778999999998 99999999999999999999
Q ss_pred Eecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
||++. +++.+.+.+.. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||.+........
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~-~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC-EEecCCccccccCCccc
Confidence 99995 58877776654 5788889999999999999999999999999999999998887 99999999877644332
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
......... .................++..|+|||.... ...+.++|+||||++++++++|..||.....
T Consensus 158 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 158 PESNKGDAT---------NIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccCCCCCc---------cccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 111000000 000000000011122345788999999877 5588899999999999999999999988775
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH----hhhhcCC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA----RSALEHE 314 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~----~~il~h~ 314 (323)
........... ......+++.+.++|++||+.+|++||++ .++++||
T Consensus 228 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 228 YLTFQKILKLE-----------------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred HHHHHHHHhcC-----------------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence 44444333110 01113357889999999999999999999 9999999
Q ss_pred CC
Q 036739 315 YF 316 (323)
Q Consensus 315 ~~ 316 (323)
||
T Consensus 279 ~~ 280 (280)
T cd05581 279 FF 280 (280)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=279.03 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=199.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.++||+|++|.||+|.. .++..||+|.+.... .....+.+|+.+++.++|+|++++++.+. ....++++|
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred HHceeeeeeccCccceEEeeec-CCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 5799999999999999999986 467789999885332 23467889999999999999999999874 556899999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
++.+ ++.+.+.......++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~-~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC-CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC-EEEccCcceeecCCCCccc
Confidence 9964 8888877665667788889999999999999999999999999999999998887 9999999987654221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
. ....++..|+|||.+.. ..++.++|+||||+++|++++ |+.||......
T Consensus 160 ~----------------------------~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 210 (260)
T cd05067 160 R----------------------------EGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210 (260)
T ss_pred c----------------------------cCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence 0 00123567999999876 567899999999999999999 99999877665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+.+.... +.....+..+.++|.+||+.+|++||++.++++
T Consensus 211 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 211 EVIQNLERGYRM----------------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 554443221110 111236788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=281.24 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=200.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|++|.||++++..++..||+|.+.... ........+.+|+.+++.++|||++++++++.+.+..+++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 478999999999999999999999999999999876432 2223345678899999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 80 FEYLDL-DLKKHMDSC--PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+||+.+ ++.+.+... ....+++..+..++.||+.||.|||++|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~-~~l~d~g~~~~~~~~ 159 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC-EEECccccceeccch
Confidence 999986 666655432 2234688888999999999999999999999999999999998887 999999988765422
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.... ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...
T Consensus 160 ~~~~-----------------------------~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 160 TTAA-----------------------------HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hHHH-----------------------------hcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 1110 01234778999999877 55789999999999999999999998665
Q ss_pred ChH-HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEI-DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
... ............+. .....++..+.++|.+||+.+|++||++.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 210 KMNLFSLCQKIEQCDYPP--------------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred cccHHHHHHHHhcCCCCC--------------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 322 22222221111000 001236678999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=280.08 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=196.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.++||+|++|.||+|++..+ ..|++|.+.... ...+.+.+|+.+++.++|+||+++++.+. +...++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 5899999999999999999988554 469999885422 22357888999999999999999999874 456899999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+ ++.+.+.+.....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~-~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTA 159 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc-EEeccCCceeecccccccc
Confidence 9975 8888877654445688889999999999999999999999999999999998887 9999999987654322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. ...++..|+|||.... ..++.++|+||||+++|+|++ |..||......
T Consensus 160 ~~----------------------------~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~ 210 (262)
T cd05071 160 RQ----------------------------GAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210 (262)
T ss_pred cc----------------------------CCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence 00 0123667999999876 558999999999999999999 88899877655
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+...... .....+++.+.++|.+|++.||++||++.++++
T Consensus 211 ~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 211 EVLDQVERGYRM----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHhcCCCC----------------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 544433221000 011246788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=280.84 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=200.2
Q ss_pred CCcceeeeeccccceeEEEEEEccC---CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT---NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|+||.||+|.+... ...|++|.+.... .......+..|+.+++.++||||+++++.+.+.+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 5799999999999999999987654 3579999875432 22234567789999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
+||++.+ +|.+.+..... .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 83 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~-~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV-CKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC-EEECccchhhcccccc
Confidence 9999976 67766655433 5788899999999999999999999999999999999998887 9999999998764211
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
...... ...+++.|+|||.+.. ..++.++|+||||+++|+|++ |..||...
T Consensus 161 ~~~~~~---------------------------~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 161 ATYTTK---------------------------GGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cceecc---------------------------CCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 111000 0122567999999877 568999999999999999998 99999776
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
...+....+.+....+ .....++.+.+++.+|++.+|++||++.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 213 SNQDVIKAVEDGYRLP----------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 6555444433211000 012367889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=283.23 Aligned_cols=241 Identities=15% Similarity=0.182 Sum_probs=192.7
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEecccCC-CCchhHHHHHHHHHhcCCCCeeeeeEEEec----CceEEEEEec
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHS----EKKLYLVFEY 82 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~ 82 (323)
..+++|+++.||++.. +|+.||+|.+....... ...+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999986 78899999986543222 123667799999999999999999999876 4578999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
+.| +|.+.+.+.. .+++.....++.|++.||.+||+. +++|+||||+||+++.++. +||+|||++.........
T Consensus 104 ~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~-~kl~dfg~~~~~~~~~~~- 179 (283)
T PHA02988 104 CTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK-LKIICHGLEKILSSPPFK- 179 (283)
T ss_pred CCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc-EEEcccchHhhhcccccc-
Confidence 986 6777766543 467778889999999999999984 9999999999999999887 999999998754321110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
..|+..|+|||.+.+. ..++.++||||||+++|+|++|..||......
T Consensus 180 -------------------------------~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~ 228 (283)
T PHA02988 180 -------------------------------NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK 228 (283)
T ss_pred -------------------------------ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH
Confidence 1347889999998752 46899999999999999999999999987766
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+......+ ......++.+.+++.+||+.||++||++.++++
T Consensus 229 ~~~~~i~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 229 EIYDLIINKNNSL---------------------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHhcCCCC---------------------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 5555443211110 011236788999999999999999999999986
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=279.45 Aligned_cols=246 Identities=25% Similarity=0.355 Sum_probs=192.4
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-h
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-D 86 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g-~ 86 (323)
+.||+|++|+||++++..++..+++|.+... ........+.+|+++++.++||||+++++++.+....++|+||+.| +
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4689999999999999889999999987432 2223346788999999999999999999999999999999999976 6
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccC
Q 036739 87 LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166 (323)
Q Consensus 87 l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 166 (323)
+.+.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. +||+|||.+............
T Consensus 80 L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~---- 153 (252)
T cd05084 80 FLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV-LKISDFGMSREEEDGVYASTG---- 153 (252)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc-EEECccccCcccccccccccC----
Confidence 66666543 335688889999999999999999999999999999999998887 999999998654321100000
Q ss_pred CcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 036739 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKI 245 (323)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~ 245 (323)
.....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+
T Consensus 154 -----------------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~ 209 (252)
T cd05084 154 -----------------------GMKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209 (252)
T ss_pred -----------------------CCCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH
Confidence 00112456999999877 558899999999999999998 88999776554433333
Q ss_pred HHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...... ......+..+.+++.+||+.+|++||++.++++
T Consensus 210 ~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 210 EQGVRL----------------------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HcCCCC----------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 221000 111236788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=279.34 Aligned_cols=253 Identities=28% Similarity=0.474 Sum_probs=207.6
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+|++.+.||+|++|.||++.+..++..+++|.+............+.+|+..++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 68999999999999999999988999999999876544444456777899999999999999999999999999999999
Q ss_pred chh-hHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 83 LDL-DLKKHMDSCP--DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 83 ~~g-~l~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
+.| ++.+.+.... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~-~kl~d~g~~~~~~~~~~~ 159 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL-VKIGDLGISKVLKKNMAK 159 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc-EEEeeccchhhhccCCcc
Confidence 976 7777665422 245688889999999999999999999999999999999998777 999999998766433110
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
...+++.|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+..
T Consensus 160 -------------------------------~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~ 207 (256)
T cd08530 160 -------------------------------TQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207 (256)
T ss_pred -------------------------------cccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0134778999999977 66788999999999999999999999877654
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
+....+.... .......++..+.+++.+||+.+|++||++.++++||++
T Consensus 208 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 208 DLRYKVQRGK----------------------------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHhcCC----------------------------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 4333322110 011112467889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.82 Aligned_cols=257 Identities=29% Similarity=0.462 Sum_probs=220.9
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++.|.+.+.||+|.|+.|.++++..++..||||.+.+...+......+.+|+++++.+.||||++++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 35799999999999999999999999999999999888777766678899999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| .+.+++..... +.+..++.++.|+++|++|+|+++|||+|||++||+++.+.+ +||+|||++..+......
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn-ikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN-IKIADFGFSTFFDYGLML 211 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc-eeeeccccceeecccccc
Confidence 99965 88888877553 455889999999999999999999999999999999999888 999999999988644332
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.. -+|++.|+|||.+.+..+.+++.|+||+|+++|.|+.|..||.+..-.
T Consensus 212 qt------------------------------~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk 261 (596)
T KOG0586|consen 212 QT------------------------------FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK 261 (596)
T ss_pred cc------------------------------cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc
Confidence 22 266899999999999888899999999999999999999999877654
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+...+..... --+.-.++-++.++|+++|-.+|.+|++++++++|.|.+..
T Consensus 262 ~Lr~rvl~gk-----------------------------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 262 ELRPRVLRGK-----------------------------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred cccchheeee-----------------------------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 4443332211 01122367788999999999999999999999999998754
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=277.63 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=201.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+. ++..+++|.+.... .....+.+|+..++.++|+|++++++++.++...++++|
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 68999999999999999999974 55779999875332 234678899999999999999999999999899999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
++.+ ++.+.+.......++...+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~-~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV-CKIADFGLARLIEDDEYTA 160 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC-EEECccccceeccchhhhh
Confidence 9975 7888887665556788899999999999999999999999999999999999887 9999999987654311110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
... ...+..|+|||.+.+ ...+.++|+||+|+++|++++ |+.||.+....
T Consensus 161 ~~~----------------------------~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 161 REG----------------------------AKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred hhc----------------------------cCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 000 012456999999987 568899999999999999998 99999877665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.....+...... ......++.+.+++.+||+.+|++||++.++++
T Consensus 212 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 212 EVLEQVERGYRM----------------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 555544322111 011234678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=284.92 Aligned_cols=260 Identities=23% Similarity=0.372 Sum_probs=200.8
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|++|.||++.+..++..||+|.+....... ....+..|+.++... .|+||+++++++.+....+++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 478999999999999999999998889999999986543222 234455566656556 499999999999999999999
Q ss_pred EecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+++.+.+.+..... .+++..+..++.||+.+|.|||+ .|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 93 ~e~~~~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~-~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 93 MELMSTCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN-VKLCDFGISGRLVDSKA 170 (296)
T ss_pred eeccCcCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC-EEECccccchhccCCCc
Confidence 99998877666655333 67888889999999999999997 59999999999999998777 99999998865432111
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC---CCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS---RHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.. ...+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||..
T Consensus 171 ~~------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 171 KT------------------------------RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred cc------------------------------CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 10 01236779999998753 3478899999999999999999999976
Q ss_pred CChH-HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 236 DSEI-DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
.... +.+..+... . .... +....+++.+.++|.+||+.||.+||++.++++||
T Consensus 221 ~~~~~~~~~~~~~~---~-~~~~----------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 221 CKTEFEVLTKILQE---E-PPSL----------------------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred chhHHHHHHHHhcC---C-CCCC----------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 4332 222222211 0 0000 00113678899999999999999999999999999
Q ss_pred CCccc
Q 036739 315 YFRDV 319 (323)
Q Consensus 315 ~~~~~ 319 (323)
||...
T Consensus 275 ~~~~~ 279 (296)
T cd06618 275 FIRRY 279 (296)
T ss_pred hhhcc
Confidence 99864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=286.50 Aligned_cols=283 Identities=33% Similarity=0.511 Sum_probs=216.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-C-CC----eeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-H-GN----IVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~-~~----i~~~~~~~~~~~~ 75 (323)
++|.++..+|+|.||.|-.+.+..++..||+|+++.-.. -.+...-|++++.++. + |+ .+++.++|...+.
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k---YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK---YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH---HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 689999999999999999999999999999998853321 2244456889999994 2 22 5677777988999
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC----------------
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT---------------- 139 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~---------------- 139 (323)
.|||||.++.++.+++..+...+++...++.|+.|+++++.+||+.+++|-||||+||++-.+.
T Consensus 166 iCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 166 ICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred eEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 9999999999999999999998999999999999999999999999999999999999993211
Q ss_pred ---CceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhh
Q 036739 140 ---NALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDV 216 (323)
Q Consensus 140 ---~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di 216 (323)
..++++|||.+..-...... .+.|..|.|||++.+ -.+++..||
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~hs~--------------------------------iVsTRHYRAPEViLg-LGwS~pCDv 292 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHHST--------------------------------IVSTRHYRAPEVILG-LGWSQPCDV 292 (415)
T ss_pred CCCcceEEEecCCcceeccCcce--------------------------------eeeccccCCchheec-cCcCCccCc
Confidence 13899999998765433311 244899999999999 669999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCc--------------ccccc
Q 036739 217 WSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKE--------------LGTVV 282 (323)
Q Consensus 217 ~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~ 282 (323)
||+||||+|+++|...|...++.++++.+..-++..............-+....-.|.... .....
T Consensus 293 WSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~ 372 (415)
T KOG0671|consen 293 WSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYM 372 (415)
T ss_pred eeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHh
Confidence 9999999999999999999998888877766666433322221111000111111111100 00001
Q ss_pred c---CCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 283 R---NLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 283 ~---~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
. ..-..+.+|+++||..||++|+|+.|+|.||||+...
T Consensus 373 ~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 373 LQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred ccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 1 1122478999999999999999999999999998753
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=276.81 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=197.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+. .+..+++|.+..... ....+.+|+.++++++|+|++++++++. ....+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 68999999999999999999874 566799998864322 2357889999999999999999999885 456889999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+ ++.+.+.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~-~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV-CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce-EEeCCceeeeeccCccccc
Confidence 9975 7888776655556788889999999999999999999999999999999998776 9999999997654322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. ...++..|+|||.+.. ..++.++|+||||+++|+|++ |..||......
T Consensus 160 ~~----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 160 RQ----------------------------GAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred cc----------------------------CCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 00 0122556999999876 568899999999999999999 89999877665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+.+... .+.....+..+.+++.+|+..+|++||++.++.+
T Consensus 211 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 211 EVLEQVERGYR----------------------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHcCCC----------------------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 55544332100 0111346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=283.55 Aligned_cols=253 Identities=25% Similarity=0.432 Sum_probs=201.9
Q ss_pred eeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
....||+|++|.||++....+++.+++|.+.... ......+.+|+.+++.++|+|++++++.+...+..+++|||+.+
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 3467999999999999998999999999874332 22345688899999999999999999999999999999999987
Q ss_pred hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccccc
Q 036739 86 DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHW 165 (323)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 165 (323)
+.+..+.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 102 ~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~-~~l~dfg~~~~~~~~~~~~----- 173 (292)
T cd06657 102 GALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRR----- 173 (292)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEEcccccceecccccccc-----
Confidence 4444444332 4688889999999999999999999999999999999998887 9999999876543221110
Q ss_pred CCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 036739 166 GSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKI 245 (323)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~ 245 (323)
....+++.|++||.+.. ..++.++|+||+|+++|+|++|..||......+....+
T Consensus 174 ------------------------~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~ 228 (292)
T cd06657 174 ------------------------KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228 (292)
T ss_pred ------------------------cccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 01234788999999876 56789999999999999999999999877665544433
Q ss_pred HHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
..... .. ......+++.+.+++.+||+.+|.+||++.++++||||...
T Consensus 229 ~~~~~----~~----------------------~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 229 RDNLP----PK----------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred HhhCC----cc----------------------cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 22110 00 00113467889999999999999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=280.49 Aligned_cols=255 Identities=20% Similarity=0.287 Sum_probs=198.3
Q ss_pred CCcceeeeeccccceeEEEEEEcc-----CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|++|.||+|.+.. .+..|++|.+.... .......+.+|+.+++.++|+||+++++++.+....
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 578999999999999999999876 67789999774332 122235678899999999999999999999988899
Q ss_pred EEEEecchh-hHHHhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC--CceEEeccc
Q 036739 77 YLVFEYLDL-DLKKHMDSCPD-----FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFG 148 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~--~~~kl~df~ 148 (323)
++|+||+.| +|.+.+..... ..+++..+.+++.||+.+|.|||+++++|+||+|+||+++.++ ..+||+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 999999965 77777755432 2468888999999999999999999999999999999998654 258999999
Q ss_pred cceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh
Q 036739 149 LARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t 228 (323)
.+............ .....+..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 165 ~~~~~~~~~~~~~~---------------------------~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 165 MARDIYRASYYRKG---------------------------GRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred cccccCCccceecC---------------------------CCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHc
Confidence 98765221110000 00112456999999977 568999999999999999997
Q ss_pred -CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH
Q 036739 229 -QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 229 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
|..||...........+.... . ......+++.+.+++.+|++.+|++||++
T Consensus 217 ~g~~pf~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~ 268 (277)
T cd05036 217 LGYMPYPGRTNQEVMEFVTGGG-R---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNF 268 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcCC-c---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 999998776654443322110 0 01123467889999999999999999999
Q ss_pred hhhhcC
Q 036739 308 RSALEH 313 (323)
Q Consensus 308 ~~il~h 313 (323)
.++++|
T Consensus 269 ~~vl~~ 274 (277)
T cd05036 269 ATILER 274 (277)
T ss_pred HHHHHH
Confidence 999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=281.55 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=197.9
Q ss_pred CCCcceeeeeccccceeEEEEEEc----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNC----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
+++|++.+.||+|+||+||++.+. ..+..+++|.+.... .......+.+|+.+++.++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 367999999999999999999853 355789999875332 222235678899999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC
Q 036739 77 YLVFEYLDL-DLKKHMDSCP---------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN 140 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~---------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~ 140 (323)
+++|||+.+ ++.+.+.... ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 999999975 7777764321 124577788899999999999999999999999999999998877
Q ss_pred ceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHH
Q 036739 141 ALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220 (323)
Q Consensus 141 ~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG 220 (323)
+||+|||++............ ....++..|+|||.+.+ ..++.++|+||||
T Consensus 163 -~kl~dfg~~~~~~~~~~~~~~---------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG 213 (283)
T cd05090 163 -VKISDLGLSREIYSADYYRVQ---------------------------PKSLLPIRWMPPEAIMY-GKFSSDSDIWSFG 213 (283)
T ss_pred -EEeccccccccccCCcceecc---------------------------cCCCccceecChHHhcc-CCCCchhhhHHHH
Confidence 999999998765322111100 00123567999999876 5589999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhccc
Q 036739 221 CIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299 (323)
Q Consensus 221 ~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 299 (323)
+++|+|++ |..||.+....+....+.... . ......+++.+.+++.+||+.
T Consensus 214 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~ 265 (283)
T cd05090 214 VVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ-L---------------------------LPCSEDCPPRMYSLMTECWQE 265 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c---------------------------CCCCCCCCHHHHHHHHHHccc
Confidence 99999998 999997766544444332210 0 011234678899999999999
Q ss_pred CCCCCCCHhhhhcC
Q 036739 300 DPSRRITARSALEH 313 (323)
Q Consensus 300 dp~~R~s~~~il~h 313 (323)
||++||++.+|+++
T Consensus 266 ~p~~Rp~~~~i~~~ 279 (283)
T cd05090 266 GPSRRPRFKDIHTR 279 (283)
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=310.96 Aligned_cols=273 Identities=25% Similarity=0.334 Sum_probs=201.1
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
|++|++.+.||+|++|.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 68999999999999999999999999999999998654322 22345678899999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccc
Q 036739 80 FEYLDL-DLKKHMDSCP---------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGL 149 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~ 149 (323)
|||++| +|.+.+.... ....+...+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||+
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~-vKLiDFGL 159 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE-VVILDWGA 159 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC-EEEEecCc
Confidence 999976 6666664321 122345667889999999999999999999999999999998887 99999999
Q ss_pred ceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhC
Q 036739 150 ARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ 229 (323)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg 229 (323)
+..................+ .............||+.|+|||.+.+ ..++.++|+||+||++|+|++|
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~-----------s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG 227 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERN-----------ICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTL 227 (932)
T ss_pred ceeccccccccccccccccc-----------ccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHC
Confidence 98763221111000000000 00000011123467999999999887 5679999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
..||............. ... ... ......+++.+.+++.+||+.||++|++..+
T Consensus 228 ~~PF~~~~~~ki~~~~~--i~~--P~~----------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~e 281 (932)
T PRK13184 228 SFPYRRKKGRKISYRDV--ILS--PIE----------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQ 281 (932)
T ss_pred CCCCCCcchhhhhhhhh--ccC--hhh----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99997754432221100 000 000 0011357888999999999999999987665
Q ss_pred hhc
Q 036739 310 ALE 312 (323)
Q Consensus 310 il~ 312 (323)
.+.
T Consensus 282 eLl 284 (932)
T PRK13184 282 ELK 284 (932)
T ss_pred HHH
Confidence 553
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=285.79 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=194.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCce--EEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNET--IALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 77 (323)
+++|++.+.||+|+||.||+|.+..++.. +++|.+... ........+.+|+.++.++ +|+||+++++++.+++..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 47899999999999999999998777764 466655321 1222335677899999999 8999999999999999999
Q ss_pred EEEecchh-hHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCce
Q 036739 78 LVFEYLDL-DLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNAL 142 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~ 142 (323)
+|+||+.+ ++.+.+.... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++. +
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~-~ 163 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-A 163 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc-E
Confidence 99999965 7777775432 124678889999999999999999999999999999999998887 9
Q ss_pred EEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHH
Q 036739 143 KLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCI 222 (323)
Q Consensus 143 kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~l 222 (323)
+|+|||++.......... ...++..|+|||.+.. ..++.++|+||||++
T Consensus 164 kl~dfg~~~~~~~~~~~~------------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~i 212 (303)
T cd05088 164 KIADFGLSRGQEVYVKKT------------------------------MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVL 212 (303)
T ss_pred EeCccccCcccchhhhcc------------------------------cCCCcccccCHHHHhc-cCCcccccchhhhhH
Confidence 999999875321110000 0012456999999876 568899999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCC
Q 036739 223 FAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301 (323)
Q Consensus 223 l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp 301 (323)
+|+|+| |..||......+......... .......+++.+.++|.+||+.+|
T Consensus 213 l~ellt~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p 264 (303)
T cd05088 213 LWEIVSLGGTPYCGMTCAELYEKLPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKP 264 (303)
T ss_pred HHHHHhcCCCCcccCChHHHHHHHhcCC----------------------------cCCCCCCCCHHHHHHHHHHcCCCh
Confidence 999998 999997766544333221100 000112367889999999999999
Q ss_pred CCCCCHhhhhcC
Q 036739 302 SRRITARSALEH 313 (323)
Q Consensus 302 ~~R~s~~~il~h 313 (323)
++||++.+++++
T Consensus 265 ~~Rp~~~~il~~ 276 (303)
T cd05088 265 YERPSFAQILVS 276 (303)
T ss_pred hhCcCHHHHHHH
Confidence 999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=276.87 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=198.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.+|++.+.||+|++|.||++.+. ++..+++|.+..... ....+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 46899999999999999999875 566899998753322 23567889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| ++.+.+..... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. +||+|||.+..........
T Consensus 80 ~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~-~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 80 YMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV-VKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred cCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc-EEECCcccceecccccccc
Confidence 9965 77777765443 5788889999999999999999999999999999999998887 9999999886543211110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
. .. ..++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......
T Consensus 158 ~---~~-------------------------~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 208 (256)
T cd05059 158 S---QG-------------------------TKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS 208 (256)
T ss_pred c---CC-------------------------CCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH
Confidence 0 00 012456999999987 568899999999999999999 89999877665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
+....+..... .......++.+.+++.+||..+|++||++.++++.
T Consensus 209 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 209 EVVESVSAGYR----------------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 55444322110 01112367889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=280.64 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=195.1
Q ss_pred ceeeeeccccceeEEEEEEc----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 5 EKVEKIGEGTYGVVYKARNC----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 5 ~~~~~lg~g~~~~v~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
.+.+.||.|.||.||+|+.. ..+..|++|.+.. .........+.+|+..+++++||||+++++++...+..++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 46789999999999999986 3456899998833 222223578889999999999999999999999888899999
Q ss_pred ecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+. |+|.+.+.......+++..+..|+.||+.||.|||+++++|++|+++||+++.++. +||+|||.+.........
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~-~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ-VKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE-EEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccc
Confidence 9997 58888888875567899999999999999999999999999999999999999886 999999999876222111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCh
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSE 238 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~ 238 (323)
.. .........|+|||.+.. ..++.++||||||+++|||++ |..||.....
T Consensus 160 ~~---------------------------~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~ 211 (259)
T PF07714_consen 160 KN---------------------------DSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN 211 (259)
T ss_dssp EE---------------------------STTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred cc---------------------------cccccccccccccccccc-cccccccccccccccccccccccccccccccc
Confidence 10 001123677999999987 458999999999999999999 7899988876
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.+....+.+... ......++..+.++|..||+.||++||++.++++
T Consensus 212 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 212 EEIIEKLKQGQR----------------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHTTEE----------------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cccccccccccc----------------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 666655533211 1112347888999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.31 Aligned_cols=253 Identities=28% Similarity=0.459 Sum_probs=201.0
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|++|.||++.+..++..|++|.+..... +......+.+|+.++++++|+|++++++.+.+.+..+++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 4789999999999999999999988999999998865432 233356788999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 80 FEYLDL-DLKKHMDSC--PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
|||+.| +|.+.+... ....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~-~~l~d~~~~~~~~~~ 159 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV-VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc-EEEeccceeeeccCC
Confidence 999975 777766532 2345788889999999999999999999999999999999998887 999999988654322
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus 160 ~~~~-----------------------------~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 160 TTAA-----------------------------HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred Cccc-----------------------------ceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 1110 01134778999999877 56789999999999999999999998654
Q ss_pred ChH--HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCccccc-ccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEI--DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTV-VRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
... +......... ..+. ...++..+.++|.+||..+|++||++.+|++
T Consensus 210 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 210 KMNLYSLCKKIEKCD----------------------------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred CccHHHHHhhhhcCC----------------------------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 321 1111111100 0001 1246788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=274.75 Aligned_cols=244 Identities=23% Similarity=0.379 Sum_probs=196.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEe-cCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-SEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv 79 (323)
+++|++.+.||+|++|.||++.. .+..+++|.+... .....+.+|+.++++++|+|++++++++. .++..+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 36899999999999999999975 5788999987432 23457889999999999999999999764 55678999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
+||+.+ ++.+.+.......+++..+..++.|++.+|.+||++|++|+||+|+||+++.++. +||+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~-~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQD 157 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc-EEecCCccceeccccCC
Confidence 999975 8888877655555788889999999999999999999999999999999998887 99999998865432111
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDS 237 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~ 237 (323)
. ..++..|+|||.+.. ..++.++|+||||+++|+|++ |..||....
T Consensus 158 ~--------------------------------~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 158 T--------------------------------GKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred C--------------------------------CccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 0 122556999999876 568899999999999999998 999998766
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
..+....+.+... ......+++.+.+++.+|++.+|++||++.++++
T Consensus 205 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 205 LKDVVPRVEKGYK----------------------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 5444443322100 0112346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=286.44 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=195.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCce----EEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNET----IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|+||+||+|++..++.. ||+|.+... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 5799999999999999999997666654 889987532 2223346788899999999999999999999765 567
Q ss_pred EEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
++++++. |++.+.+..... .++...+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++......
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~-~kl~DfG~a~~~~~~ 162 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAD 162 (316)
T ss_pred eeeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc-EEEccccccccccCC
Confidence 8999986 578777765433 4677888899999999999999999999999999999998887 999999999876433
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
....... ...++..|++||.+.. ..++.++|+||||+++|+|++ |..||.+
T Consensus 163 ~~~~~~~---------------------------~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 163 EKEYHAE---------------------------GGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred Ccceecc---------------------------CCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 2211110 0122567999999977 668999999999999999998 9999987
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
....+.. .+....... +.....+..+.+++.+||+.+|++||++.+++.+
T Consensus 215 ~~~~~~~-~~~~~~~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 215 IPASEIS-SILEKGERL---------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCHHHHH-HHHhCCCCC---------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6554432 222210000 1112356788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=280.84 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=199.7
Q ss_pred CCcceeeeeccccceeEEEEEEcc-----CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|.+.+.||+|++|.||++.+.. ++..|++|.+..... ......+.+|+++++.+.|+|++++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 578999999999999999998643 357899998854322 22346788999999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceE
Q 036739 77 YLVFEYLDL-DLKKHMDSCP------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALK 143 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~k 143 (323)
+++|||+.| +|.+++.... ...+++..+..++.|++.+|.+||++|++|+||+|+||+++.++. ++
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~-~k 162 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV-VK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe-EE
Confidence 999999975 7777765432 234577788999999999999999999999999999999999887 99
Q ss_pred EeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHH
Q 036739 144 LADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIF 223 (323)
Q Consensus 144 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll 223 (323)
|+|||.+........... .....+++.|+|||++.+ ..++.++|+||||+++
T Consensus 163 l~d~g~~~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il 214 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRV---------------------------GGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVL 214 (280)
T ss_pred ECCcccceecccCcceec---------------------------CCCCcccceecChhhhcc-CCcchhhhHHHHHHHH
Confidence 999999865422111000 001123677999999987 5689999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCC
Q 036739 224 AEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 224 ~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~ 302 (323)
|+|++ |..||......+....+.+... ......++..+.+++++||+.||+
T Consensus 215 ~e~~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~ 266 (280)
T cd05049 215 WEIFTYGKQPWYGLSNEEVIECITQGRL----------------------------LQRPRTCPSEVYDIMLGCWKRDPQ 266 (280)
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcc
Confidence 99998 9999987766555444332100 011124678899999999999999
Q ss_pred CCCCHhhhhc
Q 036739 303 RRITARSALE 312 (323)
Q Consensus 303 ~R~s~~~il~ 312 (323)
+||++.++++
T Consensus 267 ~Rp~~~eil~ 276 (280)
T cd05049 267 QRINIKDIHE 276 (280)
T ss_pred cCCCHHHHHH
Confidence 9999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=279.44 Aligned_cols=254 Identities=20% Similarity=0.296 Sum_probs=195.5
Q ss_pred CCcceeeeeccccceeEEEEEEcc-----CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|++|.||++.+.. .+..||+|.+.... .......+.+|+.+++.++|+||+++++++.++...
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 589999999999999999998643 34679999874321 112234677899999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 77 YLVFEYLDL-DLKKHMDSCPD--------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
++|+||+.+ +|.+.+.+... ...+...+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+||
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~-~~l~df 163 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDF 163 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC-EEECCC
Confidence 999999975 77766654321 23466778889999999999999999999999999999998887 999999
Q ss_pred ccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH
Q 036739 148 GLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~ 227 (323)
|++............ ....+++.|+|||.+.. ..++.++|+||||+++|+|+
T Consensus 164 g~~~~~~~~~~~~~~---------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 164 GMTRDIYETDYYRKG---------------------------GKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred CCccccCCcceeecC---------------------------CCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHH
Confidence 988654321110000 00133677999999887 56899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC
Q 036739 228 N-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT 306 (323)
Q Consensus 228 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 306 (323)
+ |..||...........+.... . .......++.+.+++.+||+.||++||+
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps 267 (277)
T cd05062 216 TLAEQPYQGMSNEQVLRFVMEGG-L---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPS 267 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCC-c---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 9 788998766544443332210 0 0011236788999999999999999999
Q ss_pred HhhhhcC
Q 036739 307 ARSALEH 313 (323)
Q Consensus 307 ~~~il~h 313 (323)
+.+++++
T Consensus 268 ~~e~l~~ 274 (277)
T cd05062 268 FLEIISS 274 (277)
T ss_pred HHHHHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=282.74 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=195.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc--eEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE--TIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|++|.||++.++.++. .+++|.+... ........+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 689999999999999999999876664 4688876422 2222345678899999999 79999999999999999999
Q ss_pred EEecchh-hHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceE
Q 036739 79 VFEYLDL-DLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALK 143 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~k 143 (323)
++||+.+ +|.+.+.... ...+++..+..++.||+.||++||++|++|+||||+||+++.++. +|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~-~k 159 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA-SK 159 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe-EE
Confidence 9999964 7877775432 124678889999999999999999999999999999999998877 99
Q ss_pred EeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHH
Q 036739 144 LADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIF 223 (323)
Q Consensus 144 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll 223 (323)
|+|||++........... ...+..|+|||.+.. ..++.++|+||||+++
T Consensus 160 l~dfg~~~~~~~~~~~~~------------------------------~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il 208 (297)
T cd05089 160 IADFGLSRGEEVYVKKTM------------------------------GRLPVRWMAIESLNY-SVYTTKSDVWSFGVLL 208 (297)
T ss_pred ECCcCCCccccceeccCC------------------------------CCcCccccCchhhcc-CCCCchhhHHHHHHHH
Confidence 999998753221100000 011446999999877 5688999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCC
Q 036739 224 AEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 224 ~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~ 302 (323)
|+|++ |..||......+....+.+.... .....+++.+.++|.+||+.+|.
T Consensus 209 ~el~t~g~~pf~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~ 260 (297)
T cd05089 209 WEIVSLGGTPYCGMTCAELYEKLPQGYRM----------------------------EKPRNCDDEVYELMRQCWRDRPY 260 (297)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChh
Confidence 99997 99999887665554443221100 11134778899999999999999
Q ss_pred CCCCHhhhhcC
Q 036739 303 RRITARSALEH 313 (323)
Q Consensus 303 ~R~s~~~il~h 313 (323)
+||++.++++.
T Consensus 261 ~Rp~~~~i~~~ 271 (297)
T cd05089 261 ERPPFAQISVQ 271 (297)
T ss_pred hCcCHHHHHHH
Confidence 99999999653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=278.90 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=199.8
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|++|.||++++..++..+++|.+.... ........+.+|+.+++.++|+|++++++++.+++..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 578999999999999999999998899999999876432 2222345778899999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 80 FEYLDL-DLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+|++.| ++.+.+.. .....+++..+..++.||+.+|.|||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~-~~l~dfg~~~~~~~~ 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC-EEECcchhhhccccC
Confidence 999976 67666543 22345788889999999999999999999999999999999998887 999999988765322
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.... ....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...
T Consensus 160 ~~~~-----------------------------~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 160 TTAA-----------------------------HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred Cccc-----------------------------ccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1110 01134778999999877 55788999999999999999999999754
Q ss_pred ChH-HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEI-DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
... ....+... ..... +.....+++.+.++|.+||..||++||++.+|++
T Consensus 210 ~~~~~~~~~~~~---~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 210 KMNLYSLCKKIE---QCDYP-----------------------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred cchHHHHhhhhh---cCCCC-----------------------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 332 11111111 00000 0011236788999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=274.13 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=197.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+... ..+++|.+.... ...+.+.+|+.+++.++|+|++++++++. ....+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 5799999999999999999987544 469999864322 23467888999999999999999999885 456789999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+ ++.+.+.......++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~-~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV-CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe-EEECCCccceEccCCcccc
Confidence 9975 8888887655555788889999999999999999999999999999999998887 9999999987654322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. ...++..|+|||...+ ...+.++|+||||+++|+|++ |..||.+....
T Consensus 160 ~~----------------------------~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 210 (260)
T cd05069 160 RQ----------------------------GAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210 (260)
T ss_pred cC----------------------------CCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 00 0122567999999876 558899999999999999999 89999887665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+...... .....++..+.+++.+||..||++||++.++++
T Consensus 211 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 211 EVLEQVERGYRM----------------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHcCCCC----------------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 554443321100 111246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=273.09 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=202.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC---CCCchhHHHHHHHHHhcCCCCeeeeeEEEecC--ceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 76 (323)
++|++.+.||+|++|.||++++..++..+++|.+...... ......+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999999999999999987543221 22335777899999999999999999998753 568
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
++++||+.| ++.+.+.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~-~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC-EEECcccccccccc
Confidence 999999976 6777766543 3678888899999999999999999999999999999998877 99999999876532
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
....... .....++..|+|||.+.+ ...+.++|+||||+++|+|++|+.||..
T Consensus 159 ~~~~~~~--------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 159 ICMSGTG--------------------------IKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred ccccCcc--------------------------ccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 1110000 001234788999999887 5578999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
........++.. ... .+.....+++.+.++|.+|+. +|..||++.+++.|||
T Consensus 212 ~~~~~~~~~~~~---~~~------------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 212 YEAMAAIFKIAT---QPT------------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred cCHHHHHHHHHc---CCC------------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence 655544433221 110 112234578899999999999 5799999999999998
Q ss_pred C
Q 036739 316 F 316 (323)
Q Consensus 316 ~ 316 (323)
.
T Consensus 264 ~ 264 (264)
T cd06653 264 V 264 (264)
T ss_pred C
Confidence 4
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=273.77 Aligned_cols=244 Identities=24% Similarity=0.363 Sum_probs=200.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.. .++.|++|.+..... ....+.+|+.+++.++|+|++++++++.+....++|+|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 5799999999999999999986 478899998854432 34678889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
++.+ ++.+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~-~~l~d~g~~~~~~~~~~~- 158 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV-AKVSDFGLAKEASQGQDS- 158 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC-EEEccccccccccccccc-
Confidence 9975 8888877665556788999999999999999999999999999999999998887 999999998765322110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
...+..|+|||.+.. ..++.++|+||||+++|++++ |..||......
T Consensus 159 -------------------------------~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 206 (256)
T cd05039 159 -------------------------------GKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred -------------------------------CCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 012456999999876 567889999999999999997 99999877655
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+..... ......+++.+.++|.+||..+|++||++.++++
T Consensus 207 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 207 DVVPHVEKGYR----------------------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHhcCCC----------------------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 44333321100 0111346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=265.84 Aligned_cols=264 Identities=25% Similarity=0.314 Sum_probs=201.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec-----CceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 76 (323)
+||++.+.||+|||+-||++....++..||+|.+.... .+..+...+|++..++++|||+++++++... ....
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 58999999999999999999999999999999987665 3456788899999999999999999888653 3469
Q ss_pred EEEEecch-hhHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEecCCCceEEeccccce
Q 036739 77 YLVFEYLD-LDLKKHMDSCP--DFANDPRLIKTFLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (323)
Q Consensus 77 ~lv~e~~~-g~l~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~~~Nil~~~~~~~~kl~df~~~~ 151 (323)
|++++|.. |++++.+.... +..+++..+.+|+.+|+.||.+||... +.|+||||.||++..++. ++|.|||++.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~-~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL-PVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc-eEEEeccCcc
Confidence 99999995 78999987543 446799999999999999999999998 999999999999998787 9999999998
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--CCCCCCchhhHHHHHHHHHHHhC
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQ 229 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~ll~~l~tg 229 (323)
.......+.... .+.+..--. .-|..|.|||.+.- ....+.++|||||||++|.|+.|
T Consensus 178 ~a~i~i~~~~~a---------------~~lQe~a~e-----~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~ 237 (302)
T KOG2345|consen 178 QAPIQIEGSRQA---------------LRLQEWAEE-----RCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFG 237 (302)
T ss_pred ccceEeechHHH---------------HHHHHHHHH-----hCCCcccCchheecccCcccccccchhhhhHHHHHHHHc
Confidence 765443332211 011111011 11677999999864 24578899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
..||..... ++ +... +.-...+. .-+....+|+.+.++|..||+.||.+||++.+
T Consensus 238 ~sPfe~~~~--------~G-gSla---------LAv~n~q~-------s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ 292 (302)
T KOG2345|consen 238 ESPFERIYQ--------QG-GSLA---------LAVQNAQI-------SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPE 292 (302)
T ss_pred CCcchHHhh--------cC-CeEE---------Eeeecccc-------ccCCCCCccHHHHHHHHHHhcCCcccCCCHHH
Confidence 999943211 00 0000 00000000 00111238999999999999999999999999
Q ss_pred hhcC
Q 036739 310 ALEH 313 (323)
Q Consensus 310 il~h 313 (323)
++.+
T Consensus 293 ll~~ 296 (302)
T KOG2345|consen 293 LLSK 296 (302)
T ss_pred HHHH
Confidence 9864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.36 Aligned_cols=263 Identities=22% Similarity=0.404 Sum_probs=204.6
Q ss_pred CcceeeeeccccceeEEEEEEc---cCCceEEEEEEEeccc--CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNC---VTNETIALKKIRLEQE--DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 76 (323)
+|++.+.||.|++|.||++.+. .+|..||+|.+..... .....+.+.+|+.+++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999874 3788999999865422 222346677899999999 589999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
++|+||+.| ++.+.+.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC-EEEeeCccceeccc
Confidence 999999976 7777776543 4678888899999999999999999999999999999998877 99999998876532
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-CCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
...... ....|+..|++||.+... ...+.++|+||+|+++|+|++|..||.
T Consensus 158 ~~~~~~----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 158 DEVERA----------------------------YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred cccccc----------------------------ccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 211100 012457889999998752 346789999999999999999999997
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhh
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARS 309 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~ 309 (323)
..........+.+..... ..+....+++.+.+++++||+.||++|+ ++.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~ 264 (290)
T cd05613 210 VDGEKNSQAEISRRILKS-------------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADE 264 (290)
T ss_pred cCCccccHHHHHHHhhcc-------------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHH
Confidence 543322222222211110 0011234778899999999999999997 8999
Q ss_pred hhcCCCCccccc
Q 036739 310 ALEHEYFRDVEF 321 (323)
Q Consensus 310 il~h~~~~~~~~ 321 (323)
+++||||+.++|
T Consensus 265 l~~~~~~~~~~~ 276 (290)
T cd05613 265 IKKHPFFQKINW 276 (290)
T ss_pred HHcCcccccCCH
Confidence 999999998864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=277.68 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=198.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc---eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|++|.||++.+..++. .+++|.+..... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 589999999999999999998765543 689998754322 2234577889999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| ++.+.+.... ..++...+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~-~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe-EEeCCCCccccccccc
Confidence 9999976 6766665543 35688888999999999999999999999999999999998877 9999999987664322
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
....... ...++..|++||.+.+ ..++.++|+||||+++|++++ |..||...
T Consensus 161 ~~~~~~~--------------------------~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 161 EAAYTTR--------------------------GGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred ceeeecC--------------------------CCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 1110000 0112457999999987 568999999999999999886 99999877
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+....+.+.... +....+++.+.+++.+|++.+|.+||++.++++
T Consensus 214 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 214 SNQDVIKAIEEGYRL----------------------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHhCCCcC----------------------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 655544433321100 011236788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=297.37 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=214.7
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.|..++.||.|+||.||.|++..+.+.||||++...... .+--..+.+|+.+++++.|||++.+-|+|..+.+.|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 477789999999999999999999999999998765422 2223577889999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
||-|+.-+.+.-.. .++.+..+..|..+.+.||.|||+.+.+|+|||.-|||+++.+. |||+|||++....+...
T Consensus 107 YClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~-VKLaDFGSAsi~~PAns--- 181 (948)
T KOG0577|consen 107 YCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL-VKLADFGSASIMAPANS--- 181 (948)
T ss_pred HHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe-eeeccccchhhcCchhc---
Confidence 99886666554332 36788888899999999999999999999999999999999887 99999999977643321
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhh--CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILL--GSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
-+|||.|||||++. ....|+-+.||||||++-.||...++|+.+++-.
T Consensus 182 ------------------------------FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM 231 (948)
T KOG0577|consen 182 ------------------------------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 231 (948)
T ss_pred ------------------------------ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH
Confidence 26699999999986 3577999999999999999999999999999988
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
..+++|-+.-.. .+. ...-|+.+++|+..||++-|.+|||.+++++|+|...
T Consensus 232 SALYHIAQNesP----tLq-----------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 232 SALYHIAQNESP----TLQ-----------------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHHhcCCC----CCC-----------------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 888887663111 100 0224778999999999999999999999999999754
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=275.77 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=197.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc---eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|+..+.||+|++|.||+|+++.++. .+++|.+.... .......+.+|+.+++.++|+|++++.+++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 578999999999999999999876554 68899875432 22234578889999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+++ +|.+.+... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 84 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~-~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 84 ITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE-CKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc-EEECCCccceeccccc
Confidence 9999986 666665443 235788888999999999999999999999999999999998877 9999999987654322
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
....... ....++.|+|||.+.. ..++.++|+||||+++|+|++ |..||...
T Consensus 162 ~~~~~~~--------------------------~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 162 EGTYTTS--------------------------GGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred ccceecc--------------------------CCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 1111000 0011456999999877 567899999999999999997 99999776
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+....+...... +.....+..+.+++.+|++.+|++||++.++++
T Consensus 215 ~~~~~~~~i~~~~~~----------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 215 SNHEVMKAINDGFRL----------------------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 655444443321100 001235788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=274.79 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=191.8
Q ss_pred eeccccceeEEEEEE--ccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-
Q 036739 9 KIGEGTYGVVYKARN--CVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL- 85 (323)
Q Consensus 9 ~lg~g~~~~v~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g- 85 (323)
.||+|++|.||++.. ..++..+|+|++.....+......+.+|+.+++.+.|+||+++++++. ....++|+||+.+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 456789999988654433334567888999999999999999999885 4567899999975
Q ss_pred hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccccc
Q 036739 86 DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHW 165 (323)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 165 (323)
++.+.+.... .+++..+..++.|++.||.+||++|++|+||||+||+++.++. ++|+|||.+..............
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~- 156 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY-AKISDFGLSKALGADENYYKAKT- 156 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe-EEECCCccccccCCCCCeeeecC-
Confidence 6777765433 4688889999999999999999999999999999999998876 99999999876543322111000
Q ss_pred CCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 036739 166 GSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELFK 244 (323)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~ 244 (323)
...+++.|+|||.+.. ..++.++|+||||+++|+|++ |..||......+....
T Consensus 157 -------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 210 (257)
T cd05116 157 -------------------------HGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM 210 (257)
T ss_pred -------------------------CCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 0122567999999866 568889999999999999998 9999988766555444
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+.+.. .......+++.+.++|.+|++.||++||++.+|..
T Consensus 211 i~~~~----------------------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 211 IESGE----------------------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHCCC----------------------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 43210 00112347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=280.18 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=197.8
Q ss_pred CCcceeeeeccccceeEEEEEEccC-----CceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT-----NETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|++|.||++..... ...+++|.+..... ......+.+|+.+++.+ +|+||+++++++..++.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 5799999999999999999987543 36899998754322 22235677899999999 79999999999999999
Q ss_pred EEEEEecchh-hHHHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC
Q 036739 76 LYLVFEYLDL-DLKKHMDSC--------------PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN 140 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~--------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~ 140 (323)
++++|||+.+ ++.+.+... ....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe
Confidence 9999999965 777776542 2345678889999999999999999999999999999999998877
Q ss_pred ceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHH
Q 036739 141 ALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220 (323)
Q Consensus 141 ~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG 220 (323)
+||+|||.+............. ...++..|+|||.+.+ ..++.++|+||||
T Consensus 171 -~kL~Dfg~~~~~~~~~~~~~~~---------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG 221 (293)
T cd05053 171 -MKIADFGLARDIHHIDYYRKTT---------------------------NGRLPVKWMAPEALFD-RVYTHQSDVWSFG 221 (293)
T ss_pred -EEeCccccccccccccceeccC---------------------------CCCCCccccCHHHhcc-CCcCcccceeehh
Confidence 9999999987654321110000 0122567999999877 5688999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhccc
Q 036739 221 CIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299 (323)
Q Consensus 221 ~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 299 (323)
|++|++++ |..||......+....+..... .......++.+.+++.+|++.
T Consensus 222 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~ 273 (293)
T cd05053 222 VLLWEIFTLGGSPYPGIPVEELFKLLKEGYR----------------------------MEKPQNCTQELYHLMRDCWHE 273 (293)
T ss_pred hHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHccc
Confidence 99999997 9999987765544433322100 001123678899999999999
Q ss_pred CCCCCCCHhhhhcC
Q 036739 300 DPSRRITARSALEH 313 (323)
Q Consensus 300 dp~~R~s~~~il~h 313 (323)
||++|||+.+++++
T Consensus 274 ~p~~Rps~~eil~~ 287 (293)
T cd05053 274 VPSQRPTFKQLVED 287 (293)
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=273.24 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=200.7
Q ss_pred eeeccccceeEEEEEEccC---CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecch
Q 036739 8 EKIGEGTYGVVYKARNCVT---NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLD 84 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (323)
+.||+|++|.||++.+... +..+++|.+....... ....+.+|+..++.++|+|++++++++.+....++++||+.
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 4689999999999998766 8899999986543322 45788899999999999999999999999999999999995
Q ss_pred -hhHHHhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 85 -LDLKKHMDSCP-------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 85 -g~l~~~~~~~~-------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+++.+.+.... ...+++..+..++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~-~~l~dfg~~~~~~~~ 158 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV-VKISDFGLSRDVYDD 158 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc-EEEcccccccccccc
Confidence 57877776642 346789999999999999999999999999999999999999887 999999999876543
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
..... .....+++.|+|||.+.. ..++.++|+||+|+++|+|++ |..||..
T Consensus 159 ~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~ 210 (262)
T cd00192 159 DYYRK---------------------------KTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPG 210 (262)
T ss_pred ccccc---------------------------ccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence 22000 001234778999999887 468999999999999999999 6999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
....+....+.... .......+++.+.+++.+||..+|++||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 211 LSNEEVLEYLRKGY----------------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCHHHHHHHHHcCC----------------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 86655544443210 001123467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=275.69 Aligned_cols=253 Identities=20% Similarity=0.271 Sum_probs=195.1
Q ss_pred cceeeeeccccceeEEEEEEccC---CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc------
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVT---NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK------ 74 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 74 (323)
|++.+.||+|++|.||+|....+ +..+|+|.+............+.+|+..++.++|+|++++++.+....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999986543 378999988654333333457888999999999999999999886544
Q ss_pred eEEEEEecchh-hHHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccc
Q 036739 75 KLYLVFEYLDL-DLKKHMDSC----PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGL 149 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~ 149 (323)
..++++||+.+ ++...+... ....+++..+..++.|++.||.|||+.+++|+||||+||+++.++. +||+|||.
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~ 159 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT-VCVADFGL 159 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe-EEECCccc
Confidence 37999999975 666665432 2235788889999999999999999999999999999999998877 99999999
Q ss_pred ceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-
Q 036739 150 ARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN- 228 (323)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t- 228 (323)
+............ ....++..|++||.+.. ..++.++|+||||+++|+|++
T Consensus 160 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~ 211 (273)
T cd05035 160 SKKIYSGDYYRQG---------------------------RIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATR 211 (273)
T ss_pred eeecccccccccc---------------------------ccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhC
Confidence 8765322111000 00122567999999866 668999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|..||.+....+....+..... ......+++.+.+++.+||+.||++||++.
T Consensus 212 g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 263 (273)
T cd05035 212 GQTPYPGVENHEIYDYLRHGNR----------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFT 263 (273)
T ss_pred CCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 8899987766554443322100 011234678899999999999999999999
Q ss_pred hhhcC
Q 036739 309 SALEH 313 (323)
Q Consensus 309 ~il~h 313 (323)
+++++
T Consensus 264 e~~~~ 268 (273)
T cd05035 264 KLREV 268 (273)
T ss_pred HHHHH
Confidence 99873
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=278.60 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=197.4
Q ss_pred CCcceeeeeccccceeEEEEEEc-----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|.+.+.||+|++|.||++.+. .++..+++|.+.... ......+.+|+.+++.++|||++++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46899999999999999999852 344568888875332 22345688899999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEE
Q 036739 77 YLVFEYLDL-DLKKHMDSCP-----------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKL 144 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl 144 (323)
++++||+.+ +|.+.+.... ...+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~-~kl 161 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-VKI 161 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc-EEe
Confidence 999999975 7777765332 124788889999999999999999999999999999999998887 999
Q ss_pred eccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHH
Q 036739 145 ADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFA 224 (323)
Q Consensus 145 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~ 224 (323)
+|||.+............ ....+++.|+|||.+.+ ..++.++|+||||+++|
T Consensus 162 ~dfg~~~~~~~~~~~~~~---------------------------~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~ 213 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVG---------------------------GHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLW 213 (288)
T ss_pred ccCCccccccCCceeecC---------------------------CCCCccccccCHHHhcc-CCCCchhhHHHHHHHHH
Confidence 999998755322111000 01123667999999877 56899999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC
Q 036739 225 EMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303 (323)
Q Consensus 225 ~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~ 303 (323)
+|++ |..||......+....+.+... ......+++.+.+++.+||+.||.+
T Consensus 214 ~l~t~g~~p~~~~~~~~~~~~i~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~ 265 (288)
T cd05093 214 EIFTYGKQPWYQLSNNEVIECITQGRV----------------------------LQRPRTCPKEVYDLMLGCWQREPHM 265 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHccCChhh
Confidence 9998 8999987766555444432110 0011246788999999999999999
Q ss_pred CCCHhhhhc
Q 036739 304 RITARSALE 312 (323)
Q Consensus 304 R~s~~~il~ 312 (323)
||++.++++
T Consensus 266 Rpt~~~v~~ 274 (288)
T cd05093 266 RLNIKEIHS 274 (288)
T ss_pred CCCHHHHHH
Confidence 999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=286.10 Aligned_cols=255 Identities=22% Similarity=0.354 Sum_probs=193.9
Q ss_pred CCcceeeeeccccceeEEEEEEcc-----CCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEec-Cc
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-----TNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS-EK 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~ 74 (323)
++|++.+.||+|+||.||+|.... +++.||+|.+.... .......+.+|+.+++++ +|+||+++++++.. +.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 489999999999999999997433 34789999885332 122234567899999999 79999999998864 56
Q ss_pred eEEEEEecchh-hHHHhhhcCCC---------------------------------------------------------
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPD--------------------------------------------------------- 96 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~--------------------------------------------------------- 96 (323)
.+++++||+.| ++.+.+.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 78999999976 66666543221
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceee
Q 036739 97 --FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174 (323)
Q Consensus 97 --~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (323)
..++...+..++.||+.||.|||++||+|+||||+||+++.++. ++|+|||++..+........
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~-vkL~DfG~a~~~~~~~~~~~------------- 231 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVR------------- 231 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc-EEEeccccchhcccCcchhh-------------
Confidence 24677888999999999999999999999999999999998877 99999999876532211110
Q ss_pred hhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 036739 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPN 253 (323)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (323)
.+...++..|+|||++.+ ..++.++|+|||||++|+|++ |..||......+...........
T Consensus 232 --------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-- 294 (337)
T cd05054 232 --------------KGDARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-- 294 (337)
T ss_pred --------------ccCCCCCccccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC--
Confidence 011233567999999987 668999999999999999998 99999775443333322211000
Q ss_pred CCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 254 EDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.......++.+.+++.+||+.+|++||++.++++|
T Consensus 295 -------------------------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 295 -------------------------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred -------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00112467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=279.37 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=198.1
Q ss_pred CCcceeeeeccccceeEEEEEEccC-----CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT-----NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
.+|++.+.||+|++|.||++.+..+ +..||+|++.... .....+.+.+|..+++.++||||+++++++.+....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 4688999999999999999987543 4689999886432 122235678899999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCc
Q 036739 77 YLVFEYLDL-DLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA 141 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~ 141 (323)
++++||+.+ ++...+.... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~- 162 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN- 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc-
Confidence 999999975 6666664221 124677788899999999999999999999999999999998877
Q ss_pred eEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHH
Q 036739 142 LKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGC 221 (323)
Q Consensus 142 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 221 (323)
+||+|||++........... .+...+++.|+|||.+.. ..++.++|+||||+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~ 214 (283)
T cd05091 163 VKISDLGLFREVYAADYYKL---------------------------MGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGV 214 (283)
T ss_pred eEecccccccccccchheee---------------------------ccCccCCccccCHHHHhc-CCCCcchhHHHHHH
Confidence 99999998876532211100 011133677999999876 55889999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccC
Q 036739 222 IFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300 (323)
Q Consensus 222 ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~d 300 (323)
++|+|++ |..||.+....+....+.+... ......+++.+.+++.+||+.+
T Consensus 215 ~l~el~~~g~~p~~~~~~~~~~~~i~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~ 266 (283)
T cd05091 215 VLWEVFSYGLQPYCGYSNQDVIEMIRNRQV----------------------------LPCPDDCPAWVYTLMLECWNEF 266 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHhCCC
Confidence 9999998 8889987766555554433210 0112347788999999999999
Q ss_pred CCCCCCHhhhhc
Q 036739 301 PSRRITARSALE 312 (323)
Q Consensus 301 p~~R~s~~~il~ 312 (323)
|.+||++.+|++
T Consensus 267 p~~RP~~~~i~~ 278 (283)
T cd05091 267 PSRRPRFKDIHS 278 (283)
T ss_pred cccCCCHHHHHH
Confidence 999999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=275.33 Aligned_cols=254 Identities=25% Similarity=0.422 Sum_probs=199.5
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc---CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE---DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+|.+.+.||+|++|.||++.+...+..+++|+...... .......+..|+.+++.++|||++++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 68999999999999999999877777777776643321 222334566788999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 80 FEYLDL-DLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+||+.+ ++...+.. .....+++..+..++.|++.||.+||+.|++|+||+|+||+++. +. ++|+|||.+......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~-~~l~d~g~~~~~~~~ 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NL-LKIGDFGVSRLLMGS 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CC-EeecccCceeecCCC
Confidence 999976 66655543 22346788899999999999999999999999999999999974 44 999999988665322
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.... ....+++.|+|||.+.. ..++.++|+||+|+++|+|++|..||...
T Consensus 159 ~~~~-----------------------------~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 159 CDLA-----------------------------TTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred cccc-----------------------------cCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1111 01234778999999876 55788999999999999999999999766
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
........+.... .......+++.+.++|.+||+.+|++||++.++++||||
T Consensus 209 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 209 NFLSVVLRIVEGP----------------------------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred cHHHHHHHHHcCC----------------------------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 5544443332210 001123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=272.04 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=198.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+ ..+..+++|.+.... .....+.+|+.+++.++|+|++++++.+.+ ...++++|
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cceeEEeEecCccceEEEEEEe-cCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 6899999999999999999986 455679999875322 224678889999999999999999999977 77899999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+ ++.+.+.+......+...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~-~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV-CKIADFGLARVIEDNEYTA 159 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc-EEECCCcceeeccCCCccc
Confidence 9964 8888887765556788888899999999999999999999999999999998887 9999999987653221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. ...++..|+|||++.. ..++.++|+||||+++|++++ |..||......
T Consensus 160 ~~----------------------------~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 210 (260)
T cd05073 160 RE----------------------------GAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210 (260)
T ss_pred cc----------------------------CCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence 00 0122566999999877 568889999999999999999 99999877665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+.+... .+.....+..+.+++.+|++.+|++||++.++++
T Consensus 211 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 211 EVIRALERGYR----------------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHhCCCC----------------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 54443322100 0111346788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=279.06 Aligned_cols=254 Identities=21% Similarity=0.331 Sum_probs=198.5
Q ss_pred CCcceeeeeccccceeEEEEEEc-----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|++|.||++.+. ..+..+|+|.+.... .....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 47889999999999999999753 234579999875432 222345688899999999 79999999999999999
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
.++++||+.+ +|.+.+.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++++|||.+....
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~~l~dfg~~~~~~ 192 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI-VKICDFGLARDIM 192 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe-EEECCCccccccc
Confidence 9999999974 7777776554444788899999999999999999999999999999999998776 9999999987553
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLF 233 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~ 233 (323)
........ ....+++.|+|||.+.. ..++.++|+||+|+++|+|++ |..||
T Consensus 193 ~~~~~~~~---------------------------~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~ 244 (302)
T cd05055 193 NDSNYVVK---------------------------GNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPY 244 (302)
T ss_pred CCCceeec---------------------------CCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCc
Confidence 22111000 00123677999999877 557899999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
......+...+....... .......++.+.+++.+||+.+|++||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 245 PGMPVDSKFYKLIKEGYR---------------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCchHHHHHHHHcCCc---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 877655544333321000 0011236788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=295.03 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=208.8
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecc--cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc--eEEEEEec
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK--KLYLVFEY 82 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~ 82 (323)
...||+|+|-+||+|.|..+|-.||.-.++... ......+.|..|+.+|+.|+||||++++.+|.+.. +..+|||.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 568999999999999999999999987665443 34445589999999999999999999999998654 58899999
Q ss_pred c-hhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 83 L-DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH--RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 83 ~-~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
+ +|+|..+..+.. ..+.+.++.|++||+.||.|||++ .|+|||||.+||+++.+...|||+|+|++........+
T Consensus 125 ~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak 202 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK 202 (632)
T ss_pred ccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccc
Confidence 9 468888877655 468889999999999999999988 59999999999999888778999999999887544332
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
. +.|||.|||||++.. .|+...||||||+.++||.|+.-||+-+...
T Consensus 203 s-------------------------------vIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~ 249 (632)
T KOG0584|consen 203 S-------------------------------VIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNP 249 (632)
T ss_pred e-------------------------------eccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCH
Confidence 2 578999999999975 6899999999999999999999999999887
Q ss_pred HHHHHHH-HHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 240 DELFKIF-RVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
..+++.. ++..... .-+--.+.+++||.+||.. .++|+|+.|+|.||||..
T Consensus 250 AQIYKKV~SGiKP~s---------------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 250 AQIYKKVTSGIKPAA---------------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred HHHHHHHHcCCCHHH---------------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 7766544 3221110 0011257899999999999 899999999999999986
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
-
T Consensus 302 d 302 (632)
T KOG0584|consen 302 D 302 (632)
T ss_pred c
Confidence 3
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.47 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=215.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+.|.+++.||-|+||.||+|.++.++-..|.|++... .....+.+.-|+.+|....||+|+++++.|..++.++++.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 3478899999999999999999888888888887543 34456788899999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+|+|+.-+.+.-.-+..+.+..+..+++|++.||.|||+++|+|+|||.-|||++.+|. ++|.|||.+..........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd-irLADFGVSAKn~~t~qkR- 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD-IRLADFGVSAKNKSTRQKR- 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc-EeeecccccccchhHHhhh-
Confidence 99887666665444556888999999999999999999999999999999999999999 9999999986543211111
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
+.-.|||.|||||+... ..+|++++||||||++|.+|..+.+|-...+
T Consensus 188 ----------------------------DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln 239 (1187)
T KOG0579|consen 188 ----------------------------DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN 239 (1187)
T ss_pred ----------------------------ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence 11266999999999743 4789999999999999999999999998888
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
+...+.++..- .++.+ ..+..-+..+.+++.+||.+||..||+++++++||||+
T Consensus 240 pMRVllKiaKS----ePPTL----------------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 240 PMRVLLKIAKS----EPPTL----------------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred hHHHHHHHhhc----CCCcc----------------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 87777665431 11111 01123466788999999999999999999999999999
Q ss_pred ccc
Q 036739 318 DVE 320 (323)
Q Consensus 318 ~~~ 320 (323)
+++
T Consensus 294 ~~~ 296 (1187)
T KOG0579|consen 294 NAP 296 (1187)
T ss_pred cCC
Confidence 875
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=275.24 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=197.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc---eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|++|.||+|.+..+++ .|++|.+.... .......+..|+.+++.++||||+++++++.++...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 579999999999999999999876665 59999875432 22234678889999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
|+||+++ ++.+.+.... ..++...+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~-~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 83 ITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc-EEECCCccccccccCc
Confidence 9999976 5666655433 35788889999999999999999999999999999999998776 9999999886653222
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
....... ..+ ...+..|+|||.+.. ..++.++|+||+|+++|++++ |..||...
T Consensus 161 ~~~~~~~--~~~----------------------~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 161 SDPTYTS--SLG----------------------GKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred ccccccc--ccC----------------------CCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 1110000 000 011456999999876 567899999999999999886 99999877
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+....+...... +....++..+.+++.+||+.+|.+||++.+++.
T Consensus 216 ~~~~~~~~i~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 216 SNQDVINAIEQDYRL----------------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CHHHHHHHHHcCCcC----------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 655444433211000 011236778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=276.95 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=199.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCC----------------ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeee
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTN----------------ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~----------------~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 65 (323)
++|++++.||+|+||.||++.+...+ ..+++|.+..... ....+.+.+|++++++++|||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEeE
Confidence 58999999999999999999876543 4579998754422 233467788999999999999999
Q ss_pred eeEEEecCceEEEEEecchh-hHHHhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 036739 66 LQDVVHSEKKLYLVFEYLDL-DLKKHMDSCP---------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLI 135 (323)
Q Consensus 66 ~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~ 135 (323)
+++++.++...++++|++.+ ++.+.+.... ...+++..+..++.|++.||.|||+.|++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 99999999999999999975 7777765543 1256888899999999999999999999999999999999
Q ss_pred ecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchh
Q 036739 136 DRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVD 215 (323)
Q Consensus 136 ~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~D 215 (323)
+.++. ++|+|||.+........... .....+++.|+|||.+.. ..++.++|
T Consensus 164 ~~~~~-~~l~dfg~~~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~D 214 (296)
T cd05051 164 GKNYT-IKIADFGMSRNLYSSDYYRV---------------------------QGRAPLPIRWMAWESVLL-GKFTTKSD 214 (296)
T ss_pred cCCCc-eEEccccceeecccCcceee---------------------------cCcCCCCceecCHHHhhc-CCCCccch
Confidence 98877 99999999876432211100 011233677999999877 56899999
Q ss_pred hHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHH
Q 036739 216 VWSVGCIFAEMVN--QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293 (323)
Q Consensus 216 i~slG~ll~~l~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 293 (323)
+||||+++|+|++ |..||......+............... ........+++.+.+++
T Consensus 215 v~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li 273 (296)
T cd05051 215 VWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQ---------------------IYLPRPPNCPKDIYELM 273 (296)
T ss_pred hhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccccc---------------------ccCCCccCCCHHHHHHH
Confidence 9999999999998 678887766555444333211100000 00011234678899999
Q ss_pred HhhcccCCCCCCCHhhhhc
Q 036739 294 SKMLCMDPSRRITARSALE 312 (323)
Q Consensus 294 ~~~l~~dp~~R~s~~~il~ 312 (323)
.+||+.||++||++.++++
T Consensus 274 ~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 274 LECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHhccChhcCCCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=271.73 Aligned_cols=245 Identities=24% Similarity=0.305 Sum_probs=192.3
Q ss_pred eeeccccceeEEEEEEccCC---ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecch
Q 036739 8 EKIGEGTYGVVYKARNCVTN---ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLD 84 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (323)
+.||+|++|.||+|.....+ ..+++|.+...... .....+.+|+.+++.+.|+|++++++++. ....++++||+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 47999999999999865555 78999988644332 33467888999999999999999999875 456799999996
Q ss_pred h-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccc
Q 036739 85 L-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163 (323)
Q Consensus 85 g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~ 163 (323)
+ +|.+.+.... .+++..+..++.|++.+|.+||..+++|+||+|+||+++.++. ++|+|||.+.............
T Consensus 79 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~-~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ-AKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc-EEeccccccceeecCCcccccc
Confidence 5 7888877654 5688889999999999999999999999999999999998887 9999999987654322211100
Q ss_pred ccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 036739 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDEL 242 (323)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~ 242 (323)
. ...++..|+|||.+.. ..++.++|+||||+++|++++ |..||......+..
T Consensus 156 ~--------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~ 208 (257)
T cd05060 156 T--------------------------AGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI 208 (257)
T ss_pred c--------------------------CccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 0 0122457999999877 568999999999999999998 99999877665444
Q ss_pred HHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
..+.+.. .......+++.+.++|.+||..+|++||++.++++
T Consensus 209 ~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 209 AMLESGE----------------------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4332210 00112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=288.31 Aligned_cols=254 Identities=21% Similarity=0.324 Sum_probs=195.1
Q ss_pred CCcceeeeeccccceeEEEEEEccC-----CceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT-----NETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|+||.||++++... +..||+|++... ......+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 5788999999999999999986432 346999988543 22233467889999999996 9999999999999999
Q ss_pred EEEEEecchh-hHHHhhhcCC-----------------------------------------------------------
Q 036739 76 LYLVFEYLDL-DLKKHMDSCP----------------------------------------------------------- 95 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~----------------------------------------------------------- 95 (323)
.++||||+.+ +|.+.+....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999965 7776654321
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC
Q 036739 96 -----------------------------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN 140 (323)
Q Consensus 96 -----------------------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~ 140 (323)
...+++..+..++.||+.||.|||+.+++|+||||+||+++.++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE
Confidence 123566777889999999999999999999999999999998776
Q ss_pred ceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHH
Q 036739 141 ALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220 (323)
Q Consensus 141 ~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG 220 (323)
+||+|||++........... .....+++.|+|||.+.+ ..++.++||||||
T Consensus 276 -~kL~DfGla~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlG 326 (400)
T cd05105 276 -VKICDFGLARDIMHDSNYVS---------------------------KGSTFLPVKWMAPESIFD-NLYTTLSDVWSYG 326 (400)
T ss_pred -EEEEeCCcceeccccccccc---------------------------cCCcCCCcceEChhhhcC-CCCCchhhHHHHH
Confidence 99999999876532211100 001133677999999877 5689999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhccc
Q 036739 221 CIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299 (323)
Q Consensus 221 ~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 299 (323)
+++|+|++ |..||................... .....+++.+.+++.+||+.
T Consensus 327 vil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~ 379 (400)
T cd05105 327 ILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM---------------------------AKPDHATQEVYDIMVKCWNS 379 (400)
T ss_pred HHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHCcc
Confidence 99999997 999998765544443322210000 01124678899999999999
Q ss_pred CCCCCCCHhhhhc
Q 036739 300 DPSRRITARSALE 312 (323)
Q Consensus 300 dp~~R~s~~~il~ 312 (323)
||++||++.++.+
T Consensus 380 dP~~RPt~~~l~~ 392 (400)
T cd05105 380 EPEKRPSFLHLSD 392 (400)
T ss_pred CHhHCcCHHHHHH
Confidence 9999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=270.40 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=196.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.+|++.+.||+|++|.||++.+. ++..+++|.+.... .....+.+|++++++++|||++++++++......++++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 57899999999999999999874 46789999875332 223578899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+.... ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~-~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 80 FMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV-VKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred cCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe-EEECCCcceeecccCcccc
Confidence 9976 5655554433 34678888999999999999999999999999999999998776 9999999887653221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
. . ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus 158 ~---~-------------------------~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05112 158 S---T-------------------------GTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208 (256)
T ss_pred c---C-------------------------CCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 0 0 0122567999999877 568889999999999999998 99999877665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.....+...... ......++.+.+++.+||+.+|++||++.++++.
T Consensus 209 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 209 EVVETINAGFRL----------------------------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHhCCCCC----------------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 544443211000 0012257889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=274.47 Aligned_cols=253 Identities=20% Similarity=0.281 Sum_probs=194.1
Q ss_pred cceeeeeccccceeEEEEEEccCCc--eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------ce
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNE--TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------KK 75 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 75 (323)
+.+.+.||+|++|.||++.+..++. .+|+|.+..........+.+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4577899999999999999866665 689998865543344456788899999999999999999986421 35
Q ss_pred EEEEEecchh-hHHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccc
Q 036739 76 LYLVFEYLDL-DLKKHMDSC----PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~ 150 (323)
.++++||+.+ ++.+.+... ....+++..+..++.|++.||.|||+++++|+||||+||+++.++. ++|+|||.+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~ 159 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN-VCVADFGLS 159 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC-EEECCCCcc
Confidence 7899999974 776666322 2234688889999999999999999999999999999999998887 999999998
Q ss_pred eecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-C
Q 036739 151 RAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-Q 229 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g 229 (323)
............ ....+++.|++||.... ..++.++|+||||+++|+|++ |
T Consensus 160 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g 211 (272)
T cd05075 160 KKIYNGDYYRQG---------------------------RIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRG 211 (272)
T ss_pred cccCcccceecC---------------------------CcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCC
Confidence 765432211000 01123667999999877 568999999999999999999 8
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
..||......+....+..... ......+++.+.++|.+||+.||++||++.+
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 263 (272)
T cd05075 212 QTPYPGVENSEIYDYLRQGNR----------------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFET 263 (272)
T ss_pred CCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 899987665544433322100 0011246778999999999999999999999
Q ss_pred hhcC
Q 036739 310 ALEH 313 (323)
Q Consensus 310 il~h 313 (323)
++++
T Consensus 264 l~~~ 267 (272)
T cd05075 264 LRCE 267 (272)
T ss_pred HHHH
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=274.76 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=196.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCC-----ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTN-----ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|++|.||++.+...+ ..+++|.+.... .......+.+|+.+++.+.|+|++++++++......
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 68999999999999999999876433 789999874332 122235677899999999999999999999999999
Q ss_pred EEEEecch-hhHHHhhhcCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 77 YLVFEYLD-LDLKKHMDSCPD--------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 77 ~lv~e~~~-g~l~~~~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
++||||+. |+|.+.+..... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. +||+||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~-~kl~df 163 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT-VKIGDF 163 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC-EEECCc
Confidence 99999996 477777754321 23567788899999999999999999999999999999999887 999999
Q ss_pred ccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH
Q 036739 148 GLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~ 227 (323)
|.+........... .....++..|+|||.+.. ..++.++|+||||+++|+++
T Consensus 164 g~~~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~ 215 (277)
T cd05032 164 GMTRDIYETDYYRK---------------------------GGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMA 215 (277)
T ss_pred ccchhhccCccccc---------------------------CCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhh
Confidence 98865432211000 001133677999999876 55899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC
Q 036739 228 N-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT 306 (323)
Q Consensus 228 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 306 (323)
+ |..||......+....+... .. .......++.+.++|.+||+.+|++||+
T Consensus 216 t~g~~p~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt 267 (277)
T cd05032 216 TLAEQPYQGLSNEEVLKFVIDG-GH---------------------------LDLPENCPDKLLELMRMCWQYNPKMRPT 267 (277)
T ss_pred ccCCCCCccCCHHHHHHHHhcC-CC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCC
Confidence 8 99999876655444333210 00 0111235788999999999999999999
Q ss_pred Hhhhhc
Q 036739 307 ARSALE 312 (323)
Q Consensus 307 ~~~il~ 312 (323)
+.++++
T Consensus 268 ~~~l~~ 273 (277)
T cd05032 268 FLEIVS 273 (277)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=276.86 Aligned_cols=263 Identities=22% Similarity=0.401 Sum_probs=202.2
Q ss_pred CcceeeeeccccceeEEEEEEc---cCCceEEEEEEEeccc--CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNC---VTNETIALKKIRLEQE--DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 76 (323)
+|++.+.||+|++|.||++++. .++..+|+|.+..... .......+.+|+.+++++ +|||++++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999854 3567899998864321 222345677899999999 599999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
++||||+.| ++.+.+.... .+++..++.++.|++.+|.+||+.+++|+||+|.||+++.++. ++|+|||.+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC-EEEEECcccccccc
Confidence 999999975 7777765532 4688888999999999999999999999999999999998887 99999998765432
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCC-CCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR-HYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
...... ....|+..|++||.+.+.. ..+.++|+||+|+++|+|++|..||.
T Consensus 158 ~~~~~~----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 158 EEEERA----------------------------YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred cccccc----------------------------ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 211100 0123477899999987632 36889999999999999999999996
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC---Hhhhh
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT---ARSAL 311 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s---~~~il 311 (323)
..........+.+..... .......+++.+.++|.+||+.||++||+ +.+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l 264 (288)
T cd05583 210 VDGEQNSQSEISRRILKS-------------------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIK 264 (288)
T ss_pred cCcccchHHHHHHHHHcc-------------------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence 543222222211111000 01122346788999999999999999998 56779
Q ss_pred cCCCCccccc
Q 036739 312 EHEYFRDVEF 321 (323)
Q Consensus 312 ~h~~~~~~~~ 321 (323)
+||||+++.|
T Consensus 265 ~~~~~~~~~~ 274 (288)
T cd05583 265 NHPFFQGIDW 274 (288)
T ss_pred cCcccccCCH
Confidence 9999999865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=270.99 Aligned_cols=245 Identities=22% Similarity=0.298 Sum_probs=189.5
Q ss_pred eeccccceeEEEEEEc--cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-
Q 036739 9 KIGEGTYGVVYKARNC--VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL- 85 (323)
Q Consensus 9 ~lg~g~~~~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g- 85 (323)
.||+|++|.||++.+. ..+..+|+|.+... ......+.+.+|+.++++++|+||+++++.+. ....++|+||+.|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 4899999999999764 34557999987543 22333467889999999999999999999885 4578999999976
Q ss_pred hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccccc
Q 036739 86 DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHW 165 (323)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 165 (323)
+|.+.+... ...+++..+..++.||+.||.+||++|++|+||||+||+++.++. +||+|||.+..............
T Consensus 80 ~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~- 156 (257)
T cd05115 80 PLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY-AKISDFGLSKALGADDSYYKARS- 156 (257)
T ss_pred CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc-EEeccCCccccccCCccceeccC-
Confidence 666665543 335788999999999999999999999999999999999998877 99999999876543222111100
Q ss_pred CCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 036739 166 GSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELFK 244 (323)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~ 244 (323)
...+++.|+|||.+.. ..++.++|+||||+++|++++ |..||......+....
T Consensus 157 -------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 210 (257)
T cd05115 157 -------------------------AGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF 210 (257)
T ss_pred -------------------------CCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 0112467999999876 558899999999999999996 9999988776555444
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+.+... .......++.+.++|.+||+.+|++||++.+|++
T Consensus 211 ~~~~~~----------------------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 211 IEQGKR----------------------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHCCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 332110 0112346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=274.51 Aligned_cols=251 Identities=21% Similarity=0.292 Sum_probs=195.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc----eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE----TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|++|+||+|++..++. .||+|.+.... .......+.+|...++.++|+||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 579999999999999999999777776 47899875332 22234577789999999999999999999865 4567
Q ss_pred EEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+++|++. |++.+.+.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++. +||+|||++......
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~-~kL~dfG~~~~~~~~ 162 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDID 162 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc-EEECCCCceeecccc
Confidence 8999996 57777766543 35788889999999999999999999999999999999988777 999999998776432
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
....... ...+++.|+|||...+ ..++.++|+|||||++|+|++ |..||..
T Consensus 163 ~~~~~~~---------------------------~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 163 ETEYHAD---------------------------GGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred cceeecC---------------------------CCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 2211100 0122567999999877 568899999999999999998 8999977
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.........+... .. .+.....++.+.++|.+||+.||++||++.+++.
T Consensus 215 ~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 215 IPAREIPDLLEKG-ER---------------------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCHHHHHHHHHCC-Cc---------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6554433322211 00 0111236788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=270.76 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=196.1
Q ss_pred eeeccccceeEEEEEEcc-CCc--eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecch
Q 036739 8 EKIGEGTYGVVYKARNCV-TNE--TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLD 84 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~-~~~--~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (323)
+.||+|++|.||++.+.. ++. .+|+|.+...... .....+.+|+..+++++|+||+++++.+.+ ...++++|++.
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998755 333 6899988654432 445678899999999999999999999988 89999999996
Q ss_pred h-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccc
Q 036739 85 L-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163 (323)
Q Consensus 85 g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~ 163 (323)
+ +|.+.+.......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. +||+|||.+.............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK-VKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE-EEeccccccccccccccceecc
Confidence 4 8888877654345788889999999999999999999999999999999999887 9999999987764322211110
Q ss_pred ccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 036739 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDEL 242 (323)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~ 242 (323)
....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||......+..
T Consensus 158 --------------------------~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 210 (257)
T cd05040 158 --------------------------EHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL 210 (257)
T ss_pred --------------------------cCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 01234677999999877 568999999999999999999 99999877666554
Q ss_pred HHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
..+.... .. ......++..+.+++.+||+.+|++||++.++++
T Consensus 211 ~~~~~~~-----~~----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 211 KKIDKEG-----ER----------------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHhcC-----Cc----------------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 4443210 00 0011236788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=293.06 Aligned_cols=260 Identities=26% Similarity=0.436 Sum_probs=229.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
.+.+++..||-|+||.|-++.-......+|+|++++.. -+....+.+..|-.+|...+.|.|++++..|.+..++|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 46678889999999999999976666679999886553 34556678889999999999999999999999999999999
Q ss_pred ecc-hhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYL-DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~-~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|.| +|.++..+..+.. +++..++.++..+++|++|||.+||++|||||+|.+++.+|. +||.|||++..++....+
T Consensus 500 EaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy-~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY-LKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred HhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc-eEEeehhhHHHhccCCce
Confidence 999 5699998877664 577888999999999999999999999999999999999999 999999999999877776
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
+.. +||+.|.|||.+.+.. -+.+.|.|+||+++|||++|.+||++.++.
T Consensus 577 wTF------------------------------cGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpm 625 (732)
T KOG0614|consen 577 WTF------------------------------CGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPM 625 (732)
T ss_pred eee------------------------------cCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence 654 6799999999999844 588999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----HhhhhcCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALEHE 314 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~h~ 314 (323)
.++..+.+++.... .++.++..+.+||+++...+|++|+. +.+|-+|.
T Consensus 626 ktYn~ILkGid~i~---------------------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 626 KTYNLILKGIDKIE---------------------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred HHHHHHHhhhhhhh---------------------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 99999888754432 22458889999999999999999994 88999999
Q ss_pred CCcccccc
Q 036739 315 YFRDVEFV 322 (323)
Q Consensus 315 ~~~~~~~~ 322 (323)
||.+.+|.
T Consensus 679 Wf~gfdwe 686 (732)
T KOG0614|consen 679 WFEGFDWE 686 (732)
T ss_pred hhhcCChh
Confidence 99999884
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=274.88 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=197.1
Q ss_pred CCcceeeeeccccceeEEEEEEc-----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
.+|++.+.||+|++|.||++... .++..+++|.+... .......+.+|++.++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 47889999999999999999742 24567888876432 222346788999999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCce
Q 036739 77 YLVFEYLDL-DLKKHMDSCPD-------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNAL 142 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~ 142 (323)
++++||+.+ +|.+.+..... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. +
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~-~ 161 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV-V 161 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC-E
Confidence 999999965 77777654321 24678889999999999999999999999999999999998777 9
Q ss_pred EEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHH
Q 036739 143 KLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCI 222 (323)
Q Consensus 143 kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~l 222 (323)
+|+|||++........... .....+++.|+|||.+.+ ..++.++|+|||||+
T Consensus 162 kL~dfg~~~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~i 213 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRV---------------------------GGRTMLPIRWMPPESILY-RKFTTESDIWSFGVV 213 (280)
T ss_pred EECCCCceeEcCCCceeec---------------------------CCCccccccccCHHHhcc-CCcCchhhHHHHHHH
Confidence 9999999876532211000 001123577999999887 568999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCC
Q 036739 223 FAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301 (323)
Q Consensus 223 l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp 301 (323)
+|+|++ |.+||......+....+.+.... .....+++.+.++|.+||+.||
T Consensus 214 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~P 265 (280)
T cd05092 214 LWEIFTYGKQPWYQLSNTEAIECITQGREL----------------------------ERPRTCPPEVYAIMQGCWQREP 265 (280)
T ss_pred HHHHHcCCCCCCccCCHHHHHHHHHcCccC----------------------------CCCCCCCHHHHHHHHHHccCCh
Confidence 999998 89999877665555443321100 1113467889999999999999
Q ss_pred CCCCCHhhhhc
Q 036739 302 SRRITARSALE 312 (323)
Q Consensus 302 ~~R~s~~~il~ 312 (323)
.+||++.++++
T Consensus 266 ~~Rp~~~~l~~ 276 (280)
T cd05092 266 QQRMVIKDIHS 276 (280)
T ss_pred hhCCCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=278.16 Aligned_cols=254 Identities=25% Similarity=0.352 Sum_probs=195.7
Q ss_pred CCcceeeeeccccceeEEEEEEccC-------CceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecC
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT-------NETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 73 (323)
++|.+.+.||+|+||.||++.+... ...+|+|.+.... .......+..|+.+++.+ +|+||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 5799999999999999999986432 2469999885432 222345677899999999 799999999999999
Q ss_pred ceEEEEEecchh-hHHHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC
Q 036739 74 KKLYLVFEYLDL-DLKKHMDSCPD--------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138 (323)
Q Consensus 74 ~~~~lv~e~~~g-~l~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~ 138 (323)
+..++|+||+.+ +|.+++..... ..++...+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 999999999975 88888765421 246778889999999999999999999999999999999988
Q ss_pred CCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 139 TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 139 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
+. ++|+|||.+............. ...+++.|+|||.+.+ ..++.++|+||
T Consensus 177 ~~-~kL~dfg~a~~~~~~~~~~~~~---------------------------~~~~~~~y~aPE~~~~-~~~~~~~Dvws 227 (307)
T cd05098 177 NV-MKIADFGLARDIHHIDYYKKTT---------------------------NGRLPVKWMAPEALFD-RIYTHQSDVWS 227 (307)
T ss_pred Cc-EEECCCcccccccccchhhccc---------------------------cCCCccceeChHHhcc-CCCCcHHHHHH
Confidence 87 9999999886543211100000 0012467999999877 56789999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 219 VGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 219 lG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
||+++|+|++ |..||......+....+.... . ......++..+.++|.+||
T Consensus 228 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~~l 279 (307)
T cd05098 228 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-R---------------------------MDKPSNCTNELYMMMRDCW 279 (307)
T ss_pred HHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC-C---------------------------CCCCCcCCHHHHHHHHHHc
Confidence 9999999998 888987665433333322110 0 0111246788999999999
Q ss_pred ccCCCCCCCHhhhhcC
Q 036739 298 CMDPSRRITARSALEH 313 (323)
Q Consensus 298 ~~dp~~R~s~~~il~h 313 (323)
..+|++||++.+++++
T Consensus 280 ~~~p~~Rps~~evl~~ 295 (307)
T cd05098 280 HAVPSQRPTFKQLVED 295 (307)
T ss_pred ccChhhCcCHHHHHHH
Confidence 9999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=263.88 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=203.0
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 79 (323)
+|+.+.+..||+|.-|+||+++...+|...|+|.+......+ ....+...++++..- .+|.|++++|+|-.+..+++.
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke-e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH-HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 356678899999999999999999999999999996654333 234444455554444 489999999999999999999
Q ss_pred EecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
||.++--..+.+. +...++++..+-++...++.||+||-. .+++|||+||+|||++..|+ +|++|||.+-.+-....
T Consensus 170 MelMs~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn-iKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 170 MELMSTCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN-IKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC-EEeecccccceeecccc
Confidence 9988643333332 223368998899999999999999995 58999999999999999999 99999999866521111
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC--CCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS--RHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
+ ..+ .|-+.||+||.+... ..|+.++||||||+.++||.||+.||.+.
T Consensus 248 ---h--trs-------------------------AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c 297 (391)
T KOG0983|consen 248 ---H--TRS-------------------------AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC 297 (391)
T ss_pred ---c--ccc-------------------------cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence 1 111 346779999998753 56888999999999999999999999987
Q ss_pred ChH-HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 237 SEI-DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 237 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
+.. +.+-++.+.. . +.+++ ...+|+.+++|+..||++|+.+||.-.++|+|||
T Consensus 298 ~tdFe~ltkvln~e-P---P~L~~----------------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 298 KTDFEVLTKVLNEE-P---PLLPG----------------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred CccHHHHHHHHhcC-C---CCCCc----------------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 654 5555555411 1 11111 1238999999999999999999999999999999
Q ss_pred Ccccc
Q 036739 316 FRDVE 320 (323)
Q Consensus 316 ~~~~~ 320 (323)
+...+
T Consensus 352 i~~ye 356 (391)
T KOG0983|consen 352 IKRYE 356 (391)
T ss_pred eeecc
Confidence 98664
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=269.88 Aligned_cols=245 Identities=30% Similarity=0.479 Sum_probs=200.2
Q ss_pred eccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc-hhhH
Q 036739 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL-DLDL 87 (323)
Q Consensus 10 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~-~g~l 87 (323)
||.|++|.||++.+..+++.+++|.+...... ......+..|+.+++.++|+|++++++.+.++...+++||++ ++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999998665432 224567888999999999999999999999999999999999 4588
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCC
Q 036739 88 KKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167 (323)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 167 (323)
.+.+.... .+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~-~~l~d~~~~~~~~~~~~~~------- 150 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRT------- 150 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc-EEEeecCcceecccCCCcc-------
Confidence 88876653 4688889999999999999999999999999999999998887 9999999987754322100
Q ss_pred cCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 036739 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFR 247 (323)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~ 247 (323)
....++..|+|||...+ ...+.++|+||||+++|++++|..||...........+..
T Consensus 151 ----------------------~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 207 (250)
T cd05123 151 ----------------------NTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK 207 (250)
T ss_pred ----------------------cCCcCCccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 01234778999999877 4578899999999999999999999987765443333322
Q ss_pred HhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH---hhhhcCCCC
Q 036739 248 VLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA---RSALEHEYF 316 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~---~~il~h~~~ 316 (323)
. .......+++.+.++|++||..||++||++ .++++||||
T Consensus 208 ~-----------------------------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 208 D-----------------------------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred C-----------------------------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 0 001123357889999999999999999999 899999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=278.99 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=215.3
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
|.++++||+|++|.||+|.++.+|..+|||..... ...+++.+|+.++++...|++++++|.|.-...+++|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 67889999999999999999999999999988554 24578889999999999999999999999999999999999
Q ss_pred hhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccc
Q 036739 84 DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163 (323)
Q Consensus 84 ~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~ 163 (323)
+.+.-+.+.+.+..++++.++..++...+.+|+|||...-+|||||.-|||++.+|. .||.|||.+..+.-...+
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~-AKLADFGVAGQLTDTMAK---- 185 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI-AKLADFGVAGQLTDTMAK---- 185 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch-hhhhhccccchhhhhHHh----
Confidence 865555666666668999999999999999999999999999999999999999998 999999998665322211
Q ss_pred ccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 036739 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243 (323)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~ 243 (323)
.+++.||+-|+|||++.. .-|+.+.||||||++..||..|++||.+-.+...+.
T Consensus 186 -------------------------RNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF 239 (502)
T KOG0574|consen 186 -------------------------RNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF 239 (502)
T ss_pred -------------------------hCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeE
Confidence 345788999999999987 558999999999999999999999998877654443
Q ss_pred HHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccccc
Q 036739 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVEFV 322 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~~~ 322 (323)
.+- ...++.+ .+ +..-|+.+.++|++||.++|++|-++.++++|||.++.+.|
T Consensus 240 MIP----T~PPPTF---~K-------------------PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 240 MIP----TKPPPTF---KK-------------------PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred ecc----CCCCCCC---CC-------------------hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 321 0111110 00 11246778899999999999999999999999999988654
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=276.09 Aligned_cols=260 Identities=22% Similarity=0.279 Sum_probs=196.1
Q ss_pred CCcceeeeeccccceeEEEEEEccC--------------CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeee
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT--------------NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~--------------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 67 (323)
++|++.+.||+|++|.||++++... ...||+|.+.... .......+.+|++++++++|+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 5899999999999999999986443 2358999875432 222345688899999999999999999
Q ss_pred EEEecCceEEEEEecchh-hHHHhhhcCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEe
Q 036739 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPD----------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLID 136 (323)
Q Consensus 68 ~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~----------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~ 136 (323)
+++...+..++||||+.+ ++.+.+..... ...+...+..++.|++.||.|||+.|++|+||||+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 999999999999999976 77766644321 1356778889999999999999999999999999999999
Q ss_pred cCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhh
Q 036739 137 RRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDV 216 (323)
Q Consensus 137 ~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di 216 (323)
.++. +||+|||++........... .....+++.|+|||.+.. ..++.++|+
T Consensus 164 ~~~~-~kl~dfg~~~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv 214 (295)
T cd05097 164 NHYT-IKIADFGMSRNLYSGDYYRI---------------------------QGRAVLPIRWMAWESILL-GKFTTASDV 214 (295)
T ss_pred CCCc-EEecccccccccccCcceec---------------------------cCcCcCceeecChhhhcc-CCcCchhhH
Confidence 8777 99999999865432211000 001123567999999877 558999999
Q ss_pred HHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHH
Q 036739 217 WSVGCIFAEMVN--QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294 (323)
Q Consensus 217 ~slG~ll~~l~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 294 (323)
||||+++|+|++ |..||......+................ .......+++.+.++|.
T Consensus 215 wSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~l~~li~ 273 (295)
T cd05097 215 WAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQI---------------------YLSQTPLCPSPVFKLMM 273 (295)
T ss_pred HHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccc---------------------cCCCCCCCCHHHHHHHH
Confidence 999999999998 5678877666555444332111000000 00112236789999999
Q ss_pred hhcccCCCCCCCHhhhhc
Q 036739 295 KMLCMDPSRRITARSALE 312 (323)
Q Consensus 295 ~~l~~dp~~R~s~~~il~ 312 (323)
+|++.||++||++.+|++
T Consensus 274 ~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 274 RCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHcCCCchhCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=269.50 Aligned_cols=242 Identities=24% Similarity=0.390 Sum_probs=195.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++. .+++.+++|.+.... ....+.+|+.+++.++|||++++++++..+ ..++++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 579999999999999999986 478889999875332 235788899999999999999999998655 4689999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| ++.+.+.......++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~-~kl~Dfg~~~~~~~~~~~- 156 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV-AKVSDFGLARVGSMGVDN- 156 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc-EEECCCccceeccccCCC-
Confidence 9975 8888887665556788889999999999999999999999999999999998887 999999988654321110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
...+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus 157 -------------------------------~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 204 (254)
T cd05083 157 -------------------------------SKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK 204 (254)
T ss_pred -------------------------------CCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 011456999999876 568899999999999999998 99999877655
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+.+... ......+++.+.+++++||+.+|.+||++.+++.
T Consensus 205 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 205 EVKECVEKGYR----------------------------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHhCCCC----------------------------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 44433322100 0011346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=274.56 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=193.3
Q ss_pred CcceeeeeccccceeEEEEEEccC-----CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVT-----NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
+|++.+.||+|+||.||++++... ...+++|.+..... ......+.+|+.+++.+.||||+++++.+..++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 588999999999999999986432 24688887743321 122356888999999999999999999999999999
Q ss_pred EEEecchh-hHHHhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 036739 78 LVFEYLDL-DLKKHMDSCP----------------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLL 134 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~----------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil 134 (323)
+++||+.+ ++.+.+.... ...++...+..++.|++.||.+||+.+++|+||+|+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 99999975 7766654321 124577888999999999999999999999999999999
Q ss_pred EecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCch
Q 036739 135 IDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPV 214 (323)
Q Consensus 135 ~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~ 214 (323)
++.++. ++|+|||.+............ ....++..|+|||.+.+ ..++.++
T Consensus 160 l~~~~~-~kl~dfg~~~~~~~~~~~~~~---------------------------~~~~~~~~y~apE~~~~-~~~~~~~ 210 (290)
T cd05045 160 VAEGRK-MKISDFGLSRDVYEEDSYVKR---------------------------SKGRIPVKWMAIESLFD-HIYTTQS 210 (290)
T ss_pred EcCCCc-EEeccccccccccCccchhcc---------------------------cCCCCCccccCHHHHcc-CCcchHh
Confidence 998776 999999998654322110000 00123567999999876 5689999
Q ss_pred hhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHH
Q 036739 215 DVWSVGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293 (323)
Q Consensus 215 Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 293 (323)
|+||||+++++|++ |..||.+............... ......++..+.+++
T Consensus 211 Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i 262 (290)
T cd05045 211 DVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR----------------------------MERPENCSEEMYNLM 262 (290)
T ss_pred HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC----------------------------CCCCCCCCHHHHHHH
Confidence 99999999999998 9999977665443332221100 011134678899999
Q ss_pred HhhcccCCCCCCCHhhhhc
Q 036739 294 SKMLCMDPSRRITARSALE 312 (323)
Q Consensus 294 ~~~l~~dp~~R~s~~~il~ 312 (323)
.+||+.+|++||++.++++
T Consensus 263 ~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 263 LTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=275.42 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=195.9
Q ss_pred CCcceeeeeccccceeEEEEEEcc-----CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
.+|.+.+.||+|++|.||++.+.. ++..+++|.+.... ......+.+|+..++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 478999999999999999997533 34468888764222 12235678899999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCc
Q 036739 77 YLVFEYLDL-DLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA 141 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~ 141 (323)
++||||+.+ ++.+++.... ...+++..+..++.||+.||.+||++|++|+||||+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~- 161 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL- 161 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc-
Confidence 999999965 7777775432 234678889999999999999999999999999999999998887
Q ss_pred eEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHH
Q 036739 142 LKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGC 221 (323)
Q Consensus 142 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 221 (323)
++|+|||.+........... .....+++.|+|||.+.+ ..++.++|+||||+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ 213 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRV---------------------------GGHTMLPIRWMPPESIMY-RKFTTESDVWSFGV 213 (291)
T ss_pred EEECCCCcccccCCCceeec---------------------------CCCCCcceeecChHHhcc-CCCCchhhHHHHHH
Confidence 99999999875533211100 001134677999999887 56889999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccC
Q 036739 222 IFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300 (323)
Q Consensus 222 ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~d 300 (323)
++|+|++ |..||......+....+..... ......++..+.+++.+||+.+
T Consensus 214 il~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~ 265 (291)
T cd05094 214 ILWEIFTYGKQPWFQLSNTEVIECITQGRV----------------------------LERPRVCPKEVYDIMLGCWQRE 265 (291)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHhCCCC----------------------------CCCCccCCHHHHHHHHHHcccC
Confidence 9999999 9999987766554433221100 0011236788999999999999
Q ss_pred CCCCCCHhhhhc
Q 036739 301 PSRRITARSALE 312 (323)
Q Consensus 301 p~~R~s~~~il~ 312 (323)
|++||++.++++
T Consensus 266 P~~Rpt~~~v~~ 277 (291)
T cd05094 266 PQQRLNIKEIYK 277 (291)
T ss_pred hhhCcCHHHHHH
Confidence 999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=274.63 Aligned_cols=260 Identities=20% Similarity=0.275 Sum_probs=195.6
Q ss_pred CCcceeeeeccccceeEEEEEEcc----------------CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeee
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV----------------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~----------------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 65 (323)
++|++.+.||+|++|.||++.+.. ++..+|+|.+.... .......+.+|+.+++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986432 34468999875432 2223457889999999999999999
Q ss_pred eeEEEecCceEEEEEecchh-hHHHhhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 036739 66 LQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPD---------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLI 135 (323)
Q Consensus 66 ~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~ 135 (323)
+++++.+.+..++++||+.+ ++.+++..... ..++...+..++.|++.||.+||+.|++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 99999999999999999965 78777765332 235667789999999999999999999999999999999
Q ss_pred ecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchh
Q 036739 136 DRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVD 215 (323)
Q Consensus 136 ~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~D 215 (323)
+.++. ++|+|||.+..+........ .....+++.|++||.... ..++.++|
T Consensus 164 ~~~~~-~~l~dfg~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~pe~~~~-~~~~~~~D 214 (296)
T cd05095 164 GKNYT-IKIADFGMSRNLYSGDYYRI---------------------------QGRAVLPIRWMSWESILL-GKFTTASD 214 (296)
T ss_pred cCCCC-EEeccCcccccccCCcceec---------------------------cCcCcCccccCCHHHHhc-CCccchhh
Confidence 98877 99999999876532211000 001122567999998876 56899999
Q ss_pred hHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHH
Q 036739 216 VWSVGCIFAEMVN--QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293 (323)
Q Consensus 216 i~slG~ll~~l~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 293 (323)
+|||||++|+|++ |..||......+.............. ....+....+++.+.+++
T Consensus 215 iwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~li 273 (296)
T cd05095 215 VWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGR---------------------QVYLPKPALCPDSLYKLM 273 (296)
T ss_pred hhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccc---------------------cccCCCCCCCCHHHHHHH
Confidence 9999999999998 77888776655444322211100000 000011234678899999
Q ss_pred HhhcccCCCCCCCHhhhhc
Q 036739 294 SKMLCMDPSRRITARSALE 312 (323)
Q Consensus 294 ~~~l~~dp~~R~s~~~il~ 312 (323)
.+||+.||++||++.+|++
T Consensus 274 ~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 274 LSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHcCCCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=267.65 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=191.0
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-h
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-D 86 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g-~ 86 (323)
+.||+|++|.||++.. .++..+++|.+.... .......+.+|+.+++.++||||+++++.+.+.+..++||||+.| +
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 3689999999999986 467889999875332 122234677899999999999999999999999999999999975 7
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccC
Q 036739 87 LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166 (323)
Q Consensus 87 l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 166 (323)
+.+.+.... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 79 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~-~~l~d~g~~~~~~~~~~~~~----- 151 (250)
T cd05085 79 FLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV-LKISDFGMSRQEDDGIYSSS----- 151 (250)
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe-EEECCCccceeccccccccC-----
Confidence 766665433 34688888999999999999999999999999999999998887 99999998865432111100
Q ss_pred CcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 036739 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKI 245 (323)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~ 245 (323)
....+++.|+|||++.. ..++.++|+||||+++|++++ |..||...........+
T Consensus 152 -----------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~ 207 (250)
T cd05085 152 -----------------------GLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207 (250)
T ss_pred -----------------------CCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 01122567999999876 568899999999999999998 99999877655444433
Q ss_pred HHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...... .....++..+.+++.+|++.+|++||++.++++
T Consensus 208 ~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 208 EKGYRM----------------------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HcCCCC----------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 221100 111246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=280.20 Aligned_cols=262 Identities=24% Similarity=0.336 Sum_probs=193.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc-eEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-KLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~ 80 (323)
++|.-...||+|+||.||++.. .++..||||.+....... ..+|.+|+.++.+++|||+++++|+|.+.+ ..+||+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY 151 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY 151 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence 4677778999999999999987 445899999775443322 456999999999999999999999999888 599999
Q ss_pred ecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCcEEEecCCCceEEeccccceecCC-
Q 036739 81 EYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI- 155 (323)
Q Consensus 81 e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~- 155 (323)
||+. |+|.+++.......+++..+.+|+.++|.||+|||.. .|+|||||++|||+|.+.. .||+|||++.....
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~-aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN-AKLSDFGLAKLGPEG 230 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC-EEccCccCcccCCcc
Confidence 9995 6888888765543679999999999999999999975 3999999999999999888 99999999955432
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
....... ..||.+|++||++.. ...+.++||||+|+++.|+++|+.+...
T Consensus 231 ~~~~~~~-----------------------------~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 231 DTSVSTT-----------------------------VMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred ccceeee-----------------------------cCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCC
Confidence 1111100 045899999999987 6789999999999999999999988765
Q ss_pred CC--hHH-HHHHHHHHhCCCCCCCCCCcccCCcccc-cCCCCCCCccccccc-CCChHHHHHHHhhcccCCCCCCCHhhh
Q 036739 236 DS--EID-ELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVR-NLEPAGIDLLSKMLCMDPSRRITARSA 310 (323)
Q Consensus 236 ~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~s~~~~~li~~~l~~dp~~R~s~~~i 310 (323)
.. ... ...-........ ...++.+ .+.. ..... ..-..+..+...|++.+|.+||++.+|
T Consensus 281 ~~~~~~~~l~~w~~~~~~~~---------~~~eiiD~~l~~------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~V 345 (361)
T KOG1187|consen 281 SRPRGELSLVEWAKPLLEEG---------KLREIVDPRLKE------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQV 345 (361)
T ss_pred CCCcccccHHHHHHHHHHCc---------chhheeCCCccC------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHH
Confidence 42 111 111111111110 0000000 0000 00000 011236688899999999999999998
Q ss_pred hc
Q 036739 311 LE 312 (323)
Q Consensus 311 l~ 312 (323)
++
T Consensus 346 v~ 347 (361)
T KOG1187|consen 346 VK 347 (361)
T ss_pred HH
Confidence 65
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=287.67 Aligned_cols=249 Identities=31% Similarity=0.492 Sum_probs=202.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHH-HHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREIS-LLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+.|.+...+|.|+|+.|-.+.+..++..+++|++.... ....+|.. .++..+|||+++.++.+.++...|+||
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 57888899999999999999999999999999986552 22234553 444557999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE-ecCCCceEEeccccceecCCCcc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLI-DRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~-~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|.+.| .+++.+....... ..+..|+.+|+.|++|||.+|++||||||+|||+ +..+. ++|+|||.+......-.
T Consensus 396 e~l~g~ell~ri~~~~~~~---~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~-lrltyFG~a~~~~~~~~ 471 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC---SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH-LRLTYFGFWSELERSCD 471 (612)
T ss_pred hhccccHHHHHHHhcchhH---HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc-EEEEEechhhhCchhhc
Confidence 99976 6677766654432 6677899999999999999999999999999999 47776 99999999987754410
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
..+.|..|.|||+... +.++.++|+||||++||+|++|+.||.....
T Consensus 472 --------------------------------tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 472 --------------------------------TPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred --------------------------------ccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 1134888999999985 7899999999999999999999999988766
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
...+...++ .... ...+|+.+++||++||+.||.+|+++.++..||||-+
T Consensus 519 ~~ei~~~i~---~~~~---------------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 519 GIEIHTRIQ---MPKF---------------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred hHHHHHhhc---CCcc---------------------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence 533322221 1111 1358999999999999999999999999999999966
Q ss_pred ccccC
Q 036739 319 VEFVP 323 (323)
Q Consensus 319 ~~~~~ 323 (323)
.++.|
T Consensus 569 ~~t~p 573 (612)
T KOG0603|consen 569 HPTFP 573 (612)
T ss_pred CCCCC
Confidence 65543
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.77 Aligned_cols=250 Identities=27% Similarity=0.388 Sum_probs=200.7
Q ss_pred cceeeeeccccceeEEEEEEccCC----ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTN----ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++.+.||.|++|.||++.+...+ ..+|+|.+..... ......+.+|+..++.++|+|++++++.+.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 467899999999999999987766 8899998854322 22456888999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
||++.| ++.+.+.......+++..+..++.|++.||++||+.+++|+||+|+||+++.++. ++|+|||.+........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~-~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDY 158 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe-EEEcccCCceecccccc
Confidence 999976 7777776554433788999999999999999999999999999999999998886 99999999877643311
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDS 237 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~ 237 (323)
.... ...+++.|+|||.+.. ..++.++|+||||+++++|++ |..||....
T Consensus 159 ~~~~----------------------------~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~ 209 (258)
T smart00219 159 YKKK----------------------------GGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMS 209 (258)
T ss_pred cccc----------------------------cCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 1100 0023678999999865 668999999999999999998 889998766
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
..+....+.+... .......+..+.+++.+||..||++||++.++++
T Consensus 210 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 210 NEEVLEYLKKGYR----------------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHhcCCC----------------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 6555544432110 0111236788999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=267.76 Aligned_cols=245 Identities=26% Similarity=0.355 Sum_probs=192.9
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-h
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-D 86 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g-~ 86 (323)
+.||+|++|.||++.+.. ++.|++|.+...... .....+.+|+.+++++.|+||+++++++.+....++|+|++.| +
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 468999999999999866 999999987544322 2346788999999999999999999999999999999999975 6
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccC
Q 036739 87 LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166 (323)
Q Consensus 87 l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 166 (323)
+.+++.... ..++...+..++.+++.+|.+||+++++|+||+|+||+++.++. ++|+|||.+............
T Consensus 79 l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~-~~l~d~g~~~~~~~~~~~~~~---- 152 (251)
T cd05041 79 LLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV-LKISDFGMSREEEGGIYTVSD---- 152 (251)
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc-EEEeeccccccccCCcceecc----
Confidence 777765533 25678888899999999999999999999999999999998887 999999998754321111000
Q ss_pred CcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 036739 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKI 245 (323)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~ 245 (323)
.....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+
T Consensus 153 -----------------------~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~ 208 (251)
T cd05041 153 -----------------------GLKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208 (251)
T ss_pred -----------------------ccCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH
Confidence 00122556999999876 568999999999999999999 88999777654433332
Q ss_pred HHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
..... .......+..+.+++.+||..+|.+||++.++++
T Consensus 209 ~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 209 ESGYR----------------------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred hcCCC----------------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 21100 0011236788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=271.48 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=190.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCce----EEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNET----IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|++|+||++.+..++.. +++|.+... ........+..|+..++.+.||||+++++++. +...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 5799999999999999999998777764 666665321 11222345667788889999999999999875 45577
Q ss_pred EEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+++||+. |++.+.+..... .+++..+..++.||+.||.|||+.+++|+||||+||+++.++. +||+|||.+......
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~-~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI-VQIADFGVADLLYPD 162 (279)
T ss_pred EEEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc-EEEcCCccceeccCC
Confidence 8899986 588888765433 5788889999999999999999999999999999999998777 999999998765322
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
...... ....++..|++||.+.. ..++.++|+||||+++|++++ |..||.+
T Consensus 163 ~~~~~~---------------------------~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 163 DKKYFY---------------------------SEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred Cccccc---------------------------CCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 111110 01133667999999977 568999999999999999998 9999987
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
........ +....... ......+..+.+++.+|+..||++||++.++++
T Consensus 215 ~~~~~~~~-~~~~~~~~---------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 215 MRPHEVPD-LLEKGERL---------------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCHHHHHH-HHHCCCcC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 65543322 22210000 001124567889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=273.29 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=196.3
Q ss_pred CCcceeeeeccccceeEEEEEEcc-----CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|++|.||++.+.. ++..+++|.+.... .......+.+|+.+++.+.|||++++++++.++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 689999999999999999998743 56789999875332 222235688899999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 036739 77 YLVFEYLDL-DLKKHMDSCPD--------------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLI 135 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~--------------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~ 135 (323)
++++||+.+ +|.+.+..... ..+++..+..++.||+.||.+||+++++|+||+|+||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 999999975 77777753221 235677788999999999999999999999999999999
Q ss_pred ecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchh
Q 036739 136 DRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVD 215 (323)
Q Consensus 136 ~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~D 215 (323)
+.++. ++|+|||.+............ .....++.|+|||.+.+ ..++.++|
T Consensus 164 ~~~~~-~~l~dfg~~~~~~~~~~~~~~---------------------------~~~~~~~~y~aPE~~~~-~~~~~~~D 214 (288)
T cd05050 164 GENMV-VKIADFGLSRNIYSADYYKAS---------------------------ENDAIPIRWMPPESIFY-NRYTTESD 214 (288)
T ss_pred cCCCc-eEECccccceecccCcccccc---------------------------CCCccChhhcCHHHHhc-CCCCchhH
Confidence 98887 999999998754322110000 00122556999999877 56899999
Q ss_pred hHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHH
Q 036739 216 VWSVGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294 (323)
Q Consensus 216 i~slG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 294 (323)
+||||+++|+|++ |..||.+....+....+..... ......++..+.++|.
T Consensus 215 v~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~ 266 (288)
T cd05050 215 VWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV----------------------------LSCPDNCPLELYNLMR 266 (288)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHH
Confidence 9999999999998 8889877666554443321100 0011236788999999
Q ss_pred hhcccCCCCCCCHhhhhc
Q 036739 295 KMLCMDPSRRITARSALE 312 (323)
Q Consensus 295 ~~l~~dp~~R~s~~~il~ 312 (323)
+||+.+|++||++.++++
T Consensus 267 ~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 267 LCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHcccCcccCCCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=275.18 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=196.8
Q ss_pred CCcceeeeeccccceeEEEEEEc-------cCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecC
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 73 (323)
++|++.+.||+|++|.||+++.. ..+..+++|.+.... .......+.+|+.+++.+ +||||+++++.+...
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 57899999999999999999742 233479999875332 223346788899999999 799999999999999
Q ss_pred ceEEEEEecchh-hHHHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC
Q 036739 74 KKLYLVFEYLDL-DLKKHMDSCPD--------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138 (323)
Q Consensus 74 ~~~~lv~e~~~g-~l~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~ 138 (323)
...+++|||+.+ +|.+++..... ..++...+..++.||+.||.|||++|++|+||||+||+++.+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~ 173 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCC
Confidence 999999999975 77777765421 245677788999999999999999999999999999999988
Q ss_pred CCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 139 TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 139 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
+. +||+|||.+............. ...+++.|+|||.+.+ ..++.++|+||
T Consensus 174 ~~-~kl~D~g~~~~~~~~~~~~~~~---------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~s 224 (304)
T cd05101 174 NV-MKIADFGLARDVNNIDYYKKTT---------------------------NGRLPVKWMAPEALFD-RVYTHQSDVWS 224 (304)
T ss_pred Cc-EEECCCccceeccccccccccc---------------------------CCCCCceeeCchhhcc-CCCCchhhHHH
Confidence 77 9999999987664322111000 0123567999999877 56889999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 219 VGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 219 lG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
||+++|+|++ |..||......+....+..... ......++..+.++|.+||
T Consensus 225 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl 276 (304)
T cd05101 225 FGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCW 276 (304)
T ss_pred HHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHc
Confidence 9999999998 7888877765554443321100 0011246788999999999
Q ss_pred ccCCCCCCCHhhhhc
Q 036739 298 CMDPSRRITARSALE 312 (323)
Q Consensus 298 ~~dp~~R~s~~~il~ 312 (323)
+.+|.+||++.++++
T Consensus 277 ~~~p~~Rps~~e~l~ 291 (304)
T cd05101 277 HAIPSHRPTFKQLVE 291 (304)
T ss_pred ccChhhCCCHHHHHH
Confidence 999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=274.96 Aligned_cols=253 Identities=26% Similarity=0.371 Sum_probs=195.1
Q ss_pred CCcceeeeeccccceeEEEEEEcc-------CCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecC
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-------TNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 73 (323)
++|.+.+.||+|++|.||++++.. ....+++|.+.... .......+.+|+.+++.+ +||||+++++++.+.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 478999999999999999997532 34578999875332 222345677899999999 599999999999999
Q ss_pred ceEEEEEecchh-hHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC
Q 036739 74 KKLYLVFEYLDL-DLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138 (323)
Q Consensus 74 ~~~~lv~e~~~g-~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~ 138 (323)
+..++++||+.+ +|.+++.... ...++...+..++.||+.||.|||++|++|+||||+||+++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC
Confidence 999999999965 7777775532 2346778888999999999999999999999999999999988
Q ss_pred CCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 139 TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 139 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
+. +||+|||.+........... .. ...++..|+|||.+.+ ..++.++|+||
T Consensus 171 ~~-~kL~Dfg~~~~~~~~~~~~~-~~--------------------------~~~~~~~y~aPE~~~~-~~~~~~~Diws 221 (314)
T cd05099 171 NV-MKIADFGLARGVHDIDYYKK-TS--------------------------NGRLPVKWMAPEALFD-RVYTHQSDVWS 221 (314)
T ss_pred Cc-EEEccccccccccccccccc-cc--------------------------cCCCCccccCHHHHcc-CCcCccchhhH
Confidence 87 99999999876532111000 00 0012456999999877 56899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 219 VGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 219 lG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
||+++|+|++ |..||......+....+.... . ......++..+.++|.+||
T Consensus 222 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~l~~li~~cl 273 (314)
T cd05099 222 FGILMWEIFTLGGSPYPGIPVEELFKLLREGH-R---------------------------MDKPSNCTHELYMLMRECW 273 (314)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C---------------------------CCCCCCCCHHHHHHHHHHc
Confidence 9999999999 889997766544444332210 0 0111346778999999999
Q ss_pred ccCCCCCCCHhhhhc
Q 036739 298 CMDPSRRITARSALE 312 (323)
Q Consensus 298 ~~dp~~R~s~~~il~ 312 (323)
..+|++||++.++++
T Consensus 274 ~~~p~~Rps~~~ll~ 288 (314)
T cd05099 274 HAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCcccCcCHHHHHH
Confidence 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=292.29 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=207.9
Q ss_pred eeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchhhHH
Q 036739 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDLDLK 88 (323)
Q Consensus 9 ~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~l~ 88 (323)
.||.|-+|+||-+++..+....|||.+.- .+....+-+..|+.+.++++|.||++++|++..++.+-|.||.+.|+.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 68999999999999999999999999743 3344457788899999999999999999999999999999999987665
Q ss_pred HhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccC
Q 036739 89 KHMDSCPDFAN--DPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166 (323)
Q Consensus 89 ~~~~~~~~~~~--~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 166 (323)
+.+.+..=.++ ++..+-.+-+||++||.|||.+.|||||||.+||+++.-..++||+|||.++.+..-...
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~------- 732 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC------- 732 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcc-------
Confidence 55554433344 788889999999999999999999999999999999887778999999999876422211
Q ss_pred CcCcceeehhhhhhhccCccceeeccccccccccchhhhC-CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 036739 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG-SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKI 245 (323)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~ 245 (323)
..+-.||+.|||||++.. .+-|+.++|||||||++.||.||++||...-..+..--.
T Consensus 733 ----------------------TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk 790 (1226)
T KOG4279|consen 733 ----------------------TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK 790 (1226)
T ss_pred ----------------------ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh
Confidence 111256999999999975 455899999999999999999999999766544332211
Q ss_pred HHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.. +....++++..+|..++.+|.+|+.+||.+||++.++|..||++.-
T Consensus 791 VG--------------------------myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 791 VG--------------------------MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred hc--------------------------ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 11 1122345566789999999999999999999999999999999854
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=287.96 Aligned_cols=237 Identities=25% Similarity=0.399 Sum_probs=196.6
Q ss_pred ceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecch
Q 036739 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLD 84 (323)
Q Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (323)
.-++.||+|+-|.||+++ -.++.||||+++ +.=..++.-|+.|+|+||+++.|.|.....+|||||||.
T Consensus 127 sELeWlGSGaQGAVF~Gr--l~netVAVKKV~---------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGR--LHNETVAVKKVR---------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhhccCcccceeeee--ccCceehhHHHh---------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 446789999999999998 478899999863 222357888999999999999999999999999999995
Q ss_pred -hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccccc
Q 036739 85 -LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163 (323)
Q Consensus 85 -g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~ 163 (323)
|-|...+...+ .+.......|..+|+.+++|||.++|+|+|||.-||||..+.. |||+|||.++......+++..
T Consensus 196 ~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~-VKIsDFGTS~e~~~~STkMSF- 271 (904)
T KOG4721|consen 196 QGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV-VKISDFGTSKELSDKSTKMSF- 271 (904)
T ss_pred cccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce-EEeccccchHhhhhhhhhhhh-
Confidence 67777777655 4677788899999999999999999999999999999998776 999999999887544333322
Q ss_pred ccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 036739 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELF 243 (323)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~ 243 (323)
+||..|||||++.+ .+++.|.||||||++||||+||..||++-+...++.
T Consensus 272 -----------------------------aGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw 321 (904)
T KOG4721|consen 272 -----------------------------AGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW 321 (904)
T ss_pred -----------------------------hhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEE
Confidence 56999999999999 779999999999999999999999998766544332
Q ss_pred HHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.+-.. .-..+++...++.++=||+.||+..|..||+..+|+.|
T Consensus 322 GVGsN---------------------------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 322 GVGSN---------------------------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred eccCC---------------------------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 21100 00123445578889999999999999999999999998
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=269.13 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=195.0
Q ss_pred CCcceeeeeccccceeEEEEEEccC---CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT---NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|++|.||+|.+... ...+++|...... .....+.+.+|+.+++.+.|+|++++++++.+ ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 5789999999999999999986544 3468999874332 22234678889999999999999999999865 45689
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
|+||+.+ ++.+.+.+... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~-~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC-eEEccCceeeeccccc
Confidence 9999975 77777755432 5788889999999999999999999999999999999998887 9999999887653221
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
..... ...++..|+|||.+.. ..++.++|+||||+++|++++ |..||...
T Consensus 162 ~~~~~----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 162 YYKAS----------------------------KGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred ceecC----------------------------CCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 10000 0112456999999876 567899999999999999996 99999887
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+....+.+... ......+++.+.++|.+|+..+|++||++.+++.
T Consensus 213 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 213 KNNDVIGRIENGER----------------------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 76555544322110 0112346789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=270.23 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=196.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc----eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE----TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|++|+||++.++.+++ .+++|.+..... ......+.+|+..++.+.|+|++++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 579999999999999999999776665 588887643322 2234577789999999999999999999977 7889
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+++||+.+ ++.+.+.+... .+++..+..++.||+.||.|||+.+++|+||+|+||+++.++. ++|+|||.+......
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~-~kL~dfg~~~~~~~~ 162 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVD 162 (279)
T ss_pred EEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe-EEECCCcccccccCc
Confidence 99999965 77777765433 4788899999999999999999999999999999999998777 999999998766422
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
....... ...++..|+|||.+.. ..++.++|+||+|+++|++++ |..||..
T Consensus 163 ~~~~~~~---------------------------~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~ 214 (279)
T cd05057 163 EKEYHAE---------------------------GGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEG 214 (279)
T ss_pred ccceecC---------------------------CCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence 2211100 0112567999999876 567899999999999999998 9999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
....+....+..... .......+..+.+++.+||..+|.+||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 215 IPAVEIPDLLEKGER----------------------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHhCCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 765554443332100 0111235678899999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=271.73 Aligned_cols=266 Identities=26% Similarity=0.339 Sum_probs=192.9
Q ss_pred CCc-ceeeeeccccceeEEEEE----EccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--Cc
Q 036739 2 DQY-EKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EK 74 (323)
Q Consensus 2 ~~y-~~~~~lg~g~~~~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 74 (323)
++| ++.+.||+|++|+||++. ...++..||+|.+..... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 566 899999999999998764 345677899998864422 2234677889999999999999999998765 34
Q ss_pred eEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
..+++|||+.+ ++.+.+... .+++..+..++.|++.||.+||++|++|+||||+||+++.++. ++|+|||.+...
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~~l~dfg~~~~~ 157 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL-VKIGDFGLAKAV 157 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc-EEEeeccccccc
Confidence 68999999976 666666543 4788889999999999999999999999999999999998877 999999998765
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
........... ...++..|+|||.+.. ..++.++|+||||+++|+|++|..||
T Consensus 158 ~~~~~~~~~~~--------------------------~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~ 210 (283)
T cd05080 158 PEGHEYYRVRE--------------------------DGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSK 210 (283)
T ss_pred CCcchhhccCC--------------------------CCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCC
Confidence 43222111000 0122556999999876 56889999999999999999999998
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...... ....... ....... ........ .....+....++..+.+++.+||+.+|++||++.++++
T Consensus 211 ~~~~~~--~~~~~~~----~~~~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 211 QSPPKK--FEEMIGP----KQGQMTV-VRLIELLE------RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCcch--hhhhhcc----cccccch-hhhhhhhh------cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 654321 1000000 0000000 00000000 00011223457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=270.57 Aligned_cols=253 Identities=20% Similarity=0.283 Sum_probs=197.0
Q ss_pred CCcceeeeeccccceeEEEEEEcc----CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec-CceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (323)
++|++.+.||+|++|.||++.+.. .+..+++|.+... ........+.+|+.+++.++|+|++++++++.. ....
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 589999999999999999999865 2578899887432 233334667889999999999999999998765 5678
Q ss_pred EEEEecch-hhHHHhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccc
Q 036739 77 YLVFEYLD-LDLKKHMDSCPD------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGL 149 (323)
Q Consensus 77 ~lv~e~~~-g~l~~~~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~ 149 (323)
+++++++. |++.+.+..... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. +||+|||+
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~-~kl~d~g~ 163 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ-VKITDNAL 163 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc-EEECCCCC
Confidence 99999996 477777755432 35788889999999999999999999999999999999998877 99999999
Q ss_pred ceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-
Q 036739 150 ARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN- 228 (323)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t- 228 (323)
+..+......... ....++..|+|||.+.+ ..++.++||||||+++|++++
T Consensus 164 ~~~~~~~~~~~~~---------------------------~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~ 215 (280)
T cd05043 164 SRDLFPMDYHCLG---------------------------DNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTL 215 (280)
T ss_pred cccccCCceEEeC---------------------------CCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcC
Confidence 8765322211100 00123567999999977 568999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|..||......+....+..... ......+++.+.+++.+|++.||++||++.
T Consensus 216 g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 267 (280)
T cd05043 216 GQTPYVEIDPFEMAAYLKDGYR----------------------------LAQPINCPDELFAVMACCWALDPEERPSFS 267 (280)
T ss_pred CCCCcCcCCHHHHHHHHHcCCC----------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHH
Confidence 9999987765554433222100 001123578899999999999999999999
Q ss_pred hhhc
Q 036739 309 SALE 312 (323)
Q Consensus 309 ~il~ 312 (323)
++++
T Consensus 268 ~~~~ 271 (280)
T cd05043 268 QLVQ 271 (280)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=272.20 Aligned_cols=240 Identities=15% Similarity=0.222 Sum_probs=184.7
Q ss_pred eeeccccceeEEEEEEccCCc-------eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 8 EKIGEGTYGVVYKARNCVTNE-------TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~-------~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+.||+|+||.||++.+...+. .+++|.+.... ....+.+.+|..+++.++|||++++++.+..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 468999999999998755443 48888764322 223456788999999999999999999999989999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCc-------eEEecccccee
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA-------LKLADFGLARA 152 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~-------~kl~df~~~~~ 152 (323)
||+.+ +|.+.+.... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.. ++++|||.+..
T Consensus 79 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 79 EYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred ecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99976 5666655443 357888888999999999999999999999999999999877653 68999998754
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC-C
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR-P 231 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~-~ 231 (323)
..... ...+++.|+|||.+.+...++.++|+||||+++|+|++|. .
T Consensus 158 ~~~~~---------------------------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~ 204 (258)
T cd05078 158 VLPKE---------------------------------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDK 204 (258)
T ss_pred cCCch---------------------------------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 32110 0133777999999987566899999999999999999985 6
Q ss_pred CCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhh
Q 036739 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSAL 311 (323)
Q Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il 311 (323)
|+............... .......+..+.++|.+||+.||++||++.+++
T Consensus 205 ~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 254 (258)
T cd05078 205 PLSALDSQKKLQFYEDR------------------------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAII 254 (258)
T ss_pred ChhhccHHHHHHHHHcc------------------------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHH
Confidence 66555443332211100 011123457789999999999999999999998
Q ss_pred cC
Q 036739 312 EH 313 (323)
Q Consensus 312 ~h 313 (323)
+.
T Consensus 255 ~~ 256 (258)
T cd05078 255 RD 256 (258)
T ss_pred Hh
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=279.17 Aligned_cols=255 Identities=23% Similarity=0.361 Sum_probs=191.7
Q ss_pred CCcceeeeeccccceeEEEEEE-----ccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEec-Cc
Q 036739 2 DQYEKVEKIGEGTYGVVYKARN-----CVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS-EK 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~ 74 (323)
++|++.+.||+|+||.||+|.+ ..+++.||+|.+..... ......+.+|+.++..+ +|+||+++++++.. +.
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 5899999999999999999984 34567899998854322 22235677899999999 68999999998864 45
Q ss_pred eEEEEEecchh-hHHHhhhcCCC---------------------------------------------------------
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPD--------------------------------------------------------- 96 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~--------------------------------------------------------- 96 (323)
..++++||+.+ +|.+.+.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 78999999975 77766653211
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCc
Q 036739 97 --------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGST 168 (323)
Q Consensus 97 --------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~ 168 (323)
..++...+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~------ 238 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVRK------ 238 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc-EEEEecccccccccCcchhhc------
Confidence 12456677889999999999999999999999999999998877 999999998764322111000
Q ss_pred CcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 036739 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKIFR 247 (323)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~~~ 247 (323)
....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||..............
T Consensus 239 ---------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 296 (343)
T cd05103 239 ---------------------GDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 296 (343)
T ss_pred ---------------------CCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh
Confidence 01123567999999877 568999999999999999997 9999977554333322221
Q ss_pred HhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 248 VLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
..... ......++.+.+++.+||+.||++||++.++++|
T Consensus 297 ~~~~~---------------------------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 297 EGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCCC---------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 10000 0012256788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=268.10 Aligned_cols=241 Identities=18% Similarity=0.245 Sum_probs=183.2
Q ss_pred eeeccccceeEEEEEEcc------------CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCce
Q 036739 8 EKIGEGTYGVVYKARNCV------------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~------------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (323)
+.||+|++|.||+++... .+..+++|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999998432 2235888876433 22334577788999999999999999999999999
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC------ceEEecccc
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN------ALKLADFGL 149 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~------~~kl~df~~ 149 (323)
.+++|||++++.++.+.......+++..+..++.||+.||+|||+.+++|+||||+||+++.++. .++++|||.
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999875555555444445788889999999999999999999999999999999976553 289999998
Q ss_pred ceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH-h
Q 036739 150 ARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV-N 228 (323)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~-t 228 (323)
+........ ..++..|+|||.+.....++.++||||||+++|+|+ +
T Consensus 159 ~~~~~~~~~---------------------------------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 159 PITVLSRQE---------------------------------CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CccccCccc---------------------------------ccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 755421110 133677999999875577899999999999999998 5
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|..||......+.. ..... .. ......++.+.++|.+||+.||++||++.
T Consensus 206 ~~~p~~~~~~~~~~-~~~~~---~~--------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~ 255 (262)
T cd05077 206 GEIPLKDKTLAEKE-RFYEG---QC--------------------------MLVTPSCKELADLMTHCMNYDPNQRPFFR 255 (262)
T ss_pred CCCCCCCcchhHHH-HHHhc---Cc--------------------------cCCCCChHHHHHHHHHHcCCChhhCcCHH
Confidence 88888765433221 11110 00 00112456789999999999999999999
Q ss_pred hhhcC
Q 036739 309 SALEH 313 (323)
Q Consensus 309 ~il~h 313 (323)
+|+++
T Consensus 256 ~il~~ 260 (262)
T cd05077 256 AIMRD 260 (262)
T ss_pred HHHHh
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=276.34 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=195.6
Q ss_pred CCcceeeeeccccceeEEEEEEccC-------CceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecC
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT-------NETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 73 (323)
.+|++.+.||+|+||.||+|++... +..+++|.+... ........+.+|+.+++++ +||||+++++.+..+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3689999999999999999986432 236899977533 2222346788899999999 799999999999999
Q ss_pred ceEEEEEecchh-hHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC
Q 036739 74 KKLYLVFEYLDL-DLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138 (323)
Q Consensus 74 ~~~~lv~e~~~g-~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~ 138 (323)
+..++++||+.+ +|.+.+.+.. ...++...+..++.|++.||.|||++|++|+||+|+||+++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 999999999965 7777776432 2235667788899999999999999999999999999999988
Q ss_pred CCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 139 TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 139 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
+. +||+|||.+............. ...++..|+|||.+.+ ..++.++|+||
T Consensus 171 ~~-~kL~Dfg~~~~~~~~~~~~~~~---------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~s 221 (334)
T cd05100 171 NV-MKIADFGLARDVHNIDYYKKTT---------------------------NGRLPVKWMAPEALFD-RVYTHQSDVWS 221 (334)
T ss_pred Cc-EEECCcccceeccccccccccc---------------------------CCCcCceEcCHHHhcc-CCcCchhhhHH
Confidence 87 9999999987653221110000 0122456999999977 56889999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 219 VGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 219 lG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
||+++|+|++ |..||......+....+..... .......+..+.+++.+||
T Consensus 222 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl 273 (334)
T cd05100 222 FGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR----------------------------MDKPANCTHELYMIMRECW 273 (334)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHc
Confidence 9999999998 8899987765554433322100 0111246778999999999
Q ss_pred ccCCCCCCCHhhhhcC
Q 036739 298 CMDPSRRITARSALEH 313 (323)
Q Consensus 298 ~~dp~~R~s~~~il~h 313 (323)
+.+|++||++.+++++
T Consensus 274 ~~~p~~Rps~~ell~~ 289 (334)
T cd05100 274 HAVPSQRPTFKQLVED 289 (334)
T ss_pred ccChhhCcCHHHHHHH
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=297.68 Aligned_cols=149 Identities=28% Similarity=0.479 Sum_probs=130.1
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++++.||.|+||+||++.+..+++.||+|++..... .......+..|+.+++.++|+||+++++.+.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 5799999999999999999999988999999999865432 222336778899999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
|||+.| +|.+.+.... .+++..++.++.||+.||.|||.++|+|+||||+|||++.++. ++|+|||++..
T Consensus 83 mEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~-vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH-IKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC-EEEEeCCCCcc
Confidence 999965 7777765433 4678889999999999999999999999999999999998887 99999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=270.19 Aligned_cols=240 Identities=18% Similarity=0.228 Sum_probs=181.3
Q ss_pred eeccccceeEEEEEEccC------------------------CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCee
Q 036739 9 KIGEGTYGVVYKARNCVT------------------------NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64 (323)
Q Consensus 9 ~lg~g~~~~v~~~~~~~~------------------------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 64 (323)
.||+|+||.||++....+ ...+++|.+.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 689999999999874221 2358888774332 22235677889999999999999
Q ss_pred eeeEEEecCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC----
Q 036739 65 RLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---- 140 (323)
Q Consensus 65 ~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~---- 140 (323)
++++++.+....++||||++++.++.+.......+++..+..++.||+.||.|||+++++|+||||+||+++..+.
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 9999999999999999999875544444433345788889999999999999999999999999999999976432
Q ss_pred --ceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 141 --ALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 141 --~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
.++++|||.+........ ..++..|+|||.+.+...++.++|+||
T Consensus 160 ~~~~kl~d~g~~~~~~~~~~---------------------------------~~~~~~~~aPe~~~~~~~~~~~~Dv~s 206 (274)
T cd05076 160 SPFIKLSDPGVSFTALSREE---------------------------------RVERIPWIAPECVPGGNSLSTAADKWS 206 (274)
T ss_pred cceeeecCCccccccccccc---------------------------------cccCCcccCchhhcCCCCCCcHHHHHH
Confidence 379999998754321100 123667999999876566899999999
Q ss_pred HHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 219 VGCIFAEMV-NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 219 lG~ll~~l~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
||+++|+++ +|..||......+.... .... . ......++.+.++|.+||
T Consensus 207 lG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~-~----------------------------~~~~~~~~~~~~li~~cl 256 (274)
T cd05076 207 FGTTLLEICFDGEVPLKERTPSEKERF-YEKK-H----------------------------RLPEPSCKELATLISQCL 256 (274)
T ss_pred HHHHHHHHHhCCCCCccccChHHHHHH-HHhc-c----------------------------CCCCCCChHHHHHHHHHc
Confidence 999999985 68999977654333221 1100 0 001124567889999999
Q ss_pred ccCCCCCCCHhhhhcC
Q 036739 298 CMDPSRRITARSALEH 313 (323)
Q Consensus 298 ~~dp~~R~s~~~il~h 313 (323)
+.+|++||++.+++++
T Consensus 257 ~~~p~~Rps~~~il~~ 272 (274)
T cd05076 257 TYEPTQRPSFRTILRD 272 (274)
T ss_pred ccChhhCcCHHHHHHh
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=266.34 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=184.9
Q ss_pred eeeccccceeEEEEEEcc---CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEe-cCceEEEEEecc
Q 036739 8 EKIGEGTYGVVYKARNCV---TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-SEKKLYLVFEYL 83 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~ 83 (323)
+.||+|++|.||++.+.. .+..+|+|.+... ........+.+|+.+++.++|||++++++.+. .++..++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 468999999999998643 2357999986422 12222457778999999999999999999775 466789999999
Q ss_pred hh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 84 DL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 84 ~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
.+ ++.+.+..... ..+...+..++.||+.||.|||+.+++|+||+|+||+++.++. +||+|||++............
T Consensus 80 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~-~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT-VKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc-EEECCccccccccCCcceeec
Confidence 75 77777655433 3566677889999999999999999999999999999998887 999999998754322111000
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDE 241 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~ 241 (323)
.. ....++..|+|||.+.. ..++.++|+||||+++|+|++ |.+||...+..+.
T Consensus 158 ~~-------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~ 211 (262)
T cd05058 158 NH-------------------------TGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI 211 (262)
T ss_pred cc-------------------------ccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 00 01123667999999877 568899999999999999999 5677776655444
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+.+.. .......+++.+.+++.+||+.+|++||++.++++
T Consensus 212 ~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 212 TVYLLQGR----------------------------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHhcCC----------------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 43332210 00011235788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=266.76 Aligned_cols=252 Identities=26% Similarity=0.462 Sum_probs=197.6
Q ss_pred CcceeeeeccccceeEEEEEEcc-CCceEEEEEEEeccc--------CCCCchhHHHHHHHHHh-cCCCCeeeeeEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCV-TNETIALKKIRLEQE--------DEGVPSTAIREISLLKE-MQHGNIVRLQDVVHS 72 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~--------~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~ 72 (323)
.|++.+.||+|++|.||++.+.. .+..+++|.+..... .......+.+|+.+++. ++|+|++++++.+.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999877 678999998864421 11223446678887765 789999999999999
Q ss_pred CceEEEEEecchh-hHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccc
Q 036739 73 EKKLYLVFEYLDL-DLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFG 148 (323)
Q Consensus 73 ~~~~~lv~e~~~g-~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~ 148 (323)
++..++++||+.| ++.+.+.. .....+++..+..++.|++.+|.+||+ .+++|+||+|.||+++.++. ++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~-~~l~dfg 159 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK-VTITDFG 159 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc-EEEeccc
Confidence 9999999999976 66666533 223457888899999999999999996 68999999999999998887 9999999
Q ss_pred cceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh
Q 036739 149 LARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t 228 (323)
.+......... ....++..|++||.+.+ ..++.++|+||||+++|+|++
T Consensus 160 ~~~~~~~~~~~------------------------------~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~ 208 (269)
T cd08528 160 LAKQKQPESKL------------------------------TSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCT 208 (269)
T ss_pred ceeeccccccc------------------------------ccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHh
Confidence 98765432210 01234778999999987 557999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|..||...........+......+ .....+++.+.++|.+||+.||++||++.
T Consensus 209 g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ 261 (269)
T cd08528 209 LQPPFYSTNMLSLATKIVEAVYEP---------------------------LPEGMYSEDVTDVITSCLTPDAEARPDII 261 (269)
T ss_pred CCCcccccCHHHHHHHHhhccCCc---------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHH
Confidence 999998776554444433211110 00123678899999999999999999999
Q ss_pred hhhcC
Q 036739 309 SALEH 313 (323)
Q Consensus 309 ~il~h 313 (323)
++..+
T Consensus 262 e~~~~ 266 (269)
T cd08528 262 QVSAM 266 (269)
T ss_pred HHHHH
Confidence 98763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=270.30 Aligned_cols=267 Identities=23% Similarity=0.372 Sum_probs=192.5
Q ss_pred CcceeeeeccccceeEEEEEE----ccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC--ceE
Q 036739 3 QYEKVEKIGEGTYGVVYKARN----CVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KKL 76 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 76 (323)
-|++++.||+|++|.||++.. ..++..+++|.+.... .......+.+|+.+++.+.|||++++++++.+. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 468999999999999999973 4567899999875432 233346788999999999999999999998764 678
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
++||||+.| +|.+.+.+.. ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~-~~l~dfg~~~~~~~ 161 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIET 161 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC-EEECCCcccccccc
Confidence 999999975 6766665443 35688889999999999999999999999999999999998887 99999999876543
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
........ ....++..|+|||.+.+ ..++.++|+||||+++|+|+++..|...
T Consensus 162 ~~~~~~~~--------------------------~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~ 214 (284)
T cd05079 162 DKEYYTVK--------------------------DDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESS 214 (284)
T ss_pred Cccceeec--------------------------CCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCcc
Confidence 22211000 01123667999999877 5688999999999999999998766433
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.... ..... +. ......... ...... .....+....+++.+.+|+.+||+.+|.+||++.++++
T Consensus 215 ~~~~--~~~~~---~~-~~~~~~~~~----~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 215 PMTL--FLKMI---GP-THGQMTVTR----LVRVLE---EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred ccch--hhhhc---cc-ccccccHHH----HHHHHH---cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 2110 00000 00 000000000 000000 00011123457889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=267.69 Aligned_cols=244 Identities=25% Similarity=0.335 Sum_probs=187.8
Q ss_pred eeeccccceeEEEEEEccCCc--eEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEEecch
Q 036739 8 EKIGEGTYGVVYKARNCVTNE--TIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVFEYLD 84 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (323)
+.||+|++|.||++.++.++. .+++|.+... ........+.+|+.++..+ +||||+++++++...+..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999999877765 4677776422 2223345778899999999 79999999999999999999999996
Q ss_pred -hhHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccc
Q 036739 85 -LDLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGL 149 (323)
Q Consensus 85 -g~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~ 149 (323)
|+|.+.+.... ...++...+..++.|++.||.|||+.|++|+||||+||+++.++. +||+|||+
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~-~kl~dfgl 158 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGL 158 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe-EEECCCCC
Confidence 47877775432 124678888999999999999999999999999999999998887 99999998
Q ss_pred ceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-
Q 036739 150 ARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN- 228 (323)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t- 228 (323)
+.......... ....+..|+|||.+.. ..++.++|+||||+++|+|++
T Consensus 159 ~~~~~~~~~~~------------------------------~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~ 207 (270)
T cd05047 159 SRGQEVYVKKT------------------------------MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSL 207 (270)
T ss_pred ccccchhhhcc------------------------------CCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcC
Confidence 74321100000 0012456999999876 568999999999999999997
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|..||......+....+.... .......++..+.+++.+|++.+|.+||++.
T Consensus 208 g~~pf~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 259 (270)
T cd05047 208 GGTPYCGMTCAELYEKLPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFA 259 (270)
T ss_pred CCCCccccCHHHHHHHHhCCC----------------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHH
Confidence 999997765544443322100 0001123677899999999999999999999
Q ss_pred hhhc
Q 036739 309 SALE 312 (323)
Q Consensus 309 ~il~ 312 (323)
++++
T Consensus 260 ~il~ 263 (270)
T cd05047 260 QILV 263 (270)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=268.04 Aligned_cols=268 Identities=24% Similarity=0.385 Sum_probs=192.3
Q ss_pred CCcceeeeeccccceeEEEEE----EccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--Cce
Q 036739 2 DQYEKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 75 (323)
++|++.+.||+|++|+||++. +..++..|++|.+.... ......+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 578999999999999999997 44578899999875432 2223577889999999999999999998743 457
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
+++|+||+.+ +|.+.+..... .+++..+..++.|++.||.|||++|++|+||||+||+++.++. ++|+|||++....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~-~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe-EEECCCccccccc
Confidence 8999999965 77777755432 4688888999999999999999999999999999999998887 9999999987664
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
.......... ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..++.
T Consensus 160 ~~~~~~~~~~--------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 160 QDKEYYKVRE--------------------------PGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred CCCcceeecC--------------------------CCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 3222111000 0012445999999877 568899999999999999999887765
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
..... ..+.. ....... ............ ....+....+++.+.++|.+||+.+|++|||+.++++
T Consensus 213 ~~~~~--~~~~~---~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 213 SPPAE--FMRMM---GNDKQGQ----MIVYHLIELLKN---NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred Ccchh--hhhhc---ccccccc----cchHHHHHHHhc---CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 43321 00000 0000000 000000000000 0011122457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=267.91 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=191.5
Q ss_pred eeeccccceeEEEEEEccCC------ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 8 EKIGEGTYGVVYKARNCVTN------ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+.||+|++|.||+++..... ..+++|.+.... .......+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 46899999999999875433 679999875432 22335678889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC----CceEEeccccce
Q 036739 82 YLDL-DLKKHMDSCP-----DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT----NALKLADFGLAR 151 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~----~~~kl~df~~~~ 151 (323)
|+.| ++.+++.... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ ..++++|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 9965 8877775432 23367788889999999999999999999999999999998866 149999999986
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CC
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QR 230 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~ 230 (323)
.......... .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |.
T Consensus 160 ~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~ 211 (269)
T cd05044 160 DIYKSDYYRK---------------------------EGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQ 211 (269)
T ss_pred cccccccccc---------------------------CcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCC
Confidence 5532211000 001123567999999877 568999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh
Q 036739 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310 (323)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i 310 (323)
.||......+....+.... .......+++.+.++|.+||+.+|.+||++.++
T Consensus 212 ~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 263 (269)
T cd05044 212 QPYPALNNQEVLQHVTAGG----------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRI 263 (269)
T ss_pred CCCcccCHHHHHHHHhcCC----------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHH
Confidence 9998766554443332100 001123467889999999999999999999998
Q ss_pred hc
Q 036739 311 LE 312 (323)
Q Consensus 311 l~ 312 (323)
++
T Consensus 264 ~~ 265 (269)
T cd05044 264 QE 265 (269)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=279.89 Aligned_cols=255 Identities=21% Similarity=0.303 Sum_probs=196.0
Q ss_pred CCcceeeeeccccceeEEEEEEc-----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 75 (323)
++|.+.+.||+|+||.||++++. ..+..||+|++.... .......+.+|+.++.++. ||||+++++++...+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 46788899999999999999853 345689999986432 2222346788999999997 9999999999999999
Q ss_pred EEEEEecchh-hHHHhhhcCCC----------------------------------------------------------
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPD---------------------------------------------------------- 96 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~---------------------------------------------------------- 96 (323)
.++|+||+.+ +|.+.+.....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999975 88777754321
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC
Q 036739 97 --------------------------------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138 (323)
Q Consensus 97 --------------------------------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~ 138 (323)
..++...+..++.||+.||.|||+.+++|+||||+||+++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCC
Confidence 124555677899999999999999999999999999999987
Q ss_pred CCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 139 TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 139 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
+. ++|+|||++........... .....+++.|+|||.+.. ..++.++|+||
T Consensus 276 ~~-~kL~DfGla~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dvws 326 (401)
T cd05107 276 KL-VKICDFGLARDIMRDSNYIS---------------------------KGSTFLPLKWMAPESIFN-NLYTTLSDVWS 326 (401)
T ss_pred CE-EEEEecCcceeccccccccc---------------------------CCCcCCCCceeChHHhcC-CCCCcHhHHHH
Confidence 76 99999999876432211000 011234678999999977 56789999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 219 VGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 219 lG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
||+++|+|++ |..||......+...........+ .....++..+.+++.+|+
T Consensus 327 lGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl 379 (401)
T cd05107 327 FGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM---------------------------AKPAHASDEIYEIMQKCW 379 (401)
T ss_pred HHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC---------------------------CCCCCCCHHHHHHHHHHc
Confidence 9999999998 889998766555444333211000 111246789999999999
Q ss_pred ccCCCCCCCHhhhhcC
Q 036739 298 CMDPSRRITARSALEH 313 (323)
Q Consensus 298 ~~dp~~R~s~~~il~h 313 (323)
..+|.+||++.+|++.
T Consensus 380 ~~~P~~RPs~~ell~~ 395 (401)
T cd05107 380 EEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCChhHCcCHHHHHHH
Confidence 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=294.39 Aligned_cols=251 Identities=26% Similarity=0.373 Sum_probs=207.8
Q ss_pred CcceeeeeccccceeEEEEEEcc-----CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCV-----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
+.+..+.||+|+||.||+++... ....||||.++.. .+.....+|++|++++..++|||||+++|.+..++.++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 45678899999999999998433 2347999988433 34445689999999999999999999999999999999
Q ss_pred EEEecch-hhHHHhhhcCCC--------CC----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEE
Q 036739 78 LVFEYLD-LDLKKHMDSCPD--------FA----NDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKL 144 (323)
Q Consensus 78 lv~e~~~-g~l~~~~~~~~~--------~~----~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl 144 (323)
+||||+. |+|-+++..+.. .. ++..+...|+.|||.|+.||-++.+||+||.+.|+|+.++-. |||
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~-VKI 644 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV-VKI 644 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE-EEe
Confidence 9999995 799888865441 22 677889999999999999999999999999999999998666 999
Q ss_pred eccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHH
Q 036739 145 ADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFA 224 (323)
Q Consensus 145 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~ 224 (323)
+|||+++..- ..+++.+...-.-.++|||||.+.- +.++.+|||||+|++||
T Consensus 645 sDfGLsRdiY---------------------------ssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLW 696 (774)
T KOG1026|consen 645 SDFGLSRDIY---------------------------SSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLW 696 (774)
T ss_pred cccccchhhh---------------------------hhhhhcccCCceeeeecCCHHHhhc-Ccccchhhhhhhhhhhh
Confidence 9999997542 1223333333344788999999988 77999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC
Q 036739 225 EMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303 (323)
Q Consensus 225 ~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~ 303 (323)
|+++ |..||.+..+.+.+..+.++-- -.-+...+..+.+|+..||+.+|++
T Consensus 697 EIFsyG~QPy~glSn~EVIe~i~~g~l----------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~ 748 (774)
T KOG1026|consen 697 EIFSYGKQPYYGLSNQEVIECIRAGQL----------------------------LSCPENCPTEVYSLMLECWNENPKR 748 (774)
T ss_pred hhhccccCcccccchHHHHHHHHcCCc----------------------------ccCCCCCCHHHHHHHHHHhhcCccc
Confidence 9998 8999999999988887765311 1223468899999999999999999
Q ss_pred CCCHhhhh
Q 036739 304 RITARSAL 311 (323)
Q Consensus 304 R~s~~~il 311 (323)
||+.+||-
T Consensus 749 RPsF~eI~ 756 (774)
T KOG1026|consen 749 RPSFKEIH 756 (774)
T ss_pred CCCHHHHH
Confidence 99999874
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=265.33 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=196.8
Q ss_pred CCcceeeeeccccceeEEEEEEccC-----CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT-----NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|++|.||+++.+.. ...+++|.+... ........+.+|++++++++|+|++++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 5799999999999999999996543 457888876432 1122346788999999999999999999999998999
Q ss_pred EEEEecchh-hHHHhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccc
Q 036739 77 YLVFEYLDL-DLKKHMDSCPD-------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~ 148 (323)
++|+||+.+ +|.+.+..... ..+++..+..++.|++.+|.|||+.+++|+||||+||+++.++. ++++|||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~-~~l~~~~ 162 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE-VKVSLLS 162 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc-EEEcccc
Confidence 999999975 77777765442 24788899999999999999999999999999999999999887 9999999
Q ss_pred cceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh
Q 036739 149 LARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t 228 (323)
.+.......... .....++..|+|||.+.+ ...+.++|+||||+++|+|++
T Consensus 163 ~~~~~~~~~~~~----------------------------~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~ 213 (275)
T cd05046 163 LSKDVYNSEYYK----------------------------LRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFT 213 (275)
T ss_pred cccccCcccccc----------------------------cCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHh
Confidence 876432111000 001133667999999876 457889999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH
Q 036739 229 -QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 229 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
|..||.................. + .....+++.+.+++.+||+.+|++||++
T Consensus 214 ~~~~p~~~~~~~~~~~~~~~~~~~-----~----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~ 266 (275)
T cd05046 214 QGELPFYGLSDEEVLNRLQAGKLE-----L----------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSF 266 (275)
T ss_pred CCCCCccccchHHHHHHHHcCCcC-----C----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence 78899766554444333211000 0 0112477889999999999999999999
Q ss_pred hhhhcC
Q 036739 308 RSALEH 313 (323)
Q Consensus 308 ~~il~h 313 (323)
.++++.
T Consensus 267 ~~~l~~ 272 (275)
T cd05046 267 SELVSA 272 (275)
T ss_pred HHHHHH
Confidence 999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=283.39 Aligned_cols=289 Identities=28% Similarity=0.441 Sum_probs=221.6
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
|..++.||-|+||.|.+++...+...||+|.+.+.. ...+.....+.|-.+|..-.++=||+++..|+++..+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 667899999999999999998899999999886553 3445567778899999999999999999999999999999999
Q ss_pred ch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 LD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+. |++...+++.. -+++..++.++..+..|+++.|+.|++||||||+||||+.+|. +||+|||+|.-+.......-
T Consensus 711 IPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH-IKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc-eeeeeccccccceecccccc
Confidence 95 58888888765 4688999999999999999999999999999999999999999 99999999987765444321
Q ss_pred ccc-----cCC-cC------cceeehhhhhhhccC-ccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh
Q 036739 162 HEH-----WGS-TG------ISIYFSFLRYRVLAG-SLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 162 ~~~-----~~~-~~------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t 228 (323)
... .++ .. .+.-..-++.+.... ..+..-..+||+.|+|||++.. .-+....|.||.|+|||||+.
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHhh
Confidence 110 000 00 000011111111111 1122344589999999999987 457889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC---
Q 036739 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI--- 305 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~--- 305 (323)
|++||....+.++..++.. |-..-.-....++|+++.+||+++++ +++.|+
T Consensus 867 g~~pf~~~tp~~tq~kv~n-------------------------w~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkn 920 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVIN-------------------------WRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKN 920 (1034)
T ss_pred CCCCccCCCCCcceeeeee-------------------------hhhccccccccccCHHHHHHHHHHhc-Chhhhhccc
Confidence 9999988877665544432 11111112235689999999998774 556787
Q ss_pred CHhhhhcCCCCcccccc
Q 036739 306 TARSALEHEYFRDVEFV 322 (323)
Q Consensus 306 s~~~il~h~~~~~~~~~ 322 (323)
.+++|-.||||++|+|+
T Consensus 921 g~d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 921 GADQVKAHPFFKGIDFS 937 (1034)
T ss_pred chhhhhcCccccccchH
Confidence 45678899999999985
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=264.20 Aligned_cols=252 Identities=19% Similarity=0.294 Sum_probs=186.3
Q ss_pred eeeccccceeEEEEEEcc--CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCV--TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|+||.||++.... ....+++|.+... ........+.+|+..++.++|+||+++++.+.+....++||||+.+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 468999999999996432 3346777765432 2222335677899999999999999999999999999999999975
Q ss_pred -hHHHhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 86 -DLKKHMDSCPD---FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 86 -~l~~~~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+|.+.+..... ...++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||.+..........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~-~kl~dfg~~~~~~~~~~~~- 157 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS-VKIGDYGLALEQYPEDYYI- 157 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc-EEEeccccccccccchhee-
Confidence 77777765432 22356778899999999999999999999999999999999887 9999999875432111000
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC------CCCCCCchhhHHHHHHHHHHHh-CCCCCC
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG------SRHYSTPVDVWSVGCIFAEMVN-QRPLFP 234 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~ll~~l~t-g~~p~~ 234 (323)
......+++.|+|||++.. ...++.++|+|||||++|+|++ |..||.
T Consensus 158 --------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (269)
T cd05042 158 --------------------------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211 (269)
T ss_pred --------------------------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCC
Confidence 0011133667999999753 2356889999999999999999 788998
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.....+.............. .+.....+++.+.+++..|+ .||++||++++|++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 212 DLSDEQVLKQVVREQDIKLP-----------------------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred cCCHHHHHHHHhhccCccCC-----------------------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 77766555444332111000 01122347788889999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=299.78 Aligned_cols=275 Identities=28% Similarity=0.442 Sum_probs=203.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec---------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--------- 72 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 72 (323)
++|+.+..||+||||.||+|+++-+|..||||++.... .......+.+|+..+.+++||||++++..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 57889999999999999999999999999999998776 55556788899999999999999998776500
Q ss_pred ---------------------------------------------------------------------C----------
Q 036739 73 ---------------------------------------------------------------------E---------- 73 (323)
Q Consensus 73 ---------------------------------------------------------------------~---------- 73 (323)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------ceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 036739 74 -------------------------------KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122 (323)
Q Consensus 74 -------------------------------~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 122 (323)
..+||=||||+-++++.+.......-....+++++++|++||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 1268889999998888888776653346678899999999999999999
Q ss_pred cccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccch
Q 036739 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPE 202 (323)
Q Consensus 123 i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE 202 (323)
++||||||.||+++.++. |||+|||++................. -+..++.....+..+||-.|+|||
T Consensus 718 iIHRDLKP~NIFLd~~~~-VKIGDFGLAt~~~~~~~~~d~~~~~~-----------~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNS-VKIGDFGLATDLKENLESIDQDLSFS-----------TNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred eeeccCCcceeEEcCCCC-eeecccccchhhhhhhhhHhhccCcc-----------ccccCCCCcccccccceeeeecHH
Confidence 999999999999999888 99999999987432111000000000 001111222345678999999999
Q ss_pred hhhCCC--CCCCchhhHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCccc
Q 036739 203 ILLGSR--HYSTPVDVWSVGCIFAEMVNQRPLFPGD-SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELG 279 (323)
Q Consensus 203 ~~~~~~--~~~~~~Di~slG~ll~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (323)
.+.+.. .|+.|.|+||||+++|||+. ||... .+...+..+ .....+ .. ++
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~L----R~g~iP---~~---~~-------------- 838 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNL----RKGSIP---EP---AD-------------- 838 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhc----ccCCCC---CC---cc--------------
Confidence 998755 69999999999999999995 35432 222222222 211111 00 00
Q ss_pred ccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 280 TVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 280 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
...+--+.-.++|++|++.||++||||.++|++.||-
T Consensus 839 -f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 839 -FFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred -cccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 0111223456999999999999999999999999986
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=271.66 Aligned_cols=258 Identities=25% Similarity=0.409 Sum_probs=215.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 79 (323)
-+|..+..||.|+||.|-++..+++.+.||||++++.. ...+..+--..|-++|..-. -|.+++++.+|++-.++|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46889999999999999999999999999999997774 23334445556777777664 67889999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| +|..++.+-.. +-+..+..++..|+-+|-+||++||++||||.+||+++.+|. +||.|||.+..--.+..
T Consensus 429 MEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH-iKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc-eEeeecccccccccCCc
Confidence 999965 88888877654 455667789999999999999999999999999999999999 99999999875322211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
+ ..+-+||+.|+|||.+.- ++|+.+.|.||+|++||||+.|++||.+.+.
T Consensus 506 T-----------------------------TkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 506 T-----------------------------TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred c-----------------------------eeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 1 122378999999999987 7899999999999999999999999999998
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH-----hhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA-----RSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~-----~~il~h 313 (323)
.+....+.... -..++++|.++.+++..+|.+.|.+|+.. .+|-.|
T Consensus 556 ~elF~aI~ehn-----------------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H 606 (683)
T KOG0696|consen 556 DELFQAIMEHN-----------------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREH 606 (683)
T ss_pred HHHHHHHHHcc-----------------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhC
Confidence 88887776431 12346789999999999999999999843 477789
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||+.++|
T Consensus 607 ~FFR~iDW 614 (683)
T KOG0696|consen 607 PFFRRIDW 614 (683)
T ss_pred cchhhccH
Confidence 99999987
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=262.07 Aligned_cols=228 Identities=22% Similarity=0.310 Sum_probs=180.8
Q ss_pred ccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-hHHHhh
Q 036739 13 GTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHM 91 (323)
Q Consensus 13 g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g-~l~~~~ 91 (323)
|.++.||++.++.+++.||+|.+.... ...++...+....|||++++++++.+....+++|||+.| +|.+.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 889999999999999999999986542 223445555556799999999999999999999999975 777777
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcc
Q 036739 92 DSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171 (323)
Q Consensus 92 ~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~ 171 (323)
.+.. .+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++++|||.+.........
T Consensus 77 ~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~l~df~~~~~~~~~~~~------------ 141 (237)
T cd05576 77 SKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH-IQLTYFSRWSEVEDSCDG------------ 141 (237)
T ss_pred HHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC-EEEecccchhcccccccc------------
Confidence 6543 4688889999999999999999999999999999999999888 999999977554321111
Q ss_pred eeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 036739 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGT 251 (323)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 251 (323)
..++..|+|||.+.. ..++.++|+||+|+++|+|++|..|+...... . .
T Consensus 142 --------------------~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~----~---- 190 (237)
T cd05576 142 --------------------EAVENMYCAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG--I----N---- 190 (237)
T ss_pred --------------------CCcCccccCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh--c----c----
Confidence 122566999998866 55788999999999999999999876432110 0 0
Q ss_pred CCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH-----hhhhcCCCC
Q 036739 252 PNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA-----RSALEHEYF 316 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~-----~~il~h~~~ 316 (323)
. .........+++.+.++|.+||+.||++|+++ .++++||||
T Consensus 191 ---~--------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 191 ---T--------------------HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ---c--------------------ccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0 00001123478889999999999999999986 899999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=269.63 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=191.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc----eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE----TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|+..+.||+|++|.||++.+..++. .+++|.+... ........+.+|+.+++.++||||+++++.+... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 578999999999999999999877776 4677776432 1222234677899999999999999999998654 467
Q ss_pred EEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+++|++. |++.+.+.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++. +||+|||.+......
T Consensus 85 ~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~-~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGD 162 (303)
T ss_pred eeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc-eEEccccccccccCc
Confidence 8999996 57777766543 24678888999999999999999999999999999999988777 999999999765432
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
...... ....++..|++||.+.+ ..++.++|+||||+++|+|++ |..||.+
T Consensus 163 ~~~~~~---------------------------~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 163 EKEYNA---------------------------DGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred cccccc---------------------------CCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 211110 01123667999999876 668999999999999999997 8999977
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
....+... ..+..... ......+..+.+++.+|+..+|++||++.++++
T Consensus 215 ~~~~~~~~-~~~~~~~~---------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 215 IPTREIPD-LLEKGERL---------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred CCHHHHHH-HHHCCCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 65433322 22210000 001235678899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=266.69 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=195.4
Q ss_pred CCcceeeeeccccceeEEEEEEc----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--Cce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 75 (323)
++|++.+.||+|++|.||+++.. .++..+|+|.+...... .....+.+|+..++.+.|+||+++++++.. +..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 47889999999999999999854 34789999998644332 235688899999999999999999999877 568
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
.++++||+.+ ++.+.+..... .++...+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL-VKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC-EEEcccccccccc
Confidence 9999999965 77777765443 4788889999999999999999999999999999999998877 9999999988765
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
........... ..++..|++||.+.. ..++.++|+||||+++++|++|..|+.
T Consensus 161 ~~~~~~~~~~~--------------------------~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 161 EDKDYYYVKEP--------------------------GESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred cCCcceeccCC--------------------------CCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcc
Confidence 33221111000 112456999999877 568899999999999999999999886
Q ss_pred CCChHHH-----------HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC
Q 036739 235 GDSEIDE-----------LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303 (323)
Q Consensus 235 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~ 303 (323)
....... ........... ...+....++..+.+++.+||+.+|++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~ 269 (284)
T cd05038 214 SPPAEFLRMIGIAQGQMIVTRLLELLKEG------------------------ERLPRPPSCPDEVYDLMKLCWEAEPQD 269 (284)
T ss_pred cccchhccccccccccccHHHHHHHHHcC------------------------CcCCCCccCCHHHHHHHHHHhccChhh
Confidence 5432110 01111000000 000111235678999999999999999
Q ss_pred CCCHhhhhc
Q 036739 304 RITARSALE 312 (323)
Q Consensus 304 R~s~~~il~ 312 (323)
||++.++++
T Consensus 270 Rpt~~ei~~ 278 (284)
T cd05038 270 RPSFADLIL 278 (284)
T ss_pred CCCHHHHHH
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=262.83 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=186.0
Q ss_pred eeeccccceeEEEEEEcc--CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCV--TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|+||.||++.... ++..+++|.+..... ......+.+|+.++++++||||+++++++.+....++||||+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 468999999999998543 446799998754422 22234677899999999999999999999998999999999975
Q ss_pred -hHHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 86 -DLKKHMDSCP---DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 86 -~l~~~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+|.+.+.... ....+...+..++.|++.||+|||+.+++|+||||+||+++.++. ++|+|||.+..........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~-~kL~dfg~~~~~~~~~~~~- 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT-VKIGDYGLSHNKYKEDYYV- 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc-EEECCccccccccCcceee-
Confidence 7777775432 224466778889999999999999999999999999999998877 9999999885432111100
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC------CCCCCchhhHHHHHHHHHHHh-CCCCCC
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS------RHYSTPVDVWSVGCIFAEMVN-QRPLFP 234 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------~~~~~~~Di~slG~ll~~l~t-g~~p~~ 234 (323)
......+++.|+|||++... ..++.++|+||||+++|+|++ |..||.
T Consensus 158 --------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 211 (269)
T cd05087 158 --------------------------TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR 211 (269)
T ss_pred --------------------------cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 00012346779999998642 135789999999999999996 999998
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.....+............ ...+......++.+.+++..|+ .+|++||++.+|+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 212 HLSDEQVLTYTVREQQLK-----------------------LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCChHHHHHHHhhcccCC-----------------------CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 766554433322110000 0011112236778899999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=278.94 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=203.9
Q ss_pred CcceeeeeccccceeEEEEEEccCCc---e-EEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNE---T-IALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~---~-~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
+..+.+.||+|+||.||+++-+..+. . ||+|...... .......++.+|++++++++||||++++|+...+..++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 45667999999999999998665432 3 8999876532 44556678889999999999999999999999999999
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+|||+|.| +|.+++....+ .++..+...++.+.+.||+|||+++++||||...|+|++.++. +||+|||++..-..-
T Consensus 238 ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~-vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV-VKISDFGLSRAGSQY 315 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe-EEeCccccccCCcce
Confidence 99999975 88888887665 5778888899999999999999999999999999999998776 899999997654311
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
..... .......|+|||.+.. ..++.++||||+|+++||+++ |..||.+
T Consensus 316 ~~~~~-----------------------------~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g 365 (474)
T KOG0194|consen 316 VMKKF-----------------------------LKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPG 365 (474)
T ss_pred eeccc-----------------------------cccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCC
Confidence 11110 0112467999999988 589999999999999999999 8899999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
....+...++.........+ ...+..+..++.+|+..+|++||++.++.+
T Consensus 366 ~~~~~v~~kI~~~~~r~~~~---------------------------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 366 MKNYEVKAKIVKNGYRMPIP---------------------------SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCHHHHHHHHHhcCccCCCC---------------------------CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 99988888874422211111 235677889999999999999999998875
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=307.66 Aligned_cols=261 Identities=29% Similarity=0.451 Sum_probs=215.3
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+++....||.|-||.||-|.+..+|+-.|+|.+..+...........+|+.++..+.|||+++.+|+=.+....+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 45667889999999999999999999999999988877777778889999999999999999999999999999999999
Q ss_pred chhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 83 LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 83 ~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
|+|+.+..+..... ..++...+.+-.|++.|+.|||+.||||+||||.||+++.+|. +|++|||.+........+...
T Consensus 1316 C~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~-iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL-IKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred hccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc-EEeecccceeEecCchhcCCH
Confidence 98755555544432 3466677788999999999999999999999999999999996 999999999877554322221
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCC--CCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH--YSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
+.. ...||+.|||||++.+... -..+.|||||||++.||+||+.||...+...
T Consensus 1394 el~-------------------------~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~ 1448 (1509)
T KOG4645|consen 1394 ELQ-------------------------SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW 1448 (1509)
T ss_pred HHH-------------------------hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh
Confidence 111 2367999999999987432 3568999999999999999999999887776
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
.+--.+.... .++.+..+|+...+||..||..||+.|+++.++++|-|=+
T Consensus 1449 aIMy~V~~gh---------------------------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1449 AIMYHVAAGH---------------------------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred HHHhHHhccC---------------------------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 6543333322 2334455899999999999999999999999999998754
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=263.26 Aligned_cols=252 Identities=19% Similarity=0.290 Sum_probs=191.5
Q ss_pred cceeeeeccccceeEEEEEEcc---CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc------
Q 036739 4 YEKVEKIGEGTYGVVYKARNCV---TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK------ 74 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 74 (323)
|++.+.||+|++|.||+|.... ++..+|+|.+..........+.+.+|+.+++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788999999999999998543 5678999998655444434567888999999999999999999886432
Q ss_pred eEEEEEecchh-hHHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccc
Q 036739 75 KLYLVFEYLDL-DLKKHMDSC----PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGL 149 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~ 149 (323)
..++++||+.+ ++...+... ....++...+..++.||+.||.|||++|++|+||+|+||+++.++. ++|+|||+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~-~kl~dfg~ 159 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT-VCVADFGL 159 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC-EEECcccc
Confidence 34788999865 665554321 1234678888999999999999999999999999999999998877 99999998
Q ss_pred ceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-
Q 036739 150 ARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN- 228 (323)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t- 228 (323)
+............. ...+++.|++||.+.. ..++.++|+||||+++|+|++
T Consensus 160 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~ 211 (273)
T cd05074 160 SKKIYSGDYYRQGC---------------------------ASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTR 211 (273)
T ss_pred cccccCCcceecCC---------------------------CccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhC
Confidence 87653221110000 0122566999999877 567889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|..||......+....+.... .. ......++.+.+++.+||+.+|++||++.
T Consensus 212 g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~ 263 (273)
T cd05074 212 GQTPYAGVENSEIYNYLIKGN-RL---------------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQ 263 (273)
T ss_pred CCCCCCCCCHHHHHHHHHcCC-cC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 889998776544443332210 00 00123678899999999999999999999
Q ss_pred hhhc
Q 036739 309 SALE 312 (323)
Q Consensus 309 ~il~ 312 (323)
++++
T Consensus 264 ~~~~ 267 (273)
T cd05074 264 HLRD 267 (273)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=264.39 Aligned_cols=262 Identities=18% Similarity=0.249 Sum_probs=184.2
Q ss_pred CCcceeeeeccccceeEEEEEEccC---CceEEEEEEEecccCCCCc---------hhHHHHHHHHHhcCCCCeeeeeEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT---NETIALKKIRLEQEDEGVP---------STAIREISLLKEMQHGNIVRLQDV 69 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~---------~~~~~e~~~l~~l~~~~i~~~~~~ 69 (323)
++|++.+.||+|+||+||+|.+..+ +..+++|+........... .....+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4799999999999999999998776 6677777643322111000 111223344556689999999987
Q ss_pred EecCc----eEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEe
Q 036739 70 VHSEK----KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLA 145 (323)
Q Consensus 70 ~~~~~----~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~ 145 (323)
+.... ..+++++++..++.+.+.... ..++..+..++.|++.||.|||+.+++||||||+||+++.++. ++|+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~-~~l~ 168 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR-GYII 168 (294)
T ss_pred eeEecCCceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc-EEEE
Confidence 65432 457888888766666554432 2467778899999999999999999999999999999998877 9999
Q ss_pred ccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHH
Q 036739 146 DFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAE 225 (323)
Q Consensus 146 df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~ 225 (323)
|||++............... ......||+.|+|||.+.+ ..++.++|||||||++|+
T Consensus 169 DFGla~~~~~~~~~~~~~~~----------------------~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKE----------------------QKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLK 225 (294)
T ss_pred EcCCceeeccCCcccccccc----------------------cccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHH
Confidence 99999776432211110000 0011246999999999887 668999999999999999
Q ss_pred HHhCCCCCCCCChH-HHHHHHH-HHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC
Q 036739 226 MVNQRPLFPGDSEI-DELFKIF-RVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303 (323)
Q Consensus 226 l~tg~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~ 303 (323)
|++|..||...... +...... .......... ......++.+.+++..|+..+|++
T Consensus 226 l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~ 282 (294)
T PHA02882 226 WAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGK-----------------------IKIKNANKFIYDFIECVTKLSYEE 282 (294)
T ss_pred HHhCCCCCCccccchHHHHHhHHHHHHHhhhhh-----------------------hccCCCCHHHHHHHHHHHhCCCCC
Confidence 99999999877432 2221111 1100000000 011235678999999999999999
Q ss_pred CCCHhhhhc
Q 036739 304 RITARSALE 312 (323)
Q Consensus 304 R~s~~~il~ 312 (323)
||+..++++
T Consensus 283 rp~~~~l~~ 291 (294)
T PHA02882 283 KPDYDALIK 291 (294)
T ss_pred CCCHHHHHH
Confidence 999999875
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=260.97 Aligned_cols=237 Identities=19% Similarity=0.280 Sum_probs=182.4
Q ss_pred eeeccccceeEEEEEEccCC----------ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 8 EKIGEGTYGVVYKARNCVTN----------ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~----------~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
+.||+|++|.||++.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999987666 34777766433211 5788899999999999999999999988 7789
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC------ceEEeccccc
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN------ALKLADFGLA 150 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~------~~kl~df~~~ 150 (323)
+|+||+.+ ++.+.+..... .++...+..++.||+.||.|||+.|++|+||||+||+++.++. .++|+|||.+
T Consensus 77 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999976 66666555433 5788889999999999999999999999999999999998771 3999999998
Q ss_pred eecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-CCCCCchhhHHHHHHHHHHHh-
Q 036739 151 RAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-RHYSTPVDVWSVGCIFAEMVN- 228 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~ll~~l~t- 228 (323)
........ ..++..|+|||.+... ..++.++|+||||+++|+|++
T Consensus 156 ~~~~~~~~---------------------------------~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~ 202 (259)
T cd05037 156 ITVLSREE---------------------------------RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202 (259)
T ss_pred cccccccc---------------------------------cccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhC
Confidence 76532100 1235669999998874 468999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|..||......+....... . .. ........+.++|.+||..+|++||++.
T Consensus 203 ~~~p~~~~~~~~~~~~~~~----~--~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 252 (259)
T cd05037 203 GEEPLSTLSSSEKERFYQD----Q--HR------------------------LPMPDCAELANLINQCWTYDPTKRPSFR 252 (259)
T ss_pred CCCCcccCCchhHHHHHhc----C--CC------------------------CCCCCchHHHHHHHHHhccChhhCCCHH
Confidence 5777866643322221110 0 00 0001126788999999999999999999
Q ss_pred hhhc
Q 036739 309 SALE 312 (323)
Q Consensus 309 ~il~ 312 (323)
++++
T Consensus 253 ~il~ 256 (259)
T cd05037 253 AILR 256 (259)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=258.89 Aligned_cols=279 Identities=36% Similarity=0.576 Sum_probs=223.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 75 (323)
.+|.-++.+|.|+- .|.-|.+.-.+++|++|+...............+|+..+..+.|+|+++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 36777888899888 889999999999999998876655555567788999999999999999999999643 46
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
.|+|||++++++.+.+.. .++-+.+..++.|++.|+.+||+.||+||||||+||++..+.. +||.|||++...+.
T Consensus 96 ~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~-lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT-LKILDFGLARTEDT 170 (369)
T ss_pred HHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh-eeeccchhhcccCc
Confidence 899999999999888873 4566788999999999999999999999999999999998776 99999999976543
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
... +...++|..|.|||++.+-+ +....||||+||++.||++|...|.+
T Consensus 171 ~~~------------------------------mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 171 DFM------------------------------MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred ccc------------------------------cCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecC
Confidence 311 11125588899999999944 89999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCccc--------C-----CcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTS--------L-----PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~-----~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~ 302 (323)
.+..+...++.+.++.+.++....... . ..+...+............+.-+..+++++.+||-.||+
T Consensus 220 ~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe 299 (369)
T KOG0665|consen 220 KDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPE 299 (369)
T ss_pred chHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChh
Confidence 999999999988888877642221111 0 112222222222222222234456789999999999999
Q ss_pred CCCCHhhhhcCCCCc
Q 036739 303 RRITARSALEHEYFR 317 (323)
Q Consensus 303 ~R~s~~~il~h~~~~ 317 (323)
+|.|+.++|+|||++
T Consensus 300 ~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 300 KRISVDDALRHPYIK 314 (369)
T ss_pred hcccHHHHhcCCeee
Confidence 999999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=248.61 Aligned_cols=280 Identities=32% Similarity=0.572 Sum_probs=214.0
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEec--CceEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHS--EKKLY 77 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~ 77 (323)
+++|++++++|+|.++.||.+++..+++.++||+++... ...+.+|+.+++.+. +|||+++++...+ .....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 478999999999999999999999999999999986443 367889999999997 9999999999876 46789
Q ss_pred EEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 78 LVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 78 lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
+|||+++..-.+.+-. +++.-.++.++.+++.||.|+|+.||.|+|+||.|++++.....++|+|+|++....+..
T Consensus 112 LiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9999998744444333 356666889999999999999999999999999999999887789999999998887654
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC-CCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF-PGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~-~~~ 236 (323)
.-... +-+..|--||.+..-+.++..-|+|||||++..|+..+-|| .+.
T Consensus 188 eYnVR------------------------------VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 188 EYNVR------------------------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred eeeee------------------------------eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 43221 22556889999998888999999999999999999988765 567
Q ss_pred ChHHHHHHHHHHhCCCCCC------CCCCcccCCcccc--cCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 237 SEIDELFKIFRVLGTPNED------TWPGVTSLPDFKS--AFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
++.+.+.++.+.++..... .+.-.+...++.. ....|..--......-.++++.+|+.++|..|-.+|+|+.
T Consensus 238 dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTak 317 (338)
T KOG0668|consen 238 DNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAK 317 (338)
T ss_pred CCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchH
Confidence 7777777766665542110 0000001011000 0111111111111123578999999999999999999999
Q ss_pred hhhcCCCCccc
Q 036739 309 SALEHEYFRDV 319 (323)
Q Consensus 309 ~il~h~~~~~~ 319 (323)
|.+.||||..+
T Consensus 318 Eam~HpyF~~~ 328 (338)
T KOG0668|consen 318 EAMAHPYFAPV 328 (338)
T ss_pred HHhcCchHHHH
Confidence 99999999754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=289.30 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=203.6
Q ss_pred CcceeeeeccccceeEEEEEEccCCc-----eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNE-----TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
+.+..+.||+|+||.||.++-..... .||+|.+... .+.....+|.+|..+++.+.||||++++|.+.+....+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34678899999999999998544333 4899988544 34445688999999999999999999999999999999
Q ss_pred EEEecchh-hHHHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccce
Q 036739 78 LVFEYLDL-DLKKHMDSCP-----DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~ 151 (323)
|++||++| +|++++.+.+ ...++......++.|||+|++||++++++||||...|+|++.... +||+|||+++
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~-VKIaDFGlAr 850 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV-VKIADFGLAR 850 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc-EEEcccchhH
Confidence 99999965 9999987652 234577788899999999999999999999999999999999855 9999999998
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeecc-ccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-C
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLK-VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-Q 229 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g 229 (323)
.+-.. +++..... .--..|||||.+.. ..++.|+||||||+++||++| |
T Consensus 851 Diy~~----------------------------~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG 901 (1025)
T KOG1095|consen 851 DIYDK----------------------------DYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLG 901 (1025)
T ss_pred hhhhc----------------------------hheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCC
Confidence 43211 00111111 11357999999998 779999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
..||.+..+.+......... .. ..+..+++.+.+++.+||+.+|++||+...
T Consensus 902 ~~PY~~~~n~~v~~~~~~gg-RL---------------------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~ 953 (1025)
T KOG1095|consen 902 ATPYPSRSNFEVLLDVLEGG-RL---------------------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRT 953 (1025)
T ss_pred CCCCCCcchHHHHHHHHhCC-cc---------------------------CCCCCCChHHHHHHHHHccCChhhCccHHH
Confidence 99999999888877555432 11 122458889999999999999999999999
Q ss_pred hhc
Q 036739 310 ALE 312 (323)
Q Consensus 310 il~ 312 (323)
|++
T Consensus 954 i~~ 956 (1025)
T KOG1095|consen 954 IVE 956 (1025)
T ss_pred HHh
Confidence 986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=256.14 Aligned_cols=252 Identities=20% Similarity=0.273 Sum_probs=184.2
Q ss_pred eeeccccceeEEEEEEccCC--ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTN--ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|+||.||++.....+ ..+++|.+.... .......+.+|+..++.++||||+++++.+.+....++||||+.+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 36999999999999753332 345666654332 222346788899999999999999999999999999999999975
Q ss_pred -hHHHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 86 -DLKKHMDSCPD--FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 86 -~l~~~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
+|.+++..... ...+...+..++.||+.||.|||+.+++|+||||+||+++.++. ++|+|||.+..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~-~~l~Dfg~~~~~~~~~~~~-- 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT-VKVGDYGIGPSRYKEDYIE-- 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc-EEecccccccccCcchhhh--
Confidence 77777765322 23456677889999999999999999999999999999998887 9999999875321110000
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC------CCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS------RHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
......++..|+|||++... ..++.++|+||||+++|+|++ |..||..
T Consensus 157 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 157 -------------------------TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred -------------------------cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 00112447789999987531 235778999999999999997 5678877
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
....+.+..+....... ...+.....+++.+.+++..|+ .+|.+||++.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 212 LSDREVLNHVIKDQQVK-----------------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCHHHHHHHHHhhcccc-----------------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 76655555443211000 0011122346788999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=255.90 Aligned_cols=260 Identities=26% Similarity=0.409 Sum_probs=214.3
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 78 (323)
+++|.+++.||+|+++.|-+++.+.+.+.||+|++++.- .+.+.....+.|..+..+-+ ||.++-++.+|+++..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 478999999999999999999999999999999987764 34556678888888888884 8999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
|-||+.| +|.=++.+++ .++++.++.+...|..||+|||++||+++|||.+|++++..|. +||+|+|.+..--.+.
T Consensus 329 vieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh-ikltdygmcke~l~~g 405 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc-eeecccchhhcCCCCC
Confidence 9999976 7776666655 4688999999999999999999999999999999999999999 9999999987643222
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC--
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG-- 235 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~-- 235 (323)
... .+-+|||.|.|||.+.+ ..|+...|.|+||++++||+.|+.||.-
T Consensus 406 d~t-----------------------------stfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 406 DTT-----------------------------STFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred ccc-----------------------------ccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 211 12378999999999999 6799999999999999999999999952
Q ss_pred -----CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----
Q 036739 236 -----DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI----- 305 (323)
Q Consensus 236 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~----- 305 (323)
.+..+.+.+++- ....-+++++|-.+..++...|++||.+|.
T Consensus 456 m~n~d~ntedylfqvil----------------------------ekqiriprslsvkas~vlkgflnkdp~erlgc~~~ 507 (593)
T KOG0695|consen 456 MDNPDMNTEDYLFQVIL----------------------------EKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQ 507 (593)
T ss_pred CCCcccchhHHHHHHHh----------------------------hhcccccceeehhhHHHHHHhhcCCcHHhcCCCcc
Confidence 122233333221 111233456777788999999999999998
Q ss_pred -CHhhhhcCCCCccccc
Q 036739 306 -TARSALEHEYFRDVEF 321 (323)
Q Consensus 306 -s~~~il~h~~~~~~~~ 321 (323)
...++-.|+||+.++|
T Consensus 508 ~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 508 TGFSDIKSHAFFRSIDW 524 (593)
T ss_pred cchhhhhcchhhhhCCH
Confidence 4678889999999876
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=282.62 Aligned_cols=275 Identities=25% Similarity=0.342 Sum_probs=172.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccC----CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEE------E
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVT----NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV------V 70 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------~ 70 (323)
.++|++.+.||+|+||.||+|++..+ +..||+|.+..... .+...++ .++...+.++..+... .
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 36899999999999999999999888 89999998642211 1111111 1111122222221111 2
Q ss_pred ecCceEEEEEecchh-hHHHhhhcCCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 036739 71 HSEKKLYLVFEYLDL-DLKKHMDSCPD------------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQ 131 (323)
Q Consensus 71 ~~~~~~~lv~e~~~g-~l~~~~~~~~~------------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~ 131 (323)
..+...++|+||+++ +|.+.+..... .......+..++.||+.||+|||+.+|+|+||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 356689999999976 66666654321 01123446689999999999999999999999999
Q ss_pred cEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCC---
Q 036739 132 NLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR--- 208 (323)
Q Consensus 132 Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--- 208 (323)
|||++.+...+||+|||++..+........ ....+++.|+|||.+....
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~----------------------------~~~~~t~~Y~APE~~~~~~~~~ 336 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIP----------------------------KEFLLDPRYAAPEQYIMSTQTP 336 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCC----------------------------cccccCCCccChHHhhccCCCC
Confidence 999987544599999999975532211110 0124588899999764311
Q ss_pred ------------------CCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccC
Q 036739 209 ------------------HYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAF 270 (323)
Q Consensus 209 ------------------~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (323)
.+..++||||+||++|+|+++..++. ................ ...| ....
T Consensus 337 ~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~-~~~~---------~~~~ 404 (566)
T PLN03225 337 SAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYD-LVAW---------RKLV 404 (566)
T ss_pred CCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCc-HHHH---------HHhh
Confidence 23446799999999999998765532 2222222222211110 0000 0000
Q ss_pred CCCCCCc---ccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccccc
Q 036739 271 PKWPSKE---LGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVEF 321 (323)
Q Consensus 271 ~~~~~~~---~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~~ 321 (323)
......+ .-...........+||.+||+.||++||++.++|+||||++...
T Consensus 405 ~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 405 EPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 0000000 00111223445669999999999999999999999999998654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=271.25 Aligned_cols=282 Identities=31% Similarity=0.498 Sum_probs=213.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCC------CCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH------GNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~ 75 (323)
++|.+....|.|=|++|.+|.+...|..||||++..... ....=..|+.+|+.|.. -|.++++..|...+.
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 589999999999999999999999999999999965431 11222368999999952 478899999999999
Q ss_pred EEEEEecchhhHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 76 LYLVFEYLDLDLKKHMDS-CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
+|+|||.+.-+|...+.. ..+..+....++.++.|++.||..|-++|++|.||||+|||+.++..++||||||.+...+
T Consensus 509 LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 509 LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFAS 588 (752)
T ss_pred eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccc
Confidence 999999999988888865 3345567788999999999999999999999999999999999999999999999997765
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
....+.- ..+.-|.|||.+.+ -+|+...|+||+||+||||.||+..|.
T Consensus 589 eneitPY-------------------------------LVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 589 ENEITPY-------------------------------LVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred cccccHH-------------------------------HHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecC
Confidence 4333211 22566999999999 779999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcc--------cCCcccccCCCCCCCcccccc----------------cCCC----
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVT--------SLPDFKSAFPKWPSKELGTVV----------------RNLE---- 286 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~----------------~~~s---- 286 (323)
+..+.+++.......+....-.+-... .+..+.....++.......+. +.++
T Consensus 637 G~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~ 716 (752)
T KOG0670|consen 637 GRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQP 716 (752)
T ss_pred CCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhH
Confidence 988877765544433332211100000 000011111111111111111 1122
Q ss_pred ---hHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 287 ---PAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 287 ---~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
..+.+|+.+||..||++|.++.++|+||||+.
T Consensus 717 ~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 717 KIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 25789999999999999999999999999974
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=270.69 Aligned_cols=249 Identities=23% Similarity=0.335 Sum_probs=210.0
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+.++.++||.|.+|.||.+.++.-.-.||+|.++-..+ ..++|..|.++|+.++|||+++++|.|..+..+|||+||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 35678999999999999999998889999999864433 348999999999999999999999999999999999999
Q ss_pred c-hhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 83 L-DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 83 ~-~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
+ .|+|++++.++.....+.....+|+.||.+|++||.+++++|+||...|+|+.++.- +|+.|||+++.+..+.-+--
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi-VKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI-VKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce-EEeeccchhhhhcCCceecc
Confidence 8 689999999998888888889999999999999999999999999999999998776 99999999988753322211
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEID 240 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~ 240 (323)
+.. .-.+.|.|||.+.- ..++.++|||+||++||||.| |-.||.+-+..+
T Consensus 424 AGA----------------------------KFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq 474 (1157)
T KOG4278|consen 424 AGA----------------------------KFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 474 (1157)
T ss_pred cCc----------------------------cCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHH
Confidence 100 11456999999877 678999999999999999999 889999987766
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.+..+.+.+.... ...+++.+.+|++.||+++|++||+..++-+
T Consensus 475 VY~LLEkgyRM~~----------------------------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 475 VYGLLEKGYRMDG----------------------------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHhccccccC----------------------------CCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 6665554332211 2458899999999999999999999988743
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=254.31 Aligned_cols=263 Identities=21% Similarity=0.321 Sum_probs=200.9
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHH-HHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISL-LKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+.+-++.||.|+||+|++...+..|...|+|.+....... ....+..|.+. ++.-.+|||++++|+...++..|+.||
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k-eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK-EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH-HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 4556788999999999999999999999999997654422 22444455554 445579999999999999999999999
Q ss_pred cchhhHHHhh---hcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 82 YLDLDLKKHM---DSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 82 ~~~g~l~~~~---~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
.++-++-... .+.....++++.+-.|..-.+.||.||-. .+|+||||||+|||++..|. +||+|||.+-.+-...
T Consensus 144 LMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~-vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 144 LMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD-VKLCDFGICGQLVDSI 222 (361)
T ss_pred HHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC-EeeecccchHhHHHHH
Confidence 9986554443 33444567888888888888999999985 48999999999999999999 9999999986542111
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCC-CCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH-YSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
......|-..|+|||.+.+... ++.+||+||||+++||+.||..||..-
T Consensus 223 ------------------------------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 223 ------------------------------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred ------------------------------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 1222345667999999988666 889999999999999999999999653
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
+ +...++.+....-.+... .+.-.-+++..+.++|+.||.+|.++||.-.+++++||+
T Consensus 273 ~--svfeql~~Vv~gdpp~l~--------------------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fy 330 (361)
T KOG1006|consen 273 D--SVFEQLCQVVIGDPPILL--------------------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFY 330 (361)
T ss_pred H--HHHHHHHHHHcCCCCeec--------------------CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchh
Confidence 3 334444433211111100 011113478899999999999999999999999999998
Q ss_pred ccc
Q 036739 317 RDV 319 (323)
Q Consensus 317 ~~~ 319 (323)
+..
T Consensus 331 r~y 333 (361)
T KOG1006|consen 331 RMY 333 (361)
T ss_pred hhh
Confidence 753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=247.50 Aligned_cols=243 Identities=42% Similarity=0.649 Sum_probs=195.2
Q ss_pred cceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-hHHHhhh
Q 036739 14 TYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMD 92 (323)
Q Consensus 14 ~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g-~l~~~~~ 92 (323)
++|.||++.+..+++.+++|++........ ...+.+|+..+++++|+|++++++.+......++++|++++ ++.+.+.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 578999999988899999999865433221 57888999999999999999999999999999999999987 7777776
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcce
Q 036739 93 SCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172 (323)
Q Consensus 93 ~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (323)
.... ++...+..++.+++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 80 ~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~-~~l~d~~~~~~~~~~~~~~------------ 144 (244)
T smart00220 80 KRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH-VKLADFGLARQLDPGGLLT------------ 144 (244)
T ss_pred hccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc-EEEccccceeeeccccccc------------
Confidence 5443 688889999999999999999999999999999999998877 9999999998765432111
Q ss_pred eehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 036739 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTP 252 (323)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 252 (323)
...++..|++||.+.. ...+.++|+|++|++++++++|..||......+............
T Consensus 145 ------------------~~~~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~ 205 (244)
T smart00220 145 ------------------TFVGTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP 205 (244)
T ss_pred ------------------cccCCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC
Confidence 1234777999999886 557889999999999999999999998744433333322210000
Q ss_pred CCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 253 NEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
. ......++..+.+++.+|+..+|++||++.++++||||
T Consensus 206 ~-------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 206 F-------------------------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred C-------------------------ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0 00001167789999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=263.48 Aligned_cols=268 Identities=24% Similarity=0.379 Sum_probs=208.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-----cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEe-cCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-----EDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-SEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (323)
++|-+++.||+|||+.||+|.+....+.||+|+-.... ...+-....-+|.++.+.+.||.||+++++|. +...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 57889999999999999999999999999999754332 11222344557999999999999999999996 6778
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCcEEEecCCC--ceEEeccccce
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH--RVLHRDLKPQNLLIDRRTN--ALKLADFGLAR 151 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~ 151 (323)
+|-|.|||+|+-++++..... .+++.+++.|+.||++||.||... .|+|-||||.|||+-.... .+||+|||++.
T Consensus 543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 999999999977777776554 579999999999999999999976 5999999999999953221 49999999998
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC---CCCCCCchhhHHHHHHHHHHHh
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG---SRHYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~ll~~l~t 228 (323)
.++-+.-... +.........||..|.|||.+.- .+..+.+.||||+|+|+|.++.
T Consensus 622 IMdddSy~~v----------------------dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY 679 (775)
T KOG1151|consen 622 IMDDDSYNSV----------------------DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY 679 (775)
T ss_pred hccCCccCcc----------------------cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence 8753322110 00112223477999999999752 3568899999999999999999
Q ss_pred CCCCCCCCChHHHHHH---HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC
Q 036739 229 QRPLFPGDSEIDELFK---IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI 305 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~ 305 (323)
|+.||........+.. +.+..+..+ +..+.+++.++.||++||++.-++|.
T Consensus 680 GrKPFGhnqsQQdILqeNTIlkAtEVqF--------------------------P~KPvVsseAkaFIRRCLaYRKeDR~ 733 (775)
T KOG1151|consen 680 GRKPFGHNQSQQDILQENTILKATEVQF--------------------------PPKPVVSSEAKAFIRRCLAYRKEDRI 733 (775)
T ss_pred cCCCCCCchhHHHHHhhhchhcceeccC--------------------------CCCCccCHHHHHHHHHHHHhhhhhhh
Confidence 9999987754433321 211111110 11245889999999999999999999
Q ss_pred CHhhhhcCCCCcc
Q 036739 306 TARSALEHEYFRD 318 (323)
Q Consensus 306 s~~~il~h~~~~~ 318 (323)
++.++..||||.-
T Consensus 734 DV~qLA~dpyllP 746 (775)
T KOG1151|consen 734 DVQQLACDPYLLP 746 (775)
T ss_pred hHHHHccCccccc
Confidence 9999999999863
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=255.72 Aligned_cols=315 Identities=27% Similarity=0.355 Sum_probs=208.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC--------CCCeeeeeEEEe--
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ--------HGNIVRLQDVVH-- 71 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~-- 71 (323)
++|.+.++||=|.|+|||++.+..+.+.||+|+.+... .-.+....|+.+|++++ ..+||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 58999999999999999999999999999999885332 22356668999999984 246999999996
Q ss_pred --cCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCC--------
Q 036739 72 --SEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTN-------- 140 (323)
Q Consensus 72 --~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~-------- 140 (323)
++..+|+|||+++.+|++.|.......++...++.|++||+.||.|||. +||+|-||||+|||+-.+..
T Consensus 155 GpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~ 234 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDARE 234 (590)
T ss_pred CCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhh
Confidence 4568999999999999999999888889999999999999999999995 69999999999999833200
Q ss_pred --------------ceEE--------------e------------------------------------------ccccc
Q 036739 141 --------------ALKL--------------A------------------------------------------DFGLA 150 (323)
Q Consensus 141 --------------~~kl--------------~------------------------------------------df~~~ 150 (323)
.++- . +....
T Consensus 235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~ 314 (590)
T KOG1290|consen 235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES 314 (590)
T ss_pred hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence 0000 0 00000
Q ss_pred eecCCCcc------cccccc-cCC-------c------------------Ccc------eee-hhhhhhhccCcc-----
Q 036739 151 RAFGIPVR------TFTHEH-WGS-------T------------------GIS------IYF-SFLRYRVLAGSL----- 186 (323)
Q Consensus 151 ~~~~~~~~------~~~~~~-~~~-------~------------------~~~------~~~-~~~~~~~~~~~~----- 186 (323)
........ ...... ... . ..+ +.. ....+.......
T Consensus 315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK 394 (590)
T KOG1290|consen 315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK 394 (590)
T ss_pred chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence 00000000 000000 000 0 000 000 000000000000
Q ss_pred ce-----------eeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHHHh
Q 036739 187 IL-----------QFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD------SEIDELFKIFRVL 249 (323)
Q Consensus 187 ~~-----------~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~------~~~~~~~~~~~~~ 249 (323)
++ -.....|..|.|||++.+ ..|+..+||||++|+.|||.||...|... .+.++++.++..+
T Consensus 395 IaDlGNACW~~khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELL 473 (590)
T KOG1290|consen 395 IADLGNACWVHKHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELL 473 (590)
T ss_pred EeeccchhhhhhhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHH
Confidence 00 122345889999999999 56999999999999999999999888643 4567888888877
Q ss_pred CCCCCCCCCCcccCCcccc---------cCCCCCCCcccccc----cCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 250 GTPNEDTWPGVTSLPDFKS---------AFPKWPSKELGTVV----RNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~----~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
+....-......-..+|.. ++.-|.-.+...-. ..-...+.+|+.-||+.+|++|++|.+.|+|||+
T Consensus 474 G~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwL 553 (590)
T KOG1290|consen 474 GKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWL 553 (590)
T ss_pred hhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccc
Confidence 7644322111111111111 11122111111000 0113357899999999999999999999999999
Q ss_pred cccc
Q 036739 317 RDVE 320 (323)
Q Consensus 317 ~~~~ 320 (323)
+.+.
T Consensus 554 n~~~ 557 (590)
T KOG1290|consen 554 NPVA 557 (590)
T ss_pred cCCC
Confidence 9774
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=267.37 Aligned_cols=253 Identities=26% Similarity=0.351 Sum_probs=210.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc---eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++..+.++||+|.||.|+++.++..+. .||+|++....... ....|.+|+.+|..|+|+|++++||...+ ....+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 455678899999999999999876543 79999986554433 56899999999999999999999999988 77889
Q ss_pred EEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
|||.+. |+|++.+.......+.....+.++.||+.||.||.+++++||||...|+++..... +||+|||+++.++...
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt-VKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT-VKICDFGLMRALGENE 266 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce-eeeecccceeccCCCC
Confidence 999996 59999998855556777888999999999999999999999999999999987554 9999999999887654
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
.... ..........|+|||.+.. ..++.+||+|++|+++|||++ |..||.+.
T Consensus 267 d~Yv--------------------------m~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 267 DMYV--------------------------MAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred cceE--------------------------ecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 4332 2222333667999999988 779999999999999999999 78999999
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+.+..+..+- ..+-.+.+++++.+++..||..+|.+||+...|.+
T Consensus 320 ~g~qIL~~iD~~e----------------------------rLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 320 RGIQILKNIDAGE----------------------------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CHHHHHHhccccc----------------------------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 9888877665321 12223458899999999999999999999998854
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=249.84 Aligned_cols=285 Identities=36% Similarity=0.615 Sum_probs=223.1
Q ss_pred ceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC-----ceEEEE
Q 036739 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KKLYLV 79 (323)
Q Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv 79 (323)
+=-+.||.|+||.||.+++..+|+.+++|++..-..+......+..|+.++.-++|.|++..+++.+.. ..+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 345789999999999999999999999999865554445567888999999999999999998887643 356889
Q ss_pred EecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 80 FEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
+|.+..+|-+.+.+-. .++...++-+++||+.+|.|||+.+|.|+||||-|.+++.|-. +||+|||+++........
T Consensus 136 TELmQSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv-LKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI-LKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHHhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce-EEecccccccccchhhhh
Confidence 9999889988887744 5677778889999999999999999999999999999997655 999999999876544433
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.+ ...+.|..|.+||.+.+.+.|+.+.||||+|||+.|++..+..|....+.
T Consensus 213 hM----------------------------TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi 264 (449)
T KOG0664|consen 213 NM----------------------------THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI 264 (449)
T ss_pred hh----------------------------HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence 22 23356888999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCc--ccccCCCCCCC---cccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPD--FKSAFPKWPSK---ELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
+.+..+...++.+..+.+....+-.. ......+.... -...+...-......++..|+..||.+|.+..+.+.|+
T Consensus 265 qQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 265 EQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 99999988888876654322211000 00000011000 01111122334567899999999999999999999999
Q ss_pred CCcccc
Q 036739 315 YFRDVE 320 (323)
Q Consensus 315 ~~~~~~ 320 (323)
++...+
T Consensus 345 ~~~e~R 350 (449)
T KOG0664|consen 345 YLEEGR 350 (449)
T ss_pred cccccc
Confidence 987764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=267.34 Aligned_cols=203 Identities=29% Similarity=0.427 Sum_probs=169.9
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------ceEE
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------KKLY 77 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~ 77 (323)
+...+.||.|+||.||+++++.+|+.||+|.+.... .....+..-.|++++++++|+|||+.+++=.+. ....
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 456788999999999999999999999999986543 444556677899999999999999999886543 3578
Q ss_pred EEEecchh-hHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC---CceEEecccccee
Q 036739 78 LVFEYLDL-DLKKHMDSCP-DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT---NALKLADFGLARA 152 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~---~~~kl~df~~~~~ 152 (323)
++||||.| +|.+.+.+-. ...+++.+++.++.++..||+|||.+||+||||||.||++.... .+-||+|||.++.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999965 7777776532 35678999999999999999999999999999999999986544 2689999999988
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
++.+.. ....+||+.|.+||++....+++...|.||+||++|++.||..|
T Consensus 174 l~d~s~------------------------------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP 223 (732)
T KOG4250|consen 174 LDDNSL------------------------------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP 223 (732)
T ss_pred CCCCCe------------------------------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence 754431 12357899999999998667899999999999999999999999
Q ss_pred CCCCC
Q 036739 233 FPGDS 237 (323)
Q Consensus 233 ~~~~~ 237 (323)
|....
T Consensus 224 F~p~~ 228 (732)
T KOG4250|consen 224 FIPFG 228 (732)
T ss_pred CCcCC
Confidence 86543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=257.09 Aligned_cols=257 Identities=22% Similarity=0.296 Sum_probs=208.3
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
..+.++||+|-||.|.++.- ..+..||+|.++... .......|.+|+++|.+++||||+.++|.|..++.+++|+||+
T Consensus 540 L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred eehhhhhcCcccceeEEEEe-cCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 46789999999999999985 346899999986553 3334588999999999999999999999999999999999999
Q ss_pred h-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 84 D-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 84 ~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
+ |+|.+++....-...+.+.-.+|+.||++|+.||.+.++|||||.+.|+|++.++. +||+|||.++.+-
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~-iKiadfgmsR~ly-------- 688 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT-IKIADFGMSRNLY-------- 688 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc-EEecCcccccccc--------
Confidence 6 68888888764333344445579999999999999999999999999999999988 9999999987542
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh--CCCCCCCCChHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QRPLFPGDSEID 240 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t--g~~p~~~~~~~~ 240 (323)
.++++-+++..+-.++|+|||.+.. ..++.+||+|++|+++||+++ ...||....+++
T Consensus 689 -------------------sg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 689 -------------------SGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred -------------------cCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 2344555666666889999999988 779999999999999999886 679999888877
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
........+...... .....+.-++..+.+++.+|++.|.++||+.+++-.
T Consensus 749 vven~~~~~~~~~~~---------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 749 VVENAGEFFRDQGRQ---------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHhhhhhcCCCCcc---------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 766554433222111 112223447788999999999999999999998854
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=265.24 Aligned_cols=258 Identities=27% Similarity=0.418 Sum_probs=214.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEe-----cCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVH-----SEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-----~~~~ 75 (323)
+-|++...+|.|.+|.||+++...++...|+|+..... +..+++..|.++++... |||++.++++|. .++.
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 45889999999999999999999999999999886443 34477888899999884 999999999985 3578
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
+|||||+|+| +..+.+....+..+.+..+..|++.++.||.+||++.++|+|||-.|||++.++. +||.|||.+..+.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~-VKLvDFGvSaQld 174 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLD 174 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc-EEEeeeeeeeeee
Confidence 9999999975 7777777776888999999999999999999999999999999999999999998 9999999998876
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC----CCCCCchhhHHHHHHHHHHHhCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS----RHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
....... +-+||+.|||||++... ..|+..+|+||||++..||-.|.
T Consensus 175 sT~grRn-----------------------------T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~ 225 (953)
T KOG0587|consen 175 STVGRRN-----------------------------TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGA 225 (953)
T ss_pred ccccccc-----------------------------CcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCC
Confidence 5444332 23779999999999753 34677899999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh
Q 036739 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310 (323)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i 310 (323)
+|+-++-+...+..+-+. .++. +. -+..-+..+.++|..||.+|.++||+..++
T Consensus 226 PPl~DmHPmraLF~IpRN----PPPk-------------Lk---------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~l 279 (953)
T KOG0587|consen 226 PPLCDMHPMRALFLIPRN----PPPK-------------LK---------RPKKWSKKFNDFISTCLVKDYEQRPSTEEL 279 (953)
T ss_pred CCccCcchhhhhccCCCC----CCcc-------------cc---------chhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence 999998877666554321 0000 00 012246678899999999999999999999
Q ss_pred hcCCCCcc
Q 036739 311 LEHEYFRD 318 (323)
Q Consensus 311 l~h~~~~~ 318 (323)
|+|||++.
T Consensus 280 l~hpFi~e 287 (953)
T KOG0587|consen 280 LKHPFITE 287 (953)
T ss_pred ccCCcccc
Confidence 99999974
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=259.99 Aligned_cols=248 Identities=26% Similarity=0.372 Sum_probs=197.2
Q ss_pred cceeeeeccccceeEEEEEEcc--CC--ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 4 YEKVEKIGEGTYGVVYKARNCV--TN--ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~--~~--~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
.+..++||.|.||.||.+.-.. .| --||||.-+.... .+..+.|.+|..+++.+.||||++++|.+. +...|||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wiv 468 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIV 468 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEE
Confidence 3456789999999999997332 22 2688888755433 344789999999999999999999999995 4567899
Q ss_pred Eecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
||.+. |.|..++..+.. .++.....-+++||..||.|||+.++|||||...|||+....- +||+|||+++.+.-..
T Consensus 469 mEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C-VKLaDFGLSR~~ed~~- 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC-VKLADFGLSRYLEDDA- 545 (974)
T ss_pred EecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce-eeecccchhhhccccc-
Confidence 99996 688888776654 5777778889999999999999999999999999999998776 9999999997653111
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDS 237 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~ 237 (323)
++......-.+.|+|||.+.- +.++.+||||+||+.+||++. |..||.+-+
T Consensus 546 ---------------------------yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvk 597 (974)
T KOG4257|consen 546 ---------------------------YYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVK 597 (974)
T ss_pred ---------------------------hhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCcccccc
Confidence 111111122567999999876 558999999999999999987 999999988
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+.+.+-++.++- ..+.++++++.+..|+.+||+.+|.+||...++..
T Consensus 598 NsDVI~~iEnGe----------------------------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 598 NSDVIGHIENGE----------------------------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred ccceEEEecCCC----------------------------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 777666555432 22334568999999999999999999998887754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=258.46 Aligned_cols=272 Identities=21% Similarity=0.383 Sum_probs=180.5
Q ss_pred CCcceeeeeccccceeEEEEEEc----------------cCCceEEEEEEEecccC------------CCCchhHHHHHH
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC----------------VTNETIALKKIRLEQED------------EGVPSTAIREIS 53 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~----------------~~~~~~aiK~~~~~~~~------------~~~~~~~~~e~~ 53 (323)
++|++.++||+|+||+||++... ..+..||+|.+...... ....+....|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 68999999999999999998642 34467999988543211 111233345677
Q ss_pred HHHhcCCCCe-----eeeeEEEec--------CceEEEEEecchh-hHHHhhhcCC----------------------CC
Q 036739 54 LLKEMQHGNI-----VRLQDVVHS--------EKKLYLVFEYLDL-DLKKHMDSCP----------------------DF 97 (323)
Q Consensus 54 ~l~~l~~~~i-----~~~~~~~~~--------~~~~~lv~e~~~g-~l~~~~~~~~----------------------~~ 97 (323)
++.+++|.++ ++++++|.. ++..++|+||+++ +|.+.+.... ..
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7777776554 556666542 3568999999975 6666654321 11
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhh
Q 036739 98 ANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177 (323)
Q Consensus 98 ~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (323)
..+...++.++.|++.+|.|||+.+++|+||||+||+++.++. +||+|||++............
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~-~kL~DFGla~~~~~~~~~~~~--------------- 368 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ-VKIIDFGAAVDMCTGINFNPL--------------- 368 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc-EEEEeCcCccccccCCccCcc---------------
Confidence 2345678889999999999999999999999999999998887 999999998654322111000
Q ss_pred hhhhccCccceeeccccccccccchhhhCCCC-------------------C--CCchhhHHHHHHHHHHHhCCC-CCCC
Q 036739 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRH-------------------Y--STPVDVWSVGCIFAEMVNQRP-LFPG 235 (323)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-------------------~--~~~~Di~slG~ll~~l~tg~~-p~~~ 235 (323)
...+++.|++||.+..... + ..+.|+||+||++++|++|.. |+..
T Consensus 369 -------------~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 369 -------------YGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred -------------ccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 0123788999999764211 1 124799999999999999875 6654
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCC---CCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP---SRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp---~~R~s~~~il~ 312 (323)
........+... .....|.. ... ... .-......++...+|+.+||..+| .+|+|+.++|+
T Consensus 436 ~~~f~~~~~~~~----~~~~~~r~------~~~-----~~~-~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 436 IRLFNTELRQYD----NDLNRWRM------YKG-----QKY-DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hhhhhhHHhhcc----chHHHHHh------hcc-----cCC-CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 322211111000 00000000 000 000 001234578999999999999876 68999999999
Q ss_pred CCCCcc
Q 036739 313 HEYFRD 318 (323)
Q Consensus 313 h~~~~~ 318 (323)
||||..
T Consensus 500 Hp~f~~ 505 (507)
T PLN03224 500 HRFFLP 505 (507)
T ss_pred CCCcCC
Confidence 999964
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=264.21 Aligned_cols=258 Identities=23% Similarity=0.342 Sum_probs=213.2
Q ss_pred CcceeeeeccccceeEEEEEEccCCc---eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
...+.+.||.|.||.|++++.+..++ .||||.++.-. .+....+|..|+.+|-++.||||+++.|........+||
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45688999999999999999877664 79999986543 344567889999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
+||++. +|..++..+.+ .+...+..-|++.|+.++.||-+.|+|||||...|||++.+-. +|++|||+++.+..+..
T Consensus 709 TEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv-CKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE-EEeccccceeecccCCC
Confidence 999975 55555555554 4777777789999999999999999999999999999998665 99999999998754442
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDS 237 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~ 237 (323)
..-...-+ .=.++|.|||.+.- +.++.+|||||+|++|||.++ |..||=...
T Consensus 787 ~~ytt~GG--------------------------KIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 787 AAYTTLGG--------------------------KIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred ccccccCC--------------------------ccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccc
Confidence 11111000 11467999999988 778999999999999999887 999999999
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc--CCC
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE--HEY 315 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~--h~~ 315 (323)
+.+.+..+.+.+..+.+.. .+..+.+|+..||++|-.+||...+|+. +..
T Consensus 840 NQdVIkaIe~gyRLPpPmD----------------------------CP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 840 NQDVIKAIEQGYRLPPPMD----------------------------CPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred hHHHHHHHHhccCCCCCCC----------------------------CcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 9999999998877765553 6788999999999999999999999987 344
Q ss_pred Ccc
Q 036739 316 FRD 318 (323)
Q Consensus 316 ~~~ 318 (323)
+++
T Consensus 892 Irn 894 (996)
T KOG0196|consen 892 IRN 894 (996)
T ss_pred hcC
Confidence 443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=266.28 Aligned_cols=250 Identities=30% Similarity=0.397 Sum_probs=192.4
Q ss_pred eeeeccccce-eEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEEecch
Q 036739 7 VEKIGEGTYG-VVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVFEYLD 84 (323)
Q Consensus 7 ~~~lg~g~~~-~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (323)
.+.+|.|+.| .||++. ..|+.||+|.+... ......+|+..++.- .||||+++++.-++....||+.|.|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 3567888887 589998 57889999987432 235667899998888 59999999999999999999999999
Q ss_pred hhHHHhhhcC-CCCCC-CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec---CC-CceEEeccccceecCCCcc
Q 036739 85 LDLKKHMDSC-PDFAN-DPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RT-NALKLADFGLARAFGIPVR 158 (323)
Q Consensus 85 g~l~~~~~~~-~~~~~-~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~---~~-~~~kl~df~~~~~~~~~~~ 158 (323)
.+|.+.+... ..... .......++.|++.||++||+.+|+||||||.|||+.. ++ .+++|+|||+|..++....
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 9999998873 21111 11345678999999999999999999999999999987 34 3799999999999887766
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ-RPLFPGDS 237 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg-~~p~~~~~ 237 (323)
...... ...||-+|+|||.+.... -..+.||||+||++|+.++| ..||.+..
T Consensus 667 S~~r~s--------------------------~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 667 SFSRLS--------------------------GGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred hhhccc--------------------------CCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH
Confidence 655421 235689999999998844 46799999999999999995 89998775
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
.++.-. ........ .....-...+.+||.+|+.++|..||+|.+||.||+|=
T Consensus 720 ~R~~NI--l~~~~~L~--------------------------~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 720 ERQANI--LTGNYTLV--------------------------HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred Hhhhhh--hcCcccee--------------------------eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 543221 11100000 00000111678999999999999999999999999994
Q ss_pred c
Q 036739 318 D 318 (323)
Q Consensus 318 ~ 318 (323)
+
T Consensus 772 ~ 772 (903)
T KOG1027|consen 772 D 772 (903)
T ss_pred C
Confidence 3
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=245.93 Aligned_cols=310 Identities=27% Similarity=0.447 Sum_probs=216.4
Q ss_pred CCcceeeeeccccceeEEEEEEcc---CCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV---TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 77 (323)
+.|.++.+||+|.|++||++++.. .++.||+|.+... .....+.+|++++..+. +.||+++.+++..++..+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 568899999999999999999877 7789999988543 33467889999999995 899999999999999999
Q ss_pred EEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 78 LVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 78 lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
+|+||++..-...+.. .++...++++++.++.||.++|++||+|+||||+|++++.....-.|.|||++.......
T Consensus 112 ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred EEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 9999998855555554 345777999999999999999999999999999999999888888999999987322211
Q ss_pred ccccccc----cCCc-Ccce---------eehhhhhhhccCcc-ceeeccccccccccchhhhCCCCCCCchhhHHHHHH
Q 036739 158 RTFTHEH----WGST-GISI---------YFSFLRYRVLAGSL-ILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCI 222 (323)
Q Consensus 158 ~~~~~~~----~~~~-~~~~---------~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~l 222 (323)
....... ...+ .... ..+...+..-+++. ..--...||++|.|||++..-+.-+.+.|+||.|+|
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 1100000 0000 0000 00111111112222 223456899999999999886777889999999999
Q ss_pred HHHHHhCCCCCCCC-ChHHHHHHHHHHhCC--------CCCC--CC--CCcccCCcccccCCCCC-----C-----Cccc
Q 036739 223 FAEMVNQRPLFPGD-SEIDELFKIFRVLGT--------PNED--TW--PGVTSLPDFKSAFPKWP-----S-----KELG 279 (323)
Q Consensus 223 l~~l~tg~~p~~~~-~~~~~~~~~~~~~~~--------~~~~--~~--~~~~~~~~~~~~~~~~~-----~-----~~~~ 279 (323)
+.-+++++.||... ++.+.+.++..-++. .... .| +......+....+.+.. + ....
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 99999999887543 333333333222211 0000 11 11111122222222221 0 1122
Q ss_pred ccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 280 TVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 280 ~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.....++..+.+|+.+||..||.+|.+++++|+||||.+.
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 2233456689999999999999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=275.34 Aligned_cols=251 Identities=21% Similarity=0.275 Sum_probs=178.4
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
++...+.||+|++|.||+|.+..++..||+|.+.... .....|++.+++++||||+++++++.+....++||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN------SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc------cccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 4566788999999999999998899999999874321 1223468889999999999999999999999999999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
+.| ++.+.+.. +++..+..++.||+.||+||| +.+++|+||||+||+++.++. .++. ++........
T Consensus 765 ~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~-~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 765 IEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE-PHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc-eEEE-eccccccccC--
Confidence 975 67666642 577888999999999999999 669999999999999988766 5654 4433221100
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
....+++.|+|||++.+ ..++.++||||+|+++|||++|+.||.....
T Consensus 836 -------------------------------~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~ 883 (968)
T PLN00113 836 -------------------------------TKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFG 883 (968)
T ss_pred -------------------------------CCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccC
Confidence 01144788999999877 6689999999999999999999999854321
Q ss_pred H-HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 239 I-DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 239 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
. ....+..+..... .. ...+.+.. ... ...........+.+++.+|++.||++||++.++++
T Consensus 884 ~~~~~~~~~~~~~~~--~~------~~~~~~~~---~~~-~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 884 VHGSIVEWARYCYSD--CH------LDMWIDPS---IRG-DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred CCCcHHHHHHHhcCc--cc------hhheeCcc---ccC-CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 1 1111111110000 00 00000000 000 00000112235778999999999999999999986
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=246.76 Aligned_cols=200 Identities=29% Similarity=0.426 Sum_probs=174.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc------cCCCCchhHHHHHHHHHhcC---CCCeeeeeEEEec
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ------EDEGVPSTAIREISLLKEMQ---HGNIVRLQDVVHS 72 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~ 72 (323)
-+|+.++.+|+|+||.|++|+++.+...|+||.+.+.. .+....-.+..|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46999999999999999999999999999999886653 12233445667888988886 9999999999999
Q ss_pred CceEEEEEecch-h-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccc
Q 036739 73 EKKLYLVFEYLD-L-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (323)
Q Consensus 73 ~~~~~lv~e~~~-g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~ 150 (323)
++++||+||..+ | +|++++...+ .+++.++..|++|++.++.+||+.||+|||||-+||.++.+|. +||+|||++
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~-~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF-VKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe-EEEeeccch
Confidence 999999999984 5 9999998866 4688889999999999999999999999999999999999999 999999998
Q ss_pred eecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 151 RAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
......+..- -.||..|+|||++.+..+.+..-|||+||+++|.++...
T Consensus 718 a~~ksgpfd~-------------------------------f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyke 766 (772)
T KOG1152|consen 718 AYTKSGPFDV-------------------------------FVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKE 766 (772)
T ss_pred hhhcCCCcce-------------------------------eeeeccccchhhhCCCccCCCcchhhhhhheeeEEEecc
Confidence 7765433321 156999999999999888899999999999999999999
Q ss_pred CCCCC
Q 036739 231 PLFPG 235 (323)
Q Consensus 231 ~p~~~ 235 (323)
+||..
T Consensus 767 npyyn 771 (772)
T KOG1152|consen 767 NPYYN 771 (772)
T ss_pred CCCcC
Confidence 98853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=212.07 Aligned_cols=213 Identities=41% Similarity=0.650 Sum_probs=178.4
Q ss_pred eccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-hHH
Q 036739 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLK 88 (323)
Q Consensus 10 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g-~l~ 88 (323)
||+|++|.||++....+++.+++|++....... ....+.+|+..++.+.|++++++++++......++++|++.| ++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999987779999999986543221 346788999999999999999999999999999999999985 777
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec-CCCceEEeccccceecCCCcccccccccCC
Q 036739 89 KHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLARAFGIPVRTFTHEHWGS 167 (323)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 167 (323)
+.+.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++. ++|+||+.+...........
T Consensus 80 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~-~~l~d~~~~~~~~~~~~~~~------ 151 (215)
T cd00180 80 DLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK-VKLADFGLSKLLTSDKSLLK------ 151 (215)
T ss_pred HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc-EEEecCCceEEccCCcchhh------
Confidence 7766542 35688889999999999999999999999999999999998 665 99999999987654432000
Q ss_pred cCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 036739 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFR 247 (323)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~ 247 (323)
...+...|++||.+......+.++|+|++|++++++
T Consensus 152 -----------------------~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------- 187 (215)
T cd00180 152 -----------------------TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------- 187 (215)
T ss_pred -----------------------cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------
Confidence 012367799999987743778999999999999999
Q ss_pred HhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 248 VLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
+.+.+++.+|++.+|++||++.++++|+
T Consensus 188 ---------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2355999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=243.55 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=200.9
Q ss_pred ceeeeeccccceeEEEEEEccCCc----eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 5 EKVEKIGEGTYGVVYKARNCVTNE----TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+..+.||+|+||+||++.+...|+ +||||++... .......++..|+-++.++.|||++++++.+.... ..||+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 456889999999999999877766 7888887443 33344578888999999999999999999997655 88999
Q ss_pred ecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
+|+. |.|++++...++ .+-.+....|..||++||.|||.+.++||||...|||+++-.. +||.|||++..+......
T Consensus 777 q~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h-vkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH-VKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe-EEEEecchhhccCccccc
Confidence 9996 588888877554 5677788899999999999999999999999999999998777 999999999998776665
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCh
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSE 238 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~ 238 (323)
.....- ...+.|++-|.+.. +.++.++||||+|+++||++| |..|+.+...
T Consensus 855 y~~~~g---------------------------K~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 855 YSAPGG---------------------------KVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred cccccc---------------------------ccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 544321 12456888888877 779999999999999999998 9999988876
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.+.-..+..+... .-++..+-++..++.+||..|+..||.++++..
T Consensus 907 ~eI~dlle~geRL----------------------------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 907 EEIPDLLEKGERL----------------------------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHhhHHHhccccC----------------------------CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 6554443332111 112346788999999999999999999998764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=244.29 Aligned_cols=251 Identities=28% Similarity=0.386 Sum_probs=195.4
Q ss_pred ceeeeeccccceeEEEEEEcc-------CCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceE
Q 036739 5 EKVEKIGEGTYGVVYKARNCV-------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 5 ~~~~~lg~g~~~~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 76 (323)
.+.+.||+|.||.|+++.-.. ....||+|.++..... .....+..|+.+++.+. |+|++.+.|++...+..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 456699999999999997321 1447999987554443 56688899999999995 99999999999999999
Q ss_pred EEEEecch-hhHHHhhhcCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCc
Q 036739 77 YLVFEYLD-LDLKKHMDSCP------------D--FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA 141 (323)
Q Consensus 77 ~lv~e~~~-g~l~~~~~~~~------------~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~ 141 (323)
++|.||+. |+|++++...+ . ..+.......++.||+.|++||++++++||||...||++..+..
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~- 456 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV- 456 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE-
Confidence 99999995 69998887765 0 12667788899999999999999999999999999999998755
Q ss_pred eEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHH
Q 036739 142 LKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGC 221 (323)
Q Consensus 142 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 221 (323)
+||+|||+++.......-......+ .-...|+|||.+.. ..++.+|||||+|+
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~--------------------------~LP~kWmApEsl~~-~~ft~kSDVWSfGI 509 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAG--------------------------TLPVKWMAPESLFD-RVFTSKSDVWSFGI 509 (609)
T ss_pred EEEccccceeccCCCCceEecCCCC--------------------------ccceeecCHHHhcc-CcccccchhhHHHH
Confidence 9999999997543221111000000 01345999999998 88999999999999
Q ss_pred HHHHHHh-CCCCCCCCC-hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhccc
Q 036739 222 IFAEMVN-QRPLFPGDS-EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299 (323)
Q Consensus 222 ll~~l~t-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 299 (323)
++|||++ |..||.+.. ..+....+.++... ..+...++++.++++.|++.
T Consensus 510 ~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~----------------------------~~P~~c~~eiY~iM~~CW~~ 561 (609)
T KOG0200|consen 510 LLWEIFTLGGTPYPGIPPTEELLEFLKEGNRM----------------------------EQPEHCSDEIYDLMKSCWNA 561 (609)
T ss_pred HHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHhCC
Confidence 9999999 889998855 33333333322111 11234788999999999999
Q ss_pred CCCCCCCHhhhhc
Q 036739 300 DPSRRITARSALE 312 (323)
Q Consensus 300 dp~~R~s~~~il~ 312 (323)
+|++||+..++.+
T Consensus 562 ~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 562 DPEDRPTFSECVE 574 (609)
T ss_pred CcccCCCHHHHHH
Confidence 9999999998875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=230.36 Aligned_cols=193 Identities=25% Similarity=0.342 Sum_probs=157.3
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc--CCCCeeeeeEEEecCc----eE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM--QHGNIVRLQDVVHSEK----KL 76 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~~----~~ 76 (323)
..++.+.+|+|.||.||+|. -+++.||+|++.... .+.+.+|.++.+.. +|+||++++++-.... .+
T Consensus 211 pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQE-----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred chhhHHHhhcCccceeehhh--ccCceeEEEecCHHH-----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 45677889999999999998 467999999986443 36777888887765 7999999999876554 89
Q ss_pred EEEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCcEEEecCCCceEEec
Q 036739 77 YLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH---------RVLHRDLKPQNLLIDRRTNALKLAD 146 (323)
Q Consensus 77 ~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---------~i~H~dl~~~Nil~~~~~~~~kl~d 146 (323)
+||++|.. |+|.+++... .+++...++|+..++.||+|||.. .|+|||||.+|||++.|.. ..|+|
T Consensus 284 wLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT-ccIaD 359 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT-CCIAD 359 (534)
T ss_pred eEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc-EEeec
Confidence 99999995 7888888765 578888999999999999999963 5999999999999999888 99999
Q ss_pred cccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCC-----CchhhHHHHH
Q 036739 147 FGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYS-----TPVDVWSVGC 221 (323)
Q Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-----~~~Di~slG~ 221 (323)
||++..+.+....... . ..+||.+|||||++.+...+. .+.||||+|.
T Consensus 360 FGLAl~~~p~~~~~d~-----~----------------------~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgL 412 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDT-----H----------------------GQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGL 412 (534)
T ss_pred cceeEEecCCCCCcch-----h----------------------hhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHH
Confidence 9999888633221110 0 147899999999998866555 3579999999
Q ss_pred HHHHHHhCCCCC
Q 036739 222 IFAEMVNQRPLF 233 (323)
Q Consensus 222 ll~~l~tg~~p~ 233 (323)
++|||++....+
T Consensus 413 VLWEi~SRC~~~ 424 (534)
T KOG3653|consen 413 VLWEIASRCTDA 424 (534)
T ss_pred HHHHHHhhcccc
Confidence 999999865443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=206.43 Aligned_cols=211 Identities=23% Similarity=0.394 Sum_probs=165.1
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHh-cCCCCeeeeeEEEecCceEEEEEec
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKE-MQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
...+..||+|++|.|-+.+...+|...|+|.+..... ......+..|+.+..+ ..+|.++.++|.+.++...++.||.
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3456789999999999999999999999998854432 2222344456665443 4699999999999999999999999
Q ss_pred chhhHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 83 LDLDLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 83 ~~g~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
+..++-.+..+ ..+..+++..+-+|+..++.||.|||++ .++|||+||+|||++.+|. +|++|||.+-.+-....+
T Consensus 127 M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq-VKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 127 MDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ-VKICDFGISGYLVDSIAK 205 (282)
T ss_pred hhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc-EEEcccccceeehhhhHH
Confidence 98777655543 3355789999999999999999999976 8999999999999999998 999999998765322222
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC---CCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS---RHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.. ..|-..|+|||.+... .-|+-++||||||+.+.||.+++.||..-
T Consensus 206 t~------------------------------daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 206 TM------------------------------DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred HH------------------------------hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 11 1335569999998642 35888999999999999999999999764
Q ss_pred -ChHHHHHHHH
Q 036739 237 -SEIDELFKIF 246 (323)
Q Consensus 237 -~~~~~~~~~~ 246 (323)
.+.+.+.++.
T Consensus 256 ~tpF~qLkqvV 266 (282)
T KOG0984|consen 256 GTPFQQLKQVV 266 (282)
T ss_pred CCHHHHHHHHh
Confidence 3444444443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=222.90 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=180.9
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHh--cCCCCeeeeeEEEecC----ceE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKE--MQHGNIVRLQDVVHSE----KKL 76 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~----~~~ 76 (323)
+.++.+.||+|-||.||++.+ .|+.||+|+|.... .....+|.++.+. ++|+||+.++++=-.+ ..+
T Consensus 212 qI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred eeEEEEEecCccccceeeccc--cCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 567899999999999999985 89999999985321 2344456666555 4999999998874322 379
Q ss_pred EEEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEEecCCCceEEecc
Q 036739 77 YLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH--------RVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 77 ~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
+||++|.+ |+|.+++.+. +++.+...+++..+++||.+||.. .|.|||||..|||+++++. +.|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~-C~IADL 360 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADL 360 (513)
T ss_pred EEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc-EEEeec
Confidence 99999996 6999998874 678888999999999999999953 4999999999999999998 999999
Q ss_pred ccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCC----C-CchhhHHHHHH
Q 036739 148 GLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHY----S-TPVDVWSVGCI 222 (323)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~----~-~~~Di~slG~l 222 (323)
|++-.......... +..+.++||.+|||||++...... + ..+||||||.+
T Consensus 361 GLAv~h~~~t~~id-------------------------i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV 415 (513)
T KOG2052|consen 361 GLAVRHDSDTDTID-------------------------IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV 415 (513)
T ss_pred eeeEEecccCCccc-------------------------CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence 99988765543222 223446889999999999764221 1 25799999999
Q ss_pred HHHHHhC----------CCCCCCCChHH-HHHHHH-----HHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCC
Q 036739 223 FAEMVNQ----------RPLFPGDSEID-ELFKIF-----RVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLE 286 (323)
Q Consensus 223 l~~l~tg----------~~p~~~~~~~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 286 (323)
+||+.-. +.||.+-.+.+ ....+. +.+....++.|.... .-
T Consensus 416 lWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~-----------------------~l 472 (513)
T KOG2052|consen 416 LWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDP-----------------------AL 472 (513)
T ss_pred HHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCH-----------------------HH
Confidence 9998732 36664432211 111111 112222222221111 11
Q ss_pred hHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 287 PAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 287 ~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
..+-++++.||..+|.-|.++-.+-+
T Consensus 473 ~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 473 RVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred HHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 23568899999999999999876643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=240.68 Aligned_cols=260 Identities=26% Similarity=0.392 Sum_probs=211.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|+.+.++|+|.+|.||+++++.+++..|+|+++.... ....-+++|+-+++..+||||+.+++.|.....++++||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 689999999999999999999999999999999876653 445778899999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
||+|+.++.+....+ .+++..+..+.+..+.+|+|||+.|-.|||||..||+++..+. +|+.|||.+..+.....+..
T Consensus 93 ycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD-vklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD-VKLADFGVSAQITATIAKRK 170 (829)
T ss_pred ecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc-eeecccCchhhhhhhhhhhh
Confidence 999866666655433 5788888999999999999999999999999999999999998 99999999987754443322
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhh--CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILL--GSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
. ..||+.|++||+-. ...-|....|+|++|+.-.|+-.-++|-...-+.
T Consensus 171 s-----------------------------fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 171 S-----------------------------FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred c-----------------------------ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 1 36799999999953 2345888999999999999999888886665555
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
........-...+.... . ...-++.+-+|++.+|.++|++||+++.+|.|||...
T Consensus 222 r~l~LmTkS~~qpp~lk---------------------D---k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLK---------------------D---KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHhhccCCCCCccc---------------------C---CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 54443332211111100 0 0124677889999999999999999999999999764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=216.31 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=188.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEE-EecCceEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDV-VHSEKKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~-~~~~~~~~lv 79 (323)
+.|.+.+.||+|.||.+-++++..++..+++|.+..... ...+|.+|+.----+ .|.||+..++. |++.+.++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 679999999999999999999999999999998865432 335666666654444 48888877655 6778899999
Q ss_pred Eecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec-CCCceEEeccccceecCCCc
Q 036739 80 FEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~-~~~~~kl~df~~~~~~~~~~ 157 (323)
+||+. |+|.+.+... .+-+....+++.|+++||.|||++++||||||.+|||+.. +..++||+|||.....+...
T Consensus 101 qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred eccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 99996 6888877653 3566777889999999999999999999999999999844 55589999999987765444
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
..... +..|.+||.... .-...+.+|+|.||+++|.++||..||
T Consensus 178 ~~~~~--------------------------------~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW 225 (378)
T KOG1345|consen 178 KYLEY--------------------------------VNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW 225 (378)
T ss_pred hhhhh--------------------------------hcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence 32221 566999998753 233567889999999999999999999
Q ss_pred CCCChHHH-HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCC---CCHhh
Q 036739 234 PGDSEIDE-LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRR---ITARS 309 (323)
Q Consensus 234 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R---~s~~~ 309 (323)
......+. +..-.+-.+... ...+..+..+|+.+.++.++-|..+|++| .+++.
T Consensus 226 Qka~~~d~~Y~~~~~w~~rk~----------------------~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 226 QKASIMDKPYWEWEQWLKRKN----------------------PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred hhhhccCchHHHHHHHhcccC----------------------ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 75322221 111111111100 01233345689999999999999999999 44444
Q ss_pred hhcCCC
Q 036739 310 ALEHEY 315 (323)
Q Consensus 310 il~h~~ 315 (323)
.....|
T Consensus 284 ~rk~~w 289 (378)
T KOG1345|consen 284 MRKCLW 289 (378)
T ss_pred HHHHHH
Confidence 444444
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=205.29 Aligned_cols=208 Identities=38% Similarity=0.577 Sum_probs=171.3
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
|.+.+.||+|++++||++....++..+++|.+...... .....+.+|+..++.++|+|++++++++......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 67889999999999999999878899999998654332 23578888999999999999999999999999999999999
Q ss_pred hh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 84 DL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 84 ~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
.+ ++.+.+...... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++. ++|+|||.+............
T Consensus 80 ~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~-~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 80 EGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL-VKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEeeCceeeEecCccccccc
Confidence 87 888777664431 678888999999999999999999999999999999998876 999999998877544310000
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC-CChHHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG-DSEIDE 241 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~-~~~~~~ 241 (323)
...++..|++||.+.....++.++|+|+||+++++|++|+.||.. ......
T Consensus 158 ----------------------------~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~ 209 (225)
T smart00221 158 ----------------------------TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSL 209 (225)
T ss_pred ----------------------------ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHH
Confidence 113366799999984436677899999999999999999999977 444433
Q ss_pred H
Q 036739 242 L 242 (323)
Q Consensus 242 ~ 242 (323)
+
T Consensus 210 ~ 210 (225)
T smart00221 210 L 210 (225)
T ss_pred H
Confidence 3
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=247.09 Aligned_cols=228 Identities=17% Similarity=0.184 Sum_probs=149.0
Q ss_pred hcCC-CCeeeeeEEE-------ecCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 036739 57 EMQH-GNIVRLQDVV-------HSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDL 128 (323)
Q Consensus 57 ~l~~-~~i~~~~~~~-------~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl 128 (323)
.++| +||.+++++| .....++.++|+.+++|.+++... ...+++..+..++.||+.||.|||++||+|+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3444 4677777766 233468889999999999998653 335788899999999999999999999999999
Q ss_pred CCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceee---hhhhhhh---ccC--ccceeecccccccccc
Q 036739 129 KPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF---SFLRYRV---LAG--SLILQFLKVVTLWYRA 200 (323)
Q Consensus 129 ~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---~~~--~~~~~~~~~~~~~y~~ 200 (323)
||+|||++..+. +|++|||.+............ ....+..... ....... ..+ .........||+.|+|
T Consensus 107 KP~NiLl~~~~~-~k~~d~~~~~~~~~~~~~~~k--i~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 107 RPSCFVMSSFNH-VSFIESASCSDSGSDEDATTK--SREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred CchhEEEcccCc-EEEeeccccCcccccccCccc--ccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999987665 777777766543321110000 0000000000 0000000 000 0011223467999999
Q ss_pred chhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccc
Q 036739 201 PEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGT 280 (323)
Q Consensus 201 PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (323)
||++.+ ..++.++|||||||++|||++|.+|+.... .....+..... .+.
T Consensus 184 PE~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~---~~~------------------------ 233 (793)
T PLN00181 184 PEEDNG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL---PPQ------------------------ 233 (793)
T ss_pred hhhhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc---Chh------------------------
Confidence 999887 568999999999999999999988865322 11111111100 000
Q ss_pred cccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 281 VVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 281 ~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.....+...+++.+||+.+|.+||++.++++||||...
T Consensus 234 -~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 -ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred -hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 00013446689999999999999999999999999763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=208.18 Aligned_cols=252 Identities=17% Similarity=0.229 Sum_probs=192.7
Q ss_pred CCcceeeeeccccceeEEEEEEccC-----CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEe-cCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT-----NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-SEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (323)
+|++..-.+.+|.||.||.+.+... .+.|.+|..+.. .+.-....+.+|--++.-+.|||++++.+... +...
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 4567777889999999999965322 235666665322 22333456667888888889999999988875 4567
Q ss_pred EEEEEecch-hhHHHhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccc
Q 036739 76 LYLVFEYLD-LDLKKHMDSCPD------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148 (323)
Q Consensus 76 ~~lv~e~~~-g~l~~~~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~ 148 (323)
.+.++++.+ |+|..++.-+++ .+........++.|++.|++|||+.|++|.||...|.++++.-. +||+|=.
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq-VkltDsa 441 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ-VKLTDSA 441 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee-EEeccch
Confidence 788899987 588888874332 23444556679999999999999999999999999999998755 9999998
Q ss_pred cceecCCC-cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH
Q 036739 149 LARAFGIP-VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~ 227 (323)
+++.+-+. -....... .....|++||.+.+ ..++.++|+||||+++|||+
T Consensus 442 LSRDLFP~DYhcLGDnE----------------------------nRPvkWMslEal~n-~~yssasDvWsfGVllWELm 492 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNE----------------------------NRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELM 492 (563)
T ss_pred hccccCcccccccCCCC----------------------------CCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHH
Confidence 88765321 11111111 11456999999988 67999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC
Q 036739 228 N-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT 306 (323)
Q Consensus 228 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 306 (323)
| |+.||..-++.+....+..+..... +-++++++..++..||...|++||+
T Consensus 493 tlg~~PyaeIDPfEm~~ylkdGyRlaQ----------------------------P~NCPDeLf~vMacCWallpeeRPs 544 (563)
T KOG1024|consen 493 TLGKLPYAEIDPFEMEHYLKDGYRLAQ----------------------------PFNCPDELFTVMACCWALLPEERPS 544 (563)
T ss_pred hcCCCCccccCHHHHHHHHhccceecC----------------------------CCCCcHHHHHHHHHHHhcCcccCCC
Confidence 9 9999999998888776665433222 2358899999999999999999999
Q ss_pred Hhhhhc
Q 036739 307 ARSALE 312 (323)
Q Consensus 307 ~~~il~ 312 (323)
.+++..
T Consensus 545 f~Qlv~ 550 (563)
T KOG1024|consen 545 FSQLVI 550 (563)
T ss_pred HHHHHH
Confidence 999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-25 Score=197.50 Aligned_cols=260 Identities=22% Similarity=0.206 Sum_probs=191.6
Q ss_pred CcceeeeeccccceeEEEEEEccCC-ceEEEEEEEecccCCCCchhHHHHHHHHHhcC----CCCeeeeeEEE-ecCceE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQ----HGNIVRLQDVV-HSEKKL 76 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~ 76 (323)
+|++.+.||+|+||.||++.+...+ ..+|+|.-....... . ..+..|..++..+. .+++..+++.+ ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~-~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK-P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC-C-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 7999999999999999999987664 578888765442222 2 26778888888887 36899999999 578899
Q ss_pred EEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC----CceEEecccccee
Q 036739 77 YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT----NALKLADFGLARA 152 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~----~~~kl~df~~~~~ 152 (323)
++||+.++.+|.+.........++...+.+++.|++.+|.+||+.|++||||||+|+++.... ..+.|+|||++..
T Consensus 97 ~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 97 FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 999999999999988766667889999999999999999999999999999999999998764 4599999999983
Q ss_pred cC--CCcccc-cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhC
Q 036739 153 FG--IPVRTF-THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ 229 (323)
Q Consensus 153 ~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg 229 (323)
.. ...... ....... ..-.||..|+|+....+ ...+.+.|+|||+.++.+++.|
T Consensus 177 ~~~~~~~~~~~~~~r~~~----------------------~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g 233 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQK----------------------GLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKG 233 (322)
T ss_pred ccccCCCCcccccCCCCc----------------------cCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcC
Confidence 22 221111 1111100 01146999999999888 6789999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
..||..........+..+......... .....+..+.++...+-..+..++|.-..
T Consensus 234 ~LPW~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~ 289 (322)
T KOG1164|consen 234 SLPWEALEMTDLKSKFEKDPRKLLTDR------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEK 289 (322)
T ss_pred CCCCccccccchHHHHHHHhhhhcccc------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHH
Confidence 999987665434333322211111000 01123345566666666677778886665
Q ss_pred hh
Q 036739 310 AL 311 (323)
Q Consensus 310 il 311 (323)
+.
T Consensus 290 ~~ 291 (322)
T KOG1164|consen 290 LA 291 (322)
T ss_pred HH
Confidence 54
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=188.78 Aligned_cols=167 Identities=19% Similarity=0.218 Sum_probs=124.4
Q ss_pred hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 85 LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 85 g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
|+|.+.+... +..+++..+..++.||+.||.|||+.+ ||+||+++.++. +++ ||.+.......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~-~~~--fG~~~~~~~~~------- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL-LKL--DGSVAFKTPEQ------- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc-eee--ccceEeecccc-------
Confidence 5677777653 335899999999999999999999998 999999998887 888 99887653211
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH-HH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE-LF 243 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~-~~ 243 (323)
..|++.|+|||++.+ ..++.++||||+||++|+|++|..||........ ..
T Consensus 64 ---------------------------~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~ 115 (176)
T smart00750 64 ---------------------------SRVDPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILE 115 (176)
T ss_pred ---------------------------CCCcccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHH
Confidence 134788999999987 5689999999999999999999999976544322 22
Q ss_pred HHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCCh--HHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEP--AGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
............ .......+++ .+.++|.+||..+|++||++.++++|+|+..
T Consensus 116 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 116 ILLNGMPADDPR----------------------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhccCCcc----------------------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 222211110000 0001112333 6899999999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=180.75 Aligned_cols=214 Identities=22% Similarity=0.282 Sum_probs=174.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCC-CCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH-GNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 80 (323)
+.|+++++||+|+||.+|++....+|+.||||+-... .....+.-|..+.+.+++ .+|+.+..++.++.+-.+||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeeccc----CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 6799999999999999999999999999999975433 233566778999999974 78888888888999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEeccccceecCCCcc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVR 158 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~~~~~~~~ 158 (323)
|.++.+|.+.+..+.. .++..++.-++.|++.-++|+|.++++|+||||+|+|+..+.. .+.++|||++..+....+
T Consensus 91 dLLGPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred eccCccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 9999999888877654 5788899999999999999999999999999999999855332 589999999988754444
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
..-.+... +..-.||..|+|-....+ ..-+...|+-|+|.++.++..|..||.+...
T Consensus 170 ~~HIpyre----------------------~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 170 RQHIPYRE----------------------DRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccCcccc----------------------CCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 32222211 222467999999888776 4568899999999999999999999998765
Q ss_pred HHHHH
Q 036739 239 IDELF 243 (323)
Q Consensus 239 ~~~~~ 243 (323)
....+
T Consensus 227 ~tk~Q 231 (341)
T KOG1163|consen 227 ATKKQ 231 (341)
T ss_pred hhHHH
Confidence 54433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-27 Score=222.53 Aligned_cols=267 Identities=29% Similarity=0.386 Sum_probs=199.9
Q ss_pred eeeeeccccceeEEEEEEccCCceEEEEEEEec----ccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRLE----QEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
-.+.+|.|++|.++.+......+.+..|.+... .........+..|+-+-..++|+|++.....+++.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 467889999998888887777777777765421 1111111125567777888899999888777776655555599
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
||.++|...+.+.. .+....+..++.|++.|+.|+|+.|+.|+|+|++|+++..++. +||+|||.+..+..+.....
T Consensus 402 ~~~~Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~-lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 402 YCPYDLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI-LKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred cccHHHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc-eEEeecCcceeeccCcchhh
Confidence 99888888888752 3566678899999999999999999999999999999999886 99999999988866655432
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
.... ..+|+-.|+|||.+.+........||||.|++++.|.+|+.||......+.
T Consensus 479 ~~~~-------------------------g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 479 HESS-------------------------GIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred hhhc-------------------------CcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 2222 235677899999999966666678999999999999999999987765433
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
...-... ............+...++...+.+|.+||+.||.+|.++.+|++.+||+.++
T Consensus 534 ~~~~~~~--------------------~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 534 SFKTNNY--------------------SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred chhhhcc--------------------ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 2200000 0000011112234455778889999999999999999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=191.58 Aligned_cols=143 Identities=20% Similarity=0.171 Sum_probs=111.9
Q ss_pred CCCcceeeeeccccceeEEEEEEcc-CCceEEEEEEEeccc---CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCV-TNETIALKKIRLEQE---DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
.++|++.+.||+|+||+||+|++.. ++..+|+|++..... .......+.+|+.+++.++|+|++..+.. .+..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 3689999999999999999998776 677789998643211 12234568899999999999998853322 2457
Q ss_pred EEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCcEEEecCCCceEEeccccceecCC
Q 036739 77 YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDL-KPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl-~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
++||||+.|..+..... .. ...++.|++.+|.+||+.||+|||| ||+||+++.++. ++|+|||++..+..
T Consensus 94 ~LVmE~~~G~~L~~~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~-ikLiDFGlA~~~~~ 164 (365)
T PRK09188 94 GLVRGWTEGVPLHLARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE-AAVIDFQLASVFRR 164 (365)
T ss_pred EEEEEccCCCCHHHhCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC-EEEEECccceeccc
Confidence 99999998854443211 11 1367889999999999999999999 999999988776 99999999988754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=179.66 Aligned_cols=207 Identities=25% Similarity=0.354 Sum_probs=175.2
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.|++.++||+|+||..+++.+..++++||||.-.... ...++..|.+..+.|. .++|+..+.+.+.+-+-.+|+|
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 5999999999999999999999999999999654332 2357788999999885 7999999999998989999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC----CCceEEeccccceecCCCc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR----TNALKLADFGLARAFGIPV 157 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~----~~~~kl~df~~~~~~~~~~ 157 (323)
.++.+|.+.+.-+.. .++.+.+..++.|++.-++++|.+.+++|||||+|+||..- .+.+.|+|||.+..+.-+.
T Consensus 105 LLGPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred hhCcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 999999888887754 58999999999999999999999999999999999999543 3369999999999987666
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
++.-.+...... ..||.+|||-....+ +.-+...|+-|||-++++.+-|..||.+.+
T Consensus 184 TkqHIPYrE~KS----------------------LsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 184 TKQHIPYREHKS----------------------LSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred ccccCccccccc----------------------cccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 654333222111 245889999999888 667999999999999999999999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-22 Score=176.06 Aligned_cols=269 Identities=35% Similarity=0.536 Sum_probs=199.7
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC-CchhHHHHHHHHHhcCCC-CeeeeeEEEecCceEEEEEe
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG-VPSTAIREISLLKEMQHG-NIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e 81 (323)
|.+...||.|+++.||++.+. ..+++|.+........ ....+.+|...++.+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778999999999999999975 7889998876654443 567888899999999988 79999999987778899999
Q ss_pred cchh-hHHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCPD-FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
++.| .+.+.+..... ..+....+..++.|++.++.++|..+++|+|+||+||+++..+..++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9987 55534333321 257888899999999999999999999999999999999987734999999998754433221
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS--RHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.... .......|+..|.+||.+... ...+...|+|++|++++++++|..||....
T Consensus 159 ~~~~-----------------------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 159 SSIP-----------------------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred cccc-----------------------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1100 011123668999999999874 468899999999999999999999987776
Q ss_pred h---HHHHHHHHHHhCCC-CCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 238 E---IDELFKIFRVLGTP-NEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 238 ~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
. .............. ..... ..... ......+.+++..++..+|..|.+..+...+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 216 NSSATSQTLKIILELPTPSLASPL-----------------SPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccHHHHHHHHHhcCCccccccc-----------------Ccccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 4 23333222221111 00000 00000 1223578899999999999999999998887
Q ss_pred CCCcc
Q 036739 314 EYFRD 318 (323)
Q Consensus 314 ~~~~~ 318 (323)
++...
T Consensus 276 ~~~~~ 280 (384)
T COG0515 276 DLLAH 280 (384)
T ss_pred hHhhC
Confidence 66543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=195.12 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=194.2
Q ss_pred eccccceeEEEEEE---ccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEEEecchh
Q 036739 10 IGEGTYGVVYKARN---CVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 10 lg~g~~~~v~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+|.|.+|.|++++. ...+.-+++|+.++..........-..|..++...+ ||.+++++..++.+...+++.++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68999999998863 234667999988776544444445566888888887 99999999999999999999999976
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
.+......... +.+..+..+...++.+++++|+.+++|+|+|++||+++.+|. +++.|||.+...-....
T Consensus 82 g~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh-i~~tdfglske~v~~~~------ 152 (612)
T KOG0603|consen 82 GDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH-IKLTDFGLSKEAVKEKI------ 152 (612)
T ss_pred chhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc-cccCCchhhhHhHhhhh------
Confidence 77777766553 466667788899999999999999999999999999999998 99999999876432211
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
.+||..|++||.+.+ ...+.|.||+|+++++|+||..||.. +....
T Consensus 153 ---------------------------~cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~ 198 (612)
T KOG0603|consen 153 ---------------------------ACGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKR 198 (612)
T ss_pred ---------------------------cccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHH
Confidence 156999999999874 57899999999999999999999988 33333
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH-----hhhhcCCCCccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA-----RSALEHEYFRDV 319 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~-----~~il~h~~~~~~ 319 (323)
+... ....++.++..+++++..++..+|..|... .++.+|+||+.+
T Consensus 199 Il~~-----------------------------~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 199 ILKA-----------------------------ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred Hhhh-----------------------------ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence 3221 112234577889999999999999999954 688999999999
Q ss_pred ccc
Q 036739 320 EFV 322 (323)
Q Consensus 320 ~~~ 322 (323)
+|.
T Consensus 250 ~~~ 252 (612)
T KOG0603|consen 250 DWN 252 (612)
T ss_pred eHh
Confidence 875
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=175.66 Aligned_cols=235 Identities=20% Similarity=0.271 Sum_probs=147.3
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC-CCchhHHHHHHHHHhcC----------CCCeeeeeEEEe-
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQ----------HGNIVRLQDVVH- 71 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~----------~~~i~~~~~~~~- 71 (323)
+...+.||.|+++.||.+++..+++.+++|++....... ...+.+++|.-....+. |-.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 456889999999999999999999999999987665222 12233333332222221 223333333332
Q ss_pred -----------cCc-----eEEEEEecchhhHHHhhh---cCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 036739 72 -----------SEK-----KLYLVFEYLDLDLKKHMD---SCPDF--ANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKP 130 (323)
Q Consensus 72 -----------~~~-----~~~lv~e~~~g~l~~~~~---~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~ 130 (323)
..+ +.+++|+.+.++|...+. ..... .........+..|++..+++||..|++|+||+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 111 347889988887766653 22221 112233445568999999999999999999999
Q ss_pred CcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC---
Q 036739 131 QNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS--- 207 (323)
Q Consensus 131 ~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--- 207 (323)
+|++++.+|. ++|+||+.....+...... ..+..|.|||.....
T Consensus 174 ~nfll~~~G~-v~Lg~F~~~~r~g~~~~~~--------------------------------~~~~~~~PPe~~~~~~~~ 220 (288)
T PF14531_consen 174 ENFLLDQDGG-VFLGDFSSLVRAGTRYRCS--------------------------------EFPVAFTPPELESCAGQF 220 (288)
T ss_dssp GGEEE-TTS--EEE--GGGEEETTEEEEGG--------------------------------GS-TTTS-HHHHHHHTSC
T ss_pred eeEEEcCCCC-EEEcChHHHeecCceeecc--------------------------------CCCcccCChhhhhhhccc
Confidence 9999999998 9999999887655322210 115669999987542
Q ss_pred ----CCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCccccccc
Q 036739 208 ----RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVR 283 (323)
Q Consensus 208 ----~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (323)
-.++.+.|.|+||+++|.|..|..||........... .+. ...
T Consensus 221 ~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------------------------~f~---------~C~ 267 (288)
T PF14531_consen 221 GQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------------------------DFS---------RCR 267 (288)
T ss_dssp HHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------------------------GGT---------TSS
T ss_pred CcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------------------------cch---------hcC
Confidence 2367789999999999999999999976643211100 000 112
Q ss_pred CCChHHHHHHHhhcccCCCCC
Q 036739 284 NLEPAGIDLLSKMLCMDPSRR 304 (323)
Q Consensus 284 ~~s~~~~~li~~~l~~dp~~R 304 (323)
++++.+++||.+||+.||.+|
T Consensus 268 ~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 268 DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ---HHHHHHHHHHT-SSGGGS
T ss_pred CcCHHHHHHHHHHccCCcccC
Confidence 588999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-24 Score=200.90 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=176.7
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHH--HHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISL--LKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+|...+.||++.|=.|.+|.+ .+..|++|++-++. +.-....+.+.+.- ...+++||.+.+.-.-..+...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~--~eG~vVvKVFvk~~-p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD--REGLVVVKVFVKQD-PTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccC--CCceEEEEEEeccC-CCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHH
Confidence 466788999999999999986 34449999996553 23333444443332 55568999998888777778888999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
+|+..+|.+.+..++- +...+.++|+.||+.||..+|..||||||||.+|||++.-+. +.|+||..=+..-.+....
T Consensus 101 qyvkhnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW-~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 101 QYVKHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW-LYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHhhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech-hhhhcccccCCccCCCCCc
Confidence 9999999999888764 356667899999999999999999999999999999998666 8999998654332222110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC----------CCCCCchhhHHHHHHHHHHHh-C
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS----------RHYSTPVDVWSVGCIFAEMVN-Q 229 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----------~~~~~~~Di~slG~ll~~l~t-g 229 (323)
+-..|+. ++-....+|.|||.+... ....++-||||+||+++||++ |
T Consensus 178 --------adf~fFF--------------DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg 235 (1431)
T KOG1240|consen 178 --------ADFTFFF--------------DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEG 235 (1431)
T ss_pred --------ccceEEE--------------ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcC
Confidence 0001110 001114579999998651 125678899999999999998 8
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccc-cCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVV-RNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
++||.-.. +....++. .... .... +--+..++.||..|++.||++|.+++
T Consensus 236 ~PlF~LSQ----L~aYr~~~-~~~~------------------------e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAe 286 (1431)
T KOG1240|consen 236 RPLFTLSQ----LLAYRSGN-ADDP------------------------EQLLEKIEDVSLRNLILSMIQRDPSKRLSAE 286 (1431)
T ss_pred CCcccHHH----HHhHhccC-ccCH------------------------HHHHHhCcCccHHHHHHHHHccCchhccCHH
Confidence 99884221 11100000 0000 0000 00134678999999999999999999
Q ss_pred hhhcC
Q 036739 309 SALEH 313 (323)
Q Consensus 309 ~il~h 313 (323)
+.|+-
T Consensus 287 dyL~~ 291 (1431)
T KOG1240|consen 287 DYLQK 291 (1431)
T ss_pred HHHHh
Confidence 99974
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=164.06 Aligned_cols=142 Identities=19% Similarity=0.137 Sum_probs=106.7
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCC-------ch-----------------hHHHHHHHHHhcCCCC
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGV-------PS-----------------TAIREISLLKEMQHGN 62 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~-------~~-----------------~~~~e~~~l~~l~~~~ 62 (323)
.+.||+|++|.||+|.+. +|++||+|+++........ .. ....|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 578999999999999986 8999999999765321111 11 2234889999998777
Q ss_pred eeeeeEEEecCceEEEEEecchhhHHH-hhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCcEEEecCCC
Q 036739 63 IVRLQDVVHSEKKLYLVFEYLDLDLKK-HMDSCPDFANDPRLIKTFLYQILRGIAYC-HSHRVLHRDLKPQNLLIDRRTN 140 (323)
Q Consensus 63 i~~~~~~~~~~~~~~lv~e~~~g~l~~-~~~~~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~i~H~dl~~~Nil~~~~~~ 140 (323)
+......... ..++||||++|+.+. ..... ..++...+..++.|++.+|.++ |+.|++|+||||+||+++. +.
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~ 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GK 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-Cc
Confidence 6443333222 238999999885432 22222 3568888999999999999999 6999999999999999984 55
Q ss_pred ceEEeccccceecCC
Q 036739 141 ALKLADFGLARAFGI 155 (323)
Q Consensus 141 ~~kl~df~~~~~~~~ 155 (323)
++|+|||++...+.
T Consensus 156 -v~LiDFG~a~~~~~ 169 (190)
T cd05147 156 -LYIIDVSQSVEHDH 169 (190)
T ss_pred -EEEEEccccccCCC
Confidence 99999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=167.14 Aligned_cols=139 Identities=13% Similarity=0.109 Sum_probs=109.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC-Cch------hHHHHHHHHHhcCCCCeeeeeEEEecC-
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG-VPS------TAIREISLLKEMQHGNIVRLQDVVHSE- 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~------~~~~e~~~l~~l~~~~i~~~~~~~~~~- 73 (323)
++|++++.+|.|+||.||++.. ++..+++|++........ ... .+.+|+..+.++.|++|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 6899999999999999999765 466899999865532221 111 257899999999999999998886533
Q ss_pred -------ceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEec
Q 036739 74 -------KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLAD 146 (323)
Q Consensus 74 -------~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~d 146 (323)
+..+++|||++|..+..+. ..++ ....+++.+|..+|..|++|||++|+||+++.++ ++++|
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liD 177 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIID 177 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEE
Confidence 3589999999984433332 1233 2456999999999999999999999999998766 99999
Q ss_pred cccceec
Q 036739 147 FGLARAF 153 (323)
Q Consensus 147 f~~~~~~ 153 (323)
||.....
T Consensus 178 fg~~~~~ 184 (232)
T PRK10359 178 LSGKRCT 184 (232)
T ss_pred CCCcccc
Confidence 9987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=192.38 Aligned_cols=237 Identities=27% Similarity=0.400 Sum_probs=170.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|..++.+..|++|.||+++++.+..++|+| +.++.. .+++ ++....+|.++
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------ilRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------ILRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hhhc---cccccCCccee-----------------
Confidence 57899999999999999999999999999994 433321 1111 22223344433
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|+-...+..-... + .+++.+++|||+.||+|+|+||+|.+++.-|. +|++|||++........+..
T Consensus 136 ---gDc~tllk~~g~l--P--------vdmvla~Eylh~ygivhrdlkpdnllIT~mGh-iKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGPL--P--------VDMVLAVEYLHSYGIVHRDLKPDNLLITSMGH-IKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ---chhhhhcccCCCC--c--------chhhHHhHhhccCCeecCCCCCCcceeeeccc-ccccchhhhhhhhhhccchh
Confidence 3333332222211 1 12378899999999999999999999999998 99999999876533322211
Q ss_pred ccccCCcCcceeehhhhhhhccCcc-ceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSL-ILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
.. .+ +..... ..+..++||+.|.|||++.. +-|+...|+|++|+|+|+.+-|..||.+..+++
T Consensus 202 ~e-----------g~----I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 202 KE-----------GH----IEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred hh-----------cc----hHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 10 00 001111 23455799999999999988 568999999999999999999999999999988
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC---CHhhhhcCCCCc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI---TARSALEHEYFR 317 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~---s~~~il~h~~~~ 317 (323)
.....+.......+. ....+++++++|.++|+.+|-+|. .+-++.+|+||+
T Consensus 266 lfg~visd~i~wpE~--------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~ 319 (1205)
T KOG0606|consen 266 LFGQVISDDIEWPEE--------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQ 319 (1205)
T ss_pred HHhhhhhhhcccccc--------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhcccee
Confidence 887766532222111 123678999999999999999998 566788899999
Q ss_pred cccc
Q 036739 318 DVEF 321 (323)
Q Consensus 318 ~~~~ 321 (323)
.++|
T Consensus 320 ~LDw 323 (1205)
T KOG0606|consen 320 LLDW 323 (1205)
T ss_pred eccc
Confidence 9876
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=172.07 Aligned_cols=197 Identities=26% Similarity=0.328 Sum_probs=140.8
Q ss_pred CCCCeeeeeEEEec---------------------------CceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHH
Q 036739 59 QHGNIVRLQDVVHS---------------------------EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQI 111 (323)
Q Consensus 59 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi 111 (323)
.||||+.+.+.|.+ ...+|+||..+..+|..++..+. .+.....-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHHHH
Confidence 49999999888732 24699999999999999998764 4667778899999
Q ss_pred HHHHHHHHhCCcccCCCCCCcEEEecCCC---ceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccce
Q 036739 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLIL 188 (323)
Q Consensus 112 ~~~L~~LH~~~i~H~dl~~~Nil~~~~~~---~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (323)
++|+.|||+.|+.|+|+|.+||++.-+.. .+.++|||.+-.-.. ......-. +.
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~-hGlqlpy~----------------------S~ 407 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDN-HGLQLPYE----------------------SD 407 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccc-cccccccc----------------------cc
Confidence 99999999999999999999999966544 589999998743211 11111000 01
Q ss_pred eeccccccccccchhhhCCCC-----CCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccC
Q 036739 189 QFLKVVTLWYRAPEILLGSRH-----YSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSL 263 (323)
Q Consensus 189 ~~~~~~~~~y~~PE~~~~~~~-----~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (323)
+-..-|.-.-++||...-.+- .-.+.|.|+.|.+-||+++..+||.+.-... + .
T Consensus 408 ~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L----------~---------- 466 (598)
T KOG4158|consen 408 EVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-L----------D---------- 466 (598)
T ss_pred cccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-e----------c----------
Confidence 111223455789998754111 1237899999999999999999997732110 0 0
Q ss_pred CcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 264 PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
.++....+.++....+++.+++++..+|+.||++|+++.
T Consensus 467 ------~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 467 ------TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ------hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 001112234455567899999999999999999999764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-22 Score=162.86 Aligned_cols=244 Identities=18% Similarity=0.232 Sum_probs=189.4
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
+..+..+|.+...|..|++++ +|..++.|++............|..|.-.++-+.||||+.+++.+.....+.++..|
T Consensus 191 ~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 344567788999999999996 566778888877766666678899999999999999999999999999999999999
Q ss_pred ch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEecCCC-ceEEeccccceecCCCcc
Q 036739 83 LD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVR 158 (323)
Q Consensus 83 ~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~~~Nil~~~~~~-~~kl~df~~~~~~~~~~~ 158 (323)
+. |+|...+....+.-.+..++.+++.+++.++.|||+.. |.---|+...++++++-. ++...|--++....
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~---- 344 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV---- 344 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeecc----
Confidence 96 68888888887777777788899999999999999873 334468889999987655 23333433332210
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCC--CCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH--YSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.....+.|++||.+...+. .-.+.|+|||++++||+.|...||...
T Consensus 345 --------------------------------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl 392 (448)
T KOG0195|consen 345 --------------------------------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL 392 (448)
T ss_pred --------------------------------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC
Confidence 0123778999999876433 234789999999999999999999988
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhh
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSAL 311 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il 311 (323)
.+.+---++-- ..-...+++.++.....|+.-|+..||.+||....|+
T Consensus 393 spmecgmkial---------------------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 393 SPMECGMKIAL---------------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred Cchhhhhhhhh---------------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 77655433210 0112345567899999999999999999999887765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-21 Score=157.32 Aligned_cols=143 Identities=17% Similarity=0.137 Sum_probs=109.4
Q ss_pred eeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCC------------------------chhHHHHHHHHHhcCCC
Q 036739 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGV------------------------PSTAIREISLLKEMQHG 61 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~~~ 61 (323)
+.+.||+|++|+||+|.+. +|+.||+|++......... ...+..|...+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 8999999998765321000 11235688899999998
Q ss_pred CeeeeeEEEecCceEEEEEecchhh-HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCC
Q 036739 62 NIVRLQDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRT 139 (323)
Q Consensus 62 ~i~~~~~~~~~~~~~~lv~e~~~g~-l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~ 139 (323)
++.....+.... .++||||++|. +....... ..++...+..++.|++.+|.++|+ .|++|+||||+||+++ ++
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 875544443332 47999999875 33332222 245777888999999999999999 9999999999999998 56
Q ss_pred CceEEeccccceecCC
Q 036739 140 NALKLADFGLARAFGI 155 (323)
Q Consensus 140 ~~~kl~df~~~~~~~~ 155 (323)
. ++|+|||.+...+.
T Consensus 155 ~-~~liDFG~a~~~~~ 169 (190)
T cd05145 155 K-PYIIDVSQAVELDH 169 (190)
T ss_pred C-EEEEEcccceecCC
Confidence 5 99999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-21 Score=184.77 Aligned_cols=194 Identities=23% Similarity=0.323 Sum_probs=152.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC---CCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ---HGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 78 (323)
+.|.|.+.+|+|++|+||+|.... |+.||+|+-+.. ..-+|.--..++.+|+ -+.|+.+..++...+.-++
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~-----~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPP-----NPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCC-----CceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 357899999999999999999844 999999975322 2344554555666666 3455666666666777789
Q ss_pred EEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec------CCCceEEeccccce
Q 036739 79 VFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR------RTNALKLADFGLAR 151 (323)
Q Consensus 79 v~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~------~~~~~kl~df~~~~ 151 (323)
|+||.+ |+|++.+.. ..-+++..+..++.|++..+++||..+|+||||||+|+++.. +...++|+|||.+.
T Consensus 772 v~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 999996 688888883 345788899999999999999999999999999999999943 23369999999998
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCC
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~ 231 (323)
.+..-....... .+++|-.+-.+|+..+ +++++..|.|+|+.+++-|++|+-
T Consensus 850 Dm~lfp~~~~F~---------------------------~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFK---------------------------AVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEe---------------------------eeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence 775544431111 1355777999999999 889999999999999999999873
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.9e-20 Score=149.59 Aligned_cols=201 Identities=18% Similarity=0.080 Sum_probs=138.3
Q ss_pred ceeeeeccccceeEEEEEEccCCceEEEEEEEecccC--CCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEEEe
Q 036739 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED--EGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 81 (323)
-+...|++|+||+|+++.. .+.+++.+.+.....- .-....+.+|+++++++. ++++++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4678899999999998874 6778887776433321 111125788999999995 5889999885 34689999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDL-KPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl-~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.|..+...... . ...++.|++.+|.++|..|++|+|| ||+||+++.++. ++|+|||++...+......
T Consensus 79 yI~G~~L~~~~~~-----~---~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~-i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 79 YLAGAAMYQRPPR-----G---DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS-PAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eecCccHHhhhhh-----h---hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC-EEEEECCCceecCCcchHH
Confidence 9988544322111 1 1357789999999999999999999 799999998877 9999999998654322110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCC-CchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYS-TPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
. .+.++.+..- ....+.+++.|++|+...--...+ ...+.++.|+-+|.++|+..+.-++
T Consensus 150 r--------------~L~~rDl~~l--lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 150 R--------------LLAREDLRHL--LKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred H--------------HHHHHHHHHH--HHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0000000000 011123477888888765432334 5678889999999999999876443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-19 Score=148.49 Aligned_cols=145 Identities=18% Similarity=0.135 Sum_probs=109.1
Q ss_pred cceeeeeccccceeEEEEE-EccCCceEEEEEEEecccCCC----------------------CchhHHHHHHHHHhcCC
Q 036739 4 YEKVEKIGEGTYGVVYKAR-NCVTNETIALKKIRLEQEDEG----------------------VPSTAIREISLLKEMQH 60 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~-~~~~~~~~aiK~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~~ 60 (323)
|++.+.||+|++|.||+|+ +..+|..||+|++........ ....+..|+..++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7788999999999999999 667899999999875432100 01234679999999975
Q ss_pred C--CeeeeeEEEecCceEEEEEecchhh-HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCcEEEe
Q 036739 61 G--NIVRLQDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR-VLHRDLKPQNLLID 136 (323)
Q Consensus 61 ~--~i~~~~~~~~~~~~~~lv~e~~~g~-l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-i~H~dl~~~Nil~~ 136 (323)
. .++++++. ...++||||++|. +....... .......+..++.||+.+|.+||+.| ++|+||||+||+++
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 3 34444442 2358999999984 43333222 23455567789999999999999999 99999999999999
Q ss_pred cCCCceEEeccccceecCCC
Q 036739 137 RRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 137 ~~~~~~kl~df~~~~~~~~~ 156 (323)
++. ++|+|||.+...+.+
T Consensus 184 -~~~-i~LiDFg~a~~~~~~ 201 (237)
T smart00090 184 -DGK-VVIIDVSQSVELDHP 201 (237)
T ss_pred -CCC-EEEEEChhhhccCCc
Confidence 555 999999998765543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.8e-18 Score=140.86 Aligned_cols=137 Identities=18% Similarity=0.286 Sum_probs=103.4
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-----CCCCeeeeeEEEecCc---e
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-----QHGNIVRLQDVVHSEK---K 75 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~ 75 (323)
+.-...||+|+++.||. +..++.. +||++..... .....+.+|+..++.+ .||||++++++++++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 34467899999999995 5555554 6998865322 2346789999999999 5799999999998763 4
Q ss_pred -EEEEEecch---hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCcccCCCCCCcEEEecCC---CceEEecc
Q 036739 76 -LYLVFEYLD---LDLKKHMDSCPDFANDPRLIKTFLYQILRGI-AYCHSHRVLHRDLKPQNLLIDRRT---NALKLADF 147 (323)
Q Consensus 76 -~~lv~e~~~---g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L-~~LH~~~i~H~dl~~~Nil~~~~~---~~~kl~df 147 (323)
+.+|+||.+ |+|.+.+.+. .+++. ..++.|++.++ +|||+.+|+|+||||+||+++..+ ..++|+|+
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 347899954 5888777553 24444 25577888777 999999999999999999997533 25999994
Q ss_pred ccc
Q 036739 148 GLA 150 (323)
Q Consensus 148 ~~~ 150 (323)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=157.26 Aligned_cols=207 Identities=23% Similarity=0.349 Sum_probs=150.3
Q ss_pred HHhcCCCCeeeeeEEEecCceEEEEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccCCCCCCc
Q 036739 55 LKEMQHGNIVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV-LHRDLKPQN 132 (323)
Q Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i-~H~dl~~~N 132 (323)
|+.+.|.|+.+++|.+.+++..++|.+||+ |++.+.+.. ....++.-....++++|+.+|.|||+..| +||.+++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 357889999999999999999999999996 566666555 55567777788899999999999998765 899999999
Q ss_pred EEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC---C-
Q 036739 133 LLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS---R- 208 (323)
Q Consensus 133 il~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~- 208 (323)
.+++..+. +||+|||+...... ...... .. .......|.|||.+... .
T Consensus 80 Clvd~~w~-lklt~~Gl~~~~~~-~~~~~~---~~-----------------------~~~~~~lw~aPellr~~~~~~~ 131 (484)
T KOG1023|consen 80 CLVDSRWV-LKLTDFGLNSLLEE-TAEPEA---HH-----------------------PIRKALLWTAPELLRGALSQSL 131 (484)
T ss_pred ceeeeeEE-EEechhhhcccccc-cccccc---cc-----------------------hhHHHHhccCHHHhcccccccc
Confidence 99999887 99999999877643 000000 00 00125569999998763 1
Q ss_pred --CCCCchhhHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccc
Q 036739 209 --HYSTPVDVWSVGCIFAEMVNQRPLFPGDSE----IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVV 282 (323)
Q Consensus 209 --~~~~~~Di~slG~ll~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (323)
..+.+.|+||+|++++|+++...||..... .+.+..+.+....+.-+. .. ..
T Consensus 132 ~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~---i~-------------------~~ 189 (484)
T KOG1023|consen 132 ESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPS---IE-------------------LL 189 (484)
T ss_pred cccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcc---hh-------------------hh
Confidence 146778999999999999999999976322 223333322010000000 00 00
Q ss_pred cCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 283 RNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 283 ~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
..+.+.+..+++.|+..+|+.||+++++-.
T Consensus 190 ~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 190 NELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred hhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 134567889999999999999999987753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-17 Score=138.05 Aligned_cols=136 Identities=19% Similarity=0.224 Sum_probs=108.5
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCC------CchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG------VPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++.||+|++|.||++.. .+..+++|.......... ....+.+|+.++..+.++++.....++.+....+++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999986 777899997643322111 1235667999999999999887777777778889999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
||++| ++.+.+.... . .+..++.+++.+|.++|+.+++|+|++|.||+++ ++. ++++|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~-~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGK-IYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCC-EEEEECCcccC
Confidence 99987 6665554321 1 5778999999999999999999999999999999 555 99999998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-19 Score=169.13 Aligned_cols=266 Identities=26% Similarity=0.357 Sum_probs=201.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCC-ceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 79 (323)
..|.+.+.||+|+++.|-++.+..+. ..++.|.+...............|..+.+.+. |+|++.+++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 46889999999999999998864433 35666655444434444555666888888887 99999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEEecCCCceEEeccccceecCC-C
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH-SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-P 156 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~-~ 156 (323)
+++..| ++...+........+...+..++.|+..++.|+| ..++.|+||+|+|.+++.++..+++.|||++..+.. .
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 999876 6666662222213455557789999999999999 999999999999999999883399999999988765 2
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeecccc-ccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVV-TLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.... .....+| ++.|++||...+........|+||.|+++..+++|..||..
T Consensus 180 g~~~---------------------------~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~ 232 (601)
T KOG0590|consen 180 GAER---------------------------SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDF 232 (601)
T ss_pred Ccce---------------------------eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccc
Confidence 2111 1112355 88899999998866778899999999999999999999977
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
....+....-. ... ........+..++....+++.+++..+|+.|.+.+++-.+||
T Consensus 233 ~~~~~~~~~~~--------------------~~~----~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~ 288 (601)
T KOG0590|consen 233 PSRKDGRYSSW--------------------KSN----KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNW 288 (601)
T ss_pred cccccccceee--------------------ccc----ccccccCccccCChhhhhcccccccCCchhcccccccccccc
Confidence 65543211100 000 001112334568888999999999999999999999999999
Q ss_pred Ccc
Q 036739 316 FRD 318 (323)
Q Consensus 316 ~~~ 318 (323)
+..
T Consensus 289 ~~~ 291 (601)
T KOG0590|consen 289 LSS 291 (601)
T ss_pred ccc
Confidence 987
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-18 Score=154.23 Aligned_cols=184 Identities=27% Similarity=0.437 Sum_probs=130.9
Q ss_pred ceEEEEEecchh-hHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccce
Q 036739 74 KKLYLVFEYLDL-DLKKHMDS-CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (323)
Q Consensus 74 ~~~~lv~e~~~g-~l~~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~ 151 (323)
.++||.|++|.- +|.+++.. +.....+......++.|++.++.| ++.+|+|+||.||++..+.. +||.|||+..
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q-~kIgDFgl~t 404 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ-LKIGDFGLVT 404 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh-hhhhhhhhee
Confidence 368999999965 77777763 334455667788999999999999 99999999999999988776 9999999988
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhC-C
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ-R 230 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg-~ 230 (323)
...............+ ..+||+.|++||.+.+ +.|+.++|||+||+|++|++.. .
T Consensus 405 s~~~~~~~~~~~a~~t-----------------------~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~ 460 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHT-----------------------QQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFS 460 (516)
T ss_pred ecccCCcccchhhhhh-----------------------hcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhc
Confidence 7765552221111111 2377999999999999 7799999999999999999972 2
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh
Q 036739 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310 (323)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i 310 (323)
.++..... ...+. ...++ + ...... +.-..|+++|+.+.|++||++.+.
T Consensus 461 T~~er~~t---~~d~r-------~g~ip----------------~----~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 461 TQFERIAT---LTDIR-------DGIIP----------------P----EFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cHHHHHHh---hhhhh-------cCCCC----------------h----HHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 22211110 01111 11110 0 001112 234599999999999999988887
Q ss_pred hcCCCC
Q 036739 311 LEHEYF 316 (323)
Q Consensus 311 l~h~~~ 316 (323)
--|+|.
T Consensus 510 ~~~~~~ 515 (516)
T KOG1033|consen 510 ALHEFL 515 (516)
T ss_pred hhhhhc
Confidence 778775
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=135.65 Aligned_cols=141 Identities=23% Similarity=0.245 Sum_probs=106.0
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC--------------------CchhHHHHHHHHHhcCCCC-
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG--------------------VPSTAIREISLLKEMQHGN- 62 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~~~~- 62 (323)
|.+.+.||+|++|.||++... +|+.+|+|++........ .......|...+..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 778899999999999999874 799999998764321100 1123567888888887764
Q ss_pred -eeeeeEEEecCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCc
Q 036739 63 -IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA 141 (323)
Q Consensus 63 -i~~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~ 141 (323)
++..++ ....+++|||+.|..+..+... .....++.+++.++.++|+.|++|+||+|.||+++.++.
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~- 163 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK- 163 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc-
Confidence 444443 2445899999988554443321 224578899999999999999999999999999998776
Q ss_pred eEEeccccceecCCCc
Q 036739 142 LKLADFGLARAFGIPV 157 (323)
Q Consensus 142 ~kl~df~~~~~~~~~~ 157 (323)
++|+|||.+.......
T Consensus 164 ~~liDfg~~~~~~~~~ 179 (198)
T cd05144 164 IYIIDWPQMVSTDHPN 179 (198)
T ss_pred EEEEECCccccCCCcc
Confidence 9999999997665433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.1e-17 Score=133.83 Aligned_cols=132 Identities=20% Similarity=0.261 Sum_probs=101.4
Q ss_pred eeccccceeEEEEEEccCCceEEEEEEEecccCCC------CchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEec
Q 036739 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG------VPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 9 ~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
.||+|++|.||++. ..+..+++|.......... ....+.+|+.+++.+.++++.....++......+++|||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 37999999999998 4678899998643321111 124566799999999988765555555566677899999
Q ss_pred chh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 83 LDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 83 ~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
++| ++.+.+.... . .++.+++.+|.+||+.|++|+|++|.||+++ ++. ++++|||.+...
T Consensus 79 ~~g~~l~~~~~~~~-----~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~-~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGN-----D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK-LYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcH-----H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc-EEEEECCCCcCC
Confidence 987 5555443311 0 6889999999999999999999999999999 555 999999988663
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=130.32 Aligned_cols=135 Identities=22% Similarity=0.216 Sum_probs=97.0
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchh----------------------HHHHHHHHHhcCCCC--
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPST----------------------AIREISLLKEMQHGN-- 62 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~~~~-- 62 (323)
.+.||+|++|+||+|.+. +++.||+|++............ ...|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999985 7899999998654321111111 134555566654433
Q ss_pred eeeeeEEEecCceEEEEEecchh-----hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEe
Q 036739 63 IVRLQDVVHSEKKLYLVFEYLDL-----DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLID 136 (323)
Q Consensus 63 i~~~~~~~~~~~~~~lv~e~~~g-----~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~ 136 (323)
++++++. ...+++|||++| ..+..... . ..+..++.+++.++.++|. .|++|+||+|+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~------~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL------L-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhh------c-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 4444443 235899999987 22222211 1 4467899999999999999 9999999999999999
Q ss_pred cCCCceEEeccccceecCC
Q 036739 137 RRTNALKLADFGLARAFGI 155 (323)
Q Consensus 137 ~~~~~~kl~df~~~~~~~~ 155 (323)
++. ++++|||.+.....
T Consensus 150 -~~~-~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGK-VYIIDVPQAVEIDH 166 (187)
T ss_pred -CCc-EEEEECcccccccC
Confidence 565 99999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.5e-16 Score=149.02 Aligned_cols=136 Identities=20% Similarity=0.208 Sum_probs=105.7
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC------CCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE------GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
|...+.||+|++|+||++.. .+..+++|+........ ...+.+.+|+.+++.++|++++....++.+....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~--~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEY--LGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEee--cCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 45678999999999999986 34445555432221111 11245778999999999999988877777777789
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
+||||++| ++.+.+. ....++.+++.+|.+||+.|++||||||+||+++ ++. ++|+|||.+...
T Consensus 413 lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~~-~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDR-LYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CCc-EEEEeCcccccC
Confidence 99999987 5555543 2457899999999999999999999999999994 455 999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4e-15 Score=136.71 Aligned_cols=168 Identities=20% Similarity=0.311 Sum_probs=128.8
Q ss_pred EEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh--hHHHhhhcCCCC
Q 036739 20 KARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL--DLKKHMDSCPDF 97 (323)
Q Consensus 20 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g--~l~~~~~~~~~~ 97 (323)
.+..+..+.++.+.+++.... ...+...+.+..++.++||||+++++.+..++..|+|||.+.. ..++.+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~----- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELG----- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhH-----
Confidence 466667889999998866544 5567788899999999999999999999999999999999964 3333322
Q ss_pred CCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehh
Q 036739 98 ANDPRLIKTFLYQILRGIAYCH-SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176 (323)
Q Consensus 98 ~~~~~~~~~i~~qi~~~L~~LH-~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (323)
...++..+.||+.||.+|| +++++|+||+.+.|+++..|. +||++|.++........ ....
T Consensus 103 ---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge-WkLggle~v~~~~~~~~--~~~~------------ 164 (690)
T KOG1243|consen 103 ---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE-WKLGGLELVSKASGFNA--PAKS------------ 164 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc-EEEeeeEEEeccccCCc--cccc------------
Confidence 5568889999999999998 678999999999999999998 99999998865422111 0000
Q ss_pred hhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
...-..|..|+.+..+ .-..|.|.|||++++++.|.
T Consensus 165 ---------------~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 165 ---------------LYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ---------------chhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCcc
Confidence 0002236677755442 24569999999999999993
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.6e-15 Score=117.88 Aligned_cols=133 Identities=20% Similarity=0.236 Sum_probs=108.5
Q ss_pred eeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCC--CCeeeeeEEEecCceEEEEEecc
Q 036739 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH--GNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
+++.||+|.++.||++... +..+++|....... ...+.+|...++.+++ .++++++.++...+..++++||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 5688999999999999973 37899998743321 4678899999999976 58999999888888999999999
Q ss_pred hhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 84 DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 84 ~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
.|.....+ +......++.+++.+|..||.. +++|+|++|.||+++..+. ++++||+.+...
T Consensus 76 ~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~-~~l~Df~~~~~~ 139 (155)
T cd05120 76 EGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI-LGIIDWEYAGYG 139 (155)
T ss_pred CCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE-EEEEecccccCC
Confidence 87544332 3344567889999999999985 6999999999999998655 999999988654
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.8e-15 Score=124.23 Aligned_cols=136 Identities=19% Similarity=0.212 Sum_probs=101.9
Q ss_pred eeec-cccceeEEEEEEccCCceEEEEEEEecc------c-----CCCCchhHHHHHHHHHhcCCCCe--eeeeEEEecC
Q 036739 8 EKIG-EGTYGVVYKARNCVTNETIALKKIRLEQ------E-----DEGVPSTAIREISLLKEMQHGNI--VRLQDVVHSE 73 (323)
Q Consensus 8 ~~lg-~g~~~~v~~~~~~~~~~~~aiK~~~~~~------~-----~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~ 73 (323)
..|| .|+.|+||.+.. .+..+++|.+.... . .......+.+|+.++..+.|+++ ++.+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 899999999985 47789999885421 0 11223567789999999998775 6666664332
Q ss_pred -c---eEEEEEecchh--hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 74 -K---KLYLVFEYLDL--DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 74 -~---~~~lv~e~~~g--~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
. ..++|||++.| ++.+.+... .+++. .+.+|+.+|.+||++||+|+||||.|||++.++. ++|+||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~-v~LIDf 186 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGK-FWLIDF 186 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC-EEEEEC
Confidence 2 23599999986 565555432 33443 3678999999999999999999999999998776 999999
Q ss_pred ccceec
Q 036739 148 GLARAF 153 (323)
Q Consensus 148 ~~~~~~ 153 (323)
|.+...
T Consensus 187 g~~~~~ 192 (239)
T PRK01723 187 DRGELR 192 (239)
T ss_pred CCcccC
Confidence 988764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.8e-16 Score=129.99 Aligned_cols=211 Identities=19% Similarity=0.206 Sum_probs=145.3
Q ss_pred HHHHHHHhcCCCCeeeeeEEEecC-----ceEEEEEecch-hhHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 036739 50 REISLLKEMQHGNIVRLQDVVHSE-----KKLYLVFEYLD-LDLKKHMDSCP--DFANDPRLIKTFLYQILRGIAYCHSH 121 (323)
Q Consensus 50 ~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~-g~l~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~ 121 (323)
.-+..+-++.|.|+++++.++.+. ....+++||++ |++.+++.+.. ...+......+|+.||++||.|||+.
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 344456666799999999998653 46899999996 67777765432 34567778889999999999999988
Q ss_pred --CcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccc
Q 036739 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYR 199 (323)
Q Consensus 122 --~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 199 (323)
-|+|+++....|++..++. +|+..-.................... .+-++|.
T Consensus 196 ~PpiihgnlTc~tifiq~ngL-Ikig~~ap~s~h~s~~~~~~~Ek~~~-------------------------~~~~g~~ 249 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGL-IKIGSVAPDSTHPSVNSTREAEKSVN-------------------------TSLPGFS 249 (458)
T ss_pred CCccccCCcchhheeecCCce-EEecccCccccchhhhhhhHhhhhcc-------------------------ccCCccc
Confidence 5999999999999998887 78765444333322222221111111 2256789
Q ss_pred cchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC-CC---hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCC
Q 036739 200 APEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG-DS---EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPS 275 (323)
Q Consensus 200 ~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (323)
+||+-.. .....++|||++|+...+|..+..--.. .. ..+.++.....+
T Consensus 250 a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l-------------------------- 302 (458)
T KOG1266|consen 250 APESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL-------------------------- 302 (458)
T ss_pred cCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec--------------------------
Confidence 9997544 3456789999999999999887643211 11 111121111100
Q ss_pred CcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccccc
Q 036739 276 KELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVEFV 322 (323)
Q Consensus 276 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~~~ 322 (323)
-.+.-+.+|++|+...|..||++.+++.||.+-+|+.+
T Consensus 303 ---------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhsl 340 (458)
T KOG1266|consen 303 ---------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSL 340 (458)
T ss_pred ---------cCccccCcCcccccCCCCCCcchhhhhcCceeeecchH
Confidence 11122478899999999999999999999998887643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.5e-15 Score=135.62 Aligned_cols=264 Identities=20% Similarity=0.188 Sum_probs=193.7
Q ss_pred Ccceeeeecc--ccceeEEEEEE--ccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEE
Q 036739 3 QYEKVEKIGE--GTYGVVYKARN--CVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 3 ~y~~~~~lg~--g~~~~v~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 77 (323)
.+.+.+.+|. |.++.+|.+.. ..++..+|+|.-+...........=.+++...+.+. |++.++.+..+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4567888999 99999999988 778889999975444332222233334555656664 899999899999999999
Q ss_pred EEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 78 LVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILR----GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 78 lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~----~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
+-+|.++.++.++...... .+++..+...+.+... ||.++|+.+++|.|++|.||+...++...+++||+....+
T Consensus 195 iqtE~~~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 195 IQTELCGESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred eeeccccchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEc
Confidence 9999999888877665433 3567778888889998 9999999999999999999999999555999999999988
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
+........... ....|.-.|++||...+ -++..+|+|++|.++.+-.+|..+.
T Consensus 274 ~~~~~~~~~~~~------------------------~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 274 SDGNFSSVFKVS------------------------KRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred cCCccccceeee------------------------ecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccc
Confidence 766543322211 11123556999999876 4788999999999999998887655
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.........+ ++.+- .........+..+...+..|++.+|-.|+++..+..|
T Consensus 328 ~~g~~~~W~~--------------------------~r~~~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 328 SVGKNSSWSQ--------------------------LRQGY--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cCCCCCCccc--------------------------ccccc--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 4432110000 00000 0112233456667779999999999999999999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
++.....+
T Consensus 380 ~~i~s~~~ 387 (524)
T KOG0601|consen 380 NVIHSKLF 387 (524)
T ss_pred ccccchhh
Confidence 98876544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.3e-15 Score=143.94 Aligned_cols=291 Identities=24% Similarity=0.293 Sum_probs=198.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
++.+.+.+-+.+|.++.++.+.-...|...++|+...... .....+....+-.++-...+|-++.....+.-....+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 3567788889999999999998777787777776544321 222223333333333333455555555555556788999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
++|++| ++...+.... ..+++.++..+..+..++++||...+.|+|++|.|.+...++. .++.||+.....+.-..
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh-~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH-RPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC-cccCccccccccccccC
Confidence 999976 6665555443 4566667778888999999999999999999999999999998 89999985544433222
Q ss_pred ccccc--ccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 159 TFTHE--HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 159 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
..... ....................+.........||+.|.+||...+ ..-....|.|+.|+.+++.++|.+||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 22111 1000100111111111222222344677889999999999998 44578889999999999999999999888
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh---hhhcC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR---SALEH 313 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~---~il~h 313 (323)
.+......+..+ ...|+ ......++.+++++..++..+|.+|..+. ++-.|
T Consensus 1039 tpq~~f~ni~~~-----~~~~p---------------------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~ 1092 (1205)
T KOG0606|consen 1039 TPQQIFENILNR-----DIPWP---------------------EGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGH 1092 (1205)
T ss_pred chhhhhhccccC-----CCCCC---------------------CCccccChhhhhhhhhhhccCchhccCcccccccccC
Confidence 775555333221 11111 12234678899999999999999999888 77789
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
+||++++|
T Consensus 1093 ~~~~~~~~ 1100 (1205)
T KOG0606|consen 1093 PFFQDVDW 1100 (1205)
T ss_pred CccCCCCc
Confidence 99999976
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.1e-12 Score=106.61 Aligned_cols=141 Identities=21% Similarity=0.176 Sum_probs=100.4
Q ss_pred eeeeccccceeEEEEEEcc------CCceEEEEEEEeccc-----------C---------CCCchhHH----HHHHHHH
Q 036739 7 VEKIGEGTYGVVYKARNCV------TNETIALKKIRLEQE-----------D---------EGVPSTAI----REISLLK 56 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~------~~~~~aiK~~~~~~~-----------~---------~~~~~~~~----~e~~~l~ 56 (323)
...||.|--+.||.|.... .+..+|+|+++.... + ......+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998643 357999998864421 0 11122333 6888888
Q ss_pred hcCC--CCeeeeeEEEecCceEEEEEecchhh-HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCc
Q 036739 57 EMQH--GNIVRLQDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFLYQILRGIAYC-HSHRVLHRDLKPQN 132 (323)
Q Consensus 57 ~l~~--~~i~~~~~~~~~~~~~~lv~e~~~g~-l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~i~H~dl~~~N 132 (323)
++.. -++++.++. ...++|||+++++ +...... ...++......+..+++.+|..| |+.|++||||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 8864 455666654 4568999999863 2221111 11234455667889999999988 89999999999999
Q ss_pred EEEecCCCceEEeccccceecCC
Q 036739 133 LLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 133 il~~~~~~~~kl~df~~~~~~~~ 155 (323)
|+++. +. +.++|||.+.....
T Consensus 156 IL~~~-~~-v~iIDF~qav~~~h 176 (197)
T cd05146 156 MLWHD-GK-VWFIDVSQSVEPTH 176 (197)
T ss_pred EEEEC-Cc-EEEEECCCceeCCC
Confidence 99974 55 99999999877643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.8e-12 Score=101.64 Aligned_cols=151 Identities=19% Similarity=0.235 Sum_probs=112.3
Q ss_pred eeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCC-----CchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEG-----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
.+..+-+|+-+.|+++. ..|+...||.-..+. .+.. ......+|.+.+.++.--+|....-++-+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 46678899999999998 478888888543221 1111 224555788888888765665555566667777899
Q ss_pred Eecchh--hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCce--EEeccccceecCC
Q 036739 80 FEYLDL--DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNAL--KLADFGLARAFGI 155 (323)
Q Consensus 80 ~e~~~g--~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~--kl~df~~~~~~~~ 155 (323)
||+++| ++.+++.+.-...........++.+|-+.+.-||..+++||||+++||++..++..+ .++|||++..-..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~~ 168 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSRL 168 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcccC
Confidence 999998 778887765544444444468899999999999999999999999999998877755 8999999876544
Q ss_pred Ccc
Q 036739 156 PVR 158 (323)
Q Consensus 156 ~~~ 158 (323)
+..
T Consensus 169 ~ED 171 (229)
T KOG3087|consen 169 PED 171 (229)
T ss_pred ccc
Confidence 433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.3e-12 Score=118.39 Aligned_cols=143 Identities=20% Similarity=0.227 Sum_probs=93.3
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCC----------------------C--C--------------chhH
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE----------------------G--V--------------PSTA 48 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~----------------------~--~--------------~~~~ 48 (323)
.+.||+|+.|+||+|+. .+|+.||||+.+...... . . .-.+
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 35799999999999987 578999999985432100 0 0 0023
Q ss_pred HHHHHHHHhcC----CCCeeeeeEEE-ecCceEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 036739 49 IREISLLKEMQ----HGNIVRLQDVV-HSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILR-GIAYCHSH 121 (323)
Q Consensus 49 ~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~-~L~~LH~~ 121 (323)
.+|...+.++. +.+-+.+-..+ ...+..++||||++| ++.+....... ..+ ...++.+++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhC
Confidence 34555555552 22222222222 224457999999988 44333321111 111 2345666665 57889999
Q ss_pred CcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 122 ~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
|++|+|++|.||+++.++. ++++|||.+..+..
T Consensus 277 g~~H~D~hPgNilv~~~g~-i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGK-IIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEECCCCc-EEEEeCCCeeECCH
Confidence 9999999999999988877 99999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.4e-12 Score=103.38 Aligned_cols=128 Identities=20% Similarity=0.173 Sum_probs=93.5
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCe-eeeeEEEecCceEEEEEecchh
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-VRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~g 85 (323)
++.++.|.++.||+++. .+..+++|....... ....+..|+..++.+.+.++ ++++... ....++|||+++|
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence 56789999999999986 477899998643321 12356788999998865443 4555543 3345799999998
Q ss_pred hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccCCCCCCcEEEecCCCceEEecccccee
Q 036739 86 DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV-----LHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i-----~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
....... .. ...++.+++.+|..||+.++ +|+|++|.||+++ ++. ++++||+.+..
T Consensus 76 ~~l~~~~------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~-~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTED------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGR-LWLIDWEYAGM 136 (170)
T ss_pred Ccccccc------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCe-EEEEecccccC
Confidence 4432210 11 12456789999999999885 9999999999999 455 99999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.1e-11 Score=106.49 Aligned_cols=213 Identities=15% Similarity=0.236 Sum_probs=155.3
Q ss_pred cceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec----CceEEEEEecchh--hH
Q 036739 14 TYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS----EKKLYLVFEYLDL--DL 87 (323)
Q Consensus 14 ~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~g--~l 87 (323)
...+.|+++...+|..|++|.+... ..........-+++++++.|.|++++.+.|.. +..+++|++|..+ +|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~--r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGD--RDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccc--cccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 4568999999999999999988322 12223344567889999999999999999873 4578999999964 66
Q ss_pred HHhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 88 KKHMDSCP-------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 88 ~~~~~~~~-------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
.+..-... +...+++.++.++.|+..||.++|+.|+..+-|.+.+|+++.+. +++|+..|....+.
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceeeec
Confidence 65553222 12346788999999999999999999999999999999999766 49999888776553
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCC-CC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP-LF 233 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~-p~ 233 (323)
.+.. |.+ .-.++.|.-.||.+++.|.||.. -+
T Consensus 445 ~d~~-------------------------------------------~~l----e~~Qq~D~~~lG~ll~aLAt~~~ns~ 477 (655)
T KOG3741|consen 445 EDPT-------------------------------------------EPL----ESQQQNDLRDLGLLLLALATGTENSN 477 (655)
T ss_pred CCCC-------------------------------------------cch----hHHhhhhHHHHHHHHHHHhhcccccc
Confidence 2220 111 12457799999999999999963 23
Q ss_pred CCCChHHH-HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 234 PGDSEIDE-LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 234 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
......+. +..+ ....|.+++++|.-+...++.+ .++.+++.
T Consensus 478 ~~d~~~~s~~~~I------------------------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 478 RTDSTQSSHLTRI------------------------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred cccchHHHHHHHh------------------------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence 33322222 1111 1346788889999998888877 77888776
Q ss_pred C
Q 036739 313 H 313 (323)
Q Consensus 313 h 313 (323)
+
T Consensus 521 ~ 521 (655)
T KOG3741|consen 521 M 521 (655)
T ss_pred H
Confidence 3
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=8.6e-13 Score=122.83 Aligned_cols=145 Identities=14% Similarity=0.235 Sum_probs=91.7
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC---------------------C-----------CCch----
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED---------------------E-----------GVPS---- 46 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---------------------~-----------~~~~---- 46 (323)
.|.. +.||+|+.|+||+|+.+.+|+.||+|+..+.... . +...
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 7899999999999999777999999999654210 0 0001
Q ss_pred --hHHHHHHHHHhcC----CCCeeeeeEEEec-CceEEEEEecchh-hHHHh--hhcCCCC---CCCHHHHHHHHHHHHH
Q 036739 47 --TAIREISLLKEMQ----HGNIVRLQDVVHS-EKKLYLVFEYLDL-DLKKH--MDSCPDF---ANDPRLIKTFLYQILR 113 (323)
Q Consensus 47 --~~~~e~~~l~~l~----~~~i~~~~~~~~~-~~~~~lv~e~~~g-~l~~~--~~~~~~~---~~~~~~~~~i~~qi~~ 113 (323)
.+.+|+..+.++. +.+.+.+-..|.+ .+..++||||+.| .+.+. +... +. .+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~-g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA-GTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc-CCCHHHHHHHHHHHHHHH---
Confidence 2333444444442 3333443344432 5567899999988 44332 2211 11 1222223333333
Q ss_pred HHHHHHhCCcccCCCCCCcEEEecCC---CceEEeccccceecCCC
Q 036739 114 GIAYCHSHRVLHRDLKPQNLLIDRRT---NALKLADFGLARAFGIP 156 (323)
Q Consensus 114 ~L~~LH~~~i~H~dl~~~Nil~~~~~---~~~kl~df~~~~~~~~~ 156 (323)
+...|++|+|++|.||+++.++ ..++++|||.+..++..
T Consensus 276 ----if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 ----VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ----HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 4468999999999999999877 13999999999887544
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.5e-12 Score=117.35 Aligned_cols=165 Identities=22% Similarity=0.330 Sum_probs=115.7
Q ss_pred HHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCcc
Q 036739 108 LYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSL 186 (323)
Q Consensus 108 ~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (323)
+.+.+.|+.++|. .++||++|.|++|.++.++. +||..|+++.....+.. ..-..++..-....
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~-wkl~Gf~f~v~~~~~~~-~p~~~yd~~lp~~~------------- 169 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD-WKLAGFSFCVNANGPTE-YPFSEYDPPLPLLL------------- 169 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcc-eeeccchhhhccCCCCc-cccccCCCCCChhh-------------
Confidence 4456699999995 49999999999999999888 99999998876654333 11111111100000
Q ss_pred ceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCc
Q 036739 187 ILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPD 265 (323)
Q Consensus 187 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (323)
.-...|.+||++.+ .....++|+||+|+++|.+.. |...+........... ........
T Consensus 170 ------~~~~~f~apE~~~~-~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~~~~~~~~------------ 229 (700)
T KOG2137|consen 170 ------QPHLNFLAPEYLLG-TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-SRNLLNAG------------ 229 (700)
T ss_pred ------ccCcccccchhhcc-ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-hhcccccc------------
Confidence 12567999999988 778999999999999999995 4444444433222222 11111100
Q ss_pred ccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 266 FKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.-....++++++++=+.+++..++.-||++..++..|||.+.
T Consensus 230 ------------~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 230 ------------AFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred ------------cccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 001115688999999999999999999999999999999986
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.9e-10 Score=90.74 Aligned_cols=132 Identities=18% Similarity=0.300 Sum_probs=94.1
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCC-----chhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGV-----PSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
..+++|+-+.++.+.. -|.++++|.-.++. ....- ...-.+|++++.++.--+|....=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578999999999954 45557777543221 22221 2344468888888876666555555556777789999
Q ss_pred cchhhHHH-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 82 YLDLDLKK-HMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 82 ~~~g~l~~-~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
|++|.+++ .+.+. .. .++..+-.-+.-||..||+||||+++||++..+ . +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-----~~----~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----RP----DLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-R-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----ch----HHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-c-EEEEECCcccc
Confidence 99997666 44443 22 455666666778999999999999999999864 3 89999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.8e-11 Score=111.74 Aligned_cols=252 Identities=22% Similarity=0.223 Sum_probs=167.6
Q ss_pred CCcceeeeeccccceeEEEEEEc-cCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-VTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 79 (323)
.+|..+..||.|.++.++.+... .++..|++|..............-..|+-+...+ .|.+++.....|......++=
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 46888999999999999997643 4667888887644322111111112334444444 488888877777776777788
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
-|||+| ++.... .-...+.+...+++..|++.++.++|+..++|+|++|+||++..++...++.||+....+.-...
T Consensus 345 ~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~ 422 (524)
T KOG0601|consen 345 LEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG 422 (524)
T ss_pred hhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceecc
Confidence 899966 332222 11224566668889999999999999999999999999999987644489999998764322111
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.... .+..|..+|.+........+.|+++||.-+.+.++|.+.-.....
T Consensus 423 ~~~~-------------------------------~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~ 471 (524)
T KOG0601|consen 423 VFHH-------------------------------IDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ 471 (524)
T ss_pred cccc-------------------------------cccccccchhhccccccccccccccccccccccccCcccCccccc
Confidence 1111 122232356555557788899999999999999998754322221
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
... +.+ ..-+.....+..++.+...++..++..|+.+.++..|.-|..
T Consensus 472 ~~~---i~~-----------------------------~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 472 SLT---IRS-----------------------------GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred cee---eec-----------------------------ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 100 000 001111234467788999999999999999999988876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.1e-10 Score=91.88 Aligned_cols=129 Identities=25% Similarity=0.302 Sum_probs=83.1
Q ss_pred eEEEEEEccCCceEEEEEEEecccC-----------CC-------------CchhHHHHHHHHHhcCCC--CeeeeeEEE
Q 036739 17 VVYKARNCVTNETIALKKIRLEQED-----------EG-------------VPSTAIREISLLKEMQHG--NIVRLQDVV 70 (323)
Q Consensus 17 ~v~~~~~~~~~~~~aiK~~~~~~~~-----------~~-------------~~~~~~~e~~~l~~l~~~--~i~~~~~~~ 70 (323)
.||.|.. .+|..+|+|+....... .. ......+|.+.|.++..- ++++.+++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888986 67889999988643210 00 012445799999999866 466666543
Q ss_pred ecCceEEEEEecch--hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 71 HSEKKLYLVFEYLD--LDLKKHMDSCPDFANDPRLIKTFLYQILRGIA-YCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 71 ~~~~~~~lv~e~~~--g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~-~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
..++||||++ |..+..+....- +......++.+++..+. .+|..|++||||++.||+++.+ . +.++||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~~---~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~-~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVDL---SPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K-VYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCGG---GGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C-EEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhccc---cchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e-EEEEec
Confidence 3469999998 755555554321 12234567788888444 4679999999999999999976 5 999999
Q ss_pred ccceecCC
Q 036739 148 GLARAFGI 155 (323)
Q Consensus 148 ~~~~~~~~ 155 (323)
|.+.....
T Consensus 151 ~qav~~~~ 158 (188)
T PF01163_consen 151 GQAVDSSH 158 (188)
T ss_dssp TTEEETTS
T ss_pred CcceecCC
Confidence 99877653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.3e-10 Score=93.67 Aligned_cols=142 Identities=15% Similarity=0.192 Sum_probs=101.1
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC--eeeeeEEEecC---ceEEEEEe
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN--IVRLQDVVHSE---KKLYLVFE 81 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~---~~~~lv~e 81 (323)
.+.|+.|..+.+|+++.. +|+.+++|........ .....+.+|+.+++.+.+.+ +++++.+.... +..++|||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 367899999999999863 3678999986443221 24567889999999997644 57777776553 36789999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS----------------------------------------- 120 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~----------------------------------------- 120 (323)
+++|..+...... ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 81 RVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988433332211 134555566677777777777773
Q ss_pred ---------------CCcccCCCCCCcEEEecC-CCceEEecccccee
Q 036739 121 ---------------HRVLHRDLKPQNLLIDRR-TNALKLADFGLARA 152 (323)
Q Consensus 121 ---------------~~i~H~dl~~~Nil~~~~-~~~~kl~df~~~~~ 152 (323)
..++|||+.+.||+++.+ +..+.++||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236899999999999884 23478999998865
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=9.5e-10 Score=94.32 Aligned_cols=137 Identities=15% Similarity=0.117 Sum_probs=94.6
Q ss_pred cceeEEEEEEccCCceEEEEEEEecccC---------CCCchhHHHHHHHHHhcCCCCe--eeeeEEEec-----CceEE
Q 036739 14 TYGVVYKARNCVTNETIALKKIRLEQED---------EGVPSTAIREISLLKEMQHGNI--VRLQDVVHS-----EKKLY 77 (323)
Q Consensus 14 ~~~~v~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~-----~~~~~ 77 (323)
....|.++. .+|+.|.+|........ ......+.+|...+..+...+| ++.++++.. ....+
T Consensus 34 ~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 34 EGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred CCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 334466664 46778999966322210 0111247788898888865444 334555532 23578
Q ss_pred EEEecchh--hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC------CCceEEecccc
Q 036739 78 LVFEYLDL--DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR------TNALKLADFGL 149 (323)
Q Consensus 78 lv~e~~~g--~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~------~~~~kl~df~~ 149 (323)
+|||+++| ++.+.+........+......++.+++..+..||..|++|+|++++||+++.+ ...+.++||+.
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 99999988 56666543222344566777899999999999999999999999999999852 23599999998
Q ss_pred cee
Q 036739 150 ARA 152 (323)
Q Consensus 150 ~~~ 152 (323)
+..
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 854
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.2e-08 Score=83.05 Aligned_cols=108 Identities=26% Similarity=0.302 Sum_probs=81.9
Q ss_pred chhHHHHHHHHHhcCCCC--eeeeeEEEecC----ceEEEEEecchh--hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 036739 45 PSTAIREISLLKEMQHGN--IVRLQDVVHSE----KKLYLVFEYLDL--DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116 (323)
Q Consensus 45 ~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~----~~~~lv~e~~~g--~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~ 116 (323)
.....+|...+..+..-+ +++.+++.... ...++|||+++| ++.+.+..... .+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 456778888888886444 35555555432 346899999987 56666655332 455667789999999999
Q ss_pred HHHhCCcccCCCCCCcEEEecCC--CceEEeccccceecC
Q 036739 117 YCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAFG 154 (323)
Q Consensus 117 ~LH~~~i~H~dl~~~Nil~~~~~--~~~kl~df~~~~~~~ 154 (323)
-||..|++|+|+++.|||++.++ ..+.++||+-+....
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999999999999999877 238999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.5e-08 Score=80.60 Aligned_cols=139 Identities=12% Similarity=0.118 Sum_probs=101.0
Q ss_pred ccccceeEEEEEEccCCceEEEEEEEecc----cCCCCchhHHHHHHHHHhcCCCC--eeeeeEEEe-c----CceEEEE
Q 036739 11 GEGTYGVVYKARNCVTNETIALKKIRLEQ----EDEGVPSTAIREISLLKEMQHGN--IVRLQDVVH-S----EKKLYLV 79 (323)
Q Consensus 11 g~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~-~----~~~~~lv 79 (323)
++||-|.|+...- .|..+-+|.-.... ........|.+|+..++.+..-+ ++++. ++. . .-.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 4588899999874 44468888543111 11335678899999999996433 44444 222 1 2357899
Q ss_pred Eecchh--hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC-ceEEecccccee
Q 036739 80 FEYLDL--DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARA 152 (323)
Q Consensus 80 ~e~~~g--~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~-~~kl~df~~~~~ 152 (323)
||-++| +|.+.+....-...++.....++.+++.++.-||+.|+.|+|+.+.||+++.++. .++++||.-+..
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999986 7777765544334567777899999999999999999999999999999985543 489999997754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1e-08 Score=85.83 Aligned_cols=137 Identities=22% Similarity=0.234 Sum_probs=98.6
Q ss_pred ceeeeeccccceeEEEEEEccCCceEEEEEEEecc----------------cCC----CCchhHHHHHHHHHhcCCC--C
Q 036739 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ----------------EDE----GVPSTAIREISLLKEMQHG--N 62 (323)
Q Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----------------~~~----~~~~~~~~e~~~l~~l~~~--~ 62 (323)
.+...||-|--+.||.+.+ ..|.++++|.=.... .+. -......+|+..|..+... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3567899999999999998 478999999432110 000 1123556789999999765 5
Q ss_pred eeeeeEEEecCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCce
Q 036739 63 IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNAL 142 (323)
Q Consensus 63 i~~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~ 142 (323)
+++.++ -+..++|||+++|..+....- +.+....++..|+.-+..+-..|++|||+++=||+++.++. +
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-~ 241 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-I 241 (304)
T ss_pred CCCccc----cccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC-E
Confidence 665554 467789999999944433221 12223455666777777777899999999999999999988 9
Q ss_pred EEeccccceec
Q 036739 143 KLADFGLARAF 153 (323)
Q Consensus 143 kl~df~~~~~~ 153 (323)
.++||..+...
T Consensus 242 ~vIDwPQ~v~~ 252 (304)
T COG0478 242 VVIDWPQAVPI 252 (304)
T ss_pred EEEeCcccccC
Confidence 99999988654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=9e-08 Score=84.59 Aligned_cols=250 Identities=12% Similarity=0.079 Sum_probs=145.3
Q ss_pred eeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEE------Eec-CceEE
Q 036739 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDV------VHS-EKKLY 77 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~------~~~-~~~~~ 77 (323)
..+.||+|+.+.+|-.-. -+. -+.|++....- ..-.+.+..|... .||-+-.-+.+ .-+ +....
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Ppp-----a~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPP-----AAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCccccCCccceeeecch--hhc-hhheeecCCCc-----hHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 457899999999997742 222 34576643321 1112233333333 34433220111 012 23377
Q ss_pred EEEecchh--hHHHhh---hcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccce
Q 036739 78 LVFEYLDL--DLKKHM---DSCPD-FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (323)
Q Consensus 78 lv~e~~~g--~l~~~~---~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~ 151 (323)
+.|+.+.| .....+ .++.+ -..++..+.+.++.++.+-..||..|.+-||++++|+|+++++. +.|.|=+.-.
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~-V~LVdsDsfq 165 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK-VVLVDSDSFQ 165 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce-EEEEccccee
Confidence 88888876 222222 22222 23467778899999999999999999999999999999999888 8888755433
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC----CCCCCchhhHHHHHHHHHHH
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS----RHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~ll~~l~ 227 (323)
.. ...+... -.+|...|.+||.=.-. -.-+...|.|.||+++|+++
T Consensus 166 i~-~ng~~~~-----------------------------cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL 215 (637)
T COG4248 166 IN-ANGTLHL-----------------------------CPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLL 215 (637)
T ss_pred ec-cCCceEe-----------------------------cccCccccCCHHHhccccccccCCCccccchhHHHHHHHHH
Confidence 22 1111111 12568889999984310 22355789999999999999
Q ss_pred hC-CCCCCCCC-------hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhccc
Q 036739 228 NQ-RPLFPGDS-------EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299 (323)
Q Consensus 228 tg-~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 299 (323)
.| +.||++-. ..+. .|-.+........-.+ ....+ ...-+.-++++++.|..+|+..
T Consensus 216 ~ggrHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~~~g-----------~~p~P--~~~P~~~Lpp~vqAlF~qaF~~ 280 (637)
T COG4248 216 FGGRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQRRG-----------LKPPP--RSIPLSMLPPDVQALFQQAFTE 280 (637)
T ss_pred hcCCCCCCcccccCCCCCcchh--hhhcceeeechhccCC-----------CCCCC--CCCChhhcCHHHHHHHHHHhcc
Confidence 86 89997632 1121 1111100000000000 00000 1111234788999999999865
Q ss_pred C--CCCCCCHhh
Q 036739 300 D--PSRRITARS 309 (323)
Q Consensus 300 d--p~~R~s~~~ 309 (323)
. +.-||+++.
T Consensus 281 ~~~~~~RP~a~a 292 (637)
T COG4248 281 SGVATPRPTAKA 292 (637)
T ss_pred cCCCCCCCCHHH
Confidence 4 678998763
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.3e-07 Score=76.12 Aligned_cols=138 Identities=17% Similarity=0.217 Sum_probs=87.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC-C------chhHHHHHHHHHhcCCC---CeeeeeEEE-
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG-V------PSTAIREISLLKEMQHG---NIVRLQDVV- 70 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-~------~~~~~~e~~~l~~l~~~---~i~~~~~~~- 70 (323)
++|.+.+.+-.....-|.+.. .+|..+++|.......... . -....+.+.....+... ....++.+.
T Consensus 31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 468888888888888888886 5788899998754321100 0 01122233333444332 222222222
Q ss_pred ----ecCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEec
Q 036739 71 ----HSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLAD 146 (323)
Q Consensus 71 ----~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~d 146 (323)
......++++||++|--+..+.. +++ .+...+.+++.-||+.|++|||..|.|++++. +. ++++|
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~-i~iID 177 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NG-IRIID 177 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-Cc-EEEEE
Confidence 12356679999999943322221 222 24456778899999999999999999999985 44 89999
Q ss_pred ccccee
Q 036739 147 FGLARA 152 (323)
Q Consensus 147 f~~~~~ 152 (323)
++....
T Consensus 178 ~~~k~~ 183 (229)
T PF06176_consen 178 TQGKRM 183 (229)
T ss_pred Cccccc
Confidence 987643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.3e-07 Score=76.99 Aligned_cols=142 Identities=18% Similarity=0.144 Sum_probs=96.8
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCC----------------------chhHHHHHHHHHhcCC--CC
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGV----------------------PSTAIREISLLKEMQH--GN 62 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~~--~~ 62 (323)
...|+.|--+.||+|.. .++..+|+|++......-.. .....+|+..|+++.. -.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 45677888889999986 67889999999755421110 1122357777777743 33
Q ss_pred eeeeeEEEecCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCc
Q 036739 63 IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNA 141 (323)
Q Consensus 63 i~~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~ 141 (323)
+++.+... .-.||||+++.. ..-.-...........+..+..+++..+.-|-. .++|||||+.=|||+. ++.
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~-g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~- 204 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDD-GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE- 204 (268)
T ss_pred CCCceeec----CCeEEEEeccCC-CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe-
Confidence 45555544 336999999753 111112222233344677788899999988887 8999999999999999 455
Q ss_pred eEEeccccceecCCC
Q 036739 142 LKLADFGLARAFGIP 156 (323)
Q Consensus 142 ~kl~df~~~~~~~~~ 156 (323)
+.+||++.+.....+
T Consensus 205 p~iID~~QaV~~~hp 219 (268)
T COG1718 205 PYIIDVSQAVTIDHP 219 (268)
T ss_pred EEEEECccccccCCC
Confidence 899999998776533
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.2e-06 Score=71.02 Aligned_cols=71 Identities=21% Similarity=0.180 Sum_probs=53.4
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC--eeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN--IVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
..||+|..+.||+. .+..+++|..... .......+|.++++.+..-+ +++.+++....+...+|||+++|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 57899999999984 2456888876432 12356788999999987544 46778887777788899999988
Q ss_pred h
Q 036739 86 D 86 (323)
Q Consensus 86 ~ 86 (323)
.
T Consensus 79 ~ 79 (226)
T TIGR02172 79 K 79 (226)
T ss_pred c
Confidence 3
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.6e-06 Score=80.84 Aligned_cols=145 Identities=18% Similarity=0.206 Sum_probs=89.5
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEecccC--------------------CC----C--------------chhHH
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQED--------------------EG----V--------------PSTAI 49 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--------------------~~----~--------------~~~~~ 49 (323)
..|++++-|+||+|+- .+|+.||+|+.++.... .. . .-.+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4678999999999998 45999999988543210 00 0 01223
Q ss_pred HHHHHHHhcC-----CCCeeeeeEEEecCceEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 036739 50 REISLLKEMQ-----HGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILR-GIAYCHSHR 122 (323)
Q Consensus 50 ~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~-~L~~LH~~~ 122 (323)
+|...+.++. .+++.-..=+++..+.-+++|||++| .+.+. ........+.+. ++..++. .+..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~-~~l~~~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDI-AALKSAGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccH-HHHHhcCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 3555555542 23332222223335667899999998 44333 221112334332 2232322 233344589
Q ss_pred cccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 123 i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
++|+|.+|-||++..++. +.+.|||....++....
T Consensus 286 ffHaDpHpGNi~v~~~g~-i~~lDfGi~g~l~~~~r 320 (517)
T COG0661 286 FFHADPHPGNILVRSDGR-IVLLDFGIVGRLDPKFR 320 (517)
T ss_pred ccccCCCccceEEecCCc-EEEEcCcceecCCHHHH
Confidence 999999999999999988 99999999988765444
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.37 E-value=7e-06 Score=69.92 Aligned_cols=71 Identities=17% Similarity=0.163 Sum_probs=50.0
Q ss_pred eeccccc-eeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEEEecchhh
Q 036739 9 KIGEGTY-GVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLVFEYLDLD 86 (323)
Q Consensus 9 ~lg~g~~-~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (323)
.|..|.+ +.||++.. .+..+++|...... ...+..|+.+++.+. +--+++++++....+..++|||++.|.
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 4455555 78999975 34678888763221 345678898888885 344667788777667789999999873
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.26 E-value=9.6e-06 Score=68.26 Aligned_cols=73 Identities=19% Similarity=0.249 Sum_probs=51.4
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC--eeeeeEEEe---cCceEEEEEe
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN--IVRLQDVVH---SEKKLYLVFE 81 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~---~~~~~~lv~e 81 (323)
++.++.|..+.||++.... ..+++|..... .....+..|..+++.+...+ +++++.... .....+++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5788999999999999643 58999986432 23467778888888886433 556666443 2345799999
Q ss_pred cchh
Q 036739 82 YLDL 85 (323)
Q Consensus 82 ~~~g 85 (323)
++.|
T Consensus 76 ~i~g 79 (239)
T PF01636_consen 76 YIPG 79 (239)
T ss_dssp EESS
T ss_pred Eecc
Confidence 9977
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.6e-05 Score=77.97 Aligned_cols=149 Identities=15% Similarity=0.230 Sum_probs=91.6
Q ss_pred eeeeeccccceeEEEEEEccCC--ceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCe--eeeeEEEecC---ceEE
Q 036739 6 KVEKIGEGTYGVVYKARNCVTN--ETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNI--VRLQDVVHSE---KKLY 77 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~ 77 (323)
.+..++.|.++.+|++.....+ ..+++|+...... ......+.+|+.+++.+. |.++ ++++.++.+. +..|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 3677899999999999764332 4677776533221 122356889999999996 6664 7778877654 4678
Q ss_pred EEEecchhhHHH------------------------hhhcCCCC---------C--CCHHHHHHHHH-------------
Q 036739 78 LVFEYLDLDLKK------------------------HMDSCPDF---------A--NDPRLIKTFLY------------- 109 (323)
Q Consensus 78 lv~e~~~g~l~~------------------------~~~~~~~~---------~--~~~~~~~~i~~------------- 109 (323)
+|||+++|.... .+...... . .....+.++..
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 999999874210 11111100 0 00112222111
Q ss_pred --HHHHHHHHHHh-----------CCcccCCCCCCcEEEecC-CCceEEeccccceecCC
Q 036739 110 --QILRGIAYCHS-----------HRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI 155 (323)
Q Consensus 110 --qi~~~L~~LH~-----------~~i~H~dl~~~Nil~~~~-~~~~kl~df~~~~~~~~ 155 (323)
.+...+.+|.. ..++|||+++.||+++.+ +.+.-|+||..+..-++
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 12234556632 249999999999999853 34468999998876544
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.14 E-value=9.4e-05 Score=60.54 Aligned_cols=130 Identities=22% Similarity=0.324 Sum_probs=91.9
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecc--------------cCCCCchhHHHHHHHHHhcC------CCCeeee
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ--------------EDEGVPSTAIREISLLKEMQ------HGNIVRL 66 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------~~~i~~~ 66 (323)
...||+|+.-.||.- ......+||+..... .......+..+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457899999999986 456678899886654 11223456666777766666 7889999
Q ss_pred eEEEecCceEEEEEecc---hh----hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC
Q 036739 67 QDVVHSEKKLYLVFEYL---DL----DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT 139 (323)
Q Consensus 67 ~~~~~~~~~~~lv~e~~---~g----~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~ 139 (323)
+|..+++....+|+|.+ +| +|.+++... .+++ . +...+-.-..+|-..+|+.+|++|.||++....
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 99999999999999998 22 455555332 2343 2 233344555677888999999999999996654
Q ss_pred C---ceEEec
Q 036739 140 N---ALKLAD 146 (323)
Q Consensus 140 ~---~~kl~d 146 (323)
. .+.|+|
T Consensus 156 ~~~~~lvlID 165 (199)
T PF10707_consen 156 SGEFRLVLID 165 (199)
T ss_pred CCceEEEEEe
Confidence 3 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.13 E-value=5.3e-05 Score=61.65 Aligned_cols=127 Identities=24% Similarity=0.313 Sum_probs=89.0
Q ss_pred CCcceeeeeccccc-eeEEEEEEccCCceEEEEEEE---ecccC-------C---------CCchhHHHHHHHHHhcC--
Q 036739 2 DQYEKVEKIGEGTY-GVVYKARNCVTNETIALKKIR---LEQED-------E---------GVPSTAIREISLLKEMQ-- 59 (323)
Q Consensus 2 ~~y~~~~~lg~g~~-~~v~~~~~~~~~~~~aiK~~~---~~~~~-------~---------~~~~~~~~e~~~l~~l~-- 59 (323)
.+++.++.||.|.- |.||++. -.|..||+|.+. ..... . ....-|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 36788999999999 9999998 478899999932 11100 0 12345667777766664
Q ss_pred -CCCe--eeeeEEEe-c-----------------CceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 036739 60 -HGNI--VRLQDVVH-S-----------------EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118 (323)
Q Consensus 60 -~~~i--~~~~~~~~-~-----------------~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~L 118 (323)
+.++ ++|+|+.. + .....||.|+....- .+.. .-+.+|.+-|..+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHH
Confidence 5667 99999973 1 123577888765422 1222 2356777788889
Q ss_pred HhCCcccCCCCCCcEEEecCCCceEEeccccc
Q 036739 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (323)
Q Consensus 119 H~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~ 150 (323)
|+.||+-+|+++.|.. + -+|+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~----~--G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR----G--GKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc----C--CEEEecccC
Confidence 9999999999999986 1 478999865
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.4e-05 Score=60.89 Aligned_cols=129 Identities=19% Similarity=0.230 Sum_probs=90.7
Q ss_pred ceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCe-eeeeEEEecCceEEEEEecc
Q 036739 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-VRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~ 83 (323)
++.+.|+.|.+|.||++.+ .|..+|+|+-.. ......+..|++++..++-.++ ++++.+..+ ++.|||+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i 94 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI 94 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence 4578899999999999985 666899997632 3345678889999999987665 344444322 2449999
Q ss_pred hh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC-CCcEEEecCCCceEEeccccceec
Q 036739 84 DL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLK-PQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 84 ~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~-~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
.| .|.+..... . ++-+..+++.-.-|-..||-|+.|+ |...++..+.. +.|+||..++.-
T Consensus 95 ~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~-~~iIDFd~At~k 156 (201)
T COG2112 95 DGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRD-VYIIDFDSATFK 156 (201)
T ss_pred cCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCc-EEEEEccchhhc
Confidence 98 666554432 1 1234556676666778899999997 55555444445 899999998744
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.0001 Score=62.26 Aligned_cols=72 Identities=13% Similarity=0.211 Sum_probs=46.5
Q ss_pred eeeeccccceeEEEEEEcc-CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCe-eeeeEEEecCceEEEEEecch
Q 036739 7 VEKIGEGTYGVVYKARNCV-TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-VRLQDVVHSEKKLYLVFEYLD 84 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~ 84 (323)
++.|..|-...+|++.... .++.|++|...... .......+|+.+++.+...++ +++++.+. + .+++||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---ELIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---cceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeC
Confidence 5678889999999997532 35689899764321 112334578888888864443 44444432 2 37999987
Q ss_pred h
Q 036739 85 L 85 (323)
Q Consensus 85 g 85 (323)
|
T Consensus 76 G 76 (235)
T cd05157 76 G 76 (235)
T ss_pred C
Confidence 6
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.02 E-value=3e-05 Score=76.87 Aligned_cols=201 Identities=18% Similarity=0.205 Sum_probs=125.4
Q ss_pred HHHHHHHHHhcCCCCeeeeeEEEecCceE----EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 036739 48 AIREISLLKEMQHGNIVRLQDVVHSEKKL----YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122 (323)
Q Consensus 48 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 122 (323)
...|+..+....|+|+...+.+....... .+..+++.+ ++...+.+.. ..+...++.+..++..+|.++|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 34467778888999999998887654322 233455554 4444444332 4577788889999999999999986
Q ss_pred cccCCCCCC---cEEEecCCCceEEe--ccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccc
Q 036739 123 VLHRDLKPQ---NLLIDRRTNALKLA--DFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLW 197 (323)
Q Consensus 123 i~H~dl~~~---Nil~~~~~~~~kl~--df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (323)
..|.-+..+ +-..+.++. ..++ ||+.+..++.......... +..
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~-~~~sl~~~~ss~~l~d~~~~~~~~~------------------------------~~~ 355 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGV-VAISLSDFDSSKPLPDNEKSFSDLL------------------------------AEI 355 (1351)
T ss_pred cceeEEecccccccccCccce-eecchhhhcccccCCCcccchhhcC------------------------------ccc
Confidence 555544444 222333332 4555 8887776654444333221 334
Q ss_pred cccchhhhCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCC
Q 036739 198 YRAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSK 276 (323)
Q Consensus 198 y~~PE~~~~~-~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (323)
+.+||....+ ...+...|+|++|.+...+..|..+-........+ ..
T Consensus 356 ~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~~---l~----------------------------- 403 (1351)
T KOG1035|consen 356 RNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVSL---LD----------------------------- 403 (1351)
T ss_pred cccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchhhh---hc-----------------------------
Confidence 5666665441 22334579999999999998876432211111000 00
Q ss_pred cccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 277 ELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 277 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
........++..+|+.-++++|+++.+++.|+|.+--
T Consensus 404 ------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 404 ------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred ------cccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 0011145688899999999999999999999998754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.6e-05 Score=71.79 Aligned_cols=142 Identities=20% Similarity=0.179 Sum_probs=87.1
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEecccCC-----------------------------CC------chhHHHHH
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE-----------------------------GV------PSTAIREI 52 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-----------------------------~~------~~~~~~e~ 52 (323)
+.||..+.++|++|+.+. |+.||+|+-+...... +. .-.|.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 578899999999999854 9999999874332110 00 01222333
Q ss_pred HHHHhc----CCCC------eeeeeEEEecCceEEEEEecchhh---HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 036739 53 SLLKEM----QHGN------IVRLQDVVHSEKKLYLVFEYLDLD---LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119 (323)
Q Consensus 53 ~~l~~l----~~~~------i~~~~~~~~~~~~~~lv~e~~~g~---l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH 119 (323)
+..++. .|-+ |++++-.+ ....+++|||++|. -.+.+.+. .++...+..-+.++.. +.+=
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~--~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYL--EQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHH--HHHH
Confidence 333333 3434 34443333 45678999999883 23444433 3455443333333222 2333
Q ss_pred hCCcccCCCCCCcEEEecC---CCceEEeccccceecCCCc
Q 036739 120 SHRVLHRDLKPQNLLIDRR---TNALKLADFGLARAFGIPV 157 (323)
Q Consensus 120 ~~~i~H~dl~~~Nil~~~~---~~~~kl~df~~~~~~~~~~ 157 (323)
..|++|+|=.|-||++.++ +..+.+-|+|+...+....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence 5689999999999999953 4469999999987765433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=2.8e-06 Score=79.05 Aligned_cols=243 Identities=18% Similarity=0.136 Sum_probs=152.1
Q ss_pred ceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC-eeeeeEEEecCceEEEEEecc
Q 036739 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN-IVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~ 83 (323)
...+.+++++.+.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++.++.+...++.++++
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 34456778888888888764444333 4444221 34456788999999999 666677777788999999999
Q ss_pred hhh--HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 84 DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 84 ~g~--l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
++. ....+. .....+.+-....+.+.-+.+++++|+.-=+|+| ||+... +. .+..+|+....+.......
T Consensus 317 s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~-~~~~~~~v~~~L~~~~~~~- 388 (829)
T KOG0576|consen 317 STGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EE-VKLLDFAVPPQLTRTMKPR- 388 (829)
T ss_pred cCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cc-cccccccCCcccCcccccc-
Confidence 764 222211 1112233334455666677899999988667887 777665 44 7999999887765443111
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
...+++..++||+... ..+...-|.|++|.--.++--|.+|-..+...
T Consensus 389 -----------------------------t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~-- 436 (829)
T KOG0576|consen 389 -----------------------------TAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV-- 436 (829)
T ss_pred -----------------------------cCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCccc--
Confidence 1244888999998877 56788999999998766677777765542110
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.. ........+...++ ..|.... -.++...|+..-|..|+..-+++.|.+|++-
T Consensus 437 ~~------------~~g~~p~s~~L~~~-~aw~~~~-----------~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 437 LP------------MIGNGPNSPMLTDK-SAWSPVF-----------HRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred cC------------CCCCCCCccccchh-hhcCccc-----------ccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 00 00000000000000 1111100 0145667888889999999999999988864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.89 E-value=7.6e-05 Score=63.19 Aligned_cols=69 Identities=10% Similarity=0.170 Sum_probs=43.0
Q ss_pred eeeccccce-eEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCC---CeeeeeEEEecC---ceEEEEE
Q 036739 8 EKIGEGTYG-VVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG---NIVRLQDVVHSE---KKLYLVF 80 (323)
Q Consensus 8 ~~lg~g~~~-~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~lv~ 80 (323)
+.++.|+.. .||++. ..+++|.... ......+..|..+++.+... -++++++..... ...+++|
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~----~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA----AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc----cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 467766665 599872 3577786432 12235788899999888632 344555443322 2457899
Q ss_pred ecchh
Q 036739 81 EYLDL 85 (323)
Q Consensus 81 e~~~g 85 (323)
+++.|
T Consensus 74 ~~i~G 78 (235)
T cd05155 74 RWLEG 78 (235)
T ss_pred EeecC
Confidence 99876
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00012 Score=64.52 Aligned_cols=146 Identities=22% Similarity=0.211 Sum_probs=98.9
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEeccc---C-----------------CCCc----hhHHHHHHHHHhcCCCC
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE---D-----------------EGVP----STAIREISLLKEMQHGN 62 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~-----------------~~~~----~~~~~e~~~l~~l~~~~ 62 (323)
-++|.-|--+.||.|+. .+|+.+|||+++.... + .+.. -....|++.|.+++..+
T Consensus 149 nGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred ccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 45677788899999987 6788899998854421 0 0111 13346888888887666
Q ss_pred eeeeeEEEecCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEEecCCCc
Q 036739 63 IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH-SHRVLHRDLKPQNLLIDRRTNA 141 (323)
Q Consensus 63 i~~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~i~H~dl~~~Nil~~~~~~~ 141 (323)
|+-.--+.. ...+|||++++++-+.. -...+..++...+..+-.|++..+.-|- .+++||.||+-=|+|+.. |.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~a-PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~- 302 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAA-PKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GK- 302 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcC-cccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CE-
Confidence 543333332 34579999997532211 1112234566667788888888887776 579999999999999985 55
Q ss_pred eEEeccccceecCCCcc
Q 036739 142 LKLADFGLARAFGIPVR 158 (323)
Q Consensus 142 ~kl~df~~~~~~~~~~~ 158 (323)
+.|+|.+.+....-+..
T Consensus 303 lyiIDVSQSVE~DHP~a 319 (520)
T KOG2270|consen 303 LYIIDVSQSVEHDHPHA 319 (520)
T ss_pred EEEEEccccccCCChhH
Confidence 89999998877655443
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00033 Score=61.84 Aligned_cols=140 Identities=18% Similarity=0.156 Sum_probs=80.2
Q ss_pred eeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC--eeeeeEEE------ecCceEE
Q 036739 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN--IVRLQDVV------HSEKKLY 77 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~------~~~~~~~ 77 (323)
.++.++.|....+|++.. ++..+++|..... .....+..+.++++.+...+ +++++... ...+..+
T Consensus 26 ~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT--DVGRYILTLYEKR----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred eccccCCccccceEEEEe--CCCcEEEEEecCC----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 356677888889999864 3446888976431 12345566777777775333 34444321 1245678
Q ss_pred EEEecchhhH---------------HHhhhcCC-CCC--------CCH-H-H-HH----------HHHHHHHHHHHHHHh
Q 036739 78 LVFEYLDLDL---------------KKHMDSCP-DFA--------NDP-R-L-IK----------TFLYQILRGIAYCHS 120 (323)
Q Consensus 78 lv~e~~~g~l---------------~~~~~~~~-~~~--------~~~-~-~-~~----------~i~~qi~~~L~~LH~ 120 (323)
+++++++|.. +..+.... +.. .+. . . .. .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 9999986621 11111100 100 000 0 0 00 011122334555532
Q ss_pred -------CCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 121 -------HRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 121 -------~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
.++||||+++.||+++.++. ..|+||+.+..
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~-~~vIDfd~~~~ 217 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSV-KGVIDFYFACT 217 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCce-EEEeecccccC
Confidence 58999999999999988653 78999998854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00032 Score=60.16 Aligned_cols=135 Identities=20% Similarity=0.251 Sum_probs=76.6
Q ss_pred eeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCe-eeeeEEEecCceEEEEEecchhhH
Q 036739 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-VRLQDVVHSEKKLYLVFEYLDLDL 87 (323)
Q Consensus 9 ~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~g~l 87 (323)
.+..|-.+.+|++. .+++.+++|........ ......+|..+++.+...++ ++++... . -++|+||++|..
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~ 74 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA--LGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEV 74 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc--ccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcc
Confidence 45678888999997 46778889875322111 11235778889998865433 3444433 2 258999997732
Q ss_pred HH------------------hhhcCC--CCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCcccCCCC
Q 036739 88 KK------------------HMDSCP--DFANDPR-LIKTFLYQI---------LRGIAYCHS--------HRVLHRDLK 129 (323)
Q Consensus 88 ~~------------------~~~~~~--~~~~~~~-~~~~i~~qi---------~~~L~~LH~--------~~i~H~dl~ 129 (323)
.. .+.+.+ ...++.. .+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 21 111111 1111111 111211111 111222221 258999999
Q ss_pred CCcEEEecCCCceEEeccccceec
Q 036739 130 PQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 130 ~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
|.||+++.++ +.++||+.+..-
T Consensus 155 ~~Nil~~~~~--~~lIDwE~a~~g 176 (256)
T TIGR02721 155 AYNLVVTPQG--LKLIDWEYASDG 176 (256)
T ss_pred cCcEEEeCCC--CEEEeccccCcC
Confidence 9999998755 789999988654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00031 Score=61.59 Aligned_cols=138 Identities=18% Similarity=0.127 Sum_probs=80.9
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC--eeeeeEE------EecCceEEE
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN--IVRLQDV------VHSEKKLYL 78 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~l 78 (323)
++.+..|....+|++.. .+..+++|.+.. .....+..|+.+++.+...+ +++++.. ....+..+.
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 66777888889999864 445788998642 22345667788888875433 4444432 123456789
Q ss_pred EEecchhhHH---------------HhhhcCC-CCCC--------CH--HHHH--------HHHHHHHHHHHHHHh----
Q 036739 79 VFEYLDLDLK---------------KHMDSCP-DFAN--------DP--RLIK--------TFLYQILRGIAYCHS---- 120 (323)
Q Consensus 79 v~e~~~g~l~---------------~~~~~~~-~~~~--------~~--~~~~--------~i~~qi~~~L~~LH~---- 120 (323)
++++++|... ..+.... .... .. .... .....+..++..+.+
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9999976221 1111100 0000 00 0000 011112334444443
Q ss_pred ---CCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 121 ---HRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 121 ---~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
.++||||+.|.||+++.++. +.|+||+.+..
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~-~~iIDfe~a~~ 205 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDEL-SGVIDFYFACT 205 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCce-EEEeehhhhcC
Confidence 37999999999999997543 68999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0015 Score=59.37 Aligned_cols=77 Identities=17% Similarity=0.178 Sum_probs=52.6
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEeccc---C--CCCchhHHHHHHHHHhcC---CCCeeeeeEEEecCceEEE
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE---D--EGVPSTAIREISLLKEMQ---HGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~--~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 78 (323)
.+.||.|....||++.+...++.+++|.-..... . .-..+....|.+.|+.+. ..++++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4689999999999999854335899997432211 1 123456667888888763 3457777776 3456789
Q ss_pred EEecchh
Q 036739 79 VFEYLDL 85 (323)
Q Consensus 79 v~e~~~g 85 (323)
|||++++
T Consensus 109 VME~L~~ 115 (401)
T PRK09550 109 VMEDLSD 115 (401)
T ss_pred EEecCCC
Confidence 9999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00068 Score=59.65 Aligned_cols=72 Identities=18% Similarity=0.214 Sum_probs=46.3
Q ss_pred eeeeccccceeEEEEEEcc------CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCe-eeeeEEEecCceEEEE
Q 036739 7 VEKIGEGTYGVVYKARNCV------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-VRLQDVVHSEKKLYLV 79 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv 79 (323)
++.+..|-...+|++.... .++.+++|+..... .......+|..+++.+...++ +++++.+.+ ..|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 4567788888999997532 25789999864332 223456678888888864433 445555532 257
Q ss_pred Eecchh
Q 036739 80 FEYLDL 85 (323)
Q Consensus 80 ~e~~~g 85 (323)
+++++|
T Consensus 76 ~e~i~G 81 (302)
T cd05156 76 EEFIPS 81 (302)
T ss_pred hheeCC
Confidence 888765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00027 Score=57.56 Aligned_cols=101 Identities=18% Similarity=0.138 Sum_probs=76.6
Q ss_pred HHHHHHHHhcCC-CCeeeeeEEEecCceEEEEEecchh-hHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 036739 49 IREISLLKEMQH-GNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDS-CPDFANDPRLIKTFLYQILRGIAYCHS---HR 122 (323)
Q Consensus 49 ~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ 122 (323)
.+|.-+++.+++ +++++++|++ +. ++++|+.+. ++...... ..-...++..+.+|+.++++.+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C--G~--~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC--GR--FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC--CC--EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888875 6999999998 22 578999874 44321100 011234788899999999999999997 34
Q ss_pred cccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 123 i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
+...|++++|+-++.++. +|++|.+......
T Consensus 83 ~~lcDv~~~nfgv~~~~~-lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGR-LKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCc-EEEEechhcchhH
Confidence 677899999999998877 9999999876654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00092 Score=59.62 Aligned_cols=141 Identities=16% Similarity=0.188 Sum_probs=79.1
Q ss_pred eeeeccccceeEEEEEEccC---CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCe-eeeeEEEecCceEEEEEec
Q 036739 7 VEKIGEGTYGVVYKARNCVT---NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-VRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~ 82 (323)
++.|..|-...+|++..... +..|++|+..... +..-.-.+|..+++.+...++ +++++++. ++ +|.+|
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~f 91 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSF 91 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehh
Confidence 45666688889999975332 2378999774332 122334578888888876555 45565553 22 47888
Q ss_pred chhhHH------------------HhhhcCC--CCC-CC-HHHHHHHHHH----------------------HHHHHHHH
Q 036739 83 LDLDLK------------------KHMDSCP--DFA-ND-PRLIKTFLYQ----------------------ILRGIAYC 118 (323)
Q Consensus 83 ~~g~l~------------------~~~~~~~--~~~-~~-~~~~~~i~~q----------------------i~~~L~~L 118 (323)
++|..+ ..+.+.. ... .+ ...+..+..+ +..-+..+
T Consensus 92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 171 (330)
T PLN02421 92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL 171 (330)
T ss_pred hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence 765321 1111111 000 10 1112222211 11112222
Q ss_pred ---H-hC----CcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 119 ---H-SH----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 119 ---H-~~----~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
. .. -+||+|+.+.||+++.++..++++||.++..-.
T Consensus 172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd 215 (330)
T PLN02421 172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY 215 (330)
T ss_pred HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence 1 11 379999999999998654449999999986644
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0024 Score=56.65 Aligned_cols=138 Identities=17% Similarity=0.170 Sum_probs=74.1
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC--eeeeeEE------EecCceEEE
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN--IVRLQDV------VHSEKKLYL 78 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~l 78 (323)
++.++.|...++|++.. ++..+++|++. . .....+..+..+++.+...+ +++.+.. ....+..++
T Consensus 27 ~~~l~~G~~n~~y~v~t--~~g~~vLK~~~-~----~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~ 99 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT--TQGEYVLTLFE-R----LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA 99 (319)
T ss_pred cchhccccccceEEEEe--CCCcEEEEEec-c----CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence 45567788789999974 33468899764 1 11234445566666664222 3333321 123456789
Q ss_pred EEecchhhH------------HHh---hhcCC-CCC------CC--H--HHHH-----------HHHHH-HHHHHHHHH-
Q 036739 79 VFEYLDLDL------------KKH---MDSCP-DFA------ND--P--RLIK-----------TFLYQ-ILRGIAYCH- 119 (323)
Q Consensus 79 v~e~~~g~l------------~~~---~~~~~-~~~------~~--~--~~~~-----------~i~~q-i~~~L~~LH- 119 (323)
++++++|.. .+. +.... +.. .. . .... ..+.+ +...+..+.
T Consensus 100 l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (319)
T PRK05231 100 IVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLAS 179 (319)
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhc
Confidence 999987631 111 11110 100 00 0 0000 11111 111222222
Q ss_pred ------hCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 120 ------SHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 120 ------~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
..++||||+.|.||+++.+ .+..|+||+.+..
T Consensus 180 ~~~~~lp~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~~ 217 (319)
T PRK05231 180 AAWPALPRGVIHADLFRDNVLFEGD-RLSGFIDFYFACN 217 (319)
T ss_pred cccccCCcccCCCCCCCCcEEEECC-ceEEEEecccccC
Confidence 2389999999999999854 4368999998754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0024 Score=57.31 Aligned_cols=141 Identities=16% Similarity=0.108 Sum_probs=80.1
Q ss_pred eeeeeccccceeEEEEEEcc----CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCe-eeeeEEEecCceEEEEE
Q 036739 6 KVEKIGEGTYGVVYKARNCV----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-VRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~ 80 (323)
-+..+..|-+..+|++.... .++.|++|+..... ...-...+|..+++.+...++ +++++.+.++ .|+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 35566678889999987432 24689999775432 122233678889888875554 3556666333 478
Q ss_pred ecchhhHHH---------------h---hhcCC--CCC-CC-HHHHHHHHHHH-----------------HHHHHHH---
Q 036739 81 EYLDLDLKK---------------H---MDSCP--DFA-ND-PRLIKTFLYQI-----------------LRGIAYC--- 118 (323)
Q Consensus 81 e~~~g~l~~---------------~---~~~~~--~~~-~~-~~~~~~i~~qi-----------------~~~L~~L--- 118 (323)
+|++|..+. . +.+.. ... .. ...+..+..++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 887652211 1 11111 000 11 11222222111 1111112
Q ss_pred -H----hCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 119 -H----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 119 -H----~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
. ...++|+|+++.||+++..+..+.++||..+..-
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 1 2258999999999999865445999999998654
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00038 Score=63.86 Aligned_cols=173 Identities=22% Similarity=0.289 Sum_probs=107.8
Q ss_pred hhHHHHHHHHHhcCCCCeeeeeEEEecC-ceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 036739 46 STAIREISLLKEMQHGNIVRLQDVVHSE-KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVL 124 (323)
Q Consensus 46 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~ 124 (323)
..+.-.+.+++.+.|+|....+..-... .+..+|+|+++-++.+....+.... + ++. ..++.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~l~~--~--------s~~-------~~~~~ 89 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGNLKD--E--------SLL-------AHGVL 89 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcccch--h--------hhc-------ccccc
Confidence 3445567789999999999888887543 3588999999999988887764211 1 111 12222
Q ss_pred cCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhh
Q 036739 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEIL 204 (323)
Q Consensus 125 H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 204 (323)
|- |+ .+++| .+. |. | |
T Consensus 90 ~~-----~~--------~~~td-~~~--------------------------------------------t~-~--~--- 105 (725)
T KOG1093|consen 90 HL-----NI--------IYITD-HFL--------------------------------------------TK-Y--P--- 105 (725)
T ss_pred ee-----hh--------hhccc-ccc--------------------------------------------cc-C--C---
Confidence 22 22 34444 000 00 1 0
Q ss_pred hCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccC
Q 036739 205 LGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRN 284 (323)
Q Consensus 205 ~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (323)
.+..+|+|||++|.++.++.-|...+......+....+........+.... . ....+.-.
T Consensus 106 ---~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~-a----------------~e~~~~~~ 165 (725)
T KOG1093|consen 106 ---SPIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLST-A----------------MEHLIQLL 165 (725)
T ss_pred ---CCCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHH-H----------------HHHHHHHh
Confidence 112359999999999999999998887666555554444433222111100 0 00011122
Q ss_pred CChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 285 LEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 285 ~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.+..+.++..+|+...|..||...+..+++-|..+
T Consensus 166 ~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 166 ADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred hhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 45567889999999999999988888889888765
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0023 Score=55.49 Aligned_cols=33 Identities=30% Similarity=0.462 Sum_probs=27.0
Q ss_pred CcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 122 ~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
.++|||+++.||+++.++....|+||+.+..-+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 489999999999999755546799999886643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00037 Score=60.52 Aligned_cols=137 Identities=17% Similarity=0.246 Sum_probs=93.4
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecc-------c---------CCCC----chhHHHHHHHHHhcCCCC-
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-------E---------DEGV----PSTAIREISLLKEMQHGN- 62 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-------~---------~~~~----~~~~~~e~~~l~~l~~~~- 62 (323)
+.+...||-|--+.+|.+-+ ..|.+.++|.=...- . ...| .-...+|++.|+.+....
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 45678899999999999987 578888888321110 0 0001 112346888888886433
Q ss_pred -eeeeeEEEecCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCc
Q 036739 63 -IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA 141 (323)
Q Consensus 63 -i~~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~ 141 (323)
+++.+ +-+..++|||.+.|-.+....... + +..+...+...+--|-..|++|||.+-=||+++.++.
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~----d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~- 240 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHVE----D---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK- 240 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeecC----C---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC-
Confidence 33333 356788999999884333333221 2 2345666777777889999999999999999998887
Q ss_pred eEEeccccceec
Q 036739 142 LKLADFGLARAF 153 (323)
Q Consensus 142 ~kl~df~~~~~~ 153 (323)
++++||..+...
T Consensus 241 i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 241 IVVIDFPQMVST 252 (465)
T ss_pred EEEeechHhhcc
Confidence 999999976543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0077 Score=53.75 Aligned_cols=75 Identities=16% Similarity=0.131 Sum_probs=46.9
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEeccc----C-CCCchhHHHHHHHHHhcC--CC-CeeeeeEEEecCceEEEE
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQE----D-EGVPSTAIREISLLKEMQ--HG-NIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~----~-~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv 79 (323)
+.||-|....||++.+...++.++||.-..... + .-......-|...|+... .| .+++++.+ +.....+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 357999999999999754346799995422111 1 223345556777777664 34 44544433 46666789
Q ss_pred Eecch
Q 036739 80 FEYLD 84 (323)
Q Consensus 80 ~e~~~ 84 (323)
||+++
T Consensus 79 MEdL~ 83 (370)
T TIGR01767 79 MEDLS 83 (370)
T ss_pred HhhCc
Confidence 99984
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0064 Score=53.44 Aligned_cols=147 Identities=16% Similarity=0.172 Sum_probs=85.9
Q ss_pred ceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCC--CCeeeeeEEEecCc--eEEEEE
Q 036739 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH--GNIVRLQDVVHSEK--KLYLVF 80 (323)
Q Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~--~~~lv~ 80 (323)
.++..+..|-...+|..... +++++++ ...............+|+.+++.+.- .-+...++++.++. ..+.||
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34555555666677777653 7888888 33222333345666778888888854 33455566665554 779999
Q ss_pred ecchh-hHHHh------------------hhc---CC-----CCC----CCHHHHHHHHH--------------HHHHHH
Q 036739 81 EYLDL-DLKKH------------------MDS---CP-----DFA----NDPRLIKTFLY--------------QILRGI 115 (323)
Q Consensus 81 e~~~g-~l~~~------------------~~~---~~-----~~~----~~~~~~~~i~~--------------qi~~~L 115 (323)
++++| .+... +.. -. ... .....+..+.. ......
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 99976 22111 110 00 000 00000111111 112233
Q ss_pred HHHHhC--------CcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 116 AYCHSH--------RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 116 ~~LH~~--------~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
.+++.+ .++|||+++.|++++.++. +-++||+.+..-++
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~-~gVlDwe~~~lGDP 231 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP-TGVLDWELATLGDP 231 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe-eEEEeccccccCCc
Confidence 444432 4899999999999999888 99999999876544
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0071 Score=54.69 Aligned_cols=76 Identities=14% Similarity=0.148 Sum_probs=48.4
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEeccc---C-CCCchhHHHHHHHHHhcC--CC-CeeeeeEEEecCceEEEE
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE---D-EGVPSTAIREISLLKEMQ--HG-NIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~-~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv 79 (323)
++.||-|....||++.+...++.++||.-..... + .-..+...-|...|+... .| ++++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6789999999999999743356799984322211 1 223445556777777764 34 45555443 45566778
Q ss_pred Eecch
Q 036739 80 FEYLD 84 (323)
Q Consensus 80 ~e~~~ 84 (323)
||+++
T Consensus 112 MEdL~ 116 (409)
T PRK12396 112 MEDLS 116 (409)
T ss_pred HHhCc
Confidence 88873
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.012 Score=51.69 Aligned_cols=104 Identities=19% Similarity=0.165 Sum_probs=73.8
Q ss_pred eeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCC---CCeeeeeEEEec---CceEEEE
Q 036739 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH---GNIVRLQDVVHS---EKKLYLV 79 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~~~lv 79 (323)
-.+.||.|..+.||.... .+..+++|..+ . ......+..|...++.+.. -.++++++.+.+ .+..++|
T Consensus 18 ~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~-~---~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 18 RVECISEQPYAALWALYD--SQGNPMPLMAR-S---FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeeecCCccceeEEEEEc--CCCCEEEEEec-c---cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 467899999999999974 33357778742 2 1123688899999999863 368888887754 3668999
Q ss_pred EecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 036739 80 FEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121 (323)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 121 (323)
||+++|...... ..+......+..+++.+|..||+.
T Consensus 92 mE~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 92 LERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EeccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 999998433221 123344556778888999999985
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.023 Score=51.59 Aligned_cols=74 Identities=14% Similarity=0.238 Sum_probs=44.5
Q ss_pred eeeeeccccceeEEEEEEccC-Cce-----EEEEEEEecccCCCCchhHHHHHHHHHhcCCCCe-eeeeEEEecCceEEE
Q 036739 6 KVEKIGEGTYGVVYKARNCVT-NET-----IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-VRLQDVVHSEKKLYL 78 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~-~~~-----~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~l 78 (323)
.++.|..|-...+|++..... +.. |.++... ......-.-.+|..+++.+...++ +++++.+.+ ++
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g---~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS---TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEecc---CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 355666788899999975332 223 3333321 112222334568999999976555 556666632 48
Q ss_pred EEecchhh
Q 036739 79 VFEYLDLD 86 (323)
Q Consensus 79 v~e~~~g~ 86 (323)
+.||++|.
T Consensus 127 l~efIeGr 134 (383)
T PTZ00384 127 IQEWVEGN 134 (383)
T ss_pred EEEEeccc
Confidence 89998763
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0069 Score=50.25 Aligned_cols=31 Identities=39% Similarity=0.573 Sum_probs=20.7
Q ss_pred CcccCCCCCCcEEE-ecCCCceEEeccccceec
Q 036739 122 RVLHRDLKPQNLLI-DRRTNALKLADFGLARAF 153 (323)
Q Consensus 122 ~i~H~dl~~~Nil~-~~~~~~~kl~df~~~~~~ 153 (323)
.++|+|+.+.||++ ..++. ++++||.++..-
T Consensus 144 v~cHnDl~~~Nil~~~~~~~-~~lIDfEya~~n 175 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGE-VKLIDFEYAGYN 175 (211)
T ss_dssp EEE-S--SGGGEEETSSSSC-EEE--GTT-EEE
T ss_pred eEeeccCccccEEeccCCCe-EEEecHHHHhhc
Confidence 58999999999999 55566 999999998653
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.02 Score=49.92 Aligned_cols=73 Identities=15% Similarity=0.205 Sum_probs=50.4
Q ss_pred ceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC---CCCeeeeeEEEecCceEEEEEe
Q 036739 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ---HGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+-.+.++.|..+.+|++. .+++.+++|+-. ......+..|.+-|+.+. .-.+++++++....+..++++|
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC-----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 446788999999999998 678889999764 223467888999988884 4558888998887777799999
Q ss_pred cch
Q 036739 82 YLD 84 (323)
Q Consensus 82 ~~~ 84 (323)
+++
T Consensus 93 ~l~ 95 (288)
T PF03881_consen 93 FLE 95 (288)
T ss_dssp ---
T ss_pred eec
Confidence 984
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.037 Score=51.34 Aligned_cols=74 Identities=16% Similarity=0.157 Sum_probs=46.5
Q ss_pred eeeeeccccceeEEEEEEccC--------CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCee-eeeEEEecCceE
Q 036739 6 KVEKIGEGTYGVVYKARNCVT--------NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV-RLQDVVHSEKKL 76 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~--------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~ 76 (323)
-++.|..|-...+|++..... ++.|++|+..... +..-...+|..+++.+...++. ++++.+. +
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g--- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELYNPISEFEVYKTMSKYRIAPQLLNTFS-G--- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---
Confidence 466777888889999975321 4578888774332 1222445688888888755553 4555553 2
Q ss_pred EEEEecchhh
Q 036739 77 YLVFEYLDLD 86 (323)
Q Consensus 77 ~lv~e~~~g~ 86 (323)
+.|.+|++|.
T Consensus 182 g~I~efi~g~ 191 (442)
T PTZ00296 182 GRIEEWLYGD 191 (442)
T ss_pred CEEEEeeCCc
Confidence 3567887653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.036 Score=48.97 Aligned_cols=30 Identities=20% Similarity=0.242 Sum_probs=27.1
Q ss_pred CcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 122 ~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
++||||+.+.|++++.++. +.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~-~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG-GYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC-EEEEEhhhccc
Confidence 7999999999999988776 89999998865
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.039 Score=49.05 Aligned_cols=73 Identities=26% Similarity=0.357 Sum_probs=56.6
Q ss_pred cCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEecCCCceEEeccccc
Q 036739 72 SEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (323)
Q Consensus 72 ~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~~~Nil~~~~~~~~kl~df~~~ 150 (323)
+..+.|++|++.++.+...- ....+++..++.+.+..++-+.++ ..-|+|+...||+++ +|+ +.|+||.++
T Consensus 297 e~~y~yl~~kdhgt~is~ik------~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn-vtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDHGTPISIIK------ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN-VTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecCCceeeeee------cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc-eEEEEeeee
Confidence 34577888888766543221 124455778899999988888866 688999999999999 788 999999999
Q ss_pred ee
Q 036739 151 RA 152 (323)
Q Consensus 151 ~~ 152 (323)
+.
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 84
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.00058 Score=70.12 Aligned_cols=157 Identities=15% Similarity=0.068 Sum_probs=102.4
Q ss_pred hhHHHHHHHHHhcCCCCeeeeeEEEec--CceEEEEEecch-hhHHHhhhcCCCCCCC-HHHHHHHHHHH-HHHHHHHHh
Q 036739 46 STAIREISLLKEMQHGNIVRLQDVVHS--EKKLYLVFEYLD-LDLKKHMDSCPDFAND-PRLIKTFLYQI-LRGIAYCHS 120 (323)
Q Consensus 46 ~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~-g~l~~~~~~~~~~~~~-~~~~~~i~~qi-~~~L~~LH~ 120 (323)
+....|....+...|+++.....-... ....+..++++. |.+...+.+......+ .+.......++ +....-.|.
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 344455556666788887665554432 345678888886 5888888765543211 11222233333 555555554
Q ss_pred C-----CcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccc
Q 036739 121 H-----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVT 195 (323)
Q Consensus 121 ~-----~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (323)
. --+|.++++.|.++..+.. +++.++|+.+..++... ... ...++
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~-v~~gk~gLdKIknp~~s-f~G----------------------------l~l~s 1403 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYN-VKLGKGGLDKIKNPVLS-FFG----------------------------LELCS 1403 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCc-ccccccccccccCchHh-hhh----------------------------hhhCC
Confidence 3 2678899999999999888 99999999873322211 111 12335
Q ss_pred cccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 196 LWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 196 ~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
+-|+.|+.... ..++.++|+|..|+.+|....|..+|
T Consensus 1404 p~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1404 PIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 66777777655 56777899999999999999888776
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.042 Score=45.48 Aligned_cols=103 Identities=23% Similarity=0.242 Sum_probs=65.0
Q ss_pred ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHH
Q 036739 28 ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTF 107 (323)
Q Consensus 28 ~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i 107 (323)
.+.++|++......- ....+.++.+++.+++ +|+++..- +.-.+.++.|+|..- .... ..+
T Consensus 86 G~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-----------~i~~---~N~ 146 (308)
T PF07387_consen 86 GPLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-----------KINF---SNF 146 (308)
T ss_pred chhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc-----------ccch---hHH
Confidence 345566553222110 2356677888887664 46666533 455678899988520 0011 111
Q ss_pred HHHHHHHHHHHHh--CCcccCCCCCCcEEEecCCCceEEeccccc
Q 036739 108 LYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (323)
Q Consensus 108 ~~qi~~~L~~LH~--~~i~H~dl~~~Nil~~~~~~~~kl~df~~~ 150 (323)
+.-=+.+|.-+|+ .+.+|||-.|+||+.++.|. +||.|-+..
T Consensus 147 i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~-lKlVDP~~L 190 (308)
T PF07387_consen 147 ITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGY-LKLVDPVCL 190 (308)
T ss_pred HHHhHHHHHHhhccCCCeecCCCChhheeecCCCC-EEecChhhh
Confidence 2212567888894 37999999999999999999 999997754
|
The function of this family is unknown. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.049 Score=47.78 Aligned_cols=80 Identities=24% Similarity=0.256 Sum_probs=50.5
Q ss_pred EEEEEecchhhH---HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH---H-hCCcccCCCCCCcEEEecCCC--------
Q 036739 76 LYLVFEYLDLDL---KKHMDSCPDFANDPRLIKTFLYQILRGIAYC---H-SHRVLHRDLKPQNLLIDRRTN-------- 140 (323)
Q Consensus 76 ~~lv~e~~~g~l---~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H-~~~i~H~dl~~~Nil~~~~~~-------- 140 (323)
-.+|++.+.++. ........+.....+-++.+..||+.-.-.+ - -.+++|.||||+|||+.++..
T Consensus 250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 329 (444)
T PHA03111 250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKD 329 (444)
T ss_pred cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECC
Confidence 467888775432 2222233344445566788899988755333 2 236999999999999976553
Q ss_pred ---------ceEEeccccceecCC
Q 036739 141 ---------ALKLADFGLARAFGI 155 (323)
Q Consensus 141 ---------~~kl~df~~~~~~~~ 155 (323)
+.+|.||++|...+.
T Consensus 330 ~~~vF~Epi~~~LnDFDfSqv~~i 353 (444)
T PHA03111 330 ATYVFNEPIKACLNDFDFSQVANI 353 (444)
T ss_pred eEEEeccchhhhhcccCHHHHccc
Confidence 245677777765443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.44 Score=42.39 Aligned_cols=69 Identities=14% Similarity=0.109 Sum_probs=40.5
Q ss_pred ccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCe--eeee---E--EEecCceEEEEEecchh
Q 036739 13 GTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI--VRLQ---D--VVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 13 g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~---~--~~~~~~~~~lv~e~~~g 85 (323)
+....||++.. .++..+++|+..... .....+..|...+..+....+ +... | ....++..+.++++++|
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~---~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPER---WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCccc---CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 34567899875 456679999874221 234566678888777743222 2211 1 11224567889998865
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.049 Score=47.98 Aligned_cols=81 Identities=22% Similarity=0.247 Sum_probs=51.6
Q ss_pred EEEEEecchhhH---HHhhhcCCCCCCCHHHHHHHHHHHHHHH---HHHH-hCCcccCCCCCCcEEEecCCC--------
Q 036739 76 LYLVFEYLDLDL---KKHMDSCPDFANDPRLIKTFLYQILRGI---AYCH-SHRVLHRDLKPQNLLIDRRTN-------- 140 (323)
Q Consensus 76 ~~lv~e~~~g~l---~~~~~~~~~~~~~~~~~~~i~~qi~~~L---~~LH-~~~i~H~dl~~~Nil~~~~~~-------- 140 (323)
-.+|++.+.++. ........+.....+-++.+..||+.-. ..|- -.+.+|.||||+|||+.++..
T Consensus 246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 357888875433 2223333344445566778888887644 2233 236999999999999966544
Q ss_pred ---------ceEEeccccceecCCC
Q 036739 141 ---------ALKLADFGLARAFGIP 156 (323)
Q Consensus 141 ---------~~kl~df~~~~~~~~~ 156 (323)
.++|.||++|...+..
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv~~i~ 350 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQVANII 350 (434)
T ss_pred eEEEecccceeeecccCHHHhcccc
Confidence 2567788877665433
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.35 E-value=0.58 Score=48.33 Aligned_cols=32 Identities=34% Similarity=0.480 Sum_probs=26.6
Q ss_pred CCcccCCCCCCcEEEecCC--CceEEecccccee
Q 036739 121 HRVLHRDLKPQNLLIDRRT--NALKLADFGLARA 152 (323)
Q Consensus 121 ~~i~H~dl~~~Nil~~~~~--~~~kl~df~~~~~ 152 (323)
.+++|+|+++.||+++.++ .+.-|+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999998765 4456999998754
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.067 Score=46.18 Aligned_cols=49 Identities=27% Similarity=0.363 Sum_probs=38.0
Q ss_pred HHHHHHHHHHHHHHHHhC--CcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 104 IKTFLYQILRGIAYCHSH--RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 104 ~~~i~~qi~~~L~~LH~~--~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
....+..+-.++.-.+.. -.||+|+.|.|++.+..+. ++|+||..+..-
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~-l~LIDWEyAg~~ 184 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGG-LFLIDWEYAGLN 184 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCc-EEEEecccCCCc
Confidence 344555566666666655 5899999999999998777 999999998664
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.12 Score=45.44 Aligned_cols=30 Identities=20% Similarity=0.391 Sum_probs=25.5
Q ss_pred CCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 121 ~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
.+++|||+.+.||+++. +. +.++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~-i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE-VYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc-EEEEECccccc
Confidence 47899999999999987 55 88999997643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 323 | ||||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-111 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-111 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-111 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-111 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-111 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-111 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-110 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-110 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-110 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-110 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-110 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-110 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-110 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-110 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-110 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-110 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-110 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-110 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-110 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-110 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-110 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-110 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-110 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-110 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-110 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-110 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-110 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-110 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-110 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-109 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-109 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-109 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-109 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-109 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-109 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-100 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-100 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-100 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-99 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-95 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-95 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-94 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-93 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-85 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-83 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-66 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-66 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-65 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-63 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-63 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-63 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-63 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-60 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-53 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-52 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-51 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-51 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-51 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-51 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-48 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-48 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-47 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-47 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-47 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-47 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-47 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-47 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-47 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-47 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-47 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-47 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-47 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-47 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-47 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-47 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-47 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-47 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-47 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-47 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-47 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-47 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-47 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-46 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-46 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-46 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-46 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-46 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-46 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-46 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-46 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-46 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-46 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-46 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-46 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-46 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-46 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-46 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-46 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-46 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-46 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-45 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-45 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-45 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-45 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-45 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-45 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-45 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-45 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-45 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-45 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-45 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-45 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-45 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-45 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-45 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-45 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-45 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-45 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-45 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-45 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-45 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-45 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-45 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-45 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-45 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-45 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-45 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-45 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-45 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-45 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-45 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-45 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-45 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-45 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-45 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-45 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-45 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-45 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-45 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-44 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-44 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-44 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-44 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-44 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-44 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-44 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-44 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-44 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-44 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-44 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-44 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-44 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-44 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-43 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-41 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-41 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-41 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-41 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-41 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-41 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-41 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-41 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-41 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-41 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-41 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-41 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-41 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-41 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-41 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-41 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-41 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-41 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-41 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-41 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-41 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-41 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-41 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-40 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-40 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-40 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-39 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-39 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-39 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-39 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-39 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-39 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-38 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-38 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-38 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-38 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-38 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-38 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-38 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-38 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-38 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-38 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-38 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-38 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-37 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-37 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-37 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-37 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-37 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-37 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-36 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-36 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-36 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-36 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-36 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-36 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-36 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-36 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-36 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-35 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-35 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-33 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-33 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-33 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-32 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-31 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-31 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-30 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-30 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-30 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-30 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-30 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-30 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-30 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-30 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-30 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-30 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-30 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-30 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-30 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-30 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-30 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-30 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-30 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-30 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-30 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-30 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-30 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-30 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-30 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-27 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-27 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-27 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-27 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-27 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-27 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-27 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-26 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-26 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-26 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-26 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-26 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-26 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-25 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-24 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-24 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-24 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-24 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-24 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-24 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-24 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-24 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-24 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-24 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-24 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-24 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-24 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-24 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-24 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-23 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-23 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-23 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-23 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-23 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-23 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-23 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-23 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-23 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-23 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-23 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-22 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-22 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-22 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-22 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-22 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-22 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-22 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-22 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-22 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-22 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-22 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-22 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-22 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-22 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-21 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-21 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-21 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-20 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-20 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-20 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-20 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-20 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-20 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-20 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-20 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-20 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-20 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-20 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-20 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-20 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-20 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-20 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-20 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-20 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-20 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-19 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-19 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-19 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-19 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-19 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-18 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-18 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-17 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-17 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-17 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-17 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-17 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-17 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-17 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-17 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-17 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-17 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-17 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-17 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-17 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-17 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-17 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-16 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-16 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-16 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-16 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-16 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-15 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-15 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-15 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-15 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-15 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-15 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-14 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-14 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-09 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-09 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-09 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-09 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-09 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 6e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-09 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 7e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-08 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 1e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-08 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-07 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-07 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 4e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-06 |
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 553 bits (1428), Expect = 0.0
Identities = 182/328 (55%), Positives = 235/328 (71%), Gaps = 36/328 (10%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+D+Y ++ K+GEGTYG VYKA + VTNET+A+K+IRLE E+EGVP TAIRE+SLLKE+QH
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NI+ L+ V+H +L+L+FEY + DLKK+MD PD R+IK+FLYQ++ G+ +CHS
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDV--SMRVIKSFLYQLINGVNFCHS 150
Query: 121 HRVLHRDLKPQNLLIDRRTNA----LKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
R LHRDLKPQNLL+ + LK+ DFGLARAFGIP+R FTHE
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE------------- 197
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
++TLWYR PEILLGSRHYST VD+WS+ CI+AEM+ + PLFPGD
Sbjct: 198 ----------------IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRN-LEPAGIDLLSK 295
SEID+LFKIF VLG P++ TWPGVT+LPD+K +FPK+ K L V+ L+ G+DLL+
Sbjct: 242 SEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTA 301
Query: 296 MLCMDPSRRITARSALEHEYFRDVEFVP 323
ML MDP +RI+A++ALEH YF +F P
Sbjct: 302 MLEMDPVKRISAKNALEHPYFSHNDFDP 329
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 551 bits (1422), Expect = 0.0
Identities = 182/319 (57%), Positives = 227/319 (71%), Gaps = 32/319 (10%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M++Y +EKIGEGTYGVVYKA+N ET ALKKIRLE+EDEG+PST IREIS+LKE++H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV+L DV+H++K+L LVFE+LD DLKK +D C + K+FL Q+L GIAYCH
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHD 118
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
RVLHRDLKPQNLLI+R LK+ADFGLARAFGIPVR +THE
Sbjct: 119 RRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHE----------------- 160
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
+VTLWYRAP++L+GS+ YST +D+WSVGCIFAEMVN PLFPG SE D
Sbjct: 161 ------------IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
+L +IFR+LGTPN WP VT LP + F + + ++ L+ +GIDLLSKML +D
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD 268
Query: 301 PSRRITARSALEHEYFRDV 319
P++RITA+ ALEH YF++
Sbjct: 269 PNQRITAKQALEHAYFKEN 287
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 543 bits (1401), Expect = 0.0
Identities = 171/321 (53%), Positives = 223/321 (69%), Gaps = 34/321 (10%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M +YEK+EKIGEGTYG V+KA+N T+E +ALK++RL+ +DEGVPS+A+REI LLKE++H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIVRL DV+HS+KKL LVFE+ D DLKK+ DSC DP ++K+FL+Q+L+G+ +CHS
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS 119
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
VLHRDLKPQNLLI+R LKLA+FGLARAFGIPVR ++ E
Sbjct: 120 RNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAE----------------- 161
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR-PLFPGDSEI 239
VVTLWYR P++L G++ YST +D+WS GCIFAE+ N PLFPG+
Sbjct: 162 ------------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKE-LGTVVRNLEPAGIDLLSKMLC 298
D+L +IFR+LGTP E+ WP +T LPD+K +P +P+ L VV L G DLL +L
Sbjct: 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKP-YPMYPATTSLVNVVPKLNATGRDLLQNLLK 268
Query: 299 MDPSRRITARSALEHEYFRDV 319
+P +RI+A AL+H YF D
Sbjct: 269 CNPVQRISAEEALQHPYFSDF 289
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 543 bits (1401), Expect = 0.0
Identities = 174/321 (54%), Positives = 224/321 (69%), Gaps = 33/321 (10%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M++Y+K+EK+GEGTYGVVYKA++ +ALK+IRL+ EDEG+PSTAIREISLLKE+ H
Sbjct: 20 MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV L DV+HSE+ L LVFE+++ DLKK +D IK +LYQ+LRG+A+CH
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGL-QDSQIKIYLYQLLRGVAHCHQ 137
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HR+LHRDLKPQNLLI+ ALKLADFGLARAFGIPVR++THE
Sbjct: 138 HRILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHE----------------- 179
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAP++L+GS+ YST VD+WS+GCIFAEM+ +PLFPG ++ D
Sbjct: 180 ------------VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
+L KIF +LGTPN WP V LP +K F + K +++ GIDLLS MLC
Sbjct: 228 QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCF 287
Query: 300 DPSRRITARSALEHEYFRDVE 320
DP++RI+AR A+ H YF+D++
Sbjct: 288 DPNKRISARDAMNHPYFKDLD 308
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 541 bits (1396), Expect = 0.0
Identities = 153/328 (46%), Positives = 213/328 (64%), Gaps = 40/328 (12%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Q++++EK+G GTY VYK N T +ALK+++L+ E EG PSTAIREISL+KE++H
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKH 62
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFAN----DPRLIKTFLYQILRGIA 116
NIVRL DV+H+E KL LVFE++D DLKK+MDS + L+K F +Q+L+G+A
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
+CH +++LHRDLKPQNLLI++R LKL DFGLARAFGIPV TF+ E
Sbjct: 123 FCHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAFGIPVNTFSSE------------- 168
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
VVTLWYRAP++L+GSR YST +D+WS GCI AEM+ +PLFPG
Sbjct: 169 ----------------VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRN-----LEPAGID 291
++ ++L IF ++GTPNE WP VT LP + + P ++L V++ L+ +D
Sbjct: 213 NDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMD 272
Query: 292 LLSKMLCMDPSRRITARSALEHEYFRDV 319
L +L ++P R++A+ AL H +F +
Sbjct: 273 FLHGLLQLNPDMRLSAKQALHHPWFAEY 300
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 538 bits (1389), Expect = 0.0
Identities = 158/320 (49%), Positives = 214/320 (66%), Gaps = 33/320 (10%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+ Y K++K+GEGTY VYK ++ +T+ +ALK+IRLE E EG P TAIRE+SLLK+++H
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKH 59
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV L D++H+EK L LVFEYLD DLK+++D C + + +K FL+Q+LRG+AYCH
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNII-NMHNVKLFLFQLLRGLAYCHR 118
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
+VLHRDLKPQNLLI+ R LKLADFGLARA IP +T+ +E
Sbjct: 119 QKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNE----------------- 160
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYR P+ILLGS YST +D+W VGCIF EM RPLFPG + +
Sbjct: 161 ------------VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSA-FPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
+L IFR+LGTP E+TWPG+ S +FK+ +PK+ ++ L + L+ G DLL+K+L
Sbjct: 209 QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQF 268
Query: 300 DPSRRITARSALEHEYFRDV 319
+ RI+A A++H +F +
Sbjct: 269 EGRNRISAEDAMKHPFFLSL 288
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 537 bits (1385), Expect = 0.0
Identities = 110/325 (33%), Positives = 173/325 (53%), Gaps = 33/325 (10%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M++YEK+ KIGEG+YGVV+K RN T + +A+KK ++D + A+REI +LK+++H
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
N+V L +V +++L+LVFEY D + +D L+K+ +Q L+ + +CH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHK 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
H +HRD+KP+N+LI + + +KL DFG AR P + E
Sbjct: 121 HNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDE----------------- 162
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
V T WYR+PE+L+G Y PVDVW++GC+FAE+++ PL+PG S++D
Sbjct: 163 ------------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKW-PSKELGTVVRNLEPAGIDLLSKMLC 298
+L+ I + LG ++ F P + L N+ + LL L
Sbjct: 211 QLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLH 270
Query: 299 MDPSRRITARSALEHEYFRDVEFVP 323
MDP+ R+T L H YF ++ +
Sbjct: 271 MDPTERLTCEQLLHHPYFENIREIE 295
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 536 bits (1384), Expect = 0.0
Identities = 128/321 (39%), Positives = 185/321 (57%), Gaps = 35/321 (10%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE---GVPSTAIREISLLKE 57
+YEK++ +GEG + VYKAR+ TN+ +A+KKI+L E G+ TA+REI LL+E
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
+ H NI+ L D + + LVF++++ DL+ + P IK ++ L+G+ Y
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVL-TPSHIKAYMLMTLQGLEY 127
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
H H +LHRDLKP NLL+D LKLADFGLA++FG P R +TH+
Sbjct: 128 LHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQ-------------- 172
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
VVT WYRAPE+L G+R Y VD+W+VGCI AE++ + P PGDS
Sbjct: 173 ---------------VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
++D+L +IF LGTP E+ WP + SLPD+ + F +P L + +DL+ +
Sbjct: 218 DLDQLTRIFETLGTPTEEQWPDMCSLPDYVT-FKSFPGIPLHHIFSAAGDDLLDLIQGLF 276
Query: 298 CMDPSRRITARSALEHEYFRD 318
+P RITA AL+ +YF +
Sbjct: 277 LFNPCARITATQALKMKYFSN 297
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 536 bits (1382), Expect = 0.0
Identities = 114/323 (35%), Positives = 170/323 (52%), Gaps = 33/323 (10%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M++YE + +GEG+YG+V K RN T +A+KK +D+ V A+REI LLK+++H
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
N+V L +V +K+ YLVFE++D + ++ P+ D ++++ +L+QI+ GI +CHS
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHS 142
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
H ++HRD+KP+N+L+ + +KL DFG AR P + E
Sbjct: 143 HNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDE----------------- 184
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
V T WYRAPE+L+G Y VDVW++GC+ EM PLFPGDS+ID
Sbjct: 185 ------------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID 232
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKE-LGTVVRNLEPAGIDLLSKMLC 298
+L+ I LG P F P+ +E L L IDL K L
Sbjct: 233 QLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLH 292
Query: 299 MDPSRRITARSALEHEYFRDVEF 321
+DP +R L H++F+ F
Sbjct: 293 IDPDKRPFCAELLHHDFFQMDGF 315
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 521 bits (1344), Expect = 0.0
Identities = 139/329 (42%), Positives = 196/329 (59%), Gaps = 43/329 (13%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNC-VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ 59
QYE V +IGEG YG V+KAR+ +ALK++R++ +EG+P + IRE+++L+ ++
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 60 ---HGNIVRLQDVVHS-----EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQI 111
H N+VRL DV E KL LVFE++D DL ++D P+ IK ++Q+
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
LRG+ + HSHRV+HRDLKPQN+L+ +KLADFGLAR + + T
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMA-LTSV-------- 179
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231
VVTLWYRAPE+LL S Y+TPVD+WSVGCIFAEM ++P
Sbjct: 180 ---------------------VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKP 217
Query: 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291
LF G S++D+L KI V+G P E+ WP +LP F ++ + V +++ G D
Sbjct: 218 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA--FHSKSAQPIEKFVTDIDELGKD 275
Query: 292 LLSKMLCMDPSRRITARSALEHEYFRDVE 320
LL K L +P++RI+A SAL H YF+D+E
Sbjct: 276 LLLKCLTFNPAKRISAYSALSHPYFQDLE 304
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 517 bits (1334), Expect = 0.0
Identities = 134/334 (40%), Positives = 189/334 (56%), Gaps = 45/334 (13%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG---VPSTAIREISLLKE 57
+YE V +IG G YG VYKAR+ + +ALK +R+ G +P + +RE++LL+
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 58 MQ---HGNIVRLQDVVHS-----EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLY 109
++ H N+VRL DV + E K+ LVFE++D DL+ ++D P IK +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTG 169
Q LRG+ + H++ ++HRDLKP+N+L+ +KLADFGLAR + + T
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMA-LTPV------ 179
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ 229
VVTLWYRAPE+LL S Y+TPVD+WSVGCIFAEM +
Sbjct: 180 -----------------------VVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRR 215
Query: 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAG 289
+PLF G+SE D+L KIF ++G P ED WP SLP FP + + +VV +E +G
Sbjct: 216 KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA--FPPRGPRPVQSVVPEMEESG 273
Query: 290 IDLLSKMLCMDPSRRITARSALEHEYFRDVEFVP 323
LL +ML +P +RI+A AL+H Y E P
Sbjct: 274 AQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 307
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 494 bits (1275), Expect = e-178
Identities = 113/333 (33%), Positives = 182/333 (54%), Gaps = 46/333 (13%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ +YEK+ KIG+GT+G V+KAR+ T + +ALKK+ +E E EG P TA+REI +L+ ++H
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 61 GNIVRLQDVVHSEK--------KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQIL 112
N+V L ++ ++ +YLVF++ + DL + + IK + +L
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLL 134
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT----FTHEHWGST 168
G+ Y H +++LHRD+K N+LI R LKLADFGLARAF + + +T+
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNR----- 188
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228
VVTLWYR PE+LLG R Y P+D+W GCI AEM
Sbjct: 189 ------------------------VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
Query: 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSA-FPKWPSKELGTVVRNL-- 285
+ P+ G++E +L I ++ G+ + WP V + ++ K +++ ++
Sbjct: 225 RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR 284
Query: 286 EPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
+P +DL+ K+L +DP++RI + AL H++F
Sbjct: 285 DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 464 bits (1196), Expect = e-165
Identities = 114/350 (32%), Positives = 175/350 (50%), Gaps = 63/350 (18%)
Query: 2 DQYEKV-EKIGEGTYGVVYKARN--CVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM 58
D +E K+G GTYG VYKA+ ++ ALK+I E G+ +A REI+LL+E+
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLREL 75
Query: 59 QHGNIVRLQDVV--HSEKKLYLVFEYLDLDLKKHMDSCPDFAN-------DPRLIKTFLY 109
+H N++ LQ V H+++K++L+F+Y + DL + ++K+ LY
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGLARAFGIPVRTFTHEHWG 166
QIL GI Y H++ VLHRDLKP N+L+ +K+AD G AR F P++
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD-- 193
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
VVT WYRAPE+LLG+RHY+ +D+W++GCIFAE+
Sbjct: 194 ------------------------PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229
Query: 227 VNQRPLFPGDSEI---------DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWP--- 274
+ P+F E D+L +IF V+G P + W + +P+ + +
Sbjct: 230 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNT 289
Query: 275 ------SKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
K + + LL K+L MDP +RIT+ A++ YF +
Sbjct: 290 YTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 427 bits (1099), Expect = e-150
Identities = 103/327 (31%), Positives = 167/327 (51%), Gaps = 47/327 (14%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Y + IG G++GVV++A+ ++E +A+KK+ ++ + RE+ +++ ++H
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------RELQIMRIVKH 91
Query: 61 GNIVRLQDVVHS------EKKLYLVFEYLDLDLKKHMDSCPDFAN--DPRLIKTFLYQIL 112
N+V L+ +S E L LV EY+ + + LIK ++YQ+L
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
R +AY HS + HRD+KPQNLL+D + LKL DFG A+ I
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSY--------- 201
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
+ + +YRAPE++ G+ +Y+T +D+WS GC+ AE++ +PL
Sbjct: 202 --------------------ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL 241
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVR-NLEPAGID 291
FPG+S ID+L +I +VLGTP+ + + + FP+ V R P ID
Sbjct: 242 FPGESGIDQLVEIIKVLGTPSREQIKTMNPN-YMEHKFPQIRPHPFSKVFRPRTPPDAID 300
Query: 292 LLSKMLCMDPSRRITARSALEHEYFRD 318
L+S++L PS R+TA AL H +F +
Sbjct: 301 LISRLLEYTPSARLTAIEALCHPFFDE 327
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 406 bits (1045), Expect = e-142
Identities = 100/326 (30%), Positives = 163/326 (50%), Gaps = 48/326 (14%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Y + IG G++GVVY+A+ C + E +A+KK+ ++ + RE+ +++++ H N
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCN 108
Query: 63 IVRLQDVVHS------EKKLYLVFEYLDLDLKKHMDSCPDFAN--DPRLIKTFLYQILRG 114
IVRL+ +S E L LV +Y+ + + +K ++YQ+ R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+AY HS + HRD+KPQNLL+D T LKL DFG A+ +
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSY----------- 216
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
+ + +YRAPE++ G+ Y++ +DVWS GC+ AE++ +P+FP
Sbjct: 217 ------------------ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258
Query: 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSL-PDFKSAFPKWPSKELGTVVR-NLEPAGIDL 292
GDS +D+L +I +VLGTP + + +FK FP+ + V R P I L
Sbjct: 259 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIAL 316
Query: 293 LSKMLCMDPSRRITARSALEHEYFRD 318
S++L P+ R+T A H +F +
Sbjct: 317 CSRLLEYTPTARLTPLEACAHSFFDE 342
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 391 bits (1005), Expect = e-135
Identities = 113/356 (31%), Positives = 168/356 (47%), Gaps = 43/356 (12%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D+YE IG G+YG V +A + + +A+KKI ED +REI++L + H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 62 NIVRLQDVVHSE-----KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
++V++ D+V + +LY+V E D D KK + IKT LY +L G+
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL--HIKTLLYNLLVGVK 170
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
Y HS +LHRDLKP N L++ + ++K+ DFGLAR P + +
Sbjct: 171 YVHSAGILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ------- 229
+ + VVT WYRAPE++L +Y+ +DVWS+GCIFAE++N
Sbjct: 230 FPHTKNLKRQLTGH--VVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 230 ----RPLFPGDS--------------------EIDELFKIFRVLGTPNEDTWPGVTS--L 263
PLFPG S D+L IF +LGTP+E+ +
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDA 347
Query: 264 PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319
+ FPK +L I LL +ML +P++RIT L H +F++V
Sbjct: 348 KRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 385 bits (990), Expect = e-135
Identities = 96/332 (28%), Positives = 162/332 (48%), Gaps = 53/332 (15%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
D Y+ V K+G G Y V++A N NE + +K ++ ++ + REI +L+ ++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRG 89
Query: 61 G-NIVRLQDVVH--SEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
G NI+ L D+V + LVFE+++ D K+ + D+ I+ ++Y+IL+ +
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY-----DIRFYMYEILKALD 144
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
YCHS ++HRD+KP N++ID L+L D+GLA F P + +
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVR------------- 190
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR-PLFPG 235
V + +++ PE+L+ + Y +D+WS+GC+ A M+ ++ P F G
Sbjct: 191 ----------------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSL---PDFKSAFPKWPSKELGTVV-----RNLEP 287
D+L +I +VLGT + + ++ P F + K V + P
Sbjct: 235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 294
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319
+D L K+L D R+TAR A+EH YF V
Sbjct: 295 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-133
Identities = 101/336 (30%), Positives = 155/336 (46%), Gaps = 55/336 (16%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-- 58
MD+++ G+GT+G V + T ++A+KK+ + P RE+ +++++
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------PRFRNRELQIMQDLAV 75
Query: 59 -QHGNIVRLQDVVHS-------EKKLYLVFEYLDLDLKKHMDSCPDFAND--PRLIKTFL 108
H NIV+LQ ++ + L +V EY+ L + + P LIK FL
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 109 YQILRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166
+Q++R I H S V HRD+KP N+L++ LKL DFG A+ P
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAY--- 191
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
+ + +YRAPE++ G++HY+T VD+WSVGCIFAEM
Sbjct: 192 --------------------------ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM 225
Query: 227 VNQRPLFPGDSEIDELFKIFRVLGTPNEDTW----PGVTSLPDFKSAFPKWPSKELGTVV 282
+ P+F GD+ +L +I RVLG P+ + P T + + S W S
Sbjct: 226 MLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPW-SNVFSDHS 284
Query: 283 RNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
DLLS +L P R+ AL H YF +
Sbjct: 285 LKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 359 bits (922), Expect = e-124
Identities = 92/359 (25%), Positives = 162/359 (45%), Gaps = 78/359 (21%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+Y + +G G++G+V + + + + ALKK+ + P RE+ ++K + H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD------PRYKNRELDIMKVLDH 59
Query: 61 GNIVRLQDVVHS--------------------------------------EKKLYLVFEY 82
NI++L D ++ K L ++ EY
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 83 LDLDLKKHMDSCPDFAND--PRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN 140
+ L K + S LI ++YQ+ R + + HS + HRD+KPQNLL++ + N
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 141 ALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRA 200
LKL DFG A+ IP + + +YRA
Sbjct: 180 TLKLCDFGSAKKL-IPSEPSVAY-----------------------------ICSRFYRA 209
Query: 201 PEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGV 260
PE++LG+ Y+ +D+WS+GC+F E++ +PLF G++ ID+L +I +++GTP ++ +
Sbjct: 210 PELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRM 269
Query: 261 TSLPDFKSAFPKWPSKELGTVVRNLEPA-GIDLLSKMLCMDPSRRITARSALEHEYFRD 318
+ FP +K+ ++ P+ IDLL ++L +P RI A+ H +F
Sbjct: 270 NP-HYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-101
Identities = 95/333 (28%), Positives = 157/333 (47%), Gaps = 52/333 (15%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+Y ++ +G G G+V+ A + ++ +A+KKI L D A+REI +++ + H
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHD 68
Query: 62 NIVRLQDVVHSEKK--------------LYLVFEYLDLDLK---KHMDSCPDFANDPRLI 104
NIV++ +++ +Y+V EY++ DL + +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH------A 122
Query: 105 KTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164
+ F+YQ+LRG+ Y HS VLHRDLKP NL I+ LK+ DFGLAR +
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR-------IMDPHY 175
Query: 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFA 224
+S +VT WYR+P +LL +Y+ +D+W+ GCIFA
Sbjct: 176 SHKGHLSEG-------------------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 216
Query: 225 EMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTS-LPDFKSAFPKWPSKELGTVVR 283
EM+ + LF G E++++ I + +E+ + S +P + P K L ++
Sbjct: 217 EMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLP 276
Query: 284 NLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316
+ +D L ++L P R+TA AL H Y
Sbjct: 277 GISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-101
Identities = 113/328 (34%), Positives = 169/328 (51%), Gaps = 38/328 (11%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA---IREISLLKEM 58
++ +GEG YGVV A + T E +A+KKI + P A +REI +LK
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK----PLFALRTLREIKILKHF 66
Query: 59 QHGNIVRLQDVVHSE-----KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILR 113
+H NI+ + ++ + ++Y++ E + DL + + S ++D I+ F+YQ LR
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDH--IQYFIYQTLR 123
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
+ H V+HRDLKP NLLI+ LK+ DFGLAR + +G+ +
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
V T WYRAPE++L S YS +DVWS GCI AE+ +RP+F
Sbjct: 183 -------------------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLP---DFKSAFPKWPSKELGTVVRNLEPAGI 290
PG +L IF ++GTP+ D P ++ + P +P+ L + + P GI
Sbjct: 224 PGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGI 283
Query: 291 DLLSKMLCMDPSRRITARSALEHEYFRD 318
DLL +ML DP++RITA+ ALEH Y +
Sbjct: 284 DLLQRMLVFDPAKRITAKEALEHPYLQT 311
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = e-100
Identities = 113/353 (32%), Positives = 166/353 (47%), Gaps = 45/353 (12%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D Y IG G+YG VY A + T + +A+KK+ ED +REI++L ++
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 62 NIVRLQDVVHSE-----KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
I+RL D++ + +LY+V E D DLKK + + IKT LY +L G
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEH--IKTILYNLLLGEN 143
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
+ H ++HRDLKP N L+++ ++K+ DFGLAR T +
Sbjct: 144 FIHESGIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-------- 228
+ L VVT WYRAPE++L +Y+ +D+WS GCIFAE++N
Sbjct: 203 NLKKQLTSH-------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 229 ---QRPLFPGDSE-----------------IDELFKIFRVLGTPNEDTWPGVTSLP--DF 266
+ PLFPG S D+L IF ++GTP ED + +
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315
Query: 267 KSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319
FP L ++ GI+LL ML +P++RIT AL+H Y +DV
Sbjct: 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = e-100
Identities = 96/335 (28%), Positives = 147/335 (43%), Gaps = 52/335 (15%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPST---------AIREI 52
Y I G+YG V + +A+K++ D + +REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 53 SLLKEMQHGNIVRLQDVVHSE-----KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTF 107
LL H NI+ L+D+ KLYLV E + DL + + + I+ F
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH-IQYF 139
Query: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167
+Y IL G+ H V+HRDL P N+L+ N + + DF LAR
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLAD-NNDITICDFNLAREDT-----------AD 187
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
+ Y V WYRAPE+++ + ++ VD+WS GC+ AEM
Sbjct: 188 ANKTHY-------------------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
Query: 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPD----FKSAFPKWPSKELGTVVR 283
N++ LF G + ++L KI V+GTP + +S P +++ P++ VV
Sbjct: 229 NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSS-PSARDYLRNSLSNVPARAWTAVVP 287
Query: 284 NLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
+P +DL++KML +P RRI+ AL H YF
Sbjct: 288 TADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 1e-98
Identities = 112/324 (34%), Positives = 170/324 (52%), Gaps = 38/324 (11%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+Y + IGEG YG+V A + + +A+KKI + + +REI +L +H
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHE 85
Query: 62 NIVRLQDVVHSE-----KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
NI+ + D++ + K +Y+V + ++ DL K + + +ND I FLYQILRG+
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDH--ICYFLYQILRGLK 142
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
Y HS VLHRDLKP NLL++ T LK+ DFGLAR +H + ++ Y
Sbjct: 143 YIHSANVLHRDLKPSNLLLNT-TCDLKICDFGLAR-------VADPDHDHTGFLTEY--- 191
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
V T WYRAPEI+L S+ Y+ +D+WSVGCI AEM++ RP+FPG
Sbjct: 192 ----------------VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLP--DFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294
+D+L I +LG+P+++ + +L ++ + P + N + +DLL
Sbjct: 236 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD 295
Query: 295 KMLCMDPSRRITARSALEHEYFRD 318
KML +P +RI AL H Y
Sbjct: 296 KMLTFNPHKRIEVEQALAHPYLEQ 319
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 1e-97
Identities = 105/344 (30%), Positives = 172/344 (50%), Gaps = 45/344 (13%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-H 60
+YE V+K+G+G YG+V+K+ + T E +A+KKI ++ REI +L E+ H
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 61 GNIVRLQDVVHSE--KKLYLVFEYLDLDLKKHMDSCPDFANDPRL----IKTFLYQILRG 114
NIV L +V+ ++ + +YLVF+Y++ DL + + L + +YQ+++
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA-------NILEPVHKQYVVYQLIKV 121
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
I Y HS +LHRD+KP N+L++ +K+ADFGL+R+F R + + F
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNA-ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 175 SFLRYRVLAGSLILQFLK--VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
+ L V T WYRAPEILLGS Y+ +D+WS+GCI E++ +P+
Sbjct: 181 DDDQ----------PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTS---------LPDFKSAFPKWPSKELGTVVR 283
FPG S +++L +I V+ P+ + + S L +
Sbjct: 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN 290
Query: 284 NLE---------PAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
L +DLL K+L +P++RI+A AL+H +
Sbjct: 291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 3e-97
Identities = 109/325 (33%), Positives = 156/325 (48%), Gaps = 45/325 (13%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Y +G G YG V A + + E +A+KK+ + E A RE+ LLK MQH
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 62 NIVRLQDVVHSEKK------LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
N++ L DV YLV ++ DL+K M F+ + I+ +YQ+L+G+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL--KFSEEK--IQYLVYQMLKGL 139
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y HS V+HRDLKP NL ++ LK+ DFGLAR ++ Y
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNE-DCELKILDFGLARHA-------------DAEMTGY-- 183
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
VVT WYRAPE++L HY+ VD+WSVGCI AEM+ + LF G
Sbjct: 184 -----------------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLP--DFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
+D+L +I +V G P + + + + P+ P K+ + P DLL
Sbjct: 227 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 286
Query: 294 SKMLCMDPSRRITARSALEHEYFRD 318
KML +D +R+TA AL H +F
Sbjct: 287 EKMLELDVDKRLTAAQALTHPFFEP 311
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 1e-96
Identities = 109/325 (33%), Positives = 157/325 (48%), Gaps = 44/325 (13%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++Y+ + +G G YG V A + T +A+KK+ + RE+ LLK M+H
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 62 NIVRLQDVVHSEKK------LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
N++ L DV + +YLV + DL + D ++ +YQILRG+
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDH-VQFLIYQILRGL 145
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y HS ++HRDLKP NL ++ LK+ DFGLAR + ++ Y
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNE-DCELKILDFGLARHT-------------ADEMTGY-- 189
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
V T WYRAPEI+L HY+ VD+WSVGCI AE++ R LFPG
Sbjct: 190 -----------------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLP--DFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
ID+L I R++GTP + ++S ++ + + P V P +DLL
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 294 SKMLCMDPSRRITARSALEHEYFRD 318
KML +D +RITA AL H YF
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQ 317
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 6e-96
Identities = 106/325 (32%), Positives = 160/325 (49%), Gaps = 44/325 (13%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Y ++ +G G YG V A + T +A+KK+ + E A RE+ LLK M+H
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 62 NIVRLQDVVHSEKK------LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
N++ L DV ++ YLV ++ DL K M I+ +YQ+L+G+
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRIQFLVYQMLKGL 141
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y H+ ++HRDLKP NL ++ LK+ DFGLAR + ++ Y
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNE-DCELKILDFGLARQA-------------DSEMTGY-- 185
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
VVT WYRAPE++L Y+ VD+WSVGCI AEM+ + LF G
Sbjct: 186 -----------------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLP--DFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
+D+L +I +V GTP + + S ++ P+ K+ +++ N P ++LL
Sbjct: 229 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 288
Query: 294 SKMLCMDPSRRITARSALEHEYFRD 318
KML +D +R+TA AL H YF
Sbjct: 289 EKMLVLDAEQRVTAGEALAHPYFES 313
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 2e-93
Identities = 106/347 (30%), Positives = 159/347 (45%), Gaps = 62/347 (17%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ +Y+ ++ IG G G+V A + + +A+KK+ +++ A RE+ L+K + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 61 GNIVRLQDVVHSEKK------LYLVFEYLDLDLKK--HMDSCPDFANDPRLIKTFLYQIL 112
NI+ L +V +K +Y+V E +D +L + M+ + + LYQ+L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MSYLLYQML 137
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
GI + HS ++HRDLKP N+++ LK+ DFGLAR G + T
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAG--------TSFMMTP--- 185
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
Y VVT +YRAPE++LG Y VD+WSVGCI EM+ L
Sbjct: 186 ------Y-------------VVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL 225
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPG--------VTSLP-----DFKSAFPKWPSKELG 279
FPG ID+ K+ LGTP + V + P F+ FP
Sbjct: 226 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADS 285
Query: 280 TVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY---FRDVEFVP 323
+ DLLSKML +D S+RI+ AL+H Y + D
Sbjct: 286 EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 332
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 2e-93
Identities = 106/336 (31%), Positives = 157/336 (46%), Gaps = 59/336 (17%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+Y+ ++ IG G G+V A + V + +A+KK+ +++ A RE+ L+K + H
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 62 NIVRLQDVVHSE------KKLYLVFEYLDLDLKK--HMDSCPDFANDPRLIKTFLYQILR 113
NI+ L +V + + +YLV E +D +L + M+ + + LYQ+L
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQMLC 175
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
GI + HS ++HRDLKP N+++ LK+ DFGLAR G + T
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAG--------TSFMMTP---- 222
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
Y VVT +YRAPE++L Y VD+WSVGCI EMV + LF
Sbjct: 223 -----Y-------------VVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILF 263
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPG--------VTSLP-----DFKSAFPKWPSKELGT 280
PG ID+ K+ LGTP + V + P F FP
Sbjct: 264 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 323
Query: 281 VVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316
+ DLLSKML +DP++RI+ AL+H Y
Sbjct: 324 HNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-75
Identities = 79/328 (24%), Positives = 125/328 (38%), Gaps = 72/328 (21%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Y +++IG G V++ N + A+K + LE+ D + EI+ L ++Q +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 63 --IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
I+RL D +++ +Y+V E ++DL + DP K++ +L + H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQ 145
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
H ++H DLKP N LI LKL DFG+A + +
Sbjct: 146 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDS---------------- 187
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRH----------YSTPVDVWSVGCIFAEMVNQR 230
G T+ Y PE + S DVWS+GCI M +
Sbjct: 188 -QVG----------TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 231 PLFPG-DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAG 289
F ++I +L I P+ + FP P K+L
Sbjct: 237 TPFQQIINQISKLHAIID----------------PNHEIEFPDIPEKDL----------- 269
Query: 290 IDLLSKMLCMDPSRRITARSALEHEYFR 317
D+L L DP +RI+ L H Y +
Sbjct: 270 QDVLKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 3e-72
Identities = 79/328 (24%), Positives = 125/328 (38%), Gaps = 72/328 (21%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Y +++IG G V++ N + A+K + LE+ D + EI+ L ++Q +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 63 --IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
I+RL D +++ +Y+V E ++DL + DP K++ +L + H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQ 126
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
H ++H DLKP N LI LKL DFG+A + +
Sbjct: 127 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDS---------------- 168
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRH----------YSTPVDVWSVGCIFAEMVNQR 230
G T+ Y PE + S DVWS+GCI M +
Sbjct: 169 -QVG----------TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
Query: 231 PLFPG-DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAG 289
F ++I +L I P+ + FP P K+L
Sbjct: 218 TPFQQIINQISKLHAIID----------------PNHEIEFPDIPEKDL----------- 250
Query: 290 IDLLSKMLCMDPSRRITARSALEHEYFR 317
D+L L DP +RI+ L H Y +
Sbjct: 251 QDVLKCCLKRDPKQRISIPELLAHPYVQ 278
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 5e-71
Identities = 78/328 (23%), Positives = 124/328 (37%), Gaps = 72/328 (21%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Y +++IG G V++ N + A+K + LE+ D + EI+ L ++Q +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 63 --IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
I+RL D +++ +Y+V E ++DL + DP K++ +L + H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQ 173
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
H ++H DLKP N LI LKL DFG+A + +
Sbjct: 174 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDS---------------- 215
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGS----------RHYSTPVDVWSVGCIFAEMVNQR 230
G + Y PE + S DVWS+GCI M +
Sbjct: 216 -QVG----------AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
Query: 231 PLFPG-DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAG 289
F ++I +L I P+ + FP P K+L
Sbjct: 265 TPFQQIINQISKLHAIID----------------PNHEIEFPDIPEKDL----------- 297
Query: 290 IDLLSKMLCMDPSRRITARSALEHEYFR 317
D+L L DP +RI+ L H Y +
Sbjct: 298 QDVLKCCLKRDPKQRISIPELLAHPYVQ 325
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 4e-70
Identities = 81/331 (24%), Positives = 132/331 (39%), Gaps = 63/331 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+E++ +G+G +G V KARN + + A+KKIR +E ST + E+ LL + H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASLNHQ 62
Query: 62 NIVRLQDV-------------VHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTF 107
+VR V + L++ EY + L + S
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYWRL 121
Query: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167
QIL ++Y HS ++HRDLKP N+ ID N +K+ DFGLA+ + +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVV-TLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
G S + + T Y A E+L G+ HY+ +D++S+G IF EM
Sbjct: 181 PGSSDNLT----------------SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224
Query: 227 VNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLE 286
+ P G ++ L K+ +F F K
Sbjct: 225 IY--PFSTGMERVNILKKLRS--------------VSIEFPPDFDDNKMKVE-------- 260
Query: 287 PAGIDLLSKMLCMDPSRRITARSALEHEYFR 317
++ ++ DP++R AR+ L +
Sbjct: 261 ---KKIIRLLIDHDPNKRPGARTLLNSGWLP 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-62
Identities = 71/322 (22%), Positives = 133/322 (41%), Gaps = 66/322 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M++Y +++KIGEG++G ++ +K+I + + + RE+++L M+H
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
NIV+ ++ LY+V +Y + DL K +++ I + QI + + H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
++LHRD+K QN+ + + ++L DFG+AR
Sbjct: 143 DRKILHRDIKSQNIFLTK-DGTVQLGDFGIAR---------------------------- 173
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
VL ++ L + T +Y +PEI + Y+ D+W++GC+ E+ + F S
Sbjct: 174 -VLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMK 231
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWP---SKELGTVVRNLEPAGIDLLSKM 296
+ + KI +FP S +L L+S++
Sbjct: 232 NLVLKI--------------------ISGSFPPVSLHYSYDL-----------RSLVSQL 260
Query: 297 LCMDPSRRITARSALEHEYFRD 318
+P R + S LE +
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAK 282
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-62
Identities = 75/335 (22%), Positives = 132/335 (39%), Gaps = 64/335 (19%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ +E ++ +G G +GVV++A+N V + A+K+IRL + +RE+ L +++H
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKLEH 62
Query: 61 GNIVRLQDV------------VHSEKKLYLVFEYLD-LDLKKHMDSCPDFAN-DPRLIKT 106
IVR + + LY+ + +LK M+ + +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 107 FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166
QI + + HS ++HRDLKP N+ + +K+ DFGL A +
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTA-------MDQDEEE 174
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
T ++ ++ R+ G T Y +PE + G YS VD++S+G I E+
Sbjct: 175 QTVLTPMPAYARHTGQVG----------TKLYMSPEQIHG-NSYSHKVDIFSLGLILFEL 223
Query: 227 VNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLE 286
+ P F E R FP +++
Sbjct: 224 L--YP-FSTQMERVRTLTDVR-------------------NLKFPPLFTQKY-------- 253
Query: 287 PAGIDLLSKMLCMDPSRRITARSALEHEYFRDVEF 321
P ++ ML P R A + +E+ F D++F
Sbjct: 254 PCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 5e-62
Identities = 77/344 (22%), Positives = 134/344 (38%), Gaps = 80/344 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QH 60
+ + +G G+ G V +A+K++ ++ D A+ EI LL E H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDH 68
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDL-----KKHMDSCPDFANDPRLIKTFLYQILRGI 115
N++R +++ LY+ E +L+L K++ + L QI G+
Sbjct: 69 PNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNA------------LKLADFGLARAFGIPVRTFTHE 163
A+ HS +++HRDLKPQN+L+ + + ++DFGL + +F
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS------RHYSTPVDVW 217
+G T +RAPE+L S R + +D++
Sbjct: 189 LNNPSG-------------------------TSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 218 SVGCIFAEMVNQ-RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSK 276
S+GC+F ++++ + F + I R G+ SL + K +
Sbjct: 224 SMGCVFYYILSKGKHPFGDKYSRES--NIIR-----------GIFSLDEMKCLHDRSLIA 270
Query: 277 ELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
E DL+S+M+ DP +R TA L H F
Sbjct: 271 E-----------ATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS 303
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 2e-61
Identities = 90/364 (24%), Positives = 160/364 (43%), Gaps = 83/364 (22%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIR-----LEQEDEGVPSTAIREISLLK 56
+YE ++ IG+G++G V KA + ++ +ALK +R Q A EI +L+
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ--------AAEEIRILE 148
Query: 57 EMQHG------NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQ 110
++ N++ + + + + FE L ++L + + L++ F +
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 111 ILRGIAYCHSHRVLHRDLKPQN-LLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTG 169
IL+ + H +R++H DLKP+N LL + + +K+ DFG + + H+
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--------CYEHQR----- 255
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ 229
+ Y + + +YRAPE++LG+R Y P+D+WS+GCI AE++
Sbjct: 256 VYTY-------------------IQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTG 295
Query: 230 RPLFPGDSEIDELFKIFRVLGTPNED------------------TWPGVTSLPDFKSAFP 271
PL PG+ E D+L + +LG P++ + VT+L D
Sbjct: 296 YPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLN 355
Query: 272 K-----------WPSKELGTVVRNLEPAG-IDLLSKMLCMDPSRRITARSALEHEYFRDV 319
S+E G ++ + +D L + L DP+ R+T AL H + R
Sbjct: 356 GGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415
Query: 320 EFVP 323
P
Sbjct: 416 LPKP 419
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 5e-61
Identities = 79/331 (23%), Positives = 125/331 (37%), Gaps = 75/331 (22%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ YE + IG G+YG K R + + K++ E + E++LL+E++H
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 61 GNIVRLQDVVHSE--KKLYLVFEYLDL-DLKKHMDSCPDFAN--DPRLIKTFLYQILRGI 115
NIVR D + LY+V EY + DL + D + + Q+ +
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 116 AYCHS-----HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGI 170
CH H VLHRDLKP N+ +D +KL DFGLAR
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLAR------------------- 164
Query: 171 SIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230
+L V T +Y +PE + Y+ D+WS+GC+ E+
Sbjct: 165 ----------ILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALM 213
Query: 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWP---SKELGTVVRNLEP 287
P F S+ + KI + F + P S EL
Sbjct: 214 PPFTAFSQKELAGKI--------------------REGKFRRIPYRYSDEL--------- 244
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
+++++ML + R + LE+ +
Sbjct: 245 --NEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-60
Identities = 71/318 (22%), Positives = 113/318 (35%), Gaps = 65/318 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-Q 59
++++ ++G G+YG V+K R+ A+K+ + + E+ +++ Q
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
H VRL+ LYL E L++H ++ + + + +L L +A+ H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQ-VWGYLRDTLLALAHLH 174
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
S ++H D+KP N+ + KL DFGL G E G
Sbjct: 175 SQGLVHLDVKPANIFLG-PRGRCKLGDFGLLVELGTAGAGEVQE--GDPR---------- 221
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
Y APE+L GS Y T DV+S+G E+ L G
Sbjct: 222 ------------------YMAPELLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGW 261
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
+L + + F S EL +L ML
Sbjct: 262 QQLRQGY-------------------LPPEFTAGLSSEL-----------RSVLVMMLEP 291
Query: 300 DPSRRITARSALEHEYFR 317
DP R TA + L R
Sbjct: 292 DPKLRATAEALLALPVLR 309
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-60
Identities = 68/335 (20%), Positives = 116/335 (34%), Gaps = 88/335 (26%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
++++E IG G +G V+KA++ + +T +K+++ E A RE+ L ++ H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDH 63
Query: 61 GNIVRLQD----------------VVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRL 103
NIV K L++ E+ D L++ ++ D L
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 104 IKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
QI +G+ Y HS ++++RDLKP N+ + +K+ DFGL + +
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTSL-----KNDGK 177
Query: 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIF 223
S G TL Y +PE + + Y VD++++G I
Sbjct: 178 RTRSKG-------------------------TLRYMSPEQISS-QDYGKEVDLYALGLIL 211
Query: 224 AEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVR 283
AE++ E + F R K+
Sbjct: 212 AELL--HVCDTA-FETSKFFTDLR-------------------DGIISDIFDKKE----- 244
Query: 284 NLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
LL K+L P R L
Sbjct: 245 ------KTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-59
Identities = 71/321 (22%), Positives = 120/321 (37%), Gaps = 68/321 (21%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQ 59
+ + +KIG G + VY+A + +ALKK+++ + D + I+EI LLK++
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 60 HGNIVRLQDVVHSEKKLYLVFEY-----LDLDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
H N+++ + +L +V E L +K R + + Q+
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI--PERTVWKYFVQLCSA 148
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+ + HS RV+HRD+KP N+ I T +KL D GL R
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITA-TGVVKLGDLGLGR----------------------- 184
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
+ V T +Y +PE + Y+ D+WS+GC+ EM + F
Sbjct: 185 ------FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 237
Query: 235 GDS-EIDELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
GD + L KI + +P PS + L
Sbjct: 238 GDKMNLYSLCKKI--------------------EQCDYPPLPSD-------HYSEELRQL 270
Query: 293 LSKMLCMDPSRRITARSALEH 313
++ + DP +R +
Sbjct: 271 VNMCINPDPEKRPDVTYVYDV 291
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 8e-59
Identities = 71/326 (21%), Positives = 127/326 (38%), Gaps = 67/326 (20%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHG 61
+ + +G G G + R N +A+K+I E A RE+ LL+E +H
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHP 78
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
N++R + Y+ E L+++++ DFA+ T L Q G+A+ HS
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 122 RVLHRDLKPQNLLIDRRTNA----LKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
++HRDLKP N+LI ++DFGL + + +F+ G G
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS-GVPG-------- 188
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGS--RHYSTPVDVWSVGCIFAEMVNQ-RPLFP 234
T + APE+L + + VD++S GC+F ++++ F
Sbjct: 189 -----------------TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294
+ + ++ + +L+
Sbjct: 232 KSLQRQANILL------------------GACSLDCLHPE--------KHEDVIARELIE 265
Query: 295 KMLCMDPSRRITARSALEHEYFRDVE 320
KM+ MDP +R +A+ L+H +F +E
Sbjct: 266 KMIAMDPQKRPSAKHVLKHPFFWSLE 291
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 8e-58
Identities = 81/361 (22%), Positives = 127/361 (35%), Gaps = 94/361 (26%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEM 58
+Y IG+G+YGVV A T A+K + ++ Q + E+ L+K++
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEY------LDLDLKKHMDSCPDFANDP----------- 101
H NI RL +V E+ + LV E LD DS A D
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 102 ----------------------RLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT 139
+LI + QI + Y H+ + HRD+KP+N L
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 140 NA-LKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWY 198
+ +KL DFGL++ F + G T ++
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG-------------------------TPYF 240
Query: 199 RAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTW 257
APE+L + Y D WS G + ++ FPG ++ D + ++
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN---------- 290
Query: 258 PGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317
F++ P + L P DLLS +L + R A AL+H +
Sbjct: 291 ----KKLCFEN--PNYNV---------LSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335
Query: 318 D 318
Sbjct: 336 Q 336
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-57
Identities = 67/346 (19%), Positives = 129/346 (37%), Gaps = 71/346 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAI-------- 49
++ Y + + +G + + N+ ALK K LE++ + S
Sbjct: 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 50 ----REISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFA 98
E+ ++ ++++ + + ++ + ++Y+++EY++ + +D
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 99 NDPRLIKTFLYQILRGIAYCHSHR-VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157
++IK + +L +Y H+ + + HRD+KP N+L+D+ +KL+DFG
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGE-------- 198
Query: 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTP-VDV 216
S Y + + G T + PE Y+ VD+
Sbjct: 199 -------------SEYMVDKKIKGSRG----------TYEFMPPEFFSNESSYNGAKVDI 235
Query: 217 WSVGCIFAEMVNQRPLFPGDSEIDELF-KIFRV-LGTPNEDTWPGVTSLPDFKSAFPKWP 274
WS+G M F + ELF I + P + + +
Sbjct: 236 WSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFL 295
Query: 275 SKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
S E ID L L +P+ RIT+ AL+HE+ D
Sbjct: 296 SNED-----------IDFLKLFLRKNPAERITSEDALKHEWLADTN 330
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-56
Identities = 58/336 (17%), Positives = 113/336 (33%), Gaps = 65/336 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEM 58
+ + +G+G V++ R+ T + A+K I + + +RE +LK++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKL 64
Query: 59 QHGNIVRLQDVV--HSEKKLYLVFEYL---DL-DLKKHMDSCPDFANDPRLIKTFLYQIL 112
H NIV+L + + + L+ E+ L + + + L ++
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVV 122
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNA---LKLADFGLARAFGIPVRTFTHEHWGSTG 169
G+ + + ++HR++KP N++ + KL DFG AR + +
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-------- 174
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG-------SRHYSTPVDVWSVGCI 222
L G T Y P++ + Y VD+WS+G
Sbjct: 175 ------------LYG----------TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 223 FAEMVNQRPLF----PGDSEIDELFKIFRVLGTPNEDTWPGVTSLP-DFKSAFPKWPSKE 277
F F + ++KI + + P D+ P S
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS-- 270
Query: 278 LGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313
+ R L+ +L+ +L D +
Sbjct: 271 ---LSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 3e-56
Identities = 70/322 (21%), Positives = 110/322 (34%), Gaps = 62/322 (19%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Y ++K+GEG + V ALK+I ++ + A RE + + H N
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRLFNHPN 87
Query: 63 IVRLQDVVHSEK----KLYLVFEYLDL-DLKKHMDSCPDFAN--DPRLIKTFLYQILRGI 115
I+RL E+ + +L+ + L ++ D N I L I RG+
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
H+ HRDLKP N+L+ L D G I V
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQ-PVLMDLGSMNQACIHVEG---------------- 190
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH--YSTPVDVWSVGCIFAEMVNQRPLF 233
A +L + T+ YRAPE+ H DVWS+GC+ M+ +
Sbjct: 191 ----SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWP--SKELGTVVRNLEPAGID 291
+ + + V + + P+ P S L
Sbjct: 247 DMVFQKGDSVAL-AVQN----------------QLSIPQSPRHSSAL-----------WQ 278
Query: 292 LLSKMLCMDPSRRITARSALEH 313
LL+ M+ +DP +R L
Sbjct: 279 LLNSMMTVDPHQRPHIPLLLSQ 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-56
Identities = 64/317 (20%), Positives = 105/317 (33%), Gaps = 67/317 (21%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ ++G G++G V++ ++ T A+KK+RLE E+ +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSS 109
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
IV L V + + E L+ L K M P+ +L Q L G+
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE-----DRALYYLGQALEGLE 164
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
Y H+ R+LH D+K N+L+ + L DFG A + S
Sbjct: 165 YLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL--------------QPDGLGKSL 210
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
L + G T + APE+++G VD+WS C+ M+N +
Sbjct: 211 LTGDYIPG----------TETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQY 259
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKM 296
KI +E P + P + +
Sbjct: 260 FRGPLCLKI------ASEPP--------------PIREIPP------SCAPLTAQAIQEG 293
Query: 297 LCMDPSRRITARSALEH 313
L +P R +A
Sbjct: 294 LRKEPVHRASAMELRRK 310
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 6e-56
Identities = 86/319 (26%), Positives = 141/319 (44%), Gaps = 66/319 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59
++ +E +G+G +G VY AR + +ALK + Q E GV RE+ + ++
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
H NI+RL H ++YL+ EY L + + + F T++ ++ ++YC
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ--RTATYITELANALSYC 125
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
HS RV+HRD+KP+NLL+ LK+ADFG S++ R
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGE-LKIADFGW---------------------SVHAPSSR 163
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
L G TL Y PE++ G R + VD+WS+G + E + +P F ++
Sbjct: 164 RTDLCG----------TLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
+ +I RV +F FP + ++ DL+S++L
Sbjct: 213 QETYKRISRV----------------EFT--FPDFVTEGA-----------RDLISRLLK 243
Query: 299 MDPSRRITARSALEHEYFR 317
+PS+R R LEH +
Sbjct: 244 HNPSQRPMLREVLEHPWIT 262
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-55
Identities = 62/340 (18%), Positives = 110/340 (32%), Gaps = 90/340 (26%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QH 60
++ ++EKIG G +G V+K + A+K+ + A+RE+ + QH
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 61 GNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGI 115
++VR + + + EY L + ++ F +K L Q+ RG+
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYF--KEAELKDLLLQVGRGL 128
Query: 116 AYCHSHRVLHRDLKPQNLLIDRR------------------TNALKLADFGLARAFGIPV 157
Y HS ++H D+KP N+ I R K+ D G P
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP- 187
Query: 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVW 217
+V G + A E+L + + D++
Sbjct: 188 ----------------------QVEEG----------DSRFLANEVLQENYTHLPKADIF 215
Query: 218 SVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKE 277
++ PL D+ +I + P+ P
Sbjct: 216 ALALTVVCAAGAEPLP---RNGDQWHEI--------------------RQGRLPRIPQ-- 250
Query: 278 LGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317
L +LL M+ DP RR +A + ++H
Sbjct: 251 ------VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-55
Identities = 74/326 (22%), Positives = 132/326 (40%), Gaps = 77/326 (23%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59
++ ++ +G+G++ VY+A + T +A+K I + G+ E+ + +++
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 60 HGNIVRLQDVVHSEKKLYLVFEY-----LDLDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
H +I+ L + +YLV E ++ LK + + + F++QI+ G
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE-----NEARHFMHQIITG 124
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+ Y HSH +LHRDL NLL+ R N +K+ADFGLA T
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMN-IKIADFGLA----------TQLKMPH------- 166
Query: 175 SFLRYRVLAGSLILQFLKVV--TLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
+ + T Y +PEI + DVWS+GC+F ++ RP
Sbjct: 167 --------------EKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPP 211
Query: 233 FPGDSEIDELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291
F + K+ D++ P + S E D
Sbjct: 212 FD-TDTVKNTLNKVVLA----------------DYE--MPSFLSIEA-----------KD 241
Query: 292 LLSKMLCMDPSRRITARSALEHEYFR 317
L+ ++L +P+ R++ S L+H +
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 6e-55
Identities = 95/365 (26%), Positives = 144/365 (39%), Gaps = 90/365 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIR-----LEQEDEGVPSTAIREISLLK 56
D+YE IG+G++G V KA + V E +A+K I+ L Q A E+ LL+
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ--------AQIEVRLLE 105
Query: 57 EMQH------GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQ 110
M IV L+ L LVFE L +L + + L + F Q
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 111 ILRGIAYCHSHR--VLHRDLKPQN-LLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167
+ + + + ++H DLKP+N LL + + +A+K+ DFG + +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--------CQLGQR--- 214
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
I Y + + +YR+PE+LLG Y +D+WS+GCI EM
Sbjct: 215 --IYQY-------------------IQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMH 252
Query: 228 NQRPLFPGDSEIDELFKIFRVLGTPNED-------------------------------- 255
PLF G +E+D++ KI VLG P
Sbjct: 253 TGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREY 312
Query: 256 TWPGVTSLPDFKSAFPKWP-SKELGTVVRNLEPAG--IDLLSKMLCMDPSRRITARSALE 312
PG L + P + G + DL+ +ML DP RI AL+
Sbjct: 313 KPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ 372
Query: 313 HEYFR 317
H +F+
Sbjct: 373 HSFFK 377
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-54
Identities = 49/351 (13%), Positives = 86/351 (24%), Gaps = 86/351 (24%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQHG 61
+ + VE + G VV+ R+ E ALK + E+ + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 62 NIVRLQDVVH--------------------------SEKKLYLVFEYLDLDLKKHMDSCP 95
+ +D + L+ +DL+ +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 96 DFANDPRL-----IKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150
+ Q++R A S ++H P NL I L L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LMLGDVSAL 241
Query: 151 RAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH- 209
G V + Y E L S
Sbjct: 242 WKVGTRGPAS--------------------------------SVPVTYAPREFLNASTAT 269
Query: 210 YSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSA 269
++ ++ W +G + F + + L P D+
Sbjct: 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA----------- 318
Query: 270 FPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
F L L+ + L D RR+ A+E F ++
Sbjct: 319 FGSCT---------PLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-54
Identities = 71/328 (21%), Positives = 118/328 (35%), Gaps = 82/328 (25%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59
+Y + +G+G + ++ + T E A K + EIS+ + +
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRLIKTFLYQIL 112
H ++V +++V E +K + + +L QI+
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT--------EPEARYYLRQIV 151
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
G Y H +RV+HRDLK NL ++ +K+ DFGLA
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDG--------------- 195
Query: 173 YFSFLRYRVLAGSLILQFLKVV--TLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230
+ KV+ T Y APE+L + +S VDVWS+GCI ++ +
Sbjct: 196 ----------------ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGK 238
Query: 231 PLFPGDSEIDELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAG 289
P F S + E + +I + ++ PK +
Sbjct: 239 PPFE-TSCLKETYLRIKKN----------------EYS--IPKHINPVA----------- 268
Query: 290 IDLLSKMLCMDPSRRITARSALEHEYFR 317
L+ KML DP+ R T L E+F
Sbjct: 269 ASLIQKMLQTDPTARPTINELLNDEFFT 296
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-54
Identities = 86/319 (26%), Positives = 138/319 (43%), Gaps = 66/319 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59
+D ++ +G+G +G VY AR +ALK + Q E EGV REI + ++
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
H NI+R+ + H K++YL+ E+ +L K + F TF+ ++ + YC
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ--RSATFMEELADALHYC 130
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
H +V+HRD+KP+NLL+ + LK+ADFG S++ LR
Sbjct: 131 HERKVIHRDIKPENLLMGYKGE-LKIADFGW---------------------SVHAPSLR 168
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
R + G TL Y PE++ G + + VD+W G + E + P F S
Sbjct: 169 RRTMCG----------TLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
+ +I V D K FP + S DL+SK+L
Sbjct: 218 TETHRRIVNV----------------DLK--FPPFLSDGS-----------KDLISKLLR 248
Query: 299 MDPSRRITARSALEHEYFR 317
P +R+ + +EH + +
Sbjct: 249 YHPPQRLPLKGVMEHPWVK 267
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-54
Identities = 71/328 (21%), Positives = 118/328 (35%), Gaps = 82/328 (25%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59
+Y + +G+G + ++ + T E A K + EIS+ + +
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRLIKTFLYQIL 112
H ++V +++V E +K + + +L QI+
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT--------EPEARYYLRQIV 125
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
G Y H +RV+HRDLK NL ++ +K+ DFGLA
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDG--------------- 169
Query: 173 YFSFLRYRVLAGSLILQFLKVV--TLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230
+ KV+ T Y APE+L + +S VDVWS+GCI ++ +
Sbjct: 170 ----------------ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGK 212
Query: 231 PLFPGDSEIDELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAG 289
P F S + E + +I + ++ PK +
Sbjct: 213 PPFE-TSCLKETYLRIKKN----------------EYS--IPKHINPVA----------- 242
Query: 290 IDLLSKMLCMDPSRRITARSALEHEYFR 317
L+ KML DP+ R T L E+F
Sbjct: 243 ASLIQKMLQTDPTARPTINELLNDEFFT 270
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-53
Identities = 71/375 (18%), Positives = 128/375 (34%), Gaps = 110/375 (29%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIR-----LEQEDEGVPSTAIREISLLK 56
+ + + K+G+GT+G V ++ + A+K +R A E +LK
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRS--------AKIEADILK 86
Query: 57 EMQHG-----NIVRLQDVVHSEKKLYLVFEYLDLDL----KKHMDSCPDFANDP-RLIKT 106
++Q+ NIV+ + L+FE L L ++ ++ IK
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRN-----NYNGFHIEDIKL 141
Query: 107 FLYQILRGIAYCHSHRVLHRDLKPQNLLI------------------------DRRTNAL 142
+ +IL+ + Y + H DLKP+N+L+ ++ +
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 143 KLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPE 202
KL DFG A TF ++ + T YRAPE
Sbjct: 202 KLIDFGCA--------TFKSDY-----HGSI-------------------INTRQYRAPE 229
Query: 203 ILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNED------- 255
++L + D+WS GC+ AE+ LF ++ L + ++ ++
Sbjct: 230 VILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATK 288
Query: 256 --------------TWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301
WP S + K D L +L +DP
Sbjct: 289 TNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF----CDFLYSILQIDP 344
Query: 302 SRRITARSALEHEYF 316
+ R + L+H++
Sbjct: 345 TLRPSPAELLKHKFL 359
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-53
Identities = 86/325 (26%), Positives = 141/325 (43%), Gaps = 72/325 (22%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ Y++V+K+G G YG V R+ VT+ A+K IR S + E+++LK + H
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 62 NIVRLQDVVHSEKKLYLVFEY------LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
NI++L D ++ YLV E D + + + + Q+L G+
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN-------EVDAAVIIKQVLSGV 149
Query: 116 AYCHSHRVLHRDLKPQNLLIDRR--TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
Y H H ++HRDLKP+NLL++ + +K+ DFGL+ F +
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKE----------- 197
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
++ T +Y APE+L + Y DVWS+G I ++ P F
Sbjct: 198 ------------------RLGTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPF 237
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
G ++ + L K+ + F S P+W N+ DL+
Sbjct: 238 GGQTDQEILRKVEK--------------GKYTFDS--PEWK---------NVSEGAKDLI 272
Query: 294 SKMLCMDPSRRITARSALEHEYFRD 318
+ML D RRI+A+ ALEH + ++
Sbjct: 273 KQMLQFDSQRRISAQQALEHPWIKE 297
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-53
Identities = 75/324 (23%), Positives = 123/324 (37%), Gaps = 68/324 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60
D+ +G+GTYG+VY R+ IA+K+I S + EI+L K ++H
Sbjct: 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY---SQPLHEEIALHKHLKH 78
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
NIV+ + + E + L + ++ + I + QIL G+
Sbjct: 79 KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP--LKDNEQTIGFYTKQILEGLK 136
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
Y H ++++HRD+K N+LI+ + LK++DFG ++ + +F
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-------------AGINPCTETF 183
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPE-ILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
G TL Y APE I G R Y D+WS+GC EM +P F
Sbjct: 184 ------TG----------TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227
Query: 236 -DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294
+FK+ P +P+ ++ +
Sbjct: 228 LGEPQAAMFKV------GMFKVHP---EIPE------------------SMSAEAKAFIL 260
Query: 295 KMLCMDPSRRITARSALEHEYFRD 318
K DP +R A L E+ +
Sbjct: 261 KCFEPDPDKRACANDLLVDEFLKV 284
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-53
Identities = 58/336 (17%), Positives = 113/336 (33%), Gaps = 65/336 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEM 58
+ + +G+G V++ R+ T + A+K I + + +RE +LK++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ----MREFEVLKKL 64
Query: 59 QHGNIVRLQDVV--HSEKKLYLVFEYL---DL-DLKKHMDSCPDFANDPRLIKTFLYQIL 112
H NIV+L + + + L+ E+ L + + + L ++
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVV 122
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNA---LKLADFGLARAFGIPVRTFTHEHWGSTG 169
G+ + + ++HR++KP N++ + KL DFG AR + +
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-------- 174
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG-------SRHYSTPVDVWSVGCI 222
L G T Y P++ + Y VD+WS+G
Sbjct: 175 ------------LYG----------TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 223 FAEMVNQRPLF----PGDSEIDELFKIFRVLGTPNEDTWPGVTSLP-DFKSAFPKWPSKE 277
F F + ++KI + + P D+ P S
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS-- 270
Query: 278 LGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313
+ R L+ +L+ +L D +
Sbjct: 271 ---LSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 6e-53
Identities = 79/333 (23%), Positives = 131/333 (39%), Gaps = 53/333 (15%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+E E++G G +G V + + T E +A+K+ R E + EI ++K++ H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC-LEIQIMKKLNH 71
Query: 61 GNIVRLQDVVHSEKKL------YLVFEYLDL-DLKKHMDSCPDFANDPRL----IKTFLY 109
N+V ++V +KL L EY + DL+K+++ F N L I+T L
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN---QFENCCGLKEGPIRTLLS 128
Query: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA--LKLADFGLARAFGIPVRTFTHEHWGS 167
I + Y H +R++HRDLKP+N+++ K+ D G A+
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD------------- 175
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
G L +F V TL Y APE+L + Y+ VD WS G + E +
Sbjct: 176 ---------------QGELCTEF--VGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECI 217
Query: 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEP 287
F + + + R + + +T F S P L ++
Sbjct: 218 TGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTP--NHLSGILAGKL- 274
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
L ML +R T F+ ++
Sbjct: 275 --ERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-53
Identities = 82/368 (22%), Positives = 138/368 (37%), Gaps = 100/368 (27%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG- 61
+Y V K+G G + V+ A++ V N +A+K +R D+ A EI LL+ +
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDAD 76
Query: 62 ----------NIVRLQD--------VVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRL 103
+I++L D VH + +VFE L +L +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVH----VVMVFEVLGENLLALIKKYEHRGIPLIY 132
Query: 104 IKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLID-----RRTNALKLADFGLARAFGIPV 157
+K Q+L G+ Y H ++H D+KP+N+L++ +K+AD G A
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA------- 185
Query: 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVW 217
+ EH + + T YR+PE+LLG+ + D+W
Sbjct: 186 -CWYDEH-----YTNS-------------------IQTREYRSPEVLLGA-PWGCGADIW 219
Query: 218 SVGCIFAEMVNQRPLFPGDS------EIDELFKIFRVLGTPNED---------------- 255
S C+ E++ LF D + D + +I +LG
Sbjct: 220 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 279
Query: 256 -----TWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310
+ L D + K+ E + + D LS ML +DP +R A
Sbjct: 280 LLRNISKLKFWPLEDVLTEKYKFSKDE----AKEI----SDFLSPMLQLDPRKRADAGGL 331
Query: 311 LEHEYFRD 318
+ H + +D
Sbjct: 332 VNHPWLKD 339
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-52
Identities = 74/333 (22%), Positives = 115/333 (34%), Gaps = 88/333 (26%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAI-REISLLK 56
QY+ +G G +G VY N +A+K K R+ E T + E+ LLK
Sbjct: 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101
Query: 57 EMQHG--NIVRLQDVVHSEKKLYLVFEYLD--------LDLKKHMDSCPDFANDPRLIKT 106
++ G ++RL D L+ E + + + + L ++
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ--------EELARS 153
Query: 107 FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWG 166
F +Q+L + +CH+ VLHRD+K +N+LID LKL DFG +
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG--------ALLKDT-- 203
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
Y G+ + Y PE + R++ VWS+G + +M
Sbjct: 204 -----------VYTDFDGTRV----------YSPPEWIRYHRYHGRSAAVWSLGILLYDM 242
Query: 227 VNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLE 286
V F D EI F + S E
Sbjct: 243 VCGDIPFEHDEEIIR--GQVF----------------------FRQRVSSEC-------- 270
Query: 287 PAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319
L+ L + PS R T H + +DV
Sbjct: 271 ---QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-52
Identities = 73/334 (21%), Positives = 125/334 (37%), Gaps = 80/334 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI------RLEQEDEGVPSTAIREISLL 55
D+Y + +G G G V A T + +A++ I + EI +L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 56 KEMQHGNIVRLQDVVHSEKKLYLVFEYLD----LDL---KKHMDSCPDFANDPRLIKTFL 108
K++ H I+++++ + Y+V E ++ D K + K +
Sbjct: 195 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE--------ATCKLYF 245
Query: 109 YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEHWG 166
YQ+L + Y H + ++HRDLKP+N+L+ + +K+ DFG ++ G T
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT----- 300
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH--YSTPVDVWSVGCIFA 224
L G T Y APE+L+ Y+ VD WS+G I
Sbjct: 301 ---------------LCG----------TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335
Query: 225 EMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRN 284
++ P F L ++ + +F W
Sbjct: 336 ICLSGYPPFSEHRTQVSLKD--QIT-----------SGKYNFIP--EVWA---------E 371
Query: 285 LEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
+ +DL+ K+L +DP R T AL H + +D
Sbjct: 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-52
Identities = 91/367 (24%), Positives = 139/367 (37%), Gaps = 98/367 (26%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTN-ETIALKKIR-----LEQEDEGVPSTAIREISLL 55
+YE V+ +GEG +G V + + +A+K ++ E A EI +L
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA--------ARSEIQVL 65
Query: 56 KEMQHG------NIVRLQDVVHSEKKLYLVFEYLDLDL----KKHMDSCPDFANDP-RLI 104
+ + V++ + + +VFE L L K++ F I
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKEN-----GFLPFRLDHI 120
Query: 105 KTFLYQILRGIAYCHSHRVLHRDLKPQNLLI------------------DRRTNALKLAD 146
+ YQI + + + HS+++ H DLKP+N+L +K+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 147 FGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG 206
FG A T+ EH S V T YRAPE++L
Sbjct: 181 FGSA--------TYDDEH-----HSTL-------------------VSTRHYRAPEVILA 208
Query: 207 SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNED----------- 255
+S P DVWS+GCI E +FP + L + R+LG +
Sbjct: 209 LG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYF 267
Query: 256 -----TWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310
W +S + S K P KE DL+ KML DP++RIT R A
Sbjct: 268 HHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326
Query: 311 LEHEYFR 317
L+H +F
Sbjct: 327 LKHPFFD 333
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-52
Identities = 84/325 (25%), Positives = 134/325 (41%), Gaps = 72/325 (22%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++Y V +G+G++G V K ++ +T + A+K I ST +RE+ LLK++ H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 62 NIVRLQDVVHSEKKLYLVFEY------LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
NI++L +++ Y+V E D +K+ S + Q+ GI
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS-------EHDAARIIKQVFSGI 134
Query: 116 AYCHSHRVLHRDLKPQNLLIDRR--TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
Y H H ++HRDLKP+N+L++ + +K+ DFGL+ F
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKD----------- 182
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
++ T +Y APE+L Y DVWS G I +++ P F
Sbjct: 183 ------------------RIGTAYYIAPEVL--RGTYDEKCDVWSAGVILYILLSGTPPF 222
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
G +E D L ++ F P+W + DL+
Sbjct: 223 YGKNEYDILKRVET--------------GKYAFDL--PQWR---------TISDDAKDLI 257
Query: 294 SKMLCMDPSRRITARSALEHEYFRD 318
KML PS RITA LEH + +
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-52
Identities = 85/326 (26%), Positives = 142/326 (43%), Gaps = 73/326 (22%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60
D+Y+ +G+G++G V ++ +T + A+K I Q + ++ RE+ LLK++ H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 61 GNIVRLQDVVHSEKKLYLVFEY------LDLDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
NI++L + + YLV E D + + S + Q+L G
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-------EVDAARIIRQVLSG 138
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
I Y H ++++HRDLKP+NLL++ ++ +++ DFGL+ F + + G
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-----EASKKMKDKIG--- 190
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
T +Y APE+L Y DVWS G I +++ P
Sbjct: 191 ----------------------TAYYIAPEVL--HGTYDEKCDVWSTGVILYILLSGCPP 226
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
F G +E D L K+ + F+ P+W + + DL
Sbjct: 227 FNGANEYDILKKVEK--------------GKYTFEL--PQWK---------KVSESAKDL 261
Query: 293 LSKMLCMDPSRRITARSALEHEYFRD 318
+ KML PS RI+AR AL+HE+ +
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQT 287
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-52
Identities = 86/328 (26%), Positives = 139/328 (42%), Gaps = 78/328 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEM 58
++Y V +G+G++G V K ++ +T + A+K I + +D ST +RE+ LLK++
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT---STILREVELLKKL 78
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEY------LDLDLKKHMDSCPDFANDPRLIKTFLYQIL 112
H NI++L +++ Y+V E D +K+ S D + Q+
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD-------AARIIKQVF 131
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEHWGSTGI 170
GI Y H H ++HRDLKP+N+L++ + +K+ DFGL+ F +
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--------- 182
Query: 171 SIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230
++ T +Y APE+L Y DVWS G I +++
Sbjct: 183 ---------------------RIGTAYYIAPEVL--RGTYDEKCDVWSAGVILYILLSGT 219
Query: 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGI 290
P F G +E D L ++ F P+W +
Sbjct: 220 PPFYGKNEYDILKRVET--------------GKYAFDL--PQWR---------TISDDAK 254
Query: 291 DLLSKMLCMDPSRRITARSALEHEYFRD 318
DL+ KML PS RITA LEH + +
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-52
Identities = 76/335 (22%), Positives = 125/335 (37%), Gaps = 82/335 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI------RLEQEDEGVPSTAIREISLL 55
D+Y + +G G G V A T + +A+K I + EI +L
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 56 KEMQHGNIVRLQDVVHSEKKLYLVFEYLD----LD---LKKHMDSCPDFANDPRLIKTFL 108
K++ H I+++++ +E Y+V E ++ D K + K +
Sbjct: 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKE--------ATCKLYF 120
Query: 109 YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEHWG 166
YQ+L + Y H + ++HRDLKP+N+L+ + +K+ DFG ++ G T
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT----- 175
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS--RHYSTPVDVWSVGCIFA 224
L G T Y APE+L+ Y+ VD WS+G I
Sbjct: 176 ---------------LCG----------TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210
Query: 225 EMVNQRPLFPGDSEIDELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVR 283
++ P F L +I G + W
Sbjct: 211 ICLSGYPPFSEHRTQVSLKDQITS-----------GKYNFIP-----EVWA--------- 245
Query: 284 NLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
+ +DL+ K+L +DP R T AL H + +D
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-52
Identities = 86/368 (23%), Positives = 139/368 (37%), Gaps = 96/368 (26%)
Query: 2 DQYEKVEKIGEGTYGVVYKAR-NCVTNETIALKKIR-----LEQEDEGVPSTAIREISLL 55
++YE V +GEGT+G V + + +ALK IR E A EI++L
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA--------ARLEINVL 70
Query: 56 KEMQHG------NIVRLQDVVHSEKKLYLVFEYLDLDL----KKHMDSCPDFANDP-RLI 104
K+++ V + D + + + FE L + K++ +F P +
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKEN-----NFQPYPLPHV 125
Query: 105 KTFLYQILRGIAYCHSHRVLHRDLKPQNLLI------------------DRRTNALKLAD 146
+ YQ+ + + H +++ H DLKP+N+L + ++++AD
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 147 FGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG 206
FG A TF HEH + V T YR PE++L
Sbjct: 186 FGSA--------TFDHEH-----HTTI-------------------VATRHYRPPEVILE 213
Query: 207 SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDF 266
++ P DVWS+GCI E LF + L + ++LG F
Sbjct: 214 LG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYF 272
Query: 267 KSAFPKWP------------SKELGTVVRNLEP---AGIDLLSKMLCMDPSRRITARSAL 311
W K L + + DL+ +ML DP++RIT AL
Sbjct: 273 YKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332
Query: 312 EHEYFRDV 319
H +F +
Sbjct: 333 LHPFFAGL 340
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 5e-52
Identities = 85/337 (25%), Positives = 133/337 (39%), Gaps = 85/337 (25%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAI-----------R 50
+ Y KV K+G G YG V + + A+K I+ Q D+G S
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 51 EISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRL 103
EISLLK + H NI++L DV +K YLV E+ + + + D
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE--------CD 147
Query: 104 IKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFT 161
+ QIL GI Y H H ++HRD+KP+N+L++ + + +K+ DFGL+ F
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-KDYKLR 206
Query: 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGC 221
++ T +Y APE+L + Y+ DVWS G
Sbjct: 207 D-----------------------------RLGTAYYIAPEVL--KKKYNEKCDVWSCGV 235
Query: 222 IFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTV 281
I ++ P F G ++ D + K+ + F W
Sbjct: 236 IMYILLCGYPPFGGQNDQDIIKKVEK--------------GKYYFDF--NDWK------- 272
Query: 282 VRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
N+ +L+ ML D ++R TA AL + +
Sbjct: 273 --NISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 5e-52
Identities = 89/328 (27%), Positives = 136/328 (41%), Gaps = 77/328 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEM 58
D Y+ E++G+G + VV + + T A K I +L D RE + +++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF---QKLEREARICRKL 62
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEY------LDLDLKKHMDSCPDFANDPRLIKTFLYQIL 112
QH NIVRL D + E YLVF+ + + + S D ++ + QIL
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH-------CIQQIL 115
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEHWGSTGI 170
IAYCHS+ ++HR+LKP+NLL+ + A+KLADFGLA
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--------- 166
Query: 171 SIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230
AG T Y +PE+L YS PVD+W+ G I ++
Sbjct: 167 -----------FAG----------TPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGY 204
Query: 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGI 290
P F + + +I D+ S P+W + P
Sbjct: 205 PPFWDEDQHRLYAQIKA--------------GAYDYPS--PEWD---------TVTPEAK 239
Query: 291 DLLSKMLCMDPSRRITARSALEHEYFRD 318
L+ ML ++P +RITA AL+ + +
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICN 267
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 6e-52
Identities = 80/332 (24%), Positives = 135/332 (40%), Gaps = 68/332 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEM 58
D YE E IG+G + VV + N T + A+K + + RE S+ +
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYL---DL--DLKKHMDSCPDFANDPRLIKTFLYQILR 113
+H +IV L + S+ LY+VFE++ DL ++ K D+ ++ + ++ QIL
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--AVASHYMRQILE 141
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
+ YCH + ++HRD+KP +L+ + N +KL FG+A G
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--------- 192
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231
G T + APE++ Y PVDVW G I +++
Sbjct: 193 ----------RVG----------TPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCL 231
Query: 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291
F G E LF+ ++ +W ++ + D
Sbjct: 232 PFYGTKE--RLFE--GII-----------KGKYKMNP--RQWS---------HISESAKD 265
Query: 292 LLSKMLCMDPSRRITARSALEHEYFRDVEFVP 323
L+ +ML +DP+ RIT AL H + ++ +
Sbjct: 266 LVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-51
Identities = 65/322 (20%), Positives = 127/322 (39%), Gaps = 77/322 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI--RLEQEDEGVPSTAIREISLLKEMQ 59
D Y+ +E++G G +GVV++ T K I + V EIS++ ++
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV----KNEISIMNQLH 106
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRLIKTFLYQIL 112
H ++ L D + ++ L+ E+L + + + S + N ++ Q
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN-------YMRQAC 159
Query: 113 RGIAYCHSHRVLHRDLKPQNLLI-DRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
G+ + H H ++H D+KP+N++ ++ +++K+ DFGLA P
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIV----------- 207
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231
+V T + APEI+ D+W++G + +++
Sbjct: 208 --------KVTTA----------TAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLS 248
Query: 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291
F G+ +++ L + R +ED + V+ P D
Sbjct: 249 PFAGEDDLETLQNVKRCDWEFDEDAFSSVS-------------------------PEAKD 283
Query: 292 LLSKMLCMDPSRRITARSALEH 313
+ +L +P +R+T ALEH
Sbjct: 284 FIKNLLQKEPRKRLTVHDALEH 305
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-51
Identities = 73/327 (22%), Positives = 123/327 (37%), Gaps = 74/327 (22%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEM 58
D + K+G G +G V+ + +K I R + E + EI +LK +
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI----EAEIEVLKSL 77
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
H NI+++ +V +Y+V E + L+ + ++ + + Q++
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE-GYVAELMKQMMNA 136
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
+AY HS V+H+DLKP+N+L + +K+ DFGLA F T+
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTN---------- 185
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
T Y APE+ R + D+WS G + ++
Sbjct: 186 -------------------AAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLP 224
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWP-SKELGTVVRNLEPAGID 291
F G S + K P++ P + + +D
Sbjct: 225 FTGTSLEEVQQKATY--------------KEPNYAVEC--RPLTPQ-----------AVD 257
Query: 292 LLSKMLCMDPSRRITARSALEHEYFRD 318
LL +ML DP RR +A L HE+F+
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-51
Identities = 69/333 (20%), Positives = 110/333 (33%), Gaps = 90/333 (27%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIR----LEQEDEGVPSTAIREISLLK 56
+Y +G+G +G V+ +A+K I L T E++LL
Sbjct: 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 57 ----EMQHGNIVRLQDVVHSEKKLYLVFEYLD--------LDLKKHMDSCPDFANDPRLI 104
H ++RL D +++ LV E + K +
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLG--------EGPS 141
Query: 105 KTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164
+ F Q++ I +CHS V+HRD+K +N+LID R KL DFG H+
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG--------ALLHDE 193
Query: 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFA 224
Y G+ + Y PE + ++++ P VWS+G +
Sbjct: 194 -------------PYTDFDGTRV----------YSPPEWISRHQYHALPATVWSLGILLY 230
Query: 225 EMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRN 284
+MV F D EI E FP S +
Sbjct: 231 DMVCGDIPFERDQEILE--AELH----------------------FPAHVSPDC------ 260
Query: 285 LEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317
L+ + L PS R + L + +
Sbjct: 261 -----CALIRRCLAPKPSSRPSLEEILLDPWMQ 288
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-51
Identities = 81/328 (24%), Positives = 118/328 (35%), Gaps = 80/328 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEM 58
Y IG G++G V A T A KKI +E D +EI ++K +
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR-----FKQEIEIMKSL 63
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEY------LDLDLKKHMDSCPDFANDPRLIKTFLYQIL 112
H NI+RL + +YLV E + + K + + +L
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR-------ESDAARIMKDVL 116
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEHWGSTGI 170
+AYCH V HRDLKP+N L + LKL DFGLA F T
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--------- 167
Query: 171 SIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230
KV T +Y +P++L Y D WS G + ++
Sbjct: 168 ---------------------KVGTPYYVSPQVL--EGLYGPECDEWSAGVMMYVLLCGY 204
Query: 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGI 290
P F ++ E+ ++ F W N+ P
Sbjct: 205 PPFSAPTD-SEVML--KIR-----------EGTFTFPE--KDWL---------NVSPQAE 239
Query: 291 DLLSKMLCMDPSRRITARSALEHEYFRD 318
L+ ++L P +RIT+ ALEHE+F
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFEK 267
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-51
Identities = 81/326 (24%), Positives = 132/326 (40%), Gaps = 78/326 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAI-REISLLKE 57
D YE E++G G + +V K R T + A K I RL GV I RE+++L+E
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRLIKTFLYQ 110
++H NI+ L D+ ++ + L+ E + L K+ + FL Q
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE--------DEATQFLKQ 116
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRT---NALKLADFGLARAFGIPVRTFTHEHWGS 167
IL G+ Y HS R+ H DLKP+N+++ + +KL DFG+A F
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEF------- 168
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
+ + G T + APEI+ D+WS+G I ++
Sbjct: 169 ------------KNIFG----------TPEFVAPEIVNY-EPLGLEADMWSIGVITYILL 205
Query: 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEP 287
+ F G+++ + L I V +E+ + +
Sbjct: 206 SGASPFLGETKQETLTNISAVNYDFDEEYFSNTS-------------------------E 240
Query: 288 AGIDLLSKMLCMDPSRRITARSALEH 313
D + ++L DP RR+T +LEH
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEH 266
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-51
Identities = 78/333 (23%), Positives = 133/333 (39%), Gaps = 78/333 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAI-REISLLKE 57
D Y+ E++G G + +V K R T A K I + GV I RE+S+L++
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYL-------DLDLKKHMDSCPDFANDPRLIKTFLYQ 110
+ H NI+ L DV + + L+ E + L K+ + S + + F+ Q
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL-SEEEATS-------FIKQ 123
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGLARAFGIPVRTFTHEHWGS 167
IL G+ Y H+ ++ H DLKP+N+++ + +KL DFGLA F
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF------- 175
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
+ + G T + APEI+ D+WS+G I ++
Sbjct: 176 ------------KNIFG----------TPEFVAPEIVNY-EPLGLEADMWSIGVITYILL 212
Query: 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEP 287
+ F GD++ + L I V +E+ + +
Sbjct: 213 SGASPFLGDTKQETLANITAVSYDFDEEFFSQTS-------------------------E 247
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
D + K+L + +R+T + AL H + V+
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-51
Identities = 79/331 (23%), Positives = 133/331 (40%), Gaps = 78/331 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAI-REISLLKE 57
D Y+ E++G G + VV K R T A K I R + GV I RE+S+LKE
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRLIKTFLYQ 110
+QH N++ L +V ++ + L+ E + L K+ + FL Q
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQ 122
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRT---NALKLADFGLARAFGIPVRTFTHEHWGS 167
IL G+ Y HS ++ H DLKP+N+++ R +K+ DFGLA F
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEF------- 174
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
+ + G T + APEI+ D+WS+G I ++
Sbjct: 175 ------------KNIFG----------TPEFVAPEIVNY-EPLGLEADMWSIGVITYILL 211
Query: 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEP 287
+ F GD++ + L + V ++ + +
Sbjct: 212 SGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS-------------------------A 246
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
D + ++L DP +R+T + +L+H + +
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-51
Identities = 66/329 (20%), Positives = 124/329 (37%), Gaps = 81/329 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEM 58
D Y+ E++G G +GVV++ T A K + ++ +EI + +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-----VRKEIQTMSVL 211
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYLD--------LDLKKHMDSCPDFANDPRLIKTFLYQ 110
+H +V L D + ++ +++E++ D M ++ Q
Sbjct: 212 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE--------DEAVEYMRQ 263
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLI-DRRTNALKLADFGLARAFGIPVRTFTHEHWGSTG 169
+ +G+ + H + +H DLKP+N++ +R+N LKL DFGL +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD------PKQ------ 311
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ 229
+V G T + APE+ G + D+WSVG + +++
Sbjct: 312 --------SVKVTTG----------TAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSG 352
Query: 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAG 289
F G+++ + L + W + + + G
Sbjct: 353 LSPFGGENDDETLRNVKSC-------DW-------NMDD--SAFS---------GISEDG 387
Query: 290 IDLLSKMLCMDPSRRITARSALEHEYFRD 318
D + K+L DP+ R+T ALEH +
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHPWLTP 416
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-51
Identities = 78/336 (23%), Positives = 127/336 (37%), Gaps = 82/336 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI-------RLEQEDEGVPSTAIREISL 54
+ YE E +G G VV + + T + A+K I +E + + ++E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 55 LKEM-QHGNIVRLQDVVHSEKKLYLVFEY------LDLDLKKHMDSCPDFANDPRLIKTF 107
L+++ H NI++L+D + +LVF+ D +K S +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK-------I 129
Query: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167
+ +L I H ++HRDLKP+N+L+D N +KL DFG + +
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLRE------ 182
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-----RHYSTPVDVWSVGCI 222
+ G T Y APEI+ S Y VD+WS G I
Sbjct: 183 --------------VCG----------TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
Query: 223 FAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVV 282
++ P F ++ L I F S P+W
Sbjct: 219 MYTLLAGSPPFWHRKQMLMLRMIMS--------------GNYQFGS--PEWD-------- 254
Query: 283 RNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
+ DL+S+ L + P +R TA AL H +F+
Sbjct: 255 -DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-51
Identities = 63/326 (19%), Positives = 133/326 (40%), Gaps = 76/326 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++Y E +G G +G+V++ + +T K ++++ D+ +EIS+L +H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHR 61
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD--------LDLKKHMDSCPDFANDPRLIKTFLYQILR 113
NI+ L + S ++L ++FE++ ++ R I ++++Q+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNE--------REIVSYVHQVCE 113
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNA-LKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
+ + HSH + H D++P+N++ R ++ +K+ +FG AR P F
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNF------------ 160
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
R+L Y APE+ ST D+WS+G + +++
Sbjct: 161 -------RLLFT----------APEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINP 202
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
F ++ + I T +E+ + ++ +D
Sbjct: 203 FLAETNQQIIENIMNAEYTFDEEAFKEIS-------------------------IEAMDF 237
Query: 293 LSKMLCMDPSRRITARSALEHEYFRD 318
+ ++L + R+TA AL+H + +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-51
Identities = 76/333 (22%), Positives = 131/333 (39%), Gaps = 78/333 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAI-REISLLKE 57
D Y+ E++G G + +V K R T A K K + GV I RE+S+L++
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRLIKTFLYQ 110
+ H N++ L DV + + L+ E + L K+ + +F+ Q
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------EEATSFIKQ 123
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGLARAFGIPVRTFTHEHWGS 167
IL G+ Y H+ ++ H DLKP+N+++ + +KL DFGLA F
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF------- 175
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
+ + G T + APEI+ D+WS+G I ++
Sbjct: 176 ------------KNIFG----------TPEFVAPEIVNY-EPLGLEADMWSIGVITYILL 212
Query: 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEP 287
+ F GD++ + L I V +E+ + +
Sbjct: 213 SGASPFLGDTKQETLANITSVSYDFDEEFFSHTS-------------------------E 247
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
D + K+L + +R+T + AL H + V+
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-50
Identities = 84/325 (25%), Positives = 138/325 (42%), Gaps = 70/325 (21%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++Y+ E++G+G + VV + + + A I ++ RE + + ++H
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD----LD--LKKHMDSCPDFANDPRLIKTFLYQILRGI 115
NIVRL D + E YL+F+ + + + + S D ++ I+ QIL +
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH---CIQ----QILEAV 123
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
+CH V+HR+LKP+NLL+ + A+KLADFGLA + +
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG----------- 172
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
AG T Y +PE+L Y PVD+W+ G I ++ P F
Sbjct: 173 --------FAG----------TPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPF 213
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
+ + +I DF S P+W + P DL+
Sbjct: 214 WDEDQHRLYQQIKA--------------GAYDFPS--PEWD---------TVTPEAKDLI 248
Query: 294 SKMLCMDPSRRITARSALEHEYFRD 318
+KML ++PS+RITA AL+H +
Sbjct: 249 NKMLTINPSKRITAAEALKHPWISH 273
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-50
Identities = 91/333 (27%), Positives = 139/333 (41%), Gaps = 77/333 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEM 58
D Y+ E++G+G + VV + + T A K I +L D RE + +++
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF---QKLEREARICRKL 85
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYL------DLDLKKHMDSCPDFANDPRLIKTFLYQIL 112
QH NIVRL D + E YLVF+ + + + + S D ++ + QIL
Sbjct: 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH-------CIQQIL 138
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEHWGSTGI 170
IAYCHS+ ++HR+LKP+NLL+ + A+KLADFGLA
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--------- 189
Query: 171 SIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230
AG T Y +PE+L YS PVD+W+ G I ++
Sbjct: 190 -----------FAG----------TPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGY 227
Query: 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGI 290
P F + + +I D+ S P+W + P
Sbjct: 228 PPFWDEDQHRLYAQIKA--------------GAYDYPS--PEWD---------TVTPEAK 262
Query: 291 DLLSKMLCMDPSRRITARSALEHEYFRDVEFVP 323
L+ ML ++P +RITA AL+ + + E V
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWICNRERVA 295
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-50
Identities = 83/329 (25%), Positives = 135/329 (41%), Gaps = 79/329 (24%)
Query: 2 DQYE--KVEKIGEGTYGVVYKARNCVTNETIALKKI--RLEQEDEGVPSTAIREISLLKE 57
Y K E +G G +G V+K T +A K I R ++ E V EIS++ +
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV----KNEISVMNQ 142
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLD----LDL---KKHMDSCPDFANDPRLIKTFLYQ 110
+ H N+++L D S+ + LV EY+D D + + + D F+ Q
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL-------FMKQ 195
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLL-IDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTG 169
I GI + H +LH DLKP+N+L ++R +K+ DFGLAR + P
Sbjct: 196 ICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKL--------- 245
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ 229
+V G T + APE++ S P D+WSVG I +++
Sbjct: 246 ----------KVNFG----------TPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSG 284
Query: 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAG 289
F GD++ + L I ++ + ++
Sbjct: 285 LSPFLGDNDAETLNNILACRWDLEDEEFQDIS-------------------------EEA 319
Query: 290 IDLLSKMLCMDPSRRITARSALEHEYFRD 318
+ +SK+L + S RI+A AL+H + D
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-50
Identities = 86/320 (26%), Positives = 136/320 (42%), Gaps = 74/320 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D +E ++G G +VY+ + T + ALK ++ + + V EI +L + H
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV----RTEIGVLLRLSHP 108
Query: 62 NIVRLQDVVHSEKKLYLVFEY------LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
NI++L+++ + ++ LV E D ++K S D A+ + QIL +
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD-------AVKQILEAV 161
Query: 116 AYCHSHRVLHRDLKPQNLL-IDRRTNA-LKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
AY H + ++HRDLKP+NLL +A LK+ADFGL++ V T
Sbjct: 162 AYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT------------ 209
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
+ G T Y APEIL G Y VD+WSVG I ++ F
Sbjct: 210 --------VCG----------TPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPF 250
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
+ +F+ R+L F S P W + DL+
Sbjct: 251 YDERGDQFMFR--RIL-----------NCEYYFIS--PWWD---------EVSLNAKDLV 286
Query: 294 SKMLCMDPSRRITARSALEH 313
K++ +DP +R+T AL+H
Sbjct: 287 RKLIVLDPKKRLTTFQALQH 306
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-50
Identities = 84/333 (25%), Positives = 137/333 (41%), Gaps = 84/333 (25%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAIREISLLKE 57
+ +Y + +GEG+YG V + + T A+K K +L + G + +EI LL+
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK-KEIQLLRR 62
Query: 58 MQHGNIVRLQDVVHSE--KKLYLVFEY--------LDLDLKKHMDSCPDFANDPRLIKTF 107
++H N+++L DV+++E +K+Y+V EY LD +K A +
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP--VCQA------HGY 114
Query: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167
Q++ G+ Y HS ++H+D+KP NLL+ LK++ G+A A F +
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT-LKISALGVAEAL----HPFAADDTCR 169
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTP-VDVWSVGCI-FAE 225
T GS ++ PEI G +S VD+WS G +
Sbjct: 170 TS-------------QGSPA----------FQPPEIANGLDTFSGFKVDIWSAGVTLYNI 206
Query: 226 MVNQRPLFPGDSEIDELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRN 284
P F GD+ I +LF I + + P L
Sbjct: 207 TTGLYP-FEGDN-IYKLFENIGK----------------GSYA--IPGDCGPPL------ 240
Query: 285 LEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317
DLL ML +P++R + R +H +FR
Sbjct: 241 -----SDLLKGMLEYEPAKRFSIRQIRQHSWFR 268
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 6e-50
Identities = 70/327 (21%), Positives = 122/327 (37%), Gaps = 80/327 (24%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ------EDEGVPSTAIREISL 54
+Y + +G G +G V+ A + N+ + +K I+ E+ ++ EI++
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 55 LKEMQHGNIVRLQDVVHSEKKLYLVFEYLD--LDLKKHMDSCPDFANDPRLIKTFLYQIL 112
L ++H NI+++ D+ ++ LV E LDL +D P D L Q++
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL--DEPLASYIFRQLV 140
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEHWGSTGI 170
+ Y ++HRD+K +N++I +KL DFG A G TF
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFT-IKLIDFGSAAYLERGKLFYTF---------- 189
Query: 171 SIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230
G++ Y APE+L+G+ + +++WS+G +V +
Sbjct: 190 ------------CGTIE----------YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
Query: 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGI 290
F EL + P SKEL +
Sbjct: 228 NPF------CELEETVEA----------------AIH--PPYLVSKEL-----------M 252
Query: 291 DLLSKMLCMDPSRRITARSALEHEYFR 317
L+S +L P RR T + +
Sbjct: 253 SLVSGLLQPVPERRTTLEKLVTDPWVT 279
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 8e-50
Identities = 77/322 (23%), Positives = 124/322 (38%), Gaps = 78/322 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI--RLEQEDEGVPSTAIREISLLKEMQ 59
+ +E +G G + V+ + +T + ALK I D + EI++LK+++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL----ENEIAVLKKIK 64
Query: 60 HGNIVRLQDVVHSEKKLYLVFEY------LDLDLKKHMDSCPDFANDPRLIKTFLYQILR 113
H NIV L+D+ S YLV + D L++ + + D + + Q+L
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------VIQQVLS 117
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
+ Y H + ++HRDLKP+NLL + + DFGL++ +
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-------------- 163
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231
G T Y APE+L + YS VD WS+G I ++ P
Sbjct: 164 -------MSTACG----------TPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYP 205
Query: 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291
F ++E KI W ++ +SA K D
Sbjct: 206 PFYEETESKLFEKIKEGYYEFESPFWDDIS-----ESA--K------------------D 240
Query: 292 LLSKMLCMDPSRRITARSALEH 313
+ +L DP+ R T AL H
Sbjct: 241 FICHLLEKDPNERYTCEKALSH 262
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-49
Identities = 83/326 (25%), Positives = 137/326 (42%), Gaps = 79/326 (24%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ Y ++ IG+G + V AR+ +T +A+K I Q + RE+ ++K + H
Sbjct: 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRLIKTFLYQILR 113
NIV+L +V+ +EK LYL+ EY L M + ++ QI+
Sbjct: 74 PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK--------EKEARSKFRQIVS 125
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEHWGSTGIS 171
+ YCH R++HRDLK +NLL+D N +K+ADFG + F G + F
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAF----------- 173
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231
G+ Y APE+ G ++ VDVWS+G I +V+
Sbjct: 174 -----------CGA----------PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
Query: 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291
F G + + EL + RVL ++ P + S + +
Sbjct: 213 PFDGQN-LKELRE--RVLR-------------GKYR--IPFYMSTDC-----------EN 243
Query: 292 LLSKMLCMDPSRRITARSALEHEYFR 317
LL + L ++P +R T ++ +
Sbjct: 244 LLKRFLVLNPIKRGTLEQIMKDRWIN 269
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-49
Identities = 73/338 (21%), Positives = 128/338 (37%), Gaps = 97/338 (28%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRL------EQEDEGVPSTAIREISLL 55
+Y+ + IG G VV + + T A+K + + ++ E V RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 56 KEM-QHGNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIK----- 105
+++ H +I+ L D S ++LVF+ + D L +
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD---------------YLTEKVALS 198
Query: 106 -----TFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160
+ + +L +++ H++ ++HRDLKP+N+L+D ++L+DFG + +
Sbjct: 199 EKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ-IRLSDFGFSCHLEPGEKLR 257
Query: 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-----RHYSTPVD 215
L G T Y APEIL S Y VD
Sbjct: 258 E--------------------LCG----------TPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 216 VWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPS 275
+W+ G I ++ P F + + + ++ F S P+W
Sbjct: 288 LWACGVILFTLLAGSPPFWHRRQ-ILMLR--MIM-----------EGQYQFSS--PEWDD 331
Query: 276 KELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313
DL+S++L +DP R+TA AL+H
Sbjct: 332 ---------RSSTVKDLISRLLQVDPEARLTAEQALQH 360
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 5e-49
Identities = 81/330 (24%), Positives = 127/330 (38%), Gaps = 82/330 (24%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAIREISLLKE 57
++ ++ V+ +GEG YG V A N VT E +A+K R E + +EI + K
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI----KKEICINKM 61
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRLIKTFLYQ 110
+ H N+V+ YL EY ++ M A + F +Q
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP--EPDA------QRFFHQ 113
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGI 170
++ G+ Y H + HRD+KP+NLL+D R N LK++DFGLA F + +
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLA-------TVFRYNNRE---- 161
Query: 171 SIYFSFLRYRVLAGSLILQFLKVV--TLWYRAPEILLGSRHYSTPVDVWSVGCI-FAEMV 227
+ L + TL Y APE+L ++ PVDVWS G + A +
Sbjct: 162 ------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEP 287
+ P E W + ++
Sbjct: 204 GELPWDQPSDSCQEYSDWKEK----------------KTY--LNPW---------KKIDS 236
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEYFR 317
A + LL K+L +PS RIT + ++
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-49
Identities = 83/353 (23%), Positives = 141/353 (39%), Gaps = 103/353 (29%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRL-------------------- 37
++QY ++IG+G+YGVV A N N A+K K +L
Sbjct: 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 38 -EQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKKLYLVFEY------LDLDLK 88
+ G +EI++LK++ H N+V+L +V+ +E LY+VFE +++
Sbjct: 72 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 89 KHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148
K + D A + + +++GI Y H +++HRD+KP NLL+ + +K+ADFG
Sbjct: 132 KPLS--EDQA------RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH-IKIADFG 182
Query: 149 LARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR 208
++ F + L G+ + APE L +R
Sbjct: 183 VS-------NEFKGSD----------ALL--SNTVGTPA----------FMAPESLSETR 213
Query: 209 H-YSTP-VDVWSVGCI-FAEMVNQRPLFPGDSEIDELF-KIFRVLGTPNEDTWPGVTSLP 264
+S +DVW++G + + Q P F + I L KI
Sbjct: 214 KIFSGKALDVWAMGVTLYCFVFGQCP-FMDER-IMCLHSKIKS----------------Q 255
Query: 265 DFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317
+ FP P ++ DL+++ML +P RI H +
Sbjct: 256 ALE--FPDQP---------DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-49
Identities = 71/335 (21%), Positives = 131/335 (39%), Gaps = 77/335 (22%)
Query: 2 DQYE-KVEKIGEGTYGVVYKARNCVTNETIALKKI---RLEQEDEGVPSTAIREISLLKE 57
+ Y +++G G + VV + + T + A K + R Q+ + + EI++L+
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR---AEILHEIAVLEL 84
Query: 58 MQHG-NIVRLQDVVHSEKKLYLVFEYL------DLDLKKHMDSCPDFANDPRLIKTFLYQ 110
+ ++ L +V + ++ L+ EY L L + + + + + Q
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE-----NDVIRLIKQ 139
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAFGIPVRTFTHEHWGST 168
IL G+ Y H + ++H DLKPQN+L+ +K+ DFG++R G
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACEL-------- 190
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228
R + G T Y APEIL +T D+W++G I ++
Sbjct: 191 -----------REIMG----------TPEYLAPEILNYD-PITTATDMWNIGIIAYMLLT 228
Query: 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPA 288
F G+ + I +V +E+T+ V+ + A
Sbjct: 229 HTSPFVGEDNQETYLNISQVNVDYSEETFSSVS------------------------QLA 264
Query: 289 GIDLLSKMLCMDPSRRITARSALEHEYFRDVEFVP 323
D + +L +P +R TA L H + + +F
Sbjct: 265 -TDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-48
Identities = 84/330 (25%), Positives = 128/330 (38%), Gaps = 82/330 (24%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAIREISLLKE 57
++ ++ V+ +GEG YG V A N VT E +A+K R E + +EI + K
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI----KKEICINKM 61
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRLIKTFLYQ 110
+ H N+V+ YL EY ++ M A + F +Q
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP--EPDA------QRFFHQ 113
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGST-- 168
++ G+ Y H + HRD+KP+NLL+D R N LK++DFGLA F R E +
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVF----RYNNRERLLNKMC 168
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCI-FAEMV 227
G TL Y APE+L ++ PVDVWS G + A +
Sbjct: 169 G-------------------------TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203
Query: 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEP 287
+ P E K+ W + ++
Sbjct: 204 GELPWDQPSDSCQEYSDWKEK------------------KTYLNPW---------KKIDS 236
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEYFR 317
A + LL K+L +PS RIT + ++
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-48
Identities = 84/329 (25%), Positives = 134/329 (40%), Gaps = 84/329 (25%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59
+ Y + +G GT+G V + +T +A+K + ++ V REI LK +
Sbjct: 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRLIKTFLYQIL 112
H +I++L V+ + ++V EY+ + ++ + QIL
Sbjct: 70 HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE--------EMEARRLFQQIL 121
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEHWGSTGI 170
+ YCH H V+HRDLKP+N+L+D N K+ADFGL+ G +RT GS
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRTSC----GSPN- 175
Query: 171 SIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCI-FAEMVNQ 229
Y APE++ G + VD+WS G I +A +
Sbjct: 176 ---------------------------YAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
Query: 230 RPLFPGDSEIDELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPA 288
P F + + LF KI G F P++ ++ +
Sbjct: 209 LP-FDDEH-VPTLFKKIRG--G--------------VFY--IPEYLNRSV---------- 238
Query: 289 GIDLLSKMLCMDPSRRITARSALEHEYFR 317
LL ML +DP +R T + EHE+F+
Sbjct: 239 -ATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-48
Identities = 92/325 (28%), Positives = 137/325 (42%), Gaps = 81/325 (24%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHG 61
Y E +GEG++G V A + T + +ALK I + + + REIS LK ++H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDL------KKHMDSCPDFANDPRLIKTFLYQILRGI 115
+I++L DV+ + + +V EY +L KK M + F QI+ I
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMT--------EDEGRRFFQQIICAI 121
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEHWGSTGISIY 173
YCH H+++HRDLKP+NLL+D N +K+ADFGL+ G ++T GS
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSC----GSPN---- 172
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
Y APE++ G + VDVWS G + M+ R F
Sbjct: 173 ------------------------YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208
Query: 234 PGDSEIDELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
+ I LF K+ V +PDF L P L
Sbjct: 209 DDEF-IPNLFKKVNS-----------CVYVMPDF------------------LSPGAQSL 238
Query: 293 LSKMLCMDPSRRITARSALEHEYFR 317
+ +M+ DP +RIT + +F
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWFN 263
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 8e-48
Identities = 63/318 (19%), Positives = 117/318 (36%), Gaps = 68/318 (21%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL- 66
+IG G++ VYK + T +A +++ + + E +LK +QH NIVR
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 67 ---QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
+ V +K + LV E + LK ++ ++++++ QIL+G+ + H+
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM--KIKVLRSWCRQILKGLQFLHTRT 149
Query: 123 --VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
++HRDLK N+ I T ++K+ D GLA T + I
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLA--------TLKRASFAKAVI---------- 191
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
G T + APE + Y VDV++ G EM +
Sbjct: 192 ---G----------TPEFMAPE--MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAA 236
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
++++ P S P +++ + +
Sbjct: 237 QIYRR------VTSGVKP--ASFDKVAI------------------PEVKEIIEGCIRQN 270
Query: 301 PSRRITARSALEHEYFRD 318
R + + L H +F++
Sbjct: 271 KDERYSIKDLLNHAFFQE 288
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 9e-47
Identities = 81/324 (25%), Positives = 134/324 (41%), Gaps = 54/324 (16%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D YE E IG G VV A E +A+K+I LE+ + ++EI + + H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAMSQCHHP 73
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDP---RLIKTFLYQILRG 114
NIV + +L+LV + L LD+ KH+ + + + I T L ++L G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+ Y H + +HRD+K N+L+ + ++ADFG++ + +TG I
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSV-QIADFGVSA-------------FLATGGDITR 179
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
+ +R V T + APE++ R Y D+WS G E+ +
Sbjct: 180 NKVRKTF-----------VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY- 227
Query: 235 GDSEIDELFKIFRVLG-TPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
+ + +VL T D P + + K K+ K ++
Sbjct: 228 --HKYPPM----KVLMLTLQNDP-PSLETGVQDKEMLKKY-GKSF-----------RKMI 268
Query: 294 SKMLCMDPSRRITARSALEHEYFR 317
S L DP +R TA L H++F+
Sbjct: 269 SLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 9e-47
Identities = 86/343 (25%), Positives = 133/343 (38%), Gaps = 97/343 (28%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREIS-LLKEMQH 60
D YE E IG G+Y V + + TN A+K I + D EI LL+ QH
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQH 75
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIK----------T 106
NI+ L+DV K +Y+V E + LD ++++
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLD---------------KILRQKFFSEREASA 120
Query: 107 FLYQILRGIAYCHSHRVLHRDLKPQNLL-IDRRTNA--LKLADFGLARAFGIPVRTFTHE 163
L+ I + + Y H+ V+HRDLKP N+L +D N +++ DFG A+
Sbjct: 121 VLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM-- 178
Query: 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIF 223
T T + APE+L + Y D+WS+G +
Sbjct: 179 ----T-----------------------PCYTANFVAPEVLER-QGYDAACDIWSLGVLL 210
Query: 224 AEMVNQRPLF---PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGT 280
M+ F P D+ + L +I + + W V+ +A K
Sbjct: 211 YTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD-----TA--K-------- 255
Query: 281 VVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVEFVP 323
DL+SKML +DP +R+TA L H + + +P
Sbjct: 256 ----------DLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 9e-47
Identities = 62/329 (18%), Positives = 117/329 (35%), Gaps = 73/329 (22%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HG 61
+ + EG + VY+A++ + ALK++ +E++ I+E+ +K++ H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHP 86
Query: 62 NIVRLQD-------VVHSEKKLYLVFEYL----DLDLKKHMDSCPDFANDPRLIKTFLYQ 110
NIV+ + + +L+ L ++ K M+S + YQ
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL--SCDTVLKIFYQ 144
Query: 111 ILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGST 168
R + + H + ++HRDLK +NLL+ + +KL DFG A
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT-IKLCDFGSATTI--------------- 188
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEI--LLGSRHYSTPVDVWSVGCIFAEM 226
S Y + + + + T YR PEI L + D+W++GCI +
Sbjct: 189 --SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246
Query: 227 VNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWP--SKELGTVVRN 284
++ F + +I K + P
Sbjct: 247 CFRQHPFEDGA----KLRIVNG------------------KYSIPPHDTQYTVF------ 278
Query: 285 LEPAGIDLLSKMLCMDPSRRITARSALEH 313
L+ ML ++P R++ +
Sbjct: 279 -----HSLIRAMLQVNPEERLSIAEVVHQ 302
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 1e-46
Identities = 89/329 (27%), Positives = 138/329 (41%), Gaps = 84/329 (25%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59
+ Y + +G GT+G V ++ +T +A+K + ++ V REI LK +
Sbjct: 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRLIKTFLYQIL 112
H +I++L V+ + +++V EY+ + +D + + QIL
Sbjct: 75 HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLD--------EKESRRLFQQIL 126
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEHWGSTGI 170
G+ YCH H V+HRDLKP+N+L+D N K+ADFGL+ G +RT GS
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRTSC----GSPN- 180
Query: 171 SIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCI-FAEMVNQ 229
Y APE++ G + VD+WS G I +A +
Sbjct: 181 ---------------------------YAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
Query: 230 RPLFPGDSEIDELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPA 288
P F D + LF KI G+ P + L P+
Sbjct: 214 LP-FDDDH-VPTLFKKICD-----------GIFYTPQY------------------LNPS 242
Query: 289 GIDLLSKMLCMDPSRRITARSALEHEYFR 317
I LL ML +DP +R T + EHE+F+
Sbjct: 243 VISLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-46
Identities = 89/330 (26%), Positives = 136/330 (41%), Gaps = 82/330 (24%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQ 59
D+Y+ V+ IG G +GV R+ +T E +A+K I R DE V REI + ++
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV----QREIINHRSLR 74
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLD-------LDLKKHMDSCPDFANDPRLIKTFLYQIL 112
H NIVR ++V+ + L ++ EY + D A + F Q+L
Sbjct: 75 HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS--EDEA------RFFFQQLL 126
Query: 113 RGIAYCHSHRVLHRDLKPQNLLID-RRTNALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
G++YCHS ++ HRDLK +N L+D LK+ DFG +++ +
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--------------- 171
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTP-VDVWSVGCI-FAEMVNQ 229
S + V G+ Y APE+LL + Y DVWS G + +V
Sbjct: 172 ---SQPKSTV--GTPA----------YIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGA 215
Query: 230 RPLFPGDSEIDELFK--IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEP 287
P F D E ++ I R+L S+PD S E
Sbjct: 216 YP-FE-DPEEPRDYRKTIQRILS--------VKYSIPDD-----IRISPEC--------- 251
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEYFR 317
L+S++ DP+ RI+ H +F
Sbjct: 252 --CHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 65/377 (17%), Positives = 120/377 (31%), Gaps = 107/377 (28%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVT------------NETIALKKIRLE---------- 38
+ +E ++ +G G +GVV++A+N V N +A +K+ E
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 39 ----------------------------------QEDEGVPSTAIREISLLKEMQHGNIV 64
+I + N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 65 RLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFAN-DPRLIKTFLYQILRGIAYCHSHR 122
+ LY+ + +LK M+ + + + QI + + HS
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
++HRDLKP N+ + +K+ DFGL + T ++ ++ +
Sbjct: 185 LMHRDLKPSNIFFTMD-DVVKVGDFGLV-------TAMDQDEEEQTVLTPMPAYATHTGQ 236
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242
G T Y +PE + G +YS VD++S+G I E++ F E +
Sbjct: 237 VG----------TKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRI 282
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
R FP +++ P ++ ML P+
Sbjct: 283 ITDVR-------------------NLKFPLLFTQKY--------PQEHMMVQDMLSPSPT 315
Query: 303 RRITARSALEHEYFRDV 319
R A +E+ F ++
Sbjct: 316 ERPEATDIIENAIFENL 332
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-45
Identities = 78/343 (22%), Positives = 136/343 (39%), Gaps = 90/343 (26%)
Query: 2 DQYE---KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM 58
Y+ K + +GEG++ + K + +N+ A+K I E +EI+ LK
Sbjct: 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN-----TQKEITALKLC 62
Query: 59 Q-HGNIVRLQDVVHSEKKLYLVFEYLD----LD--LKKHMDSCPDFANDPRLIKTFLYQI 111
+ H NIV+L +V H + +LV E L+ + KK S + + +++ ++
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS---YIMR----KL 115
Query: 112 LRGIAYCHSHRVLHRDLKPQNLL-IDRRTNA-LKLADFGLARAFGIPVRTFTHEHWGSTG 169
+ +++ H V+HRDLKP+NLL D N +K+ DFG AR +
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT------- 168
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ 229
TL Y APE+L + Y D+WS+G I M++
Sbjct: 169 ----------------------PCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSG 205
Query: 230 RPLFPGDSE------IDELFKIFRVL-GTPN--EDTWPGVTSLPDFKSAFPKWPSKELGT 280
+ F E+ K ++ G + + W V+ A K
Sbjct: 206 QVPFQSHDRSLTCTSAVEIMK--KIKKGDFSFEGEAWKNVSQ-----EA--K-------- 248
Query: 281 VVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVEFVP 323
DL+ +L +DP++R+ +E+ +D +
Sbjct: 249 ----------DLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-45
Identities = 62/340 (18%), Positives = 111/340 (32%), Gaps = 50/340 (14%)
Query: 2 DQYEKVEKIGEG--TYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ 59
YE + IG+G V AR T E + +++I LE + + E+ + K
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
H NIV + ++ +L++V ++ DL D N+ I L +L+ +
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMNEL-AIAYILQGVLKAL 141
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y H +HR +K ++LI L+ + +H
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKV-YLSGLRSNLSM------ISHGQRQRVVHDFPKY 194
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH-YSTPVDVWSVGCIFAEMVNQRP--- 231
V L + +PE+L + Y D++SVG E+ N
Sbjct: 195 S----------------VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238
Query: 232 -------LF-------PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKE 277
L P + + + G++ + P
Sbjct: 239 DMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298
Query: 278 LGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317
R P + + L +P R +A + L H +F+
Sbjct: 299 SHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-44
Identities = 68/337 (20%), Positives = 122/337 (36%), Gaps = 81/337 (24%)
Query: 2 DQYE-KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLL-KEMQ 59
D Y+ + +G G G V + + T + ALK + + A +E+ +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-DSPK------ARQEVDHHWQASG 80
Query: 60 HGNIVRL----QDVVHSEKKLYLVFEYLD----LD--LKKHMDSCPDFA-NDPRLIKTFL 108
+IV + +++ H ++ L ++ E ++ ++ + F + I +
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA---FTEREAAEI---M 134
Query: 109 YQILRGIAYCHSHRVLHRDLKPQNLL-IDRRTNA-LKLADFGLARAFGIPVRTFTHEHWG 166
I I + HSH + HRD+KP+NLL + +A LKL DFG A+
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT------------ 182
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
+L T +Y APE+L Y D+WS+G I +
Sbjct: 183 ----------------QNAL---QTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYIL 222
Query: 227 VNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLE 286
+ P F ++ + R + F + P+W +
Sbjct: 223 LCGFPPFYSNTGQAISPGMKRRIRLGQ----------YGFPN--PEWS---------EVS 261
Query: 287 PAGIDLLSKMLCMDPSRRITARSALEHEYFRDVEFVP 323
L+ +L DP+ R+T + H + VP
Sbjct: 262 EDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-44
Identities = 77/325 (23%), Positives = 132/325 (40%), Gaps = 79/325 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ KIGEG+ G+V AR + +A+K + L ++ E+ ++++ QH
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHF 102
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRL----IKTFLYQILRGIAY 117
N+V + ++L+++ E+L + D + RL I T +L+ +AY
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQG------GALTDIVSQVRLNEEQIATVCEAVLQALAY 156
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
H+ V+HRD+K ++L+ KL+DFG
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRV-KLSDFG----------------------------- 186
Query: 178 RYRVLAGSLILQFLK----VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFA-EMVNQRPL 232
+ K V T ++ APE++ S Y+T VD+WS+G I EMV+ P
Sbjct: 187 ----FCAQISKDVPKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLG-IMVIEMVDGEPP 240
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
+ DS + + ++ + P K++ K S L D
Sbjct: 241 YFSDSPVQAMKRL------RDSPP-------PKLKNS-HKV-SPVL-----------RDF 274
Query: 293 LSKMLCMDPSRRITARSALEHEYFR 317
L +ML DP R TA+ L+H +
Sbjct: 275 LERMLVRDPQERATAQELLDHPFLL 299
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-44
Identities = 70/337 (20%), Positives = 126/337 (37%), Gaps = 67/337 (19%)
Query: 2 DQYE-KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ- 59
D Y+ + + +GEG + V N +T++ A+K I + S RE+ +L + Q
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI--RSRVFREVEMLYQCQG 69
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLD----LD--LKKHMDSCPDFANDPRLIKTFLYQILR 113
H N++ L + E + YLVFE + L K+ + + + +++ +
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---VVVQ----DVAS 122
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
+ + H+ + HRDLKP+N+L + +K+ DF L
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI----------KLNGDCSP 172
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMV 227
I L G + Y APE++ + Y D+WS+G I ++
Sbjct: 173 ISTPELLTPC--G----------SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220
Query: 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTS-LPDFKSAFPKWPS-----KELGTV 281
+ P F G D + + + +F W K
Sbjct: 221 SGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD--KDWAHISCAAK----- 273
Query: 282 VRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
DL+SK+L D +R++A L+H + +
Sbjct: 274 ---------DLISKLLVRDAKQRLSAAQVLQHPWVQG 301
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-43
Identities = 77/325 (23%), Positives = 137/325 (42%), Gaps = 79/325 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+Y + EKIG+G G VY A + T + +A++++ L+Q+ + I EI +++E ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNP 77
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRL----IKTFLYQILRGIAY 117
NIV D +L++V EYL S D + + I + L+ + +
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLA------GGSLTDVVTETCMDEGQIAAVCRECLQALEF 131
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
HS++V+HRD+K N+L+ + KL DFG
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSV-KLTDFG----------------------------- 161
Query: 178 RYRVLAGSLILQFLK----VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFA-EMVNQRPL 232
+ + K V T ++ APE++ Y VD+WS+G I A EM+ P
Sbjct: 162 ----FCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLG-IMAIEMIEGEPP 215
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
+ ++ + L+ I T P+ ++ K S D
Sbjct: 216 YLNENPLRALYLI------ATNGT-------PELQNP-EKL-SAIF-----------RDF 249
Query: 293 LSKMLCMDPSRRITARSALEHEYFR 317
L++ L MD +R +A+ L+H++ +
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-43
Identities = 77/338 (22%), Positives = 122/338 (36%), Gaps = 82/338 (24%)
Query: 2 DQYEKVEK-IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ- 59
D Y+ + +G G G V + N T E ALK ++ + RE+ L
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKAR------REVELHWRASQ 113
Query: 60 HGNIVRL----QDVVHSEKKLYLVFEYLD----LD--LKKHMDSCPDFA-NDPRLIKTFL 108
+IVR+ +++ K L +V E LD + + F + I +
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEI---M 167
Query: 109 YQILRGIAYCHSHRVLHRDLKPQNLL-IDRRTNA-LKLADFGLARAFGIPVRTFTHEHWG 166
I I Y HS + HRD+KP+NLL +R NA LKL DFG A+ T
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT----- 222
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
T +Y APE+ LG Y D+WS+G I +
Sbjct: 223 -------------------------PCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYIL 256
Query: 227 VNQRPLFPGDSEIDELFKIF-RVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNL 285
+ P F + + + R+ +F + P+W +
Sbjct: 257 LCGYPPFYSNHGLAISPGMKTRIR-----------MGQYEFPN--PEWS---------EV 294
Query: 286 EPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVEFVP 323
L+ +L +P++R+T + H + VP
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-41
Identities = 78/332 (23%), Positives = 125/332 (37%), Gaps = 80/332 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ +E V ++G+G +G VYKA+N T A K I + E+E I EI +L H
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILATCDHP 76
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
IV+L + + KL+++ E+ + +D I+ Q+L + +
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL----TEPQIQVVCRQMLEALNF 132
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
HS R++HRDLK N+L+ + +LADFG
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDI-RLADFG----------------------------- 162
Query: 178 RYRVLAGSLILQFLK----VVTLWYRAPEILLGSR----HYSTPVDVWSVGCIFA-EMVN 228
++ + K + T ++ APE+++ Y D+WS+G I EM
Sbjct: 163 ----VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQ 217
Query: 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPA 288
P + + L KI D P + KW S E
Sbjct: 218 IEPPHHELNPMRVLLKI------AKSDP-------PTLLTP-SKW-SVEF---------- 252
Query: 289 GIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
D L L +P R +A LEH + +
Sbjct: 253 -RDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-41
Identities = 80/328 (24%), Positives = 137/328 (41%), Gaps = 79/328 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ ++ +EK+GEG+YG VYKA + T + +A+K++ +E + + + I+EIS++++
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI----IKEISIMQQCDSP 84
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
++V+ L++V EY D+ + + I T L L+G+ Y
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDI---IRLRNKTLTEDE-IATILQSTLKGLEY 140
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
H R +HRD+K N+L++ +A KLADFG
Sbjct: 141 LHFMRKIHRDIKAGNILLNTEGHA-KLADFG----------------------------- 170
Query: 178 RYRVLAGSLILQFLK----VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFA-EMVNQRPL 232
+AG L K + T ++ APE++ Y+ D+WS+G I A EM +P
Sbjct: 171 ----VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLG-ITAIEMAEGKPP 224
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
+ + +F I P P F+ W S D
Sbjct: 225 YADIHPMRAIFMI------PTNPP-------PTFRKP-ELW-SDNF-----------TDF 258
Query: 293 LSKMLCMDPSRRITARSALEHEYFRDVE 320
+ + L P +R TA L+H + R +
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVRSAK 286
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-41
Identities = 73/337 (21%), Positives = 131/337 (38%), Gaps = 59/337 (17%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
D +EK+ ++G G GVV+K + + +A K I LE + + IRE+ +L E
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNS 90
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
IV +S+ ++ + E++D + K P+ +++ +++G+
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLT 145
Query: 117 YCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y H+++HRD+KP N+L++ R KL DFG++ G + + + G
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSRGEI-KLCDFGVS---GQLIDSMANSFVG--------- 192
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
T Y +PE L G+ HYS D+WS+G EM R P
Sbjct: 193 -------------------TRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPP 232
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKE------LGTVVRNLEP-- 287
+ + +T P + + F L +V P
Sbjct: 233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL 292
Query: 288 -------AGIDLLSKMLCMDPSRRITARSALEHEYFR 317
D ++K L +P+ R + + H + +
Sbjct: 293 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-41
Identities = 74/323 (22%), Positives = 129/323 (39%), Gaps = 73/323 (22%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE-QEDEGVPSTAIREISLLKEMQH 60
+ + +IG G++G VY AR+ +E +A+KK+ ++ I+E+ L++++H
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLD---LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
N ++ + E +LV EY DL ++ + I + L+G+AY
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDL---LEVHKKPLQEVE-IAAVTHGALQGLAY 169
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
HSH ++HRD+K N+L+ KL DFG A + P +F
Sbjct: 170 LHSHNMIHRDVKAGNILLSEPGLV-KLGDFGSA-SIMAPANSF----------------- 210
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSR--HYSTPVDVWSVGCIFA-EMVNQRPLFP 234
V T ++ APE++L Y VDVWS+G I E+ ++P
Sbjct: 211 ---------------VGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLF 254
Query: 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294
+ + L+ I ++ P +S W S+ + +
Sbjct: 255 NMNAMSALYHI------AQNES-------PALQS--GHW-SEYF-----------RNFVD 287
Query: 295 KMLCMDPSRRITARSALEHEYFR 317
L P R T+ L+H +
Sbjct: 288 SCLQKIPQDRPTSEVLLKHRFVL 310
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-41
Identities = 42/361 (11%), Positives = 99/361 (27%), Gaps = 110/361 (30%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIRE----------- 51
+ +G+ +A + T E+ + + ++E
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 52 ---------------ISLLKEMQHGNIVRLQDVVHSE--KKLYLVFEYLDLDLKKHMDSC 94
L+K+ Q ++R++ + ++ + +L+ +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 95 PDFANDPRLI-----KTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGL 149
++ + + Q++R +A H + ++H L+P ++++D+R + L F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEH 252
Query: 150 ARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEIL----- 204
G V + V+ + PE+
Sbjct: 253 LVRDGARVVS---------------------------------SVSRGFEPPELEARRAT 279
Query: 205 -----LGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPG 259
+ D W++G + + D+ + IFR
Sbjct: 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR-----------S 328
Query: 260 VTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319
++P VR LL L R+ A+E + +
Sbjct: 329 CKNIPQP---------------VR-------ALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
Query: 320 E 320
Sbjct: 367 R 367
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-40
Identities = 84/325 (25%), Positives = 140/325 (43%), Gaps = 80/325 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ + K+EKIG+G++G V+K + T + +A+K I LE+ ++ + +EI++L +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI-EDIQQEITVLSQCDSP 80
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
+ + + KL+++ EYL LDL ++ P D I T L +IL+G+ Y
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDL---LEPGPL---DETQIATILREILKGLDY 134
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
HS + +HRD+K N+L+ KLADFG
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEV-KLADFG----------------------------- 164
Query: 178 RYRVLAGSLILQFLK----VVTLWYRAPEILLGSRHYSTPVDVWSVGCIFA-EMVNQRPL 232
+AG L +K V T ++ APE++ S Y + D+WS+G I A E+ P
Sbjct: 165 ----VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLG-ITAIELARGEPP 218
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
+ LF I P + P + + SK L +
Sbjct: 219 HSELHPMKVLFLI------PKNNP-------PTLEG---NY-SKPL-----------KEF 250
Query: 293 LSKMLCMDPSRRITARSALEHEYFR 317
+ L +PS R TA+ L+H++
Sbjct: 251 VEACLNKEPSFRPTAKELLKHKFIL 275
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 7e-40
Identities = 76/368 (20%), Positives = 135/368 (36%), Gaps = 60/368 (16%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+Y + K+G G + V+ + + + +A+K ++ E TA+ EI LLK +++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNS 93
Query: 62 N--------IVRLQDV--------VHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIK 105
+ +V+L D H + +VFE L L K + +K
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTH----ICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 106 TFLYQILRGIAYCHSH-RVLHRDLKPQNLLI-----DRRTNALKLADFGLARAFGIPVRT 159
+ Q+L+G+ Y H+ R++H D+KP+N+L+ R A + ++ + A
Sbjct: 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLK-----------VVTLWYRAPEILLGSR 208
+ + + + I + T YR+ E+L+GS
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS- 268
Query: 209 HYSTPVDVWSVGCIFAEMVNQRPLFPG------DSEIDELFKIFRVLGTPNEDTWPGVTS 262
Y+TP D+WS C+ E+ LF + D + I +LG
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328
Query: 263 LPDF---------KSAFPKWPSKELGTVVRNLEP----AGIDLLSKMLCMDPSRRITARS 309
+F + W E+ D L ML + P +R TA
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388
Query: 310 ALEHEYFR 317
L H +
Sbjct: 389 CLRHPWLN 396
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-40
Identities = 71/338 (21%), Positives = 113/338 (33%), Gaps = 103/338 (30%)
Query: 2 DQYEKVEK-IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-Q 59
D Y+ + +G G G V + N T E ALK ++ + RE+ L Q
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKAR------REVELHWRASQ 69
Query: 60 HGNIVRL----QDVVHSEKKLYLVFEYLD----LD--LKKHMDSCPDFA-NDPRLIKTFL 108
+IVR+ +++ K L +V E LD + + F + I +
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEI---M 123
Query: 109 YQILRGIAYCHSHRVLHRDLKPQNLL-IDRRTNA-LKLADFGLARAFGIPVRTFTHEHWG 166
I I Y HS + HRD+KP+NLL +R NA LKL DFG
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------- 166
Query: 167 STGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226
A E Y D+WS+G I +
Sbjct: 167 ---------------------------------AKETT--GEKYDKSCDMWSLGVIMYIL 191
Query: 227 VNQRPLFPGDSEIDELFKIF-RVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNL 285
+ P F + + + R+ +F + P+W +
Sbjct: 192 LCGYPPFYSNHGLAISPGMKTRIR-----------MGQYEFPN--PEWS---------EV 229
Query: 286 EPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVEFVP 323
L+ +L +P++R+T + H + VP
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-39
Identities = 40/355 (11%), Positives = 96/355 (27%), Gaps = 99/355 (27%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE---------------------- 40
+ +G+ +A + T E+ + +
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 41 -DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKK-----LYLVFEYLDLDLKKHMDSC 94
++ +R I ++ ++ V E+ + ++ + +L+ +
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 95 PDFANDPRLI-----KTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGL 149
++ + + Q++R +A H + ++H L+P ++++D+R + L F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-GGVFLTGFEH 257
Query: 150 ARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH 209
G + + A +L +H
Sbjct: 258 LVRDGASAVSPIGRGFAPPE----------------------------TTAERMLPFGQH 289
Query: 210 ----YSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPD 265
+ D W++G + D+ + IFR ++P
Sbjct: 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR-----------SCKNIPQ 338
Query: 266 FKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
VR LL L R+ A+E + +
Sbjct: 339 P---------------VR-------ALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 70/329 (21%), Positives = 124/329 (37%), Gaps = 65/329 (19%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREIS-LLKEMQ 59
+ + + +IG G YG V K + + + +A+K+IR DE + ++ +++
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDVVMRSSD 79
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDP---RLIKTFLYQILRGIA 116
IV+ + E ++ E + K +D ++ ++ +
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 117 YCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
+ +++HRD+KP N+L+DR N KL DFG++ G V +
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNI-KLCDFGIS---GQLVDSIAK------------- 182
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH---YSTPVDVWSVGCIFAEMVNQR-P 231
AG Y APE + S Y DVWS+G E+ R P
Sbjct: 183 ----TRDAG----------CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
Query: 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291
+S D+L ++ V G P P L + S ++ S I+
Sbjct: 229 YPKWNSVFDQLTQV--VKGDP-----P---QLSN--SEEREF-SPSF-----------IN 264
Query: 292 LLSKMLCMDPSRRITARSALEHEYFRDVE 320
++ L D S+R + L+H + E
Sbjct: 265 FVNLCLTKDESKRPKYKELLKHPFILMYE 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 46/340 (13%), Positives = 95/340 (27%), Gaps = 86/340 (25%)
Query: 2 DQYEKVEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLK 56
+GEG + VY+A + + LK + E + + LK
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF--YIGTQLMERLK 122
Query: 57 EMQHGNIVRLQDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQIL 112
++ + LV E L+ + P+ L+ +F ++L
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTN----------ALKLADFGLARAFGI-PVRTFT 161
I H ++H D+KP N ++ L L D G + + P T
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGC 221
++G ++ E+L + ++ +D + V
Sbjct: 243 TAKCETSG----------------------------FQCVEMLSN-KPWNYQIDYFGVAA 273
Query: 222 IFAEMVNQRPLFPGDSEIDELFK-IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGT 280
M+ + + + + +FR P+ D W
Sbjct: 274 TVYCMLFGTYMKVKNEGGECKPEGLFR--RLPHLDMWN---------------------- 309
Query: 281 VVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
+ ML + + + L + + +
Sbjct: 310 ----------EFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-39
Identities = 57/233 (24%), Positives = 102/233 (43%), Gaps = 29/233 (12%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
E +G+G +G K + T E + +K+ L + DE T ++E+ +++ ++H N+++
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 68 DVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
V++ +K+L + EY+ L +K P +F I G+AY HS
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP-----WSQRVSFAKDIASGMAYLHSMN 128
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
++HRDL N L+ + +ADFGLAR + + +
Sbjct: 129 IIHRDLNSHNCLVR-ENKNVVVADFGLAR-----LMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
G ++ APE++ G R Y VDV+S G + E++ + P
Sbjct: 183 VG----------NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-38
Identities = 68/328 (20%), Positives = 119/328 (36%), Gaps = 67/328 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREIS-LLKEMQ 59
D E + ++G G YGVV K R+ + + +A+K+IR + + ++ ++ +
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTVD 64
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFAN--DPRLIKTFLYQILRGIAY 117
V + E +++ E +D L K D ++ I++ + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 118 CHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
HS V+HRD+KP N+LI+ K+ DFG++ G V +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQV-KMCDFGIS---GYLVDDVAKDID----------- 169
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSR---HYSTPVDVWSVGCIFAEMVNQR-PL 232
Y APE + YS D+WS+G E+ R P
Sbjct: 170 ----------------AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
+ +L ++ E + P LP K+ S E +D
Sbjct: 214 DSWGTPFQQLKQV------VEEPS-P---QLPA-----DKF-SAEF-----------VDF 246
Query: 293 LSKMLCMDPSRRITARSALEHEYFRDVE 320
S+ L + R T ++H +F E
Sbjct: 247 TSQCLKKNSKERPTYPELMQHPFFTLHE 274
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-38
Identities = 81/338 (23%), Positives = 130/338 (38%), Gaps = 88/338 (26%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QH 60
+E VE +G GTYG VYK R+ T + A+K + + ++E +EI++LK+ H
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHH 80
Query: 61 GNIVRL------QDVVHSEKKLYLVFEYLD----LDLKKHMDSCPDFANDPRLIKTFLYQ 110
NI ++ + +L+LV E+ DL + + I +
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL---IKNTKGNTLKEEWIAYICRE 137
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGI 170
ILRG+++ H H+V+HRD+K QN+L+ KL DFG
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEV-KLVDFG---------------------- 174
Query: 171 SIYFSFLRYRVLAGSLILQFLK----VVTLWYRAPEILLGSRH----YSTPVDVWSVGCI 222
++ L + + T ++ APE++ + Y D+WS+G I
Sbjct: 175 -----------VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG-I 222
Query: 223 FA-EMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTV 281
A EM P + LF I P P KS KW SK+
Sbjct: 223 TAIEMAEGAPPLCDMHPMRALFLI------PRNPA-------PRLKS--KKW-SKKF--- 263
Query: 282 VRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319
+ L + S+R ++H + RD
Sbjct: 264 --------QSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-38
Identities = 68/331 (20%), Positives = 116/331 (35%), Gaps = 74/331 (22%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREIS-LLKEMQ 59
++ E + ++G GT G V+K R T IA+K++R ++ + ++ +LK
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVLKSHD 82
Query: 60 HGNIVRLQDVVHSEKKLYLVFEY----LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
IV+ + +++ E + K+ P+ R++ I++ +
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE-----RILGKMTVAIVKAL 137
Query: 116 AYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
Y H V+HRD+KP N+L+D R KL DFG++ G V
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQI-KLCDFGIS---GRLVDDKAK------------ 181
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR----HYSTPVDVWSVGCIFAEMVNQR 230
AG Y APE + Y DVWS+G E+ +
Sbjct: 182 -----DRSAG----------CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
Query: 231 -PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAG 289
P ++ + L K+ + P P + F F
Sbjct: 227 FPYKNCKTDFEVLTKV--LQEEP-----PLLPGHMGFSGDF------------------- 260
Query: 290 IDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
+ L D +R LEH + + E
Sbjct: 261 QSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 66/240 (27%), Positives = 99/240 (41%), Gaps = 46/240 (19%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ E E +G G +GVV KA+ + +A+K+I E E + I E+ L + H
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERK----AFIVELRQLSRVNH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSC-PDFANDPRLIKTFLYQILRGIAYC 118
NIV+L + LV EY + L + P ++ Q +G+AY
Sbjct: 61 PNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 119 HSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
HS + ++HRDLKP NLL+ LK+ DFG A T + G
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMT----NNKG------ 165
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
+ + APE+ GS +YS DV+S G I E++ +R F
Sbjct: 166 -------------------SAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDE 205
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 48/241 (19%), Positives = 87/241 (36%), Gaps = 48/241 (19%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAI-----REISLLKEMQHGN 62
++IG+G +G+V+K R +A+K + L + RE+ ++ + H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 63 IVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
IV+L ++H +V E++ DL + + + I GI Y +
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPI-KWSVKLRLMLDIALGIEYMQNQ 141
Query: 122 R--VLHRDLKPQNLLIDRRTNA----LKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
++HRDL+ N+ + K+ADFGL++ +G
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----------QSVHSVSG------ 185
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLG-SRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
L G + APE + Y+ D +S I ++ F
Sbjct: 186 ------LLG----------NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 235 G 235
Sbjct: 230 E 230
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 37/232 (15%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
EKIG G++G V++A +A+K + + + +RE++++K ++H NIV
Sbjct: 43 EKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHM-DSCPDFANDPRLIKTFLYQILRGIAYCHSHR--V 123
V L +V EYL L + + S D R + Y + +G+ Y H+ +
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
+HR+LK NLL+D++ +K+ DFGL+R + + G
Sbjct: 161 VHRNLKSPNLLVDKKYT-VKVCDFGLSRLKASTFLSSK----SAAG-------------- 201
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
T + APE+L + DV+S G I E+ + +
Sbjct: 202 -----------TPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-34
Identities = 50/238 (21%), Positives = 91/238 (38%), Gaps = 41/238 (17%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
E IG+G +G VY R + +A++ I +E+++E RE+ ++ +H N+V
Sbjct: 39 ELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHR 126
S L ++ L + D + +I++G+ Y H+ +LH+
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHK 154
Query: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHW-GSTGISIYFSFLRYRVLAGS 185
DLK +N+ D + + DFGL G+ + G
Sbjct: 155 DLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNG---------------- 196
Query: 186 LILQFLKVVTLWYRAPEILLGSR--------HYSTPVDVWSVGCIFAEMVNQRPLFPG 235
L + APEI+ +S DV+++G I+ E+ + F
Sbjct: 197 ---------WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 60/246 (24%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIVR 65
E IG G +G VY+A + +A+K R + +++ + +E L ++H NI+
Sbjct: 13 EIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 66 LQDVVHSEKKLYLVFEYL------DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
L+ V E L LV E+ + K + P ++ + QI RG+ Y H
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI--------PPDILVNWAVQIARGMNYLH 122
Query: 120 SHR---VLHRDLKPQNLLIDRRTNA-------LKLADFGLARAFGIPVRTFTHEHWGSTG 169
++HRDLK N+LI ++ LK+ DFGLAR + + + G
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM------SAAG 176
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ 229
+ APE++ S +S DVWS G + E++
Sbjct: 177 -------------------------AYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTG 210
Query: 230 RPLFPG 235
F G
Sbjct: 211 EVPFRG 216
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-33
Identities = 50/231 (21%), Positives = 98/231 (42%), Gaps = 36/231 (15%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
++IG G++G VYK + + +A+K + + E+ +L++ +H NI+
Sbjct: 30 QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHR 126
+ +L +V ++ + L H+ + +LI Q RG+ Y H+ ++HR
Sbjct: 87 GYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLID-IARQTARGMDYLHAKSIIHR 144
Query: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSL 186
DLK N+ + N +K+ DFGLA ++ L+G
Sbjct: 145 DLKSNNIFLHED-NTVKIGDFGLAT-----EKSRWSGSHQFEQ------------LSG-- 184
Query: 187 ILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
++ + APE++ S YS DV++ G + E++ + +
Sbjct: 185 --------SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 71/237 (29%), Positives = 109/237 (45%), Gaps = 36/237 (15%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE-QEDEGVPSTAIREISLLKEMQHGN 62
Y+ V+K+G G VY A + + N +A+K I + +E E RE+ ++ H N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 63 IVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
IV + DV + YLV EY++ L ++++S F QIL GI + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
R++HRD+KPQN+LID LK+ DFG+A+A T T+ G+ YFS
Sbjct: 131 RIVHRDIKPQNILID-SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ---YFS------ 180
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTP-VDVWSVGCIFAEMVNQRPLFPGDS 237
PE G + D++S+G + EM+ P F G++
Sbjct: 181 -------------------PEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGET 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 73/337 (21%), Positives = 131/337 (38%), Gaps = 84/337 (24%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALK---KIRLEQEDEGVPSTAIREISLLKE 57
+ ++ + +GEG++ V AR T+ A+K K + +E++ VP RE ++
Sbjct: 29 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYV-TRERDVMSR 86
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLY--QILRG 114
+ H V+L ++KLY Y +L K++ F T Y +I+
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSA 142
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF---GIPVRTFTHEHWGSTGIS 171
+ Y H ++HRDLKP+N+L++ + +++ DFG A+ R +
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANS---------- 191
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231
G T Y +PE+L D+W++GCI ++V P
Sbjct: 192 ----------FVG----------TAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLP 230
Query: 232 LFPGDSEIDELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGI 290
F +E +F KI ++ + FP+ P
Sbjct: 231 PFRAGNE-YLIFQKIIKL------------------EYDFPEK-----------FFPKAR 260
Query: 291 DLLSKMLCMDPSRRITARSA------LEHEYFRDVEF 321
DL+ K+L +D ++R+ H +F V +
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 297
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 37/235 (15%), Positives = 73/235 (31%), Gaps = 44/235 (18%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
K+ E G ++K R I +K +++ E L+ H N++ +
Sbjct: 16 TKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 68 DVVHS--EKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR-- 122
S L+ ++ L + +F D F + RG+A+ H+
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
+ L ++++ID A +++ + +F + G
Sbjct: 134 IPRHALNSRSVMIDEDMTA-RISMADVKFSF---------QSPGRMY------------- 170
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSR--HYSTPVDVWSVGCIFAEMVNQRPLFPG 235
+ APE L D+WS + E+V + F
Sbjct: 171 ------------APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 68/322 (21%), Positives = 127/322 (39%), Gaps = 74/322 (22%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVRL- 66
IG+G++G V + T + A+K + ++ E V + +E+ +++ ++H +V L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV-FKELQIMQGLEHPFLVNLW 81
Query: 67 ---QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
QD E+ +++V + L DL+ H+ F + +K F+ +++ + Y + R
Sbjct: 82 YSFQD----EEDMFMVVDLLLGGDLRYHLQQNVHFKEE--TVKLFICELVMALDYLQNQR 135
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182
++HRD+KP N+L+D + + DF +A + T +
Sbjct: 136 IIHRDMKPDNILLDEHGHV-HITDFNIAAMLPRETQITT--------------------M 174
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRH--YSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
AG T Y APE+ + YS VD WS+G E++ R + S
Sbjct: 175 AG----------TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-T 223
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
+I F++ +PS + LL K+L +
Sbjct: 224 SSKEIVHT-----------------FETTVVTYPS--------AWSQEMVSLLKKLLEPN 258
Query: 301 PSRRI-TARSALEHEYFRDVEF 321
P +R Y D+ +
Sbjct: 259 PDQRFSQLSDVQNFPYMNDINW 280
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 66/324 (20%), Positives = 126/324 (38%), Gaps = 74/324 (22%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVRLQ 67
+G+G +G V + T + A KK+ ++ + +G + E +L+++ +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSLA 250
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHR 126
++ L LV ++ DLK H+ + +I G+ H R+++R
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310
Query: 127 DLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTF--THEHWGSTGISIYFSFLRYRVL 182
DLKP+N+L+D + ++++D GLA G ++ T
Sbjct: 311 DLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVG------------------- 350
Query: 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242
Y APE++ R Y+ D W++GC+ EM+ + F + +
Sbjct: 351 ---------------YMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
++ R + + + + S + L S++LC DP+
Sbjct: 395 EEVER--------------LVKEVPEEYSERFSPQ-----------ARSLCSQLLCKDPA 429
Query: 303 RRI--TARSALE---HEYFRDVEF 321
R+ SA E H F+ + F
Sbjct: 430 ERLGCRGGSAREVKEHPLFKKLNF 453
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (295), Expect = 7e-31
Identities = 58/376 (15%), Positives = 108/376 (28%), Gaps = 122/376 (32%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGV------PSTAIREISLL 55
++ ++ EKIGEG +G V++ + +A+K I +E D + EI +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 56 KEMQ---------HGNIVRLQDVVH------------------------------SEKKL 76
KE+ + L V + +L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 77 YLVFEYLD--LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH-SHRVLHRDLKPQNL 133
++V E+ +DL++ K+ L+Q+ +A S R HRDL N+
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSL----ATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 134 LIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKV 193
L+ + + KL ++ IP
Sbjct: 194 LLKKTSL-KKLHYTLNGKSSTIPSCGLQVS------------------------------ 222
Query: 194 VTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPN 253
Y+ +F ++ LF GD D F I+R++ N
Sbjct: 223 -------------IIDYTLSRLERDGIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKEN 267
Query: 254 EDTWPG-------------VTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
+ W + + K + + + R ++ + ML
Sbjct: 268 NNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQ----EFHRTMLNFS 323
Query: 301 PSRRITARSALEHEYF 316
+A L
Sbjct: 324 -----SATDLLCQHSL 334
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 66/327 (20%), Positives = 122/327 (37%), Gaps = 77/327 (23%)
Query: 10 IGEGTYGVVYKARNCVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVRLQ 67
+G G +G V+ + T + A KK+ ++ + +G + E +L ++ IV L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-MVEKKILAKVHSRFIVSLA 251
Query: 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLY--QILRGIAYCHSHRVL 124
++ L LV ++ D++ H+ + + + + Y QI+ G+ + H ++
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLARAF---GIPVRTF--THEHWGSTGISIYFSFLRY 179
+RDLKP+N+L+D N ++++D GLA + + T
Sbjct: 312 YRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPG---------------- 354
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
+ APE+LLG Y VD +++G EM+ R F E
Sbjct: 355 ------------------FMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEK 395
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
E ++ + + +P S D +L
Sbjct: 396 VENKELKQRVLEQAVT--------------YPDKFSPA-----------SKDFCEALLQK 430
Query: 300 DPSRRITARSA-----LEHEYFRDVEF 321
DP +R+ R H FRD+ +
Sbjct: 431 DPEKRLGFRDGSCDGLRTHPLFRDISW 457
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-30
Identities = 55/237 (23%), Positives = 92/237 (38%), Gaps = 36/237 (15%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE-QEDEGVPSTAIREISLLKEMQHGN 62
Y +G G G VY+A + V +ALK + D + RE +Q +
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 63 IVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
+V + D + +LY+ ++ +DL + P + QI + H+
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
HRD+KP+N+L+ A L DFG+A A T G ++
Sbjct: 154 GATHRDVKPENILVSADDFA-YLVDFGIASATTDEKLT-------QLGNTV--------- 196
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTP-VDVWSVGCIFAEMVNQRPLFPGDS 237
G TL+Y APE ++T D++++ C+ E + P + GD
Sbjct: 197 --G----------TLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 63/241 (26%), Positives = 102/241 (42%), Gaps = 38/241 (15%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE-QEDEGVPSTAIREISLLKEMQHGN 62
YE E +G G V+ AR+ + +A+K +R + D RE + H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 63 IVRLQDV----VHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
IV + D + Y+V EY+D + L+ + + + P+ + + + +
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNF 131
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
H + ++HRD+KP N++I TNA+K+ DFG+ARA + T T I
Sbjct: 132 SHQNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQ-----TAAVI----- 180
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTP-VDVWSVGCIFAEMVNQRPLFPGD 236
G T Y +PE G DV+S+GC+ E++ P F GD
Sbjct: 181 ------G----------TAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
Query: 237 S 237
S
Sbjct: 223 S 223
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 58/243 (23%), Positives = 91/243 (37%), Gaps = 49/243 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKAR-NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
QYE I G G +Y A V + LK + D + A+ E L E+ H
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLV-HSGDAEAQAMAMAERQFLAEVVH 138
Query: 61 GNIVRLQDVV-----HSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
+IV++ + V H + Y+V EY+ LK+ +L +IL
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLP----VAEAIAYLLEILPA 194
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
++Y HS +++ DLKP+N+++ LKL D G S G
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTE--EQLKLIDLGAVSRI------------NSFG----- 235
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
L G T ++APEI+ + D+++VG A + P
Sbjct: 236 ------YLYG----------TPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRN 277
Query: 235 GDS 237
G
Sbjct: 278 GRY 280
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 72/333 (21%), Positives = 126/333 (37%), Gaps = 74/333 (22%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ--EDEGVPSTAI-REI-SLLK 56
M+ + IG G +G VY R T + A+K + ++ +G R + SL+
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 57 EMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
IV + H+ KL + + ++ DL H+ F+ ++ + +I+ G+
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA--DMRFYAAEIILGL 305
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
+ H+ V++RDLKP N+L+D + ++++D GLA F +
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDF-SKKKPHA-------------- 349
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
G T Y APE+L Y + D +S+GC+ +++ F
Sbjct: 350 ------SVG----------THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
Query: 236 DSEID--ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
D E+ + L E P S E LL
Sbjct: 394 HKTKDKHEIDR--MTLTMAVE---------------LPDSFSPE-----------LRSLL 425
Query: 294 SKMLCMDPSRRI--TARSALE---HEYFRDVEF 321
+L D +RR+ R A E +FR +++
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 70/335 (20%), Positives = 116/335 (34%), Gaps = 71/335 (21%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Q + V++IG+G YG V+ + E +A+K +E EI M+H
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEAS---WFRETEIYQTVLMRHE 91
Query: 62 NIVRL----QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
NI+ S +LYL+ +Y + L ++ S D + + Y + G+
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLC 148
Query: 117 YCHSHR--------VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGST 168
+ H+ + HRDLK +N+L+ + +AD GLA F
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC-CIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-----RHYSTPVDVWSVGCIF 223
G T Y PE+L S D++S G I
Sbjct: 208 G-------------------------TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242
Query: 224 AEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAF------PKWPSKE 277
E+ R + G E +L P D P S D + P +P++
Sbjct: 243 WEVAR-RCVSGGIVEEYQL---------PYHDLVPSDPSYEDMREIVCIKKLRPSFPNR- 291
Query: 278 LGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312
L+++ +P+ R+TA +
Sbjct: 292 --WSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-28
Identities = 51/243 (20%), Positives = 88/243 (36%), Gaps = 56/243 (23%)
Query: 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIRE--ISLLKEMQHGN 62
+E +G+G YG V++ E +A+K E RE + ++H N
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKS-----WFRETELYNTVMLRHEN 63
Query: 63 IVRL----QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
I+ HS +L+L+ Y ++ L ++ D + I G+A+
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAH 120
Query: 118 CHSHR--------VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTG 169
H + HRDLK +N+L+ + +AD GLA ++ G+
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC-CIADLGLAVMH---SQSTNQLDVGNNP 176
Query: 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-----RHYSTPVDVWSVGCIFA 224
+V T Y APE+L + VD+W+ G +
Sbjct: 177 ----------------------RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214
Query: 225 EMV 227
E+
Sbjct: 215 EVA 217
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-28
Identities = 66/332 (19%), Positives = 133/332 (40%), Gaps = 80/332 (24%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKE 57
+ ++ + +G G++G V+ R+ A LKK + + + V T E +L
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHT-NDERLMLSI 62
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLY--QILRG 114
+ H I+R+ ++++++ +Y++ +L + F N Y ++
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP----VAKFYAAEVCLA 118
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+ Y HS +++RDLKP+N+L+D+ + +K+ DFG A+ +P T+T
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFAKY--VPDVTYT------------- 162
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
L G T Y APE++ + + +D WS G + EM+ F
Sbjct: 163 -------LCG----------TPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFY 204
Query: 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294
+ + ++ ++L ++P DLLS
Sbjct: 205 DSNT-MKTYE--KILNAE------------------LRFP--------PFFNEDVKDLLS 235
Query: 295 KMLCMDPSRRI-----TARSALEHEYFRDVEF 321
+++ D S+R+ H +F++V +
Sbjct: 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 74/331 (22%), Positives = 133/331 (40%), Gaps = 78/331 (23%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEM 58
+DQ+++++ +G G++G V ++ + A+K + ++ + + + T + E +L+ +
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAV 98
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLY--QILRGI 115
+V+L+ LY+V EY+ ++ H+ F+ Y QI+
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP----HARFYAAQIVLTF 154
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y HS +++RDLKP+NLLID++ +++ DFG A+ + RT+T
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR--VKGRTWT-------------- 197
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
L G T APEI+L + + VD W++G + EM P F
Sbjct: 198 ------LCG----------TPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSK 295
D I KI K FP DLL
Sbjct: 241 DQPIQIYEKIVSG------------------KVRFPSH-----------FSSDLKDLLRN 271
Query: 296 MLCMDPSRRI-----TARSALEHEYFRDVEF 321
+L +D ++R H++F ++
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 48/244 (19%), Positives = 83/244 (34%), Gaps = 52/244 (21%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
E IG+G +G V++ + E +A+K +E EI ++H
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERS---WFREAEIYQTVMLRHE 96
Query: 62 NIVRL----QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
NI+ + +L+LV +Y + L +++ + G+A
Sbjct: 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLA 153
Query: 117 YCHSHR--------VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGST 168
+ H + HRDLK +N+L+ + +AD GLA T
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC-CIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-----RHYSTPVDVWSVGCIF 223
G T Y APE+L S D++++G +F
Sbjct: 213 G-------------------------TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247
Query: 224 AEMV 227
E+
Sbjct: 248 WEIA 251
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 68/334 (20%), Positives = 116/334 (34%), Gaps = 70/334 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIR---LEQEDEGVPSTAIREISLLKE 57
D +E ++ IG G + V + T + A+K + + + E R++ L
Sbjct: 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV--LVN 117
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
I +L E LYLV EY DL + + + +L +I+ I
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLAEIVMAID 176
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
H +HRD+KP N+L+DR + ++LADFG +
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSL------------VA 223
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLG------SRHYSTPVDVWSVGCIFAEMVNQR 230
V T Y +PEIL + Y D W++G EM +
Sbjct: 224 ----------------VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
Query: 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGI 290
F DS E + +++ + P + +E
Sbjct: 268 TPFYADST-AETYG--KIVHYKEHLSLP----------LVDEGVPEE-----------AR 303
Query: 291 DLLSKMLCMDPSRRITARSALE---HEYFRDVEF 321
D + ++LC P R+ A + H +F +++
Sbjct: 304 DFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-27
Identities = 66/344 (19%), Positives = 121/344 (35%), Gaps = 89/344 (25%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ +E G +G V+KA+ NE +A+K ++ + E+ L M+H
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS---WQNEYEVYSLPGMKHE 78
Query: 62 NIVRL----QDVVHSEKKLYLVFEYLD---LD--LKKHMDSCPDFANDPRLIKTFLYQIL 112
NI++ + + L+L+ + + L LK ++ S + + +
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCH-------IAETMA 131
Query: 113 RGIAYCHSH----------RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162
RG+AY H + HRD+K +N+L+ A +ADFGLA F
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA-CIADFGLALKFEA-----GK 185
Query: 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS----RHYSTPVDVWS 218
+ G +V T Y APE+L G+ R +D+++
Sbjct: 186 SAGDTHG----------------------QVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223
Query: 219 VGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSA--------- 269
+G + E+ ++ G + L P E+ SL D +
Sbjct: 224 MGLVLWELASRCTAADGPVDEYML---------PFEEEIGQHPSLEDMQEVVVHKKKRPV 274
Query: 270 FPK-WPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312
W ++ + + + D R++A E
Sbjct: 275 LRDYWQKHAGMAML-------CETIEECWDHDAEARLSAGCVGE 311
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 73/330 (22%), Positives = 117/330 (35%), Gaps = 68/330 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEM 58
+ YE V+ IG G +G V R+ T + A+K + + + E ++
Sbjct: 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF-WEERDIMAFA 126
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
+V+L ++ LY+V EY+ DL M S D + + +++ +
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEK--WARFYTAEVVLALDA 183
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
HS +HRD+KP N+L+D+ + LKLADFG
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCD--------------- 227
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILL---GSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
G T Y +PE+L G +Y D WSVG EM+ F
Sbjct: 228 ---TAVG----------TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274
Query: 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLS 294
DS + KI SL FP ++ +L+
Sbjct: 275 ADSLVGTYSKIMN-----------HKNSLT-----FPDDN---------DISKEAKNLIC 309
Query: 295 KMLCMDPSRRITARSALE---HEYFRDVEF 321
L D R+ E H +F++ ++
Sbjct: 310 AFLT-DREVRLGRNGVEEIKRHLFFKNDQW 338
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-27
Identities = 61/233 (26%), Positives = 107/233 (45%), Gaps = 44/233 (18%)
Query: 5 EKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTA---IREISLLKE 57
+ ++++G+G +G V R T E +A+KK++ REI +LK
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKS 67
Query: 58 MQHGNIVRLQDVVHSEKK--LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRG 114
+QH NIV+ + V +S + L L+ EYL L+ ++ + + +L++ + QI +G
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 126
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+ Y + R +HRDL +N+L++ N +K+ DFGL + +
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKV-------------------LPQ 166
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
++V + WY APE L S+ +S DVWS G + E+
Sbjct: 167 DKEFFKVKEPG------ESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-27
Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 44/233 (18%)
Query: 5 EKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTA---IREISLLKE 57
+ ++++G+G +G V R T E +A+KK++ REI +LK
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKS 98
Query: 58 MQHGNIVRLQDVVHSEKK--LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRG 114
+QH NIV+ + V +S + L L+ EYL L+ ++ + + +L++ + QI +G
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 157
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+ Y + R +HRDL +N+L++ N +K+ DFGL + +
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKV-------------------LPQ 197
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
Y+V + WY APE L S+ +S DVWS G + E+
Sbjct: 198 DKEYYKVKEPG------ESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 242
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-27
Identities = 70/337 (20%), Positives = 118/337 (35%), Gaps = 62/337 (18%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+D + +E IG G YG VYK + +A+K + I + M+H
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQN---FINEKNIYRVPLMEH 66
Query: 61 GNIVRL-----QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRG 114
NI R + + LV EY L K++ +D + + RG
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRG 123
Query: 115 IAYCHS---------HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHW 165
+AY H+ + HRDL +N+L+ ++DFGL+ E
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC-VISDFGLSMRLTGNRLVRPGEED 182
Query: 166 GSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS------RHYSTPVDVWSV 219
+ +V T+ Y APE+L G+ VD++++
Sbjct: 183 NAA---------------------ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221
Query: 220 GCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELG 279
G I+ E+ + + E F+ N T+ + L + PK+P
Sbjct: 222 GLIYWEIFMRCTDLFPGESVPEYQMAFQTE-VGNHPTFEDMQVLVSREKQRPKFPEAW-- 278
Query: 280 TVVRNLEPAGIDLLSKML--C--MDPSRRITARSALE 312
+ L + + C D R+TA+ A E
Sbjct: 279 ----KENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 84/323 (26%), Positives = 141/323 (43%), Gaps = 80/323 (24%)
Query: 10 IGEGTYGVVYKARNCVTNETIA---LKKIRLEQEDEGVPSTAI-REISLLKEMQHGNIVR 65
+G+G++G V+ A TN+ A LKK + +D+ V T + + + L +H +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD-VECTMVEKRV-LSLAWEHPFLTH 82
Query: 66 LQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVL 124
+ +++ L+ V EYL+ DL H+ SC F + R + +I+ G+ + HS ++
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSR-ATFYAAEIILGLQFLHSKGIV 140
Query: 125 HRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTF--THEHWGSTGISIYFSFLRY 179
+RDLK N+L+D+ + +K+ADFG+ + TF T +
Sbjct: 141 YRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPD---------------- 183
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
Y APEILLG + Y+ VD WS G + EM+ + F G E
Sbjct: 184 ------------------YIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE- 223
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
+ELF S+ +P+W KE DLL K+
Sbjct: 224 EELFH-----------------SIRMDNPFYPRWLEKE-----------AKDLLVKLFVR 255
Query: 300 DPSRRITARSAL-EHEYFRDVEF 321
+P +R+ R + +H FR++ +
Sbjct: 256 EPEKRLGVRGDIRQHPLFREINW 278
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 37/223 (16%)
Query: 5 EKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+++ +GEG +G V R T E +A+K ++ E + +EI +L+ + H
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN-HIADLKKEIEILRNLYH 82
Query: 61 GNIVRLQDVVHSEKK--LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
NIV+ + + + + L+ E+L LK+++ + N + +K + QI +G+ Y
Sbjct: 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK-YAVQICKGMDY 141
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
S + +HRDL +N+L++ + +K+ DFGL +A I
Sbjct: 142 LGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKA-------------------IETDKE 181
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
Y V F WY APE L+ + DVWS G
Sbjct: 182 YYTVKDDRDSPVF------WY-APECLM-QSKFYIASDVWSFG 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 77/328 (23%), Positives = 129/328 (39%), Gaps = 87/328 (26%)
Query: 10 IGEGTYGVVYKARNCVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
+G+GT+G V R T A L+K + +DE V T + E +L+ +H + L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHT-VTESRVLQNTRHPFLTAL 70
Query: 67 QDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLY--QILRGIAYCHSHRV 123
+ + +L V EY + +L H+ F + + Y +I+ + Y HS V
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE----RARFYGAEIVSALEYLHSRDV 126
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTF--THEHWGSTGISIYFSFLR 178
++RD+K +NL++D+ + +K+ DFGL + + G ++TF T E
Sbjct: 127 VYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPE--------------- 170
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
Y APE+L Y VD W +G + EM+ R F
Sbjct: 171 -------------------YLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
+ LF+ + + FP+ S E LL+ +L
Sbjct: 211 -ERLFE-----------------LILMEEIRFPRTLSPE-----------AKSLLAGLLK 241
Query: 299 MDPSRRI--TARSALE---HEYFRDVEF 321
DP +R+ A E H +F + +
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINW 269
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 63/234 (26%), Positives = 101/234 (43%), Gaps = 46/234 (19%)
Query: 5 EKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ + ++G+G +G V R T +A+K+++ D+ REI +LK +
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHS 83
Query: 61 GNIVRLQDVVHSEKK--LYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILR 113
IV+ + V + + L LV EYL L L++H + RL+ + QI +
Sbjct: 84 DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL----DASRLLL-YSSQICK 138
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
G+ Y S R +HRDL +N+L++ +K+ADFGLA+ ++
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESE-AHVKIADFGLAKLLP-----LDKDY--------- 183
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
Y V F WY APE L +S DVWS G + E+
Sbjct: 184 -----YVVREPGQSPIF------WY-APESLS-DNIFSRQSDVWSFGVVLYELF 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-26
Identities = 63/332 (18%), Positives = 113/332 (34%), Gaps = 68/332 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIR---LEQEDEGVPSTAIREISLLKE 57
+ +E ++ IG G +G V + ++ A+K + + + E R++ L
Sbjct: 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVN 130
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
I L + LYLV +Y DL + D + + +L +++ I
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLAEMVIAID 189
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
H +HRD+KP N+L+D + ++LADFG +
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSS------------VA 236
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH----YSTPVDVWSVGCIFAEMVNQRPL 232
V T Y +PEIL Y D WS+G EM+
Sbjct: 237 ----------------VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
F +S ++ KI FP + ++ DL
Sbjct: 281 FYAESLVETYGKIMN-----------HKERFQ-----FPTQVT--------DVSENAKDL 316
Query: 293 LSKMLCMDPSRRITARSALE---HEYFRDVEF 321
+ +++C R+ + H +F +++
Sbjct: 317 IRRLIC-SREHRLGQNGIEDFKKHPFFSGIDW 347
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 75/326 (23%), Positives = 135/326 (41%), Gaps = 82/326 (25%)
Query: 10 IGEGTYGVVYKARNCVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
+G+G++G V + T+E A LKK + Q+D+ V T + + L + + +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD-VECTMVEKRVLALPGKPPFLTQL 407
Query: 67 QDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
+ +LY V EY++ DL H+ F +P + +I G+ + S +++
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF-KEPH-AVFYAAEIAIGLFFLQSKGIIY 465
Query: 126 RDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTF--THEHWGSTGISIYFSFLRYR 180
RDLK N+++D + +K+ADFG+ + G+ +TF T +
Sbjct: 466 RDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPD----------------- 507
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
Y APEI+ + Y VD W+ G + EM+ + F G+ E D
Sbjct: 508 -----------------YIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-D 548
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
ELF+ S+ + A+PK SKE + + ++
Sbjct: 549 ELFQ-----------------SIMEHNVAYPKSMSKE-----------AVAICKGLMTKH 580
Query: 301 PSRRI--TARSALE---HEYFRDVEF 321
P +R+ + H +FR +++
Sbjct: 581 PGKRLGCGPEGERDIKEHAFFRYIDW 606
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 61/227 (26%), Positives = 92/227 (40%), Gaps = 47/227 (20%)
Query: 5 EKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+K+ +GEG +G V N T E +A+K ++ S +EI +L+ + H
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRTLYH 92
Query: 61 GNIVRLQDVVHSEKK--LYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILR 113
+I++ + L LV EY+ L L +H + F QI
Sbjct: 93 EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ-------LLLFAQQICE 145
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
G+AY H+ +HRDL +N+L+D +K+ DFGLA+A +
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDND-RLVKIGDFGLAKA-------------------VP 185
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
YRV F WY APE L + + DVWS G
Sbjct: 186 EGHEYYRVREDGDSPVF------WY-APECLKEYK-FYYASDVWSFG 224
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 75/329 (22%), Positives = 134/329 (40%), Gaps = 88/329 (26%)
Query: 10 IGEGTYGVVYKARNCVTNETIA---LKKIRLEQEDEGVPSTAI-REISLLKEMQHGNIVR 65
+G+G++G V + T+E A LKK + Q+D+ V T + + + L + + +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD-VECTMVEKRV-LALPGKPPFLTQ 85
Query: 66 LQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLY--QILRGIAYCHSHR 122
L + +LY V EY++ DL H+ F Y +I G+ + S
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAAEIAIGLFFLQSKG 141
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTF--THEHWGSTGISIYFSFL 177
+++RDLK N+++D + +K+ADFG+ + G+ +TF T +
Sbjct: 142 IIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPD-------------- 186
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
Y APEI+ + Y VD W+ G + EM+ + F G+
Sbjct: 187 --------------------YIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
E DELF+ S+ + A+PK SKE + + ++
Sbjct: 226 E-DELFQ-----------------SIMEHNVAYPKSMSKE-----------AVAICKGLM 256
Query: 298 CMDPSRRI--TARSALE---HEYFRDVEF 321
P +R+ + H +FR +++
Sbjct: 257 TKHPGKRLGCGPEGERDIKEHAFFRYIDW 285
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 73/330 (22%), Positives = 131/330 (39%), Gaps = 89/330 (26%)
Query: 10 IGEGTYGVVYKARNCVTNETIA---LKKIRLEQEDEGVPSTAI-REISLLKEMQHGNIVR 65
+G+G++G V AR T + A LKK + Q+D+ V T + I L H + +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD-VECTMTEKRI-LSLARNHPFLTQ 88
Query: 66 LQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLY--QILRGIAYCHSHR 122
L + +L+ V E+++ DL H+ F + Y +I+ + + H
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA----RARFYAAEIISALMFLHDKG 144
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTF--THEHWGSTGISIYFSFL 177
+++RDLK N+L+D + KLADFG+ + G+ TF T +
Sbjct: 145 IIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPD-------------- 189
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
Y APEIL Y VD W++G + EM+ F ++
Sbjct: 190 --------------------YIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAEN 228
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
E D+LF+ +L +P W ++ +L +
Sbjct: 229 E-DDLFE--AILNDEVV---------------YPTWLHED-----------ATGILKSFM 259
Query: 298 CMDPSRRITARSA------LEHEYFRDVEF 321
+P+ R+ + + L H +F+++++
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 72/335 (21%), Positives = 140/335 (41%), Gaps = 71/335 (21%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETI------ALKKIRLEQEDEGVPSTAIREISL 54
++ +E ++ +G G YG V+ R ++T LKK + Q+ + T E +
Sbjct: 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-RTERQV 111
Query: 55 LKEMQHGN-IVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQIL 112
L+ ++ +V L +E KL+L+ +Y++ +L H+ F ++ ++ +I+
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH--EVQIYVGEIV 169
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
+ + H +++RD+K +N+L+D + + L DFGL++ F +
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAY---------- 218
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH-YSTPVDVWSVGCIFAEMVNQRP 231
F G T+ Y AP+I+ G + VD WS+G + E++
Sbjct: 219 --DFC------G----------TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
Query: 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291
F D E + +I R + L + +P+ S D
Sbjct: 261 PFTVDGEKNSQAEISRRI-------------LKS-EPPYPQEMSAL-----------AKD 295
Query: 292 LLSKMLCMDPSRRI--TARSALE---HEYFRDVEF 321
L+ ++L DP +R+ R A E H +F+ + +
Sbjct: 296 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 4e-24
Identities = 82/327 (25%), Positives = 137/327 (41%), Gaps = 81/327 (24%)
Query: 10 IGEGTYGVVYKARNCVTNETI------ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
+G+G YG V++ R T LKK + + + T E ++L+E++H I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFI 83
Query: 64 VRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLY--QILRGIAYCHS 120
V L + KLYL+ EYL +L ++ F D Y +I + + H
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED----TACFYLAEISMALGHLHQ 139
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
+++RDLKP+N++++ + + +KL DFGL + I T TH +F
Sbjct: 140 KGIIYRDLKPENIMLNHQGH-VKLTDFGLCKE-SIHDGTVTH------------TFC--- 182
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
G T+ Y APEIL+ S ++ VD WS+G + +M+ P F G++
Sbjct: 183 ---G----------TIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENR-K 227
Query: 241 ELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
+ KI + K P + ++E DLL K+L
Sbjct: 228 KTIDKILKC------------------KLNLPPYLTQE-----------ARDLLKKLLKR 258
Query: 300 DPSRRI--TARSALE---HEYFRDVEF 321
+ + R+ A E H +FR + +
Sbjct: 259 NAASRLGAGPGDAGEVQAHPFFRHINW 285
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 81/338 (23%), Positives = 137/338 (40%), Gaps = 88/338 (26%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKE 57
M+++E ++ +G+GT+G V + T A LKK + +DE V T + E +L+
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE-VAHT-LTENRVLQN 204
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLY--QILRG 114
+H + L+ + +L V EY + +L H+ F+ D + Y +I+
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARFYGAEIVSA 260
Query: 115 IAYCHSHR-VLHRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTF--THEHWGST 168
+ Y HS + V++RDLK +NL++D+ + +K+ DFGL + G ++TF T E
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPE----- 314
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228
Y APE+L Y VD W +G + EM+
Sbjct: 315 -----------------------------YLAPEVLED-NDYGRAVDWWGLGVVMYEMMC 344
Query: 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPA 288
R F ++LF+ + + FP+ E
Sbjct: 345 GRLPFYNQDH-EKLFE-----------------LILMEEIRFPRTLGPE----------- 375
Query: 289 GIDLLSKMLCMDPSRRITA--RSALE---HEYFRDVEF 321
LLS +L DP +R+ A E H +F + +
Sbjct: 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-24
Identities = 75/332 (22%), Positives = 125/332 (37%), Gaps = 89/332 (26%)
Query: 6 KVEKIGEGTYGVVYKARNCVTNETIA---LKKIRLEQEDEGVPSTAI-REISLLKEMQHG 61
KV IG+G++G V AR+ A L+K + ++ E R + LLK ++H
Sbjct: 44 KV--IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE-EKHIMSERNV-LLKNVKHP 99
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLY--QILRGIAYC 118
+V L + KLY V +Y++ +L H+ F + Y +I + Y
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----RARFYAAEIASALGYL 155
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTF--THEHWGSTGISIY 173
HS +++RDLKP+N+L+D + + + L DFGL + TF T E
Sbjct: 156 HSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPE---------- 204
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
Y APE+L + Y VD W +G + EM+ P F
Sbjct: 205 ------------------------YLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPF 239
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
+ E++ +L P + + LL
Sbjct: 240 YSRNT-AEMYD--NILNKPLQ---------------LKPNITNS-----------ARHLL 270
Query: 294 SKMLCMDPSRRITARSALE----HEYFRDVEF 321
+L D ++R+ A+ H +F + +
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-23
Identities = 78/333 (23%), Positives = 134/333 (40%), Gaps = 77/333 (23%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETI------ALKKIRLEQEDEGVPSTAIREISL 54
Q+E ++ +G+G++G V+ + ++ LKK L+ D V + R+I
Sbjct: 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR-VRTKMERDI-- 79
Query: 55 LKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILR 113
L E+ H IV+L +E KLYL+ ++L DL + F +K +L ++
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--TEEDVKFYLAELAL 137
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
+ + HS +++RDLKP+N+L+D + +KL DFGL++ I +
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKE-SIDHEKKAY----------- 184
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
SF G T+ Y APE++ R ++ D WS G + EM+ F
Sbjct: 185 -SFC------G----------TVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
G E +L K P++ S E LL
Sbjct: 227 QGKDR-KETMT--MILKA---------------KLGMPQFLSPE-----------AQSLL 257
Query: 294 SKMLCMDPSRRI--TARSALE---HEYFRDVEF 321
+ +P+ R+ E H +F +++
Sbjct: 258 RMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-23
Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 43/232 (18%)
Query: 5 EKVEKIGEGTYGVVYKAR-NCVTNETI--ALKKIRLEQEDEGVPSTA-IREISLLKEMQH 60
+EK+G+G++GVV + + + +T+ A+K ++ + + IRE++ + + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 61 GNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGI 115
N++RL VV + +V E L L+KH L + + Q+ G+
Sbjct: 81 RNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLL----GTLSR-YAVQVAEGM 134
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y S R +HRDL +NLL+ R + +K+ DFGL RA + +
Sbjct: 135 GYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRA-------------------LPQN 174
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
Y + KV W APE L +R +S D W G EM
Sbjct: 175 DDHYVMQEHR------KVPFAWC-APESLK-TRTFSHASDTWMFGVTLWEMF 218
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 48/240 (20%), Positives = 93/240 (38%), Gaps = 69/240 (28%)
Query: 2 DQYEKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKE 57
+++K++ +G G +G VYK +A+K++R E + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMAS 73
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQIL 112
+ + ++ RL + + L+ + + L +++H D+ + + + QI
Sbjct: 74 VDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIG-----SQYLLNWCVQIA 127
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG------------IPVRTF 160
+G+ Y R++HRDL +N+L+ +K+ DFGLA+ G +P++
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-- 184
Query: 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
W A E +L R Y+ DVWS G
Sbjct: 185 ------------------------------------WM-ALESIL-HRIYTHQSDVWSYG 206
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 32/215 (14%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
E+IG G +G V+ R N +A+K R E + + ++E +LK+ H NIVRL
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
V ++ +Y+V E + D + + L++ + G+ Y S +H
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQ-MVGDAAAGMEYLESKCCIH 236
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGS 185
RDL +N L+ + N LK++DFG++R + G + +
Sbjct: 237 RDLAARNCLVTEK-NVLKISDFGMSRE--EADGVYAASG-GLRQVPV------------- 279
Query: 186 LILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
K W APE L YS+ DVWS G
Sbjct: 280 ------K----WT-APEALN-YGRYSSESDVWSFG 302
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-22
Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 49/238 (20%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIV 64
K+G G YG VY+ + T+A+K ++ E ++E +++KE++H N+V
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 65 RLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
+L V E Y++ E++ +L L++ L+ QI + Y
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA---VVLLY-MATQISSAMEYLE 128
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
+HRDL +N L+ + +K+ADFGL+R + Y
Sbjct: 129 KKNFIHRDLAARNCLVGEN-HLVKVADFGLSR---------------------LMTGDTY 166
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QRPLFPG 235
AG+ +K W APE L +S DVW+ G + E+ P +PG
Sbjct: 167 TAHAGAKFP--IK----WT-APESLA-YNKFSIKSDVWAFGVLLWEIATYGMSP-YPG 215
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 58/243 (23%), Positives = 95/243 (39%), Gaps = 53/243 (21%)
Query: 7 VEKIGEGTYGVVYKAR-NCVTNETI--ALKKIRLEQEDEGVPSTA----IREISLLKEMQ 59
+ IG G G V R + A+K ++ G + E S++ +
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-----AGYTERQRRDFLSEASIMGQFD 108
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRG 114
H NI+RL+ VV + +V EY+ LD L+ H +L+ L + G
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT----IMQLVG-MLRGVGAG 163
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+ Y +HRDL +N+L+D K++DFGL+R +
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSN-LVCKVSDFGLSRV-------------------LED 203
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QRPL 232
G I ++ W APE + R +S+ DVWS G + E++ +RP
Sbjct: 204 DPDAAYTTTGGKIP--IR----WT-APEAIA-FRTFSSASDVWSFGVVMWEVLAYGERP- 254
Query: 233 FPG 235
+
Sbjct: 255 YWN 257
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-22
Identities = 32/233 (13%), Positives = 76/233 (32%), Gaps = 59/233 (25%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIR-----LEQEDEGVPSTAIREISLLKEMQHG 61
E +G+GT+ ++K + L + L++ + S++ ++ H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
++V V + LV E++ L ++ + N ++ Q+ + +
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE-VAKQLAAAMHFLEE 131
Query: 121 HRVLHRDLKPQNLLIDRRTNAL-------KLADFGLARAFG------IPVRTFTHEHWGS 167
+ ++H ++ +N+L+ R + KL+D G++ +
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP--------- 182
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
W PE + ++ + D WS G
Sbjct: 183 -----------------------------WV-PPECIENPKNLNLATDKWSFG 205
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-22
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 42/226 (18%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
K+G G YG VY+ + T+A+K ++ ED ++E +++KE++H N+V+L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 67 QDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
V E Y++ E++ +L L++ L+ QI + Y
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA---VVLLY-MATQISSAMEYLEKK 337
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+HR+L +N L+ + +K+ADFGL+R Y
Sbjct: 338 NFIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT---------------------YTA 375
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
AG+ K W APE L +S DVW+ G + E+
Sbjct: 376 HAGA------KFPIKWT-APESLA-YNKFSIKSDVWAFGVLLWEIA 413
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-22
Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 34/215 (15%)
Query: 9 KIGEGTYGVVYKARNCVTNETI--ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
++G G +G V K + A+K ++ E D + + E ++++++ + IVR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
+ + LV E +L L K++ D +I+ ++Q+ G+ Y +H
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIE-LVHQVSMGMKYLEESNFVH 140
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGS 185
RDL +N+L+ + + K++DFGL++A + Y+
Sbjct: 141 RDLAARNVLLVTQ-HYAKISDFGLSKA-------------------LRADENYYKAQTHG 180
Query: 186 LILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
+K WY APE + +S+ DVWS G
Sbjct: 181 KWP--VK----WY-APECIN-YYKFSSKSDVWSFG 207
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-22
Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 45/236 (19%)
Query: 9 KIGEGTYGVVYKARNCVTNETI--ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
++G G +G V + + + I A+K ++ + ++ +RE ++ ++ + IVRL
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 67 QDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
V + L LV E L L + P + + L+Q+ G+ Y
Sbjct: 76 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIP----VSNVAE-LLHQVSMGMKYLEEK 129
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+HRDL +N+L+ R + K++DFGL++A + Y
Sbjct: 130 NFVHRDLAARNVLLVNR-HYAKISDFGLSKA-------------------LGADDSYYTA 169
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QRPLFPG 235
+ K WY APE + R +S+ DVWS G E ++ Q+P +
Sbjct: 170 RSAG------KWPLKWY-APECIN-FRKFSSRSDVWSYGVTMWEALSYGQKP-YKK 216
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 38/185 (20%), Positives = 72/185 (38%), Gaps = 34/185 (18%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Q+ +KIG G +G++Y A E A +++E ++ G E+ + + +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG---PLFSELKFYQRVAKKD 94
Query: 63 IVRLQDVVHSEKKL-------------------YLVFEYLDLDLKKHMDSCPDFANDPRL 103
++ L ++V E L +DL+K F
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFK----- 149
Query: 104 IKTFL---YQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGIPVRT 159
T L ++L + Y H + +H D+K NLL+ + + + LAD+GL+ +
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG-- 207
Query: 160 FTHEH 164
H+
Sbjct: 208 -NHKQ 211
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 66/228 (28%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA-IREISLLKEMQHGNIVR 65
++ IG+G +G V +A+K I+ + A + E S++ +++H N+V+
Sbjct: 26 LQTIGKGEFGDVMLGD--YRGNKVAVKCIK-----NDATAQAFLAEASVMTQLRHSNLVQ 78
Query: 66 LQDVV-HSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
L V+ + LY+V EY+ L L+ S L+K F + + Y
Sbjct: 79 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG---DCLLK-FSLDVCEAMEYLE 134
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-----AFG--IPVRTFTHEHWGSTGISI 172
+ +HRDL +N+L+ N K++DFGL + +PV+
Sbjct: 135 GNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQDTGKLPVK-------------- 179
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
W APE L + +ST DVWS G
Sbjct: 180 ------------------------WT-APEALR-EKKFSTKSDVWSFG 201
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 47/225 (20%), Positives = 88/225 (39%), Gaps = 45/225 (20%)
Query: 5 EKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
K++ +G G +G V+K + +K I ++ + + + H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-DKSGRQSFQAVTDHMLAIGSLDH 74
Query: 61 GNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGI 115
+IVRL + L LV +YL L +++H + P+L+ + QI +G+
Sbjct: 75 AHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALG-----PQLLLNWGVQIAKGM 128
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y H ++HR+L +N+L+ + +++ADFG+A +
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSP-SQVQVADFGVADLLP------PDDK----------- 170
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
+ + + K W A E + Y+ DVWS G
Sbjct: 171 ---QLLYSEA------KTPIKWM-ALESIH-FGKYTHQSDVWSYG 204
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 51/228 (22%), Positives = 88/228 (38%), Gaps = 62/228 (27%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIV 64
V++IG G +G+V+ + + +A+K IR EG S I E ++ ++ H +V
Sbjct: 13 VQEIGSGQFGLVHLGY-WLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 65 RLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
+L V + + LV E+++ L ++ + L+ + G+AY V
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG-MCLDVCEGMAYLEEACV 125
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFG-----------IPVRTFTHEHWGSTGISI 172
+HRDL +N L+ +K++DFG+ R PV+
Sbjct: 126 IHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-------------- 170
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
W +PE+ YS+ DVWS G
Sbjct: 171 ------------------------WA-SPEVFS-FSRYSSKSDVWSFG 192
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-21
Identities = 69/330 (20%), Positives = 114/330 (34%), Gaps = 80/330 (24%)
Query: 10 IGEGTYGVVYKARNCVTNETIA---LKKIRLEQEDEGVPSTAI-REISLLKEMQHGNIVR 65
IG G+Y V R T+ A +KK + +++ + + + + H +V
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED-IDWVQTEKHV-FEQASNHPFLVG 74
Query: 66 LQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLY--QILRGIAYCHSHR 122
L +E +L+ V EY++ DL HM + Y +I + Y H
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE----HARFYSAEISLALNYLHERG 130
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTF--THEHWGSTGISIYFSFL 177
+++RDLK N+L+D + +KL D+G+ + G TF T
Sbjct: 131 IIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPN-------------- 175
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
Y APEIL G Y VD W++G + EM+ R F
Sbjct: 176 --------------------YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
D + + + P+ S + +L L
Sbjct: 215 SSDNPD---------QNTEDYLFQVILEKQIRIPRSLSVK-----------AASVLKSFL 254
Query: 298 CMDPSRRITARSA------LEHEYFRDVEF 321
DP R+ H +FR+V++
Sbjct: 255 NKDPKERLGCHPQTGFADIQGHPFFRNVDW 284
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 53/243 (21%)
Query: 7 VEKIGEGTYGVVYKAR-NCVTNETI--ALKKIRLEQEDEGVPSTA----IREISLLKEMQ 59
+ +G G +G V R + + I A+K ++ G + E S++ +
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-----VGYTEKQRRDFLGEASIMGQFD 104
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRG 114
H NI+RL+ VV K + +V EY+ LD L+KH +L+ L I G
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT----VIQLVG-MLRGIASG 159
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
+ Y +HRDL +N+LI+ K++DFGL R +
Sbjct: 160 MKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLGRV-------------------LED 199
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QRPL 232
G K+ W +PE + R +++ DVWS G + E+++ +RP
Sbjct: 200 DPEAAYTTRGG------KIPIRWT-SPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERP- 250
Query: 233 FPG 235
+
Sbjct: 251 YWE 253
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 69/330 (20%), Positives = 114/330 (34%), Gaps = 80/330 (24%)
Query: 10 IGEGTYGVVYKARNCVTNETIA---LKKIRLEQEDEGVPSTAI-REISLLKEMQHGNIVR 65
IG G+Y V R T+ A +KK + +++ + + + + H +V
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED-IDWVQTEKHV-FEQASNHPFLVG 117
Query: 66 LQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLY--QILRGIAYCHSHR 122
L +E +L+ V EY++ DL HM + Y +I + Y H
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE----HARFYSAEISLALNYLHERG 173
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLAR---AFGIPVRTF--THEHWGSTGISIYFSFL 177
+++RDLK N+L+D + +KL D+G+ + G TF T
Sbjct: 174 IIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPN-------------- 218
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
Y APEIL G Y VD W++G + EM+ R F
Sbjct: 219 --------------------YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVG 257
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
D + + + P+ S + +L L
Sbjct: 258 SSDNPD---------QNTEDYLFQVILEKQIRIPRSLSVK-----------AASVLKSFL 297
Query: 298 CMDPSRRITARSA------LEHEYFRDVEF 321
DP R+ H +FR+V++
Sbjct: 298 NKDPKERLGCHPQTGFADIQGHPFFRNVDW 327
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 44/226 (19%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
K+G+G +G V+ +A+K ++ P ++E ++K+++H +V+L
Sbjct: 272 EVKLGQGCFGEVWMGT-WNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQL 327
Query: 67 QDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
VV SE+ +Y+V EY+ L LK + P+L+ QI G+AY
Sbjct: 328 YAVV-SEEPIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVD-MAAQIASGMAYVERM 382
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+HRDL+ N+L+ K+ADFGLAR T
Sbjct: 383 NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGA----------------- 424
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
K W APE L ++ DVWS G + E+
Sbjct: 425 ----------KFPIKWT-APEAAL-YGRFTIKSDVWSFGILLTELT 458
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 4e-21
Identities = 55/245 (22%), Positives = 98/245 (40%), Gaps = 65/245 (26%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIV 64
++++G G +GVV + +A+K I+ EG S +E + ++ H +V
Sbjct: 13 LKELGSGQFGVVKLGK-WKGQYDVAVKMIK-----EGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 65 RLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
+ V E +Y+V EY+ L ++ S +L++ Y + G+A+ SH+
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE-MCYDVCEGMAFLESHQF 125
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFG-----------IPVRTFTHEHWGSTGISI 172
+HRDL +N L+DR +K++DFG+ R PV+
Sbjct: 126 IHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYVSSVGTKFPVK-------------- 170
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QR 230
W APE+ YS+ DVW+ G + E+ + +
Sbjct: 171 ------------------------WS-APEVFH-YFKYSSKSDVWAFGILMWEVFSLGKM 204
Query: 231 PLFPG 235
P +
Sbjct: 205 P-YDL 208
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 5e-21
Identities = 54/232 (23%), Positives = 96/232 (41%), Gaps = 37/232 (15%)
Query: 9 KIGEGTYGVVYKARNCVTNETI--ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
++G G +G V + + + I A+K ++ E +RE ++ ++ + IVRL
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRL 401
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
V + L LV E L K + + + + L+Q+ G+ Y +H
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLHQVSMGMKYLEEKNFVH 459
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGS 185
R+L +N+L+ R + K++DFGL++A + Y +
Sbjct: 460 RNLAARNVLLVNR-HYAKISDFGLSKA-------------------LGADDSYYTARSAG 499
Query: 186 LILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QRPLFPG 235
K WY APE + R +S+ DVWS G E ++ Q+P +
Sbjct: 500 ------KWPLKWY-APECIN-FRKFSSRSDVWSYGVTMWEALSYGQKP-YKK 542
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-21
Identities = 36/148 (24%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIV 64
++++G G +GVV + +A+K I+ EG S I E ++ + H +V
Sbjct: 29 LKELGTGQFGVVKYGK-WRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 65 RLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
+L V ++ ++++ EY+ L ++ +L++ + + Y S +
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-MCKDVCEAMEYLESKQF 141
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLAR 151
LHRDL +N L++ + +K++DFGL+R
Sbjct: 142 LHRDLAARNCLVNDQ-GVVKVSDFGLSR 168
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 9e-21
Identities = 23/151 (15%), Positives = 48/151 (31%), Gaps = 7/151 (4%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGN 62
Y + G ++A + + +AL + + + V + L +
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 63 IVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
+ R+ DVVH+ +V E++ L++ D+ P P + + H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPS----PVGAIRAMQSLAAAADAAHRA 148
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARA 152
V P + + + LA
Sbjct: 149 GVALSIDHPSRVRVS-IDGDVVLAYPATMPD 178
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 48/241 (19%), Positives = 89/241 (36%), Gaps = 66/241 (27%)
Query: 2 DQYE-------KVEKIGEGTYGVVYKAR-NCVTNETI--ALKKIRLEQEDEGVPSTAIRE 51
QY +GEG +G VY+ E I A+K + + + E
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSE 63
Query: 52 ISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQ 110
++K + H +IV+L ++ E+ +++ E +L +++ + L+ + Q
Sbjct: 64 AVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL-YSLQ 121
Query: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG-----------IPVRT 159
I + +AY S +HRD+ +N+L+ +KL DFGL+R +P++
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIK- 179
Query: 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSV 219
W +PE + R ++T DVW
Sbjct: 180 -------------------------------------WM-SPESIN-FRRFTTASDVWMF 200
Query: 220 G 220
Sbjct: 201 A 201
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 48/240 (20%), Positives = 93/240 (38%), Gaps = 69/240 (28%)
Query: 2 DQYEKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKE 57
+++K++ +G G +G VYK +A+K++R E + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMAS 73
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQIL 112
+ + ++ RL + + L+ + + L +++H D+ + + + QI
Sbjct: 74 VDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIG-----SQYLLNWCVQIA 127
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG------------IPVRTF 160
+G+ Y R++HRDL +N+L+ +K+ DFGLA+ G +P++
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-- 184
Query: 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
W A E +L R Y+ DVWS G
Sbjct: 185 ------------------------------------WM-ALESIL-HRIYTHQSDVWSYG 206
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 44/231 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ K+G+G +G V+ +A+K ++ P ++E ++K+++H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 239
Query: 62 NIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
+V+L VV SE+ +Y+V EY+ L LK + P+L+ QI G+A
Sbjct: 240 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVD-MAAQIASGMA 294
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
Y +HRDL+ N+L+ K+ADFGLAR T
Sbjct: 295 YVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGA------------ 341
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
K W APE L ++ DVWS G + E+
Sbjct: 342 ---------------KFPIKWT-APEAAL-YGRFTIKSDVWSFGILLTELT 375
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-20
Identities = 53/250 (21%), Positives = 98/250 (39%), Gaps = 70/250 (28%)
Query: 7 VEKIGEGTYGVVYKAR-NCVTNETI--ALKKIRLEQEDEGVPSTA----IREISLLKEMQ 59
IGEG +G V++ N + A+K + + ++E +++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-----NCTSDSVREKFLQEALTMRQFD 74
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
H +IV+L V+ +E ++++ E L +L+ + + LI + YQ+ +AY
Sbjct: 75 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALAYL 132
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG-----------IPVRTFTHEHWGS 167
S R +HRD+ +N+L+ + +KL DFGL+R +P++
Sbjct: 133 ESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIK--------- 182
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
W APE + R +++ DVW G E++
Sbjct: 183 -----------------------------WM-APESIN-FRRFTSASDVWMFGVCMWEIL 211
Query: 228 N--QRPLFPG 235
+P F G
Sbjct: 212 MHGVKP-FQG 220
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-20
Identities = 53/185 (28%), Positives = 81/185 (43%), Gaps = 21/185 (11%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++Y KIG G++G +Y + E +A+K E P E + K MQ G
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQ-LHIESKIYKMMQGG 64
Query: 62 -NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCP-DFANDPRLIKTFL---YQILRGIA 116
I ++ +V E L L+ + C F+ +KT L Q++ I
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFS-----LKTVLLLADQMISRIE 119
Query: 117 YCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIPVRTFTH----EHWGSTGI 170
Y HS +HRD+KP N L+ + N + + DFGLA+ + RT H E+ TG
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY-RDARTHQHIPYRENKNLTGT 178
Query: 171 SIYFS 175
+ Y S
Sbjct: 179 ARYAS 183
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-20
Identities = 45/150 (30%), Positives = 78/150 (52%), Gaps = 15/150 (10%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
VE++G G +G V+ + +A+K ++ + P + E +L+K++QH +VRL
Sbjct: 18 VERLGAGQFGEVWMGY-YNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 67 QDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
VV +++ +Y++ EY+ L LK +L+ QI G+A+
Sbjct: 74 YAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLD-MAAQIAEGMAFIEER 128
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
+HRDL+ N+L+ T + K+ADFGLAR
Sbjct: 129 NYIHRDLRAANILVS-DTLSCKIADFGLAR 157
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 52/228 (22%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA-IREISLLKEMQHGNIVR 65
++ IG+G +G V +A+K I+ + A + E S++ +++H N+V+
Sbjct: 198 LQTIGKGEFGDVMLGD--YRGNKVAVKCIK-----NDATAQAFLAEASVMTQLRHSNLVQ 250
Query: 66 LQDVV-HSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
L V+ + LY+V EY+ L L+ S L+K F + + Y
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG---DCLLK-FSLDVCEAMEYLE 306
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
+ +HRDL +N+L+ N K++DFGL +
Sbjct: 307 GNNFVHRDLAARNVLVSED-NVAKVSDFGLTK----------EASSTQDTG--------- 346
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
K+ W APE L + +ST DVWS G + E+
Sbjct: 347 ------------KLPVKWT-APEALR-EKKFSTKSDVWSFGILLWEIY 380
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 55/244 (22%), Positives = 99/244 (40%), Gaps = 54/244 (22%)
Query: 7 VEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTA----IREISLLKEM 58
+ IG G +G VYK + +A+K ++ G + E ++ +
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-----AGYTEKQRVDFLGEAGIMGQF 103
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILR 113
H NI+RL+ V+ K + ++ EY+ LD L++ +L+ L I
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS----VLQLVG-MLRGIAA 158
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
G+ Y + +HRDL +N+L++ K++DFGL+R +
Sbjct: 159 GMKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRV-------------------LE 198
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QRP 231
+G K+ W APE + R +++ DVWS G + E++ +RP
Sbjct: 199 DDPEATYTTSGG------KIPIRWT-APEAIS-YRKFTSASDVWSFGIVMWEVMTYGERP 250
Query: 232 LFPG 235
+
Sbjct: 251 -YWE 253
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-20
Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 16/159 (10%)
Query: 7 VEKIGEGTYGVVYK--ARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++G+G++G+VY+ A+ V +E +A+K + E + E S++KE
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCH 88
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSC-PDFANDPRLIK-------TFLYQIL 112
++VRL VV + ++ E + DLK ++ S P AN+P L +I
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
G+AY ++++ +HRDL +N ++ +K+ DFG+ R
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMTR 186
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 56/239 (23%), Positives = 101/239 (42%), Gaps = 48/239 (20%)
Query: 7 VEKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTA----IREISLLKEMQ 59
IGEG +G V++ +A+K + + ++E +++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-----NCTSDSVREKFLQEALTMRQFD 449
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
H +IV+L V+ +E ++++ E L +L+ + + LI + YQ+ +AY
Sbjct: 450 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-YAYQLSTALAYL 507
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
S R +HRD+ +N+L+ + +KL DFGL+R + S Y
Sbjct: 508 ESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYM--------ED-------STY----- 546
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN--QRPLFPG 235
Y+ G K+ W APE + R +++ DVW G E++ +P F G
Sbjct: 547 YKASKG-------KLPIKWM-APESIN-FRRFTSASDVWMFGVCMWEILMHGVKP-FQG 595
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 19/184 (10%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+++ KIG G++G +Y N TNE +A+K ++ + + E + + +Q G
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGG 62
Query: 62 -NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFL---YQILRGIAY 117
I ++ LV + L L+ + C + +KT L Q++ + +
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLS----LKTVLMLADQMINRVEF 118
Query: 118 CHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIPVRTFTH----EHWGSTGIS 171
HS LHRD+KP N L+ R N + + DFGLA+ + T H E+ TG +
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGTA 177
Query: 172 IYFS 175
Y S
Sbjct: 178 RYAS 181
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-20
Identities = 56/237 (23%), Positives = 96/237 (40%), Gaps = 66/237 (27%)
Query: 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
+K+G G +G V+ A + +A+K ++ + E +++K +QH +V+L
Sbjct: 193 EKKLGAGQFGEVWMAT-YNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKL 248
Query: 67 QDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
VV +++ +Y++ E++ L LK S P+LI F QI G+A+
Sbjct: 249 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL---PKLID-FSAQIAEGMAFIEQR 303
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG-----------IPVRTFTHEHWGSTGI 170
+HRDL+ N+L+ + K+ADFGLAR P++
Sbjct: 304 NYIHRDLRAANILVS-ASLVCKIADFGLARVIEDNEYTAREGAKFPIK------------ 350
Query: 171 SIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
W APE + ++ DVWS G + E+V
Sbjct: 351 --------------------------WT-APEAIN-FGSFTIKSDVWSFGILLMEIV 379
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-20
Identities = 54/186 (29%), Positives = 82/186 (44%), Gaps = 23/186 (12%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG- 61
+ +KIG G +G + +N TNE +A+K LE P E K++ G
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQ-LHLEYRFYKQLGSGD 65
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCP-DFANDPRLIKTFL---YQILRGIAY 117
I ++ K +V E L L+ D C F+ +KT L Q++ + Y
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFS-----LKTVLMIAIQLISRMEY 120
Query: 118 CHSHRVLHRDLKPQNLLIDR----RTNALKLADFGLARAFGIPVRTFTH----EHWGSTG 169
HS +++RD+KP+N LI R + + DF LA+ + I T H EH TG
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY-IDPETKKHIPYREHKSLTG 179
Query: 170 ISIYFS 175
+ Y S
Sbjct: 180 TARYMS 185
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 45/187 (24%), Positives = 77/187 (41%), Gaps = 23/187 (12%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Y+ +IGEG++GV+++ N + N+ +A+K E P E K +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQ-LRDEYRTYKLLAGC 65
Query: 62 -NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCP-DFANDPRLIKTFL---YQILRGIA 116
I + LV + L L+ +D C F+ +KT Q+L +
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS-----VKTVAMAAKQMLARVQ 120
Query: 117 YCHSHRVLHRDLKPQNLLI----DRRTNALKLADFGLARAFGIPVRTFTH----EHWGST 168
H +++RD+KP N LI + N + + DFG+ + + T H E +
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPYREKKNLS 179
Query: 169 GISIYFS 175
G + Y S
Sbjct: 180 GTARYMS 186
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 34/158 (21%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 7 VEKIGEGTYGVVYKA--RNCVTNET-IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
+ +GEG +G V + + +A+K ++L+ + + E + +K+ H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 64 VRLQDVV-----HSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILR 113
+RL V K ++ ++ DL L + + F+ I
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
G+ Y + LHRDL +N ++ + +ADFGL++
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSK 195
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 25/168 (14%)
Query: 7 VEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QH 60
+ +G G +G V +A T+A+K ++ + E+ +L + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSYLGNH 86
Query: 61 GNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIK---------- 105
NIV L ++ EY DL L++ DS P +++
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 106 --TFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
+F YQ+ +G+A+ S +HRDL +N+L+ K+ DFGLAR
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG-RITKICDFGLAR 193
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-19
Identities = 42/168 (25%), Positives = 68/168 (40%), Gaps = 29/168 (17%)
Query: 7 VEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTA---IREISLLKEM 58
++GEG +G V+ A +A+K ++ + + RE LL +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-----DPTLAARKDFQREAELLTNL 74
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKT------- 106
QH +IV+ V L +VFEY+ DL+ L+ H +
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 107 ---FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
QI G+ Y S +HRDL +N L+ +K+ DFG++R
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN-LLVKIGDFGMSR 181
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-19
Identities = 44/167 (26%), Positives = 72/167 (43%), Gaps = 28/167 (16%)
Query: 7 VEKIGEGTYGVVYK--ARNCVTNE---TIALKKIRLEQEDEGVPSTA---IREISLLKEM 58
++GEG +G V+ N + + +A+K ++ E S RE LL +
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-----EASESARQDFQREAELLTML 100
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKT------- 106
QH +IVR V + L +VFEY+ DL+ L+ H A +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 107 --FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
Q+ G+ Y +HRDL +N L+ + +K+ DFG++R
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSR 206
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-19
Identities = 42/169 (24%), Positives = 70/169 (41%), Gaps = 30/169 (17%)
Query: 7 VEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTA----IREISLLKE 57
+E++GE +G VYK + +A+K ++ + E L
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-----DKAEGPLREEFRHEAMLRAR 68
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKT------ 106
+QH N+V L VV ++ L ++F Y DL L + D
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 107 ----FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
+ QI G+ Y SH V+H+DL +N+L+ + +K++D GL R
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK-LNVKISDLGLFR 176
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-19
Identities = 34/159 (21%), Positives = 67/159 (42%), Gaps = 15/159 (9%)
Query: 7 VEKIGEGTYGVVYKAR---NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
+G+G +G V +A+ + +A+K ++ + +RE + +KE H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 64 VRLQDVV------HSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRL----IKTFLYQIL 112
+L V ++ ++ DL + + N L + F+ I
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
G+ Y S +HRDL +N ++ + +ADFGL+R
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLA-EDMTVCVADFGLSR 185
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-19
Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 28/167 (16%)
Query: 7 VEKIGEGTYGVVYKAR--NCVTNETIALKKIRLEQEDEGVPSTA----IREISLLKEM-Q 59
+ IGEG +G V KAR A+K+++ E E+ +L ++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDHRDFAGELEVLCKLGH 84
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKH--MDSCPDFANDPRLIKT------ 106
H NI+ L LYL EY +L L+K +++ P FA T
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 107 --FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
F + RG+ Y + +HRDL +N+L+ K+ADFGL+R
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSR 190
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 36/162 (22%), Positives = 64/162 (39%), Gaps = 22/162 (13%)
Query: 7 VEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTA----IREISLLKE 57
+ +G G +G VY+ + N + +A+K + E + E ++ +
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-----EVCSEQDELDFLMEALIISK 89
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHM-DSCPDFANDPRLIKT----FLYQI 111
H NIVR V +++ E + DLK + ++ P + L I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLAR 151
G Y + +HRD+ +N L+ K+ DFG+AR
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 63/231 (27%), Positives = 95/231 (41%), Gaps = 52/231 (22%)
Query: 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHGNIVRL 66
K+GEG +GVVYK V N T+A+KK+ + +EI ++ + QH N+V L
Sbjct: 38 KMGEGGFGVVYKG--YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 67 QDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFL-----YQIL----RGIA 116
L LV+ Y+ L + D L +I GI
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRL-----SCLDGTPP---LSWHMRCKIAQGAANGIN 147
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
+ H + +HRD+K N+L+D A K++DFGLARA T ++
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTA-KISDFGLARAS--EKFAQTVM---TS-------- 193
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
R+ G T Y APE L G + D++S G + E++
Sbjct: 194 ---RI-VG----------TTAYMAPEALRG--EITPKSDIYSFGVVLLEII 228
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 8/150 (5%)
Query: 7 VEKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
E IG G +G VY + A+K + D G S + E ++K+ H N+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 64 VRLQDVV-HSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
+ L + SE +V Y+ DL+ + + LI F Q+ +G+ Y S
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQVAKGMKYLASK 147
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
+ +HRDL +N ++D +K+ADFGLAR
Sbjct: 148 KFVHRDLAARNCMLD-EKFTVKVADFGLAR 176
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 36/162 (22%), Positives = 64/162 (39%), Gaps = 22/162 (13%)
Query: 7 VEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTA----IREISLLKE 57
+ +G G +G VY+ + N + +A+K + E + E ++ +
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-----EVCSEQDELDFLMEALIISK 130
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHM-DSCPDFANDPRLIKT----FLYQI 111
H NIVR V +++ E + DLK + ++ P + L I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLAR 151
G Y + +HRD+ +N L+ K+ DFG+AR
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-18
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 8/149 (5%)
Query: 8 EKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
IG+G +GVVY + A+K + + +RE L++ + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 65 RLQDVV-HSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR 122
L ++ E +++ Y+ DL + + S LI F Q+ RG+ Y +
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS-FGLQVARGMEYLAEQK 144
Query: 123 VLHRDLKPQNLLIDRRTNALKLADFGLAR 151
+HRDL +N ++D + +K+ADFGLAR
Sbjct: 145 FVHRDLAARNCMLD-ESFTVKVADFGLAR 172
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 8 EKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
E IG G +G VY + A+K + D G S + E ++K+ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 65 RLQDVV-HSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
L + SE +V Y+ DL ++ + LI F Q+ +G+ +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV----KDLIG-FGLQVAKGMKFL 208
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
S + +HRDL +N ++D +K+ADFGLAR
Sbjct: 209 ASKKFVHRDLAARNCMLD-EKFTVKVADFGLAR 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 39/164 (23%), Positives = 70/164 (42%), Gaps = 21/164 (12%)
Query: 7 VEKIGEGTYGVVYKA-----RNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QH 60
+ +G G +G V +A +A+K ++ + E+ ++ + QH
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSELKIMSHLGQH 109
Query: 61 GNIVRLQDVVHSEKKLYLVFEYL---DL-----DLKKHMDSCPDFANDPRLIKT-----F 107
NIV L + ++ EY DL + +++ P FA T F
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
Q+ +G+A+ S +HRD+ +N+L+ + K+ DFGLAR
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNG-HVAKIGDFGLAR 212
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-17
Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 33/172 (19%)
Query: 7 VEKIGEGTYGVVYKAR-------NCVTNETIALKKIRLEQEDEGVPSTA----IREISLL 55
+ +GEG +G V A T+A+K ++ + + E+ ++
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDLSDLVSEMEMM 140
Query: 56 KEM-QHGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIK---- 105
K + +H NI+ L + LY++ EY +L L+ +++ D +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 106 ------TFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
+ YQ+ RG+ Y S + +HRDL +N+L+ N +K+ADFGLAR
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLAR 251
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 35/173 (20%)
Query: 7 VEKIGEGTYGVVYKAR-------NCVTNETIALKKIRLEQEDEGVPSTA----IREISLL 55
+ +GEG +G V A T+A+K ++ + + E+ ++
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDLSDLVSEMEMM 94
Query: 56 KEM-QHGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFAND--------- 100
K + +H NI+ L + LY++ EY +L L+ +++ D
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 101 --PRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
L+ YQ+ RG+ Y S + +HRDL +N+L+ N +K+ADFGLAR
Sbjct: 155 TFKDLVS-CTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLAR 205
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 8e-17
Identities = 29/169 (17%), Positives = 64/169 (37%), Gaps = 18/169 (10%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKK-----IRLEQEDEGVPSTAIREISLLKE 57
Q++ G++Y+A T + + ++L+ +D + + K
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 58 MQHGNIVRLQDV------------VHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIK 105
+Q +L VH +K +LV L L+ +D P R +
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVL 162
Query: 106 TFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLARAF 153
++L + + H + +H ++ +N+ +D + + LA +G A +
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 33/172 (19%)
Query: 7 VEKIGEGTYGVVYKAR-------NCVTNETIALKKIRLEQEDEGVPSTA----IREISLL 55
+ +GEG +G V A +A+K ++ I E+ ++
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-----SDATEKDLSDLISEMEMM 128
Query: 56 KEM-QHGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIK---- 105
K + +H NI+ L + LY++ EY +L L+ +++ +P
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 106 ------TFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
+ YQ+ RG+ Y S + +HRDL +N+L+ N +K+ADFGLAR
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLAR 239
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 42/174 (24%), Positives = 76/174 (43%), Gaps = 32/174 (18%)
Query: 7 VEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ +GEG +G V KA T+A+K ++ E + E ++LK++ H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASPSELRDLLSEFNVLKQVNHP 86
Query: 62 NIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFAND---------------- 100
++++L + L L+ EY L L++ P +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 101 ---PRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
LI F +QI +G+ Y +++HRDL +N+L+ +K++DFGL+R
Sbjct: 147 LTMGDLIS-FAWQISQGMQYLAEMKLVHRDLAARNILVAEG-RKMKISDFGLSR 198
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 38/167 (22%), Positives = 73/167 (43%), Gaps = 24/167 (14%)
Query: 7 VEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QH 60
+ +G G +G V +A T T+A+K ++ E + E+ +L + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHH 90
Query: 61 GNIVRLQDVV-HSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKT-------- 106
N+V L L ++ E+ +L L+ + + P +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 107 --FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
+ +Q+ +G+ + S + +HRDL +N+L+ + N +K+ DFGLAR
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLAR 196
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 40/173 (23%), Positives = 73/173 (42%), Gaps = 30/173 (17%)
Query: 7 VEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QH 60
+ +G G +G V A + +A+K ++ E+ D + E+ ++ ++ H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSH 108
Query: 61 GNIVRLQDVVHSEKKLYLVFEYL---DL--------------DLKKHMDSCPDFANDPRL 103
NIV L +YL+FEY DL +++ + D +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 104 IKT-----FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
+ F YQ+ +G+ + +HRDL +N+L+ +K+ DFGLAR
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGLAR 220
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 38/177 (21%)
Query: 7 VEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTA----IREISLLKE 57
V IGEG +G V++AR +A+K ++ E + RE +L+ E
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-----EEASADMQADFQREAALMAE 106
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYL---DLD--LKKHMDSCPDFANDPRLIKT------ 106
+ NIV+L V K + L+FEY+ DL+ L+ + L
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 107 ------------FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
Q+ G+AY + +HRDL +N L+ +K+ADFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLSR 222
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 50/231 (21%)
Query: 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
+G G +G VYK R +A+K+++ E +G E+ ++ H N++RL+
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEE-RTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 69 VVHSEKKLYLVFEY-----LDLDLKKHMDSCPDFANDPRLIKTFLYQIL----RGIAYCH 119
+ + LV+ Y + L++ +S P R +I RG+AY H
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ------RIALGSARGLAYLH 148
Query: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
H +++HRD+K N+L+D A + DFGLA+ TH +T
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEA-VVGDFGLAKLMD---YKDTHV---TT-------- 193
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
V G T+ + APE L + S DV+ G + E++
Sbjct: 194 ---AV-RG----------TIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELI 229
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 36/187 (19%), Positives = 69/187 (36%), Gaps = 37/187 (19%)
Query: 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTA---IREISLLKEMQ 59
++ IG+G +G +Y A ++E++ + PS E+ +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADM-NSSESVGSD---APCVVKVEPSDNGPLFTELKFYQRAA 91
Query: 60 HGNIVRLQDVVHSEKKL-------------------YLVFEYLDLDLKKHMDSCP-DFAN 99
++ K L +++ + DL+K ++ F+
Sbjct: 92 KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFS- 150
Query: 100 DPRLIKTFL---YQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGI 155
KT L +IL + Y H H +H D+K NLL++ + + + L D+GLA +
Sbjct: 151 ----RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY-C 205
Query: 156 PVRTFTH 162
P
Sbjct: 206 PEGVHKA 212
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 31/168 (18%)
Query: 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIR----EISLLKEMQHGNIV 64
IG G +G VYK +ALK R E S I EI L +H ++V
Sbjct: 46 LIGHGVFGKVYKGV-LRDGAKVALK--RRTPES----SQGIEEFETEIETLSFCRHPHLV 98
Query: 65 RLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDP-----RLIKTFLYQIL----RG 114
L ++ L+++Y++ +LK+H+ D RL +I RG
Sbjct: 99 SLIGFCDERNEMILIYKYMENGNLKRHL-YGSDLPTMSMSWEQRL------EICIGAARG 151
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162
+ Y H+ ++HRD+K N+L+D K+ DFG+++ TH
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVP-KITDFGISKKG--TELDQTH 196
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 25/125 (20%), Positives = 47/125 (37%), Gaps = 6/125 (4%)
Query: 32 LKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHM 91
L+ R E R+ ++ R D + S + + L
Sbjct: 118 LRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177
Query: 92 DSCPDFANDPRLIKT-----FLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLAD 146
+ + + +Q+ +G+ + S + +HRDL +N+L+ N +K+ D
Sbjct: 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICD 236
Query: 147 FGLAR 151
FGLAR
Sbjct: 237 FGLAR 241
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 22/133 (16%), Positives = 45/133 (33%), Gaps = 9/133 (6%)
Query: 8 EKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHG 61
+ +G G +G V +A T T+A+K ++ E + E+ +L + H
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHL 86
Query: 62 NIVRLQDVV-HSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
N+V L L ++ E+ +L ++ S + + Q +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 120 SHRVLHRDLKPQN 132
D +
Sbjct: 147 VDLKRRLDSITSS 159
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 323 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.02 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.66 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.62 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.46 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.1 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.06 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.75 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.65 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.63 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.59 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.55 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.53 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.37 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.24 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.11 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.07 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.05 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.96 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.96 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.28 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.98 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.93 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.91 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.83 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-62 Score=431.23 Aligned_cols=259 Identities=26% Similarity=0.467 Sum_probs=220.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
|++|++++.||+|+||+||+|+++.+|+.||+|++.+........+.+.+|+.++++++||||++++++|.+++.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 68999999999999999999999999999999999776554445678889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|||+| +|.+.+.......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-vKl~DFGla~~~~~~~~- 180 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT-VQLGDFGIARVLNSTVE- 180 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC-EEECSTTEESCCCHHHH-
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC-EEEcccccceeecCCcc-
Confidence 99975 9999998777777899999999999999999999999999999999999999888 99999999976532111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 181 ----------------------------~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~ 231 (350)
T 4b9d_A 181 ----------------------------LARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMK 231 (350)
T ss_dssp ----------------------------HHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ----------------------------cccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 0112468999999999988 66899999999999999999999999998888
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
+.+.++.+... +.....+|+.+++||.+||+.||++|||+.++|+||||+.
T Consensus 232 ~~~~~i~~~~~----------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 232 NLVLKIISGSF----------------------------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHHHTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHHHHHcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 87777765311 1122358899999999999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-61 Score=413.90 Aligned_cols=255 Identities=31% Similarity=0.507 Sum_probs=208.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999999976643 334456788999999999999999999999999999999
Q ss_pred EecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 80 FEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|||++|+|.+.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........
T Consensus 92 mEy~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~-vkl~DFGla~~~~~~~~- 167 (275)
T 3hyh_A 92 IEYAGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNF- 167 (275)
T ss_dssp EECCCEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC-EEECCSSCC---------
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC-EEEeecCCCeecCCCCc-
Confidence 9999999999998754 5799999999999999999999999999999999999999887 99999999976432211
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
....+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..
T Consensus 168 -----------------------------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~ 218 (275)
T 3hyh_A 168 -----------------------------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 218 (275)
T ss_dssp ------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -----------------------------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 112367999999999998666678999999999999999999999988776
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
+....+..... ..+..+|+.+++||.+||+.||++|||+.++++||||+
T Consensus 219 ~~~~~i~~~~~-----------------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 219 VLFKNISNGVY-----------------------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp HHHHHHHHTCC-----------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred HHHHHHHcCCC-----------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 66665544210 11234789999999999999999999999999999997
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-61 Score=420.06 Aligned_cols=260 Identities=25% Similarity=0.436 Sum_probs=225.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++++.||+|+||+||+|+++.+++.||+|++.+.. .+......+.+|+.++++++||||++++++|++++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 68999999999999999999999999999999997654 23445678899999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||++| +|.+.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..+......
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~-vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC-EEEEEcCCceecCCCCCc
Confidence 99975 8888887643 5799999999999999999999999999999999999999888 999999999876432221
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 189 ~---------------------------~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 240 (311)
T 4aw0_A 189 A---------------------------RANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEG 240 (311)
T ss_dssp C---------------------------CBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred c---------------------------cccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1 1122478999999999988 66899999999999999999999999998887
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh------hhcC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS------ALEH 313 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~------il~h 313 (323)
+...++.+... .....+|+.+++||.+||+.||++|||+.| |++|
T Consensus 241 ~~~~~i~~~~~-----------------------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~H 291 (311)
T 4aw0_A 241 LIFAKIIKLEY-----------------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 291 (311)
T ss_dssp HHHHHHHHTCC-----------------------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred HHHHHHHcCCC-----------------------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCC
Confidence 77777665210 111347899999999999999999999988 5789
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 292 p~F~~idw 299 (311)
T 4aw0_A 292 PFFESVTW 299 (311)
T ss_dssp GGGTTCCC
T ss_pred CCcCCCCH
Confidence 99999987
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=414.50 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=219.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|+++++||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+++.++||||++++++|.+++.+|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 36999999999999999999999999999999997553 3345778899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| +|.+.+... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..+......
T Consensus 152 y~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-vKl~DFGla~~~~~~~~~- 226 (346)
T 4fih_A 152 FLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPR- 226 (346)
T ss_dssp CCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSSSCC-
T ss_pred CCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC-EEEecCcCceecCCCCCc-
Confidence 9976 777766543 4799999999999999999999999999999999999999888 999999999876433221
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+....+
T Consensus 227 ----------------------------~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 277 (346)
T 4fih_A 227 ----------------------------RKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 277 (346)
T ss_dssp ----------------------------BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ----------------------------ccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 112478999999999977 668999999999999999999999999888777
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.+..+....... ......+|+.+++||.+||+.||++|||+.|+++||||++.
T Consensus 278 ~~~~i~~~~~~~--------------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 278 AMKMIRDNLPPR--------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHHHSSCCC--------------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHcCCCCC--------------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 776665421100 01124589999999999999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-60 Score=413.11 Aligned_cols=258 Identities=25% Similarity=0.415 Sum_probs=213.3
Q ss_pred CCcceeeeeccccceeEEEEEEc---cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC---VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++++.||+|+||+||+|++. .+++.||+|++.+..........+.+|+.++++++||||++++++|.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999874 357789999997665444444578889999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||++| +|.+.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC-EEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC-EEecccccceeccCCC
Confidence 9999975 8888887643 5799999999999999999999999999999999999999988 9999999997543221
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. ....+||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 181 ~~-----------------------------~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 181 KK-----------------------------AYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp CC-----------------------------CCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc-----------------------------ccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 11 112477999999999988 678999999999999999999999999988
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----Hhhhhc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALE 312 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~ 312 (323)
..+....+.+... ..+..+|+.+++||.+||+.||++||+ ++++++
T Consensus 231 ~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 231 RKETMTMILKAKL-----------------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHcCCC-----------------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 8877777664210 112348899999999999999999998 479999
Q ss_pred CCCCccccc
Q 036739 313 HEYFRDVEF 321 (323)
Q Consensus 313 h~~~~~~~~ 321 (323)
||||++++|
T Consensus 282 Hp~f~~idw 290 (304)
T 3ubd_A 282 HSFFSTIDW 290 (304)
T ss_dssp SGGGTTCCH
T ss_pred CccccCCCH
Confidence 999999865
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-58 Score=415.48 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=219.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+.|+++++||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+++.++||||++++++|.+++.+|+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 46999999999999999999999999999999997543 3345778899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||+| +|.+.+... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..+......
T Consensus 229 y~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~-vKl~DFGla~~~~~~~~~- 303 (423)
T 4fie_A 229 FLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPR- 303 (423)
T ss_dssp CCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC-EEECCCTTCEECCSSCCC-
T ss_pred CCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC-EEEecCccceECCCCCcc-
Confidence 9976 777766543 4799999999999999999999999999999999999999888 999999999876432221
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+....+
T Consensus 304 ----------------------------~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 354 (423)
T 4fie_A 304 ----------------------------RKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 354 (423)
T ss_dssp ----------------------------BCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ----------------------------ccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 112478999999999987 668999999999999999999999999888877
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.+..+....... ......+|+.+++||.+||..||++|||+.|+|+||||+..
T Consensus 355 ~~~~i~~~~~~~--------------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 355 AMKMIRDNLPPR--------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHHHHHHSCCCC--------------------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHcCCCCC--------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 776665421110 01123589999999999999999999999999999999865
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-58 Score=417.87 Aligned_cols=291 Identities=37% Similarity=0.665 Sum_probs=235.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec------Cce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS------EKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~ 75 (323)
++|++++.||+|+||+||+|++..+|+.||||++............+.+|+.+++.++||||+++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999999999999999986544333334567789999999999999999998753 467
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
+|+||||++|+|.+.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..+..
T Consensus 134 ~~ivmE~~~g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~-~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE-LKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEEECCSEEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC-EEECCCTTCBCC--
T ss_pred EEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC-EEEeecceeeeccc
Confidence 99999999999999987654 5799999999999999999999999999999999999999888 99999999976543
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
....... .....+||+.|+|||++.+...++.++||||+||++|+|++|++||.+
T Consensus 211 ~~~~~~~-------------------------~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g 265 (398)
T 4b99_A 211 SPAEHQY-------------------------FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265 (398)
T ss_dssp -----CC-------------------------CCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred Ccccccc-------------------------ccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence 2211110 112247899999999998877789999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCc--ccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPD--FKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.+..+.+..+....+.+....+........ ....+............+.+++.+.+||.+||..||++|||+.++|+|
T Consensus 266 ~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 266 KNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp SSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 999999999999888876655443322111 111222233333344556789999999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||++.+
T Consensus 346 p~f~~~~ 352 (398)
T 4b99_A 346 PFLAKYH 352 (398)
T ss_dssp GGGTTTC
T ss_pred HhhCcCC
Confidence 9999763
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-58 Score=397.03 Aligned_cols=254 Identities=23% Similarity=0.366 Sum_probs=208.6
Q ss_pred Cc-ceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec----CceEE
Q 036739 3 QY-EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS----EKKLY 77 (323)
Q Consensus 3 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~ 77 (323)
+| ++.++||+|+||+||+|++..++..||+|++..........+.+.+|+.++++++||||++++++|.+ +..+|
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 44 67788999999999999999999999999997665444445778999999999999999999999864 45789
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEec-CCCceEEeccccceec
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR--VLHRDLKPQNLLIDR-RTNALKLADFGLARAF 153 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~~~Nil~~~-~~~~~kl~df~~~~~~ 153 (323)
+||||++| +|.+.+.+.. .+++..++.++.||+.||+|||++| |+||||||+|||++. ++. +||+|||++...
T Consensus 106 lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~-vKl~DFGla~~~ 182 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS-VKIGDLGLATLK 182 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC-EEECCTTGGGGC
T ss_pred EEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC-EEEEeCcCCEeC
Confidence 99999975 8888876543 5789999999999999999999998 999999999999975 565 999999999643
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
.... ....+||+.|+|||++.+ .++.++|||||||++|+|+||+.||
T Consensus 183 ~~~~-------------------------------~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf 229 (290)
T 3fpq_A 183 RASF-------------------------------AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp CTTS-------------------------------BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCc-------------------------------cCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 2111 112478999999999875 4899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
........+.+....... ........++.+.+||.+||+.||++|||+.++|+|
T Consensus 230 ~~~~~~~~~~~~i~~~~~--------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 230 SECQNAAQIYRRVTSGVK--------------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTCSSHHHHHHHHTTTCC--------------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCcHHHHHHHHHcCCC--------------------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 877665555433321000 011224478899999999999999999999999999
Q ss_pred CCCcc
Q 036739 314 EYFRD 318 (323)
Q Consensus 314 ~~~~~ 318 (323)
|||++
T Consensus 284 p~~~~ 288 (290)
T 3fpq_A 284 AFFQE 288 (290)
T ss_dssp GGGC-
T ss_pred ccccC
Confidence 99985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=401.14 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=212.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+.|++.++||+|+||.||+|+++.+|+.||+|++.... ...+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 56888999999999999999999999999999996542 22479999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| +|.+.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||++..+.......
T Consensus 131 y~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred ccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 9975 8888886643 579999999999999999999999999999999999999887559999999998765332211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+
T Consensus 209 ~~------------------------~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 263 (336)
T 4g3f_A 209 SL------------------------LTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263 (336)
T ss_dssp -----------------------------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC
T ss_pred ce------------------------ecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 10 01122468999999999988 678999999999999999999999998877666
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh----------
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA---------- 310 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i---------- 310 (323)
...++.... + ........+++.+.+||.+||+.||++|||+.|+
T Consensus 264 ~~~~i~~~~--~------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 264 LCLKIASEP--P------------------------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp CHHHHHHSC--C------------------------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCC--C------------------------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 666555420 0 0112235689999999999999999999999997
Q ss_pred ---hcCCCCccc
Q 036739 311 ---LEHEYFRDV 319 (323)
Q Consensus 311 ---l~h~~~~~~ 319 (323)
++|||+.+.
T Consensus 318 ~~~l~hPw~~~~ 329 (336)
T 4g3f_A 318 VGGLKSPWKGEY 329 (336)
T ss_dssp TTSSCSCSSSSC
T ss_pred hhhccCCCcCCC
Confidence 679999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=390.49 Aligned_cols=270 Identities=27% Similarity=0.426 Sum_probs=197.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc-------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK------- 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------- 74 (323)
++|++++.||+|+||+||+|+++.+|+.||+|++.... .....+.+.+|+.++++++||||++++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 57999999999999999999999999999999986543 2223467889999999999999999999987543
Q ss_pred -----eEEEEEecchh-hHHHhhhcCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 75 -----KLYLVFEYLDL-DLKKHMDSCPDF-ANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 75 -----~~~lv~e~~~g-~l~~~~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
.+|+|||||.| +|.+.+...... ..+...++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~-vKl~DF 162 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDF 162 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc-EEEccC
Confidence 47999999975 788877655432 2355668899999999999999999999999999999999887 999999
Q ss_pred ccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH
Q 036739 148 GLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~ 227 (323)
|++............... ..........+||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 163 Gla~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell 224 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTP-----------------MPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL 224 (299)
T ss_dssp CCC-------------------------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHH
T ss_pred ccceecCCCccccccccc-----------------cccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHc
Confidence 999876543322111000 000111233578999999999988 67899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH
Q 036739 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 228 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
+ ||.+... ....+...... ..++.....++.+.+||.+||+.||++|||+
T Consensus 225 ~---Pf~~~~~--~~~~~~~~~~~-------------------------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~ 274 (299)
T 4g31_A 225 Y---PFSTQME--RVRTLTDVRNL-------------------------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEA 274 (299)
T ss_dssp S---CCSSHHH--HHHHHHHHHTT-------------------------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCH
T ss_pred c---CCCCccH--HHHHHHHHhcC-------------------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCH
Confidence 6 7754322 22211111100 0112223456778899999999999999999
Q ss_pred hhhhcCCCCccccc
Q 036739 308 RSALEHEYFRDVEF 321 (323)
Q Consensus 308 ~~il~h~~~~~~~~ 321 (323)
.++++||||++++|
T Consensus 275 ~eil~h~~~~~~~~ 288 (299)
T 4g31_A 275 INIIENAVFEDLDF 288 (299)
T ss_dssp HHHHTSGGGCCC--
T ss_pred HHHhcCHhhCCCCC
Confidence 99999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=386.70 Aligned_cols=309 Identities=24% Similarity=0.374 Sum_probs=214.3
Q ss_pred CCcceeeeeccccceeEEEEEEc---cCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC---VTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|+||+||+|+++ .+++.||+|.+... .....+.+|+.+++.+ +||||++++++|.+.+.+|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 57999999999999999999875 35678999987432 2345678899999998 6999999999999999999
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+||||++| +|.+.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+...+||+|||++......
T Consensus 97 lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999975 7777763 37889999999999999999999999999999999999987545999999999876543
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
............... ....................+||+.|+|||++.+...++.++||||+||++|+|++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 172 KIELLKFVQSEAQQE-RCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp SCGGGGGC---------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccc-ccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 322111100000000 0000000000001112234578999999999988677999999999999999999999998554
Q ss_pred -ChHHHHHHHHHHhCCCCCC--------------CCCCc--ccC----CcccccCCC-----CCCCcccccccCCChHHH
Q 036739 237 -SEIDELFKIFRVLGTPNED--------------TWPGV--TSL----PDFKSAFPK-----WPSKELGTVVRNLEPAGI 290 (323)
Q Consensus 237 -~~~~~~~~~~~~~~~~~~~--------------~~~~~--~~~----~~~~~~~~~-----~~~~~~~~~~~~~s~~~~ 290 (323)
+..+.+..+.+..+.+... ..+.. ... ......... ............+|+.++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 4555566665544321100 00000 000 000000000 000011123456899999
Q ss_pred HHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 291 DLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 291 ~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
+||.+||..||++|+|+.|+|+||||++++
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=409.52 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=213.1
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHH---HHHHHhcCCCCeeeeeEEEecCceE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIRE---ISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
|++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+| +.+++.++||||++++++|++.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 5899999999999999999999999999999999976542 22223334444 5566677899999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
|+||||+.| +|...+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~-vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC-EEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC-EEecccceeeecCC
Confidence 999999975 8888887643 5799999999999999999999999999999999999999998 99999999987643
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
... ...+||+.|+|||++.....++.++|+|||||++|+|++|.+||.+
T Consensus 345 ~~~-------------------------------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 345 KKP-------------------------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp CCC-------------------------------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred CCC-------------------------------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 211 1237899999999997656789999999999999999999999976
Q ss_pred CChHHH---HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----H
Q 036739 236 DSEIDE---LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----A 307 (323)
Q Consensus 236 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~ 307 (323)
....+. ...+... . ...+..+|+.+++||.+||+.||++|++ +
T Consensus 394 ~~~~~~~~i~~~i~~~--~---------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga 444 (689)
T 3v5w_A 394 HKTKDKHEIDRMTLTM--A---------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 444 (689)
T ss_dssp GGCCCHHHHHHHHHHC--C---------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTH
T ss_pred CChHHHHHHHHhhcCC--C---------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCH
Confidence 533222 2222211 0 1122458999999999999999999998 7
Q ss_pred hhhhcCCCCccccc
Q 036739 308 RSALEHEYFRDVEF 321 (323)
Q Consensus 308 ~~il~h~~~~~~~~ 321 (323)
.+|++||||++++|
T Consensus 445 ~ei~~HpfF~~idW 458 (689)
T 3v5w_A 445 QEVKESPFFRSLDW 458 (689)
T ss_dssp HHHTTSGGGTTCCH
T ss_pred HHHhcCccccCCCH
Confidence 99999999999976
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=369.87 Aligned_cols=288 Identities=58% Similarity=1.016 Sum_probs=243.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
|++|++.+.||+|++|+||+|++..+++.||+|++............+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 68999999999999999999999999999999999776655555577889999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||++|++.+.+..... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+..........
T Consensus 81 e~~~~~l~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp ECCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCSCCSCC
T ss_pred ecCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEeecccceecCCccccc
Confidence 9999999988876543 5799999999999999999999999999999999999999887 9999999998764332211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC-CCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL-FPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p-~~~~~~~ 239 (323)
. ...||+.|+|||.+.+...++.++||||||+++|+|++|..| |......
T Consensus 159 ~-----------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~ 209 (292)
T 3o0g_A 159 S-----------------------------AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_dssp C-----------------------------SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred c-----------------------------CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH
Confidence 1 125588999999998866689999999999999999987766 6666667
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+....+.+..+.+....++...........-..............+++.+++||.+||+.||++|||+.++++||||+++
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 77788888888888887777666555443333223333444556789999999999999999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=369.82 Aligned_cols=288 Identities=63% Similarity=1.083 Sum_probs=244.4
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++++.||+|+||+||+|++ .+++.||+|++............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 68999999999999999999998 67899999999766555555678889999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++++++.+.+..... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||.+..........
T Consensus 80 e~~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp ECCSEEHHHHHHTSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECCTTHHHHHCC-----
T ss_pred EecCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC-EEEeECccccccCcccccc
Confidence 9999999888876543 5788899999999999999999999999999999999999887 9999999987654322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...||+.|+|||.+.+...++.++|+|||||++|+|++|..||......+
T Consensus 158 ~-----------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 208 (288)
T 1ob3_A 158 T-----------------------------HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208 (288)
T ss_dssp ---------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred c-----------------------------cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0 12458899999999876678999999999999999999999999998888
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
....+.+..+.+....++.....+.+...+..............+++.+.+||.+||+.||++||++.++++||||++.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288 (288)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC--
T ss_pred HHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcC
Confidence 88888888888887777776666655555555444444555677899999999999999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-53 Score=372.68 Aligned_cols=288 Identities=59% Similarity=1.042 Sum_probs=239.1
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++++.||+|+||+||+|++. +++.||+|++............+.+|+.+++.++||||+++++++.+++..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 478999999999999999999984 5899999998765554445577889999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||++|++.+.+..... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++...+......
T Consensus 99 e~~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 99 EFMEKDLKKVLDENKT-GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp ECCSEEHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEETTSCCC--
T ss_pred cCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC-EEEccCcCceecCCCcccc
Confidence 9999999988876543 5789999999999999999999999999999999999999887 9999999998764332221
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...||+.|+|||.+.+...++.++|||||||++|+|++|..||.+....+
T Consensus 177 ~-----------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (311)
T 3niz_A 177 T-----------------------------HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227 (311)
T ss_dssp ------------------------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT
T ss_pred c-----------------------------CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 1 12458899999999876778999999999999999999999999998888
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCC-CCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFP-KWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
....+....+.+....++.......+..... .............+++.+.+||.+||+.||++|||+.++++||||+++
T Consensus 228 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 228 QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred HHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 8888888888887777766555444333221 222222334556788999999999999999999999999999999998
Q ss_pred c
Q 036739 320 E 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 308 ~ 308 (311)
T 3niz_A 308 D 308 (311)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=372.34 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=200.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+++++.++||+|+||+||+|+.. ..||+|+++.........+.|.+|+.++++++||||+++++++.+ +.+++|||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 57889999999999999999752 369999986554444445788999999999999999999998854 56899999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| +|.+.+.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||++..........
T Consensus 112 y~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~-~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT-VKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE-EEECCCSSCBC--------
T ss_pred cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc-EEEeeccCceecccCCcce
Confidence 9975 7877776543 35899999999999999999999999999999999999998887 9999999997653221111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS--RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.....+||+.|+|||++... ..++.++|||||||++|||+||+.||.....
T Consensus 190 ---------------------------~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 190 ---------------------------QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp -------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ---------------------------eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 01124679999999999752 4589999999999999999999999998777
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+........... ........+++.+.+||.+||+.||++|||+.+|++
T Consensus 243 ~~~~~~~~~~~~~~p-----------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 243 RDQIIFMVGRGYASP-----------------------DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp HHHHHHHHHTTCCCC-----------------------CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred HHHHHHHHhcCCCCC-----------------------CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 666655443211100 011223457899999999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=372.12 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=208.8
Q ss_pred CCcceeeeeccccceeEEEEEEc-----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|+||+||+|+.. .++..||+|++... .....+.|.+|+.++++++||||+++++++.+++.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 57899999999999999999864 35778999998543 223346789999999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEE
Q 036739 77 YLVFEYLDL-DLKKHMDSC-----------PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKL 144 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl 144 (323)
++||||++| +|.+.+... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++. +||
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~-~Ki 169 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-VKI 169 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc-EEE
Confidence 999999975 888888653 2346899999999999999999999999999999999999999887 999
Q ss_pred eccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHH
Q 036739 145 ADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFA 224 (323)
Q Consensus 145 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~ 224 (323)
+|||++.......... ......||+.|+|||.+.+ ..++.++|||||||++|
T Consensus 170 ~DFGla~~~~~~~~~~---------------------------~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~ 221 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYR---------------------------VGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLW 221 (299)
T ss_dssp CCCSCHHHHTGGGCEE---------------------------ETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHH
T ss_pred CCcccceecCCCCcee---------------------------ecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHH
Confidence 9999997653221110 1112357999999999988 66899999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC
Q 036739 225 EMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303 (323)
Q Consensus 225 ~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~ 303 (323)
||+| |+.||.+....+....+.+.... ..+..+++.+.+||.+||+.||++
T Consensus 222 Ellt~G~~Pf~~~~~~~~~~~i~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~ 273 (299)
T 4asz_A 222 EIFTYGKQPWYQLSNNEVIECITQGRVL----------------------------QRPRTCPQEVYELMLGCWQREPHM 273 (299)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCccchHHHHHHHHHHcCCChhH
Confidence 9999 89999998887777766553111 112347899999999999999999
Q ss_pred CCCHhhhhcCCCCccc
Q 036739 304 RITARSALEHEYFRDV 319 (323)
Q Consensus 304 R~s~~~il~h~~~~~~ 319 (323)
|||+.+|++ |++++
T Consensus 274 RPs~~~i~~--~L~~~ 287 (299)
T 4asz_A 274 RKNIKGIHT--LLQNL 287 (299)
T ss_dssp SCCHHHHHH--HHHHH
T ss_pred CcCHHHHHH--HHHHH
Confidence 999999953 55543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=402.64 Aligned_cols=261 Identities=24% Similarity=0.418 Sum_probs=222.0
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++.+.||+|+||.||+|+++.+|+.||+|++..... ...+.+.+|+.+|+.++||||++++++|.+.+.+|+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch--hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 4789999999999999999999999999999999865432 22467889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC--CCceEEeccccceecCCCc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR--TNALKLADFGLARAFGIPV 157 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~--~~~~kl~df~~~~~~~~~~ 157 (323)
||++| +|.+.+....+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +. +||+|||++..+....
T Consensus 234 E~~~gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~-vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 234 EFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp ECCCCCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCC-EEECCCSSCEECCTTS
T ss_pred eecCCCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCC-EEEeeccceeEccCCC
Confidence 99975 88888765433 57899999999999999999999999999999999999864 44 9999999998765332
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 312 ~~------------------------------~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~ 360 (573)
T 3uto_A 312 SV------------------------------KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360 (573)
T ss_dssp EE------------------------------EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ce------------------------------eeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 21 12367999999999988 668999999999999999999999999998
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
..+.+..+.+..... .......+|+.+++||.+||+.||++||++.++|+||||+
T Consensus 361 ~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~ 415 (573)
T 3uto_A 361 DDETLRNVKSCDWNM-------------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415 (573)
T ss_dssp HHHHHHHHHTTCCCC-------------------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred HHHHHHHHHhCCCCC-------------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence 887777665431111 1122346899999999999999999999999999999999
Q ss_pred cccc
Q 036739 318 DVEF 321 (323)
Q Consensus 318 ~~~~ 321 (323)
..++
T Consensus 416 ~~~~ 419 (573)
T 3uto_A 416 PGNA 419 (573)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 7653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=374.67 Aligned_cols=292 Identities=61% Similarity=1.083 Sum_probs=242.0
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++.+.||+|++|+||+|++..+++.||+|++............+.+|+.+++.++||||+++++++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 47899999999999999999999999999999998766555555667789999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC----CceEEeccccceecCCC
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT----NALKLADFGLARAFGIP 156 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~----~~~kl~df~~~~~~~~~ 156 (323)
||++|+|.+.+.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++ ..+||+|||++......
T Consensus 113 e~~~~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 113 EYAENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp ECCSEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred ecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 999999999988765 468889999999999999999999999999999999995332 24999999999765432
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.... ....||+.|+|||.+.+...++.++|||||||++|+|++|..||...
T Consensus 191 ~~~~-----------------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 191 IRQF-----------------------------THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp --------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc-----------------------------CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 2211 11255889999999988677899999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccc-cccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGT-VVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
...+....+....+.+....++.......+...+.......... ....+++.+.+||.+||+.||++|||+.++++|||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 242 SEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 99999999999988888888887777777666655554444332 23348899999999999999999999999999999
Q ss_pred CccccccC
Q 036739 316 FRDVEFVP 323 (323)
Q Consensus 316 ~~~~~~~~ 323 (323)
|++.+|-|
T Consensus 322 f~~~~~~P 329 (329)
T 3gbz_A 322 FSHNDFDP 329 (329)
T ss_dssp GSSSCSCC
T ss_pred cCCCCCCC
Confidence 99999876
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=370.85 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=207.8
Q ss_pred CCcceeeeeccccceeEEEEEEc-----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
+++++.++||+|+||+||+|+.. .++..||||++... ......+.|.+|+.++++++||||++++|++.+++.+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC--CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc-cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 46788999999999999999853 35678999998543 3344557899999999999999999999999999999
Q ss_pred EEEEecch-hhHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCc
Q 036739 77 YLVFEYLD-LDLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA 141 (323)
Q Consensus 77 ~lv~e~~~-g~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~ 141 (323)
++||||++ |+|.+++.... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~- 183 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN- 183 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC-
Confidence 99999996 58888885432 235788899999999999999999999999999999999999887
Q ss_pred eEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHH
Q 036739 142 LKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGC 221 (323)
Q Consensus 142 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 221 (323)
+||+|||++......... .......||+.|+|||.+.+ ..++.++|||||||
T Consensus 184 ~Ki~DFGlar~~~~~~~~---------------------------~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGv 235 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYY---------------------------KLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGV 235 (308)
T ss_dssp EEECCSCCBCGGGGGGCB---------------------------CSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHH
T ss_pred EEECCcccceeccCCCce---------------------------eEecccccCCcccCHHHHhC-CCCCccchhhhHHH
Confidence 999999998754321110 11122367999999999988 67899999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccC
Q 036739 222 IFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300 (323)
Q Consensus 222 ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~d 300 (323)
++|||+| |..||.+....+....+.+... .+.+..+++.+.+|+.+||+.|
T Consensus 236 vl~El~t~g~~Pf~~~~~~~~~~~i~~~~~----------------------------~~~p~~~~~~~~~li~~C~~~d 287 (308)
T 4gt4_A 236 VLWEVFSYGLQPYCGYSNQDVVEMIRNRQV----------------------------LPCPDDCPAWVYALMIECWNEF 287 (308)
T ss_dssp HHHHHHTTTCCTTTTCCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSS
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCcccchHHHHHHHHHHcCCC
Confidence 9999998 8999999887776666543211 1122357889999999999999
Q ss_pred CCCCCCHhhhhcC
Q 036739 301 PSRRITARSALEH 313 (323)
Q Consensus 301 p~~R~s~~~il~h 313 (323)
|++||++.+|+++
T Consensus 288 P~~RPs~~ei~~~ 300 (308)
T 4gt4_A 288 PSRRPRFKDIHSR 300 (308)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhHCcCHHHHHHH
Confidence 9999999999874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=372.30 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=202.2
Q ss_pred CCcceeeeeccccceeEEEEEEc-----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|.+.++||+|+||+||+|+.. .++..||||++... .....+.|.+|+.++++++||||+++++++.+.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46788999999999999999864 35789999998533 223346789999999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCce
Q 036739 77 YLVFEYLDL-DLKKHMDSCP-------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNAL 142 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~-------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~ 142 (323)
++||||++| +|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++. +
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~-~ 197 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV-V 197 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE-E
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc-E
Confidence 999999975 8888776532 235788999999999999999999999999999999999998887 9
Q ss_pred EEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHH
Q 036739 143 KLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCI 222 (323)
Q Consensus 143 kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~l 222 (323)
||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 198 Ki~DFGla~~~~~~~~~~---------------------------~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvv 249 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYR---------------------------VGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVV 249 (329)
T ss_dssp EECCCC-------------------------------------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHH
T ss_pred EEcccccceeccCCCcce---------------------------ecCcccccccccChhhhcC-CCCCccccccchHHH
Confidence 999999997653221111 1112357999999999988 678999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCC
Q 036739 223 FAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301 (323)
Q Consensus 223 l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp 301 (323)
+|||+| |+.||......+.+..+.+.... ..+..+++.+.+|+.+||+.||
T Consensus 250 l~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~----------------------------~~p~~~~~~~~~li~~cl~~dP 301 (329)
T 4aoj_A 250 LWEIFTYGKQPWYQLSNTEAIDCITQGREL----------------------------ERPRACPPEVYAIMRGCWQREP 301 (329)
T ss_dssp HHHHHTTSCCTTCSSCHHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHCCSST
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCcccccHHHHHHHHHHcCcCh
Confidence 999999 89999998887777666553211 1123478999999999999999
Q ss_pred CCCCCHhhhhcC
Q 036739 302 SRRITARSALEH 313 (323)
Q Consensus 302 ~~R~s~~~il~h 313 (323)
++|||+.+|+++
T Consensus 302 ~~RPs~~ei~~~ 313 (329)
T 4aoj_A 302 QQRHSIKDVHAR 313 (329)
T ss_dssp TTSCCHHHHHHH
T ss_pred hHCcCHHHHHHH
Confidence 999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=365.82 Aligned_cols=289 Identities=52% Similarity=0.941 Sum_probs=226.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
.++|++++.||+|++|+||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 368999999999999999999999999999999986553 3344578889999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 81 EYLDLDLKKHMDSCP----DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 81 e~~~g~l~~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
||++|+|.+.+.... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||.+......
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCSSCEETTSC
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC-EEECcCccceecCCC
Confidence 999999988876432 235788899999999999999999999999999999999999887 999999999876433
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
..... ...||+.|+|||.+.+...++.++|||||||++|+|++|..||.+.
T Consensus 162 ~~~~~-----------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 162 VNTFS-----------------------------SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp CCCCC-----------------------------CCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCC-----------------------------CCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22111 1245889999999987667899999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcc-----cccccCCChHHHHHHHhhcccCCCCCCCHhhhh
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKEL-----GTVVRNLEPAGIDLLSKMLCMDPSRRITARSAL 311 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il 311 (323)
...+....+.+..+.+....++.....+.+............ ......+++.+.+||.+||+.||++|||+.+++
T Consensus 213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 213 NDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp SHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 988888888888888777766665554444333332222221 112236889999999999999999999999999
Q ss_pred cCCCCcccc
Q 036739 312 EHEYFRDVE 320 (323)
Q Consensus 312 ~h~~~~~~~ 320 (323)
+||||++..
T Consensus 293 ~hp~f~~~~ 301 (317)
T 2pmi_A 293 HHPWFAEYY 301 (317)
T ss_dssp TSGGGGGGC
T ss_pred CChhhhccc
Confidence 999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=366.77 Aligned_cols=288 Identities=55% Similarity=0.983 Sum_probs=235.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
|++|++++.||+|++|+||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 6899999999999999999999999999999999865432 222334557999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||++|++.+.+..... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+..........
T Consensus 80 e~~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 80 EYLDKDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp ECCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC-EEECSSSEEECC-------
T ss_pred cccccCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC-EEEccCcccccccCCcccc
Confidence 9999999998877543 5788899999999999999999999999999999999999887 9999999987654322211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...||+.|+|||.+.+...++.++||||||+++|+|++|..||.+....+
T Consensus 158 ~-----------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 208 (324)
T 3mtl_A 158 D-----------------------------NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208 (324)
T ss_dssp ----------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred c-----------------------------cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 12558899999999876778999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccc-cCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
....+.+..+.+....++.......+.. ................+++.+.+||.+||+.||++|||+.++++||||.++
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 209 QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 9999999988888887766554433222 222222233334456789999999999999999999999999999999987
Q ss_pred c
Q 036739 320 E 320 (323)
Q Consensus 320 ~ 320 (323)
.
T Consensus 289 ~ 289 (324)
T 3mtl_A 289 G 289 (324)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=355.69 Aligned_cols=285 Identities=46% Similarity=0.820 Sum_probs=234.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc---CCCCchhHHHHHHHHHhcC---CCCeeeeeEEEecCc-
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE---DEGVPSTAIREISLLKEMQ---HGNIVRLQDVVHSEK- 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~- 74 (323)
++|++.+.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.++ ||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 689999999999999999999999999999999876542 2233456777888877775 999999999997654
Q ss_pred ----eEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccc
Q 036739 75 ----KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (323)
Q Consensus 75 ----~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~ 150 (323)
..+++||+++|+|.+.+.......+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~a 167 (308)
T 3g33_A 89 DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGLA 167 (308)
T ss_dssp SSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC-EEECSCSCT
T ss_pred CCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC-EEEeeCccc
Confidence 589999999999999998877666899999999999999999999999999999999999998887 999999998
Q ss_pred eecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 151 RAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
......... ....||+.|+|||.+.+ ..++.++|||||||++|+|++|.
T Consensus 168 ~~~~~~~~~------------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~ 216 (308)
T 3g33_A 168 RIYSYQMAL------------------------------TPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRK 216 (308)
T ss_dssp TTSTTCCCS------------------------------GGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSS
T ss_pred cccCCCccc------------------------------CCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCC
Confidence 765322211 11256899999999988 56899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh
Q 036739 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310 (323)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i 310 (323)
.||......+....+.+..+.+....|+.....+. ..+..............+++.+.+||.+||+.||++|||+.++
T Consensus 217 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 294 (308)
T 3g33_A 217 PLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR--GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294 (308)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCG--GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhccchhhccc--cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHH
Confidence 99999999999999998888877776665444332 2233333333444556789999999999999999999999999
Q ss_pred hcCCCCcccc
Q 036739 311 LEHEYFRDVE 320 (323)
Q Consensus 311 l~h~~~~~~~ 320 (323)
|+||||++.+
T Consensus 295 l~h~~~~~~~ 304 (308)
T 3g33_A 295 LQHSYLHKDE 304 (308)
T ss_dssp HTSTTC----
T ss_pred hcCccccCCC
Confidence 9999999764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=360.39 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=219.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++.+.||+|+||.||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 47899999999999999999999999999999999766544444567889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||++| ++.+.+.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++. +||+|||++.........
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECSTTCCGGGSSSCGG
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC-EEEeeccCceecCCCCcc
Confidence 99965 8888876643 4788999999999999999999999999999999999999888 999999998765432211
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
....||+.|+|||.+.+....+.++||||+||++|+|++|..||.+....
T Consensus 171 ------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 220 (328)
T 3fe3_A 171 ------------------------------DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220 (328)
T ss_dssp ------------------------------GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ------------------------------ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH
Confidence 11256999999999998655568999999999999999999999998877
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+....+..... .....+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus 221 ~~~~~i~~~~~-----------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 221 ELRERVLRGKY-----------------------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHHHHHhCCC-----------------------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 76666654211 1112478899999999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=363.22 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=204.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCC-----ceEEEEEEEecccCCCCchhHHHHHHHHHhcCC-CCeeeeeEEEec-Cc
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTN-----ETIALKKIRLEQEDEGVPSTAIREISLLKEMQH-GNIVRLQDVVHS-EK 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~-~~ 74 (323)
++|++.+.||+|+||+||+|++...+ +.||+|.+.... .......+.+|+.++.++.| |||++++++|.. ++
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 57999999999999999999976543 579999885332 22234568899999999965 899999999865 46
Q ss_pred eEEEEEecchh-hHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT 139 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~ 139 (323)
.+++|||||+| +|.+++.... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 78999999975 8888886432 23468888999999999999999999999999999999999988
Q ss_pred CceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHH
Q 036739 140 NALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSV 219 (323)
Q Consensus 140 ~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 219 (323)
. +||+|||+++........ .......||+.|+|||.+.+ ..++.++|||||
T Consensus 223 ~-vKi~DFGlar~~~~~~~~---------------------------~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~ 273 (353)
T 4ase_A 223 V-VKICDFGLARDIYKDPDY---------------------------VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSF 273 (353)
T ss_dssp C-EEECCCGGGSCTTTCTTS---------------------------EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHH
T ss_pred C-EEECcchhhhhcccCCCc---------------------------eeeccccccccccCHHHHhc-CCCCCcccEeeh
Confidence 7 999999999765432211 11223467999999999988 678999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcc
Q 036739 220 GCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298 (323)
Q Consensus 220 G~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~ 298 (323)
||++|||+| |..||.+....+.+.+.......+ ..+..+++.+.++|.+||+
T Consensus 274 Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~ 326 (353)
T 4ase_A 274 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWH 326 (353)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcC
Confidence 999999998 999998876655554443321111 1123478899999999999
Q ss_pred cCCCCCCCHhhhhcC
Q 036739 299 MDPSRRITARSALEH 313 (323)
Q Consensus 299 ~dp~~R~s~~~il~h 313 (323)
.||++|||+.+|++|
T Consensus 327 ~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 327 GEPSQRPTFSELVEH 341 (353)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred cChhHCcCHHHHHHH
Confidence 999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=356.37 Aligned_cols=259 Identities=26% Similarity=0.407 Sum_probs=219.4
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++++.||+|+||+||+|+++.+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 4799999999999999999999999999999999976532 334456788999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| +|...+.... .+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++........
T Consensus 84 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC-EEEeeccchhhcccCCC
Confidence 999976 7777776543 5788999999999999999999999999999999999999888 99999999875322111
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
. .....||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 161 ~-----------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 210 (337)
T 1o6l_A 161 T-----------------------------MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp C-----------------------------BCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred c-----------------------------ccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCH
Confidence 1 012367999999999987 5689999999999999999999999998877
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h 313 (323)
......+.... . .....+++.+.++|.+||+.||++|| ++.++++|
T Consensus 211 ~~~~~~i~~~~--~---------------------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 211 ERLFELILMEE--I---------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHHHCC--C---------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHcCC--C---------------------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 66665554310 0 11134789999999999999999999 89999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 262 ~~f~~~~~ 269 (337)
T 1o6l_A 262 RFFLSINW 269 (337)
T ss_dssp GGGTTCCH
T ss_pred CCcCCCCH
Confidence 99999865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=356.54 Aligned_cols=291 Identities=38% Similarity=0.714 Sum_probs=236.3
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--------
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-------- 72 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------- 72 (323)
+++|++.+.||+|++|+||+|++..+++.||+|++............+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 478999999999999999999999999999999987666555566788899999999999999999999976
Q ss_pred CceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 73 EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 73 ~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
.+..++||||++|++...+..... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++..
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg~a~~ 173 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARA 173 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEE
T ss_pred CceEEEEEeccCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC-EEEccchhccc
Confidence 456899999999999888876543 4789999999999999999999999999999999999999887 99999999987
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
........... .....||+.|+|||.+.+...++.++|||||||++|+|++|..|
T Consensus 174 ~~~~~~~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 228 (351)
T 3mi9_A 174 FSLAKNSQPNR-------------------------YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 228 (351)
T ss_dssp CCCCSSSSCCC-------------------------CCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccccccc-------------------------cCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCC
Confidence 65332221111 11235689999999998767789999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccc-----cCCChHHHHHHHhhcccCCCCCCCH
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVV-----RNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
|.+....+....+.+..+......++.......... ...... ...... ...++.+.+||.+||+.||++||++
T Consensus 229 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 306 (351)
T 3mi9_A 229 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK-LELVKG-QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306 (351)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTS-SCCCSS-CCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCChHHHHHHHHHHhCCCChhhccccccchhhcc-cccccc-cccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH
Confidence 999998888888888888777776665544332111 111100 000000 1137789999999999999999999
Q ss_pred hhhhcCCCCcccc
Q 036739 308 RSALEHEYFRDVE 320 (323)
Q Consensus 308 ~~il~h~~~~~~~ 320 (323)
.++++||||++.+
T Consensus 307 ~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 307 DDALNHDFFWSDP 319 (351)
T ss_dssp HHHHTSGGGGSSS
T ss_pred HHHhCCCCcCCCC
Confidence 9999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=359.37 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=220.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC----CchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|+||+||+|+++.+|..||+|++........ ..+.+.+|+.+++.++||||+++++++.+...++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 579999999999999999999999999999999976643222 3467889999999999999999999999999999
Q ss_pred EEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC---ceEEeccccceec
Q 036739 78 LVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGLARAF 153 (323)
Q Consensus 78 lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~---~~kl~df~~~~~~ 153 (323)
+||||+. |+|.+.+.... .+++..+..++.||+.||.|||+.||+|+||||+||+++.++. .+||+|||++...
T Consensus 92 lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999996 58888876543 5789999999999999999999999999999999999987762 4999999999876
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
....... ...||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||
T Consensus 170 ~~~~~~~------------------------------~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf 218 (361)
T 2yab_A 170 EDGVEFK------------------------------NIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF 218 (361)
T ss_dssp CTTCCCC------------------------------CCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CCCCccc------------------------------cCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCC
Confidence 4322111 1256999999999987 56899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.+....+....+....... .......+++.+++||.+||..||++||++.++++|
T Consensus 219 ~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 219 LGDTKQETLANITAVSYDF-------------------------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCSSHHHHHHHHHTTCCCC-------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHhcCCCC-------------------------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9888777666654321110 112235688999999999999999999999999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||+++++
T Consensus 274 p~~~~~~~ 281 (361)
T 2yab_A 274 PWITPVDT 281 (361)
T ss_dssp TTTSCSSH
T ss_pred cCcCCCch
Confidence 99997653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=353.60 Aligned_cols=290 Identities=37% Similarity=0.705 Sum_probs=221.9
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++++.||+|++|+||+|++..+++.||+|++............+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 58999999999999999999999999999999998655433333466778999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||++|+++..+..... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++. +||+|||.+..........
T Consensus 82 e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV-IKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp ECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECC------
T ss_pred EeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC-EEEeeCCCchhccCccccc
Confidence 9999866665554332 4788999999999999999999999999999999999998887 9999999997754322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....||+.|+|||.+.+...++.++|+||||+++|+|++|..||.+....+
T Consensus 160 -----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 210 (311)
T 4agu_A 160 -----------------------------DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210 (311)
T ss_dssp -----------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----------------------------CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 112558889999999876778999999999999999999999999998888
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCC---CcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPS---KELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
....+....+............ ..+......... .........+++.+.+||.+||+.||++|||+.++++||||+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 289 (311)
T 4agu_A 211 QLYLIRKTLGDLIPRHQQVFST-NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289 (311)
T ss_dssp HHHHHHHHHCSCCHHHHHHHHT-CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred HHHHHHHHhccccccccccccc-ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence 7777666554432211000000 000000000000 011122356889999999999999999999999999999999
Q ss_pred ccccc
Q 036739 318 DVEFV 322 (323)
Q Consensus 318 ~~~~~ 322 (323)
++..+
T Consensus 290 ~~~~~ 294 (311)
T 4agu_A 290 NIREI 294 (311)
T ss_dssp TCC--
T ss_pred hccCH
Confidence 98643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=355.88 Aligned_cols=287 Identities=44% Similarity=0.833 Sum_probs=231.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC---CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|++|.||++++..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 6899999999999999999999889999999998654321 2234578899999999999999999999999999999
Q ss_pred EEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 79 VFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
||||+++++...+.... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++........
T Consensus 90 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 90 VFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCCGGGSTTTSCCC
T ss_pred EEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC-EEEEecccceeccCCcc
Confidence 99999999888876543 35677788999999999999999999999999999999999887 99999999976543221
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.. ....||+.|+|||.+.+...++.++|||||||++|+|++|.+||.+...
T Consensus 168 ~~-----------------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~ 218 (346)
T 1ua2_A 168 AY-----------------------------THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218 (346)
T ss_dssp CC-----------------------------CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cC-----------------------------CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 11 1125589999999998766789999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+.+..+....+.+....|+......+... +..............+++.+.+||.+||+.||++|||+.++++||||++
T Consensus 219 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 219 LDQLTRIFETLGTPTEEQWPDMCSLPDYVT-FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp HHHHHHHHHHHCCCCTTTSSSTTSSTTCCC-CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred HHHHHHHHHHcCCCChhhhhhhccCccccc-ccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 888888888888887777766554443221 1111112222344678899999999999999999999999999999987
Q ss_pred cc
Q 036739 319 VE 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 298 ~~ 299 (346)
T 1ua2_A 298 RP 299 (346)
T ss_dssp SS
T ss_pred CC
Confidence 64
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=360.33 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=217.1
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 78 (323)
+++|++++.||+|+||.||+|+++.+++.||+|++.... ........+.+|..+++.+ .||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999999999999999997653 2333456777899999988 69999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| +|...+.... .+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 102 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~-ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC-EEEccccceeecccCC
Confidence 9999976 8877776543 4789999999999999999999999999999999999999888 9999999986532211
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. ....+||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||....
T Consensus 179 ~~-----------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 179 VT-----------------------------TATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp ------------------------------------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc-----------------------------ccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 11 112367999999999987 568999999999999999999999999988
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH------hhhh
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA------RSAL 311 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~------~~il 311 (323)
..+....+..... .....+++.+.++|.+||+.||++||++ .+++
T Consensus 229 ~~~~~~~i~~~~~-----------------------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il 279 (353)
T 3txo_A 229 EDDLFEAILNDEV-----------------------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAIL 279 (353)
T ss_dssp HHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHH
T ss_pred HHHHHHHHHcCCC-----------------------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHh
Confidence 8777777665210 1113378899999999999999999998 8999
Q ss_pred cCCCCccccc
Q 036739 312 EHEYFRDVEF 321 (323)
Q Consensus 312 ~h~~~~~~~~ 321 (323)
+||||++++|
T Consensus 280 ~hp~f~~~~w 289 (353)
T 3txo_A 280 RHPFFKEIDW 289 (353)
T ss_dssp TSGGGTTCCH
T ss_pred hCCcccCCCH
Confidence 9999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=351.30 Aligned_cols=256 Identities=22% Similarity=0.384 Sum_probs=220.2
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|..+++.++||||+++++++.+...+++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 4789999999999999999999999999999999976532 334456788899999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| +|.+.+.... .+++..++.++.||+.||.|||++|++|+||||+||+++.++. +||+|||++........
T Consensus 85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-~kL~Dfg~a~~~~~~~~ 161 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTY 161 (318)
T ss_dssp ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC-EEECCCSSCEECSSCBC
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC-EEEeecCcceecCCccc
Confidence 999975 8888877643 4788899999999999999999999999999999999999888 99999999976532111
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
...||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.....
T Consensus 162 --------------------------------~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 208 (318)
T 1fot_A 162 --------------------------------TLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208 (318)
T ss_dssp --------------------------------CCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred --------------------------------cccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 1256999999999987 6689999999999999999999999998887
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h 313 (323)
.+....+..... .....+++.+.++|.+||+.||++|| ++.++++|
T Consensus 209 ~~~~~~i~~~~~-----------------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 209 MKTYEKILNAEL-----------------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHHhCCC-----------------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 777766654210 01134788999999999999999999 89999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 260 p~f~~~~~ 267 (318)
T 1fot_A 260 PWFKEVVW 267 (318)
T ss_dssp GGGSSCCH
T ss_pred ccccCCCH
Confidence 99998865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=345.53 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=217.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 589999999999999999999999999999999865432 335678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++..........
T Consensus 98 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 98 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp CCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSTTCCB
T ss_pred CCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC-EEEeeCCCceecCCccccc
Confidence 9965 777777654 4788999999999999999999999999999999999999887 9999999987764332211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.......
T Consensus 174 -----------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 223 (297)
T 3fxz_A 174 -----------------------------STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (297)
T ss_dssp -----------------------------CCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -----------------------------CCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 11256899999999988 568999999999999999999999999887776
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
....+........ .....+++.+.++|.+||+.||++||++.++++||||+...
T Consensus 224 ~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 224 ALYLIATNGTPEL--------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHHHCSCCC--------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHhCCCCCC--------------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 6655544311110 11234788999999999999999999999999999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=371.21 Aligned_cols=282 Identities=36% Similarity=0.616 Sum_probs=221.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 75 (323)
++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 689999999999999999999999999999999976544444456788999999999999999999999654 46
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
+|+||||+++++.+.+.. .+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++.....
T Consensus 142 ~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 142 VYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGT 216 (464)
T ss_dssp EEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCCCC-----
T ss_pred EEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC-EEEEEEEeeeecCC
Confidence 799999999998888764 3788899999999999999999999999999999999999887 99999999976543
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.... ....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 217 ~~~~------------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 217 SFMM------------------------------TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp CCCC----------------------------------CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Cccc------------------------------CCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2111 11356999999999988 5789999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCC-cccccCCCCCCCcccc------------cccCCChHHHHHHHhhcccCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLP-DFKSAFPKWPSKELGT------------VVRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~------------~~~~~s~~~~~li~~~l~~dp~ 302 (323)
.+..+.+.++.+.++.+....+....... .+............+. .....++.+.+||.+||..||+
T Consensus 266 ~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~ 345 (464)
T 3ttj_A 266 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345 (464)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChh
Confidence 99999999888888776544332221100 0000001111100000 0111256799999999999999
Q ss_pred CCCCHhhhhcCCCCccc
Q 036739 303 RRITARSALEHEYFRDV 319 (323)
Q Consensus 303 ~R~s~~~il~h~~~~~~ 319 (323)
+|||+.++|+||||+..
T Consensus 346 ~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 346 KRISVDDALQHPYINVW 362 (464)
T ss_dssp TSCCHHHHHTSTTTGGG
T ss_pred hCCCHHHHhcChhhhhc
Confidence 99999999999999853
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=356.31 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=211.4
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 78 (323)
+++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|..+++++ +||||+++++++.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4689999999999999999999999999999999976543 334456788899999887 89999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| +|...+.... .+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~-ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC-EEEeecceeeecccCC
Confidence 9999976 7777776543 5789999999999999999999999999999999999999988 9999999987532111
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. ....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||....
T Consensus 208 ~~-----------------------------~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~ 257 (396)
T 4dc2_A 208 DT-----------------------------TSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVG 257 (396)
T ss_dssp CC-----------------------------BCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred Cc-----------------------------cccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 11 112367999999999988 668999999999999999999999996432
Q ss_pred h--------HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH--
Q 036739 238 E--------IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA-- 307 (323)
Q Consensus 238 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~-- 307 (323)
. .+......... .......+++.+++||.+||+.||++||++
T Consensus 258 ~~~~~~~~~~~~~~~~i~~~----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~ 309 (396)
T 4dc2_A 258 SSDNPDQNTEDYLFQVILEK----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHP 309 (396)
T ss_dssp C------CCHHHHHHHHHHC----------------------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCST
T ss_pred cccccchhhHHHHHHHHhcc----------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCC
Confidence 1 12222221110 011223578999999999999999999985
Q ss_pred ----hhhhcCCCCccccc
Q 036739 308 ----RSALEHEYFRDVEF 321 (323)
Q Consensus 308 ----~~il~h~~~~~~~~ 321 (323)
.++++||||++++|
T Consensus 310 ~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 310 QTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp TTHHHHHHHSTTTTTCCH
T ss_pred CCCHHHHhcCccccCCCH
Confidence 79999999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=353.15 Aligned_cols=259 Identities=29% Similarity=0.467 Sum_probs=218.3
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 78 (323)
+++|++.+.||+|+||.||+|+++.+++.||+|++..... .......+..|..+++.+ +||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 4799999999999999999999999999999999976532 233456677889998877 89999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| +|.+.+.... .+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 96 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGD 172 (345)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC-EEEeEChhhhhcccCC
Confidence 9999965 8888876543 4788899999999999999999999999999999999999887 9999999987532211
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. ....+||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+..
T Consensus 173 ~~-----------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 173 AK-----------------------------TNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp CC-----------------------------BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cc-----------------------------ccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 10 012366999999999988 568999999999999999999999999888
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh-hhhcCCCC
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR-SALEHEYF 316 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~-~il~h~~~ 316 (323)
..+....+.... . .....+++.+.+||.+||..||++||++. ++++||||
T Consensus 223 ~~~~~~~i~~~~--~---------------------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f 273 (345)
T 1xjd_A 223 EEELFHSIRMDN--P---------------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273 (345)
T ss_dssp HHHHHHHHHHCC--C---------------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred HHHHHHHHHhCC--C---------------------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence 776666654321 0 11134789999999999999999999998 99999999
Q ss_pred ccccc
Q 036739 317 RDVEF 321 (323)
Q Consensus 317 ~~~~~ 321 (323)
++++|
T Consensus 274 ~~~~w 278 (345)
T 1xjd_A 274 REINW 278 (345)
T ss_dssp TTCCH
T ss_pred cCCCH
Confidence 99875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=360.31 Aligned_cols=306 Identities=33% Similarity=0.591 Sum_probs=219.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecC--ceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSE--KKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~l 78 (323)
++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.+. ||||+++++++... ..+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 6899999999999999999999999999999998654433344566778999999997 99999999999754 47899
Q ss_pred EEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 79 VFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
||||++|+|.+.+... .+++..+..++.||+.||.|||+.||+||||||+||+++.++. +||+|||++........
T Consensus 89 v~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 89 VFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEECCSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEESSSCCC
T ss_pred EecccCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC-EEecCCccccccccccc
Confidence 9999999998888763 5788889999999999999999999999999999999999887 99999999987643222
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
........... ...............+||+.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.
T Consensus 165 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 165 VTNNIPLSINE--------NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp CCCCGGGCCC-----------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccc--------cccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 11100000000 0000000111122347799999999998767789999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCc--ccccC---CCCCCCccc-------------ccccCCChHHHHHHHhhcccC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPD--FKSAF---PKWPSKELG-------------TVVRNLEPAGIDLLSKMLCMD 300 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~-------------~~~~~~s~~~~~li~~~l~~d 300 (323)
.+.+..+....+.+....+........ ..... ......... .....+++.+.+||.+||+.|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 888888888777665432211110000 00000 000000000 011257899999999999999
Q ss_pred CCCCCCHhhhhcCCCCccc
Q 036739 301 PSRRITARSALEHEYFRDV 319 (323)
Q Consensus 301 p~~R~s~~~il~h~~~~~~ 319 (323)
|++|||+.++++||||+..
T Consensus 317 P~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 317 PNKRISANDALKHPFVSIF 335 (388)
T ss_dssp GGGSCCHHHHTTSTTTTTT
T ss_pred cccCCCHHHHhCCHHHHHh
Confidence 9999999999999998765
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=344.11 Aligned_cols=286 Identities=48% Similarity=0.858 Sum_probs=235.9
Q ss_pred CCcceeeeeccccceeEEEEEEc-cCCceEEEEEEEecccCCCCchhHHHHHHHHHhc---CCCCeeeeeEEEe-----c
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-VTNETIALKKIRLEQEDEGVPSTAIREISLLKEM---QHGNIVRLQDVVH-----S 72 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~ 72 (323)
++|++.+.||+|++|.||+|++. .+++.||+|++............+.+|+.+++.+ .||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 68999999999999999999985 6788999999977655555556777888887777 8999999999987 5
Q ss_pred CceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 73 EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 73 ~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
....++|+|+++|+|.+.+.......+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+..
T Consensus 91 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~-~kl~Dfg~~~~ 169 (326)
T 1blx_A 91 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARI 169 (326)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECSCCSCCC
T ss_pred CceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC-EEEecCccccc
Confidence 67899999999999999998776666899999999999999999999999999999999999999887 99999999876
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
....... ....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..|
T Consensus 170 ~~~~~~~------------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p 218 (326)
T 1blx_A 170 YSFQMAL------------------------------TSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPL 218 (326)
T ss_dssp CCGGGGG------------------------------CCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCCCc------------------------------cccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCC
Confidence 5321110 11245889999999987 5689999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
|.+....+....+....+.+....++....... ..+..............+++.+.+||.+||+.||++||++.++++
T Consensus 219 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 219 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR--QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG--GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHHcCCCCcccCccccccch--hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 999998888888888877776665554333222 112222222333445678999999999999999999999999999
Q ss_pred CCCCccccc
Q 036739 313 HEYFRDVEF 321 (323)
Q Consensus 313 h~~~~~~~~ 321 (323)
||||++++.
T Consensus 297 hp~~~~~~~ 305 (326)
T 1blx_A 297 HPYFQDLER 305 (326)
T ss_dssp SGGGTTCCC
T ss_pred Cccccccch
Confidence 999998854
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=363.72 Aligned_cols=261 Identities=29% Similarity=0.440 Sum_probs=217.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||+|.+..++..+|+|++............+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 57999999999999999999999999999999997654433345678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC--CCceEEeccccceecCCCcc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR--TNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~--~~~~kl~df~~~~~~~~~~~ 158 (323)
|+.| +|.+.+.... .+++..+..++.||+.||.|||++||+|+||||+||+++.+ +..+||+|||++........
T Consensus 91 ~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 91 LVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp CCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred eCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 9976 8888887654 47899999999999999999999999999999999999842 23499999999976543222
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.. ....||+.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+...
T Consensus 169 ~~-----------------------------~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~ 218 (444)
T 3soa_A 169 AW-----------------------------FGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218 (444)
T ss_dssp BC-----------------------------CCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ee-----------------------------ecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccH
Confidence 11 11256999999999987 5689999999999999999999999998887
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+.........+ ....+++.+.+||.+||+.||++||++.++|+||||++
T Consensus 219 ~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 219 HRLYQQIKAGAYDFPSP-------------------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHHTCCCCCTT-------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHHhCCCCCCcc-------------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 77777666532222111 12457899999999999999999999999999999975
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 274 ~ 274 (444)
T 3soa_A 274 R 274 (444)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=352.89 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=220.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++++.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 478999999999999999999999999999999997653 2334457788999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++........
T Consensus 120 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-~kL~DFg~a~~~~~~~~ 196 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp EECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECSSCBC
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC-EEEcccccceeccCCcc
Confidence 999965 8888877643 4789999999999999999999999999999999999999887 99999999986532211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
...||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.....
T Consensus 197 --------------------------------~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 243 (350)
T 1rdq_E 197 --------------------------------TLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp --------------------------------CCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --------------------------------cccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCH
Confidence 1256999999999987 5689999999999999999999999998887
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----HhhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~h 313 (323)
.+....+..... .....+++.+.++|.+||+.||++||+ +.++++|
T Consensus 244 ~~~~~~i~~~~~-----------------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 244 IQIYEKIVSGKV-----------------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHHHCCC-----------------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHHcCCC-----------------------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 777666654210 111347899999999999999999998 9999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 295 ~~f~~~~w 302 (350)
T 1rdq_E 295 KWFATTDW 302 (350)
T ss_dssp GGGTTCCH
T ss_pred cCcCCCCH
Confidence 99999876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=360.53 Aligned_cols=263 Identities=25% Similarity=0.341 Sum_probs=220.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++++.||+|+||+||+|+++.+++.||+|++.+.. ........+.+|..+++.++||||+++++++.+...+|+||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999999999999999997643 23344567889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+... .+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++.........
T Consensus 149 E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~-ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 149 EYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp CCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCTTSEE
T ss_pred eCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC-EEEeccceeEeeccCCcc
Confidence 99965 887777553 4789999999999999999999999999999999999999888 999999999776433211
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCC---CCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH---YSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~---~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
. ....+||+.|+|||++..... ++.++|+|||||++|+|++|..||.+.
T Consensus 225 ~----------------------------~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 225 R----------------------------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp E----------------------------CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred c----------------------------ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 1 112367999999999987332 778999999999999999999999998
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC--CCCHhhhhcCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR--RITARSALEHE 314 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~--R~s~~~il~h~ 314 (323)
...+...++.+....... +....+++.+++||.+||..+|.+ |+++.+|++||
T Consensus 277 ~~~~~~~~i~~~~~~~~~-------------------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 277 SLVGTYSKIMNHKNSLTF-------------------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp SHHHHHHHHHTHHHHCCC-------------------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred ChhhHHHHHHhccccccC-------------------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 887777776543111100 011247899999999999999988 99999999999
Q ss_pred CCccccc
Q 036739 315 YFRDVEF 321 (323)
Q Consensus 315 ~~~~~~~ 321 (323)
||++++|
T Consensus 332 ~f~~~~w 338 (410)
T 3v8s_A 332 FFKNDQW 338 (410)
T ss_dssp GGCCSSC
T ss_pred cccCCCH
Confidence 9999876
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=354.56 Aligned_cols=256 Identities=30% Similarity=0.439 Sum_probs=213.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 478999999999999999999999999999999987653 2334457888999999999999999999999999999999
Q ss_pred EecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 80 FEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|||++|++.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.........
T Consensus 88 ~E~~~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~-~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp ECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC-EEECCSSCTBTTTTSBTT
T ss_pred EECCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC-EEEEEeccceeccCCccc
Confidence 9999999999887654 4788999999999999999999999999999999999999887 999999998765332111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
. ...||+.|+|||.+.+....+.++||||||+++|+|++|..||......
T Consensus 165 ~------------------------------~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~ 214 (336)
T 3h4j_B 165 K------------------------------TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214 (336)
T ss_dssp C------------------------------CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST
T ss_pred c------------------------------cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH
Confidence 1 1256899999999988555588999999999999999999999764321
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
+... ............+++.+.+||.+||+.||.+|||+.++++||||+.
T Consensus 215 ~~~~-----------------------------~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 215 NLFK-----------------------------KVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp TCBC-----------------------------CCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred HHHH-----------------------------HHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 1100 0001111223458899999999999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=358.57 Aligned_cols=283 Identities=37% Similarity=0.676 Sum_probs=225.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 75 (323)
++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 579999999999999999999999999999999855433333345678899999999999999999999765 35
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
+|+|||+++++|.+.+... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.....
T Consensus 105 ~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQADS 180 (367)
T ss_dssp CEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCS
T ss_pred EEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC-EEEEeeeccccccc
Confidence 6999999988888887763 5788999999999999999999999999999999999999887 99999999987542
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
... ...+|+.|+|||.+.+...++.++|+||+||++|+|++|+.||.+
T Consensus 181 ~~~--------------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 181 EMT--------------------------------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp SCC--------------------------------SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccC--------------------------------cCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 211 124588999999998866789999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCccc--CCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
....+.+..+.+..+.+....+..... ...+...+...............++.+.+||.+||+.||++|||+.++++|
T Consensus 229 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 229 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 998888888888777654432211111 011112223333334445556789999999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||++++
T Consensus 309 p~f~~~~ 315 (367)
T 1cm8_A 309 PYFESLH 315 (367)
T ss_dssp GGGTTTC
T ss_pred hHHHhhc
Confidence 9999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=357.87 Aligned_cols=296 Identities=20% Similarity=0.244 Sum_probs=218.0
Q ss_pred CCcceeeeeccc--cceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 2 DQYEKVEKIGEG--TYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g--~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
++|++++.||+| ++|+||+|++..+++.||+|++............+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 689999999999 999999999999999999999977654444557788899999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| +|.+.+.......+++..+..++.||+.||.|||++||+|+||||+||+++.++. +||+|||.+........
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~-~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK-VYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCGGGCEECEETTE
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEcccccceeeccccc
Confidence 999975 8888887765556899999999999999999999999999999999999998887 99999998765432211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
...... .......||+.|+|||.+.+. ..++.++|||||||++|+|++|..||.+..
T Consensus 184 ~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 184 RQRVVH----------------------DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp ECSCBC----------------------CCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccc----------------------cccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 110000 001112568899999999874 468999999999999999999999998876
Q ss_pred hHHHHHHHHHHhCCCCCCC-------CCCcc----------cCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccC
Q 036739 238 EIDELFKIFRVLGTPNEDT-------WPGVT----------SLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~-------~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~d 300 (323)
..+....+........... +.... .......................+++.+.+||.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 321 (389)
T 3gni_B 242 ATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321 (389)
T ss_dssp STTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCSC
T ss_pred HHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcC
Confidence 6555544332111000000 00000 000000000000111122344568999999999999999
Q ss_pred CCCCCCHhhhhcCCCCcccc
Q 036739 301 PSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 301 p~~R~s~~~il~h~~~~~~~ 320 (323)
|++|||+.++++||||+++.
T Consensus 322 P~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 322 PDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp TTTSCCHHHHTTSGGGGGC-
T ss_pred cccCCCHHHHhcCHHHHHHh
Confidence 99999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=366.93 Aligned_cols=315 Identities=36% Similarity=0.606 Sum_probs=216.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec-----CceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 76 (323)
++|++.+.||+|+||+||+|++..+++.||+|++............+.+|+.+++.++||||+++++++.. ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 68999999999999999999999999999999986544333345678899999999999999999999943 3579
Q ss_pred EEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 77 YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
|+|||+++|+|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 133 ~lv~e~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~-~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 133 YVVLEIADSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYP 209 (458)
T ss_dssp EEEECCCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC-EEECCCTTCBCTTSC
T ss_pred EEEEeccccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC-EeecccccchhccCc
Confidence 9999999999999887643 5789999999999999999999999999999999999999887 999999999876543
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh--------
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-------- 228 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-------- 228 (323)
............ ........+.............+||+.|+|||++.....++.++|||||||++|+|++
T Consensus 210 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 210 ENGNSQLPISPR--EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp TTCCCCCC-----------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred cccccccccCcc--ccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 321110000000 0000000000000001112334779999999998665779999999999999999999
Q ss_pred ---CCCCCCCCC--------------------hHHHHHHHHHHhCCCCCCCCCCccc--CCcccccCCCCCCCccccccc
Q 036739 229 ---QRPLFPGDS--------------------EIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVR 283 (323)
Q Consensus 229 ---g~~p~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 283 (323)
|.++|.+.. ..+.+..+...++.+....+..... ...+...+.............
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 666675543 1344555666666554432221111 001111222222233344456
Q ss_pred CCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccccc
Q 036739 284 NLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVEF 321 (323)
Q Consensus 284 ~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~~ 321 (323)
..++.+.+||.+||..||++|||+.++|+||||+++++
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 67999999999999999999999999999999999854
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=352.23 Aligned_cols=289 Identities=38% Similarity=0.728 Sum_probs=222.0
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++.+.||+|++|.||++++..+++.||+|++............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 47899999999999999999999999999999998655433333456778999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||++|+++..+..... .+++..+..++.||+.||.+||+.|++|+||||+||+++.++. +||+|||.+..........
T Consensus 104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~ 181 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPGEVY 181 (331)
T ss_dssp ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCTTC----------
T ss_pred ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc-EEEEeCCCceeecCCcccc
Confidence 9999877776654433 4789999999999999999999999999999999999998887 9999999987654322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...|++.|+|||.+.+...++.++||||||+++|+|++|..||......+
T Consensus 182 ~-----------------------------~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 232 (331)
T 4aaa_A 182 D-----------------------------DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID 232 (331)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred C-----------------------------CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 1 12458889999999886678999999999999999999999999998888
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccc-cCCCCC-CCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKS-AFPKWP-SKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
....+....+.............+.+.. ...... ..........+++.+.+||.+||+.||++||++.++|+||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 233 QLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred HHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 7777665544432211000000000000 000000 01112233468999999999999999999999999999999987
Q ss_pred cc
Q 036739 319 VE 320 (323)
Q Consensus 319 ~~ 320 (323)
..
T Consensus 313 ~~ 314 (331)
T 4aaa_A 313 DG 314 (331)
T ss_dssp GG
T ss_pred CC
Confidence 54
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=351.46 Aligned_cols=259 Identities=22% Similarity=0.376 Sum_probs=218.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 78 (323)
+++|++++.||+|+||.||+|+++.+++.||+|++..... .......+..|..++..+ +||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4789999999999999999999998999999999976532 334456778899999887 79999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 99 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~-vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc-EEEEeCCcccccccCC
Confidence 9999965 8888876543 4788999999999999999999999999999999999999888 9999999987532211
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. ....+||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+..
T Consensus 176 ~~-----------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 176 VT-----------------------------TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CC-----------------------------BCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc-----------------------------cccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 10 011366999999999987 568999999999999999999999999888
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----Hhhhhc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALE 312 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~ 312 (323)
..+....+..... .....+++.+.+||.+||+.||++||+ +.++++
T Consensus 226 ~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 226 EDELFQSIMEHNV-----------------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHHHHHHhCCC-----------------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 7777666654210 111347899999999999999999994 699999
Q ss_pred CCCCccccc
Q 036739 313 HEYFRDVEF 321 (323)
Q Consensus 313 h~~~~~~~~ 321 (323)
||||++++|
T Consensus 277 h~~f~~~~w 285 (353)
T 2i0e_A 277 HAFFRYIDW 285 (353)
T ss_dssp SGGGTTCCH
T ss_pred CccccCCCH
Confidence 999999876
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=363.12 Aligned_cols=310 Identities=36% Similarity=0.583 Sum_probs=224.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC-----ceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 76 (323)
++|++.+.||+|++|.||+|++..+++.||+|++............+.+|+.+++.++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 689999999999999999999999999999999865443333456788999999999999999999999765 579
Q ss_pred EEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 77 YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
|+|||+++|+|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++......
T Consensus 106 ~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~-~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 106 YIVLEIADSDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSE 182 (432)
T ss_dssp EEEEECCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEEC---
T ss_pred EEEEecCCcCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC-EEEccCCCccccccc
Confidence 9999999999999887643 5789999999999999999999999999999999999999887 999999999877543
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhC-------
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ------- 229 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg------- 229 (323)
............. ................+||+.|+|||.+.....++.++|||||||++|+|++|
T Consensus 183 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 183 KDTNIVNDLEENE-------EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp -----------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred ccccccccccccc-------cccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 3221100000000 00000000001123347799999999986667799999999999999999984
Q ss_pred ----CCCCCCCC-----------------hHHHHHHHHHHhCCCCCCCCCCcccC--CcccccCCCCCCCcccccccCCC
Q 036739 230 ----RPLFPGDS-----------------EIDELFKIFRVLGTPNEDTWPGVTSL--PDFKSAFPKWPSKELGTVVRNLE 286 (323)
Q Consensus 230 ----~~p~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s 286 (323)
.++|.+.. ..+.+..+...++.+....+...... ..+................+.++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 34444332 24555666666666554332221110 01111122222222333446689
Q ss_pred hHHHHHHHhhcccCCCCCCCHhhhhcCCCCccccc
Q 036739 287 PAGIDLLSKMLCMDPSRRITARSALEHEYFRDVEF 321 (323)
Q Consensus 287 ~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~~ 321 (323)
+.+.+||.+||+.||++|||+.++|+||||+++++
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 99999999999999999999999999999999854
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=350.98 Aligned_cols=257 Identities=23% Similarity=0.418 Sum_probs=216.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||++++..++..||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 68999999999999999999999999999999985432 233567899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec--CCCceEEeccccceecCCCcc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~--~~~~~kl~df~~~~~~~~~~~ 158 (323)
|++| +|.+.+... ...+++..+..++.||+.||.|||+.|++|+||||+||+++. ++. +||+|||++........
T Consensus 82 ~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~-~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSST-IKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCC-EEECCCTTCEECCTTCE
T ss_pred eCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCC-EEEEECCCCeECCCCCc
Confidence 9976 888777654 335789999999999999999999999999999999999987 455 99999999987643221
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
. ....||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 160 ~------------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 208 (321)
T 1tki_A 160 F------------------------------RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp E------------------------------EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred c------------------------------ccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCH
Confidence 1 11256899999999987 5679999999999999999999999999887
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+....... .......+++.+.++|.+||..||++|||+.++++||||++
T Consensus 209 ~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 209 QQIIENIMNAEYTF-------------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHHHTCCCC-------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHHHHcCCCCC-------------------------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 77776665532111 11223458899999999999999999999999999999976
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 264 ~ 264 (321)
T 1tki_A 264 K 264 (321)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=345.87 Aligned_cols=261 Identities=28% Similarity=0.416 Sum_probs=218.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC----CchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|+||.||+|++..++..||+|++........ ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 469999999999999999999999999999999976543221 3467889999999999999999999999999999
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC---ceEEeccccceec
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGLARAF 153 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~---~~kl~df~~~~~~ 153 (323)
+||||+.| +|.+.+... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++. .+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 99999965 888877654 35789999999999999999999999999999999999988762 4999999999876
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
....... ...||+.|+|||.+.. ..++.++|+||||+++|+|++|..||
T Consensus 169 ~~~~~~~------------------------------~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf 217 (326)
T 2y0a_A 169 DFGNEFK------------------------------NIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF 217 (326)
T ss_dssp CTTSCCC------------------------------CCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CCCCccc------------------------------cccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 4322111 1246899999999977 56899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.+....+....+....... .......+++.+.+||.+||+.||++||++.++++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 218 LGDTKQETLANVSAVNYEF-------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCSSHHHHHHHHHHTCCCC-------------------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHhcCCCc-------------------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9887776666554421110 112234578999999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||++..
T Consensus 273 p~~~~~~ 279 (326)
T 2y0a_A 273 PWIKPKD 279 (326)
T ss_dssp TTTSCCS
T ss_pred CCccCCc
Confidence 9998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=360.66 Aligned_cols=266 Identities=23% Similarity=0.358 Sum_probs=221.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++++.||+|+||+||+++++.+++.||+|++.... ........+.+|..+++.++||||+++++++.+.+.+|+||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999997643 22334456889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++.........
T Consensus 154 Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~-vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCTTSCE
T ss_pred ecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC-EEEcchhhhhhcccCCCc
Confidence 99965 8887776533 35799999999999999999999999999999999999999888 999999999765432221
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhh----CCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILL----GSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~----~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
. ....+||+.|+|||++. +...++.++|+|||||++|+|++|..||.+
T Consensus 232 ~----------------------------~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 232 Q----------------------------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp E----------------------------CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred c----------------------------cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 1 11136799999999987 235689999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC--CCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR--RITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~--R~s~~~il~h 313 (323)
....+...++........ .+.....+++.+++||++||..+|++ |+++.++++|
T Consensus 284 ~~~~~~~~~i~~~~~~~~------------------------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 284 ESLVETYGKIMNHKERFQ------------------------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp SSHHHHHHHHHTHHHHCC------------------------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred CChhHHHHhhhhcccccc------------------------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 888877777654211110 01112347899999999999998888 9999999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 340 pff~~i~w 347 (437)
T 4aw2_A 340 PFFSGIDW 347 (437)
T ss_dssp GGGTTCCT
T ss_pred CccCCCCH
Confidence 99999876
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=352.96 Aligned_cols=260 Identities=31% Similarity=0.435 Sum_probs=217.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||.||++.+..++..||+|++............+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 47999999999999999999999999999999997654433344678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEeccccceecCCCcc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~~~~~~~~ 158 (323)
|+.| +|.+.+.... .+++..+..++.||+.||.|||+.||+|+||||+||+++.++. .+||+|||++........
T Consensus 109 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 109 LVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp CCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 9976 8888876543 5789999999999999999999999999999999999976432 499999999876542211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
. ....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.....
T Consensus 187 ~------------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 235 (362)
T 2bdw_A 187 W------------------------------HGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235 (362)
T ss_dssp C------------------------------CCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred c------------------------------ccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 1 01256999999999987 5689999999999999999999999998887
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+........ ......+++.+.+||.+||+.||++||++.++++||||.+
T Consensus 236 ~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 236 HRLYAQIKAGAYDYP-------------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHHTCCCCC-------------------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHhCCCCCC-------------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 766666554321111 1122457899999999999999999999999999999975
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 291 ~ 291 (362)
T 2bdw_A 291 R 291 (362)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=345.81 Aligned_cols=262 Identities=30% Similarity=0.471 Sum_probs=211.4
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++.+.||+|+||+||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999999865432 223467889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.........
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC-EEEEEeeccceeccCCcc
Confidence 99976 7777765443 4788999999999999999999999999999999999999887 999999999765322211
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.. .....||+.|+|||.+.+....+.++||||||+++|+|++|..||......
T Consensus 162 ~~---------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 214 (323)
T 3tki_A 162 RL---------------------------LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (323)
T ss_dssp CC---------------------------BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred cc---------------------------cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 10 111356999999999988555688999999999999999999999876654
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
............ .......+++.+.+||.+||+.||++||++.++++||||+..
T Consensus 215 ~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 215 CQEYSDWKEKKT--------------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp SHHHHHHHTTCT--------------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHhcccc--------------------------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 333222221000 001124578999999999999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=357.51 Aligned_cols=283 Identities=38% Similarity=0.663 Sum_probs=215.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 75 (323)
++|++++.||+|++|.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 689999999999999999999999999999999865433333446777899999999999999999999654 56
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
.++++|+++++|.+.+.. ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.....
T Consensus 109 ~~lv~e~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~-~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTAD 184 (367)
T ss_dssp CEEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECC---------
T ss_pred EEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC-EEEeeccccccccc
Confidence 899999998888877754 25789999999999999999999999999999999999999887 99999999876432
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
... ...||+.|+|||.+.+...++.++|||||||++|+|++|+.||.+
T Consensus 185 ~~~--------------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 185 EMT--------------------------------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp --------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCC--------------------------------CcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 111 125588999999998767789999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccC--CcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSL--PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.+..+.+..+.+..+.+....+...... ..+...................++.+.+||.+||+.||++||++.++|+|
T Consensus 233 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 9988888888888777654433222211 11112222223333344456788999999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||++..
T Consensus 313 p~~~~~~ 319 (367)
T 2fst_X 313 AYFAQYH 319 (367)
T ss_dssp GGGTTTC
T ss_pred hhhhhcc
Confidence 9999763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=354.96 Aligned_cols=281 Identities=31% Similarity=0.619 Sum_probs=219.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec---------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--------- 72 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 72 (323)
++|++.+.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 68999999999999999999999999999999885432 223479999999999999999999843
Q ss_pred -----------------------------CceEEEEEecchhhHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 036739 73 -----------------------------EKKLYLVFEYLDLDLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSH 121 (323)
Q Consensus 73 -----------------------------~~~~~lv~e~~~g~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 121 (323)
...+++||||++|++.+.+.. .....+++..++.++.||+.||.|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp -----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345899999999987766653 2334678999999999999999999999
Q ss_pred CcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccc
Q 036739 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAP 201 (323)
Q Consensus 122 ~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 201 (323)
||+|+||||+||+++.....+||+|||.+.......... ...||+.|+||
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~------------------------------~~~~t~~y~aP 210 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV------------------------------AYICSRFYRAP 210 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC------------------------------CCCCCSSCCCH
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc------------------------------CcccCCCccCH
Confidence 999999999999998544459999999998764332211 12458889999
Q ss_pred hhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCc-ccc
Q 036739 202 EILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKE-LGT 280 (323)
Q Consensus 202 E~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 280 (323)
|.+.+...++.++||||+||++|+|++|..||.+....+.+..+.+..+.+....+......- ....+....... ...
T Consensus 211 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 289 (383)
T 3eb0_A 211 ELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHY-TEVRFPTLKAKDWRKI 289 (383)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC---CCCCCCCCCCHHHH
T ss_pred HHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccc-ccccCCccCcccHHhh
Confidence 999886678999999999999999999999999999988888888877765443211110000 000111111111 112
Q ss_pred cccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 281 VVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 281 ~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
....+++.+.+||.+||+.||++|||+.++++||||+++
T Consensus 290 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 290 LPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp SCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 334588999999999999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=351.64 Aligned_cols=260 Identities=23% Similarity=0.426 Sum_probs=214.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++++.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 478999999999999999999999999999999997653 2344557788999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| +|...+.... .+++..++.++.||+.||.|||+.||+|+||||+||+++.++. +||+|||++........
T Consensus 94 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~-vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQ 170 (384)
T ss_dssp ECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCTTCC
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC-EEEeccceeeeccCCCc
Confidence 999966 7777776543 5789999999999999999999999999999999999999888 99999999987643221
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC--CCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS--RHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.. ...||+.|+|||.+... ..++.++|+|||||++|+|++|..||...
T Consensus 171 ~~------------------------------~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 171 IT------------------------------TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp BC------------------------------CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ee------------------------------ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 11 13569999999998752 35789999999999999999999999754
Q ss_pred ChHH--HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-HhhhhcC
Q 036739 237 SEID--ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-ARSALEH 313 (323)
Q Consensus 237 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-~~~il~h 313 (323)
.... .......... ......+++.+.+||.+||+.||++||+ +.++++|
T Consensus 221 ~~~~~~~~~~~~~~~~----------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 221 SSTSSKEIVHTFETTV----------------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp TTSCHHHHHHHHHHCC----------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred CCccHHHHHHHHhhcc----------------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 3322 2222211110 0112347899999999999999999998 8999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 273 p~f~~~~w 280 (384)
T 4fr4_A 273 PYMNDINW 280 (384)
T ss_dssp GGGTTCCH
T ss_pred hhhhcCCH
Confidence 99999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=348.17 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=211.3
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 78 (323)
+++|++++.||+|+||.||+|+++.+++.||+|++...... ......+.+|..+++++ +||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 47899999999999999999999999999999999765432 22345677899999888 89999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| +|...+.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++. +||+|||++.......
T Consensus 88 v~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC-EEEEeccccccccCCC
Confidence 9999965 8877776543 5789999999999999999999999999999999999999887 9999999987532211
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. .....||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||....
T Consensus 165 ~~-----------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~ 214 (345)
T 3a8x_A 165 DT-----------------------------TSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214 (345)
T ss_dssp CC-----------------------------BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred Cc-----------------------------ccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence 10 011356999999999988 568999999999999999999999996531
Q ss_pred h--------HHHH-HHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH-
Q 036739 238 E--------IDEL-FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA- 307 (323)
Q Consensus 238 ~--------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~- 307 (323)
. .... ..+... . ......+++.+.++|.+||+.||++||++
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~--~---------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 265 (345)
T 3a8x_A 215 SSDNPDQNTEDYLFQVILEK--Q---------------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCH 265 (345)
T ss_dssp C-------CHHHHHHHHHHC--C---------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCC
T ss_pred cccccccccHHHHHHHHHcC--C---------------------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCC
Confidence 1 1112 222211 0 01123578999999999999999999996
Q ss_pred -----hhhhcCCCCccccc
Q 036739 308 -----RSALEHEYFRDVEF 321 (323)
Q Consensus 308 -----~~il~h~~~~~~~~ 321 (323)
.++++||||++++|
T Consensus 266 ~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 266 PQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp TTTHHHHHHTSGGGTTCCH
T ss_pred CcCCHHHHhcCCccCCCCH
Confidence 79999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=341.10 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=205.4
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC------------------------CCCchhHHHHHHHHH
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED------------------------EGVPSTAIREISLLK 56 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~------------------------~~~~~~~~~e~~~l~ 56 (323)
+++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47899999999999999999999999999999998655321 112467889999999
Q ss_pred hcCCCCeeeeeEEEec--CceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 036739 57 EMQHGNIVRLQDVVHS--EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLL 134 (323)
Q Consensus 57 ~l~~~~i~~~~~~~~~--~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil 134 (323)
.++||||+++++++.+ +...++||||++++.+..+.. ...+++..+..++.||+.||.|||+.|++|+||||+||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 9999999999999986 678999999998643333332 235789999999999999999999999999999999999
Q ss_pred EecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCC--CCC
Q 036739 135 IDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH--YST 212 (323)
Q Consensus 135 ~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~ 212 (323)
++.++. +||+|||++.......... ....||+.|+|||.+.+... .+.
T Consensus 170 ~~~~~~-~kl~Dfg~~~~~~~~~~~~-----------------------------~~~~gt~~y~aPE~~~~~~~~~~~~ 219 (298)
T 2zv2_A 170 VGEDGH-IKIADFGVSNEFKGSDALL-----------------------------SNTVGTPAFMAPESLSETRKIFSGK 219 (298)
T ss_dssp ECTTSC-EEECCCTTCEECSSSSCEE-----------------------------CCCCSCGGGCCGGGCCTTCCCEESH
T ss_pred ECCCCC-EEEecCCCccccccccccc-----------------------------cCCcCCccccChhhhccCCCCCCCc
Confidence 999887 9999999997764322111 11256899999999876432 477
Q ss_pred chhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHH
Q 036739 213 PVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292 (323)
Q Consensus 213 ~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 292 (323)
++||||||+++|+|++|..||...........+....... +....+++.+.++
T Consensus 220 ~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~l 272 (298)
T 2zv2_A 220 ALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF---------------------------PDQPDIAEDLKDL 272 (298)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------------------------CSSSCCCHHHHHH
T ss_pred hhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCC---------------------------CCccccCHHHHHH
Confidence 8999999999999999999998877655544443311000 0113478999999
Q ss_pred HHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 293 LSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 293 i~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
|.+||+.||++||++.++++||||+.
T Consensus 273 i~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 273 ITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHhhcChhhCCCHHHHhcCccccC
Confidence 99999999999999999999999963
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=353.16 Aligned_cols=281 Identities=38% Similarity=0.663 Sum_probs=225.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE-----
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL----- 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----- 76 (323)
++|++.+.||+|++|+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 589999999999999999999999999999999865443333456778899999999999999999999876654
Q ss_pred -EEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 77 -YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 -~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
++||||+++++.+.+.. .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+.....
T Consensus 122 ~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~-~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHADA 196 (371)
T ss_dssp CEEEEECCCEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECSTTCC-----
T ss_pred EEEEEccccccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC-EEEEecCccccccc
Confidence 99999999998887743 3789999999999999999999999999999999999999887 99999999875432
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
... ...||+.|+|||.+.+...++.++||||||+++|+|++|..||.+
T Consensus 197 ~~~--------------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 197 EMT--------------------------------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp -----------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcC--------------------------------CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 211 124588899999998767789999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCccc--CCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
....+....+....+.+....+..... ...+..................+++.+.+||.+||+.||++||++.++++|
T Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 245 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 998888888877766654332221111 001111222222233334445689999999999999999999999999999
Q ss_pred CCCccc
Q 036739 314 EYFRDV 319 (323)
Q Consensus 314 ~~~~~~ 319 (323)
|||+.+
T Consensus 325 p~f~~~ 330 (371)
T 4exu_A 325 PFFEPF 330 (371)
T ss_dssp GGGTTT
T ss_pred cccccC
Confidence 999976
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=358.42 Aligned_cols=265 Identities=26% Similarity=0.365 Sum_probs=218.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++++.||+|+||.||+++++.+++.||+|++.+... .......+.+|..++..++||||+++++++++.+.+|+||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 689999999999999999999999999999999975421 2233456888999999999999999999999999999999
Q ss_pred ecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+. |+|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++.........
T Consensus 141 E~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~-vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCTTSCE
T ss_pred cCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC-EEEeechhheeccCCCcc
Confidence 9995 58888876532 25789999999999999999999999999999999999999888 999999999876433221
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC------CCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG------SRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
. ....+||+.|+|||++.. ...++.++|+|||||++|+|++|+.||
T Consensus 219 ~----------------------------~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 270 (412)
T 2vd5_A 219 R----------------------------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270 (412)
T ss_dssp E----------------------------CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred c----------------------------cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence 1 112367999999999873 256899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCC---CCHhhh
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRR---ITARSA 310 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R---~s~~~i 310 (323)
......+...++.+...... .+.....+++.+++||++||. +|++| +++.++
T Consensus 271 ~~~~~~~~~~~i~~~~~~~~------------------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei 325 (412)
T 2vd5_A 271 YADSTAETYGKIVHYKEHLS------------------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF 325 (412)
T ss_dssp CCSSHHHHHHHHHTHHHHCC------------------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH
T ss_pred CCCCHHHHHHHHHhcccCcC------------------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence 99888777766654211100 011123588999999999999 99998 599999
Q ss_pred hcCCCCccccc
Q 036739 311 LEHEYFRDVEF 321 (323)
Q Consensus 311 l~h~~~~~~~~ 321 (323)
++||||++++|
T Consensus 326 ~~Hpff~~i~w 336 (412)
T 2vd5_A 326 RTHPFFFGLDW 336 (412)
T ss_dssp HTSGGGTTCCS
T ss_pred hcCCCcCCCCH
Confidence 99999999876
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=342.48 Aligned_cols=263 Identities=24% Similarity=0.397 Sum_probs=219.0
Q ss_pred CCccee-eeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEE
Q 036739 2 DQYEKV-EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 2 ~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 79 (323)
++|.+. +.||+|+||+||++++..+++.||+|++............+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 357777 8999999999999999999999999999766555555678889999999995 69999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec---CCCceEEeccccceecCC
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGLARAFGI 155 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~---~~~~~kl~df~~~~~~~~ 155 (323)
|||+.| +|.+.+.......+++..+..++.||+.||.+||+.|++|+||||+||+++. ++. +||+|||++.....
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~-~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGD-IKIVDFGMSRKIGH 186 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCC-EEECCGGGCEEC--
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCc-EEEeeCccccccCC
Confidence 999976 7777776655567899999999999999999999999999999999999987 555 99999999987643
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
..... ...||+.|+|||.+.. ..++.++|+||||+++|+|++|..||..
T Consensus 187 ~~~~~------------------------------~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 187 ACELR------------------------------EIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp -------------------------------------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccc------------------------------cccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22111 1246899999999987 5689999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
....+....+......... .....+++.+.++|.+||+.||++||++.++++|||
T Consensus 236 ~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 236 EDNQETYLNISQVNVDYSE-------------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp SSHHHHHHHHHHTCCCCCT-------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred CCchHHHHHHHhcccccCc-------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 8877776666553222111 112457889999999999999999999999999999
Q ss_pred Cccccc
Q 036739 316 FRDVEF 321 (323)
Q Consensus 316 ~~~~~~ 321 (323)
|++.+|
T Consensus 291 ~~~~~~ 296 (327)
T 3lm5_A 291 LQQWDF 296 (327)
T ss_dssp GCCCCT
T ss_pred hccccc
Confidence 998865
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=342.53 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=207.0
Q ss_pred CCcceeeeeccccceeEEEEEEc---cCCceEEEEEEEeccc--CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC---VTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|+||.||++++. .+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 68999999999999999999975 5788999999865432 223446677899999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
++||||+.| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC-EEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc-EEEEeCCccccccc
Confidence 999999975 8877776543 4688889999999999999999999999999999999999887 99999999865322
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.... .....||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 174 ~~~~-----------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 174 DGTV-----------------------------THTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp ----------------------------------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCcc-----------------------------ccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 1110 011256899999999987 5689999999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhh
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSA 310 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~i 310 (323)
....+....+..... .....+++.+.++|.+||+.||++|| ++.++
T Consensus 224 ~~~~~~~~~i~~~~~-----------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~ 274 (327)
T 3a62_A 224 ENRKKTIDKILKCKL-----------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEV 274 (327)
T ss_dssp SSHHHHHHHHHHTCC-----------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHH
T ss_pred CCHHHHHHHHHhCCC-----------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHH
Confidence 887777666654210 11134788999999999999999999 88999
Q ss_pred hcCCCCccccc
Q 036739 311 LEHEYFRDVEF 321 (323)
Q Consensus 311 l~h~~~~~~~~ 321 (323)
++||||++++|
T Consensus 275 l~hp~f~~~~~ 285 (327)
T 3a62_A 275 QAHPFFRHINW 285 (327)
T ss_dssp HHSGGGSSCCH
T ss_pred HcCCcccCCCH
Confidence 99999998865
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=350.42 Aligned_cols=287 Identities=38% Similarity=0.678 Sum_probs=228.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC-----ceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 76 (323)
++|++++.||+|++|.||+|.+..++..||+|++... ........+.+|+.++++++||||+++++++... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 5899999999999999999999999999999998532 2222336678899999999999999999999654 478
Q ss_pred EEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 77 YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
++|+|+++|+|.+.+... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||.+......
T Consensus 106 ~iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPD 181 (364)
T ss_dssp EEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCGG
T ss_pred EEEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC-EEEEeCcceEecCCC
Confidence 999999999999888764 4788999999999999999999999999999999999999887 999999999876432
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
...... .....||+.|+|||.+.+...++.++|||||||++|+|++|..||.+.
T Consensus 182 ~~~~~~--------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 235 (364)
T 3qyz_A 182 HDHTGF--------------------------LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235 (364)
T ss_dssp GCBCCT--------------------------TCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcccc--------------------------ccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence 221110 011256999999999877677899999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCC--cccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLP--DFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
...+....+....+.+....+....... .+..................+++.+.+||.+||+.||++||++.++++||
T Consensus 236 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 236 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp SGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 9888888887776665443221111100 00111111111222334456889999999999999999999999999999
Q ss_pred CCccc
Q 036739 315 YFRDV 319 (323)
Q Consensus 315 ~~~~~ 319 (323)
||++.
T Consensus 316 ~~~~~ 320 (364)
T 3qyz_A 316 YLEQY 320 (364)
T ss_dssp GGTTT
T ss_pred chhhc
Confidence 99975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=355.27 Aligned_cols=280 Identities=35% Similarity=0.658 Sum_probs=219.2
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec------CceE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS------EKKL 76 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (323)
+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++.. ...+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 6999999999999999999999999999999885432 233479999999999999999999853 2357
Q ss_pred EEEEecchhhHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 77 YLVFEYLDLDLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
++||||+.+++.+.+.. .....+++..+..++.||+.||.|||+.||+|+||||+|||++.++..+||+|||++....
T Consensus 129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 89999999887766543 2234678999999999999999999999999999999999999776668999999998754
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
...... ...||+.|+|||.+.+...++.++|||||||++|+|++|+.||.
T Consensus 209 ~~~~~~------------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~ 258 (420)
T 1j1b_A 209 RGEPNV------------------------------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258 (420)
T ss_dssp TTCCCC------------------------------SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCce------------------------------eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 322111 12458899999999876678999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCccc-CCcccccCCCCCCCccc-ccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTS-LPDFKSAFPKWPSKELG-TVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+.+.++.+.++.+..+.+..... ...+ .+......... .....+++.+.+||.+||..||++||++.++++
T Consensus 259 ~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 259 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 9988888888888776654332211100 0000 01111111111 122457899999999999999999999999999
Q ss_pred CCCCcccc
Q 036739 313 HEYFRDVE 320 (323)
Q Consensus 313 h~~~~~~~ 320 (323)
||||++++
T Consensus 337 hp~f~~~~ 344 (420)
T 1j1b_A 337 HSFFDELR 344 (420)
T ss_dssp SGGGGGGG
T ss_pred CHhhcccc
Confidence 99998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=349.98 Aligned_cols=279 Identities=27% Similarity=0.385 Sum_probs=218.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-----CCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-----HGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~ 76 (323)
++|++++.||+|+||+||+|++..+++.||+|++.... .....+..|+.+++.+. ||||+++++++...+..
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK---KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH---HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch---hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 68999999999999999999999999999999985321 22356677999999997 99999999999999999
Q ss_pred EEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec-------------------
Q 036739 77 YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR------------------- 137 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~------------------- 137 (323)
++|||+++++|.+.+.......+++..+..++.||+.||.|||++||+|+||||+||+++.
T Consensus 112 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 112 CLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 9999999889999998877667899999999999999999999999999999999999974
Q ss_pred ------CCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCC
Q 036739 138 ------RTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYS 211 (323)
Q Consensus 138 ------~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 211 (323)
++. +||+|||++........ ...||+.|+|||.+.+ ..++
T Consensus 192 ~~~~~~~~~-~kl~DFG~a~~~~~~~~--------------------------------~~~gt~~y~aPE~~~~-~~~~ 237 (360)
T 3llt_A 192 QIYRTKSTG-IKLIDFGCATFKSDYHG--------------------------------SIINTRQYRAPEVILN-LGWD 237 (360)
T ss_dssp EEEEESCCC-EEECCCTTCEETTSCCC--------------------------------SCCSCGGGCCHHHHTT-CCCC
T ss_pred cccccCCCC-EEEEeccCceecCCCCc--------------------------------CccCcccccCcHHHcC-CCCC
Confidence 444 99999999976432211 1245889999999988 5689
Q ss_pred CchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCccc--------CCcccccCCCCCC--------
Q 036739 212 TPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTS--------LPDFKSAFPKWPS-------- 275 (323)
Q Consensus 212 ~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~-------- 275 (323)
.++|||||||++|+|++|..||......+....+...........+..... .............
T Consensus 238 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 317 (360)
T 3llt_A 238 VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV 317 (360)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHH
T ss_pred CccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhh
Confidence 999999999999999999999999888887777766554433211100000 0000000000000
Q ss_pred -CcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 276 -KELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 276 -~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
...+......++.+.+||.+||+.||++|||+.++|+||||+
T Consensus 318 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 000111123457888999999999999999999999999996
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=349.05 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=208.9
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHH-HHhcCCCCeeeeeEEEecCceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISL-LKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
+++|++++.||+|+||.||+|+++.++..||+|++.+... .......+..|..+ ++.++||||+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3689999999999999999999999999999999976643 22233455566665 567899999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| +|.+.+.... .+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~-ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC-EEEeeCccccccccCC
Confidence 9999976 8877776543 4688889999999999999999999999999999999999888 9999999986532111
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. ....+||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||....
T Consensus 194 ~~-----------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 194 ST-----------------------------TSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp CC-----------------------------CCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred Cc-----------------------------cccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 10 112367999999999987 668999999999999999999999999888
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH----hhhhcC
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA----RSALEH 313 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~----~~il~h 313 (323)
..+....+..... .....+++.+.+||.+||+.||++||++ .++++|
T Consensus 244 ~~~~~~~i~~~~~-----------------------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 244 TAEMYDNILNKPL-----------------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp HHHHHHHHHHSCC-----------------------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred HHHHHHHHHhccc-----------------------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 7777766654210 1123478999999999999999999987 589999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 295 ~~f~~~~w 302 (373)
T 2r5t_A 295 VFFSLINW 302 (373)
T ss_dssp GGGTTCCH
T ss_pred ccccCCCH
Confidence 99999876
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=333.64 Aligned_cols=262 Identities=31% Similarity=0.432 Sum_probs=219.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 68999999999999999999999999999999997665444445678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEeccccceecCCCcc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~~~~~~~~ 158 (323)
|+.| ++.+.+.... .+++..+..++.|++.||.+||++|++|+||||+||+++.++. .+||+|||.+........
T Consensus 86 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 86 LVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 9976 7777776643 4788899999999999999999999999999999999976543 499999999976543222
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.. ...||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 164 ~~------------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 212 (284)
T 3kk8_A 164 WH------------------------------GFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQ 212 (284)
T ss_dssp CC------------------------------CSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cc------------------------------CCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCch
Confidence 11 1245889999999987 5689999999999999999999999998887
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
......+......... .....+++.+.++|.+||+.||++||++.++++||||++
T Consensus 213 ~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 213 HRLYAQIKAGAYDYPS-------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp HHHHHHHHHTCCCCCT-------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred hHHHHHHHhccccCCc-------------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 7766665543221111 112357899999999999999999999999999999998
Q ss_pred ccc
Q 036739 319 VEF 321 (323)
Q Consensus 319 ~~~ 321 (323)
...
T Consensus 268 ~~~ 270 (284)
T 3kk8_A 268 RER 270 (284)
T ss_dssp CCC
T ss_pred Chh
Confidence 653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=340.11 Aligned_cols=261 Identities=27% Similarity=0.404 Sum_probs=218.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC----CchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|++|.||+|++..++..||+|++........ ..+.+.+|+.+++.+.||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 479999999999999999999999999999999976543222 3467889999999999999999999999999999
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC---ceEEeccccceec
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGLARAF 153 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~---~~kl~df~~~~~~ 153 (323)
+||||+.| +|.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. .+||+|||.+...
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999965 8888776543 5788899999999999999999999999999999999988772 4999999999776
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
....... ...||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||
T Consensus 170 ~~~~~~~------------------------------~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf 218 (321)
T 2a2a_A 170 EDGVEFK------------------------------NIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF 218 (321)
T ss_dssp CTTCCCC------------------------------CCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred Ccccccc------------------------------ccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCC
Confidence 4322111 1245889999999987 56899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
......+....+....... .......+++.+.++|.+||+.||++||++.++++|
T Consensus 219 ~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 219 LGDTKQETLANITSVSYDF-------------------------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCSSHHHHHHHHHTTCCCC-------------------------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHhccccc-------------------------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9887766665544321100 112234578899999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||++++
T Consensus 274 p~~~~~~ 280 (321)
T 2a2a_A 274 PWITPVD 280 (321)
T ss_dssp TTTSCSS
T ss_pred ccccCCC
Confidence 9999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=347.05 Aligned_cols=263 Identities=29% Similarity=0.463 Sum_probs=213.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc---CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE---DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|+||+||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 479999999999999999999999999999999875432 22245778899999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEeccccceec
Q 036739 79 VFEYLDL-DLKKHMDSC--PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAF 153 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~~~ 153 (323)
||||++| +|.+.+... ....+++..+..++.||+.||.|||++|++|+||||+||+++.++. .+||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 9999975 777766543 2345789999999999999999999999999999999999976543 4999999999876
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
....... ....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||
T Consensus 184 ~~~~~~~-----------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf 233 (351)
T 3c0i_A 184 GESGLVA-----------------------------GGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPF 233 (351)
T ss_dssp CTTSCBC-----------------------------CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCeee-----------------------------cCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCC
Confidence 4322111 11256999999999987 56899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.... .+....+....... .......+++.+.+||.+||+.||++||++.++++|
T Consensus 234 ~~~~-~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 234 YGTK-ERLFEGIIKGKYKM-------------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CSSH-HHHHHHHHHTCCCC-------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCcH-HHHHHHHHcCCCCC-------------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 8753 23333333311100 111224578999999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||++.+
T Consensus 288 p~~~~~~ 294 (351)
T 3c0i_A 288 PWLKERD 294 (351)
T ss_dssp HHHHTHH
T ss_pred hhhcCCc
Confidence 9998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=358.69 Aligned_cols=259 Identities=26% Similarity=0.396 Sum_probs=208.9
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 368999999999999999999999999999999997653 2333446677899999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
|||++| +|...+.... .+++..+..++.||+.||.|||+ .||+|+||||+||+++.++. +||+|||++.......
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDG 303 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC-EEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC-EEEccCCCceeccCCC
Confidence 999976 7777776543 57889999999999999999998 99999999999999999887 9999999986432211
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. .....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||....
T Consensus 304 ~~-----------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 304 AT-----------------------------MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp --------------------------------CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc-----------------------------cccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 11 111366999999999987 668999999999999999999999999887
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALE 312 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~ 312 (323)
.......+..... .....+++.+.+||.+||+.||.+|| ++.++++
T Consensus 354 ~~~~~~~i~~~~~-----------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 354 HEKLFELILMEEI-----------------------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHhCCC-----------------------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 7666665543110 11234789999999999999999999 9999999
Q ss_pred CCCCccccc
Q 036739 313 HEYFRDVEF 321 (323)
Q Consensus 313 h~~~~~~~~ 321 (323)
||||++++|
T Consensus 405 hp~f~~~~~ 413 (446)
T 4ejn_A 405 HRFFAGIVW 413 (446)
T ss_dssp SGGGTTCCH
T ss_pred CccccCCCH
Confidence 999999865
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=353.12 Aligned_cols=282 Identities=35% Similarity=0.598 Sum_probs=212.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc------e
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK------K 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~ 75 (323)
++|++.+.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 6899999999999999999999999999999998755433334467788999999999999999999997654 7
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
.++||||++|++.+.+.. .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.....
T Consensus 105 ~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 105 VYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEECCSEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECCCCC------
T ss_pred eEEEEEcCCCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC-EEEEEeeccccccc
Confidence 899999999999888863 4788889999999999999999999999999999999999887 99999999876532
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.... ....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+
T Consensus 180 ~~~~------------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 180 SFMM------------------------------TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp ----------------------------------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc------------------------------CCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2110 11256899999999988 5689999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccC-CcccccCCCCCCCc------------ccccccCCChHHHHHHHhhcccCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSL-PDFKSAFPKWPSKE------------LGTVVRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~------------~~~~~~~~s~~~~~li~~~l~~dp~ 302 (323)
.+..+....+.+..+.+....+...... ..+........... ........++.+++||.+||+.||+
T Consensus 229 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 308 (371)
T 2xrw_A 229 TDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308 (371)
T ss_dssp SSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGG
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChh
Confidence 8888777777665444332211111000 00000000000000 0001112356799999999999999
Q ss_pred CCCCHhhhhcCCCCccc
Q 036739 303 RRITARSALEHEYFRDV 319 (323)
Q Consensus 303 ~R~s~~~il~h~~~~~~ 319 (323)
+|||+.++++||||+..
T Consensus 309 ~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 309 KRISVDEALQHPYINVW 325 (371)
T ss_dssp GSCCHHHHHHSHHHHTT
T ss_pred hCCCHHHHhCCcchhhh
Confidence 99999999999999853
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=347.43 Aligned_cols=259 Identities=23% Similarity=0.435 Sum_probs=215.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch--hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 579999999999999999999999999999999864421 123568899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC-CCceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~-~~~~kl~df~~~~~~~~~~~~ 159 (323)
|+.| +|.+.+... ...+++..+..++.||+.||.|||++|++|+||||+||+++.+ ...+||+|||++.........
T Consensus 129 ~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 129 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred cCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 9976 777776644 3457899999999999999999999999999999999999743 234999999999876432211
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
. ...||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+....
T Consensus 208 ~------------------------------~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 256 (387)
T 1kob_A 208 K------------------------------VTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256 (387)
T ss_dssp E------------------------------EECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred e------------------------------eeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH
Confidence 1 1245899999999987 66899999999999999999999999988877
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+....+........ ......+++.+.+||.+||+.||++||++.++++||||++.
T Consensus 257 ~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 257 ETLQNVKRCDWEFD-------------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp HHHHHHHHCCCCCC-------------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHhCCCCCC-------------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 66665544211110 11224578999999999999999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=345.52 Aligned_cols=285 Identities=33% Similarity=0.590 Sum_probs=220.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCC---------chhHHHHHHHHHhcCCCCeeeeeEEEe-
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGV---------PSTAIREISLLKEMQHGNIVRLQDVVH- 71 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~- 71 (323)
++|++.+.||+|++|.||++.+. ++..||+|++......... ...+.+|+.++++++||||+++++++.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 68999999999999999999985 4899999998655433222 267889999999999999999999984
Q ss_pred ----cCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 72 ----SEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 72 ----~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
....+++||||++|++.+.+.... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+||
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-~kl~Df 178 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND-ITICDF 178 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCT
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC-EEEEec
Confidence 344789999999999999988653 35789999999999999999999999999999999999998887 999999
Q ss_pred ccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH
Q 036739 148 GLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~ 227 (323)
|.+.......... ...||+.|+|||.+.+...++.++|+|||||++|+|+
T Consensus 179 g~~~~~~~~~~~~------------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 228 (362)
T 3pg1_A 179 NLAREDTADANKT------------------------------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228 (362)
T ss_dssp TC---------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred Ccccccccccccc------------------------------eecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH
Confidence 9986433221111 1245888999999987667899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcc---cCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCC
Q 036739 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVT---SLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRR 304 (323)
Q Consensus 228 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R 304 (323)
+|..||......+....+....+.+......... ....+...................++.+.+||.+||+.||++|
T Consensus 229 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 308 (362)
T 3pg1_A 229 NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308 (362)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhC
Confidence 9999999998888888877766554322110000 0000011112222223334456678999999999999999999
Q ss_pred CCHhhhhcCCCCccc
Q 036739 305 ITARSALEHEYFRDV 319 (323)
Q Consensus 305 ~s~~~il~h~~~~~~ 319 (323)
||+.++++||||+++
T Consensus 309 pt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 309 ISTEQALRHPYFESL 323 (362)
T ss_dssp CCHHHHHTSGGGTTT
T ss_pred CCHHHHHcCchhhhc
Confidence 999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=360.89 Aligned_cols=260 Identities=25% Similarity=0.439 Sum_probs=217.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||.||+|++..+|+.||+|++.... ........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57999999999999999999999999999999997653 23344567889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|...+.......+++..+..++.||+.||.|||++||+|+||||+||+++.++. +||+|||++.........
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~-vKL~DFGla~~~~~~~~~ 342 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTI 342 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-EEECCCTTCEECCTTCCE
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC-eEEEecccceecccCccc
Confidence 99965 8888887765556899999999999999999999999999999999999999887 999999999775432211
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh-
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE- 238 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~- 238 (323)
....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.....
T Consensus 343 ------------------------------~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~ 391 (576)
T 2acx_A 343 ------------------------------KGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391 (576)
T ss_dssp ------------------------------ECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC
T ss_pred ------------------------------cccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccc
Confidence 11256999999999987 5689999999999999999999999987643
Q ss_pred --HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhh
Q 036739 239 --IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSAL 311 (323)
Q Consensus 239 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il 311 (323)
...+......... .....+++.+.+||.+||+.||++|| ++.+++
T Consensus 392 ~~~~~i~~~i~~~~~----------------------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil 443 (576)
T 2acx_A 392 IKREEVERLVKEVPE----------------------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK 443 (576)
T ss_dssp CCHHHHHHHHHHCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHH
T ss_pred hhHHHHHHHhhcccc----------------------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHH
Confidence 2223222221100 11234789999999999999999999 789999
Q ss_pred cCCCCccccc
Q 036739 312 EHEYFRDVEF 321 (323)
Q Consensus 312 ~h~~~~~~~~ 321 (323)
+||||++++|
T Consensus 444 ~HpfF~~i~w 453 (576)
T 2acx_A 444 EHPLFKKLNF 453 (576)
T ss_dssp TSGGGTTCCH
T ss_pred hChhhccCCH
Confidence 9999999865
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=346.34 Aligned_cols=259 Identities=29% Similarity=0.440 Sum_probs=200.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++++.||+|+||+||++++..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 68999999999999999999999999999999986432 334778899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC-ceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~-~~kl~df~~~~~~~~~~~~ 159 (323)
|+.| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. .+||+|||++.........
T Consensus 97 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 97 YASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred eCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 9965 8888776543 4789999999999999999999999999999999999986553 4999999988643211110
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
....||+.|+|||.+.+....+.++|||||||++|+|++|..||......
T Consensus 175 ------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 175 ------------------------------KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp ------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred ------------------------------CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence 11256999999999988554455699999999999999999999876543
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.......+........ .+....+++.+.+||.+||+.||++|||+.++++||||..
T Consensus 225 ~~~~~~~~~~~~~~~~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 225 RDYRKTIQRILSVKYS-----------------------IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp CCHHHHHHHHHTTCCC-----------------------CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred HHHHHHHHHHhcCCCC-----------------------CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 3332222221110000 0011247899999999999999999999999999999954
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=353.56 Aligned_cols=282 Identities=29% Similarity=0.515 Sum_probs=222.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc------CCCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM------QHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.+ .|+||+++++.+...+.
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 57999999999999999999999999999999985432 2235666788888877 46799999999999999
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC-ceEEeccccceecC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFG 154 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~-~~kl~df~~~~~~~ 154 (323)
.++|||++++++.+.+.......+++..++.++.||+.||.|||+.||+|+||||+||+++.++. .+||+|||++....
T Consensus 174 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 99999999999999998877667899999999999999999999999999999999999998764 38999999986643
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
.... ...||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.
T Consensus 254 ~~~~--------------------------------~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 254 QRVY--------------------------------TYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp CCCC--------------------------------SSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred Cccc--------------------------------ccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 2211 1255889999999988 568999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccC------------------------------CCCCCCcccccccC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAF------------------------------PKWPSKELGTVVRN 284 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~ 284 (323)
.....+.+..+....+.+....+........+.... ..............
T Consensus 301 ~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 380 (429)
T 3kvw_A 301 GEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGC 380 (429)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTC
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhcccc
Confidence 999888888888776665433211111100000000 00000000111223
Q ss_pred CChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 285 LEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 285 ~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
.++.+.+||.+||+.||++|||+.++|+||||++.
T Consensus 381 ~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 381 DDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred chHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 57889999999999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=349.83 Aligned_cols=281 Identities=35% Similarity=0.638 Sum_probs=216.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 75 (323)
.+|++.+.||+|+||+||+|++..++. +|+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 479999999999999999999866555 8888875432 2223799999999999999999999543 34
Q ss_pred EEEEEecchhhHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 76 LYLVFEYLDLDLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
+++||||+++++.+.+.. .....+++..++.++.||+.||.|||++||+||||||+||+++.....+||+|||++...
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 899999999887766542 123467889999999999999999999999999999999999943334999999999876
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
....... ...||+.|+|||.+.+...++.++||||+||++|+|++|..||
T Consensus 193 ~~~~~~~------------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 242 (394)
T 4e7w_A 193 IAGEPNV------------------------------SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242 (394)
T ss_dssp CTTCCCC------------------------------SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCCCc------------------------------ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 4332211 1245888999999988667999999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCccc-ccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELG-TVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.+....+.+..+.+..+.+....+..... ......+......... .....+++.+.+||.+||+.||++||++.++++
T Consensus 243 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 243 PGESGIDQLVEIIKVLGTPSREQIKTMNP-NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHHCG-GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhhCh-hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 99998888888888776654432211100 0000011111111111 122358899999999999999999999999999
Q ss_pred CCCCcccc
Q 036739 313 HEYFRDVE 320 (323)
Q Consensus 313 h~~~~~~~ 320 (323)
||||++++
T Consensus 322 hp~f~~~~ 329 (394)
T 4e7w_A 322 HPFFDELR 329 (394)
T ss_dssp SGGGSTTT
T ss_pred Chhhhhhc
Confidence 99999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=331.73 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=209.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||++.+..++..+|+|++.... .....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 57999999999999999999999999999999986553 33345788899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec---CCCceEEeccccceecCC
Q 036739 82 YLDL-DLKKHMDSC--PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGLARAFGI 155 (323)
Q Consensus 82 ~~~g-~l~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~---~~~~~kl~df~~~~~~~~ 155 (323)
|+.| +|.+.+... ....+++..+..++.||+.||.+||+.|++|+||||+||+++. ++. +||+|||.+.....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~-~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSP-IKIIDFGLAELFKS 179 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCC-EEECCCCCCCC---
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCC-EEEEeeecceecCC
Confidence 9976 888777542 2346789999999999999999999999999999999999953 344 99999999976543
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
..... ...||+.|+|||.+.. .++.++|+||||+++|+|++|..||..
T Consensus 180 ~~~~~------------------------------~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 180 DEHST------------------------------NAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp -------------------------------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCc------------------------------CcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 22111 1245889999999864 578999999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
....+............ ......+++.+.++|.+||+.||++||++.++++|||
T Consensus 228 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 228 TSLEEVQQKATYKEPNY--------------------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp SSHHHHHHHHHHCCCCC--------------------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred CCHHHHHhhhccCCccc--------------------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 87666554443311000 0111237889999999999999999999999999999
Q ss_pred Cccc
Q 036739 316 FRDV 319 (323)
Q Consensus 316 ~~~~ 319 (323)
|++.
T Consensus 282 f~~a 285 (285)
T 3is5_A 282 FKQA 285 (285)
T ss_dssp GGC-
T ss_pred hhcC
Confidence 9863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=355.61 Aligned_cols=256 Identities=31% Similarity=0.478 Sum_probs=217.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999999976532 234456788999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| +|.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++........
T Consensus 95 ~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~-vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC-EEECCCSSCEECCTTCC
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC-eEEEeccchhhcccccc
Confidence 999965 8888776543 5789999999999999999999999999999999999999887 99999999987643211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.. ...||+.|+|||.+.+....+.++|||||||++|+|++|..||.....
T Consensus 172 ~~------------------------------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 172 LR------------------------------TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp BC------------------------------CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS
T ss_pred cc------------------------------ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH
Confidence 11 125689999999998855568899999999999999999999998877
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
......+..... .....+++.+.+||.+||+.||++||++.++++||||++
T Consensus 222 ~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 222 PTLFKKICDGIF-----------------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHHHTTCC-----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred HHHHHHHhcCCc-----------------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 666655543210 011347889999999999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=345.24 Aligned_cols=286 Identities=33% Similarity=0.551 Sum_probs=210.4
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc------
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK------ 74 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 74 (323)
+++|++.+.||+|+||+||++++..++..||+|++... ......+.+++..++.++||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECC---TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC---ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 47899999999999999999999999999999988543 233456777888899999999999999996532
Q ss_pred -eEEEEEecchhhHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCcEEEecCCCceEEecccc
Q 036739 75 -KLYLVFEYLDLDLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGL 149 (323)
Q Consensus 75 -~~~lv~e~~~g~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~i~H~dl~~~Nil~~~~~~~~kl~df~~ 149 (323)
..++||||++|++...+.. .....+++..+..++.|++.||.||| +.|++|+||||+||+++.....+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 3899999999987766543 33446788889999999999999999 999999999999999997333499999999
Q ss_pred ceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhC
Q 036739 150 ARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ 229 (323)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg 229 (323)
+.......... ...||+.|+|||.+.+...++.++|||||||++|+|++|
T Consensus 179 a~~~~~~~~~~------------------------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g 228 (360)
T 3e3p_A 179 AKKLSPSEPNV------------------------------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228 (360)
T ss_dssp CBCCCTTSCCC------------------------------STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred ceecCCCCCcc------------------------------cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 97654322211 124588899999998766789999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCc----ccccccCCChHHHHHHHhhcccCCCCCC
Q 036739 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKE----LGTVVRNLEPAGIDLLSKMLCMDPSRRI 305 (323)
Q Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~~li~~~l~~dp~~R~ 305 (323)
..||...........+.+..+.+....+.......... ......... ........++.+.+||.+||+.||.+||
T Consensus 229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 307 (360)
T 3e3p_A 229 EPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDV-DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307 (360)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCG-GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSC
T ss_pred CCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhc-cccccccCCcccccchhhccccHHHHHHHHHHhccCccccC
Confidence 99999998888888877766554332211111000000 000000000 1111223577899999999999999999
Q ss_pred CHhhhhcCCCCcccc
Q 036739 306 TARSALEHEYFRDVE 320 (323)
Q Consensus 306 s~~~il~h~~~~~~~ 320 (323)
++.++++||||+++.
T Consensus 308 t~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 308 KPYEALCHPYFDELH 322 (360)
T ss_dssp CHHHHTTSGGGGGGG
T ss_pred CHHHHhcCccccccC
Confidence 999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=345.30 Aligned_cols=282 Identities=38% Similarity=0.657 Sum_probs=222.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCce------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKK------ 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------ 75 (323)
++|++.+.||+|++|+||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 58999999999999999999999999999999986543333334677889999999999999999999976643
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
+++|||+++|++.+.+.. .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||.+.....
T Consensus 104 ~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHADA 178 (353)
T ss_dssp CEEEEECCSEEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC-EEECSTTCTTC---
T ss_pred EEEEeccccCCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc-EEEeecccccCCCC
Confidence 599999999988777643 4789999999999999999999999999999999999999887 99999999865432
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
... ...||+.|+|||.+.+...++.++|+||||+++|+|++|..||.+
T Consensus 179 ~~~--------------------------------~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 179 EMT--------------------------------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp -------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred Ccc--------------------------------ccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 211 124588899999998766789999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccC--CcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSL--PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
....+.+..+.+..+.+....+...... ..+..................+++.+.+||.+||+.||++||++.++++|
T Consensus 227 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 227 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp SCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 8888877777776555433221111110 00111111122222233445689999999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||+.+.
T Consensus 307 p~f~~~~ 313 (353)
T 3coi_A 307 PFFEPFR 313 (353)
T ss_dssp GGGTTTC
T ss_pred cchhhcc
Confidence 9998763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=358.34 Aligned_cols=259 Identities=31% Similarity=0.522 Sum_probs=218.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++++.||+|+||+||+|++..+++.||+|++............+.+|+.++++++||||+++++++.+...+++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 57999999999999999999999999999999997665555566788999999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC--CceEEeccccceecCCCcc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~--~~~kl~df~~~~~~~~~~~ 158 (323)
|+.| +|.+.+.... .+++..+..++.||+.||.|||++||+|+||||+||+++..+ ..+||+|||++........
T Consensus 102 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 102 LYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 9975 8888776643 478999999999999999999999999999999999995432 2499999999876533211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
. ....||+.|+|||.+.+ .++.++|||||||++|+|++|..||.+...
T Consensus 180 ~------------------------------~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 227 (486)
T 3mwu_A 180 M------------------------------KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (486)
T ss_dssp --------------------------------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred c------------------------------CCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 11256999999999876 489999999999999999999999999888
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+........ .+.+..+|+.+++||.+||+.||++|||+.++|+||||+.
T Consensus 228 ~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 228 YDILKRVETGKYAFD-------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp HHHHHHHHHTCCCSC-------------------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHhCCCCCC-------------------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 777766655321111 1123458899999999999999999999999999999986
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 283 ~ 283 (486)
T 3mwu_A 283 Y 283 (486)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=339.82 Aligned_cols=253 Identities=26% Similarity=0.342 Sum_probs=202.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||+||+|++..+++.||+|++...............|+..+..+ .||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 469999999999999999999998999999998754433222233444555555555 8999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++++++.+.+.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++. +||+|||++..........
T Consensus 137 e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~-~kl~DFG~a~~~~~~~~~~ 214 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGE 214 (311)
T ss_dssp ECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC-EEECCCTTCEECC------
T ss_pred eccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC-EEEccceeeeecccCCCCc
Confidence 999999988887653 35799999999999999999999999999999999999999887 9999999987654322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
...||+.|+|||.+.+ .++.++||||||+++|+|++|..|+......
T Consensus 215 ------------------------------~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~- 261 (311)
T 3p1a_A 215 ------------------------------VQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW- 261 (311)
T ss_dssp ------------------------------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-
T ss_pred ------------------------------ccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-
Confidence 1246899999999876 5899999999999999999997766543221
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
..+.+. .........+++.+.++|.+||+.||++||++.++++||||++
T Consensus 262 --~~~~~~---------------------------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 262 --QQLRQG---------------------------YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp --HHHTTT---------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred --HHHhcc---------------------------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 111110 0011223457899999999999999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=341.17 Aligned_cols=258 Identities=21% Similarity=0.254 Sum_probs=185.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC----ceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE----KKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~ 77 (323)
++|.+.+.||+|+||+||+|+. +|+.||||++..... .......|+..+.+++||||+++++++.++ ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4788999999999999999986 689999999854321 112233456666788999999999999754 3689
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEEecCCCceEEeccc
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH--------RVLHRDLKPQNLLIDRRTNALKLADFG 148 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~i~H~dl~~~Nil~~~~~~~~kl~df~ 148 (323)
+||||++| +|.+.+... .++++.+.+++.|++.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 78 lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~-~Ki~DFG 153 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC-EEECCCT
T ss_pred EEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC-EEEEeCC
Confidence 99999975 888887654 468888999999999999999987 9999999999999999887 9999999
Q ss_pred cceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCC-----CCCCchhhHHHHHHH
Q 036739 149 LARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR-----HYSTPVDVWSVGCIF 223 (323)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-----~~~~~~Di~slG~ll 223 (323)
++............ .....+||+.|+|||++.+.. .++.++|||||||++
T Consensus 154 la~~~~~~~~~~~~-------------------------~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl 208 (303)
T 3hmm_A 154 LAVRHDSATDTIDI-------------------------APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp TCEEEETTTTEESC-------------------------C-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred CCccccCCCCceee-------------------------ecccccccccccCHHHhcccccccCCccChhHhhhhHHHHH
Confidence 99876443322111 111246799999999997632 356789999999999
Q ss_pred HHHHhCCCCCCCCChHH-----------HHHHHHHHhCC-CCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHH
Q 036739 224 AEMVNQRPLFPGDSEID-----------ELFKIFRVLGT-PNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291 (323)
Q Consensus 224 ~~l~tg~~p~~~~~~~~-----------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 291 (323)
|||+||.+||......+ ....+.+.... ...+..+ . .......++.+.+
T Consensus 209 ~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p-----------------~--~~~~~~~~~~l~~ 269 (303)
T 3hmm_A 209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP-----------------N--RWQSCEALRVMAK 269 (303)
T ss_dssp HHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC-----------------G--GGGSSHHHHHHHH
T ss_pred HHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCC-----------------c--cccchHHHHHHHH
Confidence 99999987764332110 01111111000 0000000 0 0000113356889
Q ss_pred HHHhhcccCCCCCCCHhhhhc
Q 036739 292 LLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 292 li~~~l~~dp~~R~s~~~il~ 312 (323)
|+.+||+.||++|||+.+|++
T Consensus 270 li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 270 IMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHTTCCSSGGGSCCHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHH
Confidence 999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=332.57 Aligned_cols=256 Identities=32% Similarity=0.528 Sum_probs=214.3
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|++|+||++.+..++..||+|++.... ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 478999999999999999999999999999999986543 2233456788999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||++| ++.+.+.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~-~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRR 164 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC-EEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC-EEEEeccccccCCcccc
Confidence 999975 7777776543 4688889999999999999999999999999999999999887 99999998754332211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
. ...|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 165 ~-------------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 212 (279)
T 3fdn_A 165 T-------------------------------DLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212 (279)
T ss_dssp ----------------------------------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred c-------------------------------ccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcH
Confidence 1 1245888999999987 6689999999999999999999999998877
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+..... .....+++.+.+||.+||+.||++||++.++++||||++
T Consensus 213 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 213 QETYKRISRVEF-----------------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp HHHHHHHHHTCC-----------------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHhCCC-----------------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 666665544211 111337889999999999999999999999999999986
Q ss_pred cc
Q 036739 319 VE 320 (323)
Q Consensus 319 ~~ 320 (323)
..
T Consensus 264 ~~ 265 (279)
T 3fdn_A 264 NS 265 (279)
T ss_dssp HC
T ss_pred Cc
Confidence 53
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=340.65 Aligned_cols=295 Identities=37% Similarity=0.668 Sum_probs=226.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC-----ceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 76 (323)
++|++.+.||+|++|+||+|++..+++.||+|++... ........+.+|+.+++.++||||+++++++... ...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 6899999999999999999999889999999998432 1222235667899999999999999999987654 679
Q ss_pred EEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 77 YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
++|+|+++|+|.+.+... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++......
T Consensus 90 ~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 90 YIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDES 165 (353)
T ss_dssp EEEECCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-EEECCCTTCEECC--
T ss_pred EEEEeccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc-EEEEecccccccccc
Confidence 999999999998888763 5788999999999999999999999999999999999999887 999999999876543
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
........ +.........||+.|+|||.+.....++.++|+|||||++|+|++|..||.+.
T Consensus 166 ~~~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 166 AADNSEPT-------------------GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp ---------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCcc-------------------ccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22211100 00001112356999999999877677899999999999999999999999999
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCC---cccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLP---DFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
...+....+....+.+............ .+..................+++.+.+||.+||+.||++||++.++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 227 DYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp SHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 8888777777766655433221111111 0111122222222233445789999999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||++..
T Consensus 307 p~~~~~~ 313 (353)
T 2b9h_A 307 PYLQTYH 313 (353)
T ss_dssp GGGTTTC
T ss_pred ccccccC
Confidence 9999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=357.04 Aligned_cols=259 Identities=32% Similarity=0.539 Sum_probs=213.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++++.||+|+||+||+|+++.++..||+|++............+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46999999999999999999999999999999997765555556888999999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC--CceEEeccccceecCCCcc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~--~~~kl~df~~~~~~~~~~~ 158 (323)
|+.| +|.+.+.... .+++..+..++.||+.||.|||++||+|+||||+||+++..+ ..+||+|||++........
T Consensus 117 ~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 117 CYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 9975 8878776643 468888999999999999999999999999999999997643 2499999999977643221
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.. ...||+.|+|||.+.. .++.++||||+||++|+|++|..||.+...
T Consensus 195 ~~------------------------------~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 242 (494)
T 3lij_A 195 MK------------------------------ERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTD 242 (494)
T ss_dssp BC------------------------------CCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cc------------------------------ccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 11 1256999999999864 589999999999999999999999999888
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+......... +.+..+++.+.+||.+||+.||++|||+.++|+||||++
T Consensus 243 ~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 243 QEILRKVEKGKYTFDS-------------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHHHTCCCCCS-------------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHhCCCCCCc-------------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 7777766553222111 123458899999999999999999999999999999976
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 298 ~ 298 (494)
T 3lij_A 298 M 298 (494)
T ss_dssp H
T ss_pred C
Confidence 4
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=356.42 Aligned_cols=260 Identities=25% Similarity=0.377 Sum_probs=216.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||.||+|+++.+|+.||+|++..... .......+.+|..+++.++||||+++++++.+...+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 689999999999999999999999999999999976532 2344567889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 81 EYLDL-DLKKHMDSCP--DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||+.| +|...+.... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++. +||+|||++.......
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~-vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQ 343 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-EEECCCTTCEECCTTC
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC-EEEeecceeeeccCCC
Confidence 99975 7777776543 346889999999999999999999999999999999999999888 9999999998764322
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
... ....||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||....
T Consensus 344 ~~~-----------------------------~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 344 TKT-----------------------------KGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp CCB-----------------------------CCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred ccc-----------------------------ccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 111 11256999999999988 668999999999999999999999998763
Q ss_pred h----HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----Hh
Q 036739 238 E----IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----AR 308 (323)
Q Consensus 238 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~ 308 (323)
. .+....+.... ......+++.+.+||.+||+.||++||+ +.
T Consensus 394 ~~~~~~~~~~~i~~~~-----------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ 444 (543)
T 3c4z_A 394 EKVENKELKQRVLEQA-----------------------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCD 444 (543)
T ss_dssp CCCCHHHHHHHHHHCC-----------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSH
T ss_pred cchhHHHHHHHHhhcc-----------------------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHH
Confidence 2 22223332210 0112357899999999999999999995 58
Q ss_pred hhhcCCCCccccc
Q 036739 309 SALEHEYFRDVEF 321 (323)
Q Consensus 309 ~il~h~~~~~~~~ 321 (323)
++++||||++++|
T Consensus 445 ei~~Hpff~~i~w 457 (543)
T 3c4z_A 445 GLRTHPLFRDISW 457 (543)
T ss_dssp HHHTSGGGTTCCH
T ss_pred HHHcCccccCCCH
Confidence 8999999999865
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=333.03 Aligned_cols=259 Identities=27% Similarity=0.468 Sum_probs=192.8
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|++|.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 4789999999999999999999989999999999865532 233457788999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+++ ++.+.+... ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. +||+|||.+........
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~-~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN-IKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC-EEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC-EEEEeecceeeccCCCC
Confidence 999976 666666543 346789999999999999999999999999999999999998887 99999999877643221
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.. ....||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 168 ~~-----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 168 KH-----------------------------YTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ------------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred cc-----------------------------eeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 11 01245889999999877 5678999999999999999999999977654
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+.. ........+++.+.++|.+||+.||++||++.++++||||++
T Consensus 218 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 218 KNTLNKVVL-----------------------------ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp C-----CCS-----------------------------SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred HHHHHHHhh-----------------------------cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 332211100 000112347889999999999999999999999999999987
Q ss_pred cc
Q 036739 319 VE 320 (323)
Q Consensus 319 ~~ 320 (323)
..
T Consensus 269 ~~ 270 (278)
T 3cok_A 269 NS 270 (278)
T ss_dssp --
T ss_pred CC
Confidence 53
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=343.52 Aligned_cols=269 Identities=28% Similarity=0.428 Sum_probs=214.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc---CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE---DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|++|+||+|++..++..||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 579999999999999999999999999999999875532 33455788899999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 036739 79 VFEYLDL-DLKKHMDSCP--------------------------------------DFANDPRLIKTFLYQILRGIAYCH 119 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~--------------------------------------~~~~~~~~~~~i~~qi~~~L~~LH 119 (323)
||||+.| +|.+.+.... ...+++..+..++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999965 7777764210 112256678889999999999999
Q ss_pred hCCcccCCCCCCcEEEecCCC-ceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeecccccccc
Q 036739 120 SHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWY 198 (323)
Q Consensus 120 ~~~i~H~dl~~~Nil~~~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 198 (323)
+.|++|+||||+||+++.++. .+||+|||.+........... .......||+.|
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~-------------------------~~~~~~~gt~~y 240 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY-------------------------YGMTTKAGTPYF 240 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------------------------------CCCGGG
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCcccc-------------------------ccccccCCCccc
Confidence 999999999999999987662 499999999976532221110 011123569999
Q ss_pred ccchhhhCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCc
Q 036739 199 RAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKE 277 (323)
Q Consensus 199 ~~PE~~~~~-~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (323)
+|||.+.+. ..++.++||||||+++|+|++|..||......+....+........
T Consensus 241 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------------ 296 (345)
T 3hko_A 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE------------------------ 296 (345)
T ss_dssp CCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT------------------------
T ss_pred cCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC------------------------
Confidence 999999752 5688999999999999999999999999888777766655211111
Q ss_pred ccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 278 LGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 278 ~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
.+....+++.+.++|.+||+.||.+||++.++++||||+++.
T Consensus 297 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 297 -NPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp -SGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred -CcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 112234789999999999999999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=338.22 Aligned_cols=256 Identities=29% Similarity=0.421 Sum_probs=198.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|+||+|++..+++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 46999999999999999999999899999999986432 23567789999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec---CCCceEEeccccceecCCCc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~---~~~~~kl~df~~~~~~~~~~ 157 (323)
|+.| +|.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++. ++. +||+|||++.......
T Consensus 129 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~-~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAP-LKIADFGLSKIVEHQV 205 (349)
T ss_dssp CCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCC-EEECCCC---------
T ss_pred eCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCC-EEEccCccccccCccc
Confidence 9975 8888776543 4788999999999999999999999999999999999975 555 9999999987653221
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. ....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||....
T Consensus 206 ~~------------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 206 LM------------------------------KTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp -------------------------------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred cc------------------------------ccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 10 11256899999999987 568999999999999999999999998776
Q ss_pred hHHHHH-HHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 238 EIDELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
..+... .+....... ..+....+++.+.+||.+||+.||++||++.++++||||
T Consensus 255 ~~~~~~~~i~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 255 GDQFMFRRILNCEYYF-------------------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp CHHHHHHHHHTTCCCC-------------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred ccHHHHHHHHhCCCcc-------------------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 655333 332210000 011224578999999999999999999999999999999
Q ss_pred cccc
Q 036739 317 RDVE 320 (323)
Q Consensus 317 ~~~~ 320 (323)
++..
T Consensus 310 ~~~~ 313 (349)
T 2w4o_A 310 TGKA 313 (349)
T ss_dssp TSTT
T ss_pred CCCc
Confidence 8763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=341.93 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=206.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||.||+|.++.+++.||+|++.... ....+|+.++.++ +||||+++++++.+++..|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999986442 2345688888887 7999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC---ceEEeccccceecCCC
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGLARAFGIP 156 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~---~~kl~df~~~~~~~~~ 156 (323)
||+.| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||++..+.. .+||+|||++......
T Consensus 96 E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99965 8888887653 4789999999999999999999999999999999999854332 4999999999875432
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.... ....||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||...
T Consensus 174 ~~~~-----------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 174 NGLL-----------------------------MTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp TCCB-----------------------------CCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CCce-----------------------------eccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 2111 11256899999999977 45788999999999999999999999863
Q ss_pred ---ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 237 ---SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 237 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
...+....+........ ...+..+++.+.+||.+||..||++||++.++++|
T Consensus 224 ~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 224 PDDTPEEILARIGSGKFSLS-------------------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTSCHHHHHHHHHHCCCCCC-------------------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CcCCHHHHHHHHccCCcccC-------------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22233333332111110 11224588999999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||.+..
T Consensus 279 p~~~~~~ 285 (342)
T 2qr7_A 279 PWIVHWD 285 (342)
T ss_dssp HHHHTGG
T ss_pred CeecCcc
Confidence 9997654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=348.62 Aligned_cols=287 Identities=39% Similarity=0.733 Sum_probs=210.7
Q ss_pred Ccce-eeeeccccceeEEEEEEc--cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEe--cCceEE
Q 036739 3 QYEK-VEKIGEGTYGVVYKARNC--VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKKLY 77 (323)
Q Consensus 3 ~y~~-~~~lg~g~~~~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~ 77 (323)
.|++ .++||+|+||+||+|+++ .++..||+|++.. ......+.+|+.+++.++||||+++++++. .....+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG----TGISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSS----SSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECC----CCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 4666 447999999999999965 4688999998843 233467889999999999999999999995 477899
Q ss_pred EEEecchhhHHHhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----ecCCCceEEec
Q 036739 78 LVFEYLDLDLKKHMDSCP-------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLI----DRRTNALKLAD 146 (323)
Q Consensus 78 lv~e~~~g~l~~~~~~~~-------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~----~~~~~~~kl~d 146 (323)
+||||++|++.+.+.... ...+++..++.++.||+.||.|||+.||+|+||||+||++ +.++. +||+|
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~-~kl~D 175 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR-VKIAD 175 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC-EEECC
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc-EEEEE
Confidence 999999999988875321 2347889999999999999999999999999999999999 44455 99999
Q ss_pred cccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHH
Q 036739 147 FGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226 (323)
Q Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l 226 (323)
||++........... ......||+.|+|||.+.+...++.++|||||||++|+|
T Consensus 176 fg~a~~~~~~~~~~~--------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 229 (405)
T 3rgf_A 176 MGFARLFNSPLKPLA--------------------------DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229 (405)
T ss_dssp TTCCC------------------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHH
T ss_pred CCCceecCCCCcccc--------------------------cCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHH
Confidence 999977643221110 011236699999999998866789999999999999999
Q ss_pred HhCCCCCCCCCh---------HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCc---------ccccccCCChH
Q 036739 227 VNQRPLFPGDSE---------IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKE---------LGTVVRNLEPA 288 (323)
Q Consensus 227 ~tg~~p~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~s~~ 288 (323)
++|..||..... .+.+..+....+.+....|......+............. ........++.
T Consensus 230 l~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (405)
T 3rgf_A 230 LTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309 (405)
T ss_dssp HHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSH
T ss_pred HhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHH
Confidence 999999976543 467778888888887777665544333221111100000 00111224778
Q ss_pred HHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 289 GIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 289 ~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
+.+||.+||+.||++|||+.++|+||||++.+
T Consensus 310 ~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 310 AFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred HHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 99999999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=332.40 Aligned_cols=254 Identities=27% Similarity=0.453 Sum_probs=211.6
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecc
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYL 83 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (323)
|...+.||+|++|+||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 677889999999999999998899999999986442 334567889999999999999999999999999999999999
Q ss_pred hh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 84 DL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 84 ~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
.| +|.+.+... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++..........
T Consensus 125 ~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~~~~-- 198 (321)
T 2c30_A 125 QGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKR-- 198 (321)
T ss_dssp CSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSSSCCB--
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc-EEEeeeeeeeecccCcccc--
Confidence 76 666655432 5789999999999999999999999999999999999998887 9999999987764332211
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDEL 242 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~ 242 (323)
....||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+..
T Consensus 199 ---------------------------~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~ 250 (321)
T 2c30_A 199 ---------------------------KSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250 (321)
T ss_dssp ---------------------------CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred ---------------------------ccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 11256899999999987 66899999999999999999999999888776665
Q ss_pred HHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
..+....... ......+++.+.++|.+||+.||++||++.++++||||.+.
T Consensus 251 ~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 251 KRLRDSPPPK--------------------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHHHSSCCC--------------------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHhcCCCCC--------------------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 5544321000 00113478899999999999999999999999999999865
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=338.92 Aligned_cols=289 Identities=33% Similarity=0.612 Sum_probs=214.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEe----------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH---------- 71 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---------- 71 (323)
++|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 68999999999999999999999899999999886432 223467789999999999999999999873
Q ss_pred ----cCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 72 ----SEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 72 ----~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
+....++||||++|+|.+.+... .+++..+..++.||+.||+|||++|++|+||||+||+++.++..+||+||
T Consensus 89 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMETDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp --CCSCSEEEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccccCceeEEeeccCCCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 34688999999999998887643 57888999999999999999999999999999999999865556999999
Q ss_pred ccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH
Q 036739 148 GLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~ 227 (323)
|.+............ .....++..|+|||.+.....++.++|+||||+++|+|+
T Consensus 166 g~~~~~~~~~~~~~~--------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 219 (320)
T 2i6l_A 166 GLARIMDPHYSHKGH--------------------------LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219 (320)
T ss_dssp TTCBCC--------C--------------------------CCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccCCCcccccc--------------------------cccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH
Confidence 999765432111100 011245888999999887677899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCccc-CCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC
Q 036739 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTS-LPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT 306 (323)
Q Consensus 228 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 306 (323)
+|..||......+....+................. .+....................+++.+.++|.+||+.||++||+
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 99999999888777766665433221111000000 00000000000111122333568999999999999999999999
Q ss_pred HhhhhcCCCCccccc
Q 036739 307 ARSALEHEYFRDVEF 321 (323)
Q Consensus 307 ~~~il~h~~~~~~~~ 321 (323)
+.++++||||+...+
T Consensus 300 ~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 300 AEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHHHTSHHHHTTCC
T ss_pred HHHHhCCcccccccC
Confidence 999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=340.82 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=213.3
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 58999999999999999999999999999999865432 12223567899999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|+.|++.+.+.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++. +||+|||++.......
T Consensus 135 ~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~DfG~a~~~~~~~---- 208 (348)
T 1u5q_A 135 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPAN---- 208 (348)
T ss_dssp CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE-EEECCCTTCBSSSSBC----
T ss_pred cCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC-EEEeeccCceecCCCC----
Confidence 99999888876433 35788999999999999999999999999999999999998887 9999999986643211
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
...||+.|+|||.+.. ...++.++||||||+++|+|++|..||......
T Consensus 209 -----------------------------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 259 (348)
T 1u5q_A 209 -----------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 259 (348)
T ss_dssp -----------------------------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred -----------------------------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 1245899999999863 356889999999999999999999999888777
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+....+....... .....+++.+.++|.+||+.||++||++.++++||||...
T Consensus 260 ~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 260 SALYHIAQNESPA---------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHHHHSCCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 6665554421100 0113468899999999999999999999999999999754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=356.05 Aligned_cols=258 Identities=33% Similarity=0.523 Sum_probs=217.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||+||+|++..+++.||+|++...... ......+.+|+.++++++||||+++++++.+.+..++|+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4799999999999999999999999999999998765432 345677889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEe---cCCCceEEeccccceecCCC
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLID---RRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~---~~~~~~kl~df~~~~~~~~~ 156 (323)
||+.| +|.+.+.... .+++..+..++.||+.||.|||++||+|+||||+||+++ .++. +||+|||++......
T Consensus 106 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~-~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 106 EVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDAN-IRIIDFGLSTHFEAS 182 (484)
T ss_dssp CCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCC-EEECCTTHHHHBCCC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCc-EEEEeeeeeEEcccc
Confidence 99965 8888877654 478899999999999999999999999999999999994 4455 999999998765432
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.... ...||+.|+|||.+.+ .++.++|||||||++|+|++|..||...
T Consensus 183 ~~~~------------------------------~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 183 KKMK------------------------------DKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGA 230 (484)
T ss_dssp CSHH------------------------------HHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc------------------------------cCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence 2111 1256999999999977 4899999999999999999999999998
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
...+....+........ .+.+..+++.+++||.+||+.||++|||+.++++||||
T Consensus 231 ~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 231 NEYDILKKVEKGKYTFE-------------------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp SHHHHHHHHHHCCCCCC-------------------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred CHHHHHHHHHcCCCCCC-------------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 88777776655321111 11234588999999999999999999999999999999
Q ss_pred ccc
Q 036739 317 RDV 319 (323)
Q Consensus 317 ~~~ 319 (323)
+..
T Consensus 286 ~~~ 288 (484)
T 3nyv_A 286 QTY 288 (484)
T ss_dssp HHH
T ss_pred ccc
Confidence 864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=328.32 Aligned_cols=256 Identities=31% Similarity=0.430 Sum_probs=214.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|+||++.+..++..+|+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 579999999999999999999999999999999865432 335788899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---ecCCCceEEeccccceecCCCc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLI---DRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~---~~~~~~~kl~df~~~~~~~~~~ 157 (323)
|++| +|.+.+.... .+++..+..++.|++.||.+||++|++|+||||+||++ +.++. ++|+|||.+.......
T Consensus 87 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~-~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP-LKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC-EEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCc-EEEEecccceeccCcc
Confidence 9976 7777776543 47888999999999999999999999999999999999 55565 9999999987764332
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
... ...||+.|+|||.+.+ .++.++|+||||+++|+|++|..||....
T Consensus 164 ~~~------------------------------~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 164 MMR------------------------------TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp CBC------------------------------CCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred chh------------------------------ccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 211 1245889999999876 38999999999999999999999999988
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
..+....+....... .......+++.+.++|.+||+.||++||++.++++||||+
T Consensus 212 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~ 266 (277)
T 3f3z_A 212 DSEVMLKIREGTFTF-------------------------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266 (277)
T ss_dssp HHHHHHHHHHCCCCC-------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred HHHHHHHHHhCCCCC-------------------------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 777666655421111 0111235789999999999999999999999999999998
Q ss_pred cc
Q 036739 318 DV 319 (323)
Q Consensus 318 ~~ 319 (323)
+.
T Consensus 267 ~~ 268 (277)
T 3f3z_A 267 KQ 268 (277)
T ss_dssp HH
T ss_pred cc
Confidence 64
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=333.01 Aligned_cols=260 Identities=22% Similarity=0.333 Sum_probs=198.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|+||++.+..+++.||+|++............+..+...++.++||||+++++++.+++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 68999999999999999999999999999999986543322223344455556888899999999999999999999999
Q ss_pred cchhhHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 82 YLDLDLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|++|++.+.+.. .....+++..+..++.||+.||.|||++ |++|+||||+||+++.++. +||+|||.+........
T Consensus 87 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 87 LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ-VKMCDFGISGYLVDDVA 165 (290)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC-EEBCCC-----------
T ss_pred hhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC-EEEeecCCccccccccc
Confidence 999988776653 2234678999999999999999999998 9999999999999998887 99999999876543221
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhh---CCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILL---GSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.. ...||+.|+|||.+. ....++.++|+||||+++|+|++|..||..
T Consensus 166 ~~------------------------------~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 166 KD------------------------------IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ----------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cc------------------------------ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 11 124588899999973 346688999999999999999999999987
Q ss_pred CChH-HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 236 DSEI-DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
.... ............. .....+++.+.++|.+||+.||++||++.++++||
T Consensus 216 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp 268 (290)
T 3fme_A 216 WGTPFQQLKQVVEEPSPQ---------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP 268 (290)
T ss_dssp CSCHHHHHHHHHHSCCCC---------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred cCchHHHHHHHhccCCCC---------------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence 4433 3333333211000 01134788999999999999999999999999999
Q ss_pred CCccc
Q 036739 315 YFRDV 319 (323)
Q Consensus 315 ~~~~~ 319 (323)
||+..
T Consensus 269 ~f~~~ 273 (290)
T 3fme_A 269 FFTLH 273 (290)
T ss_dssp HHHHH
T ss_pred ccccC
Confidence 99754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=365.34 Aligned_cols=259 Identities=22% Similarity=0.375 Sum_probs=220.2
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 78 (323)
+++|++++.||+|+||.||+|+++.+++.||+|++.... ......+.+..|..++..+ +||+|+++++++++.+.+|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 478999999999999999999999999999999997653 2344557778899999887 69999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| +|...+.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++.......
T Consensus 420 V~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~-ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC-EEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc-EEEeecceeeccccCC
Confidence 9999975 8887777643 4789999999999999999999999999999999999999988 9999999987532221
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. .....||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+
T Consensus 497 ~~-----------------------------~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 497 VT-----------------------------TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CC-----------------------------BCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc-----------------------------cccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 11 112367999999999987 668999999999999999999999999988
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH-----hhhhc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA-----RSALE 312 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~-----~~il~ 312 (323)
..+....+.... ......+++.+.+||.+||+.||++||++ .+|++
T Consensus 547 ~~~~~~~i~~~~-----------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 547 EDELFQSIMEHN-----------------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHHHHSSC-----------------------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHHHHhCC-----------------------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 877777665311 01123588999999999999999999998 89999
Q ss_pred CCCCccccc
Q 036739 313 HEYFRDVEF 321 (323)
Q Consensus 313 h~~~~~~~~ 321 (323)
||||++++|
T Consensus 598 h~ff~~i~w 606 (674)
T 3pfq_A 598 HAFFRYIDW 606 (674)
T ss_dssp SGGGSSCCH
T ss_pred CccccCCCH
Confidence 999999876
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=334.09 Aligned_cols=279 Identities=32% Similarity=0.578 Sum_probs=211.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEec--CceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHS--EKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~l 78 (323)
++|++.+.||+|++|+||+|++..+++.||+|++.. .....+.+|+.+++.+. ||||+++++++.+ ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 689999999999999999999999999999999852 23467889999999997 9999999999987 678999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.+ ++.+.+. .+++..+..++.||+.||.|||++|++|+||||+||+++.++..+||+|||++.......
T Consensus 111 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999986 5555543 368888999999999999999999999999999999999877569999999997654332
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC-
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD- 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~- 236 (323)
... ...|++.|+|||.+.+...++.++|||||||++|+|++|..||...
T Consensus 186 ~~~------------------------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 235 (330)
T 3nsz_A 186 EYN------------------------------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235 (330)
T ss_dssp CCC------------------------------SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccc------------------------------cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 211 1245888999999987677899999999999999999999998544
Q ss_pred ChHHHHHHHHHHhCCCCCC------CCCCcccCCcc--cccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 237 SEIDELFKIFRVLGTPNED------TWPGVTSLPDF--KSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
...+....+....+..... ........... ......|...........+++.+.+||.+||+.||++|||+.
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 315 (330)
T 3nsz_A 236 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315 (330)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred chHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHH
Confidence 3334444333322210000 00000000000 000001111111122334789999999999999999999999
Q ss_pred hhhcCCCCcccc
Q 036739 309 SALEHEYFRDVE 320 (323)
Q Consensus 309 ~il~h~~~~~~~ 320 (323)
++|+||||+++.
T Consensus 316 e~l~hp~f~~~~ 327 (330)
T 3nsz_A 316 EAMEHPYFYTVV 327 (330)
T ss_dssp HHHTSGGGTTCC
T ss_pred HHhcCccHhhhc
Confidence 999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=326.40 Aligned_cols=261 Identities=30% Similarity=0.476 Sum_probs=212.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++..++|+|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 689999999999999999999998999999999865432 3345778899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| +|.+.+... ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. +||+|||.+..........
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC-EEEeeCCCccccCCCcchh
Confidence 9976 777776543 35788899999999999999999999999999999999998887 9999999987653221111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. .....|++.|+|||.+.+....+.++|+||||+++|+|++|..||.......
T Consensus 163 ~---------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 215 (276)
T 2yex_A 163 L---------------------------LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (276)
T ss_dssp C---------------------------BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS
T ss_pred c---------------------------ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 0 0112558899999999875555789999999999999999999998765543
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
........... .......+++.+.++|.+||+.||++||++.++++||||++.
T Consensus 216 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 216 QEYSDWKEKKT--------------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHHTTCT--------------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHhhhccc--------------------------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 32222111000 001123578999999999999999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=355.26 Aligned_cols=259 Identities=32% Similarity=0.484 Sum_probs=214.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC-----------CCchhHHHHHHHHHhcCCCCeeeeeEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE-----------GVPSTAIREISLLKEMQHGNIVRLQDVV 70 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (323)
++|++++.||+|+||+||+|+++.++..||+|++....... ...+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 58999999999999999999999999999999987654221 3456788999999999999999999999
Q ss_pred ecCceEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEecc
Q 036739 71 HSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADF 147 (323)
Q Consensus 71 ~~~~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df 147 (323)
.+...+++||||+.| +|.+.+.... .+++..+..++.||+.||.|||+.||+|+||||+||+++.++. .+||+||
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 999999999999976 8888876643 4789999999999999999999999999999999999987763 4999999
Q ss_pred ccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH
Q 036739 148 GLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~ 227 (323)
|++.......... ...||+.|+|||.+.+ .++.++||||+||++|+|+
T Consensus 194 g~a~~~~~~~~~~------------------------------~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll 241 (504)
T 3q5i_A 194 GLSSFFSKDYKLR------------------------------DRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILL 241 (504)
T ss_dssp TTCEECCTTSCBC------------------------------CCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHH
T ss_pred CCCEEcCCCCccc------------------------------cccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHH
Confidence 9998764332211 1256999999999865 5899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH
Q 036739 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 228 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
+|..||.+....+....+....... ....+..+++.+++||.+||+.||++|||+
T Consensus 242 ~g~~pf~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~ 296 (504)
T 3q5i_A 242 CGYPPFGGQNDQDIIKKVEKGKYYF-------------------------DFNDWKNISDEAKELIKLMLTYDYNKRCTA 296 (504)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCC-------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred hCCCCCCCCCHHHHHHHHHcCCCCC-------------------------CccccCCCCHHHHHHHHHHcCCChhHCCCH
Confidence 9999999988877777665531111 112234688999999999999999999999
Q ss_pred hhhhcCCCCccc
Q 036739 308 RSALEHEYFRDV 319 (323)
Q Consensus 308 ~~il~h~~~~~~ 319 (323)
.++|+||||++.
T Consensus 297 ~e~l~h~~~~~~ 308 (504)
T 3q5i_A 297 EEALNSRWIKKY 308 (504)
T ss_dssp HHHHTSHHHHHT
T ss_pred HHHhcCHhhhhc
Confidence 999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=336.17 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=208.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC------CCchhHHHHHHHHHhcCCCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE------GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|+||+||+|++..+++.||+|++....... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 57999999999999999999999999999999997654222 244577889999999999999999999999999
Q ss_pred EEEEEecch-h-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 76 LYLVFEYLD-L-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 76 ~~lv~e~~~-g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
.++|||++. | ++.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT-IKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc-EEEeecccceEC
Confidence 999999984 4 7777776644 4789999999999999999999999999999999999999887 999999999776
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
....... ...||+.|+|||.+.+....+.++||||||+++|+|++|..||
T Consensus 181 ~~~~~~~------------------------------~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 230 (335)
T 3dls_A 181 ERGKLFY------------------------------TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230 (335)
T ss_dssp CTTCCBC------------------------------EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCCcee------------------------------ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCch
Confidence 4332211 1256899999999988555588999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
...... .. ........+++.+.+||.+||+.||++||++.++++|
T Consensus 231 ~~~~~~---------~~--------------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 231 CELEET---------VE--------------------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SSGGGG---------TT--------------------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hhHHHH---------Hh--------------------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 653210 00 0001122378999999999999999999999999999
Q ss_pred CCCccc
Q 036739 314 EYFRDV 319 (323)
Q Consensus 314 ~~~~~~ 319 (323)
|||++.
T Consensus 276 p~~~~~ 281 (335)
T 3dls_A 276 PWVTQP 281 (335)
T ss_dssp TTTTCC
T ss_pred ccccCC
Confidence 999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=347.72 Aligned_cols=281 Identities=26% Similarity=0.405 Sum_probs=214.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC--------CCCeeeeeEEEe--
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ--------HGNIVRLQDVVH-- 71 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~-- 71 (323)
++|++.+.||+|+||+||+|++..+++.||+|++.... .....+.+|+.+++.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 68999999999999999999999999999999985331 22356778999999985 788999999997
Q ss_pred --cCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEecCC---------
Q 036739 72 --SEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRT--------- 139 (323)
Q Consensus 72 --~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~~~Nil~~~~~--------- 139 (323)
+...+++|||++++++++.+.......+++..++.++.||+.||.|||++ ||+|+||||+||+++.++
T Consensus 114 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 114 GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp ETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 56789999999999999999877666789999999999999999999998 999999999999998765
Q ss_pred ---------------------------------------CceEEeccccceecCCCcccccccccCCcCcceeehhhhhh
Q 036739 140 ---------------------------------------NALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180 (323)
Q Consensus 140 ---------------------------------------~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (323)
..+||+|||.+........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~---------------------- 251 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT---------------------- 251 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSC----------------------
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCc----------------------
Confidence 1499999999977542211
Q ss_pred hccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCC
Q 036739 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS------EIDELFKIFRVLGTPNE 254 (323)
Q Consensus 181 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~------~~~~~~~~~~~~~~~~~ 254 (323)
...||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.... ..+....+.+..+....
T Consensus 252 ----------~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~ 320 (397)
T 1wak_A 252 ----------EDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPR 320 (397)
T ss_dssp ----------SCCSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCH
T ss_pred ----------cCCCCCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCCh
Confidence 1245899999999988 568999999999999999999999997654 33444555554444322
Q ss_pred CCCCCcccCCccccc------CCCCCCCc-------ccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 255 DTWPGVTSLPDFKSA------FPKWPSKE-------LGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~------~~~~~~~~-------~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
..+........+... ........ ........++.+.+||.+||+.||++||++.++|+||||++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 321 KLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred HHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 110000000000000 00000000 00112234567899999999999999999999999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=343.48 Aligned_cols=255 Identities=29% Similarity=0.369 Sum_probs=200.1
Q ss_pred CCccee-eeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHH-HhcCCCCeeeeeEEEec----Cce
Q 036739 2 DQYEKV-EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLL-KEMQHGNIVRLQDVVHS----EKK 75 (323)
Q Consensus 2 ~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~~~ 75 (323)
++|.+. +.||+|+||+||++.+..+++.||+|++.. ...+.+|+.++ +..+||||++++++|.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 578887 689999999999999999999999999852 25677888886 45589999999999875 678
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec---CCCceEEeccccce
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGLAR 151 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~---~~~~~kl~df~~~~ 151 (323)
+|+||||+.| +|.+.+.......+++..+..++.||+.||.|||+.||+|+||||+||+++. ++. +||+|||++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~-~kl~DFG~a~ 212 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI-LKLTDFGFAK 212 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCC-EEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCcc-EEEEeccccc
Confidence 9999999975 8888888766667899999999999999999999999999999999999987 455 9999999987
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCC
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~ 231 (323)
........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 213 ~~~~~~~~------------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~ 261 (400)
T 1nxk_A 213 ETTSHNSL------------------------------TTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_dssp ECC-----------------------------------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCCcc------------------------------ccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCC
Confidence 65322110 11356899999999876 668999999999999999999999
Q ss_pred CCCCCChHH----HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH
Q 036739 232 LFPGDSEID----ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 232 p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
||....... ....+....... .......+++.+.+||.+||+.||++||++
T Consensus 262 pf~~~~~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 316 (400)
T 1nxk_A 262 PFYSNHGLAISPGMKTRIRMGQYEF-------------------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 316 (400)
T ss_dssp SCCCCTTCSSCCSHHHHHHHTCCCC-------------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred CCCCCccccccHHHHHHHHcCcccC-------------------------CCcccccCCHHHHHHHHHHCCCChhHCcCH
Confidence 997654322 222222211000 001124578999999999999999999999
Q ss_pred hhhhcCCCCcccc
Q 036739 308 RSALEHEYFRDVE 320 (323)
Q Consensus 308 ~~il~h~~~~~~~ 320 (323)
.++++||||.+..
T Consensus 317 ~eil~hp~~~~~~ 329 (400)
T 1nxk_A 317 TEFMNHPWIMQST 329 (400)
T ss_dssp HHHHHSHHHHTTT
T ss_pred HHHhcCccccCCC
Confidence 9999999997643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=328.07 Aligned_cols=255 Identities=30% Similarity=0.505 Sum_probs=215.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|++|.||++++..++..||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 4789999999999999999999988999999999865532 233456788999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.+ +|.+.+.... .+++..+..++.||+.||.+||++|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRR 169 (284)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC-EEECCCTTCEECSSSCB
T ss_pred EEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC-EEEecccccccCccccc
Confidence 999975 8888876643 4788899999999999999999999999999999999998887 99999999865432211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
. ...|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 170 ~-------------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 217 (284)
T 2vgo_A 170 R-------------------------------TMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217 (284)
T ss_dssp C-------------------------------CCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred c-------------------------------cccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCH
Confidence 0 1245888999999987 5689999999999999999999999988876
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+.... ......+++.+.++|.+||+.||++||++.++++||||++
T Consensus 218 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 218 TETHRRIVNVD-----------------------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp HHHHHHHHTTC-----------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred hHHHHHHhccc-----------------------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 66555443210 0111347889999999999999999999999999999986
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 269 ~ 269 (284)
T 2vgo_A 269 N 269 (284)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=336.76 Aligned_cols=261 Identities=26% Similarity=0.439 Sum_probs=191.0
Q ss_pred CCccee---eeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEE
Q 036739 2 DQYEKV---EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~---~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 77 (323)
++|++. +.||+|+||+||++.+..+++.||+|++... ....+.+|+.+++.+. ||||+++++++.++...+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 356664 7899999999999999999999999998543 2356778999999997 999999999999999999
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEeccccceecC
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFG 154 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~~~~ 154 (323)
+||||++| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. .+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 99999976 8888887653 5789999999999999999999999999999999999987652 49999999997654
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
...... ....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 161 ~~~~~~-----------------------------~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~ 210 (325)
T 3kn6_A 161 PDNQPL-----------------------------KTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQ 210 (325)
T ss_dssp C----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCCcc-----------------------------cccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 322111 11255889999999977 568999999999999999999999998
Q ss_pred CCChHHH---HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhh
Q 036739 235 GDSEIDE---LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSAL 311 (323)
Q Consensus 235 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il 311 (323)
....... .......+.... ..........+++.+.+||.+||+.||++||++.+++
T Consensus 211 ~~~~~~~~~~~~~~~~~i~~~~---------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 211 SHDRSLTCTSAVEIMKKIKKGD---------------------FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp -------CCCHHHHHHHHTTTC---------------------CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred CCccccccccHHHHHHHHHcCC---------------------CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 6543211 111111111100 0001122345889999999999999999999999999
Q ss_pred cCCCCcccc
Q 036739 312 EHEYFRDVE 320 (323)
Q Consensus 312 ~h~~~~~~~ 320 (323)
+||||++..
T Consensus 270 ~h~w~~~~~ 278 (325)
T 3kn6_A 270 YNEWLQDGS 278 (325)
T ss_dssp TCGGGCTTC
T ss_pred cChhhccCc
Confidence 999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=344.79 Aligned_cols=255 Identities=29% Similarity=0.424 Sum_probs=206.8
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh-
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL- 85 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g- 85 (323)
.+.||+|+||.||+|++..++..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 6789999999999999999999999999865432 2346788999999999999999999999999999999999975
Q ss_pred hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec-CCCceEEeccccceecCCCcccccccc
Q 036739 86 DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~-~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|.+.+.... ..+++..+..++.||+.||.|||+.||+|+||||+||++.. +...+||+|||++..........
T Consensus 172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~---- 246 (373)
T 2x4f_A 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK---- 246 (373)
T ss_dssp EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC----
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc----
Confidence 7777776543 35788889999999999999999999999999999999953 23359999999998764332211
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFK 244 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~ 244 (323)
...||+.|+|||.+.. ..++.++|||||||++|+|++|..||......+....
T Consensus 247 --------------------------~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 299 (373)
T 2x4f_A 247 --------------------------VNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN 299 (373)
T ss_dssp --------------------------CCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred --------------------------cccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1246899999999877 6689999999999999999999999999888777766
Q ss_pred HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
+........ ......+++.+.+||.+||+.||++||++.++++||||++.+
T Consensus 300 i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 300 ILACRWDLE-------------------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HHHTCCCSC-------------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHhccCCCC-------------------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 655311110 112245789999999999999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=331.94 Aligned_cols=263 Identities=27% Similarity=0.414 Sum_probs=216.0
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc--CCCCchhHHHHHHHHHhcCCCCeeeeeEEEe--cCceE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKKL 76 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~ 76 (323)
+++|++.+.||+|++|.||++.+..++..||+|++..... .......+.+|+.+++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4799999999999999999999999999999999865532 2334577889999999999999999999984 45689
Q ss_pred EEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 77 YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
++||||+++++.+.+.......+++..+..++.||+.||.+||++|++|+||||+||+++.++. +||+|||.+......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~-~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT-LKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEECCTT
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc-EEeeccccccccCcc
Confidence 9999999998888888766667899999999999999999999999999999999999998887 999999999876432
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCC-CCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR-HYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
..... .....|++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||..
T Consensus 163 ~~~~~---------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 163 AADDT---------------------------CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp CSSCE---------------------------ECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccc---------------------------cccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 21111 01124588999999987632 347799999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
....+....+..... .....+++.+.++|.+||+.||++||++.++++|||
T Consensus 216 ~~~~~~~~~i~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 216 DNIYKLFENIGKGSY-----------------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp SSHHHHHHHHHHCCC-----------------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred chHHHHHHHHhcCCC-----------------------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 776665555443210 111347889999999999999999999999999999
Q ss_pred Ccccc
Q 036739 316 FRDVE 320 (323)
Q Consensus 316 ~~~~~ 320 (323)
|++..
T Consensus 267 ~~~~~ 271 (305)
T 2wtk_C 267 FRKKH 271 (305)
T ss_dssp HHSCC
T ss_pred cccCC
Confidence 98763
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=330.42 Aligned_cols=261 Identities=27% Similarity=0.381 Sum_probs=209.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||+|++..++..||+|++... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 5799999999999999999999989999999998543 23345788899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| ++.+.+... ...+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. +||+|||.+.........
T Consensus 97 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~- 173 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD-IRLADFGVSAKNLKTLQK- 173 (302)
T ss_dssp CCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC-EEECCCHHHHHHHHHHHC-
T ss_pred eCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC-EEEEECCCCccccccccc-
Confidence 9977 555555442 335789999999999999999999999999999999999998887 999999987432110000
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhh----CCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILL----GSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~----~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.....|++.|+|||.+. ....++.++|+||||+++|+|++|..||...
T Consensus 174 ----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 174 ----------------------------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp ---------------------------------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ----------------------------cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 01124588899999984 3366889999999999999999999999988
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
........+....... ......+++.+.++|.+||+.||++||++.++++||||
T Consensus 226 ~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 279 (302)
T 2j7t_A 226 NPMRVLLKIAKSDPPT--------------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279 (302)
T ss_dssp CHHHHHHHHHHSCCCC--------------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTT
T ss_pred CHHHHHHHHhccCCcc--------------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHH
Confidence 7766655544321000 01123478899999999999999999999999999999
Q ss_pred ccccc
Q 036739 317 RDVEF 321 (323)
Q Consensus 317 ~~~~~ 321 (323)
+++..
T Consensus 280 ~~~~~ 284 (302)
T 2j7t_A 280 SSITS 284 (302)
T ss_dssp TTCCC
T ss_pred hhhcc
Confidence 98753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=338.18 Aligned_cols=282 Identities=28% Similarity=0.452 Sum_probs=217.6
Q ss_pred CCcceeeeeccccceeEEEEEE-ccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCC------CeeeeeEEEecCc
Q 036739 2 DQYEKVEKIGEGTYGVVYKARN-CVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG------NIVRLQDVVHSEK 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~ 74 (323)
++|++.+.||+|++|+||++.+ ..++..||+|++.... .....+.+|+.+++.++|+ +++++++++.+.+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 6899999999999999999998 5678899999985321 2235677899999888655 4999999999999
Q ss_pred eEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec-----------------
Q 036739 75 KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR----------------- 137 (323)
Q Consensus 75 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~----------------- 137 (323)
..++||||+++++.+.+.......+++..+..++.||+.||.|||++|++|+||||+||+++.
T Consensus 91 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 91 HICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 999999999889999998877667889999999999999999999999999999999999987
Q ss_pred --CCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchh
Q 036739 138 --RTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVD 215 (323)
Q Consensus 138 --~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~D 215 (323)
++. +||+|||.+........ ...||+.|+|||.+.+ ..++.++|
T Consensus 171 ~~~~~-~kl~Dfg~~~~~~~~~~--------------------------------~~~gt~~y~aPE~~~~-~~~~~~~D 216 (339)
T 1z57_A 171 LINPD-IKVVDFGSATYDDEHHS--------------------------------TLVSTRHYRAPEVILA-LGWSQPCD 216 (339)
T ss_dssp ESCCC-EEECCCSSCEETTSCCC--------------------------------SSCSCGGGCCHHHHTT-SCCCTHHH
T ss_pred ccCCC-ceEeeCcccccCccccc--------------------------------cccCCccccChHHhhC-CCCCcchh
Confidence 344 99999999876432211 1245889999999987 56899999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCC---------------cccc
Q 036739 216 VWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSK---------------ELGT 280 (323)
Q Consensus 216 i~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~ 280 (323)
|||||+++|+|++|..||......+....+.+..+......+........+......|... ....
T Consensus 217 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (339)
T 1z57_A 217 VWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296 (339)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCS
T ss_pred hHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcc
Confidence 9999999999999999999988877776666655443221110000000000000000000 0001
Q ss_pred cccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 281 VVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 281 ~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
.....++.+.+||.+||+.||++||++.++++||||+.++
T Consensus 297 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp CCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred cchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 1122457789999999999999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=327.55 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=206.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|+||+|++..+++.||+|++............+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 579999999999999999999998999999999976654444556778899999999 8999999999999999999999
Q ss_pred ecchh-hHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC------------------
Q 036739 81 EYLDL-DLKKHMDSCP--DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT------------------ 139 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~------------------ 139 (323)
||++| +|.+.+.... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 99976 8888876532 13578999999999999999999999999999999999998543
Q ss_pred CceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHH
Q 036739 140 NALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSV 219 (323)
Q Consensus 140 ~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 219 (323)
..+||+|||.+........ ..||+.|+|||.+.+...++.++|||||
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~---------------------------------~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSPQV---------------------------------EEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp CCEEECCCTTCEETTCSCC---------------------------------CCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred eEEEEcccccccccCCccc---------------------------------cCCCccccChhHhcCCCCCCchhhHHHH
Confidence 2499999999877643221 1348889999999886567789999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhccc
Q 036739 220 GCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299 (323)
Q Consensus 220 G~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 299 (323)
|+++|+|++|.+++...... ..+.+. ........+++.+.++|.+||+.
T Consensus 218 G~il~~l~~~~~~~~~~~~~---~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~ 266 (289)
T 1x8b_A 218 ALTVVCAAGAEPLPRNGDQW---HEIRQG----------------------------RLPRIPQVLSQEFTELLKVMIHP 266 (289)
T ss_dssp HHHHHHHTTCCCCCSSSHHH---HHHHTT----------------------------CCCCCSSCCCHHHHHHHHHHTCS
T ss_pred HHHHHHHhcCCCCCcchhHH---HHHHcC----------------------------CCCCCCcccCHHHHHHHHHHhCC
Confidence 99999999999877554322 222110 00112235789999999999999
Q ss_pred CCCCCCCHhhhhcCCCCccc
Q 036739 300 DPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 300 dp~~R~s~~~il~h~~~~~~ 319 (323)
||++||++.++++||||++.
T Consensus 267 dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 267 DPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp SGGGSCCHHHHHTCTTC---
T ss_pred CcccCCCHHHHhhChHhhhh
Confidence 99999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=338.25 Aligned_cols=268 Identities=26% Similarity=0.380 Sum_probs=202.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc-------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK------- 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------- 74 (323)
++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 68999999999999999999999999999999996543 3334577889999999999999999999985432
Q ss_pred --------------------------------------------------eEEEEEecchh-hHHHhhhcCCC-CCCCHH
Q 036739 75 --------------------------------------------------KLYLVFEYLDL-DLKKHMDSCPD-FANDPR 102 (323)
Q Consensus 75 --------------------------------------------------~~~lv~e~~~g-~l~~~~~~~~~-~~~~~~ 102 (323)
..++||||++| +|.+.+..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 38999999976 77777765443 233556
Q ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhc
Q 036739 103 LIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVL 182 (323)
Q Consensus 103 ~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (323)
.+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++................
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~DfG~a~~~~~~~~~~~~~~~~---------------- 227 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPM---------------- 227 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECSCC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC-EEEeecCcccccccchhhccccccc----------------
Confidence 68899999999999999999999999999999998887 9999999998876543221110000
Q ss_pred cCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCccc
Q 036739 183 AGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTS 262 (323)
Q Consensus 183 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (323)
..........||+.|+|||.+.+ ..++.++|+||||+++|+|++|..|+.. ...........
T Consensus 228 -~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~----------- 289 (332)
T 3qd2_B 228 -PAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNL----------- 289 (332)
T ss_dssp -----CCCSCC-CGGGSCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTT-----------
T ss_pred -cccccccccCCCcCccChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhcc-----------
Confidence 00011122367999999999988 5689999999999999999998765421 11111111000
Q ss_pred CCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 263 LPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
..+......++.+.++|.+||+.||++||++.++++||||+++
T Consensus 290 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 290 --------------KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp --------------CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred --------------CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 0111223456788999999999999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=327.38 Aligned_cols=261 Identities=28% Similarity=0.426 Sum_probs=214.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC----CchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|++|+||++++..+++.||+|++........ ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999998999999999876543222 3567889999999999999999999999999999
Q ss_pred EEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC---ceEEeccccceec
Q 036739 78 LVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGLARAF 153 (323)
Q Consensus 78 lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~---~~kl~df~~~~~~ 153 (323)
+|||++. ++|.+.+.... .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. .+||+|||.+...
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999996 48888776533 5788999999999999999999999999999999999987762 4999999998765
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
....... ...|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||
T Consensus 163 ~~~~~~~------------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~ 211 (283)
T 3bhy_A 163 EAGNEFK------------------------------NIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF 211 (283)
T ss_dssp C--------------------------------------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCCccc------------------------------ccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCC
Confidence 4322110 1245888999999977 56899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
......+....+...... ........+++.+.++|.+||+.||++||++.++++|
T Consensus 212 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 212 LGETKQETLTNISAVNYD-------------------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCSSHHHHHHHHHTTCCC-------------------------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CCcchHHHHHHhHhcccC-------------------------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 988776655544321100 0112234578899999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||+++.
T Consensus 267 ~~~~~~~ 273 (283)
T 3bhy_A 267 SWIKAIR 273 (283)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=326.75 Aligned_cols=260 Identities=31% Similarity=0.524 Sum_probs=217.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||+|++..+++.||+|++............+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 57999999999999999999998899999999997766555667788999999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEeccccceecCCCcc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~~~~~~~~ 158 (323)
++.| ++.+.+.... .+++..+..++.||+.||.+||++|++|+||+|+||+++.++. .+||+|||.+........
T Consensus 102 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 102 LYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 9965 8877776543 4788999999999999999999999999999999999976442 499999999876543221
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.. ...|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.....
T Consensus 180 ~~------------------------------~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (287)
T 2wei_A 180 MK------------------------------DRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (287)
T ss_dssp CS------------------------------CHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cc------------------------------cccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 10 1245888999999876 378999999999999999999999998877
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+........ .+....+++.+.++|.+||+.||++||++.++++||||++
T Consensus 228 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 228 YDILKRVETGKYAFD-------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHHHHHHCCCCCC-------------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHHHHHHcCCCCCC-------------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 666655544211110 1112457899999999999999999999999999999987
Q ss_pred cc
Q 036739 319 VE 320 (323)
Q Consensus 319 ~~ 320 (323)
..
T Consensus 283 ~~ 284 (287)
T 2wei_A 283 YS 284 (287)
T ss_dssp HC
T ss_pred cc
Confidence 54
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=340.85 Aligned_cols=282 Identities=32% Similarity=0.541 Sum_probs=218.2
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CC-----CeeeeeEEEecCc
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HG-----NIVRLQDVVHSEK 74 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~~~~ 74 (323)
+++|++.+.||+|+||+||+|++..+++.||+|++.... .....+..|+.+++.+. |+ +++++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 378999999999999999999999999999999985321 22355667888888885 44 4999999999999
Q ss_pred eEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCcEEEec--CCCceEEeccccc
Q 036739 75 KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH--SHRVLHRDLKPQNLLIDR--RTNALKLADFGLA 150 (323)
Q Consensus 75 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~i~H~dl~~~Nil~~~--~~~~~kl~df~~~ 150 (323)
..++|||+++|+|.+.+.......+++..+..++.||+.||.||| +.||+|+||||+||+++. ++. +||+|||++
T Consensus 130 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~-~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCC-EEECCCTTC
T ss_pred ceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCc-EEEEeccCc
Confidence 999999999999999998776556899999999999999999999 579999999999999954 444 999999999
Q ss_pred eecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 151 RAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
...+..... ..||+.|+|||.+.+ ..++.++|||||||++|+|++|.
T Consensus 209 ~~~~~~~~~--------------------------------~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~ 255 (382)
T 2vx3_A 209 CQLGQRIYQ--------------------------------YIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGE 255 (382)
T ss_dssp EETTCCCCS--------------------------------SCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSS
T ss_pred eeccccccc--------------------------------ccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCC
Confidence 876432111 245888999999988 56899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCC--------------CCC---Cccccc------------
Q 036739 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPK--------------WPS---KELGTV------------ 281 (323)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~---~~~~~~------------ 281 (323)
.||.+....+.+..+.+..+.+....++.......+...... ... ......
T Consensus 256 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 335 (382)
T 2vx3_A 256 PLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR 335 (382)
T ss_dssp CSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTT
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccc
Confidence 999999988888888877666543322221111111110000 000 000000
Q ss_pred ------ccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 282 ------VRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 282 ------~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
....++.+.+||.+||+.||++|||+.++|+||||++.
T Consensus 336 ~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 00011478999999999999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=328.52 Aligned_cols=257 Identities=27% Similarity=0.420 Sum_probs=211.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|+||++++..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 479999999999999999999999999999999875432 233678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---ecCCCceEEeccccceecCCCc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLI---DRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~---~~~~~~~kl~df~~~~~~~~~~ 157 (323)
|++| +|.+.+.... .+++..+..++.||+.||.+||+.|++|+||+|+||++ +.++. ++|+|||.+.......
T Consensus 87 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~-~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 87 LVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSK-IMITDFGLSKMEQNGI 163 (304)
T ss_dssp CCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCC-EEBCSCSTTCCCCCBT
T ss_pred cCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCC-EEEccCCcceecCCCc
Confidence 9975 8888776543 47888999999999999999999999999999999999 55555 9999999986543211
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. ...|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....
T Consensus 164 ~~-------------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 164 MS-------------------------------TACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp TH-------------------------------HHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cc-------------------------------cccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 10 1245889999999877 568999999999999999999999999887
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
..+....+.+...... ......+++.+.++|.+||+.||++||++.++++||||+
T Consensus 212 ~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (304)
T 2jam_A 212 ESKLFEKIKEGYYEFE-------------------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266 (304)
T ss_dssp HHHHHHHHHHCCCCCC-------------------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHHHHHHHcCCCCCC-------------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence 7666665554221110 112245789999999999999999999999999999998
Q ss_pred ccc
Q 036739 318 DVE 320 (323)
Q Consensus 318 ~~~ 320 (323)
+..
T Consensus 267 ~~~ 269 (304)
T 2jam_A 267 GNT 269 (304)
T ss_dssp SSC
T ss_pred CCC
Confidence 753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=328.10 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=209.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+..++..||+|.+... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 5799999999999999999999889999999998643 235778899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| +|.+.+... ...+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. +||+|||.+..........
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH-AKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECBTTBSCB
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC-EEEeecccchhhhhhcccc
Confidence 9987 777666532 335789999999999999999999999999999999999998887 9999999997654322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.......
T Consensus 183 -----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 232 (314)
T 3com_A 183 -----------------------------NTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232 (314)
T ss_dssp -----------------------------CCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -----------------------------CccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 11245888999999987 568999999999999999999999998877665
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
....+...... . ......+++.+.++|.+||+.||++||++.++++||||++..
T Consensus 233 ~~~~~~~~~~~----~----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 233 AIFMIPTNPPP----T----------------------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHHHSCCC----C----------------------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHhcCCCc----c----------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 55443321100 0 001234688999999999999999999999999999999875
Q ss_pred c
Q 036739 321 F 321 (323)
Q Consensus 321 ~ 321 (323)
.
T Consensus 287 ~ 287 (314)
T 3com_A 287 G 287 (314)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=325.21 Aligned_cols=257 Identities=29% Similarity=0.432 Sum_probs=209.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|++|.||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 3789999999999999999999988999999999876532 334556888999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
||++.| +|.+.+.... .+++..+..++.||+.||.+||++|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC-EEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC-EEEeecccccccCCCcc
Confidence 999975 8888876543 4688889999999999999999999999999999999998887 99999999876543211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.. ...|++.|+|||.+.+....+.++|+||||+++|+|++|..||.....
T Consensus 167 ~~------------------------------~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 216 (276)
T 2h6d_A 167 LR------------------------------TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216 (276)
T ss_dssp ----------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ee------------------------------cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 10 124588899999998855557899999999999999999999988776
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
......+..... .....+++.+.++|.+||+.||++||++.++++||||++
T Consensus 217 ~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 217 PTLFKKIRGGVF-----------------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHHhhcCcc-----------------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 655554433110 011346788999999999999999999999999999976
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 268 ~ 268 (276)
T 2h6d_A 268 D 268 (276)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=330.06 Aligned_cols=259 Identities=27% Similarity=0.421 Sum_probs=209.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEec------Cc
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS------EK 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~~ 74 (323)
++|++.+.||+|++|.||+|++..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 68999999999999999999999999999999986432 3347888999999999 79999999999976 56
Q ss_pred eEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
..++||||++| +|.+.+.......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. +||+|||++...
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~-~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQL 179 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC-EEECCCTTTC--
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC-EEEeeCcCceec
Confidence 89999999976 8888887665557889999999999999999999999999999999999998887 999999998765
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHhC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQ 229 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~tg 229 (323)
....... ....|++.|+|||.+.. ...++.++||||||+++|+|++|
T Consensus 180 ~~~~~~~-----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 230 (326)
T 2x7f_A 180 DRTVGRR-----------------------------NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230 (326)
T ss_dssp ----------------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHS
T ss_pred CcCcccc-----------------------------ccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhC
Confidence 4221110 11245889999999863 25688999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 230 RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
..||...........+...... ......+++.+.++|.+||..||++||++.+
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 283 (326)
T 2x7f_A 231 APPLCDMHPMRALFLIPRNPAP---------------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283 (326)
T ss_dssp SCTTTTSCHHHHHHHHHHSCCC---------------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCCCcHHHHHHHhhcCccc---------------------------cCCccccCHHHHHHHHHHhccChhhCCCHHH
Confidence 9999887766655544331100 0011347889999999999999999999999
Q ss_pred hhcCCCCcccc
Q 036739 310 ALEHEYFRDVE 320 (323)
Q Consensus 310 il~h~~~~~~~ 320 (323)
+++||||++.+
T Consensus 284 ll~hp~~~~~~ 294 (326)
T 2x7f_A 284 LMKHPFIRDQP 294 (326)
T ss_dssp HHTSHHHHCCT
T ss_pred HhhChHHhhCc
Confidence 99999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=322.77 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=216.0
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC-------CCchhHHHHHHHHHhcC-CCCeeeeeEEEec
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE-------GVPSTAIREISLLKEMQ-HGNIVRLQDVVHS 72 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 72 (323)
.++|++.+.||+|++|.||++++..+++.||+|++....... ...+.+.+|+.+++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999999999999999986543211 12345678999999996 9999999999999
Q ss_pred CceEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccce
Q 036739 73 EKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (323)
Q Consensus 73 ~~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~ 151 (323)
.+..++||||++| +|.+.+.... .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. +||+|||.+.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc-EEEecccchh
Confidence 9999999999975 8888876543 5788899999999999999999999999999999999999887 9999999987
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhh-----CCCCCCCchhhHHHHHHHHHH
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILL-----GSRHYSTPVDVWSVGCIFAEM 226 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~~Di~slG~ll~~l 226 (323)
......... ...|++.|+|||.+. ....++.++|+||||+++|+|
T Consensus 173 ~~~~~~~~~------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l 222 (298)
T 1phk_A 173 QLDPGEKLR------------------------------EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 222 (298)
T ss_dssp ECCTTCCBC------------------------------CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred hcCCCcccc------------------------------cccCCccccCHHHhccccccccccCCcccccHhHHHHHHHH
Confidence 764322111 124588899999986 235678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC
Q 036739 227 VNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT 306 (323)
Q Consensus 227 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 306 (323)
++|..||...........+........ .+....+++.+.++|.+||+.||++||+
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps 277 (298)
T 1phk_A 223 LAGSPPFWHRKQMLMLRMIMSGNYQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYT 277 (298)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHCCCCCcCccHHHHHHHHhcCCcccC-------------------------cccccccCHHHHHHHHHHccCCcccCCC
Confidence 999999988877666655544211110 0112357889999999999999999999
Q ss_pred HhhhhcCCCCcccc
Q 036739 307 ARSALEHEYFRDVE 320 (323)
Q Consensus 307 ~~~il~h~~~~~~~ 320 (323)
+.++++||||++..
T Consensus 278 ~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 278 AEEALAHPFFQQYV 291 (298)
T ss_dssp HHHHTTSGGGCTTC
T ss_pred HHHHHhChHhhhcc
Confidence 99999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=343.81 Aligned_cols=263 Identities=26% Similarity=0.436 Sum_probs=203.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC------CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED------EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.++++++||||+++++++.. +.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 5799999999999999999999999999999999765321 2233467899999999999999999999854 45
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEecccccee
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARA 152 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~~ 152 (323)
.++||||+.| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. .+||+|||++..
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred eEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 7899999976 7777766543 5789999999999999999999999999999999999975432 499999999976
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--CCCCCCchhhHHHHHHHHHHHhCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
....... ....||+.|+|||.+.+ ...++.++|+||||+++|+|++|.
T Consensus 292 ~~~~~~~------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~ 341 (419)
T 3i6u_A 292 LGETSLM------------------------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341 (419)
T ss_dssp CC-----------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCccc------------------------------cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 5422111 11356999999999853 355788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh
Q 036739 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310 (323)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i 310 (323)
.||.................. ...+.....+++.+.+||.+||+.||++||++.++
T Consensus 342 ~pf~~~~~~~~~~~~i~~~~~------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 397 (419)
T 3i6u_A 342 PPFSEHRTQVSLKDQITSGKY------------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397 (419)
T ss_dssp CSSCCCSSSCCHHHHHHTTCC------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCcchHHHHHHHhcCCC------------------------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 999876543333222221000 00122334588999999999999999999999999
Q ss_pred hcCCCCccccc
Q 036739 311 LEHEYFRDVEF 321 (323)
Q Consensus 311 l~h~~~~~~~~ 321 (323)
++||||++.++
T Consensus 398 l~hp~~~~~~~ 408 (419)
T 3i6u_A 398 LRHPWLQDEDM 408 (419)
T ss_dssp HHSGGGCCHHH
T ss_pred hCCcccCChhH
Confidence 99999998643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=325.28 Aligned_cols=255 Identities=23% Similarity=0.354 Sum_probs=207.5
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec----CceEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS----EKKLYL 78 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l 78 (323)
.|++.+.||+|++|+||+|.+..++..||+|.+............+.+|+.+++.++||||+++++++.. ...+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 5888999999999999999999999999999987655444455678899999999999999999999864 467999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEe-cCCCceEEeccccceecC
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR--VLHRDLKPQNLLID-RRTNALKLADFGLARAFG 154 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~~~Nil~~-~~~~~~kl~df~~~~~~~ 154 (323)
||||++| +|.+.+.... .+++..+..++.||+.||.|||+.| ++|+||||+||+++ .++. +||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~-~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS-VKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC-EEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC-EEEeeCCCccccc
Confidence 9999965 8888776543 4688889999999999999999999 99999999999998 5555 9999999986543
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
..... ...||+.|+|||.+.+ .++.++|+||||+++|+|++|..||.
T Consensus 184 ~~~~~-------------------------------~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~ 230 (290)
T 1t4h_A 184 ASFAK-------------------------------AVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp TTSBE-------------------------------ESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ccccc-------------------------------cccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 22111 1245889999998875 48999999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
................. ........++.+.++|.+||+.||++||++.++++||
T Consensus 231 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 231 ECQNAAQIYRRVTSGVK--------------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp TCSSHHHHHHHHTTTCC--------------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CcCcHHHHHHHHhccCC--------------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 86665554433221000 1112234678899999999999999999999999999
Q ss_pred CCccc
Q 036739 315 YFRDV 319 (323)
Q Consensus 315 ~~~~~ 319 (323)
||++-
T Consensus 285 ~f~~~ 289 (290)
T 1t4h_A 285 FFQEE 289 (290)
T ss_dssp GGC--
T ss_pred ccccC
Confidence 99863
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=337.63 Aligned_cols=265 Identities=24% Similarity=0.415 Sum_probs=210.0
Q ss_pred CCCcceeeeeccccceeEEEEEEc---cCCceEEEEEEEeccc--CCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCc
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNC---VTNETIALKKIRLEQE--DEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEK 74 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 74 (323)
+++|++.+.||+|+||+||++++. .+++.||+|++..... .......+.+|+.+++.+ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 368999999999999999999984 4789999999865431 233456677899999999 6999999999999999
Q ss_pred eEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
.+++||||+.| +|.+.+.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++. +||+|||++...
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc-EEEeeCCCCeec
Confidence 99999999975 8888876543 4788899999999999999999999999999999999999887 999999998765
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-CCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
........ ....||+.|+|||.+.+. ..++.++|||||||++|+|++|..|
T Consensus 210 ~~~~~~~~----------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~p 261 (355)
T 1vzo_A 210 VADETERA----------------------------YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261 (355)
T ss_dssp CGGGGGGG----------------------------CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCCCCcc----------------------------cCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 32221111 113569999999999863 4478899999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CH
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TA 307 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~ 307 (323)
|...........+.+..... .......+++.+.+||.+||+.||++|| ++
T Consensus 262 f~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~ 316 (355)
T 1vzo_A 262 FTVDGEKNSQAEISRRILKS-------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 316 (355)
T ss_dssp TSCTTSCCCHHHHHHHHHHC-------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTH
T ss_pred CccCCccchHHHHHHHHhcc-------------------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCH
Confidence 97543322222211111000 0111234788999999999999999999 99
Q ss_pred hhhhcCCCCccccc
Q 036739 308 RSALEHEYFRDVEF 321 (323)
Q Consensus 308 ~~il~h~~~~~~~~ 321 (323)
.++++||||++++|
T Consensus 317 ~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 317 DEIKEHLFFQKINW 330 (355)
T ss_dssp HHHHTSGGGTTCCH
T ss_pred HHHHcCcchhcCCh
Confidence 99999999998865
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=337.43 Aligned_cols=282 Identities=27% Similarity=0.412 Sum_probs=217.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCC-ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC------eeeeeEEEecCc
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN------IVRLQDVVHSEK 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~~~ 74 (323)
++|++.+.||+|++|+||+|.+..++ ..||+|++.... .....+.+|+.+++.++|++ ++.+++++...+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 68999999999999999999997776 689999985322 22356778999999997655 899999999999
Q ss_pred eEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE-------------------
Q 036739 75 KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLI------------------- 135 (323)
Q Consensus 75 ~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~------------------- 135 (323)
..++|||++++++++.+.......+++..+..++.||+.||.|||++||+|+||||+||++
T Consensus 96 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 96 HMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred eEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 9999999999999999988766678999999999999999999999999999999999999
Q ss_pred ecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchh
Q 036739 136 DRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVD 215 (323)
Q Consensus 136 ~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~D 215 (323)
+.++. +||+|||++........ ...||+.|+|||.+.+ ..++.++|
T Consensus 176 ~~~~~-~kl~Dfg~~~~~~~~~~--------------------------------~~~gt~~y~aPE~~~~-~~~~~~~D 221 (355)
T 2eu9_A 176 VKNTS-IRVADFGSATFDHEHHT--------------------------------TIVATRHYRPPEVILE-LGWAQPCD 221 (355)
T ss_dssp ESCCC-EEECCCTTCEETTSCCC--------------------------------SSCSCGGGCCHHHHTT-CCCCTHHH
T ss_pred cCCCc-EEEeecCcccccccccc--------------------------------CCcCCCcccCCeeeec-CCCCCccc
Confidence 44555 99999999876432211 1255899999999987 56899999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCC---------------cccc
Q 036739 216 VWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSK---------------ELGT 280 (323)
Q Consensus 216 i~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~ 280 (323)
+||||+++|+|++|..||......+....+....+......+........+......|... ....
T Consensus 222 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (355)
T 2eu9_A 222 VWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301 (355)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCS
T ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccccc
Confidence 9999999999999999999988877776666655443221110000000000000000000 0000
Q ss_pred cccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 281 VVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 281 ~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
.....++.+.+||.+||+.||++||++.++++||||++++
T Consensus 302 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp CCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred ccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 1112345789999999999999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=335.20 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=213.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC------CCchhHHHHHHHHHhc-CCCCeeeeeEEEecCc
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE------GVPSTAIREISLLKEM-QHGNIVRLQDVVHSEK 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 74 (323)
++|++.+.||+|++|+||+|++..+|+.||+|++....... .....+.+|+.+++.+ .||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 46999999999999999999998899999999986543211 1134667899999999 7999999999999999
Q ss_pred eEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
..++||||+.| +|.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||.+...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~-ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ-IRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEEEecCccccc
Confidence 99999999976 7877776533 5788999999999999999999999999999999999999887 999999998776
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC-----CCCCCCchhhHHHHHHHHHHHh
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG-----SRHYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~~Di~slG~ll~~l~t 228 (323)
....... ...||+.|+|||.+.+ ...++.++||||||+++|+|++
T Consensus 251 ~~~~~~~------------------------------~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~ 300 (365)
T 2y7j_A 251 EPGEKLR------------------------------ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300 (365)
T ss_dssp CTTCCBC------------------------------CCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHH
T ss_pred CCCcccc------------------------------cCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHH
Confidence 4322111 1256899999999863 2357889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 229 QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|..||...........+....... ..+....+++.+.++|.+||+.||++||++.
T Consensus 301 g~~pf~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 355 (365)
T 2y7j_A 301 GSPPFWHRRQILMLRMIMEGQYQF-------------------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAE 355 (365)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCC-------------------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCC-------------------------CCcccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 999998877666655554421111 0112245788999999999999999999999
Q ss_pred hhhcCCCCcc
Q 036739 309 SALEHEYFRD 318 (323)
Q Consensus 309 ~il~h~~~~~ 318 (323)
++++||||+.
T Consensus 356 ell~hp~f~r 365 (365)
T 2y7j_A 356 QALQHPFFER 365 (365)
T ss_dssp HHHHSGGGCC
T ss_pred HHhcCcccCC
Confidence 9999999973
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=330.22 Aligned_cols=268 Identities=24% Similarity=0.363 Sum_probs=203.2
Q ss_pred CCccee-eeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEE
Q 036739 2 DQYEKV-EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 2 ~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 79 (323)
++|++. +.||+|++|+||+|++..+++.||+|++.... ......+.+|+.+++++ +||||+++++++.+++.+++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 578885 78999999999999998999999999986542 33457788999999985 799999999999999999999
Q ss_pred Eecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEeccccceecCCC
Q 036739 80 FEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIP 156 (323)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~~~~~~ 156 (323)
|||+. |+|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. .+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99997 48888876643 4788899999999999999999999999999999999987654 3899999998765322
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC----CCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS----RHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
........ .......||+.|+|||.+... ..++.++|||||||++|+|++|..|
T Consensus 168 ~~~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p 225 (316)
T 2ac3_A 168 GDCSPIST----------------------PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225 (316)
T ss_dssp ------------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCS
T ss_pred Cccccccc----------------------cccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCC
Confidence 11110000 001113569999999998641 3478899999999999999999999
Q ss_pred CCCCChH--------------H-HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 233 FPGDSEI--------------D-ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 233 ~~~~~~~--------------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
|...... . ....+...... ........+++.+++||.+||
T Consensus 226 f~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~L 280 (316)
T 2ac3_A 226 FVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE-------------------------FPDKDWAHISCAAKDLISKLL 280 (316)
T ss_dssp CCCCCCSCSCC----CCHHHHHHHHHHHHHCCCC-------------------------CCHHHHTTSCHHHHHHHHHHS
T ss_pred CcccccccccccccccchhHHHHHHHHHhccCcc-------------------------cCchhcccCCHHHHHHHHHHh
Confidence 9775421 1 11122111000 001112457899999999999
Q ss_pred ccCCCCCCCHhhhhcCCCCcccc
Q 036739 298 CMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 298 ~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
+.||++||++.++++||||++..
T Consensus 281 ~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 281 VRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp CSSTTTSCCHHHHHHSTTCC---
T ss_pred hCChhhCCCHHHHhcChhhcCCC
Confidence 99999999999999999999763
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=325.18 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=214.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|.||++.+..+++.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 589999999999999999999999999999999865532 2233467788999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||++| ++.+.+.... .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. +||+|||.+.........
T Consensus 95 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGER 171 (294)
T ss_dssp ECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCSTTCC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC-EEEEeccCceecccCccc
Confidence 99985 7777665533 5788899999999999999999999999999999999998887 999999998776432211
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
. ....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......
T Consensus 172 ~-----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 221 (294)
T 2rku_A 172 K-----------------------------KVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221 (294)
T ss_dssp B-----------------------------CCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred c-----------------------------ccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1 01245888999999987 56799999999999999999999999888766
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+....+.... ......+++.+.++|.+||+.||++||++.++++||||++.
T Consensus 222 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 222 ETYLRIKKNE-----------------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHTTC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHhhcc-----------------------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 6554443210 01123478899999999999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=334.64 Aligned_cols=276 Identities=22% Similarity=0.368 Sum_probs=215.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCc---------------hhHHHHHHHHHhcCCCCeeee
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVP---------------STAIREISLLKEMQHGNIVRL 66 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~---------------~~~~~e~~~l~~l~~~~i~~~ 66 (323)
++|++.+.||+|++|.||+|.+ +++.||+|.+.......... ..+.+|+.+++.++||||+++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 6899999999999999999998 89999999997664332211 788899999999999999999
Q ss_pred eEEEecCceEEEEEecchh-hHHHh------hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecC
Q 036739 67 QDVVHSEKKLYLVFEYLDL-DLKKH------MDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRR 138 (323)
Q Consensus 67 ~~~~~~~~~~~lv~e~~~g-~l~~~------~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~ 138 (323)
++++.+.+..++||||++| +|.+. +.......+++..+..++.||+.||.|||+ .|++|+||+|+||+++.+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 9999999999999999987 77776 554435578999999999999999999999 999999999999999998
Q ss_pred CCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCC-chhhH
Q 036739 139 TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYST-PVDVW 217 (323)
Q Consensus 139 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~~Di~ 217 (323)
+. +||+|||.+........ ....|++.|+|||.+.+...++. ++|+|
T Consensus 189 ~~-~kl~dfg~~~~~~~~~~-------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~ 236 (348)
T 2pml_X 189 GR-VKLSDFGESEYMVDKKI-------------------------------KGSRGTYEFMPPEFFSNESSYNGAKVDIW 236 (348)
T ss_dssp SC-EEECCCTTCEECBTTEE-------------------------------CSSCSCGGGCCGGGGSSCCCEEHHHHHHH
T ss_pred Cc-EEEeccccccccccccc-------------------------------cCCCCCcCccCchhhcCCCCCCcchhhHH
Confidence 87 99999999977543211 01245888999999988545555 99999
Q ss_pred HHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhh
Q 036739 218 SVGCIFAEMVNQRPLFPGDSE-IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKM 296 (323)
Q Consensus 218 slG~ll~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 296 (323)
|||+++|+|++|..||..... .+....+...... ++.... .+ ...............+++.+.+||.+|
T Consensus 237 slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~-----~~~~~~--~~---~~~~~~~~~~~~~~~~~~~l~~li~~~ 306 (348)
T 2pml_X 237 SLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE-----YPLDRN--HF---LYPLTNKKSTCSNNFLSNEDIDFLKLF 306 (348)
T ss_dssp HHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCC-----CCCSSS--SS---TTTTCC--------CCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcC-----Cccchh--hh---hccccccccccchhhcCHHHHHHHHHH
Confidence 999999999999999988776 3433333221110 000000 00 000111111222356889999999999
Q ss_pred cccCCCCCCCHhhhhcCCCCccccc
Q 036739 297 LCMDPSRRITARSALEHEYFRDVEF 321 (323)
Q Consensus 297 l~~dp~~R~s~~~il~h~~~~~~~~ 321 (323)
|+.||++||++.++++||||++.++
T Consensus 307 L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 307 LRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp CCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred ccCChhhCCCHHHHhcCccccCCCH
Confidence 9999999999999999999998764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=331.04 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=214.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||.||++.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999865532 2233467788999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||++| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.........
T Consensus 121 e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 121 ELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGER 197 (335)
T ss_dssp CCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-EEECCCTTCEECCSTTCC
T ss_pred ecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC-EEEeeccCceecccCccc
Confidence 99986 7777665533 5788899999999999999999999999999999999999887 999999999776422211
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
. ....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......
T Consensus 198 ~-----------------------------~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 247 (335)
T 2owb_A 198 K-----------------------------KVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247 (335)
T ss_dssp B-----------------------------CCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred c-----------------------------cccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 1 01245889999999987 56799999999999999999999999888766
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+....+..... .....+++.+.++|.+||+.||++||++.++++||||++.
T Consensus 248 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 248 ETYLRIKKNEY-----------------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHTCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHhcCCC-----------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 66555443210 0113477889999999999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=333.56 Aligned_cols=258 Identities=29% Similarity=0.417 Sum_probs=204.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCC--CCeeeeeEEEecCceEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH--GNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv 79 (323)
++|++.+.||+|+||.||++.+ .++..||+|++............+.+|+.+++.++| +||+++++++.++...++|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 5799999999999999999998 568899999987654444445678899999999976 9999999999999999999
Q ss_pred EecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 80 FEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.+|+|.+.+.... .+++..+..++.||+.||.|||+.||+|+||||+||+++ ++. +||+|||++.........
T Consensus 88 ~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~-~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 88 MECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM-LKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp ECCCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTE-EEECCCSSSCCC------
T ss_pred EeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCc-EEEeecccccccCccccc
Confidence 9988889999988754 568888999999999999999999999999999999997 455 999999999765432221
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----------CCCCCCchhhHHHHHHHHHHHhC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----------SRHYSTPVDVWSVGCIFAEMVNQ 229 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----------~~~~~~~~Di~slG~ll~~l~tg 229 (323)
.. .....||+.|+|||.+.+ ...++.++|||||||++|+|++|
T Consensus 164 ~~---------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 216 (343)
T 3dbq_A 164 VV---------------------------KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216 (343)
T ss_dssp ---------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHS
T ss_pred cc---------------------------CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence 10 112356999999999863 25678899999999999999999
Q ss_pred CCCCCCCChHH-HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 230 RPLFPGDSEID-ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 230 ~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
..||....... ....+.. ..... ......++.+.++|.+||+.||.+||++.
T Consensus 217 ~~pf~~~~~~~~~~~~~~~---~~~~~------------------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~ 269 (343)
T 3dbq_A 217 KTPFQQIINQISKLHAIID---PNHEI------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIP 269 (343)
T ss_dssp SCTTTTCCSHHHHHHHHHC---TTSCC------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCcchhhhhHHHHHHHHhc---CCccc------------------------CCcccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 99998754432 2222221 11000 11123567899999999999999999999
Q ss_pred hhhcCCCCcc
Q 036739 309 SALEHEYFRD 318 (323)
Q Consensus 309 ~il~h~~~~~ 318 (323)
++++||||+.
T Consensus 270 e~l~hp~~~~ 279 (343)
T 3dbq_A 270 ELLAHPYVQI 279 (343)
T ss_dssp HHHTSHHHHS
T ss_pred HHHhCccccc
Confidence 9999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=338.69 Aligned_cols=258 Identities=28% Similarity=0.410 Sum_probs=204.2
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC--CCCeeeeeEEEecCceEEEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ--HGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+|++.+.||+|+||+||++.+.. +..||+|++............+.+|+.+++.+. ||||+++++++...+.+++||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 59999999999999999999854 889999999765544444577889999999996 599999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+++|.+.+.... .+++..+..++.||+.||.|||+.||+|+||||+||+++ ++. +||+|||++..........
T Consensus 136 E~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~-~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 136 ECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM-LKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp ECCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSC-EEECCCSSSCCC-------
T ss_pred ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCe-EEEEecCccccccCCCccc
Confidence 977789999887754 568888999999999999999999999999999999995 455 9999999997654322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----------CCCCCCchhhHHHHHHHHHHHhCC
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----------SRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----------~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
. .....||+.|+|||++.+ ...++.++|||||||++|+|++|.
T Consensus 212 ~---------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~ 264 (390)
T 2zmd_A 212 V---------------------------KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264 (390)
T ss_dssp -----------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSS
T ss_pred c---------------------------CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCC
Confidence 0 112356999999999875 235888999999999999999999
Q ss_pred CCCCCCChH-HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 231 PLFPGDSEI-DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 231 ~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
.||...... ..+..+... .... ......++.+.+||.+||+.||++||++.+
T Consensus 265 ~Pf~~~~~~~~~~~~~~~~---~~~~------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 317 (390)
T 2zmd_A 265 TPFQQIINQISKLHAIIDP---NHEI------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPE 317 (390)
T ss_dssp CTTTTCCCHHHHHHHHHCT---TSCC------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CcchhhhHHHHHHHHHhCc---cccC------------------------CCCccchHHHHHHHHHHcccChhhCCCHHH
Confidence 999875433 223322211 0000 011224678999999999999999999999
Q ss_pred hhcCCCCccc
Q 036739 310 ALEHEYFRDV 319 (323)
Q Consensus 310 il~h~~~~~~ 319 (323)
+++||||+..
T Consensus 318 ll~hp~~~~~ 327 (390)
T 2zmd_A 318 LLAHPYVQIQ 327 (390)
T ss_dssp HHTSHHHHSC
T ss_pred HhhCcCcccc
Confidence 9999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=330.08 Aligned_cols=274 Identities=25% Similarity=0.364 Sum_probs=193.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|+||++.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 689999999999999999999988999999998854432 2334677889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 82 YLDL-DLKKHMDS------CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 82 ~~~g-~l~~~~~~------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
|+.| +|.+.+.. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. +||+|||.+....
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS-VQIADFGVSAFLA 172 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC-EEECCCHHHHHCC
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC-EEEEeccchheec
Confidence 9965 77777653 12345789999999999999999999999999999999999998887 9999999987654
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
......... ......||+.|+|||.+.....++.++|+||||+++|+|++|..||.
T Consensus 173 ~~~~~~~~~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 228 (303)
T 2vwi_A 173 TGGDITRNK------------------------VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228 (303)
T ss_dssp ---------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cCCCccchh------------------------hhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 322111000 01112568899999998754457899999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
..................... ..........+++.+.++|.+||+.||++||++.++++||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 229 KYPPMKVLMLTLQNDPPSLET-------------------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp TSCGGGHHHHHHTSSCCCTTC------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred cCchhhHHHHHhccCCCcccc-------------------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 877665554333211000000 0001123346788999999999999999999999999999
Q ss_pred CCcccc
Q 036739 315 YFRDVE 320 (323)
Q Consensus 315 ~~~~~~ 320 (323)
||++..
T Consensus 290 ~~~~~~ 295 (303)
T 2vwi_A 290 FFQKAK 295 (303)
T ss_dssp TC----
T ss_pred hhhcCC
Confidence 999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=322.47 Aligned_cols=255 Identities=28% Similarity=0.432 Sum_probs=213.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++++..+++.||+|++..... ......+.+|+.+++.+.||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 569999999999999999999999999999999865532 3345788899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| ++.+.+.. ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. +||+|||.+..........
T Consensus 101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECBTTBCCB
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC-EEEeecccceecCcccccc
Confidence 9986 66666653 25789999999999999999999999999999999999998887 9999999997764322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.......
T Consensus 177 -----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 226 (303)
T 3a7i_A 177 -----------------------------NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMK 226 (303)
T ss_dssp -----------------------------CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -----------------------------CccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH
Confidence 11245888999999987 568899999999999999999999998877665
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
....+..... ......+++.+.++|.+||+.||++||++.++++||||...
T Consensus 227 ~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 227 VLFLIPKNNP----------------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp HHHHHHHSCC----------------------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred HHHHhhcCCC----------------------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 5554433110 11123578899999999999999999999999999999653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=324.16 Aligned_cols=260 Identities=28% Similarity=0.436 Sum_probs=213.3
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEe--cCceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l 78 (323)
+++|++.+.||+|++|.||++.+..+++.||+|.+..........+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 37899999999999999999999999999999999765444444567889999999999999999999874 4678999
Q ss_pred EEecchh-hHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCcEEEecCCCceEEeccccc
Q 036739 79 VFEYLDL-DLKKHMDSCP--DFANDPRLIKTFLYQILRGIAYCHSHR-----VLHRDLKPQNLLIDRRTNALKLADFGLA 150 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~-----i~H~dl~~~Nil~~~~~~~~kl~df~~~ 150 (323)
||||++| +|.+.+.... ...+++..+..++.||+.||.+||+.| ++|+||+|+||+++.++. +||+|||.+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~-~kl~dfg~~ 163 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLA 163 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC-EEECCCCHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC-EEEecCchh
Confidence 9999976 8888776432 334789999999999999999999999 999999999999998887 999999998
Q ss_pred eecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 151 RAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
.......... ....|++.|+|||.+.+ ..++.++|+||||+++|+|++|.
T Consensus 164 ~~~~~~~~~~-----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~ 213 (279)
T 2w5a_A 164 RILNHDTSFA-----------------------------KTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALM 213 (279)
T ss_dssp HHC---CHHH-----------------------------HHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSS
T ss_pred eeeccccccc-----------------------------cccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCC
Confidence 7654321110 01245888999999988 56899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh
Q 036739 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310 (323)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i 310 (323)
.||......+....+...... .....+++.+.++|.+||+.||++||++.++
T Consensus 214 ~p~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 265 (279)
T 2w5a_A 214 PPFTAFSQKELAGKIREGKFR----------------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265 (279)
T ss_dssp CSSCCSSHHHHHHHHHHTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCcccCHHHHHHHHhhcccc----------------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 999988766655555432110 1123478899999999999999999999999
Q ss_pred hcCCCCccc
Q 036739 311 LEHEYFRDV 319 (323)
Q Consensus 311 l~h~~~~~~ 319 (323)
++|+|+.+-
T Consensus 266 l~~~~~~~~ 274 (279)
T 2w5a_A 266 LENPLILEH 274 (279)
T ss_dssp HTSTTCCGG
T ss_pred HhChhhhhh
Confidence 999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=327.45 Aligned_cols=261 Identities=28% Similarity=0.456 Sum_probs=205.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc------CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE------DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 579999999999999999999999999999999865421 1223456789999999999999999999997655
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEecccccee
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARA 152 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~~~ 152 (323)
.++||||+.| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. .+||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 8999999976 7777776543 5788899999999999999999999999999999999986543 499999999977
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhh--CCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILL--GSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
....... ....||+.|+|||.+. ....++.++|+||||+++|+|++|.
T Consensus 167 ~~~~~~~------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 216 (322)
T 2ycf_A 167 LGETSLM------------------------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216 (322)
T ss_dssp CCCCHHH------------------------------HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSS
T ss_pred ccccccc------------------------------ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 6432111 0124588999999984 3356889999999999999999999
Q ss_pred CCCCCCChHHHHH-HHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 231 PLFPGDSEIDELF-KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 231 ~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
.||.......... .+...... ..+.....+++.+.++|.+||+.||++||++.+
T Consensus 217 ~pf~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~ 271 (322)
T 2ycf_A 217 PPFSEHRTQVSLKDQITSGKYN-------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 271 (322)
T ss_dssp CSSCSTTCSSCHHHHHHHTCCC-------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCcccchHHHHHHHHHhCccc-------------------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHH
Confidence 9998765433222 22221000 011223457899999999999999999999999
Q ss_pred hhcCCCCcccc
Q 036739 310 ALEHEYFRDVE 320 (323)
Q Consensus 310 il~h~~~~~~~ 320 (323)
+++||||++..
T Consensus 272 ~l~h~~~~~~~ 282 (322)
T 2ycf_A 272 ALRHPWLQDED 282 (322)
T ss_dssp HHTSGGGCCHH
T ss_pred HhhCcCcCCHH
Confidence 99999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=331.87 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=208.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc----eE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK----KL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~ 76 (323)
++|++.+.||+|++|.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 6899999999999999999999999999999998654322 122346778999999999999999999987544 45
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
++||||++| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC-EEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC-EEEeeccCcccccc
Confidence 999999965 8877776543 5788899999999999999999999999999999999999887 99999999876543
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
....... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 169 ~~~~~~~--------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 169 SGNSVTQ--------------------------TAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp ---------------------------------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccc--------------------------ccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2211110 111356999999999988 5689999999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
....+...........+ .......+++.+.++|.+||+.||++||++.+++.|+|
T Consensus 222 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 276 (311)
T 3ork_A 222 DSPVSVAYQHVREDPIP-------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276 (311)
T ss_dssp SSHHHHHHHHHHCCCCC-------------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CChHHHHHHHhcCCCCC-------------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence 88776665544321100 11122457899999999999999999999999999999
Q ss_pred Ccccc
Q 036739 316 FRDVE 320 (323)
Q Consensus 316 ~~~~~ 320 (323)
++..+
T Consensus 277 ~~~~~ 281 (311)
T 3ork_A 277 VRVHN 281 (311)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 87543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=328.03 Aligned_cols=273 Identities=20% Similarity=0.312 Sum_probs=206.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc--eEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK--KLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv 79 (323)
++|++.+.||+|+||+||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.... ..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 579999999999999999999999999999999864432 233567789999999999999999999997654 78999
Q ss_pred Eecchh-hHHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----ecCCCceEEeccccceec
Q 036739 80 FEYLDL-DLKKHMDSCPD-FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLI----DRRTNALKLADFGLARAF 153 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~----~~~~~~~kl~df~~~~~~ 153 (323)
|||+.| +|.+.+..... ..+++..+..++.||+.||.|||+.|++|+||||+||++ +.++ .+||+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAAREL 166 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE-EEEECCCTTCEEC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc-eEEEccCCCceec
Confidence 999975 77777765432 337899999999999999999999999999999999998 4444 4999999999876
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC-------CCCCCCchhhHHHHHHHHHH
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG-------SRHYSTPVDVWSVGCIFAEM 226 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~ll~~l 226 (323)
....... ...||+.|+|||.+.. ...++.++|||||||++|+|
T Consensus 167 ~~~~~~~------------------------------~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el 216 (319)
T 4euu_A 167 EDDEQFV------------------------------SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (319)
T ss_dssp CTTCCBC------------------------------CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHH
T ss_pred CCCCcee------------------------------ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHH
Confidence 4332211 1245899999999862 35689999999999999999
Q ss_pred HhCCCCCCCCCh----HHHHHHHHHHhCCCCCCCCCCcccCCc----ccccCCCCCCCcccccccCCChHHHHHHHhhcc
Q 036739 227 VNQRPLFPGDSE----IDELFKIFRVLGTPNEDTWPGVTSLPD----FKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298 (323)
Q Consensus 227 ~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~ 298 (323)
++|..||..... .+....+...... ..+........ +...+. ........+++.+.++|.+||+
T Consensus 217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~p~---~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~ll~~~L~ 288 (319)
T 4euu_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPS---GAISGVQKAENGPIDWSGDMP-----VSCSLSRGLQVLLTPVLANILE 288 (319)
T ss_dssp HHSSCSEECTTCGGGCHHHHHHHHHHCCT---TCCEEEECSTTCCEEEESSCC-----TTCSSCHHHHHHHHHHHHHHSC
T ss_pred HhCCCCCCCCCccchhHHHHHHHhcCCCc---ccchhhhcccCCccccCccCC-----cccccchhHHHHhHHHHHHhcc
Confidence 999999975433 2333344333211 11111111000 111111 0112223466788999999999
Q ss_pred cCCCCCCCHhhhhcCC
Q 036739 299 MDPSRRITARSALEHE 314 (323)
Q Consensus 299 ~dp~~R~s~~~il~h~ 314 (323)
.||++||++.++++||
T Consensus 289 ~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 289 ADQEKCWGFDQFFAET 304 (319)
T ss_dssp CCTTTSCCHHHHHHHH
T ss_pred CChhhhccHHHhhhcc
Confidence 9999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=346.85 Aligned_cols=251 Identities=15% Similarity=0.204 Sum_probs=196.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHH---HHHhcCCCCeeeee-------EEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREIS---LLKEMQHGNIVRLQ-------DVV 70 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~---~l~~l~~~~i~~~~-------~~~ 70 (323)
++|++.+.||+|+||+||+|++..+++.||+|++..... .....+.+.+|+. .++.++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 579999999999999999999988999999999976532 3334567888994 55555799999988 666
Q ss_pred ecCc-----------------eEEEEEecchhhHHHhhhcCCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 036739 71 HSEK-----------------KLYLVFEYLDLDLKKHMDSCPDFA-----NDPRLIKTFLYQILRGIAYCHSHRVLHRDL 128 (323)
Q Consensus 71 ~~~~-----------------~~~lv~e~~~g~l~~~~~~~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl 128 (323)
.+.+ ..+++|||++|+|.+.+....... +++..+..++.||+.||+|||++||+|+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDi 232 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 232 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred hccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 5443 389999999999999887643221 124677789999999999999999999999
Q ss_pred CCCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-
Q 036739 129 KPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS- 207 (323)
Q Consensus 129 ~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~- 207 (323)
||+||+++.++. +||+|||++...+... ....| +.|+|||.+.+.
T Consensus 233 kp~NIll~~~~~-~kL~DFG~a~~~~~~~--------------------------------~~~~g-~~y~aPE~~~~~~ 278 (377)
T 3byv_A 233 RPVDIVLDQRGG-VFLTGFEHLVRDGARV--------------------------------VSSVS-RGFEPPELEARRA 278 (377)
T ss_dssp CGGGEEECTTCC-EEECCGGGCEETTCEE--------------------------------ECCCC-TTCCCHHHHHHHT
T ss_pred CHHHEEEcCCCC-EEEEechhheecCCcc--------------------------------cCCCC-cCccChhhhcccc
Confidence 999999998887 9999999987533211 11255 779999999873
Q ss_pred ---------CCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcc
Q 036739 208 ---------RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKEL 278 (323)
Q Consensus 208 ---------~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (323)
..++.++|||||||++|+|++|..||...........+
T Consensus 279 ~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~--------------------------------- 325 (377)
T 3byv_A 279 TISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI--------------------------------- 325 (377)
T ss_dssp STHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG---------------------------------
T ss_pred cccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh---------------------------------
Confidence 26899999999999999999999999654422111000
Q ss_pred cccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 279 GTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 279 ~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
......+++.+.+||.+||+.||++||++.++++||||+++
T Consensus 326 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 326 FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 01114578999999999999999999999999999999876
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=335.62 Aligned_cols=283 Identities=24% Similarity=0.365 Sum_probs=210.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|+||++.+..++..||+|++.... .......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 58999999999999999999999999999999986542 22334678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|+.| +|.+.+.... .+++..+..++.|++.||.|||+. |++|+||||+||+++.++. +||+|||++........
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~- 187 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMA- 187 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC-EEECCCCCCHHHHHHC--
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC-EEEEECCCCcccccccc-
Confidence 9976 8888776543 468888999999999999999986 9999999999999999887 99999998854321100
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||......
T Consensus 188 ------------------------------~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 236 (360)
T 3eqc_A 188 ------------------------------NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236 (360)
T ss_dssp ---------------------------------CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH
T ss_pred ------------------------------cCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 11255889999999987 56899999999999999999999999887655
Q ss_pred HHHHHHHHHhCCCCCCCCCC----cccCCcccccCCCCC-----------CCcccccccCCChHHHHHHHhhcccCCCCC
Q 036739 240 DELFKIFRVLGTPNEDTWPG----VTSLPDFKSAFPKWP-----------SKELGTVVRNLEPAGIDLLSKMLCMDPSRR 304 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~-----------~~~~~~~~~~~s~~~~~li~~~l~~dp~~R 304 (323)
+................... ......+........ ..........+++.+.+||.+||+.||++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 316 (360)
T 3eqc_A 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316 (360)
T ss_dssp HHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTS
T ss_pred HHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhC
Confidence 44322111100000000000 000000000000000 000001123478899999999999999999
Q ss_pred CCHhhhhcCCCCcccc
Q 036739 305 ITARSALEHEYFRDVE 320 (323)
Q Consensus 305 ~s~~~il~h~~~~~~~ 320 (323)
||+.++++||||++..
T Consensus 317 pt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 317 ADLKQLMVHAFIKRSD 332 (360)
T ss_dssp CCHHHHHTSHHHHHHH
T ss_pred CCHHHHhhChHhhcch
Confidence 9999999999998753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=336.38 Aligned_cols=282 Identities=27% Similarity=0.443 Sum_probs=211.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-----------CCCeeeeeEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-----------HGNIVRLQDVV 70 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~ 70 (323)
++|++.+.||+|++|+||+|++..+++.||+|++.... .....+.+|+.+++++. |+||+++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 68999999999999999999999999999999985332 12356778899888886 78999999999
Q ss_pred ecCc----eEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEecCC-----C
Q 036739 71 HSEK----KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRT-----N 140 (323)
Q Consensus 71 ~~~~----~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~~~Nil~~~~~-----~ 140 (323)
...+ .++++||+++++|.+.+.......+++..+..++.||+.||.|||++ |++|+||||+||+++.++ .
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred hccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 7644 89999999988999999876666689999999999999999999998 999999999999996443 1
Q ss_pred ceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHH
Q 036739 141 ALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220 (323)
Q Consensus 141 ~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG 220 (323)
.+||+|||.+........ ...||+.|+|||.+.+ ..++.++||||||
T Consensus 176 ~~kl~Dfg~a~~~~~~~~--------------------------------~~~~t~~y~aPE~~~~-~~~~~~~Di~slG 222 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHYT--------------------------------NSIQTREYRSPEVLLG-APWGCGADIWSTA 222 (373)
T ss_dssp EEEECCCTTCEETTBCCC--------------------------------SCCSCGGGCCHHHHHT-CCCCTHHHHHHHH
T ss_pred eEEEcccccccccCCCCC--------------------------------CCCCCccccCcHHHhC-CCCCchHhHHHHH
Confidence 499999999976542211 1245889999999988 5689999999999
Q ss_pred HHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCCCCCCCcccCC------cc---cccCCCCCCC----ccccc
Q 036739 221 CIFAEMVNQRPLFPGDS------EIDELFKIFRVLGTPNEDTWPGVTSLP------DF---KSAFPKWPSK----ELGTV 281 (323)
Q Consensus 221 ~ll~~l~tg~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~----~~~~~ 281 (323)
+++|+|++|..||.... ..+.+..+....+......+....... .. ......+... .....
T Consensus 223 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (373)
T 1q8y_A 223 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 302 (373)
T ss_dssp HHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCC
T ss_pred HHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccC
Confidence 99999999999998654 334455555554443221100000000 00 0000000000 00011
Q ss_pred ccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 282 VRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 282 ~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
....++.+.+||.+||+.||++||++.++++||||++.
T Consensus 303 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 303 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp CHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred CcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 23456788999999999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=325.96 Aligned_cols=261 Identities=22% Similarity=0.299 Sum_probs=193.4
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++++.||+|++|.||+|.+..+++.||+|++............+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 46899999999999999999999889999999998654332222234445556788889999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+++.+...... ....+++..+..++.||+.||.|||++ |++|+||+|+||+++.++. +||+|||.+.........
T Consensus 104 e~~~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~~~~ 181 (318)
T 2dyl_A 104 ELMGTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ-IKLCDFGISGRLVDDKAK 181 (318)
T ss_dssp CCCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC-EEECCCTTC---------
T ss_pred eccCCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC-EEEEECCCchhccCCccc
Confidence 9996555444433 233578999999999999999999995 9999999999999998887 999999998665322111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
. ...|++.|+|||.+.. ...++.++||||||+++|+|++|..||..
T Consensus 182 ~------------------------------~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 182 D------------------------------RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp -----------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred c------------------------------ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 0 1245889999999852 35678899999999999999999999987
Q ss_pred CChH-HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 236 DSEI-DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
.... +....+.+...... +....+++.+.++|.+||+.||.+||++.++++||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 232 CKTDFEVLTKVLQEEPPLL--------------------------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp CCSHHHHHHHHHHSCCCCC--------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CCccHHHHHHHhccCCCCC--------------------------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 5433 33444433211000 01124788999999999999999999999999999
Q ss_pred CCccc
Q 036739 315 YFRDV 319 (323)
Q Consensus 315 ~~~~~ 319 (323)
||++.
T Consensus 286 ~~~~~ 290 (318)
T 2dyl_A 286 FIKRY 290 (318)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=315.29 Aligned_cols=249 Identities=21% Similarity=0.305 Sum_probs=205.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|+||++++. ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 58999999999999999999985 67789999986432 234678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| ++.+.+.... ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++. +||+|||.+..........
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC-EEECCTTGGGGBCCHHHHS
T ss_pred eCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC-EEecccccccccccccccc
Confidence 9976 6766665543 35789999999999999999999999999999999999998887 9999999987654322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus 164 ~~----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~ 214 (269)
T 4hcu_A 164 ST----------------------------GTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 214 (269)
T ss_dssp TT----------------------------STTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred cc----------------------------CcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 11 1234778999999987 568999999999999999999 99999988877
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
+....+...... ......++.+.+++.+||+.||++||++.++++|
T Consensus 215 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 215 EVVEDISTGFRL----------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCccC----------------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 666655432111 1113468899999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=321.15 Aligned_cols=258 Identities=28% Similarity=0.417 Sum_probs=204.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++++.||+|++|+||++++..++..||+|.+..... .......+.+|+.++++++||||+++++++.+++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 589999999999999999999999999999999865432 2223457788999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||++| +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.........
T Consensus 91 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT-LKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEEeCCCcccccccccc
Confidence 99976 8887776543 5788999999999999999999999999999999999999887 999999998765322111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
. .....||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||......
T Consensus 168 ~----------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~ 218 (294)
T 4eqm_A 168 Q----------------------------TNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218 (294)
T ss_dssp -----------------------------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH
T ss_pred c----------------------------cCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 1 111356999999999988 56899999999999999999999999988776
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
+...+..... . ..........+++.+.++|.+||+.||++||+..+.+.+.|
T Consensus 219 ~~~~~~~~~~---~---------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 219 SIAIKHIQDS---V---------------------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp HHHHHHHSSC---C---------------------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred HHHHHHhhcc---C---------------------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 5554433210 0 00011223458899999999999999999995555554443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=337.77 Aligned_cols=265 Identities=18% Similarity=0.169 Sum_probs=189.9
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhc--CCCCeeeee-------EEEec
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEM--QHGNIVRLQ-------DVVHS 72 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l--~~~~i~~~~-------~~~~~ 72 (323)
+|++.+.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.+ .|||+++++ +.+..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 58999999999999999999999999999999976543 222345666775544444 699988755 34432
Q ss_pred C-----------------ceEEEEEecchhhHHHhhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCcccCCCC
Q 036739 73 E-----------------KKLYLVFEYLDLDLKKHMDSCPDFANDPRLI------KTFLYQILRGIAYCHSHRVLHRDLK 129 (323)
Q Consensus 73 ~-----------------~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~------~~i~~qi~~~L~~LH~~~i~H~dl~ 129 (323)
. ..+++||||++|+|.+.+..... .++...+ ..++.||+.||.|||++||+|+|||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 2 44899999999999999876422 1233334 5677999999999999999999999
Q ss_pred CCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC-CC
Q 036739 130 PQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG-SR 208 (323)
Q Consensus 130 ~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~ 208 (323)
|+||+++.++. +||+|||++...+.... ...+|+.|+|||.+.+ ..
T Consensus 222 p~NIll~~~~~-~kL~DFG~a~~~~~~~~--------------------------------~~~~t~~y~aPE~~~~~~~ 268 (371)
T 3q60_A 222 PDNLFIMPDGR-LMLGDVSALWKVGTRGP--------------------------------ASSVPVTYAPREFLNASTA 268 (371)
T ss_dssp GGGEEECTTSC-EEECCGGGEEETTCEEE--------------------------------GGGSCGGGCCHHHHTCSEE
T ss_pred HHHEEECCCCC-EEEEecceeeecCCCcc--------------------------------CccCCcCCcChhhccCCCC
Confidence 99999999887 99999999986542211 1134788999999975 24
Q ss_pred CCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChH
Q 036739 209 HYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPA 288 (323)
Q Consensus 209 ~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 288 (323)
.++.++|||||||++|+|++|..||........ ..+..... ..........+....+++.
T Consensus 269 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------------~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 328 (371)
T 3q60_A 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK-------------GSWKRPSL-------RVPGTDSLAFGSCTPLPDF 328 (371)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT-------------TCCCBCCT-------TSCCCCSCCCTTSSCCCHH
T ss_pred CcCccccHHHHHHHHHHHHhCCCCCCCcCcccc-------------cchhhhhh-------hhccccccchhhccCCCHH
Confidence 579999999999999999999999977643100 00000000 0000001111223468999
Q ss_pred HHHHHHhhcccCCCCCCCHhhhhcCCCCccccc
Q 036739 289 GIDLLSKMLCMDPSRRITARSALEHEYFRDVEF 321 (323)
Q Consensus 289 ~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~~ 321 (323)
+.+||.+||+.||++||++.++++||||+++.+
T Consensus 329 ~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 329 VKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp HHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 999999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=321.67 Aligned_cols=257 Identities=24% Similarity=0.352 Sum_probs=203.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||++++ ++..||+|++............+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 5899999999999999999986 68899999986554444444678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 82 YLDL-DLKKHMDSCPD-FANDPRLIKTFLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
|+.| +|.+.+..... ..+++..+..++.||+.||.|||+.| ++|+||||+||+++.++. +||+|||++.......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~-~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT-VKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC-EEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc-EEECCCCCCccccccc
Confidence 9976 77777765432 23788889999999999999999999 999999999999999887 9999999986543221
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. .....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus 194 ~~-----------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 194 LS-----------------------------SKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp -------------------------------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cc-----------------------------cccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 011256899999999988 567999999999999999999999999887
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc--CCC
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE--HEY 315 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~--h~~ 315 (323)
..+....+...... ......+++.+.++|.+||+.||++||++.++++ .++
T Consensus 244 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 244 PAQVVAAVGFKCKR---------------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp HHHHHHHHHHSCCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCC---------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 76665544321111 1122457899999999999999999999999987 455
Q ss_pred Ccc
Q 036739 316 FRD 318 (323)
Q Consensus 316 ~~~ 318 (323)
++.
T Consensus 297 ~~~ 299 (309)
T 3p86_A 297 IKS 299 (309)
T ss_dssp HC-
T ss_pred HHh
Confidence 443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=314.28 Aligned_cols=260 Identities=27% Similarity=0.405 Sum_probs=204.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|.....||+|++|+||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 34556669999999999999999999999999986442 3345778899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec-CCCceEEeccccceecCCCcc
Q 036739 82 YLDL-DLKKHMDSCP-DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~-~~~~~kl~df~~~~~~~~~~~ 158 (323)
++.| +|.+.+.... ....++..+..++.||+.||.+||+.|++|+||+|+||+++. ++. +||+|||.+........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~-~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV-LKISDFGTSKRLAGINP 178 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC-EEECCTTTCEESCC---
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC-EEEeecccccccCCCCC
Confidence 9965 7777776543 335678888899999999999999999999999999999998 555 99999999876543211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-CCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. ....|++.|+|||.+.+. ..++.++|+||||+++|+|++|..||....
T Consensus 179 ~~-----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (295)
T 2clq_A 179 CT-----------------------------ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229 (295)
T ss_dssp -------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred cc-----------------------------cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence 10 012458899999998753 237889999999999999999999997654
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
.............. .......+++.+.++|.+||+.||++||++.++++||||+
T Consensus 230 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 283 (295)
T 2clq_A 230 EPQAAMFKVGMFKV--------------------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 283 (295)
T ss_dssp SHHHHHHHHHHHCC--------------------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGC
T ss_pred chhHHHHhhccccc--------------------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 43322211111110 0112235788999999999999999999999999999998
Q ss_pred cc
Q 036739 318 DV 319 (323)
Q Consensus 318 ~~ 319 (323)
..
T Consensus 284 ~~ 285 (295)
T 2clq_A 284 VS 285 (295)
T ss_dssp C-
T ss_pred hc
Confidence 65
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=324.86 Aligned_cols=263 Identities=19% Similarity=0.283 Sum_probs=192.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc---eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE--
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL-- 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-- 76 (323)
++|++.+.||+|++|+||+|++..++. .||+|++..........+.+.+|+.++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 579999999999999999999876665 899999876544444567888999999999999999999999876654
Q ss_pred ----EEEEecchh-hHHHhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 77 ----YLVFEYLDL-DLKKHMDSCP----DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 77 ----~lv~e~~~g-~l~~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
++|+||+.| +|.+.+.... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+||
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~-~kl~Df 181 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT-VCVADF 181 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC-EEECCC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC-EEEeec
Confidence 999999976 7777775322 235788999999999999999999999999999999999998887 999999
Q ss_pred ccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH
Q 036739 148 GLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~ 227 (323)
|.+............ ....+++.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 182 g~a~~~~~~~~~~~~---------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell 233 (323)
T 3qup_A 182 GLSRKIYSGDYYRQG---------------------------CASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIM 233 (323)
T ss_dssp CC--------------------------------------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccc---------------------------ccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHH
Confidence 999765432211110 01134778999999988 56899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC
Q 036739 228 N-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT 306 (323)
Q Consensus 228 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 306 (323)
+ |..||......+....+...... .....+++.+.++|.+||+.||++||+
T Consensus 234 ~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps 285 (323)
T 3qup_A 234 TRGQTPYAGIENAEIYNYLIGGNRL----------------------------KQPPECMEEVYDLMYQCWSADPKQRPS 285 (323)
T ss_dssp TTSCCTTTTCCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred hCCCCCccccChHHHHHHHhcCCCC----------------------------CCCCccCHHHHHHHHHHccCChhhCcC
Confidence 9 99999988877666655432111 112347889999999999999999999
Q ss_pred -------HhhhhcCCCCccccc
Q 036739 307 -------ARSALEHEYFRDVEF 321 (323)
Q Consensus 307 -------~~~il~h~~~~~~~~ 321 (323)
+.++++|||+.....
T Consensus 286 ~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 286 FTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp HHHHHHHHHHHHHC--------
T ss_pred HHHHHHHHHHHHHHhhhcCCCC
Confidence 888889999987543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=322.90 Aligned_cols=250 Identities=28% Similarity=0.415 Sum_probs=207.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC----CCchhHHHHHHHHHhcC--CCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE----GVPSTAIREISLLKEMQ--HGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|+||.||+|++..++..||+|++....... .....+.+|+.+++.+. |+||+++++++.+.+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 68999999999999999999999999999999997654322 23466778999999996 5999999999999999
Q ss_pred EEEEEecch--hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 76 LYLVFEYLD--LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 76 ~~lv~e~~~--g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
.++|+|++. ++|.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.+...+||+|||.+...
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 999999996 68888877643 57888999999999999999999999999999999999944445999999998776
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
...... ...||+.|+|||.+......+.++|+||||+++|+|++|..||
T Consensus 201 ~~~~~~-------------------------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 249 (320)
T 3a99_A 201 KDTVYT-------------------------------DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249 (320)
T ss_dssp CSSCBC-------------------------------CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccc-------------------------------CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCC
Confidence 432111 1245889999999987555678999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
..... +... .. .....+++.+.++|.+||+.||++||++.++++|
T Consensus 250 ~~~~~------~~~~--~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 250 EHDEE------IIRG--QV---------------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CSHHH------HHHC--CC---------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CChhh------hhcc--cc---------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 65321 1110 00 0113478899999999999999999999999999
Q ss_pred CCCccc
Q 036739 314 EYFRDV 319 (323)
Q Consensus 314 ~~~~~~ 319 (323)
|||+++
T Consensus 295 p~~~~~ 300 (320)
T 3a99_A 295 PWMQDV 300 (320)
T ss_dssp GGGSSC
T ss_pred HhhcCc
Confidence 999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=323.29 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=205.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc---eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|+||+||++.+..++. .||+|++.... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 579999999999999999999876555 49999985432 22234678899999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||++| +|.+.+... ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++. +||+|||++.......
T Consensus 128 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV-CKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCSSCEECC---
T ss_pred EeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC-EEECCCCcccccccCc
Confidence 9999976 777776544 335789999999999999999999999999999999999998887 9999999998765432
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
...... ....+|+.|+|||.+.+ ..++.++||||||+++|+|++ |..||...
T Consensus 206 ~~~~~~--------------------------~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 206 DAAYTT--------------------------TGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp -CCEEC--------------------------C---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cceeec--------------------------cCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 221111 11234778999999987 568999999999999999999 99999988
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+....+...... .....+++.+.++|.+||+.||++||++.++++
T Consensus 259 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 259 TNRDVISSVEEGYRL----------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCCCC----------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 877766655432111 112347889999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=324.65 Aligned_cols=260 Identities=24% Similarity=0.324 Sum_probs=182.6
Q ss_pred CCcceee-eeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec----CceE
Q 036739 2 DQYEKVE-KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS----EKKL 76 (323)
Q Consensus 2 ~~y~~~~-~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 76 (323)
++|++.+ .||+|++|+||+|++..+++.||+|++.... .........++.+.||||+++++++.. +...
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 6899965 5999999999999999999999999985321 222233344677789999999999975 5568
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC--CceEEeccccceec
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAF 153 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~--~~~kl~df~~~~~~ 153 (323)
++||||+.| +|.+.+.......+++..+..++.||+.||.|||++|++|+||||+||+++.++ ..+||+|||.+...
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999999976 888888877666789999999999999999999999999999999999997632 24999999998765
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
...... ...||+.|+|||.+.. ..++.++||||||+++|+|++|..||
T Consensus 182 ~~~~~~-------------------------------~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 182 TQNALQ-------------------------------TPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp ------------------------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred cccccc-------------------------------cCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 322111 1245888999999866 56788999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.................... ..........+++.+.+||.+||+.||++||++.++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 230 YSNTGQAISPGMKRRIRLGQ---------------------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ------------------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCccchhhhhhHHHhhhccc---------------------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 76654332211111000000 000111224578999999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||++..
T Consensus 289 p~~~~~~ 295 (336)
T 3fhr_A 289 PWINQSM 295 (336)
T ss_dssp HHHHTGG
T ss_pred ccccccc
Confidence 9998754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=316.99 Aligned_cols=271 Identities=29% Similarity=0.441 Sum_probs=200.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec---------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--------- 72 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 72 (323)
++|++.+.||+|++|+||+|++..+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 57999999999999999999999999999999986432 234678889999999999999999998854
Q ss_pred ----CceEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 73 ----EKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 73 ----~~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
.+..++||||++| +|.+.+.... ..+++..+..++.||+.||.+||++|++|+||+|+||+++.++. +||+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~-~kl~df 160 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN-VKIGDF 160 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC-EEEeeC
Confidence 4678999999975 8888876543 35677888999999999999999999999999999999998887 999999
Q ss_pred ccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH
Q 036739 148 GLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~ 227 (323)
|.+................ ..+.........|++.|+|||.+.+...++.++|+||||+++|+|+
T Consensus 161 g~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 225 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQN---------------LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225 (303)
T ss_dssp CCCSCTTC----------------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHH
T ss_pred cchhhcccccchhcccccc---------------ccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHH
Confidence 9987664322111000000 0000111122356899999999987667899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH
Q 036739 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 228 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
+ ||.................... ........++.+.++|.+||+.||++||++
T Consensus 226 ~---p~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 278 (303)
T 1zy4_A 226 Y---PFSTGMERVNILKKLRSVSIEF------------------------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGA 278 (303)
T ss_dssp S---CCSSHHHHHHHHHHHHSTTCCC------------------------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCH
T ss_pred h---ccCCchhHHHHHHhcccccccc------------------------CccccccchHHHHHHHHHHHhcCcccCcCH
Confidence 8 5543322222222221110000 011123467789999999999999999999
Q ss_pred hhhhcCCCCccc
Q 036739 308 RSALEHEYFRDV 319 (323)
Q Consensus 308 ~~il~h~~~~~~ 319 (323)
.++++||||+..
T Consensus 279 ~~ll~h~~~~~~ 290 (303)
T 1zy4_A 279 RTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHSSCSCCC
T ss_pred HHHhCCCCcCCC
Confidence 999999999865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=323.30 Aligned_cols=264 Identities=21% Similarity=0.365 Sum_probs=187.9
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHH-HHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREIS-LLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
.++|++.+.||+|+||.||++.+..+++.||+|++....... ....+..|+. +++.++||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 368999999999999999999999999999999986542211 2234444554 67778999999999999999999999
Q ss_pred EecchhhHHHhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 80 FEYLDLDLKKHMDS---CPDFANDPRLIKTFLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 80 ~e~~~g~l~~~~~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
|||++|++.+.+.. .....+++..+..++.|++.||.+||+. |++|+||||+||+++.++. +||+|||++.....
T Consensus 100 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~-~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 100 MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN-IKLCDFGISGQLVD 178 (327)
T ss_dssp ECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE-EEECCCSSSCC---
T ss_pred EeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC-EEEccCCCceeccc
Confidence 99999988777653 2344678999999999999999999998 9999999999999998887 99999999876532
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhh---CCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILL---GSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
..... ...||+.|+|||.+. ....++.++|+||||+++|+|++|..|
T Consensus 179 ~~~~~------------------------------~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (327)
T 3aln_A 179 SIAKT------------------------------RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228 (327)
T ss_dssp ---------------------------------------------------------CCSHHHHHHHHHHHHHHHHSCCC
T ss_pred ccccc------------------------------cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 21110 124588899999984 225588999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
|......... . ...... ............+++.+.++|.+||+.||++||++.++++
T Consensus 229 f~~~~~~~~~--~----~~~~~~-----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 229 YPKWNSVFDQ--L----TQVVKG-----------------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SSCC-------------CCCCCS-----------------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcchHHHH--H----HHHhcC-----------------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 9764321100 0 000000 0000011122457899999999999999999999999999
Q ss_pred CCCCccc
Q 036739 313 HEYFRDV 319 (323)
Q Consensus 313 h~~~~~~ 319 (323)
||||.+.
T Consensus 286 hp~~~~~ 292 (327)
T 3aln_A 286 HPFILMY 292 (327)
T ss_dssp SHHHHHH
T ss_pred ChHHHHh
Confidence 9999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=312.47 Aligned_cols=249 Identities=21% Similarity=0.315 Sum_probs=205.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+. ++..||+|++..... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 68999999999999999999874 567899999864332 34678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| ++.+.+.... ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||.+..........
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC-VKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC-EEECCTTCEEECCTTCEEE
T ss_pred ccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC-EEEccCccceecchhhhhc
Confidence 9975 6777775532 34788999999999999999999999999999999999999887 9999999998764332211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus 162 ~~----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (268)
T 3sxs_A 162 SV----------------------------GTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS 212 (268)
T ss_dssp CC----------------------------SCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred cc----------------------------CCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChH
Confidence 11 1134678999999987 568899999999999999999 99999888777
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
+....+...... ......++.+.++|.+||+.||++||++.+++++
T Consensus 213 ~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 213 EVVLKVSQGHRL----------------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCC----------------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 666555432111 1112367889999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=312.57 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=210.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|+||++.+..++..||+|.+... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 5799999999999999999999999999999998532 2334678899999999999999999999999999999999
Q ss_pred cch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
++. ++|.+.+.......+++..+..++.||+.||.+||+.|++|+||||+||+++.++. ++|+|||.+..........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~~~ 168 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTA 168 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC-EEECCCCGGGTSCSSSSEE
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC-EEEccCccceeccCCcccc
Confidence 998 58888888766667899999999999999999999999999999999999998887 9999999987654332211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
. ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus 169 ~----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~ 219 (288)
T 3kfa_A 169 H----------------------------AGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 219 (288)
T ss_dssp E----------------------------TTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred c----------------------------cCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 1 11244778999999987 568999999999999999999 99999887766
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.....+...... .....+++.+.++|.+||+.||++||++.++++
T Consensus 220 ~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 220 QVYELLEKDYRM----------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp GHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCCC----------------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 655544321110 112347889999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=312.80 Aligned_cols=249 Identities=18% Similarity=0.280 Sum_probs=202.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||++.+. ++..||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 58999999999999999999874 67789999986432 234678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+.... ..+++..+..++.||+.||.+||++|++|+||||+||+++.++. +||+|||.+..........
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 100 YMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC-EEECSTTGGGGBCCHHHHS
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC-EEEcccccccccccccccc
Confidence 9965 7777776532 35789999999999999999999999999999999999998887 9999999987654322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus 178 ~~----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~ 228 (283)
T 3gen_A 178 SV----------------------------GSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228 (283)
T ss_dssp TT----------------------------STTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred cc----------------------------CCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChh
Confidence 10 1134778999999987 558999999999999999998 99999988877
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
+....+.+..... .....++.+.++|.+||+.||++||++.++++|
T Consensus 229 ~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 229 ETAEHIAQGLRLY----------------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcccCCC----------------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 6666554421111 112367889999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=316.06 Aligned_cols=259 Identities=29% Similarity=0.406 Sum_probs=203.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC--CCCeeeeeEEEecCceEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ--HGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~lv 79 (323)
++|++.+.||+|++|.||++.+. +++.||+|++............+.+|+.+++.+. |+||+++++++.+.+..++|
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 47999999999999999999984 5889999999765444444577889999999997 59999999999999999999
Q ss_pred EecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 80 FEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.+++|.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++. +. +||+|||.+.........
T Consensus 107 ~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~-~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 107 MECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM-LKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp ECCCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TE-EEECCCSSSCC-------
T ss_pred EecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-Ce-EEEeeccccccccCcccc
Confidence 9987889999988754 5688889999999999999999999999999999999964 54 999999998765432221
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC----------CCCCCchhhHHHHHHHHHHHhC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS----------RHYSTPVDVWSVGCIFAEMVNQ 229 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----------~~~~~~~Di~slG~ll~~l~tg 229 (323)
.. .....|++.|+|||.+.+. ..++.++||||||+++|+|++|
T Consensus 183 ~~---------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g 235 (313)
T 3cek_A 183 VV---------------------------KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235 (313)
T ss_dssp ----------------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHS
T ss_pred cc---------------------------ccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhC
Confidence 10 1112568999999998652 3578899999999999999999
Q ss_pred CCCCCCCChHHH-HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 230 RPLFPGDSEIDE-LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 230 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
..||........ ...... .... .......++.+.++|.+||+.||++||++.
T Consensus 236 ~~pf~~~~~~~~~~~~~~~---~~~~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 288 (313)
T 3cek_A 236 KTPFQQIINQISKLHAIID---PNHE------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288 (313)
T ss_dssp SCTTTTCCSHHHHHHHHHC---TTSC------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCchhhHHHHHHHHHHHHh---cccc------------------------cCCcccchHHHHHHHHHHccCCcccCcCHH
Confidence 999987644322 222211 1000 011123578899999999999999999999
Q ss_pred hhhcCCCCccc
Q 036739 309 SALEHEYFRDV 319 (323)
Q Consensus 309 ~il~h~~~~~~ 319 (323)
++++||||+..
T Consensus 289 ell~h~~~~~~ 299 (313)
T 3cek_A 289 ELLAHPYVQIQ 299 (313)
T ss_dssp HHHTSHHHHCC
T ss_pred HHhcCccccCC
Confidence 99999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=322.34 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=205.1
Q ss_pred CCcceeeeeccccceeEEEEEEcc-------CCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecC
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-------TNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 73 (323)
++|++.+.||+|+||+||+|++.. ++..||+|++.... .......+.+|+.+++.+ +||||+++++++.+.
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 579999999999999999998642 34579999885432 222345788999999999 899999999999999
Q ss_pred ceEEEEEecchh-hHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC
Q 036739 74 KKLYLVFEYLDL-DLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138 (323)
Q Consensus 74 ~~~~lv~e~~~g-~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~ 138 (323)
+.+|+||||+.| +|.+++.... ...++...+..++.||+.||.|||++|++|+||||+||+++.+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC
Confidence 999999999976 8888887543 2346888899999999999999999999999999999999998
Q ss_pred CCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 139 TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 139 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
+. +||+|||++............ ....+++.|+|||.+.+ ..++.++||||
T Consensus 240 ~~-~kl~DFG~a~~~~~~~~~~~~---------------------------~~~~~t~~y~aPE~~~~-~~~~~~~Dvws 290 (370)
T 2psq_A 240 NV-MKIADFGLARDINNIDYYKKT---------------------------TNGRLPVKWMAPEALFD-RVYTHQSDVWS 290 (370)
T ss_dssp CC-EEECCCSSCEETTCCCTTCTT---------------------------TTTTSCGGGCCHHHHHT-CCCCHHHHHHH
T ss_pred CC-EEEccccCCcccCcccceecc---------------------------cCCCcccceECHhHhcC-CCCCcHHHHHH
Confidence 87 999999999865432211100 01134788999999988 66899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 219 VGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 219 lG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
|||++|+|++ |..||......+....+..... ......+++.+.++|.+||
T Consensus 291 lG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l 342 (370)
T 2psq_A 291 FGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCW 342 (370)
T ss_dssp HHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHc
Confidence 9999999999 9999988776665544432110 0112347889999999999
Q ss_pred ccCCCCCCCHhhhhcC
Q 036739 298 CMDPSRRITARSALEH 313 (323)
Q Consensus 298 ~~dp~~R~s~~~il~h 313 (323)
+.||++||++.+++++
T Consensus 343 ~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 343 HAVPSQRPTFKQLVED 358 (370)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCChhhCcCHHHHHHH
Confidence 9999999999999873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=308.17 Aligned_cols=248 Identities=18% Similarity=0.275 Sum_probs=205.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC--ceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 78 (323)
+++|++.+.||+|++|+||++++ ++..||+|++............+.+|+.++++++||||+++++++.+. +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 36899999999999999999997 488999999876544444456788999999999999999999999876 78899
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
||||+.| +|.+.+.......+++..+..++.||+.||.|||+.| ++|+||||+||+++.++. ++|+||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~-~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT-ARISMADVKFSFQS 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC-EEEEGGGSCCTTSC
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc-eeEEeccceeeecc
Confidence 9999975 8888888776667899999999999999999999999 999999999999998887 89998887644221
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCC--CCCchhhHHHHHHHHHHHhCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH--YSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
. ...||+.|+|||.+.+... ++.++||||||+++|+|++|..||
T Consensus 166 ~----------------------------------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 211 (271)
T 3kmu_A 166 P----------------------------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211 (271)
T ss_dssp T----------------------------------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTT
T ss_pred c----------------------------------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 1 1245888999999987322 233899999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
......+........... ......+++.+.++|.+||+.||++||++.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 212 ADLSNMEIGMKVALEGLR---------------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TTSCHHHHHHHHHHSCCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccChHHHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 988777666554432111 1122457899999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=322.00 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=203.8
Q ss_pred CCcceeeeeccccceeEEEEE-----EccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCc-
Q 036739 2 DQYEKVEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEK- 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~- 74 (323)
++|++.+.||+|+||.||+|+ +..+++.||+|++.... .......+.+|+.+++++ +||||+++++++.+.+
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 689999999999999999998 45566899999985432 222235688999999999 7899999999998754
Q ss_pred eEEEEEecchh-hHHHhhhcCCC---------------------------------------------------------
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPD--------------------------------------------------------- 96 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~--------------------------------------------------------- 96 (323)
..++||||+.| +|.+.+.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 58999999976 88887765432
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccccCCcC
Q 036739 97 -------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTG 169 (323)
Q Consensus 97 -------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~ 169 (323)
..+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+..........
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~~--------- 250 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYV--------- 250 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCCGGGSCTTSCTTCE---------
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc-EEEEeccceeeecccccch---------
Confidence 12788889999999999999999999999999999999998887 9999999997653322111
Q ss_pred cceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 036739 170 ISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKIFRV 248 (323)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~ 248 (323)
......||+.|+|||.+.+ ..++.++||||||+++|+|++ |..||......+........
T Consensus 251 ------------------~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 311 (359)
T 3vhe_A 251 ------------------RKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311 (359)
T ss_dssp ------------------EC--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH
T ss_pred ------------------hccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc
Confidence 1112355888999999987 668999999999999999998 99999887765555444432
Q ss_pred hCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 249 LGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.... .....+++.+.++|.+||+.||++||++.++++|
T Consensus 312 ~~~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 312 GTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp TCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC---------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1111 1123478899999999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=308.04 Aligned_cols=259 Identities=19% Similarity=0.211 Sum_probs=206.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|++|.||+|++..+++.||+|++... .....+.+|+..++.+ +|+|++++++++.+....++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC----CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 5799999999999999999999999999999988533 2345688899999999 7999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC----ceEEeccccceecCCC
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN----ALKLADFGLARAFGIP 156 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~----~~kl~df~~~~~~~~~ 156 (323)
||++++|.+.+..... .+++..+..++.||+.||.|||++|++|+||||+||+++.++. .+||+|||++......
T Consensus 86 e~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 86 DLLGPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp ECCCCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EecCCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 9997789888876533 5789999999999999999999999999999999999976543 4999999999877544
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
......... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 165 ~~~~~~~~~----------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 165 VTKQHIPYR----------------------EKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp TTCCBCCCC----------------------CCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccc----------------------CccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 332111100 0112356999999999987 56899999999999999999999999875
Q ss_pred C---hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 S---EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
. .......+........ .......+++.+.++|.+||+.||++||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 222 KAATNKQKYERIGEKKQSTP------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp CSCCHHHHHHHHHHHHHHSC------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hccccHHHHHHHHhhccCcc------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 3 2233333322111000 11122357899999999999999999999999876
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=326.24 Aligned_cols=258 Identities=19% Similarity=0.248 Sum_probs=205.0
Q ss_pred CCcceeeeeccccceeEEEEE-----EccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|+||+||+|+ +..++..||+|.+... ........+.+|+.+++.++||||+++++++.+....
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 579999999999999999999 4456778999998532 2222335677899999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEeccc
Q 036739 77 YLVFEYLDL-DLKKHMDSCPD-----FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFG 148 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~ 148 (323)
++||||+.| +|.+.+..... ..+++..+..++.||+.||.|||++||+||||||+||+++.++. .+||+|||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 999999965 88888865432 35788889999999999999999999999999999999985432 59999999
Q ss_pred cceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh
Q 036739 149 LARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t 228 (323)
++.......... ......||+.|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 230 ~a~~~~~~~~~~---------------------------~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt 281 (367)
T 3l9p_A 230 MARDIYRAGYYR---------------------------KGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFS 281 (367)
T ss_dssp HHHHHHHHSSCT---------------------------TCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccc---------------------------cCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHh
Confidence 986542111100 0111245888999999987 568999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH
Q 036739 229 -QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 229 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
|..||......+....+...... .....+++.+.++|.+||+.||++||++
T Consensus 282 ~g~~pf~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~ 333 (367)
T 3l9p_A 282 LGYMPYPSKSNQEVLEFVTSGGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNF 333 (367)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCH
Confidence 99999988877666555432111 1123478899999999999999999999
Q ss_pred hhhhcCCCC
Q 036739 308 RSALEHEYF 316 (323)
Q Consensus 308 ~~il~h~~~ 316 (323)
.+++++.++
T Consensus 334 ~eil~~l~~ 342 (367)
T 3l9p_A 334 AIILERIEY 342 (367)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999987553
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=314.34 Aligned_cols=258 Identities=21% Similarity=0.241 Sum_probs=203.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+|+.+++.+ +||||+++++++.+++..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 57999999999999999999999999999999885432 235688999999999 8999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC----ceEEeccccceecCCC
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN----ALKLADFGLARAFGIP 156 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~----~~kl~df~~~~~~~~~ 156 (323)
|+++++|.+.+... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++. .+||+|||++......
T Consensus 85 e~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 85 ELLGPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp ECCCCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred EeCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 99977888888765 336899999999999999999999999999999999999987654 2999999999876543
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
......... ......||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus 164 ~~~~~~~~~----------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 164 ETKKHIPYR----------------------EHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp TTCCBCCCC----------------------CCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCcccccc----------------------ccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 322111100 0112366999999999988 66899999999999999999999999875
Q ss_pred ChH---HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEI---DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
... +....+........ ........+ .+.++|..||+.||++||++.++++
T Consensus 221 ~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 221 KADTLKERYQKIGDTKRATP------------------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CCSSHHHHHHHHHHHHHHSC------------------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccccHHHHHHHHHhhhccCC------------------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 432 22333222110000 000111233 8999999999999999999998876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=305.73 Aligned_cols=248 Identities=26% Similarity=0.393 Sum_probs=192.4
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC--CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED--EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
.++|++.+.||+|++|+||++.+ ++..||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 47899999999999999999996 4889999988654322 2345678899999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCcEEEec--------CCCceEEec
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR---VLHRDLKPQNLLIDR--------RTNALKLAD 146 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~~~Nil~~~--------~~~~~kl~d 146 (323)
||||++| ++.+.+. . ..+++..+..++.|++.||.+||+.| ++|+||||+||+++. ++. +||+|
T Consensus 84 v~e~~~~~~L~~~~~-~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~-~kl~D 159 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-G--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI-LKITD 159 (271)
T ss_dssp EEECCTTEEHHHHHT-S--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC-EEECC
T ss_pred EEEcCCCCCHHHHhh-c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc-eEEcc
Confidence 9999976 5555553 2 25789999999999999999999999 889999999999986 444 99999
Q ss_pred cccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHH
Q 036739 147 FGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226 (323)
Q Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l 226 (323)
||.+......... ...|++.|+|||.+.+ ..++.++|+||||+++|+|
T Consensus 160 fg~~~~~~~~~~~-------------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l 207 (271)
T 3dtc_A 160 FGLAREWHRTTKM-------------------------------SAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWEL 207 (271)
T ss_dssp CCC--------------------------------------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHH
T ss_pred CCccccccccccc-------------------------------CCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHH
Confidence 9998765322211 1245889999999987 5689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC
Q 036739 227 VNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT 306 (323)
Q Consensus 227 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 306 (323)
++|..||................. .......+++.+.++|.+||+.||++||+
T Consensus 208 ~~g~~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps 260 (271)
T 3dtc_A 208 LTGEVPFRGIDGLAVAYGVAMNKL---------------------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPS 260 (271)
T ss_dssp HHCCCTTTTSCHHHHHHHHHTSCC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCCHHHHHHhhhcCCC---------------------------CCCCCcccCHHHHHHHHHHhcCCcccCcC
Confidence 999999998876655544332100 01122357889999999999999999999
Q ss_pred HhhhhcC
Q 036739 307 ARSALEH 313 (323)
Q Consensus 307 ~~~il~h 313 (323)
+.+++++
T Consensus 261 ~~e~l~~ 267 (271)
T 3dtc_A 261 FTNILDQ 267 (271)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=314.03 Aligned_cols=260 Identities=23% Similarity=0.329 Sum_probs=202.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||++.+..+++.||+|.+... .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 6899999999999999999999999999999987432 23344678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+.... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||.+..........
T Consensus 88 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 88 YIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN-VVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC-EEECCCTTCEECC------
T ss_pred ecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC-EEEeecccceecccccccc
Confidence 9976 7777776543 35788999999999999999999999999999999999999887 9999999998765433321
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
...... ............||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.......
T Consensus 166 ~~~~~~---------------~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~ 229 (310)
T 3s95_A 166 EGLRSL---------------KKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229 (310)
T ss_dssp -----------------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC
T ss_pred cccccc---------------cccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH
Confidence 110000 0000011123467999999999987 678999999999999999999999886543211
Q ss_pred H-----HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 241 E-----LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 241 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
. ...... ......+++.+.++|.+||+.||++||++.++++
T Consensus 230 ~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 230 MDFGLNVRGFLD-------------------------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TTSSBCHHHHHH-------------------------------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhhhhhcccc-------------------------------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 000000 0112347788999999999999999999999987
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=310.47 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=192.6
Q ss_pred CCcceeeeeccccceeEEEEEEccC---CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT---NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|+||.||+|++..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++. ++..++
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 5899999999999999999998654 346899987432 22223457888999999999999999999984 567889
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| +|.+.+... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDST 170 (281)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-EEECC-----------
T ss_pred EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC-EEECccccccccCccc
Confidence 9999986 777777654 335788999999999999999999999999999999999998887 9999999987654322
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
.... ....+++.|+|||.+.. ..++.++|+||||+++|+|++ |..||...
T Consensus 171 ~~~~----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 171 YYKA----------------------------SKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp ------------------------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccc----------------------------ccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 1110 01134778999999987 568999999999999999997 99999988
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+....+..... ......+++.+.++|.+||+.||++||++.++++
T Consensus 222 ~~~~~~~~i~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 222 KNNDVIGRIENGER----------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp CGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 77666655543110 0112357899999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=326.01 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=204.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||.||+|++..++..||+|.+... ........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 5789999999999999999999889999999988533 222233567789999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+.... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++. +||+|||++..........
T Consensus 193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~-~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV-LKISDFGMSREEADGVYAA 270 (377)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCGGGCEECTTSEEEC
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc-EEECcCCCceecCCCceee
Confidence 9964 8887776432 24788889999999999999999999999999999999998887 9999999987643221111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
. .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||......
T Consensus 271 ~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~ 322 (377)
T 3cbl_A 271 S---------------------------GGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQ 322 (377)
T ss_dssp C---------------------------SSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH
T ss_pred c---------------------------CCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 0 001134678999999987 568999999999999999998 99999988776
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+...... +....+++.+.++|.+||+.||++||++.++++
T Consensus 323 ~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 323 QTREFVEKGGRL----------------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 655444321110 112346789999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=316.01 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=204.0
Q ss_pred CCcceeeeeccccceeEEEEEEc-----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|++|.||+|++. .++..||+|++... ........+.+|+.+++++ .||||+++++++...+.
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 57899999999999999999963 35568999998643 2334557889999999999 89999999999999999
Q ss_pred EEEEEecchh-hHHHhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPD---------------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNL 133 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~---------------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Ni 133 (323)
.++||||+.| +|.+.+..... ..+++..+..++.||+.||.|||+.|++|+||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 9999999965 88888876542 2368888999999999999999999999999999999
Q ss_pred EEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCc
Q 036739 134 LIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTP 213 (323)
Q Consensus 134 l~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 213 (323)
+++.++. +||+|||++.......... ......||+.|+|||.+.+ ..++.+
T Consensus 204 ll~~~~~-~kL~Dfg~~~~~~~~~~~~---------------------------~~~~~~~t~~y~aPE~~~~-~~~~~~ 254 (344)
T 1rjb_A 204 LVTHGKV-VKICDFGLARDIMSDSNYV---------------------------VRGNARLPVKWMAPESLFE-GIYTIK 254 (344)
T ss_dssp EEETTTE-EEECCCGGGSCGGGCTTSE---------------------------EETTEEECGGGCCHHHHHH-CCCCHH
T ss_pred EEcCCCc-EEeCCCccCcccccCccce---------------------------eccCccCccCccCHHHhcc-CCCChh
Confidence 9998886 9999999997653221110 1112345788999999987 568999
Q ss_pred hhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHH
Q 036739 214 VDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292 (323)
Q Consensus 214 ~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 292 (323)
+||||||+++|+|++ |..||................... .....+++.+.++
T Consensus 255 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~l 307 (344)
T 1rjb_A 255 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYII 307 (344)
T ss_dssp HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHH
T ss_pred HhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHH
Confidence 999999999999998 999998876655555444321110 1113468899999
Q ss_pred HHhhcccCCCCCCCHhhhhcC
Q 036739 293 LSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 293 i~~~l~~dp~~R~s~~~il~h 313 (323)
|.+||+.||.+||++.++++|
T Consensus 308 i~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 308 MQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHHH
Confidence 999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=318.95 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=206.2
Q ss_pred CCcceeeeeccccceeEEEEEEccC-------CceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecC
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT-------NETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 73 (323)
++|++.+.||+|+||+||+|++... +..||+|++... ........+.+|+.+++.+ +||||+++++++.+.
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 5799999999999999999997543 357999988543 2222346788999999999 899999999999999
Q ss_pred ceEEEEEecchh-hHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC
Q 036739 74 KKLYLVFEYLDL-DLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138 (323)
Q Consensus 74 ~~~~lv~e~~~g-~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~ 138 (323)
+..++||||+.| +|.+.+.... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 227 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCC
Confidence 999999999976 8888887654 2357899999999999999999999999999999999999988
Q ss_pred CCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 139 TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 139 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
+. +||+|||++............ ....+|+.|+|||.+.+ ..++.++||||
T Consensus 228 ~~-~kL~DFG~a~~~~~~~~~~~~---------------------------~~~~~t~~y~aPE~~~~-~~~~~~~Diws 278 (382)
T 3tt0_A 228 NV-MKIADFGLARDIHHIDYYKKT---------------------------TNGRLPVKWMAPEALFD-RIYTHQSDVWS 278 (382)
T ss_dssp CC-EEECSCSCCCCSSCCCTTCCC---------------------------TTCCCGGGGSCHHHHHS-CCCCHHHHHHH
T ss_pred Cc-EEEcccCcccccccccccccc---------------------------cCCCCCcceeCHHHhcC-CCCCchhHHHH
Confidence 87 999999999765432211100 01244788999999988 66899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 219 VGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 219 lG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
||+++|+|++ |..||......+....+...... .....+++.+.++|.+||
T Consensus 279 lG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l 330 (382)
T 3tt0_A 279 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM----------------------------DKPSNCTNELYMMMRDCW 330 (382)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC----------------------------CCCSSCCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHc
Confidence 9999999999 99999888766655544332110 112347889999999999
Q ss_pred ccCCCCCCCHhhhhcC
Q 036739 298 CMDPSRRITARSALEH 313 (323)
Q Consensus 298 ~~dp~~R~s~~~il~h 313 (323)
+.||++||++.+++++
T Consensus 331 ~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 331 HAVPSQRPTFKQLVED 346 (382)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCChhhCcCHHHHHHH
Confidence 9999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=305.61 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=204.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 58999999999999999999985 677899999864332 23678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
+++| +|.+.+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. +||+|||.+..........
T Consensus 84 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~-~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC-EEECCTTGGGGBCCHHHHS
T ss_pred CCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC-EEEcccccccccccccccc
Confidence 9975 7777776543 35788999999999999999999999999999999999998887 9999999987653221111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
. ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus 162 ~----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (267)
T 3t9t_A 162 S----------------------------TGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212 (267)
T ss_dssp T----------------------------TSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred c----------------------------ccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHH
Confidence 0 01134778999999987 567999999999999999999 89999888776
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
+....+...... ......++.+.++|.+||+.||++||++.+++++
T Consensus 213 ~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 213 EVVEDISTGFRL----------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCcC----------------------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 665554332110 1112467889999999999999999999999873
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=317.51 Aligned_cols=253 Identities=25% Similarity=0.333 Sum_probs=205.8
Q ss_pred CCcceeeeeccccceeEEEEEEcc-----CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|+||.||++++.. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 689999999999999999999863 45789999985432 222346788999999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 036739 77 YLVFEYLDL-DLKKHMDSCP----------------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNL 133 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~----------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Ni 133 (323)
++||||+.| +|.+.+.... ...+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 205 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 205 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceE
Confidence 999999976 8888876542 14678899999999999999999999999999999999
Q ss_pred EEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCc
Q 036739 134 LIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTP 213 (323)
Q Consensus 134 l~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 213 (323)
+++.++. +||+|||++.......... ......+++.|+|||.+.+ ..++.+
T Consensus 206 l~~~~~~-~kl~Dfg~~~~~~~~~~~~---------------------------~~~~~~~t~~y~aPE~~~~-~~~~~~ 256 (343)
T 1luf_A 206 LVGENMV-VKIADFGLSRNIYSADYYK---------------------------ADGNDAIPIRWMPPESIFY-NRYTTE 256 (343)
T ss_dssp EECGGGC-EEECCCSCHHHHTGGGCBC-------------------------------CCBCGGGCCHHHHHH-CCCCHH
T ss_pred EECCCCe-EEEeecCCCcccccCcccc---------------------------ccCCCcccceecChhhhcc-CCcCcc
Confidence 9998887 9999999987653221100 0111245888999999987 568999
Q ss_pred hhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHH
Q 036739 214 VDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292 (323)
Q Consensus 214 ~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 292 (323)
+|+||||+++|+|++ |..||......+....+..... ......+++.+.++
T Consensus 257 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~l 308 (343)
T 1luf_A 257 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNL 308 (343)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHH
T ss_pred cccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHH
Confidence 999999999999999 9999998877666555433110 01123478899999
Q ss_pred HHhhcccCCCCCCCHhhhhc
Q 036739 293 LSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 293 i~~~l~~dp~~R~s~~~il~ 312 (323)
|.+||+.||++||++.++++
T Consensus 309 i~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 309 MRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=315.42 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=196.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC----CCchhHHHHHHHHHhc----CCCCeeeeeEEEecC
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE----GVPSTAIREISLLKEM----QHGNIVRLQDVVHSE 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l----~~~~i~~~~~~~~~~ 73 (323)
++|++.+.||+|++|.||+|++..+++.||+|++....... .....+.+|+.+++++ +|+||+++++++.+.
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 58999999999999999999998999999999986543211 2334566789999998 899999999999999
Q ss_pred ceEEEEEec-ch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEe-cCCCceEEeccccc
Q 036739 74 KKLYLVFEY-LD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLID-RRTNALKLADFGLA 150 (323)
Q Consensus 74 ~~~~lv~e~-~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~-~~~~~~kl~df~~~ 150 (323)
+..++|+|+ +. ++|.+.+.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++ .++ .+||+|||.+
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~kl~dfg~~ 187 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSG 187 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT-EEEECCCSSC
T ss_pred CeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC-eEEEEEcchh
Confidence 999999999 54 58888887643 478899999999999999999999999999999999999 555 4999999998
Q ss_pred eecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 151 RAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
......... ...|++.|+|||.+.+....+.++|+||||+++|+|++|.
T Consensus 188 ~~~~~~~~~-------------------------------~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 236 (312)
T 2iwi_A 188 ALLHDEPYT-------------------------------DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236 (312)
T ss_dssp EECCSSCBC-------------------------------CCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred hhcccCccc-------------------------------ccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCC
Confidence 876432211 1245888999999887555566999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh
Q 036739 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310 (323)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i 310 (323)
.||..... +... . ......+++.+.++|.+||+.||++||++.++
T Consensus 237 ~pf~~~~~------~~~~--~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 281 (312)
T 2iwi_A 237 IPFERDQE------ILEA--E---------------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281 (312)
T ss_dssp CSCCSHHH------HHHT--C---------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCChHH------Hhhh--c---------------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99965321 1110 0 01123478899999999999999999999999
Q ss_pred hcCCCCccc
Q 036739 311 LEHEYFRDV 319 (323)
Q Consensus 311 l~h~~~~~~ 319 (323)
++||||++.
T Consensus 282 l~~~~~~~~ 290 (312)
T 2iwi_A 282 LLDPWMQTP 290 (312)
T ss_dssp HHSTTTCC-
T ss_pred hcChhhcCc
Confidence 999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=313.74 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=205.2
Q ss_pred CCcceeeeeccccceeEEEEEEc-----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|+||.||++++. .++..||+|++... ........+.+|+.+++.++||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 57999999999999999999873 34578999988533 2222346778899999999999999999999999999
Q ss_pred EEEEecch-hhHHHhhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 036739 77 YLVFEYLD-LDLKKHMDSCPD----------------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNL 133 (323)
Q Consensus 77 ~lv~e~~~-g~l~~~~~~~~~----------------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Ni 133 (323)
++||||+. |+|.+.+..... ..+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI 181 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence 99999997 488888876432 2368888999999999999999999999999999999
Q ss_pred EEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCc
Q 036739 134 LIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTP 213 (323)
Q Consensus 134 l~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 213 (323)
+++.++. +||+|||++............ ....+++.|+|||.+.+ ..++.+
T Consensus 182 li~~~~~-~kl~Dfg~~~~~~~~~~~~~~---------------------------~~~~~~~~y~aPE~~~~-~~~~~~ 232 (314)
T 2ivs_A 182 LVAEGRK-MKISDFGLSRDVYEEDSYVKR---------------------------SQGRIPVKWMAIESLFD-HIYTTQ 232 (314)
T ss_dssp EEETTTE-EEECCCTTCEECTTTSCEECS---------------------------SCCCSCGGGCCHHHHHH-CEECHH
T ss_pred EEcCCCC-EEEccccccccccccccceec---------------------------cCCCCcccccChhhhcC-CCcCch
Confidence 9998877 999999999876433221110 01234788999999987 568999
Q ss_pred hhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHH
Q 036739 214 VDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292 (323)
Q Consensus 214 ~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 292 (323)
+||||||+++|+|++ |..||...........+..... ......+++.+.++
T Consensus 233 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~l 284 (314)
T 2ivs_A 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR----------------------------MERPDNCSEEMYRL 284 (314)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc----------------------------CCCCccCCHHHHHH
Confidence 999999999999999 9999988776655544332110 01123578999999
Q ss_pred HHhhcccCCCCCCCHhhhhcC
Q 036739 293 LSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 293 i~~~l~~dp~~R~s~~~il~h 313 (323)
|.+||+.||++||++.+++++
T Consensus 285 i~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 285 MLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=311.09 Aligned_cols=255 Identities=23% Similarity=0.338 Sum_probs=206.8
Q ss_pred CCcceeeeeccccceeEEEEEE-----ccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARN-----CVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|+||.||++++ ..++..||+|.+.... .....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 5899999999999999999985 3467799999985432 122346788999999999 89999999999999999
Q ss_pred EEEEEecchh-hHHHhhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPD----------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~ 138 (323)
.++||||+.| +|.+.+..... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC
Confidence 9999999975 88888876542 247889999999999999999999999999999999999988
Q ss_pred CCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 139 TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 139 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
+. +||+|||++........... .....+++.|+|||.+.+ ..++.++||||
T Consensus 182 ~~-~kl~Dfg~~~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s 232 (313)
T 1t46_A 182 RI-TKICDFGLARDIKNDSNYVV---------------------------KGNARLPVKWMAPESIFN-CVYTFESDVWS 232 (313)
T ss_dssp TE-EEECCCGGGSCTTSCTTSEE---------------------------CSSSEECGGGCCHHHHHH-CCCCHHHHHHH
T ss_pred CC-EEEcccccccccccccccee---------------------------ccCCCCcceeeChHHhcC-CCCChHHHHHH
Confidence 76 99999999976643322110 111245788999999887 56899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 219 VGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 219 lG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
||+++|+|++ |..||................... .....+++.+.++|.+||
T Consensus 233 lG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l 285 (313)
T 1t46_A 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCW 285 (313)
T ss_dssp HHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHc
Confidence 9999999999 999998877655554444321111 111347889999999999
Q ss_pred ccCCCCCCCHhhhhcC
Q 036739 298 CMDPSRRITARSALEH 313 (323)
Q Consensus 298 ~~dp~~R~s~~~il~h 313 (323)
+.||++||++.+++++
T Consensus 286 ~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 286 DADPLKRPTFKQIVQL 301 (313)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCCchhCcCHHHHHHH
Confidence 9999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=325.86 Aligned_cols=262 Identities=27% Similarity=0.397 Sum_probs=193.9
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.|.+.+.||+|+||+||.+. ..+|+.||+|.+.... .+.+.+|+.+++.+ +||||+++++++.+++..++|||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 45567889999999998764 4689999999986432 35677899999876 89999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCC-----CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC------------CceEE
Q 036739 82 YLDLDLKKHMDSCPDFAN-----DPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT------------NALKL 144 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~-----~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~------------~~~kl 144 (323)
+++|+|.+.+........ .+..+..++.||+.||.|||++||+|+||||+||+++.++ ..+||
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 999999998876543211 2223567999999999999999999999999999997643 25999
Q ss_pred eccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC------CCCCCCchhhHH
Q 036739 145 ADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG------SRHYSTPVDVWS 218 (323)
Q Consensus 145 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~s 218 (323)
+|||++............. .....||+.|+|||.+.+ ...++.++||||
T Consensus 170 ~DFG~a~~~~~~~~~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwS 224 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTN-------------------------LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224 (434)
T ss_dssp CCCTTCEECCC---------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHH
T ss_pred cccccceecCCCCccceee-------------------------ecCCCCCCCccCHHHhccccccccccCcchhhhhHh
Confidence 9999998765432211100 112356999999999965 256889999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 219 VGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 219 lG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
|||++|+|++ |..||....... ..+.......... .......+++.+.++|.+||
T Consensus 225 lG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~----------------------~~~~~~~~~~~~~~li~~~L 280 (434)
T 2rio_A 225 MGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEM----------------------KCLHDRSLIAEATDLISQMI 280 (434)
T ss_dssp HHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCC----------------------TTCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccc----------------------cccccccchHHHHHHHHHHh
Confidence 9999999999 999997665433 2222211110000 00001235678999999999
Q ss_pred ccCCCCCCCHhhhhcCCCCccc
Q 036739 298 CMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 298 ~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+.||++||++.++++||||.+.
T Consensus 281 ~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 281 DHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp CSSGGGSCCHHHHHTSGGGSCH
T ss_pred hCChhhCCCHHHHHhCCccCCc
Confidence 9999999999999999999753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=314.66 Aligned_cols=252 Identities=21% Similarity=0.335 Sum_probs=196.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceE----EEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETI----ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|+||+||+|++..+++.+ |+|.+... ........+.+|+.++++++||||+++++++.+.. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 58999999999999999999987777755 66665432 23344578889999999999999999999998765 67
Q ss_pred EEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+|++++. |++.+.+..... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++......
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~-~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE-EEECCTTHHHHHTTT
T ss_pred EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC-EEEccCcceeEccCC
Confidence 8888886 588888776443 5788899999999999999999999999999999999999887 999999999876543
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
....... ...+|+.|+|||.+.+ ..++.++||||||+++|+|++ |..||..
T Consensus 171 ~~~~~~~---------------------------~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~ 222 (327)
T 3poz_A 171 EKEYHAE---------------------------GGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp CC----------------------------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccc---------------------------CCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence 3221110 1234778999999987 668999999999999999999 9999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
....+....+...... ......+..+.+++.+||+.||++||++.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 223 IPASEISSILEKGERL----------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CCGGGHHHHHHTTCCC----------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 7766554443321111 1123467889999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=314.31 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=199.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCce----EEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNET----IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|+||+||+|++..++.. |++|.+... ........+.+|+.+++.++||||+++++++. ++..+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCT-TSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccc-ccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 6899999999999999999999888876 566655322 23334567778999999999999999999985 56688
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+|+||+.| +|.+.+.... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++......
T Consensus 91 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ-VQVADFGVADLLPPD 168 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC-EEECSCSGGGGSCCC
T ss_pred EEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe-EEECCCCcccccCcc
Confidence 99999975 8888776543 35677889999999999999999999999999999999998887 999999999876433
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
...... ....|++.|+|||.+.+ ..++.++||||||+++|+|++ |..||..
T Consensus 169 ~~~~~~---------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~ 220 (325)
T 3kex_A 169 DKQLLY---------------------------SEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAG 220 (325)
T ss_dssp TTCCC--------------------------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccc---------------------------cCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccc
Confidence 221111 11244778999999987 568999999999999999999 9999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
....+....+...... .....+++.+.++|.+||+.||++||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 221 LRLAEVPDLLEKGERL----------------------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp SCTTHHHHHHHTTCBC----------------------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred cCHHHHHHHHHcCCCC----------------------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7766555444321100 1112356678899999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=313.41 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=202.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceE--EEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETI--ALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~--aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|++|.||+|++..++..+ ++|.+... ........+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 68999999999999999999998888865 89988543 3334457788999999999 89999999999999999999
Q ss_pred EEecchh-hHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceE
Q 036739 79 VFEYLDL-DLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALK 143 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~k 143 (323)
||||+.| +|.+.+.... ...+++..+..++.||+.||.+||+.|++|+||||+||+++.++. +|
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~-~k 182 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AK 182 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-EE
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe-EE
Confidence 9999965 8888876543 246789999999999999999999999999999999999998887 99
Q ss_pred EeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHH
Q 036739 144 LADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIF 223 (323)
Q Consensus 144 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll 223 (323)
|+|||++......... ....+++.|+|||.+.+ ..++.++|+||||+++
T Consensus 183 L~Dfg~~~~~~~~~~~------------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il 231 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKK------------------------------TMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLL 231 (327)
T ss_dssp ECCTTCEESSCEECCC----------------------------------CCTTTCCHHHHHH-CEECHHHHHHHHHHHH
T ss_pred EcccCcCccccccccc------------------------------cCCCCCccccChhhhcc-ccCCchhcchHHHHHH
Confidence 9999998643211110 01133778999999977 5678999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCC
Q 036739 224 AEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 224 ~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~ 302 (323)
|+|++ |..||......+....+..... ......+++.+.++|.+||+.||+
T Consensus 232 ~ellt~g~~pf~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~ 283 (327)
T 1fvr_A 232 WEIVSLGGTPYCGMTCAELYEKLPQGYR----------------------------LEKPLNCDDEVYDLMRQCWREKPY 283 (327)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHGGGTCC----------------------------CCCCTTBCHHHHHHHHHHTCSSGG
T ss_pred HHHHcCCCCCCCCCcHHHHHHHhhcCCC----------------------------CCCCCCCCHHHHHHHHHHccCChh
Confidence 99998 9999988876655544322100 011234788999999999999999
Q ss_pred CCCCHhhhhcC
Q 036739 303 RRITARSALEH 313 (323)
Q Consensus 303 ~R~s~~~il~h 313 (323)
+||++.+++++
T Consensus 284 ~Rps~~ell~~ 294 (327)
T 1fvr_A 284 ERPSFAQILVS 294 (327)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=330.28 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=209.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||.||++++..++..||+|.+... ....+.+.+|+.++++++||||+++++++.+...+++|||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc---ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 4688999999999999999999888999999998543 2235788999999999999999999999999999999999
Q ss_pred cch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+. |+|.+.+.......+++..+..++.||+.||.|||++||+|+||||+||+++.++. +||+|||++..........
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL-VKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-EEECCTTCEECCTTCCEEC
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc-EEEeecccceeccCCceee
Confidence 997 58988888766666889999999999999999999999999999999999998887 9999999998754322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. ...+++.|+|||.+.. ..++.++||||||+++|+|++ |..||......
T Consensus 376 ~~----------------------------~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~ 426 (495)
T 1opk_A 376 HA----------------------------GAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426 (495)
T ss_dssp CT----------------------------TCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred cC----------------------------CCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 00 1133678999999987 568999999999999999999 99999888766
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+...... .....+++.+.+||.+||+.||++||++.++++
T Consensus 427 ~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 427 QVYELLEKDYRM----------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp GHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 655444321110 112347889999999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=326.24 Aligned_cols=259 Identities=27% Similarity=0.388 Sum_probs=194.5
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+|++.+.||+|++|+|+.. ...+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+....++|||
T Consensus 25 ~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPE-----CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTT-----TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 5889999999999997643 3468899999998532 234567899999999 79999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC---C-ceEEeccccceecCCCc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT---N-ALKLADFGLARAFGIPV 157 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~---~-~~kl~df~~~~~~~~~~ 157 (323)
+++|+|.+.+..... ...+..+..++.||+.||.|||+.||+|+||||+||+++.++ . .+||+|||++.......
T Consensus 99 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 99 LCAATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp CCSEEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCCCCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 999999999876543 234444678999999999999999999999999999995322 1 48899999998764332
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--CCCCCCchhhHHHHHHHHHHHh-CCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVN-QRPLFP 234 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~ll~~l~t-g~~p~~ 234 (323)
..... .....||+.|+|||.+.+ ...++.++|||||||++|+|++ |..||.
T Consensus 178 ~~~~~--------------------------~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 178 HSFSR--------------------------RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp ----------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred cceee--------------------------ccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 21111 112356999999999874 2456789999999999999999 999996
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
.......... . ....... .......+..+.+||.+||+.||++||++.++++||
T Consensus 232 ~~~~~~~~~~-~---~~~~~~~----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 232 KSLQRQANIL-L---GACSLDC----------------------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp STTTHHHHHH-T---TCCCCTT----------------------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred hhhHHHHHHH-h---ccCCccc----------------------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 6544332211 1 1100000 000112355688999999999999999999999999
Q ss_pred CCcccc
Q 036739 315 YFRDVE 320 (323)
Q Consensus 315 ~~~~~~ 320 (323)
||.++.
T Consensus 286 ~f~~~~ 291 (432)
T 3p23_A 286 FFWSLE 291 (432)
T ss_dssp TTCCHH
T ss_pred cccChH
Confidence 998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=307.01 Aligned_cols=255 Identities=21% Similarity=0.331 Sum_probs=193.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||++.+ ...+|+|++............+.+|+.++++++||||++++++. .....++|||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred cceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 5899999999999999999975 34599999865544444456788999999999999999999965 5667899999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+... ...+++..+..++.||+.||.+||+.|++|+||||+||+++.++. +||+|||.+..........
T Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 100 WCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT-VKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE-EEECCCC------------
T ss_pred ecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC-EEEccceeccccccccccc
Confidence 9976 666666543 345788999999999999999999999999999999999998887 9999999987543221111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
. .....||+.|+|||.+.. ...++.++||||||+++|+|++|..||.....
T Consensus 178 ~---------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 230 (289)
T 3og7_A 178 Q---------------------------FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230 (289)
T ss_dssp ---------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred c---------------------------ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence 0 011246899999999862 35678899999999999999999999998777
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.+............. ........+++.+.++|.+||+.||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 231 RDQIIEMVGRGSLSP-----------------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHHHHTSCCC-----------------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcccccCc-----------------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 666655444321110 011122357899999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=315.39 Aligned_cols=262 Identities=21% Similarity=0.303 Sum_probs=208.6
Q ss_pred CCcceeeeeccccceeEEEEEEc-----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|++|.||+|++. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 57999999999999999999876 356789999885332 222234678899999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 77 YLVFEYLDL-DLKKHMDSCP--------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~--------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
++||||+.| +|.+.+.... ...+++..+..++.||+.||.+||++|++|+||||+||+++.++. +||+||
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~-~kl~Df 182 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDF 182 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC-EEECCT
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe-EEECcC
Confidence 999999975 8887775422 134688889999999999999999999999999999999999887 999999
Q ss_pred ccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH
Q 036739 148 GLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~ 227 (323)
|++........... .....+++.|+|||.+.+ ..++.++|+||||+++|+|+
T Consensus 183 g~~~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~ 234 (322)
T 1p4o_A 183 GMTRDIYETDYYRK---------------------------GGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIA 234 (322)
T ss_dssp TCCCGGGGGGCEEG---------------------------GGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccc---------------------------ccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHH
Confidence 99865432211100 011245788999999987 56899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC
Q 036739 228 N-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT 306 (323)
Q Consensus 228 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 306 (323)
+ |..||......+....+..... ......+++.+.++|.+||+.||++||+
T Consensus 235 ~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps 286 (322)
T 1p4o_A 235 TLAEQPYQGLSNEQVLRFVMEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPS 286 (322)
T ss_dssp HTSCCTTTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hcCCCccccCCHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 9 8999988876665554432110 0112357889999999999999999999
Q ss_pred HhhhhcC------CCCccccc
Q 036739 307 ARSALEH------EYFRDVEF 321 (323)
Q Consensus 307 ~~~il~h------~~~~~~~~ 321 (323)
+.++++| ++|+++.|
T Consensus 287 ~~e~l~~L~~~~~~~~~~~~~ 307 (322)
T 1p4o_A 287 FLEIISSIKEEMEPGFREVSF 307 (322)
T ss_dssp HHHHHHHHGGGSCTTHHHHCS
T ss_pred HHHHHHHHHHhhccCCccccc
Confidence 9999985 67666543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=320.99 Aligned_cols=253 Identities=22% Similarity=0.303 Sum_probs=193.6
Q ss_pred CCcceeeeeccccceeEEEEEEc---cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC---VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|+||.||++++. .++..||+|.+.... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 47999999999999999999876 456789999985432 22234578899999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| +|.+.+... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.......
T Consensus 124 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV-CKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCC----------
T ss_pred EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC-EEECcCccccccccCC
Confidence 9999965 777777654 345788899999999999999999999999999999999998887 9999999987764332
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
...... ....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...
T Consensus 202 ~~~~~~--------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 202 EAAYTT--------------------------RGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp --------------------------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred ccceec--------------------------cCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 111100 01133678999999987 568999999999999999998 99999888
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+....+...... +....+++.+.++|.+||+.||++||++.++++
T Consensus 255 ~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 255 SNQDVIKAVDEGYRL----------------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CHHHHHHHHHTTEEC----------------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCCCC----------------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 776655544332111 111246788999999999999999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=305.80 Aligned_cols=253 Identities=22% Similarity=0.280 Sum_probs=202.8
Q ss_pred CCcceee-eeccccceeEEEEEEc--cCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVE-KIGEGTYGVVYKARNC--VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~-~lg~g~~~~v~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|.+.+ .||+|++|+||++.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 5677877 9999999999999853 467789999986432 223346788999999999999999999999 4556899
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
|||++.| +|.+.+... ...+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADD 164 (287)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE-EEECCCTTCEECTTCS
T ss_pred EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC-EEECcccceeeeccCc
Confidence 9999986 676666543 345789999999999999999999999999999999999998886 9999999998765433
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
...... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...
T Consensus 165 ~~~~~~--------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 165 SYYTAR--------------------------SAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp CEECCC--------------------------CSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ceeecc--------------------------ccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 221111 01234788999999986 568999999999999999998 99999888
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
...+....+..... ......+++.+.++|.+||+.||++||++.+++++
T Consensus 218 ~~~~~~~~i~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 218 KGPEVMAFIEQGKR----------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp CTHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCc----------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77665554433110 11123578999999999999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=306.48 Aligned_cols=252 Identities=20% Similarity=0.283 Sum_probs=201.3
Q ss_pred CCcceee-eeccccceeEEEEE--EccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVE-KIGEGTYGVVYKAR--NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~-~lg~g~~~~v~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+ .||+|++|+||++. ...++..||+|++..........+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4788888 99999999999995 445678999999865544444457788999999999999999999999 5667899
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
|||++.| +|.+.+.... .+++..+..++.||+.||.+||+.|++|+||||+||+++.++. +||+|||.+.......
T Consensus 95 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY-AKISDFGLSKALRADE 171 (291)
T ss_dssp EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE-EEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc-EEEccCCcceeeccCC
Confidence 9999975 7888777643 4788899999999999999999999999999999999998887 9999999998765433
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
...... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...
T Consensus 172 ~~~~~~--------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 172 NYYKAQ--------------------------THGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp SEEEC------------------------------CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred Cccccc--------------------------ccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 221111 01134678999999977 557889999999999999999 99999988
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+....+.... .......+++.+.++|.+||+.||++||++.++++
T Consensus 225 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 225 KGSEVTAMLEKGE----------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CHHHHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7765554443211 01112357899999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=303.10 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=199.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC-----CchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG-----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|++|+||+|++..+++.||+|++........ ....+.+|+.+++.++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 689999999999999999999999999999999865433222 2267889999999999999999999996665
Q ss_pred EEEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEecCCC----ceEEecccc
Q 036739 77 YLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTN----ALKLADFGL 149 (323)
Q Consensus 77 ~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~~~Nil~~~~~~----~~kl~df~~ 149 (323)
++||||+. |++.+.+.... ..+++..+..++.|++.||.|||+.| ++|+||||+||+++.++. .+||+|||.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 69999997 48877776543 35789999999999999999999999 999999999999976553 389999999
Q ss_pred ceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC-CCCCCCchhhHHHHHHHHHHHh
Q 036739 150 ARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG-SRHYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~~Di~slG~ll~~l~t 228 (323)
+........ ...||+.|+|||.+.. ...++.++|+||||+++|+|++
T Consensus 176 ~~~~~~~~~--------------------------------~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~ 223 (287)
T 4f0f_A 176 SQQSVHSVS--------------------------------GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223 (287)
T ss_dssp CBCCSSCEE--------------------------------CCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH
T ss_pred ccccccccc--------------------------------ccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc
Confidence 864322111 1245889999999843 2457889999999999999999
Q ss_pred CCCCCCCCChHHHH--HHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC
Q 036739 229 QRPLFPGDSEIDEL--FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT 306 (323)
Q Consensus 229 g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 306 (323)
|..||......... ...... .. .......+++.+.++|.+||+.||++||+
T Consensus 224 g~~pf~~~~~~~~~~~~~~~~~--~~-------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps 276 (287)
T 4f0f_A 224 GEGPFDEYSYGKIKFINMIREE--GL-------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPH 276 (287)
T ss_dssp SSCTTTTCCCCHHHHHHHHHHS--CC-------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCccccccHHHHHHHHhcc--CC-------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcC
Confidence 99999876544332 222211 00 01122457899999999999999999999
Q ss_pred Hhhhhc
Q 036739 307 ARSALE 312 (323)
Q Consensus 307 ~~~il~ 312 (323)
+.++++
T Consensus 277 ~~~ll~ 282 (287)
T 4f0f_A 277 FSYIVK 282 (287)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=308.56 Aligned_cols=246 Identities=15% Similarity=0.237 Sum_probs=197.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCC-------ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTN-------ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (323)
++|++.+.||+|+||+||++++..++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 68999999999999999999988777 469999885432 234567889999999999999999999999999
Q ss_pred eEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCc-------eEEec
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA-------LKLAD 146 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~-------~kl~d 146 (323)
..++||||+.| +|.+.+..... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.. +||+|
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 99999999975 88877766432 47888899999999999999999999999999999999887753 89999
Q ss_pred cccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHH
Q 036739 147 FGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM 226 (323)
Q Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l 226 (323)
||.+....... ...|++.|+|||.+.+...++.++||||||+++|+|
T Consensus 165 fg~~~~~~~~~---------------------------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 211 (289)
T 4fvq_A 165 PGISITVLPKD---------------------------------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211 (289)
T ss_dssp CCSCTTTSCHH---------------------------------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHH
T ss_pred CcccccccCcc---------------------------------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHH
Confidence 99885442111 013478899999998756689999999999999999
Q ss_pred HhCC-CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC
Q 036739 227 VNQR-PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI 305 (323)
Q Consensus 227 ~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~ 305 (323)
++|. +||.......... ...... ......++.+.++|.+||+.||++||
T Consensus 212 ~~g~~~~~~~~~~~~~~~-~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rp 261 (289)
T 4fvq_A 212 CSGGDKPLSALDSQRKLQ-FYEDRH-----------------------------QLPAPKAAELANLINNCMDYEPDHRP 261 (289)
T ss_dssp HTTTCCTTTTSCHHHHHH-HHHTTC-----------------------------CCCCCSSCTTHHHHHHHSCSSGGGSC
T ss_pred HcCCCCCccccchHHHHH-HhhccC-----------------------------CCCCCCCHHHHHHHHHHcCCChhHCc
Confidence 9955 5555544433332 222100 11123467788999999999999999
Q ss_pred CHhhhhcC
Q 036739 306 TARSALEH 313 (323)
Q Consensus 306 s~~~il~h 313 (323)
++.++++|
T Consensus 262 s~~~ll~~ 269 (289)
T 4fvq_A 262 SFRAIIRD 269 (289)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999984
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=311.11 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=196.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCC----ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTN----ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|++|+||+|.+..++ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 57889999999999999999876554 359999985432 2223456788999999999999999999999999999
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+||||+.| +|.+.+... ...+++..+..++.||+.||.+||+.|++|+||||+||+++.++. +||+|||.+......
T Consensus 123 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCCCC-------
T ss_pred EEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc-EEECCCCcchhhccc
Confidence 99999976 777776654 335788999999999999999999999999999999999998887 999999999776433
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
....... ....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||..
T Consensus 201 ~~~~~~~--------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 201 PEATYTT--------------------------SGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp ------------------------------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccc--------------------------CCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 2211100 01134778999999987 568999999999999999999 9999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
....+....+...... +....+++.+.++|.+||+.||++||++.++++
T Consensus 254 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 254 LSNHEVMKAINDGFRL----------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp CCHHHHHHHHHTTCCC----------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHCCCcC----------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7776655544332110 111246789999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=305.38 Aligned_cols=241 Identities=28% Similarity=0.382 Sum_probs=191.5
Q ss_pred CCCccee-eeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHH-HhcCCCCeeeeeEEEec----Cc
Q 036739 1 MDQYEKV-EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLL-KEMQHGNIVRLQDVVHS----EK 74 (323)
Q Consensus 1 ~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~~ 74 (323)
+++|.+. +.||+|++|.||++.+..+++.||+|++.. ...+.+|+.++ +..+||||+++++++.+ ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3688888 779999999999999999999999999852 25677888887 66689999999999976 77
Q ss_pred eEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec---CCCceEEeccccc
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGLA 150 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~---~~~~~kl~df~~~ 150 (323)
..++||||+.| +|.+.+.......+++..+..++.||+.||.|||+.|++|+||||+||+++. ++. +||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~-~kl~Dfg~a 167 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI-LKLTDFGFA 167 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC-EEECCCTTC
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCc-EEEeccccc
Confidence 89999999975 9988888776667899999999999999999999999999999999999987 455 999999988
Q ss_pred eecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 151 RAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
.... ...++.++|+|||||++|+|++|.
T Consensus 168 ~~~~----------------------------------------------------~~~~~~~~DiwslG~il~el~tg~ 195 (299)
T 3m2w_A 168 KETT----------------------------------------------------GEKYDKSCDMWSLGVIMYILLCGY 195 (299)
T ss_dssp EECT----------------------------------------------------TCGGGGHHHHHHHHHHHHHHHHSS
T ss_pred cccc----------------------------------------------------cccCCchhhHHHHHHHHHHHHHCC
Confidence 5431 134677999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh
Q 036739 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310 (323)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i 310 (323)
.||............ ..................+++.+.++|.+||+.||++||++.++
T Consensus 196 ~pf~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~ 254 (299)
T 3m2w_A 196 PPFYSNHGLAISPGM---------------------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254 (299)
T ss_dssp CSCCC-------CCS---------------------CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCcchhhhHHH---------------------HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 999765432211000 00000000011112235689999999999999999999999999
Q ss_pred hcCCCCcccccc
Q 036739 311 LEHEYFRDVEFV 322 (323)
Q Consensus 311 l~h~~~~~~~~~ 322 (323)
++||||++....
T Consensus 255 l~hp~~~~~~~~ 266 (299)
T 3m2w_A 255 MNHPWIMQSTKV 266 (299)
T ss_dssp HTSHHHHTGGGS
T ss_pred hcChhhcccccC
Confidence 999999876543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=308.62 Aligned_cols=254 Identities=24% Similarity=0.303 Sum_probs=196.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|++|.||++++..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 47899999999999999999999989999999998654322 22236788899999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
+|+++| +|.+.+.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. +||+|||.+........
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF-AYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC-EEEecCccCcccccccc
Confidence 999976 8887776543 4788899999999999999999999999999999999998887 99999999876543221
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
... ....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 190 ~~~----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (309)
T 2h34_A 190 TQL----------------------------GNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQL 240 (309)
T ss_dssp -----------------------------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred ccc----------------------------cccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchH
Confidence 110 11245889999999877 5689999999999999999999999987765
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-CHhhhhc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-TARSALE 312 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-s~~~il~ 312 (323)
......+... . . ........+++.+.++|.+||+.||++|| ++.++++
T Consensus 241 ~~~~~~~~~~-~-~------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 241 SVMGAHINQA-I-P------------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHSC-C-C------------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHhccC-C-C------------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 4222222110 0 0 01122345788999999999999999999 8888775
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=310.31 Aligned_cols=251 Identities=21% Similarity=0.337 Sum_probs=196.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceE----EEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETI----ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++++.||+|+||+||+|++..+++.+ ++|.+.. .........+.+|+.+++.++||||+++++++.+.. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECC-CSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecc-ccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 68999999999999999999998888866 4444422 223445678889999999999999999999998765 67
Q ss_pred EEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+|++++. |++.+.+..... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++......
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~-~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE-EEECCTTC-------
T ss_pred EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC-EEEccCcceeEccCc
Confidence 8888886 488888776543 5788999999999999999999999999999999999998887 999999999876433
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
....... ...+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||..
T Consensus 171 ~~~~~~~---------------------------~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 171 EKEYHAE---------------------------GGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp ------------------------------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccc---------------------------CCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2221110 1234778999999987 668999999999999999999 9999988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
....+....+...... .....+++.+.++|.+||+.||++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 223 IPASEISSILEKGERL----------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp CCGGGHHHHHHTTCCC----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8776655444322111 112347889999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=315.26 Aligned_cols=262 Identities=13% Similarity=0.126 Sum_probs=201.2
Q ss_pred CCcceeeeeccccceeEEEEEEcc--------CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeee--------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV--------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR-------- 65 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-------- 65 (323)
++|++.+.||+|++|.||+|++.. .+..||+|.+... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 689999999999999999999877 4889999998533 46889999999999998887
Q ss_pred -------eeEEEec-CceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec
Q 036739 66 -------LQDVVHS-EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR 137 (323)
Q Consensus 66 -------~~~~~~~-~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~ 137 (323)
+++++.. +...++||||++++|.+.+.......+++..+..++.||+.||.|||++|++|+||||+||+++.
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred CccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 6677765 78899999999779999988764557899999999999999999999999999999999999998
Q ss_pred CCC-ceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhh
Q 036739 138 RTN-ALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDV 216 (323)
Q Consensus 138 ~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di 216 (323)
++. .+||+|||++............... ......||+.|+|||.+.+ ..++.++||
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~----------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 251 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEG----------------------SRSPHEGDLEFISMDLHKG-CGPSRRSDL 251 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTT----------------------SSCTTCSCTTTCCHHHHTT-CCCCHHHHH
T ss_pred CCCceEEEecCcceeeccCCCcccccccc----------------------ccccccCCccccCHHHHcc-CCCCchhhH
Confidence 771 4999999999776533221110000 0111256899999999987 568999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHh
Q 036739 217 WSVGCIFAEMVNQRPLFPGDS-EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSK 295 (323)
Q Consensus 217 ~slG~ll~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 295 (323)
||||+++|+|++|..||.... ................... .. .......+++.+.++|.+
T Consensus 252 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~---------~~~~~~~~~~~l~~li~~ 312 (352)
T 2jii_A 252 QSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPF----------VG---------PCGHWIRPSETLQKYLKV 312 (352)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCE----------EC---------TTSCEECCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhh----------hh---------hccccCCCcHHHHHHHHH
Confidence 999999999999999998764 3333333222111110000 00 001123578999999999
Q ss_pred hcccCCCCCCCHhhhhc
Q 036739 296 MLCMDPSRRITARSALE 312 (323)
Q Consensus 296 ~l~~dp~~R~s~~~il~ 312 (323)
||+.||++||++.++++
T Consensus 313 ~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 313 VMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHTCCTTCCCCHHHHHH
T ss_pred HHhCChhhCCCHHHHHH
Confidence 99999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=320.71 Aligned_cols=243 Identities=25% Similarity=0.390 Sum_probs=201.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc-eEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-KLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~ 80 (323)
++|++.+.||+|+||.||++.. ++..||+|++... .....+.+|+.++++++||||+++++++.... ..++||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSC----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCc----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 5799999999999999999986 4779999998533 24578899999999999999999999987654 799999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.......+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.........
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~~~~ 345 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQDT 345 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC-EEECCCTTCEECC-----
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC-EEEeeCCCcccccccccC
Confidence 99975 8888887765545788889999999999999999999999999999999998887 999999998754321110
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCh
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSE 238 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~ 238 (323)
..+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.....
T Consensus 346 --------------------------------~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 392 (450)
T 1k9a_A 346 --------------------------------GKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392 (450)
T ss_dssp ---------------------------------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT
T ss_pred --------------------------------CCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 133778999999987 568999999999999999998 9999988776
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.+....+.+.... .....+++.+.++|.+||+.||++||++.++++
T Consensus 393 ~~~~~~i~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 393 KDVVPRVEKGYKM----------------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp TTHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCC----------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6665554432111 112347899999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=313.07 Aligned_cols=258 Identities=19% Similarity=0.251 Sum_probs=201.3
Q ss_pred CCcceeeeeccccceeEEEEE-----EccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|++|.||+++ +..++..||+|.+... ........+.+|+.+++.++||||+++++++.+....
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 689999999999999999998 5567789999998532 2222345778899999999999999999999999999
Q ss_pred EEEEecch-hhHHHhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC--CceEEeccc
Q 036739 77 YLVFEYLD-LDLKKHMDSCPD-----FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFG 148 (323)
Q Consensus 77 ~lv~e~~~-g~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~--~~~kl~df~ 148 (323)
++||||+. |+|.+.+..... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ ..+||+|||
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 99999995 588888876542 3478888999999999999999999999999999999998433 259999999
Q ss_pred cceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh
Q 036739 149 LARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t 228 (323)
.+........... .....|++.|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 189 ~~~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt 240 (327)
T 2yfx_A 189 MARDIYRASYYRK---------------------------GGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFS 240 (327)
T ss_dssp HHHHHHC---------------------------------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccc---------------------------CCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHc
Confidence 9865432211110 111245888999999987 568999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH
Q 036739 229 -QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 229 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
|..||......+....+..... ......+++.+.++|.+||+.||++||++
T Consensus 241 ~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 292 (327)
T 2yfx_A 241 LGYMPYPSKSNQEVLEFVTSGGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNF 292 (327)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCCCcCHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 9999988776655544432110 01123478899999999999999999999
Q ss_pred hhhhcCCCC
Q 036739 308 RSALEHEYF 316 (323)
Q Consensus 308 ~~il~h~~~ 316 (323)
.++++|.|+
T Consensus 293 ~~ll~~l~~ 301 (327)
T 2yfx_A 293 AIILERIEY 301 (327)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=309.35 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=195.5
Q ss_pred CCcceeeeeccccceeEEEEE----EccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--Cce
Q 036739 2 DQYEKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 75 (323)
++|++++.||+|+||+||+++ +..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 689999999999999999998 56688999999885332 2233578899999999999999999999864 356
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
+++||||+.| +|.+.+..... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++....
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-VKIGDFGLTKVLP 165 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-EEECCCCSCC---
T ss_pred eEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe-EEEccCccccccc
Confidence 8999999965 88888766533 4788899999999999999999999999999999999998887 9999999997764
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
......... ....++..|+|||.+.+ ..++.++||||||+++|+|++|..|+.
T Consensus 166 ~~~~~~~~~--------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 166 QDKEFFKVK--------------------------EPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp ------------------------------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred CCcceeeec--------------------------cCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccC
Confidence 332211110 11234777999999987 568999999999999999999999986
Q ss_pred CCChHHH------------HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCC
Q 036739 235 GDSEIDE------------LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 235 ~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~ 302 (323)
....... .......... ....+....+++.+.++|.+||+.||+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~ 274 (295)
T 3ugc_A 219 SPPAEFMRMIGNDKQGQMIVFHLIELLKN------------------------NGRLPRPDGCPDEIYMIMTECWNNNVN 274 (295)
T ss_dssp SHHHHHHHHHCTTCCTHHHHHHHHHHHHT------------------------TCCCCCCTTCCHHHHHHHHHHSCSSGG
T ss_pred CChHHHHhhhcCccccchhHHHHHHHHhc------------------------cCcCCCCcCcCHHHHHHHHHHcCCChh
Confidence 5422100 0011111000 001112345789999999999999999
Q ss_pred CCCCHhhhhc
Q 036739 303 RRITARSALE 312 (323)
Q Consensus 303 ~R~s~~~il~ 312 (323)
+||++.++++
T Consensus 275 ~Rps~~el~~ 284 (295)
T 3ugc_A 275 QRPSFRDLAL 284 (295)
T ss_dssp GSCCHHHHHH
T ss_pred hCCCHHHHHH
Confidence 9999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=304.95 Aligned_cols=244 Identities=25% Similarity=0.423 Sum_probs=200.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec---------
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--------- 72 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 72 (323)
++|++.+.||+|++|.||++.+..+++.||+|.+... ...+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC------SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4799999999999999999999889999999998643 2567889999999999999999998854
Q ss_pred -------CceEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEE
Q 036739 73 -------EKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKL 144 (323)
Q Consensus 73 -------~~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl 144 (323)
....++||||+++ +|.+.+.......+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. +||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl 163 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ-VKI 163 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE-EEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC-EEE
Confidence 4568999999986 8888887665557899999999999999999999999999999999999998887 999
Q ss_pred eccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHH
Q 036739 145 ADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFA 224 (323)
Q Consensus 145 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~ 224 (323)
+|||.+.......... ...|++.|+|||.+.+ ..++.++|+||||+++|
T Consensus 164 ~Dfg~~~~~~~~~~~~------------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ 212 (284)
T 2a19_B 164 GDFGLVTSLKNDGKRT------------------------------RSKGTLRYMSPEQISS-QDYGKEVDLYALGLILA 212 (284)
T ss_dssp CCCTTCEESSCCSCCC------------------------------CCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHH
T ss_pred Ccchhheecccccccc------------------------------ccCCcccccChhhhcc-CCCcchhhhHHHHHHHH
Confidence 9999987765432111 1245889999999987 56899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCC
Q 036739 225 EMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRR 304 (323)
Q Consensus 225 ~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R 304 (323)
+|++|..|+.... .....+.. . .....+++.+.++|.+||+.||++|
T Consensus 213 ~l~~~~~~~~~~~--~~~~~~~~----~---------------------------~~~~~~~~~~~~li~~~l~~dp~~R 259 (284)
T 2a19_B 213 ELLHVCDTAFETS--KFFTDLRD----G---------------------------IISDIFDKKEKTLLQKLLSKKPEDR 259 (284)
T ss_dssp HHHSCCSSHHHHH--HHHHHHHT----T---------------------------CCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhcCCcchhHH--HHHHHhhc----c---------------------------cccccCCHHHHHHHHHHccCChhhC
Confidence 9999998774221 11111110 0 0113477889999999999999999
Q ss_pred CCHhhhhcCCCC
Q 036739 305 ITARSALEHEYF 316 (323)
Q Consensus 305 ~s~~~il~h~~~ 316 (323)
|++.++++|.+.
T Consensus 260 ps~~e~l~~l~~ 271 (284)
T 2a19_B 260 PNTSEILRTLTV 271 (284)
T ss_dssp CCHHHHHHHHHH
T ss_pred cCHHHHHHHHHH
Confidence 999999998653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=313.81 Aligned_cols=264 Identities=20% Similarity=0.267 Sum_probs=201.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||++++ .++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred hccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 6899999999999999999996 46889999987543 23345678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 82 YLDL-DLKKHMDSCP--DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|+.| +|.+.+.... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||.+........
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV-PKITDFGISKKGTELDQ 194 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC-EEECCCTTCEECSSSSC
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC-EEEeecccccccccccc
Confidence 9975 7777765433 235788999999999999999999999999999999999998887 99999999876432221
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 195 ~~~---------------------------~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 195 THL---------------------------STVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp CCC---------------------------BCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred ccc---------------------------ccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 110 011246899999999987 5689999999999999999999999976543
Q ss_pred HHHHH---HHHHHhCCCCCCCCCCcccCCcccccCCCCCC-CcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 239 IDELF---KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPS-KELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 239 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.+... .......... ...... ..........++.+.+++.+||+.||++||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 247 REMVNLAEWAVESHNNGQ----------------LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SSCCCHHHHTHHHHTTTC----------------CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhhhcccccc----------------HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22111 0000000000 000000 00111223356778999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=308.73 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=202.7
Q ss_pred CCcceeeeeccccceeEEEEEE-----ccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecC-c
Q 036739 2 DQYEKVEKIGEGTYGVVYKARN-----CVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE-K 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~ 74 (323)
++|++.+.||+|++|+||+|.+ ..+++.||+|++.... .......+.+|+.+++.+ +||||+++++++... .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 5899999999999999999985 3466899999985432 222335678899999999 689999999998765 4
Q ss_pred eEEEEEecchh-hHHHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPD--------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT 139 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~ 139 (323)
.+++||||+.| +|.+.+..... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence 59999999975 88888776543 1268888999999999999999999999999999999999888
Q ss_pred CceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHH
Q 036739 140 NALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSV 219 (323)
Q Consensus 140 ~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 219 (323)
. +||+|||.+........... .....||+.|+|||.+.+ ..++.++|+|||
T Consensus 186 ~-~kl~Dfg~~~~~~~~~~~~~---------------------------~~~~~~t~~y~aPE~~~~-~~~~~~~Di~sl 236 (316)
T 2xir_A 186 V-VKICDFGLARDIYKDPDYVR---------------------------KGDARLPLKWMAPETIFD-RVYTIQSDVWSF 236 (316)
T ss_dssp C-EEECCCGGGSCTTTCTTSEE---------------------------ETTEEECGGGCCHHHHHH-CCCCHHHHHHHH
T ss_pred C-EEECCCccccccccCcccee---------------------------ccCCCcceeecCchhhcc-ccccchhHHHHH
Confidence 7 99999999976543221110 111245788999999987 568999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcc
Q 036739 220 GCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298 (323)
Q Consensus 220 G~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~ 298 (323)
|+++|+|++ |..||......+............ .....+++.+.++|.+||+
T Consensus 237 G~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~ 289 (316)
T 2xir_A 237 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWH 289 (316)
T ss_dssp HHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCCCCcccchhHHHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcC
Confidence 999999998 999998876555544333321111 1113468899999999999
Q ss_pred cCCCCCCCHhhhhcC
Q 036739 299 MDPSRRITARSALEH 313 (323)
Q Consensus 299 ~dp~~R~s~~~il~h 313 (323)
.||++||++.++++|
T Consensus 290 ~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 290 GEPSQRPTFSELVEH 304 (316)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=324.27 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=204.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||.||++.+. ++..||+|++.... ...+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 57899999999999999999984 57789999986432 23578899999999999999999999986 567899999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+ +|.+.+.......++...+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++..........
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV-CKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC-EEECSTTGGGGBCCHHHHT
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc-EEEeeCCCceEcCCCceec
Confidence 9965 8888887554445688889999999999999999999999999999999998887 9999999997653221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
. ....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+....
T Consensus 342 ~----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~ 392 (454)
T 1qcf_A 342 R----------------------------EGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392 (454)
T ss_dssp T----------------------------CSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred c----------------------------CCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 0 01133678999999987 568999999999999999999 99999988877
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+.+....+ ....+++.+.++|.+||+.||++||++.+|++
T Consensus 393 ~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 393 EVIRALERGYRMP----------------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 7766655432111 11347889999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=311.70 Aligned_cols=254 Identities=20% Similarity=0.321 Sum_probs=204.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc-----eEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE-----TIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|+||.||++.+..++. .||+|.+.... .......+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 579999999999999999999876654 79999885432 222346788999999999 89999999999999999
Q ss_pred EEEEEecchh-hHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCce
Q 036739 76 LYLVFEYLDL-DLKKHMDSCP------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNAL 142 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~ 142 (323)
.++||||+.| +|.+.+.... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-~ 203 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV-A 203 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE-E
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe-E
Confidence 9999999975 8888776432 235688899999999999999999999999999999999998886 9
Q ss_pred EEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHH
Q 036739 143 KLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCI 222 (323)
Q Consensus 143 kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~l 222 (323)
||+|||++.......... ......+++.|+|||.+.+ ..++.++||||||++
T Consensus 204 kl~Dfg~~~~~~~~~~~~---------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~i 255 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYI---------------------------VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGIL 255 (333)
T ss_dssp EBCCCGGGCCGGGCTTSE---------------------------ECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHH
T ss_pred EECcccccccccccccee---------------------------ecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHH
Confidence 999999997653221110 0111245788999999987 568999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCC
Q 036739 223 FAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301 (323)
Q Consensus 223 l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp 301 (323)
+|+|++ |..||.................... .....++.+.++|.+||+.||
T Consensus 256 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p 308 (333)
T 2i1m_A 256 LWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA---------------------------QPAFAPKNIYSIMQACWALEP 308 (333)
T ss_dssp HHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHcCCCCCCcccchhHHHHHHHhcCCCCC---------------------------CCCCCCHHHHHHHHHHhccCh
Confidence 999998 9999988766555554443321110 112367889999999999999
Q ss_pred CCCCCHhhhhc
Q 036739 302 SRRITARSALE 312 (323)
Q Consensus 302 ~~R~s~~~il~ 312 (323)
.+||++.++++
T Consensus 309 ~~Rps~~~l~~ 319 (333)
T 2i1m_A 309 THRPTFQQICS 319 (333)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=302.54 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=201.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|.||++.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 57999999999999999999974 56789999885332 23578889999999999999999999986 456899999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+.......+++..+..++.|++.||.+||+.|++|+||||+||+++.++. +||+|||.+..........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECSSSCEEC
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC-EEECCCcccccccCccccc
Confidence 9965 8887776543335788899999999999999999999999999999999998887 9999999998765332211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus 167 ~~----------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 217 (279)
T 1qpc_A 167 RE----------------------------GAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217 (279)
T ss_dssp CT----------------------------TCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred cc----------------------------CCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH
Confidence 11 1133778999999986 567899999999999999999 99999888776
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+....+.+.... .....+++.+.++|.+||+.||++||++.++++
T Consensus 218 ~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 218 EVIQNLERGYRM----------------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcccCC----------------------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 655544332100 111347889999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=307.63 Aligned_cols=255 Identities=20% Similarity=0.263 Sum_probs=196.6
Q ss_pred CCcceeeeeccccceeEEEEEEcc---CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc----
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV---TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK---- 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 74 (323)
++|++.+.||+|++|.||+|+... ++..||+|.+............+.+|+.++++++||||+++++++.+..
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 579999999999999999998765 3458999998655444434567889999999999999999999997654
Q ss_pred -eEEEEEecchh-hHHHhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccc
Q 036739 75 -KLYLVFEYLDL-DLKKHMDS----CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148 (323)
Q Consensus 75 -~~~lv~e~~~g-~l~~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~ 148 (323)
..++||||+.+ +|.+.+.. .....+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~-~kl~Dfg 192 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT-VCVADFG 192 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC-EEECSCS
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc-EEEeecC
Confidence 45999999976 77777643 22346789999999999999999999999999999999999998887 9999999
Q ss_pred cceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh
Q 036739 149 LARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN 228 (323)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t 228 (323)
.+........... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++
T Consensus 193 ~~~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~ 244 (313)
T 3brb_A 193 LSKKIYSGDYYRQ---------------------------GRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIAT 244 (313)
T ss_dssp CC-------------------------------------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHT
T ss_pred cceecccccccCc---------------------------ccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHh
Confidence 9876543221110 001234778999999987 668999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH
Q 036739 229 -QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 229 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
|..||......+....+..... ......+++.+.++|.+||+.||++||++
T Consensus 245 ~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 296 (313)
T 3brb_A 245 RGMTPYPGVQNHEMYDYLLHGHR----------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTF 296 (313)
T ss_dssp TSCCSSTTCCGGGHHHHHHTTCC----------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred cCCCCCccCCHHHHHHHHHcCCC----------------------------CCCCccccHHHHHHHHHHcCCChhhCcCH
Confidence 8999988877666655443211 01123478899999999999999999999
Q ss_pred hhhhcC
Q 036739 308 RSALEH 313 (323)
Q Consensus 308 ~~il~h 313 (323)
.+++++
T Consensus 297 ~~l~~~ 302 (313)
T 3brb_A 297 SVLRLQ 302 (313)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=309.61 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=203.8
Q ss_pred CCcceeeeeccccceeEEEEEEc-------cCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecC
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 73 (323)
++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++++ +||||+++++++.+.
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 68999999999999999999975 356789999885332 222345678899999999 899999999999999
Q ss_pred ceEEEEEecchh-hHHHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC
Q 036739 74 KKLYLVFEYLDL-DLKKHMDSCPD--------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138 (323)
Q Consensus 74 ~~~~lv~e~~~g-~l~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~ 138 (323)
+..++||||+.| +|.+.+..... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 193 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC
Confidence 999999999976 88888765432 247888899999999999999999999999999999999988
Q ss_pred CCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 139 TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 139 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
+. +||+|||++............ ....+++.|+|||.+.+ ..++.++||||
T Consensus 194 ~~-~kL~Dfg~~~~~~~~~~~~~~---------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~s 244 (334)
T 2pvf_A 194 NV-MKIADFGLARDINNIDYYKKT---------------------------TNGRLPVKWMAPEALFD-RVYTHQSDVWS 244 (334)
T ss_dssp CC-EEECCCTTCEECTTTSSEECC---------------------------SCCCCCGGGCCHHHHHH-CEECHHHHHHH
T ss_pred CC-EEEcccccccccccccccccc---------------------------CCCCcccceeChHHhcC-CCcChHHHHHH
Confidence 87 999999999876433211100 01134778999999987 56899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 219 VGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 219 lG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
||+++|+|++ |..||......+....+...... .....+++.+.++|.+||
T Consensus 245 lG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l 296 (334)
T 2pvf_A 245 FGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM----------------------------DKPANCTNELYMMMRDCW 296 (334)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHc
Confidence 9999999999 99999888766655544432110 112347889999999999
Q ss_pred ccCCCCCCCHhhhhcC
Q 036739 298 CMDPSRRITARSALEH 313 (323)
Q Consensus 298 ~~dp~~R~s~~~il~h 313 (323)
+.||++||++.+++++
T Consensus 297 ~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 297 HAVPSQRPTFKQLVED 312 (334)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999873
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=304.72 Aligned_cols=258 Identities=19% Similarity=0.205 Sum_probs=198.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEE-ecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-HSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~ 80 (323)
++|++.+.||+|++|+||++++..+++.||+|++.... ....+.+|+.+++.++|++++..+..+ .+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 68999999999999999999999999999999865432 234678899999999987766655554 6778899999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---ecCCCceEEeccccceecCCCc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLI---DRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~---~~~~~~~kl~df~~~~~~~~~~ 157 (323)
|+++++|.+.+..... .+++..+..++.||+.||.|||+.|++|+||||+||++ +.++. +||+|||.+.......
T Consensus 85 e~~~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~-~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 85 ELLGPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL-VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp ECCCCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC-EEECCCTTCEECBCTT
T ss_pred EccCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe-EEEecCccceeccCcc
Confidence 9997788888875433 57899999999999999999999999999999999999 66666 9999999998765443
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
....... .......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus 163 ~~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 163 THQHIPY----------------------RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TCCBCCC----------------------CCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cCccCCC----------------------CcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 3211100 00112356999999999988 568999999999999999999999997643
Q ss_pred hH---HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 238 EI---DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 238 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.. .....+....... ........+++.+.++|.+||+.||++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 220 AATKRQKYERISEKKMST------------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CSSSSSHHHHHHHHHHHS------------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhhhhhhhcccccc------------------------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 32 2222222110000 011122457899999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=303.14 Aligned_cols=251 Identities=20% Similarity=0.270 Sum_probs=198.4
Q ss_pred CCcceeeeeccccceeEEEEEEccC---CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT---NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|++|+||++++... +..||+|.+.... .....+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 6899999999999999999986543 3369999875432 222346788899999999999999999998654 5689
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
|||++.| +|.+.+.... ..+++..+..++.||+.||.+||++|++|+||||+||+++.++. +||+|||.+.......
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC-VKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE-EEECCCCGGGCC----
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc-EEeCccCCCccccccc
Confidence 9999975 7777775533 35788899999999999999999999999999999999998886 9999999987654322
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
.... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...
T Consensus 168 ~~~~----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 168 YYKA----------------------------SVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp ---------------------------------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccc----------------------------ccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 1110 01134778999999987 568999999999999999998 99999877
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
...+....+...... .....+++.+.++|.+||+.||++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 219 ENKDVIGVLEKGDRL----------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CGGGHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 766665544432111 1113478899999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=299.38 Aligned_cols=258 Identities=19% Similarity=0.202 Sum_probs=200.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEE-ecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-HSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~ 80 (323)
++|++.+.||+|++|.||++++..+++.||+|++.... ....+.+|+.+++.++|++++..+..+ ......++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 68999999999999999999999999999999885432 235788999999999987765555544 6678889999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEe---cCCCceEEeccccceecCCCc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLID---RRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~---~~~~~~kl~df~~~~~~~~~~ 157 (323)
||++++|.+.+..... .+++..+..++.||+.||.|||++|++|+||||+||+++ .++. +||+|||.+.......
T Consensus 85 e~~~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~-~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 85 ELLGPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL-VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp ECCCCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC-EEECCCTTCEECBCTT
T ss_pred EecCCCHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe-EEEeeCCCcccccccc
Confidence 9997788888874433 579999999999999999999999999999999999995 5555 9999999998765443
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
....... .......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus 163 ~~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 163 THQHIPY----------------------RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TCCBCCC----------------------CCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccc----------------------ccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 3211100 00112356999999999988 568999999999999999999999998643
Q ss_pred h---HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 238 E---IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 238 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
. .+....+....... ........+++.+.++|.+||+.||++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 220 AATKRQKYERISEKKMST------------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CSSSSSHHHHHHHHHHHS------------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chhhhhhhhhhcccccCC------------------------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 2 22222222210000 001122457899999999999999999999999886
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=311.23 Aligned_cols=266 Identities=16% Similarity=0.115 Sum_probs=194.9
Q ss_pred CCcceeeeeccccceeEEEEEEcc---CCceEEEEEEEecccC---------CCCchhHHHHHHHHHhcCCCCeeeeeEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV---TNETIALKKIRLEQED---------EGVPSTAIREISLLKEMQHGNIVRLQDV 69 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 69 (323)
++|++.+.||+|+||.||+|++.. ++..+|+|++...... ......+.+|+..++.+.||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999977 7889999998654211 0122345677888899999999999999
Q ss_pred Eec----CceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC--CceE
Q 036739 70 VHS----EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALK 143 (323)
Q Consensus 70 ~~~----~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~--~~~k 143 (323)
+.+ ....++||||++++|.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++ . +|
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~-~k 193 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ-VY 193 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS-EE
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc-EE
Confidence 987 78999999999668888876654 678999999999999999999999999999999999999876 5 99
Q ss_pred EeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHH
Q 036739 144 LADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIF 223 (323)
Q Consensus 144 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll 223 (323)
|+|||++..+............ ......||+.|+|||.+.+ ..++.++||||||+++
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~----------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il 250 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQEN----------------------PRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCM 250 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCC----------------------GGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHH
T ss_pred EEeCCCceecccccccccchhc----------------------cccccCCCccccCHHHhcC-CCCCchhhHHHHHHHH
Confidence 9999999876532211110000 0012356999999999988 5689999999999999
Q ss_pred HHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCC
Q 036739 224 AEMVNQRPLFPGDS-EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 224 ~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~ 302 (323)
|+|++|..||.... .................... . . ......+++.+.++|.+||+.||+
T Consensus 251 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~---~------~~~~~~~~~~l~~li~~~l~~dp~ 311 (345)
T 2v62_A 251 LRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSV----------L---K------WAPSGSSCCEIAQFLVCAHSLAYD 311 (345)
T ss_dssp HHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHH----------H---H------HSCTTSCCHHHHHHHHHHHTCCTT
T ss_pred HHHHhCCCCccccccccHHHHHHHHhhcccccHHH----------H---h------hccccccHHHHHHHHHHHhhcCcc
Confidence 99999999996532 22222221111100000000 0 0 000125788999999999999999
Q ss_pred CCCCHhhhhc
Q 036739 303 RRITARSALE 312 (323)
Q Consensus 303 ~R~s~~~il~ 312 (323)
+||++.++++
T Consensus 312 ~Rps~~~l~~ 321 (345)
T 2v62_A 312 EKPNYQALKK 321 (345)
T ss_dssp CCCCHHHHHH
T ss_pred cCCCHHHHHH
Confidence 9999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=303.75 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=192.7
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|++|.||++.+..++..||+|++.... ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 368999999999999999999999999999999986432 2223346778899999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 80 FEYLDL-DLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
||++.| +|.+.+.. .....+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. +||+|||++......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~-~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSK 189 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCC---------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC-EEEEeccceeeecCC
Confidence 999976 77776653 22345788999999999999999999999999999999999998887 999999998765322
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.... ....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus 190 ~~~~-----------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 190 TTAA-----------------------------HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp --------------------------------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred Cccc-----------------------------cccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 1110 01245888999999987 56899999999999999999999999765
Q ss_pred ChH-HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEI-DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
... ............+ ......+++.+.++|.+||+.||++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 240 KMNLYSLCKKIEQCDYP--------------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp -CCHHHHHHHHHTTCSC--------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhHHHHHHHhhcccCC--------------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 322 1222211110000 0011347889999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=304.05 Aligned_cols=254 Identities=23% Similarity=0.315 Sum_probs=197.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCC---ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEE-ecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTN---ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-HSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~ 77 (323)
.+|++.+.||+|+||+||+|++..++ ..+++|.+... ........+.+|+.++++++||||+++++++ ..++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 36899999999999999999865433 35888877432 2222346778999999999999999999985 4567889
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+||||++| +|.+.+... ...+++..+..++.|++.||.+||+.|++|+||||+||+++.++. +||+|||.+......
T Consensus 104 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDK 181 (298)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC-EEECSCGGGCCCSCG
T ss_pred EEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC-EEECccccccccccc
Confidence 99999987 777777553 345788889999999999999999999999999999999998887 999999999766433
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
........ ....+|+.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||..
T Consensus 182 ~~~~~~~~-------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 182 EYYSVHNK-------------------------TGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp GGCBC------------------------------CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred chhccccc-------------------------cCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 22111111 11244788999999987 568999999999999999999 6677777
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
....+....+.+.... .....+++.+.++|.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 236 VNTFDITVYLLQGRRL----------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp SCTTTHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6665555544432111 111346788999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=304.15 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=198.7
Q ss_pred CCcceeeeeccccceeEEEEE----EccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC--ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 75 (323)
++|++.+.||+|++|.||+|+ +..+++.||+|++.... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 468999999999999999998 56788999999986543 334457888999999999999999999999876 67
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
+++||||+.| +|.+.+.... ..+++..+..++.||+.||++||+.|++|+||||+||+++.++. ++|+|||.+....
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE-EEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC-EEECccccccccc
Confidence 8999999976 7877775443 35788999999999999999999999999999999999998887 9999999998765
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
........ .....||..|+|||.+.+ ..++.++|+||||+++|+|++|..|+.
T Consensus 178 ~~~~~~~~--------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 178 TDKEYYTV--------------------------KDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp TTCCEEEC--------------------------CCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCCcceec--------------------------cCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 44322111 111245788999999987 567899999999999999999998864
Q ss_pred CCCh-----------HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC
Q 036739 235 GDSE-----------IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303 (323)
Q Consensus 235 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~ 303 (323)
.... ............. .........+++.+.++|.+||+.||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~ 286 (302)
T 4e5w_A 231 SPMALFLKMIGPTHGQMTVTRLVNTLKE------------------------GKRLPCPPNCPDEVYQLMRKCWEFQPSN 286 (302)
T ss_dssp SHHHHHHHHHCSCCGGGHHHHHHHHHHT------------------------TCCCCCCTTCCHHHHHHHHHTTCSSGGG
T ss_pred chhhHHhhccCCcccccCHHHHHHHHhc------------------------cCCCCCCCCCCHHHHHHHHHHcCCCCCC
Confidence 3211 0111111111000 0011122457899999999999999999
Q ss_pred CCCHhhhhc
Q 036739 304 RITARSALE 312 (323)
Q Consensus 304 R~s~~~il~ 312 (323)
||++.++++
T Consensus 287 Rps~~~ll~ 295 (302)
T 4e5w_A 287 RTSFQNLIE 295 (302)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHHH
Confidence 999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=309.86 Aligned_cols=267 Identities=22% Similarity=0.313 Sum_probs=200.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|++|+||++++ .++..||+|++..... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 107 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 107 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence 6899999999999999999985 4688999999865432 2233478899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 82 YLDL-DLKKHMDSCPD--FANDPRLIKTFLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
|+.| +|.+.+..... ..+++..+..++.|++.||.|||+. |++|+||||+||+++.++. +||+|||++.....
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~ 186 (326)
T 3uim_A 108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-AVVGDFGLAKLMDY 186 (326)
T ss_dssp CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC-EEECCCSSCEECCS
T ss_pred eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC-EEeccCccccccCc
Confidence 9976 88877766443 3478889999999999999999999 9999999999999998887 99999999987643
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
...... ....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 187 ~~~~~~----------------------------~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (326)
T 3uim_A 187 KDTHVT----------------------------TAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL 237 (326)
T ss_dssp SSSCEE----------------------------CCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred cccccc----------------------------ccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccc
Confidence 322211 11246899999999977 5589999999999999999999999952
Q ss_pred CC----hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhh
Q 036739 236 DS----EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSAL 311 (323)
Q Consensus 236 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il 311 (323)
.. ............ .......... ............++.+.+++.+||+.||++|||+.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 303 (326)
T 3uim_A 238 ARLANDDDVMLLDWVKGL--LKEKKLEALV------------DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303 (326)
T ss_dssp HHHTTTSCSBHHHHHTTT--TSSCCSTTSS------------CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHH
T ss_pred cccccccchhHHHHHHHH--hhchhhhhhc------------ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHH
Confidence 11 100111111100 0000000000 00001112223457799999999999999999999999
Q ss_pred cCC
Q 036739 312 EHE 314 (323)
Q Consensus 312 ~h~ 314 (323)
+|-
T Consensus 304 ~~L 306 (326)
T 3uim_A 304 RML 306 (326)
T ss_dssp HHH
T ss_pred HHh
Confidence 864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=321.76 Aligned_cols=271 Identities=21% Similarity=0.314 Sum_probs=201.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc--eEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK--KLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv 79 (323)
++|++.+.||+|+||+||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.. ..++|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 579999999999999999999999999999999864432 233567789999999999999999999998654 78999
Q ss_pred Eecchh-hHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----ecCCCceEEeccccceec
Q 036739 80 FEYLDL-DLKKHMDSCP-DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLI----DRRTNALKLADFGLARAF 153 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~----~~~~~~~kl~df~~~~~~ 153 (323)
|||+.| +|.+.+.... ...+++..+..++.||+.||.|||++||+|+||||+||++ +.++ .+||+|||.+...
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~a~~~ 166 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAAREL 166 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE-EEEECCGGGCEEC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce-eEEEecCCCceEc
Confidence 999975 7777776533 2337899999999999999999999999999999999998 4444 4999999999876
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-------CCCCCchhhHHHHHHHHHH
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-------RHYSTPVDVWSVGCIFAEM 226 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-------~~~~~~~Di~slG~ll~~l 226 (323)
....... ...||+.|+|||.+... ..++.++|||||||++|+|
T Consensus 167 ~~~~~~~------------------------------~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el 216 (396)
T 4eut_A 167 EDDEQFV------------------------------SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (396)
T ss_dssp CCGGGSS------------------------------CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCccc------------------------------cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence 4322111 12458999999998641 3467799999999999999
Q ss_pred HhCCCCCCCCC----hHHHHHHHHHHhCCCCCCCCCCcccC----CcccccCCCCCCCcccccccCCChHHHHHHHhhcc
Q 036739 227 VNQRPLFPGDS----EIDELFKIFRVLGTPNEDTWPGVTSL----PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298 (323)
Q Consensus 227 ~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~ 298 (323)
++|..||.... ..+....+.... ....+...... ..|...... .......+++.+.++|++||+
T Consensus 217 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~~~~~~l~~ll~~~L~ 288 (396)
T 4eut_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGK---PSGAISGVQKAENGPIDWSGDMPV-----SCSLSRGLQVLLTPVLANILE 288 (396)
T ss_dssp HHSSCSEECTTCTTTCHHHHHHHHHSC---CTTCCEEEECSTTCCEEEESSCCT-----TCSSCHHHHHHHHHHHHHHSC
T ss_pred HHCCCCCCCCCcccchHHHHHHHhcCC---CcccchhheeccCCCcccCccCCc-----ccccchHHHhhchHHHHHhhc
Confidence 99999997533 233344443321 11111111100 001111111 112223456778999999999
Q ss_pred cCCCCCCCHhhhhc
Q 036739 299 MDPSRRITARSALE 312 (323)
Q Consensus 299 ~dp~~R~s~~~il~ 312 (323)
.||++||++.++++
T Consensus 289 ~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 289 ADQEKCWGFDQFFA 302 (396)
T ss_dssp CCTTTSCCHHHHHH
T ss_pred cChhhhccHHHHHH
Confidence 99999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=301.03 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=195.8
Q ss_pred CcceeeeeccccceeEEEEEEccCCc---eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE-EE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL-YL 78 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~l 78 (323)
.|++.+.||+|+||+||+|++..++. .+|+|.+... ......+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35667999999999999999755554 7999987432 2222346778999999999999999999999866554 99
Q ss_pred EEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
++|++. |+|.+.+... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++. +||+|||.+.......
T Consensus 101 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~-~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT-VKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC-EEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc-EEeCcCCCcccccCCc
Confidence 999996 4777777653 345788889999999999999999999999999999999998887 9999999997654322
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhC-CCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ-RPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg-~~p~~~~ 236 (323)
...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++| .+||...
T Consensus 179 ~~~~~~-------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~ 232 (298)
T 3pls_A 179 YYSVQQ-------------------------HRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232 (298)
T ss_dssp GGCSCC-------------------------SSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred cccccc-------------------------CcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccC
Confidence 111110 011244888999999987 5689999999999999999995 5556655
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+....+...... .....+++.+.++|.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 233 DPFDLTHFLAQGRRL----------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHhhcCCCC----------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 555544444322111 112347889999999999999999999999886
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=302.30 Aligned_cols=243 Identities=23% Similarity=0.370 Sum_probs=193.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec-CceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 80 (323)
++|++.+.||+|++|+||++.+ ++..||+|++... ...+.+.+|+.+++.++||||+++++++.+ .+..++||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 6899999999999999999986 5889999988532 245778899999999999999999999755 45789999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+.......+++..+..++.|++.||.+||++|++|+||||+||+++.++. ++|+|||.+.........
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~~ 173 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQDT 173 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC-EEECCCCC----------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc-EEEeeccccccccccccC
Confidence 99976 8888887644334688889999999999999999999999999999999998887 999999988654322111
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCCh
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSE 238 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~ 238 (323)
..+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.....
T Consensus 174 --------------------------------~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 220 (278)
T 1byg_A 174 --------------------------------GKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220 (278)
T ss_dssp ----------------------------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred --------------------------------CCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 133778999999987 568999999999999999998 9999988766
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.+....+.... .......+++.+.++|.+||+.||++||++.++++
T Consensus 221 ~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 221 KDVVPRVEKGY----------------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp GGHHHHHTTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCC----------------------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 55554432210 01112357899999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=311.20 Aligned_cols=267 Identities=13% Similarity=0.126 Sum_probs=194.3
Q ss_pred CCcceeeeeccccceeEEEEEEccC-----CceEEEEEEEecccC---------CCCchhHHHHHHHHHhcCCCCeeeee
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT-----NETIALKKIRLEQED---------EGVPSTAIREISLLKEMQHGNIVRLQ 67 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~aiK~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~ 67 (323)
++|++.+.||+|+||+||+|.+..+ ++.||+|++...... ......+..++..++.+.||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4899999999999999999998664 578999998643210 00112233455556677899999999
Q ss_pred EEEecC----ceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEe--cCCCc
Q 036739 68 DVVHSE----KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNA 141 (323)
Q Consensus 68 ~~~~~~----~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~--~~~~~ 141 (323)
+++... ...++||||++++|.+.+... ...+++..+..++.||+.||.|||+.||+|+||||+||+++ .++.
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~- 192 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRFGSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ- 192 (364)
T ss_dssp EEEEEEETTEEEEEEEEECEEEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC-
T ss_pred eeeeeccCCcceEEEEEeCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe-
Confidence 998764 568999999977888887764 33589999999999999999999999999999999999998 6666
Q ss_pred eEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHH
Q 036739 142 LKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGC 221 (323)
Q Consensus 142 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 221 (323)
+||+|||++..+............. .....||+.|+|||.+.+ ..++.++|||||||
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~----------------------~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~ 249 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADP----------------------KRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGY 249 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCS----------------------SCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHH
T ss_pred EEEEECCcceecccCCcccccccCc----------------------ccccCCCCCccCHHHhCC-CCCCchhhHHHHHH
Confidence 9999999998765332211111000 012356999999999987 56899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccC
Q 036739 222 IFAEMVNQRPLFPGDSEIDELFK-IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300 (323)
Q Consensus 222 ll~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~d 300 (323)
++|+|++|..||........... .......... .+... ......+++.+.+++..||+.|
T Consensus 250 ~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~---------~~~~~~~~~~~~~li~~cl~~~ 310 (364)
T 3op5_A 250 CMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIA----------SLMDK---------CFPAANAPGEIAKYMETVKLLD 310 (364)
T ss_dssp HHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHH----------HHHHH---------HSCTTCCCHHHHHHHHHHHTCC
T ss_pred HHHHHHhCCCCccccccCHHHHHHHHHHhhhhHH----------HHHHH---------hcccccCHHHHHHHHHHHhcCC
Confidence 99999999999986433222221 1111000000 00000 0001347889999999999999
Q ss_pred CCCCCCHhhhhc
Q 036739 301 PSRRITARSALE 312 (323)
Q Consensus 301 p~~R~s~~~il~ 312 (323)
|++||++.++++
T Consensus 311 p~~RP~~~~l~~ 322 (364)
T 3op5_A 311 YTEKPLYENLRD 322 (364)
T ss_dssp TTCCCCHHHHHH
T ss_pred CCCCCCHHHHHH
Confidence 999999998875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=321.44 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=203.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||.||++.+. .+..||+|++.... ...+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 57899999999999999999985 45679999985432 234678999999999999999999999866 67899999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+.......+++..+..++.||+.||+|||++|++|+||||+||+++.++. +||+|||++..........
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCCCTTC---------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC-EEECCCccceecCCCceec
Confidence 9975 8888886544445788899999999999999999999999999999999998887 9999999997654221110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
. ....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+....
T Consensus 338 ~----------------------------~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 388 (452)
T 1fmk_A 338 R----------------------------QGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388 (452)
T ss_dssp ---------------------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred c----------------------------cCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 0 01134678999999987 568999999999999999999 99999988877
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc--CCCCc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE--HEYFR 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~--h~~~~ 317 (323)
+....+.+.... +....+++.+.++|.+||+.||++||++.++++ ..++.
T Consensus 389 ~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 389 EVLDQVERGYRM----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 666555432111 112347889999999999999999999999987 46655
Q ss_pred cc
Q 036739 318 DV 319 (323)
Q Consensus 318 ~~ 319 (323)
..
T Consensus 441 ~~ 442 (452)
T 1fmk_A 441 ST 442 (452)
T ss_dssp CS
T ss_pred cC
Confidence 43
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=306.12 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=199.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
.++|++.+.||+|++|+||++.+. ..+++|++............+.+|+.++++++||||+++++++.+.+..++|+
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWH---GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEES---SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEc---CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 368999999999999999999864 35999998766555556677889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||+.| +|.+.+... ...+++..+..++.||+.||.+||+.|++|+||||+||+++ ++. +||+|||++.........
T Consensus 109 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~-~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK-VVITDFGLFSISGVLQAG 185 (319)
T ss_dssp BCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C-CEECCCSCCC--------
T ss_pred ecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCC-EEEeecCCcccccccccc
Confidence 99975 676666543 34578888999999999999999999999999999999998 455 999999997655322211
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--------CCCCCCchhhHHHHHHHHHHHhCCC
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--------SRHYSTPVDVWSVGCIFAEMVNQRP 231 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~~Di~slG~ll~~l~tg~~ 231 (323)
.... ......|++.|+|||.+.. ...++.++||||||+++|+|++|..
T Consensus 186 ~~~~------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 241 (319)
T 2y4i_B 186 RRED------------------------KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241 (319)
T ss_dssp --CC------------------------SCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccc------------------------ccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 1100 0111246899999999874 2457889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhh
Q 036739 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSAL 311 (323)
Q Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il 311 (323)
||...........+....... .....+++.+.++|.+||+.||++||++.+++
T Consensus 242 p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~ 294 (319)
T 2y4i_B 242 PFKTQPAEAIIWQMGTGMKPN---------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLM 294 (319)
T ss_dssp SSSSCCHHHHHHHHHTTCCCC---------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCCCCCHHHHHHHhccCCCCC---------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 998887766555443211000 00124678899999999999999999999998
Q ss_pred c
Q 036739 312 E 312 (323)
Q Consensus 312 ~ 312 (323)
+
T Consensus 295 ~ 295 (319)
T 2y4i_B 295 D 295 (319)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=309.59 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=191.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC----ceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE----KKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~ 77 (323)
++|++.+.||+|+||+||+|++ .++.||+|++..... .......|+.++++++||||+++++++.+. ..++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhchhhheecccCceEEEEEEE--CCCEEEEEEeecCch---HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 6899999999999999999986 478999999854321 224555688889999999999999999764 3579
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccCCCCCCcEEEecCCCceEEec
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH----------RVLHRDLKPQNLLIDRRTNALKLAD 146 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----------~i~H~dl~~~Nil~~~~~~~~kl~d 146 (323)
+||||+.+ +|.+.+... .+++..+..++.||+.||.|||+. |++|+||||+||+++.++. +||+|
T Consensus 99 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~-~kL~D 174 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT-ACIAD 174 (322)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC-EEECC
T ss_pred EEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe-EEEcc
Confidence 99999976 888887654 478899999999999999999999 9999999999999998887 99999
Q ss_pred cccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC----CCCCCchhhHHHHHH
Q 036739 147 FGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS----RHYSTPVDVWSVGCI 222 (323)
Q Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~~Di~slG~l 222 (323)
||.+............ ....||+.|+|||.+.+. ..++.++|||||||+
T Consensus 175 Fg~a~~~~~~~~~~~~---------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i 227 (322)
T 3soc_A 175 FGLALKFEAGKSAGDT---------------------------HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227 (322)
T ss_dssp CTTCEEECTTSCCCCC---------------------------TTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHH
T ss_pred CCcccccccccCcccc---------------------------ccCccCccccCHhhcccccccCcCCCccchhHHHHHH
Confidence 9999776543221110 112569999999999863 234557899999999
Q ss_pred HHHHHhCCCCCCCCChHHH------------HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccc--cccCCChH
Q 036739 223 FAEMVNQRPLFPGDSEIDE------------LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGT--VVRNLEPA 288 (323)
Q Consensus 223 l~~l~tg~~p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~ 288 (323)
+|+|++|..||.+...... ............. ...... .....++.
T Consensus 228 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~ 287 (322)
T 3soc_A 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK--------------------RPVLRDYWQKHAGMAM 287 (322)
T ss_dssp HHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC--------------------CCCCCGGGGSSHHHHH
T ss_pred HHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccC--------------------CCCccccccccchHHH
Confidence 9999999999976432111 0011110000000 000000 00113456
Q ss_pred HHHHHHhhcccCCCCCCCHhhhhc
Q 036739 289 GIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 289 ~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+.++|.+||+.||++|||+.++++
T Consensus 288 l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 288 LCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHH
Confidence 899999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=308.34 Aligned_cols=261 Identities=21% Similarity=0.318 Sum_probs=184.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEe--------c
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVH--------S 72 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--------~ 72 (323)
.+|++.+.||+|+||.||++++..+++.||+|++.... ......+.+|+.+++++. ||||+++++++. .
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 37999999999999999999999999999999885442 223456788999999996 999999999983 4
Q ss_pred CceEEEEEecchhhHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEecCCCceEEecccc
Q 036739 73 EKKLYLVFEYLDLDLKKHMDS-CPDFANDPRLIKTFLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGL 149 (323)
Q Consensus 73 ~~~~~lv~e~~~g~l~~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~~~Nil~~~~~~~~kl~df~~ 149 (323)
...+++++||++|+|.+.+.. .....+++..+..++.||+.||.|||+.| ++|+||||+||+++.++. +||+|||.
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~ 184 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT-IKLCDFGS 184 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC-EEBCCCTT
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC-EEEecCcc
Confidence 567899999999999888865 22335799999999999999999999999 999999999999998887 99999999
Q ss_pred ceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhh--CCCCCCCchhhHHHHHHHHHHH
Q 036739 150 ARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILL--GSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~~Di~slG~ll~~l~ 227 (323)
+................. .........||+.|+|||.+. ....++.++||||||+++|+|+
T Consensus 185 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~ 247 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRA-----------------LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247 (337)
T ss_dssp CBCCSSCC------------------------------------------------CCTTSCSSHHHHHHHHHHHHHHHH
T ss_pred ceeccccCcccccccccc-----------------cchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHH
Confidence 987654322111000000 000011235689999999984 2356788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH
Q 036739 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 228 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
+|..||............ . ........++.+.++|.+||+.||++||++
T Consensus 248 ~g~~p~~~~~~~~~~~~~---~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 296 (337)
T 3ll6_A 248 FRQHPFEDGAKLRIVNGK---Y----------------------------SIPPHDTQYTVFHSLIRAMLQVNPEERLSI 296 (337)
T ss_dssp HSSCCC---------------C----------------------------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCH
T ss_pred hCCCCCcchhHHHhhcCc---c----------------------------cCCcccccchHHHHHHHHHccCChhhCcCH
Confidence 999999654432211100 0 001113356778999999999999999999
Q ss_pred hhhhcC
Q 036739 308 RSALEH 313 (323)
Q Consensus 308 ~~il~h 313 (323)
.++++|
T Consensus 297 ~e~l~~ 302 (337)
T 3ll6_A 297 AEVVHQ 302 (337)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=309.89 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=200.8
Q ss_pred CCcceeeeeccccceeEEEEE----EccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEe--cCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~ 75 (323)
++|++.+.||+|++|.||+++ +..++..||+|++.... ......+.+|+.++++++||||+++++++. +...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 689999999999999999998 56788999999985432 222356889999999999999999999986 4567
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
.++||||++| +|.+.+..... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH-VKIADFGLAKLLP 178 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE-EEECCGGGCEECC
T ss_pred EEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC-EEEcccccceecc
Confidence 9999999965 77777765332 4789999999999999999999999999999999999999887 9999999998765
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
......... ....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 179 ~~~~~~~~~--------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 179 LDKDYYVVR--------------------------EPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp TTCSEEECS--------------------------SCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cCCccceee--------------------------ccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 433221111 11245888999999987 567899999999999999999999986
Q ss_pred CCChHHHH-----------HHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCC
Q 036739 235 GDSEIDEL-----------FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSR 303 (323)
Q Consensus 235 ~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~ 303 (323)
........ ......... .........+++.+.++|.+||+.||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~ 287 (327)
T 3lxl_A 232 SPSAEFLRMMGCERDVPALSRLLELLEE------------------------GQRLPAPPACPAEVHELMKLCWAPSPQD 287 (327)
T ss_dssp SHHHHHHHHCC----CCHHHHHHHHHHT------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred cccchhhhhcccccccccHHHHHHHhhc------------------------ccCCCCCCcccHHHHHHHHHHcCCChhh
Confidence 54332110 111110000 0011223457899999999999999999
Q ss_pred CCCHhhhhcC
Q 036739 304 RITARSALEH 313 (323)
Q Consensus 304 R~s~~~il~h 313 (323)
||++.+++++
T Consensus 288 Rps~~ell~~ 297 (327)
T 3lxl_A 288 RPSFSALGPQ 297 (327)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=298.50 Aligned_cols=242 Identities=29% Similarity=0.412 Sum_probs=190.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||++.+ .++.||+|.+.. ......+.+|+.++++++||||+++++++.+ ..++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 5899999999999999999986 578899998742 2334678899999999999999999999864 4789999
Q ss_pred cchh-hHHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 82 YLDL-DLKKHMDSCPD-FANDPRLIKTFLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
|+.| +|.+.+..... ..++...+..++.||+.||.|||+ +|++|+||||+||+++.++..+||+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9975 88887765443 236788889999999999999999 899999999999999988876899999998654321
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.. ...||+.|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 160 ~~--------------------------------~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 160 MT--------------------------------NNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp -------------------------------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred cc--------------------------------cCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 11 1145889999999987 56899999999999999999999999765
Q ss_pred ChHHH--HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDE--LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
..... ....... . .......+++.+.++|.+||+.||++||++.++++
T Consensus 207 ~~~~~~~~~~~~~~--~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 207 GGPAFRIMWAVHNG--T--------------------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp CSSHHHHHHHHHTT--C--------------------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccHHHHHHHHhcC--C--------------------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 33221 1111110 0 11122457889999999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=336.07 Aligned_cols=283 Identities=25% Similarity=0.326 Sum_probs=204.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec------Cc
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS------EK 74 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~ 74 (323)
+++|++.+.||+|+||+||++.+..+|..||+|++... ........+.+|+.+++.++||||+++++++.. ++
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 47899999999999999999999999999999987543 222234667889999999999999999999765 67
Q ss_pred eEEEEEecchh-hHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC--ceEEeccccc
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCP-DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLA 150 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--~~kl~df~~~ 150 (323)
..++||||+.| +|.+.+.... ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. .+||+|||.+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 78999999965 8888776643 234677889999999999999999999999999999999987654 4899999999
Q ss_pred eecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 151 RAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
.......... ...||+.|+|||.+.+ ..++.++|+||||+++|+|++|.
T Consensus 172 ~~~~~~~~~~------------------------------~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~ 220 (676)
T 3qa8_A 172 KELDQGELCT------------------------------EFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGF 220 (676)
T ss_dssp CBTTSCCCCC------------------------------CCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSC
T ss_pred cccccccccc------------------------------cccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCC
Confidence 7654322111 1245889999999877 67899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh
Q 036739 231 PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA 310 (323)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i 310 (323)
.||................................+.... .........+++.+.++|.+||..||++||++.++
T Consensus 221 ~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~l-----p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 221 RPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVL-----PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp SSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSS-----CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred CCCCcccchhhhhhhhhcccchhhhhhhhhcccccccccc-----CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 9998764432211100000000000000000000000000 01112334477889999999999999999999999
Q ss_pred hcCCCCcccc
Q 036739 311 LEHEYFRDVE 320 (323)
Q Consensus 311 l~h~~~~~~~ 320 (323)
++||||+.++
T Consensus 296 L~hp~F~~l~ 305 (676)
T 3qa8_A 296 PNVGCFQALD 305 (676)
T ss_dssp CCCTTHHHHH
T ss_pred hcCHHHHHHH
Confidence 9999998763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=324.00 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=206.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||.||++.+. .+..||+|++.... ...+.+.+|+.+++.++|+||+++++++.+ +..++|||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 57899999999999999999985 45679999986432 234678999999999999999999999866 67899999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+ +|.+++.......+++..+..++.||+.||.|||++||+|+||||+|||++.++. +||+|||++..........
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCTTSTTTCCCHHHHT
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc-EEEcccccceecCCCceec
Confidence 9975 8888886544445788899999999999999999999999999999999998887 9999999987653211110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
. ....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||......
T Consensus 421 ~----------------------------~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~ 471 (535)
T 2h8h_A 421 R----------------------------QGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471 (535)
T ss_dssp T----------------------------CSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH
T ss_pred c----------------------------cCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 0 01133678999999987 568999999999999999999 99999988877
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc--CCCCc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE--HEYFR 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~--h~~~~ 317 (323)
+....+.+.... .....+++.+.+||.+||+.||++||++.+|++ ..+|.
T Consensus 472 ~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 472 EVLDQVERGYRM----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 666655432111 111347889999999999999999999999987 35665
Q ss_pred cc
Q 036739 318 DV 319 (323)
Q Consensus 318 ~~ 319 (323)
..
T Consensus 524 ~~ 525 (535)
T 2h8h_A 524 ST 525 (535)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=311.40 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=189.8
Q ss_pred CcceeeeeccccceeEEEEEEccCC---ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEe-cCceEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTN---ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-SEKKLYL 78 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~l 78 (323)
+|++.+.||+|+||+||++++..++ ..||+|.+... ........+.+|+.++++++||||+++++++. .++..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4778899999999999999875443 36888887432 22334467889999999999999999999865 4568899
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| +|.+.+... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++. +||+|||++.......
T Consensus 169 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~-~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKE 246 (373)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCC----------
T ss_pred EEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC-EEEeeccccccccccc
Confidence 9999976 777777654 335688889999999999999999999999999999999998887 9999999997653322
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||...
T Consensus 247 ~~~~~~-------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 247 FDSVHN-------------------------KTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp ------------------------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred cccccc-------------------------cCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 111100 011234778999999987 568999999999999999999 78888877
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+....+.+.... .....+++.+.++|.+||+.||++||++.++++
T Consensus 301 ~~~~~~~~~~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 301 NTFDITVYLLQGRRL----------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp CSSCHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 665554444321100 111347889999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=314.46 Aligned_cols=258 Identities=19% Similarity=0.230 Sum_probs=202.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCC-CCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH-GNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||.||++++..+++.||+|++.... ....+..|+.+++.+.| +++..+..++......++||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC----SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc----ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999875442 23467889999999986 56666666677788999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---ecCCCceEEeccccceecCCCc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLI---DRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~---~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||++++|.+.+..... .+++..+..++.||+.||.|||++||+|+||||+|||+ +.++. +||+|||++.......
T Consensus 83 e~~g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~-vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 83 DLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ-VYIIDFGLAKKYRDTS 160 (483)
T ss_dssp ECCCCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC-EEECCCTTCEECBCTT
T ss_pred ECCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe-EEEEeCCcceeccCCc
Confidence 9998899888875433 57999999999999999999999999999999999999 45565 9999999998765433
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
....... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||....
T Consensus 161 ~~~~~~~----------------------~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 161 THQHIPY----------------------RENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp TCCBCCC----------------------CCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccc----------------------ccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 2211100 00112366999999999988 668999999999999999999999998754
Q ss_pred hH---HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 238 EI---DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 238 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.. +.+..+...... .........+++.+.++|..||+.||++||++.+|++
T Consensus 218 ~~~~~~~~~~i~~~~~~------------------------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 218 AGTKKQKYEKISEKKVA------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp CSSHHHHHHHHHHHHHH------------------------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred chhHHHHHHHHhhcccc------------------------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 42 222222221100 0011222457899999999999999999999987764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=300.68 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=194.3
Q ss_pred CCcceeeeeccccceeEEEEEEccC-Cc--eEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT-NE--TIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~-~~--~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|++|+||++++... +. .||+|++..... .....+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 5899999999999999999986433 33 689998865432 2234567889999999999999999999997665 88
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+|+|++.+ +|.+.+.... ..+++..+..++.||+.||.+||+.|++|+||||+||+++.++. +||+|||.+......
T Consensus 97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~-~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQN 174 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE-EEECCCTTCEECCC-
T ss_pred eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC-EEEcccccccccccc
Confidence 99999975 8888776542 24788899999999999999999999999999999999998887 999999999876533
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||..
T Consensus 175 ~~~~~~--------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 175 DDHYVM--------------------------QEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp CCEEEC-------------------------------CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccchhh--------------------------hccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 221111 011244778999999987 557899999999999999999 9999998
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
....+....+...... ......+++.+.++|.+||+.||++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 228 LNGSQILHKIDKEGER---------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCHHHHHHHHHTSCCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHccCCC---------------------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8776665554321100 0112347899999999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.02 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=190.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHh--cCCCCeeeeeEEEec----Cce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKE--MQHGNIVRLQDVVHS----EKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~----~~~ 75 (323)
++|++.+.||+|+||+||++++ +++.||+|++... ....+..|.+++.. ++||||+++++++.+ ...
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 6899999999999999999986 7899999998533 23455567777766 789999999998653 457
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCcEEEecCCCceEEec
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH--------SHRVLHRDLKPQNLLIDRRTNALKLAD 146 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--------~~~i~H~dl~~~Nil~~~~~~~~kl~d 146 (323)
.++||||+++ +|.+.+... .+++..+..++.||+.||.||| +.|++|+||||+||+++.++. +||+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~-~kl~D 156 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIAD 156 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC-EEECC
T ss_pred eEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC-EEEee
Confidence 8999999976 887777433 5788999999999999999999 999999999999999998887 99999
Q ss_pred cccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCC-----CCCchhhHHHHH
Q 036739 147 FGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH-----YSTPVDVWSVGC 221 (323)
Q Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-----~~~~~Di~slG~ 221 (323)
||++............. .....||+.|+|||.+.+... ++.++||||||+
T Consensus 157 fg~a~~~~~~~~~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~ 211 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVG-------------------------NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211 (301)
T ss_dssp CTTCEEEETTTTEEECC-------------------------CCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHH
T ss_pred CCCeeeccccccccccc-------------------------ccccccccceeChhhhcCcCCCCcccCCchhhHHHHHH
Confidence 99997654333221111 111256999999999987432 346899999999
Q ss_pred HHHHHHhC----------CCCCCCCChHHH-HHHHHHHhCCCC-CCCCCCcccCCcccccCCCCCCCcccccccCCChHH
Q 036739 222 IFAEMVNQ----------RPLFPGDSEIDE-LFKIFRVLGTPN-EDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAG 289 (323)
Q Consensus 222 ll~~l~tg----------~~p~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 289 (323)
++|+|++| ..||........ ............ .... .........++.+
T Consensus 212 il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~l 272 (301)
T 3q4u_A 212 VLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNI-------------------PNRWFSDPTLTSL 272 (301)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC-------------------CGGGGGSHHHHHH
T ss_pred HHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCC-------------------ChhhccCccHHHH
Confidence 99999999 788865432211 111111111100 0000 0001112356789
Q ss_pred HHHHHhhcccCCCCCCCHhhhhc
Q 036739 290 IDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 290 ~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.++|.+||+.||++|||+.++++
T Consensus 273 ~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 273 AKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhhcChhhCCCHHHHHH
Confidence 99999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=323.58 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=197.9
Q ss_pred Ccceee-eeccccceeEEEEEEcc--CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 3 QYEKVE-KIGEGTYGVVYKARNCV--TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 3 ~y~~~~-~lg~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
++.+.+ .||+|+||.||++.... ++..||+|++... ......+.+.+|+.++++++||||+++++++.+ +.+++|
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 344445 89999999999998653 4567999998644 333456788999999999999999999999976 568999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| +|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++. +||+|||++........
T Consensus 414 ~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~-vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY-AKISDFGLSKALGADDS 491 (613)
T ss_dssp EECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-EEECCCSTTTTCC----
T ss_pred EEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc-EEEeeccCcccccCCCc
Confidence 999976 677766543 445789999999999999999999999999999999999998886 99999999976543221
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDS 237 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~ 237 (323)
..... ....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||....
T Consensus 492 ~~~~~--------------------------~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 492 YYTAR--------------------------SAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp ------------------------------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eeeec--------------------------cCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 11100 01133678999999987 568999999999999999998 999999988
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
..+....+.+.... .....+++.+.++|.+||+.||++||++.++++
T Consensus 545 ~~~~~~~i~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 545 GPEVMAFIEQGKRM----------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp SHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCCC----------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77766655432110 112347899999999999999999999999865
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=301.73 Aligned_cols=264 Identities=25% Similarity=0.335 Sum_probs=199.4
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecc--cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
|...+.||+|++|+||++.+ ++..||+|++.... ........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44558999999999999985 68899999986543 223345678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCP-DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|+.| +|.+.+.... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+.........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT-AKISDFGLARASEKFAQT 189 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-EEECCCTTCEECCSCSSC
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc-EEEeeccccccccccccc
Confidence 9965 8877776432 345788999999999999999999999999999999999998887 999999998765432221
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.. .....||+.|+|||.+.+ .++.++|+||||+++|+|++|..||......
T Consensus 190 ~~---------------------------~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 190 VM---------------------------TSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp EE---------------------------CSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred cc---------------------------ccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 11 011245889999999876 4789999999999999999999999876543
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.....+......... .+.... ...........++.+.+++.+||+.||++||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~----------~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 241 QLLLDIKEEIEDEEK----------TIEDYI----DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SBTTHHHHHHHTTSC----------CHHHHS----CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHhhhhhh----------hhhhhc----cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 332222221111000 000000 000111123356778999999999999999999999873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=302.58 Aligned_cols=262 Identities=24% Similarity=0.295 Sum_probs=197.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEe----cCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH----SEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~ 77 (323)
++|++.+.||+|++|.||++.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++. .....+
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 57999999999999999999999999999999886532 223467889999999999999999999986 345889
Q ss_pred EEEecchh-hHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 78 LVFEYLDL-DLKKHMDSC--PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
+|+||+.+ +|.+.+... ....+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||.+....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~-~kl~dfg~~~~~~ 185 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ-PVLMDLGSMNQAC 185 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-EEECCCSSCEESC
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC-EEEEecCcchhcc
Confidence 99999976 887777642 3346789999999999999999999999999999999999998887 9999999887643
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCC--CCCCchhhHHHHHHHHHHHhCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR--HYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
.......... .........||+.|+|||.+.... .++.++||||||+++|+|++|..|
T Consensus 186 ~~~~~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 245 (317)
T 2buj_A 186 IHVEGSRQAL--------------------TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245 (317)
T ss_dssp EEEESHHHHH--------------------HHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred cccccccccc--------------------cccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCC
Confidence 2111100000 000001124588899999987632 268899999999999999999999
Q ss_pred CCCCChH-HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhh
Q 036739 233 FPGDSEI-DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSAL 311 (323)
Q Consensus 233 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il 311 (323)
|...... +........ .. ..+....+++.+.++|.+||+.||.+||++.+++
T Consensus 246 ~~~~~~~~~~~~~~~~~--~~-------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 298 (317)
T 2buj_A 246 YDMVFQKGDSVALAVQN--QL-------------------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLL 298 (317)
T ss_dssp THHHHHTTSCHHHHHHC--C---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hhhhhcccchhhHHhhc--cC-------------------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 9532110 011111110 00 0011134788999999999999999999999999
Q ss_pred cC
Q 036739 312 EH 313 (323)
Q Consensus 312 ~h 313 (323)
++
T Consensus 299 ~~ 300 (317)
T 2buj_A 299 SQ 300 (317)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=323.95 Aligned_cols=246 Identities=21% Similarity=0.304 Sum_probs=197.9
Q ss_pred eeeccccceeEEEEEE--ccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARN--CVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
+.||+|+||.||++.+ +..+..||+|++............+.+|+.+++.++||||+++++++.+ +..++||||+.|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999954 4456789999987655545556789999999999999999999999965 457899999975
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|.+.+.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++. +||+|||++............
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~-~kL~DFGla~~~~~~~~~~~~-- 528 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY-AKISDFGLSKALRADENYYKA-- 528 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-EEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC-EEEEEcCCccccccCcccccc--
Confidence 7888876543 4688899999999999999999999999999999999998887 999999999776433221111
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELF 243 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~ 243 (323)
.....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+....+...
T Consensus 529 ------------------------~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~ 583 (635)
T 4fl3_A 529 ------------------------QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 583 (635)
T ss_dssp ------------------------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred ------------------------ccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 011234788999999987 568999999999999999998 999999988877666
Q ss_pred HHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.+...... .....+++.+.++|.+||+.||++||++.++++
T Consensus 584 ~i~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 584 MLEKGERM----------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 55432111 112347899999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=301.31 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=197.0
Q ss_pred CCc-ceeeeeccccceeEEEEE----EccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--Cc
Q 036739 2 DQY-EKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EK 74 (323)
Q Consensus 2 ~~y-~~~~~lg~g~~~~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 74 (323)
++| ++++.||+|+||+||+++ +..+++.||+|++... ........+.+|+.+++.++||||+++++++.+ ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 345 999999999999998875 4457889999998643 222234668899999999999999999999987 46
Q ss_pred eEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
.+++||||+.+ +|.+.+... .+++..+..++.||+.||.+||+.|++|+||||+||+++.++. +||+|||.+...
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~-~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL-VKIGDFGLAKAV 184 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCGGGCEEC
T ss_pred eEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC-EEECCccccccc
Confidence 88999999976 777777654 3788999999999999999999999999999999999999887 999999999876
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||
T Consensus 185 ~~~~~~~~~--------------------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~ 237 (318)
T 3lxp_A 185 PEGHEYYRV--------------------------REDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSS 237 (318)
T ss_dssp CTTCSEEEC-----------------------------CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred ccccccccc--------------------------ccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcc
Confidence 543221111 111244778999999987 56789999999999999999999998
Q ss_pred CCCChHH-----------HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCC
Q 036739 234 PGDSEID-----------ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 234 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~ 302 (323)
....... ............ ........+++.+.++|.+||+.||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~dP~ 293 (318)
T 3lxp_A 238 QSPPTKFLELIGIAQGQMTVLRLTELLERG------------------------ERLPRPDKCPAEVYHLMKNCWETEAS 293 (318)
T ss_dssp GSHHHHHHHHHCSCCHHHHHHHHHHHHHTT------------------------CCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred cccchhhhhhhcccccchhHHHHHHHHhcc------------------------cCCCCCccccHHHHHHHHHHcCCCcc
Confidence 7643211 111111111000 01112245789999999999999999
Q ss_pred CCCCHhhhhc
Q 036739 303 RRITARSALE 312 (323)
Q Consensus 303 ~R~s~~~il~ 312 (323)
+||++.++++
T Consensus 294 ~Rps~~ell~ 303 (318)
T 3lxp_A 294 FRPTFENLIP 303 (318)
T ss_dssp GSCCHHHHHH
T ss_pred cCcCHHHHHH
Confidence 9999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=316.82 Aligned_cols=250 Identities=15% Similarity=0.167 Sum_probs=190.6
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCC-CCe---------ee------
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH-GNI---------VR------ 65 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~-~~i---------~~------ 65 (323)
+|+..+.||+|+||+||+|++..+|+.||+|++.... ......+.+.+|+.+++.+.| +|. +.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 4778899999999999999999999999999886332 233446788899999999976 221 11
Q ss_pred ------eeEEEec-----CceEEEEEecchhhHHHhhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 036739 66 ------LQDVVHS-----EKKLYLVFEYLDLDLKKHMD-----SCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLK 129 (323)
Q Consensus 66 ------~~~~~~~-----~~~~~lv~e~~~g~l~~~~~-----~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~ 129 (323)
+..++.. ...++++++.+.++|.+.+. ......+++..+..++.||+.||.|||++||+|||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiK 238 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238 (413)
T ss_dssp CCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred cCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcc
Confidence 1111111 23578899999988888774 2223345677888899999999999999999999999
Q ss_pred CCcEEEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhh----
Q 036739 130 PQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILL---- 205 (323)
Q Consensus 130 ~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---- 205 (323)
|+|||++.++. +||+|||++...+... ....| +.|+|||.+.
T Consensus 239 p~NILl~~~~~-~kL~DFG~a~~~~~~~--------------------------------~~~~g-~~y~aPE~~~~~~~ 284 (413)
T 3dzo_A 239 PVDIVLDQRGG-VFLTGFEHLVRDGASA--------------------------------VSPIG-RGFAPPETTAERML 284 (413)
T ss_dssp GGGEEECTTCC-EEECCGGGCEETTEEE--------------------------------CCCCC-TTTCCHHHHHHHTS
T ss_pred cceEEEecCCe-EEEEeccceeecCCcc--------------------------------ccCCC-CceeCchhhhcccc
Confidence 99999999988 9999999987643221 11255 7799999994
Q ss_pred -----CCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccc
Q 036739 206 -----GSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGT 280 (323)
Q Consensus 206 -----~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (323)
....++.++|||||||++|+|++|+.||...........+ + .
T Consensus 285 ~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~------------------------~---------~ 331 (413)
T 3dzo_A 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI------------------------F---------R 331 (413)
T ss_dssp TTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG------------------------G---------S
T ss_pred ccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH------------------------H---------h
Confidence 3355788999999999999999999999766432111100 0 0
Q ss_pred cccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 281 VVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 281 ~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
....+++.+.+||.+||+.||++||++.++++||||+++
T Consensus 332 ~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 332 SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 112478999999999999999999999999999999876
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=299.13 Aligned_cols=256 Identities=24% Similarity=0.373 Sum_probs=197.7
Q ss_pred CCcceeeeeccccceeEEEEE----EccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC--ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKAR----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 75 (323)
++|++.+.||+|++|.||+++ +..+++.||+|++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 469999999999999999998 4568899999998542 223346788999999999999999999998754 37
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
.++|||++.| +|.+.+..... .+++..+..++.||+.||.+||+.|++|+||||+||+++.++. +||+|||.+....
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~-~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-VKIGDFGLTKVLP 196 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE-EEECCCTTCEECC
T ss_pred eEEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc-EEEecCcchhhcc
Confidence 8999999976 88888766533 5788899999999999999999999999999999999998887 9999999998765
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
......... ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 197 ~~~~~~~~~--------------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 197 QDKEYYKVK--------------------------EPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp SSCSEEECS--------------------------SCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred ccccccccc--------------------------cCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 433211110 01134777999999987 557899999999999999999998886
Q ss_pred CCChH------------HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCC
Q 036739 235 GDSEI------------DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 235 ~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~ 302 (323)
..... .....+....... ...+....+++.+.++|.+||+.||+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~cl~~dP~ 305 (326)
T 2w1i_A 250 SPPAEFMRMIGNDKQGQMIVFHLIELLKNN------------------------GRLPRPDGCPDEIYMIMTECWNNNVN 305 (326)
T ss_dssp SHHHHHHHHHCTTCCTHHHHHHHHHHHHTT------------------------CCCCCCTTCCHHHHHHHHHHSCSSGG
T ss_pred CCHHHHHHhhccccchhhhHHHHHHHhhcC------------------------CCCCCCCcccHHHHHHHHHHcCCChh
Confidence 43211 0001111110000 00112245789999999999999999
Q ss_pred CCCCHhhhhc
Q 036739 303 RRITARSALE 312 (323)
Q Consensus 303 ~R~s~~~il~ 312 (323)
+||++.++++
T Consensus 306 ~Rps~~el~~ 315 (326)
T 2w1i_A 306 QRPSFRDLAL 315 (326)
T ss_dssp GSCCHHHHHH
T ss_pred hCcCHHHHHH
Confidence 9999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=296.14 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=187.0
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhc--CCCCeeeeeEEEecC----ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM--QHGNIVRLQDVVHSE----KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~----~~ 75 (323)
++|++.+.||+|+||.||++++ ++..||+|++.... ......|.+++... +||||+++++++... ..
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 5799999999999999999986 48999999985332 23444555555554 899999999999876 78
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEEecCCCceEEec
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH--------RVLHRDLKPQNLLIDRRTNALKLAD 146 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--------~i~H~dl~~~Nil~~~~~~~~kl~d 146 (323)
.++||||+.| +|.+.+... .+++..+..++.|++.||.|||+. |++|+||||+||+++.++. +||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~-~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT-CCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC-EEECC
T ss_pred eEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC-EEEEe
Confidence 9999999976 888887654 478899999999999999999998 9999999999999998887 99999
Q ss_pred cccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCC------chhhHHHH
Q 036739 147 FGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYST------PVDVWSVG 220 (323)
Q Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~------~~Di~slG 220 (323)
||++............. .....||+.|+|||.+.+.. ... ++||||||
T Consensus 186 fg~a~~~~~~~~~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG 239 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIP-------------------------PNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFG 239 (337)
T ss_dssp CTTCEECC----------------------------------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHH
T ss_pred CCCceeeccccccccCC-------------------------CCCCccCcceeChhhccccc-CCccccCccccchHHHH
Confidence 99997664332221110 01125699999999998733 344 49999999
Q ss_pred HHHHHHHhC----------CCCCCCCChHHH-HHHHHHHhCCC-CCCCCCCcccCCcccccCCCCCCCcccccccCCChH
Q 036739 221 CIFAEMVNQ----------RPLFPGDSEIDE-LFKIFRVLGTP-NEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPA 288 (323)
Q Consensus 221 ~ll~~l~tg----------~~p~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 288 (323)
|++|+|++| ..||........ ........... ..... ........+++.
T Consensus 240 ~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~ 300 (337)
T 3mdy_A 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF-------------------PNRWSSDECLRQ 300 (337)
T ss_dssp HHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC-------------------CGGGGGSHHHHH
T ss_pred HHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccc-------------------cccchhhHHHHH
Confidence 999999999 666654322111 11111111000 00000 000111235677
Q ss_pred HHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 289 GIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 289 ~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
+.++|.+||+.||++||++.++++|
T Consensus 301 l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 301 MGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhhhChhhCCCHHHHHHH
Confidence 9999999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=319.66 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=199.7
Q ss_pred CCcceeeeeccccceeEEEEEEccC---CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT---NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|+||.||+|++..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++. ++..++
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 5789999999999999999997554 346888877432 22223467889999999999999999999984 456899
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.| +|.+.+... ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++.......
T Consensus 468 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~-vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDST 545 (656)
T ss_dssp EEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-EEECCCCCCCSCCC--
T ss_pred EEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC-EEEEecCCCeecCCCc
Confidence 9999975 777777654 345788899999999999999999999999999999999998887 9999999987654321
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
.... ....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.
T Consensus 546 ~~~~----------------------------~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 546 YYKA----------------------------SKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp ------------------------------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ceec----------------------------cCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 1110 01234778999999987 568999999999999999997 99999988
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
...+....+...... .....+++.+.++|.+||+.||++||++.++++
T Consensus 597 ~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 597 KNNDVIGRIENGERL----------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp CHHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCCCC----------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 877766665542111 112347889999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=299.33 Aligned_cols=244 Identities=16% Similarity=0.211 Sum_probs=190.0
Q ss_pred CCcceeeeeccccceeEEEE-----EEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC---CCCeeeeeEEEecC
Q 036739 2 DQYEKVEKIGEGTYGVVYKA-----RNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ---HGNIVRLQDVVHSE 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~-----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~ 73 (323)
++|++.+.||+|+||+||+| .+..+++.||+|++... ....+..|..+++.++ |+||+++++++...
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 57999999999999999999 46678899999998432 3467788888888887 89999999999999
Q ss_pred ceEEEEEecch-hhHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec-----------C
Q 036739 74 KKLYLVFEYLD-LDLKKHMDSC---PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-----------R 138 (323)
Q Consensus 74 ~~~~lv~e~~~-g~l~~~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~-----------~ 138 (323)
+..++||||++ |+|.+.+... ....+++..+..++.||+.||+|||++||+||||||+|||++. +
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence 99999999997 4888877532 3446899999999999999999999999999999999999988 6
Q ss_pred CCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 139 TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 139 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
+. +||+|||++.......... ......||+.|+|||++.+ ..++.++||||
T Consensus 220 ~~-~kl~DFG~a~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~Diws 270 (365)
T 3e7e_A 220 AG-LALIDLGQSIDMKLFPKGT---------------------------IFTAKCETSGFQCVEMLSN-KPWNYQIDYFG 270 (365)
T ss_dssp TT-EEECCCTTCEEGGGSCTTE---------------------------EECCSSCTTSCCCHHHHTT-CCBSTHHHHHH
T ss_pred CC-EEEeeCchhhhhhccCCCc---------------------------eeeeecCCCCCCChHHhcC-CCCCccccHHH
Confidence 66 9999999997653221111 1112367999999999988 55899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcc
Q 036739 219 VGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298 (323)
Q Consensus 219 lG~ll~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~ 298 (323)
|||++|+|++|+.||........ . ....+.. ...++.+.+++..||+
T Consensus 271 lG~il~elltg~~pf~~~~~~~~--------------------~---~~~~~~~----------~~~~~~~~~~~~~~l~ 317 (365)
T 3e7e_A 271 VAATVYCMLFGTYMKVKNEGGEC--------------------K---PEGLFRR----------LPHLDMWNEFFHVMLN 317 (365)
T ss_dssp HHHHHHHHHHSSCCCEEEETTEE--------------------E---ECSCCTT----------CSSHHHHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCccccCCCCce--------------------e---echhccc----------cCcHHHHHHHHHHHcC
Confidence 99999999999999854432100 0 0000000 0245678899999999
Q ss_pred cCCCCCCCHhhhhc
Q 036739 299 MDPSRRITARSALE 312 (323)
Q Consensus 299 ~dp~~R~s~~~il~ 312 (323)
.+|.+|++..+.+.
T Consensus 318 ~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 318 IPDCHHLPSLDLLR 331 (365)
T ss_dssp CCCTTCCCCHHHHH
T ss_pred CCCCCcchHHHHHH
Confidence 99999976555444
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=297.94 Aligned_cols=282 Identities=24% Similarity=0.312 Sum_probs=186.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHH--HHhcCCCCeeeeeEEEe-----cC
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISL--LKEMQHGNIVRLQDVVH-----SE 73 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~-----~~ 73 (323)
+++|++.+.||+|+||.||+++. +++.||+|++.... ...+..|..+ +..++||||+++++.+. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 57999999999999999999975 78999999986432 2334444444 44579999999998653 24
Q ss_pred ceEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCcEEEecCCCceE
Q 036739 74 KKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH---------RVLHRDLKPQNLLIDRRTNALK 143 (323)
Q Consensus 74 ~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---------~i~H~dl~~~Nil~~~~~~~~k 143 (323)
..+++||||++| +|.+.+.... .++..+..++.||+.||.|||+. |++|+||||+||+++.++. +|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~-~k 160 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT-CV 160 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC-EE
T ss_pred ceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc-EE
Confidence 478999999965 8888876543 37788889999999999999999 9999999999999998887 99
Q ss_pred EeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC------CCCCCchhhH
Q 036739 144 LADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS------RHYSTPVDVW 217 (323)
Q Consensus 144 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------~~~~~~~Di~ 217 (323)
|+|||++.............. ........||+.|+|||.+.+. ..++.++|||
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 219 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEE---------------------DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219 (336)
T ss_dssp ECCCTTCEECSSSSCC------------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHH
T ss_pred EeeccceeecccccccCcccc---------------------ccccccCCCccceeCchhhcCCcccccccccccccchH
Confidence 999999987654322111000 0001123569999999998763 2345689999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCC-CCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHh
Q 036739 218 SVGCIFAEMVNQRPLFPGDSEIDEL-FKIFRVLGT-PNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSK 295 (323)
Q Consensus 218 slG~ll~~l~tg~~p~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 295 (323)
||||++|+|++|..||......... ......... +.................+.. ........++.+.++|.+
T Consensus 220 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~ 294 (336)
T 3g2f_A 220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE-----AWKENSLAVRSLKETIED 294 (336)
T ss_dssp HHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT-----TCCCCSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc-----ccccccchHHHHHHHHHH
Confidence 9999999999997665332211000 000000000 000000000000000000000 000011245679999999
Q ss_pred hcccCCCCCCCHhhhhc------CCCCccc
Q 036739 296 MLCMDPSRRITARSALE------HEYFRDV 319 (323)
Q Consensus 296 ~l~~dp~~R~s~~~il~------h~~~~~~ 319 (323)
||+.||++|||+.++++ ++|-++-
T Consensus 295 cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 295 CWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp HSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred HhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 99999999999999954 6666553
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=305.45 Aligned_cols=248 Identities=20% Similarity=0.277 Sum_probs=189.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc------CCCCchhHHHHHHHHHhcC---------CCCeeee
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE------DEGVPSTAIREISLLKEMQ---------HGNIVRL 66 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------~~~i~~~ 66 (323)
++|++.+.||+|+||+||+|++ +++.||+|++..... .......+.+|+.+++.++ ||||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 5799999999999999999997 789999999976642 2223367889999999886 7777776
Q ss_pred eEEE-----------------ec-------------CceEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 036739 67 QDVV-----------------HS-------------EKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGI 115 (323)
Q Consensus 67 ~~~~-----------------~~-------------~~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L 115 (323)
.+.+ .+ .+..|+||||+.| ++++.+.. ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 6653 22 6789999999965 57777754 3578999999999999999
Q ss_pred HHHH-hCCcccCCCCCCcEEEecCC-------------------CceEEeccccceecCCCcccccccccCCcCcceeeh
Q 036739 116 AYCH-SHRVLHRDLKPQNLLIDRRT-------------------NALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175 (323)
Q Consensus 116 ~~LH-~~~i~H~dl~~~Nil~~~~~-------------------~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (323)
.||| ++||+||||||+|||++.++ ..+||+|||++......
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------------- 235 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------------- 235 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------------------
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------------------
Confidence 9999 99999999999999999876 14999999999765421
Q ss_pred hhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHH-HHHHHhCCCCCCCCChHHHH-HHHHHHhCCCC
Q 036739 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCI-FAEMVNQRPLFPGDSEIDEL-FKIFRVLGTPN 253 (323)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~l-l~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~ 253 (323)
...||+.|+|||.+.+.. +.++||||++++ .+++++|..||......... ..+.......
T Consensus 236 ---------------~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~- 297 (336)
T 2vuw_A 236 ---------------IVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK- 297 (336)
T ss_dssp ---------------EEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS-
T ss_pred ---------------cEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC-
Confidence 125689999999998743 889999998777 77788899988443221111 2222110000
Q ss_pred CCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhh-cCCCCc
Q 036739 254 EDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSAL-EHEYFR 317 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il-~h~~~~ 317 (323)
..........+++.+.+||.+||+.| |+.++| +||||+
T Consensus 298 ---------------------~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 298 ---------------------TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp ---------------------SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ---------------------cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 01111233457889999999999977 999999 999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=291.43 Aligned_cols=257 Identities=21% Similarity=0.279 Sum_probs=193.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHh--cCCCCeeeeeEEEecCc----e
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKE--MQHGNIVRLQDVVHSEK----K 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~----~ 75 (323)
++|++.+.||+|++|+||++.+ +++.||+|++... ....+.+|..+++. ++||||+++++++.... .
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 5799999999999999999987 5899999998533 23566788888887 68999999999998765 8
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCcEEEecCCCceEEec
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH--------SHRVLHRDLKPQNLLIDRRTNALKLAD 146 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--------~~~i~H~dl~~~Nil~~~~~~~~kl~d 146 (323)
.++||||+.+ +|.+.+... .+++..+..++.||+.||.||| +.|++|+||||+||+++.++. +||+|
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~-~kL~D 190 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIAD 190 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC-EEECC
T ss_pred eEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC-EEEEE
Confidence 9999999976 888887653 4788899999999999999999 899999999999999999887 99999
Q ss_pred cccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCC-----CCchhhHHHHH
Q 036739 147 FGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHY-----STPVDVWSVGC 221 (323)
Q Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-----~~~~Di~slG~ 221 (323)
||++............. .....||+.|+|||.+.+.... +.++||||||+
T Consensus 191 fg~~~~~~~~~~~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~ 245 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIA-------------------------PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245 (342)
T ss_dssp CTTCEEEETTTTEEEEC-------------------------CCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHH
T ss_pred CCCceeccccccccccc-------------------------cccCCcCcccCCHhhhcccccccccccCCcccHHHHHH
Confidence 99997765433221110 1123568999999999874322 26899999999
Q ss_pred HHHHHHhC----------CCCCCCCChHH-HHHHHHHHhC-CCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHH
Q 036739 222 IFAEMVNQ----------RPLFPGDSEID-ELFKIFRVLG-TPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAG 289 (323)
Q Consensus 222 ll~~l~tg----------~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 289 (323)
++|+|++| ..||......+ .......... .......+ ........++.+
T Consensus 246 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l 306 (342)
T 1b6c_B 246 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP-------------------NRWQSCEALRVM 306 (342)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC-------------------GGGGTSHHHHHH
T ss_pred HHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCc-------------------ccccchhHHHHH
Confidence 99999999 77886543211 1111111110 00000000 000011245678
Q ss_pred HHHHHhhcccCCCCCCCHhhhhcC
Q 036739 290 IDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 290 ~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.++|.+||+.||++||++.++++|
T Consensus 307 ~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 307 AKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhccChhhCCCHHHHHHH
Confidence 999999999999999999999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=280.92 Aligned_cols=226 Identities=15% Similarity=0.113 Sum_probs=179.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||.||++++..+++.||+|++...... ......+.+|+..++.++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 5799999999999999999999888999999998644322 122367889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||++| +|.+.+... .....+.+++.||+.||.|||++||+|+||||+||+++.++. +||++++
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~-~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD-VVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC-EEECSCC-----------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC-EEEEecc-----------
Confidence 99976 777776432 355667889999999999999999999999999999999887 8887443
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
|++ .++.++|||||||++|+|++|+.||......
T Consensus 175 --------------------------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 175 --------------------------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp --------------------------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred --------------------------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 222 3688999999999999999999999876532
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
+.+.. ..................+++.+.++|.+||+.||++| |+.++++
T Consensus 209 ~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 209 SGLAP----------------------AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp CCSEE----------------------CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred hhhHH----------------------HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 11000 00000000011112335689999999999999999999 9999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=316.80 Aligned_cols=239 Identities=25% Similarity=0.334 Sum_probs=190.6
Q ss_pred CCcceeeeeccccceeEEEEEEcc-CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCce-----
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKK----- 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----- 75 (323)
++|++.+.||+|+||+||++.+.. +++.||+|++... ........+.+|+.++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 689999999999999999999976 7899999987532 222233567789999999999999999999986554
Q ss_pred EEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
.|+||||++| +|.+.+.. .+++..+..++.||+.+|.|||++||+|+||||+||+++.+ . +||+|||++....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~-~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-Q-LKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-C-EEECCCTTCEETT
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-c-EEEEecccchhcc
Confidence 7999999986 55544333 57899999999999999999999999999999999999874 4 9999999997654
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
... ...||+.|+|||.+.+. .+.++||||||+++|+|++|..||.
T Consensus 233 ~~~---------------------------------~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~ 277 (681)
T 2pzi_A 233 SFG---------------------------------YLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRN 277 (681)
T ss_dssp CCS---------------------------------CCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEET
T ss_pred cCC---------------------------------ccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCc
Confidence 320 12468999999998773 3889999999999999999998876
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
..... ..+ ........++.+.++|.+||+.||++||+..+++.|+
T Consensus 278 ~~~~~----------------~~~-------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 322 (681)
T 2pzi_A 278 GRYVD----------------GLP-------------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ 322 (681)
T ss_dssp TEECS----------------SCC-------------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred ccccc----------------ccc-------------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHH
Confidence 42110 000 0000112467899999999999999999999999888
Q ss_pred CCc
Q 036739 315 YFR 317 (323)
Q Consensus 315 ~~~ 317 (323)
|+.
T Consensus 323 l~~ 325 (681)
T 2pzi_A 323 LTG 325 (681)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=252.00 Aligned_cols=187 Identities=17% Similarity=0.088 Sum_probs=128.9
Q ss_pred eeccccceeEEEEEEccCCceEEEEEEEecccC--------CCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEEE
Q 036739 9 KIGEGTYGVVYKARNCVTNETIALKKIRLEQED--------EGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 9 ~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 79 (323)
..+.|+.+....++....|+.|++|++.+.... ....+.+.+|+.+|+++ .|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 345677777777777788999999999765321 12335688999999999 699999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||++| +|.+.+.... .+++. +|+.||+.||+|+|++||+||||||+|||++.++. +||+|||+++.......
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~-vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH-ARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC-EEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC-EEEeecccCeeCCCCCc
Confidence 999987 7777776643 34543 58999999999999999999999999999999887 99999999976543221
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
. ....+||+.|+|||.+.+ .+..++|+|++|++++.+.++..+
T Consensus 395 ~-----------------------------~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 W-----------------------------PTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C-----------------------------SHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred c-----------------------------ccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 1 122478999999999877 357789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=211.31 Aligned_cols=192 Identities=17% Similarity=0.209 Sum_probs=139.7
Q ss_pred eeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC------CchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG------VPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
..+.||+|+||.||++. ..+..+++|.......... ..+.+.+|+.++++++||||+++..++.+....++|
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 35689999999999994 5788899998754322111 123478999999999999999666665567777999
Q ss_pred Eecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||++ ++|.+.+.. +..++.||+.+|.|||++||+|+||||+||+++. . +||+|||++........
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~-~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--D-LYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--S-EEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--e-EEEEECccCEECCCccc
Confidence 99997 588777665 4579999999999999999999999999999997 4 99999999988654322
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC-CCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS-RHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
.... .........||+.|+|||++... ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 485 ~~~~----------------------~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVD----------------------LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHH----------------------HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccc----------------------hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1100 00011234679999999998751 236777899999888888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=179.01 Aligned_cols=133 Identities=18% Similarity=0.222 Sum_probs=104.2
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC----------------CchhHHHHHHHHHhcCCCCeeeee
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG----------------VPSTAIREISLLKEMQHGNIVRLQ 67 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~----------------~~~~~~~e~~~l~~l~~~~i~~~~ 67 (323)
|.+.+.||+|++|.||+|.+ .+|..||+|++........ ....+.+|+.+++.++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 44569999999999999999 8899999999864321111 1345789999999999 4 5555
Q ss_pred EEEecCceEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEec
Q 036739 68 DVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLAD 146 (323)
Q Consensus 68 ~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~d 146 (323)
+.+. .+..++||||++| +|.+ +.. . ....++.||+.||.+||+.|++|+||||+||+++ ++. +||+|
T Consensus 168 ~~~~-~~~~~lvmE~~~g~~L~~-l~~------~--~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~-vkl~D 235 (282)
T 1zar_A 168 KVYA-WEGNAVLMELIDAKELYR-VRV------E--NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG-IWIID 235 (282)
T ss_dssp CEEE-EETTEEEEECCCCEEGGG-CCC------S--CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE-EEECC
T ss_pred eEEe-ccceEEEEEecCCCcHHH-cch------h--hHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc-EEEEE
Confidence 5553 3566999999976 6665 321 1 1447999999999999999999999999999999 666 99999
Q ss_pred ccccee
Q 036739 147 FGLARA 152 (323)
Q Consensus 147 f~~~~~ 152 (323)
||++..
T Consensus 236 FG~a~~ 241 (282)
T 1zar_A 236 FPQSVE 241 (282)
T ss_dssp CTTCEE
T ss_pred CCCCeE
Confidence 999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=161.19 Aligned_cols=139 Identities=15% Similarity=0.166 Sum_probs=105.8
Q ss_pred cceeeeeccccceeEEEEEEccCCce--EEEEEEEecccCCCC----------------------chhHHHHHHHHHhcC
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNET--IALKKIRLEQEDEGV----------------------PSTAIREISLLKEMQ 59 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~--~aiK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~ 59 (323)
|++.+.||+|++|.||+|.+..+|.. ||+|++......... ...+.+|+..++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999998778888 999987543211000 125778999999998
Q ss_pred CCCe--eeeeEEEecCceEEEEEecchh------hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCC
Q 036739 60 HGNI--VRLQDVVHSEKKLYLVFEYLDL------DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH-SHRVLHRDLKP 130 (323)
Q Consensus 60 ~~~i--~~~~~~~~~~~~~~lv~e~~~g------~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~i~H~dl~~ 130 (323)
|+++ +.++.. ...++||||+++ .+.+.... .++..+..++.||+.+|.+|| +.|++|+||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8764 334432 356899999953 44444322 123346789999999999999 99999999999
Q ss_pred CcEEEecCCCceEEeccccceecC
Q 036739 131 QNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 131 ~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
+|||++. . ++|+|||++....
T Consensus 200 ~NILl~~--~-~~liDFG~a~~~~ 220 (258)
T 1zth_A 200 YNIMYID--K-VYFIDMGQAVTLR 220 (258)
T ss_dssp TSEEESS--S-EEECCCTTCEETT
T ss_pred HHEEEcC--c-EEEEECcccccCC
Confidence 9999987 4 9999999997754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=9.6e-18 Score=149.32 Aligned_cols=142 Identities=16% Similarity=0.212 Sum_probs=99.5
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC------------Cch--------hHHHHHHHHHhcCCCCe
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG------------VPS--------TAIREISLLKEMQHGNI 63 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~------------~~~--------~~~~e~~~l~~l~~~~i 63 (323)
|++.+.||.|++|.||+|.+ .+|+.||+|+++.....-. ... ....|...+.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 88999999999999999998 5789999998864321100 000 11245666666655443
Q ss_pred eeeeEEEecCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC---
Q 036739 64 VRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--- 140 (323)
Q Consensus 64 ~~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~--- 140 (323)
....-+.. ...++||||++|..+..+... + .+..++.||+.+|.+||++|++||||||.|||++.++.
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~-----~--~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV-----P--DPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCCC-----S--CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhccc-----H--HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 22211111 223799999988444333221 1 24578899999999999999999999999999988763
Q ss_pred ------ceEEeccccceecCC
Q 036739 141 ------ALKLADFGLARAFGI 155 (323)
Q Consensus 141 ------~~kl~df~~~~~~~~ 155 (323)
.+.|+||+.+.....
T Consensus 247 ~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp TTSEEEEEEECCCTTCEETTS
T ss_pred ccccccceEEEEeCCcccCCC
Confidence 378999998876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.5e-12 Score=110.99 Aligned_cols=140 Identities=16% Similarity=0.160 Sum_probs=108.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+.|++...++.|+.+.||++.. .+..+++|....... .....+.+|+.+++.+. +..++++++++.+.+..|+||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 5788999999999999999974 468899998754321 22356889999999995 667888999998888999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS--------------------------------------- 120 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--------------------------------------- 120 (323)
|+++| ++.+.+.. ......++.+++.+|..||+
T Consensus 90 e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 90 SEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp ECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99998 54443211 11134678899999999998
Q ss_pred --------------------CCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 121 --------------------HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 121 --------------------~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
..++|||++|.||+++. +..+.|+||+.+..-
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSGRA 214 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCEEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcccC
Confidence 34889999999999975 444679999987653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=2.3e-11 Score=103.17 Aligned_cols=135 Identities=12% Similarity=0.052 Sum_probs=98.3
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC--eeeeeEEEecCceEEEEE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN--IVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~ 80 (323)
.|.+....+.|..+.||++.. .+|..+++|..... ....+..|+.+++.+.+.+ +++++++..+++..++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 455544444666699999964 45778999986422 2356788999999986544 566888888888899999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR-------------------------------------- 122 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-------------------------------------- 122 (323)
|+++|..+. ... .+ ...++.+++..|..||+..
T Consensus 95 e~i~G~~l~-~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 95 GEVPGQDLL-SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp ECCSSEETT-TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EecCCcccC-cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 999984444 211 12 2256778888888888754
Q ss_pred --------------------cccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 123 --------------------VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 123 --------------------i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
++|||++|.||+++.+ ..+.|+||+.+...
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~~g 215 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGVA 215 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhcccC
Confidence 9999999999999764 43679999997653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.8e-10 Score=102.65 Aligned_cols=142 Identities=15% Similarity=0.209 Sum_probs=103.9
Q ss_pred ceeeeeccccceeEEEEEEccCCceEEEEEEE--ecccCCCCchhHHHHHHHHHhcCC--CCeeeeeEEEecC---ceEE
Q 036739 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIR--LEQEDEGVPSTAIREISLLKEMQH--GNIVRLQDVVHSE---KKLY 77 (323)
Q Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~--~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~~~ 77 (323)
..++.++.|.++.||++.. .+..+++|... ... .......+.+|..+++.+.. ..+++++..+.+. +..+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3567899999999999985 34678888764 221 11223577889999999974 4578888888765 4589
Q ss_pred EEEecchhhHH-HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 036739 78 LVFEYLDLDLK-KHMDSCPDFANDPRLIKTFLYQILRGIAYCHS------------------------------------ 120 (323)
Q Consensus 78 lv~e~~~g~l~-~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~------------------------------------ 120 (323)
+|||+++|..+ +... ..+++.....++.+++.+|..||+
T Consensus 118 ~vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 99999998443 2111 135677778899999999999997
Q ss_pred ----------------------CCcccCCCCCCcEEEecCC-CceEEeccccceec
Q 036739 121 ----------------------HRVLHRDLKPQNLLIDRRT-NALKLADFGLARAF 153 (323)
Q Consensus 121 ----------------------~~i~H~dl~~~Nil~~~~~-~~~kl~df~~~~~~ 153 (323)
..++|||+++.||+++.++ .++.|+||+.+..-
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 3589999999999998765 34689999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.02 E-value=3e-10 Score=98.85 Aligned_cols=135 Identities=17% Similarity=0.199 Sum_probs=95.9
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCC--eeeeeEEEecCc---eEEEEE
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGN--IVRLQDVVHSEK---KLYLVF 80 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~lv~ 80 (323)
++.++.|..+.||++. ..+++|..... .....+..|.++++.+. +.. +++++......+ ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4568899999999984 46889975322 22467888999998884 333 445555543333 458899
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS--------------------------------------- 120 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--------------------------------------- 120 (323)
++++| .+...... .++.+....++.+++..|..||+
T Consensus 96 ~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99998 44332222 35666677888888888888886
Q ss_pred -------------------CCcccCCCCCCcEEEecC-CCceEEeccccceecC
Q 036739 121 -------------------HRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFG 154 (323)
Q Consensus 121 -------------------~~i~H~dl~~~Nil~~~~-~~~~kl~df~~~~~~~ 154 (323)
..++|||++|.||+++.+ +..+.++||+.+..-+
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 136999999999999975 4458899999987654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=3.1e-07 Score=79.81 Aligned_cols=135 Identities=19% Similarity=0.194 Sum_probs=92.8
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCC---CeeeeeEEEe-cCceEEEEEec
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG---NIVRLQDVVH-SEKKLYLVFEY 82 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~e~ 82 (323)
++.++.|....||++ +..+++|+... ......+..|.++++.+.+. .+++.+.+.. ..+..++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456788888899998 56788997421 12245788999999999753 3566676664 45667899999
Q ss_pred chhhHHHh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 036739 83 LDLDLKKH-MDSCPDFANDPRLIKTFLYQILRGIAYCHSH---------------------------------------- 121 (323)
Q Consensus 83 ~~g~l~~~-~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---------------------------------------- 121 (323)
++|..+.. ... .++......++.++...|..||+.
T Consensus 95 i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 95 VQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred cCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 98843322 111 124444455566666666666642
Q ss_pred --------------------CcccCCCCCCcEEEec---CCCceEEeccccceecC
Q 036739 122 --------------------RVLHRDLKPQNLLIDR---RTNALKLADFGLARAFG 154 (323)
Q Consensus 122 --------------------~i~H~dl~~~Nil~~~---~~~~~kl~df~~~~~~~ 154 (323)
.++|+|+++.||+++. ++..+.|+||+.+..-+
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3489999999999987 45546899999887643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=9e-07 Score=75.21 Aligned_cols=133 Identities=15% Similarity=0.170 Sum_probs=92.4
Q ss_pred eeccccce-eEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEEEecchh-
Q 036739 9 KIGEGTYG-VVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLVFEYLDL- 85 (323)
Q Consensus 9 ~lg~g~~~-~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~g- 85 (323)
.+..|..+ .||+......+..+++|.-... ....+..|...++.+. +--++++++++.+.+..++|||++.|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34445554 6999987777788999986432 2356778999999885 33477888888888999999999988
Q ss_pred hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 036739 86 DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH-------------------------------------------- 121 (323)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-------------------------------------------- 121 (323)
++.+..... ......+..++...|..||..
T Consensus 106 ~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 106 TAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp EHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 443333221 111224455555555555531
Q ss_pred --------------CcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 122 --------------RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 122 --------------~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
.++|||+.+.||+++.++ ++-|+||+.+..-
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~g 224 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECcccccC
Confidence 268999999999998644 4779999988654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=6.8e-06 Score=73.94 Aligned_cols=78 Identities=17% Similarity=0.126 Sum_probs=50.3
Q ss_pred eeeeeccccceeEEEEEEccCCceEEEEEEEeccc----C-CCCchhHHHHHHHHHhcCC--C-CeeeeeEEEecCceEE
Q 036739 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE----D-EGVPSTAIREISLLKEMQH--G-NIVRLQDVVHSEKKLY 77 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~----~-~~~~~~~~~e~~~l~~l~~--~-~i~~~~~~~~~~~~~~ 77 (323)
..+.+|.|..+.||++.....+..+++|....... . ......+..|.++++.+.. + .+++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 36789999999999997655678899997643211 0 1233556778888888742 3 34556644 344568
Q ss_pred EEEecchh
Q 036739 78 LVFEYLDL 85 (323)
Q Consensus 78 lv~e~~~g 85 (323)
+|||+++|
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=3.1e-06 Score=74.99 Aligned_cols=80 Identities=4% Similarity=0.049 Sum_probs=54.1
Q ss_pred eeeee-ccccceeEEEEEEc--c----CCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCC---CCeeeeeEEEecC-
Q 036739 6 KVEKI-GEGTYGVVYKARNC--V----TNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQH---GNIVRLQDVVHSE- 73 (323)
Q Consensus 6 ~~~~l-g~g~~~~v~~~~~~--~----~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~- 73 (323)
..+.| +.|..+.+|++... . ++..+++|....... .......+..|+.+++.+.. -.+++++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 35677 88889999998753 0 256788987543220 01123567788888888853 3577788877654
Q ss_pred --ceEEEEEecchh
Q 036739 74 --KKLYLVFEYLDL 85 (323)
Q Consensus 74 --~~~~lv~e~~~g 85 (323)
+..++|||+++|
T Consensus 104 ~~g~~~~v~e~l~G 117 (357)
T 3ats_A 104 VLGTPFFLMDYVEG 117 (357)
T ss_dssp TTSSCEEEEECCCC
T ss_pred ccCCceEEEEecCC
Confidence 456899999987
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.10 E-value=2e-05 Score=69.06 Aligned_cols=138 Identities=15% Similarity=0.196 Sum_probs=77.1
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCC--CCeeeeeEE------EecCceEEE
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH--GNIVRLQDV------VHSEKKLYL 78 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~------~~~~~~~~l 78 (323)
++.|+.|..+.+|++.. .+..+++|..... ...+..|..+++.+.. -.+++++.. ....+..++
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 45566677889999975 3345899987531 2344455666665532 123444431 134667899
Q ss_pred EEecchhhH---------------HHhhhcC-CCC--C---------CCHH--------H--------------------
Q 036739 79 VFEYLDLDL---------------KKHMDSC-PDF--A---------NDPR--------L-------------------- 103 (323)
Q Consensus 79 v~e~~~g~l---------------~~~~~~~-~~~--~---------~~~~--------~-------------------- 103 (323)
++++++|.. +..+... ... . .... .
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 999997731 1122110 000 0 0110 0
Q ss_pred ---HHHHHHHHHHHHHHHH-------------hCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 104 ---IKTFLYQILRGIAYCH-------------SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 104 ---~~~i~~qi~~~L~~LH-------------~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
+..+..++..++..|+ ...++|||+++.||+++.++. +.++||+.+..-
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~-~~lIDfe~a~~g 253 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQ-IWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGC-EEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCc-EEEEehhhcccC
Confidence 1111122334555664 357999999999999987666 999999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.89 E-value=0.0001 Score=63.47 Aligned_cols=71 Identities=14% Similarity=0.114 Sum_probs=45.7
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCe-eeeeEEEecCceEEEEEec
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-VRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~ 82 (323)
+.-++.|+.|....+|++ ..+++|+..... .......+|+.+++.+...++ +++++.. ...-++++|+
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~ 88 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRY 88 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEEC
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEee
Confidence 444788999999999999 568899875331 112234568888877753333 4555543 3334689999
Q ss_pred c-hh
Q 036739 83 L-DL 85 (323)
Q Consensus 83 ~-~g 85 (323)
+ +|
T Consensus 89 i~~g 92 (301)
T 3dxq_A 89 IAGA 92 (301)
T ss_dssp CTTC
T ss_pred cCCC
Confidence 9 65
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00023 Score=61.67 Aligned_cols=73 Identities=18% Similarity=0.166 Sum_probs=58.0
Q ss_pred eeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC---CCCeeeeeEEEecCceEEEEEec
Q 036739 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ---HGNIVRLQDVVHSEKKLYLVFEY 82 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~ 82 (323)
-.+.|+.|....+|++.. .+..+++|..... ....+..|.+.++.+. ...+++++......+..++|||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 467889999999999984 5678999976532 2467788999988884 35688888888878889999999
Q ss_pred chh
Q 036739 83 LDL 85 (323)
Q Consensus 83 ~~g 85 (323)
++|
T Consensus 113 l~G 115 (312)
T 3jr1_A 113 LNK 115 (312)
T ss_dssp CCC
T ss_pred ccC
Confidence 975
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00038 Score=62.97 Aligned_cols=76 Identities=13% Similarity=0.231 Sum_probs=45.7
Q ss_pred eeeeeccccceeEEEEEEccCCceEEEEEEEeccc--CCC---CchhHHHHHHHHHhc---CCCCeeeeeEEEecCceEE
Q 036739 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE--DEG---VPSTAIREISLLKEM---QHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~---~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~ 77 (323)
-++.+|.|..+.||++.. ++..+++|....... ... .......|.+++..+ ....+++++.+. .+..+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 467889999999999963 567899994422111 111 012222233333322 234567777765 46678
Q ss_pred EEEecc-hh
Q 036739 78 LVFEYL-DL 85 (323)
Q Consensus 78 lv~e~~-~g 85 (323)
+|||++ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00024 Score=64.54 Aligned_cols=71 Identities=13% Similarity=0.189 Sum_probs=49.0
Q ss_pred eeeeccccceeEEEEEEcc-------CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCe-eeeeEEEecCceEEE
Q 036739 7 VEKIGEGTYGVVYKARNCV-------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-VRLQDVVHSEKKLYL 78 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~l 78 (323)
++.|+.|....+|++.... .+..+++|+.... .....+..|..+++.+...++ +++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 5678889999999998642 2578999987321 112566689999888864444 567776643 28
Q ss_pred EEecchh
Q 036739 79 VFEYLDL 85 (323)
Q Consensus 79 v~e~~~g 85 (323)
|+||++|
T Consensus 150 v~e~l~G 156 (429)
T 1nw1_A 150 LEEYIPS 156 (429)
T ss_dssp EECCCCE
T ss_pred EEEEeCC
Confidence 8999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00065 Score=54.94 Aligned_cols=98 Identities=11% Similarity=0.014 Sum_probs=60.5
Q ss_pred hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCC-CCCCcEEEecCCCceEEeccccceecCCCccccccc
Q 036739 86 DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRD-LKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163 (323)
Q Consensus 86 ~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~d-l~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~ 163 (323)
+|.+.+. ..+.++++++++.++.|.+.+|..+-. +. -|.. +.|..|++..+|. |-..+ ..+..
T Consensus 34 SL~eIL~-~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~-V~f~~-~~s~~----------- 98 (229)
T 2yle_A 34 SLEEILR-LYNQPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGA-VTLAP-AADDA----------- 98 (229)
T ss_dssp EHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSC-EEECC-C---------------
T ss_pred cHHHHHH-HcCCCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCc-eeccc-ccccc-----------
Confidence 4444444 345589999999999999999887732 22 2333 4578999999988 54442 11100
Q ss_pred ccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC
Q 036739 164 HWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR 230 (323)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~ 230 (323)
....+.|||... ...+.+.-|||||+++|..+--.
T Consensus 99 ------------------------------~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 99 ------------------------------GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --------------------------------------CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ------------------------------cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence 022266787653 23467889999999999988643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00043 Score=61.63 Aligned_cols=140 Identities=14% Similarity=0.118 Sum_probs=79.9
Q ss_pred eeeeccccceeEEEEEEcc-------CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC-eeeeeEEEecCceEEE
Q 036739 7 VEKIGEGTYGVVYKARNCV-------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN-IVRLQDVVHSEKKLYL 78 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~l 78 (323)
++.+..|-...+|++.... ++..+++|+.... ......+.+|.++++.+...+ .+++++.+.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 4567778889999998632 3578999985321 123456668999998885333 3566766643 28
Q ss_pred EEecchhhHH------------------HhhhcCC---CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 036739 79 VFEYLDLDLK------------------KHMDSCP---DFAND--PRLIKTFLYQILR-------------------GIA 116 (323)
Q Consensus 79 v~e~~~g~l~------------------~~~~~~~---~~~~~--~~~~~~i~~qi~~-------------------~L~ 116 (323)
|+||++|..+ ..+.... ..... ...+.++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999976221 1111111 11111 2334444444321 223
Q ss_pred HHH----h----CCcccCCCCCCcEEEecC---CCceEEeccccceec
Q 036739 117 YCH----S----HRVLHRDLKPQNLLIDRR---TNALKLADFGLARAF 153 (323)
Q Consensus 117 ~LH----~----~~i~H~dl~~~Nil~~~~---~~~~kl~df~~~~~~ 153 (323)
.|. . ..++|+|+.+.||+++.+ ...+.++||..+..-
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 332 2 258999999999999876 234999999998653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00028 Score=61.27 Aligned_cols=139 Identities=16% Similarity=0.096 Sum_probs=76.5
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC--eeeeeEE------EecCceEEE
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN--IVRLQDV------VHSEKKLYL 78 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~l 78 (323)
++.|+.|....+|++.. ++..+++|..... .....+..|..+++.+...+ +++++.. ....+..++
T Consensus 27 ~~~i~~G~~n~~~~v~~--~~g~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHT--TKDPLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEECC---EEEEEEEE--SSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eeccCCCcccceEEEEe--CCccEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 56677888899999975 2336889987532 12356667888887775322 2333321 112456789
Q ss_pred EEecchhhH---------------HHhhhcC-CCCC------CCHHHHHH---------------HHHHHHHHHHHHHh-
Q 036739 79 VFEYLDLDL---------------KKHMDSC-PDFA------NDPRLIKT---------------FLYQILRGIAYCHS- 120 (323)
Q Consensus 79 v~e~~~g~l---------------~~~~~~~-~~~~------~~~~~~~~---------------i~~qi~~~L~~LH~- 120 (323)
++++++|.. +..+... .... ........ +...+...+..+..
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999997631 1112110 0100 01000000 00113344555552
Q ss_pred ------CCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 121 ------HRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 121 ------~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
.+++|+|+++.||+++.+ ..+.++||+.+..
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 217 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred CcccCCcccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence 369999999999999865 3357999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0021 Score=54.83 Aligned_cols=74 Identities=12% Similarity=0.122 Sum_probs=52.0
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCC---CCeeeeeEEEecCceEEEEE
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH---GNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~~~~~lv~ 80 (323)
..-+..+|.|..+.||+++. .+|+.|++|+.... .......+..|.+.|+.+.. --++++++.. . -++||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~--~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~ 89 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDD--APALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAM 89 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTT--CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEE
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCC--CcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEE
Confidence 34577899999999999986 57889999975322 22234578889999998853 2345555542 2 36889
Q ss_pred ecch
Q 036739 81 EYLD 84 (323)
Q Consensus 81 e~~~ 84 (323)
|++.
T Consensus 90 e~l~ 93 (288)
T 3f7w_A 90 EWVD 93 (288)
T ss_dssp ECCC
T ss_pred Eeec
Confidence 9874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0025 Score=58.22 Aligned_cols=73 Identities=12% Similarity=0.131 Sum_probs=47.6
Q ss_pred eeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCe-eeeeEEEecCceEEEEEecch
Q 036739 6 KVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-VRLQDVVHSEKKLYLVFEYLD 84 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~ 84 (323)
-++.|+.|....+|++.....+..+++|+..... ...-....|..+++.+...++ +++++.+. ++ .|+||++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~G---~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEIINREREKKISCILYNKNIAKKIYVFFT-NG---RIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCSCHHHHHHHHHHHTTSSSBCCEEEEET-TE---EEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-Ce---EEEEeeC
Confidence 3567888999999999864335789999874321 111223589999999975555 56777663 22 4999986
Q ss_pred h
Q 036739 85 L 85 (323)
Q Consensus 85 g 85 (323)
|
T Consensus 185 G 185 (458)
T 2qg7_A 185 G 185 (458)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0011 Score=57.82 Aligned_cols=34 Identities=29% Similarity=0.282 Sum_probs=27.6
Q ss_pred CCcccCCCCCCcEEEecC---CCceEEeccccceecC
Q 036739 121 HRVLHRDLKPQNLLIDRR---TNALKLADFGLARAFG 154 (323)
Q Consensus 121 ~~i~H~dl~~~Nil~~~~---~~~~kl~df~~~~~~~ 154 (323)
..++|||+.+.||+++.+ ...+.++||+.+..-.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 469999999999999864 1348999999887644
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0048 Score=53.46 Aligned_cols=73 Identities=11% Similarity=0.147 Sum_probs=46.6
Q ss_pred eeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC--eeeeeEE-----EecCceEEEEE
Q 036739 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN--IVRLQDV-----VHSEKKLYLVF 80 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~lv~ 80 (323)
..++ |....||++.. .+|+.+++|...... .....+..|..+++.+...+ +++++.. ...++..++++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 4566 78889999864 356679999874221 12356677888888775322 3444443 12245668899
Q ss_pred ecchh
Q 036739 81 EYLDL 85 (323)
Q Consensus 81 e~~~g 85 (323)
++++|
T Consensus 107 ~~i~G 111 (328)
T 1zyl_A 107 PSVGG 111 (328)
T ss_dssp ECCCC
T ss_pred EecCC
Confidence 99976
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0096 Score=52.05 Aligned_cols=33 Identities=15% Similarity=0.258 Sum_probs=27.8
Q ss_pred CCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 121 ~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
..++|||+.+.||+++.++. +.++||+.+..-.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~-~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEES-IYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGC-EEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCe-EEEEECCCCeeCC
Confidence 36999999999999987666 8999998876543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.006 Score=53.92 Aligned_cols=72 Identities=14% Similarity=0.098 Sum_probs=42.9
Q ss_pred eeeeccccceeEEEEEEcc--------CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC-eeeeeEEEecCceEE
Q 036739 7 VEKIGEGTYGVVYKARNCV--------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN-IVRLQDVVHSEKKLY 77 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~ 77 (323)
+..++.|....+|++.... .+..+++|+...... .......|..+++.+...+ .+++++.. .+ +
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--G 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ceecHHHHHHHHHHHHhcCCCCceEEec--CC--c
Confidence 5677888889999998643 136788887643211 1123457888888885434 44666554 22 5
Q ss_pred EEEecchh
Q 036739 78 LVFEYLDL 85 (323)
Q Consensus 78 lv~e~~~g 85 (323)
+|+++++|
T Consensus 111 ~v~e~i~G 118 (369)
T 3c5i_A 111 RIEEWLYG 118 (369)
T ss_dssp EEEECCCS
T ss_pred EEEEEecC
Confidence 89999876
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.28 E-value=0.035 Score=49.98 Aligned_cols=73 Identities=12% Similarity=0.096 Sum_probs=47.5
Q ss_pred eeeeeccccceeEEEEEEccC-------CceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC-eeeeeEEEecCceEE
Q 036739 6 KVEKIGEGTYGVVYKARNCVT-------NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN-IVRLQDVVHSEKKLY 77 (323)
Q Consensus 6 ~~~~lg~g~~~~v~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~ 77 (323)
-++.+..|-...+|++..... +..+++|+.... ....-...+|..+++.+...+ .+++++.+ .+ +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~---t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH---VGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC---C-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC---cchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 356778888999999986421 578999986332 122234457888888885333 35556544 22 6
Q ss_pred EEEecchh
Q 036739 78 LVFEYLDL 85 (323)
Q Consensus 78 lv~e~~~g 85 (323)
.|++|++|
T Consensus 147 ~I~efI~G 154 (424)
T 3mes_A 147 RIEEFIDG 154 (424)
T ss_dssp EEEECCCS
T ss_pred EEEEEeCC
Confidence 88999976
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.98 E-value=0.042 Score=49.11 Aligned_cols=32 Identities=25% Similarity=0.304 Sum_probs=25.4
Q ss_pred CcccCCCCCCcEEEec-----CCCceEEeccccceec
Q 036739 122 RVLHRDLKPQNLLIDR-----RTNALKLADFGLARAF 153 (323)
Q Consensus 122 ~i~H~dl~~~Nil~~~-----~~~~~kl~df~~~~~~ 153 (323)
.+||+|+.+.||++.. ....+.++||.++..-
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 3689999999999943 2345999999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.93 E-value=1.4 Score=35.58 Aligned_cols=86 Identities=14% Similarity=0.096 Sum_probs=60.7
Q ss_pred CCCCeeeeeEEEecCceEEEEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCcccCCCCCCcEEEe
Q 036739 59 QHGNIVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIA-YCHSHRVLHRDLKPQNLLID 136 (323)
Q Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~-~LH~~~i~H~dl~~~Nil~~ 136 (323)
.||++ . ..+-.+++.+.+.++.-. +..+..+.. .+.....+++.+|+.... ++ ..-+|--|+|+|++++
T Consensus 48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 57888 3 333366777778777763 444555533 466677788888777554 33 4457788999999999
Q ss_pred cCCCceEEeccccceecC
Q 036739 137 RRTNALKLADFGLARAFG 154 (323)
Q Consensus 137 ~~~~~~kl~df~~~~~~~ 154 (323)
.++. +++.-.|....+.
T Consensus 119 ~~~~-p~i~hRGi~~~lp 135 (219)
T 4ano_A 119 RALE-PFFLHVGVKESLP 135 (219)
T ss_dssp TTCC-EEESCCEETTTBS
T ss_pred CCCc-EEEEEcCCcccCC
Confidence 9888 9999999865543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.91 E-value=0.74 Score=36.98 Aligned_cols=86 Identities=12% Similarity=0.076 Sum_probs=61.6
Q ss_pred CCCCeeeeeEEEecCceEEEEEecch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec
Q 036739 59 QHGNIVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR 137 (323)
Q Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~ 137 (323)
.+|+++.+ .+-.+++.+.+.++.-+ +..+..+.. .+.....+++.+|+....+++ .-+|--|+|+|++++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-----~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-----FTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-----SCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-----cCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcC
Confidence 58888877 45556667777776654 444444443 466677888998888774443 3477889999999999
Q ss_pred CCCceEEeccccceec
Q 036739 138 RTNALKLADFGLARAF 153 (323)
Q Consensus 138 ~~~~~kl~df~~~~~~ 153 (323)
++. +++.-.|....+
T Consensus 115 ~~~-p~i~~RGik~~l 129 (215)
T 4ann_A 115 DGL-PIAKTRGLQNVV 129 (215)
T ss_dssp TSC-EEESCCEETTTB
T ss_pred CCC-EEEEEccCccCC
Confidence 888 999998876544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.83 E-value=0.13 Score=46.90 Aligned_cols=61 Identities=11% Similarity=0.174 Sum_probs=16.0
Q ss_pred eeeeccccceeEEEEEEccCCceEEE------EEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEE
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIAL------KKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV 70 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~ai------K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (323)
.+.+| ||.||++....+..+||+ |.........+....+.++..+++...|||+++.+++.
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 45555 999999987665568888 65543333344445667788888889999999987765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 323 | ||||
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-93 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-87 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-83 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-82 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-80 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-76 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-75 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-74 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-72 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-72 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-71 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-70 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-70 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-69 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-69 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-69 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-69 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-68 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-67 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-64 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-63 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-62 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-62 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-60 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-60 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-59 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-58 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-55 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-55 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-54 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-52 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-52 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-49 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-22 |
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 278 bits (712), Expect = 1e-93
Identities = 195/319 (61%), Positives = 240/319 (75%), Gaps = 30/319 (9%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M+ ++KVEKIGEGTYGVVYKARN +T E +ALKKIRL+ E EGVPSTAIREISLLKE+ H
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV+L DV+H+E KLYLVFE+L DLKK MD+ LIK++L+Q+L+G+A+CHS
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
HRVLHRDLKPQNLLI+ +KLADFGLARAFG+PVRT+THE
Sbjct: 121 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHE----------------- 162
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
VVTLWYRAPEILLG ++YST VD+WS+GCIFAEMV +R LFPGDSEID
Sbjct: 163 ------------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 210
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
+LF+IFR LGTP+E WPGVTS+PD+K +FPKW ++ VV L+ G LLS+ML D
Sbjct: 211 QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYD 270
Query: 301 PSRRITARSALEHEYFRDV 319
P++RI+A++AL H +F+DV
Sbjct: 271 PNKRISAKAALAHPFFQDV 289
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 261 bits (668), Expect = 3e-87
Identities = 181/318 (56%), Positives = 228/318 (71%), Gaps = 32/318 (10%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M++Y +EKIGEGTYGVVYKA+N ET ALKKIRLE+EDEG+PST IREIS+LKE++H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV+L DV+H++K+L LVFE+LD DLKK +D C + + K+FL Q+L GIAYCH
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
RVLHRDLKPQNLLI+R LK+ADFGLARAFGIPVR +TH
Sbjct: 119 RRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTH------------------ 159
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
++VTLWYRAP++L+GS+ YST +D+WSVGCIFAEMVN PLFPG SE D
Sbjct: 160 -----------EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
+L +IFR+LGTPN WP VT LP + F + + ++ L+ +GIDLLSKML +D
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD 268
Query: 301 PSRRITARSALEHEYFRD 318
P++RITA+ ALEH YF++
Sbjct: 269 PNQRITAKQALEHAYFKE 286
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (641), Expect = 4e-83
Identities = 126/317 (39%), Positives = 184/317 (58%), Gaps = 35/317 (11%)
Query: 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE---QEDEGVPSTAIREISLLKEMQHG 61
EK++ +GEG + VYKAR+ TN+ +A+KKI+L + +G+ TA+REI LL+E+ H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
NI+ L D + + LVF++++ DL+ + P IK ++ L+G+ Y H H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+LHRDLKP NLL+D LKLADFGLA++FG P R +TH
Sbjct: 120 WILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTH------------------- 159
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
+VVT WYRAPE+L G+R Y VD+W+VGCI AE++ + P PGDS++D+
Sbjct: 160 ----------QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 209
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301
L +IF LGTP E+ WP + SLPD+ + F +P L + +DL+ + +P
Sbjct: 210 LTRIFETLGTPTEEQWPDMCSLPDYVT-FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNP 268
Query: 302 SRRITARSALEHEYFRD 318
RITA AL+ +YF +
Sbjct: 269 CARITATQALKMKYFSN 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (636), Expect = 2e-82
Identities = 169/319 (52%), Positives = 219/319 (68%), Gaps = 32/319 (10%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M +YEK+EKIGEGTYG V+KA+N T+E +ALK++RL+ +DEGVPS+A+REI LLKE++H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIVRL DV+HS+KKL LVFE+ D DLKK+ DSC DP ++K+FL+Q+L+G+ +CHS
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHS 119
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
VLHRDLKPQNLLI+R KLA+FGLARAFGIPVR ++ E
Sbjct: 120 RNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAE----------------- 161
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239
VVTLWYR P++L G++ YST +D+WS GCIFAE+ N RPLFPG+
Sbjct: 162 ------------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
D+L +IFR+LGTP E+ WP +T LPD+K + L VV L G DLL +L
Sbjct: 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC 269
Query: 300 DPSRRITARSALEHEYFRD 318
+P +RI+A AL+H YF D
Sbjct: 270 NPVQRISAEEALQHPYFSD 288
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (622), Expect = 5e-80
Identities = 111/329 (33%), Positives = 179/329 (54%), Gaps = 38/329 (11%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ +YEK+ KIG+GT+G V+KAR+ T + +ALKK+ +E E EG P TA+REI +L+ ++H
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68
Query: 61 GNIVRLQDVVHS--------EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQIL 112
N+V L ++ + + +YLVF++ + DL + + IK + +L
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRVMQMLL 127
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
G+ Y H +++LHRD+K N+LI R LKLADFGLARAF + + + +
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVV--- 183
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
TLWYR PE+LLG R Y P+D+W GCI AEM + P+
Sbjct: 184 ----------------------TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDF-KSAFPKWPSKELGTVVRN--LEPAG 289
G++E +L I ++ G+ + WP V + + K K +++ ++ +P
Sbjct: 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 281
Query: 290 IDLLSKMLCMDPSRRITARSALEHEYFRD 318
+DL+ K+L +DP++RI + AL H++F
Sbjct: 282 LDLIDKLLVLDPAQRIDSDDALNHDFFWS 310
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 2e-76
Identities = 100/327 (30%), Positives = 163/327 (49%), Gaps = 46/327 (14%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Y + IG G++GVVY+A+ C + E +A+KK+ ++ + RE+ +++++ H
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHC 73
Query: 62 NIVRLQDVVHS------EKKLYLVFEYLDLDLKKHMDSCPDFAN--DPRLIKTFLYQILR 113
NIVRL+ +S E L LV +Y+ + + +K ++YQ+ R
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
+AY HS + HRD+KPQNLL+D T LKL DFG A+ E S
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL------VRGEPNVSY----- 182
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
+ + +YRAPE++ G+ Y++ +DVWS GC+ AE++ +P+F
Sbjct: 183 -------------------ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVR-NLEPAGIDL 292
PGDS +D+L +I +VLGTP + + + FP+ + V R P I L
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYT-EFKFPQIKAHPWTKVFRPRTPPEAIAL 282
Query: 293 LSKMLCMDPSRRITARSALEHEYFRDV 319
S++L P+ R+T A H +F ++
Sbjct: 283 CSRLLEYTPTARLTPLEACAHSFFDEL 309
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 3e-75
Identities = 138/328 (42%), Positives = 196/328 (59%), Gaps = 43/328 (13%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVT-NETIALKKIRLEQEDEGVPSTAIREISLLKEM-- 58
QYE V +IGEG YG V+KAR+ +ALK++R++ +EG+P + IRE+++L+ +
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 59 -QHGNIVRLQDVVHS-----EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQIL 112
+H N+VRL DV E KL LVFE++D DL ++D P+ IK ++Q+L
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
RG+ + HSHRV+HRDLKPQN+L+ KLADFGLAR + + +
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSV---------- 175
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232
VVTLWYRAPE+LL Y+TPVD+WSVGCIFAEM ++PL
Sbjct: 176 --------------------VVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPL 214
Query: 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292
F G S++D+L KI V+G P E+ WP +LP + AF ++ + V +++ G DL
Sbjct: 215 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALP--RQAFHSKSAQPIEKFVTDIDELGKDL 272
Query: 293 LSKMLCMDPSRRITARSALEHEYFRDVE 320
L K L +P++RI+A SAL H YF+D+E
Sbjct: 273 LLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 1e-74
Identities = 79/336 (23%), Positives = 139/336 (41%), Gaps = 53/336 (15%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D +EK+ ++G G GVV+K + + +A K I LE + + IRE+ +L E
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSP 64
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
IV +S+ ++ + E++D L + + +++ +++G+ Y
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLRE 122
Query: 121 -HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
H+++HRD+KP N+L++ R +KL DFG++ + + + G
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQL---IDSMANSFVG------------- 165
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV-NQRPLFPGDSE 238
T Y +PE L G HYS D+WS+G EM + P+ P D++
Sbjct: 166 ---------------TRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209
Query: 239 IDELFKIFRVLG----TPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEP------- 287
EL +V G TP PG + P EL + N P
Sbjct: 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGV 269
Query: 288 ---AGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320
D ++K L +P+ R + + H + + +
Sbjct: 270 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 1e-72
Identities = 110/324 (33%), Positives = 156/324 (48%), Gaps = 38/324 (11%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+Y + IGEG YG+V A + V +A+KKI E + +REI +L +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHE 66
Query: 62 NIVRLQDVVHSE-----KKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
NI+ + D++ + K +YLV + DL K + + I FLYQILRG+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLK 123
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
Y HS VLHRDLKP NLL++ + LK+ DFGLAR
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTE----------- 171
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
V T WYRAPEI+L S+ Y+ +D+WSVGCI AEM++ RP+FPG
Sbjct: 172 ---------------YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAF--PKWPSKELGTVVRNLEPAGIDLLS 294
+D+L I +LG+P+++ + +L P + N + +DLL
Sbjct: 217 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD 276
Query: 295 KMLCMDPSRRITARSALEHEYFRD 318
KML +P +RI AL H Y
Sbjct: 277 KMLTFNPHKRIEVEQALAHPYLEQ 300
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 224 bits (571), Expect = 7e-72
Identities = 64/321 (19%), Positives = 126/321 (39%), Gaps = 61/321 (19%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+D Y+ E++G G +GVV++ T A K + E + T +EI + ++H
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRH 82
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
+V L D + ++ +++E++ +L + + + ++ Q+ +G+ + H
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM-SEDEAVEYMRQVCKGLCHMH 141
Query: 120 SHRVLHRDLKPQNLLID-RRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
+ +H DLKP+N++ +R+N LKL DFGL
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT------------- 188
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
+ APE+ G + D+WSVG + +++ F G+++
Sbjct: 189 -----------------AEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGEND 230
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
+ L + ++ + G++ G D + K+L
Sbjct: 231 DETLRNVKSCDWNMDDSAFSGIS-------------------------EDGKDFIRKLLL 265
Query: 299 MDPSRRITARSALEHEYFRDV 319
DP+ R+T ALEH +
Sbjct: 266 ADPNTRMTIHQALEHPWLTPG 286
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 1e-71
Identities = 105/326 (32%), Positives = 159/326 (48%), Gaps = 44/326 (13%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Y ++ +G G YG V A + T +A+KK+ + E A RE+ LLK M+H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 62 NIVRLQDVVHSEKKL------YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
N++ L DV ++ L YLV ++ DL K M I+ +YQ+L+G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRIQFLVYQMLKGL 134
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y H+ ++HRDLKP NL ++ K+ DFGLAR + +
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLARQADSEMTGY--------------- 178
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
VVT WYRAPE++L Y+ VD+WSVGCI AEM+ + LF G
Sbjct: 179 -----------------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
+D+L +I +V GTP + + S ++ P+ K+ +++ N P ++LL
Sbjct: 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 281
Query: 294 SKMLCMDPSRRITARSALEHEYFRDV 319
KML +D +R+TA AL H YF +
Sbjct: 282 EKMLVLDAEQRVTAGEALAHPYFESL 307
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 3e-70
Identities = 106/325 (32%), Positives = 153/325 (47%), Gaps = 44/325 (13%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++Y+ + +G G YG V A + T +A+KK+ + RE+ LLK M+H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 62 NIVRLQDVVHSEKK------LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
N++ L DV + +YLV + DL + ++ +YQILRG+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT---DDHVQFLIYQILRGL 134
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
Y HS ++HRDLKP NL ++ LK+ DFGLAR + +
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTDDEMTGYVA------------- 180
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
T WYRAPEI+L HY+ VD+WSVGCI AE++ R LFPG
Sbjct: 181 -------------------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLP--DFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
ID+L I R++GTP + ++S ++ + + P V P +DLL
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 281
Query: 294 SKMLCMDPSRRITARSALEHEYFRD 318
KML +D +RITA AL H YF
Sbjct: 282 EKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 8e-70
Identities = 80/316 (25%), Positives = 127/316 (40%), Gaps = 56/316 (17%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ ++ V+ +GEG YG V A N VT E +A+K + +++ + P +EI + K + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHE 63
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
N+V+ YL EY PD + F +Q++ G+ Y H
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDR-IEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+ HRD+KP+NLL+D R N LK++DFGLA F R
Sbjct: 123 GITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNK----------------- 164
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
TL Y APE+L ++ PVDVWS G + M+ + S+ +
Sbjct: 165 ----------MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301
+ ++ T W ++ A + LL K+L +P
Sbjct: 215 EYSDWKEKKTY-----------------LNPWK---------KIDSAPLALLHKILVENP 248
Query: 302 SRRITARSALEHEYFR 317
S RIT + ++
Sbjct: 249 SARITIPDIKKDRWYN 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-69
Identities = 84/319 (26%), Positives = 139/319 (43%), Gaps = 66/319 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59
++ +E +G+G +G VY AR + +ALK + Q E GV RE+ + ++
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
H NI+RL H ++YL+ EY L + + + F D + T++ ++ ++YC
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF--DEQRTATYITELANALSYC 122
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
HS RV+HRD+KP+NLL+ LK+ADFG + + G
Sbjct: 123 HSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAP------SSRRTTLCG--------- 166
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
TL Y PE++ G R + VD+WS+G + E + +P F ++
Sbjct: 167 ----------------TLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
+ +I RV T FP + ++ DL+S++L
Sbjct: 210 QETYKRISRVEFT------------------FPDFVTEGA-----------RDLISRLLK 240
Query: 299 MDPSRRITARSALEHEYFR 317
+PS+R R LEH +
Sbjct: 241 HNPSQRPMLREVLEHPWIT 259
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 218 bits (555), Expect = 2e-69
Identities = 62/318 (19%), Positives = 125/318 (39%), Gaps = 59/318 (18%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D Y+ +E++G G +GVV++ T K I + T EIS++ ++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHP 86
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
++ L D + ++ L+ E+L + D+ + ++ Q G+ + H H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 122 RVLHRDLKPQNLLID-RRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
++H D+KP+N++ + ++ +++K+ DFGLA
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT------------------ 188
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
T + APEI+ D+W++G + +++ F G+ +++
Sbjct: 189 ------------TATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
L + R +ED + V+ P D + +L +
Sbjct: 236 TLQNVKRCDWEFDEDAFSSVS-------------------------PEAKDFIKNLLQKE 270
Query: 301 PSRRITARSALEHEYFRD 318
P +R+T ALEH + +
Sbjct: 271 PRKRLTVHDALEHPWLKG 288
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 215 bits (549), Expect = 7e-69
Identities = 94/332 (28%), Positives = 162/332 (48%), Gaps = 53/332 (15%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ- 59
D Y+ V K+G G Y V++A N NE + +K ++ ++ + REI +L+ ++
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRG 88
Query: 60 HGNIVRLQDVVHS--EKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
NI+ L D+V + LVFE+++ D K+ + D+ I+ ++Y+IL+ +
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD-----IRFYMYEILKALD 143
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
YCHS ++HRD+KP N++ID L+L D+GLA + P + +
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNV-------------- 188
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR-PLFPG 235
+V + +++ PE+L+ + Y +D+WS+GC+ A M+ ++ P F G
Sbjct: 189 ---------------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSL---PDFKSAFPKWPSKELGTVVR-----NLEP 287
D+L +I +VLGT + + ++ P F + K V + P
Sbjct: 234 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 293
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319
+D L K+L D R+TAR A+EH YF V
Sbjct: 294 EALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 9e-69
Identities = 72/322 (22%), Positives = 135/322 (41%), Gaps = 61/322 (18%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+Y + EKIG+G G VY A + T + +A++++ L+Q+ + I EI +++E ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNP 77
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
NIV D +L++V EYL D + D I + L+ + + HS+
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+V+HRD+K N+L+ + +KL DFG +
Sbjct: 136 QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVG---------------- 178
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
T ++ APE++ + Y VD+WS+G + EM+ P + ++ +
Sbjct: 179 -------------TPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301
L+ I P+ + P+ S D L++ L MD
Sbjct: 225 LYLIAT-------------NGTPELQ--NPEKLSAIF-----------RDFLNRCLDMDV 258
Query: 302 SRRITARSALEHEYFRDVEFVP 323
+R +A+ L+H++ + + +
Sbjct: 259 EKRGSAKELLQHQFLKIAKPLS 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-68
Identities = 62/318 (19%), Positives = 135/318 (42%), Gaps = 62/318 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++Y E +G G +G+V++ + +T K ++++ D+ +EIS+L +H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHR 61
Query: 62 NIVRLQDVVHSEKKLYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NI+ L + S ++L ++FE++ LD+ + +++ F + R I ++++Q+ + + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS 120
Query: 121 HRVLHRDLKPQNLLIDRRTNA-LKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
H + H D++P+N++ R ++ +K+ +FG AR
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--------------- 165
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
Y APE+ ST D+WS+G + +++ F ++
Sbjct: 166 ---------------APEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
+ I T +E+ + ++ +D + ++L
Sbjct: 210 QIIENIMNAEYTFDEEAFKEIS-------------------------IEAMDFVDRLLVK 244
Query: 300 DPSRRITARSALEHEYFR 317
+ R+TA AL+H + +
Sbjct: 245 ERKSRMTASEALQHPWLK 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-67
Identities = 74/320 (23%), Positives = 121/320 (37%), Gaps = 62/320 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D +E + ++G+G +G VYKA+N T+ A K I + E+E + EI +L H
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHP 69
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
NIV+L D + E L+++ E+ + + I+ Q L + Y H +
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+++HRDLK N+L + +KLADFG++ ++
Sbjct: 130 KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDS------------------- 169
Query: 182 LAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
+ T ++ APE+++ R Y DVWS+G EM P +
Sbjct: 170 ----------FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
+ L KI S P + +W D L K L
Sbjct: 220 PMRVLLKI--------------AKSEPPTLAQPSRWS------------SNFKDFLKKCL 253
Query: 298 CMDPSRRITARSALEHEYFR 317
+ R T L+H +
Sbjct: 254 EKNVDARWTTSQLLQHPFVT 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (516), Expect = 4e-64
Identities = 71/319 (22%), Positives = 126/319 (39%), Gaps = 62/319 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
D Y+ + +G G + V A + T + +A+K I + EG + EI++L +++H
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKK-ALEGKEGSMENEIAVLHKIKHP 67
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NIV L D+ S LYL+ + + +L + + R ++Q+L + Y H
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDAVKYLHD 125
Query: 121 HRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
++HRDLKP+NLL + + ++DFGL++ T
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST----------------- 168
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
T Y APE+L + YS VD WS+G I ++ P F +++
Sbjct: 169 -------------ACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
+I + + W ++ + D + ++
Sbjct: 215 AKLFEQILKAEYEFDSPYWDDIS-------------------------DSAKDFIRHLME 249
Query: 299 MDPSRRITARSALEHEYFR 317
DP +R T AL+H +
Sbjct: 250 KDPEKRFTCEQALQHPWIA 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 6e-64
Identities = 75/324 (23%), Positives = 120/324 (37%), Gaps = 69/324 (21%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ YE + IG G+YG K R + + K++ E + E++LL+E++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 62 NIVRLQDVVHSE--KKLYLVFEYLDL-DLKKHMDSCPDFAN--DPRLIKTFLYQILRGIA 116
NIVR D + LY+V EY + DL + D + + Q+ +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 117 YCH-----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
CH H VLHRDLKP N+ +D + N +KL DFGLAR
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVG------ 176
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231
T +Y +PE + Y+ D+WS+GC+ E+ P
Sbjct: 177 -----------------------TPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMP 212
Query: 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291
F S+ + KI + F + P +
Sbjct: 213 PFTAFSQKELAGKI--------------------REGKFRRIPY--------RYSDELNE 244
Query: 292 LLSKMLCMDPSRRITARSALEHEY 315
++++ML + R + LE+
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPL 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (510), Expect = 3e-63
Identities = 68/319 (21%), Positives = 121/319 (37%), Gaps = 65/319 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH 60
+ + +IG G++G VY AR+ +E +A+KK+ + I+E+ L++++H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
N ++ + E +LV EY ++ I + L+G+AY HS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
H ++HRD+K N+L+ +KL DFG A P +F
Sbjct: 134 HNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMA-PANSF-------------------- 171
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRH--YSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
V T ++ APE++L Y VDVWS+G E+ ++P +
Sbjct: 172 ------------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
+ L+ I + + + S+ + + L
Sbjct: 220 MSALYHIAQ----------------NESPALQSGHWSEYF-----------RNFVDSCLQ 252
Query: 299 MDPSRRITARSALEHEYFR 317
P R T+ L+H +
Sbjct: 253 KIPQDRPTSEVLLKHRFVL 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 199 bits (508), Expect = 3e-63
Identities = 74/335 (22%), Positives = 133/335 (39%), Gaps = 74/335 (22%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE-------QEDEGVPSTAIREISL 54
+ YE E +G G VV + + T + A+K I + +E + + ++E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 55 LKEMQ-HGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQIL 112
L+++ H NI++L+D + +LVF+ + +L ++ + + + +L
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL--SEKETRKIMRALL 120
Query: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISI 172
I H ++HRDLKP+N+L+D N +KL DFG + +
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREV---------- 169
Query: 173 YFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH-----YSTPVDVWSVGCIFAEMV 227
T Y APEI+ S + Y VD+WS G I ++
Sbjct: 170 --------------------CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 209
Query: 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEP 287
P F ++ L I +++ P+W +
Sbjct: 210 AGSPPFWHRKQMLMLRMIMS----------------GNYQFGSPEWD---------DYSD 244
Query: 288 AGIDLLSKMLCMDPSRRITARSALEHEYFRDVEFV 322
DL+S+ L + P +R TA AL H +F+ ++V
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQ--QYV 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-62
Identities = 66/328 (20%), Positives = 124/328 (37%), Gaps = 68/328 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH 60
+ ++ + +GEG++ V AR T+ A+K + E RE ++ + H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 61 GNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
V+L ++KLY Y +L K++ F D + + +I+ + Y H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH 125
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
++HRDLKP+N+L++ + +++ DFG A+ + +
Sbjct: 126 GKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSF-------------- 170
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
V T Y +PE+L + D+W++GCI ++V P F +E
Sbjct: 171 -------------VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 216
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
KI ++ FP+ + DL+ K+L +
Sbjct: 217 LIFQKIIKLEYD------------------FPEKFFPKA-----------RDLVEKLLVL 247
Query: 300 DPSRRITARSA------LEHEYFRDVEF 321
D ++R+ H +F V +
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFFESVTW 275
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 7e-62
Identities = 103/337 (30%), Positives = 153/337 (45%), Gaps = 55/337 (16%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
+ +Y+ ++ IG G G+V A + V + +A+KK+ +++ A RE+ L+K + H
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 61 GNIVRLQDVVHSEKK------LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRG 114
NI+ L +V +K +YLV E +D +L + + D + LYQ+L G
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCG 131
Query: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYF 174
I + HS ++HRDLKP N+++ K+ DFGLAR G +
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPY------------ 178
Query: 175 SFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234
VVT +YRAPE++LG Y VD+WSVGCI EMV + LFP
Sbjct: 179 ------------------VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFP 219
Query: 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSL-------------PDFKSAFPKWPSKELGTV 281
G ID+ K+ LGTP + + F FP
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 282 VRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318
+ DLLSKML +DP++RI+ AL+H Y
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-61
Identities = 75/328 (22%), Positives = 128/328 (39%), Gaps = 66/328 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIR---LEQEDEGVPSTAI-REISLLKE 57
D Y+ E++G G + VV K R T A K I+ + GV I RE+S+LKE
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
+QH N++ L +V ++ + L+ E + L + FL QIL G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL--TEEEATEFLKQILNGVY 127
Query: 117 YCHSHRVLHRDLKPQNLLIDRRTNA---LKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
Y HS ++ H DLKP+N+++ R +K+ DFGLA
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI----------- 176
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
T + APEI+ D+WS+G I +++ F
Sbjct: 177 -------------------FGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF 216
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
GD++ + L + V ++ + + D +
Sbjct: 217 LGDTKQETLANVSAVNYEFEDEYFSNTS-------------------------ALAKDFI 251
Query: 294 SKMLCMDPSRRITARSALEHEYFRDVEF 321
++L DP +R+T + +L+H + + +
Sbjct: 252 RRLLVKDPKKRMTIQDSLQHPWIKPKDT 279
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-60
Identities = 63/321 (19%), Positives = 118/321 (36%), Gaps = 68/321 (21%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
+ +IG G++ VYK + T +A +++ + + E +LK +QH NI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 64 VRL----QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
VR + V +K + LV E + LK ++ ++++++ QIL+G+ +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM--KIKVLRSWCRQILKGLQFL 128
Query: 119 HSH--RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
H+ ++HRDLK N+ I T ++K+ D GLA +F G
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIG---------- 175
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
T + APE+ Y VDV++ G EM +
Sbjct: 176 ------------------TPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSEC 215
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKM 296
++++ P F K E+ +++
Sbjct: 216 QNAAQIYRRVTSGVKPAS---------------FDKVAIPEV-----------KEIIEGC 249
Query: 297 LCMDPSRRITARSALEHEYFR 317
+ + R + + L H +F+
Sbjct: 250 IRQNKDERYSIKDLLNHAFFQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-60
Identities = 76/332 (22%), Positives = 122/332 (36%), Gaps = 68/332 (20%)
Query: 1 MDQYEKVEK-IGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREIS-LLKEM 58
+D Y+ + +G G G V + N T E ALK ++ + A RE+ +
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 62
Query: 59 QHGNIVRLQDVVHS----EKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILR 113
Q +IVR+ DV + K L +V E LD +L + D A R + I
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNA--LKLADFGLARAFGIPVRTFTHEHWGSTGIS 171
I Y HS + HRD+KP+NLL + LKL DFG A+ T +
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY------- 175
Query: 172 IYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231
T +Y APE+L Y D+WS+G I ++ P
Sbjct: 176 -----------------------TPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYP 211
Query: 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGID 291
F + + + + + ++ P+W +
Sbjct: 212 PFYSNHGLAISPGMKTRI------------RMGQYEFPNPEWS---------EVSEEVKM 250
Query: 292 LLSKMLCMDPSRRITARSALEHEYFRDVEFVP 323
L+ +L +P++R+T + H + VP
Sbjct: 251 LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 191 bits (486), Expect = 5e-59
Identities = 71/331 (21%), Positives = 125/331 (37%), Gaps = 70/331 (21%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE----QEDEGVPSTAIREISLLK 56
M+ + IG G +G VY R T + A+K + + ++ E + +SL+
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 57 EMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
IV + H+ KL + + ++ DL H+ F ++ + +I+ G+
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGL 120
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
+ H+ V++RDLKP N+L+D + ++++D GLA F + H G
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFS---KKKPHASVG--------- 167
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
T Y APE+L Y + D +S+GC+ +++ F
Sbjct: 168 -------------------THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSK 295
D+ L E P S EL LL
Sbjct: 209 HKTKDKHEIDRMTLTMAVE---------------LPDSFSPEL-----------RSLLEG 242
Query: 296 MLCMDPSRRIT-----ARSALEHEYFRDVEF 321
+L D +RR+ A+ E +FR +++
Sbjct: 243 LLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-58
Identities = 78/325 (24%), Positives = 136/325 (41%), Gaps = 66/325 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE--QEDEGVPSTAIREISLLKEM 58
++ + + +G+G++G V+ A TN+ A+K ++ + D+ V T + + L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
+H + + +++ L+ V EYL+ DL H+ SC F D + +I+ G+ +
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF--DLSRATFYAAEIILGLQF 118
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
HS +++RDLK N+L+D+ + K+ADFG+ + +
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNT--------------- 162
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
T Y APEILLG + Y+ VD WS G + EM+ + F G
Sbjct: 163 --------------FCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
E + I P +P+W KE DLL K+
Sbjct: 208 EEELFHSIRM--DNPF----------------YPRWLEKEA-----------KDLLVKLF 238
Query: 298 CMDPSRRITARSA-LEHEYFRDVEF 321
+P +R+ R +H FR++ +
Sbjct: 239 VREPEKRLGVRGDIRQHPLFREINW 263
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 9e-58
Identities = 70/324 (21%), Positives = 109/324 (33%), Gaps = 72/324 (22%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLE----QEDEGVPSTAIREISLLKE 57
QY+ +G G +G VY N +A+K + + + + E+ LLK+
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 58 MQHG--NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
+ G ++RL D L+ E + A L ++F +Q+L +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
+CH+ VLHRD+K +N+LID LKL DFG + +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA--------LLKDTVYTD------- 168
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
T Y PE + R++ VWS+G + +MV F
Sbjct: 169 ----------------FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSK 295
D EI F + S E L+
Sbjct: 213 DEEIIRGQVF------------------------FRQRVSSEC-----------QHLIRW 237
Query: 296 MLCMDPSRRITARSALEHEYFRDV 319
L + PS R T H + +DV
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQDV 261
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 4e-55
Identities = 53/315 (16%), Positives = 109/315 (34%), Gaps = 59/315 (18%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Q ++IG G++G VYK + + +A+K + + E+ +L++ +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
NI+ + +L +V ++ + L H+ + + Q +G+ Y H+
Sbjct: 65 NILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHA 122
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
++HRDLK N+ + K+ DFGLA + E
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTV-KIGDFGLATVKSRWSGSHQFEQ---------------- 165
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
++ + APE++ YS DV++ G + E++ + + +
Sbjct: 166 -----------LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
D++ + P ++ + N A L+++ L
Sbjct: 215 RDQIIFMVG-----RGYLSPDLSKVRS------------------NCPKAMKRLMAECLK 251
Query: 299 MDPSRRITARSALEH 313
R L
Sbjct: 252 KKRDERPLFPQILAS 266
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 179 bits (456), Expect = 5e-55
Identities = 59/327 (18%), Positives = 125/327 (38%), Gaps = 70/327 (21%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59
+ ++ + +G G++G V+ R+ A+K ++ E E +L +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCH 119
H I+R+ ++++++ +Y++ + + K + ++ + Y H
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-RKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRY 179
S +++RDLKP+N+L+D+ + +K+ DFG A+ T
Sbjct: 122 SKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCG----------------- 163
Query: 180 RVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239
T Y APE++ + Y+ +D WS G + EM+ F + +
Sbjct: 164 ---------------TPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 207
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
KI + FP + ++++ DLLS+++
Sbjct: 208 KTYEKILNA------------------ELRFPPFFNEDV-----------KDLLSRLITR 238
Query: 300 DPSRRI-----TARSALEHEYFRDVEF 321
D S+R+ H +F++V +
Sbjct: 239 DLSQRLGNLQNGTEDVKNHPWFKEVVW 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 176 bits (448), Expect = 3e-54
Identities = 69/322 (21%), Positives = 119/322 (36%), Gaps = 61/322 (18%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQH 60
D+YE E +G G V+ AR+ + +A+K +R + D RE + H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 61 GNIVRLQDVVHSEKK----LYLVFEYLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
IV + D +E Y+V EY+D + L+ + + P+ + + +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM--TPKRAIEVIADACQAL 124
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
+ H + ++HRD+KP N++I K+ DFG+ARA + T
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAV-KVMDFGIARAIADSGNSVTQTA----------- 172
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235
+ T Y +PE G DV+S+GC+ E++ P F G
Sbjct: 173 ---------------AVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTG 216
Query: 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSK 295
DS + ++ R P G+ S +L ++ K
Sbjct: 217 DSPVSVAYQHVREDPIPPSARHEGL--------------SADL-----------DAVVLK 251
Query: 296 MLCMDPSRRITARSALEHEYFR 317
L +P R + + + R
Sbjct: 252 ALAKNPENRYQTAAEMRADLVR 273
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 173 bits (439), Expect = 4e-52
Identities = 74/351 (21%), Positives = 128/351 (36%), Gaps = 66/351 (18%)
Query: 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Y V K+G G + V+ A++ V N +A+K +R D+ A EI LL+ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADN 71
Query: 64 VRLQDVVH---------------SEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFL 108
+ + + + +VFE L +L + +K
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 109 YQILRGIAYCHSHR-VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167
Q+L G+ Y H ++H D+KP+N+L++ + L +A G H
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD-LGNACWYDEHYTNSI 190
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
T YR+PE+LLG + D+WS C+ E++
Sbjct: 191 Q--------------------------TREYRSPEVLLG-APWGCGADIWSTACLIFELI 223
Query: 228 NQRPLFPGDS------EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSA---------FPK 272
LF D + D + +I +LG F ++
Sbjct: 224 TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF 283
Query: 273 WPSKELGT----VVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319
WP +++ T ++ D LS ML +DP +R A + H + +D
Sbjct: 284 WPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 5e-52
Identities = 72/328 (21%), Positives = 125/328 (38%), Gaps = 69/328 (21%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59
M+ ++ ++ +G+GT+G V R T A+K +R E + + + E +L+ +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
H + L+ + +L V EY + L H+ F + + +I+ + Y
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF--TEERARFYGAEIVSALEYL 121
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
HS V++RD+K +NL++D+ + +K+ DFGL + GI G
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGH-IKITDFGLCK-EGISDGATMKTFCG------------ 167
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
T Y APE+L Y VD W +G + EM+ R F
Sbjct: 168 ----------------TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
I ++P R L P LL+ +L
Sbjct: 211 ERLFELI---------------------LMEEIRFP--------RTLSPEAKSLLAGLLK 241
Query: 299 MDPSRRI-----TARSALEHEYFRDVEF 321
DP +R+ A+ +EH +F + +
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINW 269
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-51
Identities = 61/333 (18%), Positives = 130/333 (39%), Gaps = 67/333 (20%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCV---TNETIALKKIRLEQ--EDEGVPSTAIREISLL 55
++ +E ++ +G G YG V+ R T + A+K ++ + E +L
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 56 KEMQHG-NIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILR 113
+ ++ +V L +E KL+L+ +Y++ +L H+ F ++ ++ +I+
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF--TEHEVQIYVGEIVL 140
Query: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIY 173
+ + H +++RD+K +N+L+D + + L DFGL++ F ++ G+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE---- 195
Query: 174 FSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233
+ + G + VD WS+G + E++ F
Sbjct: 196 -----------------------YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232
Query: 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLL 293
D E + +I R + + +P+ S DL+
Sbjct: 233 TVDGEKNSQAEISR--------------RILKSEPPYPQEMSALA-----------KDLI 267
Query: 294 SKMLCMDPSRRI-----TARSALEHEYFRDVEF 321
++L DP +R+ A EH +F+ + +
Sbjct: 268 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 6e-51
Identities = 56/312 (17%), Positives = 106/312 (33%), Gaps = 61/312 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ V++IG G +G+V+ + + +A+K IR E I E ++ ++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHP 60
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
+V+L V + + LVFE+++ + + G+AY
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
V+HRDL +N L+ K++DFG+ R T +
Sbjct: 121 CVIHRDLAARNCLVGENQVI-KVSDFGMTRFVLDDQYTSSTGTKF--------------- 164
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241
+ + +PE+ SR YS+ DVWS G + E+ ++ + + E
Sbjct: 165 -------------PVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
Query: 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDP 301
+ + F+ P+ S + +++ P
Sbjct: 211 VVEDIS----------------TGFRLYKPRLASTHV-----------YQIMNHCWKERP 243
Query: 302 SRRITARSALEH 313
R L
Sbjct: 244 EDRPAFSRLLRQ 255
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 8e-51
Identities = 60/316 (18%), Positives = 114/316 (36%), Gaps = 71/316 (22%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
M + + ++ IG+G +G V +A+K I+ + + + E S++ +++H
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAF----LAEASVMTQLRH 59
Query: 61 GNIVRLQDVVHSEK-KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
N+V+L V+ EK LY+V EY+ L ++ S + F + + Y
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
+ +HRDL +N+L+ A K++DFGL + T
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVA-KVSDFGLTKEASSTQDTGKL---------------- 162
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV-NQRPLFPGDS 237
+ + APE L + +ST DVWS G + E+ R +P
Sbjct: 163 ----------------PVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
D + ++ + +K P + +++
Sbjct: 206 LKDVVPRVEK-----------------GYKMDAPDGCPPAV-----------YEVMKNCW 237
Query: 298 CMDPSRRITARSALEH 313
+D + R + E
Sbjct: 238 HLDAAMRPSFLQLREQ 253
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-49
Identities = 62/341 (18%), Positives = 116/341 (34%), Gaps = 86/341 (25%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNET-----IALKKIRLEQEDEGVPSTAIREISLLK 56
+ E + +G G +G V A ++T +A+K ++ E+ D + E+ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMT 95
Query: 57 EM-QHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFAN--------------- 99
++ H NIV L +YL+FEY DL ++ S + +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 100 ------DPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153
+ F YQ+ +G+ + +HRDL +N+L+ K+ DFGLAR
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV-KICDFGLARDI 214
Query: 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTP 213
+ + + + APE L Y+
Sbjct: 215 MSDSNYVVRGNA---------------------------RLPVKWMAPESLFEG-IYTIK 246
Query: 214 VDVWSVGCIFAEMVNQ-RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPK 272
DVWS G + E+ + +PG +K+ + FK P
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ----------------NGFKMDQPF 290
Query: 273 WPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313
+ ++E+ ++ D +R + +
Sbjct: 291 YATEEI-----------YIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (421), Expect = 1e-49
Identities = 71/328 (21%), Positives = 126/328 (38%), Gaps = 72/328 (21%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59
+DQ+++++ +G G++G V ++ + A+K + ++ + E +L+ +
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 60 HGNIVRLQDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
+V+L+ LY+V EY+ + H+ F + + QI+ Y
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--SEPHARFYAAQIVLTFEYL 157
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
HS +++RDLKP+NLLID++ +++ DFG A+ T
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCG---------------- 200
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
T APEI+L + Y+ VD W++G + EM P F D
Sbjct: 201 ----------------TPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
I KI K FP S +L DLL +L
Sbjct: 244 IQIYEKIVS------------------GKVRFPSHFSSDL-----------KDLLRNLLQ 274
Query: 299 MDPSRRI-----TARSALEHEYFRDVEF 321
+D ++R H++F ++
Sbjct: 275 VDLTKRFGNLKNGVNDIKNHKWFATTDW 302
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-48
Identities = 66/323 (20%), Positives = 124/323 (38%), Gaps = 67/323 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ + VE++G G +G V+ + +A+K ++ + P + E +L+K++QH
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
+VRL VV +++ +Y++ EY++ L + + + QI G+A+
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
+HRDL+ N+L+ + K+ADFGLAR +E+ G
Sbjct: 128 RNYIHRDLRAANILVSDTLSC-KIADFGLARLIE------DNEYTAREGA---------- 170
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV-NQRPLFPGDSEI 239
+ + APE + ++ DVWS G + E+V + R +PG +
Sbjct: 171 ------------KFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
+ + + R ++ P +EL L+
Sbjct: 218 EVIQNLER-----------------GYRMVRPDNCPEEL-----------YQLMRLCWKE 249
Query: 300 DPSRRITARSALE--HEYFRDVE 320
P R T ++F E
Sbjct: 250 RPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 4e-48
Identities = 67/323 (20%), Positives = 111/323 (34%), Gaps = 67/323 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
+ K+G+G +G V+ T +A+K ++ ++E ++K+++H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP---EAFLQEAQVMKKLRHE 72
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLD-LKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
+V+L VV E +Y+V EY+ L + + QI G+AY
Sbjct: 73 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
+HRDL+ N+L+ K+ADFGLAR T
Sbjct: 132 MNYVHRDLRAANILVGENLVC-KVADFGLARLIEDNEYTARQGAKF-------------- 176
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV-NQRPLFPGDSEI 239
+ + APE L R ++ DVWS G + E+ R +PG
Sbjct: 177 --------------PIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221
Query: 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCM 299
+ L ++ R P P + DL+ +
Sbjct: 222 EVLDQVERGYRMPCPPECP----------------------------ESLHDLMCQCWRK 253
Query: 300 DPSRRITARSALE--HEYFRDVE 320
+P R T +YF E
Sbjct: 254 EPEERPTFEYLQAFLEDYFTSTE 276
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 6e-48
Identities = 54/323 (16%), Positives = 98/323 (30%), Gaps = 55/323 (17%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++Y KIG G++G +Y + E +A+K ++ + + E + K MQ G
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL----HIESKIYKMMQGG 62
Query: 62 NIVRLQDVVHSEKK-LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
+ +E +V E L L+ + C + + Q++ I Y HS
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHS 121
Query: 121 HRVLHRDLKPQNLLIDRRTNALKL--ADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
+HRD+KP N L+ + DFGLA+ + + + +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL-------- 173
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238
T Y + LG S D+ S+G + + G
Sbjct: 174 --------------TGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218
Query: 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298
+ K R+ + K E L+
Sbjct: 219 ATKRQKYERISEKK----------MSTPIEVLCKGYPSEF-----------ATYLNFCRS 257
Query: 299 MDPSRRITA---RSALEHEYFRD 318
+ + R + + R
Sbjct: 258 LRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (402), Expect = 2e-47
Identities = 53/312 (16%), Positives = 111/312 (35%), Gaps = 61/312 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
K+G G YG VY+ + T+A+K ++ + + ++E +++KE++H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHP 73
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
N+V+L V E Y++ E++ +L ++ C ++ QI + Y
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYR 180
+HRDL +N L+ +K+ADFGL+ R
Sbjct: 134 KNFIHRDLAARNCLVGENHL-VKVADFGLS-----------------------------R 163
Query: 181 VLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240
++ G L +S DVW+ G + E+ ++
Sbjct: 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
+++++ D++ P+ +++ +L+ +
Sbjct: 224 QVYELLE----------------KDYRMERPEGCPEKV-----------YELMRACWQWN 256
Query: 301 PSRRITARSALE 312
PS R + +
Sbjct: 257 PSDRPSFAEIHQ 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 6e-47
Identities = 48/313 (15%), Positives = 105/313 (33%), Gaps = 63/313 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
++++G G +GVV + +A+K I+ E I E ++ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHE 59
Query: 62 NIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSH 121
+V+L V ++ ++++ EY+ + + + + + Y S
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRV 181
+ LHRDL +N L++ + K++DFGL+R T +
Sbjct: 120 QFLHRDLAARNCLVNDQGVV-KVSDFGLSRYVLDDEYTSSVGSKF--------------- 163
Query: 182 LAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV-NQRPLFPGDSEID 240
+ + PE+L+ +S+ D+W+ G + E+ + + + +
Sbjct: 164 -------------PVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209
Query: 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMD 300
I + L P S+++ ++
Sbjct: 210 TAEHIAQGLRLY-----------------RPHLASEKV-----------YTIMYSCWHEK 241
Query: 301 PSRRITARSALEH 313
R T + L +
Sbjct: 242 ADERPTFKILLSN 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 157 bits (398), Expect = 9e-47
Identities = 52/316 (16%), Positives = 96/316 (30%), Gaps = 54/316 (17%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Y+ +IGEG++GV+++ N + N+ +A+K + + E K +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL----RDEYRTYKLLAGC 60
Query: 62 N-IVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS 120
I + LV + L L+ +D C + + Q+L + H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHE 119
Query: 121 HRVLHRDLKPQNLLIDR----RTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSF 176
+++RD+KP N LI R N + + DFG+ + + PV + +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL------ 173
Query: 177 LRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236
T Y + LG R S D+ ++G +F + + G
Sbjct: 174 ----------------SGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGL 216
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKM 296
K R+ P +EL +
Sbjct: 217 KAATNKQKYERI------------------GEKKQSTPLREL---CAGFPEEFYKYMHYA 255
Query: 297 LCMDPSRRITARSALE 312
+
Sbjct: 256 RNLAFDATPDYDYLQG 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (395), Expect = 3e-46
Identities = 51/317 (16%), Positives = 106/317 (33%), Gaps = 59/317 (18%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNET---IALKKIRLEQEDEGVPSTAIREISLLKE 57
+ + + IG G +G V + + +A+K ++ ++ + E S++ +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQ 83
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
H N++ L+ VV + ++ E+++ D + L I G+ Y
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
+HRDL +N+L++ K++DFGL+R T+
Sbjct: 144 LADMNYVHRDLAARNILVNSNLVC-KVSDFGLSRFLEDDTSDPTYTSALG---------- 192
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ-RPLFPGD 236
+ + + APE + R +++ DVWS G + E+++ +
Sbjct: 193 --------------GKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKM 296
+ D + I D++ P L L+
Sbjct: 238 TNQDVINAI-----------------EQDYRLPPPMDCPSAL-----------HQLMLDC 269
Query: 297 LCMDPSRRITARSALEH 313
D + R +
Sbjct: 270 WQKDRNHRPKFGQIVNT 286
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-46
Identities = 59/317 (18%), Positives = 118/317 (37%), Gaps = 65/317 (20%)
Query: 9 KIGEGTYGVVYKA--RNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
++G G +G V K + +T+A+K ++ E D + + E ++++++ + IVR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 67 QDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLH 125
+ +E LV E +L L K++ + I ++Q+ G+ Y +H
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYLQQNRHV--KDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGS 185
RDL +N+L+ + A K++DFGL++A + + G
Sbjct: 131 RDLAARNVLLVTQHYA-KISDFGLSKALRADENYYKAQTHG------------------- 170
Query: 186 LILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ-RPLFPGDSEIDELFK 244
+ + APE + +S+ DVWS G + E + + + G +
Sbjct: 171 -------KWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 222
Query: 245 IFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRR 304
+ + + P +E+ DL++ D R
Sbjct: 223 LEK-----------------GERMGCPAGCPREM-----------YDLMNLCWTYDVENR 254
Query: 305 ITARSALE--HEYFRDV 319
+ Y+ DV
Sbjct: 255 PGFAAVELRLRNYYYDV 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 5e-46
Identities = 57/317 (17%), Positives = 107/317 (33%), Gaps = 61/317 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTN---ETIALKKIRLEQ-EDEGVPSTAIREISLLKE 57
+EK+G+G++GVV + + ++A+K ++ + IRE++ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
+ H N++RL VV + +V E L + + Q+ G+ Y
Sbjct: 68 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
S R +HRDL +NLL+ R +K+ DFGL RA + +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQE------------- 172
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ-RPLFPGD 236
+ L +R +S D W G EM + + G
Sbjct: 173 --------------HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218
Query: 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKM 296
+ L KI + + P+ +++ +++ +
Sbjct: 219 NGSQILHKIDK----------------EGERLPRPEDCPQDI-----------YNVMVQC 251
Query: 297 LCMDPSRRITARSALEH 313
P R T + +
Sbjct: 252 WAHKPEDRPTFVALRDF 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-44
Identities = 61/316 (19%), Positives = 109/316 (34%), Gaps = 64/316 (20%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNET---IALKKIRLEQEDEGVPSTAIREISLLKEM 58
++ E IGEG +G V++ +A+K + + V ++E +++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQF 65
Query: 59 QHGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYC 118
H +IV+L V+ E ++++ E L + ++ D + + YQ+ +AY
Sbjct: 66 DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLR 178
S R +HRD+ +N+L+ KL DFGL+R +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCV-KLGDFGLSRYMEDSTYYKASKGKL------------ 171
Query: 179 YRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEM-VNQRPLFPGDS 237
+ + APE + R +++ DVW G E+ ++ F G
Sbjct: 172 ----------------PIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
D + +I P P L L++K
Sbjct: 215 NNDVIGRIENGERLP-----------------MPPNCPPTL-----------YSLMTKCW 246
Query: 298 CMDPSRRITARSALEH 313
DPSRR
Sbjct: 247 AYDPSRRPRFTELKAQ 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-44
Identities = 54/316 (17%), Positives = 108/316 (34%), Gaps = 62/316 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNET----IALKKIRLEQEDEGVPSTAIREISLLKE 57
+++K++ +G G +G VYK E +A+K++R + + E ++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMAS 67
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
+ + ++ RL + + + L ++ D + + + QI +G+ Y
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNY 126
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
R++HRDL +N+L+ + K+ DFGLA+ G + + E
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHV-KITDFGLAKLLGAEEKEYHAEGG------------ 173
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
V + + A E +L R Y+ DVWS G E++
Sbjct: 174 ---------------KVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
E+ I + P + ++ ++ K
Sbjct: 218 PASEISSILE----------------KGERLPQPPICTIDV-----------YMIMVKCW 250
Query: 298 CMDPSRRITARSALEH 313
+D R R +
Sbjct: 251 MIDADSRPKFRELIIE 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-44
Identities = 62/330 (18%), Positives = 114/330 (34%), Gaps = 61/330 (18%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
E IG+G +G V++ + E +A+K +E EI ++H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWF---REAEIYQTVMLRHE 57
Query: 62 NIVRLQDVVHSE----KKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIA 116
NI+ + + +L+LV +Y + L +++ + G+A
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLA 114
Query: 117 YCHSH--------RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGST 168
+ H + HRDLK +N+L+ + +AD GLA T
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC-CIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 169 GISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRH-----YSTPVDVWSVGCIF 223
G T Y APE+L S + D++++G +F
Sbjct: 174 G-------------------------TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208
Query: 224 AEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFP-KWPSKELGTVV 282
E+ + + G E +L V P+ + V + P +W S E V+
Sbjct: 209 WEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM 267
Query: 283 RNLEPAGIDLLSKMLCMDPSRRITARSALE 312
++ + + + R+TA +
Sbjct: 268 A-------KIMRECWYANGAARLTALRIKK 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-43
Identities = 54/315 (17%), Positives = 106/315 (33%), Gaps = 60/315 (19%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNE----TIALKKIRLEQEDEGVPSTAIREISLLKE 57
+ + IG G +G VYK ++ +A+K ++ ++ + E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQ 65
Query: 58 MQHGNIVRLQDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAY 117
H NI+RL+ V+ K + ++ EY++ D + L I G+ Y
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFL 177
+ +HRDL +N+L++ K++DFGL+R T+ G
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVC-KVSDFGLSRVLE-DDPEATYTTSGGKI-------- 175
Query: 178 RYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237
+ + APE + + + DVWS G + E++ +
Sbjct: 176 -----------------PIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWEL 217
Query: 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297
E+ K F+ P + L+ +
Sbjct: 218 SNHEVMKAIN----------------DGFRLPTPMDCPSAI-----------YQLMMQCW 250
Query: 298 CMDPSRRITARSALE 312
+ +RR +
Sbjct: 251 QQERARRPKFADIVS 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-43
Identities = 59/314 (18%), Positives = 104/314 (33%), Gaps = 64/314 (20%)
Query: 9 KIGEGTYGVVYKARNCVTNE--TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
++G G +G V + + + +A+K ++ E +RE ++ ++ + IVRL
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIMHQLDNPYIVRL 74
Query: 67 QDVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHR 126
V + L LV E + L+Q+ G+ Y +HR
Sbjct: 75 IGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSL 186
DL +N+L+ R A K++DFGL++A G +T G
Sbjct: 134 DLAARNVLLVNRHYA-KISDFGLSKALGADDSYYTARSAG-------------------- 172
Query: 187 ILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ-RPLFPGDSEIDELFKI 245
L + APE + R +S+ DVWS G E ++ + + + + I
Sbjct: 173 ------KWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 225
Query: 246 FRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI 305
+ P EL L+S R
Sbjct: 226 EQGKRME-----------------CPPECPPEL-----------YALMSDCWIYKWEDRP 257
Query: 306 TARS---ALEHEYF 316
+ + Y+
Sbjct: 258 DFLTVEQRMRACYY 271
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 7e-43
Identities = 58/311 (18%), Positives = 107/311 (34%), Gaps = 61/311 (19%)
Query: 8 EKIGEGTYGVVYKARNCVTNET---IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
E IG G +G VY + A+K + D G S + E ++K+ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 65 RLQDV-VHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRV 123
L + + SE +V Y+ ++ + + F Q+ +G+ + S +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLA 183
+HRDL +N ++D + K+ADFGLAR H G+
Sbjct: 152 VHRDLAARNCMLDEKFTV-KVADFGLARDMYDKEFDSVHNKTGAKL-------------- 196
Query: 184 GSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV-NQRPLFPGDSEIDEL 242
+ + A E L + +T DVWS G + E++ P +P + D
Sbjct: 197 -----------PVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 244
Query: 243 FKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302
+ + + P++ L +++ K
Sbjct: 245 VYLLQ-----------------GRRLLQPEYCPDPL-----------YEVMLKCWHPKAE 276
Query: 303 RRITARSALEH 313
R + +
Sbjct: 277 MRPSFSELVSR 287
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-42
Identities = 65/332 (19%), Positives = 110/332 (33%), Gaps = 80/332 (24%)
Query: 1 MDQYEKVEKIGEGTYGVVYKARNCVTNE--TIALKKIRLEQEDEGVPSTAIREISLLKEM 58
+ + + IGEG +G V KAR A+K+++ + E+ +L ++
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKL 67
Query: 59 -QHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFANDPRL------------- 103
H NI+ L LYL EY +L + DP
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 104 -IKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162
+ F + RG+ Y + +HRDL +N+L+ A K+ADFGL+R + V+
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMG 186
Query: 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCI 222
+ + + A E L S + +T DVWS G +
Sbjct: 187 ------------------------------RLPVRWMAIESLNYSVY-TTNSDVWSYGVL 215
Query: 223 FAEMV-NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTV 281
E+V + G + + K+ ++ P E+
Sbjct: 216 LWEIVSLGGTPYCGMTCAELYEKL-----------------PQGYRLEKPLNCDDEV--- 255
Query: 282 VRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313
DL+ + P R + L
Sbjct: 256 --------YDLMRQCWREKPYERPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-42
Identities = 63/335 (18%), Positives = 116/335 (34%), Gaps = 81/335 (24%)
Query: 2 DQYEKVEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLK 56
++ + +G G +G V +A T+A+K ++ + + E+ +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL-MSELKVLS 81
Query: 57 EM-QHGNIVRLQDVVHSEKKLYLVFEY-----LDLDLKKHMDSC------------PDFA 98
+ H NIV L ++ EY L L++ DS + A
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 99 NDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158
D + +F YQ+ +G+A+ S +HRDL +N+L+ K+ DFGLAR
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSN 200
Query: 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218
+ + + + APE + Y+ DVWS
Sbjct: 201 YVVKGNA---------------------------RLPVKWMAPESIFN-CVYTFESDVWS 232
Query: 219 VGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKE 277
G E+ + +PG + +K+ + F+ P+ E
Sbjct: 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIK----------------EGFRMLSPEHAPAE 276
Query: 278 LGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312
+ D++ DP +R T + ++
Sbjct: 277 M-----------YDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 5e-42
Identities = 65/340 (19%), Positives = 113/340 (33%), Gaps = 87/340 (25%)
Query: 2 DQYEKVEKIGEGTYGVVYKAR-----NCVTNETIALKKIRLEQEDEGVPSTAIREISLLK 56
+ E V IGEG +G V++AR +A+K ++ E + + RE +L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMA 71
Query: 57 EMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFAN---------------- 99
E + NIV+L V K + L+FEY+ DL + + S
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 100 ------DPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153
Q+ G+AY + +HRDL +N L+ K+ADFGL+R
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV-KIADFGLSRNI 190
Query: 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTP 213
+ + + + PE + Y+T
Sbjct: 191 YSADYYKADGN---------------------------DAIPIRWMPPESIFY-NRYTTE 222
Query: 214 VDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPK 272
DVW+ G + E+ + + G + + ++ + A P+
Sbjct: 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV-----------------RDGNILACPE 265
Query: 273 WPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312
EL +L+ P+ R + S
Sbjct: 266 NCPLEL-----------YNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-39
Identities = 67/335 (20%), Positives = 126/335 (37%), Gaps = 80/335 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNCVTNE-------TIALKKIRLEQEDEGVPSTAIREISL 54
D+ + +GEG +G V A ++ +A+K ++ + ++ + S I E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEM 71
Query: 55 LKEM-QHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSC--------------PDFA 98
+K + +H NI+ L + LY++ EY +L++++ + P+
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 99 NDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158
+ + + YQ+ RG+ Y S + +HRDL +N+L+ K+ADFGLAR
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHHIDY 190
Query: 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218
+ + + + APE L R Y+ DVWS
Sbjct: 191 YKKTTNG---------------------------RLPVKWMAPEALFD-RIYTHQSDVWS 222
Query: 219 VGCIFAEMVNQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKEL 278
G + E+ ++ELFK+ + + P + EL
Sbjct: 223 FGVLLWEIFTLGGSPYPGVPVEELFKLLK----------------EGHRMDKPSNCTNEL 266
Query: 279 GTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313
++ PS+R T + +E
Sbjct: 267 -----------YMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-38
Identities = 59/334 (17%), Positives = 117/334 (35%), Gaps = 78/334 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARNC-----VTNETIALKKIRLEQEDEGVPSTAIREISLLK 56
D+ + + +G G +G V +A T T+A+K ++ + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 57 EMQHGNIVRLQDVVHSE-KKLYLVFEYLDL-DLKKHMDSCPDFANDPRL----------- 103
H N+V L L ++ E+ +L ++ S + ++
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 104 ---IKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160
+ + +Q+ +G+ + S + +HRDL +N+L+ + +K+ DFGLAR +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIY---KDP 188
Query: 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
+ G + L + APE + R Y+ DVWS G
Sbjct: 189 DYVRKGDA------------------------RLPLKWMAPETIFD-RVYTIQSDVWSFG 223
Query: 221 CIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELG 279
+ E+ + +PG +E + + + P + + E+
Sbjct: 224 VLLWEIFSLGASPYPGVKIDEEFCRRLK----------------EGTRMRAPDYTTPEM- 266
Query: 280 TVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313
+ +PS+R T +EH
Sbjct: 267 ----------YQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 5e-38
Identities = 62/341 (18%), Positives = 118/341 (34%), Gaps = 79/341 (23%)
Query: 2 DQYEKVEKIGEGTYGVVYKARN-----CVTNETIALKKIRLEQEDEGVPSTAIREISLLK 56
++ ++G+G++G+VY+ +A+K + E + E S++K
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMK 78
Query: 57 EMQHGNIVRLQDVVHSEKKLYLVFEYLDL-DLKKHMDSCPDFAN--------DPRLIKTF 107
E ++VRL VV + ++ E + DLK ++ S +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGS 167
+I G+AY ++++ +HRDL +N ++ +K+ DFG+ R + G
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYET----DYYRKGG 193
Query: 168 TGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227
G ++ + + +PE L ++T DVWS G + E+
Sbjct: 194 KG-----------------------LLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIA 229
Query: 228 N-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLE 286
+ G S L + G+ PD N
Sbjct: 230 TLAEQPYQGLSNEQVLRFVME----------GGLLDKPD------------------NCP 261
Query: 287 PAGIDLLSKMLCMDPSRRITARSALE------HEYFRDVEF 321
+L+ +P R + + FR+V F
Sbjct: 262 DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.8 bits (222), Expect = 4e-22
Identities = 28/225 (12%), Positives = 60/225 (26%), Gaps = 56/225 (24%)
Query: 8 EKIGEGTYGVVYKARNCVTNETIALKKIRLEQED--------EGVPSTAIREISLLKEMQ 59
+ +GEG V+ + +K ++ + +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 60 HGNIVRLQDVVHSEK----KLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGI 115
+ +LQ + + ++ E +D + L IL +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENP--------DEVLDMILEEV 116
Query: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFS 175
A + ++H DL N+L+ + + DF + E +
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEG--IWIIDFPQS-------VEVGEEG--------WRE 159
Query: 176 FLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVG 220
L V + + ++ R Y T D+ S
Sbjct: 160 ILERDV----------RNIITYFS--------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 323 | |||
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.69 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.18 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.02 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.59 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.14 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.79 |
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-60 Score=410.79 Aligned_cols=291 Identities=66% Similarity=1.129 Sum_probs=253.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
||+|++++.||+|+||+||+|++..+++.||+|++............+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 68999999999999999999999999999999999766555556788999999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
||++|++...+.......+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||.+..........
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~-~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECSTTHHHHHCCCSBCT
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc-ceeccCCcceeccCCcccc
Confidence 999998888887776667899999999999999999999999999999999999998887 9999999997654332211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...||+.|+|||.+.....++.++|+||+||++|+|++|+.||.+.+..+
T Consensus 160 ~-----------------------------~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~ 210 (298)
T d1gz8a_ 160 T-----------------------------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 210 (298)
T ss_dssp T-----------------------------CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred e-----------------------------eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH
Confidence 1 12568999999999887778999999999999999999999999999888
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
....+.+..+.+....+...............+...........+|+.+.+||.+||..||++|||+.++++||||++++
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 211 QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 88999988888888888777777776666766666666667778999999999999999999999999999999999985
Q ss_pred c
Q 036739 321 F 321 (323)
Q Consensus 321 ~ 321 (323)
-
T Consensus 291 ~ 291 (298)
T d1gz8a_ 291 K 291 (298)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-59 Score=401.08 Aligned_cols=261 Identities=30% Similarity=0.482 Sum_probs=213.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++++.||+|+||+||+|+++.+|+.||+|++..... ....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 5899999999999999999999999999999999876532 233467889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||++| +|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.........
T Consensus 83 Ey~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~-~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-EEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC-EEEccchhheeeccCCcc
Confidence 99976 8887775533 5789999999999999999999999999999999999998887 999999999875432211
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
. .....+||+.|+|||++.+...++.++||||+||++|+|++|+.||......
T Consensus 160 ~---------------------------~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 160 R---------------------------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp C---------------------------CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred c---------------------------cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 1 0112367999999999988555678899999999999999999999876554
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
............ .......+|+.+.+||.+||+.||++|||+.++++||||+.
T Consensus 213 ~~~~~~~~~~~~--------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 213 CQEYSDWKEKKT--------------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp SHHHHHHHTTCT--------------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHhcCCC--------------------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 433332221100 01112457899999999999999999999999999999984
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-59 Score=397.47 Aligned_cols=254 Identities=32% Similarity=0.532 Sum_probs=218.3
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++.+.||+|+||+||+|+++.+++.||+|++.+.. .+......+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 579999999999999999999999999999999987654 2344567788999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||++| +|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........
T Consensus 85 mEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~-~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRR 161 (263)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCCSCSCCCCCCC
T ss_pred EeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC-EeecccceeeecCCCcc
Confidence 999975 8877776543 4789999999999999999999999999999999999999887 99999999865432211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 162 -------------------------------~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 209 (263)
T d2j4za1 162 -------------------------------TTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209 (263)
T ss_dssp -------------------------------EETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred -------------------------------cccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCH
Confidence 12367999999999988 5689999999999999999999999998877
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+.+.. ...+..+|+.+++||.+||+.||++|||+.++++||||+.
T Consensus 210 ~~~~~~i~~~~-----------------------------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 210 QETYKRISRVE-----------------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHHTTC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHcCC-----------------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 66666554310 0112347899999999999999999999999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-57 Score=395.11 Aligned_cols=286 Identities=63% Similarity=1.092 Sum_probs=249.6
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+|+|++++.||+|+||+||+|+++ +++.||+|++............+.+|+.++++++||||+++++++.+++..++++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 689999999999999999999984 7899999999776655666788999999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++.++++..+....+ .+++..++.++.||+.||+|||+.||+||||||+||+++.++. +|++|||.+..........
T Consensus 80 e~~~~~~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~-~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp ECCSEEHHHHHHTSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECCTTHHHHHCC-----
T ss_pred EeehhhhHHHHHhhcC-CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC-EEecccccceecccCcccc
Confidence 9999988877766543 5899999999999999999999999999999999999999888 9999999997764332211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ...|++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+....+
T Consensus 158 ~-----------------------------~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~ 208 (286)
T d1ob3a_ 158 T-----------------------------HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208 (286)
T ss_dssp ---------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred c-----------------------------eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH
Confidence 1 12458889999999887788999999999999999999999999999888
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
...++....+.+....+...........................+++.+.+||.+||+.||++|||+.|+++||||++
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 999999999888888887777777666666666666666677889999999999999999999999999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=394.68 Aligned_cols=256 Identities=28% Similarity=0.462 Sum_probs=217.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++++.||+|+||+||+|++..+|+.||+|++..... ...+.+.+|+.++++++||||++++++|.+++.+|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 479999999999999999999999999999999875532 235678999999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..........
T Consensus 98 y~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~-vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 98 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp CCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSTTCCB
T ss_pred ecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc-Eeeccchhheeeccccccc
Confidence 9976 666655443 5799999999999999999999999999999999999999887 9999999998764322111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+....+
T Consensus 174 -----------------------------~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 223 (293)
T d1yhwa1 174 -----------------------------STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (293)
T ss_dssp -----------------------------CCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -----------------------------cccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHH
Confidence 11367999999999988 668999999999999999999999999888777
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
....+....... ......+|+.+++||.+||+.||++|||+.++++||||+..
T Consensus 224 ~~~~~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 224 ALYLIATNGTPE--------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHHHHCSCC--------------------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHhCCCCC--------------------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 766655431110 01124588999999999999999999999999999999754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-58 Score=397.26 Aligned_cols=260 Identities=25% Similarity=0.443 Sum_probs=219.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||+||+|+++.+++.||+|++.+.. ........+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997654 23445578899999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
||++| +|.+.+.... .+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||++..+......
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~-vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce-EEecccccceecccCCcc
Confidence 99975 7877776543 5789999999999999999999999999999999999999888 999999999876432221
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..
T Consensus 165 ~~---------------------------~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 216 (288)
T d1uu3a_ 165 AR---------------------------ANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 216 (288)
T ss_dssp --------------------------------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cc---------------------------cccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHH
Confidence 11 112367999999999988 56899999999999999999999999988777
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh------hhcC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS------ALEH 313 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~------il~h 313 (323)
+...++.+.. ......+++.+++||.+||+.||++|||++| +++|
T Consensus 217 ~~~~~i~~~~-----------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~H 267 (288)
T d1uu3a_ 217 LIFQKIIKLE-----------------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267 (288)
T ss_dssp HHHHHHHTTC-----------------------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred HHHHHHHcCC-----------------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcC
Confidence 7666654320 0112347899999999999999999999998 5789
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 268 pff~~i~w 275 (288)
T d1uu3a_ 268 PFFESVTW 275 (288)
T ss_dssp GGGTTCCC
T ss_pred CccCCCCH
Confidence 99999876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-57 Score=394.41 Aligned_cols=284 Identities=44% Similarity=0.829 Sum_probs=231.9
Q ss_pred ceeeeeccccceeEEEEEEccCCceEEEEEEEecccC---CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 5 EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+.++.||+|+||+||+|+++.+|+.||+|++...... ......+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 3578999999999999999999999999998655322 2234678899999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|+.|++...+.... ..+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||.+..........
T Consensus 81 ~~~~~~~~~~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~-~KL~DFG~a~~~~~~~~~~- 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAY- 157 (299)
T ss_dssp CCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCCGGGSTTTSCCCCC-
T ss_pred hhcchHHhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc-cccccCccccccCCCcccc-
Confidence 99987777666543 35788889999999999999999999999999999999999887 9999999997654332211
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHHH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEIDE 241 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~~ 241 (323)
...+||+.|+|||.+.....++.++||||+||++|+|++|..||.+....+.
T Consensus 158 ----------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~ 209 (299)
T d1ua2a_ 158 ----------------------------THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 209 (299)
T ss_dssp ----------------------------CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ----------------------------cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH
Confidence 1125699999999998767789999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcccc
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDVE 320 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~~ 320 (323)
+..+.+..+.+....++......... .+..............+++.+.+||.+||+.||++|||+.|+|+||||++.+
T Consensus 210 l~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 210 LTRIFETLGTPTEEQWPDMCSLPDYV-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp HHHHHHHHCCCCTTTSSSTTSSTTCC-CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred HHHHHHhcCCCChhhccchhccchhh-hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 99999988887777665544433222 2222222333344567899999999999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=394.51 Aligned_cols=258 Identities=28% Similarity=0.386 Sum_probs=215.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
+.|++++.||+|+||+||+|+++.++..||+|++.... ....+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 46999999999999999999999999999999986542 3345778899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.| +|.+.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.........
T Consensus 90 y~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~-~Kl~DFG~a~~~~~~~~~- 166 (288)
T d2jfla1 90 FCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQR- 166 (288)
T ss_dssp CCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECHHHHHH-
T ss_pred cCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC-EEEEechhhhccCCCccc-
Confidence 9976 666655543 335899999999999999999999999999999999999999887 999999998654321110
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC----CCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG----SRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.....||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.
T Consensus 167 ----------------------------~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 167 ----------------------------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp ----------------------------HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ----------------------------ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 112367999999999853 355789999999999999999999999998
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYF 316 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~ 316 (323)
...+...++.+.... .......+|+.+.+||.+||+.||++|||+.++++||||
T Consensus 219 ~~~~~~~~i~~~~~~--------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 219 NPMRVLLKIAKSEPP--------------------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp CGGGHHHHHHHSCCC--------------------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred CHHHHHHHHHcCCCC--------------------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 887777766542110 001124578999999999999999999999999999999
Q ss_pred cc
Q 036739 317 RD 318 (323)
Q Consensus 317 ~~ 318 (323)
+.
T Consensus 273 ~~ 274 (288)
T d2jfla1 273 TV 274 (288)
T ss_dssp CC
T ss_pred CC
Confidence 74
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-57 Score=393.77 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=203.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||+|+++.+++.||+|++....... ....+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46999999999999999999999999999999997654332 23567899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec---CCCceEEeccccceecCCCc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~---~~~~~kl~df~~~~~~~~~~ 157 (323)
|++| +|.+.+.... .+++..+..++.||+.||+|||++||+||||||+||++.. ++. +||+|||++.......
T Consensus 88 ~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~-vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK-IMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCC-EEECCC----------
T ss_pred ccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCce-EEEeccceeEEccCCC
Confidence 9974 8888887643 5799999999999999999999999999999999999953 455 9999999997653221
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
.. ...+||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 165 ~~------------------------------~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 165 VL------------------------------STACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp --------------------------------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ee------------------------------eeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 11 11367999999999988 668999999999999999999999999888
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
..+....+.+..... ..+....+|+.+++||.+||+.||++|||+.|+++||||+
T Consensus 214 ~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 268 (307)
T d1a06a_ 214 DAKLFEQILKAEYEF-------------------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268 (307)
T ss_dssp HHHHHHHHHTTCCCC-------------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred HHHHHHHHhccCCCC-------------------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 777666655421111 1122345889999999999999999999999999999998
Q ss_pred cc
Q 036739 318 DV 319 (323)
Q Consensus 318 ~~ 319 (323)
+-
T Consensus 269 ~~ 270 (307)
T d1a06a_ 269 GD 270 (307)
T ss_dssp SS
T ss_pred CC
Confidence 53
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-57 Score=397.40 Aligned_cols=259 Identities=26% Similarity=0.403 Sum_probs=222.2
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
|++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||++++++|++.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 5899999999999999999999999999999999976542 344567788999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| +|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........
T Consensus 84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~-vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC-EEEeecccccccccCCc
Confidence 999976 7777776644 5688999999999999999999999999999999999999888 99999999976532221
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
. ....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.
T Consensus 161 ~-----------------------------~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 161 T-----------------------------MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp C-----------------------------BCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred c-----------------------------cccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence 1 112367999999999988 5689999999999999999999999999887
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----HhhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~il~h 313 (323)
.+....+.... ...+..+|+.+++||++||+.||++|++ +.++++|
T Consensus 211 ~~~~~~i~~~~-----------------------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 211 ERLFELILMEE-----------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHHHHCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHhcCC-----------------------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 77666555421 0112458899999999999999999994 8999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 262 p~f~~i~~ 269 (337)
T d1o6la_ 262 RFFLSINW 269 (337)
T ss_dssp GGGTTCCH
T ss_pred cccccCCH
Confidence 99998864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-56 Score=389.07 Aligned_cols=286 Identities=48% Similarity=0.859 Sum_probs=236.8
Q ss_pred CCcceeeeeccccceeEEEEEEccC-CceEEEEEEEecccCCCCchhHHHHHHHHHhc---CCCCeeeeeEEEec-----
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT-NETIALKKIRLEQEDEGVPSTAIREISLLKEM---QHGNIVRLQDVVHS----- 72 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~----- 72 (323)
++|++++.||+|+||+||+|++..+ ++.||+|++............+.+|+.+++.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6899999999999999999998655 56799999987766555566677888887766 79999999999853
Q ss_pred CceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 73 EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 73 ~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
....++++|+++|++...........+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||.+..
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~-~kl~dfg~~~~ 165 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARI 165 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECSCCSCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC-eeecchhhhhh
Confidence 45789999999998777776666667899999999999999999999999999999999999999887 99999999865
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
...... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.|
T Consensus 166 ~~~~~~------------------------------~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~p 214 (305)
T d1blxa_ 166 YSFQMA------------------------------LTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPL 214 (305)
T ss_dssp CCGGGG------------------------------GCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred hccccc------------------------------CCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCC
Confidence 432211 112367999999999988 6789999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
|.+.+..+.+..+.+..+.+....++....... ..+..............+++.+.+||.+||+.||++|||+.|+|+
T Consensus 215 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 215 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR--QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG--GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHhhCCCchhcccccccchh--hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 999999999999988888877666654443322 222333333344556678999999999999999999999999999
Q ss_pred CCCCccccc
Q 036739 313 HEYFRDVEF 321 (323)
Q Consensus 313 h~~~~~~~~ 321 (323)
||||++++.
T Consensus 293 Hpff~~i~~ 301 (305)
T d1blxa_ 293 HPYFQDLER 301 (305)
T ss_dssp SGGGTTCCC
T ss_pred ChhhcCchh
Confidence 999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-57 Score=394.86 Aligned_cols=256 Identities=22% Similarity=0.384 Sum_probs=220.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
+++|++++.||+|+||+||+|+++.+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 579999999999999999999999999999999997654 2344567888999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+.| ++...+.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........
T Consensus 83 mE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~-vkL~DFG~a~~~~~~~~ 159 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTY 159 (316)
T ss_dssp ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC-EEECCCSSCEECSSCBC
T ss_pred eeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC-EEEecCccceEeccccc
Confidence 999987 5566555544 4578888899999999999999999999999999999999887 99999999987642211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 160 --------------------------------~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 206 (316)
T d1fota_ 160 --------------------------------TLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206 (316)
T ss_dssp --------------------------------CCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred --------------------------------cccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCH
Confidence 1367999999999987 5689999999999999999999999999888
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h 313 (323)
.+...++.+... .....+++.+.++|.+||..||++|+ +++++++|
T Consensus 207 ~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 207 MKTYEKILNAEL-----------------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHHcCCC-----------------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 777776654210 11234789999999999999999996 99999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 258 p~f~~i~~ 265 (316)
T d1fota_ 258 PWFKEVVW 265 (316)
T ss_dssp GGGSSCCH
T ss_pred cccccCCH
Confidence 99999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=389.85 Aligned_cols=256 Identities=29% Similarity=0.445 Sum_probs=206.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--CceEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKKLYLV 79 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 79 (323)
++|++++.||+|+||+||+|+++.+|+.||+|++..........+.+.+|+.++++++||||+++++++.+ .+.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 78999999999999999999999999999999997665444445678899999999999999999999865 4678999
Q ss_pred Eecchh-hHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCcEEEecCCCceEEeccccce
Q 036739 80 FEYLDL-DLKKHMDSC--PDFANDPRLIKTFLYQILRGIAYCHSHR-----VLHRDLKPQNLLIDRRTNALKLADFGLAR 151 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----i~H~dl~~~Nil~~~~~~~~kl~df~~~~ 151 (323)
|||++| +|.+.+... ....+++..++.++.||+.||.|||+.| |+||||||+|||++.++. +||+|||++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~-vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC-EEECCHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc-EEEeecccee
Confidence 999975 777776532 2346899999999999999999999876 999999999999999887 9999999997
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCC
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~ 231 (323)
........ .....||+.|+|||.+.+ ..++.++|||||||++|+|++|..
T Consensus 163 ~~~~~~~~-----------------------------~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~ 212 (269)
T d2java1 163 ILNHDTSF-----------------------------AKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMP 212 (269)
T ss_dssp HC----------------------------------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ecccCCCc-----------------------------cccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCC
Confidence 75432211 112366999999999977 668999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhh
Q 036739 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSAL 311 (323)
Q Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il 311 (323)
||.+.+..+....+..... ......+|+.+.+||.+||+.||++|||+.+++
T Consensus 213 Pf~~~~~~~~~~~i~~~~~----------------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 213 PFTAFSQKELAGKIREGKF----------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp SCCCSSHHHHHHHHHHTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCC----------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9998887776666554211 112235789999999999999999999999999
Q ss_pred cCCCC
Q 036739 312 EHEYF 316 (323)
Q Consensus 312 ~h~~~ 316 (323)
+|||+
T Consensus 265 ~hp~i 269 (269)
T d2java1 265 ENPLI 269 (269)
T ss_dssp TSTTC
T ss_pred hCCcC
Confidence 99996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.6e-57 Score=398.93 Aligned_cols=260 Identities=24% Similarity=0.426 Sum_probs=220.1
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch--hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4789999999999999999999999999999999864422 22467889999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEec--CCCceEEeccccceecCCCc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~--~~~~~kl~df~~~~~~~~~~ 157 (323)
||++| +|.+.+....+ .+++..++.++.||+.||.|||++|++||||||+|||++. ++ .+||+|||++.......
T Consensus 103 E~~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~-~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 103 EFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSC-CEEECCCTTCEECCTTS
T ss_pred EcCCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCC-eEEEeecchheeccccc
Confidence 99975 77777765433 5899999999999999999999999999999999999964 34 49999999998765332
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
... ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 181 ~~~------------------------------~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 181 SVK------------------------------VTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp CEE------------------------------EECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc------------------------------eecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence 211 2366999999999988 668999999999999999999999999888
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCc
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFR 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~ 317 (323)
..+.+..+.+...... ......+|+.+++||.+||+.||++|||+.++|+||||+
T Consensus 230 ~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~ 284 (350)
T d1koaa2 230 DDETLRNVKSCDWNMD-------------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284 (350)
T ss_dssp HHHHHHHHHHTCCCSC-------------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred HHHHHHHHHhCCCCCC-------------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 8777777665321111 122345889999999999999999999999999999998
Q ss_pred ccc
Q 036739 318 DVE 320 (323)
Q Consensus 318 ~~~ 320 (323)
+.+
T Consensus 285 ~~~ 287 (350)
T d1koaa2 285 PGN 287 (350)
T ss_dssp CTT
T ss_pred CCC
Confidence 764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-56 Score=385.57 Aligned_cols=262 Identities=28% Similarity=0.412 Sum_probs=219.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC----CCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE----GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+..... ...+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46999999999999999999999999999999997664322 23467889999999999999999999999999999
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCC---ceEEeccccceec
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGLARAF 153 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~---~~kl~df~~~~~~ 153 (323)
+||||++| +|.+.+.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++. .+||+|||++...
T Consensus 90 iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 99999975 7877776543 5799999999999999999999999999999999999987664 4999999999876
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
....... ...||+.|+|||++.+ ..++.++||||+||++|+|++|..||
T Consensus 168 ~~~~~~~------------------------------~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf 216 (293)
T d1jksa_ 168 DFGNEFK------------------------------NIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF 216 (293)
T ss_dssp TTSCBCS------------------------------CCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCcccc------------------------------ccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCC
Confidence 4332211 1255889999999987 67899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.+....+....+.+.... ........+|+.+++||.+||+.||++|||+.++++|
T Consensus 217 ~~~~~~~~~~~i~~~~~~-------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 217 LGDTKQETLANVSAVNYE-------------------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCSSHHHHHHHHHTTCCC-------------------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHhcCCC-------------------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 988877777665432110 1122335689999999999999999999999999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++.++
T Consensus 272 p~~~~~~~ 279 (293)
T d1jksa_ 272 PWIKPKDT 279 (293)
T ss_dssp TTTCC---
T ss_pred cccCCCCh
Confidence 99997653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-56 Score=394.66 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=221.8
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecc-cCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (323)
|++|++++.||+|+||.||+|+++.+|+.||+|++.+.. ......+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 578999999999999999999999999999999987653 3344557788999999999999999999999999999999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
+||+.| ++...+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++........
T Consensus 120 ~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~-ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp EECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECSSCBC
T ss_pred cccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC-EEeeeceeeeecccccc
Confidence 999976 7777776544 5789999999999999999999999999999999999999887 99999999987642211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 197 --------------------------------~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 243 (350)
T d1rdqe_ 197 --------------------------------TLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp --------------------------------CCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --------------------------------cccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCH
Confidence 1367999999999988 6689999999999999999999999998887
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CHhhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TARSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~~~il~h 313 (323)
......+..... .....+++.+.+||++||+.||++|+ ++.++++|
T Consensus 244 ~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 244 IQIYEKIVSGKV-----------------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHHHCCC-----------------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHhcCCC-----------------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 777766654211 11234789999999999999999995 99999999
Q ss_pred CCCccccc
Q 036739 314 EYFRDVEF 321 (323)
Q Consensus 314 ~~~~~~~~ 321 (323)
|||++++|
T Consensus 295 p~f~~~~~ 302 (350)
T d1rdqe_ 295 KWFATTDW 302 (350)
T ss_dssp GGGTTCCH
T ss_pred ccccCCCH
Confidence 99999876
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.5e-56 Score=394.60 Aligned_cols=258 Identities=24% Similarity=0.441 Sum_probs=218.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+|+.++++++||||++++++|.+++.+|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 679999999999999999999999999999999865432 123567889999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEe--cCCCceEEeccccceecCCCcc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~--~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|++| +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++. +||+|||++........
T Consensus 107 ~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~-vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 107 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCC-EEECCCTTCEECCTTSC
T ss_pred cCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCe-EEEeecccceecCCCCc
Confidence 9976 777766544 34589999999999999999999999999999999999997 3455 99999999987654322
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.. ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 185 ~~------------------------------~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 233 (352)
T d1koba_ 185 VK------------------------------VTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 233 (352)
T ss_dssp EE------------------------------EECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ee------------------------------eccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 11 1356899999999988 6689999999999999999999999999888
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+.+..+.+....... .....+|+.+.+||.+||+.||++|||+.++|+||||++
T Consensus 234 ~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 234 LETLQNVKRCDWEFDE-------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp HHHHHHHHHCCCCCCS-------------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHHHHHHhCCCCCCc-------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 8877776653222111 122458899999999999999999999999999999986
Q ss_pred c
Q 036739 319 V 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 289 ~ 289 (352)
T d1koba_ 289 D 289 (352)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-56 Score=380.86 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=207.1
Q ss_pred Cc-ceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec----CceEE
Q 036739 3 QY-EKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS----EKKLY 77 (323)
Q Consensus 3 ~y-~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~ 77 (323)
+| ++.++||+|+||+||+|++..++..||+|++..........+.+.+|++++++++||||+++++++.+ +..++
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 45 67778999999999999999999999999987665444445678899999999999999999999864 46789
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEec-CCCceEEeccccceec
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHR--VLHRDLKPQNLLIDR-RTNALKLADFGLARAF 153 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~~~Nil~~~-~~~~~kl~df~~~~~~ 153 (323)
+||||++| +|.+.+.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++. ++. +||+|||++...
T Consensus 89 ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~-~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS-VKIGDLGLATLK 165 (270)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC-EEECCTTGGGGC
T ss_pred EEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC-EEEeecCcceec
Confidence 99999976 7777776543 5788999999999999999999998 999999999999975 555 999999999653
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
..... ....||+.|+|||.+.+ .++.++|||||||++|+|++|+.||
T Consensus 166 ~~~~~-------------------------------~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf 212 (270)
T d1t4ha_ 166 RASFA-------------------------------KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPY 212 (270)
T ss_dssp CTTSB-------------------------------EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCcc-------------------------------CCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCC
Confidence 22111 12367999999999876 4899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
........+.+....... ........++.+.+||.+||+.||++|||+.|+|+|
T Consensus 213 ~~~~~~~~~~~~i~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 213 SECQNAAQIYRRVTSGVK--------------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TTCSSHHHHHHHHTTTCC--------------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCcccHHHHHHHHHcCCC--------------------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 877665554433221000 111224578899999999999999999999999999
Q ss_pred CCCc
Q 036739 314 EYFR 317 (323)
Q Consensus 314 ~~~~ 317 (323)
|||+
T Consensus 267 p~fk 270 (270)
T d1t4ha_ 267 AFFQ 270 (270)
T ss_dssp GGGC
T ss_pred cccC
Confidence 9996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-56 Score=388.95 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=213.1
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
.|++++.||+|+||+||+|++..+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 499999999999999999999999999999998755322 2234568899999999999999999999999999999999
Q ss_pred cchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCccccc
Q 036739 82 YLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161 (323)
Q Consensus 82 ~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~ 161 (323)
|+.|+++..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~-~Kl~DFG~a~~~~~~~---- 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPAN---- 169 (309)
T ss_dssp CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE-EEECCCTTCBSSSSBC----
T ss_pred ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC-EEEeecccccccCCCC----
Confidence 99876655443322 35799999999999999999999999999999999999998887 9999999987543211
Q ss_pred ccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC--CCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 162 HEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG--SRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
...||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+....
T Consensus 170 -----------------------------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~ 220 (309)
T d1u5ra_ 170 -----------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220 (309)
T ss_dssp -----------------------------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred -----------------------------ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH
Confidence 1256999999999865 245889999999999999999999999988877
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
+.+.++.+..... .....+|+.+.+||.+||+.||++|||+.++|+||||..
T Consensus 221 ~~~~~i~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 221 SALYHIAQNESPA---------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHHHHSCCCC---------------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHHHhCCCCC---------------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 7776665531111 011347899999999999999999999999999999964
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=394.20 Aligned_cols=283 Identities=25% Similarity=0.390 Sum_probs=211.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
|+|++++.||+|+||+||+|++..+|+.||+|++.... .......+.+|+.++++++||||++++++|.+++.+|+|||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 68999999999999999999999999999999986542 33445678899999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCCceEEeccccceecCCCccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~ 159 (323)
|+.| +|.+.+.+.. .+++..++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++.......
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~-vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC-EEECCCCCCHHHHHHT--
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC-EEEeeCCCccccCCCc--
Confidence 9986 7777776543 47899999999999999999997 59999999999999999887 9999999987542110
Q ss_pred ccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH
Q 036739 160 FTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI 239 (323)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~ 239 (323)
.+..+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..
T Consensus 160 -----------------------------~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 160 -----------------------------ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp -----------------------------C---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred -----------------------------cccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 112367999999999998 67999999999999999999999999876543
Q ss_pred HHHHH-HHHHhCCCCC----CCCCCcccCCcccccCCCC---------CCCccc-ccccCCChHHHHHHHhhcccCCCCC
Q 036739 240 DELFK-IFRVLGTPNE----DTWPGVTSLPDFKSAFPKW---------PSKELG-TVVRNLEPAGIDLLSKMLCMDPSRR 304 (323)
Q Consensus 240 ~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~---------~~~~~~-~~~~~~s~~~~~li~~~l~~dp~~R 304 (323)
+.... .....+.... ................... .....+ .....+|+.+++||.+||+.||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R 289 (322)
T d1s9ja_ 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289 (322)
T ss_dssp HHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHC
Confidence 32211 1111111000 0000000000000000000 000000 0112468899999999999999999
Q ss_pred CCHhhhhcCCCCcccc
Q 036739 305 ITARSALEHEYFRDVE 320 (323)
Q Consensus 305 ~s~~~il~h~~~~~~~ 320 (323)
||+.++|+||||++.+
T Consensus 290 ~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 290 ADLKQLMVHAFIKRSD 305 (322)
T ss_dssp CCHHHHHTSHHHHHHH
T ss_pred cCHHHHhhCHhhCcCC
Confidence 9999999999998653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=377.01 Aligned_cols=288 Identities=57% Similarity=1.005 Sum_probs=239.1
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
|++|++++.||+|+||+||+|++..+++.||+|+++...........+.+|+.+++.++||||+++++++.+....++++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 68999999999999999999999999999999999776655556678889999999999999999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
+++.|+.+..+.... ..+++..++.++.|++.||+|||++||+|+||||+||+++.++. +||+|||.+..........
T Consensus 81 ~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~-~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 81 EFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp ECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSCCSCC
T ss_pred eeccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc-eeeeecchhhcccCCCccc
Confidence 999886665555443 35688899999999999999999999999999999999999887 9999999998765433221
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC-CCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF-PGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~-~~~~~~ 239 (323)
.. ..+++.|+|||.+.....++.++||||+||++|+|++|+.|| .+.+..
T Consensus 159 ~~-----------------------------~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 209 (292)
T d1unla_ 159 SA-----------------------------EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_dssp CS-----------------------------CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred ee-----------------------------eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH
Confidence 11 133777999999988677899999999999999999999885 455555
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
+....+......+....+............-..............+++.+.+||.+||+.||++|||++|+|+||||+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 66677777777777666666655554443333333344455567789999999999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5e-55 Score=375.80 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=219.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCC-------chhHHHHHHHHHhcC-CCCeeeeeEEEecC
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGV-------PSTAIREISLLKEMQ-HGNIVRLQDVVHSE 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~-------~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 73 (323)
++|++.+.||+|+||+||+|++..+++.||+|++.+....... .+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 7999999999999999999999999999999999766433222 235778999999997 99999999999999
Q ss_pred ceEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 74 KKLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 74 ~~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
+.+|+||||++| +|.+.+.... .+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++..
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~-~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC-eEEccchheeE
Confidence 999999999975 8888886543 5799999999999999999999999999999999999998887 99999999987
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhC-----CCCCCCchhhHHHHHHHHHHH
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLG-----SRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~~Di~slG~ll~~l~ 227 (323)
........ ...||+.|+|||.+.+ ...++.++||||+||++|+|+
T Consensus 160 ~~~~~~~~------------------------------~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml 209 (277)
T d1phka_ 160 LDPGEKLR------------------------------EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 209 (277)
T ss_dssp CCTTCCBC------------------------------CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred ccCCCcee------------------------------eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhc
Confidence 65432211 1256899999999863 345788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCH
Q 036739 228 NQRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITA 307 (323)
Q Consensus 228 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~ 307 (323)
+|+.||.+....+....+.+...... .....++|+.+++||.+||+.||++||++
T Consensus 210 ~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~ 264 (277)
T d1phka_ 210 AGSPPFWHRKQMLMLRMIMSGNYQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTA 264 (277)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred cCCCCCCCCCHHHHHHHHHhCCCCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCH
Confidence 99999999887777666665321111 11224589999999999999999999999
Q ss_pred hhhhcCCCCcc
Q 036739 308 RSALEHEYFRD 318 (323)
Q Consensus 308 ~~il~h~~~~~ 318 (323)
.++++||||+.
T Consensus 265 ~eil~h~~~~~ 275 (277)
T d1phka_ 265 EEALAHPFFQQ 275 (277)
T ss_dssp HHHTTSGGGCT
T ss_pred HHHHcCHHHHH
Confidence 99999999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-55 Score=393.63 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=212.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHH---HHHHHhcCCCCeeeeeEEEecCceE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIRE---ISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
|++|++.+.||+|+||.||+|++..+|+.||+|++.+... .......+.+| +.+++.+.||||+++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 6899999999999999999999999999999999875532 12222334444 6666777899999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
|+||||+.| +|.+.+.+.. .+++..++.++.||+.||.|||++|++||||||+|||++.++. +||+|||++.....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~-iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC-EEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc-EEEeeeceeeecCC
Confidence 999999975 8887776643 4688899999999999999999999999999999999999887 99999999987643
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.... ...||+.|+|||++.....++.++|||||||++|+|++|+.||..
T Consensus 160 ~~~~-------------------------------~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 160 KKPH-------------------------------ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp SCCC-------------------------------SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred Cccc-------------------------------ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 2211 125699999999997657789999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC-----Hhhh
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT-----ARSA 310 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s-----~~~i 310 (323)
....+... +.+..... .......+|+.+++||.+||+.||++||+ ++++
T Consensus 209 ~~~~~~~~-~~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~ei 262 (364)
T d1omwa3 209 HKTKDKHE-IDRMTLTM-------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262 (364)
T ss_dssp SCSSCHHH-HHHHSSSC-------------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHH
T ss_pred CCHHHHHH-HHHhcccC-------------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHH
Confidence 65433322 22211110 11122458999999999999999999999 7999
Q ss_pred hcCCCCccccc
Q 036739 311 LEHEYFRDVEF 321 (323)
Q Consensus 311 l~h~~~~~~~~ 321 (323)
++||||++++|
T Consensus 263 l~Hp~f~~i~~ 273 (364)
T d1omwa3 263 KESPFFRSLDW 273 (364)
T ss_dssp HTSGGGTTCCH
T ss_pred HcCccccCCCH
Confidence 99999999865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=385.06 Aligned_cols=259 Identities=29% Similarity=0.469 Sum_probs=217.5
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEeccc-CCCCchhHHHHHHHH-HhcCCCCeeeeeEEEecCceEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE-DEGVPSTAIREISLL-KEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
|++|++.+.||+|+||+||+|+++.+++.||+|++.+... .....+.+..|..++ +.++||||+++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 6899999999999999999999999999999999976532 233445566666665 47899999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||++| +|.+.+.... .+++..++.++.||+.||+|||++|++||||||+|||++.++. +||+|||.+.......
T Consensus 81 vmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~-~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc-eeccccchhhhccccc
Confidence 9999976 8888776544 4688899999999999999999999999999999999999888 9999999997654322
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDS 237 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~ 237 (323)
... ....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+
T Consensus 158 ~~~-----------------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 158 AKT-----------------------------NTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp CCB-----------------------------CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc-----------------------------cccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 211 11366999999999988 668999999999999999999999999888
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHh-hhhcCCCC
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITAR-SALEHEYF 316 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~-~il~h~~~ 316 (323)
..+....+... .+ ..++.+|+.+.+||++||+.||++||++. ++++||||
T Consensus 208 ~~~~~~~i~~~--~~---------------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff 258 (320)
T d1xjda_ 208 EEELFHSIRMD--NP---------------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258 (320)
T ss_dssp HHHHHHHHHHC--CC---------------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred HHHHHHHHHcC--CC---------------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchh
Confidence 77766665432 11 11235789999999999999999999996 89999999
Q ss_pred ccccc
Q 036739 317 RDVEF 321 (323)
Q Consensus 317 ~~~~~ 321 (323)
++++|
T Consensus 259 ~~~~~ 263 (320)
T d1xjda_ 259 REINW 263 (320)
T ss_dssp TTCCH
T ss_pred ccCCH
Confidence 98754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-54 Score=377.15 Aligned_cols=291 Identities=38% Similarity=0.713 Sum_probs=227.2
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec--------
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-------- 72 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------- 72 (323)
+++|++++.||+|+||+||+|++..+|+.||+|++............+.+|+.+++.++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 579999999999999999999999999999999987776666667888999999999999999999999854
Q ss_pred CceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 73 EKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 73 ~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
++..++|||++++++........ ..+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++..
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~-~kl~dfg~~~~ 166 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARA 166 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-EEECCCTTCEE
T ss_pred CceEEEEEeccCCCccchhhhcc-cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc-EEeeecceeee
Confidence 35689999999988777665443 35788889999999999999999999999999999999999887 99999999987
Q ss_pred cCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC
Q 036739 153 FGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
............ ....||+.|+|||.+.+...++.++||||+||++|+|++|+.|
T Consensus 167 ~~~~~~~~~~~~-------------------------~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~p 221 (318)
T d3blha1 167 FSLAKNSQPNRY-------------------------TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221 (318)
T ss_dssp CCC-----CCCC-------------------------CSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccc-------------------------cceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCC
Confidence 654333222111 1135699999999998867789999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcc--ccc--ccCCChHHHHHHHhhcccCCCCCCCHh
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKEL--GTV--VRNLEPAGIDLLSKMLCMDPSRRITAR 308 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~s~~~~~li~~~l~~dp~~R~s~~ 308 (323)
|.+....+....+.+..+......+.......... .......... ... ....++.+.+||.+||+.||++|||+.
T Consensus 222 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~ 300 (318)
T d3blha1 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE-KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300 (318)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC--------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCHHHHHHHHHHhcCCCChhhccccchhhhhh-hhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence 99988888888888887776665544333322211 1111111110 000 112477889999999999999999999
Q ss_pred hhhcCCCCccc
Q 036739 309 SALEHEYFRDV 319 (323)
Q Consensus 309 ~il~h~~~~~~ 319 (323)
|+|+||||++-
T Consensus 301 elL~Hpff~~~ 311 (318)
T d3blha1 301 DALNHDFFWSD 311 (318)
T ss_dssp HHHHSGGGSSS
T ss_pred HHHcChhhccC
Confidence 99999999963
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-55 Score=384.07 Aligned_cols=258 Identities=23% Similarity=0.425 Sum_probs=218.2
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
.++|++.+.||+|+||+||+|+++.+++.||+|++..... ....+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 4799999999999999999999999999999999865432 2356789999999999999999999999999999999
Q ss_pred ecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC-CceEEeccccceecCCCcc
Q 036739 81 EYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGIPVR 158 (323)
Q Consensus 81 e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~-~~~kl~df~~~~~~~~~~~ 158 (323)
||++| +|.+.+... ...+++..++.++.||+.||.|||+.||+||||||+||+++.++ ..+||+|||++........
T Consensus 81 E~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 81 EFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred ecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99976 788777654 33589999999999999999999999999999999999997644 2599999999987543222
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.. ...||+.|+|||.+.+ ..++.++||||+||++|+|++|..||.....
T Consensus 160 ~~------------------------------~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~ 208 (321)
T d1tkia_ 160 FR------------------------------LLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp EE------------------------------EEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cc------------------------------ccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence 11 1255889999999987 6689999999999999999999999999888
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCcc
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRD 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~ 318 (323)
.+....+.+..... .......+|+.+++||.+||..||++|||+.++++||||+.
T Consensus 209 ~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 209 QQIIENIMNAEYTF-------------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHHHTCCCC-------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHHHHHhCCCCC-------------------------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 87777766531111 11223458999999999999999999999999999999964
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-54 Score=382.34 Aligned_cols=280 Identities=34% Similarity=0.629 Sum_probs=220.6
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec------CceE
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS------EKKL 76 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (323)
+|+.++.||+|+||+||+|++..+|+.||+|++.... ....+|+.++++++||||++++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5899999999999999999999999999999986442 233479999999999999999999853 3468
Q ss_pred EEEEecchhhHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecC
Q 036739 77 YLVFEYLDLDLKKHMDS--CPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~ 154 (323)
++||||+++++.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||++....
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99999999877666542 2344689999999999999999999999999999999999999887569999999987764
Q ss_pred CCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCC
Q 036739 155 IPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFP 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~ 234 (323)
...... ...||+.|+|||.+.+...++.++||||+||++|+|++|..||.
T Consensus 175 ~~~~~~------------------------------~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 175 RGEPNV------------------------------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp TTSCCC------------------------------SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred CCcccc------------------------------cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence 322211 12558899999999876789999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCC-cccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 235 GDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSK-ELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.....+.+..+.+..+.+....+....... ....+...... ........+++.+.+||.+||..||++|||+.|+|+|
T Consensus 225 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNY-TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHHhCCChHHhhhhhccch-hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 999888888888776665433221111000 00001110000 0112234578999999999999999999999999999
Q ss_pred CCCccc
Q 036739 314 EYFRDV 319 (323)
Q Consensus 314 ~~~~~~ 319 (323)
|||+++
T Consensus 304 p~f~~~ 309 (350)
T d1q5ka_ 304 SFFDEL 309 (350)
T ss_dssp GGGGGG
T ss_pred Hhhccc
Confidence 999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=385.08 Aligned_cols=283 Identities=37% Similarity=0.681 Sum_probs=224.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCc------e
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK------K 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~ 75 (323)
++|++++.||+|+||+||+|++..+|+.||+|++............+.+|+.++++++||||++++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 5899999999999999999999999999999998655444444567889999999999999999999997654 5
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
+|+||||+++++...+... .+++..++.++.||+.||+|||++||+|+||||+|||++.++. +|++|||.+.....
T Consensus 98 ~~lv~e~~~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~-~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQADS 173 (346)
T ss_dssp CEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCS
T ss_pred EEEEEecccccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc-cccccccceeccCC
Confidence 7999999977777766543 5799999999999999999999999999999999999999888 99999999987643
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.... ..||+.|+|||.+.+...++.++||||+||++|+|++|+.||.+
T Consensus 174 ~~~~--------------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 174 EMTG--------------------------------YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp SCCS--------------------------------SCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc--------------------------------ccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 3221 25589999999998867789999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCccc--CCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.+..+.........+.+....+..... ......................+++.+.+||.+||..||++|||+.++|+|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 988888777776655543321111110 011111222333334445556789999999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||++++
T Consensus 302 p~f~~~~ 308 (346)
T d1cm8a_ 302 PYFESLH 308 (346)
T ss_dssp GGGTTTC
T ss_pred hhhCcCC
Confidence 9999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=372.75 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=207.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCC----CCchhHHHHHHHHHhcC--CCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDE----GVPSTAIREISLLKEMQ--HGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|+||+||+|++..+|..||+|++....... .....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 68999999999999999999999999999999997653221 23355778999999997 8999999999999999
Q ss_pred EEEEEecchh--hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 76 LYLVFEYLDL--DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 76 ~~lv~e~~~g--~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
.++|||++.| ++.+.+.... .+++..++.++.||+.||+|||++||+||||||+||+++.+...+||+|||++...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999964 5666665543 57899999999999999999999999999999999999977556999999999765
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLF 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~ 233 (323)
...... ...||+.|+|||++.+...++.++||||+||++|+|++|+.||
T Consensus 162 ~~~~~~-------------------------------~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf 210 (273)
T d1xwsa_ 162 KDTVYT-------------------------------DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210 (273)
T ss_dssp CSSCBC-------------------------------CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccc-------------------------------ccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCC
Confidence 322111 1256999999999987566678899999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 234 PGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.... .+.+. . ......+|+.+++||.+||+.||++|||+.++++|
T Consensus 211 ~~~~------~i~~~--~---------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 211 EHDE------EIIRG--Q---------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CSHH------HHHHC--C---------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCch------HHhhc--c---------------------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 7532 11111 0 01123588999999999999999999999999999
Q ss_pred CCCccc
Q 036739 314 EYFRDV 319 (323)
Q Consensus 314 ~~~~~~ 319 (323)
|||+++
T Consensus 256 p~~~~~ 261 (273)
T d1xwsa_ 256 PWMQDV 261 (273)
T ss_dssp GGGSSC
T ss_pred HhhCCC
Confidence 999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=380.45 Aligned_cols=260 Identities=28% Similarity=0.360 Sum_probs=207.1
Q ss_pred CCCcceee-eeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHh-cCCCCeeeeeEEEec----Cc
Q 036739 1 MDQYEKVE-KIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKE-MQHGNIVRLQDVVHS----EK 74 (323)
Q Consensus 1 ~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~----~~ 74 (323)
+++|++++ .||+|+||+||+|++..+++.||+|++.. ...+.+|+.++.+ .+||||++++++|.+ +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 47899986 49999999999999999999999999853 2567789988654 589999999999875 46
Q ss_pred eEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC--CceEEeccccce
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLAR 151 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~--~~~kl~df~~~~ 151 (323)
.+|+|||||+| +|.+.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++ ..+||+|||++.
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 79999999975 899988876666789999999999999999999999999999999999998633 249999999998
Q ss_pred ecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCC
Q 036739 152 AFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRP 231 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~ 231 (323)
......... ...||+.|+|||.+.+ ..++.++|||||||++|+|++|+.
T Consensus 163 ~~~~~~~~~------------------------------~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~ 211 (335)
T d2ozaa1 163 ETTSHNSLT------------------------------TPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYP 211 (335)
T ss_dssp ECCCCCCCC------------------------------CCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSC
T ss_pred eccCCCccc------------------------------cccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCC
Confidence 764332211 1356999999999877 668999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhh
Q 036739 232 LFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSAL 311 (323)
Q Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il 311 (323)
||.+....+....+........ ..........+|+.+.+||++||+.||++|||+.+++
T Consensus 212 Pf~~~~~~~~~~~~~~~i~~~~---------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 270 (335)
T d2ozaa1 212 PFYSNHGLAISPGMKTRIRMGQ---------------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270 (335)
T ss_dssp SCEETTCC--------CCCSCS---------------------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHHHhcCC---------------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 9987655443333222110000 0001122345899999999999999999999999999
Q ss_pred cCCCCccc
Q 036739 312 EHEYFRDV 319 (323)
Q Consensus 312 ~h~~~~~~ 319 (323)
+||||.+-
T Consensus 271 ~hp~~~~~ 278 (335)
T d2ozaa1 271 NHPWIMQS 278 (335)
T ss_dssp HSHHHHTT
T ss_pred cCHHhhCC
Confidence 99999754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-52 Score=367.92 Aligned_cols=281 Identities=31% Similarity=0.550 Sum_probs=213.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEec--CceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHS--EKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~l 78 (323)
|+|++++.||+|+||+||+|+++.+|+.||+|++... ....+.+|+.+++.+. ||||++++++|.. ...+++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 6899999999999999999999999999999998532 2467889999999995 9999999999974 457999
Q ss_pred EEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 79 VFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
||||++++.+..+.. .+++..++.++.||+.||.|||++||+|+||||+|||++.++..+||+|||.+........
T Consensus 110 v~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 110 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp EEECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred EEeecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 999998754444332 5799999999999999999999999999999999999998776699999999987654322
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
.. ...+|+.|+|||.+.+...++.++|+||+||++|+|++|..||.....
T Consensus 186 ~~------------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 186 YN------------------------------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp CC------------------------------SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred cc------------------------------ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 11 124588999999998877789999999999999999999999976654
Q ss_pred H-HHHHHHHHHhCCCCCC------CCCCcccCCcccc--cCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhh
Q 036739 239 I-DELFKIFRVLGTPNED------TWPGVTSLPDFKS--AFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARS 309 (323)
Q Consensus 239 ~-~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~ 309 (323)
. +....+....+.+... ............. ....+...........+++.+.+||.+||..||++|||++|
T Consensus 236 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 315 (328)
T d3bqca1 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315 (328)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 3 3333333322211000 0000000000000 00000011111233457899999999999999999999999
Q ss_pred hhcCCCCccccc
Q 036739 310 ALEHEYFRDVEF 321 (323)
Q Consensus 310 il~h~~~~~~~~ 321 (323)
+|+||||+++.+
T Consensus 316 ~L~Hp~F~~v~~ 327 (328)
T d3bqca1 316 AMEHPYFYTVVK 327 (328)
T ss_dssp HHTSGGGTTSCC
T ss_pred HhcCcccCCCCC
Confidence 999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-52 Score=362.35 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=207.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||+|++..++..||+|++... ....+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 4788999999999999999999999999999988533 2345778999999999999999999999999999999999
Q ss_pred cch-hhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLD-LDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~-g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++ |++.+.+.......+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++..........
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~-~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCCCCTTTCCSSSSEE
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc-EEEccccceeecCCCCcee
Confidence 997 48888887776677899999999999999999999999999999999999999887 9999999997654322211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChHH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEID 240 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~~ 240 (323)
. ....|++.|+|||.+.+ ..++.++||||+||++|+|++|..||.......
T Consensus 173 ~----------------------------~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~ 223 (287)
T d1opja_ 173 H----------------------------AGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223 (287)
T ss_dssp E----------------------------TTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred e----------------------------ccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH
Confidence 1 11245888999999987 568999999999999999999766655444444
Q ss_pred HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 241 ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.+.+...... .......+++.+.+||.+||+.||++|||+.++++
T Consensus 224 ~~~~~i~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 224 QVYELLEKDY---------------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHTTC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCC---------------------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 4443332110 01122457899999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=359.58 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=204.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||+|+. +..||+|++..........+.+.+|+.++++++||||+++++++. ++.+++|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 5899999999999999999974 346999998766555566678889999999999999999999874 456899999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|++| +|.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++..........
T Consensus 84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~-~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS-EEECCCCCSCC--------
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC-EEEccccceeeccccCCcc
Confidence 9975 7777776543 35799999999999999999999999999999999999999887 9999999987654222111
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCC--CCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGS--RHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
. .....||+.|+|||.+... ..++.++|||||||++|||+||+.||.+...
T Consensus 162 ~---------------------------~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 162 Q---------------------------FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp -------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred c---------------------------ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 0 1123569999999999752 3578999999999999999999999998877
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
...+........... ........+++.+.+||.+||+.||++|||+.+|+++
T Consensus 215 ~~~~~~~~~~~~~~p-----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 215 RDQIIFMVGRGYLSP-----------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHTSCCC-----------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCC-----------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 666654443321110 0112234578999999999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=355.55 Aligned_cols=249 Identities=21% Similarity=0.301 Sum_probs=197.2
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||+|++. ++..||+|++... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 58999999999999999999974 5678999998543 2334788999999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+ +|.+.+... ...+++..+..++.||+.||.|||+++|+||||||+||+++.++. +||+|||++..........
T Consensus 81 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~-~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC-EEECSCC------------
T ss_pred ecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC-eEecccchheeccCCCcee
Confidence 9975 666666554 345788889999999999999999999999999999999999887 9999999987654332211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
. ....||+.|+|||.+.+ ..++.++|||||||++|||+| |.+||......
T Consensus 159 ~----------------------------~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~ 209 (263)
T d1sm2a_ 159 S----------------------------TGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209 (263)
T ss_dssp ----------------------------------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH
T ss_pred e----------------------------cceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH
Confidence 1 11256889999999987 568999999999999999999 56777766665
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
+....+....... .+...++.+.++|.+||+.||++|||+++|++|
T Consensus 210 ~~~~~i~~~~~~~----------------------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 210 EVVEDISTGFRLY----------------------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCC----------------------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 5555554421111 113467899999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=372.26 Aligned_cols=282 Identities=36% Similarity=0.584 Sum_probs=216.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec------Cce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS------EKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~ 75 (323)
++|++++.||+|+||+||+|+++.+|+.||+|++.....+......+.+|+.++++++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999999999999999997665444445678899999999999999999999963 468
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
+|+||||+.|++++.+.. .+++..++.++.||+.||+|||+.||+|+||||+|||++.++. ++++|||.+.....
T Consensus 97 ~~iv~Ey~~~~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~-~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGT 171 (355)
T ss_dssp EEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCCCC------
T ss_pred eEEEEeccchHHHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc-eeeechhhhhcccc
Confidence 999999999998888754 4788999999999999999999999999999999999999888 99999998776543
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
.... ....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+
T Consensus 172 ~~~~------------------------------~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 172 SFMM------------------------------TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp ---------------------------------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc------------------------------ccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCC
Confidence 2211 11356899999999988 6789999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCc-ccccC------------CCCCCCcccccccCCChHHHHHHHhhcccCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPD-FKSAF------------PKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~------------~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~ 302 (323)
.+......++......+..+.+........ +.... ..............+++.+.+||.+||..||+
T Consensus 221 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~ 300 (355)
T d2b1pa1 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred CCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChh
Confidence 988888888777666544432222111100 00000 00000111112233577899999999999999
Q ss_pred CCCCHhhhhcCCCCccc
Q 036739 303 RRITARSALEHEYFRDV 319 (323)
Q Consensus 303 ~R~s~~~il~h~~~~~~ 319 (323)
+|||++|+|+||||+..
T Consensus 301 ~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 301 KRISVDDALQHPYINVW 317 (355)
T ss_dssp TSCCHHHHHTSTTTGGG
T ss_pred HCcCHHHHhcCcccCCC
Confidence 99999999999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=352.95 Aligned_cols=249 Identities=18% Similarity=0.284 Sum_probs=208.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||+++. .++..||+|++..... ..+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 6899999999999999999997 4778899999875432 34789999999999999999999999999999999999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+++ ++...+.... ..+++..+.+++.||+.||.|||++||+||||||+||+++.++. +||+|||++..........
T Consensus 80 y~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~-~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 80 YMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp CCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC-EEECCCSSCCBCSSSSCCC
T ss_pred ccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc-EEECcchhheeccCCCcee
Confidence 9975 6666655443 35788889999999999999999999999999999999998887 9999999997654332221
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~ 239 (323)
.. ...||+.|+|||.+.+ ..++.++||||||+++|||+| |+.||......
T Consensus 158 ~~----------------------------~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 158 SV----------------------------GSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp CC----------------------------CSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred ec----------------------------ccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 11 1245889999999987 568999999999999999998 89999998887
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
+....+.+.... ..+...++.+.+||.+||+.||++|||+.++++|
T Consensus 209 ~~~~~i~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 209 ETAEHIAQGLRL----------------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCC----------------------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 766665542111 1113467899999999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=369.03 Aligned_cols=287 Identities=38% Similarity=0.674 Sum_probs=221.4
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC-----ceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 76 (323)
++|++++.||+|+||+||+|++..+|+.||+|++.... .......+.+|+.++++++|||++++++++... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 57999999999999999999999999999999986432 222335677899999999999999999999654 346
Q ss_pred EEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 77 YLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 77 ~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+++++.++|+|.+.+... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||.+......
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~-~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC-EEEcccCceeeccCC
Confidence 777777778999888754 4799999999999999999999999999999999999998887 999999999776433
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
...... .....||+.|+|||.+.....++.++||||+||++|+|++|+.||.+.
T Consensus 163 ~~~~~~--------------------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 163 HDHTGF--------------------------LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp GCBCCT--------------------------TCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Ccccee--------------------------eccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 222111 112356999999999877677899999999999999999999999998
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccC--CcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSL--PDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHE 314 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~ 314 (323)
...+...........+........... .....................+++.+++||.+||+.||++|||+.++|+||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp 296 (345)
T d1pmea_ 217 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296 (345)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 887777766665544432211100000 001111122222223344567889999999999999999999999999999
Q ss_pred CCccc
Q 036739 315 YFRDV 319 (323)
Q Consensus 315 ~~~~~ 319 (323)
||+..
T Consensus 297 f~~~~ 301 (345)
T d1pmea_ 297 YLEQY 301 (345)
T ss_dssp GGTTT
T ss_pred hhccC
Confidence 99865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=371.67 Aligned_cols=283 Identities=38% Similarity=0.664 Sum_probs=221.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC------ce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE------KK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 75 (323)
++|++++.||+|+||+||+|++..+|+.||+|++.....+......+.+|+.++++++|||++++++++... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 689999999999999999999999999999999875544444445778999999999999999999998632 34
Q ss_pred EEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 76 LYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 76 ~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
+++++++.+|+|.+.+... .+++..++.++.||+.||+|||++||+||||||+||+++.++. +|++|||.+.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~-~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCC----CCTG
T ss_pred EEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc-ccccccchhcccCc
Confidence 5566555566888776543 5899999999999999999999999999999999999999888 99999999865432
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
... ...|++.|+|||.+.+...++.++|||||||++|+|++|..||.+
T Consensus 174 ~~~--------------------------------~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 174 EMT--------------------------------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp GGS--------------------------------SSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccc--------------------------------cccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 211 125688999999988867789999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCccc--CCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTS--LPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
.+.......+.+..+............ ......................+++.+++||.+||..||++|||+.|+|+|
T Consensus 222 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 988888888777766544322111111 011111222222333334456789999999999999999999999999999
Q ss_pred CCCcccc
Q 036739 314 EYFRDVE 320 (323)
Q Consensus 314 ~~~~~~~ 320 (323)
|||++.+
T Consensus 302 p~f~~~~ 308 (348)
T d2gfsa1 302 AYFAQYH 308 (348)
T ss_dssp GGGTTTC
T ss_pred HhhCCCC
Confidence 9999763
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-52 Score=359.91 Aligned_cols=256 Identities=20% Similarity=0.285 Sum_probs=194.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc---eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE---TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|+||+||+|+++.+++ .||+|.+.... .....+.+.+|+.++++++||||+++++++.+++.+++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 578999999999999999999876665 47788764332 22234578899999999999999999999999999999
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||++| +|.+.+.. ....+++..+..++.||+.||+|||++|++||||||+|||++.++. +||+|||++.......
T Consensus 105 v~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~-~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCC----------
T ss_pred EEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc-EEECCcccceEccCCC
Confidence 9999986 55555544 3445789999999999999999999999999999999999999887 9999999997764332
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
....... .....||+.|+|||.+.. ..++.++|||||||++|||+| |..||.+.
T Consensus 183 ~~~~~~~------------------------~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 183 SDPTYTS------------------------ALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp -------------------------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred Ccceeee------------------------cccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 2111100 011245889999999987 678999999999999999998 89999988
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
...+....+.+.... +....+++.+.+||.+||+.||++|||+.+|+++
T Consensus 238 ~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 238 TNQDVINAIEQDYRL----------------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCCC----------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 877766655432111 1123478899999999999999999999998864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.2e-52 Score=357.45 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=204.9
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccC-CCCchhHHHHHHHHHhcCCCCeeeeeEEEecC----ceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSE----KKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~ 76 (323)
|+|++.+.||+|+||+||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 6799999999999999999999999999999998765432 22345688999999999999999999999754 358
Q ss_pred EEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCC
Q 036739 77 YLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~ 155 (323)
|+||||++| +|.+.+.... .+++..++.++.||+.||+|||++||+||||||+||+++.++. .+++|||.+.....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~-~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC-EEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc-ceeehhhhhhhhcc
Confidence 999999986 6666665543 5789999999999999999999999999999999999999888 99999998876543
Q ss_pred CcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCC
Q 036739 156 PVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPG 235 (323)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~ 235 (323)
...... ......||+.|+|||.+.+ ..++.++|||||||++|+|+||+.||..
T Consensus 164 ~~~~~~--------------------------~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 164 SGNSVT--------------------------QTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp -----------------------------------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccc--------------------------ccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCC
Confidence 322111 1122467999999999987 6689999999999999999999999998
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcCCC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEHEY 315 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~ 315 (323)
....+...++.+....+ .......+|+.+.++|.+||+.||++||+..+.+.|+|
T Consensus 217 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 217 DSPVSVAYQHVREDPIP-------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp SSHHHHHHHHHHCCCCC-------------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred cCHHHHHHHHHhcCCCC-------------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence 88777766655421111 11122458899999999999999999995555555666
Q ss_pred Cc
Q 036739 316 FR 317 (323)
Q Consensus 316 ~~ 317 (323)
.+
T Consensus 272 ~r 273 (277)
T d1o6ya_ 272 VR 273 (277)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=357.26 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=205.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||+|+.+ ++..||+|++... ....+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC---cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 57899999999999999999974 5778999998533 2334678999999999999999999998854 56789999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+ +|.+.+.......+++..+..++.||+.||.|||+++|+||||||+||+++.++. +||+|||++..........
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~-~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECSSSCEEC
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc-eeeccccceEEccCCcccc
Confidence 9975 7777665554456799999999999999999999999999999999999999887 9999999998764332211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhC-CCCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQ-RPLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg-~~p~~~~~~~ 239 (323)
. ....||+.|+|||.+.. ..++.++|||||||++|||+|| .+|+......
T Consensus 167 ~----------------------------~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~ 217 (272)
T d1qpca_ 167 R----------------------------EGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217 (272)
T ss_dssp C----------------------------TTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred c----------------------------cccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH
Confidence 1 11255889999999987 5689999999999999999995 5556665555
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc--CCCCc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE--HEYFR 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~--h~~~~ 317 (323)
+....+.+.... .....+++.+.+||.+||+.||++|||+.+|++ |+||+
T Consensus 218 ~~~~~i~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 218 EVIQNLERGYRM----------------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCC----------------------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 555544332111 112357889999999999999999999999998 78886
Q ss_pred c
Q 036739 318 D 318 (323)
Q Consensus 318 ~ 318 (323)
.
T Consensus 270 s 270 (272)
T d1qpca_ 270 A 270 (272)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-52 Score=356.69 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=204.9
Q ss_pred CCcceee-eeccccceeEEEEEEcc--CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVE-KIGEGTYGVVYKARNCV--TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~-~lg~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|.+.+ +||+|+||+||+|.... ++..||||++.... .....+.+.+|+.++++++||||+++++++.++ .+|+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEE
Confidence 4577777 49999999999997654 34579999986442 233356788999999999999999999999654 5789
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||++| +|.+.+... ...+++..+..++.||+.||.|||++|++||||||+||+++.++. +||+|||++.......
T Consensus 86 vmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~-~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADD 163 (285)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE-EEECCCTTCEECTTCS
T ss_pred EEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc-eeeccchhhhcccccc
Confidence 9999986 666665443 336799999999999999999999999999999999999999887 9999999998875433
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
...... ....||+.|+|||.+.. ..++.++|||||||++|||+| |..||...
T Consensus 164 ~~~~~~--------------------------~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 164 SYYTAR--------------------------SAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp CEECCC--------------------------CSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccc--------------------------cccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 222111 11256889999999987 568999999999999999998 99999988
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh---hcC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA---LEH 313 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i---l~h 313 (323)
...+....+.+... ...+..+++.+.+||.+||+.||++||++.+| |+|
T Consensus 217 ~~~~~~~~i~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 217 KGPEVMAFIEQGKR----------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp CTHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCC----------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 87766655543211 11224578999999999999999999999888 457
Q ss_pred CCCc
Q 036739 314 EYFR 317 (323)
Q Consensus 314 ~~~~ 317 (323)
+|++
T Consensus 269 ~~~~ 272 (285)
T d1u59a_ 269 CYYS 272 (285)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=361.36 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=205.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc-----eEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE-----TIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|+||+||+|++...++ .||+|.+... ........+.+|+.+++++ +||||+++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc-cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 578999999999999999999866554 6899987543 3334557888999999998 89999999999999999
Q ss_pred EEEEEecchh-hHHHhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 036739 76 LYLVFEYLDL-DLKKHMDSCPD---------------------FANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNL 133 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~~---------------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Ni 133 (323)
+++||||++| +|.+.+.+... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 9999999975 88888865432 2468888999999999999999999999999999999
Q ss_pred EEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCc
Q 036739 134 LIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTP 213 (323)
Q Consensus 134 l~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 213 (323)
+++.++. +||+|||++.......... ......||+.|+|||.+.+ ..++.+
T Consensus 196 ll~~~~~-~Kl~DFGla~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~ 246 (325)
T d1rjba_ 196 LVTHGKV-VKICDFGLARDIMSDSNYV---------------------------VRGNARLPVKWMAPESLFE-GIYTIK 246 (325)
T ss_dssp EEETTTE-EEECCCGGGSCGGGCTTSE---------------------------EETTEEECGGGCCHHHHHH-CCCCHH
T ss_pred ccccCCe-EEEeeccccccccCCCcee---------------------------eeccccCCCccCChHHHcC-CCCCcc
Confidence 9998887 9999999997653222111 1122356999999999987 668999
Q ss_pred hhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHH
Q 036739 214 VDVWSVGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292 (323)
Q Consensus 214 ~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 292 (323)
+|||||||++|||+| |..||.+....+.+.++.+....+ ..+..+|+.+.+|
T Consensus 247 ~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~l 299 (325)
T d1rjba_ 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYII 299 (325)
T ss_dssp HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHH
T ss_pred eeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHH
Confidence 999999999999998 899999877766666655422111 1123478999999
Q ss_pred HHhhcccCCCCCCCHhhhhcC
Q 036739 293 LSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 293 i~~~l~~dp~~R~s~~~il~h 313 (323)
|.+||+.||++|||+++|++|
T Consensus 300 i~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 300 MQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=356.54 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=199.2
Q ss_pred eeeccccceeEEEEEEcc--CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEecchh
Q 036739 8 EKIGEGTYGVVYKARNCV--TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 8 ~~lg~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
++||+|+||+||+|.... +++.||+|++.....+....+.+.+|+.++++++||||+++++++.++ ..++||||++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 469999999999998543 456899999865544444456789999999999999999999999654 56899999975
Q ss_pred -hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccccc
Q 036739 86 -DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEH 164 (323)
Q Consensus 86 -~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 164 (323)
+|.+.+.... .+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||++............
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~-~kl~DFGla~~~~~~~~~~~~-- 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY-AKISDFGLSKALRADENYYKA-- 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE-EEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc-ccccchhhhhhcccccccccc--
Confidence 7777776543 4788999999999999999999999999999999999999887 999999999876533322111
Q ss_pred cCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 036739 165 WGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDSEIDELF 243 (323)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~~~~~~~ 243 (323)
.....||+.|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+...
T Consensus 167 ------------------------~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~ 221 (277)
T d1xbba_ 167 ------------------------QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 221 (277)
T ss_dssp ----------------------------CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred ------------------------ccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH
Confidence 112356899999999987 568999999999999999998 899999887766555
Q ss_pred HHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhh---cCCCCc
Q 036739 244 KIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSAL---EHEYFR 317 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il---~h~~~~ 317 (323)
.+.+.. ....+..+|+.+.+||.+||+.||++|||+.+|+ +|+|++
T Consensus 222 ~i~~~~----------------------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 222 MLEKGE----------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHcCC----------------------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 544321 0112235789999999999999999999999985 566654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=360.99 Aligned_cols=265 Identities=23% Similarity=0.425 Sum_probs=214.3
Q ss_pred CCCcceeeeeccccceeEEEEEEc---cCCceEEEEEEEecc--cCCCCchhHHHHHHHHHhcCC-CCeeeeeEEEecCc
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNC---VTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQH-GNIVRLQDVVHSEK 74 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~ 74 (323)
+++|++++.||+|+||+||+|.+. .+|+.||+|++.+.. .+....+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 478999999999999999999873 468899999986553 233445778899999999966 89999999999999
Q ss_pred eEEEEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceec
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~ 153 (323)
.+++++||+.| +|.+.+.... ..++..+..++.||+.||+|||++|++|+||||+||+++.++. +||+|||++...
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~-vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC-EEEeeccchhhh
Confidence 99999999975 7877776654 3578888999999999999999999999999999999999887 999999999776
Q ss_pred CCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCC-CCCCchhhHHHHHHHHHHHhCCCC
Q 036739 154 GIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR-HYSTPVDVWSVGCIFAEMVNQRPL 232 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~ll~~l~tg~~p 232 (323)
........ ....|++.|++||.+.... .++.++|||||||++|+|++|..|
T Consensus 180 ~~~~~~~~----------------------------~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~P 231 (322)
T d1vzoa_ 180 VADETERA----------------------------YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231 (322)
T ss_dssp CGGGGGGG----------------------------CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred cccccccc----------------------------cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCC
Confidence 43322221 1235688999999997643 478899999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCC-----CH
Q 036739 233 FPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRI-----TA 307 (323)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~-----s~ 307 (323)
|......+....+.+...... ......+|+.+++||.+||+.||.+|| ++
T Consensus 232 F~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~ 286 (322)
T d1vzoa_ 232 FTVDGEKNSQAEISRRILKSE-------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA 286 (322)
T ss_dssp TSCTTSCCCHHHHHHHHHHCC-------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTH
T ss_pred CCCCCHHHHHHHHHHhcccCC-------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccH
Confidence 988765554444433211110 112245889999999999999999999 48
Q ss_pred hhhhcCCCCccccc
Q 036739 308 RSALEHEYFRDVEF 321 (323)
Q Consensus 308 ~~il~h~~~~~~~~ 321 (323)
+|+++||||++++|
T Consensus 287 ~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 287 DEIKEHLFFQKINW 300 (322)
T ss_dssp HHHHTSGGGTTCCH
T ss_pred HHHHcCHhhcCCCH
Confidence 99999999999865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=349.88 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=202.5
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEEEEe
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYLVFE 81 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (323)
++|++.+.||+|+||+||+|++. ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+ +.+++|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 68999999999999999999985 44679999985332 234789999999999999999999999854 55789999
Q ss_pred cchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccc
Q 036739 82 YLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (323)
Q Consensus 82 ~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~ 160 (323)
|+.+ ++...+.......+++..+..++.||+.||.|||++|++||||||+|||++.++. +||+|||++..........
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~-~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCCCTTC---------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc-EEEcccchhhhccCCCcee
Confidence 9976 6666666544446899999999999999999999999999999999999999887 9999999997654322211
Q ss_pred cccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCC-CCCCCCChH
Q 036739 161 THEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQR-PLFPGDSEI 239 (323)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~-~p~~~~~~~ 239 (323)
.....||+.|+|||.+.. ..++.++||||+|+++|||++|. +|+......
T Consensus 171 ----------------------------~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~ 221 (285)
T d1fmka3 171 ----------------------------RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221 (285)
T ss_dssp ---------------------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ----------------------------eccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 112356899999999987 56899999999999999999965 555555555
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc--CCCCc
Q 036739 240 DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE--HEYFR 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~--h~~~~ 317 (323)
+.+..+.+... .+....+++.+.++|.+||+.||++||++.+|++ ++||+
T Consensus 222 ~~~~~i~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 222 EVLDQVERGYR----------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHHHHhcCC----------------------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 55555443211 1122457899999999999999999999999998 89997
Q ss_pred cc
Q 036739 318 DV 319 (323)
Q Consensus 318 ~~ 319 (323)
..
T Consensus 274 ~~ 275 (285)
T d1fmka3 274 ST 275 (285)
T ss_dssp CS
T ss_pred CC
Confidence 65
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=346.07 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=192.7
Q ss_pred CCcceeeeeccccceeEEEEEEccCC----ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTN----ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|+||.||+|....++ ..||+|.+.... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 47899999999999999999876554 369999985432 2223456889999999999999999999999999999
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+|+||+.+ ++.+.+... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||++......
T Consensus 86 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~-~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCCCC-------
T ss_pred EEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe-EEEcccchhhcccCC
Confidence 99999987 445444443 346788899999999999999999999999999999999999887 999999999775432
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCC-CCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPL-FPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p-~~~ 235 (323)
...... .....||+.|+|||.+.+ ..++.++|||||||++|||++|..| +..
T Consensus 164 ~~~~~~--------------------------~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~ 216 (283)
T d1mqba_ 164 PEATYT--------------------------TSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWE 216 (283)
T ss_dssp ------------------------------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CccceE--------------------------eccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCcccc
Confidence 221110 111245889999999988 6789999999999999999996544 555
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
....+....+.+... .+....+++.+.+||.+||+.||++||++.+|++
T Consensus 217 ~~~~~~~~~i~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 217 LSNHEVMKAINDGFR----------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CCHHHHHHHHHTTCC----------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHhccCC----------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 554444444332111 1122347788999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=347.74 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=194.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCC---ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTN---ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|+||+||+|++..++ ..||+|.+... ......+.+.+|+.++++++||||+++++++. ++.+++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 58999999999999999999976544 35778876332 22333467889999999999999999999995 567899
Q ss_pred EEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCc
Q 036739 79 VFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~ 157 (323)
||||+.+ ++.+.+... ...+++..+..++.||+.||.|||+++++||||||+||+++.++. +||+|||++.......
T Consensus 85 v~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~-~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-EEECC-----------
T ss_pred EEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc-EEEccchhheeccCCc
Confidence 9999976 666655543 346789999999999999999999999999999999999999887 9999999997654322
Q ss_pred ccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCC
Q 036739 158 RTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGD 236 (323)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~ 236 (323)
.... ....||+.|+|||.+.. ..++.++|||||||++|||++ |.+||...
T Consensus 163 ~~~~----------------------------~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~ 213 (273)
T d1mp8a_ 163 YYKA----------------------------SKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGV 213 (273)
T ss_dssp ------------------------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ceec----------------------------cceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCC
Confidence 2111 11255889999999987 568999999999999999998 89999988
Q ss_pred ChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 237 SEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
...+....+.+... .+..+.+|+.+.+||.+||+.||++|||+.+|++|
T Consensus 214 ~~~~~~~~i~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 214 KNNDVIGRIENGER----------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 88777766543211 11234588999999999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=349.49 Aligned_cols=252 Identities=20% Similarity=0.304 Sum_probs=198.8
Q ss_pred CCcceeeeeccccceeEEEEEEccCCc----eEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNE----TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++++.||+|+||+||+|.+..+|+ +||+|.+... ......+.+.+|+.++++++||||+++++++.++.. +
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-Q 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE-E
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-e
Confidence 579999999999999999999877776 5777776433 334456788999999999999999999999987654 5
Q ss_pred EEEecc-hhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYL-DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~-~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
++++++ +|++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++......
T Consensus 87 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~-~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE-EEECCCSHHHHTTTT
T ss_pred EEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC-eEeeccccceecccc
Confidence 566666 568888777653 35789999999999999999999999999999999999999887 999999999876433
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||+| |.+||..
T Consensus 165 ~~~~~---------------------------~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 165 EKEYH---------------------------AEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp CC-----------------------------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccc---------------------------ccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 22111 111256899999999988 568999999999999999998 7899988
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
....+....+.+.... +....+++.+.+||.+||+.||++|||+.+|++|
T Consensus 217 ~~~~~~~~~i~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 217 IPASEISSILEKGERL----------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp SCGGGHHHHHHHTCCC----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHcCCCC----------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 7766655555442111 1123478899999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=340.13 Aligned_cols=245 Identities=23% Similarity=0.374 Sum_probs=197.2
Q ss_pred CCCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec-CceEEEE
Q 036739 1 MDQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKKLYLV 79 (323)
Q Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 79 (323)
+++|++.+.||+|+||.||+|+. +|..||+|+++. ....+.+.+|+.++++++||||+++++++.+ .+.+++|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCC----CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECc----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 47899999999999999999997 578899999843 2345788999999999999999999999854 5668999
Q ss_pred Eecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcc
Q 036739 80 FEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~ 158 (323)
|||+++ +|.+.+.......+++..+..++.||+.||.|||+.+++||||||+||+++.++. +|++|||.+........
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~-~kl~dfg~s~~~~~~~~ 158 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQD 158 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC-EEECCCCC---------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC-EeecccccceecCCCCc
Confidence 999965 8888876554445788999999999999999999999999999999999999988 99999999876532211
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCCCC
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPGDS 237 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~~~ 237 (323)
. ..+++.|+|||.+.+ ..++.++||||||+++|||+| |.+||....
T Consensus 159 ~--------------------------------~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~ 205 (262)
T d1byga_ 159 T--------------------------------GKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205 (262)
T ss_dssp -----------------------------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred c--------------------------------ccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCC
Confidence 1 134778999999987 568999999999999999998 788888877
Q ss_pred hHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 238 EIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
..+....+.+.. .......+++.+.+||.+||+.||++|||+.+++++
T Consensus 206 ~~~~~~~i~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 206 LKDVVPRVEKGY----------------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp GGGHHHHHTTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCC----------------------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 766665553211 112234578899999999999999999999999873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=339.32 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=196.1
Q ss_pred CCcceeeeeccccceeEEEEEEccC-C--ceEEEEEEEeccc-CCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT-N--ETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~-~--~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (323)
++|++.+.||+|+||+||+|+.... + ..||+|++..... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5799999999999999999985433 2 3689998865543 23334678899999999999999999999965 4678
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCC
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~ 156 (323)
+||||+++ ++.+.+..... .+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~-vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQN 164 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE-EEECCCTTCEECCC-
T ss_pred eeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc-eeeccchhhhhcccC
Confidence 99999975 77766655433 5789999999999999999999999999999999999999886 999999999876543
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHh-CCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVN-QRPLFPG 235 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~t-g~~p~~~ 235 (323)
...... .....|++.|+|||.+.+ ..++.++||||||+++|||+| |..||.+
T Consensus 165 ~~~~~~--------------------------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 165 DDHYVM--------------------------QEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp CCEEEC-------------------------------CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCccee--------------------------cCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCC
Confidence 332211 111245788999999988 668999999999999999998 8999999
Q ss_pred CChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 236 DSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
.+..+....+.+.... .+....+++.+.+||.+||+.||++|||+.+|++
T Consensus 218 ~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 218 LNGSQILHKIDKEGER---------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCHHHHHHHHHTSCCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHhCCCC---------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8887777665432111 1122457899999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-48 Score=337.57 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=205.0
Q ss_pred CCcceeeeeccccceeEEEEEEcc-----CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|+||+||+|+.+. +++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 689999999999999999999753 45789999885432 222346788999999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 036739 77 YLVFEYLDL-DLKKHMDSCP----------------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNL 133 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~----------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Ni 133 (323)
++++|++.+ +|.+.+.... ...+++..+..++.||+.||+|||+++++||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 999999965 7777775432 12367888999999999999999999999999999999
Q ss_pred EEecCCCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCc
Q 036739 134 LIDRRTNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTP 213 (323)
Q Consensus 134 l~~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 213 (323)
+++.++. +||+|||++........... .....|++.|+|||.+.. ..++.+
T Consensus 172 Lld~~~~-~Kl~DFGls~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~~~~-~~~t~k 222 (301)
T d1lufa_ 172 LVGENMV-VKIADFGLSRNIYSADYYKA---------------------------DGNDAIPIRWMPPESIFY-NRYTTE 222 (301)
T ss_dssp EECGGGC-EEECCCSCHHHHTGGGCBC-------------------------------CCBCGGGCCHHHHHH-CCCCHH
T ss_pred EECCCCc-EEEccchhheeccCCccccc---------------------------cCCCCcCcCcCCHHHHcc-CCCChh
Confidence 9999887 99999999876532221111 112356888999999988 678999
Q ss_pred hhhHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHH
Q 036739 214 VDVWSVGCIFAEMVNQR-PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292 (323)
Q Consensus 214 ~Di~slG~ll~~l~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 292 (323)
+|||||||++|||++|. +||......+....+.... .......+++.+.+|
T Consensus 223 sDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~----------------------------~~~~p~~~~~~~~~l 274 (301)
T d1lufa_ 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN----------------------------ILACPENCPLELYNL 274 (301)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC----------------------------CCCCCTTCCHHHHHH
T ss_pred hhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCccchHHHHHH
Confidence 99999999999999985 6888887777766654321 011224578899999
Q ss_pred HHhhcccCCCCCCCHhhhhc
Q 036739 293 LSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 293 i~~~l~~dp~~R~s~~~il~ 312 (323)
|.+||+.||++|||+.+|++
T Consensus 275 i~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 275 MRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=338.10 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=202.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCce--EEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCceEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNET--IALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 78 (323)
++|++.+.||+|+||+||+|+++.++.. ||+|.+... ......+.+.+|+.++.++ +||||+++++++.+++.+++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc-cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 6899999999999999999999888774 666766433 2334557899999999999 69999999999999999999
Q ss_pred EEecchh-hHHHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceE
Q 036739 79 VFEYLDL-DLKKHMDSC--------------PDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALK 143 (323)
Q Consensus 79 v~e~~~g-~l~~~~~~~--------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~k 143 (323)
||||++| +|.+.+... ....+++..+..++.||+.||.|||+.+++||||||+|||++.++. +|
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~-~k 167 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AK 167 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-EE
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc-eE
Confidence 9999975 888777543 2356789999999999999999999999999999999999999887 99
Q ss_pred EeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHH
Q 036739 144 LADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIF 223 (323)
Q Consensus 144 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll 223 (323)
|+|||++.......... ...||..|+|||.+.. ..++.++||||||+++
T Consensus 168 l~DfG~a~~~~~~~~~~------------------------------~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil 216 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKKT------------------------------MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLL 216 (309)
T ss_dssp ECCTTCEESSCEECCC----------------------------------CCTTTCCHHHHHH-CEECHHHHHHHHHHHH
T ss_pred Ecccccccccccccccc------------------------------ceecCCcccchHHhcc-CCCCccceeehhHHHH
Confidence 99999987643222211 1245888999999987 5689999999999999
Q ss_pred HHHHhCC-CCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCC
Q 036739 224 AEMVNQR-PLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPS 302 (323)
Q Consensus 224 ~~l~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~ 302 (323)
|||++|. +||...+..+....+.+.. .......+++.+.+||.+||+.||+
T Consensus 217 ~ell~~~~~p~~~~~~~~~~~~i~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~ 268 (309)
T d1fvra_ 217 WEIVSLGGTPYCGMTCAELYEKLPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPY 268 (309)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHGGGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGG
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHhcC----------------------------CCCCCccCCHHHHHHHHHHcCCChh
Confidence 9999965 6787777666555443211 1112235789999999999999999
Q ss_pred CCCCHhhhhcC
Q 036739 303 RRITARSALEH 313 (323)
Q Consensus 303 ~R~s~~~il~h 313 (323)
+|||+.+|++|
T Consensus 269 ~RPs~~eil~~ 279 (309)
T d1fvra_ 269 ERPSFAQILVS 279 (309)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999985
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=337.13 Aligned_cols=255 Identities=22% Similarity=0.353 Sum_probs=192.1
Q ss_pred CCcceeeeeccccceeEEEEEEccC-----CceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEec-Cc
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVT-----NETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS-EK 74 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~ 74 (323)
++|++.+.||+|+||.||+|++... ++.||+|++..... ......+.+|...+.++ +|+||+.+++++.. +.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 6799999999999999999997543 35799998854322 22234566677777766 68999999998765 45
Q ss_pred eEEEEEecchh-hHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCC
Q 036739 75 KLYLVFEYLDL-DLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT 139 (323)
Q Consensus 75 ~~~lv~e~~~g-~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~ 139 (323)
.+++||||++| +|.+.+.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence 78999999975 8887775432 23468889999999999999999999999999999999999988
Q ss_pred CceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHH
Q 036739 140 NALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSV 219 (323)
Q Consensus 140 ~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 219 (323)
. +||+|||++........... .....||+.|+|||.+.+ ..++.++||||+
T Consensus 172 ~-~Kl~DFGla~~~~~~~~~~~---------------------------~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~ 222 (299)
T d1ywna1 172 V-VKICDFGLARDIYKDPDYVR---------------------------KGDARLPLKWMAPETIFD-RVYTIQSDVWSF 222 (299)
T ss_dssp C-EEECC------CCSCTTSCC---------------------------TTSCCCGGGGCCHHHHHH-CCCCHHHHHHHH
T ss_pred c-EEEccCcchhhccccccccc---------------------------cCceeeCccccchhHhhc-CCCCcccceeeh
Confidence 7 99999999976543222111 112356999999999988 668999999999
Q ss_pred HHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcc
Q 036739 220 GCIFAEMVNQ-RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLC 298 (323)
Q Consensus 220 G~ll~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~ 298 (323)
||++|||++| .+||......+.+.........+ .....+++.+.++|.+||+
T Consensus 223 Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~ 275 (299)
T d1ywna1 223 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWH 275 (299)
T ss_dssp HHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcC
Confidence 9999999986 56888776655555444321111 1123478899999999999
Q ss_pred cCCCCCCCHhhhhcC
Q 036739 299 MDPSRRITARSALEH 313 (323)
Q Consensus 299 ~dp~~R~s~~~il~h 313 (323)
.||++|||+.++++|
T Consensus 276 ~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 276 GEPSQRPTFSELVEH 290 (299)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhHCcCHHHHHHH
Confidence 999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=335.48 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=199.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCC-------ceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecC
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTN-------ETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE 73 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 73 (323)
++|++.+.||+|+||.||+|+...++ ..||+|++.... .......+.+|...+.++ +||||+++++++.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 68999999999999999999875544 379999885443 222346777888888888 799999999999999
Q ss_pred ceEEEEEecchh-hHHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC
Q 036739 74 KKLYLVFEYLDL-DLKKHMDSCP--------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138 (323)
Q Consensus 74 ~~~~lv~e~~~g-~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~ 138 (323)
+..++||||+++ ++.+.+.... ...+++..+..++.||+.||+|||+.+++||||||+|||++.+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCC
Confidence 999999999975 8888876543 2357899999999999999999999999999999999999998
Q ss_pred CCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 139 TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 139 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
+. +||+|||.+........... .....|++.|+|||.+.+ ..++.++||||
T Consensus 172 ~~-~kl~dfg~~~~~~~~~~~~~---------------------------~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS 222 (299)
T d1fgka_ 172 NV-MKIADFGLARDIHHIDYYKK---------------------------TTNGRLPVKWMAPEALFD-RIYTHQSDVWS 222 (299)
T ss_dssp CC-EEECSTTCCCCGGGCCTTCC---------------------------CTTSCCGGGGSCHHHHHH-CCCCHHHHHHH
T ss_pred CC-eEeccchhhccccccccccc---------------------------cccCCCChhhhhhhHhcC-CCCCchhhhHH
Confidence 87 99999999977643222111 111355889999999987 67899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 219 VGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 219 lG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
||+++|+|++ |.+||......+....+.+... ......+++.+.+||.+||
T Consensus 223 ~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~----------------------------~~~p~~~~~~l~~li~~cl 274 (299)
T d1fgka_ 223 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR----------------------------MDKPSNCTNELYMMMRDCW 274 (299)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHT
T ss_pred hHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCC----------------------------CCCCccchHHHHHHHHHHc
Confidence 9999999998 7899988776655544332111 1112357899999999999
Q ss_pred ccCCCCCCCHhhhhc
Q 036739 298 CMDPSRRITARSALE 312 (323)
Q Consensus 298 ~~dp~~R~s~~~il~ 312 (323)
+.||++|||+.+|++
T Consensus 275 ~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 275 HAVPSQRPTFKQLVE 289 (299)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCCHhHCcCHHHHHH
Confidence 999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=334.98 Aligned_cols=262 Identities=22% Similarity=0.311 Sum_probs=210.9
Q ss_pred CCcceeeeeccccceeEEEEEEcc-----CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecCceE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCV-----TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKKL 76 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (323)
++|++.+.||+|+||+||+|++.. .+..||+|++.... .......+.+|+.++++++||||+++++.+..+...
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 689999999999999999998753 35689999885332 222335688999999999999999999999999999
Q ss_pred EEEEecchh-hHHHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 77 YLVFEYLDL-DLKKHMDSCP--------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 77 ~lv~e~~~g-~l~~~~~~~~--------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
++||||+.+ ++.+.+.... ...++...+.+++.|++.||.|||+++|+||||||+|||++.++. +||+||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~-~Kl~DF 177 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDF 177 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC-EEECCT
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce-EEEeec
Confidence 999999964 7776664321 234578889999999999999999999999999999999998887 999999
Q ss_pred ccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHH
Q 036739 148 GLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMV 227 (323)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~ 227 (323)
|++........... .....||+.|+|||.+.+ ..++.++|+||||+++|||+
T Consensus 178 Gla~~~~~~~~~~~---------------------------~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~ 229 (308)
T d1p4oa_ 178 GMTRDIYETDYYRK---------------------------GGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIA 229 (308)
T ss_dssp TCCCGGGGGGCEEG---------------------------GGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred ccceeccCCcceee---------------------------ccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHH
Confidence 99876532222111 111356899999999988 56889999999999999999
Q ss_pred hC-CCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCC
Q 036739 228 NQ-RPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRIT 306 (323)
Q Consensus 228 tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s 306 (323)
|| ..||......+....+.+.. .......+++.+.++|.+||+.||++|||
T Consensus 230 t~~~~p~~~~~~~~~~~~i~~~~----------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs 281 (308)
T d1p4oa_ 230 TLAEQPYQGLSNEQVLRFVMEGG----------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPS 281 (308)
T ss_dssp HTSCCTTTTSCHHHHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hCCCCCCCCCCHHHHHHHHHhCC----------------------------CCCCcccchHHHHHHHHHHcCCChhHCcC
Confidence 98 58888887777666554321 11122457889999999999999999999
Q ss_pred Hhhhhc------CCCCccccc
Q 036739 307 ARSALE------HEYFRDVEF 321 (323)
Q Consensus 307 ~~~il~------h~~~~~~~~ 321 (323)
+.+|++ +|+|+++.|
T Consensus 282 ~~~il~~L~~~~~~~~~~~~~ 302 (308)
T d1p4oa_ 282 FLEIISSIKEEMEPGFREVSF 302 (308)
T ss_dssp HHHHHHHHGGGSCTTHHHHCS
T ss_pred HHHHHHHHHHhcCCCCcCCCC
Confidence 999997 888887755
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-47 Score=329.34 Aligned_cols=266 Identities=20% Similarity=0.217 Sum_probs=201.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC-eeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN-IVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||+||+|++..+|+.||+|++.... ....+..|+++++.++|++ |+.+..++.+++..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 57999999999999999999999999999999876542 2346788999999998665 556667677888999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC--CCceEEeccccceecCCCcc
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR--TNALKLADFGLARAFGIPVR 158 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~--~~~~kl~df~~~~~~~~~~~ 158 (323)
|+++|++...+..... .+++..+..++.|++.||+|||++||+||||||+||+++.. +..++|+|||++........
T Consensus 83 e~~~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 83 ELLGPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp ECCCCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEcCCchhhhhhhccC-CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 9999988887765443 57899999999999999999999999999999999998542 23599999999988754333
Q ss_pred cccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCCh
Q 036739 159 TFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSE 238 (323)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~ 238 (323)
....... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.....
T Consensus 162 ~~~~~~~----------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 162 HQHIPYR----------------------ENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp CCBCCCC----------------------BCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred ccceecc----------------------ccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence 2211110 1112467999999999988 5689999999999999999999999987665
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhh---hcCCC
Q 036739 239 IDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSA---LEHEY 315 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~i---l~h~~ 315 (323)
.+......+...... ..........+|+.+.++|..||+.||++||++.++ |+|+|
T Consensus 219 ~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 219 ATKRQKYERISEKKM---------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp ------HHHHHHHHH---------------------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhcccC---------------------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 444332221100000 000112234688999999999999999999998744 56665
Q ss_pred C
Q 036739 316 F 316 (323)
Q Consensus 316 ~ 316 (323)
.
T Consensus 278 ~ 278 (299)
T d1ckia_ 278 H 278 (299)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=330.48 Aligned_cols=251 Identities=21% Similarity=0.264 Sum_probs=192.1
Q ss_pred eeeeccccceeEEEEEEccCC---ceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEec-CceEEEEEec
Q 036739 7 VEKIGEGTYGVVYKARNCVTN---ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKKLYLVFEY 82 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~ 82 (323)
.+.||+|+||+||+|+...++ ..||+|.+... .+....+.+.+|++++++++||||+++++++.+ ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 568999999999999975543 36899988532 233344678999999999999999999999764 5789999999
Q ss_pred chhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEeccccceecCCCcccccc
Q 036739 83 LDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162 (323)
Q Consensus 83 ~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~~~~~~~~~~~ 162 (323)
++++.+..+........+...+..++.|++.||.|||+.+|+||||||+|||++.++. +||+|||++............
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~-~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC-EEECSSGGGCCTTTTTCCCTT
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC-EEEecccchhhccccccccce
Confidence 9874444444444546678888899999999999999999999999999999998887 999999999876543322211
Q ss_pred cccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCCChH-HH
Q 036739 163 EHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGDSEI-DE 241 (323)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~~~~-~~ 241 (323)
... ...||+.|+|||.+.. ..++.++||||||+++|||++|..||...... +.
T Consensus 190 ~~~-------------------------~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~ 243 (311)
T d1r0pa_ 190 NKT-------------------------GAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243 (311)
T ss_dssp CTT-------------------------CSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------C
T ss_pred ecc-------------------------cccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH
Confidence 111 1245899999999887 56899999999999999999977776554333 22
Q ss_pred HHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhcC
Q 036739 242 LFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALEH 313 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~h 313 (323)
...+.+... ......+++.+.+||.+||+.||++||++.+|++|
T Consensus 244 ~~~i~~g~~----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 244 TVYLLQGRR----------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCC----------------------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 333322110 01123478899999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=329.47 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=204.4
Q ss_pred CCcceeeeeccccceeEEEEEEc-----cCCceEEEEEEEecccCCCCchhHHHHHHHHHhc-CCCCeeeeeEEEecCce
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNC-----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKK 75 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 75 (323)
++|++.+.||+|+||.||+|+.. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++.+...
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 68899999999999999999853 355689999985432 222345788899999999 69999999999999999
Q ss_pred EEEEEecchh-hHHHhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC
Q 036739 76 LYLVFEYLDL-DLKKHMDSCP----------------DFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR 138 (323)
Q Consensus 76 ~~lv~e~~~g-~l~~~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~ 138 (323)
.++||||+.| ++.+.+.... ...+++..+..++.||+.||.|||+++++||||||+||+++.+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc
Confidence 9999999975 7777765432 2357888999999999999999999999999999999999988
Q ss_pred CCceEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHH
Q 036739 139 TNALKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWS 218 (323)
Q Consensus 139 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 218 (323)
+. +|++|||.+.......... ......||+.|+|||.+.. ..++.++||||
T Consensus 182 ~~-~ki~DfG~~~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS 232 (311)
T d1t46a_ 182 RI-TKICDFGLARDIKNDSNYV---------------------------VKGNARLPVKWMAPESIFN-CVYTFESDVWS 232 (311)
T ss_dssp TE-EEECCCGGGSCTTSCTTSE---------------------------ECSSSEECGGGCCHHHHHH-CCCCHHHHHHH
T ss_pred Cc-ccccccchheeccCCCcce---------------------------EeeecccChHHcCHHHhcC-CCCCCcccccc
Confidence 87 9999999997654322211 1122467999999999987 67899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhc
Q 036739 219 VGCIFAEMVN-QRPLFPGDSEIDELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKML 297 (323)
Q Consensus 219 lG~ll~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 297 (323)
|||++|+|+| |.+||......+.+.++.+....+ ......++.+.+||.+||
T Consensus 233 ~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl 285 (311)
T d1t46a_ 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCW 285 (311)
T ss_dssp HHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHT
T ss_pred hHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHc
Confidence 9999999998 667777776666666555432111 111347889999999999
Q ss_pred ccCCCCCCCHhhhhc
Q 036739 298 CMDPSRRITARSALE 312 (323)
Q Consensus 298 ~~dp~~R~s~~~il~ 312 (323)
+.||++|||+.+|++
T Consensus 286 ~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 286 DADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CCChhHCcCHHHHHH
Confidence 999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.3e-46 Score=323.06 Aligned_cols=259 Identities=19% Similarity=0.219 Sum_probs=204.3
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCC-CCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH-GNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 80 (323)
++|++.+.||+|+||+||+|++..+|+.||+|++.... ....+.+|++.++.++| +|++.+++++.++...++||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 58999999999999999999999999999999875432 23567889999999975 89999999999999999999
Q ss_pred ecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecC----CCceEEeccccceecCCC
Q 036739 81 EYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR----TNALKLADFGLARAFGIP 156 (323)
Q Consensus 81 e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~----~~~~kl~df~~~~~~~~~ 156 (323)
|+++|++.+.+..... .++...+..++.|++.||++||++||+||||||+||+++.. ...+||+|||++......
T Consensus 81 e~~~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 81 DLLGPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp ECCCCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EecCCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 9999999888765443 57889999999999999999999999999999999999752 224999999999887544
Q ss_pred cccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHHHHHHHHhCCCCCCCC
Q 036739 157 VRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGCIFAEMVNQRPLFPGD 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ll~~l~tg~~p~~~~ 236 (323)
.......... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 160 ~~~~~~~~~~----------------------~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 160 VTKQHIPYRE----------------------KKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp TTCCBCCCCC----------------------CCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccceeecc----------------------cCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 3322211111 112367999999999988 67899999999999999999999999865
Q ss_pred ChH---HHHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHHHHhhcccCCCCCCCHhhhhc
Q 036739 237 SEI---DELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDLLSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 237 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~s~~~il~ 312 (323)
... ....++....... ......+.+++.+.+++..|+..+|++||+...+.+
T Consensus 217 ~~~~~~~~~~~i~~~~~~~------------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 217 KAATNKQKYERIGEKKQST------------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp CSCCHHHHHHHHHHHHHHS------------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cchhHHHHHHHHHhccCCC------------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 433 2222222211000 011223457889999999999999999998766543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-45 Score=326.93 Aligned_cols=281 Identities=26% Similarity=0.419 Sum_probs=200.9
Q ss_pred CcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-----------CCCeeeeeEEEe
Q 036739 3 QYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-----------HGNIVRLQDVVH 71 (323)
Q Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~ 71 (323)
+|++++.||+|+||+||+|++..+|+.||+|++..... ..+.+.+|+.+++.+. |+||+++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~---~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc---chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 69999999999999999999999999999999864421 2256677888888775 578999998886
Q ss_pred c--CceEEEEEecc--hhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEecCCC-----c
Q 036739 72 S--EKKLYLVFEYL--DLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTN-----A 141 (323)
Q Consensus 72 ~--~~~~~lv~e~~--~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~~~Nil~~~~~~-----~ 141 (323)
. ....++++.++ .++............+++..++.++.||+.||.|||+ .||+|+||||+|||++.++. .
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 4 34555555555 4455555566666678999999999999999999997 89999999999999987654 4
Q ss_pred eEEeccccceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCCCCCCchhhHHHHH
Q 036739 142 LKLADFGLARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSRHYSTPVDVWSVGC 221 (323)
Q Consensus 142 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 221 (323)
++++|||.+........ ...||+.|+|||.+.. ..++.++|+||+||
T Consensus 171 ~kl~dfg~s~~~~~~~~--------------------------------~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~ 217 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHYT--------------------------------NSIQTREYRSPEVLLG-APWGCGADIWSTAC 217 (362)
T ss_dssp EEECCCTTCEETTBCCC--------------------------------SCCSCGGGCCHHHHHT-CCCCTHHHHHHHHH
T ss_pred eeEeecccccccccccc--------------------------------cccccccccChhhccc-cCCCccccccchHH
Confidence 89999999876532211 1256899999999987 56899999999999
Q ss_pred HHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCCCCCCCCcccCCc---------ccccCCCCCC----Ccccccc
Q 036739 222 IFAEMVNQRPLFPGDSE------IDELFKIFRVLGTPNEDTWPGVTSLPD---------FKSAFPKWPS----KELGTVV 282 (323)
Q Consensus 222 ll~~l~tg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~----~~~~~~~ 282 (323)
++++|++|+.||..... .+........++............... .......+.. .......
T Consensus 218 il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (362)
T d1q8ya_ 218 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297 (362)
T ss_dssp HHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC
T ss_pred HHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccC
Confidence 99999999999975432 233444444444322111100000000 0000000000 0011122
Q ss_pred cCCChHHHHHHHhhcccCCCCCCCHhhhhcCCCCccc
Q 036739 283 RNLEPAGIDLLSKMLCMDPSRRITARSALEHEYFRDV 319 (323)
Q Consensus 283 ~~~s~~~~~li~~~l~~dp~~R~s~~~il~h~~~~~~ 319 (323)
...++.+.+||.+||..||++|||++|+|+||||+++
T Consensus 298 ~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 298 KDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred cccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 3456789999999999999999999999999999976
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=317.16 Aligned_cols=259 Identities=20% Similarity=0.239 Sum_probs=185.1
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCeeeeeEEEecC----ceEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE----KKLY 77 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~ 77 (323)
++|.+.+.||+|+||+||+|+. +|..||+|++..... .......|+..+..++||||+++++++.++ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 5789999999999999999985 788999998853321 112233355555678999999999999754 3689
Q ss_pred EEEecchh-hHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCcEEEecCCCceEEeccc
Q 036739 78 LVFEYLDL-DLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHS--------HRVLHRDLKPQNLLIDRRTNALKLADFG 148 (323)
Q Consensus 78 lv~e~~~g-~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--------~~i~H~dl~~~Nil~~~~~~~~kl~df~ 148 (323)
+||||+++ +|.+.+.+. .+++..+..++.|++.||+|||+ +||+||||||+|||++.++. +||+|||
T Consensus 78 lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~-~Kl~DFG 153 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC-EEECCCT
T ss_pred EEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC-eEEEecC
Confidence 99999965 777777654 46888889999999999999996 59999999999999999887 9999999
Q ss_pred cceecCCCcccccccccCCcCcceeehhhhhhhccCccceeeccccccccccchhhhCCC-----CCCCchhhHHHHHHH
Q 036739 149 LARAFGIPVRTFTHEHWGSTGISIYFSFLRYRVLAGSLILQFLKVVTLWYRAPEILLGSR-----HYSTPVDVWSVGCIF 223 (323)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-----~~~~~~Di~slG~ll 223 (323)
++............. .....||+.|+|||++.+.. .++.++|||||||++
T Consensus 154 l~~~~~~~~~~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl 208 (303)
T d1vjya_ 154 LAVRHDSATDTIDIA-------------------------PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp TCEEEETTTTEECC-----------------------------CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred ccccccCCCcceecc-------------------------ccceecccCcCChhhccccccccCCCcCcchhhhhhHHHH
Confidence 998765433221111 11236799999999987632 246689999999999
Q ss_pred HHHHhCCCCCCCCChHH-----------HHHHHHHHhCCCCCCCCCCcccCCcccccCCCCCCCcccccccCCChHHHHH
Q 036739 224 AEMVNQRPLFPGDSEID-----------ELFKIFRVLGTPNEDTWPGVTSLPDFKSAFPKWPSKELGTVVRNLEPAGIDL 292 (323)
Q Consensus 224 ~~l~tg~~p~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 292 (323)
|||+||..||....... ....+........ +....+ ...........+.+|
T Consensus 209 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~p~~~--~~~~~~~~~~~l~~l 270 (303)
T d1vjya_ 209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----------------LRPNIP--NRWQSCEALRVMAKI 270 (303)
T ss_dssp HHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----------------CCCCCC--GGGGGCHHHHHHHHH
T ss_pred HHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccc----------------cCCCCC--cccCChHHHHHHHHH
Confidence 99999988774322110 0111111110000 000000 000011123458899
Q ss_pred HHhhcccCCCCCCCHhhhhc
Q 036739 293 LSKMLCMDPSRRITARSALE 312 (323)
Q Consensus 293 i~~~l~~dp~~R~s~~~il~ 312 (323)
+.+||+.||++|||+.+|++
T Consensus 271 i~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 271 MRECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHTTCCSSGGGSCCHHHHHH
T ss_pred HHHHcccCHhHCcCHHHHHH
Confidence 99999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.2e-23 Score=169.73 Aligned_cols=136 Identities=17% Similarity=0.174 Sum_probs=103.3
Q ss_pred cceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCC----------------CchhHHHHHHHHHhcCCCCeeeee
Q 036739 4 YEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEG----------------VPSTAIREISLLKEMQHGNIVRLQ 67 (323)
Q Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~----------------~~~~~~~e~~~l~~l~~~~i~~~~ 67 (323)
+.+.+.||+|+||+||+|++ .+|+.||+|++........ .......|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 45789999999999999998 4789999998754321100 012234577888999999998887
Q ss_pred EEEecCceEEEEEecchhhHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEecCCCceEEecc
Q 036739 68 DVVHSEKKLYLVFEYLDLDLKKHMDSCPDFANDPRLIKTFLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADF 147 (323)
Q Consensus 68 ~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~~~Nil~~~~~~~~kl~df 147 (323)
+.. . .+++||++++.....+ +...+..++.|++.+|.+||++|++|+||||+|||++.+ . ++|+||
T Consensus 81 ~~~--~--~~lvme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~-~~liDF 146 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-G-IWIIDF 146 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-E-EEECCC
T ss_pred Eec--C--CEEEEEeeccccccch--------hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-C-EEEEEC
Confidence 654 2 3799999988544332 223356899999999999999999999999999999854 3 899999
Q ss_pred ccceecC
Q 036739 148 GLARAFG 154 (323)
Q Consensus 148 ~~~~~~~ 154 (323)
|.+....
T Consensus 147 G~a~~~~ 153 (191)
T d1zara2 147 PQSVEVG 153 (191)
T ss_dssp TTCEETT
T ss_pred CCcccCC
Confidence 9987654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.69 E-value=2.5e-07 Score=76.27 Aligned_cols=139 Identities=17% Similarity=0.161 Sum_probs=91.6
Q ss_pred CCcceeeeeccccceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcC-CCCeeeeeEEEecCceEEEEE
Q 036739 2 DQYEKVEKIGEGTYGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKKLYLVF 80 (323)
Q Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 80 (323)
+.|++++..+.++.+.||++. .++..+++|....... .....+..|...++.++ +--+++++.+..+++..++||
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 567777776666667899986 4667788887643322 23456778888888885 333677888888888999999
Q ss_pred ecchhhHH-HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 036739 81 EYLDLDLK-KHMDSCPDFANDPRLIKTFLYQILRGIAYCHS--------------------------------------- 120 (323)
Q Consensus 81 e~~~g~l~-~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--------------------------------------- 120 (323)
++++|... +...... . ...++.+++..+..||+
T Consensus 90 ~~l~G~~~~~~~~~~~----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 90 SEADGVLCSEEYEDEQ----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp ECCSSEEHHHHTTTCS----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred Eecccccccccccccc----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99988333 2221110 1 11223333333444432
Q ss_pred --------------C------CcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 121 --------------H------RVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 121 --------------~------~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
. .++|+|+.|.||+++.++. +.|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~-~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV-SGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEE-EEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCce-EEEeechhccc
Confidence 1 2789999999999986443 67999998865
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.18 E-value=1.1e-05 Score=65.77 Aligned_cols=71 Identities=14% Similarity=0.107 Sum_probs=50.5
Q ss_pred eeccccc-eeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCC--eeeeeEEEecCceEEEEEecchh
Q 036739 9 KIGEGTY-GVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN--IVRLQDVVHSEKKLYLVFEYLDL 85 (323)
Q Consensus 9 ~lg~g~~-~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~g 85 (323)
.+..|.. +.||++.. ..+..+++|.... .....+..|...++.+...+ +++++....+.+..++||++++|
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~-----~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLS-----GALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECS-----CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCc-----cCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 4455554 67899985 4566788886532 22356778888888885433 57778888888889999999975
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.02 E-value=2.4e-05 Score=68.12 Aligned_cols=77 Identities=18% Similarity=0.150 Sum_probs=49.1
Q ss_pred eeeeccccceeEEEEEEccCCceEEEEEEEeccc--C---CCCchhHHHHHHHHHhcC-C--CCeeeeeEEEecCceEEE
Q 036739 7 VEKIGEGTYGVVYKARNCVTNETIALKKIRLEQE--D---EGVPSTAIREISLLKEMQ-H--GNIVRLQDVVHSEKKLYL 78 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~---~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~~~~~~l 78 (323)
.+.||.|....||++.+..+++.+++|.-..... . .........|.+.++.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 5678999999999999877788899996533211 1 112344566888887773 2 346666654 3445678
Q ss_pred EEecchh
Q 036739 79 VFEYLDL 85 (323)
Q Consensus 79 v~e~~~g 85 (323)
|||++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999965
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.59 E-value=0.00016 Score=62.70 Aligned_cols=71 Identities=13% Similarity=0.207 Sum_probs=48.7
Q ss_pred eeeeccccceeEEEEEEcc-------CCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCe-eeeeEEEecCceEEE
Q 036739 7 VEKIGEGTYGVVYKARNCV-------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-VRLQDVVHSEKKLYL 78 (323)
Q Consensus 7 ~~~lg~g~~~~v~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~l 78 (323)
++.|+.|....+|++.... .++.|.+++.. . ........+|..+++.+.-.++ +++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N---PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C---cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 5678889999999998643 23567788763 2 2223456678899988864444 567777743 57
Q ss_pred EEecchh
Q 036739 79 VFEYLDL 85 (323)
Q Consensus 79 v~e~~~g 85 (323)
|+||+.|
T Consensus 119 I~efi~g 125 (395)
T d1nw1a_ 119 LEEYIPS 125 (395)
T ss_dssp EECCCCE
T ss_pred EEEEecc
Confidence 8899865
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.14 E-value=0.00023 Score=59.66 Aligned_cols=31 Identities=29% Similarity=0.278 Sum_probs=26.4
Q ss_pred CCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 121 ~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
.|++|||+.+.||+++.+.. .-++||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v-~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDEL-SGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEE-EEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccc-eeEeccccccc
Confidence 37999999999999997543 68999998865
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.79 E-value=0.00061 Score=57.26 Aligned_cols=131 Identities=13% Similarity=0.096 Sum_probs=74.3
Q ss_pred ceeEEEEEEccCCceEEEEEEEecccCCCCchhHHHHHHHHHhcCCCCee--eee-----EEEecCceEEEEEecchh--
Q 036739 15 YGVVYKARNCVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV--RLQ-----DVVHSEKKLYLVFEYLDL-- 85 (323)
Q Consensus 15 ~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~--~~~-----~~~~~~~~~~lv~e~~~g-- 85 (323)
...||+++. .+|..|++|+.... ....+.+..|...+..+...++. ... ..+..++..+.+++++.|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 468999986 57888999987532 12346677888888887533321 111 112345678888888753
Q ss_pred -------------hHHHhhhc---CCC----CCC-------------------CH---HHHHHHHHHHHHHHHHHHh---
Q 036739 86 -------------DLKKHMDS---CPD----FAN-------------------DP---RLIKTFLYQILRGIAYCHS--- 120 (323)
Q Consensus 86 -------------~l~~~~~~---~~~----~~~-------------------~~---~~~~~i~~qi~~~L~~LH~--- 120 (323)
.++..+.. ... ... +. ......+.++...+...-.
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 11111111 000 011 11 1122233333333333221
Q ss_pred -CCcccCCCCCCcEEEecCCCceEEecccccee
Q 036739 121 -HRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (323)
Q Consensus 121 -~~i~H~dl~~~Nil~~~~~~~~kl~df~~~~~ 152 (323)
.+++|||+.+.||+++. + ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~-~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRD-G--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESS-S--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeC-C--ceEEechhccc
Confidence 36899999999999963 3 45899998865
|